Citrus Sinensis ID: 047901
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 786 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.938 | 0.706 | 0.487 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.968 | 0.679 | 0.438 | 1e-180 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.938 | 0.670 | 0.363 | 1e-125 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.938 | 0.669 | 0.353 | 1e-114 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.961 | 0.605 | 0.331 | 1e-108 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.916 | 0.634 | 0.350 | 1e-107 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.926 | 0.647 | 0.330 | 1e-106 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.924 | 0.637 | 0.337 | 1e-106 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.921 | 0.578 | 0.329 | 1e-104 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.966 | 0.708 | 0.320 | 1e-104 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/770 (48%), Positives = 510/770 (66%), Gaps = 32/770 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + N+ L L L N+L+G IPPE+G + + L++S N+ +
Sbjct: 288 LDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLT 347
Query: 88 GTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G P L+ L+++ L +N+LSG IP I N +L+ L LDTN FTG LP ICR G
Sbjct: 348 GPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGK 407
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
LE LT++DNHF G +P +LR+C+SL+R N+ +G+ISE FG+YP L F+DLS+NNF+
Sbjct: 408 LENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFH 467
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
G++S+NW + +L I+S N+ITG IPPEI N +QL LDLSSN I GE+P + +
Sbjct: 468 GQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINR 527
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
++KL L GN+LSG +P + LLT LEY DLSSNR ++ I L + +L+Y+N S N
Sbjct: 528 ISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLD 587
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
Q IPE L L+ L LDLS+N G I S+ +L++LE+L+LSHNN+SGQIP F M
Sbjct: 588 QTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLA 647
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGN-----NFSTFYG------TSDLLSHKEA 434
L +D+S+N L+GPIP++ FRNAP ++F GN + +T G TS SHK+
Sbjct: 648 LTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKD- 706
Query: 435 SKKTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDG 494
+ IL P++GA+ +L V + FR+ + + S +T IF FDG
Sbjct: 707 -RNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIF----SFDG 761
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN--DQMSDQKE 552
K+ Y+EII+ T +FD KY IG G H VY+AKLP+ +AVKK N + S ++E
Sbjct: 762 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 820
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM 612
FLNEI+ALT+IRHRN+VK +GFCSH R++F+VYEY+ RGSL VL N+ ++ DW KR+
Sbjct: 821 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 880
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
NV+ GVA ALSYMHHD P IVHRDISS N+LL +YEA++SDFGTAKLLKP+SSNW+ +
Sbjct: 881 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 940
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
GT+GYVAP ELAY MK+TEKCDVYSFGVL LEVIKG+HPGD +S SSS
Sbjct: 941 AGTYGYVAP----------ELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSP 990
Query: 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ ++ DHRLP P+ +++E+++ I++VALLCL P +RPTM ++
Sbjct: 991 PDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1627), Expect = e-180, Method: Compositional matrix adjust.
Identities = 355/809 (43%), Positives = 500/809 (61%), Gaps = 48/809 (5%)
Query: 6 INLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGK 65
+ L++ L G++ S + +L L L N G +PP++ N+ + L L+ N+L+G
Sbjct: 323 LELSNNKLTGSIPS-SLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGS 381
Query: 66 IPP------------------------EIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLK 100
IP E+G + + +LDLS N+ +G+ P N + L+
Sbjct: 382 IPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLE 441
Query: 101 YISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGS 160
+ L N LSG+IP + N L+ L+LDTN FTG P +C+ L+ ++++ NH G
Sbjct: 442 SLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGP 501
Query: 161 IP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLG 219
IP +LR+C+SL+RA N TG+I E FGIYP+L F+D SHN F+GEISSNW K +LG
Sbjct: 502 IPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLG 561
Query: 220 TLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH 279
LI+S NNITG IP EI N +QL LDLS+N++ GE+P +G L +L++L L GNQLSG
Sbjct: 562 ALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGR 621
Query: 280 LPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS 339
+P L LT LE DLSSN ++ I + KL +N S N+F IP L+ L L+
Sbjct: 622 VPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQLT 680
Query: 340 ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGP 399
+LDLSHN G IPS++ +L+SL+KL+LSHNN+SG IP F GM L ++DIS N+L GP
Sbjct: 681 QLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGP 740
Query: 400 IPNSTVFRNAPRESFLGN-NFSTFYGTSDLLSHKE--ASKKTPFLILFPLLGALALLIVY 456
+P++ FR A ++ N + L +E KK L+++ L+ L +L++
Sbjct: 741 LPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVIL 800
Query: 457 VVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGK 516
+ F R + Q ++ +T G S+ DGK Y++II T +FD + IG
Sbjct: 801 SICANTFTYCIRKRKLQNGRNTDPET-GENMSIFSVDGKFKYQDIIESTNEFDPTHLIGT 859
Query: 517 GEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSD---QKEFLNEIKALTKIRHRNIVKFYG 573
G + VYRA L IAVK+ + ++++S ++EFLNE+KALT+IRHRN+VK +G
Sbjct: 860 GGYSKVYRANL-QDTIIAVKRLHDTI-DEEISKPVVKQEFLNEVKALTEIRHRNVVKLFG 917
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
FCSH RH+F++YEY+ +GSL +L+N+ ++ W KR+NV+ GVA ALSYMHHD PI
Sbjct: 918 FCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPI 977
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
VHRDISS N+LLD +Y A++SDFGTAKLLK +SSNW+ + GT+GYVAP E
Sbjct: 978 VHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAP----------EF 1027
Query: 694 AYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLD 753
AYTMK+TEKCDVYSFGVL LE+I GKHPGD +S SSS + ++ D R+ P
Sbjct: 1028 AYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA-LSLRSISDERVLEPRGQ 1086
Query: 754 VQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+EKL+ ++E+ALLCL P SRPTM ++
Sbjct: 1087 NREKLLKMVEMALLCLQANPESRPTMLSI 1115
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 285/783 (36%), Positives = 421/783 (53%), Gaps = 45/783 (5%)
Query: 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSG 88
A +D S N G +P + ++ LK L L EN L G IP E+G LT L LDLS+N+ +G
Sbjct: 310 AEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNG 369
Query: 89 TFPPICNLSNLKYI---SLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG 145
T P L L Y+ L +N+L G IP IG S L + N +G +P + CR
Sbjct: 370 TIPQ--ELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQ 427
Query: 146 LLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
L +L++ N G+IP +L+ C+SL + LG N LTG++ + NL L+L N
Sbjct: 428 TLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWL 487
Query: 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
G IS++ GK L L ++ NN TG IPPEIGN +++ ++SSN + G IP ELG +
Sbjct: 488 SGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCV 547
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
++ +L L GN+ SG++ + LG L LE LS NRL I + G + +L L N
Sbjct: 548 TIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLL 607
Query: 325 SQEIPEDLALLAHLS-ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGM 383
S+ IP +L L L L++SHN G+IP + NL+ LE L L+ N +SG+IPA +
Sbjct: 608 SENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNL 667
Query: 384 SGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF---STFYGTSDLLSHKEA------ 434
LL +IS N L G +P++ VF+ +F GN+ S L+ H ++
Sbjct: 668 MSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLI 727
Query: 435 --SKKTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDF 492
S++ L + ++ LI ++ + + +R + + ++ T+ F
Sbjct: 728 NGSQRQKILTITCIVIGSVFLITFLGLCWTIKR-----REPAFVALEDQTKPDVMDSYYF 782
Query: 493 DGK-IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQK 551
K Y+ ++ T++F +G+G +VY+A++ G+ IAVKK NS + S
Sbjct: 783 PKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNS--RGEGASSDN 840
Query: 552 EFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR 611
F EI L KIRHRNIVK YGFC H + ++YEY+++GSL L + DW R
Sbjct: 841 SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNAR 900
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-SSNWT 670
+ G A+ L Y+HHDC P IVHRDI SNN+LLD ++A V DFG AKL+ + S + +
Sbjct: 901 YRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS 960
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-------GD 723
+ G++GY+AP E AYTMK+TEKCD+YSFGV+ LE+I GK P GD
Sbjct: 961 AVAGSYGYIAP----------EYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD 1010
Query: 724 FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783
++ S ++ I M D RL ++ ++++AL C P SRPTM+ V
Sbjct: 1011 LVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVV 1069
Query: 784 QLL 786
++
Sbjct: 1070 AMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1057), Expect = e-114, Method: Compositional matrix adjust.
Identities = 286/809 (35%), Positives = 423/809 (52%), Gaps = 71/809 (8%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L +L L NG GT+P ++ NLS +D SEN L+G+IP E+G + L L L NQ +
Sbjct: 291 LEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLT 350
Query: 88 GTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
GT P + L NL + L N L+G IP L L L L N +G +P +
Sbjct: 351 GTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSD 410
Query: 147 LEILTVNDNHFLGSIPNLRNCRS-LVRAHLGRNNLTGNISEDF----------------- 188
L +L ++DNH G IP+ S ++ +LG NNL+GNI
Sbjct: 411 LWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLV 470
Query: 189 GIYP-------NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ 241
G +P N+ ++L N F G I G C L L ++ N TG +P EIG SQ
Sbjct: 471 GRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQ 530
Query: 242 LHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301
L L++SSN + GE+P E+ L +L + N SG LP +G L +LE LS+N L+
Sbjct: 531 LGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLS 590
Query: 302 NSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS-ELDLSHNLFKGSIPSRICNLE 360
+I ALG + +L L N F+ IP +L L L L+LS+N G IP + NL
Sbjct: 591 GTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLV 650
Query: 361 SLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN-- 418
LE L L++NN+SG+IP+ F +S LL + SYN L GPIP + RN SF+GN
Sbjct: 651 MLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGL 707
Query: 419 ----FSTFYGTSDLLSHKEASK------KTPFLILFPLLGALALLIVYVVMVFMFRRWKR 468
+ T + K I ++G ++L+++ ++ V++ RR R
Sbjct: 708 CGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALI-VYLMRRPVR 766
Query: 469 D--SQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAK 526
S +Q S+ F F +++++ T +FD + +G+G +VY+A
Sbjct: 767 TVASSAQDGQPSEMSLDIYFPPKEGFT----FQDLVAATDNFDESFVVGRGACGTVYKAV 822
Query: 527 LPSGDKIAVKKFNSPFPNDQMSD-QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585
LP+G +AVKK S ++ F EI L IRHRNIVK +GFC+H + ++Y
Sbjct: 823 LPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLY 882
Query: 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL 645
EY+ +GSL +L + S + DW KR + G A L+Y+HHDC P I HRDI SNN+LL
Sbjct: 883 EYMPKGSLGEILHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILL 940
Query: 646 DLEYEARVSDFGTAKLLK-PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCD 704
D ++EA V DFG AK++ P+S + + + G++GY+AP E AYTMK+TEK D
Sbjct: 941 DDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP----------EYAYTMKVTEKSD 990
Query: 705 VYSFGVLALEVIKGKHP-------GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEK 757
+YS+GV+ LE++ GK P GD ++ S + + +LD RL +
Sbjct: 991 IYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSH 1049
Query: 758 LISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+++++++ALLC P +RP+M+ V +L
Sbjct: 1050 MLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1010), Expect = e-108, Method: Compositional matrix adjust.
Identities = 284/858 (33%), Positives = 417/858 (48%), Gaps = 102/858 (11%)
Query: 13 LKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGL 72
L+GTL S S+ +L +L L N G LP ++ L KL+ L L EN SG+IP EIG
Sbjct: 396 LEGTLSP-SISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGN 454
Query: 73 LTHLFSLDLSLNQFSGTFPP-------------------------ICNLSNLKYISLHNN 107
T L +D+ N F G PP + N L + L +N
Sbjct: 455 CTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADN 514
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLP------RNICR--------SGLLEILT-- 151
+LSGSIP G L L LML N G LP RN+ R +G + L
Sbjct: 515 QLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGS 574
Query: 152 -------VNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNN 203
V +N F IP L N ++L R LG+N LTG I G L LD+S N
Sbjct: 575 SSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNA 634
Query: 204 FYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL 263
G I C +L + ++ N ++G IPP +G SQL L LSSN +P EL
Sbjct: 635 LTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNC 694
Query: 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ 323
L L L GN L+G +P+ +G L L +L N+ + S+ +A+G + KL+ L S N
Sbjct: 695 TKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNS 754
Query: 324 FSQEIPEDLALLAHL-SELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIG 382
+ EIP ++ L L S LDLS+N F G IPS I L LE L+LSHN ++G++P
Sbjct: 755 LTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGD 814
Query: 383 MSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN---FSTFYGTSDLLSHKE----AS 435
M L +++S+N L G + F P +SFLGN S + + S+ + ++
Sbjct: 815 MKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSA 872
Query: 436 KKTPFLILFPLLGALALLIVYVVMVFMFRR--WKRDSQSQGSCSSKNDTRGIFHSVLDFD 493
+ + L A+ L+I+ + + F R +K+ + +S + + H L +
Sbjct: 873 RSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN 932
Query: 494 GK----IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSD 549
G I +E+I+ T + ++ IG G VY+A+L +G+ +AVKK D +
Sbjct: 933 GASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI---LWKDDLMS 989
Query: 550 QKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--SFVVYEYINRGSLATVLSNN-----FA 602
K F E+K L +IRHR++VK G+CS + ++YEY+ GS+ L +
Sbjct: 990 NKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKK 1049
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
+ DW R+ + G+A + Y+HHDC PPIVHRDI S+NVLLD EA + DFG AK+L
Sbjct: 1050 KKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL 1109
Query: 663 KPNSSNWTE----LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG 718
N T+ ++GY+AP E AY++K TEK DVYS G++ +E++ G
Sbjct: 1110 TENCDTNTDSNTWFACSYGYIAP----------EYAYSLKATEKSDVYSMGIVLMEIVTG 1159
Query: 719 KHPGDFLSLFSSSSSSI-----NIEFNAMLDHRLPHPSLD-----VQEKLISIMEVALLC 768
K P D S+F + + ++E +L P L ++ ++E+AL C
Sbjct: 1160 KMPTD--SVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQC 1217
Query: 769 LDGCPNSRPTMQTVCQLL 786
P RP+ + C L
Sbjct: 1218 TKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1004), Expect = e-107, Method: Compositional matrix adjust.
Identities = 279/796 (35%), Positives = 402/796 (50%), Gaps = 76/796 (9%)
Query: 18 QEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLF 77
+E F L +DLS+N F GT+P NLS L+ L LS N ++G IP + T L
Sbjct: 317 EEIGF--MKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLV 374
Query: 78 SLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQ 136
+ NQ SG PP I L L NKL G+IP+E+ L L L N TG
Sbjct: 375 QFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGS 434
Query: 137 LPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLK 195
LP + + L L + N G IP + NC SLVR L N +TG I + G NL
Sbjct: 435 LPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLS 494
Query: 196 FLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255
FLDLS NN G + C +L L +S N + G +P + + ++L VLD+SSN + G+
Sbjct: 495 FLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGK 554
Query: 256 IPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF 315
IP LG LISLN+LIL N +G +P +LG T L+ DLSSN ++ +I E L F +
Sbjct: 555 IPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEEL---FDIQ 611
Query: 316 YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375
L+ + L+LS N G IP RI L L L++SHN +SG
Sbjct: 612 DLDIA--------------------LNLSWNSLDGFIPERISALNRLSVLDISHNMLSGD 651
Query: 376 IPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN-------FSTFYGTSDL 428
+ A G+ L+S++IS+N G +P+S VFR GNN S F S
Sbjct: 652 LSA-LSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQ 710
Query: 429 LSHKEASKKTPFLILFPLLGAL--ALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIF 486
L+ + I LL ++ L ++ V+ V ++ RD + + +
Sbjct: 711 LTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTP 770
Query: 487 HSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKF---NSPFP 543
L+F E +++ + + IGKG VY+A++P+ + IAVKK P
Sbjct: 771 FQKLNF----TVEHVLKCLVEGNV---IGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNL 823
Query: 544 NDQMSD---QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN 600
N++ + F E+K L IRH+NIV+F G C + ++Y+Y++ GSL ++L
Sbjct: 824 NEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHER 883
Query: 601 FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660
W R +I G A L+Y+HHDC PPIVHRDI +NN+L+ ++E + DFG AK
Sbjct: 884 SGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAK 943
Query: 661 LLK----PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI 716
L+ SSN + G++GY+AP +G Y+MKITEK DVYS+GV+ LEV+
Sbjct: 944 LVDDGDFARSSN--TIAGSYGYIAPEYG----------YSMKITEKSDVYSYGVVVLEVL 991
Query: 717 KGKHP-----GDFLSLFSSSSSSINIEFNAMLDHRL-PHPSLDVQEKLISIMEVALLCLD 770
GK P D L + +I+ ++D L P +V+E ++ + VALLC++
Sbjct: 992 TGKQPIDPTIPDGLHIVDWVKKIRDIQ---VIDQGLQARPESEVEE-MMQTLGVALLCIN 1047
Query: 771 GCPNSRPTMQTVCQLL 786
P RPTM+ V +L
Sbjct: 1048 PIPEDRPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (994), Expect = e-106, Method: Compositional matrix adjust.
Identities = 275/833 (33%), Positives = 413/833 (49%), Gaps = 105/833 (12%)
Query: 13 LKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGL 72
L GT+ + + +D S N G +P ++ +S+L+ L L +N+L+G IP E+
Sbjct: 313 LNGTIPK-ELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSK 371
Query: 73 LTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN 131
L +L LDLS+N +G PP NL++++ + L +N LSG IP+ +G L + N
Sbjct: 372 LRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSEN 431
Query: 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGI 190
Q +G++P IC+ L +L + N G+IP + C+SL++ + N LTG +
Sbjct: 432 QLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCK 491
Query: 191 YPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSN 250
NL ++L N F G + G C +L L ++ N + +P EI S L ++SSN
Sbjct: 492 LVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSN 551
Query: 251 HIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF 310
+ G IP E+ L +L L N G LP LG L +LE LS NR
Sbjct: 552 SLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENR----------- 600
Query: 311 MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSR--------------- 355
FS IP + L HL+EL + NLF GSIP +
Sbjct: 601 -------------FSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSY 647
Query: 356 ----------ICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTV 405
I NL L L+L++N++SG+IP F +S LL + SYN L G +P++ +
Sbjct: 648 NDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQI 707
Query: 406 FRNAPRESFLGN-------------NFSTFYGTSDLLSHKEASKKTPFLILFPLLGALAL 452
F+N SFLGN + S++ S L K S + +I+ +
Sbjct: 708 FQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSL---KAGSARRGRIIIIVSSVIGGI 764
Query: 453 LIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFH-SVLDFDGKIMY--EEIIRRTKDFD 509
++ + +V F R + + + +D F S + F K + ++I+ TK F
Sbjct: 765 SLLLIAIVVHFLR----NPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFH 820
Query: 510 AKYCIGKGEHRSVYRAKLPSGDKIAVKKFN---SPFPNDQMSDQKEFLNEIKALTKIRHR 566
Y +G+G +VY+A +PSG IAVKK N+ + F EI L KIRHR
Sbjct: 821 DSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHR 880
Query: 567 NIVKFYGFCSH--VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
NIV+ Y FC H + ++YEY++RGSL +L S DW R + G A+ L+Y
Sbjct: 881 NIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSHSMDWPTRFAIALGAAEGLAY 939
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK-PNSSNWTELVGTFGYVAPAH 683
+HHDC P I+HRDI SNN+L+D +EA V DFG AK++ P S + + + G++GY+AP
Sbjct: 940 LHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAP-- 997
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
E AYTMK+TEKCD+YSFGV+ LE++ GK P L ++ N +
Sbjct: 998 --------EYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTR---NHIR 1046
Query: 744 DHRLPHPSLD----------VQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
DH L LD + +I++ ++A+LC P+ RPTM+ V +L
Sbjct: 1047 DHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (993), Expect = e-106, Method: Compositional matrix adjust.
Identities = 271/804 (33%), Positives = 400/804 (49%), Gaps = 77/804 (9%)
Query: 36 NGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-IC 94
N G++P ++ L+KL+ L L +N L G IP EIG ++L +DLSLN SG+ P I
Sbjct: 284 NSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG 343
Query: 95 NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND 154
LS L+ + +NK SGSIP I N L L LD NQ +G +P + L +
Sbjct: 344 RLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWS 403
Query: 155 NHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWG 213
N GSIP L +C L L RN+LTG I + NL L L N+ G I G
Sbjct: 404 NQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIG 463
Query: 214 KCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRG 273
C L L + N ITG IP IG+ +++ LD SSN + G++P E+G L + L
Sbjct: 464 NCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSN 523
Query: 274 NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLA 333
N L G LP + L+ L+ D+S+N+ + I +LG + L L S N FS IP L
Sbjct: 524 NSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLG 583
Query: 334 LLAHLSELDLSHNLFKGSIPSRICNLESLE-KLNLSHNNISGQIP--------------- 377
+ + L LDL N G IPS + ++E+LE LNLS N ++G+IP
Sbjct: 584 MCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLS 643
Query: 378 --------ACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN----------F 419
A + L+S++ISYN G +P++ +FR + GN F
Sbjct: 644 HNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCF 703
Query: 420 STFYGTSDLLSHKEAS--KKTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCS 477
T+ + L +AS +K + + + L+I+ V V RR D++
Sbjct: 704 LTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARR-NIDNERDSELG 762
Query: 478 SKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKK 537
+ L+F ++IIR + + IGKG VYRA + +G+ IAVKK
Sbjct: 763 ETYKWQFTPFQKLNFS----VDQIIRCLVEPNV---IGKGCSGVVYRADVDNGEVIAVKK 815
Query: 538 FNSPFPNDQMSDQKE-----FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592
N ++ + F E+K L IRH+NIV+F G C + ++Y+Y+ GS
Sbjct: 816 LWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS 875
Query: 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR 652
L ++L S DW R ++ G A L+Y+HHDC PPIVHRDI +NN+L+ L++E
Sbjct: 876 LGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPY 934
Query: 653 VSDFGTAKLLKPNSSNWTE--LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
++DFG AKL+ + G++GY+AP +G Y+MKITEK DVYS+GV
Sbjct: 935 IADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYG----------YSMKITEKSDVYSYGV 984
Query: 711 LALEVIKGKHPGD--------FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIM 762
+ LEV+ GK P D + + S+ + LD L + ++++ ++
Sbjct: 985 VVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEV-----LDSTLRSRTEAEADEMMQVL 1039
Query: 763 EVALLCLDGCPNSRPTMQTVCQLL 786
ALLC++ P+ RPTM+ V +L
Sbjct: 1040 GTALLCVNSSPDERPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 379 bits (973), Expect = e-104, Method: Compositional matrix adjust.
Identities = 269/817 (32%), Positives = 403/817 (49%), Gaps = 93/817 (11%)
Query: 36 NGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-IC 94
N F G +P ++ N ++L+ +D N LSG+IP IG L L L L N+ G P +
Sbjct: 443 NRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLG 502
Query: 95 NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN-------------- 140
N + I L +N+LSGSIP G L L M+ N G LP +
Sbjct: 503 NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSS 562
Query: 141 ---------ICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGI 190
+C S V +N F G IP L +L R LG+N TG I FG
Sbjct: 563 NKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGK 622
Query: 191 YPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSN 250
L LD+S N+ G I G C +L + ++ N ++G IP +G L L LSSN
Sbjct: 623 ISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSN 682
Query: 251 HIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF 310
G +P E+ L ++ L L GN L+G +P+ +G L L +L N+L+ + +G
Sbjct: 683 KFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGK 742
Query: 311 MFKLFYLNFSHNQFSQEIPEDLALLAHL-SELDLSHNLFKGSIPSRICNLESLEKLNLSH 369
+ KLF L S N + EIP ++ L L S LDLS+N F G IPS I L LE L+LSH
Sbjct: 743 LSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSH 802
Query: 370 NNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLL 429
N + G++P M L +++SYN L G + F ++F+GN + G+ L
Sbjct: 803 NQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGN--AGLCGSP--L 856
Query: 430 SH---------KEASKKTPFLILFPLLGALALLIVYVVMVFMFRRWKRD--SQSQGSCSS 478
SH + S KT +++ + +LA + + V+++ +F + D + +G S+
Sbjct: 857 SHCNRAGSKNQRSLSPKT--VVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSA 914
Query: 479 KNDTRGIFHSVLDFDG----KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIA 534
+ + L +G I +++I+ T + ++ IG G VY+A+L +G+ IA
Sbjct: 915 FSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIA 974
Query: 535 VKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--SFVVYEYINRGS 592
VKK + +D MS+ K F E+K L IRHR++VK G+CS + ++YEY+ GS
Sbjct: 975 VKKI--LWKDDLMSN-KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGS 1031
Query: 593 LATVL---SNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649
+ L N E W R+ + G+A + Y+H+DC PPIVHRDI S+NVLLD
Sbjct: 1032 VWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNI 1091
Query: 650 EARVSDFGTAKLLKPNSSNWTE----LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDV 705
EA + DFG AK+L N TE G++GY+AP E AY++K TEK DV
Sbjct: 1092 EAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAP----------EYAYSLKATEKSDV 1141
Query: 706 YSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLI------ 759
YS G++ +E++ GK P + ++F + + +LD P + +EKLI
Sbjct: 1142 YSMGIVLMEIVTGKMPTE--AMFDEETDMVRW-VETVLD---TPPGSEAREKLIDSELKS 1195
Query: 760 ----------SIMEVALLCLDGCPNSRPTMQTVCQLL 786
++E+AL C P RP+ + + L
Sbjct: 1196 LLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 379 bits (973), Expect = e-104, Method: Compositional matrix adjust.
Identities = 276/860 (32%), Positives = 415/860 (48%), Gaps = 100/860 (11%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
+ ++ ++GL G++ +F + +L L L GT+PPQ+ S+L+ L L N+L
Sbjct: 214 LTTLGFAASGLSGSIPS-TFGNLVNLQTLALYDTEISGTIPPQLGLCSELRNLYLHMNKL 272
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
+G IP E+G L + SL L N SG PP I N S+L + N L+G IP ++G L+
Sbjct: 273 TGSIPKELGKLQKITSLLLWGNSLSGVIPPEISNCSSLVVFDVSANDLTGDIPGDLGKLV 332
Query: 122 KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNL 180
L L L N FTGQ+P + L L ++ N GSIP+ + N +SL L N++
Sbjct: 333 WLEQLQLSDNMFTGQIPWELSNCSSLIALQLDKNKLSGSIPSQIGNLKSLQSFFLWENSI 392
Query: 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNW------------------------GKCH 216
+G I FG +L LDLS N G I KC
Sbjct: 393 SGTIPSSFGNCTDLVALDLSRNKLTGRIPEELFSLKRLSKLLLLGNSLSGGLPKSVAKCQ 452
Query: 217 RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQL 276
L L V N ++G+IP EIG L LDL NH +G +P E+ + L L + N +
Sbjct: 453 SLVRLRVGENQLSGQIPKEIGELQNLVFLDLYMNHFSGGLPYEISNITVLELLDVHNNYI 512
Query: 277 SGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMF------------------------ 312
+G +P LG L LE DLS N +I + G +
Sbjct: 513 TGDIPAQLGNLVNLEQLDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQ 572
Query: 313 KLFYLNFSHNQFSQEIPEDLALLAHLS-ELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
KL L+ S+N S EIP++L + L+ LDLS+N F G+IP +L L+ L+LS N+
Sbjct: 573 KLTLLDLSYNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNS 632
Query: 372 ISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGN-NFSTFYGTSDLLS 430
+ G I ++ L S++IS N GPIP++ F+ S+L N N S
Sbjct: 633 LHGDI-KVLGSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCHSLDGITCSS 691
Query: 431 H--KEASKKTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHS 488
H + K+P ++ AL +I+ + + + W ++ + ++ +
Sbjct: 692 HTGQNNGVKSPKIV------ALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPST 745
Query: 489 VLDFDGK----------IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKF 538
DF I I+ D + IGKG VY+A++P+GD +AVKK
Sbjct: 746 AEDFSYPWTFIPFQKLGITVNNIVTSLTD---ENVIGKGCSGIVYKAEIPNGDIVAVKKL 802
Query: 539 NSPFPNDQMSDQK--EFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATV 596
N++ + F EI+ L IRHRNIVK G+CS+ ++Y Y G+L +
Sbjct: 803 WKTKDNNEEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQL 862
Query: 597 LSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDF 656
L N + DW R + G A L+Y+HHDC P I+HRD+ NN+LLD +YEA ++DF
Sbjct: 863 LQGN---RNLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADF 919
Query: 657 GTAKLL--KPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLAL 713
G AKL+ PN N + + G++GY+AP +G YTM ITEK DVYS+GV+ L
Sbjct: 920 GLAKLMMNSPNYHNAMSRVAGSYGYIAPEYG----------YTMNITEKSDVYSYGVVLL 969
Query: 714 EVIKGKHP-----GDFLSLFSSSSSSINIEFNAM--LDHRLPHPSLDVQEKLISIMEVAL 766
E++ G+ GD L + + A+ LD +L + ++++ + +A+
Sbjct: 970 EILSGRSAVEPQIGDGLHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAM 1029
Query: 767 LCLDGCPNSRPTMQTVCQLL 786
C++ P RPTM+ V LL
Sbjct: 1030 FCVNPSPVERPTMKEVVTLL 1049
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 786 | ||||||
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.944 | 0.718 | 0.540 | 0.0 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.941 | 0.712 | 0.530 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.941 | 0.742 | 0.530 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.944 | 0.718 | 0.536 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.940 | 0.712 | 0.522 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.941 | 0.686 | 0.520 | 0.0 | |
| 186511602 | 1045 | Leucine-rich repeat-containing protein [ | 0.938 | 0.706 | 0.487 | 0.0 | |
| 7267528 | 1027 | receptor protein kinase-like protein [Ar | 0.938 | 0.718 | 0.485 | 0.0 | |
| 297813345 | 1019 | hypothetical protein ARALYDRAFT_489780 [ | 0.938 | 0.724 | 0.487 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.946 | 0.738 | 0.510 | 0.0 |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/768 (54%), Positives = 530/768 (69%), Gaps = 26/768 (3%)
Query: 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQF 86
HL L LS N G +P + +LS LK L L +N+LSG IP E+G L L L++S NQ
Sbjct: 279 HLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQL 338
Query: 87 SGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG 145
+G+ P + NL NL+ + L +NKLS SIP EIG L KL L +DTNQ +G LP IC+ G
Sbjct: 339 NGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGG 398
Query: 146 LLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
LE TV DN +G IP +L+NC SL RA L RN LTGNISE FG+ PNL ++LS+N F
Sbjct: 399 SLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKF 458
Query: 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
YGE+S NWG+CH+L L ++GNNITG IP + G S+QL VL+LSSNH+ GEIP +LG +
Sbjct: 459 YGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVS 518
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
SL KLIL N+LSG++P LG L +L Y DLS NRLN SI E LG L YLN S+N+
Sbjct: 519 SLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKL 578
Query: 325 SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMS 384
S IP + L+HLS LDLSHNL G IPS+I L+SLEKLNLSHNN+SG IP F M
Sbjct: 579 SHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMH 638
Query: 385 GLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLL------SHKEASKKT 438
GL +DISYN+L+G IPNS F+N E GN G+ L S + + K
Sbjct: 639 GLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGN--KGLCGSVKGLQPCENRSATKGTHKA 696
Query: 439 PFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMY 498
F+I+F LLGAL +L + + + + + +R+++ + + + T +F S+ FDG+ Y
Sbjct: 697 VFIIIFSLLGALLILSAF-IGISLISQGRRNAKMEKAGDVQ--TENLF-SISTFDGRTTY 752
Query: 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
E II TKDFD YCIG+G H SVY+A+LPSG+ +AVKK + F D M+ QK+F+NEI+
Sbjct: 753 EAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDID-MAHQKDFMNEIR 810
Query: 559 ALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV 618
ALT+I+HRNIVK GFCSH RHSF+VYEY+ RGSL T+LS +++ W R+N+I GV
Sbjct: 811 ALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGV 870
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
A ALSY+HHDC PPIVHRDISSNNVLLD +YEA VSDFGTAK LK +SSNW+ L GT+GY
Sbjct: 871 AHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGY 930
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
VAP ELAYTMK+TEKCDVYSFGVLALEV++G+HPGD +S S+S N+
Sbjct: 931 VAP----------ELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVV 980
Query: 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+LD RLP P+L + +++S++++A CL+G P SRPTMQ V Q+L
Sbjct: 981 LKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/771 (53%), Positives = 518/771 (67%), Gaps = 31/771 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + +LS L L L N+LSG IP EIG L L L+LS NQ +
Sbjct: 283 LQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLN 342
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G+ P + NL+NL+ + L +N+LSG IP+EIG L KL L +DTNQ G LP IC++G
Sbjct: 343 GSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGS 402
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
L V+DNH G IP +L+NCR+L RA N LTGNISE G PNL+F+DLS+N F+
Sbjct: 403 LVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFH 462
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
GE+S NWG+C +L L ++GNNITG IP + G S+ L +LDLSSNH+ GEIP ++G L S
Sbjct: 463 GELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTS 522
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L LIL NQLSG +P LG L+ LEY DLS+NRLN SI E LG L YLN S+N+ S
Sbjct: 523 LLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLS 582
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
IP + L+HLS+LDLSHNL G IP +I L+SLE L+LSHNN+ G IP F M
Sbjct: 583 HGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPA 642
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGN-----NFSTF----YGTSDLLSHKEASK 436
L +DISYN+L+GPIP+S FRNA E GN N YG + S
Sbjct: 643 LSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSH 702
Query: 437 KTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKI 496
K F+I+FPLLGAL LL ++ + + R +R + + + D + S+ +FDG+
Sbjct: 703 KVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIE-----EGDVQNDLFSISNFDGRT 757
Query: 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND-QMSDQKEFLN 555
MYEEII+ TKDFD YCIGKG H SVY+A+LPS + +AVKK + P+D +M++QK+FLN
Sbjct: 758 MYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PSDTEMANQKDFLN 814
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
EI+ALT+I+HRNIVK GFCSH RH F+VYEY+ RGSLAT+LS A + W R+N+I
Sbjct: 815 EIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEAKK-LGWATRVNII 873
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
GVA AL+YMHHDC PPIVHRD+SSNN+LLD +YEA +SDFGTAKLLK +SSN + L GT
Sbjct: 874 KGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGT 933
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
FGY+AP ELAYTMK+TEK DV+SFGV+ALEVIKG+HPGD + S S
Sbjct: 934 FGYLAP----------ELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKD 983
Query: 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
NI MLD RLP + + ++I+I++ A+ CL P SRPTMQTV Q+L
Sbjct: 984 NIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1926), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/771 (53%), Positives = 521/771 (67%), Gaps = 31/771 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + +LS L L L N+LSG IP EIG L L L+LS NQ +
Sbjct: 241 LQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLN 300
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G+ P + NL+NL+ + L +N+LSG IP+EIG L KL L +DTNQ G LP IC+ G
Sbjct: 301 GSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGS 360
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
LE TV+DNH G IP +L+NC++L RA G N LTGNISE G PNL+++++S+N+F+
Sbjct: 361 LERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFH 420
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
GE+S NWG+ RL L ++ NNITG IP + G S+ L +LDLSSNH+ GEIP ++G + S
Sbjct: 421 GELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTS 480
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L KLIL NQLSG++P LG L +L Y DLS+NRLN SI E LG L YLN S+N+ S
Sbjct: 481 LWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLS 540
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
IP + L HLS+LDLSHNL G IP +I L+SLE LNLSHNN+SG IP F M G
Sbjct: 541 HGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLG 600
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGN-----NFSTF----YGTSDLLSHKEASK 436
L +DISYN+L+GPIPNS FR+A E+ GN N YG+ + S
Sbjct: 601 LSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSH 660
Query: 437 KTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKI 496
K F+I+FPLLGAL LL ++ + + R +R + + + + + S+ FDG+
Sbjct: 661 KVVFIIIFPLLGALVLLFAFIGIFLIAARRERTPEIK-----EGEVQNDLFSISTFDGRT 715
Query: 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND-QMSDQKEFLN 555
MYEEII+ TKDFD YCIGKG H SVY+A+LPS + +AVKK + P+D +M++QK+FLN
Sbjct: 716 MYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PSDTEMANQKDFLN 772
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
EI+ALT+I+HRNIVK GFCSH RH F+VYEY+ RGSLAT+LS A + W R+N+I
Sbjct: 773 EIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEAKK-LGWATRVNII 831
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
GVA AL+YMHHDC PPIVHRDISSNN+LLD +YEA +SDFGTAKLLK +SSN + L GT
Sbjct: 832 KGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGT 891
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
FGY+AP ELAYTMK+TEK DV+SFGV+ALEVIKG+HPGD + S S
Sbjct: 892 FGYLAP----------ELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKD 941
Query: 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
NI MLD RLP + + ++I+I++ A CL P SRPTMQTV Q+L
Sbjct: 942 NIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/768 (53%), Positives = 526/768 (68%), Gaps = 26/768 (3%)
Query: 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQF 86
HL L LS N G +P + +LS LK L L +N+LSG IP E+G L L L++S NQ
Sbjct: 279 HLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQL 338
Query: 87 SGTFPPIC-NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG 145
+G+ P + NL NL+ + L +NKLS SIP EIG L KL L +DTNQ +G LP IC+ G
Sbjct: 339 NGSIPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGG 398
Query: 146 LLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
LE TV DN +G IP +L+NC SL RA L N LTGNISE FG+ PNL ++LS+N F
Sbjct: 399 SLENFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKF 458
Query: 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
YGE+S NWG+CH+L L ++GNNITG IP + G S+QL VL+LSSNH+ GEIP +LG +
Sbjct: 459 YGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVS 518
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
SL KLIL N+LSG++P LG L +L Y DLS NRLN SI E LG L YLN S+N+
Sbjct: 519 SLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKL 578
Query: 325 SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMS 384
S IP + L+HLS LDLSHNL G IPS+I L+SLEKLNLSHNN+SG IP F M
Sbjct: 579 SHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMH 638
Query: 385 GLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLL------SHKEASKKT 438
GL +DISYN+L+G IPNS F+N E GN G+ L S + + K
Sbjct: 639 GLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGN--KGLCGSVKGLQPCENRSATKGTHKA 696
Query: 439 PFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMY 498
F+I+F LLGAL +L + + + + + +R+++ + + + T +F S+ FDG+ Y
Sbjct: 697 VFIIIFSLLGALLILSAF-IGISLISQGRRNAKMEKAGDVQ--TENLF-SISTFDGRTTY 752
Query: 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
E II TKDFD YCIG+G H SVY+A+LPSG+ +AVKK + F D M+ QK+F+NEI+
Sbjct: 753 EAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDID-MAHQKDFVNEIR 810
Query: 559 ALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV 618
ALT+I+HRNIVK GFCSH RHSF+VYEY+ RGSL T+LS +++ W R+N+I GV
Sbjct: 811 ALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGV 870
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
+ ALSY+HHDC PPIVHRDISSNNVLLD +YEA VSDFGTAK LK +SSNW+ L GT+GY
Sbjct: 871 SHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGY 930
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
VAP ELAYTMK+TEKCDVYSFGVLALEV++G+HPGD +S S S N+
Sbjct: 931 VAP----------ELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVV 980
Query: 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+LD RLP P+ + ++ S++++A CL+G P SRPTMQ V Q+L
Sbjct: 981 LKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/771 (52%), Positives = 517/771 (67%), Gaps = 32/771 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + +LS L L L N+LSG IP EIG L L L+LS NQ +
Sbjct: 283 LQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLN 342
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G+ P + NL+NL+ + L +N+LSG P+EIG L KL L +DTNQ G LP IC+ G
Sbjct: 343 GSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGS 402
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
LE TV+DNH G IP +L+NCR+L RA N LTGN+SE G PNL+F+DLS+N F+
Sbjct: 403 LERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLSYNRFH 462
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
GE+S NWG+C +L L ++GNNITG IP + G S+ L +LDLSSNH+ GEIP ++G L S
Sbjct: 463 GELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTS 522
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L LIL NQLSG +P LG L+ LEY DLS+NRLN SI E LG L YLN S+N+ S
Sbjct: 523 LLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLS 582
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
IP + L+HLS+LDLSHNL G IP++I LESLE L+LSHNN+ G IP F M
Sbjct: 583 HGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKAFEDMPA 642
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGN-----NFSTF----YGTSDLLSHKEASK 436
L +DISYN+L+GPIP+S FRNA E GN N YG + S
Sbjct: 643 LSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSH 702
Query: 437 KTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKI 496
K F+I+FPLLGAL LL ++ + + R +R + + + D + S+ FDG+
Sbjct: 703 KVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIE-----EGDVQNNLLSISTFDGRA 757
Query: 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND-QMSDQKEFLN 555
MYEEII+ TKDFD YCIGKG H SVY+A+LPSG+ +AVKK + P+D M++QK+FLN
Sbjct: 758 MYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH---PSDMDMANQKDFLN 814
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
+++A+T+I+HRNIV+ GFCS+ RHSF+VYEY+ RGSLAT+LS A + W R+ +I
Sbjct: 815 KVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEAKK-LGWATRVKII 873
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
GVA ALSYMHHDC PPIVHRDISSNN+LLD +YEA +S+ GTAKLLK +SSN ++L GT
Sbjct: 874 KGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGT 933
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
GYVAP H AYTMK+TEK DVYSFGV+ALEVIKG+HPGD + L S S
Sbjct: 934 VGYVAPEH----------AYTMKVTEKTDVYSFGVIALEVIKGRHPGDQI-LSISVSPEK 982
Query: 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
NI MLD RLP + + ++++I+++A CL+ P SRPTM+ + Q+L
Sbjct: 983 NIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQML 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/771 (52%), Positives = 508/771 (65%), Gaps = 31/771 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L + L N G +P + +LS L L L N+LSG IPPEIG L L L+LS NQ +
Sbjct: 290 LQGISLYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLN 349
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G+ P + NL+NL+ + L +N LSG P+EIG L KL L +DTN+ +G LP IC+ G
Sbjct: 350 GSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGS 409
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
L TV+DN G IP +++NCR+L RA G N LTGNISE G PNL+++DLS+N F+
Sbjct: 410 LVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFH 469
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
GE+S NWG+C +L L ++GN+ITG IP + G S+ L +LDLSSNH+ GEIP ++G L S
Sbjct: 470 GELSHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTS 529
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L +L L NQLSG +P LG L L + DLS+NRLN SI E LG L YLN S+N+ S
Sbjct: 530 LLELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLS 589
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
IP + L+HLS+LDLSHNL G IP +I LESLE LNLSHNN+SG IP F M G
Sbjct: 590 NRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRG 649
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGNN--FSTFYGTSDLLSHKEASK------- 436
L IDISYN+L+GPIPNS FR+A E GN G + A +
Sbjct: 650 LSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGH 709
Query: 437 KTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKI 496
K F+I+FPLLGAL LL ++ + + R KR + + + D + S+ FDG+
Sbjct: 710 KIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIE-----EGDVQNDLFSISTFDGRA 764
Query: 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND-QMSDQKEFLN 555
MYEEII+ TKDFD YCIGKG H SVY+A+L SG+ +AVKK + +D M++Q++F N
Sbjct: 765 MYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKL---YASDIDMANQRDFFN 821
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E++ALT+I+HRNIVK GFCSH RHSF+VYEY+ RGSLA +LS A + W R+N+I
Sbjct: 822 EVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEAKK-LGWATRINII 880
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
GVA ALSYMHHDC PPIVHRDISSNN+LLD +YE +SDFGTAKLLK +SSN + L GT
Sbjct: 881 KGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGT 940
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
FGYVAP H AYTMK+TEK DVYSFGV+ LEVIKG+HPGD + S S
Sbjct: 941 FGYVAPEH----------AYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKE 990
Query: 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
NI MLD RLP + + ++ISI+ +A CL P SRPTM+ + Q+L
Sbjct: 991 NIVLEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQML 1041
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/770 (48%), Positives = 510/770 (66%), Gaps = 32/770 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + N+ L L L N+L+G IPPE+G + + L++S N+ +
Sbjct: 288 LDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLT 347
Query: 88 GTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G P L+ L+++ L +N+LSG IP I N +L+ L LDTN FTG LP ICR G
Sbjct: 348 GPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGK 407
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
LE LT++DNHF G +P +LR+C+SL+R N+ +G+ISE FG+YP L F+DLS+NNF+
Sbjct: 408 LENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFH 467
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
G++S+NW + +L I+S N+ITG IPPEI N +QL LDLSSN I GE+P + +
Sbjct: 468 GQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINR 527
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
++KL L GN+LSG +P + LLT LEY DLSSNR ++ I L + +L+Y+N S N
Sbjct: 528 ISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLD 587
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
Q IPE L L+ L LDLS+N G I S+ +L++LE+L+LSHNN+SGQIP F M
Sbjct: 588 QTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLA 647
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGN-----NFSTFYG------TSDLLSHKEA 434
L +D+S+N L+GPIP++ FRNAP ++F GN + +T G TS SHK+
Sbjct: 648 LTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKD- 706
Query: 435 SKKTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDG 494
+ IL P++GA+ +L V + FR+ + + S +T IF FDG
Sbjct: 707 -RNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIF----SFDG 761
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN--DQMSDQKE 552
K+ Y+EII+ T +FD KY IG G H VY+AKLP+ +AVKK N + S ++E
Sbjct: 762 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 820
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM 612
FLNEI+ALT+IRHRN+VK +GFCSH R++F+VYEY+ RGSL VL N+ ++ DW KR+
Sbjct: 821 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 880
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
NV+ GVA ALSYMHHD P IVHRDISS N+LL +YEA++SDFGTAKLLKP+SSNW+ +
Sbjct: 881 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 940
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
GT+GYVAP ELAY MK+TEKCDVYSFGVL LEVIKG+HPGD +S SSS
Sbjct: 941 AGTYGYVAP----------ELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSP 990
Query: 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ ++ DHRLP P+ +++E+++ I++VALLCL P +RPTM ++
Sbjct: 991 PDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7267528|emb|CAB78010.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|7321074|emb|CAB82121.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/770 (48%), Positives = 510/770 (66%), Gaps = 32/770 (4%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + N+ L L L N+L+G IPPE+G + + L++S N+ +
Sbjct: 270 LDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLT 329
Query: 88 GTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G P L+ L+++ L +N+LSG IP I N +L+ L +DTN FTG LP ICR G
Sbjct: 330 GPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQVDTNNFTGFLPDTICRGGK 389
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
LE LT++DNHF G +P +LR+C+SL+R N+ +G+ISE FG+YP L F+DLS+NNF+
Sbjct: 390 LENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFH 449
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
G++S+NW + +L I+S N+ITG IPPEI N +QL LDLSSN I GE+P + +
Sbjct: 450 GQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINR 509
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
++KL L GN+LSG +P + LLT LEY DLSSNR ++ I L + +L+Y+N S N
Sbjct: 510 ISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLD 569
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
Q IPE L L+ L LDLS+N G I S+ +L++LE+L+LSHNN+SGQIP F M
Sbjct: 570 QTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLA 629
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGN-----NFSTFYG------TSDLLSHKEA 434
L +D+S+N L+GPIP++ FRNAP ++F GN + +T G TS SHK+
Sbjct: 630 LTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKD- 688
Query: 435 SKKTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDG 494
+ IL P++GA+ +L V + FR+ + + S +T IF FDG
Sbjct: 689 -RNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIF----SFDG 743
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN--DQMSDQKE 552
K+ Y+EII+ T +FD KY IG G H VY+AKLP+ +AVKK N + S ++E
Sbjct: 744 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 802
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM 612
FLNEI+ALT+IRHRN+VK +GFCSH R++F+VYEY+ RGSL VL N+ ++ DW KR+
Sbjct: 803 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 862
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
NV+ GVA ALSYMHHD P IVHRDISS N+LL +YEA++SDFGTAKLLKP+SSNW+ +
Sbjct: 863 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 922
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
GT+GYVAP ELAY MK+TEKCDVYSFGVL LEVIKG+HPGD +S SSS
Sbjct: 923 AGTYGYVAP----------ELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSP 972
Query: 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ ++ DHRLP P+ +++E+++ I++VALLCL P +RPTM ++
Sbjct: 973 PDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1022
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/767 (48%), Positives = 505/767 (65%), Gaps = 29/767 (3%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + N+ L L L N+LSG IPPE+G + + L++S N+ +
Sbjct: 265 LDTLSLHTNKLTGPIPSTLGNIKTLAILHLYLNQLSGSIPPELGDMEAMIDLEISENKLT 324
Query: 88 GTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G P L+ L+++ L +N+LSG IP I N +L+ L LDTN FTG LP ICRSG
Sbjct: 325 GPVPDSFGKLTVLEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRSGK 384
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
LE LT++DNHF G +P +LRNC+SLVR N+ +G+IS+ FG+YP L F+DLS+NNF+
Sbjct: 385 LENLTLDDNHFEGPVPKSLRNCKSLVRVRFKGNHFSGDISDAFGVYPTLNFIDLSNNNFH 444
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
G++S+NW + +L I+S N+I+G IPPEI N +QL+ LDLS N I GE+P + +
Sbjct: 445 GQLSANWEQSTKLVAFILSNNSISGAIPPEIWNMTQLNQLDLSFNRITGELPESISNINR 504
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
++KL L GNQLSG +P + LLT LEY DLSSN+ I L + +L+Y+N S N
Sbjct: 505 ISKLQLNGNQLSGKIPSGIRLLTNLEYLDLSSNQFGFEIPATLNNLPRLYYMNLSRNDLD 564
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
Q IPE L L+ L LDLS+N G I S+ +L++LE+L+LSHNN+SGQIP F M
Sbjct: 565 QTIPEGLTKLSQLQMLDLSYNQLDGEISSQFGSLQNLERLDLSHNNLSGQIPTSFKDMLA 624
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGNN--------FSTFYGTSDLLSHKEASKK 437
L ID+S+N L+GPIP++ FRNA + GNN TS SHK+ +
Sbjct: 625 LTHIDVSHNNLQGPIPDNAAFRNASPNALEGNNDLCGDNKALKPCSITSSKKSHKD--RN 682
Query: 438 TPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIM 497
IL P++GA+ +L V + FR+ + + S +T IF FDGK+
Sbjct: 683 LIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEENSDSESGGETLSIF----SFDGKVR 738
Query: 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND--QMSDQKEFLN 555
Y+EII+ T +FD+KY IG G H VY+AKLP+ +AVKK N + S ++EFLN
Sbjct: 739 YQEIIKATGEFDSKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSITNPSTKQEFLN 797
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
EI+ALT+IRHRN+VK +GFCSH R++F+VYEY+ RGSL VL N+ ++ DW KR+NV+
Sbjct: 798 EIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVV 857
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
GVADALSYMHHD P IVHRDISS N+LL +YEA++SDFGTAKLLKP+SSNW+ + GT
Sbjct: 858 KGVADALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGT 917
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
+GYVAP ELAY MK+TEKCDVYSFGVL LEVIKG+HPGD +S SSS
Sbjct: 918 YGYVAP----------ELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDT 967
Query: 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
++ + DHRLP P+ +++E+++ I++VAL+CL P +RPTM ++
Sbjct: 968 SLSLKTISDHRLPEPTPEIKEEVLEILKVALMCLHSDPQARPTMLSI 1014
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/770 (51%), Positives = 515/770 (66%), Gaps = 26/770 (3%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L L L N G +P + L+ L L L +N+LSG IP E+G L L +L+LS N+ +
Sbjct: 254 LTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLSGTIPKELGNLNSLSNLELSENKLT 313
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G+ P + NLS L+ + L NN+LSG IPE+I NL KLS L L +NQ TG LP+NIC+S +
Sbjct: 314 GSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSLLQLQSNQLTGYLPQNICQSKV 373
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
L+ +VNDN G IP ++R+C+SLVR HL N GNISEDFG+YP L+F+D+ +N F+
Sbjct: 374 LQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNISEDFGVYPYLQFVDIRYNKFH 433
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
GEISS WG C LGTL++SGNNI+G IPPEIGN+++L LD SSN + G IP ELG+L S
Sbjct: 434 GEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQGLDFSSNQLVGRIPKELGKLTS 493
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L ++ L NQLS +P G LT+LE DLS+NR N SI +G + KL YLN S+NQFS
Sbjct: 494 LVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSIPGNIGNLVKLNYLNLSNNQFS 553
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
QEIP L L HLS+LDLS N G IPS + ++SLE LNLS NN+SG IP M G
Sbjct: 554 QEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEVLNLSRNNLSGFIPGDLKEMHG 613
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFY---------GTSDLLSHKEASK 436
L SIDISYN+L GP+P++ F+N+ E+F GN + +++ S + K
Sbjct: 614 LSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQPCKPSSTEQGSSIKFHK 673
Query: 437 KTPFLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKI 496
+ +I PL GA +L V+ F +R K +++ S + I FDGK
Sbjct: 674 RLFLVISLPLFGAFLILSFLGVLFFQSKRSKEALEAEKSSQESEEILLI----TSFDGKS 729
Query: 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNE 556
M++EII T F+ YCIGKG SVY+AKL SG +AVKK + + QKEF +E
Sbjct: 730 MHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLHQSH-DAWKPYQKEFWSE 788
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT 616
I+ALT+I+HRNIVKFYGFCS+ +SF+VYE I +GSLAT+L +N A+++ +W KR N+I
Sbjct: 789 IRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAKELEWFKRANIIK 848
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF 676
GVA+ALSYMHHDC PPIVHRDISS N+LLD E EARVSDFG A++L +SS+ T L GTF
Sbjct: 849 GVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNLDSSHRTALAGTF 908
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736
GY+AP ELAY++ +TEKCDVYSFGVLALEVI GKHPG+ +S SSSSS+
Sbjct: 909 GYMAP----------ELAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSISSSSSTRK 958
Query: 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ ++D RLP PS +VQ +L++I+ +A CL+ P RPTM+ +C +L
Sbjct: 959 MLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 786 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.972 | 0.731 | 0.451 | 9.6e-176 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.937 | 0.658 | 0.436 | 1.1e-156 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.946 | 0.675 | 0.347 | 6.8e-111 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.965 | 0.688 | 0.330 | 1.7e-107 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.975 | 0.682 | 0.328 | 7.5e-105 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.933 | 0.646 | 0.342 | 3.1e-99 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.965 | 0.665 | 0.326 | 1.5e-97 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.586 | 0.386 | 0.316 | 2.7e-94 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.938 | 0.763 | 0.344 | 6.1e-94 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.930 | 0.583 | 0.321 | 5.5e-93 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1707 (606.0 bits), Expect = 9.6e-176, P = 9.6e-176
Identities = 358/793 (45%), Positives = 489/793 (61%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
V +N+ L G + + L L L N G +P + N+ L L L N+L
Sbjct: 264 VTLLNMFENQLSGEIPP-EIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQL 322
Query: 63 SGKIPPEIGXXXXXXXXXXXXNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
+G IPPE+G N+ +G P L+ L+++ L +N+LSG IP I N
Sbjct: 323 NGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANST 382
Query: 122 KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNL 180
+L+ L LDTN FTG LP ICR G LE LT++DNHF G +P +LR+C+SL+R N+
Sbjct: 383 ELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSF 442
Query: 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240
+G+ISE FG+YP L F+DLS+NNF+G++S+NW + +L I+S N+ITG IPPEI N +
Sbjct: 443 SGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMT 502
Query: 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300
QL LDLSSN I GE+P + + ++KL L GN+LSG +P + LLT LEY DLSSNR
Sbjct: 503 QLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRF 562
Query: 301 NNSILEALGFMFKLFYLNFSHNQFSQEIPXXXXXXXXXXXXXXXXNLFKGSIPSRICNLE 360
++ I L + +L+Y+N S N Q IP N G I S+ +L+
Sbjct: 563 SSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQ 622
Query: 361 SLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGN--- 417
+LE+L+LSHNN+SGQIP F M L +D+S+N L+GPIP++ FRNAP ++F GN
Sbjct: 623 NLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDL 682
Query: 418 --NFSTFYGTS--DLLSHKEASKKTXXXXXXXXXXXXXXXXVYVVM-VFM-FRRWKRDSQ 471
+ +T G + S K++ K + V +F+ FR+ + +
Sbjct: 683 CGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIE 742
Query: 472 SQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGD 531
S +T IF FDGK+ Y+EII+ T +FD KY IG G H VY+AKLP+
Sbjct: 743 EHTDSESGGETLSIF----SFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI 798
Query: 532 KIAVKKFNSPFPND--QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589
+AVKK N + S ++EFLNEI+ALT+IRHRN+VK +GFCSH R++F+VYEY+
Sbjct: 799 -MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYME 857
Query: 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649
RGSL VL N+ ++ DW KR+NV+ GVA ALSYMHHD P IVHRDISS N+LL +Y
Sbjct: 858 RGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDY 917
Query: 650 EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709
EA++SDFGTAKLLKP+SSNW+ + GT+GYVAP ELAY MK+TEKCDVYSFG
Sbjct: 918 EAKISDFGTAKLLKPDSSNWSAVAGTYGYVAP----------ELAYAMKVTEKCDVYSFG 967
Query: 710 VLALEVIKGKHPGDXXXXXXXXXXXINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCL 769
VL LEVIKG+HPGD + ++ DHRLP P+ +++E+++ I++VALLCL
Sbjct: 968 VLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCL 1027
Query: 770 DGCPNSRPTMQTV 782
P +RPTM ++
Sbjct: 1028 HSDPQARPTMLSI 1040
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1527 (542.6 bits), Expect = 1.1e-156, P = 1.1e-156
Identities = 332/760 (43%), Positives = 453/760 (59%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGXXXXXXXXXXXXNQFSGTF 90
L L+ N G++P NL L YL L N L+G IP E+G N+ +G+
Sbjct: 371 LQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSV 430
Query: 91 PP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEI 149
P N + L+ + L N LSG+IP + N L+ L+LDTN FTG P +C+ L+
Sbjct: 431 PDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQN 490
Query: 150 LTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEI 208
++++ NH G IP +LR+C+SL+RA N TG+I E FGIYP+L F+D SHN F+GEI
Sbjct: 491 ISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEI 550
Query: 209 SSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNK 268
SSNW K +LG LI+S NNITG IP EI N +QL LDLS+N++ GE+P +G L +L++
Sbjct: 551 SSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSR 610
Query: 269 LILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI 328
L L GNQLSG +P L LT LE DLSSN ++ I + KL +N S N+F I
Sbjct: 611 LRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSI 670
Query: 329 PXXXXXXXXXXXXXXXXNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLS 388
P N G IPS++ +L+SL+KL+LSHNN+SG IP F GM L +
Sbjct: 671 PRLSKLTQLTQLDLSH-NQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTN 729
Query: 389 IDISYNELRGPIPNSTVFRNAPRESFLGN-NFSTFYGTSDLLSHKEASK--KTXXXXXXX 445
+DIS N+L GP+P++ FR A ++ N + L +E K K
Sbjct: 730 VDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWI 789
Query: 446 XXXXXXXXXVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRT 505
+ + F R + Q ++ +T G S+ DGK Y++II T
Sbjct: 790 LVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPET-GENMSIFSVDGKFKYQDIIEST 848
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSD---QKEFLNEIKALTK 562
+FD + IG G + VYRA L IAVK+ + ++++S ++EFLNE+KALT+
Sbjct: 849 NEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTI-DEEISKPVVKQEFLNEVKALTE 906
Query: 563 IRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADAL 622
IRHRN+VK +GFCSH RH+F++YEY+ +GSL +L+N+ ++ W KR+NV+ GVA AL
Sbjct: 907 IRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHAL 966
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
SYMHHD PIVHRDISS N+LLD +Y A++SDFGTAKLLK +SSNW+ + GT+GYVAP
Sbjct: 967 SYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAP- 1025
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDXXXXXXXXXXXINIEFNAM 742
E AYTMK+TEKCDVYSFGVL LE+I GKHPGD + ++
Sbjct: 1026 ---------EFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA-LSLRSI 1075
Query: 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
D R+ P +EKL+ ++E+ALLCL P SRPTM ++
Sbjct: 1076 SDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1095 (390.5 bits), Expect = 6.8e-111, P = 6.8e-111
Identities = 270/777 (34%), Positives = 391/777 (50%)
Query: 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGXXXXXXXXXXXXNQFSG 88
A +D S N G +P + ++ LK L L EN L G IP E+G N+ +G
Sbjct: 310 AEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNG 369
Query: 89 TFPPICN-LSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL 147
T P L L + L +N+L G IP IG S L + N +G +P + CR L
Sbjct: 370 TIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTL 429
Query: 148 EILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
+L++ N G+IP +L+ C+SL + LG N LTG++ + NL L+L N G
Sbjct: 430 ILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSG 489
Query: 207 EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266
IS++ GK L L ++ NN TG IPPEIGN +++ ++SSN + G IP ELG +++
Sbjct: 490 NISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTI 549
Query: 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ 326
+L L GN+ SG++ + LG L LE LS NRL I + G + +L L N S+
Sbjct: 550 QRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSE 609
Query: 327 EIPXXXXXXXXXXXXXXXX-NLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
IP N G+IP + NL+ LE L L+ N +SG+IPA +
Sbjct: 610 NIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMS 669
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF---STFYGTSDLLSHKEASKKTXXXX 442
LL +IS N L G +P++ VF+ +F GN+ S L+ H + SK
Sbjct: 670 LLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSD-SKLNWLIN 728
Query: 443 XXXXXXXXXXXXVYVVMVFMFRR----WKRDSQSQGSCSSKNDTRGIFHSVLDFDGK-IM 497
+ + VF+ W + + ++ T+ F K
Sbjct: 729 GSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFT 788
Query: 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
Y+ ++ T++F +G+G +VY+A++ G+ IAVKK NS + S F EI
Sbjct: 789 YQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--GEGASSDNSFRAEI 846
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
L KIRHRNIVK YGFC H + ++YEY+++GSL L + DW R + G
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-SSNWTELVGTF 676
A+ L Y+HHDC P IVHRDI SNN+LLD ++A V DFG AKL+ + S + + + G++
Sbjct: 907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSY 966
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-------GDXXXXXX 729
GY+AP E AYTMK+TEKCD+YSFGV+ LE+I GK P GD
Sbjct: 967 GYIAP----------EYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVR 1016
Query: 730 XXXXXINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ I M D RL ++ ++++AL C P SRPTM+ V ++
Sbjct: 1017 RSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.7e-107, P = 1.7e-107
Identities = 265/803 (33%), Positives = 401/803 (49%)
Query: 8 LTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIP 67
L GL GT+ + + +D S N G +P ++ N+ L+ L L EN+L+G IP
Sbjct: 296 LYRNGLNGTIPR-EIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIP 354
Query: 68 PEIGXXXXXXXXXXXXNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYL 126
E+ N +G P L L + L N LSG+IP ++G L L
Sbjct: 355 VELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVL 414
Query: 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNIS 185
+ N +G++P +C + IL + N+ G+IP + C++LV+ L RNNL G
Sbjct: 415 DMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFP 474
Query: 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245
+ N+ ++L N F G I G C L L ++ N TG +P EIG SQL L
Sbjct: 475 SNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTL 534
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
++SSN + GE+P E+ L +L + N SG LP +G L +LE LS+N L+ +I
Sbjct: 535 NISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIP 594
Query: 306 EALGFMFKLFYLNFSHNQFSQEIPXXXXXXXXXXXXXXXX-NLFKGSIPSRICNLESLEK 364
ALG + +L L N F+ IP N G IP + NL LE
Sbjct: 595 VALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEF 654
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN------ 418
L L++NN+SG+IP+ F +S LL + SYN L GPIP + RN SF+GN
Sbjct: 655 LLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPP 711
Query: 419 FSTFYGTSDLLSHKEASK-----KTXXXXXXXXXXXXXXXXVYVVMVFMFRRWKRDSQSQ 473
+ T + K + + ++V++ RR R S
Sbjct: 712 LNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASS 771
Query: 474 GSCSSKND-TRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDK 532
++ + I+ + G +++++ T +FD + +G+G +VY+A LP+G
Sbjct: 772 AQDGQPSEMSLDIYFPPKE--G-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYT 828
Query: 533 IAVKKFNSPFPNDQMSD-QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRG 591
+AVKK S ++ F EI L IRHRNIVK +GFC+H + ++YEY+ +G
Sbjct: 829 LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKG 888
Query: 592 SLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651
SL +L + S + DW KR + G A L+Y+HHDC P I HRDI SNN+LLD ++EA
Sbjct: 889 SLGEILHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 946
Query: 652 RVSDFGTAKLLK-PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
V DFG AK++ P+S + + + G++GY+AP E AYTMK+TEK D+YS+GV
Sbjct: 947 HVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP----------EYAYTMKVTEKSDIYSYGV 996
Query: 711 LALEVIKGKHP-------GDXXXXXXXXXXXINIEFNAMLDHRLPHPSLDVQEKLISIME 763
+ LE++ GK P GD + + +LD RL + ++++++
Sbjct: 997 VLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSHMLTVLK 1055
Query: 764 VALLCLDGCPNSRPTMQTVCQLL 786
+ALLC P +RP+M+ V +L
Sbjct: 1056 IALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 267/814 (32%), Positives = 400/814 (49%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
+ + L L GT+ + + +D S N G +P ++ +S+L+ L L +N+L
Sbjct: 303 LKKLYLYQNQLNGTIPK-ELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKL 361
Query: 63 SGKIPPEIGXXXXXXXXXXXXNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
+G IP E+ N +G PP NL++++ + L +N LSG IP+ +G
Sbjct: 362 TGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYS 421
Query: 122 KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNL 180
L + NQ +G++P IC+ L +L + N G+IP + C+SL++ + N L
Sbjct: 422 PLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRL 481
Query: 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240
TG + NL ++L N F G + G C +L L ++ N + +P EI S
Sbjct: 482 TGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLS 541
Query: 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300
L ++SSN + G IP E+ L +L L N G LP LG L +LE LS NR
Sbjct: 542 NLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRF 601
Query: 301 NNSILEALGFMFKLFYLNFSHNQFSQEIP-XXXXXXXXXXXXXXXXNLFKGSIPSRICNL 359
+ +I +G + L L N FS IP N F G IP I NL
Sbjct: 602 SGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNL 661
Query: 360 ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN- 418
L L+L++N++SG+IP F +S LL + SYN L G +P++ +F+N SFLGN
Sbjct: 662 HLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKG 721
Query: 419 -FSTFYGTSD--------LLSHKEASKKTXXXXXXXXXXXXXXXXVYVVMVFMFRRWKRD 469
+ D + S K S + + + +V F R
Sbjct: 722 LCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLR---- 777
Query: 470 SQSQGSCSSKNDTRGIFH-SVLDFDGKIMY--EEIIRRTKDFDAKYCIGKGEHRSVYRAK 526
+ + + +D F S + F K + ++I+ TK F Y +G+G +VY+A
Sbjct: 778 NPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAV 837
Query: 527 LPSGDKIAVKKFNSPFP---NDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHS 581
+PSG IAVKK S N+ + F EI L KIRHRNIV+ Y FC H +
Sbjct: 838 MPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSN 897
Query: 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641
++YEY++RGSL +L S DW R + G A+ L+Y+HHDC P I+HRDI SN
Sbjct: 898 LLLYEYMSRGSLGELLHGG-KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSN 956
Query: 642 NVLLDLEYEARVSDFGTAKLLK-PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT 700
N+L+D +EA V DFG AK++ P S + + + G++GY+AP E AYTMK+T
Sbjct: 957 NILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAP----------EYAYTMKVT 1006
Query: 701 EKCDVYSFGVLALEVIKGKHP-------GDXXXXXXXXXXXINIEFNAMLDHRLPHPSLD 753
EKCD+YSFGV+ LE++ GK P GD ++ + +LD L D
Sbjct: 1007 EKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLT-SEILDPYLTKVEDD 1065
Query: 754 V-QEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
V +I++ ++A+LC P+ RPTM+ V +L
Sbjct: 1066 VILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 275/803 (34%), Positives = 391/803 (48%)
Query: 8 LTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIP 67
L L G + E L +DLS+N F GT+P NLS L+ L LS N ++G IP
Sbjct: 306 LWQNNLHGPIPE-EIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIP 364
Query: 68 PEIGXXXXXXXXXXXXNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYL 126
+ NQ SG PP I L L NKL G+IP+E+ L L
Sbjct: 365 SILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQAL 424
Query: 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNIS 185
L N TG LP + + L L + N G IP + NC SLVR L N +TG I
Sbjct: 425 DLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIP 484
Query: 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245
+ G NL FLDLS NN G + C +L L +S N + G +P + + ++L VL
Sbjct: 485 KGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVL 544
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
D+SSN + G+IP LG LISLN+LIL N +G +P +LG T L+ DLSSN ++ +I
Sbjct: 545 DVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIP 604
Query: 306 EALGFMFKLFYLNFSHNQFSQEIPXXXXXXXXXXXXXXXXNLFKGSIPSRICNLESLEKL 365
E L F + L+ + N N G IP RI L L L
Sbjct: 605 EEL---FDIQDLDIALN--------------------LSWNSLDGFIPERISALNRLSVL 641
Query: 366 NLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN------F 419
++SHN +SG + A G+ L+S++IS+N G +P+S VFR GNN F
Sbjct: 642 DISHNMLSGDLSA-LSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGF 700
Query: 420 -STFYGTSDLLSHKEA--SKKTXXXXXXXXXXXXXXXXVYVVMVFMFRRWKRDSQSQGSC 476
S F S L+ + S + + V+ V ++ RD S
Sbjct: 701 RSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDND--SE 758
Query: 477 SSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVK 536
+ +N F + + E +++ + + IGKG VY+A++P+ + IAVK
Sbjct: 759 TGENLWTWQFTPFQKLNFTV--EHVLKCLVEGNV---IGKGCSGIVYKAEMPNREVIAVK 813
Query: 537 KF---NSPFPNDQMSD---QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590
K P N++ + F E+K L IRH+NIV+F G C + ++Y+Y++
Sbjct: 814 KLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSN 873
Query: 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650
GSL ++L W R +I G A L+Y+HHDC PPIVHRDI +NN+L+ ++E
Sbjct: 874 GSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFE 933
Query: 651 ARVSDFGTAKLLKPN----SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
+ DFG AKL+ SSN + G++GY+AP +G Y+MKITEK DVY
Sbjct: 934 PYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYG----------YSMKITEKSDVY 981
Query: 707 SFGVLALEVIKGKHPGDXXXXXXXXXXXI--NIEFNAMLDHRLP-HPSLDVQEKLISIME 763
S+GV+ LEV+ GK P D I ++D L P +V+E ++ +
Sbjct: 982 SYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEE-MMQTLG 1040
Query: 764 VALLCLDGCPNSRPTMQTVCQLL 786
VALLC++ P RPTM+ V +L
Sbjct: 1041 VALLCINPIPEDRPTMKDVAAML 1063
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
Identities = 262/803 (32%), Positives = 390/803 (48%)
Query: 8 LTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIP 67
L L G++ L L L N G +P ++ N S LK +DLS N LSG IP
Sbjct: 281 LYENSLSGSIPR-EIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIP 339
Query: 68 PEIGXXXXXXXXXXXXNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYL 126
IG N+FSG+ P I N S+L + L N++SG IP E+G L KL+
Sbjct: 340 SSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLF 399
Query: 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNIS 185
+NQ G +P + L+ L ++ N G+IP+ L R+L + L N+L+G I
Sbjct: 400 FAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIP 459
Query: 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245
++ G +L L L N GEI S G ++ L S N + G++P EIG+ S+L ++
Sbjct: 460 QEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMI 519
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
DLS+N + G +P + L L L + NQ SG +P +LG L L LS N + SI
Sbjct: 520 DLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIP 579
Query: 306 EALGFMFKLFYLNFSHNQFSQEIPXXXXXXXXXXXXXX-XXNLFKGSIPSRICNLESLEK 364
+LG L L+ N+ S EIP N G IPS+I +L L
Sbjct: 580 TSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSI 639
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN------ 418
L+LSHN + G + A + L+S++ISYN G +P++ +FR + GN
Sbjct: 640 LDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSST 698
Query: 419 ----FSTFYGTSDLLSHKEASKKTXXXXXXXXXXXXXXXXVYVVMVFMFR-RWKRDSQSQ 473
F T+ + L +AS+ + + V + R R D++
Sbjct: 699 QDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERD 758
Query: 474 GSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKI 533
+ L+F ++IIR + + IGKG VYRA + +G+ I
Sbjct: 759 SELGETYKWQFTPFQKLNFS----VDQIIRCLVEPNV---IGKGCSGVVYRADVDNGEVI 811
Query: 534 AVKKFNSPFPN---DQMSD--QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588
AVKK N D+ + + F E+K L IRH+NIV+F G C + ++Y+Y+
Sbjct: 812 AVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYM 871
Query: 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648
GSL ++L S DW R ++ G A L+Y+HHDC PPIVHRDI +NN+L+ L+
Sbjct: 872 PNGSLGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLD 930
Query: 649 YEARVSDFGTAKLLKPNSSNWTE--LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
+E ++DFG AKL+ + G++GY+AP +G Y+MKITEK DVY
Sbjct: 931 FEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYG----------YSMKITEKSDVY 980
Query: 707 SFGVLALEVIKGKHPGDXXXXXXXXXXXI---NIEFNAMLDHRLPHPSLDVQEKLISIME 763
S+GV+ LEV+ GK P D N +LD L + ++++ ++
Sbjct: 981 SYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLG 1040
Query: 764 VALLCLDGCPNSRPTMQTVCQLL 786
ALLC++ P+ RPTM+ V +L
Sbjct: 1041 TALLCVNSSPDERPTMKDVAAML 1063
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 2.7e-94, Sum P(2) = 2.7e-94
Identities = 152/480 (31%), Positives = 228/480 (47%)
Query: 1 GRVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSEN 60
G + +I+L+ L GT++E F L L L+ N G++P + L L LDL N
Sbjct: 377 GSLEAIDLSGNLLSGTIEEV-FDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSN 434
Query: 61 ELSGKIPPEIGXXXXXXXXXXXXNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGN 119
+G+IP + N+ G P I N ++LK + L +N+L+G IP EIG
Sbjct: 435 NFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGK 494
Query: 120 LMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRN 178
L LS L L+ N F G++P + L L + N+ G IP+ + L L N
Sbjct: 495 LTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYN 554
Query: 179 NLTGNISEDFGIY------PNLKFL------DLSHNNFYGEISSNWGKCHRLGTLIVSGN 226
NL+G+I Y P+L FL DLS+N G I G+C L + +S N
Sbjct: 555 NLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNN 614
Query: 227 NITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL 286
+++G IP + + L +LDLS N + G IP E+G + L L L NQL+GH+P + GL
Sbjct: 615 HLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGL 674
Query: 287 LTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPXXXXXXXXXXXXXXXXN 346
L L +L+ N+L+ + +LG + +L +++ S N S E+ N
Sbjct: 675 LGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQN 734
Query: 347 LFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVF 406
F G IPS + NL LE L++S N +SG+IP G+ L ++++ N LRG +P+ V
Sbjct: 735 KFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVC 794
Query: 407 RNAPRESFLGNNFSTFYGTSDLLSHKEASKKTXXXXXXXXXXXXXXXXVYVVMVFMFRRW 466
++ P ++ L N G K K V+V VF RRW
Sbjct: 795 QD-PSKALLSGN-KELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFV-FVFSLRRW 851
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 275/798 (34%), Positives = 390/798 (48%)
Query: 21 SFSSFPHLAYLDLSINGFFG--TLPPQVRNLSKLKYLDLSENELSGKIPPEIGXXXXXXX 78
S + L YL+ + N TLP V L+KL ++ L L G IP IG
Sbjct: 164 SIFNLTDLEYLNFNENPELDLWTLPDSVSKLTKLTHMLLMTCMLHGNIPRSIGNLTSLVD 223
Query: 79 XXXXXNQFSGTFPP-ICNLSNLKYISLHNN-KLSGSIPEEIGNLMKLSYLMLDTNQFTGQ 136
N SG P I NLSNL+ + L+ N L+GSIPEEIGNL L+ + + ++ TG
Sbjct: 224 LELSGNFLSGEIPKEIGNLSNLRQLELYYNYHLTGSIPEEIGNLKNLTDIDISVSRLTGS 283
Query: 137 LPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLK 195
+P +IC L +L + +N G IP +L N ++L L N LTG + + G +
Sbjct: 284 IPDSICSLPNLRVLQLYNNSLTGEIPKSLGNSKTLKILSLYDNYLTGELPPNLGSSSPMI 343
Query: 196 FLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255
LD+S N G + ++ K +L +V N TG IP G+ L ++SN + G
Sbjct: 344 ALDVSENRLSGPLPAHVCKSGKLLYFLVLQNRFTGSIPETYGSCKTLIRFRVASNRLVGT 403
Query: 256 IPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF 315
IP + L ++ + L N LSG +P A+G L + SNR++ I L L
Sbjct: 404 IPQGVMSLPHVSIIDLAYNSLSGPIPNAIGNAWNLSELFMQSNRISGVIPHELSHSTNLV 463
Query: 316 YLNFSHNQFSQEIPXXXXXXXXXXXXXXXXNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375
L+ S+NQ S IP N SIP + NL+SL L+LS N ++G+
Sbjct: 464 KLDLSNNQLSGPIPSEVGRLRKLNLLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGR 523
Query: 376 IPACFIGMSGLL--SIDISYNELRGPIPNSTVFRNAPRESFLGN-NFST--FYGTSDLLS 430
IP +S LL SI+ S N L GPIP S + R ESF N N G+SDL
Sbjct: 524 IPE---NLSELLPTSINFSSNRLSGPIPVSLI-RGGLVESFSDNPNLCIPPTAGSSDLKF 579
Query: 431 H--KEASKKTXXXXXXXXXXXXXXXXVYVVMVFMFRRWKRD----SQSQGSCSS--KNDT 482
+E K + V+M ++ +R ++ Q + SS D
Sbjct: 580 PMCQEPHGKKKLSSIWAILVSVFILVLGVIMFYLRQRMSKNRAVIEQDETLASSFFSYDV 639
Query: 483 RGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPF 542
+ FH + FD + + E ++ D K +G G +VYR +L SG+ +AVKK S
Sbjct: 640 KS-FHRI-SFDQREILESLV------D-KNIVGHGGSGTVYRVELKSGEVVAVKKLWSQS 690
Query: 543 PNDQMSDQKEFLN-----EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL 597
D S+ K LN E++ L IRH+NIVK + + S + S +VYEY+ G+L L
Sbjct: 691 NKDSASEDKMHLNKELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDAL 750
Query: 598 SNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657
F +WR R + GVA L+Y+HHD PPI+HRDI S N+LLD+ Y+ +V+DFG
Sbjct: 751 HKGFVH--LEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFG 808
Query: 658 TAKLLKPNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715
AK+L+ S T + GT+GY+AP E AY+ K T KCDVYSFGV+ +E+
Sbjct: 809 IAKVLQARGKDSTTTVMAGTYGYLAP----------EYAYSSKATIKCDVYSFGVVLMEL 858
Query: 716 IKGKHP-----GDXXXXXXXXXXXINIEFNAM--LDHRLPHPSLDVQEKLISIMEVALLC 768
I GK P G+ I+ + + LD RL S + +I+ + VA+ C
Sbjct: 859 ITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSESS---KADMINALRVAIRC 915
Query: 769 LDGCPNSRPTMQTVCQLL 786
P RPTM V QLL
Sbjct: 916 TSRTPTIRPTMNEVVQLL 933
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 5.5e-93, P = 5.5e-93
Identities = 258/802 (32%), Positives = 381/802 (47%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGXXXXXXXXXXXXNQFS 87
L +D N G +P + L L L L ENEL G IP +G NQ S
Sbjct: 459 LQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLS 518
Query: 88 GTFPPICN-LSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G+ P L+ L+ ++NN L G++P+ + NL L+ + +N+F G + +C S
Sbjct: 519 GSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISP-LCGSSS 577
Query: 147 LEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
V +N F G IP L +L R LG+N TG I FG L LD+S N+
Sbjct: 578 YLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLS 637
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
G I G C +L + ++ N ++G IP +G L L LSSN G +P E+ L +
Sbjct: 638 GIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTN 697
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
+ L L GN L+G +P+ +G L L +L N+L+ + +G + KLF L S N +
Sbjct: 698 ILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALT 757
Query: 326 QEIPXXXXXXXXXXXXXXXX-NLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMS 384
EIP N F G IPS I L LE L+LSHN + G++P M
Sbjct: 758 GEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMK 817
Query: 385 GLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLLSH---------KEAS 435
L +++SYN L G + F ++F+GN + G+ LSH + S
Sbjct: 818 SLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGN--AGLCGSP--LSHCNRAGSKNQRSLS 871
Query: 436 KKTXXXXXXXXXXXXXXXXVYVVMVF------MFRRWKRDSQSQGSCSSKNDTRGIFHSV 489
KT V V+++F +F++ R S S +S + +F +
Sbjct: 872 PKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKK-VRGGNSAFSSNSSSSQAPLFSNG 930
Query: 490 LDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSD 549
I +++I+ T + ++ IG G VY+A+L +G+ IAVKK + +D MS+
Sbjct: 931 -GAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSN 987
Query: 550 QKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--SFVVYEYINRGSLATVL---SNNFASE 604
K F E+K L IRHR++VK G+CS + ++YEY+ GS+ L N E
Sbjct: 988 -KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKE 1046
Query: 605 DFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
W R+ + G+A + Y+H+DC PPIVHRDI S+NVLLD EA + DFG AK+L
Sbjct: 1047 VLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTG 1106
Query: 665 NSSNWTE----LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH 720
N TE G++GY+AP E AY++K TEK DVYS G++ +E++ GK
Sbjct: 1107 NYDTNTESNTMFAGSYGYIAP----------EYAYSLKATEKSDVYSMGIVLMEIVTGKM 1156
Query: 721 PGDXXXXXXXXXXXINIEFNAMLDHRLPHPSLDVQEKLIS----------------IMEV 764
P + +E +LD P P + +EKLI ++E+
Sbjct: 1157 PTEAMFDEETDMVRW-VE--TVLD--TP-PGSEAREKLIDSELKSLLPCEEEAAYQVLEI 1210
Query: 765 ALLCLDGCPNSRPTMQTVCQLL 786
AL C P RP+ + + L
Sbjct: 1211 ALQCTKSYPQERPSSRQASEYL 1232
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 786 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-88 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-58 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 0.002 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.004 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = 9e-88
Identities = 227/782 (29%), Positives = 362/782 (46%), Gaps = 94/782 (12%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L +LDL N G +P + NL L+YL L +N+LSG IPP I L L SLDLS N S
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G P + L NL+ + L +N +G IP + +L +L L L +N+F+G++P+N+ +
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357
Query: 147 LEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
L +L ++ N+ G IP L + +L + L N+L G I + G +L+ + L N+F
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
GE+ S + K + L +S NN+ GRI + L +L L+ N G +P +
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKR 476
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L L L NQ SG +PR LG L+EL LS N+L S
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL------------------------S 512
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
EIP++L+ L LDLSHN G IP+ + L +L+LS N +SG+IP +
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572
Query: 386 LLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLLSHKEAS--------KK 437
L+ ++IS+N L G +P +FL N S G DL S +K
Sbjct: 573 LVQVNISHNHLHGSLP--------STGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK 624
Query: 438 TP--FLILFPLLGALALLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGK 495
TP + + LGA +L + V F+F R + + + + + G + FD K
Sbjct: 625 TPSWWFYITCTLGAFLVLAL-VAFGFVFIRGRNNLELK----RVENEDGTWELQF-FDSK 678
Query: 496 IM----YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGD-KIAVKKFNSPFPNDQMSDQ 550
+ +I+ K+ + I +G+ + Y+ K + VK+ N + +
Sbjct: 679 VSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEIND---VNSIP-- 730
Query: 551 KEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRK 610
+EI + K++H NIVK G C + +++++EYI +L+ VL N W +
Sbjct: 731 ---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWER 781
Query: 611 RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670
R + G+A AL ++H C P +V ++S +++D + E + L ++
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RLSLPGLLCTDTK 837
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
+ + YVAP E T ITEK D+Y FG++ +E++ GK P D
Sbjct: 838 CFISS-AYVAP----------ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 731 S------SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
S + + +D + Q +++ +M +AL C P +RP V +
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 785 LL 786
L
Sbjct: 947 TL 948
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 6e-58
Identities = 152/450 (33%), Positives = 220/450 (48%), Gaps = 39/450 (8%)
Query: 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLS-KLKYLDLSEN 60
RV SI+L+ + G + F P++ ++LS N G +P + S L+YL+LS N
Sbjct: 70 RVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128
Query: 61 ELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGN 119
+G IP G + +L +LDLS N SG P I + S+LK + L N L G IP + N
Sbjct: 129 NFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
Query: 120 LMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNN 179
L L +L L +NQ GQ+PR LG + +SL +LG NN
Sbjct: 187 LTSLEFLTLASNQLVGQIPRE-----------------LGQM------KSLKWIYLGYNN 223
Query: 180 LTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS 239
L+G I + G +L LDL +NN G I S+ G L L + N ++G IPP I +
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR 299
+L LDLS N ++GEIP + +L +L L L N +G +P AL L L+ L SN+
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 300 LNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNL 359
+ I + LG L L+ S N + EIPE L +L +L L N +G IP +
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 360 ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN------STVFRNAPRES 413
SL ++ L N+ SG++P+ F + + +DIS N L+G I + S + R
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 414 FLGNNFSTFYGTSDL----LSHKEASKKTP 439
F G +G+ L LS + S P
Sbjct: 464 FFG-GLPDSFGSKRLENLDLSRNQFSGAVP 492
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-48
Identities = 121/332 (36%), Positives = 166/332 (50%), Gaps = 27/332 (8%)
Query: 74 THLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNL-MKLSYLMLDTN 131
+ + S+DLS SG I L ++ I+L NN+LSG IP++I L YL L N
Sbjct: 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128
Query: 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIY 191
FTG +PR GSIPNL L N L+G I D G +
Sbjct: 129 NFTGSIPR-------------------GSIPNLETL------DLSNNMLSGEIPNDIGSF 163
Query: 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNH 251
+LK LDL N G+I ++ L L ++ N + G+IP E+G L + L N+
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 252 IAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFM 311
++GEIP E+G L SLN L L N L+G +P +LG L L+Y L N+L+ I ++ +
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 312 FKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
KL L+ S N S EIPE + L +L L L N F G IP + +L L+ L L N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 372 ISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
SG+IP + L +D+S N L G IP
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G +VY A+ +G K+A+K D S +E L EI+ L K+ H NIVK Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK---KEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
G H ++V EY GSL +L N + + ++ + + L Y+H +
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 633 IVHRDISSNNVLLD-LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
I+HRD+ N+LLD + +++DFG +KLL + S +VGT Y+AP
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP---------- 162
Query: 692 E-LAYTMKITEKCDVYSFGVLALE 714
E L +EK D++S GV+ E
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 33/278 (11%)
Query: 513 CIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G G +VY+AK G +AVK + + EI+ L ++ H NIV+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK--DQTARREIRILRRLSHPNIVRL 63
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
H ++V EY G L LS + + + L Y+H +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN--- 117
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
I+HRD+ N+LLD +++DFG AK L +SS+ T VGT Y+AP
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP---------- 167
Query: 692 E-LAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
E L K DV+S GV+ E++ GK P FS + ++ +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPP------FSGENILDQLQLIRRILGPPLEF 221
Query: 751 S----LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
E+ +++ CL+ P+ RPT + + Q
Sbjct: 222 DEPKWSSGSEEAKDLIKK---CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 514 IGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G+G VY+ L ++AVK + +EFL E + + K+ H NI
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNI 63
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
VK G C+ +V EY+ G L L N ++ ++ +A + Y+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLESK 122
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGL 688
+HRD+++ N L+ ++SDFG ++ L + Y G + +
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-----------YYKVKGGKLPI 168
Query: 689 H-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDH 745
+A E K T K DV+SFGVL E+ G+ P +S + +
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA-------EVLEYLKKGY 221
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P E + ++ L C P RPT + ++L
Sbjct: 222 RLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 3e-37
Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 38/281 (13%)
Query: 514 IGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G+G VY+ KL ++AVK + +EFL E + + K+ H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNV 63
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
VK G C+ ++V EY+ G L + L N ++ +A + Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN--RPKLSLSDLLSFALQIARGMEYLESK 121
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGL 688
+HRD+++ N L+ ++SDFG ++ L + Y G + +
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-----------YYRKRGGKLPI 167
Query: 689 H-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDH 745
+A E K T K DV+SFGVL E+ G+ P +S + +
Sbjct: 168 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE-------EVLEYLKNGY 220
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P E + ++ L C P RPT + ++L
Sbjct: 221 RLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 76/274 (27%), Positives = 115/274 (41%), Gaps = 33/274 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G VY A+ +G +A+K D++ L EIK L K++H NIV+ Y
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIK---KKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 573 GFCSHVRHSFVVYEYINRGSLATVL-SNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
++V EY G L +L SED R + + AL Y+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED---EAR-FYLRQILSALEYLHSKG-- 117
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
IVHRD+ N+LLD + +++DFG A+ L P T VGT Y+AP
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAP---------- 165
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML-DHRLPHP 750
E+ + D++S GV+ E++ GK P F + + P P
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPP------FPGDDQLLELFKKIGKPKPPFPPP 219
Query: 751 SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
D+ + ++ LL D P R T + Q
Sbjct: 220 EWDISPEAKDLIR-KLLVKD--PEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 62/297 (20%)
Query: 514 IGKGEHRSVYRAKLPSGDKI----AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G+G VY+ KL D AVK + ++K+FL E + + K+ H N+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE---DASEEERKDFLKEARVMKKLGHPNVV 59
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV------ITGVADALS 623
+ G C+ ++V EY+ G L L + + +++ +A +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-----------WTEL 672
Y+ VHRD+++ N L+ + ++SDFG ++ + + W
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSS 731
AP E T K DV+SFGVL E+ G P LS
Sbjct: 175 -------AP----------ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----- 212
Query: 732 SSSINIEFNAML--DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E L +RLP P ++L +M L C P RPT + + L
Sbjct: 213 ----NEEVLEYLRKGYRLPKPE-YCPDELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 71/291 (24%), Positives = 113/291 (38%), Gaps = 57/291 (19%)
Query: 514 IGKGEHRSVYRAKL-PSGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G+G VY+ L G+ K+AVK +++EFL E + K+ H NI
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-H 627
V+ G C+ ++V EY+ G L L + E + + + +A + Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYV-----APA 682
+ VHRD+++ N L+ ++SDFG ++ + + G + AP
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAP- 173
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-------KGKHPGDFLSLFSSSSSSI 735
E K T K DV+SFGVL E+ G + L L
Sbjct: 174 ---------ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED----- 219
Query: 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+RLP P E + E+ L C P RPT + + L
Sbjct: 220 --------GYRLPRPENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 513 CIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G+G SVY A +G+ +AVK D + + EI+ L+ ++H NIV++
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 572 YGFCSHVRHSF--VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HD 628
YG + + EY++ GSL+++L + RK I + L+Y+H +
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL---EGLAYLHSNG 121
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE--LVGTFGYVAPAHGNI 686
IVHRDI N+L+D + +++DFG AK L + + GT ++AP
Sbjct: 122 ----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP----- 172
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + D++S G +E+ GK P
Sbjct: 173 -----EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 41/226 (18%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
F+ IGKG VY+A+ +G ++A+K +++ +NEI+ L K +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKH 56
Query: 566 RNIVKFYGFCSHVRHSFV--VYEYINRGSLATVLSNNFASEDFDWRKRMN------VITG 617
NIVK+YG S+++ + V E+ + GSL +L + + + V
Sbjct: 57 PNIVKYYG--SYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKE 106
Query: 618 VADALSYMH--HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
+ L Y+H I+HRDI + N+LL + E ++ DFG + L + +VGT
Sbjct: 107 LLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGT 160
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
++AP E+ K D++S G+ A+E+ +GK P
Sbjct: 161 PYWMAP----------EVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 41/219 (18%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE--FLNEIKALTKIRHRNIVK 570
IG+G VY+A +G ++A+KK + Q + +NEI + +H NIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR-------LRKQNKELIINEILIMKDCKHPNIVD 79
Query: 571 FYGFCSHV--RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN------VITGVADAL 622
+Y S++ +VV EY++ GSL +++ NF RMN V V L
Sbjct: 80 YYD--SYLVGDELWVVMEYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGL 129
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
Y+H ++HRDI S+N+LL + +++DFG A L S +VGT ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP- 185
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G++ +E+ +G+ P
Sbjct: 186 ---------EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 513 CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
IG+G VY+ L +GD +A+K+ + + K + EI L ++H NIVK+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
G +++ EY GSL ++ F + V L+Y+H
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQ--- 118
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI + N+L + +++DFG A L S + +VGT ++AP
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP---------- 168
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + D++S G +E++ G P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
D + +G+G VY+ + P+G A+KK + + +K+ L E+K L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV---DGDEEFRKQLLRELKTLRSCES 58
Query: 566 RNIVKFYG-FCSHVRHSFVVYEYINRGSLATVL-SNNFASEDFDWRKRMNVIT-GVADAL 622
+VK YG F S V+ EY++ GSLA +L E + I + L
Sbjct: 59 PYVVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPV-----LAYIARQILKGL 112
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
Y+H I+HRDI +N+L++ + E +++DFG +K+L+ VGT Y++P
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP- 169
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742
E + D++S G+ LE GK P FL S F +
Sbjct: 170 ---------ERIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPS-------FFEL 211
Query: 743 LDHRLPHPSLDVQEKLISIMEVALL--CLDGCPNSRPTMQTVCQLL 786
+ P + + S + CL P RP+ +LL
Sbjct: 212 MQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAA---ELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 39/220 (17%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSD-QKEFLNEIKALTKIRH---RNI 568
IG+G + +VYR K +P+G +A+K N P+D +SD Q+E + L+++R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE----VALLSQLRQSQPPNI 64
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT-GVADALSYMHH 627
K+YG +++ EY GS+ T++ +E + ++VI V AL Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY-----ISVIIREVLVALKYIHK 119
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIG 687
++HRDI + N+L+ ++ DFG A LL NSS + VGT ++AP
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP------ 170
Query: 688 LHLAELAYTMKITE------KCDVYSFGVLALEVIKGKHP 721
E+ ITE K D++S G+ E+ G P
Sbjct: 171 ----EV-----ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 81/278 (29%), Positives = 123/278 (44%), Gaps = 44/278 (15%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G VY A L +G+ +AVK+ ++ KE +E+K L ++H N+VK+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA----DALSYMHHD 628
G H ++ EY + G+L +L + D +VI + L+Y+H
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHG-RILD------EHVIRVYTLQLLEGLAYLHSH 118
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE----LVGTFGYVAPAHG 684
IVHRDI N+ LD ++ DFG A LK N++ E L GT Y+AP
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP--- 172
Query: 685 NIGLHLAELAYTMKITEK---CDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741
E+ K D++S G + LE+ GK P +S + I F+
Sbjct: 173 -------EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP------WSELDNEFQIMFHV 219
Query: 742 MLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPT 778
H+ P P SL + + ++ CL+ P RPT
Sbjct: 220 GAGHKPPIPDSLQLSPEGKDFLD---RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 6e-22
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 36/285 (12%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
++ IGKG VY + G +K+ + +++ ++++ LNE+K L K+ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNH 58
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN-NFASEDFDWRKRMNVITGVADALSY 624
NI+K+Y +V EY + G L+ + + F + ++ + AL Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 625 MH--HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
+H I+HRDI N+ L ++ DFG +K+L +VGT Y++P
Sbjct: 119 LHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP- 172
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742
EL K D++S G + E+ KHP F ++ +
Sbjct: 173 ---------ELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F------EGENLLELALKI 215
Query: 743 LDHRLPHPSLDVQ--EKLISIMEVALLCLDGCPNSRPTMQTVCQL 785
L + +P + Q +L +++ L P RP++ + Q
Sbjct: 216 L--KGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.5 bits (241), Expect = 1e-21
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 22/275 (8%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKFY 572
+G+G VY A+ +A+K + + FL EI+ L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKE-VERFLREIQILASLNHPPNIVKLY 64
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
F ++V EY++ GSL +L + + ++ + AL Y+H
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 633 IVHRDISSNNVLLDLEY-EARVSDFGTAKLLKPNSSN------WTELVGTFGYVAPAHGN 685
I+HRDI N+LLD + ++ DFG AKLL S + VGT GY+AP
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE--- 178
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI-NIEFNAMLD 744
+ + D++S G+ E++ G P + S++S ++ I
Sbjct: 179 ----VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779
P + + + ++ L P +R +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFL-----NEIKALTKIRHRN 567
IG G SVY SG+ +AVK+ P + D+K + EI L +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
IV++ G H + EY+ GS+A +L+N A E+ R N + + L+Y+H+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---NFVRQILKGLNYLHN 124
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT------ELVGTFGYVAP 681
I+HRDI N+L+D + ++SDFG +K L+ NS + L G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ T K D++S G L +E++ GKHP
Sbjct: 182 ----------EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
DF+ IGKG V++ + ++ A+K+ + +++E ++E + L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFA---SEDFDWRKRMNVITGVADAL 622
I+++Y +V EY G L +L ED WR + ++ G L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
+++H I+HRDI S N+ LD ++ D G AKLL N++ +VGT Y++P
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP- 170
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723
EL EK DV++ GV+ E GKHP D
Sbjct: 171 ---------ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 50/282 (17%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQM-SDQKEFLNEIKALTKIRHRNIVKF 571
IG G VY A LP+ +K+A+K+ + ++ + E E++A+++ H N+VK+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 572 YGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
Y S V ++V Y++ GSL ++ +++ D V+ V L Y+H +
Sbjct: 65 Y--TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFG-TAKLLKPNSSNW---TELVGTFGYVAPA--- 682
+HRDI + N+LL + +++DFG +A L VGT ++AP
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 683 --HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740
HG Y K D++SFG+ A+E+ G P S + + N
Sbjct: 180 QVHG----------YD----FKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQN 222
Query: 741 AMLDHRLPHPSLDVQEKLI----SIMEVALLCLDGCPNSRPT 778
PSL+ S ++ LCL P+ RPT
Sbjct: 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 46/285 (16%)
Query: 514 IGKGEHRSVYRA--KLPSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG GE V R KLP +I A+K + + Q D FL E + + H NI+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPNII 68
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
+ G + R ++ EY+ GSL L N F + + ++ G+A + Y+
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG--YVAPAHGNIG 687
+ VHRD+++ N+L++ +VSDFG ++ L+ + + +T G + AP
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP------ 177
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSS-----SSINIEFNA 741
+AY K T DV+SFG++ EV+ G+ P + S ++ +
Sbjct: 178 ---EAIAYR-KFTSASDVWSFGIVMWEVMSYGERP------YWDMSNQDVIKAVEDGY-- 225
Query: 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P +D L +M L C N RPT + L
Sbjct: 226 ----RLPPP-MDCPSALYQLM---LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G+ V+ K + K+A+K N MS++ +F+ E K + K+ H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEE-DFIEEAKVMMKLSHPKLVQLYG 66
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM--NVITGVADALSYMHHDCFP 631
C+ + ++V E++ G L L K M ++ V + + Y+ + F
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNSF- 121
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
+HRD+++ N L+ +VSDFG + + + E + G P +
Sbjct: 122 --IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFP----VKWSPP 170
Query: 692 ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLP 748
E+ K + K DV+SFGVL EV +GK P F S N E M+ RL
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP------FEKKS---NYEVVEMISRGFRLY 221
Query: 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
P L ++ EV C P RPT + + +
Sbjct: 222 RPKLASM----TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 54/287 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IGKG VY+ L ++AVK S P D +++FL E + L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
C + ++V E + GSL T L +K + + A + Y+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKL-----------LKPNSSNWTELVGTFGYVAPA 682
+HRD+++ N L+ ++SDFG ++ LK WT AP
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT---------APE 165
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK---GKHPGDFLSLFSSSSSSINIEF 739
N G + T + DV+S+G+L E +PG S+ + IE
Sbjct: 166 ALNYG----------RYTSESDVWSYGILLWETFSLGDTPYPG-----MSNQQTRERIES 210
Query: 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+R+P P L E++ +M L C P +RP+ + L
Sbjct: 211 G----YRMPAPQL-CPEEIYRLM---LQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQ-KEFL-NEIKALTKIR 564
D++ IGKG +V + + S KI V K M+++ K+ L +E+ L +++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEID---YGNMTEKEKQQLVSEVNILRELK 57
Query: 565 HRNIVKFYGFCSHVRHSFVVY---EYINRGSLATVLS-----NNFASEDFDWRKRMNVIT 616
H NIV++Y R + +Y EY G LA ++ + E+F WR ++T
Sbjct: 58 HPNIVRYYDR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILT 112
Query: 617 GVADALSYMHH--DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ AL H+ D ++HRD+ N+ LD ++ DFG AK+L +SS VG
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
T Y++P E M EK D++S G L E+ P
Sbjct: 173 TPYYMSP----------EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 66/281 (23%), Positives = 125/281 (44%), Gaps = 52/281 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G V+ + ++A+K S D + Q++F E++AL ++RH++++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKS----DDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
CS +++ E + +GSL L + + +++ VA+ ++Y+
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLK-----PNSSN----WTELVGTFGYVAPAHG 684
+HRD+++ N+L+ + +V+DFG A+L+K + WT AP
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---------AP--- 173
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAML 743
E A + K DV+SFG+L E+ G+ P ++ N E +
Sbjct: 174 -------EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---------NHEVYDQI 217
Query: 744 D--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+R+P P+ QE + IM L C P RP+ + +
Sbjct: 218 TAGYRMPCPAKCPQE-IYKIM---LECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 40/238 (16%)
Query: 499 EEIIRRTK------DFDAKYC----IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQM 547
EEI+ + + D KY IG+G +VY A + +G ++A+K+ N Q
Sbjct: 2 EEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-----QQ 56
Query: 548 SDQKEFL-NEIKALTKIRHRNIVKF---YGFCSHVRHSFVVYEYINRGSLATVLSNNFAS 603
+KE + NEI + + +H NIV + Y + +VV EY+ GSL V++
Sbjct: 57 QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL---WVVMEYLAGGSLTDVVTETCMD 113
Query: 604 EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663
E + V AL ++H + ++HRDI S+N+LL ++ +++DFG +
Sbjct: 114 EG----QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P S + +VGT ++AP E+ K D++S G++A+E+++G+ P
Sbjct: 167 PEQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 75/284 (26%), Positives = 115/284 (40%), Gaps = 80/284 (28%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
K+ IGKGE V G K+AVK +D + Q FL E +T +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLK----DDSTAAQA-FLAEASVMTTLRH 59
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG-------- 617
N+V+ G ++V EY+ +GSL L + R R VIT
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS---------RGR-AVITLAQQLGFAL 109
Query: 618 -VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF 676
V + + Y+ F VHRD+++ NVL+ + A+VSDFG AK ++ + G
Sbjct: 110 DVCEGMEYLEEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKL 161
Query: 677 --GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734
+ AP E K + K DV+SFG+L E+ +S
Sbjct: 162 PVKWTAP----------EALREKKFSTKSDVWSFGILLWEI------------YSFG--- 196
Query: 735 INIEFNAMLDHRLPHPSLDVQEKLISI-----MEVALLCLDGCP 773
R+P+P + +++ + + ME +GCP
Sbjct: 197 -----------RVPYPRIPLKDVVPHVEKGYRME----APEGCP 225
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 73/295 (24%), Positives = 130/295 (44%), Gaps = 56/295 (18%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVK--KFNSPFPNDQMSDQKEFLNEI 557
EI R + + K +G G+ V+ K+AVK K + P FL E
Sbjct: 2 EIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-------FLQEA 52
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
+ + K+RH +V+ Y CS ++V EY+++GSL L + + +++
Sbjct: 53 QIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQ 111
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--------- 668
+A+ ++Y+ + +HRD+++ N+L+ +++DFG A+L++ +
Sbjct: 112 IAEGMAYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 669 -WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLS 726
WT AP N G + T K DV+SFG+L E++ G+ P
Sbjct: 169 KWT---------APEAANYG----------RFTIKSDVWSFGILLTEIVTYGRVP----- 204
Query: 727 LFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQT 781
+ ++ +E +R+P P + E+L +M L C D P RPT +
Sbjct: 205 -YPGMTNREVLE-QVERGYRMPRPP-NCPEELYDLM---LQCWDKDPEERPTFEY 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G+ V+ K +A+K MS+ +F+ E K + K+ H N+V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSED-DFIEEAKVMMKLSHPNLVQLYG 66
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
C+ R F+V EY+ G L L +W +++ + V +A+ Y+ + F
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGF--- 121
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+++ N L+ + +VSDFG A+ + + + + G P + E+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-----QYTSSQGTKFP----VKWAPPEV 172
Query: 694 AYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSL 752
+ + K DV+SFGVL EV +GK P + S+S +E + +RL P L
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMP------YERFSNSEVVESVSA-GYRLYRPKL 225
Query: 753 DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E + + C P RP + + L
Sbjct: 226 APTE----VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 33/238 (13%)
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDF 606
MS+ EF+ E K + K+ H +V+ YG C+ R ++V EY++ G L L + + F
Sbjct: 41 MSED-EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH--GKRF 97
Query: 607 DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666
+ + + V + ++Y+ F +HRD+++ N L+D + +VSDFG ++ + +
Sbjct: 98 QPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
Query: 667 SNWTELVGT---FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPG 722
+T VG+ + P E+ K + K DV++FGVL EV GK P
Sbjct: 155 --YTSSVGSKFPVRWSPP----------EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202
Query: 723 DFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
+ F++S + + RL P L EK+ +IM C RPT Q
Sbjct: 203 E---RFNNSETVEKV----SQGLRLYRPHL-ASEKVYAIMYS---CWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 24/210 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFL-NEIKALTKIRHRNIVKF 571
IG+G +V+ A + +G ++A+K+ N Q +KE + NEI + ++++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELIINEILVMKELKNPNIVNF 81
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
FVV EY+ GSL V++ E + V AL ++H +
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN--- 134
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI S+NVLL ++ +++DFG + P S + +VGT ++AP
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP---------- 184
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G++A+E+++G+ P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 42/288 (14%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
EI R + K +G G+ V+ + +AVK M D K+FL E +
Sbjct: 2 EIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKP----GTM-DPKDFLAEAQI 54
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ K+RH +++ Y C+ ++V E + GSL L A + +++ VA
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVA 113
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---F 676
++Y+ + +HRD+++ NVL+ +V+DFG A+++K + E G
Sbjct: 114 SGMAYLEAQNY---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPI 168
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSI 735
+ AP E A + + K DV+SFG+L E++ G+ P
Sbjct: 169 KWTAP----------EAALYNRFSIKSDVWSFGILLTEIVTYGRMP---------YPGMT 209
Query: 736 NIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQT 781
N E +D R+P P ++L IM L C P+ RPT +T
Sbjct: 210 NAEVLQQVDQGYRMPCPP-GCPKELYDIM---LDCWKEDPDDRPTFET 253
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-18
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFL-NEIKALTKIRHRNIVKF 571
IG+G +VY A + +G ++A+++ N Q +KE + NEI + + ++ NIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVMRENKNPNIVNY 82
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
+VV EY+ GSL V++ E + V AL ++H +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN--- 135
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI S+N+LL ++ +++DFG + P S + +VGT ++AP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP---------- 185
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G++A+E+I+G+ P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 75/283 (26%), Positives = 109/283 (38%), Gaps = 43/283 (15%)
Query: 514 IGKGE----HRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G G + VY K ++AVK + +KEFL E + ++ H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 570 KFYGFCSHVRHSFV-VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
+ G C + V E G L L + + VA ++Y+
Sbjct: 60 RLIGVC--KGEPLMLVMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK 114
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN--I 686
F VHRD+++ NVLL ++A++SDFG ++ L S Y A G +
Sbjct: 115 HF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---------YRATTAGRWPL 162
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD- 744
+ E K + K DV+S+GV E G P + E AML+
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---------GAEVIAMLES 213
Query: 745 -HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P QE + SIM L C P RPT +
Sbjct: 214 GERLPRPEECPQE-IYSIM---LSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 41/239 (17%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKI- 563
DF IG+G +V AK +K A+K + + K E + LT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLN 59
Query: 564 RHRNIVKFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADAL 622
H I+K Y + + + V EY G L + + S D + + AL
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTR--FYAAEILLAL 115
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE----------- 671
Y+H I+HRD+ N+LLD + +++DFGTAK+L PNSS +
Sbjct: 116 EYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 672 ---------LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT YV+P EL + D+++ G + +++ GK P
Sbjct: 173 EKNRRRFASFVGTAEYVSP----------ELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 41/89 (46%), Positives = 53/89 (59%)
Query: 197 LDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI 256
L L + G I ++ K L ++ +SGN+I G IPP +G+ + L VLDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 257 PMELGRLISLNKLILRGNQLSGHLPRALG 285
P LG+L SL L L GN LSG +P ALG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 37/281 (13%)
Query: 514 IGKGEHRSVYRAKLP-SGDK---IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG GE V+R L G K +A+K + Q D FL+E + + H NI+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHNII 69
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
+ G + + + ++ EY+ G+L L ++ +F + + ++ G+A + Y+
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-SSNWTELVGTFG--YVAPAHGNI 686
+ VHRD+++ N+L++ E +VSDFG +++L+ + +T G + AP
Sbjct: 128 Y---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP----- 179
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDH 745
+AY K T DV+SFG++ EV+ G+ P +S +IN F
Sbjct: 180 ----EAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVMKAINDGF------ 227
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P +D + +M L C RP + LL
Sbjct: 228 RLPAP-MDCPSAVYQLM---LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDK---IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG GE V R +L G + +A+K S + Q +++FL+E + + H NI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNII 68
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
G + R ++ E++ G+L + L N F + + ++ G+A + Y+
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLH 689
+ VHRD+++ N+L++ +VSDFG ++ L+ ++S+ T Y + G I +
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT-------YTSSLGGKIPIR 176
Query: 690 LA---ELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN-IEFNAMLD 744
+AY K T DV+S+G++ EV+ G+ P + + S+ IN IE D
Sbjct: 177 WTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP--YWDM--SNQDVINAIE----QD 227
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+RLP P +D L +M L C N+RP + L
Sbjct: 228 YRLP-PPMDCPTALHQLM---LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFL-NEIKALTKIRHRNIVKF 571
IG+G +VY A + +G ++A+K+ N Q +KE + NEI + + ++ NIV +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNL-----QQQPKKELIINEILVMRENKNPNIVNY 81
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
+VV EY+ GSL V++ E + V AL ++H +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALDFLHSN--- 134
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI S+N+LL ++ +++DFG + P S + +VGT ++AP
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP---------- 184
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G++A+E+++G+ P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 37/269 (13%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IG G+ V+ K+A+K MS++ +F+ E + + K+ H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA----MSEE-DFIEEAQVMMKLSHPKLVQLYG 66
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
C+ +V+E++ G L+ L F + + V + ++Y+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESSNV--- 121
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---FGYVAPAHGNIGLHL 690
+HRD+++ N L+ +VSDFG + + + +T GT + +P
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSP--------- 170
Query: 691 AELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749
E+ K + K DV+SFGVL EV +GK P + + S+S + NA RL
Sbjct: 171 -EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE-----NRSNSEVVETINA--GFRLYK 222
Query: 750 PSLDVQEKLISIMEVALLCLDGCPNSRPT 778
P L Q S+ E+ C P RP+
Sbjct: 223 PRLASQ----SVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 54/297 (18%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQK---EFLNEIKAL 560
+F + IGKG+ VY+A L G +A+KK F +M D K + L EI L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI-F---EMMDAKARQDCLKEIDLL 56
Query: 561 TKIRHRNIVKFYGFCSHVRHSFV-------VYEYINRGSLATVLSNNFASED--FDWRKR 611
++ H N++K+ SF+ V E + G L+ ++ +F + R
Sbjct: 57 KQLDHPNVIKYLA-------SFIENNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTI 108
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+ AL +MH I+HRDI NV + ++ D G + ++
Sbjct: 109 WKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
Query: 672 LVGTFGYVAPA--HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GDFLSL 727
LVGT Y++P H N Y K D++S G L E+ + P GD ++L
Sbjct: 166 LVGTPYYMSPERIHEN--------GYNF----KSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+S ++ P P+ E+L ++ C++ P RP + V Q
Sbjct: 214 YSLCKKIEKCDYP-------PLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVK--KFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
+G G S Y+A+ + +G +AVK + ++Q + EI+ + ++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G H + E++ GS++ +LS A F +N + LSY+H +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 631 PPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTE----LVGTFGYVAPAHGN 685
I+HRD+ N+L+D R++DFG A L + E L+GT ++AP
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP---- 177
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + CDV+S G + +E+ K P
Sbjct: 178 ------EVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 53/286 (18%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQK-----EFLN-EIKALTKIRHR 566
IGKG + VY A + +G+ +AVK+ P D + + L EI+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
NIV++ GF + + + EY+ GS+ + L F+ + V + L+Y+H
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH 125
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK---PNSSNWTELVGTFGYVAPAH 683
I+HRD+ ++N+L+D + ++SDFG +K N N + G+ ++AP
Sbjct: 126 SK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-MSMQGSVFWMAPEV 181
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-------GDFLSLFSSSSSSIN 736
+H Y+ K+ D++S G + LE+ G+ P L + S
Sbjct: 182 ----IHSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS---- 229
Query: 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGC----PNSRPT 778
P P + +++ VAL L+ C P++RPT
Sbjct: 230 ---------APPIPP----DVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 58/291 (19%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEF---LNEIKALT 561
+D++ IG G + VY+A+ + +G+ +A+K + +F EI L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFEIIQQEISMLK 55
Query: 562 KIRHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFA--SED---FDWRKRMNV 614
+ RH NIV ++G S++R ++V EY GSL + SE + R+
Sbjct: 56 ECRHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE---T 110
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ G L+Y+H +HRDI N+LL + + +++DFG + L + +G
Sbjct: 111 LKG----LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG 163
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK------HPGDFLSLF 728
T ++AP +A + KCD+++ G+ A+E+ + + HP L L
Sbjct: 164 TPYWMAP-------EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI 216
Query: 729 SSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIM-EVALLCLDGCPNSRPT 778
S S+ P P L +EK + + CL P RPT
Sbjct: 217 SKSN--------------FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 48/292 (16%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G+G V + P GD +AVK N SD F EI+ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 569 VKFYGFC--SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
VK+ G C R ++ EY+ GSL L + + ++ + + + + Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ--RHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS----SNWTELVGTFGYVAPA 682
+HRD+++ N+L++ E ++SDFG AK+L + F Y AP
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP- 181
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI----KGKHP-GDFLSLFSSSSSSINI 737
E T K + DV+SFGV E+ + P +FL + I I
Sbjct: 182 ---------ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM-------IGI 225
Query: 738 EFNAMLDHRL-----PHPSLDVQEKLIS-IMEVALLCLDGCPNSRPTMQTVC 783
M+ RL L + ++ LC + P RP+ +
Sbjct: 226 AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 506 KDFDAKYCIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
+ FD +G+G + SVY+A +G +A+K P + D +E + EI L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV----PVE--EDLQEIIKEISILKQCD 56
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
IVK+YG ++V EY GS++ ++ ++ + ++ L Y
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEY 114
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+H +HRDI + N+LL+ E +A+++DFG + L + ++GT ++AP
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP--- 168
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + K D++S G+ A+E+ +GK P
Sbjct: 169 -------EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 513 CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLN-EIKALTKIRHRNIVK 570
CIGKG VY+A + +A+K + ++ D+ E + EI+ L++ R I K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 571 FYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
+YG S ++ S +++ EY GS +L D ++ V L Y+H +
Sbjct: 64 YYG--SFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHEE 117
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGL 688
+HRDI + N+LL E + +++DFG + L S VGT ++AP
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP------- 167
Query: 689 HLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ EK D++S G+ A+E+ KG+ P
Sbjct: 168 ---EVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 43/293 (14%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
EI R + D K +G+G V+ K+A+K P M + FL E +
Sbjct: 2 EIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEA--FLQEAQI 54
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ K+RH +V Y S ++V E++ +GSL L + + +++ +A
Sbjct: 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIA 112
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---F 676
D ++Y+ + +HRD+ + N+L+ +++DFG A+L++ N +T G
Sbjct: 113 DGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPI 167
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSI 735
+ AP E A + T K DV+SFG+L E++ KG+ P +
Sbjct: 168 KWTAP----------EAALYGRFTIKSDVWSFGILLTELVTKGRVP---------YPGMV 208
Query: 736 NIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E ++ +R+P P Q S+ E+ LC P+ RPT + + L
Sbjct: 209 NREVLEQVERGYRMPCP----QGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 37/284 (13%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
EI R + K +G G+ V+ K+AVK MS + FL E +
Sbjct: 2 EIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLKP----GTMSPES-FLEEAQI 54
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ K+RH +V+ Y S ++V EY+++GSL L + +++ VA
Sbjct: 55 MKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVA 112
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYV 679
++Y+ + +HRD+ S N+L+ +++DFG A+L++ N E G
Sbjct: 113 AGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFGLARLIEDN-----EYTARQGAK 164
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIE 738
P I E A + T K DV+SFG+L E++ KG+ P ++ N E
Sbjct: 165 FP----IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---------NRE 211
Query: 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
++ +R+P P Q+ IS+ E+ L C P RPT +
Sbjct: 212 VLEQVERGYRMPCP----QDCPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 502 IRRTKDFDAKYCIGKGEHRSVYRAKLPSGDK-IAVKKFNSPFPNDQMSDQKEFLNEIKAL 560
+ RT D K+ +G G++ VY +AVK D M +EFL E +
Sbjct: 3 MERT-DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTME-VEEFLKEAAVM 56
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
+I+H N+V+ G C+ +++ E++ G+L L ++ + + + T ++
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISS 115
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
A+ Y+ F +HRD+++ N L+ + +V+DFG ++L+ ++ Y A
Sbjct: 116 AMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----------YTA 161
Query: 681 PAHGNIGLHLA---ELAYTMKITEKCDVYSFGVLALEV 715
A + LAY K + K DV++FGVL E+
Sbjct: 162 HAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 56/291 (19%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+GKG SV + P D +AVKK + ++F EI+ L ++H NI
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ----HSTAEHLRDFEREIEILKSLQHDNI 67
Query: 569 VKFYGFC-SHVRHSF-VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
VK+ G C S R + +V EY+ GSL L + E D RK + + + + Y+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG 125
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+ VHRD+++ N+L++ E ++ DFG K+L + + P I
Sbjct: 126 SKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK-------VREPGESPI 175
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH- 745
+ E K + DV+SFGV+ E L +S S S EF M+ +
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYE----------LFTYSDKSCSPPAEFMRMMGND 225
Query: 746 ------------------RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
RLP P ++ +IM C + P+ RP+
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAP-PGCPAEIYAIM---KECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+GKG + VY A+ L + +IA+K+ P + EI + ++HRNIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI----PERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG-VADALSYMHHDCFP 631
G S + E + GSL+ +L + + D + + T + + L Y+H +
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK-DNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 632 PIVHRDISSNNVLLDLEYEA--RVSDFGTAKLL---KPNSSNWTELVGTFGYVAPA---H 683
IVHRDI +NVL++ Y ++SDFGT+K L P + +T GT Y+AP
Sbjct: 128 QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDK 183
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
G G D++S G +E+ GK P
Sbjct: 184 GPRGYGAP-----------ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 43/287 (14%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
EI R + + K +G+G V+ ++A+K MS + FL E +
Sbjct: 2 EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEA-FLQEAQV 54
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ K+RH +V+ Y S ++V EY+++GSL L + + +++ +A
Sbjct: 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIA 112
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---F 676
++Y+ + VHRD+ + N+L+ +V+DFG A+L++ N +T G
Sbjct: 113 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPI 167
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV-IKGKHPGDFLSLFSSSSSSI 735
+ AP E A + T K DV+SFG+L E+ KG+ P +
Sbjct: 168 KWTAP----------EAALYGRFTIKSDVWSFGILLTELTTKGRVP---------YPGMV 208
Query: 736 NIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
N E ++ +R+P P E S+ ++ C P RPT +
Sbjct: 209 NREVLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 68/251 (27%), Positives = 111/251 (44%), Gaps = 38/251 (15%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN---EIKALTKIRHRNIVK 570
+GKG + +VY G IAVK+ ++ ++ +KE+ E+ L ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
+ G C + E++ GS++++L+ + + K I D ++Y+H++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC- 122
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
+VHRDI NNV+L ++ DFG A+ L W L GT H N+ +
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA-----WVGLHGT-------HSNMLKSM 168
Query: 691 AELAYTMK---ITE-----KCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742
Y M I E K D++S G E+ GK P +S + F +
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP-------LASMDRLAAMF-YI 220
Query: 743 LDHRLPHPSLD 753
HR P L
Sbjct: 221 GAHRGLMPRLP 231
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G+G SV + +L + I K + PN + QK+ L E++ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL--QKQILRELEINKSCKSPYIVKYYG 66
Query: 574 FCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT---------GVADAL 622
S + EY GSL ++ +KR I V L
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKK--------VKKRGGRIGEKVLGKIAESVLKGL 118
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
SY+H I+HRDI +N+LL + + ++ DFG + L NS T GT Y+AP
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-NSLAGT-FTGTSFYMAPE 173
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ Y++ DV+S G+ LEV + + P
Sbjct: 174 ------RIQGKPYSI----TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 62/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALTKIRHRNIV 569
+GKG V + K+ A+K ++ +KE L E L++I H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK----KKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 570 K-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFA-SEDFDWRKRMNVITG-VADALSYMH 626
K Y F + ++V EY G L + LS SE+ R + AL Y+H
Sbjct: 57 KLHYAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAAEIVLALEYLH 110
Query: 627 -HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
I++RD+ N+LLD + +++DFG AK L S GT Y+AP
Sbjct: 111 SLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAP---- 162
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + D +S GVL E++ GK P
Sbjct: 163 ------EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 72/294 (24%), Positives = 115/294 (39%), Gaps = 58/294 (19%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
DF +GKG + SVY+ K L A+K+ + + + ++++ +NEI+ L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVNEIRILASVNH 58
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN-----NFASEDFDWRKRMNVITGVAD 620
NI+ + +V EY G L+ +S E WR + ++ G
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG--- 115
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
L +H I+HRD+ S N+LL ++ D G +K+LK N + T+ +GT Y+A
Sbjct: 116 -LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQ-IGTPHYMA 169
Query: 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740
P E+ + K D++S G L E+ P F
Sbjct: 170 P----------EVWKGRPYSYKSDIWSLGCLLYEMATFAPP-----------------FE 202
Query: 741 A--MLDHRL--------PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
A M D R P P + Q+ I L P RP +
Sbjct: 203 ARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS----MLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 506 KDFDAKYCIGKGEHRSV----YRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
K+ IGKGE V YR G+K+AVK ND + + FL E +T
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIK----NDATA--QAFLAEASVMT 54
Query: 562 KIRHRNIVKFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
++RH N+V+ G + ++V EY+ +GSL L + S + V +
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCE 113
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
A+ Y+ + F VHRD+++ NVL+ + A+VSDFG L K SS + A
Sbjct: 114 AMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTA 167
Query: 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715
P E K + K DV+SFG+L E+
Sbjct: 168 P----------EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G + VY+A+ +G+ +A+KK F + K L EIK L ++ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFP 631
H ++V+E+++ L ++ + + + + L++ H H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHGIL- 120
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
HRD+ N+L++ E +++DFG A+ +T V T Y AP
Sbjct: 121 ---HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP---------- 167
Query: 692 ELAYTMKI-TEKCDVYSFGVLALEVIKGK--HPGD 723
EL K + D++S G + E++ + PG
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 493 DGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKE 552
D + + E I+ + CI + +H SG ++AVK + + ++E
Sbjct: 18 DPRSLLENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDL-----RKQQRRE 63
Query: 553 FL-NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR 611
L NE+ + +H+N+V+ Y +V+ E++ G+L ++S +E+ +
Sbjct: 64 LLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QI 119
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
V V AL Y+H ++HRDI S+++LL L+ ++SDFG + +
Sbjct: 120 ATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
LVGT ++AP E+ + D++S G++ +E++ G+ P
Sbjct: 177 LVGTPYWMAP----------EVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 71/235 (30%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRN 567
IG+G + VY+A+ +G+ +A+KK M ++KE + EIK L K+RH N
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-------MENEKEGFPITAIREIKLLQKLRHPN 59
Query: 568 IVKFYGFC-SHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD----- 620
IV+ S + S ++V+EY+ D D +TG+ D
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYM----------------DHD-------LTGLLDSPEVK 96
Query: 621 ---------------ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL-KP 664
L Y+H + I+HRDI +N+L++ + +++DFG A+ K
Sbjct: 97 FTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
NS+++T V T Y P L L Y ++ D++S G + E+ GK
Sbjct: 154 NSADYTNRVITLWYRPPE-----LLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G + V + + +G+ +A+KKF +D+ +K L E+K L ++RH NIV
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDV-KKTALREVKVLRQLRHENIVNLK 66
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFP 631
++V+EY+ R +L +L + D + I + A++Y H H+
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCHSHN--- 120
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLK-PNSSNWTELVGTFGYVAPAHGNIGLHL 690
I+HRDI N+L+ ++ DFG A+ L+ +S T+ V T Y AP L +
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE-----LLV 174
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGK--HPGD 723
+ Y + DV++ G + E++ G+ PGD
Sbjct: 175 GDTNYGKPV----DVWAIGCIMAELLDGEPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 514 IGKGEHRSVYR---AKLPSGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G VY + G+ ++A+K N N M ++ EFLNE + + +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDF-------DWRKRMNVITGVAD 620
+V+ G S + + VV E + +G L + L + + +K + + +AD
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
++Y+ F VHRD+++ N ++ + ++ DFG + +
Sbjct: 131 GMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 59/281 (20%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQK--EFLNEIKALTKIRHRNIVK 570
IG G +VY A+ + + + +A+KK + + + S++K + + E++ L ++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 571 FYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMN------VITGVADALS 623
+ G C H+ ++V EY GS + +L + +K + + G L+
Sbjct: 80 YKG-CYLREHTAWLVMEYC-LGSASDILEVH--------KKPLQEVEIAAICHGALQGLA 129
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
Y+H +HRDI + N+LL +++DFG+A L+ P +S VGT ++AP
Sbjct: 130 YLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAP-- 180
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
+ L + E Y K+ DV+S G+ +E+ + K P LF+ NAM
Sbjct: 181 -EVILAMDEGQYDGKV----DVWSLGITCIELAERKPP-----LFN---------MNAM- 220
Query: 744 DHRLPH------PSLDVQEKLISIMEVALLCLDGCPNSRPT 778
L H P+L + CL P RP+
Sbjct: 221 -SALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 71/277 (25%), Positives = 108/277 (38%), Gaps = 44/277 (15%)
Query: 514 IGKGEHRSVYRA--KLPSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G G V R G I AVK S +D M D FL E + + H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENLI 59
Query: 570 KFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+ YG V +V E GSL L + F + +A+ + Y+
Sbjct: 60 RLYGV---VLTHPLMMVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLES 115
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT---ELVGTFGYVAPAHG 684
F +HRD+++ N+LL + + ++ DFG + L N ++ L F + AP
Sbjct: 116 KRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP--- 169
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSI--NIEFNA 741
E T + DV+ FGV E+ G+ P + L S S I I+
Sbjct: 170 -------ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGL---SGSQILKKIDKEG 217
Query: 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
RL P + + ++M L C P RPT
Sbjct: 218 ---ERLERPE-ACPQDIYNVM---LQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 102/358 (28%), Positives = 148/358 (41%), Gaps = 67/358 (18%)
Query: 40 GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNL 99
L + + S + LD SEN L+ P SLDL+LN+ + L+NL
Sbjct: 68 RLLSLDLLSPSGISSLDGSENLLNLLPLP---------SLDLNLNRLRSNISELLELTNL 118
Query: 100 KYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG 159
+ L NN ++ IP IG L N L+ L ++DN
Sbjct: 119 TSLDLDNNNIT-DIPPLIGL-----------------LKSN------LKELDLSDNKIES 154
Query: 160 SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLG 219
LRN PNLK LDLS N+ ++ L
Sbjct: 155 LPSPLRNL------------------------PNLKNLDLSFND-LSDLPKLLSNLSNLN 189
Query: 220 TLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH 279
L +SGN I+ +PPEI S L LDLS+N I E+ L L +L+ L L N+L
Sbjct: 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED- 246
Query: 280 LPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS 339
LP ++G L+ LE DLS+N++++ + +LG + L L+ S N S +ALL L
Sbjct: 247 LPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLS-NALPLIALLLLLL 303
Query: 340 ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
EL L+ L ++ L S+ N +N P + L ++ N L
Sbjct: 304 ELLLNLLLTLKALEL---KLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IG+GE +V + + +G K+AVK + FL E +TK+ H+N+V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY-------MH 626
H ++V E +++G+L L R R + V L + M
Sbjct: 67 VILH-NGLYIVMELMSKGNLVNFL-----------RTRGRALVSVIQLLQFSLDVAEGME 114
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+ +VHRD+++ N+L+ + A+VSDFG A+ + + ++L + AP
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKL--PVKWTAP----- 166
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSL 727
E K + K DV+S+GVL EV G+ P +SL
Sbjct: 167 -----EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQ--KEFLNEIKALTKIRHRNIVK 570
+G G SVY L GD AVK+ + + Q + K+ EI L+K++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSL-ADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
+ G + ++ E + GSLA +L + S F + L Y+H
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKK-YGS--FPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
VHRDI N+L+D +++DFG AK + S G+ ++AP
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFKGSPYWMAP--------- 170
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+A D++S G LE+ GK P
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 44/232 (18%)
Query: 514 IGKGEHRSVYRAKL----PSGDK--IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G V+ + P DK +AVK ND +K+F E + LT +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHEN 69
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG---------- 617
IVKFYG C+ +V+EY+ G L L ++ D + K + G
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH--GPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 618 ---VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+A + Y+ F VHRD+++ N L+ + ++ DFG ++ + ++++ + G
Sbjct: 128 AVQIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGG 182
Query: 675 T----FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
++ P E K T + DV+SFGV+ E+ GK P
Sbjct: 183 HTMLPIRWMPP----------ESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 40/242 (16%)
Query: 502 IRRTKDFDAKYCIGKGEHRSVYRAKL----PSGDK--IAVKKFNSPFPNDQMSDQKEFLN 555
I+R +D K +G+G V+ A+ P+ DK +AVK P ++ +K+F
Sbjct: 2 IKR-RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQR 56
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNF-------------A 602
E + LT ++H +IVKFYG C +V+EY+ G L L + A
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
+ + +++ + +A + Y+ F VHRD+++ N L+ ++ DFG ++
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSR-- 171
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM--KITEKCDVYSFGVLALEVIK-GK 719
++ T Y H + + M K T + DV+SFGV+ E+ GK
Sbjct: 172 --------DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
Query: 720 HP 721
P
Sbjct: 224 QP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 514 IGKGEHRSVYRAKLPS-GDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
I KG + V+ AK S GD A+K + DQ L E L++ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQ--VLTERDILSQAQSPYVVKL 58
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y ++ ++V EY+ G LA++L N S D D + I + AL Y+H +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVAR--IYIAEIVLALEYLHSN--- 112
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFG---------TAKLLKPNSSNWTELVGTFGYVAPA 682
I+HRD+ +N+L+D +++DFG L + +VGT Y+AP
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDYIAP- 170
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ ++ D +S G + E + G P
Sbjct: 171 ---------EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 33/268 (12%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQ-KEFLNEIKALTKIRHRNIVKF 571
IG G +VY A +++ AVKK + + Q +++ ++ + E+K L +++H N +++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS--YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 572 YGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G C H+ ++V EY GS + +L + + + + G L+Y+H
Sbjct: 87 KG-CYLKEHTAWLVMEYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
++HRDI + N+LL + +++DFG+A P +S VGT ++AP + L +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAP---EVILAM 192
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
E Y K+ DV+S G+ +E+ + K P L ++ S+ +I N P
Sbjct: 193 DEGQYDGKV----DVWSLGITCIELAERKPP---LFNMNAMSALYHIAQN-------DSP 238
Query: 751 SLDVQEKLISIMEVALLCLDGCPNSRPT 778
+L E S CL P RP
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 28/212 (13%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFL-NEIKALTKIRHRNIVKF 571
IG+G V A +G ++AVKK + + ++E L NE+ + +H NIV+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 572 YGFCSHV--RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
Y S++ +VV E++ G+L ++++ +E+ + V V ALS++H
Sbjct: 82 YS--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKALSFLHAQ- 134
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLH 689
++HRDI S+++LL + ++SDFG + LVGT ++AP
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE------V 186
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
++ L Y ++ D++S G++ +E++ G+ P
Sbjct: 187 ISRLPYGTEV----DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 36/277 (12%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G+ V+ + K+AVK MS Q FL E + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP----GTMSVQA-FLEEANLMKTLQHDKLVRLYA 68
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
+ +++ EY+ +GSL L ++ + K ++ +A+ ++Y+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERKNY--- 124
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---FGYVAPAHGNIGLHL 690
+HRD+ + NVL+ +++DFG A++++ N +T G + AP N G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFG--- 179
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749
T K DV+SFG+L E++ GK P + S+S ++ +R+P
Sbjct: 180 -------SFTIKSDVWSFGILLYEIVTYGKIP------YPGMSNS-DVMSALQRGYRMPR 225
Query: 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ ++L IM+ C RPT + +L
Sbjct: 226 ME-NCPDELYDIMK---TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 26/228 (11%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI- 563
T F+ IG+G + VY+A+ ++ K +++ +E E L K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYS 60
Query: 564 RHRNIVKFYGFCSHVRHS------FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT- 616
H NI FYG ++V E GS T L R + I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS-VTDLVKGL--RKKGKRLKEEWIAY 117
Query: 617 ---GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELV 673
L+Y+H + ++HRDI N+LL E ++ DFG + L +
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 674 GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
GT ++AP + + + DV+S G+ A+E+ GK P
Sbjct: 175 GTPYWMAPE-----VIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 75/281 (26%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 514 IGKGEHRSVY--RAKLPSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG GE V R KLP +I A+K + + Q +++FL+E + + H NI+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ---RRDFLSEASIMGQFDHPNII 68
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
G + + +V EY+ GSL L + F + + ++ G+A + Y+
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYLSDMG 126
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-SSNWTELVGTFG--YVAPAHGNI 686
+ VHRD+++ N+L++ +VSDFG +++L+ + + +T G + AP
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP----- 178
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDH 745
+AY K T DV+S+G++ EV+ G+ P + + S+ IE +
Sbjct: 179 ----EAIAYR-KFTSASDVWSYGIVMWEVMSYGERP--YWEM-SNQDVIKAIEEG----Y 226
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P +D L +M L C N RP + + +L
Sbjct: 227 RLPAP-MDCPAALHQLM---LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 36/270 (13%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG V++ + +A+K + D++ D ++ EI L++ + K+Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 573 GFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G S+++ + +++ EY+ GS +L + FD + ++ + L Y+H +
Sbjct: 69 G--SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE-- 120
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
+HRDI + NVLL + + +++DFG A L VGT ++AP
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP--------- 170
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
E+ K D++S G+ A+E+ KG+ P +S + + F L + P
Sbjct: 171 -EVIQQSAYDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLF---LIPKNNPP 219
Query: 751 SLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
+L E E CL+ P+ RPT +
Sbjct: 220 TL-TGEFSKPFKEFIDACLNKDPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 33/236 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G V K+ A+K + Q+ +E + L + H IVK Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
++ +++ EY G L T+L + +++ R I V A Y+H+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR---FYIACVVLAFEYLHNR---G 113
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP----AHGNIGL 688
I++RD+ N+LLD ++ DFG AK LK WT GT YVAP G
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKG---- 168
Query: 689 HLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
Y D +S G+L E++ G+ P F +N +L
Sbjct: 169 ------YDF----SVDYWSLGILLYELLTGRPP------FGEDDEDPMEIYNDILK 208
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFL-NEIKALTKIRHRNIVKF 571
CI +H +G ++AVKK + + ++E L NE+ + H N+V
Sbjct: 39 CIATEKH---------TGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y +VV E++ G+L ++++ +E+ + V V ALSY+H+
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ--- 137
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI S+++LL + ++SDFG + LVGT ++AP ++
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE------VIS 191
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L Y ++ D++S G++ +E+I G+ P
Sbjct: 192 RLPYGTEV----DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 514 IGKGEHRSVY--RAKLPSGDKIAVKKFNSPFPNDQMSDQKE-------FLNEIKALTK-I 563
+G G VY R K + +A+K+ N P D++E ++E+ + + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-KDKRERDKSIGDIVSEVTIIKEQL 66
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN-NFASEDFDWRKRMNVITGVADAL 622
RH NIV++Y ++V + I L ++ + F + N+ + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
Y+H + IVHRD++ NN++L + + ++DFG AK +P S T +VGT Y P
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILYSCP- 182
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFG 709
E+ EK DV++FG
Sbjct: 183 ---------EIVKNEPYGEKADVWAFG 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-13
Identities = 46/140 (32%), Positives = 61/140 (43%), Gaps = 28/140 (20%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTF 90
L L G G +P + L L+ ++LS N + G IPP +G +T L LDLS N F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-- 480
Query: 91 PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL--- 147
SIPE +G L L L L+ N +G++P + G L
Sbjct: 481 ---------------------SIPESLGQLTSLRILNLNGNSLSGRVPAAL--GGRLLHR 517
Query: 148 EILTVNDNHFLGSIPNLRNC 167
DN L IP LR C
Sbjct: 518 ASFNFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 554 LNEIKALTKIRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSNN--FASEDFDWRK 610
LNE + L ++ H +V Y F + ++V + + G L LS F+ E +
Sbjct: 48 LNERRILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEE----QV 102
Query: 611 RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670
+ I + AL Y+H I+HRDI +N+LLD + ++DF A + P++ T
Sbjct: 103 KF-WICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-T 157
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
GT GY+AP E+ + D +S GV A E ++GK P +
Sbjct: 158 STSGTPGYMAP----------EVLCRQGYSVAVDWWSLGVTAYECLRGKRP------YRG 201
Query: 731 SSSSINIEFNAM-LDHRLPHPSLDVQE 756
S +I + A + +P+ E
Sbjct: 202 HSRTIRDQIRAKQETADVLYPATWSTE 228
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNE 556
R +F+ IG+G + VYRA+ SG+ +A+KK +M ++++ L E
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-------RMDNERDGIPISSLRE 56
Query: 557 IKALTKIRHRNIVKFYGFC--SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
I L +RH NIV+ H+ F+V EY + LA++L N F + +
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCL 113
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ + L Y+H + I+HRD+ +N+LL + +++DFG A+ + T V
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGK 719
T Y AP EL T D+++ G + E++ K
Sbjct: 171 TLWYRAP----------ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 35/277 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G V + P+G +AVK N+ + QK+ L E+ L K IV FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAI--QKQILRELDILHKCNSPYIVGFY 65
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
G + + EY++ GSL +L R + V L+Y+H
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
I+HRD+ +N+L++ + ++ DFG + L NS T VGT Y+AP G
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKT-FVGTSSYMAPERIQ-GND--- 175
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRL--- 747
Y++ K D++S G+ +E+ G+ P N + + + +
Sbjct: 176 --YSV----KSDIWSLGLSLIELATGRFP----------YPPENDPPDGIFELLQYIVNE 219
Query: 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
P P L + + LCL P RP+ + + +
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G +VY+ P+G A+K + N + + +++ EI+ L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
H V+ E+++ GSL + A E F +++G+A Y+H
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLE---GTHIADEQFLADVARQILSGIA----YLHRR---H 188
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKP-----NSSNWTELVGTFGYVAPAHGNIG 687
IVHRDI +N+L++ +++DFG +++L NSS VGT Y++P N
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-----VGTIAYMSPERINTD 243
Query: 688 L-HLAELAYTMKITEKCDVYSFGVLALEVIKGKHP------GDFLSL 727
L H A Y D++S GV LE G+ P GD+ SL
Sbjct: 244 LNHGAYDGYA------GDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 51/286 (17%)
Query: 514 IGKGEHRSVYRAKLPSGDK-IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G V+ +L + + +AVK P D + +FL E + L + H NIV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 59
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
G C+ + ++V E + G T L ++ + ++ A + Y+
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH--- 114
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKL-----------LKPNSSNWTELVGTFGYVAP 681
+HRD+++ N L+ + ++SDFG ++ +K WT AP
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT---------AP 165
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFN 740
N G + +E DV+SFG+L E G P + S+ + IE
Sbjct: 166 EALNYGRYSSE----------SDVWSFGILLWEAFSLGAVP---YANLSNQQTREAIEQG 212
Query: 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P L + + +ME C + P RP+ TV Q L
Sbjct: 213 V----RLPCPEL-CPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG + V A +G+K+A+KK N F + +SD L EIK L +RH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEI- 64
Query: 573 GFCSHV---------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
H+ + +VV+E + L V+ A++D + + AL
Sbjct: 65 ---KHIMLPPSRREFKDIYVVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALK 117
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL---KPNSSNWTELVGTFGYVA 680
Y+H + HRD+ N+L + + + ++ DFG A++ P + WT+ V T Y A
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 681 PAHGNIGLHLAEL--AYTMKITEKCDVYSFGVLALEVIKGK 719
P EL ++ K T D++S G + EV+ GK
Sbjct: 175 P----------ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 514 IGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFL-NEIKALTKIRHRNIVKF 571
IG+G V A + SG +AVKK + + ++E L NE+ + +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y +VV E++ G+L ++++ +E+ + V V ALS +H
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ--- 135
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI S+++LL + ++SDFG + LVGT ++AP
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP---------- 185
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
EL + + D++S G++ +E++ G+ P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQ-KEFLNEIKALTKIRHRNIVKF 571
IG G +VY A+ + + + +A+KK + + Q +++ ++ + E++ L K+RH N +++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCF 630
G +++V EY GS + +L + + + V G L+Y+H H+
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
++HRD+ + N+LL ++ DFG+A ++ P + VGT ++AP + L +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAP---EVILAM 186
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E Y K+ DV+S G+ +E+ + K P
Sbjct: 187 DEGQYDGKV----DVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G H V++AK +G+ +A+KK + + L EIKAL +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQHPYVVKLL 65
Query: 573 GFCSHVRHSFVVYEYINRGSLATVL---SNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
H +V EY+ L+ VL RM ++ GVA YMH +
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM-LLKGVA----YMHAN- 118
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-WTELVGTFGYVAPAHGNIGL 688
I+HRD+ N+L+ + +++DFG A+L ++ V T Y AP
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP------- 169
Query: 689 HLAELAY-TMKITEKCDVYSFGVLALEVIKG 718
EL Y K D+++ G + E++ G
Sbjct: 170 ---ELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKI----AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G G +VY+ +P G+K+ A+K KE L+E + + H ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE---ETSPKANKEILDEAYVMASVDHPHV 71
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY--MH 626
V+ G C + + + + G L + N+ ++ + +N +A +SY
Sbjct: 72 VRLLGICLSSQVQLIT-QLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+VHRD+++ NVL+ +++DFG AKLL + E G V I
Sbjct: 129 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK---EYHAEGGKVP-----I 175
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
E T K DV+S+GV E++ G P
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN 613
LNEI L+ ++H NI+ +Y + EY N G+L + F+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLW 105
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELV 673
+ + A+SY+H I+HRDI + N+ L ++ DFG +K+L S +V
Sbjct: 106 YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162
Query: 674 GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733
GT Y++P EL +K K D+++ G + E++ K D +++
Sbjct: 163 GTPYYMSP----------ELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-------ATN 205
Query: 734 SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
+N+ + + P S+ E LIS++ L P RPT
Sbjct: 206 PLNLVVKIVQGNYTPVVSVYSSE-LISLVHS---LLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 69/267 (25%), Positives = 127/267 (47%), Gaps = 31/267 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQ-KEFLNEIKALTKIRHRNIVKF 571
IG G +VY A+ + + + +A+KK + + Q +++ ++ + E+K L +I+H N +++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
G +++V EY GS + +L + + + + G L+Y+H
Sbjct: 91 KGCYLREHTAWLVMEYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH--- 144
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
++HRDI + N+LL + +++DFG+A + P +S VGT ++AP + L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAP---EVILAMD 197
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPS 751
E Y K+ DV+S G+ +E+ + K P L ++ S+ +I N P+
Sbjct: 198 EGQYDGKV----DVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE-------SPT 243
Query: 752 LDVQEKLISIMEVALLCLDGCPNSRPT 778
L E CL P RPT
Sbjct: 244 LQSNEWSDYFRNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 513 CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKE---FLNEIKALTKIRHRNI 568
+G+G VY + +G ++AVK+ PF D +KE EI+ L ++H I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
V++YG + EY+ GS+ L A + RK I + + Y+H +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EGVEYLHSN 123
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT---ELVGTFGYVAPAHGN 685
IVHRDI N+L D ++ DFG +K L+ S+ T + GT +++P
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP---- 176
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K DV+S G +E++ K P
Sbjct: 177 ------EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 505 TKDFDAKYCIGKGEHRSVYR-AKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
T ++ IGKG + VY+ G AVK D +SD E EI+A I
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL------DPISDVDE---EIEAEYNI 71
Query: 564 -----RHRNIVKFYGFCSHVRHS-----FVVYEYINRGSLATVLSNNF-ASEDFDWRKRM 612
H N+VKFYG ++V E N GS+ ++ + D
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
++ G L ++H++ I+HRD+ NN+LL E ++ DFG + L
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT ++AP + E Y +CDV+S G+ A+E+ G P
Sbjct: 189 VGTPFWMAPE-----VIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 79/306 (25%)
Query: 514 IGKGEHRSVYRAK------LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+GE V +A +AVK N S+ ++ L+E L ++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE---NASSSELRDLLSEFNLLKQVNHPH 64
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVL---------------SNNFASEDFDWRKRM 612
++K YG CS ++ EY GSL + L + N + D + +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 613 NVITGVADALSY-------MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665
+ D +S+ M + +VHRD+++ NVL+ + ++SDFG ++ +
Sbjct: 125 T----MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 666 SSNWTELVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVIK-- 717
S YV + G I + L + Y T + DV+SFGVL E++
Sbjct: 181 DS----------YVKRSKGRIPVKWMAIESLFDHIY----TTQSDVWSFGVLLWEIVTLG 226
Query: 718 -----GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGC 772
G P +L + +R+ P + E++ ++M L C
Sbjct: 227 GNPYPGIAPERLFNLLKTG-------------YRMERPE-NCSEEMYNLM---LTCWKQE 269
Query: 773 PNSRPT 778
P+ RPT
Sbjct: 270 PDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (164), Expect = 5e-12
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 513 CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHR 566
+G+G + VY+A+ +G+ +A+KK ++ +++E L EI L +++H
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLKELKHP 58
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM--NVITGVADALSY 624
NIVK R ++V+EY + L L + K + ++ G+A Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----Y 113
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
H I+HRD+ N+L++ + +++DFG A+ +T V T Y AP
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPE-- 168
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK--HPGD 723
+ L Y+ + D++S G + E+I GK PGD
Sbjct: 169 ---ILLGSKHYSTAV----DIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 50/292 (17%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+GE V+ AK ++ + VK + Q EF E+ K+ H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRRELDMFRKLSHKN 69
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVL------SNNFASEDFDWRKRMNVITGVADA 621
+V+ G C +++ EY + G L L ++++ + T +A
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG---Y 678
+ ++ + F VHRD+++ N L+ + E +VS +K +S + +L +
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINI 737
+AP E + K DV+SFGVL EV +G+ P LS +
Sbjct: 185 LAP----------EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---------DE 225
Query: 738 EFNAML---DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E L LP P +L +M C P RP+ + L
Sbjct: 226 EVLNRLQAGKLELPVPE-GCPSRLYKLM---TRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 48/276 (17%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG VY+ + + +A+K + D++ D ++ EI L++ I ++Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68
Query: 573 GFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G S+++ + +++ EY+ GS +L E + ++ + L Y+H +
Sbjct: 69 G--SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY----IATILREILKGLDYLHSE-- 120
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
+HRDI + NVLL + + +++DFG A L VGT ++AP +
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE------VI 173
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGK------HPGDFLSLFSSSSSSINIEFNAMLD 744
+ AY K D++S G+ A+E+ KG+ HP L L +S
Sbjct: 174 KQSAYDF----KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP----------- 218
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
P+L+ Q E CL+ P RPT +
Sbjct: 219 -----PTLEGQYSK-PFKEFVEACLNKDPRFRPTAK 248
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 47/296 (15%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G + V++ + +G +A+KKF D +K L EI+ L +++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFP 631
R +V+EY + ++ L N +I A+++ H H+C
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNC-- 121
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
+HRD+ N+L+ + + ++ DFG A++L ++T+ V T Y AP L +
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE-----LLVG 174
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKG-----------------KHPGDFL----SLFSS 730
+ Y + DV++ G + E++ G K GD + +FS+
Sbjct: 175 DTQYGPPV----DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230
Query: 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ +F L P ++ K +I AL L GC PT + C+ L
Sbjct: 231 N------QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 7e-12
Identities = 71/307 (23%), Positives = 125/307 (40%), Gaps = 68/307 (22%)
Query: 513 CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPN--DQMSDQKEFLNEIKALTKI-RHRNI 568
+G G SVY A+ +G+ +A+KK F + + M+ L E+K+L K+ H NI
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNI 60
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
VK + V+EY+ G+L ++ + + F ++I + L+++H
Sbjct: 61 VKLKEVFRENDELYFVFEYME-GNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGL 688
F HRD+ N+L+ +++DFG A+ ++ + +T+ V T Y AP I L
Sbjct: 119 GF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAP---EILL 171
Query: 689 HLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---------------- 732
Y+ + D+++ G + E+ + P LF SS
Sbjct: 172 RSTS--YSSPV----DIWALGCIMAELYTLR-P-----LFPGSSEIDQLYKICSVLGTPT 219
Query: 733 -----------SSINIEFNAM----LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777
S + F L +P+ S + I +++ +L D P RP
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPE----AIDLIK-DMLRWD--PKKRP 272
Query: 778 TMQTVCQ 784
T Q
Sbjct: 273 TASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 30/195 (15%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592
+AVK P+ + +++FL E+K L+++ NI + G C+ ++ EY+ G
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYM------------HHDCFPPIVHRDISS 640
L L N + L YM + VHRD+++
Sbjct: 106 LNQFLQ---KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLAT 158
Query: 641 NNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT 700
N L+ Y +++DFG ++ L SS++ + G P I E K T
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLY--SSDYYRVQGR--APLP----IRWMAWESVLLGKFT 210
Query: 701 EKCDVYSFGVLALEV 715
K DV++FGV E+
Sbjct: 211 TKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 63/239 (26%), Positives = 111/239 (46%), Gaps = 35/239 (14%)
Query: 502 IRRTKDFDAKYCIGKGEHRSVYRAK----LPSGDK--IAVKKFNSPFPNDQMSDQKEFLN 555
I+R +D K+ +G+G V+ A+ LP DK +AVK S +++F
Sbjct: 2 IKR-RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQR 56
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL------------SNNFAS 603
E + LT ++H++IV+FYG C+ R +V+EY+ G L L + A
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 604 EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663
+ + + + +A + Y+ F VHRD+++ N L+ ++ DFG ++ +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173
Query: 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
S+++ + G + P I E K T + D++SFGV+ E+ GK P
Sbjct: 174 --STDYYRVGGR--TMLP----IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG V++ K+ A+K + D++ D ++ EI L++ + K+Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 573 GFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G S+++ + +++ EY+ GS +L D + ++ + L Y+H +
Sbjct: 69 G--SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE-- 120
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
+HRDI + NVLL E +++DFG A L VGT ++AP
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP--------- 170
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G+ A+E+ KG+ P
Sbjct: 171 -EVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 29/236 (12%)
Query: 498 YEEIIRRTK-------DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQ 550
YE+I+R+ + D+D IG+G V + S K+ K S F + SD
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 551 KEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRK 610
F E + +V+ + ++ ++V EY+ G L ++SN E W K
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAK 145
Query: 611 RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA-KLLKPNSSNW 669
V AL +H ++HRD+ +N+LLD +++DFGT K+ +
Sbjct: 146 FYT--AEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200
Query: 670 TELVGTFGYVAP----AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT Y++P + G G + E CD +S GV E++ G P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRE----------CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 35/270 (12%)
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV--VYE 586
+G+ +AVK S K+ EI L + H NIVK+ G CS + + E
Sbjct: 32 TGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88
Query: 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646
Y+ GSL L + + + + + + ++Y+H + +HRD+++ NVLLD
Sbjct: 89 YVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLD 141
Query: 647 LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN--IGLHLAELAYTMKITEKCD 704
+ ++ DFG AK + G Y G+ + + E K + D
Sbjct: 142 NDRLVKIGDFGLAKAVPE---------GHEYYRVREDGDSPVFWYAVECLKENKFSYASD 192
Query: 705 VYSFGVLALEVI-----KGKHPGDFLSLFSSSSSSIN-IEFNAMLD--HRLPHPSLDVQE 756
V+SFGV E++ K P F + + + +L+ RLP P + +
Sbjct: 193 VWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK-NCPQ 251
Query: 757 KLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
++ +M+ C + RPT +++ +L
Sbjct: 252 EVYILMKN---CWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 35/216 (16%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR-----N 567
I KG SVY A K +GD A+K M + + N +KA I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL----KKSDMIAKNQVTN-VKAERAIMMIQGESPY 58
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+ K Y + ++V EY+N G A+++ DW K I V + +H
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAK--QYIAEVVLGVEDLHQ 115
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK--LLKPNSSNWTELVGTFGYVAPAHGN 685
I+HRDI N+L+D +++DFG ++ L + VGT Y+AP
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAP---- 162
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E + + D +S G + E + G P
Sbjct: 163 ------ETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+GKG V++ L +AVK P + + +FL+E + L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL---KIKFLSEARILKQYDHPNIVKLIG 59
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFPP 632
C+ + ++V E + G + L ++ ++ + A ++Y+ +C
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKL----------LKPNSSNWTELVGTFGYVAPA 682
+HRD+++ N L+ ++SDFG ++ LK WT AP
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT---------APE 164
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALE 714
N G + + + DV+S+G+L E
Sbjct: 165 ALNYG----------RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 55/279 (19%)
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV--VYE 586
+G+++AVK + ++D K+ EI+ L + H NIVK+ G C+ + + + E
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646
++ GSL L N + ++++ + + Y+ + VHRD+++ NVL++
Sbjct: 89 FLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 143
Query: 647 LEYEARVSDFGTAKLLKPNSSNWT---ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKC 703
E++ ++ DFG K ++ + +T +L + AP E K
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP----------ECLIQSKFYIAS 193
Query: 704 DVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML------------------DH 745
DV+SFGV E++ + S SS F M+
Sbjct: 194 DVWSFGVTLYELLT----------YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
RLP P + E++ +M C + P+ R T Q + +
Sbjct: 244 RLPRPP-NCPEEVYQLMRK---CWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 68/291 (23%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
EI R + + K +G G+ V+ A K+AVK MS + FL E
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKP----GSMS-VEAFLAEANV 54
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ ++H +VK + + +++ E++ +GSL L ++ S+ K ++ +A
Sbjct: 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIA 112
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG-TFGY 678
+ ++++ + +HRD+ + N+L+ +++DFG A++++ N E +
Sbjct: 113 EGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737
AP N G T K DV+SFG+L +E++ G+ P +S N
Sbjct: 170 TAPEAINFG----------SFTIKSDVWSFGILLMEIVTYGRIPYPGMS---------NP 210
Query: 738 EFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E L+ R+P P +E + + + C P RPT + + +L
Sbjct: 211 EVIRALERGYRMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 48/211 (22%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G VY+A+ A K +++ D F+ EI L++ +H NIV Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
+ +++ E+ + G+L +++ + V + +AL+++H +
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+ + N+LL L+ + +++DFG + K +GT ++AP + E
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE-----VVACE- 178
Query: 694 AYTMKITE---KCDVYSFGVLALEVIKGKHP 721
T K K D++S G+ +E+ + + P
Sbjct: 179 --TFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 36/227 (15%)
Query: 514 IGKGEHRSVYRAKL----PSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G V+ A+ P DKI AVK N + K+F E + LT ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNLQHEH 68
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSL----------ATVLSNNFASEDFDWRKRMNVITG 617
IVKFYG C +V+EY+ G L A +++ + + +++
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
+A + Y+ F VHRD+++ N L+ ++ DFG ++ ++ T
Sbjct: 129 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSR----------DVYSTDY 175
Query: 678 YVAPAHGNIGLHLAELAYTM--KITEKCDVYSFGVLALEVIK-GKHP 721
Y H + + M K T + DV+S GV+ E+ GK P
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 40/289 (13%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+F + IG+G+ VYRA L +A+KK F +++ + EI L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI-FEMMDAKARQDCVKEIDLLKQLNH 61
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM-------NVITGV 618
N++K+ +V E + G L+ ++ F +KR+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKY------FKKQKRLIPERTVWKYFVQL 115
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
A+ +MH ++HRDI NV + ++ D G + ++ LVGT Y
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GDFLSLFSSSSSSIN 736
++P + E Y K D++S G L E+ + P GD ++LFS
Sbjct: 173 MSPE------RIHENGYNF----KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222
Query: 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785
++ P P+ EKL E+ +C+ P+ RP + V Q+
Sbjct: 223 CDYP-------PLPTEHYSEKL---RELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY--GFCSHVRHSFVVYE 586
+G ++A+K + P + + F E ++ H NIV G F V+E
Sbjct: 2 TGHEVAIKLLRTDAPEE-EHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59
Query: 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL- 645
Y+ +L VL+ + A + + M V DAL+ H+ IVHRD+ N+++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLM---LQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 646 --DLEYEARVSDFGTAKLLKPNSSNW--------TELVGTFGYVAPAHGNIGLHLAELAY 695
+ A+V DFG LL P + TE++GT Y AP E
Sbjct: 114 QTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAP----------EQLR 162
Query: 696 TMKITEKCDVYSFGVLALEVIKGK 719
+T D+Y++G++ LE + G+
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 47/289 (16%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
E+ R T K +G G+ V+ K+A+K MS + FL E
Sbjct: 2 EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLKQ----GSMSPEA-FLAEANL 54
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ +++H +V+ Y + +++ EY+ GSL L K +++ +A
Sbjct: 55 MKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIA 112
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---F 676
+ ++++ + +HRD+ + N+L+ +++DFG A+L++ N +T G
Sbjct: 113 EGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNE--YTAREGAKFPI 167
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK--HPGDFLSLFSSSSS 733
+ AP N G T K DV+SFG+L E++ G+ +PG
Sbjct: 168 KWTAPEAINYGT----------FTIKSDVWSFGILLTEIVTYGRIPYPG----------- 206
Query: 734 SINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
N E L+ +R+P P + E+L +M LC P RPT +
Sbjct: 207 MTNPEVIQNLERGYRMPRPD-NCPEELYELM---RLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKE-F----LNE 556
R +++ I +G + VYRA+ +I A+KK +M +KE F L E
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLRE 54
Query: 557 IKALTKIRHRNIV--KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
I L K++H NIV K S++ ++V EY+ L +++ + F + +
Sbjct: 55 INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM--KQPFLQSEVKCL 111
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ + ++++H + I+HRD+ ++N+LL+ ++ DFG A+ +T+LV
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
T Y AP L L Y+ I D++S G + E++ K
Sbjct: 169 TLWYRAPE-----LLLGAKEYSTAI----DMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 69/286 (24%), Positives = 120/286 (41%), Gaps = 40/286 (13%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+F + IG+G+ VYRA L G +A+KK F + + + EI L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNH 61
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM-------NVITGV 618
N++K+Y +V E + G L+ ++ + F +KR+ +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKH------FKKQKRLIPEKTVWKYFVQL 115
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
AL +MH ++HRDI NV + ++ D G + ++ LVGT Y
Sbjct: 116 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GDFLSLFSSSSSSIN 736
++P + E Y K D++S G L E+ + P GD ++L+S
Sbjct: 173 MSPE------RIHENGYNF----KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222
Query: 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
++ P PS E+L ++ +C++ P RP + V
Sbjct: 223 CDYP-------PLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 1/89 (1%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
++ + L + GL+G + S HL ++LS N G +PP + +++ L+ LDLS N
Sbjct: 420 IDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFSGTFP 91
+G IP +G LT L L+L+ N SG P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 32/269 (11%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEF--LNEIKALTKIRHRNIVKF 571
+G+G V+ + + K+ + K P +QM+ + NE + L + H NI+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y + +V EY G+LA + + D ++ + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 632 PIVHRDISSNNVLLDLEYE-ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
I+HRD+ + N+LLD ++ DFG +K+L S +T +VGT Y++P
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISP--------- 170
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
EL +K D+++ G + E+ K + +L + ++ F + D P
Sbjct: 171 -ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP-- 227
Query: 751 SLDVQEKLISIMEVALLCLDGCPNSRPTM 779
D+++ ++S +L LD P+ RP +
Sbjct: 228 --DLRQLILS-----MLNLD--PSKRPQL 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 42/231 (18%)
Query: 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
D + IG+G V +A++ G ++ A+K+ D D ++F E++ L K+
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKL 64
Query: 564 -RHRNIVKFYGFCSHVRHSFVVYEYINRGSL--------------ATVLSNNFASEDFDW 608
H NI+ G C H + ++ EY G+L A ++N+ AS
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSS 123
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
++ ++ VA + Y+ F +HRD+++ N+L+ Y A+++DFG ++
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR-------- 172
Query: 669 WTELVGTFGYVAPAHGNIGLH---LAELAYTMKITEKCDVYSFGVLALEVI 716
G YV G + + + L Y++ T DV+S+GVL E++
Sbjct: 173 -----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+GKG + SVY+ P+G +A+K+ + + + + E+ L K IV FY
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAVSPYIVDFY 65
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
G ++ EY++ GSL + + A+E + V L ++ +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGT-----AKLLKPNSSNWTELVGTFGYVAPAHGNIG 687
I+HRD+ NVL++ + ++ DFG A L K N +G Y+AP G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-------IGCQSYMAPERIKSG 176
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH-- 745
YT+ + DV+S G+ LE+ G++P + ++I + +A++D
Sbjct: 177 GPNQNPTYTV----QSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDGDP 227
Query: 746 -RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
LP D + ++ CL+ PN RPT
Sbjct: 228 PTLPSGYSDDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 47/230 (20%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKE---FLNEIKALT 561
DF+ +G G V + SG A+K + ++ K+ LNE + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS----KAKIVKLKQVEHVLNEKRILQ 56
Query: 562 KIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKR 611
IRH +V YG + ++V EY+ G L + L + +A++
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ------- 109
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
V AL Y+H IV+RD+ N+LLD + +++DFG AK +K + +T
Sbjct: 110 ------VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT- 157
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L GT Y+AP I L Y + D ++ G+L E++ G P
Sbjct: 158 LCGTPEYLAP---EIILS---KGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 41/264 (15%)
Query: 532 KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINR 590
K+AVK P S+++ ++E+K ++ + H NIV G C+ V+ EY
Sbjct: 67 KVAVKMLK---PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 591 GSLATVLSNNFASEDF-DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649
G L L E F ++ VA ++++ +HRD+++ NVLL
Sbjct: 124 GDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGK 178
Query: 650 EARVSDFGTAKLLKPNSSNWTELVGTF---GYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
++ DFG A+ + N SN+ ++AP + YT + DV+
Sbjct: 179 IVKICDFGLARDIM-NDSNYVVKGNARLPVKWMAPE------SIFNCVYTF----ESDVW 227
Query: 707 SFGVLALEVIKGKHPGDFLSLFSSSSSSI--NIEFNAMLD--HRLPHPSLDVQEKLISIM 762
S+G+L E+ SL S+ + + +F ++ +R+ P E + IM
Sbjct: 228 SYGILLWEI---------FSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE-IYDIM 277
Query: 763 EVALLCLDGCPNSRPTMQTVCQLL 786
+ C D P RPT + + QL+
Sbjct: 278 KT---CWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 514 IGKGEHRSVYRAKLPS-GDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVK 570
IG+G V RA + G K+ A K F ++ +D ++F E++ L K+ H NI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIIN 67
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNN--------FASE-----DFDWRKRMNVITG 617
G C + + ++ EY G+L L + FA E ++ + +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
VA + Y+ F +HRD+++ NVL+ ++++DFG ++ G
Sbjct: 128 VATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR-------------GEEV 171
Query: 678 YVAPAHGNIGLH---LAELAYTMKITEKCDVYSFGVLALEVI 716
YV G + + + L Y++ T K DV+SFGVL E++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKF-NSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G+G + V + K +G +A+KKF S D +K + EI+ L ++RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSN-NFASEDFDWRKRMNVITGVADALSYMHHDCF 630
+ ++V+E+++ TVL + D + + + + + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-- 119
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
I+HRDI N+L+ ++ DFG A+ L +T+ V T Y AP L +
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE-----LLV 173
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGK--HPGD 723
+ Y + D+++ G L E++ G+ PGD
Sbjct: 174 GDTKYGRAV----DIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
D + +G G V+ + S A+K P + ++ NE + L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSH 60
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG------VA 619
I++ + R +++ EY+ G L + L N R + TG +
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIV 111
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYV 679
AL Y+H IV+RD+ N+LLD E +++DFG AK L+ + WT L GT Y+
Sbjct: 112 CALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WT-LCGTPEYL 165
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
AP E+ + + D ++ G+L E++ G P
Sbjct: 166 AP----------EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 514 IGKGEH-RSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G R++ + S K A+K+ P + + D ++ E L K++H NIV F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFK 64
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
H ++V EY + G L + + F + + + ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---R 120
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
++HRDI S N+ L + ++ DFG+A+LL + VGT YV P E
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP----------E 170
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ M K D++S G + E+ KHP
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 52/244 (21%), Positives = 97/244 (39%), Gaps = 34/244 (13%)
Query: 499 EEIIRRTKDFDAKY------------CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQ 546
+ II R+ D K I + + S+Y+ + ++ ++ F F
Sbjct: 1 QNIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKK-FHKGH 58
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF----VVYEYINRGSLATVLSNNFA 602
NEIK L +I NI+K YGF + ++ EY RG L VL
Sbjct: 59 KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-- 116
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
+D ++ ++++ L ++ P +++++S + L+ Y+ ++ G K+L
Sbjct: 117 -KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPG 722
+ F Y + + + T K D+YS GV+ E+ GK P
Sbjct: 174 SSPPFKNVNFMVYFSY------KMLNDIFS-----EYTIKDDIYSLGVVLWEIFTGKIPF 222
Query: 723 DFLS 726
+ L+
Sbjct: 223 ENLT 226
|
Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG + V++ +G K AVK + P + + E+ N +KAL+ H N+VKFY
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEY-NILKALSD--HPNVVKFY 81
Query: 573 G--FCSHVRHS---FVVYEYINRGSLATVLSNNFASEDFDWRKRMN---VITGVADALSY 624
G + V++ ++V E N GS+ T L F +RM + + +AL
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRG----ERMEEPIIAYILHEALMG 136
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+ H +HRD+ NN+LL E ++ DFG + L VGT ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE-- 194
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ E +CDV+S G+ A+E+ G P
Sbjct: 195 ---VIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
++ IG+G +Y AK S + V K + +++ E+ L K++H N
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEID-LTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN---FASEDFDWRKRMNVITGVADALSY 624
IV F+ F+V EY + G L ++ SED + ++ ++ L +
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED----QILSWFVQISLGLKH 116
Query: 625 MHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
+H I+HRDI S N+ L A++ DFG A+ L + VGT Y++P
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP-- 171
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G + E+ KHP
Sbjct: 172 --------EICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 25/66 (37%), Positives = 36/66 (54%)
Query: 338 LSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
+ L L + +G IP+ I L L+ +NLS N+I G IP ++ L +D+SYN
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 398 GPIPNS 403
G IP S
Sbjct: 480 GSIPES 485
|
Length = 623 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 509 DAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
D KY IG+G + V AK + +K+A+KK + F N D K L EIK L +
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN--RIDAKRTLREIKLLRHL 61
Query: 564 RHRNIVKFYGFCSHV-RHSF----VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV 618
H N++ R +F +VYE ++ + S+ S+D ++ G
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG- 120
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
L Y+H ++HRD+ +N+LL+ + ++ DFG A+ TE V T Y
Sbjct: 121 ---LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
AP L L YT I DV+S G + E++ K
Sbjct: 175 RAPE-----LLLNCSEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 514 IGKGEHRSVYRAKLPS-GDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVK 570
IG+G V +A++ G ++ A K + + D ++F E++ L K+ H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIIN 60
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNN--------FASE-----DFDWRKRMNVITG 617
G C H + ++ EY G+L L + FA ++ ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
VA + Y+ F +HRD+++ N+L+ Y A+++DFG ++ G
Sbjct: 121 VARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR-------------GQEV 164
Query: 678 YVAPAHGNIGLH---LAELAYTMKITEKCDVYSFGVLALEVI 716
YV G + + + L Y++ T DV+S+GVL E++
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 60/291 (20%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G SV + K +P+G +A K + S +K+ L E++ + + R IV FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRK----RMNVITGVADA------- 621
G + + + E+++ GSL + +K + ++ +A A
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY-----------KKGGPIPVEILGKIAVAVVEGLTY 118
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
L +H I+HRDI +N+L++ + ++ DFG + L NS T VGT Y++P
Sbjct: 119 LYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELI-NSIADT-FVGTSTYMSP 171
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF---LSLFSSSSSSINIE 738
E K T K DV+S G+ +E+ GK P F I
Sbjct: 172 ----------ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI--- 218
Query: 739 FNAMLD--HRL---PHPSLDVQEKLISIMEVAL-LCLDGCPNSRPTMQTVC 783
LD ++ P P L + + CL P RPT Q +C
Sbjct: 219 ----LDLLQQIVQEPPPRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 70/299 (23%), Positives = 127/299 (42%), Gaps = 65/299 (21%)
Query: 514 IGKGEHRSVYRAKL--PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G VY+ +L P+ +A+K N + Q+EF E + ++ ++H N
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKE---NAEPKVQQEFRQEAELMSDLQHPN 69
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN-------FASEDFDWRKRM------NV 614
IV G C+ + + +++EY+ G L L N S D + + ++
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 615 ITGVADALSYM--HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
+A + Y+ HH VHRD+++ N L+ ++SDFG ++ + S+++ +
Sbjct: 130 AIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADYYRV 182
Query: 673 VGT----FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP--GDFL 725
++ P E K T + D++SFGV+ E+ G P G
Sbjct: 183 QSKSLLPVRWMPP----------EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG--- 229
Query: 726 SLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
FS N E M+ R LP P D ++ ++M + C + P RP + +
Sbjct: 230 --FS------NQEVIEMIRSRQLLPCPE-DCPARVYALM---IECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 57/243 (23%), Positives = 107/243 (44%), Gaps = 28/243 (11%)
Query: 500 EIIRRT--KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
+I+RR D++ +G G + VY+A+ ++A K P D S ++ EI
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EI 57
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATV--LSNNFASEDFDWRKRMNVI 615
+ + +H NIV ++G ++ EY GSL + ++ + + R +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
L+Y+H +HRDI N+LL + +++DFG A + + +GT
Sbjct: 117 ----QGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK------HPGDFLSLFS 729
++AP +A + + CD+++ G+ A+E+ + + HP L L S
Sbjct: 170 PYWMAP-------EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS 222
Query: 730 SSS 732
S+
Sbjct: 223 KSN 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 24/239 (10%)
Query: 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
+ +D++ IG+G V + S K+ K S F + SD F E +
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 564 RHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADAL 622
+V+ FY F R+ ++V EY+ G L ++SN E W + V AL
Sbjct: 101 NSPWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYT--AEVVLAL 155
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA-KLLKPNSSNWTELVGTFGYVAP 681
+H F +HRD+ +N+LLD +++DFGT K+ K VGT Y++P
Sbjct: 156 DAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 682 ----AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736
+ G G + E CD +S GV E++ G P SL + S +N
Sbjct: 213 EVLKSQGGDGYYGRE----------CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 1/103 (0%)
Query: 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI 304
L L + + G IP ++ +L L + L GN + G++P +LG +T LE DLS N N SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHN 346
E+LG + L LN + N S +P L L H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 29/66 (43%), Positives = 38/66 (57%)
Query: 313 KLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372
L +N S N IP L + L LDLS+N F GSIP + L SL LNL+ N++
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 373 SGQIPA 378
SG++PA
Sbjct: 503 SGRVPA 508
|
Length = 623 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 514 IGKGEHRSVYRA--KLPSGDK-IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
+G G +V + K+ +K +AVK + + + D E L E + ++ + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKD--ELLREANVMQQLDNPYIVR 60
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G C +V E G L L N + + ++ V+ + Y+ F
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYLEETNF 116
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN--IGL 688
VHRD+++ NVLL ++ A++SDFG +K L + N+ Y A HG +
Sbjct: 117 ---VHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENY--------YKAKTHGKWPVKW 164
Query: 689 HLAELAYTMKITEKCDVYSFGVLALE 714
+ E K + K DV+SFGVL E
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 25/181 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQ----MSDQKEFLNEI---KALTKIRH 565
IG+G + +VY+A+ L +G +A+KK P + +S L EI K L H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLS----TLREIALLKQLESFEH 60
Query: 566 RNIVKFYGFCSHVRHS-----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
NIV+ C R +V+E++++ LAT LS +++ +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLR 118
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
+ ++H IVHRD+ N+L+ + + +++DFG A++ + T +V T Y A
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRA 174
Query: 681 P 681
P
Sbjct: 175 P 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 502 IRRTKDFDAKYCIGKGEHRSVYRA--KLPSGDKI--AVKKFNSPFPNDQMSDQKEFLNEI 557
I+R +D CIG+G+ VY+ P +KI AVK + S +++FL E
Sbjct: 3 IQR-EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN---CTSPSVREKFLQEA 58
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
+ + H +IVK G + ++V E G L + L N D +
Sbjct: 59 YIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQ 115
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF- 676
++ AL+Y+ F VHRDI++ NVL+ ++ DFG ++ L+ + S + G
Sbjct: 116 LSTALAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLP 171
Query: 677 -GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
++AP N + T DV+ FGV E++ G P
Sbjct: 172 IKWMAPESINF----------RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 508 FDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALT 561
FD IG+G + VY+A+ +G+ +A+KK ++ ++KE + EIK L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIREIKILR 61
Query: 562 KIRHRNIVKFY----------GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR 611
++ HRNIV F ++V+EY++ L +L + F
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHI 118
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-WT 670
+ + + + L+Y H F +HRDI +N+LL+ + + +++DFG A+L S +T
Sbjct: 119 KSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709
V T Y P L L E Y I DV+S G
Sbjct: 176 NKVITLWYRPPE-----LLLGEERYGPAI----DVWSCG 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLN----EIKALTKIRHRNI 568
+G+G VY +G ++AVK+ PF D KE +N EI+ L +RH I
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQV--PFDPDSQETSKE-VNALECEIQLLKNLRHDRI 66
Query: 569 VKFYGFC--SHVRHSFVVY-EYINRGSLATVLSNNFA-SEDFDWRKRMNVITGVADALSY 624
V++YG C ++ EY+ GS+ L A +E+ R ++ GV SY
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SY 121
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP---NSSNWTELVGTFGYVAP 681
+H + IVHRDI N+L D ++ DFG +K ++ + + + GT +++P
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K DV+S +E++ K P
Sbjct: 179 ----------EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+DF+ IG+G V KL + DK+ K + + + ++ F E L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN--NFASEDFDWRKRMNVITGVADALS 623
+ I + + ++V +Y G L T+LS + ED ++ + D++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA-KLLKPNSSNWTELVGTFGYVAPA 682
+H+ VHRDI +N+L+D+ R++DFG+ KL++ + + VGT Y++P
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP- 172
Query: 683 HGNIGLHLAELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 721
E+ M K +CD +S GV E++ G+ P
Sbjct: 173 ---------EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 508 FDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RH 565
F+ +G G + VY+ + + +G A+K + +++E EI L K H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TEDEEEEIKLEINMLKKYSHH 72
Query: 566 RNIVKFYGFCSHVRHS--------FVVYEYINRGSLATVLSN---NFASEDFDWRKRMNV 614
RNI +YG + ++ S ++V E+ GS+ ++ N N ED+ +
Sbjct: 73 RNIATYYG--AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ G+A + H ++HRDI NVLL E ++ DFG + L +G
Sbjct: 131 LRGLAHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 183
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
T ++AP + + + D++S G+ A+E+ +G P
Sbjct: 184 TPYWMAPE-----VIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 32/80 (40%), Positives = 43/80 (53%)
Query: 230 GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTE 289
G IP +I L ++LS N I G IP LG + SL L L N +G +P +LG LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 290 LEYFDLSSNRLNNSILEALG 309
L +L+ N L+ + ALG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 68/275 (24%), Positives = 119/275 (43%), Gaps = 47/275 (17%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSD-QKEFLNEIKALTKIRHRNIVKF 571
+G G +VY+A L + +AVK P D + QK+ ++E++ L K I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI----PLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 572 YG-FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA----LSYMH 626
YG F R S + E+++ GSL D + +V+ +A A L+Y+
Sbjct: 65 YGAFFVENRIS-ICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYLW 112
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP---AH 683
I+HRD+ +N+L++ + ++ DFG + L +S VGT Y+AP +
Sbjct: 113 S---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISG 167
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
G+H DV+S G+ +E+ G+ P + + + S + ++ +
Sbjct: 168 EQYGIH-------------SDVWSLGISFMELALGRFP--YPQIQKNQGSLMPLQLLQCI 212
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
P P L V + + C+ P RP
Sbjct: 213 VDEDP-PVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 328 IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLL 387
IP D++ L HL ++LS N +G+IP + ++ SLE L+LS+N+ +G IP ++ L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 388 SIDISYNELRGPIPNSTVFRNAPRESFLGNNFS 420
++++ N L G +P + R R SF NF+
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASF---NFT 523
|
Length = 623 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLN-EIKALTKIRHRNIVKF 571
+G+G VY + +G ++A K+ + + S + L EI+ L ++H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 572 YGFC--SHVRHSFVVY-EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
YG C + ++ EY+ GS+ L A + RK I + +SY+H +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EGMSYLHSN 125
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP---NSSNWTELVGTFGYVAPAHGN 685
IVHRDI N+L D ++ DFG +K L+ + + + GT +++P
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP---- 178
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K DV+S G +E++ K P
Sbjct: 179 ------EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 47/228 (20%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-----EIKALTKIRHRN 567
+G+G + VY+A+ +G +A+KK + + K+ +N EIK L +++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK----LGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH- 626
I+ H + +V+E++ L V+ K +++ AD SYM
Sbjct: 64 IIGLLDVFGHKSNINLVFEFM-ETDLEKVI------------KDKSIVLTPADIKSYMLM 110
Query: 627 --------HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
H + I+HRD+ NN+L+ + +++DFG A+ + T V T Y
Sbjct: 111 TLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 679 VAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKH--PGD 723
AP EL + + D++S G + E++ PGD
Sbjct: 169 RAP----------ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 74/282 (26%), Positives = 110/282 (39%), Gaps = 45/282 (15%)
Query: 514 IGKGEHRSVYRAKLPSGDKI----AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IGKG VY L D AVK N + + ++FL E + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 570 KFYGFCSHVRHS-FVVYEYINRGSLATVL---SNNFASEDFDWRKRMNVITGVADALSYM 625
G C S VV Y+ G L + ++N +D + VA + Y+
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
F VHRD+++ N +LD + +V+DFG A+ ++ Y H
Sbjct: 115 ASKKF---VHRDLAARNCMLDESFTVKVADFGLAR----------DIYDKEYYSVHNHTG 161
Query: 686 IGLHLAELAY----TMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFN 740
L + +A T K T K DV+SFGVL E++ +G P S +I
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVDSFDITVY 214
Query: 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ RL P + L +M L C P RPT +
Sbjct: 215 LLQGRRLLQPEY-CPDPLYEVM---LSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 6e-09
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G + V A +G K+A+KK ++ F D + D K L EIK L +RH NI+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 573 G-FCSHVRHSF----VVYEYINRGSLATVL-SNNFASEDFDWRKRMNVIT-GVADALSYM 625
F +V E + L V+ S ++D + + L Y+
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDD-----HIQYFLYQILRGLKYL 119
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS---NWTELVGTFGYVAPA 682
H ++HRD+ +N+L++ + ++ DFG A+ + P+ TE V T Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH--PG 722
L L+ YT I D++S G + E++ K PG
Sbjct: 177 -----LLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 30/226 (13%)
Query: 508 FDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR 566
F+ +G G + VY+ + + +G A+K + D+ + K+ +N +K + HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYS--HHR 63
Query: 567 NIVKFYGFCSHVRHS--------FVVYEYINRGSLATVLSN---NFASEDFDWRKRMNVI 615
NI +YG + ++ + ++V E+ GS+ ++ N N E++ ++
Sbjct: 64 NIATYYG--AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
G LS++H ++HRDI NVLL E ++ DFG + L +GT
Sbjct: 122 RG----LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
++AP + + K D++S G+ A+E+ +G P
Sbjct: 175 PYWMAPE-----VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
+ IG+G + V A P+G K+A+KK SPF Q Q+ L EIK L + +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPF-EHQTFCQRT-LREIKILRRFK 61
Query: 565 HRNIVKFY------GFCSHVRHSFVVYEYINRGSLATVLSNNFASED----FDWRKRMNV 614
H NI+ F S ++V E + L ++ S D F
Sbjct: 62 HENIIGILDIIRPPSFES-FNDVYIVQELMET-DLYKLIKTQHLSNDHIQYF-------- 111
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN---WTE 671
+ + L Y+H ++HRD+ +N+LL+ + ++ DFG A++ P + TE
Sbjct: 112 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
V T Y AP I L+ YT I D++S G + E++ +
Sbjct: 169 YVATRWYRAP---EIMLNSKG--YTKAI----DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 514 IGKGEHRSVYRAKLPSGDKIA---VKKF-NSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG G V + G A VK+ S P++Q+ FL E++ ++ H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL----FLQEVQPYRELNHPNVL 58
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM--NVITGVADALSYMHH 627
+ G C +V E+ G L L +N +K + + VA L ++H
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE--LVGTFGYVAPA--- 682
F +H D++ N L + ++ D+G A P T+ ++AP
Sbjct: 119 ADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 683 --HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEF 739
++ T+K +++S GV E+ P + S ++
Sbjct: 176 IRGQDL--------LPKDQTKKSNIWSLGVTMWELFTAADQP------YPDLSDEQVLKQ 221
Query: 740 NAM-LDHRLPHPSLDVQ--EKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
D +LP P LD++ ++ +M+ L P +RPT + V +LL
Sbjct: 222 VVREQDIKLPKPQLDLKYSDRWYEVMQFCWL----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592
+AVK + + + +FL EIK ++++++ NI++ G C ++ EY+ G
Sbjct: 47 VAVKMLR---ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 593 LATVLS-----------NNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641
L LS NN S + + +A + Y+ F VHRD+++
Sbjct: 104 LNQFLSQREIESTFTHANNIPS--VSIANLLYMAVQIASGMKYLASLNF---VHRDLATR 158
Query: 642 NVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITE 701
N L+ Y +++DFG ++ L S ++ + G V P I E K T
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY--SGDYYRIQGR--AVLP----IRWMAWESILLGKFTT 210
Query: 702 KCDVYSFGVLALEV 715
DV++FGV E+
Sbjct: 211 ASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 33/136 (24%), Positives = 67/136 (49%), Gaps = 13/136 (9%)
Query: 532 KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRG 591
++A+K N M ++ EFLNE + + ++V+ G S + + V+ E + RG
Sbjct: 38 RVAIKTVNE---AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 94
Query: 592 SLATVL-------SNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644
L + L NN +K + + +AD ++Y++ + F VHRD+++ N +
Sbjct: 95 DLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCM 151
Query: 645 LDLEYEARVSDFGTAK 660
+ ++ ++ DFG +
Sbjct: 152 VAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 16/142 (11%)
Query: 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639
H F V EY+N G L + + S FD + + L ++H I++RD+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLK 123
Query: 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI 699
+NVLLD + +++DFG K + GT Y+AP E+ K
Sbjct: 124 LDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP----------EILKGQKY 173
Query: 700 TEKCDVYSFGVLALEVIKGKHP 721
E D +SFGVL E++ G+ P
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 29/82 (35%), Positives = 50/82 (60%), Gaps = 4/82 (4%)
Query: 157 FLGS-IPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKC 215
F+ + I LR+ +S+ +L N++ GNI G +L+ LDLS+N+F G I + G+
Sbjct: 433 FIPNDISKLRHLQSI---NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 216 HRLGTLIVSGNNITGRIPPEIG 237
L L ++GN+++GR+P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 53/237 (22%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+DF+ IG G + VY+A+ + ++A K P + + ++ EI + +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKH 65
Query: 566 RNIVKFYGFCSHVRHS--FVVYEYINRGSLATV--LSNNFASEDFDWRKRMNVITGVADA 621
NIV ++G S++R ++ E+ GSL + ++ + + R +
Sbjct: 66 SNIVAYFG--SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QG 118
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
L Y+H +HRDI N+LL +++DFG + + + +GT ++AP
Sbjct: 119 LYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK------HPGDFLSLFSSSS 732
+A + + CD+++ G+ A+E+ + + HP L L + S+
Sbjct: 176 -------EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G VY+AK +A K +++ D ++ EI+ L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YMVEIEILATCNHPYIVKLLG 76
Query: 574 FCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
+++ E+ G++ A +L + + + + + +AL Y+H
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSM---K 130
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTA----KLLKPNSSNWTELVGTFGYVAPAHGNIGL 688
I+HRD+ + NVLL L+ + +++DFG + K L+ S +GT ++AP
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS----FIGTPYWMAPE------ 180
Query: 689 HLAELAYTMKITE---KCDVYSFGVLALEVIKGKHP 721
+ TMK T K D++S G+ +E+ + + P
Sbjct: 181 --VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKI----AVKKFNSPFPNDQMSD 549
+I+ E +R+ K +G G +V++ +P GD I A+K D+
Sbjct: 2 RILKETELRKLK------LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-----DRSGR 50
Query: 550 Q--KEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFD 607
Q +E + + A+ + H IV+ G C V + GSL + + S D
Sbjct: 51 QTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDS--LD 107
Query: 608 WRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667
++ +N +A + Y+ +VHR++++ N+LL + +++DFG A LL P+
Sbjct: 108 PQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
+ + + I E + T + DV+S+GV E++ G P
Sbjct: 165 KY--------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
C+ KG VY+ + D +A+K + ++ S + E + E + + ++ + IV+
Sbjct: 10 CVKKG----VYKMRKKQID-VAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT---GVADALSYMHHDC 629
G C +V E + G L N F S D NV+ V+ + Y+
Sbjct: 62 GVC-EAEALMLVMEMASGGPL-----NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG-----YVAPAHG 684
F VHRD+++ NVLL ++ A++SDFG +K L + S + + G + AP
Sbjct: 116 F---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAP--- 167
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
E K + + DV+S+G+ E G+ P
Sbjct: 168 -------ECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 61/274 (22%), Positives = 116/274 (42%), Gaps = 50/274 (18%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINRG 591
+AVK +SD ++E++ + I +H+NI+ G C+ +V+ EY ++G
Sbjct: 50 VAVKMLKDDATEKDLSD---LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 592 SLATVLS-------------NNFASEDFDWRKRMNVITGVADALSYM-HHDCFPPIVHRD 637
+L L E ++ ++ VA + Y+ C +HRD
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRD 162
Query: 638 ISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLH--LAELAY 695
+++ NVL+ +++DFG A+ + N+ ++ Y +G + + E +
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDV--NNIDY--------YKKTTNGRLPVKWMAPEALF 212
Query: 696 TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE--FNAMLD-HRLPHPSL 752
T + DV+SFGVL E+ +L S I +E F + + HR+ P+
Sbjct: 213 DRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPGIPVEELFKLLKEGHRMDKPAN 263
Query: 753 DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E + + + C P+ RPT + + + L
Sbjct: 264 CTNELYMMMRD----CWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 18/141 (12%)
Query: 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFPPIVHRDISS 640
F V EY+N G L + S FD + V AL ++H H +++RD+
Sbjct: 72 FFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG----VIYRDLKL 124
Query: 641 NNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT 700
+N+LLD E +++DFG K N T GT Y+AP L EL Y +
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE------ILQELEYGPSV- 177
Query: 701 EKCDVYSFGVLALEVIKGKHP 721
D ++ GVL E++ G+ P
Sbjct: 178 ---DWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 56/278 (20%)
Query: 532 KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINR 590
K+AVK S +SD ++E++ + I +H+NI+ G C+ +V+ EY ++
Sbjct: 52 KVAVKMLKSDATEKDLSD---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 108
Query: 591 GSLATVLS-------------NNFASEDFDWRKRMNVITGVADALSYM-HHDCFPPIVHR 636
G+L L E ++ ++ VA + Y+ C +HR
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHR 164
Query: 637 DISSNNVLLDLEYEARVSDFGTAKLLK-----PNSSNWTELVGTFGYVAPAHGNIGLHLA 691
D+++ NVL+ + +++DFG A+ + ++N V ++AP
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV---KWMAP---------- 211
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE--FNAMLD-HRLP 748
E + T + DV+SFGVL E+ +L S + +E F + + HR+
Sbjct: 212 EALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPGVPVEELFKLLKEGHRMD 262
Query: 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
PS E + + + C P+ RPT + + + L
Sbjct: 263 KPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 58/231 (25%), Positives = 83/231 (35%), Gaps = 59/231 (25%)
Query: 514 IGKGEHRSVY------RAKLPSGDKIAVKKF-NSPFPNDQMSDQKEFLNEIKALTKIRHR 566
+G G VY R ++AVK S D+ +FL E ++K H+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES----DFLMEALIMSKFNHQ 69
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM----NVITGVADAL 622
NIV+ G F++ E + G L + L N + M VA
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARV---SDFGTAKLLKPNSS-----------N 668
Y+ + F +HRDI++ N LL + RV +DFG A+ + S
Sbjct: 130 KYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 669 WTE----LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715
W L G F T K DV+SFGVL E+
Sbjct: 187 WMPPEAFLDGIF-----------------------TSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 80/287 (27%), Positives = 117/287 (40%), Gaps = 33/287 (11%)
Query: 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84
+L LDL N P S LK LDLS+N++ +P + L +L +LDLS N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173
Query: 85 QFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRS 144
S + NLSNL + L NK+S +P EI L L L L
Sbjct: 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL---------------- 216
Query: 145 GLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
++N + + +L N ++L L N L ++ E G NL+ LDLS+N
Sbjct: 217 --------SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ- 266
Query: 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
S+ G L L +SGN+++ +P + L +L+L N + +EL
Sbjct: 267 -ISSISSLGSLTNLRELDLSGNSLSNALPL---IALLLLLLELLLNLLLTLKALELKLNS 322
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFM 311
L + N P AL +L L N L+ S L
Sbjct: 323 ILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALDESNLNRYIVK 368
|
Length = 394 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 58/265 (21%), Positives = 110/265 (41%), Gaps = 37/265 (13%)
Query: 532 KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRG 591
++AVK N + + ++ EFLNE + ++V+ G S + + VV E + G
Sbjct: 38 RVAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 592 SLATVL-------SNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644
L + L NN ++ + + +AD ++Y++ F VHRD+++ N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCM 151
Query: 645 LDLEYEARVSDFGTAKLLKPNSSNWTELVGTF--GYVAPAHGNIGLHLAELAYTMKITEK 702
+ ++ ++ DFG + + G ++AP G+ T
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV----------FTTS 201
Query: 703 CDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISI 761
D++SFGV+ E+ + P + S+ ++F M L P + E++ +
Sbjct: 202 SDMWSFGVVLWEITSLAEQP------YQGLSNEQVLKF-VMDGGYLDQPD-NCPERVTDL 253
Query: 762 MEVALLCLDGCPNSRPTMQTVCQLL 786
M +C P RPT + LL
Sbjct: 254 MR---MCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 67/272 (24%), Positives = 115/272 (42%), Gaps = 34/272 (12%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR 566
DF+ IG+G V K+ ++I K + + + ++ F E L +
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN--NFASEDFDWRKRMNVITGVADALSY 624
I + + ++V +Y G L T+LS + ED R + + ++
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYIAEMVLAIHSIHQ 120
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA-KLLKPNSSNWTELVGTFGYVAPAH 683
+H+ VHRDI +NVLLD+ R++DFG+ K+ + + + VGT Y++P
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP-- 172
Query: 684 GNIGLHLAELAYTM-----KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
E+ M K +CD +S GV E++ G+ P SL + +N E
Sbjct: 173 --------EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224
Query: 739 FNAMLDHRLPHPS--LDVQEKLISIMEVALLC 768
R PS DV E+ +++ L+C
Sbjct: 225 ------ERFQFPSHITDVSEEAKDLIQ-RLIC 249
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKK--FNSPFPNDQMSDQKEFLN-EIKALTKIRHRNIV 569
+G+G VY +G ++AVK+ F+ P + S + L EI+ L + H IV
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESP--ETSKEVNALECEIQLLKNLLHERIV 67
Query: 570 KFYGFC--SHVRHSFVVYEYINRGSLATVLSNNFA-SEDFDWRKRMNVITGVADALSYMH 626
++YG R + E++ GS+ L + A +E+ + ++ GV SY+H
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV----SYLH 123
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP---NSSNWTELVGTFGYVAPAH 683
+ IVHRDI N+L D ++ DFG +K L+ + + + GT +++P
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP-- 178
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ K D++S G +E++ K P
Sbjct: 179 --------EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 47/284 (16%)
Query: 512 YC----IGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR 566
YC +GKG + V + + G + +KK N N ++K E + L++++H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 567 NIVKFYGFCSHVRHS--------FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV 618
NIV + R S ++V + G L L + + + +
Sbjct: 60 NIVAY-------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQI 111
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
A AL Y+H I+HRD+ + NV L +V D G A++L+ + L+GT Y
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
++P EL K DV++ G E+ KH + ++ +N
Sbjct: 169 MSP----------ELFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMNSL 210
Query: 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+++ +LP D +L ++ +L P RP+++++
Sbjct: 211 VYRIIEGKLPPMPKDYSPELGELIA-TMLSKR--PEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 56/289 (19%)
Query: 514 IGKGEHRSVYRAKLPSGD-------KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR 566
+G G VY ++AVK ++KEFL E ++ H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK---GATDQEKKEFLKEAHLMSNFNHP 59
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVL----SNNFASEDFDWRKRMNVITGVADAL 622
NIVK G C +++ E + G L + L F ++ +++ VA
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLE-YEAR----VSDFGTAKLLKPNSSNWTELVGTFG 677
Y+ F +HRD+++ N L+ + Y+A + DFG A+ + + E G
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 678 --YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSS 734
++AP E K T + DV+SFGVL E++ G+ P L+
Sbjct: 177 VRWMAP----------ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------- 218
Query: 735 INIEFNAMLDH-----RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
N E +L H RL P + +K+ +M C P+ RPT
Sbjct: 219 -NQE---VLQHVTAGGRLQKPE-NCPDKIYQLM---TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 39/129 (30%), Positives = 53/129 (41%), Gaps = 26/129 (20%)
Query: 55 LDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIP 114
L L L G IP +I L HL S++LS N + G+IP
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLS-----------------------GNSIRGNIP 459
Query: 115 EEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAH 174
+G++ L L L N F G +P ++ + L IL +N N G +P R L RA
Sbjct: 460 PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA- 518
Query: 175 LGRNNLTGN 183
N T N
Sbjct: 519 --SFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G VY+A+ +A K +++ D ++ EI L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLD 69
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI-TGVADALSYMHHDCFPP 632
+ + +++ E+ G++ V+ E ++ V+ +AL+Y+H +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
I+HRD+ + N+L L+ + +++DFG + +GT ++AP + + E
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE-----VVMCE 178
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ K DV+S G+ +E+ + + P
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG-FCSHVRHSFVVYEY 587
+G +A+KK PF ++ K E+K L +RH NI+ F S + + V E
Sbjct: 34 TGQNVAIKKIMKPFSTPVLA--KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91
Query: 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647
+ L +L++ + F ++ G L Y+H +VHRD+ +N+L++
Sbjct: 92 LGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---AGVVHRDLKPSNILINE 143
Query: 648 EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVY 706
+ ++ DFG A + T V T Y AP E+ T K + D++
Sbjct: 144 NCDLKICDFGLA---RIQDPQMTGYVSTRYYRAP----------EIMLTWQKYDVEVDIW 190
Query: 707 SFGVLALEVIKGK--HPG-DFLSLFS 729
S G + E+++GK PG D ++ FS
Sbjct: 191 SAGCIFAEMLEGKPLFPGKDHVNQFS 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 31/224 (13%)
Query: 514 IGKGEHRSVYRAKLPSGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G+GE SV +L D K+AVK S+ +EFL+E + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMK--LDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 570 KFYGFCSHVRHS------FVVYEYINRGSLATVLSNN---FASEDFDWRKRMNVITGVAD 620
K G C V+ ++ G L + L + E + + + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
+ Y+ + F +HRD+++ N +L + V+DFG +K K S ++ G +A
Sbjct: 125 GMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK--KIYSGDYYRQ----GRIA 175
Query: 681 --PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHP 721
P LA+ Y T K DV++FGV E+ +G+ P
Sbjct: 176 KMPVKWIAIESLADRVY----TSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 506 KDFDAKYCIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
KDF +G+G + V+ A K +G+ +A+K+ ++++ + L E LT +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTK 59
Query: 565 HRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
+VK Y F + ++ EY+ G T+L+N + R M + DAL
Sbjct: 60 SEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK--LLKPNSSNWTELVGTFGYVAP 681
+ +HRD+ N L+D +++DFG +K + NS +VG+ Y+AP
Sbjct: 119 ELG------YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAP 167
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
E+ D +S G + E + G P FS S+
Sbjct: 168 ----------EVLRGKGYDFTVDYWSLGCMLYEFLCGFPP------FSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 63/227 (27%), Positives = 92/227 (40%), Gaps = 45/227 (19%)
Query: 514 IGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG VY A P ++A+KK + + +K FL E K + H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL-KKRFLREAKIAADLIHPGIVPVY 68
Query: 573 GFCSHVRHSFVVY---EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
CS VY YI +L ++L + + E K + T V LS H C
Sbjct: 69 SICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKIC 123
Query: 630 FP-------PIVHRDISSNNVLLDLEYEARVSDFGTAKLLK-------------PNS--S 667
++HRD+ +N+LL L E + D+G A K N S
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 668 NWT---ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
+ T ++VGT Y+AP E + +E D+Y+ GV+
Sbjct: 184 SMTIPGKIVGTPDYMAP----------ERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 514 IGKGEHRSVYRAKLPSGDK--------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-R 564
+G+G V RA+ DK +AVK + ++D ++E++ + I +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD---LISEMELMKLIGK 76
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLS-------------NNFASEDFDWRKR 611
H+NI+ G C+ +V+ EY +G+L L E ++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 612 MNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK-----PN 665
++ VA + Y+ C +HRD+++ NVL+ + +++DFG A+ +
Sbjct: 137 VSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725
+SN V ++AP E + T + DV+SFG+L E+
Sbjct: 193 TSNGRLPV---KWMAP----------EALFDRVYTHQSDVWSFGILMWEI---------F 230
Query: 726 SLFSSSSSSINIE--FNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+L S I +E F + + HR+ PS E + + E C P RPT + +
Sbjct: 231 TLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQL 286
Query: 783 CQLL 786
+ L
Sbjct: 287 VEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 274 NQ-LSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL 332
NQ L G +P + L L+ +LS N + +I +LG + L L+ S+N F+ IPE L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 333 ALLAHLSELDLSHNLFKGSIPS 354
L L L+L+ N G +P+
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 35/188 (18%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-F----LNEIKALTKIRHRN 567
IG+G V++A+ + +A+KK M ++KE F L EIK L ++H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 72
Query: 568 IVKFYGFC-------SHVRHSF-VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+V C + + SF +V+E+ LA +LSN + F + V+ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLL 129
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL------KPNSSNWTELV 673
+ L Y+H I+HRD+ + N+L+ + +++DFG A+ KPN +T V
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRV 184
Query: 674 GTFGYVAP 681
T Y P
Sbjct: 185 VTLWYRPP 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 508 FDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR 566
F+ +G+G + V + + +I A+KKF N+++ + L E+K L ++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETT--LRELKMLRTLKQE 60
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATV--LSNNFASEDFDWRKRMNVITGVADALSY 624
NIV+ ++V+EY+ + L + + N E K + I + A+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKAIHW 115
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK-LLKPNSSNWTELVGTFGYVAPAH 683
H + IVHRDI N+L+ ++ DFG A+ L + +++N+TE V T Y +P
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP-- 170
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK--HPGD 723
EL + D++S G + E+ G+ PG+
Sbjct: 171 --------ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 16/142 (11%)
Query: 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639
+ F V EY+N G L + + FD + + L ++H IV+RD+
Sbjct: 70 NLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLK 123
Query: 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI 699
+N+LLD + +++DFG K + GT Y+AP E+ K
Sbjct: 124 LDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP----------EILLGQKY 173
Query: 700 TEKCDVYSFGVLALEVIKGKHP 721
D +SFGVL E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G + VY+A+ +G+ +A+KK + + EI L ++ H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV--ITGVADAL--SYMHH- 627
++V+E++++ D +K M+ ++G+ L SY+
Sbjct: 66 DVIHTENKLYLVFEFLHQ----------------DLKKFMDASPLSGIPLPLIKSYLFQL 109
Query: 628 -----DCFP-PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
C ++HRD+ N+L++ E +++DFG A+ +T V T Y AP
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI--KGKHPGD 723
+ L Y+ + D++S G + E++ + PGD
Sbjct: 170 E-----ILLGCKYYSTAV----DIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 22/145 (15%)
Query: 580 HSFVVYEYINRGSLATVLSNNFASED---FDWRKRMNVITGVADALSYMHHDCFPPIVHR 636
H F V E++N G L F +D FD + + L ++H I++R
Sbjct: 70 HLFFVMEFLNGGDLM------FHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYR 120
Query: 637 DISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT 696
D+ +NV+LD + +++DFG K + + GT Y+AP E+
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP----------EILQG 170
Query: 697 MKITEKCDVYSFGVLALEVIKGKHP 721
+K T D +SFGVL E++ G+ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 61/211 (28%), Positives = 85/211 (40%), Gaps = 33/211 (15%)
Query: 218 LGTLIVSGNNITGRIPPEIG-------NSSQLHVLDLSSNHIAGEIPMELGRL---ISLN 267
L L +S N TGRIP + L LDLS N + + L L SL
Sbjct: 53 LKELCLSLNE-TGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQ 111
Query: 268 KLILRGNQLSG----HLPRALGLLTE-LEYFDLSSNRLNNSILEALGFMF----KLFYLN 318
+L L N L L + L L LE L NRL + EAL L LN
Sbjct: 112 ELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELN 171
Query: 319 FSHNQFSQE----IPEDLALLAHLSELDLSHNLF--KGSIPSRIC--NLESLEKLNLSHN 370
++N + E L +L LDL++N +G+ +L+SLE LNL N
Sbjct: 172 LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231
Query: 371 NISGQI-----PACFIGMSGLLSIDISYNEL 396
N++ A LL++ +S N++
Sbjct: 232 NLTDAGAAALASALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 62/273 (22%), Positives = 117/273 (42%), Gaps = 52/273 (19%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINRG 591
+AVK + +SD ++E++ + I +H+NI+ G C+ +V+ EY ++G
Sbjct: 47 VAVKMLKDDATDKDLSD---LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 592 SLATVL-------------SNNFASEDFDWRKRMNVITGVADALSYM-HHDCFPPIVHRD 637
+L L + E ++ ++ VA + Y+ C +HRD
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRD 159
Query: 638 ISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG---TFGYVAPAHGNIGLHLAELA 694
+++ NVL+ + +++DFG A+ + N + + ++AP E
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVH-NIDYYKKTTNGRLPVKWMAP----------EAL 208
Query: 695 YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE--FNAMLD-HRLPHPS 751
+ T + DV+SFGVL E+ +L S I +E F + + HR+ P+
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEI---------FTLGGSPYPGIPVEELFKLLKEGHRMDKPA 259
Query: 752 LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ +L IM C P+ RPT + + +
Sbjct: 260 -NCTHELYMIMRE---CWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 546 QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED 605
+++E E+ L+ ++H NIV++ + ++V +Y G L + N
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVL 97
Query: 606 FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665
F + ++ + AL ++H I+HRDI S N+ L + ++ DFG A++L
Sbjct: 98 FPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
Query: 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH 720
+GT Y++P E+ K D+++ G + E+ KH
Sbjct: 155 VELARTCIGTPYYLSP----------EICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 35/232 (15%)
Query: 507 DFDAKY----CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
D ++Y IG G + V A SG K+A+KK F D + K L E+K L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILR 59
Query: 562 KIRHRNIVK----FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
+H NI+ + + +VV + + + S+ +E+ ++ G
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN----WTELV 673
L Y+H ++HRD+ +N+L++ + E R+ DFG A+ L + + TE V
Sbjct: 120 ----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 674 GTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKH--PG 722
T Y AP EL ++ + T D++S G + E++ + PG
Sbjct: 173 ATRWYRAP----------ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 514 IGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKF 571
IG+G +V + PSG +AVK+ S D+ +QK L ++ + + IVKF
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDE-KEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM---NVITGVA----DALSY 624
YG ++ E L + + F ++ K + ++ +A AL+Y
Sbjct: 69 YGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+ + I+HRD+ +N+LLD ++ DFG + L +S T G Y+AP
Sbjct: 123 LKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPER- 178
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD-FLSLF 728
I + Y + + DV+S G+ EV GK P + S+F
Sbjct: 179 -IDPSARD-GYDV----RSDVWSLGITLYEVATGKFPYPKWNSVF 217
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G + VY+A+ + + IA+KK ++ + + EI L +++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM------NVITGVADALSYMH 626
+ ++V+EY++ L + + S DF R+ ++ G+A Y H
Sbjct: 68 DVVHSEKRLYLVFEYLDL-DLKKHMDS---SPDFAKNPRLIKTYLYQILRGIA----YCH 119
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEA-RVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
++HRD+ N+L+D A +++DFG A+ +T V T Y AP
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE--- 173
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK--HPGD 723
+ L Y+ + D++S G + E++ K PGD
Sbjct: 174 --ILLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 502 IRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKI----AVKKF---NSPFPNDQMSDQKEF 553
I + +F +G G +VY+ +P G+K+ A+K+ SP N KE
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN------KEI 56
Query: 554 LNEIKALTKIRHRNIVKFYGFC--SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR 611
L+E + + + ++ + G C S V+ ++ + + G L + + ++ +
Sbjct: 57 LDEAYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREH--KDNIGSQYL 111
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+N +A ++Y+ +VHRD+++ NVL+ +++DFG AKLL + +
Sbjct: 112 LNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSS 730
G A +I LH T + DV+S+GV E++ G P D +
Sbjct: 169 EGGKVPIKWMALESI-LHRI-------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220
Query: 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777
SS E RLP P + I + + + C +SRP
Sbjct: 221 SSILEKGE-------RLPQPPICT----IDVYMIMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 514 IGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+GKGE SV A+L S K+AVK + SD +EFL E + + H N++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVI 64
Query: 570 KFYGFCSHVRHS------FVVYEYINRGSLAT-VLSNNFASEDFDWRKRMNVITGVADAL 622
K G R V+ ++ G L T +L + E F + ++ + D
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT-LVRFMIDIA 123
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660
S M + +HRD+++ N +L+ V+DFG +K
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 30/225 (13%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+DFD IG+G V + S ++ K S F + SD F E +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 566 RNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
IV+ Y F ++ ++V EY+ G L ++SN E W + V AL
Sbjct: 103 EWIVQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFY--TAEVVLALDA 157
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA-KLLKPNSSNWTELVGTFGYVAP-- 681
+H F +HRD+ +N+LLD +++DFGT K+ VGT Y++P
Sbjct: 158 IHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214
Query: 682 -----AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
G G +CD +S GV E++ G P
Sbjct: 215 LKSQGGDGYYG-------------RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 34/247 (13%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQ-----MSDQKEFLNEIKALTKIRHRN 567
IG+G + V +L ++I A+K ND + +K + H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPF 57
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+V + F V EY+N G L + + R ++ AL+Y+H
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS---AEISLALNYLHE 114
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGYVAPAHGNI 686
I++RD+ +NVLLD E +++D+G K L+P + + GT Y+AP
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAP----- 165
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE---FNAML 743
E+ D ++ GVL E++ G+ P D + SS + N E F +L
Sbjct: 166 -----EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG--SSDNPDQNTEDYLFQVIL 218
Query: 744 DHRLPHP 750
+ ++ P
Sbjct: 219 EKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 19/142 (13%)
Query: 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642
++ +Y+N G L T L + E F + I + AL ++H I++RDI N
Sbjct: 82 LILDYVNGGELFTHL---YQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLEN 135
Query: 643 VLLDLEYEARVSDFGTAKLLKPNSSNWT-ELVGTFGYVAP--AHGNIGLHLAELAYTMKI 699
+LLD E ++DFG +K GT Y+AP G G H
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH---------- 185
Query: 700 TEKCDVYSFGVLALEVIKGKHP 721
+ D +S GVL E++ G P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 70/252 (27%), Positives = 111/252 (44%), Gaps = 38/252 (15%)
Query: 506 KDFDAKYCIGKGEHRSVY--RAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
KDFD K +G+G V R K +GD A+K Q + F E + + I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQ--ETVSFFEEERDILSI 57
Query: 564 RHRN-IVKF-YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621
+ I + Y F + ++V EY G L ++L+ + FD + + A
Sbjct: 58 SNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLA 114
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL-VGTFGYVA 680
+ +H + VHRDI NVL+D +++DFG+A L N ++L VGT Y+A
Sbjct: 115 IHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 681 PAHGNIGLHLAELAYTMKITEK------CDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734
P E+ TM K CD +S GV+A E+I G+ P F +S+
Sbjct: 172 P----------EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP------FHEGTSA 215
Query: 735 INIEFNAMLDHR 746
+N +++ +
Sbjct: 216 KT--YNNIMNFQ 225
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 555 NEIKALTKIRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSNN--FASEDFDWRKR 611
E L ++ H IVK Y F + + +++ +++ G L T LS F ED +
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF--- 102
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+ +A AL ++H I++RD+ N+LLD E +++DFG +K +
Sbjct: 103 --YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
GT Y+AP N H T+ D +SFGVL E++ G P
Sbjct: 158 FCGTVEYMAPEVVNRRGH----------TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 19/210 (9%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF- 571
+GKG V ++ + K+ A KK + + +Q LNE K L K+ R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA-LNEKKILEKVSSRFIVSLA 59
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y F + V+ +N G L + N F + + + L ++H
Sbjct: 60 YAFETKDDLCLVM-TLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
IV+RD+ NVLLD R+SD G A LK GT GY+AP
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI-KGRAGTPGYMAP---------- 163
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ D ++ G E+I G+ P
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 31/236 (13%)
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKI----AVKKFN-SPFPNDQMS 548
+I+ E ++R K +G G +VY+ +P G+ + A+K N + P +
Sbjct: 2 RILKETELKRVK------VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV- 54
Query: 549 DQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW 608
EF++E + + H ++V+ G C V + + G L + + ++
Sbjct: 55 ---EFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEH--KDNIGS 108
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
+ +N +A + Y+ +VHRD+++ NVL+ +++DFG A+LL+ +
Sbjct: 109 QLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165
Query: 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGD 723
+ G I E + K T + DV+S+GV E++ G P D
Sbjct: 166 YNADGGKM--------PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 30/81 (37%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
SINL+ ++G + S S L LDLS N F G++P + L+ L+ L+L+ N LSG
Sbjct: 446 SINLSGNSIRGNI-PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
Query: 65 KIPPEIG-LLTHLFSLDLSLN 84
++P +G L H S + + N
Sbjct: 505 RVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G + SV A +G+K+A+KK + PF ++ + K E+ L ++H N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA--KRAYRELTLLKHMQHENVIGLL 80
Query: 573 G-FCSHVRHS-----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
F S V ++V Y+ + L ++ + + + + ++ + L Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIH 134
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
I+HRD+ N+ ++ + E ++ DFG A + + T V T Y AP
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAP----- 183
Query: 687 GLHLAELAYT-MKITEKCDVYSFGVLALEVIKGK 719
E+ M + D++S G + E++ GK
Sbjct: 184 -----EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 54/235 (22%), Positives = 101/235 (42%), Gaps = 48/235 (20%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSV-YRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
E+ R +D +G G + +V +G K+A+KK PF ++ + K E++
Sbjct: 12 EVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFA--KRAYRELR 66
Query: 559 ALTKIRHRNIV-------------KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED 605
L ++H N++ +F+ F ++V ++ L ++ + SED
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDF-------YLVMPFMGT-DLGKLMKHEKLSED 118
Query: 606 FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665
+ ++ + L Y+H I+HRD+ N+ ++ + E ++ DFG A +
Sbjct: 119 ----RIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQT 168
Query: 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGK 719
S T V T Y AP E+ M T+ D++S G + E++ GK
Sbjct: 169 DSEMTGYVVTRWYRAP----------EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 59/245 (24%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKF-NSPFPNDQMSDQKEF---------LNEIKALTK 562
+G+G + V +A +G +A+KK ND D++ L E+K + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 563 IRHRNIVKFYGFCSHVRHSFVVYEYIN------RGSLATVLSNNFASEDFDWRKRM-NVI 615
I+H NI+ + +V ++IN L V+ + + + ++
Sbjct: 77 IKHENIMG-------LVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK------------LLK 663
G+ H + +HRD+S N+ ++ + +++DFG A+ +
Sbjct: 130 NGLNVL-----HKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 664 PNSS--NWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGK- 719
T V T Y AP EL K D++S G + E++ GK
Sbjct: 183 TMQRREEMTSKVVTLWYRAP----------ELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 720 -HPGD 723
PG+
Sbjct: 233 LFPGE 237
|
Length = 335 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKE---FLNEIKALTK 562
DF+ IG+G V K+ + ++ A+K N +M + E F E L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVN 57
Query: 563 IRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSN--NFASEDFDWRKRMNVITGVA 619
R I Y F + ++V +Y G L T+LS + ED R + +
Sbjct: 58 GDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLAEMVLAI 115
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA-KLLKPNSSNWTELVGTFGY 678
D++ + + VHRDI +NVLLD R++DFG+ +LL + VGT Y
Sbjct: 116 DSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169
Query: 679 VAPAHGNIGLHLAELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 721
++P E+ M + +CD +S GV E++ G+ P
Sbjct: 170 ISP----------EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 337 HLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNE 395
+L LDLS+N IP L +L+ L+LS NN++ P F G+ L S+D+S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 396 L 396
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 514 IGKGEHRSVYRAKLPSGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
+G+GE SV +L D K+AVK S+ ++FL+E + + H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 571 FYGFC--SHVRHSF----VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
G C + + V+ ++ G L + L + + + ++ + D S
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA--PA 682
M + +HRD+++ N +L+ V+DFG +K + N + + G +A P
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY-NGDYYRQ-----GRIAKMPV 178
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEV-IKGKHP 721
LA+ Y T K DV+SFGV E+ +G+ P
Sbjct: 179 KWIAIESLADRVY----TTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 17/209 (8%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFY 572
+GKG V A+L ++ K Q D + + E + L+ R H + + Y
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
F V E++N G L + S FD + + AL ++H
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDK---G 116
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
I++RD+ +NVLLD E +++DFG K N + GT Y+AP E
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP----------E 166
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ M D ++ GVL E++ G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKF 571
+G+G + V + + +P+G +AVK+ + N Q +QK L ++ + V F
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATV-NSQ--EQKRLLMDLDISMRSVDCPYTVTF 65
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM--NVI----TGVADALSYM 625
YG + R V +I + T L + F + +D + +++ + AL Y+
Sbjct: 66 YG--ALFREGDV---WICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
H ++HRD+ +NVL++ + ++ DFG + L +S T G Y+AP
Sbjct: 120 HSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER-- 174
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723
I L + Y + K DV+S G+ +E+ G+ P D
Sbjct: 175 INPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 17/169 (10%)
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSF-VVYEYINRGSLATVLSNNFASEDFDWRKRM 612
LNE + L K+ R +V + + + +V +N G L + N + FD ++ +
Sbjct: 48 LNEKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAI 105
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
+ L + + IV+RD+ N+LLD R+SD G A + P
Sbjct: 106 FYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGR 161
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT GY+AP E+ K T D + G L E+I+G+ P
Sbjct: 162 VGTVGYMAP----------EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 554 LNEIKALTKIRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSNNFA-SEDFDWRKR 611
L E + L RH + Y F + R FV+ EY+N G L LS SED R R
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM-EYVNGGELFFHLSRERVFSED---RTR 98
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+ AL Y+H IV+RD+ N++LD + +++DFG K +++
Sbjct: 99 F-YGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
GT Y+AP E+ D + GV+ E++ G+ P
Sbjct: 155 FCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 56/212 (26%)
Query: 555 NEIKALTKIRHRNIVKF--------YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDF 606
NEI AL ++ H NI+K + ++ F +Y ++ E F
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM-------------YDEAF 258
Query: 607 DWRKR------MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA- 659
DW+ R ++ + A+ Y+H ++HRDI N+ L+ + + + DFGTA
Sbjct: 259 DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 660 ---KLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI 716
K + W VGT +P LA Y E D++S G++ L+++
Sbjct: 316 PFEKEREAFDYGW---VGTVATNSPE------ILAGDGY----CEITDIWSCGLILLDML 362
Query: 717 K---------GKHPGDFLSLFSSSSSSINIEF 739
G PG L S S + EF
Sbjct: 363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPND--QMSDQKEFLNEIKALTKIRHRNIVK 570
IG G + +VY+A+ P SG +A+K D +S +E + +K L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66
Query: 571 FYGFCSHVRHS-----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
C+ R +V+E++++ L T L +++ L ++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
H +C IVHRD+ N+L+ + +++DFG A++ + T +V T Y AP
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAP---- 176
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
E+ D++S G + E+ + K
Sbjct: 177 ------EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 72/307 (23%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G+G V +A+ D +AVK + D + ++E++ + I +H+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGKHK 76
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN-----FASEDFD--------WRKRMN 613
NI+ G C+ +VV EY G+L L +AS D + ++
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-----SSN 668
VA + ++ +HRD+++ NVL+ ++ +++DFG A+ + ++N
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 669 ------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPG 722
W F V T + DV+SFGVL E+
Sbjct: 194 GRLPVKWMAPEALFDRV-------------------YTHQSDVWSFGVLLWEIF------ 228
Query: 723 DFLSLFSSSSSSINIE--FNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779
+L S I +E F + + +R+ P QE L +M C P+ RPT
Sbjct: 229 ---TLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQE-LYHLM---RDCWHEVPSQRPTF 281
Query: 780 QTVCQLL 786
+ + + L
Sbjct: 282 KQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 37/179 (20%)
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLS-----------NNFA 602
LNE + L K+ R +V + Y Y + +L VL+ +
Sbjct: 48 LNEKQILEKVNSRFVVS------------LAYAYETKDALCLVLTLMNGGDLKFHIYHMG 95
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
F+ + + + L +H + IV+RD+ N+LLD R+SD G A +
Sbjct: 96 EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 152
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P VGT GY+AP E+ + T D ++ G L E+I G+ P
Sbjct: 153 -PEGQTIKGRVGTVGYMAP----------EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 48/179 (26%), Positives = 72/179 (40%), Gaps = 37/179 (20%)
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLS-----------NNFA 602
LNE + L K+ R +V + Y Y + +L VL+ N
Sbjct: 48 LNEKQILEKVNSRFVVS------------LAYAYETKDALCLVLTLMNGGDLKFHIYNMG 95
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
+ FD + + + L +H + IV+RD+ N+LLD R+SD G A +
Sbjct: 96 NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P VGT GY+AP E+ + T D + G L E+I+GK P
Sbjct: 153 -PEGETIRGRVGTVGYMAP----------EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 19/170 (11%)
Query: 554 LNEIKALTKIRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSNNFA-SEDFDWRKR 611
L E + L RH + Y F +H R FV+ EY N G L LS SED R R
Sbjct: 43 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED---RAR 98
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+ AL Y+H + +V+RD+ N++LD + +++DFG K + +
Sbjct: 99 F-YGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
GT Y+AP E+ D + GV+ E++ G+ P
Sbjct: 156 FCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 37/179 (20%)
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLS-----------NNFA 602
LNE + L K+ + +V + Y Y + +L VL+ N
Sbjct: 48 LNEKQILEKVNSQFVVN------------LAYAYETKDALCLVLTIMNGGDLKFHIYNMG 95
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
+ F+ + + + L +H + V+RD+ N+LLD R+SD G A +
Sbjct: 96 NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI 152
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P + VGT GY+AP E+ + T D + G L E+I+G+ P
Sbjct: 153 -PEGESIRGRVGTVGYMAP----------EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 22/192 (11%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592
+AVK + +D FL EIK +++++ NI++ C ++ EY+ G
Sbjct: 49 VAVKMLREDANKNARND---FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 593 LATVLSNNFASED--------FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644
L LS + E + + + T +A + Y+ F VHRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCL 162
Query: 645 LDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCD 704
+ Y +++DFG ++ L S ++ + G V P I E K T D
Sbjct: 163 VGKNYTIKIADFGMSRNLY--SGDYYRIQGR--AVLP----IRWMSWESILLGKFTTASD 214
Query: 705 VYSFGVLALEVI 716
V++FGV E++
Sbjct: 215 VWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 64/288 (22%), Positives = 119/288 (41%), Gaps = 38/288 (13%)
Query: 514 IGKGEHRSVYRAKLPSG---DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
IG G V ++ SG ++ VK+ + + +Q +FL E + ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV---SASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDF--DWRKRMNVITGVADALSYMHHD 628
G C+ V +V E+ G L L + +E D + +A L ++H +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT--ELVGTFGYVAP----- 681
F +H D++ N LL + ++ D+G + T +L ++AP
Sbjct: 120 NF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFN 740
HGN+ + T++ +V+S GV E+ + G P LS + +
Sbjct: 177 VHGNL--------LVVDQTKESNVWSLGVTIWELFELGSQPYRHLS--DEQVLTYTVREQ 226
Query: 741 AMLDHRLPHPSLDV--QEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ +LP P L + ++ +M+ L P RP+ + V LL
Sbjct: 227 QL---KLPKPRLKLPLSDRWYEVMQFCWL----QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 42/240 (17%)
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM 612
F ++++ H+++V YG C S +V EY+ GSL T L N + W ++
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS----- 667
V +A AL ++ + H ++ + NVLL E + + + KL P S
Sbjct: 104 EVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160
Query: 668 -NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF-L 725
L+ +V P +L+ A D +SFG E+ G GD L
Sbjct: 161 KEI--LLERIPWVPPECIENPQNLSLAA---------DKWSFGTTLWEIFSG---GDKPL 206
Query: 726 SLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL---CLDGCPNSRPTMQTV 782
S S E H+LP P E+A L C+D P+ RP+ + +
Sbjct: 207 SALDSQKKLQFYEDR----HQLPAPKW---------TELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 554 LNEIKALTKIRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSNNFA-SEDFDWRKR 611
+ E + L RH + Y F +H R FV+ EY N G L LS +E+ R R
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEE---RAR 98
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+ AL Y+H +V+RDI N++LD + +++DFG K + +
Sbjct: 99 F-YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
GT Y+AP E+ D + GV+ E++ G+ P
Sbjct: 155 FCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 550 QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN-NFASEDFDW 608
+ + + E++ L + IV FYG + E+++ GSL VL E+
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG 106
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
+ + V+ G+A L H I+HRD+ +N+L++ E ++ DFG + L + +N
Sbjct: 107 KVSIAVLRGLA-YLREKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160
Query: 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT Y++P G H Y++ + D++S G+ +E+ G++P
Sbjct: 161 --SFVGTRSYMSPERLQ-GTH-----YSV----QSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 47/193 (24%), Positives = 81/193 (41%), Gaps = 56/193 (29%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRN 567
IG+G + VY+A+ +G+ +A+KK ++ + E + EI L ++ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 568 IVKFYGFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA---- 619
IV+ V HS ++V+E++ D D +K M+
Sbjct: 60 IVRLL----DVVHSENKLYLVFEFL----------------DLDLKKYMDSSPLTGLDPP 99
Query: 620 ----------DALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
++Y H H ++HRD+ N+L+D E +++DFG A+
Sbjct: 100 LIKSYLYQLLQGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155
Query: 669 WTELVGTFGYVAP 681
+T V T Y AP
Sbjct: 156 YTHEVVTLWYRAP 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 18/143 (12%)
Query: 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFPPIVHRDI 638
F V EY+N G L + S FD + + L ++H I++RD+
Sbjct: 70 RLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG----IIYRDL 122
Query: 639 SSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMK 698
+NVLLD E +++DFG K + GT Y+AP I L+ Y
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAP---EI---LSYQPYGPA 176
Query: 699 ITEKCDVYSFGVLALEVIKGKHP 721
+ D ++ GVL E++ G+ P
Sbjct: 177 V----DWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 31/160 (19%)
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+++ NVLL A++ DFG A+ + N SN YV GN L + +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIM-NDSN---------YV--VKGNARLPVKWM 281
Query: 694 A----YTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD--HR 746
A + T + DV+S+G+L E+ GK P +N +F M+ ++
Sbjct: 282 APESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--------YPGILVNSKFYKMVKRGYQ 333
Query: 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ P E + SIM+ +C + P RPT + QL+
Sbjct: 334 MSRPDFAPPE-IYSIMK---MCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 514 IGKGEHRSV---YRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
+G G + SV Y +L K+AVKK + PF + + E++ L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIG 78
Query: 571 F---YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+ + + + VY N + L+N + +I + L Y+H
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNL--MGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIG 687
I+HRD+ +NV ++ + E R+ DFG A + T V T Y AP I
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAP---EIM 187
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIKGK--HPGD 723
L+ M + D++S G + E++KGK PG+
Sbjct: 188 LNW------MHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 514 IGKGEHRSVYRA--KLPSGDK--IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G G + R KLPS + +A+ + + Q ++ FL E L + H NIV
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ---RRGFLAEALTLGQFDHSNIV 69
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
+ G + +V EY++ G+L + L + + M ++ G+A + Y+
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLH 689
+ VH+ ++++ VL++ + ++S F + K + +T + G + A I H
Sbjct: 128 Y---VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYH 183
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721
+ DV+SFG++ EV+ G+ P
Sbjct: 184 --------HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 44/245 (17%)
Query: 497 MYEEIIRRTK-DFDAKY----CIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQ 550
Y + + +T + +Y +G G + V A +G K+A+KK + PF +
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI--HA 58
Query: 551 KEFLNEIKALTKIRHRNIVKFYG-FC-----SHVRHSFVVYEYINRGSLATVLSNNFASE 604
K E++ L + H N++ F + ++V + L ++ S+
Sbjct: 59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSD 117
Query: 605 D---FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661
D F ++ + L Y+H I+HRD+ +N+ ++ + E ++ DFG A+
Sbjct: 118 DHIQF-------LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
Query: 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGK- 719
T V T Y AP E+ M + D++S G + E++ GK
Sbjct: 168 ---TDDEMTGYVATRWYRAP----------EIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
Query: 720 -HPGD 723
PG
Sbjct: 215 LFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 23/174 (13%)
Query: 551 KEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL-SNNFASEDFDWR 609
+ + E+K L + IV FYG + E+++ GSL VL E+ +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK 103
Query: 610 KRMNVITGVADALSYMH--HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667
+ V+ G L+Y+ H I+HRD+ +N+L++ E ++ DFG + L + +
Sbjct: 104 ISIAVLRG----LTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
N VGT Y++P L YT+ + D++S G+ +E+ G++P
Sbjct: 156 N--SFVGTRSYMSPE------RLQGTHYTV----QSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY--------------GF 574
++AVKK D S K L EIK + ++ H NIVK Y G
Sbjct: 29 CDKRVAVKKI---VLTDPQS-VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84
Query: 575 CSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIV 634
+ + ++V EY+ LA VL SE+ ++ G L Y+H ++
Sbjct: 85 LTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRG----LKYIHS---ANVL 136
Query: 635 HRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSN---WTELVGTFGYVAPAHGNIGLHL 690
HRD+ NV ++ E ++ DFG A+++ P+ S+ +E + T Y +P L L
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR-----LLL 191
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ YT I D+++ G + E++ GK
Sbjct: 192 SPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 47/231 (20%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEF-----LNEIKALTKIRHRN 567
+G+G VY+A ++ +G +A+KK M ++K+ L EIK L K++H N
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI-------LMHNEKDGFPITALREIKILKKLKHPN 68
Query: 568 IVK----FYGFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+V + ++V Y++ L+ +L N S + + +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLL 125
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW---------- 669
+ ++Y+H + I+HRDI + N+L+D + +++DFG A+ N
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 670 -TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
T LV T Y P L L E YT + D++ G + E+ +
Sbjct: 183 YTNLVVTRWYRPPE-----LLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 53/247 (21%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSD-QKEFLNEI 557
EI+++ +GKG + V++A + + +A+KK F N D Q+ F EI
Sbjct: 10 EILQK---------LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT--DAQRTF-REI 57
Query: 558 KALTKIR-HRNIVKFYGFCSHV------RHSFVVYEYINRGSLATVLSNNFASEDFDWRK 610
L ++ H NIVK +V + ++V+EY+ L V+ N + K
Sbjct: 58 MFLQELGDHPNIVKLL----NVIKAENDKDIYLVFEYMET-DLHAVIRANILEDV---HK 109
Query: 611 RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW- 669
R ++ + AL Y+H ++HRD+ +N+LL+ + +++DFG A+ L N
Sbjct: 110 RY-IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 670 ----TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725
T+ V T Y AP + L YT + D++S G + E++ GK
Sbjct: 166 NPVLTDYVATRWYRAPE-----ILLGSTRYTKGV----DMWSVGCILGEMLLGK------ 210
Query: 726 SLFSSSS 732
LF +S
Sbjct: 211 PLFPGTS 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 514 IGKGEHRSVYRAKLPS---GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIV 569
+G+G + V A+ + +A+KK + F ++ K L E+K L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILA--KRALRELKLLRHFRGHKNIT 65
Query: 570 KFYG----FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
Y F + ++ YE + L ++ + D ++ + I + L Y+
Sbjct: 66 CLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQ---SFIYQILCGLKYI 121
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSNWTELVGTFGYVAP 681
H ++HRD+ N+L++ + E ++ DFG A+ N + TE V T Y AP
Sbjct: 122 HS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ L+ +YT I DV+S G + E++ K
Sbjct: 179 E-----IMLSFQSYTKAI----DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 28/195 (14%)
Query: 530 GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS------HVRHSFV 583
G +AVKK + PF N + K E+ L + H+NI+ + + ++
Sbjct: 46 GINVAVKKLSRPFQNQ--THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103
Query: 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNV 643
V E ++ +L V+ + D + ++ + + ++H I+HRD+ +N+
Sbjct: 104 VMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154
Query: 644 LLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKC 703
++ + ++ DFG A+ N T V T Y AP E+ M E
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAP----------EVILGMGYKENV 203
Query: 704 DVYSFGVLALEVIKG 718
D++S G + E++KG
Sbjct: 204 DIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 22/208 (10%)
Query: 521 SVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580
+ + K P+ +AVKK N + D K EI +++H NI+ + V
Sbjct: 17 HLAKHK-PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDS 72
Query: 581 S-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639
+VV + GS +L +F E ++ V +AL Y+H F +HR +
Sbjct: 73 ELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKGF---IHRSVK 128
Query: 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-- 697
++++LL + + +S + + +V F + +L L+ +
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMI-KHGKRQRVVHDFPK------SSVKNLPWLSPEVLQ 181
Query: 698 ----KITEKCDVYSFGVLALEVIKGKHP 721
EK D+YS G+ A E+ G P
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G + SV A +G ++AVKK + PF + K E++ L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 573 GFCSHVRHSFVVYE--YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
+ R S + Y+ + L+N + +I + L Y+H
Sbjct: 83 DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 138
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
I+HRD+ +N+ ++ + E ++ DFG A + T V T Y AP I L+
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAP---EIMLNW 192
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGK 719
M + D++S G + E++ G+
Sbjct: 193 ------MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 28/155 (18%)
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNN--FASEDFDWRKRMNVITGVADALSYMHHDC 629
Y F + + SF++ + +N G L LS + F+ + + +I G L +MH+
Sbjct: 64 YAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYA-AEIILG----LEHMHNRF 117
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTA---KLLKPNSSNWTELVGTFGYVAPAHGNI 686
+V+RD+ N+LLD R+SD G A KP++S VGT GY+AP
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAP----- 164
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L + D +S G + ++++G P
Sbjct: 165 ----EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 33/161 (20%)
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+++ N+LL ++ DFG A+ + + YV G+ L L +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------YVR--KGDARLPLKWM 242
Query: 694 A----YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI--EFNAMLDH-- 745
A + T + DV+SFGVL E+ SL +S + I EF L
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEI---------FSLGASPYPGVQIDEEFCRRLKEGT 293
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
R+ P E + SIM L C P RPT + ++L
Sbjct: 294 RMRAPEYATPE-IYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 45/243 (18%)
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAV-------KKFNSPFPNDQ 546
+I+ E +++ K +G G +VY+ +P G+ + + ++ SP N
Sbjct: 2 RILKETELKKVK------VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-- 53
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFC--SHVRHSFVVYEYINRGSLATVLSNN---F 601
KE L+E + + + + G C S V+ +V + + G L + N
Sbjct: 54 ----KEILDEAYVMAGVGSPYVCRLLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRI 106
Query: 602 ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661
S+D +N +A +SY+ +VHRD+++ NVL+ +++DFG A+L
Sbjct: 107 GSQDL-----LNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
Query: 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKH 720
L + TE G V I E + T + DV+S+GV E++ G
Sbjct: 159 LDIDE---TEYHADGGKVP-----IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210
Query: 721 PGD 723
P D
Sbjct: 211 PYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 23/179 (12%)
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDF 606
M +++ F RH +V + H V EY G L + ++ F
Sbjct: 47 MCEKRIFE----TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMM----HIHTDVF 98
Query: 607 DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666
+ + V L Y+H + IV+RD+ +N+LLD E +++DFG K
Sbjct: 99 SEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155
Query: 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GD 723
+ GT ++AP L E +YT + D + GVL E++ G+ P GD
Sbjct: 156 DRTSTFCGTPEFLAPE------VLTETSYTRAV----DWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 43/130 (33%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 554 LNEIKALTKIRHRNIVKF-YGFCSHVRHSFVVYEYINRGSLATVLSN-NFASEDFDWRKR 611
L E + L RH + Y F +H R FV+ EY N G L LS SED R R
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED---RAR 98
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
V+ AL Y+H +V+RD+ N++LD + +++DFG K + +
Sbjct: 99 FYGAEIVS-ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 672 LVGTFGYVAP 681
GT Y+AP
Sbjct: 155 FCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 59/227 (25%), Positives = 86/227 (37%), Gaps = 37/227 (16%)
Query: 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
+ DF+ +G G V AK + K +M + E L ++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 564 RHRNIVKFY-GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD-- 620
H IV F R F++ E++ G L T L RK VA
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHL-----------RKAGRFPNDVAKFY 123
Query: 621 ------ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
A Y+H I++RD+ N+LLD + +V+DFG AK K +T L G
Sbjct: 124 HAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCG 177
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
T Y+AP E+ + + D ++ GVL E I G P
Sbjct: 178 TPEYLAP----------EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 10/89 (11%)
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
I++RD+ NVLLD + R+SD G A LK S GT G++AP E
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP----------E 167
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L + D ++ GV E+I + P
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 18/146 (12%)
Query: 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641
F+V EY+N G L + + R + AL+++H I++RD+ +
Sbjct: 72 FLVIEYVNGGDLMFHMQRQRKLPEEHAR---FYAAEICIALNFLHER---GIIYRDLKLD 125
Query: 642 NVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT 700
NVLLD + +++D+G K L P + T GT Y+AP L E +++
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEI----LRGEEYGFSV--- 177
Query: 701 EKCDVYSFGVLALEVIKGKHPGDFLS 726
D ++ GVL E++ G+ P D ++
Sbjct: 178 ---DWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 34/226 (15%)
Query: 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGD--KIAVKKFNSPFPNDQMSDQKEF---LNEIK 558
+ +DF+ +G G V A + D +A+K+F ++ QK+ +E K
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE----KSKIIKQKQVDHVFSERK 83
Query: 559 ALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG- 617
L I H V YG + ++V E++ G T L N KR G
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN---------KRFPNDVGC 134
Query: 618 --VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
A + + IV+RD+ N+LLD + +++DFG AK++ + L GT
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---LCGT 191
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+AP E+ + + D ++ G+ E++ G P
Sbjct: 192 PEYIAP----------EILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 66/279 (23%), Positives = 104/279 (37%), Gaps = 45/279 (16%)
Query: 514 IGKGEHR--SVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
I KG R S P + V K D ++ F ++++ H+++VK
Sbjct: 11 IYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA----FFETASLMSQLSHKHLVKL 66
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
YG C + +V EY+ G L L + W +++V +A AL Y+
Sbjct: 67 YGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK--- 120
Query: 632 PIVHRDISSNNVLL---DLEYE----ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+VH ++ N+L+ L ++SD G + E V ++AP
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE----ERVERIPWIAPECI 176
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAML 743
G +T D +SFG LE+ G+ P S+ SSS F
Sbjct: 177 RNG--------QASLTIAADKWSFGTTLLEICSNGEEP------LSTLSSSEKERFYQD- 221
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
HRLP P LI+ C P RP+ + +
Sbjct: 222 QHRLPMPDCAELANLIN------QCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 550 QKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN-NFASEDFDW 608
+ + + E++ L + IV FYG + E+++ GSL VL E
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 106
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
+ + VI G L+Y+ I+HRD+ +N+L++ E ++ DFG + L + +N
Sbjct: 107 KVSIAVIKG----LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160
Query: 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT Y++P G H Y++ + D++S G+ +E+ G++P
Sbjct: 161 --SFVGTRSYMSPERLQ-GTH-----YSV----QSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 43/190 (22%), Positives = 83/190 (43%), Gaps = 27/190 (14%)
Query: 543 PNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFA 602
P+ + + +FL E+K L++++ NI++ G C ++ EY+ G L LS++
Sbjct: 56 PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHL 115
Query: 603 SED----------------FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646
+ + ++V +A + Y+ F VHRD+++ N L+
Sbjct: 116 DDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVG 172
Query: 647 LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
+++DFG ++ L + ++ + G V P I E K T DV+
Sbjct: 173 ENLTIKIADFGMSRNLY--AGDYYRIQGR--AVLP----IRWMAWECILMGKFTTASDVW 224
Query: 707 SFGVLALEVI 716
+FGV E++
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 19/142 (13%)
Query: 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642
++ +YIN G L T LS E F ++ + AL ++H I++RDI N
Sbjct: 82 LILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLEN 135
Query: 643 VLLDLEYEARVSDFGTAK-LLKPNSSNWTELVGTFGYVAP--AHGNIGLHLAELAYTMKI 699
+LLD ++DFG +K + GT Y+AP G G H
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH---------- 185
Query: 700 TEKCDVYSFGVLALEVIKGKHP 721
+ D +S GVL E++ G P
Sbjct: 186 DKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 64/307 (20%), Positives = 101/307 (32%), Gaps = 74/307 (24%)
Query: 26 PHLAYLDLSINGFFGTLPPQVR-------NLSKLKYLDLSENELSGKIPPEIGLLTHLFS 78
P L L LS+N G +P ++ L+ LDLS+N L + L S
Sbjct: 51 PSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSS 109
Query: 79 L-DLSLNQ---------FSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLM----KLS 124
L +L LN L+ + L N+L G+ E + + L
Sbjct: 110 LQELKLNNNGLGDRGLRLLAKGLKDLPP-ALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 125 YLMLDTNQFTGQLPRNICRSG----LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180
L L N R + LE+L +N+N +L
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL-----TDEGASAL---------- 213
Query: 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240
+E +L+ L+L NN ++ G + S + +
Sbjct: 214 ----AETLASLKSLEVLNLGDNNL-----TDAGAAA-----LASAL---------LSPNI 250
Query: 241 QLHVLDLSSNHIAGEIPMELGRLI----SLNKLILRGNQLSGHLPRALGLLT-----ELE 291
L L LS N I + +L ++ SL +L LRGN+ + L ELE
Sbjct: 251 SLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELE 310
Query: 292 YFDLSSN 298
+ +
Sbjct: 311 SLWVKDD 317
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G V+ P G ++A+KK + F N + K E+K L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 573 -----GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+VV E + ++S S D ++ G L Y+H
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKYLHS 121
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS-NWTELVGTFGYVAPAHGNI 686
I+HRDI N+L++ ++ DFG A++ +P+ S + T+ V T Y AP
Sbjct: 122 ---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE---- 174
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ + YT + D++S G + E++ +
Sbjct: 175 -ILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 514 IGKGEHRSVYRAK----LPSGDK--IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
IG+G V++A+ LP +AVK + M Q +F E + + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADM--QADFQREAALMAEFDHPN 69
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN-------FASEDFDWRK---------- 610
IVK G C+ + +++EY+ G L L + + RK
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 611 --RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657
++ + VA ++Y+ F VHRD+++ N L+ +++DFG
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKF- 571
IGKG V A+ + +K K + ++K ++E L K ++H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
+ F + + FV+ +YIN G L L + R R +A AL Y+H
Sbjct: 63 FSFQTADKLYFVL-DYINGGELFYHLQRERCF--LEPRARFYA-AEIASALGYLHS---L 115
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
IV+RD+ N+LLD + ++DFG K ++ N + T GT Y+AP
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAP--------- 165
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + D + G + E++ G P
Sbjct: 166 -EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
IV+RD+ NVLLD + R+SD G A LK + T+ GT GY+AP L E
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI-TQRAGTNGYMAPE------ILKE 168
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+ + D ++ G E++ G+ P
Sbjct: 169 EPYSYPV----DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 38/169 (22%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641
+ V EY+N G L + F + + ++ L ++H I++RD+ +
Sbjct: 77 YFVMEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLD 130
Query: 642 NVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITE 701
NV+LD E +++DFG K + GT Y+AP E+ +
Sbjct: 131 NVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAP----------EIIAYQPYGK 180
Query: 702 KCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
D +++GVL E++ G+ P D + F ++++H + +P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFD--------GEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPA 682
+HH ++HRDI S N+LL ++ DFG +K+ S+ GT YVAP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP- 214
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723
E+ ++K D++S GVL E++ K P D
Sbjct: 215 ---------EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 58/264 (21%), Positives = 92/264 (34%), Gaps = 61/264 (23%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKE---FLNEIKALT 561
DF+ IG+G V+ + ++ A+K M + + E L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR----KSDMIKRNQIAHVRAERDILA 56
Query: 562 KIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
IVK +Y F H ++V EY+ G L +L + F I +
Sbjct: 57 DADSPWIVKLYYSF-QDEEHLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVL 112
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL-------- 672
AL +H F +HRDI +N+L+D + +++DFG K + L
Sbjct: 113 ALDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 673 ---------------------VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
VGT Y+AP E+ +CD +S GV+
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAP----------EVLRGTPYGLECDWWSLGVI 219
Query: 712 ALEVIKGKHPGDFLSLFSSSSSSI 735
E++ G P F S +
Sbjct: 220 LYEMLYGFPP------FYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 29/180 (16%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKF- 571
IGKG V AK + K K + +QK + E L K ++H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVL----------SNNFASEDFDWRKRMNVITGVADA 621
Y F + + FV+ +Y+N G L L + +A+E +A A
Sbjct: 63 YSFQTADKLYFVL-DYVNGGELFFHLQRERSFPEPRARFYAAE-------------IASA 108
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
L Y+H I++RD+ N+LLD + ++DFG K +S + GT Y+AP
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 54/280 (19%)
Query: 528 PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587
++ VK+ + N +Q EFL + ++H NI++ G C +V+EY
Sbjct: 20 TGVARVVVKELKA---NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76
Query: 588 INRGSLATVLSNN---FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644
G L + LS + +RM +A +++MH F +H D++ N
Sbjct: 77 CELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKHNF---LHSDLALRNCF 131
Query: 645 LDLEYEARVSDFGTA-------------KLLKPNSSNWT--ELVGTFGYVAPAHGNIGLH 689
L + +V D+G P W ELVG F HG +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LRWLAPELVGEF------HGGL--- 180
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHRLP 748
T + T+ +V++ GV E+ + P LS + I + +L
Sbjct: 181 -----ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ-----QVKLF 230
Query: 749 HPSLDV--QEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
P L++ E+ +++ L P R T + V +LL
Sbjct: 231 KPQLELPYSERWYEVLQFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 26/154 (16%)
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWR-KRMNVITGVADALSYMHHDCF 630
Y F + + F++ + +N G L LS + + + R +I G L +MH+
Sbjct: 64 YAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMHNRF- 117
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTA---KLLKPNSSNWTELVGTFGYVAPAHGNIG 687
+V+RD+ N+LLD R+SD G A KP++S VGT GY+AP G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKG 170
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
AY D +S G + ++++G P
Sbjct: 171 -----TAY----DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 23/141 (16%)
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGYV 679
AL+++H I++RD+ +NVLLD E +++D+G K ++P + T GT Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE- 738
AP E+ D ++ GVL E++ G+ P D + S + N E
Sbjct: 164 AP----------EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG--MSDNPDQNTED 211
Query: 739 --FNAMLDH--RLPHPSLDVQ 755
F +L+ R+P SL V+
Sbjct: 212 YLFQVILEKQIRIPR-SLSVK 231
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 11/171 (6%)
Query: 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKF 571
IGKG V AK G AVK ++ +QK + E L K ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 572 -YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
Y F + + FV+ +++N G L L F + +A AL Y+H
Sbjct: 62 HYSFQTTEKLYFVL-DFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
IV+RD+ N+LLD + ++DFG K S T GT Y+AP
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 29/118 (24%), Positives = 54/118 (45%), Gaps = 18/118 (15%)
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
I++RD+ +NV+LD E +++DFG K + GT Y+AP E
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAP----------E 171
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
+ + D ++FGVL E++ G+ P + + F ++++H + +P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE--------GEDEDELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 53/205 (25%)
Query: 508 FDAKYCIGKGEHRSVYRAKL---PSGDKIAVKKFNSPFPNDQ---MSDQKEFLNEIKALT 561
++ + CIG+G + VY+AK G + A+KKF S EI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA----CREIALLR 57
Query: 562 KIRHRNIVKFYG-FCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDW-------RKRM 612
+++H N+V F H S +++++Y A D KR+
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDY--------------AEHDLWQIIKFHRQAKRV 103
Query: 613 NVITGVA--------DALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR----VSDFGTAK 660
++ + + + Y+H + ++HRD+ N+L+ E R + D G A+
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
Query: 661 L----LKPNSSNWTELVGTFGYVAP 681
L LKP ++ +V T Y AP
Sbjct: 161 LFNAPLKP-LADLDPVVVTIWYRAP 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 58/244 (23%), Positives = 90/244 (36%), Gaps = 51/244 (20%)
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM 612
F ++++ H ++ +G C + +V E++ G L L W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLL-DLEYEARVSDFGTAKLLKPNSS---- 667
V +A ALSY+ +VH ++ + N+LL L S F KL P S
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFTAL 175
Query: 668 NWTELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV-------IKG 718
+ E V ++AP G L A D +SFG LE+ +K
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTA-----------ADKWSFGTTLLEICFDGEVPLKE 224
Query: 719 KHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
+ P + + HRLP PS LIS CL P RP+
Sbjct: 225 RTPSEKERFYEK-------------KHRLPEPSCKELATLIS------QCLTYEPTQRPS 265
Query: 779 MQTV 782
+T+
Sbjct: 266 FRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 30/145 (20%), Positives = 57/145 (39%), Gaps = 21/145 (14%)
Query: 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649
L T L+ S + + + + + L Y+H I+HRD+ + N+ ++
Sbjct: 140 SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVD 194
Query: 650 EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709
+ + D G A+ + + L GT AP LA Y K D++S G
Sbjct: 195 QVCIGDLGAAQ-FPVVAPAFLGLAGTVETNAPE------VLARDKYNSKA----DIWSAG 243
Query: 710 VLALEVIKGKHPGDFLSLFSSSSSS 734
++ E++ ++F S+
Sbjct: 244 IVLFEMLAYPS-----TIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 15/107 (14%)
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTF 676
+A L ++H I++RD+ +NV+LD E +++DFG K + + T GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723
Y+AP E+ + D ++FGVL E++ G+ P D
Sbjct: 166 DYIAP----------EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 10/89 (11%)
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
+++RD+ N+LLD + + DFG KL + GT Y+AP E
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAP----------E 163
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L T+ D ++ GVL E++ G P
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 35/162 (21%)
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+++ N+LL ++ DFG A+ + + YV G+ L L +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------YV--RKGSARLPLKWM 243
Query: 694 A----YTMKITEKCDVYSFGVLALEVIK---GKHPGDFLSLFSSSSSSINIEFNAMLDH- 745
A + T + DV+SFGVL E+ +PG IN EF L
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----------VQINEEFCQRLKDG 293
Query: 746 -RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
R+ P E I + L C G P RPT + ++L
Sbjct: 294 TRMRAPENATPE----IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 41/177 (23%), Positives = 79/177 (44%), Gaps = 39/177 (22%)
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFV-VYEYI------------NRGSLATVLSNNFA 602
EI + +++H NIV+ + H + + V+EY+ RG+L +F
Sbjct: 48 EISLMKELKHENIVRLHDVI-HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
+ ++ G+A + H + ++HRD+ N+L++ E +++DFG A+
Sbjct: 107 YQ---------LLKGIA----FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ ++ V T Y AP + L Y+ I D++S G + E+I G+
Sbjct: 151 GIPVNTFSNEVVTLWYRAP-----DVLLGSRTYSTSI----DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 18/104 (17%)
Query: 621 ALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK--LLKPNSSNWTELVGTFG 677
AL ++H +D IV+RD+ N+LLD + DFG +K L ++N GT
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN--TFCGTTE 161
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+AP + L E YT + D +S GVL E+ G P
Sbjct: 162 YLAPE-----VLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 67/269 (24%), Positives = 95/269 (35%), Gaps = 45/269 (16%)
Query: 123 LSYLMLDTNQFTGQLPRN--ICRSGL-----LEILTVNDNHFL----GSIPNLRNCRSLV 171
L L L N TG++PR GL L+ L ++DN G + +L SL
Sbjct: 53 LKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQ 111
Query: 172 RAHLGRNNLTGNISEDFGI------YPNLKFLDLSHNNFYGEISSNWGKCHR----LGTL 221
L NN G+ P L+ L L N G K R L L
Sbjct: 112 ELKL-NNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170
Query: 222 IVSGNNITGR----IPPEIGNSSQLHVLDLSSNHI----AGEIPMELGRLISLNKLILRG 273
++ N I + + + L VLDL++N + A + L L SL L L
Sbjct: 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230
Query: 274 NQLSGHLPRAL-----GLLTELEYFDLSSNRLNN----SILEALGFMFKLFYLNFSHNQF 324
N L+ AL L LS N + + + E L L L+ N+F
Sbjct: 231 NNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
Query: 325 SQEIPEDLALLAH-----LSELDLSHNLF 348
+E + LA L L + + F
Sbjct: 291 GEEGAQLLAESLLEPGNELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 41/248 (16%)
Query: 552 EFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL------SNNFASED 605
EF E + ++ H NIV G + + +++EY+N+G L L S+ S D
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 606 FDWRKRMNVITG--------VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657
D + ++ G +A + Y+ F VH+D+++ N+L+ + ++SD G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLG 169
Query: 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717
++ + S+++ + + P I E K + D++SFGV+ E+
Sbjct: 170 LSREIY--SADYYRVQPK--SLLP----IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
Query: 718 -GKHPGDFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPN 774
G P S N E M+ R LP D ++ S+M C P+
Sbjct: 222 FGLQPYYGFS---------NQEVIEMVRKRQLLPCSE-DCPPRMYSLMTE---CWQEGPS 268
Query: 775 SRPTMQTV 782
RP + +
Sbjct: 269 RRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 52/213 (24%)
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRM--- 612
EI L I HR I+ +++ Y + ++ V+ + + F + R
Sbjct: 136 EIDILKTISHRAIIN------------LIHAYRWKSTVCMVMPK-YKCDLFTYVDRSGPL 182
Query: 613 ---NVIT---GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL---- 662
IT + +AL+Y+H I+HRD+ + N+ LD A + DFG A L
Sbjct: 183 PLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 663 -KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P W GT +P EL K D++S G++ E+
Sbjct: 240 DTPQCYGW---SGTLETNSP----------ELLALDPYCAKTDIWSAGLVLFEMSVKN-- 284
Query: 722 GDFLSLFS----SSSSSINIEFNAMLDHRLPHP 750
++LF SSSS + M H L P
Sbjct: 285 ---VTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314
|
Length = 392 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 47/167 (28%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRN 567
IG+G + +V++AK + + +A+K+ ++ D E L EI L +++H+N
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHKN 60
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA------ 621
IV+ Y + +V+EY D D +K + G D
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC----------------DQDLKKYFDSCNGDIDPEIVKSF 104
Query: 622 -------LSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660
L++ H H+ ++HRD+ N+L++ E +++DFG A+
Sbjct: 105 MFQLLKGLAFCHSHN----VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 43/186 (23%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKF 571
IG+G V +A+ +G A+K F + +Q L EI+AL ++ H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 572 YGFCSHV------RHSFV-------VYEYI-NRGSLATVLSNNFASEDFDWRKRMNVITG 617
+ R + V +YE I R ++ + +
Sbjct: 64 ---IEVLFDRKTGRLALVFELMDMNLYELIKGR------------KRPLPEKRVKSYMYQ 108
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL--KPNSSNWTELVGT 675
+ +L +MH + I HRDI N+L+ + +++DFG+ + + KP +TE + T
Sbjct: 109 LLKSLDHMHRN---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKP---PYTEYIST 161
Query: 676 FGYVAP 681
Y AP
Sbjct: 162 RWYRAP 167
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 43/193 (22%), Positives = 82/193 (42%), Gaps = 28/193 (14%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS------HVRHSFVVYE 586
+A+KK + PF N + K E+ + + H+NI+ + + ++V E
Sbjct: 52 VAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646
++ +L V+ E RM+ + + L + H I+HRD+ +N+++
Sbjct: 110 LMD-ANLCQVIQMELDHE------RMSYL--LYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160
Query: 647 LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
+ ++ DFG A+ + +V + Y AP E+ M E D++
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAP----------EVILGMGYKENVDIW 209
Query: 707 SFGVLALEVIKGK 719
S G + E+IKG
Sbjct: 210 SVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 42/211 (19%)
Query: 556 EIKALTKIRHRNIVKFYG-------------FCSHVRHSFVVYEYINRGSLATVLSNNFA 602
E + L+K+ H IVKF+ +C + E + G LS N
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK---TLSENQV 108
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
E F + ++ GV YMH I+HRD+ + N+ L ++ DFG ++LL
Sbjct: 109 CEWF-----IQLLLGV----HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL 155
Query: 663 KPNSSNWTELVGTFGYVAP-AHGNIGL-------HLAELAYTMKITEKC-DVYSFGVLAL 713
+ T GT Y++P A + G L + Y M + +F + L
Sbjct: 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215
Query: 714 EVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
+++G P SL + S +N +ML+
Sbjct: 216 RIVEGPTP----SLPETYSRQLNSIMQSMLN 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 19/60 (31%), Positives = 26/60 (43%)
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
+L L L N+L+ A L L+ DLS N L + EA + L L+ S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 21/59 (35%), Positives = 27/59 (45%)
Query: 290 LEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLF 348
L+ DLS+NRL A + L L+ S N + PE + L L LDLS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 507 DFDAKYCIGKGEHRSVY--RAKLPSGDKIAVKKFNSPFPNDQMSDQ-KEFLNEIKALTKI 563
DF+ I G + +VY R K + + A+KK N N + +Q ++ E LT
Sbjct: 2 DFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQ--NLILRNQIQQVFVERDILTFA 58
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
+ +V + RH +V EY+ G AT+L N + D RM V AL
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVD-MARMYFAETVL-ALE 115
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661
Y+H+ IVHRD+ +N+L+ +++DFG +K+
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 55/259 (21%), Positives = 116/259 (44%), Gaps = 52/259 (20%)
Query: 546 QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL-----SNN 600
+ ++EF +E ++++H NIV G + + +++ Y + L L ++
Sbjct: 48 EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSD 107
Query: 601 FASEDFDWRKR--------MNVITGVADALSYM--HHDCFPPIVHRDISSNNVLLDLEYE 650
S D D + ++++T +A + ++ HH +VH+D+++ NVL+ +
Sbjct: 108 VGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLN 162
Query: 651 ARVSDFGTAKLLKPNSSNWTELVGT----FGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
++SD G + + ++++ +L+G +++P G K + D++
Sbjct: 163 VKISDLGLFR--EVYAADYYKLMGNSLLPIRWMSPEAIMYG----------KFSIDSDIW 210
Query: 707 SFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIME 763
S+GV+ EV G P + S+ IE M+ +R LP P D + ++M
Sbjct: 211 SYGVVLWEVFSYGLQP------YCGYSNQDVIE---MIRNRQVLPCPD-DCPAWVYTLM- 259
Query: 764 VALLCLDGCPNSRPTMQTV 782
L C + P+ RP + +
Sbjct: 260 --LECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 67/257 (26%), Positives = 92/257 (35%), Gaps = 50/257 (19%)
Query: 194 LKFLDLSHNNFYGEISSNWGKC--HRLGTLIVSGNNI-TGRIPPEIGNS----------- 239
L +DLS N E + +V+ ++ TGR E+ ++
Sbjct: 32 LVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKC 91
Query: 240 SQLHVLDLSSNHIAGEIPMELGRLIS----LNKLILRGNQL----SGHLPRALGLL---- 287
+L +DLS N E P ELG LIS L L L N L G + +AL L
Sbjct: 92 PRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNK 151
Query: 288 -----TELEYFDLSSNRLNN--SILEALGFMFK--LFYLNFSHNQFSQEIPEDLALLA-- 336
+LE NRL N L A L + N E LA L
Sbjct: 152 KAADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLF 211
Query: 337 ---HLSELDLSHNLF--KGS--IPSRICNLESLEKLNLSHNNISGQIPACFIGMS----- 384
L LDL N F +GS + +C L +L L+ +S + +
Sbjct: 212 YSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFV 271
Query: 385 -GLLSIDISYNELRGPI 400
L+ + YNE RG I
Sbjct: 272 PNLMPLPGDYNERRGGI 288
|
Length = 388 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN--NFASEDFDWRKR 611
+ E+ L ++H NIV + R +V+EY++ L L N N S
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFM 109
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
++ G LSY H I+HRD+ N+L++ + E +++DFG A+ + ++
Sbjct: 110 FQLLRG----LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
V T Y P + L Y+ I D++ G + E+ G+
Sbjct: 163 EVVTLWYRPP-----DVLLGSTEYSTPI----DMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 28/193 (14%)
Query: 533 IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS------HVRHSFVVYE 586
+A+KK + PF N + K E+ + + H+NI+ + + ++V E
Sbjct: 45 VAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646
++ +L V+ E RM+ + + L + H I+HRD+ +N+++
Sbjct: 103 LMD-ANLCQVIQMELDHE------RMSYL--LYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153
Query: 647 LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706
+ ++ DFG A+ S T V T Y AP E+ M E D++
Sbjct: 154 SDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP----------EVILGMGYKENVDIW 202
Query: 707 SFGVLALEVIKGK 719
S G + E+++ K
Sbjct: 203 SVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 24/61 (39%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 241 QLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR 299
L LDLS+N + IP L +L L L GN L+ P A L L DLS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 300 L 300
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 31/173 (17%)
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSN--NFASEDFD-WRKRMNVITGVADALS 623
N+V + + F+V ++ G L + +S N E W M V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
+H + IV RD++ NN+LLD +++ F ++ + E V Y AP
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG--EAVENM-YCAPEV 153
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736
G I + TE CD +S G + E++ GK +L S IN
Sbjct: 154 GGI----------SEETEACDWWSLGAILFELLTGK------TLVECHPSGIN 190
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 11/171 (6%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKF- 571
IGKG V AK S K + +Q + E L K ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y F + + FV+ +Y+N G L L F + VA A+ Y+H
Sbjct: 63 YSFQTAEKLYFVL-DYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---L 115
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGYVAP 681
I++RD+ N+LLD + ++DFG K ++P + T GT Y+AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 39/164 (23%)
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+++ N+LL ++ DFG A+ ++ N SN YV GN L + +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIR-NDSN---------YV--VKGNARLPVKWM 283
Query: 694 A----YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS-----SINIEFNAMLD 744
A + T + DV+S+G+L E +FS SS ++ +F M+
Sbjct: 284 APESIFNCVYTFESDVWSYGILLWE------------IFSLGSSPYPGMPVDSKFYKMIK 331
Query: 745 --HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+R+ P E + IM+ C D P RPT + + QL+
Sbjct: 332 EGYRMLSPECAPSE-MYDIMKS---CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 41/159 (25%), Positives = 66/159 (41%), Gaps = 29/159 (18%)
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLL--KPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
+HRD+++ N+LL ++ DFG A+ + P+ + ++AP
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP---------- 250
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI--EFNAMLDH--RL 747
E + T + DV+SFGVL E+ SL +S + I EF L R+
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEI---------FSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
P E + + L C G P+ RPT + + L
Sbjct: 302 RAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 36/150 (24%)
Query: 583 VVYEYINRGSLATVL--SNNFASEDFDWRKRMNVITG-VADALSYMHHDCFPPIVHRDIS 639
++ +Y++ G + T L +NF SED + +G + AL ++H IV+RDI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNF-SED-----EVRFYSGEIILALEHLHK---LGIVYRDIK 132
Query: 640 SNNVLLDLEYEARVSDFGTAK-LLKPNSSNWTELVGTFGYVAP-------AHGNIGLHLA 691
N+LLD E ++DFG +K L GT Y+AP HG
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKA----- 187
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
D +S G+L E++ G P
Sbjct: 188 -----------VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 31/212 (14%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKF-------NSPFPNDQMSDQKEFLNEIKALTKIRHR 566
+G+G + +VY+ K K+ K +PF + E L ++H
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---------IREASLLKGLKHA 63
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
NIV + +V+EY++ L + + + K + + LSY+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
I+HRD+ N+L+ E +++DFG A+ S ++ V T Y P
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP----- 172
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKG 718
+ L Y+ + D++ G + +E+I+G
Sbjct: 173 DVLLGSTEYSTCL----DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 786 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.28 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.26 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.24 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.79 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.75 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-91 Score=850.75 Aligned_cols=747 Identities=31% Similarity=0.490 Sum_probs=530.4
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|.+.+.+|. .|.++++|++|+|++|++.+..|..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 165 ~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 243 (968)
T PLN00113 165 SLKVLDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243 (968)
T ss_pred CCCEEECccCcccccCCh-hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEEC
Confidence 467888888888777776 6788888888888888887778888888888888888888888777888888888888888
Q ss_pred CCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCC
Q 047901 82 SLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGS 160 (786)
Q Consensus 82 s~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~ 160 (786)
++|++++..+ .+.++++|++|+|++|++.+..|..|.++++|++|+|++|.+++.+|..+..+++|+.|++++|.+.+.
T Consensus 244 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 323 (968)
T PLN00113 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323 (968)
T ss_pred cCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc
Confidence 8888775444 477777777777777777777777777777777777777777777777777777777777777777654
Q ss_pred CC-CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccC----------
Q 047901 161 IP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT---------- 229 (786)
Q Consensus 161 ~~-~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~---------- 229 (786)
.+ .+.++++|+.|++++|++++..|..+..+++|+.|+|++|++.+..|..+..+++|+.|++++|++.
T Consensus 324 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~ 403 (968)
T PLN00113 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403 (968)
T ss_pred CChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCC
Confidence 43 3666677777777777776666666666666666666666666555555555455555555555444
Q ss_pred --------------CCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecc
Q 047901 230 --------------GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDL 295 (786)
Q Consensus 230 --------------~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 295 (786)
+..|..|..+++|+.|++++|.+++.++..+..+++|+.|+|++|++.+..|..+ ..++|+.|++
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEEC
Confidence 4444444555555555555555555444445555555555555555555555444 3466777888
Q ss_pred ccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccccccc
Q 047901 296 SSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375 (786)
Q Consensus 296 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 375 (786)
++|++.+..+..|..+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++.+|..|.++++|+.|+|++|++++.
T Consensus 483 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562 (968)
T ss_pred cCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccccc
Confidence 88888888888889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCCCCCCCCCccccccccc---cCCCceehhh-HHHHHH
Q 047901 376 IPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLLSHKEAS---KKTPFLILFP-LLGALA 451 (786)
Q Consensus 376 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~---~~~~~~i~~~-~~~~~~ 451 (786)
+|..+.++++|+.|++++|++.+.+|....+..+...++.||+. .|+........+|. +...+.++++ ++++++
T Consensus 563 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~--lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~ 640 (968)
T PLN00113 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID--LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFL 640 (968)
T ss_pred CChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcc--ccCCccccCCCCCccccccceeeeehhHHHHHHH
Confidence 99999999999999999999999999988888888889999987 77753222222232 1122222222 222222
Q ss_pred HHHHHHHHHhheeeeccccCCCCCcCCCCCCCCcccccccccccccHHHHHHHhccCccceeeccccCceEEEEEc-CCC
Q 047901 452 LLIVYVVMVFMFRRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKL-PSG 530 (786)
Q Consensus 452 ~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~ 530 (786)
+++++++++++++++++....+............+. ......+.++++ ...|...+.||+|+||.||+|+. .++
T Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~ 715 (968)
T PLN00113 641 VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD--SKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNG 715 (968)
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccccccc--cccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCC
Confidence 222222222222222111111000000000000000 000111233333 34577888999999999999986 478
Q ss_pred CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHH
Q 047901 531 DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRK 610 (786)
Q Consensus 531 ~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 610 (786)
..||||++..... ....|++++++++|||||+++|+|.+.+..|+||||+++|+|.++++ .++|.+
T Consensus 716 ~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~ 781 (968)
T PLN00113 716 MQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWER 781 (968)
T ss_pred cEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHH
Confidence 9999999864211 11246888999999999999999999999999999999999999995 378999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchH
Q 047901 611 RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690 (786)
Q Consensus 611 ~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 690 (786)
+.+++.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+...... ....+|+.|+||
T Consensus 782 ~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aP--------- 847 (968)
T PLN00113 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAP--------- 847 (968)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCc---------
Confidence 99999999999999997666699999999999999999988876 6655433221 223688999999
Q ss_pred HHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc------chhhhhhhhccCCCCCCChhHHHHHHHHHHH
Q 047901 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS------SINIEFNAMLDHRLPHPSLDVQEKLISIMEV 764 (786)
Q Consensus 691 ~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 764 (786)
|+..+..++.|+|||||||++|||+||+.||+.......... .........+++.+........++..++.++
T Consensus 848 -E~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 848 -ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred -ccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence 555667799999999999999999999999853221100000 0000112223333322212234456678899
Q ss_pred HHhccCCCCCCCCCHHHHHHhC
Q 047901 765 ALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 765 i~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.+||+.||++||||+||++.|
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHH
Confidence 9999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=415.11 Aligned_cols=279 Identities=38% Similarity=0.661 Sum_probs=231.7
Q ss_pred cccccHHHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCccccee
Q 047901 493 DGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572 (786)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~ 572 (786)
...++++++..+|++|...+.||+|+||+||+|...+++.||||++..... .. ..+|..|++++++++|||+|+++
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~---~~-~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG---QG-EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC---cc-hhHHHHHHHHHhcCCCcCcccEE
Confidence 456899999999999999999999999999999999999999998865221 11 45699999999999999999999
Q ss_pred eEEecCC-eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 573 GFCSHVR-HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 573 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
|||.+.+ +.++|||||++|+|.+++...... .++|.++.+||.++|+||+|||+.+.|+|+||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999988 599999999999999999876433 88999999999999999999999998899999999999999999999
Q ss_pred EEeccccceecCCCCCcceee-ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 652 RVSDFGTAKLLKPNSSNWTEL-VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
||+|||+|+..+......... .||.+|+|| |+...+..+.|+|||||||++.|++||+.|.+.......
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~P----------Ey~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAP----------EYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCCh----------hhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 999999997665412222222 899999999 788888999999999999999999999998774321100
Q ss_pred C-------CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 S-------SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. .........+++|+++........++...+..++..|++.+|++||+|.||+++|
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 0 0111125677788876522212125667799999999999999999999998865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=466.93 Aligned_cols=415 Identities=33% Similarity=0.509 Sum_probs=347.6
Q ss_pred CCeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchh-ccCCCCCCEEeCcCCcccccCCccccCCCCCCEE
Q 047901 1 GRVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQ-VRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79 (786)
Q Consensus 1 g~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 79 (786)
|+|+.|+|+++++.+.++. +|..+++|+.|+|++|++.+..|.. |.++++|++|+|++|++++..|. +.+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 5799999999999988765 7999999999999999998666655 55899999999999999877764 468899999
Q ss_pred eCCCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccccccc
Q 047901 80 DLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFL 158 (786)
Q Consensus 80 ~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 158 (786)
+|++|.+++..+ .+..+++|++|+|++|.+.+..|..|.++++|++|+|++|++++.+|..+..+++|+.|++++|.+.
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 999999876544 5888999999999999998888888999999999999999998888999999999999999999888
Q ss_pred CCCC-CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCcccc
Q 047901 159 GSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIG 237 (786)
Q Consensus 159 ~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 237 (786)
+..+ .+.++++|+.|++++|++++..|..|+.+++|++|+|++|++.+..|..+..+++|+.|+|++|.+.+..|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 6544 588889999999999999888888899999999999999999888888888889999999999998888888888
Q ss_pred CCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEE
Q 047901 238 NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYL 317 (786)
Q Consensus 238 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 317 (786)
++++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+..|..++.+++|+.|++++|++.+..+..+..+++|+.|
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L 385 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence 88999999999999888888888888899999999999888888888888888999998888887777778888888888
Q ss_pred EecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCccc
Q 047901 318 NFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397 (786)
Q Consensus 318 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 397 (786)
++++|.+.+..|..+..+++|+.|+|++|++++..|..|.++++|+.|++++|++++..|..+..+++|+.|++++|++.
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~ 465 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence 88888888788888888888888888888888777888888888888888888888777777777777777777777777
Q ss_pred ccCCCCCccccCCCccccCCC
Q 047901 398 GPIPNSTVFRNAPRESFLGNN 418 (786)
Q Consensus 398 ~~~p~~~~~~~~~~~~~~~n~ 418 (786)
+.+|............+.+|.
T Consensus 466 ~~~p~~~~~~~L~~L~ls~n~ 486 (968)
T PLN00113 466 GGLPDSFGSKRLENLDLSRNQ 486 (968)
T ss_pred eecCcccccccceEEECcCCc
Confidence 766654333333333444444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=378.93 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=214.2
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-eeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR-HSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~lv 584 (786)
+.+..+.||+|..|+||+++++ +++.+|+|++.. ..+....+++.+|+++++.++||+||.++|+|..++ ...++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~---~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL---NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc---cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 4555678999999999999976 678899999954 234566789999999999999999999999999888 59999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||++|+|.+++... +++++...-.++.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+.
T Consensus 157 mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999999754 679999999999999999999996 5 99999999999999999999999999999887
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ...+++||..|||| |.+.+..|+.++||||||+.++|+.+|+.||.... .......+.+..++
T Consensus 231 nS--~a~tfvGT~~YMsP----------ERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSP----------ERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIV 295 (364)
T ss_pred hh--hcccccccccccCh----------hhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHh
Confidence 55 44678999999999 77788899999999999999999999999976431 11223445566667
Q ss_pred cCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+...+ .|.. .++.++.++|..|+++||.+|||+.|+++
T Consensus 296 ~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 296 DEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 65444 3332 35667999999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=396.86 Aligned_cols=249 Identities=28% Similarity=0.492 Sum_probs=211.3
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+.++..+.||+|.||.||.|.++...+||+|.++.. ....+.|.+|+++|++++|++||+++|+|..++..|||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 3446677889999999999999998889999999752 23456899999999999999999999999998899999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||+.|+|.+|++.. ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999873 457789999999999999999999999 999999999999999999999999999995544
Q ss_pred CCCcc-eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSNW-TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
+.+.. ....-...|.|| |++....++.|||||||||+||||+| |+.||..+. ...+.+.
T Consensus 356 ~~Y~~~~~~kfPIkWtAP----------Ea~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---------n~ev~~~ 416 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAP----------EALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---------NEEVLEL 416 (468)
T ss_pred CceeecCCCCCCceecCH----------HHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---------HHHHHHH
Confidence 33221 122335699999 88889999999999999999999998 999977543 3445555
Q ss_pred ccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 743 LDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 743 ~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
++. |++.|..++ .+++++|..||+.+|++|||++.+...
T Consensus 417 le~GyRlp~P~~CP----~~vY~lM~~CW~~~P~~RPtF~~L~~~ 457 (468)
T KOG0197|consen 417 LERGYRLPRPEGCP----DEVYELMKSCWHEDPEDRPTFETLREV 457 (468)
T ss_pred HhccCcCCCCCCCC----HHHHHHHHHHhhCCcccCCCHHHHHHH
Confidence 554 555665544 459999999999999999999987754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=393.73 Aligned_cols=252 Identities=30% Similarity=0.520 Sum_probs=208.5
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-eeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR-HSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~lv~ 585 (786)
+....+.+|+|+||+||+|.+++...||||++........ ..++|.+|+.+|++++|||||+++|+|.... ..++||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~--~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE--SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3445556999999999999998665699999986433222 2779999999999999999999999998877 789999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEcCCCCCceeeCCCC-cEEEeccccceecC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP-IVHRDISSNNVLLDLEY-EARVSDFGTAKLLK 663 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~ 663 (786)
|||++|+|.+++... ....+++..+..++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999874 457899999999999999999999999 7 99999999999999997 99999999999876
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhh--hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAY--TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~--~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
......+...||+.|||| |++. ...|+.|+||||||+++|||+||+.||..... ......
T Consensus 196 ~~~~~~~~~~GT~~wMAP----------Ev~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~ 257 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAP----------EVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASA 257 (362)
T ss_pred cccccccCCCCCccccCh----------hhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 543344447899999999 5555 56899999999999999999999999986542 112222
Q ss_pred hc--cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 ML--DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
++ ..+...|.. +...+..+|.+||+.||+.||++.+++..|
T Consensus 258 v~~~~~Rp~~p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 258 VVVGGLRPPIPKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred HHhcCCCCCCCcc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 22 223333433 344588999999999999999999998764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=390.95 Aligned_cols=250 Identities=25% Similarity=0.434 Sum_probs=222.4
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|...+.||+|||+.||.++. ..|+.||+|++.... .......+...+||+|.+.++|||||+++++|++..++|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 5699999999999999999986 789999999997632 23345567888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
.|+|+.|+|.++++++ +.+++.+++.+..||+.|+.|||+. +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999854 7899999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
+.+...+.+|||-|+|| |++.....+..+||||+||+||.|+.|++||+.. ..++.+..+..
T Consensus 171 ~~Erk~TlCGTPNYIAP----------EVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~ 232 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAP----------EVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKL 232 (592)
T ss_pred cccccceecCCCcccCh----------hHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHh
Confidence 77777789999999999 7777888999999999999999999999999842 34566666666
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....|... +.+..++|..+|+++|.+|||+++|+.
T Consensus 233 ~~Y~~P~~l----s~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 233 NEYSMPSHL----SAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cCccccccc----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 666666533 344789999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=376.66 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=213.7
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCch---hhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQM---SDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+.|.+.+.+|+|+||.|-+|.. ++|+.||||++......... .......+|+++|++++|||||+++++++..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34577889999999999999974 58999999999875432211 123346799999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEeccc
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDFG 657 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg 657 (786)
.|||||||+||+|.+++-.+ +.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999865 4566667788999999999999999 99999999999999766 789999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
+|+... ....+.+.+||+.|.|||++... +..++ .|+||||+||++|-+++|.+||+.... ..
T Consensus 325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~k--------g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~ 388 (475)
T KOG0615|consen 325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASK--------GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DP 388 (475)
T ss_pred hhhccc-cceehhhhcCCccccChhheecC--------CeecccchheeeeccceEEEEeccCCCcccccC-------Cc
Confidence 999876 34566788999999999644211 12233 489999999999999999999985321 12
Q ss_pred hhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+...+....+..+.+...+..++|.+||..||++|||++|+++
T Consensus 389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 234556677777666678888899999999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=394.97 Aligned_cols=392 Identities=23% Similarity=0.205 Sum_probs=282.6
Q ss_pred CcEEECCCCCccccCchhccCC--CCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEcc
Q 047901 28 LAYLDLSINGFFGTLPPQVRNL--SKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLH 105 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~ 105 (786)
-.-||.+++.+..+....+.+. +.-++||+++|+|+.+.+..|.++++|++++|..|.++.+|.......+|+.|+|.
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLR 133 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeee
Confidence 4556777777765544444443 23445777777777777777777777777777777777555444445567777777
Q ss_pred CCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCC-CcCCCCCCcEEEccCccccccc
Q 047901 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNI 184 (786)
Q Consensus 106 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~ 184 (786)
+|.|+++....++.++.|+.|||+.|.|+.+.-..|..-.++++|+|+.|+|+.+-. .|.++.+|..|.|++|+|+.++
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 777777777777777777777777777776555566666777777777777776443 3667777777777777777777
Q ss_pred CcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccc
Q 047901 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 185 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
+..|..|+.|+.|+|..|+|.-+.--+|.++++|+.|.|..|+|+......|.++.+++.|+|+.|+++....+++.+|+
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 77777777777777777777755566777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeecc
Q 047901 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLS 344 (786)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 344 (786)
.|+.|+|++|.|..+.++..+..++|++|+|++|+|+.++++.|..+..|++|+|++|.++.+....|.++.+|++|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 77777777777777777777777777777777777777777777777777777777777776666777777777777777
Q ss_pred CCccCCCCC---cccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCC
Q 047901 345 HNLFKGSIP---SRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF 419 (786)
Q Consensus 345 ~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 419 (786)
+|.|+..+. ..|.+|++|+.|.|.+|+|..+...+|.++.+|++|||.+|.+.+.-|+.-.........+....+
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSF 451 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccce
Confidence 777765432 456677777777777777777777777777777777777777777766654434444444444444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=367.52 Aligned_cols=201 Identities=28% Similarity=0.481 Sum_probs=180.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
..+|...+.||+|+||+||+|+++ ++..||||.+.... -.....+-...|+.+++.++|||||+++++++.++..|+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~--l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK--LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc--cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 467888899999999999999976 67899999997621 133455667899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC------CcEEEeccc
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE------YEARVSDFG 657 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~------~~~kl~Dfg 657 (786)
|||||.||||.+|++++ +.+++..++.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999975 5799999999999999999999999 99999999999999865 468999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
+|+.+.+. ....+.+|++.|||| |++..+.|+.|+|+||+|+|+|++++|+.||+.
T Consensus 161 fAR~L~~~-~~a~tlcGSplYMAP----------EV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 161 FARFLQPG-SMAETLCGSPLYMAP----------EVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhhCCch-hHHHHhhCCccccCH----------HHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998744 344567999999999 889999999999999999999999999999884
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=390.48 Aligned_cols=390 Identities=23% Similarity=0.216 Sum_probs=349.1
Q ss_pred eEEEEcCCCCCcccCCcCccCCC--CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEe
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSF--PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 80 (786)
...||.+..++. .+....+.++ +..+.|||++|++..+.+..|.++++|++++|..|.++ .+|.......+|+.|+
T Consensus 54 ~~lldcs~~~le-a~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 54 TRLLDCSDRELE-AIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred ceeeecCccccc-cccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 356788888776 3332233333 34667999999999999999999999999999999998 6676666667799999
Q ss_pred CCCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccC
Q 047901 81 LSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG 159 (786)
Q Consensus 81 Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 159 (786)
|.+|.|+++.. ++..++.|+.|||+.|.|+.+....|..-.++++|+|++|+|+....+.|.++.+|..|.|+.|+++.
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 99999998765 48889999999999999999988899998999999999999999999999999999999999999998
Q ss_pred CCCC-cCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccC
Q 047901 160 SIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGN 238 (786)
Q Consensus 160 ~~~~-l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 238 (786)
.+.. |.+++.|+.|+|.+|+|.-+..-.|.+|++|+.|.|..|.|..+..++|.++.++++|+|+.|++...-..++.+
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfg 291 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFG 291 (873)
T ss_pred cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccc
Confidence 7765 777999999999999999777889999999999999999999999999999999999999999999888899999
Q ss_pred CccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEE
Q 047901 239 SSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLN 318 (786)
Q Consensus 239 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 318 (786)
++.|+.|+||+|.|..+-+.+..-.++|++|+|++|+|+...+..|..+.+|+.|.|++|+++.+..++|..+.+|+.||
T Consensus 292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld 371 (873)
T KOG4194|consen 292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD 371 (873)
T ss_pred cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence 99999999999999988888888889999999999999999999999999999999999999999999999999999999
Q ss_pred ecccccCCCcc---hHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCc
Q 047901 319 FSHNQFSQEIP---EDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNE 395 (786)
Q Consensus 319 L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 395 (786)
|++|.|+..+. ..|.++++|+.|+|.+|+|..+....|.++++|+.|||.+|.|.++.|.+|..| .|++|-+..-.
T Consensus 372 Lr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 372 LRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred CcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 99999975543 468899999999999999997777899999999999999999999999999999 89888765433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.88 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=209.9
Q ss_pred cCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeE-EecCC-eeeE
Q 047901 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGF-CSHVR-HSFV 583 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~-~~~~~-~~~l 583 (786)
+|.+.++||+|.||+||+++ ..+|..||.|.+. +...+....+....|+.++++++|||||+++++ +.++. -.++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~--f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ--FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcc--hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 48888899999999999997 5589999999997 444556677889999999999999999999994 33344 4789
Q ss_pred EEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
|||||..|||...++... ..+.++++.+++++.|++.||.+||+. .++ |+||||||.||+++.+|.+||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999997543 345789999999999999999999994 235 9999999999999999999999999999
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
.+..........+|||.||+| |.+.+..|+.||||||+||++|||..-++||...+. ...-.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSP----------E~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~ 238 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSP----------ERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCK 238 (375)
T ss_pred HhcchhHHHHhhcCCCcccCH----------HHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHH
Confidence 998776666778999999999 889999999999999999999999999999875321 12222
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
.+-....+ +......+..+.++|..|+.+||+.||+...++
T Consensus 239 KI~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 239 KIEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred HHHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 22233222 222345566799999999999999999844433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=395.69 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=209.3
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.+....+.||+|+||.||+|+.. +...||||.++.. .+....++|.+|++++..++|||||+++|+|..++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34556678999999999999743 3457999999862 33446789999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC-------C----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC
Q 047901 580 HSFVVYEYINRGSLATVLSNNF-------A----SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~-------~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 648 (786)
..++|+|||..|||.+||..+. . ..+++..+.+.||.|||.||.||-++ .+|||||.++|+||+++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 9999999999999999997431 1 23488999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcce--eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcc
Q 047901 649 YEARVSDFGTAKLLKPNSSNWT--ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFL 725 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~ 725 (786)
..|||+|||+++.....+++.. ...-..+|||| |.+.+++||.+||||||||+|||+++ |+.||...
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp----------EsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP----------ESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCH----------HHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence 9999999999998876554321 23446799999 89999999999999999999999997 99997643
Q ss_pred ccccCCCcchhhhhhhhccC-C-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 726 SLFSSSSSSINIEFNAMLDH-R-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. ++.+.+.+.. + +..|+. ++.++++||..||+..|++||++.||-.+|
T Consensus 710 S---------n~EVIe~i~~g~lL~~Pe~----CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 710 S---------NQEVIECIRAGQLLSCPEN----CPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred c---------hHHHHHHHHcCCcccCCCC----CCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 2 2333344433 3 234443 445699999999999999999999997764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=344.54 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=206.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+...++|+|+||+||+++.+ +|+-||||+|.. ++++....+-.++|+.++++++|||+|.++++|...+..++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E--sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE--SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc--CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 35778889999999999999976 689999999975 234445566778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
+|||+. ++.+-+++. ...++...+.++++|++.|+.|+|++ +++||||||+|||++.++.+||||||+|+.+..
T Consensus 80 FE~~dh-TvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecch-HHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999987 566666654 35688899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------Ccchhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------SSSINI 737 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------~~~~~~ 737 (786)
+...++..+.|.+|.||| ..- +..|+..+||||+||++.||++|.+-|...+...+. ....-.
T Consensus 154 pgd~YTDYVATRWYRaPE----------LLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPE----------LLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred CcchhhhhhhhhhccChh----------hhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 777788889999999995 444 478999999999999999999999987654432110 000111
Q ss_pred hhhhhccC-------CCCCCCh---h---HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDH-------RLPHPSL---D---VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~-------~~~~~~~---~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+.++.. +++.|+. . .+....-+.++++.|++.||++|++.++++.
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 1111111 0 1112234789999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=350.53 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=211.4
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|+..+.||+|+||+||.++.+ +++.+|+|++++..... ..+.+....|..++.+++||.||.++..|++.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 3568999999999999999999855 67889999998743322 245667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+|+||+.||.|...+++. +.+++..++-++++|+.||.|||+. +|||||+||+|||+|.+|+++|+|||+|+..
T Consensus 102 lVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999999864 6799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
........+.+||+.|||| |++.+..|+.++|.||+|+++|||++|.+||...+ .......+
T Consensus 176 ~~~~~~t~tfcGT~eYmAP----------Eil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I 237 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAP----------EILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKI 237 (357)
T ss_pred ccCCCccccccCCccccCh----------HHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHH
Confidence 6665556678999999999 88889999999999999999999999999988532 34455566
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 777 (786)
...+...++... ..+..++++..+.+||++|-
T Consensus 238 ~~~k~~~~p~~l---s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPPGYL---SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCCccC---CHHHHHHHHHHhccCHHHhc
Confidence 666644333322 22478999999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=381.90 Aligned_cols=249 Identities=27% Similarity=0.498 Sum_probs=211.1
Q ss_pred cCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
...+.++||.|.||.||+|+++- ...||||.++..+. ..++.+|+.|+.||.+++||||+++.|+....+..+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt---ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc---HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 45677899999999999998752 34699999987543 345678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||+|||++|+|..||+.+ ++++++.+...|.++||.||.||-++ ++|||||.++|||++.+..+|++|||+++.+
T Consensus 707 IiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999987 46799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCC-cceeecc--CccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhh
Q 047901 663 KPNSS-NWTELVG--TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 663 ~~~~~-~~~~~~g--t~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 738 (786)
+++.. .++..-| ..+|.|| |.+..+++|.+|||||||++|||.++ |..||.++. +.+
T Consensus 782 edd~~~~ytt~GGKIPiRWTAP----------EAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------NQd 842 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAP----------EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------NQD 842 (996)
T ss_pred ccCCCccccccCCccceeecCh----------hHhhhcccCchhhccccceEEEEecccCCCcccccc---------hHH
Confidence 76653 3333333 4699999 88899999999999999999999886 999977543 223
Q ss_pred hhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 739 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+...+. .|++.|. +++..+++||..||++|-.+||++.+++..|
T Consensus 843 VIkaIe~gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred HHHHHHhccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 333333 3444333 3455799999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=348.49 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=211.5
Q ss_pred HhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|+....||.|..++||+|+. +.++.||||++..+ ......+.+.+|+..|+.++||||++++..|..+...|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE---kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE---KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh---hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 356899999999999999999984 47799999999873 34445788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||.||.+|++.+.+..... ..+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.+||+|||.+..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999987744 4599999999999999999999999 9999999999999999999999999998877
Q ss_pred CCCCCcc----eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 663 KPNSSNW----TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 663 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.+..... ...+||++|||||++ ......|+.|+||||||+...||.+|..||.....+. .
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl--------~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------v- 240 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVL--------MQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------V- 240 (516)
T ss_pred cccCceeeEeeccccCcccccChHHh--------hhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------H-
Confidence 6543322 456899999999531 1223569999999999999999999999998654321 1
Q ss_pred hhhhccCCCC------CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLP------HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+....+ .+.........++.+++..|+.+||.+|||++++++
T Consensus 241 Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 241 LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111 112222333467999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=360.30 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=219.1
Q ss_pred HHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCe
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~ 580 (786)
+...+|..++.||+|+|++|++|+.+ .++.+|||++.+.+... ....+.+..|-++|.++ .||.|++++.-|.+...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44668999999999999999999854 78999999997654332 23345677899999999 79999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|.|+||+++|+|.++|++. +.+++..++.++.+|+.|++|||++ |||||||||+|||+|+||++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999865 7899999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCc-------------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 047901 661 LLKPNSSN-------------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727 (786)
Q Consensus 661 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~ 727 (786)
.+.+.... ...++||..|.+| |++.+...++.+|+|||||++|.|+.|.+||...+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP----------ElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N- 291 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSP----------ELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN- 291 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCH----------HHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-
Confidence 87643111 1457999999999 88889999999999999999999999999998543
Q ss_pred ccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..-.++++++.....|+...+ .+.+||+..|..||.+|+|++++.+
T Consensus 292 -------eyliFqkI~~l~y~fp~~fp~----~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 292 -------EYLIFQKIQALDYEFPEGFPE----DARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -------HHHHHHHHHHhcccCCCCCCH----HHHHHHHHHHccCccccccHHHHhh
Confidence 345667777777777766554 3789999999999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.32 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=209.1
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCC-ee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVR-HS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~-~~ 581 (786)
.++|...+++|.|.||.||+|+. .++..||||+++..+.. .+.-.=.+|+..++++. ||||+++.+++.+.+ ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 45799999999999999999974 47889999999875432 12223358999999998 999999999998777 99
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++|||||+. +|++.++.+ ...+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 999999976 999999876 57899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS---------- 731 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~---------- 731 (786)
+... ..++..+.|.+|.||| -.+....|+.+.||||+|||++|+.+-++-|.+.+..++.
T Consensus 160 v~Sk-pPYTeYVSTRWYRAPE---------vLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 160 VRSK-PPYTEYVSTRWYRAPE---------VLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred cccC-CCcchhhhcccccchH---------HhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 8643 4456778999999996 4456778999999999999999999999888765432110
Q ss_pred ---CcchhhhhhhhccCCCC-CCCh----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 732 ---SSSINIEFNAMLDHRLP-HPSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 732 ---~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...........+..+++ .++. ....+..+..++|.+|+.+||.+||||+|.++.
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111112222222222 1111 112245678999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=357.61 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=209.2
Q ss_pred ccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
..|+...+||+|+.|.||.|+ ..+++.||||++.. ......+-+..|+.+|+..+|||||.+++.+...+..|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l----~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDL----RKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEe----ccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 457778899999999999997 45788999999976 2334456788999999999999999999998888999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||+||+|.+.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999998653 589999999999999999999999 999999999999999999999999999998887
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
......+.+||++|||| |+.....|++|+||||||++++||+.|.+||=...... ........-.
T Consensus 422 ~~~KR~TmVGTPYWMAP----------EVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-----AlyLIa~ng~ 486 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAP----------EVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNGT 486 (550)
T ss_pred ccCccccccCCCCccch----------hhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-----HHHHHhhcCC
Confidence 76677888999999999 88889999999999999999999999999965321110 0000111111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.++.. ....+..+.+++.+||..||++||++.|+++
T Consensus 487 P~lk~----~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 PKLKN----PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCcCC----ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 22222 2334556999999999999999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=385.05 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=210.7
Q ss_pred ccCccceeeccccCceEEEEEcC--CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP--SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
...+..+.||+|+||.||.|... ++. .||||.+.+ ..+..+..+|.+|..+|+.++|||||+++|+|.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 34566778999999999999854 333 489999876 234567789999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 580 HSFVVYEYINRGSLATVLSNNF----ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
..+|++|||++|||..||++.+ ....++..+.+.++.|||+|++||+++ ++|||||.++|+|++....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999998642 245689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcceee--ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCC
Q 047901 656 FGTAKLLKPNSSNWTEL--VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSS 732 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~ 732 (786)
||+|+.....+++.... .-...|||| |.+.++.++.|+|||||||++||++| |..||.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~P----------Esl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----- 910 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPP----------ESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----- 910 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCH----------HHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----
Confidence 99999766554433222 224599999 88889999999999999999999999 9999875432
Q ss_pred cchhhhhh-hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 733 SSINIEFN-AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 733 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.+.+. -+-..|+..|..++. .++++|..||+.+|++||++..+++++
T Consensus 911 ---~~v~~~~~~ggRL~~P~~CP~----~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 911 ---FEVLLDVLEGGRLDPPSYCPE----KLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred ---HHHHHHHHhCCccCCCCCCCh----HHHHHHHHHccCChhhCccHHHHHhhh
Confidence 12222 334456776665544 488999999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.74 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=206.3
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|...+++|+|.||.||+|+. .+|+.||||+++.....+. -.....+||..++.++||||+.++++|...+..-+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 4688888999999999999974 5899999999987533222 223567999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
+|||+. ||+..++.. ...++..++..++.++.+|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+.+
T Consensus 80 fEfm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999987 999999864 46789999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccC----------CCc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS----------SSS 733 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~----------~~~ 733 (786)
+.......+-|.+|.|| |.+. ...|+..+||||.|||+.||+-|.+-|.......+ ...
T Consensus 154 p~~~~~~~V~TRWYRAP----------ELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAP----------ELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP 223 (318)
T ss_pred CCcccccceeeeeccCh----------HHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence 76666666899999999 5444 45699999999999999999999887765332110 011
Q ss_pred chhhhhhhhcc---CC-CCCCC--hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEFNAMLD---HR-LPHPS--LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~~~~~~---~~-~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..-..+..+.| .+ .+.+. .....+.....+++..++..||.+|+|++|.++
T Consensus 224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11111111111 00 11110 011223345689999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=356.78 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=213.3
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCch-hhHHHHHHHHHHHhhcC-CCcccceeeEEecCCe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQM-SDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRH 580 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~ 580 (786)
..+.|..++.||+|+||+|+.|... +++.||+|.+......... ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3568999999999999999999754 7899999977653211111 33456678999999998 9999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEeccccc
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTA 659 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~a 659 (786)
.++||||+.||+|.+++... +++.+..+..+++|++.|++|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999863 6788899999999999999999999 99999999999999999 99999999999
Q ss_pred eecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcC-cC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 660 KLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMK-IT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 660 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~-~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
...........+.+||+.|+|| |++.+.. |+ .++||||+||+||.|++|+.||++. ....
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aP----------Evl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--------~~~~ 230 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAP----------EVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--------NVPN 230 (370)
T ss_pred cccCCCCCcccCCCCCcccCCH----------HHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--------cHHH
Confidence 9885334556778999999999 6777766 76 6899999999999999999999862 2233
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.......|.... +.+...++.+|+..+|.+|+|+.++++
T Consensus 231 l~~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 231 LYRKIRKGEFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHhcCCccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 44445566666665442 445889999999999999999999973
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.83 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=204.7
Q ss_pred HhccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Ce
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RH 580 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~ 580 (786)
..+.|+..++||+|.||.||+|+ ..+|+.||+|+++... ..........+||.||+++.||||+++.+..... +.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 34568888899999999999997 4589999999998632 2334455667999999999999999999988765 78
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+|+|||+. ||.-++... .-.+++.++..++.|++.||+|||.+ +|+|||||.+|||||.+|.+||+|||+|+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 9999999988 898888753 35799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCC-cceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------
Q 047901 661 LLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------- 731 (786)
Q Consensus 661 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------- 731 (786)
++..... .++..+-|.+|.|| |++. ...|+.++|+||.||||.||++|++.|.......+.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpP----------ELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPP----------ELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC 336 (560)
T ss_pred eccCCCCcccccceEEeeccCh----------HHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence 8876543 47778999999999 4444 457999999999999999999999998764321110
Q ss_pred Ccchh--hhhhhhccCCC---CCC-ChhHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 SSSIN--IEFNAMLDHRL---PHP-SLDVQ----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~--~~~~~~~~~~~---~~~-~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+ +....+..... ..+ ..... ..+.+..+|+..+|..||.+|.|+.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000 01001110000 001 11111 12346789999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=357.38 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=210.8
Q ss_pred HHHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 498 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
.++|....+++.+.+.||+|.||+||+|+|. ..||||++.-.. ...+..+.|+.|+..+++-+|.||+-+.|||..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~--pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDD--PTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCC--CCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3566666667888899999999999999996 479999997643 334578899999999999999999999999998
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
+.. .||+.+|+|-+|+.+++.. ...++..+.+.||+|||+||.|||.+ +|||||||+.||++.+++.|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 877 8999999999999999875 36789999999999999999999999 99999999999999999999999999
Q ss_pred cceecC--CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 658 TAKLLK--PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 658 ~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
++..-. ..........|...|||||++.+. ...+|++++||||||+|+|||+||..||..... .+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmq-------d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq----- 600 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ-------DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ----- 600 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhc-------ccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh-----
Confidence 986432 223334556788999999654322 145799999999999999999999999873221 11
Q ss_pred hhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 736 NIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 736 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
..=|+... .+........+..++.+|+..||..++++||++.+|+..
T Consensus 601 ---IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 601 ---IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred ---eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 00011111 122222334455679999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.88 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=214.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.. ....+.+.+.+|++|++.++|||||.++++|+...+.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46888889999999999999865 67899999987632 2334567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
.||+.| +|..++... +.+++..+..++.+++.||.|||+. +|.|||+||.|||++.++++|+||||+|+-+..
T Consensus 80 te~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999987 999999854 7799999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
+....+...||+.|||| |...++.|+..+|+||+|||+||+.+|++||... .....+..+..
T Consensus 153 ~t~vltsikGtPlYmAP----------Elv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~ 214 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAP----------ELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILK 214 (808)
T ss_pred CceeeeeccCcccccCH----------HHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhc
Confidence 76667778999999999 8888999999999999999999999999998632 22333344444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....|. .....+..++...+.+||..|.|..+++.
T Consensus 215 d~v~~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPVKPPS----TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCCcc----cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 4444333 45566889999999999999999998864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.22 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=197.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC--eee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR--HSF 582 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~ 582 (786)
.+|...+.||+|+||+||++... +|...|||.+... .....+.+.+|+.++++++|||||+++|...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc----cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 35778889999999999999865 4899999998763 1122567889999999999999999999854444 688
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEecccccee
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSDFGTAKL 661 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~ 661 (786)
++|||+++|+|.+++.+.+. .+++..++.+++||++||+|||++ |||||||||+|||++. ++.+||+|||+++.
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999987632 799999999999999999999999 9999999999999999 79999999999987
Q ss_pred cCCC---CCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 662 LKPN---SSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 662 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
.... ........||+.|||| |++..+ ...+++||||+||++.||+||++||... ......
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maP----------Evi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~ 231 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAP----------EVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEA 231 (313)
T ss_pred cccccccccccccccCCccccCc----------hhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHH
Confidence 7631 1223457899999999 555532 2335999999999999999999997642 111111
Q ss_pred hhhhhccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+........ ..|.. .+....+++..|+.++|++||||+++++
T Consensus 232 ~~~ig~~~~~P~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 232 LLLIGREDSLPEIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred HHHHhccCCCCCCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222222211 12222 3345889999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=343.64 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=208.5
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
...++++||+|.||.|..+....+.+||||+++.. .......+|.+|+++|.+++|||||+++|+|..++..++|+|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~---a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD---ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcc---cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 45677899999999999999988899999999863 344557899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
||++|+|.+|+..+.. +........+|+.|||.||+||.+. ++|||||.++|+|++.++++||+|||+++.+...+
T Consensus 616 YmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999987732 2245556677999999999999999 99999999999999999999999999999776655
Q ss_pred Ccc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh--CCCCCCccccccCCCcchhhhhhhh
Q 047901 667 SNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK--GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 667 ~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
++. ...+-..+|||| |.+.-+++|.+||||+||+.+||+++ ...||+.+.. .+..+...++
T Consensus 692 yy~vqgr~vlpiRwmaw----------EsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~ 756 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAW----------ESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEF 756 (807)
T ss_pred ceeeecceeeeeeehhH----------HHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhh
Confidence 432 234556799999 78888999999999999999999885 7889875432 2223333444
Q ss_pred ccCCC-----CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 743 LDHRL-----PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 743 ~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.+..- ..|..+ +.+++++|.+||+.|-++|||++++...
T Consensus 757 ~~~~~~~~~l~~P~~c----p~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPAC----PQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred cCCCCcceeccCCCcC----cHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 44322 233333 3458999999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.63 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=210.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
..|+..+.||+|.||.||+|... .++.||+|++..+.. ....+++.+|+.++.++++|||.++||.+..+...|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 35777889999999999999754 788999999987433 34556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||.||++.+.++.. ..+++..+.-++.++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||++..+..
T Consensus 90 Mey~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999999753 3347777778999999999999999 999999999999999999999999999998877
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
......+++||+.|||| |++....|+.|+||||||+..+||++|.+|+.....+. .-..-
T Consensus 164 ~~~rr~tfvGTPfwMAP----------EVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------vlflI 223 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAP----------EVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------VLFLI 223 (467)
T ss_pred hhhccccccccccccch----------hhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------EEEec
Confidence 66666788999999999 78888899999999999999999999999987544311 11111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
++-. |+.........+.++|..|+++||+.||||.++++
T Consensus 224 pk~~-PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 224 PKSA-PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCCC-CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1222 22223356667999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=316.19 Aligned_cols=239 Identities=25% Similarity=0.337 Sum_probs=209.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|+..+.+|.|+||.|.+++.+ +|..+|+|++..... -...+.+...+|..+++.+.||+++++++-+.+.+..|+|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 46888899999999999999866 678899999976321 1233455677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++||-|..++++. +++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||.|||+|+.+..
T Consensus 123 meyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999999864 6899999999999999999999999 999999999999999999999999999998864
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. .-+.+||+.|+|| |++....|..++|.|||||++|||+.|.+||...+ .-..+..++.
T Consensus 197 r---T~TlCGTPeYLAP----------Eii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--------~~~iY~KI~~ 255 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAP----------EIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--------PIQIYEKILE 255 (355)
T ss_pred c---EEEecCCccccCh----------HHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--------hHHHHHHHHh
Confidence 3 3467999999999 88899999999999999999999999999987533 2456677888
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCC
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 776 (786)
.+...|.....+ +.++++..+++|-.+|
T Consensus 256 ~~v~fP~~fs~~----~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKVKFPSYFSSD----AKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCCcccCHH----HHHHHHHHHhhhhHhh
Confidence 888887766554 7899999999998888
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=352.41 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=203.7
Q ss_pred hccCccceeeccccCceEEEEEcCC--C---CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS--G---DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
-++....++||+|+||.||+|+++. + ..||||..+... ........+|++|+++|+.++|||||+++|++....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3445556899999999999998642 2 238999987521 234567889999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++|||+|+||+|.+|++... +.++..+...++.++|.||+|||++ +++||||.++|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999998762 3699999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhh
Q 047901 660 KLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 660 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 738 (786)
+....-........-...|+|| |.+....|++++|||||||++||+++ |..||..+.. .+.
T Consensus 310 ~~~~~~~~~~~~~klPirWLAP----------Etl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v 371 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAP----------ETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEV 371 (474)
T ss_pred cCCcceeeccccccCcceecCh----------hhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHH
Confidence 7654111111112345799999 66777799999999999999999998 8999876442 122
Q ss_pred hhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 739 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...++. .+.+.|.. .+..+..++..||..+|++||||.++.+.+
T Consensus 372 ~~kI~~~~~r~~~~~~----~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 372 KAKIVKNGYRMPIPSK----TPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred HHHHHhcCccCCCCCC----CHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 222312 33333432 234588889999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.22 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=205.2
Q ss_pred cccccHHHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCccccee
Q 047901 493 DGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572 (786)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~ 572 (786)
...++|+++.. .+-+|.|+.|.||+|+++ ++.||||+++. .+ ..+|+-+++++||||+.|.
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~e---------lk--ETdIKHLRkLkH~NII~Fk 178 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRE---------LK--ETDIKHLRKLKHPNIITFK 178 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhh---------hh--hhhHHHHHhccCcceeeEe
Confidence 45566776533 456999999999999996 78999999853 11 1568889999999999999
Q ss_pred eEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEE
Q 047901 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR 652 (786)
Q Consensus 573 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 652 (786)
|+|.....+|||||||+.|-|.+.++.. ..++......|..+||.||.|||.+ .|||||||+=||||+.+..+|
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEE
Confidence 9999999999999999999999999854 6788899999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 653 VSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
|+|||-++...+. .....+.||..|||| |++...++++|+||||||||||||+||..||.+.+......
T Consensus 253 IsDFGTS~e~~~~-STkMSFaGTVaWMAP----------EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 253 ISDFGTSKELSDK-STKMSFAGTVAWMAP----------EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred eccccchHhhhhh-hhhhhhhhhHhhhCH----------HHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 9999999877654 344567999999999 88999999999999999999999999999988654322211
Q ss_pred cchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.. ..-...++.|..++. -|.=|++.||+..|..||++.+++.-
T Consensus 322 GV------GsNsL~LpvPstcP~----GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 322 GV------GSNSLHLPVPSTCPD----GFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ec------cCCcccccCcccCch----HHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 11 011123444544443 48889999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.48 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=217.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++++.+|+|.||.||.|+.+ ++--||+|++.+.. ........++.+|++|-+.++||||+++++|+.+....|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 357999999999999999999865 56689999987632 2223345689999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
++||.+.|.++..++.. ...++++.....++.|+|.|+.|+|.. +|+||||||+|+|++..+..|++|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999855 346788999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.....+.+||..|.+| |...+..++.++|+|++|++.||++.|.+||+... ..+.+.++.
T Consensus 176 --~~kR~tlcgt~dyl~p----------Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~ 235 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPP----------EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIR 235 (281)
T ss_pred --CCCceeeecccccCCH----------hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHH
Confidence 4456778999999999 78888899999999999999999999999998532 345667777
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..++..|..... ...++|.+|+.++|.+|.+-.|+++
T Consensus 236 k~~~~~p~~is~----~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 236 KVDLKFPSTISG----GAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HccccCCcccCh----hHHHHHHHHhccCccccccHHHHhh
Confidence 777766644333 4789999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=327.92 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=209.8
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|++.+.+|+|.||.|-+|+. ..|+.||||.++... ..+..+.-.+.+||+||+.++||||+.++++|++.+...+|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3588888899999999999975 689999999998743 34455667889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||..+|.|++|+.+. +.+++.+++.+++||+.|+.|+|.+ +++|||||.+|||+|.++.+||+|||++-.+.+
T Consensus 132 MEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999875 6799999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
. ....+++|++-|.+| |+..+..|. +.+|.||+||+||.|+.|..||+..+ ....++.+-
T Consensus 206 ~-kfLqTFCGSPLYASP----------EIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs 266 (668)
T KOG0611|consen 206 K-KFLQTFCGSPLYASP----------EIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQIS 266 (668)
T ss_pred c-cHHHHhcCCcccCCc----------cccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhh
Confidence 3 456778999999999 666666665 78999999999999999999998532 223333333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......|+... ...-+|++|+..+|++|-|..+|..
T Consensus 267 ~GaYrEP~~PS-----dA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 267 RGAYREPETPS-----DASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred cccccCCCCCc-----hHHHHHHHHHhcCcccchhHHHHhh
Confidence 34444333221 2567899999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=344.82 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=214.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+-|+.++.+|.|+.|.|..|++. +|+.+|||++..... ........+.+|+.||+-+.||||+++++++++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45888899999999999999864 899999999976432 2234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
.||+++|-|++|+.++ +++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|..-.+
T Consensus 91 lEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999865 7899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
+ .-..+.||++.|.|| |++.+.+|+ .++||||-|||||.|+||+.||++- .....+..+.
T Consensus 165 g-klLeTSCGSPHYA~P----------EIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~ 225 (786)
T KOG0588|consen 165 G-KLLETSCGSPHYAAP----------EIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQ 225 (786)
T ss_pred C-ccccccCCCcccCCc----------hhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHH
Confidence 3 445677999999999 888888887 6899999999999999999999842 2344455555
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.+..|..-. .+..+|+.+|+..||+.|.|++||++
T Consensus 226 ~G~f~MPs~Is----~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 226 RGVFEMPSNIS----SEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred cCcccCCCcCC----HHHHHHHHHHhccCccccccHHHHhh
Confidence 66666664433 34889999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.65 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=199.0
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|++.++||+|+||.||+|.+ .+++.||||++... ......+.+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 45799999999999999999973 23467999998642 2223456789999999999 89999999998875
Q ss_pred C-CeeeEEEeccCCCCHHHHhhcCCC------------------------------------------------------
Q 047901 578 V-RHSFVVYEYINRGSLATVLSNNFA------------------------------------------------------ 602 (786)
Q Consensus 578 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 602 (786)
. +..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 467899999999999999975311
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccC
Q 047901 603 -----SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGT 675 (786)
Q Consensus 603 -----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt 675 (786)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13478889999999999999999998 9999999999999999999999999999876433221 1223456
Q ss_pred ccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccCC-CCCCChh
Q 047901 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHR-LPHPSLD 753 (786)
Q Consensus 676 ~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 753 (786)
..|+|| |...+..++.++|||||||++|||++ |..||..... .......+.+.. ...+.
T Consensus 240 ~~y~aP----------E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~-- 300 (338)
T cd05102 240 LKWMAP----------ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NEEFCQRLKDGTRMRAPE-- 300 (338)
T ss_pred ccccCc----------HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHhcCCCCCCCC--
Confidence 789999 66677789999999999999999997 9999874321 111112222221 11121
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 754 VQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 754 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+..+.+++.+||+.||++|||+.|+++.|
T Consensus 301 --~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 301 --NATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.72 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=197.4
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhh--cCCCcccceeeEEecCC----e
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK--IRHRNIVKFYGFCSHVR----H 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~~----~ 580 (786)
..+..+.||+|.||.||+|++. ++.||||+|.. ...+.|..|-+|.+. ++|+||++++++-.... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 3455667999999999999986 58999999964 456778888888775 48999999999876655 8
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC------FPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
+|+|+||.+.|+|.+|+..+ ..+|....+|+..+++||+|||+.. .|+|+|||||++||||..|+++-|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 89999999999999999765 6899999999999999999999864 3689999999999999999999999
Q ss_pred ccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCC------ccc
Q 047901 655 DFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD------FLS 726 (786)
Q Consensus 655 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~------~~~ 726 (786)
|||+|..+.+... .....+||.+|||||++....++.. ...-.+.||||+|.|+|||++...-++ +..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d----~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD----RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc----HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 9999998875432 2233689999999988776665441 122247899999999999998543321 111
Q ss_pred cccCC--Ccchhhhhhhhc-c--CCCCCCChhHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 727 LFSSS--SSSINIEFNAML-D--HRLPHPSLDVQ-EKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 727 ~~~~~--~~~~~~~~~~~~-~--~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.|..- ...--+.+++.+ . .|...|..... ..+..+.+.+..||+.||+.|-|+.-|.++
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 11100 000111222222 2 12222222111 234568899999999999999999887765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.51 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=212.3
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
++|+-...+....+++|.|.||.||.|.|+. .-.||||.++. +....++|.+|..+|+.+.|||+|+++|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 4555555678889999999999999999874 45799999963 45678899999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
+...|||+|||..|+|.+|+++. ....++.-..++|+.||+.||+||..+ ++|||||.++|+|+.++..+|++|||
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999999999876 345677788899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeecc---CccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCc
Q 047901 658 TAKLLKPNSSNWTELVG---TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSS 733 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~ 733 (786)
+++.+..+.+ +...| .+.|.|| |.+....++.|+|||+|||+|||+.| |-.||...+..
T Consensus 411 LsRlMtgDTY--TAHAGAKFPIKWTAP----------EsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----- 473 (1157)
T KOG4278|consen 411 LSRLMTGDTY--TAHAGAKFPIKWTAP----------ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----- 473 (1157)
T ss_pred hhhhhcCCce--ecccCccCcccccCc----------ccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----
Confidence 9999976543 33333 5689999 66777889999999999999999998 88897765421
Q ss_pred chhhhhhhhc--cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 734 SINIEFNAML--DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 734 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.+-..+ +.++..|+.+ ++.++++|..||++.|.+||+++|+-+.
T Consensus 474 ----qVY~LLEkgyRM~~PeGC----PpkVYeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 474 ----QVYGLLEKGYRMDGPEGC----PPKVYELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred ----HHHHHHhccccccCCCCC----CHHHHHHHHHHhcCCcccCccHHHHHHH
Confidence 111222 3345555544 3469999999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.55 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=204.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC----------CchhhHHHHHHHHHHHhhcCCCcccceee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN----------DQMSDQKEFLNEIKALTKIRHRNIVKFYG 573 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~hpniv~l~~ 573 (786)
.+.|++.+.||+|.||.|-+|+.. +++.||||++.+.... ......+...+||++|++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 467999999999999999999854 7899999998764211 11122458899999999999999999999
Q ss_pred EEec--CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 574 FCSH--VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 574 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
+..+ .+..|||+|||..|.+...=. ....++..++++++++++.||+|||.+ +|+||||||+|+|++++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcE
Confidence 9854 568899999999887643221 123389999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCC-----CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 047901 652 RVSDFGTAKLLKPN-----SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLS 726 (786)
Q Consensus 652 kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~ 726 (786)
||+|||.+...... .......+||+.|+|||....+.. ....+.+.||||+||.||.|+.|+.||-+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~------~~~~g~a~DiWalGVTLYCllfG~~PF~~-- 321 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS------FSYSGFALDIWALGVTLYCLLFGQLPFFD-- 321 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC------ccccchhhhhhhhhhhHHHhhhccCCccc--
Confidence 99999999877332 122345799999999963322111 12244689999999999999999999863
Q ss_pred cccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 727 LFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.+..++...+..|... +....+.++|+++|.+||+.|.+..+|..
T Consensus 322 ------~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 322 ------DFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ------chHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhhee
Confidence 234456677777777776542 44556899999999999999999998853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.29 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=203.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe--cCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS--HVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~ 581 (786)
.++|+..+.|++|+||.||+|+.+ +++.||+|+++-.. +.....-.-.+||.++.+++|||||.+-++.. +-+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 345888889999999999999865 67889999997632 11122335679999999999999999999875 44679
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+|||||+. ||...+... ..++...++..++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 999999988 999999865 36899999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC---------
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS--------- 731 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~--------- 731 (786)
+..+...++..+-|.+|.|| |.+. ...|+.+.||||+|||+.||+++++-|.......+.
T Consensus 227 ygsp~k~~T~lVVTLWYRaP----------ELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAP----------ELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred hcCCcccCcceEEEeeecCH----------HHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 98887788888999999999 5544 456999999999999999999999988764432110
Q ss_pred -Ccchhhhh---hhhccCCC-CCCChhHHH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 -SSSINIEF---NAMLDHRL-PHPSLDVQE------KLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 -~~~~~~~~---~~~~~~~~-~~~~~~~~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+ ..+....+ ..|...... ....-++++...+..||++|-|++|.++
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000000 00000000 011111100 1245679999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.60 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=210.1
Q ss_pred HHhccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC---
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--- 578 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--- 578 (786)
...++|++.+.+|+|||+.||.++ ..++..+|+|++.-. ..++.+..++|++..++++||||+++++++..+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 346789999999999999999998 557889999999763 345677889999999999999999999987433
Q ss_pred --CeeeEEEeccCCCCHHHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 579 --RHSFVVYEYINRGSLATVLSNNFAS-EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 579 --~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
...|++++|+..|+|.+.+++...+ ..+++.+.+.|+.++++||.+||+. .|+++||||||.||++++++.+++.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 3589999999999999999876443 4789999999999999999999998 34699999999999999999999999
Q ss_pred cccceecCCC---CC------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 047901 656 FGTAKLLKPN---SS------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLS 726 (786)
Q Consensus 656 fg~a~~~~~~---~~------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~ 726 (786)
||.++...-. .. .+.....|..|.|||.++. -.+...++++|||||||++|+|+.|..||+...
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v-------k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV-------KSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec-------ccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 9999865421 10 1223467899999986643 345678899999999999999999999998533
Q ss_pred cccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 727 LFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
. ......-++....+..|.... .+..+.++|++|+++||.+||++.+++..
T Consensus 246 ~------~GgSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 Q------QGGSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred h------cCCeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2 111112233333444443322 45679999999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=344.29 Aligned_cols=244 Identities=22% Similarity=0.259 Sum_probs=199.0
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
+.||+|+||.||+|+.. +++.||||++..... ........+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999854 788999999865211 1223445678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcce
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 670 (786)
|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 80 GELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999999754 5689999999999999999999999 999999999999999999999999999986543333344
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (786)
...||+.|+|| |...+..++.++||||+||++|||++|+.||.... .......+.......|
T Consensus 154 ~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~p 215 (323)
T cd05571 154 TFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFP 215 (323)
T ss_pred ceecCccccCh----------hhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCC
Confidence 56799999999 66667788999999999999999999999986422 1222222333333333
Q ss_pred ChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 751 SLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.. ...++.+++..||.+||++|| ++.++++
T Consensus 216 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RT----LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CC----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 32 234588999999999999999 7988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.35 Aligned_cols=263 Identities=23% Similarity=0.355 Sum_probs=199.1
Q ss_pred HhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc--CCCcccceeeEEecC---
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI--RHRNIVKFYGFCSHV--- 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~l~~~~~~~--- 578 (786)
..++....+.||+|.||.||+|+|+ |+.||||+|.. .++..+.+|.+|.+.+ +|+||+.+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecc-------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3457888999999999999999997 88999999975 2345667888887765 999999999876433
Q ss_pred -CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEEcCCCCCceeeCCCCcEE
Q 047901 579 -RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD-----CFPPIVHRDISSNNVLLDLEYEAR 652 (786)
Q Consensus 579 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~k 652 (786)
.+.|+|++|.+.|+|+||+.+ ..++.....+++..+|.||+|||.. ..|.|+|||||+.||||..++++-
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 367999999999999999986 4689999999999999999999975 348999999999999999999999
Q ss_pred EeccccceecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC----------
Q 047901 653 VSDFGTAKLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG---------- 718 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg---------- 718 (786)
|+|+|+|........ .....+||.+|||||++....... .+ +.-..+||||||.|+||+...
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~-~F---esyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMK-HF---ESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChh-hh---hhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999988765432 335679999999998765332221 11 112469999999999998842
Q ss_pred CCCCCccccccCCCcchhhhhhhhccCCCC--CCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 719 KHPGDFLSLFSSSSSSINIEFNAMLDHRLP--HPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 719 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
+.||.+... .....++...-+-..++. .|. ....+....+.++|+.||..+|..|-|+=.+.+.
T Consensus 433 ~~Pyyd~Vp---~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 433 QLPYYDVVP---SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred cCCcccCCC---CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 366654322 222222222222222322 222 1234566789999999999999999998766543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.72 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=205.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+....||+|+||.||+|+.+ +|..+|+|++++. ......+.+....|-.+|...++|.||+++..|.+.+..|+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS-EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHH-HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 468999999999999999999865 6889999999762 23344556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||++|||+...|.+. +.+++..++.++.+.+-|++.+|.. |+|||||||+|+|||..|++||+|||++.-..
T Consensus 219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999864 6799999999999999999999999 99999999999999999999999999986321
Q ss_pred C----------------------CCCc-------------------------ceeeccCccccCCCCCCCCchHHHHhhh
Q 047901 664 P----------------------NSSN-------------------------WTELVGTFGYVAPAHGNIGLHLAELAYT 696 (786)
Q Consensus 664 ~----------------------~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~e~~~~ 696 (786)
. +... ....+|||.|||| |++.+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAP----------EVll~ 362 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAP----------EVLLG 362 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccch----------HHHhc
Confidence 1 0000 0125899999999 88889
Q ss_pred cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCC
Q 047901 697 MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPN 774 (786)
Q Consensus 697 ~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~ 774 (786)
..|+..+|.||+|||||||+.|.+||.... ..+.++.++.-+ +..|... +...+..++|.+|+. ||+
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~t--------p~~T~rkI~nwr~~l~fP~~~--~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSET--------PQETYRKIVNWRETLKFPEEV--DLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhhhccCCCcC--cccHHHHHHHHHHhc-CHH
Confidence 999999999999999999999999998533 233344444333 3334322 223568899999999 999
Q ss_pred CCCC---HHHHH
Q 047901 775 SRPT---MQTVC 783 (786)
Q Consensus 775 ~RPt---~~ev~ 783 (786)
+|-- ++||.
T Consensus 432 ~RLG~~G~~EIK 443 (550)
T KOG0605|consen 432 NRLGSKGAEEIK 443 (550)
T ss_pred HhcCcccHHHHh
Confidence 9964 55554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.53 Aligned_cols=256 Identities=22% Similarity=0.350 Sum_probs=197.8
Q ss_pred ccCccceeeccccCceEEEEEcCC-----------------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcc
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS-----------------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 568 (786)
++|...+.||+|+||.||+|.+++ +..||+|.+... .......+|.+|++++.+++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHHHHHHHHHHhhcCCCCe
Confidence 578899999999999999997532 236999998652 223445689999999999999999
Q ss_pred cceeeEEecCCeeeEEEeccCCCCHHHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 047901 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFA----------------SEDFDWRKRMNVITGVADALSYMHHDCFPP 632 (786)
Q Consensus 569 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ 632 (786)
+++++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999999999999999999999999999864311 12467889999999999999999999 9
Q ss_pred eEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHH
Q 047901 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710 (786)
Q Consensus 633 ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGv 710 (786)
|+||||||+||+++.++.+||+|||+++........ .....++..|+|| |......++.++||||||+
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW----------ECILMGKFTTASDVWAFGV 228 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH----------HHHhcCCCCchhhhHHHHH
Confidence 999999999999999999999999999876443221 1223457889999 6666778999999999999
Q ss_pred HHHHHHh--CCCCCCccccccCCCcchhhhhhhhccC-----CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 711 LALEVIK--GKHPGDFLSLFSSSSSSINIEFNAMLDH-----RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 711 il~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
++|||++ +..||...... ............ ....+. .++..+.+++.+||+.+|++|||+.||.
T Consensus 229 ~l~el~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDE-----QVIENAGEFFRDQGRQVYLFRPP----PCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHHHHccCCCCCCcCCHH-----HHHHHHHHHhhhccccccccCCC----CCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9999987 55676542210 000111111110 011111 1234589999999999999999999998
Q ss_pred HhC
Q 047901 784 QLL 786 (786)
Q Consensus 784 ~~L 786 (786)
+.|
T Consensus 300 ~~l 302 (304)
T cd05096 300 AFL 302 (304)
T ss_pred HHH
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.53 Aligned_cols=243 Identities=21% Similarity=0.357 Sum_probs=195.1
Q ss_pred eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec----CCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH----VRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~ 587 (786)
..||+|++|.||+|.+ +++.||||++..... ......+.|.+|+.++++++||||++++|++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 588999999875321 222335678899999999999999999999866 3467899999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+++|+|.+++... +.+++.....++.+++.|+.|||+.. +++||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999754 46889999999999999999999731 78899999999999999999999999998664322
Q ss_pred cceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc-
Q 047901 668 NWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD- 744 (786)
Q Consensus 668 ~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~- 744 (786)
....|+..|+|| |+..+ ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 178 --~~~~~~~~y~aP----------E~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~ 237 (283)
T PHA02988 178 --FKNVNFMVYFSY----------KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINK 237 (283)
T ss_pred --ccccCcccccCH----------HHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhc
Confidence 234688999999 55544 5789999999999999999999999875321 112222222
Q ss_pred -CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 -HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.+...+. ..+..+.+++.+||+.||++|||++|+++.|
T Consensus 238 ~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 238 NNSLKLPL----DCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCCCCCC----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 1222221 2344689999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.15 Aligned_cols=247 Identities=24% Similarity=0.299 Sum_probs=203.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|... +++.||+|++..... ......+.+.+|+++++.++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 36888999999999999999865 688999999864211 1123455788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 80 MEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999999754 4688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. .....||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+..
T Consensus 154 ~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~ 212 (291)
T cd05612 154 R---TWTLCGTPEYLAP----------EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILA 212 (291)
T ss_pred C---cccccCChhhcCH----------HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 2 2235799999999 77777788999999999999999999999986432 1223334444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
.+...+... ...+.+++++||+.||.+||+ ++|+++
T Consensus 213 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 213 GKLEFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCcCCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 444433322 335889999999999999995 888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=336.62 Aligned_cols=252 Identities=24% Similarity=0.276 Sum_probs=200.1
Q ss_pred CccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|+||.||+|.. .+++.||||++..... ........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh-hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 77788999999999999986 4789999999865221 112234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888653 234689999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh-hccC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA-MLDH 745 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~ 745 (786)
......||..|+|| |+..+..++.++|||||||++|||++|+.||...... ........ ....
T Consensus 157 -~~~~~~g~~~y~aP----------E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~ 220 (285)
T cd05631 157 -TVRGRVGTVGYMAP----------EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKED 220 (285)
T ss_pred -eecCCCCCCCccCH----------hhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhcc
Confidence 22345799999999 6667778999999999999999999999998743211 01111111 1111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
....+. ..+..+.+++..||+.||++||| ++++++
T Consensus 221 ~~~~~~----~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSE----KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCc----cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 112221 22345889999999999999997 788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.95 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=209.8
Q ss_pred ccCccceeeccccCceEEEEEcCCC-CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceee-EEec-----
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSG-DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYG-FCSH----- 577 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~-~~~~----- 577 (786)
.++++.+.|.+|||+.||.|+...+ ..||+|++.. .+......+.+||++|+.++ |||||.+++ ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3577888999999999999997655 9999999975 35567788999999999997 999999999 3321
Q ss_pred -CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecc
Q 047901 578 -VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDF 656 (786)
Q Consensus 578 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 656 (786)
.-+++|+||||+||.|.+++..+. ...+++.++++|++++++|+++||.. .|+|||||||-+|||++.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 236789999999999999998653 34599999999999999999999996 568999999999999999999999999
Q ss_pred ccceecCCCCCcc---------eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 047901 657 GTAKLLKPNSSNW---------TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727 (786)
Q Consensus 657 g~a~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~ 727 (786)
|.|.......... -...-|+.|+|||++ ....+...++|+|||||||+||-|.....||+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI-------Dlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI-------DLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHH-------hhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-
Confidence 9997654332110 123579999999865 55667789999999999999999999999998532
Q ss_pred ccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
-.+++..+...|.. +.++..+.+||+.||++||.+||++-+|+..+
T Consensus 263 -----------~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 263 -----------KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -----------ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 23455666665543 44566799999999999999999999998753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=342.74 Aligned_cols=247 Identities=24% Similarity=0.272 Sum_probs=203.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+.+|+.++++++||||+++++++..++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 46899999999999999999875 688999999864211 1123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999999754 5678889999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.. ....||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+..
T Consensus 171 ~~---~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~ 229 (329)
T PTZ00263 171 RT---FTLCGTPEYLAP----------EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILA 229 (329)
T ss_pred Cc---ceecCChhhcCH----------HHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhc
Confidence 32 235799999999 77777788999999999999999999999986422 1222333444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
.+...|... ...+.+++..||+.||.+||+ ++++++
T Consensus 230 ~~~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GRLKFPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCcCCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 444444322 234789999999999999997 677763
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.70 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=214.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe-eeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH-SFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-~~l 583 (786)
++|...+.+|+|+||.++..+.+ +++.+|+|++...... ...+....+|+.+++++.|||||.+.+.+..++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 56888999999999999999865 6789999999764322 2334467899999999999999999999988888 999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||+|++||++.+.+.+.. +.-++++++..++.|++.|+.|||+. +|+|||||+.||+++.+..|||+|||+|+.+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999998763 56789999999999999999999988 99999999999999999999999999999998
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
+........+||+.||+| |+..+.+|..|+||||+||++|||.+-+++|...+. ......+.
T Consensus 158 ~~~~~a~tvvGTp~YmcP----------Eil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~ 219 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCP----------EILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKIN 219 (426)
T ss_pred CchhhhheecCCCcccCH----------HHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHh
Confidence 776566778999999999 889999999999999999999999999999885331 22333333
Q ss_pred cCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 744 DHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 744 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.... +.|.. +..++..+|+.|++++|..||++.+++..
T Consensus 220 ~~~~~Plp~~----ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSM----YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCcc----ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3332 23333 34459999999999999999999999863
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.11 Aligned_cols=261 Identities=21% Similarity=0.353 Sum_probs=218.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc----hhhHHHHHHHHHHHhhc-CCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ----MSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~ 578 (786)
-..|...+++|+|..++|.++..+ +|+..|+|++........ ....+.-.+|++|++++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346888889999999999988654 788999999865332221 12244567899999999 599999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++|+|.|+.|-|.||+... -.+++++.++|+.|+..|++|||.+ .|||||+||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999753 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
|+.++++ ......+||++|.|||.+.+.+ ......|+..+|+||.|||||.++.|.+||..- ..-..
T Consensus 170 a~~l~~G-ekLrelCGTPgYLAPEtikC~m----~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQmlM 236 (411)
T KOG0599|consen 170 ACQLEPG-EKLRELCGTPGYLAPETIKCSM----YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQMLM 236 (411)
T ss_pred eeccCCc-hhHHHhcCCCcccChhheeeec----ccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HHHHH
Confidence 9988765 3456679999999998776553 234567899999999999999999999998642 12223
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.+..++.......+.+.+....++|.+|++.||.+|.|++|+++
T Consensus 237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 3445556666666678888888999999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=320.59 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=205.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-----C
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-----V 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-----~ 578 (786)
...|...+.||+|+||.|+.|..+ +|+.||||++..++. .....++..+|+.+++.++|+||+.+.+++.. -
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~--~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE--NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh--chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 445666788999999999999754 789999999986543 34567788899999999999999999998854 3
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...|+|+|+|+. ||...++.+ ..++..++..+++|+++|+.|+|+. +|+|||+||+|++++.+...||+|||+
T Consensus 99 ~DvYiV~elMet-DL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 578999999965 999999754 4589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCC--CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-----
Q 047901 659 AKLLKPN--SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----- 731 (786)
Q Consensus 659 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----- 731 (786)
|+..... ...++..+.|.+|.||| =......|+.+.||||.|||+.||++|++-|.+.+...+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPE---------lll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPE---------LLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHH---------HHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 9988642 33456778999999996 3345678999999999999999999999998875542110
Q ss_pred --Ccchh--------hhhhhhccCCCCCCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 --SSSIN--------IEFNAMLDHRLPHPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 --~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... +.....+..-...|.... +...+...+++.+||..||.+|+|++|.++
T Consensus 243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00011 111222222112221111 122345789999999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=339.72 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=197.0
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|+||+||+|+.. +++.||+|++..... ........+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999865 678999999864211 122345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 672 (786)
|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 80 LFHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99999754 4689999999999999999999999 99999999999999999999999999998654333333456
Q ss_pred ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCCh
Q 047901 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSL 752 (786)
Q Consensus 673 ~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (786)
.||+.|+|| |...+..++.++||||+||++|||++|+.||.... ...............+..
T Consensus 154 ~gt~~y~aP----------E~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~~~~~~~ 215 (312)
T cd05585 154 CGTPEYLAP----------ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEPLRFPDG 215 (312)
T ss_pred cCCcccCCH----------HHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCCCCCc
Confidence 799999999 67777789999999999999999999999986422 222333334434333332
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 047901 753 DVQEKLISIMEVALLCLDGCPNSRPT---MQTVCQ 784 (786)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~ 784 (786)
....+.+++..||..||++||+ +.|+++
T Consensus 216 ----~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 ----FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ----CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 2345889999999999999985 566653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.43 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=198.1
Q ss_pred eeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
+.||+|+||.||+++. .+++.||||++..............+..|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 357889999986522112223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+++|+|.+++... +.+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999999754 4678888899999999999999999 999999999999999999999999999986544333
Q ss_pred cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCC
Q 047901 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRL 747 (786)
Q Consensus 668 ~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (786)
......||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 156 ~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~~ 217 (323)
T cd05584 156 VTHTFCGTIEYMAP----------EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGKL 217 (323)
T ss_pred cccccCCCccccCh----------hhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 33445799999999 55566678899999999999999999999987432 1223334444444
Q ss_pred CCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
..|... ...+.+++.+||+++|++|| +++++++
T Consensus 218 ~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 444332 23488999999999999999 7888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.30 Aligned_cols=244 Identities=22% Similarity=0.258 Sum_probs=197.6
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
+.||+|+||.||+++.. +++.||+|++..... ........+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36899999999999854 689999999865221 1123445678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcce
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 670 (786)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 80 GELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999988754 4689999999999999999999999 999999999999999999999999999886543333334
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (786)
...||+.|+|| |...+..++.++|||||||++|||++|+.||.... ...............|
T Consensus 154 ~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~~~~p 215 (323)
T cd05595 154 TFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFP 215 (323)
T ss_pred cccCCcCcCCc----------ccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCCCCC
Confidence 56799999999 55566778999999999999999999999986422 1222223333333333
Q ss_pred ChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 751 SLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
... +..+.+++..||++||++|| ++.++++
T Consensus 216 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCC----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 322 33588999999999999998 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=316.84 Aligned_cols=245 Identities=26% Similarity=0.430 Sum_probs=211.5
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|++.+++|+|+||.||+|.++ .|+.||||++.. ..+.+++.+|+.+|++++.|+||++||.+......|+|||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 778889999999999999765 789999999854 3467889999999999999999999999988899999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
||..|+..+.++.+ .+.+++.++..+.+..++||+|||.. .-+|||||+-|||++.+|.+||+|||.|-.+.+..
T Consensus 109 YCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999999865 46899999999999999999999998 88999999999999999999999999998777655
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc--c
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML--D 744 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~ 744 (786)
....+..||+.|||| |++..-.|+.++||||+|+...||..|++||++.... ++++ .
T Consensus 184 AKRNTVIGTPFWMAP----------EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RAIFMIP 242 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAP----------EVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RAIFMIP 242 (502)
T ss_pred HhhCccccCcccccH----------HHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ceeEecc
Confidence 556778999999999 8888889999999999999999999999998865432 2222 2
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.....+.+.+..+.++++.|+.+.|++|-|+-++++
T Consensus 243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2222122234455677999999999999999999999876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.14 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=203.1
Q ss_pred ccCccceeeccccCceEEEEEcC---CCC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP---SGD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
+..+..++||.|.||.||+|... .|+ .||||..+.. ...+..+.|+.|..+|+.++||||++++|+|.+ ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34566778999999999999743 233 4899998763 233456789999999999999999999999986 57
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+|||.++-|-|..|++.+ ...++......+++||+.||+|||+. ++|||||.++|||+....-+||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 89999999999999999976 45688899999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCcceeecc--CccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSSNWTELVG--TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
.+.++.++. ...| ...|||| |.+...+++.+||||.|||+|||+++ |..||.....-. .
T Consensus 540 ~~ed~~yYk-aS~~kLPIKWmaP----------ESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------V- 601 (974)
T KOG4257|consen 540 YLEDDAYYK-ASRGKLPIKWMAP----------ESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------V- 601 (974)
T ss_pred hccccchhh-ccccccceeecCc----------cccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------e-
Confidence 998765433 2333 4589999 66667789999999999999999997 999987532111 0
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...--...|++.|+.++ +.++.++.+||..||.+||++.|+...|
T Consensus 602 I~~iEnGeRlP~P~nCP----p~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCP----PALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred EEEecCCCCCCCCCCCC----hHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 00011124566665544 4599999999999999999999987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.65 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=208.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|...+.+|+|.||+|++|..+ +++.+|||++++..... .++.+..+.|-.|+... +||.++.++.++...++.|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 457999999999999999999876 67899999998854433 34556777888887777 5999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
.||||+.|||+..+.+ .+.+++..++-+++.|+-||.|||++ +|||||||.+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999544443 36799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
-.......+++||+.|||| |++.+..|+.++|.|||||+||||+.|..||.. ...++.+..+
T Consensus 519 m~~g~~TsTfCGTpey~aP----------Eil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--------ddEee~FdsI 580 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAP----------EVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--------DDEEEVFDSI 580 (694)
T ss_pred CCCCCccccccCChhhcCh----------hhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHH
Confidence 6555566789999999999 888999999999999999999999999999874 2344555666
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
+......|... +.+...++++++.++|++|--+
T Consensus 581 ~~d~~~yP~~l----s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEVRYPRFL----SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCCCCCCcc----cHHHHHHHHHHhccCcccccCC
Confidence 65555544433 3457899999999999999866
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.05 Aligned_cols=244 Identities=23% Similarity=0.270 Sum_probs=198.1
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
+.||+|+||.||+|+.. +++.||||++..... ........+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999854 688999999875321 1223456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcce
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 670 (786)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 80 g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 80 GELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999988754 4689999999999999999999999 999999999999999999999999999986543333334
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (786)
...||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.......|
T Consensus 154 ~~~gt~~y~aP----------E~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~~~~~p 215 (328)
T cd05593 154 TFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEDIKFP 215 (328)
T ss_pred cccCCcCccCh----------hhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccCCccCC
Confidence 56799999999 66667788999999999999999999999986422 1112222222223333
Q ss_pred ChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 751 SLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
... ...+.+++.+||.+||++|| ++.|+++
T Consensus 216 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTL----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 222 33488999999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.55 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=202.5
Q ss_pred ccCccceeeccccCceEEEEEcCC--CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS--GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
++|+..+.||+|+||.||+|..+. +..||+|++..... ......+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 469999999999999999997543 36899999864211 112345578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999754 4688999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. .....||+.|+|| |+..+..++.++||||+||++|||++|+.||..... ......+.
T Consensus 183 ~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~ 241 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAP----------EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKIL 241 (340)
T ss_pred CC---cceecCChhhcCH----------HHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHh
Confidence 32 2345799999999 777777889999999999999999999999874321 12233333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
......|.... ..+.+++++|++.||++|+ |++++++
T Consensus 242 ~~~~~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 242 EGIIYFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred cCCCCCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 43333333322 3478999999999999995 8998875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.30 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=201.4
Q ss_pred HHHhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeE
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGF 574 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~ 574 (786)
....++|++.+.||+|+||.||+|+.. ++..||||++.... .......+.+|+++++.+ +||||++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 334557999999999999999998742 33579999997532 233456788999999999 89999999999
Q ss_pred EecCCeeeEEEeccCCCCHHHHhhcCC-----------------------------------------------------
Q 047901 575 CSHVRHSFVVYEYINRGSLATVLSNNF----------------------------------------------------- 601 (786)
Q Consensus 575 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 601 (786)
|...+..++||||+++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999986421
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 602 --------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 602 --------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
...++++..+.+++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 012478889999999999999999998 999999999999999999999999999987643322
Q ss_pred c--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhcc
Q 047901 668 N--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 668 ~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. .....++..|+|| |+.....++.++|||||||++|||++ |+.||..... ......+..
T Consensus 268 ~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--------~~~~~~~~~ 329 (374)
T cd05106 268 YVVKGNARLPVKWMAP----------ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--------NSKFYKMVK 329 (374)
T ss_pred eeeccCCCCccceeCH----------HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--------cHHHHHHHH
Confidence 1 1122355689999 66667789999999999999999997 9999874321 111222222
Q ss_pred CCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 HRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 ~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... ..+.. .+..+.+++..||+.||++|||+.+|++.|
T Consensus 330 ~~~~~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 330 RGYQMSRPDF----APPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred cccCccCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 211 11211 134588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=329.22 Aligned_cols=260 Identities=19% Similarity=0.275 Sum_probs=197.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.+ +++.||+|++..... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 46999999999999999999865 688999999865321 12234677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999985 999988754 24578899999999999999999999 999999999999999999999999999986654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------Ccch-
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------SSSI- 735 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~~~~- 735 (786)
.........+++.|+|| |... ...++.++||||+||++|||+||+.||......... ....
T Consensus 156 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07871 156 PTKTYSNEVVTLWYRPP----------DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225 (288)
T ss_pred CCccccCceecccccCh----------HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 33333445789999999 4443 356889999999999999999999998643210000 0000
Q ss_pred --------hhhhhhhccCCCC-CCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 --------NIEFNAMLDHRLP-HPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 --------~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+......... .+. ...........+++.+|+..||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 000 000111345789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.85 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=200.5
Q ss_pred ccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|++.+.||+|+||.||+|.++ .+..||+|.++... .......|.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 46889999999999999999753 35689999987532 223456789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999999764 34689999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhh
Q 047901 662 LKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 662 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
....... .....++..|+|| |...+..++.++|||||||++||+++ |+.||..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~ 218 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAP----------EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVI 218 (266)
T ss_pred ccccchhcccCCCCceeecCH----------HHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHH
Confidence 4322111 1122356789999 77777889999999999999999775 9999864321 1112
Q ss_pred hhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 740 NAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 740 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+.+. ..+.+. ..+..+.+++..||+++|++|||++++.+.|
T Consensus 219 ~~~~~~~~~~~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 219 KAVEDGFRLPAPR----NCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred HHHHCCCCCCCCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 222221 122222 2334588999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=305.46 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=215.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
++.|++.+.||+|.|+.||++... +|+.+|+|.+....-. ....+++.+|+.|.+.++||||+++..-+...+..|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~--~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc--cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 345788888999999999998654 7888998887653221 2356778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfg~a~ 660 (786)
|+|+|.|++|..-|-.+ ..+++..+..+++||+.|+.|+|.+ +|||||+||+|+++-+ .-.+||+|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999997766543 5678889999999999999999999 9999999999999953 3568999999999
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
.+. +.......+|||+|||| |+....+|+..+||||-|||+|-++.|.+||.+.. ....+.
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaP----------Evvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye 222 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSP----------EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYE 222 (355)
T ss_pred EeC-CccccccccCCCcccCH----------HHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHH
Confidence 988 44556678999999999 88889999999999999999999999999987522 344556
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......++..++...++..+++++|+..||.+|.|+.|.++
T Consensus 223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 67777777666667777788999999999999999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.17 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=202.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+.. +++.||||++..... ........+.+|++++..++||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 36899999999999999999875 588999999864211 1223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999999754 4688999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
......||+.|+|| |+..+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 154 ---~~~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~ 212 (333)
T cd05600 154 ---YANSVVGSPDYMAP----------EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKY 212 (333)
T ss_pred ---ccCCcccCccccCh----------hHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHh
Confidence 22345799999999 677777899999999999999999999999874321 111111111
Q ss_pred --CCCCCCChh--HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 --HRLPHPSLD--VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 --~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....|... ....+..+.+++..||..+|.+|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 213 WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 111111110 0122345889999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=331.26 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=197.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 357999999999999999999865 688999999865321 1223467789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 81 VFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999996 5888888654 35688899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc--------c
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS--------S 734 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~--------~ 734 (786)
..........+++.|+|| |...+ ..++.++||||+||++|||++|+.||........... .
T Consensus 155 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 224 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPP----------DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP 224 (303)
T ss_pred CCCccCCCCcccCCCCCh----------HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCC
Confidence 433334456789999999 55543 4578899999999999999999999975321100000 0
Q ss_pred hhhhhh------hhccCCCC--CCChhHH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFN------AMLDHRLP--HPSLDVQ-----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~------~~~~~~~~--~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+. .....+.. .+..... .....+.+++..|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00000000 0100000 01234779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=340.25 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=199.9
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|++.+.||+|+||+||+|.+ .++..||||+++... .....+.+.+|+++++.+ +||||++++++|..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 44689999999999999999963 235689999986422 223456788999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC-------------------------------------------------------
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA------------------------------------------------------- 602 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 602 (786)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999964311
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 603 -----------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 603 -----------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478889999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 666 SSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 666 ~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... .....++..|+|| |...+..++.++|||||||++|||++ |..||..... .......
T Consensus 268 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--------~~~~~~~ 329 (375)
T cd05104 268 SNYVVKGNARLPVKWMAP----------ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--------DSKFYKM 329 (375)
T ss_pred ccccccCCCCCCcceeCh----------hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--------hHHHHHH
Confidence 221 1123456689999 66677789999999999999999998 8889764321 1111122
Q ss_pred ccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+... ...+.. .+.++.+++..||+.||++|||+.||++.|
T Consensus 330 ~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 330 IKEGYRMLSPEC----APSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred HHhCccCCCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 2221 111211 123588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.50 Aligned_cols=200 Identities=25% Similarity=0.349 Sum_probs=174.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||.||+|+.. ++..||+|.+... ......+.+.+|++++++++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 357999999999999999999865 6788999998652 122345679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ..+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999999754 46889999999999999999999851 69999999999999999999999999998664
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
... .....|+..|+|| |...+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~--~~~~~g~~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 156 DSM--ANSFVGTRSYMSP----------ERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccc--cccCCCCcCcCCH----------hHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 322 2345789999999 666777899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.81 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=201.0
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|+..+.||+|+||.||+|+++++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 468888999999999999999988889999987642 123457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999999999754 24688999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... .....++..|+|| |......++.++||||||+++|||++ |+.||..... ........
T Consensus 154 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~ 215 (256)
T cd05114 154 EYTSSSGAKFPVKWSPP----------EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMIS 215 (256)
T ss_pred ceeccCCCCCchhhCCh----------hhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence 221 1122355689999 55556678899999999999999999 8999864321 11222222
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...+.. .+..+.+++.+||+++|++|||++|+++.|
T Consensus 216 ~~~~~~~~~~----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 216 RGFRLYRPKL----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 22 1112222 223589999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.14 Aligned_cols=248 Identities=33% Similarity=0.533 Sum_probs=194.0
Q ss_pred cceeeccccCceEEEEEcC-----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 510 AKYCIGKGEHRSVYRAKLP-----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
..+.||.|.||.||+|.+. .+..|+||.+.. .......+.|.+|++.+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 4578999999999999875 246799999954 22334578899999999999999999999999988889999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..|+.|+|.||+|||+. +++||||+++||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999999875 346789999999999999999999999 999999999999999999999999999987733
Q ss_pred CCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhh
Q 047901 665 NSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 665 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.... .....+...|+|| |......++.++||||||+++|||++ |+.||.... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~aP----------E~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~ 217 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAP----------EVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEK 217 (259)
T ss_dssp SSSEEESTTSESGGGGS-H----------HHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHH
T ss_pred ccccccccccccccccccc----------cccccccccccccccccccccccccccccccccccc--------ccccccc
Confidence 2221 1223567799999 88888889999999999999999999 788976432 1222222
Q ss_pred hccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 MLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.+... ..+.. .+..+.+++..||+.+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 LKQGQRLPIPDN----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHTTEETTSBTT----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccceeccc----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222222 22222 233488999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.85 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=220.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~ 582 (786)
...|++.+.||+|.||.||+++.+ +|+.+|+|.+....... ......+.+|+++|+++. |||||.++++++.....+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 346888899999999999999876 59999999997643222 224568899999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC----CcEEEecccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE----YEARVSDFGT 658 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~ 658 (786)
+|||++.||.|.+.+... .+++..+..++.|++.|+.|||+. ||+|||+||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 399999999999999999999998 99999999999999644 4799999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
|..... .......+||+.|+|| |+.....|+.++||||+||++|.|++|.+||.... ....
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~AP----------Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~--------~~~~ 246 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAP----------EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET--------EFEI 246 (382)
T ss_pred ceEccC-CceEeeecCCccccCc----------hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC--------hhHH
Confidence 999876 5566788999999999 77777899999999999999999999999987533 2334
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+....+..+...+...+..+.++|..|+..||.+|+|+.++++
T Consensus 247 ~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 247 FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 4566666666666677777888999999999999999999999986
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.85 Aligned_cols=239 Identities=26% Similarity=0.351 Sum_probs=194.0
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.+ +++.||||++..... ......+.+..|..++... +||||+++++++...+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999865 678999999864211 1123445677888888876 69999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 80 GGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999998754 4688999999999999999999999 99999999999999999999999999998654333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |...+..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 215 (320)
T cd05590 154 STFCGTPDYIAP----------EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVY 215 (320)
T ss_pred cccccCccccCH----------HHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCCCC
Confidence 456799999999 77777788999999999999999999999987432 122233333333333
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
+... ...+.+++..|++.||++||++
T Consensus 216 ~~~~----~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWL----SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCC----CHHHHHHHHHHcccCHHHCCCC
Confidence 3322 2347899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=323.64 Aligned_cols=253 Identities=24% Similarity=0.475 Sum_probs=207.3
Q ss_pred HhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
...+|+..+.||.|+||.||+|...+++.+|+|.+... .......+..|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999888899999998652 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999999765 345689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
..........++..|+|| |......++.++||||||+++|+|++ |+.||.... ..+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~P----------E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~ 217 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAP----------EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQI 217 (261)
T ss_pred CccccccCCCCceEecCH----------HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHH
Confidence 433222334567789999 66677788999999999999999998 899986432 11222222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +.+.+. ..+.++.++|.+||+.+|.+|||+.++++.|
T Consensus 218 ~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 218 TAGYRMPCPA----KCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HhCCcCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 221 222222 2234588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.06 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=199.0
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||.||+|+.. +++.||||++..... ......+.+..|..++..+ +||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36899999999999865 688999999875321 1223445688899999988 69999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999988653 5689999999999999999999999 99999999999999999999999999997543333333
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc-chhhhhhhhccCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS-SINIEFNAMLDHRLP 748 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~ 748 (786)
....||+.|+|| |+..+..++.++|||||||++|||++|+.||+.......... ........+......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (329)
T cd05588 154 STFCGTPNYIAP----------EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223 (329)
T ss_pred ccccCCccccCH----------HHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC
Confidence 456899999999 777777899999999999999999999999874322111111 111122333333344
Q ss_pred CCChhHHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 047901 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPT------MQTVCQ 784 (786)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~ 784 (786)
.|... +..+.+++..||+.||.+||| ++++++
T Consensus 224 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 34322 335889999999999999998 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=312.30 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=204.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc-ccceeeEEecCC---
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN-IVKFYGFCSHVR--- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~--- 579 (786)
...|...++||+|+||+||+|+.+ +|+.||+|+++..... +.......+|+.+++.++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 345777788999999999999854 7899999999875432 223446679999999999999 999999998766
Q ss_pred ---eeeEEEeccCCCCHHHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 580 ---HSFVVYEYINRGSLATVLSNNFAS-EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 580 ---~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
..++|+||++. +|..|+...... ..++...+..++.|++.|++|||++ +|+||||||.|||+++.|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 78899999976 999999875322 4577788999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccC----
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS---- 730 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~---- 730 (786)
||+|+...-+...++..++|.+|.|| |++.+. .|+...||||+|||++||+++++-|.......+
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaP----------EvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I 233 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAP----------EVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI 233 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCH----------HHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 99999776555567777999999999 555554 799999999999999999999988876443110
Q ss_pred ------CCcchhhhhhhhccCCCCCCC-----hhHHHH---HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ------SSSSINIEFNAMLDHRLPHPS-----LDVQEK---LISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....-+......+.+...+. ...... .....+++..|++.+|++|.|++..++
T Consensus 234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 011111111111222211111 111111 135889999999999999999998875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=336.51 Aligned_cols=244 Identities=23% Similarity=0.258 Sum_probs=197.8
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
+.||+|+||.||+|+.. +++.||+|++..... ........+..|+++++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999854 788999999865221 1223445677899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 80 GELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999988754 468999999999999999999997 6 99999999999999999999999999998654333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~~~~~ 215 (325)
T cd05594 154 KTFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRF 215 (325)
T ss_pred ccccCCcccCCH----------HHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcCCCCC
Confidence 456799999999 77777889999999999999999999999986422 112222222233333
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
|... ...+.+++..||++||++|+ ++.++++
T Consensus 216 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 3322 23488999999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.13 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=193.0
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||||++...... .....+.+..|..++... +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999865 5788999998752211 122334556677777654 89999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 80 GGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999998754 4688999999999999999999998 99999999999999999999999999998764433344
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~ 215 (316)
T cd05592 154 STFCGTPDYIAP----------EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILNDRPHF 215 (316)
T ss_pred ccccCCccccCH----------HHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence 456799999999 77777789999999999999999999999987432 122222232322222
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQ-TVC 783 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 783 (786)
|... ...+.+++..||+.||++||++. +++
T Consensus 216 ~~~~----~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWI----SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCC----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3222 23478999999999999999875 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=333.47 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=197.4
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||.||+|+.. +++.||||++..... ........+..|.+++..+ +||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36899999999999865 578999999865211 1223445677888888866 79999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 80 GGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 99999998754 4688999999999999999999999 99999999999999999999999999998654443334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~~~ 215 (321)
T cd05591 154 TTFCGTPDYIAP----------EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDVLY 215 (321)
T ss_pred cccccCccccCH----------HHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence 456799999999 77777889999999999999999999999987432 122233333333333
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRP-------TMQTVCQ 784 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-------t~~ev~~ 784 (786)
|... ...+.+++..|+..||++|| +++++++
T Consensus 216 p~~~----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWL----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCC----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 3222 23488999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=339.47 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=194.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|+..+.||+|+||+||+|+.. +++.||||++... ........+.+|+++++.++||||+++++++...+..++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 34667788999999999999865 6899999998642 2233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+.. ...+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999986532 345677888999999999999999 999999999999999999999999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........||..|+|||++.... ..+...+.++|||||||++|||++|+.||..... ............
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~ 290 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDL-----NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICM 290 (353)
T ss_pred ccccccccccCccccCcccccccc-----ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhc
Confidence 433334568999999997543211 1122345689999999999999999999873211 000111111111
Q ss_pred -CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 -HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+ .....++.+++..||+.||++|||+.|+++
T Consensus 291 ~~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 291 SQPPEAP----ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred cCCCCCC----CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 123345899999999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.43 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=199.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +++.||||++..... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 36889999999999999999875 678899999875322 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++++.+..+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 79 FEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999998776655432 34688999999999999999999998 999999999999999999999999999987653
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-------cchh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SSIN 736 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~~~ 736 (786)
... ......|+..|+|| |+..+..++.++||||+||++|||++|+.||.......... ....
T Consensus 153 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07848 153 GSNANYTEYVATRWYRSP----------ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222 (287)
T ss_pred cccccccccccccccCCc----------HHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCH
Confidence 322 22345789999999 77777789999999999999999999999987533210000 0000
Q ss_pred hhhhhh-ccC---CCCCC-----C----hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAM-LDH---RLPHP-----S----LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~-~~~---~~~~~-----~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .+. ....+ . ......+..+.+++.+||++||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 000 00000 0 001112446899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.15 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=195.9
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHH---hhcCCCcccceeeEEecCCeeeE
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL---TKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~hpniv~l~~~~~~~~~~~l 583 (786)
|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+.+|+.++ +.++||||+++++++...+..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 667889999999999999865 688999999864211 1122344566666554 56689999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|..++.. +.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999988853 4689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........|++.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.
T Consensus 153 ~~~~~~~~~~g~~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~ 214 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAP----------EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIV 214 (324)
T ss_pred CCCCcccccccCccccCH----------hHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 333333456799999999 66677788999999999999999999999987432 122223333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
......|... +..+.+++.+||..||.+|| ++.++++
T Consensus 215 ~~~~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 215 NDEVRYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hCCCCCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 3333333322 33478999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.25 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=197.5
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCC-cccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR-NIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-niv~l~~~~~~~~~~~lv 584 (786)
+|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+..|.+++..++|+ +|+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 4888999999999999999865 567899999865221 1123456778899999999764 688899999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999999754 4688999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........||+.|+|| |+..+..++.++||||+||++|||+||+.||.... .......+..
T Consensus 154 ~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~ 215 (324)
T cd05587 154 GGKTTRTFCGTPDYIAP----------EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIME 215 (324)
T ss_pred CCCceeeecCCccccCh----------hhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHc
Confidence 33334456799999999 66677788999999999999999999999987432 1223333444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
.....|... ...+.+++.+||.+||.+||+.
T Consensus 216 ~~~~~~~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HNVSYPKSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 443333322 3357899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=317.65 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=191.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-----e
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR-----H 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~ 580 (786)
.|...+.+|.|+||.||+|... +++.||||++-.... . -.+|+++|+.++|||||++..+|.... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---Y-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---c-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 5777889999999999999865 568999999864221 1 127999999999999999999885322 2
Q ss_pred eeEEEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEecccc
Q 047901 581 SFVVYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGT 658 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~ 658 (786)
..+||||||. +|.++++.. .....++...+.-+..|+.+|+.|||+. +|+||||||.|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 3489999997 999998742 1235677788888999999999999998 99999999999999988 9999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------ 731 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------ 731 (786)
|+....++.. .....|..|.||| .+. ...|+.+.||||.|||+.||+-|++-|.+.+...+.
T Consensus 173 AK~L~~~epn-iSYicSRyYRaPE----------Lifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 173 AKVLVKGEPN-ISYICSRYYRAPE----------LIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred ceeeccCCCc-eeEEEeccccCHH----------HHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 9998766544 3346788999994 444 467999999999999999999999998764431110
Q ss_pred -Ccchhhhhhhh-------ccCCCCCCC---hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 -SSSINIEFNAM-------LDHRLPHPS---LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 -~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+....| ..+.+.... ........+..+++.+++..+|.+|.|+.|+++
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00011111111 111111111 011223345889999999999999999999875
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.98 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=195.1
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||+|++..... ......+.+..|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36999999999999865 678999999875322 1223455677888888877 79999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999988654 5689999999999999999999999 99999999999999999999999999998654333333
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch-hhhhhhhccCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI-NIEFNAMLDHRLP 748 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 748 (786)
....||..|+|| |+..+..++.++|||||||++|||++|+.||............. ......+......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 223 (329)
T cd05618 154 STFCGTPNYIAP----------EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223 (329)
T ss_pred ccccCCccccCH----------HHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC
Confidence 456799999999 77777889999999999999999999999986432211111111 1122223333333
Q ss_pred CCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
.|... +..+.+++.+||+.||++|||+
T Consensus 224 ~p~~~----~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSL----SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCC----CHHHHHHHHHHhcCCHHHcCCC
Confidence 33322 3347899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.18 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=205.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+.. +++.||||++.... .........+.+|+++++.++||||+++++++...+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE-MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc-cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 46889999999999999999864 78999999876421 22334556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||+++|+|.+++.... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999999886432 234578899999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........|+..|+|| |...+..++.++||||+|+++|||++|+.||..... .... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~aP----------E~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~-~~~~~ 220 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSP----------ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFS-LCQKI 220 (267)
T ss_pred chhHHHhcCCCCccccCh----------hhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHH-HHHHH
Confidence 443333445788999999 666667788999999999999999999999753211 1111 11111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... ..+.......+..+.+++.+||..+|++|||+.+|++.+
T Consensus 221 ~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 221 EQC-DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred hcC-CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 111 111111223345689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.43 Aligned_cols=249 Identities=23% Similarity=0.246 Sum_probs=196.8
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|+||+||++... +++.||||++..... ......+.+..|+++++.++||||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999865 788999999864211 112234567889999999999999999999999999999999999999
Q ss_pred HHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCccee
Q 047901 593 LATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671 (786)
Q Consensus 593 L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 671 (786)
|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+............
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 998885422 235689999999999999999999999 9999999999999999999999999999876554433344
Q ss_pred eccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCC
Q 047901 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPS 751 (786)
Q Consensus 672 ~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (786)
..||+.|+|| |...+..++.++|||||||++|||++|+.||...... .................+.
T Consensus 157 ~~g~~~y~aP----------E~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAP----------ELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRILNDSVTYPD 222 (280)
T ss_pred cCCCcCccCH----------HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhcccCCCCcc
Confidence 5789999999 7777778899999999999999999999998642210 0111111222222222222
Q ss_pred hhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 752 LDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
..+..+.+++..||+.||++|| |++++++
T Consensus 223 ----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 ----KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334588999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.32 Aligned_cols=254 Identities=22% Similarity=0.410 Sum_probs=202.5
Q ss_pred ccCccceeeccccCceEEEEEcCC------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.+|++.+.||+|+||.||+|.... ...||+|.+... ........|.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468889999999999999997542 257999998642 22344567899999999999999999999999989
Q ss_pred eeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC
Q 047901 580 HSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 646 (786)
..+++|||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 99999999999999999975421 14578899999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCC
Q 047901 647 LEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGD 723 (786)
Q Consensus 647 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~ 723 (786)
.++.+||+|||+++....... ......+++.|+|| |......++.++|||||||++|||++ |..||.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP----------EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCH----------HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999986643322 12234567899999 66666778999999999999999998 999976
Q ss_pred ccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 724 FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.... ......+...... + .....+.++.+++.+||+.||++|||+.||++.|
T Consensus 229 ~~~~--------~~~~~~i~~~~~~-~--~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 229 GFSN--------QEVIEMIRSRQLL-P--CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred CCCH--------HHHHHHHHcCCcC-C--CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 4221 1122222222211 1 1123345699999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.44 Aligned_cols=240 Identities=24% Similarity=0.279 Sum_probs=191.5
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHH-HHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIK-ALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||||++...... .......+..|.. +++.++||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36899999999999865 7899999998642111 1122344555555 5678899999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999999754 5688999999999999999999999 99999999999999999999999999997654333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~ 215 (323)
T cd05575 154 STFCGTPEYLAP----------EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKPLRL 215 (323)
T ss_pred ccccCChhhcCh----------hhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence 456799999999 66677788999999999999999999999986432 122233333333332
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 780 (786)
+... +..+.+++.+|++.||++||++.
T Consensus 216 ~~~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNI----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 2222 34588999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.25 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=197.3
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||||++..... ........+..|.+++..+ +||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999865 578999999864211 1123445677889998888 69999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 80 GGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999998754 4689999999999999999999999 99999999999999999999999999997644333333
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
...+|++.|+|| |.+.+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~g~~~y~aP----------E~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~~~~ 215 (318)
T cd05570 154 STFCGTPDYIAP----------EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDEVRY 215 (318)
T ss_pred cceecCccccCH----------HHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCCC
Confidence 445799999999 77777889999999999999999999999986432 122222333333333
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTM-----QTVCQ 784 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 784 (786)
|.. .+..+.+++.+||..||++|||+ .++++
T Consensus 216 ~~~----~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRW----LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCc----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 322 23458899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.25 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=203.0
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 4578999999999999999999888889999997642 12356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999999764 345688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....++..|+|| |......+++++|||||||++|||+| |+.||..... ......
T Consensus 156 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~- 216 (261)
T cd05072 156 NEYTAREGAKFPIKWTAP----------EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSA- 216 (261)
T ss_pred CceeccCCCccceecCCH----------HHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHH-
Confidence 3221 1223456789999 66667778999999999999999998 9999763211 111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+......+. ....+..+.+++.+||..+|++|||++++.+.|
T Consensus 217 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 217 LQRGYRMPR--MENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHcCCCCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 111111111 111234588999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.21 Aligned_cols=244 Identities=22% Similarity=0.309 Sum_probs=198.2
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 584 (786)
+|+..+.||+|+||.||+|+.. +++.||||++..... ........+..|..++..+ .||+|+++++++...+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 4788899999999999999865 578999999875321 1122344567788888777 589999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999998754 4688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........||+.|+|| |+..+..++.++|||||||++|||+||+.||.... .......+..
T Consensus 154 ~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~ 215 (323)
T cd05616 154 DGVTTKTFCGTPDYIAP----------EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIME 215 (323)
T ss_pred CCCccccCCCChhhcCH----------HHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 33334456799999999 77777889999999999999999999999987432 1223333444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
.....|.. .+..+.+++.+|++++|++|+++
T Consensus 216 ~~~~~p~~----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HNVAYPKS----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCCc----CCHHHHHHHHHHcccCHHhcCCC
Confidence 44443332 23457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.55 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=198.1
Q ss_pred cCccceeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
+|++.+.||+|+||+||+++. .+++.||+|++............+.+..|+.+++.+ .||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999874 357899999986422222233455688899999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999999754 4688999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 662 LKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 662 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
...... ......||..|+|| |.+.+. .++.++|||||||++|||+||+.||...... .......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~ 220 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAP----------EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVS 220 (332)
T ss_pred ccccCCCccccccCCccccCH----------HHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHH
Confidence 543322 22345799999999 555543 4788999999999999999999998642210 0111111
Q ss_pred hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
..+.......+.. ....+.+++.+||+.||++|| +++++++
T Consensus 221 ~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 RRILKCDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHhcCCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 2222222222222 233578999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.30 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=203.2
Q ss_pred ccCccceeeccccCceEEEEEcCC------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
++|.+.+.||+|+||.||+|...+ ++.||||++... ......+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 468888999999999999997633 478999998652 22234578999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC
Q 047901 580 HSFVVYEYINRGSLATVLSNNF-----------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 648 (786)
..++||||+++|+|.+++.... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 9999999999999999997542 134578999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcc
Q 047901 649 YEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFL 725 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~ 725 (786)
+.+||+|||.++....... ......++..|+|| |......+++++|||||||++|||++ |..||...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP----------ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecCh----------hhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999986543221 11233457889999 66677789999999999999999998 99997642
Q ss_pred ccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 726 SLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. ......+.......+. ...+..+.+++.+||.+||++|||+.||++.|
T Consensus 229 ~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 229 SN--------EEVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred CH--------HHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 21 1122222222222111 12334589999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.52 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=213.1
Q ss_pred ccCccceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+..+.||+|.-|+||+++.++ +..+|+|++.+..- .......+...|.+|++.++||.++++|+.++.++..|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 357778889999999999999874 47899999976332 2344566778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||+||+|....+++ ..+.+++..++-++.+|+-||+|||.. |||+|||||+||||.++|++.|+||.++....-
T Consensus 156 meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999988776 567899999999999999999999999 999999999999999999999999999754310
Q ss_pred ------C--------------------------C-C-----------------------cceeeccCccccCCCCCCCCc
Q 047901 665 ------N--------------------------S-S-----------------------NWTELVGTFGYVAPAHGNIGL 688 (786)
Q Consensus 665 ------~--------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~ 688 (786)
. . . ....++||-.|.||
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP------- 304 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP------- 304 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc-------
Confidence 0 0 0 00135799999999
Q ss_pred hHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhc
Q 047901 689 HLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLC 768 (786)
Q Consensus 689 ~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 768 (786)
|++.+...+.++|.|+|||++|||++|..||...+ .++.+..++......|... ..+....+||+..
T Consensus 305 ---EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~--------~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~L 371 (459)
T KOG0610|consen 305 ---EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN--------NKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKL 371 (459)
T ss_pred ---eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC--------chhhHHHHhcCCCcCCCCC--cchhHHHHHHHHH
Confidence 77888889999999999999999999999998533 4566777777777766543 4456789999999
Q ss_pred cCCCCCCCCC----HHHHHH
Q 047901 769 LDGCPNSRPT----MQTVCQ 784 (786)
Q Consensus 769 l~~~p~~RPt----~~ev~~ 784 (786)
|.+||.+|-- +.||-+
T Consensus 372 LvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hccChhhhhccccchHHhhc
Confidence 9999999988 777643
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=339.89 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=204.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.. +++.||||++..... ........+..|++++..++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 36889999999999999999865 788999999864211 1123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999999764 5689999999999999999999998 999999999999999999999999999987654
Q ss_pred CC-----------------------------CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 665 NS-----------------------------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 665 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
.. .......||+.|+|| |+..+..++.++|||||||++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~el 223 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP----------EVLRGTPYGLECDWWSLGVILYEM 223 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCH----------HHHcCCCCCCceeeEecchhhhhh
Confidence 33 122345799999999 777777899999999999999999
Q ss_pred HhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 047901 716 IKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-MQTVCQ 784 (786)
Q Consensus 716 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 784 (786)
++|+.||.... .......+.. .....|... ..+..+.+++..|+. ||.+||+ ++++++
T Consensus 224 l~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 224 LYGFPPFYSDT--------LQETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ccCCCCCCCCC--------HHHHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 99999987432 1122222322 222222211 123458899999997 9999999 999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=316.41 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=206.5
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|... +++.|++|.+.... ......+.+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh--CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4778899999999999999865 68899999986422 12345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999999864 345789999999999999999999998 9999999999999999999999999999877654
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........|++.|+|| |+..+..++.++|||||||++|||++|+.||.... ...........
T Consensus 155 ~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 216 (256)
T cd08529 155 TNFANTIVGTPYYLSP----------ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRG 216 (256)
T ss_pred cchhhccccCccccCH----------HHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC
Confidence 4434455788999999 67777778899999999999999999999986432 12222222222
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... ......+.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 217 VFPPVS---QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCCCc---cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 222111 123446899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.28 Aligned_cols=253 Identities=24% Similarity=0.263 Sum_probs=200.7
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|+..+.||+|+||+||++... +++.||||++..... ........+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 3788899999999999999864 688999999864221 11223456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+++.....
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 80 TLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred eccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999988654 235689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc-
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD- 744 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~- 744 (786)
. ......|+..|+|| |...+..++.++||||+||++|||++|+.||...... .........+.
T Consensus 156 ~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~ 219 (285)
T cd05605 156 E-TIRGRVGTVGYMAP----------EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKE 219 (285)
T ss_pred C-ccccccCCCCccCc----------HHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhh
Confidence 2 22345789999999 6677778899999999999999999999998742210 01111111111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.....+ ...+..+.+++..||+.||++|| +++++++
T Consensus 220 ~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 DQEEYS----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccccC----cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111111 22344588999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.92 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=194.3
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----Ce
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV-----RH 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~ 580 (786)
+|++.+.||+|+||.||+|+.. +++.||||++.... ........+.+|+++++.++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 4888999999999999999854 78999999986422 1223445788999999999999999999987533 35
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 799999996 6899988754 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----
Q 047901 661 LLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS---- 731 (786)
Q Consensus 661 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~---- 731 (786)
....... ......||..|+|| |+... ..++.++|||||||++|||++|+.||.........
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~ 221 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAP----------ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221 (338)
T ss_pred ccccccCccccccCCCCCCCcCCH----------HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence 6532211 22345799999999 55543 57889999999999999999999998653321000
Q ss_pred ---Ccc------------hhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ---SSS------------INIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ---~~~------------~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... .......+ ....+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 222 DLLGTPSPETISRVRNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 00000000 0111101 0000112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.32 Aligned_cols=255 Identities=21% Similarity=0.384 Sum_probs=200.6
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
..++|+..+.||+|+||.||+|... .+..||||++... .......++.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4567999999999999999999753 2457999998542 222345678899999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA-------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
....++||||+++|+|.+++..... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 9999999999999999999975321 23467889999999999999999998 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 047901 651 ARVSDFGTAKLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSL 727 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~ 727 (786)
+||+|||+++......... ....++..|+|| |...+..++.++|||||||++|||++ |..||....
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~- 226 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP----------ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS- 226 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcCh----------hHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 9999999998664332211 123457789999 66667788999999999999999999 788876422
Q ss_pred ccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.............. .+. ..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 227 -------~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 227 -------NEQVLRFVMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred -------HHHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 11111112222221 121 2234589999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.93 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=193.5
Q ss_pred cCccceeeccccCceEEEEEcC--CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc---CCCcccceeeEEe-----
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP--SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCS----- 576 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~----- 576 (786)
+|++.+.||+|+||+||+|+.. +++.||||++....... .....+.+|+++++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 6889999999999999999853 46789999987533221 2234556777777665 6999999999885
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecc
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDF 656 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 656 (786)
.....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 2456889999997 5999999754 234589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc--
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS-- 734 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~-- 734 (786)
|+++..... .......||..|+|| |......++.++|||||||++|||++|++||............
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAP----------EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred cceEeccCC-cccccccccccccCh----------HHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 999876533 223445789999999 6777778899999999999999999999998754321100000
Q ss_pred -----hhhhhh-------hhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 -----INIEFN-------AMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 -----~~~~~~-------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+. .........+ .......+..+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0000000000 0001122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.27 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=195.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|+..+.||+|+||+||+|+.. +++.||||++..... ........+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 5888999999999999999754 678999999865211 12234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999999754 4688899999999999999999998 9999999999999999999999999997643110
Q ss_pred CC-----------------------------------------------cceeeccCccccCCCCCCCCchHHHHhhhcC
Q 047901 666 SS-----------------------------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMK 698 (786)
Q Consensus 666 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~ 698 (786)
.. .....+||+.|+|| |.+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP----------E~~~~~~ 224 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP----------EVLLRKG 224 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCH----------HHHcCCC
Confidence 00 01134799999999 7777778
Q ss_pred cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHh--ccCCCCC
Q 047901 699 ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALL--CLDGCPN 774 (786)
Q Consensus 699 ~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~ 774 (786)
++.++|||||||++|||++|+.||..... ......+.. .....|.. ...+.++.+++.+ |+..+|.
T Consensus 225 ~~~~~DiwSlG~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~--~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 225 YTQLCDWWSVGVILFEMLVGQPPFLAPTP--------TETQLKVINWENTLHIPPQ--VKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred CCCccceeehhhHHHHHHhCCCCCcCCCH--------HHHHHHHHccccccCCCCC--CCCCHHHHHHHHHHccCccccc
Confidence 99999999999999999999999864221 111222221 11222211 1122346777777 5566777
Q ss_pred CCCCHHHHHH
Q 047901 775 SRPTMQTVCQ 784 (786)
Q Consensus 775 ~RPt~~ev~~ 784 (786)
.|||++|+++
T Consensus 295 ~R~~~~~~l~ 304 (381)
T cd05626 295 GRNGADDIKA 304 (381)
T ss_pred CCCCHHHHhc
Confidence 7999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.91 Aligned_cols=404 Identities=30% Similarity=0.386 Sum_probs=264.0
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
+.+.|++|.+. .+.+ ...+++.|++|++++|++. ..|.+++.+..++.|+.++|+++ .+|.++..+.+|..|+.+.
T Consensus 48 ~~lils~N~l~-~l~~-dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 48 QKLILSHNDLE-VLRE-DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhccCchh-hccH-hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 45677777776 3333 3667777888888888874 55666777777777777777776 6666777777777777777
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCC
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN 163 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 163 (786)
|.+...+++++.+-.|+.|+..+|+++ ..|..+.++.+|..|++.+|+++...|+.+. ++.|+.|++..|-+..+|++
T Consensus 124 n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~ 201 (565)
T KOG0472|consen 124 NELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPE 201 (565)
T ss_pred cceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChh
Confidence 777666666666666666666666666 3444555556666666666665543333333 55555555555555555555
Q ss_pred cCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcccc
Q 047901 164 LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLH 243 (786)
Q Consensus 164 l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 243 (786)
++.+.+|..|+|.+|+|..++ .|.++..|++|+++.|+|..++.+....++++..|||.+|+++ ..|+.+.-+.+|.
T Consensus 202 lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~ 278 (565)
T KOG0472|consen 202 LGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLE 278 (565)
T ss_pred hcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhh
Confidence 555555555555555554332 4444445555555555444333333334444555555555544 3444444444455
Q ss_pred EEEeecccccccCCCCccccccccccccccccc-----------------------------------------------
Q 047901 244 VLDLSSNHIAGEIPMELGRLISLNKLILRGNQL----------------------------------------------- 276 (786)
Q Consensus 244 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l----------------------------------------------- 276 (786)
.||+|+|.|+ ..|..++++ .|+.|-+.||.+
T Consensus 279 rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~ 356 (565)
T KOG0472|consen 279 RLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFP 356 (565)
T ss_pred hhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCccc
Confidence 5555555444 333344444 444444444443
Q ss_pred ------------------CCCCccccccCC--cCceecccccccccc-----------------------chhhhhcccC
Q 047901 277 ------------------SGHLPRALGLLT--ELEYFDLSSNRLNNS-----------------------ILEALGFMFK 313 (786)
Q Consensus 277 ------------------~~~~~~~~~~l~--~L~~L~L~~N~l~~~-----------------------~~~~~~~l~~ 313 (786)
+.++..+|..-. -....++++|++.++ ++..++.+++
T Consensus 357 ~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~k 436 (565)
T KOG0472|consen 357 DIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQK 436 (565)
T ss_pred chhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhc
Confidence 332222332111 134455666655543 3455677899
Q ss_pred CcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccC
Q 047901 314 LFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISY 393 (786)
Q Consensus 314 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 393 (786)
|..|+|++|-+. ..|..++.+..|+.||+|+|++. ..|..+..+..|+.+-.++|++..+.|+.+.+|.+|+.|||.+
T Consensus 437 Lt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~n 514 (565)
T KOG0472|consen 437 LTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQN 514 (565)
T ss_pred ceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCC
Confidence 999999999996 68888999999999999999998 7899988888999999999999988888899999999999999
Q ss_pred CcccccCCCCCccccCCCccccCCCCC
Q 047901 394 NELRGPIPNSTVFRNAPRESFLGNNFS 420 (786)
Q Consensus 394 N~l~~~~p~~~~~~~~~~~~~~~n~~~ 420 (786)
|.+...+|..+...+.....+.||||.
T Consensus 515 Ndlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 515 NDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CchhhCChhhccccceeEEEecCCccC
Confidence 999999999998999999999999984
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=317.47 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=202.0
Q ss_pred hccCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|+..+.||+|+||+||+|++.. ...||||++... ........|.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 3578999999999999999998642 357999988652 223345678999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++++|.+++... .+.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 80 VMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999999999764 24789999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCcce--eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSSNWT--ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
.......... ...++..|+|| |...+..++.++||||||+++|||++ |..||.... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~P----------e~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~ 216 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAP----------EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQD 216 (266)
T ss_pred cccccccceeccCCCCCccccCh----------hhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHH
Confidence 8753222211 22345789999 66666778999999999999999998 999975322 111
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+.+. +.+.+. ..+..+.+++.+||+.+|++|||+.||++.|
T Consensus 217 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 217 VIKAVEDGYRLPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 12222221 112222 2234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=334.52 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=195.4
Q ss_pred eeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
+.||+|+||.||+++. .+++.||+|++..... .......+..|++++++++||||+++++++...+..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999864 3578999999865211 122345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999999653 4689999999999999999999999 999999999999999999999999999987654433
Q ss_pred cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCC
Q 047901 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRL 747 (786)
Q Consensus 668 ~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (786)
......||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 154 ~~~~~~g~~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAP----------EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAKL 215 (318)
T ss_pred ceecccCChhhcCH----------HHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 33456799999999 67777778999999999999999999999987432 1222233333333
Q ss_pred CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 047901 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQT 781 (786)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 781 (786)
..|... +..+.+++..||++||++|||+.+
T Consensus 216 ~~p~~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 333322 234889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=327.14 Aligned_cols=249 Identities=22% Similarity=0.435 Sum_probs=197.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+|+..+.||+|+||+||+|++. +++ .||+|++... ......+++.+|+.+++.++||||++++|+|... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 46999999999999999999854 333 4899998642 2234456788999999999999999999999764 5
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999999864 34688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
......... ....++..|+|| |......++.++|||||||++|||++ |+.||+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~ap----------E~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---------~ 218 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMAL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------S 218 (316)
T ss_pred cccCCCcceeccCCccceeecCh----------HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------H
Confidence 775433221 122346789999 66777788999999999999999998 9999864321 1
Q ss_pred hhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+... +.+.+.. +...+.+++..||..+|++|||+.++++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 219 EISSILEKGERLPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred HHHHHHhCCCCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11122221 2222222 233588999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.51 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=194.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.. +++.||||++..... ........+..|+.++.+++||||+++++++.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 36889999999999999999755 688999999864211 1123345778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 80 MEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999999754 5689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHH
Q 047901 665 NSS-----------------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709 (786)
Q Consensus 665 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslG 709 (786)
... .....+||+.|+|| |+..+..++.++||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP----------E~~~~~~~~~~~DvwSlG 223 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP----------EVFMQTGYNKLCDWWSLG 223 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCH----------HHHcCCCCCCchhhhhhH
Confidence 100 01234799999999 777778899999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccC--CCCCCCCCHHHHHH
Q 047901 710 VLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLD--GCPNSRPTMQTVCQ 784 (786)
Q Consensus 710 vil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~ev~~ 784 (786)
|++|||++|+.||..... .+....+.. .....|... .......+++.+++. .++..||+++|+++
T Consensus 224 vil~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 224 VIMYEMLIGYPPFCSETP--------QETYKKVMNWKETLIFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred HHHHHHHhCCCCCCCCCH--------HHHHHHHHcCcCcccCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 999999999999864321 122222222 122222211 012235566665432 33445799999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=328.31 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=193.3
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||.||+|+.+ +++.||+|++...... .......+..|..++... +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36999999999999865 6789999998652211 112344566788887754 89999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999998753 5688999999999999999999999 99999999999999999999999999987644333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~~~~~~~~~~~~ 215 (316)
T cd05620 154 STFCGTPDYIAP----------EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDELFESIRVDTPHY 215 (316)
T ss_pred eccCCCcCccCH----------HHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCC
Confidence 556799999999 77777889999999999999999999999986422 112222222222222
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQ-TVC 783 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 783 (786)
+.. ....+.+++.+||+.||++||++. +++
T Consensus 216 ~~~----~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRW----ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCC----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222 223578999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.11 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=199.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.. +++.||||++..... ........+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 36899999999999999999865 688999999864211 1123345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 80 ~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 80 MEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred ECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999999754 4689999999999999999999999 999999999999999999999999999876532
Q ss_pred CCC--------------------------------------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchH
Q 047901 665 NSS--------------------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706 (786)
Q Consensus 665 ~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvw 706 (786)
... .....+||+.|+|| |+.....++.++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Diw 223 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP----------EVFLQTGYNKECDWW 223 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCH----------HHHcCCCCCCeeeee
Confidence 110 00124699999999 777778899999999
Q ss_pred HHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC---HHH
Q 047901 707 SFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT---MQT 781 (786)
Q Consensus 707 slGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e 781 (786)
||||++|||++|..||..... ......+... ....+... ..+..+.+++..|+. +|.+|++ ++|
T Consensus 224 SlG~il~el~~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 224 SLGVIMYEMLVGYPPFCSDNP--------QETYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred cchhHHHHhhcCCCCCCCCCH--------HHHHHHHHcCCCccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 999999999999999874321 1122222221 12222111 123357889999996 9999998 888
Q ss_pred HHH
Q 047901 782 VCQ 784 (786)
Q Consensus 782 v~~ 784 (786)
+++
T Consensus 293 ll~ 295 (364)
T cd05599 293 IKS 295 (364)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=343.82 Aligned_cols=249 Identities=21% Similarity=0.238 Sum_probs=201.1
Q ss_pred cCccceeeccccCceEEEEEcC-C-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-S-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.|...+.||+|+||.||+|... + ++.||+|++.. ........+.+|+++++.++||||+++++++...+..|+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4889999999999999999754 3 57888887643 2234445678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||+++|+|.+++... .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999988643 2235688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 664 PNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 664 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.... .....+||+.|+|| |+..+..++.++|||||||++|||++|+.||.... .......
T Consensus 221 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~ 282 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAP----------ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQ 282 (478)
T ss_pred CccccccccccCCCccccCH----------hHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 4322 12345799999999 66677789999999999999999999999986422 1122222
Q ss_pred hccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....... .+. ..+..+.+++..||.++|++|||++++++
T Consensus 283 ~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 283 VLYGKYDPFPC----PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHhCCCCCCCc----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2222221 121 12345889999999999999999999874
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.16 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=192.7
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||||++...... .......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36899999999999865 5789999998652211 112334566788888764 89999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999999753 4688999999999999999999999 99999999999999999999999999998654333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||..|+|| |...+..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~ 215 (316)
T cd05619 154 CTFCGTPDYIAP----------EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDNPCY 215 (316)
T ss_pred eeecCCccccCH----------HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence 456799999999 777777899999999999999999999999864321 11222222222222
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQ-TVC 783 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 783 (786)
|.. ....+.+++.+||+.||++||++. ++.
T Consensus 216 ~~~----~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRW----LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred Ccc----CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 221 223478999999999999999997 654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.13 Aligned_cols=248 Identities=24% Similarity=0.418 Sum_probs=204.7
Q ss_pred CccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
....++||+|+||+||+|.|- .|+ +||+|++.. ......-.++..|+-+|.+++|||+++++|+|.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~---~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE---FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec---cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 455678999999999999753 443 689999865 233445678999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||++||+.|.|.+|++.+ ...+-.+..+.|..|||+||.|||++ ++|||||.++||||..-..+||.|||+|+..
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999876 35677889999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCcceeecc--CccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhh
Q 047901 663 KPNSSNWTELVG--TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 663 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
.++...+....| .+.|||= |.+....|+.++|||||||.+||++| |..|++.+.. ..-...
T Consensus 849 ~~d~~ey~~~~gK~pikwmal----------e~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------~eI~dl 912 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMAL----------ESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------EEIPDL 912 (1177)
T ss_pred CcccccccccccccCcHHHHH----------HHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------HHhhHH
Confidence 877665544333 4578887 88888999999999999999999999 9999886542 111111
Q ss_pred hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.+. ..|+..|+....+ ++.+|.+||..|++.||+++++...
T Consensus 913 le~-geRLsqPpiCtiD----Vy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 913 LEK-GERLSQPPICTID----VYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred Hhc-cccCCCCCCccHH----HHHHHHHHhccCcccCccHHHHHHH
Confidence 111 2346666665554 8999999999999999999998765
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=314.93 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=200.9
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|+..+.||+|+||+||+|++.++..||||.+.... ...+.|.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 4688899999999999999998777789999886421 22457899999999999999999999999888899999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....+
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999999999764 23689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcc-eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SSNW-TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~~~-~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.... ....++..|+|| |......++.++|||||||++|||++ |..||..... ......+.
T Consensus 154 ~~~~~~~~~~~~~y~~p----------e~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~ 215 (256)
T cd05113 154 EYTSSVGSKFPVRWSPP----------EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVS 215 (256)
T ss_pred ceeecCCCccChhhCCH----------HHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHh
Confidence 2211 122356789999 66666778999999999999999998 9999764221 11112222
Q ss_pred cCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.... ..+.. .+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 216 ~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 216 QGLRLYRPHL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred cCCCCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 2211 11221 234689999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=334.11 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=200.5
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~ 576 (786)
..++|.+.+.||+|+||.||+|... .+..||||++... ......+.+.+|+++++.+. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3567899999999999999999743 1346999998653 22334567999999999996 999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCC------------------------------------------------------
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFA------------------------------------------------------ 602 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 602 (786)
..+..|+||||+++|+|.+++..+..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999864310
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCce
Q 047901 603 ---------------------------------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNV 643 (786)
Q Consensus 603 ---------------------------------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 643 (786)
...+++..+..++.|++.|++|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 12478888899999999999999998 999999999999
Q ss_pred eeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCC
Q 047901 644 LLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKH 720 (786)
Q Consensus 644 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~ 720 (786)
+++.++.+||+|||+++....... ......++..|+|| |...+..+++++|||||||++|||++ |..
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwSlGvil~ellt~g~~ 338 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP----------ESIFDNLYTTLSDVWSYGILLWEIFSLGGT 338 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh----------hhhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999987643322 12234567889999 66667778999999999999999997 999
Q ss_pred CCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 721 PGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 721 Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
||..... .......+... +...+. ..+..+.+++.+||+.+|++|||+.+|.+.|
T Consensus 339 P~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 339 PYPGMIV-------DSTFYNKIKSGYRMAKPD----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred CCcccch-------hHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 9764321 01111111111 122221 2334588999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.06 Aligned_cols=241 Identities=23% Similarity=0.251 Sum_probs=190.1
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHH-HHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIK-ALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||+|++....... ......+..|.. +++.++||||+++++++...+..|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36899999999999865 67789999986421111 122234444444 5678899999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 80 GGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999999753 4577888899999999999999999 99999999999999999999999999998654433334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~ 215 (325)
T cd05602 154 STFCGTPEYLAP----------EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKPLQL 215 (325)
T ss_pred ccccCCccccCH----------HHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCCcCC
Confidence 456799999999 77777889999999999999999999999986422 122222333333322
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQT 781 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 781 (786)
+.. ....+.+++.+|+++||.+||++.+
T Consensus 216 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 216 KPN----ITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCC----CCHHHHHHHHHHcccCHHHCCCCCC
Confidence 221 2345889999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.21 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=201.1
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4699999999999999999985 47889999998642 123345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... +.+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 9999999999998753 4688999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........|+..|+|||.+.. .....++.++||||+||++|||++|+.||....... ....+..
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--------~~~~~~~ 223 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAV-------EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMSK 223 (267)
T ss_pred cccccCccccCccccCHhHccc-------ccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--------hheeeec
Confidence 3333344578899999953210 023457789999999999999999999975432111 0111111
Q ss_pred CCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 HRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 ~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+. ......+..+.+++.+||..+|++|||++++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111110 01112345689999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.12 Aligned_cols=260 Identities=16% Similarity=0.283 Sum_probs=196.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|...+.||+|+||+||+|+.+ +++.||+|++..... ......+.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 46899999999999999999865 678899999875322 12234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999985 888888654 34578899999999999999999998 999999999999999999999999999986544
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------Ccchh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------SSSIN 736 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~~~~~ 736 (786)
.........++..|+|| |... ...++.++||||+||++|||+||+.||......... .....
T Consensus 157 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (309)
T cd07872 157 PTKTYSNEVVTLWYRPP----------DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226 (309)
T ss_pred CccccccccccccccCC----------HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 33333445789999999 4443 346788999999999999999999998753310000 00000
Q ss_pred hhhhhh------ccCCCC--CCC---hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAM------LDHRLP--HPS---LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~------~~~~~~--~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+... .+...+ .+. ......+.++.+++.+|+..||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 000000 000 000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.72 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=200.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||+|++.... .........+.+|+.+++.++||||+++++++.++...|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE-MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 457999999999999999999865 68899999985411 1112234557889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998643 478888899999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-cceeeccCccccCCCCCCCCchHHHHhhh----cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 664 PNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYT----MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 664 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~----~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.... ......||+.|+||| .... ..++.++|||||||++|||++|+.||..... ...
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE----------~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~ 255 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPE----------VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGT 255 (370)
T ss_pred CCCcccCCCCCCCcCeECHH----------HhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHH
Confidence 3322 223457999999995 4432 3478899999999999999999999874321 122
Q ss_pred hhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 047901 739 FNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNS--RPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~ 784 (786)
...+.... +..|.. ...+..+.+++..|+..+|++ |||++|+++
T Consensus 256 ~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 256 YSKIMDHKNSLTFPDD--IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHcCCCcCCCCCc--CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 23333322 222221 122345889999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=327.78 Aligned_cols=200 Identities=25% Similarity=0.366 Sum_probs=173.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..++||+|+||.||+|+.. ++..+|+|.+.... .......+.+|+++++.++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 357999999999999999999876 67889999886521 22345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.+++.|+.|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999999754 45788999999999999999999741 79999999999999999999999999997654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
... .....|+..|+|| |...+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~--~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 156 DSM--ANSFVGTRSYMSP----------ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhc--cccCCCCccccCH----------HHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 321 2335789999999 667777889999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.22 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=190.7
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHH-HHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIK-ALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||+|++...... .......+.+|.. +++.++||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999865 6889999998642111 1122344555554 5788899999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99999988653 5678888999999999999999998 99999999999999999999999999997643333333
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |...+..++.++|||||||++|||++|+.||...+ .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~ 215 (321)
T cd05603 154 STFCGTPEYLAP----------EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKPLQL 215 (321)
T ss_pred ccccCCcccCCH----------HHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCCCCC
Confidence 456799999999 66777788999999999999999999999986422 122233333333433
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 780 (786)
+... ...+.+++..|+++||.+||++.
T Consensus 216 ~~~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGK----TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCC----CHHHHHHHHHHccCCHhhcCCCC
Confidence 3322 33588999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.85 Aligned_cols=249 Identities=21% Similarity=0.366 Sum_probs=214.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+-|+..+.||+|.|.+|-+|++- +|.+||||++.+.. .+......+.+|+..|+-++|||||++|++.......|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK--lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc--cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34778888999999999999854 89999999997632 1223345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-CCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-LEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~ 663 (786)
.|.-++|+|++||..+ .+.+.+.-+.+++.||+.|+.|+|.. .+|||||||+||.+- .-|-+||.|||++-.+.
T Consensus 96 LELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999876 46789999999999999999999999 999999999998764 55899999999998877
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
++ ...++.+|+..|-|| |++.+..|+ +++||||+|||||-|++|++||.- ..+-+....+
T Consensus 171 PG-~kL~TsCGSLAYSAP----------EILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe--------ANDSETLTmI 231 (864)
T KOG4717|consen 171 PG-KKLTTSCGSLAYSAP----------EILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE--------ANDSETLTMI 231 (864)
T ss_pred Cc-chhhcccchhhccCc----------hhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc--------ccchhhhhhh
Confidence 54 445678999999999 777777777 789999999999999999999873 3445667778
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+|.+...|.....+ ..++|.+|+..||++|-|.+||..
T Consensus 232 mDCKYtvPshvS~e----CrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKYTVPSHVSKE----CRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hcccccCchhhhHH----HHHHHHHHHhcCchhhccHHHHhc
Confidence 88888877665444 789999999999999999999863
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.75 Aligned_cols=240 Identities=24% Similarity=0.297 Sum_probs=191.5
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHH-HHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIK-ALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||+|++...... .......+..|.. +++.++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 35899999999999854 7889999998652211 1223345556655 4677899999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999988753 5689999999999999999999999 99999999999999999999999999997654333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |+..+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~~~~ 215 (325)
T cd05604 154 TTFCGTPEYLAP----------EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKPLVL 215 (325)
T ss_pred ccccCChhhCCH----------HHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCCccC
Confidence 456799999999 67777788999999999999999999999986432 122233333333332
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 780 (786)
+.. .+..+.+++..|+..+|.+||++.
T Consensus 216 ~~~----~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 216 RPG----ASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCC----CCHHHHHHHHHHhccCHHhcCCCC
Confidence 222 233578999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.21 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=200.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|+..+.||+|+||.||+|..+ .++.||+|++... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45888899999999999999865 5788999988641 23356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999764 235689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcc-eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSNW-TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
..... ....++..|+|| |...+..++.++|||||||++|||++ |..||..... .......
T Consensus 157 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~ 218 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAP----------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELL 218 (263)
T ss_pred ceeeccCCCCCccccCCH----------HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH
Confidence 32211 122345689999 66777788999999999999999998 9999764221 1111111
Q ss_pred cc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. .+...+. ..+.++.+++.+||+.+|++|||+.++.+.|
T Consensus 219 ~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 219 EKGYRMERPE----GCPPKVYELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred HCCCCCCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 11 1112222 1234589999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.47 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=198.9
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|+..+.||+|+||.||+|+.. +++.||+|++..... ........+.+|+.+++.++||||+++++++.+++..|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3568999999999999999999865 678899999854111 11223456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999643 478889999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-cceeeccCccccCCCCCCCCchHHHHhhhc----CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 663 KPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTM----KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 663 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~----~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
..... ......||+.|+|| |+.... .++.++||||+||++|||++|+.||.... ...
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aP----------E~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~ 254 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISP----------EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVG 254 (370)
T ss_pred ccCCceecccCCCCcccCCH----------HHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHH
Confidence 53322 22356799999999 555432 37789999999999999999999987432 122
Q ss_pred hhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 047901 738 EFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNS--RPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~ 784 (786)
....+.+.. +..|.. ...+..+.+++..|+..++.+ |||+.|+++
T Consensus 255 ~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 255 TYSKIMDHKNSLNFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHHHHhCCcccCCCCc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 233333322 222221 122345778899999755543 899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=315.92 Aligned_cols=252 Identities=24% Similarity=0.422 Sum_probs=201.9
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 35688999999999999999998778889999986421 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999997652 35689999999999999999999998 999999999999999999999999999987753
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... ......+..|+|| |......++.++||||||+++|||++ |+.||..... ..... .
T Consensus 156 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~-~ 216 (261)
T cd05068 156 DIYEAREGAKFPIKWTAP----------EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQ-Q 216 (261)
T ss_pred CcccccCCCcCceeccCc----------cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH-H
Confidence 3211 1112234589999 55566678899999999999999999 9999864221 11111 2
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
++.....+. ....+..+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 217 VDQGYRMPC--PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHcCCCCCC--CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 222111110 112334689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=318.27 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=204.6
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+. .+++.+|||.+.... .......+++.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4688888999999999999985 478999999876422 12334456889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||+++++|.+++.... ....+++..+..++.|+++|++|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999987432 235689999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........++..|+|| |...+..++.++||||||+++|||++|..||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~ap----------e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~ 221 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSP----------ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIE 221 (267)
T ss_pred cCCcccccccCCcCccCH----------HHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhh
Confidence 433333445788999999 666677788999999999999999999999753211 0011111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.... +.......+..+.+++.+||..+|++||||.+|.+.
T Consensus 222 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 222 QCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred cCCC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHH
Confidence 1111 111112234568999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.86 Aligned_cols=258 Identities=24% Similarity=0.297 Sum_probs=200.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.. +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 36889999999999999999865 788999999875221 1223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 80 MEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred ECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999999764 35689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.... .....||+.|+|||++..... .....++.++|||||||++|||++|+.||..... ......+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~ 222 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNG----DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIM 222 (330)
T ss_pred CCceeeecccCCccccCHHHhccccc----cccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHH
Confidence 3322 233478999999953321100 0145678899999999999999999999864321 11122222
Q ss_pred cCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ...|.. ...+..+.+++..|+. +|++|||++++++
T Consensus 223 ~~~~~~~~~~~--~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 223 NFQRFLKFPED--PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCccCCCCC--CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 211 111111 1123458899999997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=327.45 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=195.3
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||+||+|+.. +++.||+|++..... ......+.+.+|+.++.++ +||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36999999999999865 678999999975321 1223456688899999888 69999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 80 GGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999988753 4689999999999999999999999 99999999999999999999999999998644333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....||+.|+|| |...+..++.++|||||||++|||++|+.||+........ .........+.......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 222 (327)
T cd05617 154 STFCGTPNYIAP----------EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKPIRI 222 (327)
T ss_pred ecccCCcccCCH----------HHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCCCCC
Confidence 456799999999 7777788999999999999999999999998643211110 11112223333333333
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
|... +..+.+++.+||.+||++||++
T Consensus 223 p~~~----~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFL----SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCC----CHHHHHHHHHHhccCHHHcCCC
Confidence 3322 2347899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.38 Aligned_cols=249 Identities=25% Similarity=0.437 Sum_probs=199.8
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.+|+..+.||+|+||.||+|.++++..+|+|++.... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 3588889999999999999998877889999985421 22356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++..+ ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999999999764 24689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCcc-eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SSNW-TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~~~-~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.... ....++..|+|| |......++.++||||||+++||+++ |+.||..... .+....+.
T Consensus 154 ~~~~~~~~~~~~~y~~P----------e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~ 215 (256)
T cd05059 154 QYTSSQGTKFPVKWAPP----------EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVS 215 (256)
T ss_pred cccccCCCCCCccccCH----------HHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHH
Confidence 2111 112334579999 66667788999999999999999999 8999864221 11111111
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...+.. .+..+.+++.+||..+|++|||+.|+++.|
T Consensus 216 ~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 216 AGYRLYRPKL----APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCcCCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11 1222221 334689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.50 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=201.9
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|...+.||.|+||.||.|+. ++.+.||||++..... ...+...++.+|+..+.+++|||++.+-|||-.+...|+||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 366677899999999999985 4778999999975322 23345678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
|||-| +-.|.+..+ .+++.+.++..|+.+.+.||+|||+. +.||||||+-|||+++.|.|||+|||.|..+.+-
T Consensus 106 EYClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99954 888888765 36788889999999999999999999 9999999999999999999999999999877543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
..++|||.|||||++ -....+.|+-|+||||+|+.-.|+...++|.-.|+.+... + -+...
T Consensus 180 ----nsFvGTPywMAPEVI-------LAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------Y-HIAQN 240 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVI-------LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------Y-HIAQN 240 (948)
T ss_pred ----hcccCCccccchhHh-------eeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------H-HHHhc
Confidence 457999999999643 1123577999999999999999999999996554432111 0 01111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..|.....+.+..|..+|..|+++-|.+|||.+++++
T Consensus 241 --esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 --ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1122223455567899999999999999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.60 Aligned_cols=252 Identities=21% Similarity=0.375 Sum_probs=199.9
Q ss_pred ccCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+|++.+.||+|+||+||+|.. .++..||+|.+... ........+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4688889999999999999974 24678999998642 223345678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC
Q 047901 581 SFVVYEYINRGSLATVLSNNFA--------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 646 (786)
.|+||||+++|+|.+++..... ...+++..+..++.|++.|++|||++ +++||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 9999999999999999853311 23478899999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCC
Q 047901 647 LEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGD 723 (786)
Q Consensus 647 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~ 723 (786)
.++.+||+|||+++....... ......++..|+|| |...+..++.++|||||||++|||++ |..||.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP----------EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecCh----------HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999999987643321 12233456789999 66666778999999999999999998 999975
Q ss_pred ccccccCCCcchhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 724 FLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... .......+... ...+.. .+..+.+++..||+++|++||++.++.+.|
T Consensus 229 ~~~---------~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 229 GFS---------NQEVIEMVRKRQLLPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred CCC---------HHHHHHHHHcCCcCCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 321 11112222221 112222 234588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=326.31 Aligned_cols=244 Identities=22% Similarity=0.311 Sum_probs=197.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv 584 (786)
+|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+..|..++..+. ||+|+++++++...+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4778899999999999999865 688999999864211 11233456778888888885 57888899999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999998754 5689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .......+..
T Consensus 154 ~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~ 215 (323)
T cd05615 154 DGVTTRTFCGTPDYIAP----------EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIME 215 (323)
T ss_pred CCccccCccCCccccCH----------HHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 33333445799999999 77777889999999999999999999999987432 1223333444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
.....|... +..+.+++.+|++++|.+|++.
T Consensus 216 ~~~~~p~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 HNVSYPKSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCCccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 444333322 3357899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.25 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=203.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 4788899999999999999865 68899999986422 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++++|||.++.....
T Consensus 78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 78 EYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999998754 345678999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........|+..|+|| |...+..+++++||||||+++|+|++|..||..... ..........
T Consensus 154 ~~~~~~~~~~~~~~aP----------E~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~ 215 (255)
T cd08219 154 GAYACTYVGTPYYVPP----------EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQG 215 (255)
T ss_pred ccccccccCCccccCH----------HHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcC
Confidence 3333445789999999 677777889999999999999999999999864221 1111112122
Q ss_pred CCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 746 RLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 746 ~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
... .+. ..+..+.+++.+||++||++|||+.|++.+
T Consensus 216 ~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYKPLPS----HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCc----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 121 123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.68 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=196.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|+++++.++||||+++++++.+....|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 36889999999999999999754 788999999864211 1223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 80 MEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999754 5688999999999999999999999 999999999999999999999999999964321
Q ss_pred CCC-----------------------------------------------cceeeccCccccCCCCCCCCchHHHHhhhc
Q 047901 665 NSS-----------------------------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTM 697 (786)
Q Consensus 665 ~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~ 697 (786)
... .....+||+.|+|| |++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~ 223 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAP----------EIFLQQ 223 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCH----------HHHccC
Confidence 000 00124699999999 777778
Q ss_pred CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCC
Q 047901 698 KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNS 775 (786)
Q Consensus 698 ~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 775 (786)
.++.++|||||||++|||++|+.||..... ......+.. ..+..|.. ......+.+++..|+. +|.+
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 224 GYGQECDWWSLGAIMFECLIGWPPFCSENS--------HETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred CCCCceeeEecchhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhh
Confidence 899999999999999999999999864221 112222222 12222211 1123357899999997 6666
Q ss_pred C---CCHHHHHH
Q 047901 776 R---PTMQTVCQ 784 (786)
Q Consensus 776 R---Pt~~ev~~ 784 (786)
| ||+.|+++
T Consensus 293 r~~r~~~~~~l~ 304 (377)
T cd05629 293 RLGRGGAHEIKS 304 (377)
T ss_pred cCCCCCHHHHhc
Confidence 5 59999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.17 Aligned_cols=253 Identities=16% Similarity=0.229 Sum_probs=194.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
..+|++.+.||+|+||.||+|... +++.||+|+... ..+.+|++++++++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 357999999999999999999854 688999997532 346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|+|++. ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 161 v~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999996 6899888654 4688999999999999999999999 99999999999999999999999999997543
Q ss_pred CC-CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc---------
Q 047901 664 PN-SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS--------- 733 (786)
Q Consensus 664 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~--------- 733 (786)
.. ........||+.|+|| |+..+..+++++||||+||++|||++|+.||-..........
T Consensus 234 ~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~ 303 (391)
T PHA03212 234 DINANKYYGWAGTIATNAP----------ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303 (391)
T ss_pred cccccccccccCccCCCCh----------hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence 22 1223345799999999 666677889999999999999999999988643211100000
Q ss_pred ------------chhhhhhhh----ccCCCC----CCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 ------------SINIEFNAM----LDHRLP----HPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ------------~~~~~~~~~----~~~~~~----~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......... ...... .+. ......+..+.+++.+||+.||++|||++|+++
T Consensus 304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000000 111 011123456889999999999999999999985
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.83 Aligned_cols=250 Identities=21% Similarity=0.242 Sum_probs=194.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|++.+.||+|+||+||+|+.. +++.||||++..... ........+.+|++++++++||||+++++.+.+++..|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 6899999999999999999854 688999999864211 11223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|......
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999999754 4678888999999999999999999 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcc
Q 047901 666 S-------------------------------------------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEK 702 (786)
Q Consensus 666 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~ 702 (786)
. ......+||+.|+|| |+..+..++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~ 224 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP----------EVLLRTGYTQL 224 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH----------HHHcCCCCCcc
Confidence 0 001124799999999 77778889999
Q ss_pred cchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC---
Q 047901 703 CDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP--- 777 (786)
Q Consensus 703 sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--- 777 (786)
+|||||||++|||++|+.||..... ......+.. .....+. .......+.+++.+|+ .+|.+|+
T Consensus 225 ~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 225 CDWWSVGVILYEMLVGQPPFLADTP--------AETQLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred eeeeeccceeeehhhCCCCCCCCCH--------HHHHHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 9999999999999999999874321 111111111 1111111 1112334677787776 5999999
Q ss_pred CHHHHHH
Q 047901 778 TMQTVCQ 784 (786)
Q Consensus 778 t~~ev~~ 784 (786)
|+.|+++
T Consensus 294 t~~ell~ 300 (376)
T cd05598 294 GADEIKA 300 (376)
T ss_pred CHHHHhC
Confidence 8898875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=318.74 Aligned_cols=248 Identities=23% Similarity=0.272 Sum_probs=194.1
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|+||+||+++.+ +++.||+|++..... ........+..|++++++++||||+++++++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh-hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999865 689999999864211 111233456679999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 672 (786)
|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~ 154 (277)
T cd05607 80 LKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQR 154 (277)
T ss_pred HHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeecc
Confidence 99988654 234588999999999999999999998 99999999999999999999999999998765432 22345
Q ss_pred ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCCh
Q 047901 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSL 752 (786)
Q Consensus 673 ~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (786)
.|+..|+|| |+..+..++.++||||+||++|||++|+.||..... ..................+.
T Consensus 155 ~~~~~y~aP----------E~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~- 219 (277)
T cd05607 155 AGTNGYMAP----------EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLEDEVKFEH- 219 (277)
T ss_pred CCCCCccCH----------HHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhcccccccc-
Confidence 789999999 677777799999999999999999999999864211 00111122222222222111
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 753 DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.+++..||+.||++|||+.|+++
T Consensus 220 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 --QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred --ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 123345889999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=336.99 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=194.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|+..+.||+|+||+||+|+.. +++.||+|++.... .........+.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 5888999999999999999864 67899999986421 112234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++.+. +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999999754 4678889999999999999999999 9999999999999999999999999997532100
Q ss_pred C-----------------------------------------------CcceeeccCccccCCCCCCCCchHHHHhhhcC
Q 047901 666 S-----------------------------------------------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMK 698 (786)
Q Consensus 666 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~ 698 (786)
. ......+||+.|+|| |++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP----------E~~~~~~ 224 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP----------EVLLRTG 224 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCH----------HHhcCCC
Confidence 0 001124689999999 7777778
Q ss_pred cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCC
Q 047901 699 ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776 (786)
Q Consensus 699 ~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 776 (786)
++.++||||+||++|||++|+.||..... ......+.. .....|.. ...+.+..+++.+|+ .+|++|
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 225 YTQLCDWWSVGVILYEMLVGQPPFLAQTP--------LETQMKVINWQTSLHIPPQ--AKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred CCCeeeEEechHHHHHHHhCCCCCCCCCH--------HHHHHHHHccCCCcCCCCc--ccCCHHHHHHHHHHc-cCHhHc
Confidence 99999999999999999999999874321 111222221 12222211 112334667777765 599999
Q ss_pred CC---HHHHHH
Q 047901 777 PT---MQTVCQ 784 (786)
Q Consensus 777 Pt---~~ev~~ 784 (786)
++ ++|+++
T Consensus 294 ~~~~~~~ei~~ 304 (382)
T cd05625 294 LGKNGADEIKA 304 (382)
T ss_pred CCCCCHHHHhc
Confidence 97 887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.23 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=200.2
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.+|.+.+.||+|+||.||++... ++..+|+|.+.. ......+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 46888999999999999999742 345689998864 22344567999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC
Q 047901 580 HSFVVYEYINRGSLATVLSNNF----------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 649 (786)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999999997542 123589999999999999999999998 999999999999999999
Q ss_pred cEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccc
Q 047901 650 EARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLS 726 (786)
Q Consensus 650 ~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~ 726 (786)
.+||+|||.++....... ......++..|+|| |...+..++.++|||||||++|||++ |..||....
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP----------ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCH----------HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999986643221 11223457789999 66677788999999999999999998 899976432
Q ss_pred cccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 727 LFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. ......+...... .+.. .+.++.+++.+||+.+|.+|||+.||.+.|
T Consensus 228 ~--------~~~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 228 N--------NEVIECITQGRVLQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred H--------HHHHHHHHcCCcCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1 1122222222211 1111 234589999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.45 Aligned_cols=250 Identities=22% Similarity=0.422 Sum_probs=201.1
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++||||+++++++. .+..++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 45789999999999999999998889999999986421 23457889999999999999999999874 4568999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999998754 345689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......++..|+|| |......++.++||||||+++||+++ |+.||..... ......+
T Consensus 155 ~~~~~~~~~~~~~~y~~p----------e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~ 216 (260)
T cd05067 155 NEYTAREGAKFPIKWTAP----------EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNL 216 (260)
T ss_pred CCcccccCCcccccccCH----------HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHH
Confidence 222 11233456789999 66667778999999999999999999 9999864321 1111111
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+. ..+.++.+++.+||..+|++|||++++.+.|
T Consensus 217 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 217 ERGYRMPRPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HcCCCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 111 112222 1234589999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.86 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=201.4
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
++|...+.||+|+||.||+|+.. ++..+++|.+.. ......+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 46888899999999999999742 345688998754 23344567899999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC
Q 047901 580 HSFVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 646 (786)
..++||||+++++|.+++.... ..+.+++..++.++.|++.|++|||++ +|+||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 9999999999999999997542 124588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCC
Q 047901 647 LEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGD 723 (786)
Q Consensus 647 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~ 723 (786)
.++.+||+|||+++....... ......++..|+|| |...+..++.++|||||||++|||+| |+.||.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP----------ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecCh----------HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999976543321 11234567899999 66667788999999999999999999 999976
Q ss_pred ccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 724 FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.... ......+......... ...+..+.+++.+||.++|++|||+++|+++|
T Consensus 228 ~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 228 QLSN--------TEVIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred CCCH--------HHHHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 4221 1122222222222111 11234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.69 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=200.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|||++++++++.. ...++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-----CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 34688999999999999999998888899999986521 234578999999999999999999998854 567899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999999754 234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....++..|+|| |......++.++||||||+++|||++ |..||..... ......+
T Consensus 155 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~ 216 (260)
T cd05070 155 NEYTARQGAKFPIKWTAP----------EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQV 216 (260)
T ss_pred cccccccCCCCCccccCh----------HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH
Confidence 3221 1223456689999 66667788999999999999999999 8999864321 1111222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +.+.+ ...+..+.+++.+||.++|++|||++++.+.|
T Consensus 217 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 217 ERGYRMPCP----QDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HcCCCCCCC----CcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 111 11122 22345689999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.84 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=200.7
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC----CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4788999999999999999985 46889999998652 223346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++.. ..+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999864 3578899999999999999999999 999999999999999999999999999886654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........|++.|+|| |...+..++.++|||||||++|+|++|+.||...... .........
T Consensus 169 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~ 231 (296)
T cd06654 169 EQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATN 231 (296)
T ss_pred cccccCcccCCccccCH----------HHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcC
Confidence 33333445789999999 6666777889999999999999999999998643210 011111111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ..........+.+++.+||.++|++|||+.|+++
T Consensus 232 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 232 GTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1111 0111223345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.21 Aligned_cols=251 Identities=24% Similarity=0.414 Sum_probs=199.8
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.++||+|+||+||+|+..++..||+|++.... ...+.+.+|+++++.++||||+++++++.. ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 35699999999999999999988777789999986421 233578899999999999999999998754 567899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999999754 234678999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....++..|+|| |...+..++.++||||||+++|||+| |..||..... .......
T Consensus 155 ~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~ 216 (262)
T cd05071 155 NEYTARQGAKFPIKWTAP----------EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV 216 (262)
T ss_pred cccccccCCcccceecCH----------hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHH
Confidence 3321 1233466789999 66667778999999999999999999 8888764321 1111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+ ...+.+..+.+++.+||+++|++|||+.++++.|
T Consensus 217 -~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 217 -ERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred -hcCCCCC--CccccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 1111111 1123445689999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.42 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=204.0
Q ss_pred CccceeeccccCceEEEEEcC--CCC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP--SGD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
....+.||+|.||+|++|.|. +|+ .||||.++.... .....+|.+|+.+|.+++|||++++||+..+ ...++
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---chhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 344567999999999999885 344 589999976322 2267899999999999999999999999887 67789
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||.++.|+|.+.++.. ....+-......++.|||.||.||.++ ++||||+.++|+++-....+||+|||+.+-+.
T Consensus 188 V~ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999999873 456788888999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCccee---eccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhh
Q 047901 664 PNSSNWTE---LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 664 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
..+..+.. ..-...|+|| |.+....++.+||||+|||.+|||+| |..||-.... . .+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaP----------EsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~-qI 324 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAP----------ESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------I-QI 324 (1039)
T ss_pred CCCcceEecCCCcCcccccCH----------hHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------H-HH
Confidence 66554421 2345689999 88899999999999999999999998 8889765332 1 12
Q ss_pred hhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 740 NAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 740 ~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...+| .++..|..+.+ .|+++++.||...|++|||+.++.+.
T Consensus 325 L~~iD~~erLpRPk~cse----dIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSE----DIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHhccccccCCCCCCChH----HHHHHHHHhccCCccccccHHHHHHh
Confidence 22222 35566655444 59999999999999999999999753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.64 Aligned_cols=244 Identities=24% Similarity=0.400 Sum_probs=194.1
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
+.||+|+||+||+|+.. +++.||+|.+... ........+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 36899999999999865 7889999987642 2233456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc-
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW- 669 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 669 (786)
++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+..........
T Consensus 78 ~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 78 GDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred CcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9999999754 34688999999999999999999999 99999999999999999999999999997654321111
Q ss_pred -eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccCC-
Q 047901 670 -TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHR- 746 (786)
Q Consensus 670 -~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 746 (786)
.....+..|+|| |......++.++|||||||++|||++ |..||..... ......+...
T Consensus 153 ~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------~~~~~~~~~~~ 213 (252)
T cd05084 153 GGMKQIPVKWTAP----------EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------QQTREAIEQGV 213 (252)
T ss_pred CCCCCCceeecCc----------hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------HHHHHHHHcCC
Confidence 111234579999 55666678899999999999999998 8888764221 1111222211
Q ss_pred -CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 747 -LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 747 -~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+. ..+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 214 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 214 RLPCPE----LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred CCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 12222 2234689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.42 Aligned_cols=253 Identities=25% Similarity=0.295 Sum_probs=202.2
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++..... .......+.+|+.++..++|+||+++.+.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 46899999999999999999975 4789999999865321 2344567889999999999999999988764322
Q ss_pred ----eeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 ----HSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999997532 235689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCC--CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 655 DFGTAKLLKPNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 655 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
|||+++...... .......||+.|+|| |.+.+..++.++|||||||++|||++|+.||....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP----------E~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------ 249 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAP----------EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------ 249 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCH----------HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------
Confidence 999998765321 122345799999999 67777789999999999999999999999986422
Q ss_pred cchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 SSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.............. .+. ..+..+.+++..||+.||++|||+.++++
T Consensus 250 --~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 250 --MEEVMHKTLAGRYDPLPP----SISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred --HHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11222222222221 222 22345889999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=348.02 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=198.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+.. +++.||||++..... ......++|.+|++++++++||||+++++++.+++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999865 688999999975322 2233456799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecc
Q 047901 585 YEYINRGSLATVLSNNF--------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDF 656 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 656 (786)
|||++||+|.+++.... .....++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 99999999999986421 123456778899999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCC------------------CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC
Q 047901 657 GTAKLLKPNS------------------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG 718 (786)
Q Consensus 657 g~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg 718 (786)
|+++...... ......+||+.|+|| |...+..++.++|||||||++|||+||
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP----------E~l~g~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP----------ERLLGVPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCH----------HHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence 9998762110 011234699999999 777788899999999999999999999
Q ss_pred CCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 047901 719 KHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-MQTVCQ 784 (786)
Q Consensus 719 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 784 (786)
+.||...... ............... ...+.+..+.+++.+|+..||++||+ ++++.+
T Consensus 228 ~~PF~~~~~~-------ki~~~~~i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 228 SFPYRRKKGR-------KISYRDVILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred CCCCCCcchh-------hhhhhhhccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9998642210 000011111000000 01123345889999999999999975 454544
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.66 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=206.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|... +++.||+|.++... .......+.+.+|++++++++|+||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc-ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57899999999999999999876 78999999886422 12233466889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||+++|+|.+++.... ....+++..+..++.+++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999986532 234588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........++..|+|| |...+..++.++|||||||++|+|++|+.||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~y~ap----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~ 221 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSP----------ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIE 221 (267)
T ss_pred CCCcccceecCCccccCH----------HHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhh
Confidence 443333445788999999 666677789999999999999999999999753210 0011111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..... ..........+.+++..||..+|++|||+.+|++.|
T Consensus 222 ~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 222 KCDYP--PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred cCCCC--CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 11111 111113344688999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.98 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=197.8
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec-
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH- 577 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~- 577 (786)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++.++ +||||++++++|..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 46999999999999999999642 24689999986422 223456788899999999 79999999998864
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC-------------------------------------------------------
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA------------------------------------------------------- 602 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 602 (786)
+...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4567899999999999999864311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCcc
Q 047901 603 ---SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFG 677 (786)
Q Consensus 603 ---~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~ 677 (786)
...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12678999999999999999999999 9999999999999999999999999999876433221 123355678
Q ss_pred ccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccCC--CCCCChhH
Q 047901 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDV 754 (786)
Q Consensus 678 y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 754 (786)
|+|| |...+..++.++|||||||++|||++ |..||..... .+......... ...+.
T Consensus 241 y~aP----------E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~--- 299 (337)
T cd05054 241 WMAP----------ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--------DEEFCRRLKEGTRMRAPE--- 299 (337)
T ss_pred ccCc----------HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--------cHHHHHHHhccCCCCCCc---
Confidence 9999 66777889999999999999999998 9999864221 11111121111 11121
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 755 QEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 755 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....++.+++.+||+.+|++|||+.|+++.|
T Consensus 300 -~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 300 -YATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2234589999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.39 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=195.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+|+..+.||+|+||+||+|.+. +++ +|++|++... .......++..|+.++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 46888899999999999999864 344 4788887531 122344678888889999999999999998864 45
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++++||+++|+|.+++... .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 77899999999999999754 34689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... ......++..|+|| |...+..++.++|||||||++||+++ |+.||..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~p----------E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~ 218 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMAL----------ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---------H 218 (279)
T ss_pred eccCCCcccccCCCCCcccccCH----------HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------H
Confidence 7653322 12334567789999 66666788999999999999999998 9999864321 1
Q ss_pred hhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+.. ....+.. +...+.+++.+||..+|++|||+.|+++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 219 EVPDLLEKGERLAQPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred HHHHHHHCCCcCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111111 1122221 223478899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.58 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=197.4
Q ss_pred ccCccceeeccccCceEEEEEcC-----------------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcc
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-----------------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 568 (786)
++|++.+.||+|+||.||+++.. +...||+|++... ........+.+|+++++.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 46899999999999999998642 2336899998642 223345689999999999999999
Q ss_pred cceeeEEecCCeeeEEEeccCCCCHHHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCC
Q 047901 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFA--------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISS 640 (786)
Q Consensus 569 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 640 (786)
+++++++...+..++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 9999999999999999999999999999975421 12467889999999999999999999 999999999
Q ss_pred CceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-
Q 047901 641 NNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK- 717 (786)
Q Consensus 641 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt- 717 (786)
+||+++.++.+||+|||+++.+...... .....++..|+|| |....+.++.++|||||||++|||++
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW----------ESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH----------HHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 9999999999999999999866433211 1123446789999 66667789999999999999999998
Q ss_pred -CCCCCCccccccCCCcchhhhhhhhcc-----CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 718 -GKHPGDFLSLFSSSSSSINIEFNAMLD-----HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 718 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|..||....... .......... ...+.+.. ++..+.+++.+||+.||++|||+.||.+.|
T Consensus 229 ~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 229 CKEQPYSQLSDEQ-----VIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred CCCCCccccChHH-----HHHHHHHHHhhccccccCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 778876432110 0000111100 01111211 234588999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.90 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=199.0
Q ss_pred HHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 501 IIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 501 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
+....++|++.+.||+|+||.||+|+.+ +++.||+|++..... ........+.+|+.+++.++||||+++++++..++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3344578999999999999999999865 678899999854111 11223456788999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999998643 478888899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhh----cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 660 KLLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYT----MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 660 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~----~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
+....... ......||+.|+|| |++.. ..++.++|||||||++|||++|+.||.....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aP----------E~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------- 252 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISP----------EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (371)
T ss_pred eEcCcCCcccccCcccCccccCH----------HHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------
Confidence 87654322 22346799999999 45443 2378899999999999999999999874321
Q ss_pred hhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 047901 735 INIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNS--RPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~ 784 (786)
......+.... ...|. ....+..+.+++..|+..++.+ ||+++|+++
T Consensus 253 -~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 253 -VGTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred -HHHHHHHHcCCCcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 12223332221 22221 1123445789999999844433 789998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.66 Aligned_cols=249 Identities=25% Similarity=0.444 Sum_probs=199.4
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|.+.+.||+|++|.||+|...++..||+|++... ....+.+.+|+.++++++|||++++++++.. +..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-----TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-----CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 468889999999999999999877778999987642 1234578899999999999999999998754 5678999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999764 234588999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... .....++..|+|| |......++.++|||||||++|||+| |+.||..... ......+.
T Consensus 156 ~~~~~~~~~~~~~y~~P----------e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~ 217 (260)
T cd05069 156 EYTARQGAKFPIKWTAP----------EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVE 217 (260)
T ss_pred cccccCCCccchhhCCH----------HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 221 1223466789999 66677788999999999999999999 8999864221 11111111
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. ....+ ...+..+.+++.+||.++|++|||+++|.+.|
T Consensus 218 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 218 RGYRMPCP----QGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred cCCCCCCC----cccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 11 11112 22345689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=326.38 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=205.1
Q ss_pred CccceeeccccCceEEEEEcCCCCE-EEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDK-IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|.++..+|.|+||.||+|..++... -|.|++.. ...+..++|+-||+|+..++||+||++++.|..++..||+.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 5566779999999999998775444 46666643 445677899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
||.||.....+-.- +..+++.++.-+++|++.||.|||+. +|+|||||+-|||++-+|.++|+|||.+.......
T Consensus 110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 99999888776543 46799999999999999999999999 99999999999999999999999999987665444
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
.....+.||++|||||+.- .|-+.+.+|+.++||||||+.|.||..+.+|-...+.+ .....+-+..
T Consensus 185 qkRDsFIGTPYWMAPEVvm-----CET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--------RVllKiaKSe 251 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVM-----CETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSE 251 (1187)
T ss_pred hhhccccCCcccccchhee-----eccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--------HHHHHHhhcC
Confidence 4556789999999998543 36677889999999999999999999999995533221 1111111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+ .-..+..+..+|.++++.|+.+||..||+++++++
T Consensus 252 PP-TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 PP-TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CC-cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 11122344567999999999999999999999976
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.42 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=197.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc--ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 4788899999999999999865 68899999986532 12223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||++ ++|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 58999887654446789999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------Cc-
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----------SS- 733 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----------~~- 733 (786)
........++..|+|| |...+ ..++.++|||||||++|||+||+.||......... ..
T Consensus 155 ~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 155 VRVYTHEVVTLWYRAP----------EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred cccccCCcccccccCh----------HHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 3333344678899999 54433 34688999999999999999999998643211000 00
Q ss_pred -----chhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 -----SINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 -----~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
............... .........+.++.+++.+||..||++|||+.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000 000000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.98 Aligned_cols=253 Identities=19% Similarity=0.315 Sum_probs=199.5
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.+|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 35777888999999999999753 24689999987521 2234567889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC
Q 047901 580 HSFVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 646 (786)
..++++||+++++|.+++.... ....+++..+..++.|++.|+.|||++ +|+||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 9999999999999999985321 123578889999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCC
Q 047901 647 LEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGD 723 (786)
Q Consensus 647 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~ 723 (786)
.++.+||+|||+++....... ......+++.|+|| |......++.++|||||||++|||++ |..||.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP----------EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCH----------HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999886643221 11234567899999 66667778999999999999999998 888876
Q ss_pred ccccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 724 FLSLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... .......+.+.... .+. ..+..+.+++..||+.+|++|||+++|++.|
T Consensus 229 ~~~--------~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 229 GYS--------NQDVIEMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred CCC--------HHHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 421 11222222232221 122 2334588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.64 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=196.5
Q ss_pred ccCccceeeccccCceEEEEEcCC---------------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccc
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS---------------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~ 570 (786)
++|++.+.||+|+||.||+++..+ ...||+|++.... .......|.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 478999999999999999987532 1248999986521 2334567899999999999999999
Q ss_pred eeeEEecCCeeeEEEeccCCCCHHHHhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 047901 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFA---------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641 (786)
Q Consensus 571 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 641 (786)
+++++...+..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999964321 12468899999999999999999999 9999999999
Q ss_pred ceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh--
Q 047901 642 NVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-- 717 (786)
Q Consensus 642 Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-- 717 (786)
||+++.++.+||+|||++......... .....++..|+|| |......++.++|||||||++|||++
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW----------ESILLGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecCh----------hhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999865433211 1223456789999 56666778999999999999999998
Q ss_pred CCCCCCccccccCCCcchhhhhhhhccC-----CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 718 GKHPGDFLSLFSSSSSSINIEFNAMLDH-----RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 718 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|..||...... ............ ....+.. .+..+.+++.+||+.+|++|||+++|++.|
T Consensus 229 ~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 229 KEQPYSLLSDE-----QVIENTGEFFRNQGRQIYLSQTPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred CCCCCcccChH-----HHHHHHHHhhhhccccccCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 56676542210 000011111110 0111111 224589999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.16 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=202.1
Q ss_pred hccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|++.+.||+|+||.||+|... .+..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 357889999999999999999754 2368999998642 2223456788999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFA-------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
...++||||+++|+|.+++..... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999975321 23478899999999999999999998 99999999999999999999
Q ss_pred EEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|||+++....... ......++..|+|| |......++.++|||||||++||+++ |..||.....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 227 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP----------ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN- 227 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCH----------HHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-
Confidence 9999999986654322 12234567899999 66667778999999999999999998 9999753221
Q ss_pred cCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
........... ...|.. .+..+.+++.+||+.+|++|||+.++++.|
T Consensus 228 -------~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 228 -------EEVLKFVIDGGHLDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred -------HHHHHHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 11112222221 222222 234689999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.32 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=199.6
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
..++|++.+.||+|+||.||+|..+ .+..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4568999999999999999999643 2457999987642 222344568899999999999999999999998
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA-------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
.+..++||||+++|+|.+++..... ....++..+..++.|++.|+.|||++ +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 8999999999999999999975321 23457788899999999999999998 9999999999999999999
Q ss_pred EEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 047901 651 ARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSL 727 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~ 727 (786)
+||+|||+++........ .....++..|+|| |...+..++.++|||||||++|||++ |..||....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p----------E~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~- 226 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP----------ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS- 226 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCH----------HHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 999999999865432221 1223456789999 66667788999999999999999998 788875322
Q ss_pred ccCCCcchhhhhhhhccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.........+... ..+. ..+..+.+++..||+.+|++|||+.++++.|
T Consensus 227 -------~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 227 -------NEQVLKFVMDGGYLDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred -------HHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1112222222221 1222 1234689999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.86 Aligned_cols=260 Identities=17% Similarity=0.261 Sum_probs=196.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|...+.||+|+||.||+|+.+ +++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 56899999999999999999865 678999999865321 22334677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 83 FEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred Eeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99997 5999988754 34578999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------Ccchh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------SSSIN 736 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~~~~~ 736 (786)
.........+++.|+|| |...+ ..++.++|||||||++|||++|++||......... .....
T Consensus 157 ~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 226 (301)
T cd07873 157 PTKTYSNEVVTLWYRPP----------DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226 (301)
T ss_pred CCCcccccceeecccCc----------HHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 33333345678999999 44433 45788999999999999999999998753210000 00000
Q ss_pred hhhhhhccC----CCCCCC-------hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAMLDH----RLPHPS-------LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~~----~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+..+... ....+. ......+..+.+++.+|++.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 000000 000112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.99 Aligned_cols=244 Identities=22% Similarity=0.382 Sum_probs=195.3
Q ss_pred eeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
.||+|+||.||+|..++++.||+|++.... .......+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 689999999999998888999999986532 22334578899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc-ee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW-TE 671 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 671 (786)
|.+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 79 L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 99998754 24578999999999999999999998 99999999999999999999999999997654322111 12
Q ss_pred eccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhcc-CCCCC
Q 047901 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD-HRLPH 749 (786)
Q Consensus 672 ~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 749 (786)
..++..|+|| |+.....++.++||||||+++||+++ |..||..... ......... .+...
T Consensus 154 ~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 215 (250)
T cd05085 154 KQIPIKWTAP----------EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQVEKGYRMSC 215 (250)
T ss_pred CCCcccccCH----------HHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 2345679999 66667778999999999999999998 9999864321 111111111 11111
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+. ..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 216 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 216 PQ----KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 21 1234589999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=308.24 Aligned_cols=242 Identities=23% Similarity=0.367 Sum_probs=190.9
Q ss_pred eeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.||+|+||.||+|.+. ++..||+|++... ......+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999753 3456999998652 223345678999999999999999999998864 57899999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ...+++..++.++.|++.|++|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 78 GGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99999999753 35689999999999999999999998 99999999999999999999999999998654332211
Q ss_pred e---eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccC
Q 047901 670 T---ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 670 ~---~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
. ...++..|+|| |......++.++|||||||++||+++ |..||..... ......+..
T Consensus 153 ~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~ 213 (257)
T cd05115 153 KARSAGKWPLKWYAP----------ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---------PEVMSFIEQ 213 (257)
T ss_pred eccCCCCCCcccCCH----------HHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---------HHHHHHHHC
Confidence 1 12235689999 66667778999999999999999996 9999875321 111111111
Q ss_pred --CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 746 --RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 746 --~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+...+.. .+.++.+++..||..+|++||++.+|.+.|
T Consensus 214 ~~~~~~~~~----~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 214 GKRLDCPAE----CPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred CCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1222222 234588999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=313.18 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=200.0
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.+|+..++||+|+||.||++... ++..+|+|.+.. ........+.+|+++++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 46788899999999999999632 355789998764 23345568999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 580 HSFVVYEYINRGSLATVLSNNFA------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
..++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 99999999999999999975421 13578999999999999999999998 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCc
Q 047901 648 EYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDF 724 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~ 724 (786)
++.+||+|||+++........ .....+++.|+|| |...+..++.++|||||||++|||++ |..||..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP----------ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCH----------HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999866433211 1223456789999 66677788999999999999999998 8999753
Q ss_pred cccccCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 725 LSLFSSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... ........... ...+. ..+..+.+++.+||++||++||+++||++.|
T Consensus 228 ~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 228 LSN--------TEAIECITQGRELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred CCH--------HHHHHHHHcCccCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 221 11222222221 11122 2234588999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=308.02 Aligned_cols=242 Identities=26% Similarity=0.394 Sum_probs=192.5
Q ss_pred eeccccCceEEEEEc---CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHRSVYRAKL---PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.||+|+||.||+|.+ ++++.+|+|++.... ......+.+.+|+.+++.++||||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 589999999999964 357889999986432 223456788999999999999999999998864 56789999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++.........
T Consensus 79 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 79 LGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99999999753 4688999999999999999999998 99999999999999999999999999998765433221
Q ss_pred ---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccC
Q 047901 670 ---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 670 ---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
....++..|+|| |......++.++|||||||++|||++ |..||..... ......+..
T Consensus 153 ~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~i~~ 213 (257)
T cd05116 153 KAKTHGKWPVKWYAP----------ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---------NEVTQMIES 213 (257)
T ss_pred eecCCCCCCccccCH----------hHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHC
Confidence 122345789999 66666678889999999999999998 9999874321 111222222
Q ss_pred C--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 746 R--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 746 ~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. ...|.. .+..+.++|..||+.||++||++++|.+.|
T Consensus 214 ~~~~~~~~~----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 214 GERMECPQR----CPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CCCCCCCCC----CCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 1 222222 234588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.67 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=197.7
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecC---
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHV--- 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~--- 578 (786)
+.+.|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4567888899999999999999865 6788999998642 12345778999999998 699999999998642
Q ss_pred ---CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 579 ---RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 579 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
...|+||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4678999999999999999764 234688999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||++..............|+..|+|||++.... ..+..++.++||||+||++|||++|+.||......
T Consensus 155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------- 222 (272)
T cd06637 155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE-----NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------- 222 (272)
T ss_pred CCCceecccccccCCcccccccccCHhHhcccc-----CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------
Confidence 999987654333344567899999995332110 01346788999999999999999999998643211
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. ........... .......+..+.+++.+||..+|.+|||+.|+++
T Consensus 223 ~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 R-ALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-HHHHHhcCCCC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 01111111100 0001112345889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.47 Aligned_cols=253 Identities=22% Similarity=0.248 Sum_probs=197.9
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|+||+||+|... +++.||+|.+..... ........+.+|+++++.++|+||+++.+++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 667788999999999999864 688999999865221 112234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++++|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999988654 234689999999999999999999998 99999999999999999999999999997664322
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
......|+..|+|| |+..+..++.++||||+||++|||++|..||...... ..............
T Consensus 157 -~~~~~~g~~~~~aP----------E~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~~ 221 (285)
T cd05632 157 -SIRGRVGTVGYMAP----------EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLETE 221 (285)
T ss_pred -cccCCCCCcCccCh----------HHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhccc
Confidence 22345789999999 6777778999999999999999999999998642210 00011111111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
...+ ......+.+++..||+.||++||| ++++++
T Consensus 222 ~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYS----AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccC----ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1111 122345889999999999999999 566653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.93 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=198.4
Q ss_pred cCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
+|++.+.||+|+||.||+|... ....+++|.+... ........+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4778889999999999999742 2356888888642 122345678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 047901 581 SFVVYEYINRGSLATVLSNNF---------------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 639 (786)
.++||||+++|+|.+++.... ....+++..++.++.|++.|++|||+. +++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence 999999999999999986421 123578999999999999999999998 99999999
Q ss_pred CCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh
Q 047901 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 640 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt 717 (786)
|+||++++++.+||+|||+++........ .....++..|+|| |...+..++.++||||||+++|||++
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap----------E~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI----------ESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH----------HHHccCCcchHhHHHHHHHHHHHHHh
Confidence 99999999999999999999865433221 1223456789999 66667778999999999999999998
Q ss_pred -CCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 718 -GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 718 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|..||.... .+............+. ....+..+.+++..||+.+|++|||+.|+++.|
T Consensus 225 ~g~~p~~~~~---------~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 225 LGGNPYPGIA---------PERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred cCCCCCCCCC---------HHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 999976422 1122222222222111 112234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.42 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=200.1
Q ss_pred hccCccceeeccccCceEEEEEcCC-----------------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS-----------------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 567 (786)
..+|++.+.||+|+||.||+|...+ +..||+|++... ......+.+.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD---ASDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhcCCCC
Confidence 3578999999999999999987532 245899998652 22345678999999999999999
Q ss_pred ccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 047901 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFA--------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639 (786)
Q Consensus 568 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 639 (786)
|+++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +|+|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 99999999999999999999999999999976421 23689999999999999999999998 99999999
Q ss_pred CCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh
Q 047901 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 640 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt 717 (786)
|+||+++.++.++|+|||.++........ .....++..|+|| |......++.++|||||||++|||++
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW----------ESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH----------HHhhcCCCCccchhhhhHHHHHHHHh
Confidence 99999999999999999999866433221 1233567789999 66666788999999999999999998
Q ss_pred --CCCCCCccccccCCCcchhhhhhhhccC----CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 718 --GKHPGDFLSLFSSSSSSINIEFNAMLDH----RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 718 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|..||..... .......... ............+.++.+++.+||+.||++|||+.||++.|
T Consensus 228 ~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 228 LCREQPYEHLTD--------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred cCCCCCCCCcCh--------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 6777653221 1111111110 00000000111234689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.55 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=201.0
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|...+.||+|+||.||+|.. .++..||||++... ......+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT---AHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc---CChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 45799999999999999999963 13457999988652 1223456789999999999 79999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999997542 23489999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcc
Q 047901 658 TAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 658 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~ 734 (786)
.++........ .....++..|+|| |......++.++||||+||++|||++ |..||.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------- 249 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAP----------ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------- 249 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCH----------hhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------
Confidence 99866433221 1223457789999 66667778999999999999999998 9999764321
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+........+. ....+..+.+++.+||+++|++|||+.|+++.|
T Consensus 250 -~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 250 -DSKFYKLIKEGYRMAQ--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred -hHHHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 1122222222211110 011234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.18 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=199.0
Q ss_pred hccCccceeeccccCceEEEEEcCC------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|.+.+.||+|++|.||+|.+.+ +..||+|.+... ........|.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4568899999999999999998653 467899987542 2223346789999999999999999999999988
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC---cE
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFA----SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY---EA 651 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~ 651 (786)
+..++||||+++++|.+++..... ...+++..+..++.||+.|++|||+. +++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 899999999999999999976532 23589999999999999999999999 999999999999998654 69
Q ss_pred EEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|||+++........ ......+..|+|| |...+..+++++|||||||++|||++ |..||+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~- 227 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPP----------EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN- 227 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCH----------HHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 99999999876432211 1122335689999 77777789999999999999999997 9999864221
Q ss_pred cCCCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. +...+. ..+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 228 --------~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 228 --------QEVMEFVTGGGRLDPPK----GCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred --------HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 111222221 112222 2234588999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=312.42 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=201.5
Q ss_pred hccCccceeeccccCceEEEEEcCC-----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-C
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS-----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-V 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~ 578 (786)
.++|+..+.||+|+||.||+|...+ +..|++|++.. .......+.+.+|+.++++++||||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC---CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4578899999999999999998765 67899998864 2234456778899999999999999999998765 5
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFAS-----EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
...++++||+++|+|.+++...... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999999754222 4689999999999999999999998 9999999999999999999999
Q ss_pred eccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccC
Q 047901 654 SDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSS 730 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~ 730 (786)
+|||+++.+.+.... .....++..|+|| |......++.++|||||||++||+++ |+.||.....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap----------E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 225 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMAL----------ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--- 225 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCH----------HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---
Confidence 999999866433221 1123456789999 66667778999999999999999999 9999864321
Q ss_pred CCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 SSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. +...+. ..+.++.+++.+||+.+|++|||+.++++.|
T Consensus 226 ------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 226 ------FEMAAYLKDGYRLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred ------HHHHHHHHcCCCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111111111 112121 1234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=309.28 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=203.4
Q ss_pred ccCccceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|...+ ++.|++|.+... ...+++.+|++++++++||||+++++++......|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 578899999999999999998764 789999998641 1267899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
+||+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999999999653 35689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........++..|+|| |...+..++.++||||||+++|+|++|+.||...... .... ...
T Consensus 152 ~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~-~~~ 212 (256)
T cd06612 152 TMAKRNTVIGTPFWMAP----------EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIF-MIP 212 (256)
T ss_pred CccccccccCCccccCH----------HHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhh-hhc
Confidence 43333445688999999 7777778899999999999999999999998743211 0010 111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
................+.+++.+||+.+|++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1111111111223346899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.59 Aligned_cols=254 Identities=23% Similarity=0.404 Sum_probs=200.6
Q ss_pred hccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|+..+.||+|+||.||+|... ....+|+|.+... ........+.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 456889999999999999999754 2357899988652 2223456788999999999 79999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCcee
Q 047901 578 VRHSFVVYEYINRGSLATVLSNN-------------FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 644 (786)
++..++||||+++|+|.++++.. .....+++..++.++.|++.|++|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 99999999999999999999653 1245689999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCC
Q 047901 645 LDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHP 721 (786)
Q Consensus 645 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~P 721 (786)
++.++.+||+|||.++.+...... .....++..|+|| |......++.++|||||||++||+++ |..|
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP----------EALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCH----------HHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence 999999999999999876543221 1122345689999 66667778999999999999999997 9999
Q ss_pred CCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 722 GDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 722 f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|..... ......+... ....+. .....+.+++.+||+.+|++|||+.|+++.|
T Consensus 235 ~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 235 YPGIPV--------EELFKLLKEGYRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred CCCCCH--------HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 764221 1111111111 112222 2234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.55 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=200.0
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~ 576 (786)
..++|.+.+.||+|+||.||+|+++ .++.||||++.... .....+.+.+|++++.++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3456888899999999999999853 24579999997532 2233457889999999997 999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCC------------------------------------------------------
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFA------------------------------------------------------ 602 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 602 (786)
..+..++||||+++|+|.+++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 047901 603 -----------------------------------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641 (786)
Q Consensus 603 -----------------------------------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 641 (786)
...+++..+..++.|++.|+.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12367778899999999999999998 9999999999
Q ss_pred ceeeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-C
Q 047901 642 NVLLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-G 718 (786)
Q Consensus 642 Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g 718 (786)
||+++.++.+||+|||+++....... ......++..|+|| |......++.++|||||||++|||++ |
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslGvil~e~l~~g 338 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP----------ESIFNNLYTTLSDVWSFGILLWEIFTLG 338 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh----------HHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence 99999999999999999986543221 11234577899999 66666778999999999999999998 8
Q ss_pred CCCCCccccccCCCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 719 KHPGDFLSLFSSSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 719 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..||..... .+.....+.. +...|.. ....+.+++..||.++|.+||+++||++.|
T Consensus 339 ~~P~~~~~~--------~~~~~~~~~~~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 339 GTPYPELPM--------NEQFYNAIKRGYRMAKPAH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred CCCCCCCCc--------hHHHHHHHHcCCCCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999764321 1111122221 1222222 234589999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.65 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=199.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|+..+.||+|+||+||+|... +++.||||++..... ........+.+|+.+++.++|++|+++++.+...+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 3677789999999999999865 688999999865321 12233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 80 TLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999998654 234688999999999999999999998 9999999999999999999999999999766433
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
. ......|+..|+|| |...+..++.++||||+||++|||++|+.||..... ...........+.
T Consensus 156 ~-~~~~~~g~~~y~aP----------E~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-----~~~~~~~~~~~~~ 219 (285)
T cd05630 156 Q-TIKGRVGTVGYMAP----------EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-----KIKREEVERLVKE 219 (285)
T ss_pred c-cccCCCCCccccCh----------HHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc-----cchHHHHHhhhhh
Confidence 2 22334789999999 777778899999999999999999999999874221 0001111111111
Q ss_pred -CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 746 -RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 746 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
....+ ......+.+++..||+.||++||| ++|+++
T Consensus 220 ~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQEEYS----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhcC----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01111 122345889999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.07 Aligned_cols=251 Identities=25% Similarity=0.448 Sum_probs=199.9
Q ss_pred ccCccceeeccccCceEEEEEcC-C---CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-S---GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.+|+..+.||+|+||.||+|+.. + +..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46888999999999999999753 2 3379999986522 223456889999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++++|.+++... .+.+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999999764 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcce---eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 662 LKPNSSNWT---ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 662 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
......... ...++..|+|| |...+..++.++||||||+++||+++ |..||..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~p----------e~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~ 217 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAP----------EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QD 217 (267)
T ss_pred cccccceeeecCCCccceeecCH----------hHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HH
Confidence 654322111 12235689999 67777788999999999999999886 9999764321 11
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+.+. +.+.+. ..+..+.+++.+||+++|.+|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 218 VIKAIEEGYRLPAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred HHHHHhCCCcCCCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 12222221 112121 2234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.42 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=198.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|+.. +++.||+|.++.. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC----chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 36788889999999999999854 6889999998652 223345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... +.+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999999998754 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........|+..|+|||.+.. .....++.++||||+||++|||++|+.||...... ........
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~ 223 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAV-------ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTK 223 (267)
T ss_pred cccccccccCcccccChhhhcc-------ccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhc
Confidence 3333344578999999953210 12345788999999999999999999997532211 01111111
Q ss_pred CCCCCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+.. .....+..+.+++.+||..+|++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11111100 00112335889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=312.64 Aligned_cols=238 Identities=21% Similarity=0.348 Sum_probs=185.0
Q ss_pred eeccccCceEEEEEcCC-------------------------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc
Q 047901 513 CIGKGEHRSVYRAKLPS-------------------------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 567 (786)
.||+|+||.||+|.+.. ...||+|++.. ........|.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP----SHRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh----HHHHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999997421 12588888854 22234457888999999999999
Q ss_pred ccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 568 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
|+++++++......++||||+++|+|..++... .+.+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 999999999999999999999999999998753 35688999999999999999999998 9999999999999976
Q ss_pred CC-------cEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHH-hC
Q 047901 648 EY-------EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVI-KG 718 (786)
Q Consensus 648 ~~-------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~ell-tg 718 (786)
.+ .+|++|||.+...... ....++..|+||| ... ...++.++|||||||++||++ +|
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe----------~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPE----------CVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cCcccCccceeeecCCccccccccc----cccccCCcccCch----------hhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 43 4899999998654322 2235788899995 333 356789999999999999995 69
Q ss_pred CCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 719 KHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 719 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.||..... .............+... ...+.+++.+||+.+|++|||+.+|++.|
T Consensus 219 ~~p~~~~~~---------~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 219 EVPLKERTP---------SEKERFYEKKHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCccccCh---------HHHHHHHHhccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 999764221 11111222222222211 12488999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.81 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=193.8
Q ss_pred CccceeeccccCceEEEEEcCCCC---EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV------ 578 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------ 578 (786)
|.+.+.||+|+||.||+|++.+.. .||+|.+.... ......+.+.+|+++++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 346778999999999999875432 68999886532 2334567889999999999999999999987432
Q ss_pred CeeeEEEeccCCCCHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 579 RHSFVVYEYINRGSLATVLSNNF---ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
...++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence 24689999999999999874321 234588999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCC
Q 047901 656 FGTAKLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSS 732 (786)
Q Consensus 656 fg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~ 732 (786)
||+++......... ....+++.|+|| |......+++++||||||+++|||++ |+.||.....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 220 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAI----------ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----- 220 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCH----------HHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 99998765432211 122456789999 66667788999999999999999999 8889764221
Q ss_pred cchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 733 SSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 733 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
........... ...+. ..+..+.+++.+||.++|++|||+.|+++.|
T Consensus 221 ---~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 221 ---SEIYDYLRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred ---HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111111111 11122 1234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.34 Aligned_cols=251 Identities=25% Similarity=0.476 Sum_probs=203.4
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|..++++.||||.+... ....+++.+|+.++++++||||+++++++......++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-----TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-----ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 3578999999999999999999887889999998642 12346789999999999999999999999988899999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++..+..++.+++.|+.|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 80 ~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999765 335689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....++..|+|| |...+..+++++||||+|+++||+++ |+.||.... .......+
T Consensus 156 ~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~ 217 (261)
T cd05034 156 DEYTAREGAKFPIKWTAP----------EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQV 217 (261)
T ss_pred hhhhhhhccCCCccccCH----------HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH
Confidence 2211 1122345689999 67777788999999999999999998 999986422 11122222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+.. .+..+.+++.+||..+|++|||++++.+.|
T Consensus 218 ~~~~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 218 ERGYRMPRPPN----CPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HcCCCCCCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 221 1222221 234589999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.38 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=195.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
++|++.+.||+|+||.||+|... ++. .+++|.++.. ......+.+.+|+++++++ +||||+++++++...+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 47889999999999999999865 333 4788887631 1223456789999999999 799999999999998999
Q ss_pred eEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC
Q 047901 582 FVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 648 (786)
++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 99999999999999996532 123588999999999999999999998 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 047901 649 YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSL 727 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~ 727 (786)
+.+||+|||++........ ......+..|+|| |......++.++|||||||++|||++ |..||.....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAI----------ESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CeEEECCcCCCccccceec-cCCCCcCccccCc----------hhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999864322111 1112234579999 66666778999999999999999997 9999864321
Q ss_pred ccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......... ....+. ..+..+.+++.+||+.+|.+|||++++++.|
T Consensus 225 --------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 225 --------AELYEKLPQGYRMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred --------HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111222211 111222 1234588999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.98 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=201.8
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
..+|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC----ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 35799999999999999999985 47899999998642 22334668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999999864 3578889999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........+++.|+|| |...+..+++++|||||||++|++++|+.||........ .....
T Consensus 167 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------~~~~~ 228 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIA 228 (297)
T ss_pred CCccCcCcccCCccccCH----------HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------eeeec
Confidence 443333445788999999 666777788999999999999999999999864322110 00011
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+ +..........+.+++.+||..+|++|||++++++
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 229 TNGTP-ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCCCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10100 00111222345789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.58 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=205.2
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||.++. .+++.+++|++.... ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 488899999999999999974 468899999986422 12344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999997652 45689999999999999999999998 9999999999999999999999999999877554
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........+++.|+|| |...+..++.++||||||+++|||++|..||.... ..+........
T Consensus 155 ~~~~~~~~~~~~y~ap----------e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~ 216 (256)
T cd08221 155 YSMAETVVGTPYYMSP----------ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQG 216 (256)
T ss_pred cccccccCCCccccCH----------hhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC
Confidence 4333455789999999 55556678889999999999999999999986422 11222222222
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
..... ....+..+.+++..||..+|++|||+.|+++.
T Consensus 217 ~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 217 NYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 22211 12234458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.96 Aligned_cols=250 Identities=22% Similarity=0.415 Sum_probs=197.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
..+|+..+.||+|+||+||+|++. +++ +||+|++... ........+.+|+.+++.+.||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 357888999999999999999853 444 4899998642 223445678899999999999999999999875 4
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..+++|||+++|+|.+++..+ .+.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 567999999999999999754 34689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
+......... ....++..|+|| |...+..++.++|||||||++|||++ |..||+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------- 217 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMAL----------ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------- 217 (279)
T ss_pred eecccccceeecCCCccchhhCCH----------HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 8775432211 122346789999 66667788999999999999999998 8999764221
Q ss_pred hhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. ..+.+. ..+..+.+++..||..||++|||+.|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 218 REIPDLLEKGERLPQPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred HHHHHHHHCCCcCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111111211 111111 2334588999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=313.65 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=198.8
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|++.+.||+|+||.||+|... ++..+++|.+.. ......+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567788999999999999865 567788888754 223456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 83 FCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred ecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999999988653 35689999999999999999999999 99999999999999999999999999997664433
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
.......++..|+|||.+.... .....++.++|||||||++|||++|+.||..... ...........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~ 224 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCET-----SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE 224 (282)
T ss_pred cccccccccccccCHhhccccC-----CCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcC
Confidence 3334457899999996432110 1244578899999999999999999999864321 11111121111
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ......+..+.+++..||+.+|.+|||+.++++
T Consensus 225 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 225 PPTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 011122345889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.96 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=195.6
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
++..+.....||+|+||.||+|... ++..||+|.+.. ......+.+.+|+++++.++||||+++++++..++..+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE----RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecC----CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3445556678999999999999854 677899998864 22344568899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEecccccee
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSDFGTAKL 661 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~ 661 (786)
+|+||+++++|.+++.........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999997642222237888889999999999999998 9999999999999986 67999999999987
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
............|+..|+||| +... ..++.++||||||+++|+|++|+.||..... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE----------~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~------~~~~~~ 222 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPE----------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE------PQAAMF 222 (268)
T ss_pred cccCCCccccCCCCccccChh----------hhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC------hhhhHh
Confidence 654333233346889999995 4433 2377899999999999999999999763211 000001
Q ss_pred h-hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 N-AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. .........+. .....+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 KVGMFKIHPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhhhccCCCCCc----ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 01111111121 22345889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.84 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=200.2
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|+||+||+++.. +++.||+|++.... ..........+|+.++++++||||+++++++......++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--ccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 677899999999999999866 56689999997631 111222234569999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 79 YCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999983 35789999999999999999999999 99999999999999999999999999998753333
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
.......++..|+|| |... ...++.++||||+|+++|+|++|..||..... .............
T Consensus 153 ~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~ 217 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAP----------EVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEIIEKILKR 217 (260)
T ss_dssp SEBSSSSSSGGGSCH----------HHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHHHHHHHHT
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccccccccccccc-----hhhhhhhhhcccc
Confidence 444556889999999 7776 78899999999999999999999999875310 0111111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...............+.+++..||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111000001011246999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.52 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=202.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.+|+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++||||+++++++...+..|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC----chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 46889999999999999999864 5788999998752 223567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999999998753 25688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhc---CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM---KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~---~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.........++..|+||| ..... .++.++||||||+++|||++|+.||..... ......
T Consensus 154 ~~~~~~~~~~~~~y~~Pe----------~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~ 215 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPE----------VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFL 215 (262)
T ss_pred hhhccccccCCccccCch----------hhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 332334457888999994 44444 788899999999999999999999864321 111111
Q ss_pred hccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........+ .......+..+.+++.+||..+|.+|||+.+|++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111111 1112234556899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=316.24 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=196.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~ 580 (786)
.++|++.+.||+|+||.||+|+++ ++. .+|+|.+... ........+.+|++++.++ +||||+++++++..++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 457888999999999999999864 444 4577776531 2233456788999999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 581 SFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
.|+||||+++|+|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 9999999999999999975421 23578999999999999999999998 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccc
Q 047901 648 EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLS 726 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~ 726 (786)
++.+||+|||++....... ......++..|+|| |......++.++|||||||++|||+| |..||....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAI----------ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred CCcEEeCccccCcccchhh-hcccCCCcccccCH----------HHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999999999986432111 11112345679999 66677778999999999999999998 999986432
Q ss_pred cccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 727 LFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. ......+... +...+. ..+..+.+++.+||+.+|++|||++++++.|
T Consensus 229 ~--------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 229 C--------AELYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred h--------HHHHHHHhcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 1111112111 111121 1234588999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.21 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=200.4
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|+..+.||.|++|+||+|.. .+++.||+|.+... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4689999999999999999975 47899999998642 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999999999864 3578999999999999999999999 999999999999999999999999999886654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........++..|+|| |...+..++.++|||||||++|+|++|+.||..... .........
T Consensus 168 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~ 229 (296)
T cd06655 168 EQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIAT 229 (296)
T ss_pred ccccCCCcCCCccccCc----------chhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 43333345788999999 555666788999999999999999999999864321 111111111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... +.......+..+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 230 NGTP-ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCc-ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111 00011122345889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.26 Aligned_cols=253 Identities=25% Similarity=0.475 Sum_probs=200.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCC---EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
..+|+..+.||+|+||.||+|+.. +++ .+|+|++.... .....+.+..|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 346888999999999999999864 333 68999886421 23345678999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++++|.+++... .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999999999754 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcc-e--eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 661 LLKPNSSNW-T--ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 661 ~~~~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
......... . ....+..|+|| |......++.++|||||||++||+++ |+.||.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~ 217 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAP----------EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NH 217 (268)
T ss_pred ecccccccceeccCCCcCceecCH----------HHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HH
Confidence 765332211 1 11234579999 66777788999999999999999997 999975322 11
Q ss_pred hhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+ ......+. ..+.+.++.+++.+||..+|++||++.+|++.|
T Consensus 218 ~~~~~i-~~~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 218 EVMKAI-NDGFRLPA--PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred HHHHHH-hcCCCCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 122222 21112111 112344689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.71 Aligned_cols=238 Identities=21% Similarity=0.371 Sum_probs=186.0
Q ss_pred eeccccCceEEEEEcCC-------------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 513 CIGKGEHRSVYRAKLPS-------------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.||+|+||.||+|.+.+ ...|++|.+.. ........|.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 58999999999997532 12588888754 22334557888999999999999999999999989
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc-------EE
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE-------AR 652 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-------~k 652 (786)
..++||||+++|+|..++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +|
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999999988753 34689999999999999999999998 9999999999999987654 89
Q ss_pred EeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHH-hCCCCCCccccccC
Q 047901 653 VSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSS 730 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~ell-tg~~Pf~~~~~~~~ 730 (786)
++|||.+...... ....++..|+||| ... ...++.++|||||||++|||+ +|..||.....
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE----------~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--- 215 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPE----------CVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--- 215 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChh----------hhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch---
Confidence 9999998765422 2346788999994 443 456888999999999999998 58888653221
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
................ ....+.+++.+||+.||++||++.++++.|
T Consensus 216 ------~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 ------AEKERFYEGQCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ------hHHHHHHhcCccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0111111111111111 123588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.99 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=197.2
Q ss_pred CccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe---
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--- 580 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--- 580 (786)
|++.+.||+|+||.||+|.... +..||+|++.... ........+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI--HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5677889999999999998542 3679999987522 223345678999999999999999999998865544
Q ss_pred ---eeEEEeccCCCCHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 581 ---SFVVYEYINRGSLATVLSNNF---ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 581 ---~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
.++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 789999999999999985432 234689999999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCC
Q 047901 655 DFGTAKLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSS 731 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~ 731 (786)
|||+++......... ....++..|+|| |......++.++|||||||++|||++ |..||.....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAI----------ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---- 221 (273)
T ss_pred CccceeeccccccccccccccCCccccCH----------hhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 999998775443221 122356789999 66666778999999999999999999 8889764221
Q ss_pred CcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 SSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
........... ...+. ..+..+.+++.+||+.||++|||+.|+++.|
T Consensus 222 ----~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 222 ----HEIYDYLRHGNRLKQPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred ----HHHHHHHHcCCCCCCCc----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 12222222221 12222 2344689999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.15 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=200.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
+.|+..+.||+|++|.||+|... +++.||+|.+...... ......+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999754 6889999998653221 112234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|+||+++++|.+++... +.+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998754 4578899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 664 PNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 664 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... .....|+..|+||| ...+..++.++||||+|+++|||++|+.||..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~ 217 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPE----------VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--------MAAIF 217 (263)
T ss_pred ccccccccccCCCcCccccCcc----------eeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--------HHHHH
Confidence 32211 12346788999994 45556688999999999999999999999864321 11111
Q ss_pred hhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 741 AMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 741 ~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
..... ....+. .....+.+++..||.++|++|||+.|+++.
T Consensus 218 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTNPQLPS----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCCCCCCc----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111 111222 233458899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.56 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=196.6
Q ss_pred ccCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--C
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--V 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~ 578 (786)
.+|+..+.||+|+||+||+|.. .+++.||+|++.. ......+.+.+|++++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH----STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 4688889999999999999974 2577899999864 233445688999999999999999999998743 3
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 4678999999999999999754 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcc---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc-CC-Cc
Q 047901 659 AKLLKPNSSNW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS-SS-SS 733 (786)
Q Consensus 659 a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~-~~-~~ 733 (786)
++......... ....++..|+|| |...+..++.++|||||||++|||++|..|+....... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAP----------ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN 224 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCH----------HHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc
Confidence 98775433211 111234569999 66667778999999999999999999887754322110 00 00
Q ss_pred -----chhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 734 -----SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 734 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......+........+. ....+..+.+++.+||+.+|++|||+.||++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 225 DKQGQMIVYHLIELLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred ccccccchHHHHHHHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 000011111221111110 111234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=313.53 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=202.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|... +++.||+|.+.. ......+.|.+|++++++++||||+++++++......|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI----ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee----CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46888899999999999999865 688999999864 2334557899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 9999999999998754 34689999999999999999999999 999999999999999999999999999876654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........++..|+|||.+.. +......++.++||||||+++|||++|+.||..... ......+..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~ 222 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVAC-----ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILK 222 (280)
T ss_pred cccccceeecchhhcCHHHHhh-----cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhc
Confidence 4333345678999999953211 011234577899999999999999999999874321 111112221
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+. .......+..+.+++..||+.+|.+|||+.++++
T Consensus 223 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 223 SEPPT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCCCC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11110 0011122345889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.53 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=198.6
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
.++|.+.+.||+|+||.||+|+.. +...+|+|.+... ........+..|+++++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 357999999999999999999742 2346999998752 1223456788899999999 799999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..|+||||+++|+|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999976421 23588999999999999999999998 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCcce--eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSNWT--ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||.++.......... ...++..|+|| |...+..++.++|||||||++|||++ |.
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~~l~el~~~g~ 240 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP----------EALFDRIYTHQSDVWSFGVLLWEIFTLGG 240 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh----------HHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999976643221111 12345689999 66667778999999999999999998 88
Q ss_pred CCCCccccccCCCcchhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||.... . ......+... ...+. .....+.+++.+||..+|++|||+.+|++.|
T Consensus 241 ~p~~~~~--------~-~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 241 SPYPGVP--------V-EELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred CCCCcCC--------H-HHHHHHHHcCCCCCCCC----cCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 8875322 1 1111122211 12222 2234588999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.45 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=196.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.. +++.||||++..... ........+..|+.++..++||+|+++++++.+.+..|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 36888999999999999999865 688999999864211 1223456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 80 MEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999999754 5688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHH
Q 047901 665 NSS-----------------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709 (786)
Q Consensus 665 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslG 709 (786)
... .....+||+.|+|| |+..+..++.++||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP----------E~~~~~~~~~~~DiwSlG 223 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP----------EVFMQTGYNKLCDWWSLG 223 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH----------HHHcCCCCCCcceecccc
Confidence 100 01134799999999 777788899999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 047901 710 VLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT---MQTVCQ 784 (786)
Q Consensus 710 vil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~ 784 (786)
|++|||++|+.||..... ......+.. .....|... .......+++.+|+ .+|.+|++ ++|+++
T Consensus 224 vilyel~tG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 224 VIMYEMLIGYPPFCSETP--------QETYRKVMNWKETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ceeeecccCCCCCCCCCH--------HHHHHHHHcCCCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 999999999999874321 112222222 122222211 11234677777766 49999985 666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.29 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=201.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|++.+.||+|+||.||+|+.. +++.||+|.+.. ......+.+.+|+++++.++||||+++++++..++..++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 56889999999999999999865 578999999864 2334567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|..++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999998887643 34689999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........++..|+|||.+... ......++.++|||||||++|||++|+.||..... ......+..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~ 229 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCE-----TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK 229 (292)
T ss_pred cccccceecCCccccCceeeccc-----cccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhc
Confidence 33333456788999999754211 11234578899999999999999999999764221 111111211
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+ ........+..+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 SEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111 00011122345889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.56 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=201.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-CCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-VRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv 584 (786)
+|++.+.||+|++|.||++... +++.||+|++.... ......+.+.+|++++++++|||++++++.+.. +...++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4888999999999999999855 57889999986422 122345678899999999999999999998764 4467899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 79 MGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999999764 235689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........+++.|+|| |...+..++.++||||+|+++|||++|+.||+..+ ..........
T Consensus 155 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~ 216 (257)
T cd08223 155 QCDMASTLIGTPYYMSP----------ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIE 216 (257)
T ss_pred cCCccccccCCcCccCh----------hHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh
Confidence 43333455789999999 66667788899999999999999999999986422 1111222222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.. ....+..+.+++.+||+.+|++|||+.++++
T Consensus 217 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 217 GKLPPM---PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cCCCCC---ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 222211 1233456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.72 Aligned_cols=254 Identities=23% Similarity=0.403 Sum_probs=198.9
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
.++|.+.+.||+|+||.||+|+.. ....||+|.+... ........+.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 457889999999999999999742 2456899988642 2233456788999999999 699999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..++||||+++|+|.+++.... ....+++..+..++.|++.|+.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 99899999999999999999997532 124588999999999999999999998 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCcce--eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSNWT--ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||.++.......... ...++..|+|| |......++.++|||||||++|||++ |.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwslG~~l~el~~~g~ 234 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP----------EALFDRVYTHQSDVWSFGILMWEIFTLGG 234 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCH----------HHHccCCcCccchhhHHHHHHHHHHhCCC
Confidence 9999999999999999987653322111 12344679999 77777788999999999999999999 88
Q ss_pred CCCCccccccCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||..... ......+.... ...+. ..+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 235 ~p~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 235 SPYPGIPV--------EELFKLLREGHRMDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred CCCCCCCH--------HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 89764321 11111111111 11222 1233588999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.89 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=195.5
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|.. .+++.||+|++... ........+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD---ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC---CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 678889999999999999985 47889999998642 12334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|..+. .+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999997652 467888899999999999999999 9999999999999999999999999999866433
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
. .....|+..|+|| |...+..++.++|||||||++|+|++|+.||.......... ..........+.
T Consensus 149 ~--~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~ 215 (279)
T cd06619 149 I--AKTYVGTNAYMAP----------ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDE 215 (279)
T ss_pred c--ccCCCCChhhcCc----------eeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhcc
Confidence 2 2345789999999 55556678899999999999999999999986432111000 011111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... ........+.+++.+||+.+|++||+++|+++
T Consensus 216 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 216 DPPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11110 01112335889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.31 Aligned_cols=254 Identities=21% Similarity=0.402 Sum_probs=201.3
Q ss_pred hccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|+..+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.++++++||||+++++++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 357899999999999999999853 4678999998652 2233456799999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 047901 579 RHSFVVYEYINRGSLATVLSNNF-------------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 639 (786)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999997431 112467889999999999999999998 99999999
Q ss_pred CCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh
Q 047901 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 640 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt 717 (786)
|+||+++.++.+||+|||.+......... ......+..|+|| |...+..++.++|||||||++|||++
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP----------ESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCH----------HHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 99999999999999999999865432211 1122346679999 77777789999999999999999997
Q ss_pred -CCCCCCccccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 718 -GKHPGDFLSLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 718 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|..||..... .+....+.+.... .+. ..+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 228 ~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 228 YGMQPYYGMAH--------EEVIYYVRDGNVLSCPD----NCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred CCCCCCCCCCH--------HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 8888753221 1222222222221 122 2234589999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.30 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=195.0
Q ss_pred CccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Ce
Q 047901 508 FDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RH 580 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~ 580 (786)
|+..+.||+|+||+||++.. .+++.||+|.+.... .......+.+|+++++.++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 37889999999999988642 357789999986521 123456788999999999999999999988653 45
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999999653 589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcc---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc-----CCC
Q 047901 661 LLKPNSSNW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS-----SSS 732 (786)
Q Consensus 661 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~-----~~~ 732 (786)
......... ....++..|+|| |......++.++||||||+++|||+||..||....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~P----------E~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 225 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAV----------ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCH----------hHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc
Confidence 765432211 122456679999 66666778999999999999999999999975432100 000
Q ss_pred -cchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 733 -SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 733 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...........+.....+ .....+.++.+++..||+.+|++|||++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 226 GQMTVVRLIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred cccchhhhhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 000111111111111111 0112234689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.19 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=201.7
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||.|++|.||+|+.. +++.||+|.+.... .......+.+|+++++.++||||+++++++.++...++|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 6888889999999999999865 68899999986532 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999999743 789999999999999999999998 9999999999999999999999999999887654
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........++..|+|| |...+..++.++|||||||++|||+||+.||..... ......+...
T Consensus 152 ~~~~~~~~~~~~y~~P----------E~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~~ 213 (274)
T cd06609 152 MSKRNTFVGTPFWMAP----------EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLIPKN 213 (274)
T ss_pred ccccccccCCccccCh----------hhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHhhhc
Confidence 3333455788899999 666667789999999999999999999999864321 0111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+... ....+..+.+++.+||..+|++|||++++++
T Consensus 214 ~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 214 NPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111000 0113445889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.71 Aligned_cols=254 Identities=23% Similarity=0.399 Sum_probs=199.7
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
..+|++.+.||+|+||.||+|+.. ++..||+|.+... ......+.+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 457889999999999999999731 2347999988642 1233456788999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..++||||+++|+|.+++..... ...+++..+..++.|++.|+.|||+. +|+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999976421 23578899999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||.++......... ....++..|+|| |...+..++.++||||||+++|||++ |.
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP----------EALFDRVYTHQSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc----------hhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999998775432211 223456789999 66667778999999999999999998 78
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||..... ......+... +...+. ..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 238 ~p~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 238 SPYPGIPV--------EELFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred CCcccCCH--------HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 88754221 1111111111 111121 2334588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.82 Aligned_cols=245 Identities=26% Similarity=0.419 Sum_probs=196.4
Q ss_pred eeeccccCceEEEEEcCC--C--CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKLPS--G--DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
+.||+|++|.||+|.+.+ + ..||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 368999999999998643 2 26899998763221 556789999999999999999999999988 889999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999987532 5689999999999999999999999 999999999999999999999999999987754322
Q ss_pred cc---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 668 NW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 668 ~~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ....++..|+|| |......++.++|||||||++|||++ |+.||..... ........
T Consensus 153 ~~~~~~~~~~~~~y~~p----------E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~ 214 (257)
T cd05040 153 HYVMEEHLKVPFAWCAP----------ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKID 214 (257)
T ss_pred ceecccCCCCCceecCH----------HHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 11 123567899999 77777789999999999999999998 9999763221 11111111
Q ss_pred --cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 --DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 --~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+. ..+..+.+++.+||+.+|++|||+.++++.|
T Consensus 215 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 215 KEGERLERPE----ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred hcCCcCCCCc----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 11122221 2234688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.00 Aligned_cols=249 Identities=25% Similarity=0.438 Sum_probs=199.8
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.+|+..+.||+|+||.||+|.+.+++.+|+|++.... .....|.+|++++++++||||+++++++......++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4688889999999999999988778899999986421 22357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999999999754 24578999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... .....++..|+|| |...+..++.++||||||+++|||++ |+.||.... .........
T Consensus 154 ~~~~~~~~~~~~~~~aP----------e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~ 215 (256)
T cd05112 154 QYTSSTGTKFPVKWSSP----------EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETIN 215 (256)
T ss_pred cccccCCCccchhhcCH----------hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHh
Confidence 211 1122356789999 66666778899999999999999998 999976322 111111111
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...+.. .+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 216 ~~~~~~~~~~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 AGFRLYKPRL----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCC----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11 1111211 124589999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.97 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=194.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|+..+.||+|+||.||+|... +++.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 468999999999999999999864 688999999975432 2234567889999999999999999999886443
Q ss_pred --eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 580 --HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 580 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
..|+||||+++ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999976 6776664 2478888999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC-------
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS------- 730 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~------- 730 (786)
+++..... .......||+.|+|| |...+..++.++||||+||++|||++|+.||...+....
T Consensus 169 ~a~~~~~~-~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 169 LARTACTN-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred CccccccC-ccCCCCcccCCCCCc----------hhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99765432 222345789999999 566677889999999999999999999999875331100
Q ss_pred ---CCcc----hhhhhhhhccCCCCCCChh----------------HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ---SSSS----INIEFNAMLDHRLPHPSLD----------------VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ---~~~~----~~~~~~~~~~~~~~~~~~~----------------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ...........+...+... .......+.+++.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000011111111100000 0011245789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.93 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=198.9
Q ss_pred ccCccceeeccccCceEEEEEcCC-C---CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS-G---DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.+|++.+.||+|+||.||+|+... + ..||||.+... ........|..|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 458889999999999999998652 3 36999998653 2234567899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|+|.+++... .+.+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 81 MIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999999999764 35689999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCcc--e-eec--cCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcch
Q 047901 662 LKPNSSNW--T-ELV--GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 662 ~~~~~~~~--~-~~~--gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~ 735 (786)
........ . ... .+..|+|| |......++.++|||||||++||+++ |..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-------- 217 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAP----------EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------- 217 (269)
T ss_pred cccCccccccccccCCCcceeecCH----------hHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------
Confidence 64332211 1 111 24579999 66667788999999999999999886 9999864321
Q ss_pred hhhhhhhc-cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 736 NIEFNAML-DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 736 ~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+. +.+.+.+. +.+..+.+++.+||.++|.+|||++++++.|
T Consensus 218 ~~~~~~i~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 218 QDVINAIEQDYRLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred HHHHHHHHcCCcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111111 11222222 2334588999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.59 Aligned_cols=251 Identities=22% Similarity=0.412 Sum_probs=200.7
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 4578999999999999999999877888999988641 2235678899999999999999999999887 778999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... .....++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999999764 345678899999999999999999998 999999999999999999999999999986643
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....++..|+|| |......++.++|||||||++|++++ |+.||..... ......
T Consensus 155 ~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---------~~~~~~ 215 (260)
T cd05073 155 NEYTAREGAKFPIKWTAP----------EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---------PEVIRA 215 (260)
T ss_pred CCcccccCCcccccccCH----------hHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---------HHHHHH
Confidence 3221 1223456789999 66666778999999999999999999 9999864321 111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+......+. ....+..+.+++.+||+++|++||++.++.+.|
T Consensus 216 ~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 216 LERGYRMPR--PENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HhCCCCCCC--cccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 122211111 122334588999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.23 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=200.4
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||.||+|... ++.||+|++.... ...+++.+|+.+++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 357888999999999999999875 7899999997521 2467889999999999999999999999988999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999999999999765 224689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... ...++..|+|| |......++.++||||||+++||+++ |..||..... ......+
T Consensus 155 ~~~---~~~~~~~~~ap----------e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~ 212 (256)
T cd05039 155 GQD---SGKLPVKWTAP----------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPHV 212 (256)
T ss_pred ccc---cCCCcccccCc----------hhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHH
Confidence 221 23456689999 55566678899999999999999997 9999764221 1111111
Q ss_pred cC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...+. ..+..+.+++.+||..+|++|||+.|+++.|
T Consensus 213 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 213 EKGYRMEAPE----GCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred hcCCCCCCcc----CCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 11 111121 2234688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.51 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=203.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||.|+||+||+|... ++..+|+|++..... ....+.+.+|+++++.++||||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 46889999999999999999854 678899999864221 22567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++........+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999997653335689999999999999999999998 999999999999999999999999999987664
Q ss_pred CCCc----ceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 665 NSSN----WTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 665 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
.... .....|+..|+|| |..... .++.++|||||||++|||++|+.||...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~P----------e~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~ 216 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAP----------EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVL 216 (267)
T ss_pred CccccccccccccCChhhcCh----------HHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhH
Confidence 4322 1334688999999 555444 6889999999999999999999998743321 111
Q ss_pred hhhccCCCC-CCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 NAMLDHRLP-HPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......... .+. ......+..+.+++..||..||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 217 MLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111111 010 001123456889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.18 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=199.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|... ++..+|+|.+... .......++.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 36889999999999999999865 6778899988642 1233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... +.+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||.+.....
T Consensus 78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999999754 56889999999999999999999731 899999999999999999999999999876543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------Ccc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----------SSS 734 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----------~~~ 734 (786)
.. .....|+..|+|| |...+..++.++|||||||++|||++|+.||......... ...
T Consensus 153 ~~--~~~~~~~~~~~aP----------E~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
T cd06615 153 SM--ANSFVGTRSYMSP----------ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220 (308)
T ss_pred cc--cccCCCCcCccCh----------hHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccccc
Confidence 21 2345788999999 6666677889999999999999999999998642210000 000
Q ss_pred ------------------hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 735 ------------------INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 735 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
............. |..........+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 000001123458899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=289.13 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=200.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 584 (786)
+.+....+|.|..|+||+++.+ .|..+|||.+.+ ....++.+++...+.++..- ++|+||+++|||..+..+++-
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r---t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR---TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecc---cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3445567999999999999876 578899999976 34556778888898887766 589999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||.|.. -++..+.+- .+++++.-+=++...+++||.||.+++ +|+|||+||+|||+|+.|++|+||||.+-++.+
T Consensus 170 MelMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 999864 455555543 456888888889999999999999985 999999999999999999999999999988865
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
+. ..+...|-+.|||||.+... ...+|+.++||||||+.++||.||..||.... .+.+.+..+.+
T Consensus 245 Sk-AhtrsAGC~~YMaPERidp~-------~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-------tdFe~ltkvln 309 (391)
T KOG0983|consen 245 SK-AHTRSAGCAAYMAPERIDPP-------DKPKYDIRADVWSLGITLVELATGQYPYKGCK-------TDFEVLTKVLN 309 (391)
T ss_pred cc-ccccccCCccccCccccCCC-------CCCccchhhhhhhhccchhhhhcccCCCCCCC-------ccHHHHHHHHh
Confidence 43 33456899999999866432 24579999999999999999999999987533 12333444444
Q ss_pred CCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+ .++.. ..+..+.+++..|+.+|+.+||.+.++++
T Consensus 310 ~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 310 EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 3322 12111 14456999999999999999999999886
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.53 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=158.4
Q ss_pred ceeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCeeeEEE
Q 047901 511 KYCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRHSFVVY 585 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 585 (786)
+.+||+|+||+||+|+.. +++.||+|++... .....+.+|++++++++||||+++++++.. +...|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT------GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC------CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 457999999999999854 4578999998642 112356789999999999999999998853 45688999
Q ss_pred eccCCCCHHHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee----CCCCcEEEec
Q 047901 586 EYINRGSLATVLSNNF------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL----DLEYEARVSD 655 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~D 655 (786)
||+++ +|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99865 8888875321 123588999999999999999999999 99999999999999 4567999999
Q ss_pred cccceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 656 FGTAKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 656 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
||+|+....... ......||+.|+|| |+..+ ..++.++||||+||++|||++|++||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAP----------ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCC----------HHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 999987653321 22346789999999 55544 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.10 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=200.0
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCC--CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN--DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+|+..+.||+|+||+||+|...+++.+|||.+...... ........+.+|+++++.++||||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998888899999998753221 1223345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999754 4578899999999999999999998 999999999999999999999999999876532
Q ss_pred CC------CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 665 NS------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 665 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.. .......|+..|+|| |...+..++.++||||+||++|+|++|+.||...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~ 216 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAP----------EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--------AA 216 (265)
T ss_pred ccccccccccccccCCCccccCh----------hhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--------HH
Confidence 11 112234688999999 5666667889999999999999999999998643211 01
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...........+. ........+.+++.+||+++|++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 MFYIGAHRGLMPR-LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHhhhccCCCCC-CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111000010 01123345889999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.05 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=198.2
Q ss_pred eeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCC
Q 047901 513 CIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRG 591 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 591 (786)
++|+|.||+||-|+..+ ...+|||-+.. .+....+.+..||...+.++|.|||+++|.+..++..-|.||.++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 69999999999999764 55789998864 22334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-CCCcEEEeccccceecCCCCCc
Q 047901 592 SLATVLSNNFASEDF--DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-LEYEARVSDFGTAKLLKPNSSN 668 (786)
Q Consensus 592 ~L~~~l~~~~~~~~~--~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~ 668 (786)
+|.+.++.. .+++ .+.++--+..||++||.|||+. .|||||||-+||||+ -.|.+||+|||-++++..-..-
T Consensus 658 SLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999999864 5555 7888888999999999999999 999999999999996 4599999999999987644334
Q ss_pred ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCC
Q 047901 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLP 748 (786)
Q Consensus 669 ~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (786)
..++-||..|||||++..| ...|+.++|||||||.+.||.||++||--+.. .+...-...|.+-..+
T Consensus 733 TETFTGTLQYMAPEvIDqG--------~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-----pqAAMFkVGmyKvHP~ 799 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQG--------PRGYGKAADIWSFGCTMVEMATGRPPFVELGS-----PQAAMFKVGMYKVHPP 799 (1226)
T ss_pred ccccccchhhhChHhhccC--------CcCCCchhhhhhccceeEeeccCCCCeeecCC-----hhHhhhhhcceecCCC
Confidence 4567899999999543322 24588999999999999999999999864321 1111111233333333
Q ss_pred CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.| .+...+...+|.+|+.+||.+||++.++++
T Consensus 800 iP----eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IP----EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred Cc----HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 44 344556889999999999999999999985
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.26 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=188.0
Q ss_pred eeccccCceEEEEEcCC---CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHRSVYRAKLPS---GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.||+|+||.||+|.+.+ +..+|+|++.... .......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 58999999999997543 3578999886532 22344578899999999999999999999999899999999999
Q ss_pred CCCHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 590 RGSLATVLSNNFA--SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 590 ~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+|+|.+++..... ....++..+..++.|++.|++|||+. +++||||||+||+++.++++||+|||.++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999975422 23467788889999999999999999 999999999999999999999999999975543221
Q ss_pred c--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhh-hc
Q 047901 668 N--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNA-ML 743 (786)
Q Consensus 668 ~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~-~~ 743 (786)
. .....++..|+|||+...... ......++.++||||||+++|||++ |+.||..... .+.... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~ 224 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHG---NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--------EQVLTYTVR 224 (269)
T ss_pred eecCCCcCCcccccCHhHhccccc---cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHhh
Confidence 1 123457788999964321100 0011246789999999999999996 9999864321 111111 11
Q ss_pred c--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 D--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. .+...+.. .......+.+++..|| .+|++|||++||++.|
T Consensus 225 ~~~~~~~~~~~-~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 225 EQQLKLPKPRL-KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred cccCCCCCCcc-CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1 11111110 0112234778999999 6899999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.55 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=196.1
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-----e
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR-----H 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~ 580 (786)
+|+..+.||+|+||+||+|.. .+++.||||++.... ......+.+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 478889999999999999985 478999999986532 22234567889999999999999999999998766 7
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 899999997 5888888643 5689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC------
Q 047901 661 LLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS------ 732 (786)
Q Consensus 661 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~------ 732 (786)
....... ......++..|+|| |...+ ..++.++||||+||++|||++|+.||..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 221 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAP----------EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221 (372)
T ss_pred ecccCccccCCCCCcCCCcCCH----------HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 7643322 22334688999999 55554 457899999999999999999999997543211000
Q ss_pred -cchhh-------hhhhhc-cCCCCCCCh-----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 -SSINI-------EFNAML-DHRLPHPSL-----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 -~~~~~-------~~~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... .....+ ......+.. ........+.+++.+||+.||++|||+.|+++
T Consensus 222 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 000001 011111100 00111345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.91 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=196.4
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe-cCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS-HVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~~~~lv 584 (786)
.+|+..+.||+|+||.||+|... +..||+|.+... ...+.+.+|+.++++++|||++++++++. .+...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 46889999999999999999875 778999988541 23467889999999999999999999764 55678999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999999765 234588999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ....++..|+|| |+.....++.++|||||||++|||++ |+.||..... ......+
T Consensus 155 ~~---~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---------~~~~~~~ 212 (256)
T cd05082 155 TQ---DTGKLPVKWTAP----------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRV 212 (256)
T ss_pred cC---CCCccceeecCH----------HHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHH
Confidence 22 223456689999 77777788999999999999999998 9999763221 1111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...... ......+..+.+++.+||+.+|++|||+.++++.|
T Consensus 213 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 213 EKGYKM--DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred hcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111110 01112334588999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.13 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=187.6
Q ss_pred eeccccCceEEEEEcCC---CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHRSVYRAKLPS---GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.||+|+||.||+|...+ ...+|+|.+... ........|.+|+++++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999997543 346888877542 223345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 590 RGSLATVLSNNFA--SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 590 ~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+|+|.+++..... ....++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999976432 23356788889999999999999999 999999999999999999999999999875433221
Q ss_pred c--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhcc
Q 047901 668 N--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 668 ~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. .....++..|+|||+..... .......++.++|||||||++|||++ |..||..... .......+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~ 224 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRG---QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVR 224 (269)
T ss_pred eeccCCCCCcccccCHHHHhhcc---ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhh
Confidence 1 12234567899995321110 00123456889999999999999999 7888764221 111111111
Q ss_pred ---CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 ---HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 ---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..++.+. .....+..+.+++..|| .||++|||++||++.|
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 225 EQDIKLPKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCccCCCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1121111 11223445778889999 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.84 Aligned_cols=243 Identities=22% Similarity=0.237 Sum_probs=188.4
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc---CCCcccceeeEEecCCeeeEEEeccC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
||+|+||+||+|+.. +++.||||++..... ........+..|..++... +||||+++++++......|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI-VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH-hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 699999999999865 688999999854211 1112233455677776655 69999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999998753 5689999999999999999999999 99999999999999999999999999997654333334
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLP 748 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (786)
....||..|+|| |...+ ..++.++||||+||++|||++|+.||.... .......+......
T Consensus 154 ~~~~gt~~y~aP----------E~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~ 215 (330)
T cd05586 154 NTFCGTTEYLAP----------EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFGKVR 215 (330)
T ss_pred cCccCCccccCH----------HHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 456799999999 55543 347899999999999999999999986422 12222223322232
Q ss_pred CCChhHHHHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 047901 749 HPSLDVQEKLISIMEVALLCLDGCPNSRP----TMQTVCQ 784 (786)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP----t~~ev~~ 784 (786)
.+.. .....+.+++.+||++||++|| ++.++++
T Consensus 216 ~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 2221 1233578999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.07 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=195.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+++.. +++.||||++.... .......+.+.+|+.++..++||||+++++++..++..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 36899999999999999999865 68899999986311 11223445688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999999753 34688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhh-----hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAY-----TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~-----~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
... ......||+.|+|| |+.. ...++.++||||+||++|||++|+.||..... .+.
T Consensus 155 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~ 216 (331)
T cd05597 155 DGTVQSNVAVGTPDYISP----------EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VET 216 (331)
T ss_pred CCCccccceeccccccCH----------HHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHH
Confidence 322 22234799999999 5544 24578899999999999999999999864221 111
Q ss_pred hhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCC--CCCCCCHHHHHH
Q 047901 739 FNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGC--PNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~--p~~RPt~~ev~~ 784 (786)
...+... ....+.. ....+..+.+++.+|+..+ +..||++.++++
T Consensus 217 ~~~i~~~~~~~~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 217 YGKIMNHKEHFQFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHHHcCCCcccCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 1222211 1111111 1112345778888877543 334789998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.29 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=201.4
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 6888899999999999999875 78899999886421 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++........+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 9999999999987643345789999999999999999999963 28999999999999999999999999999766432
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
. .....++..|+|||.+.... ......++.++|||||||++|||++|+.||..... .............
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~ 225 (286)
T cd06622 157 L--AKTNIGCQSYMAPERIKSGG----PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDG 225 (286)
T ss_pred c--cccCCCccCccCcchhcCCC----CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhc
Confidence 2 22346888999997443221 11233468899999999999999999999864211 1111112222222
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... .........+.+++.+||..+|++||+++++++
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 DPP---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCC---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 111224456889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.06 Aligned_cols=250 Identities=29% Similarity=0.412 Sum_probs=200.0
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc-----hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ-----MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
+|.....||+|++|.||+|... +++.||+|.+........ ....+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777889999999999999754 678999998876433221 1223578899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++++|.+++... +.+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999754 5678899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 661 LLKPNSS------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 661 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
....... ......|+..|+|| |...+..++.++||||+||++|+|++|+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~p----------e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------- 217 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAP----------EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------- 217 (267)
T ss_pred ccccccccCCccccccccCCCcCccCh----------hHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------
Confidence 7753211 11234588899999 666667788999999999999999999999874321
Q ss_pred hhhhhhhhccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
............ ..+. ..+..+.+++.+||++||++||++.|+++
T Consensus 218 -~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 218 -LQAIFKIGENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HHHHHHHhccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111111111 1121 22345889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.14 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=200.4
Q ss_pred eeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
+.||+|+||.||+|.... +..|++|.+..... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 368999999999998653 78899999876322 12467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 588 INRGSLATVLSNNFA------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 999999999986421 36789999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCC--CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhh
Q 047901 662 LKPNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 738 (786)
..... .......++..|+|| |......++.++||||+|+++|||++ |..||..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~ 216 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAP----------ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEV 216 (262)
T ss_pred cccccccccccCCCcCccccCH----------HHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 76443 122344678899999 66666688999999999999999999 6999875321 111
Q ss_pred hhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 739 FNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 739 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+... +...+. ..+..+.+++..||..+|.+|||+.|+++.|
T Consensus 217 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 217 LEYLRKGYRLPKPE----YCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHcCCCCCCCc----cCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 2222221 222222 2244689999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.49 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=201.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
..|+..+.||+|+||.||+|... +++.||+|.+... ......+.+.+|+++++.++||||+++++++.++...++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 35778889999999999999865 5789999988642 2234456889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 81 MEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999999864 3578889999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........++..|+|| |...+..++.++|||||||++|||++|..||...... . ......
T Consensus 154 ~~~~~~~~~~~~~y~ap----------E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~-~~~~~~ 214 (277)
T cd06640 154 TQIKRNTFVGTPFWMAP----------EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------R-VLFLIP 214 (277)
T ss_pred CccccccccCcccccCH----------hHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------h-Hhhhhh
Confidence 33333345688899999 6666777899999999999999999999998643211 0 001111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. .+.......+..+.+++..||+.+|++|||+.++++
T Consensus 215 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 215 KN--NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred cC--CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 11 111122344566899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.12 Aligned_cols=242 Identities=28% Similarity=0.420 Sum_probs=191.7
Q ss_pred eeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
++||+|+||.||+|.+.. +..+|+|.+.... .....+++.+|+++++.++||||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH---IAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEe
Confidence 369999999999997532 2689999987532 11355688999999999999999999998764 567999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
+++|+|.+++... +.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 77 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 77 APLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999865 3689999999999999999999998 999999999999999999999999999987654332
Q ss_pred cce---eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 668 NWT---ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 668 ~~~---~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... ...++..|+|| |......++.++|||||||++|||++ |..||..... ......+
T Consensus 151 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---------~~~~~~~ 211 (257)
T cd05060 151 YYRATTAGRWPLKWYAP----------ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---------AEVIAML 211 (257)
T ss_pred ccccccCccccccccCH----------HHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---------HHHHHHH
Confidence 221 11234679999 66667778999999999999999998 9999864321 1111112
Q ss_pred cCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... ...+. ..+..+.+++.+||..+|++|||+.++++.|
T Consensus 212 ~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 212 ESGERLPRPE----ECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HcCCcCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111 11221 2234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=330.05 Aligned_cols=257 Identities=22% Similarity=0.255 Sum_probs=188.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|+..+.||+|+||+||+|... +++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 457999999999999999999864 6889999988531 12234799999999999999999876421
Q ss_pred ---CeeeEEEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEE
Q 047901 579 ---RHSFVVYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARV 653 (786)
Q Consensus 579 ---~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl 653 (786)
...++||||+++ ++.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 246789999985 777776532 1345689999999999999999999999 99999999999999966 47999
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
+|||+|+....... .....||+.|+|| |++.+ ..++.++||||+||++|||++|.+||..........
T Consensus 213 ~DFGla~~~~~~~~-~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 281 (440)
T PTZ00036 213 CDFGSAKNLLAGQR-SVSYICSRFYRAP----------ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281 (440)
T ss_pred eccccchhccCCCC-cccCCCCcCccCH----------HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999987654322 2335789999999 55543 468999999999999999999999987533210000
Q ss_pred -------cchhhhhhhh----ccCCCCC-CChhH-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 -------SSINIEFNAM----LDHRLPH-PSLDV-----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 -------~~~~~~~~~~----~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+....+ .+..++. ..... ...+.++.+++.+||.+||.+|||+.|+++
T Consensus 282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000000 0000000 00000 012345889999999999999999999875
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.12 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=202.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|... +++.||+|++... ......+.+.+|+++++.++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 46888899999999999999865 6888999987642 2233457889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... +.+++..+..++.+++.|+.|||+. .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999998753 4689999999999999999999973 1899999999999999999999999999876533
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC---Ccchhhhhhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS---SSSINIEFNA 741 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~---~~~~~~~~~~ 741 (786)
.. .....|+..|+|| |...+..++.++|||||||++|++++|+.||+........ ..........
T Consensus 157 ~~--~~~~~~~~~~~aP----------E~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 157 SI--ADTFVGTSTYMSP----------ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred hc--cCccccCcccCCH----------HHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 22 1235789999999 6666678889999999999999999999998753321000 0000111222
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
+........ .....+..+.+++.+||++||++|||+.|+++.
T Consensus 225 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 225 IVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 222211111 111234568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.92 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=197.6
Q ss_pred cCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--C
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--R 579 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~ 579 (786)
-|+..+.||+|+||.||+|+. .++..||+|.+... ........+.+|+++++.++||||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 478889999999999999973 35778999998652 2233456789999999999999999999998765 5
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 678999999999999999754 24589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc-ccC-----
Q 047901 660 KLLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL-FSS----- 730 (786)
Q Consensus 660 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~-~~~----- 730 (786)
+........ .....++..|+|| |...+..+++++|||||||++|||+|++.|+..... +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~ap----------E~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAP----------ECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226 (284)
T ss_pred cccccCccceeecCCCCCCccccCH----------HHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc
Confidence 876543221 1234567789999 666677789999999999999999998877432110 000
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...................+. ....+..+.+++.+||+.+|++|||++++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 227 HGQMTVTRLVRVLEEGKRLPR--PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred cccccHHHHHHHHHcCccCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 000000011111111111111 112344689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=345.07 Aligned_cols=257 Identities=19% Similarity=0.306 Sum_probs=197.9
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRH 580 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~ 580 (786)
..++|++.+.||+|+||+||+|+.. ++..||+|.+.... ........|..|+.+++.++|||||++++++.. ...
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3468999999999999999999865 56788999886532 223345678999999999999999999998854 456
Q ss_pred eeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEEcCCCCCceeeCCC-------
Q 047901 581 SFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCF----PPIVHRDISSNNVLLDLE------- 648 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~----~~ivHrdlk~~Nill~~~------- 648 (786)
.|+||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+... .+||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997532 23568999999999999999999998521 259999999999999642
Q ss_pred ----------CcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHH
Q 047901 649 ----------YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVI 716 (786)
Q Consensus 649 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~ell 716 (786)
+.+||+|||++....... ......||+.|+|| |++.+ ..+++++|||||||++|||+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAP----------EvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSP----------ELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCH----------HHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 459999999998764332 22345799999999 55533 45889999999999999999
Q ss_pred hCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 717 KGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 717 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
||+.||..... .. .....+......+. ...+..+.++|..||..+|.+|||+.|+++
T Consensus 238 TGk~PF~~~~~-------~~-qli~~lk~~p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SGKTPFHKANN-------FS-QLISELKRGPDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HCCCCCCcCCc-------HH-HHHHHHhcCCCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999864321 11 11111221111111 112345889999999999999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.78 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=191.5
Q ss_pred cceeeccc--cCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 510 AKYCIGKG--EHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 510 ~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
..++||+| +|++||+++.+ +++.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 34679999 67899999764 789999999865321 22334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++|+|.+++..+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 80 FMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred ccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999997542 34589999999999999999999998 99999999999999999999999998754432111
Q ss_pred C-------cceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 667 S-------NWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 667 ~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
. ......++..|+|| |+..+ ..++.++|||||||++|||++|+.||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 225 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSP----------EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225 (327)
T ss_pred ccccccccccccccceecccCh----------HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC
Confidence 1 11223567889999 55543 45889999999999999999999999753321100000000
Q ss_pred hhhhh-------------------ccCCC--------CCC-------ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 738 EFNAM-------------------LDHRL--------PHP-------SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 738 ~~~~~-------------------~~~~~--------~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
..... .+... ..+ ..........+.+++..||+.||++|||++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 00000 00000 000 001112345688999999999999999999997
Q ss_pred H
Q 047901 784 Q 784 (786)
Q Consensus 784 ~ 784 (786)
+
T Consensus 306 ~ 306 (327)
T cd08227 306 N 306 (327)
T ss_pred c
Confidence 5
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.59 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=195.7
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|++.+.||+|+||+||+|.. .+++.||||+++... .......+.+|++++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 35799999999999999999963 346789999986421 223456788999999999 68999999998864
Q ss_pred -CCeeeEEEeccCCCCHHHHhhcCCC------------------------------------------------------
Q 047901 578 -VRHSFVVYEYINRGSLATVLSNNFA------------------------------------------------------ 602 (786)
Q Consensus 578 -~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 602 (786)
+...++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4567899999999999999864310
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc--ce
Q 047901 603 ----------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WT 670 (786)
Q Consensus 603 ----------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~ 670 (786)
...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12367888899999999999999999 9999999999999999999999999999875432221 12
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccC-CCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDH-RLP 748 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 748 (786)
...++..|+|| |...+..++.++||||||+++|||++ |..||..... .......+... +..
T Consensus 240 ~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~ 302 (343)
T cd05103 240 DARLPLKWMAP----------ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMR 302 (343)
T ss_pred CCCCCcceECc----------HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHHHhccCCCC
Confidence 23456789999 66667788999999999999999997 9999764221 01111111111 112
Q ss_pred CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.|.. ....+.+++..||+.+|++|||+.||++.|
T Consensus 303 ~~~~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 303 APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2221 123588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.45 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=202.2
Q ss_pred HHHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 498 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
++.+....++|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 4455566788999999999999999999764 6789999987531 12235677899999999 699999999987
Q ss_pred e-----cCCeeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC
Q 047901 576 S-----HVRHSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649 (786)
Q Consensus 576 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 649 (786)
. .++..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 3 3457899999999999999886431 235688999999999999999999998 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 650 EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 650 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
.+||+|||+++.............|+..|+|||.+... ......++.++||||+||++|||++|+.||......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~- 235 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE-----QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM- 235 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchh-----hhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-
Confidence 99999999998765443333445789999999644321 112345788999999999999999999997643211
Q ss_pred CCCcchhhhhhhhcc---CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 730 SSSSSINIEFNAMLD---HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
........ .....+.. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 236 -------~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 -------RALFKIPRNPPPTLHQPEL----WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -------HHHhhccccCCCcccCCCC----cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111111 11111111 12358899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.24 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=186.1
Q ss_pred eeccccCceEEEEEcCCCC---EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHRSVYRAKLPSGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+||+|+||.||+|+..++. .+++|.+... ......+.|.+|+.+++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 5899999999999754333 4566766542 223345689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC--
Q 047901 590 RGSLATVLSNNFA-SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS-- 666 (786)
Q Consensus 590 ~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 666 (786)
+|+|.+++..... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999976422 23466777889999999999999998 99999999999999999999999999986432221
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
.......++..|+|||+...... ......++.++|||||||++|||++ |..||..... .+....+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~ 224 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHG---GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKD 224 (268)
T ss_pred hcccCCcCcccccCchhcccccC---ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhh
Confidence 11223467889999975421110 0112356789999999999999997 5678753221 1111111111
Q ss_pred ---CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 746 ---RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 746 ---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....|.. .......+.+++..|| .+|++|||+++|++.|
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 225 QQVKLFKPQL-ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cccccCCCcc-CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1111110 1112345788999999 6799999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.40 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=204.1
Q ss_pred HhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~ 582 (786)
....|++.+.||+||.+.||++...+.+-+|+|++.... .+......|..|++.+.+++ |.+||++++|-..++..|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345689999999999999999998888999999886532 34456778999999999995 999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
|||||-+. ||..+|+.. ......| .++.+..|++.|+.++|.+ ||||.||||.|+|+- .|.+||+|||.|.-+
T Consensus 437 mvmE~Gd~-DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecccc-cHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99998755 999999865 2233344 6777899999999999999 999999999999997 689999999999988
Q ss_pred CCCCCc--ceeeccCccccCCCCCCCCchHHHHh-hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 663 KPNSSN--WTELVGTFGYVAPAHGNIGLHLAELA-YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 663 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~-~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
..+... ....+||+-||+||.+..-..-.+-- ..-+.+++|||||+|||+|+|++|++||.... .....+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aKl 582 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAKL 582 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHHH
Confidence 765443 34569999999996432111000000 01136689999999999999999999987432 233455
Q ss_pred hhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 NAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.++.++.- ..|...... ++.++|+.||.+||++|||+.|+++
T Consensus 583 ~aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HhhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 66666533 333222221 2889999999999999999999986
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.00 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=198.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+++++.++||||+++++++..+...++||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 4666778999999999999754 67889999886421 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999999999853 4678999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........|+..|+|| |...+..++.++|||||||++|||++|+.||...... .........
T Consensus 155 ~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~ 216 (277)
T cd06642 155 QIKRNTFVGTPFWMAP----------EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLIPKN 216 (277)
T ss_pred chhhhcccCcccccCH----------HHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhhhhcC
Confidence 3333345688899999 6666777889999999999999999999997643211 111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+ ......+..+.+++.+||+.+|++|||+.++++
T Consensus 217 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 217 SPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111 111123345889999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.70 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=198.1
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC---CCcccceeeEEecCCeee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR---HRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~ 582 (786)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+++.+|+++++.++ |||++++++++..+...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 367778899999999999986 478899999986532 2234567889999999986 999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 99999999999999864 3688999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...........|+..|+||| ... +..++.++|||||||++|+|++|+.||....... ....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~ 213 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPE----------VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMML 213 (277)
T ss_pred CCCccccccccCCcceeCHH----------HhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhhc
Confidence 65544344457899999994 443 3456889999999999999999999987432211 0000
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 214 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 214 IPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0011 1111111113456889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.03 Aligned_cols=252 Identities=18% Similarity=0.199 Sum_probs=192.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
..|.+.+.||+|+||.||+|+.. .++.||||.... ..+.+|++++++++|||||++++++...+..++|
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 36889999999999999999865 578899996422 2356899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||++. ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99995 6999988653 24689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......||..|+|| |+..+..++.++|||||||++|||++|..|+-........... ......+
T Consensus 313 ~~~~~~~~~~~GT~~Y~AP----------E~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~-~~~l~~~ 381 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAP----------EVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY-DAQILRI 381 (461)
T ss_pred ccccccccccCCCcCCcCH----------HHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCc-HHHHHHH
Confidence 322 12235799999999 7777778999999999999999999987664221110000000 0000111
Q ss_pred ccC----------------------------CCCCCChhHH---HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDH----------------------------RLPHPSLDVQ---EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~----------------------------~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.. +.......+. .....+.+++..||+.||++|||+.|+++
T Consensus 382 i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 382 IRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 0000000011 11235789999999999999999999986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.54 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=203.3
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||++... +++.||+|++..... .....+++.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 4888999999999999999754 688999999864211 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999999999754 234578999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........|+..|+|| |...+..++.++|||||||++|+|++|+.||.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~ 216 (256)
T cd08218 155 VELARTCIGTPYYLSP----------EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRG 216 (256)
T ss_pred hhhhhhccCCccccCH----------HHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcC
Confidence 3333345688899999 66667778899999999999999999999976321 12222222222
Q ss_pred CCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... .+ ......+.+++.+||+.+|++||++.||++
T Consensus 217 ~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 217 SYPPVS----SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCCCc----ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 221 11 122345899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=323.27 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=196.0
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC----
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV---- 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~---- 578 (786)
..++|+..+.||+|+||.||+|... .++.||||++..+.. .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 3568999999999999999999854 688999999875432 233456788999999999999999999988543
Q ss_pred --CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecc
Q 047901 579 --RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDF 656 (786)
Q Consensus 579 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 656 (786)
...++||||+++ ++.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999976 67777642 478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---- 732 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---- 732 (786)
|+++..... .......||..|+|| |...+..++.++|||||||++|||++|+.||..........
T Consensus 164 g~~~~~~~~-~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 164 GLARTAGTS-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred cccccCCCc-cccCCccccCCccCH----------HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999865432 222345789999999 67777789999999999999999999999987533210000
Q ss_pred ------c----chhhhhhhhccCCC----------------CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ------S----SINIEFNAMLDHRL----------------PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ------~----~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. ..........+... +............+.+++.+|+..||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 00000011111000 0000001112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.92 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=200.8
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
.++....+.|+..+.+|+|+||.||+|+.. +++.||+|++... ......+..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 344445678999999999999999999864 6789999988541 22345678899999998 6999999999884
Q ss_pred ------cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 577 ------HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 577 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
.....|+||||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 245789999999999999999764 234578888999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 651 ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
+||+|||.+..............|+..|+|||.+.... .....++.++|||||||++|||++|+.||......
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-----~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-- 232 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE-----NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-- 232 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCccc-----CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--
Confidence 99999999876543333334457899999996432110 11456788999999999999999999998643211
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........... +.......+..+.+++..||+.||.+|||+.|+++
T Consensus 233 ------~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 ------RALFLIPRNPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------hhhhhHhhCCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11111111111 11111223456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.63 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=191.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc---CCCcccceeeEEec-----
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCSH----- 577 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~----- 577 (786)
+|+..+.||+|+||+||+|+.+ +++.||+|.+....... .....+.+|+++++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 4888899999999999999865 68899999987532211 1223455677766655 79999999998754
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
....++||||+++ +|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 3457899999985 899988754 234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
+++...... ......||..|+|| |...+..++.++||||+||++|||++|++||....... ...
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-----~~~ 217 (288)
T cd07863 154 LARIYSCQM-ALTPVVVTLWYRAP----------EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLG 217 (288)
T ss_pred ccccccCcc-cCCCccccccccCc----------hHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-----HHH
Confidence 998765322 22345789999999 66667788999999999999999999999986432100 000
Q ss_pred hhhhhc---------------cCCC----CCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAML---------------DHRL----PHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~---------------~~~~----~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .... ..+ .....+....+.+++.+|+++||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0000 000 0011122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=304.68 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=190.0
Q ss_pred eeccccCceEEEEEcCC-CC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEEecc
Q 047901 513 CIGKGEHRSVYRAKLPS-GD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
.||+|+||.||+|+..+ +. .+++|.+... ......+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 58999999999998653 43 4688887631 1233456788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 589 NRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 589 ~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
++|+|.+++.... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999997542 123578999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcc
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~ 734 (786)
||++....... .......+..|+|| |+.....++.++|||||||++|||++ |..||.....
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~ap----------E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------- 217 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAI----------ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------- 217 (270)
T ss_pred CCCccccchhh-hccCCCCccccCCh----------HHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------
Confidence 99986332111 11112335679999 66777788999999999999999997 9999864321
Q ss_pred hhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 735 INIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 735 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+... +...+. .....+.+++.+||+.+|.+|||+.++++.|
T Consensus 218 -~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 218 -AELYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred -HHHHHHHhCCCCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 1111212111 111121 1233588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.04 Aligned_cols=238 Identities=22% Similarity=0.392 Sum_probs=186.6
Q ss_pred eeccccCceEEEEEcCC--------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 513 CIGKGEHRSVYRAKLPS--------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.||+|+||.||+|..+. ..+||+|.+.. ......+.+..|+.+++.++||||+++++++..++..++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcc----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 58999999999997542 23478887753 2233456788999999999999999999999998999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc--------EEEecc
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE--------ARVSDF 656 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--------~kl~Df 656 (786)
|||+++|+|.+++..+ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +|++||
T Consensus 78 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999999765 23688999999999999999999999 9999999999999987765 699999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCC-CCCCccccccCCCcc
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGK-HPGDFLSLFSSSSSS 734 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~-~Pf~~~~~~~~~~~~ 734 (786)
|.+...... ....++..|+||| ...+ ..++.++|||||||++|||++|. .||.....
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE----------~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------- 211 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPE----------CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------- 211 (258)
T ss_pred ccccccCCc----hhccccCCccCch----------hccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-------
Confidence 998765432 2346788999995 4443 45788999999999999999985 56543211
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.........+...|... ...+.+++..||+.+|++|||++++++.|
T Consensus 212 --~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 212 --QKKLQFYEDRHQLPAPK----WTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --HHHHHHHHccccCCCCC----cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111222222222222 23488999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=305.51 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=197.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+|+..+.||+|+||+||+|.++ +++ .||+|..... ........+.+|+.++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 56888999999999999999864 232 5899987652 223445678899999999999999999999987 78
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 89999999999999999764 34589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCcce--eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSSNWT--ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
.......... ...++..|+|| |......++.++||||||+++||+++ |+.||+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~ 219 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMAL----------ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VE 219 (279)
T ss_pred cccCcccceecCCCcccccccCH----------HHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HH
Confidence 7754332211 12235689999 66666788999999999999999998 9999864321 11
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+... ....+.. ....+.+++.+||..+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 220 IPDLLEKGERLPQPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred HHHHHhCCCCCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 11122221 1222222 223488999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.11 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=195.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|+..+.||+|+||.||+|... .++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 568999999999999999999854 678999999875332 233456788999999999999999999987543
Q ss_pred -CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 579 -RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 579 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
...|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 78777742 478889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------ 731 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------ 731 (786)
+++..... .......||..|+|| |...+..++.++|||||||++|||++|+.||.........
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCH----------HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99866432 222345789999999 7777788999999999999999999999998753321000
Q ss_pred ----Ccc----hhhhhhhhccCCCCC----------------CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ----SSS----INIEFNAMLDHRLPH----------------PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ----~~~----~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ...........+... ...........+.+++.+|+..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 000000000100000 00000111235789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.28 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=188.5
Q ss_pred eeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe-cCCeeeEEEe
Q 047901 512 YCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS-HVRHSFVVYE 586 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e 586 (786)
+.||+|+||.||+|.+. +...||+|++.. .......+.+.+|+.+++.++||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc---cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 36899999999999753 235799998753 122344678889999999999999999999775 4566889999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++|+|.+++... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 78 YMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999999754 23467788899999999999999998 99999999999999999999999999998654321
Q ss_pred C----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC-CCCCCccccccCCCcchhhhhhh
Q 047901 667 S----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG-KHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 667 ~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
. ......++..|+|| |......++.++|||||||++|||++| .+||..... ......
T Consensus 153 ~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~ 214 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMAL----------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVY 214 (262)
T ss_pred ceeecccccCcCCccccCh----------hHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence 1 11223457789999 666667789999999999999999995 566653221 111222
Q ss_pred hccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 MLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.... ...+. ..+..+.+++..||..+|++|||+.||++.|
T Consensus 215 ~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 215 LLQGRRLLQPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HhcCCCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 22211 11121 1234588999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.93 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=197.1
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|.....||+|+||.||++... ++..||||++.. ......+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 444467999999999999854 688999999854 223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++++|.+++.. +.+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999998853 3578999999999999999999999 99999999999999999999999999997654433
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
.......|+..|+|| |......++.++||||||+++|||++|+.||....... ............
T Consensus 173 ~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 237 (292)
T cd06658 173 PKRKSLVGTPYWMAP----------EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDNLPPR 237 (292)
T ss_pred ccCceeecCccccCH----------HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCc
Confidence 333445789999999 66667778999999999999999999999986432110 001111111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... .......+.+++..||..||++|||++|+++
T Consensus 238 ~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 238 VKD----SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccc----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111 1122345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=312.40 Aligned_cols=254 Identities=23% Similarity=0.273 Sum_probs=205.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|++|+||+|... +++.||+|.+..... ......+.+..|+++++.++||||+++++++......|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 36888999999999999999865 588999999976322 2223556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 80 MDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999998754 345689999999999999999999998 999999999999999999999999999875532
Q ss_pred CCC-----------------------------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 665 NSS-----------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 665 ~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
... ......|+..|+|| |+..+..++.++||||||+++|+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP----------E~~~~~~~~~~~Di~slG~ll~~l 225 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP----------EVISGDGHGSAVDWWTLGILLYEM 225 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH----------HHHcCCCCCchHHHHHHHHHHHHH
Confidence 211 01123678899999 777777889999999999999999
Q ss_pred HhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 047901 716 IKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT----MQTVCQ 784 (786)
Q Consensus 716 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~ev~~ 784 (786)
++|+.||.... .......+.......+... ..+..+.+++.+||.++|++||| ++|+++
T Consensus 226 ~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 226 LYGTTPFKGSN--------RDETFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hhCCCCCCCCc--------hHHHHHHHhcCCccCCCcc--ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99999986432 1223333344333333221 13456899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.89 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=195.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.++||+|+||+||+++.+ +++.||+|++..... ........+..|+.++..++||+|+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 36889999999999999999865 577899999853110 1122344578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++.+. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999999753 34688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhh-----hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAY-----TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~-----~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
... ......||+.|+|| |+.. ...++.++|||||||++|||++|+.||..... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~ 216 (332)
T cd05623 155 DGTVQSSVAVGTPDYISP----------EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VET 216 (332)
T ss_pred CCcceecccccCccccCH----------HHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 322 22335799999999 4443 34578899999999999999999999874321 122
Q ss_pred hhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCC--CCCCHHHHHH
Q 047901 739 FNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPN--SRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~ev~~ 784 (786)
...+.... ...|.. ....+..+.+++.+|+..+++ .||+++|+++
T Consensus 217 ~~~i~~~~~~~~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 217 YGKIMNHKERFQFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred HHHHhCCCccccCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 22222221 222211 122344578888888855444 4789998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.47 Aligned_cols=247 Identities=26% Similarity=0.325 Sum_probs=202.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 36888999999999999999865 688999999864211 1223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999999764 5688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. .....+++.|+|| |.......+.++||||||+++|+|++|+.||.... ..........
T Consensus 154 ~---~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~ 212 (290)
T cd05580 154 R---TYTLCGTPEYLAP----------EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILE 212 (290)
T ss_pred C---CCCCCCCccccCh----------hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc
Confidence 3 2334688999999 55666678889999999999999999999986422 1222333334
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.....+... ...+.+++.+||..+|.+|| +++|+++
T Consensus 213 ~~~~~~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GKVRFPSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCccCCccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 444433322 34588999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=314.68 Aligned_cols=254 Identities=23% Similarity=0.399 Sum_probs=198.9
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
..+|++.+.||+|+||.||+|+.. .+..||+|.+... ......+.+.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 346899999999999999999742 1236899988642 2233456889999999999 799999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..++||||+++|+|.+++.... ....+++..+..++.|++.|+.|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999997532 123578899999999999999999998 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||+++......... ....++..|+|| |...+..++.++|||||||++|||++ |.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~ 234 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP----------EALFDRVYTHQSDVWSFGVLLWEIFTLGG 234 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH----------HHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence 999999999999999998765432211 122345689999 66667778999999999999999998 88
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||..... ......+... ....+. .....+.+++.+||+.+|++|||+.|+++.|
T Consensus 235 ~p~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 235 SPYPGIPV--------EELFKLLKEGHRMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCCCCCCH--------HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 88764321 1111222121 111222 1234588999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.69 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=196.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+++.. +++.||+|.+.... .........+.+|+.++..++||+|+++++++...+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46899999999999999999865 67889999986411 11122345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999753 24688899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhh-----cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYT-----MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~-----~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.... .....||+.|+|| |+..+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~ 216 (331)
T cd05624 155 DGTVQSSVAVGTPDYISP----------EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VET 216 (331)
T ss_pred CCceeeccccCCcccCCH----------HHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHH
Confidence 3322 2335799999999 55443 4578899999999999999999999864321 112
Q ss_pred hhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 047901 739 FNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNS--RPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~ 784 (786)
...+... +...|.. ..+.+..+.+++.+|+..++++ |++++++++
T Consensus 217 ~~~i~~~~~~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 217 YGKIMNHEERFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHcCCCcccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 2222221 2222221 1123445888999998865544 468888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.81 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=198.4
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCC-chhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPND-QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+|+..+.||+|++|.||+|... +++.||||++....... .......+..|++++++++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999865 68899999997643221 122345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+ +|+|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997642 3689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------Ccchh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------SSSIN 736 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~~~~~ 736 (786)
.........++..|+|| |... ...++.++|||||||++|||++|.+||......... .....
T Consensus 155 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (298)
T cd07841 155 PNRKMTHQVVTRWYRAP----------ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224 (298)
T ss_pred CCccccccccceeeeCH----------HHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence 43333444678899999 5443 345788999999999999999998887643221000 00000
Q ss_pred hhh---hhhccCCC--CCCCh----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEF---NAMLDHRL--PHPSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~---~~~~~~~~--~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ....+... ..+.. ........+.+++.+||+++|++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 00000000 00000 01122356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.81 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=199.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|++|.||+|+.+ +++.||+|++.... ......+.+.+|++++++++||||+++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc--cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 36888999999999999999876 68899999986422 1122345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++++.|..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 79 FEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999998888776543 4689999999999999999999998 999999999999999999999999999987765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC------cchhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS------SSINI 737 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~------~~~~~ 737 (786)
.........++..|+|| |...+ ..++.++|||||||++|||++|+.||.......... .....
T Consensus 153 ~~~~~~~~~~~~~~~aP----------E~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07847 153 PGDDYTDYVATRWYRAP----------ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222 (286)
T ss_pred CcccccCcccccccCCH----------HHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 43333345678899999 55543 457889999999999999999999986433210000 00000
Q ss_pred hhhhhccC-------CCCCCC------hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDH-------RLPHPS------LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~-------~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+..+. ..+.+. ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 000000 001122456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=302.43 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=195.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~ 581 (786)
.+|+..+.||+|+||.||+|... +++.||+|++...... ........+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999864 6889999998653221 122345678899999999999999999998865 3567
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999999754 4578899999999999999999998 999999999999999999999999999986
Q ss_pred cCCCC---CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 662 LKPNS---SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
..... .......++..|+|| |...+..++.++||||+||++|||++|+.||..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~ 217 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSP----------EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAA 217 (266)
T ss_pred cccccccCCccccCCccccccCH----------HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHH
Confidence 54321 112234688999999 666677788999999999999999999999874321 111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ ..+. ........+.+++ +||..+|++|||++||++
T Consensus 218 ~~~~~~~~-~~~~-~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQP-TNPQ-LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCC-CCCC-CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111111 0111 1112233466777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=299.30 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=195.7
Q ss_pred eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCC
Q 047901 512 YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRG 591 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 591 (786)
++||+|+||.||+|...+++.||+|++..... ......+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 36899999999999977799999999865321 235568899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc--
Q 047901 592 SLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW-- 669 (786)
Q Consensus 592 ~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 669 (786)
+|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.+..........
T Consensus 78 ~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 78 SLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 999999754 24678999999999999999999999 99999999999999999999999999998654322111
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccCC--
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHR-- 746 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 746 (786)
....++..|+|| |...++.++.++|||||||++|||+| |..||..... ......+...
T Consensus 153 ~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---------~~~~~~~~~~~~ 213 (251)
T cd05041 153 GLKQIPIKWTAP----------EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---------QQTRERIESGYR 213 (251)
T ss_pred ccCcceeccCCh----------HhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---------HHHHHHHhcCCC
Confidence 112335679999 66667778999999999999999999 8888764321 1111122211
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+ ...+..+.+++.+||..+|.+|||+.|+++.|
T Consensus 214 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 214 MPAP----QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred CCCC----ccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 1222 12334689999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.80 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=196.6
Q ss_pred ccCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.+|+..+.||+|+||.||+|...+ ...||||..... ......+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 458888999999999999998543 246899988642 223455689999999999999999999998875 557
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|+|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 8999999999999999764 24589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhh
Q 047901 662 LKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 662 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
....... .....++..|+|| |......++.++||||||+++||+++ |..||..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~ 218 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAP----------ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVI 218 (270)
T ss_pred cccccceecCCCCccccccCh----------hhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHH
Confidence 6543221 1122345689999 56666678899999999999999996 9999864321 1111
Q ss_pred hhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 740 NAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 740 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+.. .+...+.. .+..+.+++.+||..+|.+|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 219 GRIENGERLPMPPN----CPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred HHHHcCCcCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111 12222222 234588999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.44 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=199.4
Q ss_pred CccceeeccccCceEEEEEcCC-----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPS-----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
+++.+.||+|+||.||+|+..+ +..||+|++... ......+.+..|+++++.++||||+++++++...+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED---ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC---CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 3567889999999999998653 378999998652 22225678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
++|||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++..
T Consensus 78 ~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 9999999999999997642 12289999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcce-eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhh
Q 047901 663 KPNSSNWT-ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 663 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
........ ...++..|+|| |......++.++||||+|+++|+|++ |..||.... ......
T Consensus 154 ~~~~~~~~~~~~~~~~y~~P----------e~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~ 215 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAP----------ESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLE 215 (258)
T ss_pred ccccccccccCCCcccccCh----------HHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHH
Confidence 64422211 23367899999 66667778999999999999999998 888876421 111112
Q ss_pred hhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 741 AMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 741 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...... ...+.. .+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 216 ~~~~~~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRLPKPEN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCCCCCCc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 222211 112221 344588999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.73 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=198.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 36888999999999999999875 588999999865322 123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999888876543 4589999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------Ccchhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------SSSINI 737 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------~~~~~~ 737 (786)
.........++..|+||| +..+ ..++.++||||||+++|||++|++||......... ......
T Consensus 153 ~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07846 153 PGEVYTDYVATRWYRAPE----------LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222 (286)
T ss_pred CccccCcccceeeccCcH----------HhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence 444334456889999994 4433 45678999999999999999999998632210000 000000
Q ss_pred hhhh----------hccCCCCCCC---hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNA----------MLDHRLPHPS---LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~----------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... +......... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 0000000000 001122346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=305.80 Aligned_cols=261 Identities=23% Similarity=0.397 Sum_probs=201.1
Q ss_pred ccCccceeeccccCceEEEEEcC-----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--C
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--V 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~ 578 (786)
++|+..+.||+|+||.||+|++. ++..||||++..... ....+.|.+|+++++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46788899999999999999853 367899999875321 1356789999999999999999999999877 5
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 5789999999999999999764 23689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCcce---eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----
Q 047901 659 AKLLKPNSSNWT---ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS---- 731 (786)
Q Consensus 659 a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~---- 731 (786)
+........... ...++..|+|| |......++.++||||||+++|||++|+.|+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~P----------e~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 225 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAP----------ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI 225 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCc----------HHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc
Confidence 987763322111 12345679999 6666678889999999999999999999997643211000
Q ss_pred --CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 --SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...........+......+. ....+.++.+++.+||+.+|++|||+.||+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 226 AQGQMIVTRLLELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred ccccccHHHHHHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 00011111222222211111 112234689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.44 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=200.3
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
++|+..+.||+|+||+||+|+.+ +.+.|++|.+... ......+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 56888999999999999999854 3457899987541 22234567999999999999999999999999989
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 580 HSFVVYEYINRGSLATVLSNNFAS------EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
..++||||+++|+|.+++...... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 999999999999999999765322 2689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCC-CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCC
Q 047901 654 SDFGTAKLLKPNS-SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSS 731 (786)
Q Consensus 654 ~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~ 731 (786)
+|||++....... .......++..|+|| |...+..+++++||||||+++|+|++ |..||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---- 224 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAP----------EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---- 224 (275)
T ss_pred cccccccccCcccccccCCceeEEeecCh----------hhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----
Confidence 9999987543222 122334567789999 55566677889999999999999998 8888754221
Q ss_pred CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..............+. ....+..+.+++.+||+.+|.+|||+.|+++.|
T Consensus 225 ----~~~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 225 ----EEVLNRLQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred ----HHHHHHHHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 1112222212221111 112234689999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.93 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=201.7
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCC--
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVR-- 579 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~-- 579 (786)
.+++|+..+.||+|++|+||+|..+ +++.+++|++... ....+.+.+|+++++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 4578999999999999999999875 6788999998642 12346789999999999 6999999999986544
Q ss_pred ----eeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 ----HSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 4899999999999999987532 245789999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
|||.+..............|+..|+|||.+.... .....++.++|||||||++|+|++|+.||.....
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------- 223 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE-----QPDASYDARSDVWSLGITAIELADGKPPLCDMHP------- 223 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccc-----cccCCccccccHHHhHHHHHHHHhCCCCccccch-------
Confidence 9999987654433344567899999996432211 1134578899999999999999999999864221
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+...... ...........+.+++.+||..||++|||+.++++
T Consensus 224 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 224 -MRALFKIPRNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -HHHHHHhhccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111112221111 11111223456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=301.16 Aligned_cols=245 Identities=26% Similarity=0.443 Sum_probs=195.8
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|++.+.||+|+||.||++.. .++.||+|++... ...+.+.+|+.+++.++||||+++++++... ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4689999999999999999975 5778999998642 2345788999999999999999999998764 478999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999999764 234688999999999999999999998 9999999999999999999999999999765422
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhcc
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
......+..|+|| |......++.++|||||||++|||++ |+.||..... . .......
T Consensus 154 ---~~~~~~~~~y~~p----------e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~-~~~~~~~ 211 (254)
T cd05083 154 ---VDNSKLPVKWTAP----------EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------K-EVKECVE 211 (254)
T ss_pred ---CCCCCCCceecCH----------HHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------H-HHHHHHh
Confidence 1223445689999 66667788999999999999999997 9999864321 1 1111222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+. ....+.++.+++.+||+.+|++|||++++++.|
T Consensus 212 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 212 KGYRMEP--PEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred CCCCCCC--CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2211111 122345688999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.27 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=202.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|..+ +++.||+|++.... .....+++.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 5778889999999999999876 68899999987532 2245567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||+++.++.+||+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999999997642 578899999999999999999999 7 999999999999999999999999999876543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
... ....++..|+|| |...+..++.++||||||+++|+|++|+.||...... .............
T Consensus 154 ~~~--~~~~~~~~y~~P----------E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~ 218 (265)
T cd06605 154 SLA--KTFVGTSSYMAP----------ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVN 218 (265)
T ss_pred HHh--hcccCChhccCH----------HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhc
Confidence 221 126788999999 6667778899999999999999999999998643210 0111112222222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... .......+..+.++|..||..+|++|||+.++++
T Consensus 219 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 219 EPPP--RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCC--CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 2211 1111114456889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.76 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=198.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCeee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRHSF 582 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~ 582 (786)
++|+..+.||.|++|.||+|... +++.+|+|.+... ........+.+|+++++.++||||+++++++.. .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC---CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 36788899999999999999864 6788999988652 222445678999999999999999999998854 34689
Q ss_pred EEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 583 VVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
+||||+++++|.+++.... ....++...+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999999876421 245678899999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...... ....++..|+|| |...+..++.++||||+||++|+|++|+.||+...... . ........
T Consensus 155 ~~~~~~--~~~~~~~~y~~p----------E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~~~~~~~ 219 (287)
T cd06621 155 LVNSLA--GTFTGTSFYMAP----------ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP--L-GPIELLSY 219 (287)
T ss_pred cccccc--ccccCCccccCH----------HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC--C-ChHHHHHH
Confidence 543221 234578899999 66667788999999999999999999999987542100 0 00111111
Q ss_pred hccCC---CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHR---LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... +..........+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111 11111101123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.91 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=196.6
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+....||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec----ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 444457999999999999864 6889999998542 12334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999998753 4578999999999999999999999 99999999999999999999999999997655433
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
.......|+..|+|| |...+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 172 ~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~ 233 (297)
T cd06659 172 PKRKSLVGTPYWMAP----------EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRLRDSP 233 (297)
T ss_pred ccccceecCccccCH----------HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhccC
Confidence 333445789999999 677777889999999999999999999999864221 11111111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. ...........+.+++..||+.+|++|||++++++
T Consensus 234 ~~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 234 PP-KLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CC-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11 00011112345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.21 Aligned_cols=259 Identities=20% Similarity=0.293 Sum_probs=193.8
Q ss_pred HHhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC---
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--- 578 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--- 578 (786)
...++|+..+.||+|+||+||+|.. .+++.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 4467899999999999999999985 467899999986532 1223345677899999999999999999987533
Q ss_pred ---CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 579 ---RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 579 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
...|+++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3568999988 6799888753 4689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC--
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-- 732 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-- 732 (786)
||+++..... .....||..|+||| +..+ ..++.++||||+||++|||++|+.||..........
T Consensus 162 fg~~~~~~~~---~~~~~~t~~y~aPE----------~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 162 FGLARQADDE---MTGYVATRWYRAPE----------IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CccceecCCC---cCCccccccccCch----------HhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999876532 23457899999994 4444 468889999999999999999999986532110000
Q ss_pred -----cchhh--------hhhhhccCCCCCCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 -----SSINI--------EFNAMLDHRLPHPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 -----~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... ............+.... ......+.+++.+|+..||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00000000000011000 011234779999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=301.56 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=199.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+|+..+.||+|++|.||+|... +++.|++|.+...... ......+.+.+|+++++.++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999876 7899999998653211 1233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999754 4588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcC-cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMK-ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~-~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......|+..|+|| |...... ++.++|+|||||++|+|++|+.||..... ........
T Consensus 155 ~~-~~~~~~~~~~y~~p----------e~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~ 215 (258)
T cd06632 155 FS-FAKSFKGSPYWMAP----------EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIG 215 (258)
T ss_pred cc-cccccCCCcceeCH----------HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHH
Confidence 32 22345688999999 5555544 88999999999999999999999864321 11111111
Q ss_pred c-CCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 D-HRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~-~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. ... ..+ ......+.+++.+||+.+|++|||+.++++
T Consensus 216 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RSKELPPIP----DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hcccCCCcC----CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 111 111 122345889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.77 Aligned_cols=194 Identities=21% Similarity=0.365 Sum_probs=157.7
Q ss_pred ceeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe--cCCeeeEEE
Q 047901 511 KYCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS--HVRHSFVVY 585 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~~lv~ 585 (786)
+.+||+|+||+||+|+.. ++..||+|.+... .....+.+|+++++.++||||+++++++. .+...++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT------GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 357999999999999864 3468999988642 12245778999999999999999999884 356789999
Q ss_pred eccCCCCHHHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee----CCCCcEEEec
Q 047901 586 EYINRGSLATVLSNNF------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL----DLEYEARVSD 655 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~D 655 (786)
||+++ +|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99875 8888775321 123578999999999999999999999 99999999999999 5567999999
Q ss_pred cccceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 656 FGTAKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 656 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
||+++....... ......||..|+|| |...+ ..++.++|||||||++|||+||++||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAP----------ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCc----------HHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999987654322 22345789999999 55544 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=329.45 Aligned_cols=259 Identities=19% Similarity=0.206 Sum_probs=189.4
Q ss_pred HHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC------Ccccceee
Q 047901 501 IIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH------RNIVKFYG 573 (786)
Q Consensus 501 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------pniv~l~~ 573 (786)
+....++|++.+.||+|+||+||+|... .++.||||+++.. ......+..|+++++.++| ++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 3345678999999999999999999864 6788999998641 1223345667777777654 45888888
Q ss_pred EEecC-CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCC--
Q 047901 574 FCSHV-RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEY-- 649 (786)
Q Consensus 574 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~-- 649 (786)
++... .+.|+|||++ +++|.+++... +.+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 88654 5788999988 67899988754 568999999999999999999997 5 999999999999998765
Q ss_pred --------------cEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 650 --------------EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 650 --------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
.+||+|||.+..... .....+||+.|+|| |++.+..++.++|||||||++|||
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~AP----------E~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSP----------EVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCc----------HHhhcCCCCcHHHHHHHHHHHHHH
Confidence 499999998864332 22346899999999 777788899999999999999999
Q ss_pred HhCCCCCCccccccCCC------cch---------hhhhhhhccCC--C--CCCCh-----------hHHHHHHHHHHHH
Q 047901 716 IKGKHPGDFLSLFSSSS------SSI---------NIEFNAMLDHR--L--PHPSL-----------DVQEKLISIMEVA 765 (786)
Q Consensus 716 ltg~~Pf~~~~~~~~~~------~~~---------~~~~~~~~~~~--~--~~~~~-----------~~~~~~~~l~~li 765 (786)
++|+.||+......... ... ......+.+.. . ..... ........+.+|+
T Consensus 339 ltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 99999997533210000 000 00000000000 0 00000 0001123577999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 047901 766 LLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 766 ~~cl~~~p~~RPt~~ev~~ 784 (786)
..||+.||++|||++|+++
T Consensus 419 ~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHhCCcChhhCCCHHHHhc
Confidence 9999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=302.71 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=200.6
Q ss_pred cCccceeeccccCceEEEEEcCC--CCEEEEEEcCCCCCC------CchhhHHHHHHHHHHHhh-cCCCcccceeeEEec
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPS--GDKIAVKKFNSPFPN------DQMSDQKEFLNEIKALTK-IRHRNIVKFYGFCSH 577 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~ 577 (786)
.|++.+.||+|+||.||+|.... ++.+|+|.+...... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788899999999999998764 678999988643211 122344567788888865 799999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 578 VRHSFVVYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
++..++||||+++++|.+++... .....+++..++.++.|++.|+.|||+ . +++||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 124568999999999999999999996 5 899999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||.+....... ......|+..|+|| |...+..++.++||||||+++|||++|+.||.....
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~P----------e~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------- 218 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCP----------EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------- 218 (269)
T ss_pred ccceeeccccc-ccccccCcccCcCh----------hhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------
Confidence 99998765433 33445789999999 666677789999999999999999999999764221
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
................ .......+.+++.+||+.||++|||+.||.+++
T Consensus 219 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 219 LSLATKIVEAVYEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred HHHHHHHhhccCCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 1112222222211110 111234588999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.98 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=196.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Cee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~ 581 (786)
.+|+..+.||+|+||.||+|... +++.||||++...... ......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999864 6889999988642211 2223456788999999999999999999988653 467
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999999754 4578888999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC---CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 662 LKPNS---SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
..... .......|+..|+|| |...+..++.++|||||||++|||++|+.||..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~ 217 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSP----------EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--------MAA 217 (265)
T ss_pred cccccccccccccCCCCccccCh----------hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch--------HHH
Confidence 54321 122334688999999 555666788999999999999999999999864221 111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... +. ........+.+++.+|+. +|++|||++||++
T Consensus 218 ~~~~~~~~~~-~~-~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 IFKIATQPTN-PV-LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhcCCCC-CC-CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111111111 11 112233457889999994 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.22 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=195.7
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... ......+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 6888999999999999999865 578999998865211 12234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... +.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999754 4688999999999999999999998 9999999999999999999999999998742111
Q ss_pred CC---------------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 666 SS---------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 666 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
.. ......++..|+|| |......++.++|||||||++|||++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---- 220 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAP----------EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---- 220 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCc----------hhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 00 01123578899999 55566678999999999999999999999986321
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
...............+... ...+..+.+++.+||+++|++|||+.++.
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 268 (305)
T cd05609 221 ----PEELFGQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAF 268 (305)
T ss_pred ----HHHHHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHH
Confidence 1122222222222222111 12234588999999999999999954433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.49 Aligned_cols=237 Identities=25% Similarity=0.438 Sum_probs=186.0
Q ss_pred eeeccccCceEEEEEcCCCC-----------EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 512 YCIGKGEHRSVYRAKLPSGD-----------KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
+.||+|+||.||+|...+.. .|++|.+... . .....|.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD----H-RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc----h-hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 35899999999999876433 4777876541 1 125788999999999999999999999988 77
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-------cEEE
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-------EARV 653 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-------~~kl 653 (786)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 899999999999999997642 2688999999999999999999998 999999999999999887 7999
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhc--CcCcccchHHHHHHHHHHHh-CCCCCCccccccC
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM--KITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSS 730 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~--~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~ 730 (786)
+|||++..... .....++..|+||| ..... .++.++|||||||++|||++ |..||.....
T Consensus 150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE----------~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--- 212 (259)
T cd05037 150 SDPGIPITVLS----REERVERIPWIAPE----------CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--- 212 (259)
T ss_pred CCCCccccccc----ccccccCCCccChh----------hhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc---
Confidence 99999987643 22345778899995 44443 68889999999999999999 5777654321
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
........ .....+.+.. ..+.+++.+||..+|.+|||+.++++.|
T Consensus 213 ---~~~~~~~~-~~~~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 213 ---SEKERFYQ-DQHRLPMPDC------AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---hhHHHHHh-cCCCCCCCCc------hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00001100 1111222211 4588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.71 Aligned_cols=247 Identities=21% Similarity=0.359 Sum_probs=192.2
Q ss_pred ceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe--eeEEEec
Q 047901 511 KYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--SFVVYEY 587 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~ 587 (786)
..+||+|+|-+||+|... +|-.||=-.++...........++|..|+++++.++||||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 456999999999999753 4555543222221122344556899999999999999999999999876554 6689999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEeccccceecCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~ 666 (786)
|..|+|..|+.+. +.++.+.+..|++||++||.|||++ .|+|+|||||-+||+|+.+ |.|||+|.|+|+....+.
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999876 6788899999999999999999997 6799999999999999876 899999999999886442
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
.....|||.||||| +. ...|++.+||||||++|.||+|+..||.-... ....+..+..+.
T Consensus 201 --aksvIGTPEFMAPE----------mY-EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGi 260 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPE----------MY-EENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGI 260 (632)
T ss_pred --cceeccCccccChH----------HH-hhhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCC
Confidence 33479999999995 33 36799999999999999999999999763221 112222232222
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
-+ .....-..+++.++|..|+.. ..+|||+.|+++
T Consensus 261 KP--~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KP--AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CH--HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11 111111124589999999999 999999999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=320.65 Aligned_cols=254 Identities=21% Similarity=0.238 Sum_probs=194.1
Q ss_pred hccCccceeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
..+|.+.+.||+|+||.||+|... .+..||+|.+... ....+|+++++.++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 347999999999999999999743 3568999987541 2345899999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++|||++. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 162 ~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999996 589998843 35789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC--------
Q 047901 662 LKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------- 731 (786)
Q Consensus 662 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------- 731 (786)
....... .....||+.|+|| |+.....++.++|||||||++|||++|+.||.........
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSP----------ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cCcccccccccccccccCccCH----------hHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 6543221 2235799999999 6677778899999999999999999999998643221000
Q ss_pred ---------Ccc----hhhhhhhhc---cCCCCCCChh-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ---------SSS----INIEFNAML---DHRLPHPSLD-VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ---------~~~----~~~~~~~~~---~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ....+.... ......+... .......+.+++..||..||++|||+.|+++
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 000000000 0000111000 0011245788999999999999999999985
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.83 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=200.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|...+.||+|+||.||+|... +++.||+|.+.. ......+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL----QQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecc----ccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 57889999999999999999753 678999999854 2223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
+||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999999864 3478889999999999999999999 999999999999999999999999999876654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........|++.|+|| |......++.++|||||||++|++++|+.||......... ......
T Consensus 168 ~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~~~~~ 230 (293)
T cd06647 168 EQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATN 230 (293)
T ss_pred cccccccccCChhhcCc----------hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------eehhcC
Confidence 44333445788999999 5666667889999999999999999999998753321100 000001
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+ ........+.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 231 GTPELQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 11223345889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.54 Aligned_cols=252 Identities=30% Similarity=0.444 Sum_probs=199.7
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+..|+++++.++||||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 4788899999999999999854 688999999875322 2346678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ..+++..+..++.++++|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 79 EYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred ecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999999753 4578889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcc----eeeccCccccCCCCCCCCchHHHHhhhcC---cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 666 SSNW----TELVGTFGYVAPAHGNIGLHLAELAYTMK---ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 666 ~~~~----~~~~gt~~y~aPE~~~~~~~~~e~~~~~~---~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.... ....++..|+||| ...... ++.++||||||+++||+++|+.||..... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE----------~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~------~~~~~ 216 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPE----------VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------EFQIM 216 (264)
T ss_pred CCcccccccCCcCCcCccChh----------hccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc------hHHHH
Confidence 3221 2356788999995 444333 78899999999999999999999864321 00111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...........|.. ......+.+++..||+.+|.+|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 217 FHVGAGHKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHhcCCCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111112211 112345789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.58 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=195.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
..+|+..+.||+|+||.||+|.+. +++ .||+|.+... ........+.+|+.+++.++||||++++|++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 346888889999999999999854 343 5788887642 2223345788999999999999999999998754
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++++||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 467999999999999998754 34578999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
+........ .....++..|+|| |...+..++.++|||||||++||+++ |+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------- 217 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMAL----------ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------- 217 (303)
T ss_pred ccccCcccccccCCCccccccCCH----------HHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------
Confidence 876533221 1223456789999 66677788999999999999999997 9999764321
Q ss_pred hhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. +...+.. +...+.+++..||..+|++|||++++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l 265 (303)
T cd05110 218 REIPDLLEKGERLPQPPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEF 265 (303)
T ss_pred HHHHHHHHCCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111111111 2222221 223588999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=308.22 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=195.3
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4788899999999999999864 688999999865321 2223457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||++ ++|.+++... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 79 EFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9996 5899988754 245689999999999999999999998 9999999999999999999999999999866543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------Ccc
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----------SSS 734 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----------~~~ 734 (786)
........++..|+|||. ..+ ..++.++|||||||++|||+||+.||......... ...
T Consensus 154 ~~~~~~~~~~~~y~aPE~----------~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEI----------LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred ccccccccccccccCCeE----------EecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 333334467889999953 332 33578899999999999999999998643211000 000
Q ss_pred hhhhhhhhcc-----CCCCCC--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLD-----HRLPHP--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~-----~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... ...... ..........+.+++.+||+.||++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 000000 0000112245779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.87 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=200.3
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
+++....++|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.++.++ +|||++++++++.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344445778999999999999999999864 6889999998541 12335677899999998 7999999999986
Q ss_pred cC-----CeeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 577 HV-----RHSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 577 ~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
.. +..++||||+++|+|.++++... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 43 35899999999999999886421 235689999999999999999999998 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 651 ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
+||+|||.+..............|+..|+|||.+.... .....++.++|||||||++|||++|+.||.....
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--- 238 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ-----QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--- 238 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCC-----CcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---
Confidence 99999999987654333333457889999996432211 0122468899999999999999999999864321
Q ss_pred CCcchhhhhhhhccC---CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 SSSSINIEFNAMLDH---RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+... ....+ ......+.++|.+||+++|++||++.|+++
T Consensus 239 -----~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 -----VKTLFKIPRNPPPTLLHP----EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -----HHHHHHHhcCCCCCCCcc----cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111111 11111 123345889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.41 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
-|+..+.||+|+||.||+|... +++.||+|.+... ......+.+.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc---cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 4778889999999999999754 6789999987542 22234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999999864 3578999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........++..|+|| |......++.++|||||||++|+|++|..||..... ......+...
T Consensus 155 ~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~ 216 (277)
T cd06641 155 QIKRNTFVGTPFWMAP----------EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKN 216 (277)
T ss_pred hhhhccccCCccccCh----------hhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcC
Confidence 3233345688899999 555566788899999999999999999999864221 1111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+ ......+..+.+++.+||+.+|.+||++.++++
T Consensus 217 ~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 217 NPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111 111223345889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.40 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=205.5
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|+.. +++.||||++..... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 5888899999999999999876 589999999875321 145678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999754 568999999999999999999999 8 999999999999999999999999999987765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........++..|+|| |......++.++||||||+++|+|++|+.||..... .........+..
T Consensus 153 ~~~~~~~~~~~~~y~~p----------E~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~ 217 (264)
T cd06623 153 TLDQCNTFVGTVTYMSP----------ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICD 217 (264)
T ss_pred CCCcccceeecccccCH----------hhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhc
Confidence 44433455788999999 556666788999999999999999999999865431 011122222222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .....+..+.+++..||.++|++|||+.++++
T Consensus 218 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 218 GPPPSL--PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCCC--CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 221111 11113456899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.05 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=197.9
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|...+.||+|++|.||+|.. .+++.|++|++.. ......+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~----~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL----RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec----cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 355567899999999999985 4788999998854 22234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999999875 4578899999999999999999999 9999999999999999999999999988765433
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........|+..|+|| |...+..++.++|||||||++|||++|+.||..... ..........
T Consensus 169 ~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~ 230 (285)
T cd06648 169 VPRRKSLVGTPYWMAP----------EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDN 230 (285)
T ss_pred CcccccccCCccccCH----------HHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhc
Confidence 2223345689999999 666677789999999999999999999999764221 1111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... .........+.+++.+||+.+|++|||+.++++
T Consensus 231 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 LPPKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11110 011113346899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.46 Aligned_cols=191 Identities=20% Similarity=0.311 Sum_probs=162.1
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3457999999999999999999865 5678999975431 2346899999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+. ++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||.++..
T Consensus 134 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999995 5899988653 35689999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P 721 (786)
.... ......||..|+|| |+..+..++.++|||||||++|||+++..|
T Consensus 208 ~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 208 VVAP-AFLGLAGTVETNAP----------EVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ccCc-ccccccccccccCC----------eecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 3221 22345789999999 555566789999999999999999985554
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.82 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=199.7
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|... +++.+|||++.... ........+.+|++++++++||||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ--MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc--cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 4788899999999999999754 68899999986532 22344678899999999999999999999999899999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++... ....+++..+..++.+++.|++|||++ +++||||+|+||+++.+ +.+||+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999999764 234588999999999999999999999 99999999999999855 5689999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
... .....++..|+|| |...+..++.++||||||+++|+|++|+.||..... .........
T Consensus 155 ~~~-~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~ 215 (256)
T cd08220 155 KSK-AYTVVGTPCYISP----------ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMS 215 (256)
T ss_pred Ccc-ccccccCCcccCc----------hhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHh
Confidence 322 2235688999999 555566788999999999999999999999864321 111112221
Q ss_pred CCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ..+. ..+..+.+++..||+++|++|||+.|+++
T Consensus 216 ~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 216 GTFAPISD----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cCCCCCCC----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 1111 12345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.01 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=201.0
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCeeeE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRHSFV 583 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~l 583 (786)
+|++.+.+|.|+||.||+|... +++.||+|.+.... ......+.+..|+++++.++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 4788899999999999999754 67899999986422 223445678899999999999999999997753 456789
Q ss_pred EEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 584 VYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMH-----HDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
+|||+++++|.+++.... ....+++..++.++.|++.|+.||| +. +++||||+|+||+++.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999997532 2457899999999999999999999 66 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
.+..............++..|+|| |......++.++||||||+++|+|++|+.||.... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~p----------E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~ 217 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSP----------EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQ 217 (265)
T ss_pred ccccccCCcccccccccCCCccCh----------hhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHH
Confidence 998776544333445789999999 56666678899999999999999999999987432 111
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+....... .....+..+.+++.+|++.+|++|||+.+|++
T Consensus 218 ~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 218 LASKIKEGKFRR---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHhcCCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112222222211 11223446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.32 Aligned_cols=261 Identities=18% Similarity=0.299 Sum_probs=198.4
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|+.. +++.||||++..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 4788899999999999999875 688999999875322 223456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++ +|.+++........+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99985 8999887654445689999999999999999999998 9999999999999999999999999999766443
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-------cchhh
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SSINI 737 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~~~~ 737 (786)
........++..|+|| |...+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 154 ~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 154 VNTFSNEVVTLWYRAP----------DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223 (284)
T ss_pred ccccccccccccccCh----------HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 3333345678899999 44433 456889999999999999999999987533110000 00000
Q ss_pred hhhhhcc-----CCCCC-CCh----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLD-----HRLPH-PSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~-----~~~~~-~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+..+.. ...+. ... ..+..+..+.+++..|++.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00000 000 01122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=306.25 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=194.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|+.. +|+.||+|++..... .......+.+|++++++++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4788899999999999999865 688999999865321 1223356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++ +|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 79 EYCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ecCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99974 888887653 35689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC--------Ccchh
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS--------SSSIN 736 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~--------~~~~~ 736 (786)
........++..|+|| |...+ ..++.++|||||||++|||+||+.|+......... .....
T Consensus 153 ~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07839 153 VRCYSAEVVTLWYRPP----------DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222 (284)
T ss_pred CCCcCCCccccCCcCh----------HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 3333445678999999 55544 34688999999999999999999885322110000 00000
Q ss_pred hh---hhhhccCC-CC-CCCh-----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IE---FNAMLDHR-LP-HPSL-----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~---~~~~~~~~-~~-~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. .....+.. .. .+.. .....+..+.+++.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000 00 0000 00112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=303.57 Aligned_cols=245 Identities=26% Similarity=0.429 Sum_probs=193.4
Q ss_pred eeccccCceEEEEEcCC-------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 513 CIGKGEHRSVYRAKLPS-------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.||+|+||.||+|+..+ ++.+|+|.+... ........+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 58999999999998642 257899988642 11234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-----cEEEecc
Q 047901 586 EYINRGSLATVLSNNF----ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-----EARVSDF 656 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Df 656 (786)
||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++ .+|++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999997532 123478899999999999999999998 999999999999999877 8999999
Q ss_pred ccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCc
Q 047901 657 GTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSS 733 (786)
Q Consensus 657 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~ 733 (786)
|+++....... ......++..|+|| |...+..++.++|||||||++|||++ |+.||.....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------ 219 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAP----------ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------ 219 (269)
T ss_pred ccccccccccccccCcccCCCccccCH----------HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------
Confidence 99976643221 11223456789999 67777788999999999999999998 9999763221
Q ss_pred chhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 734 SINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 734 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. +...+. ..+..+.+++.+||.++|.+|||++++++.|
T Consensus 220 ---~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 220 ---QEVLQHVTAGGRLQKPE----NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred ---HHHHHHHhcCCccCCcc----cchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 111122221 122221 2345688999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=332.89 Aligned_cols=254 Identities=24% Similarity=0.438 Sum_probs=204.5
Q ss_pred ccCccceeeccccCceEEEEEcC----C----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP----S----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
++..+.+.+|+|.||.||+|... . ...||||.++.... ..+.+.+..|+++|+.+ .||||+.++|+|.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34455568999999999999732 1 45799999976332 25678899999999999 5999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCC-----C------C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCce
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNF-----A------S--EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNV 643 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 643 (786)
..+..++|+||++.|+|.+|++..+ . . ..++..+.+.++.|||.||+||++. +++|||+.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998764 0 1 1388999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeccccceecCCCCCcc-eeecc--CccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 644 LLDLEYEARVSDFGTAKLLKPNSSNW-TELVG--TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 644 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|++++..+||+|||+|+...+...+. ....| ...|||| |.+....|+.|||||||||+|||++| |.
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp----------Esl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP----------ESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH----------HHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 99999999999999999877655443 22233 3359999 78888899999999999999999998 99
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||.... ...+.+..+.++ ++..|..+.. +++++|+.||+.+|++||++.++.+.+
T Consensus 520 ~PYp~~~-------~~~~l~~~l~~G~r~~~P~~c~~----eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 520 TPYPGIP-------PTEELLEFLKEGNRMEQPEHCSD----EIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred CCCCCCC-------cHHHHHHHHhcCCCCCCCCCCCH----HHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 9976421 011222223332 3445655444 489999999999999999999998763
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.68 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=196.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Ceee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHSF 582 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~ 582 (786)
++|+..+.||+|+||.||+|... +++.+|+|++...... ......+.+|++++++++||||+++++++... +..|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46888899999999999999875 6789999998753221 22334677899999999999999999998776 8899
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 83 lv~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99999975 999988764 23689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-------cc
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SS 734 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~ 734 (786)
...........++..|+||| ...+ ..++.++||||+|+++|||++|+.||.......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE----------~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPE----------LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226 (293)
T ss_pred cCCccccccccccccccCch----------hhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 65433344456788999994 4433 346889999999999999999999987432110000 00
Q ss_pred hhhhhh---hhcc---CCCCCC-----ChhHHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFN---AMLD---HRLPHP-----SLDVQE--KLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~---~~~~---~~~~~~-----~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+. .+.. ...... ....+. ....+.+++..||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 0000 000000 000000 1345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=305.45 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=198.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|++.+.||+|+||.||+|... +++.||||++..... .......+.+|+.++++++||||+++++++......++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 4788899999999999999864 688999999875321 1234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+ +++|.+++... ...+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 79 EYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred ccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999 99999998754 25689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC----------CCcc
Q 047901 666 SS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS----------SSSS 734 (786)
Q Consensus 666 ~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~----------~~~~ 734 (786)
.. ......++..|+|||.+ .....+++++||||+|+++|||++|.+||........ ....
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~---------~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELL---------YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223 (286)
T ss_pred CCCccccccCcccccCceee---------eccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence 21 23345789999999632 1233468899999999999999999888754221000 0000
Q ss_pred hhhhhhhhcc-CCCCCC---C----hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLD-HRLPHP---S----LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~-~~~~~~---~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.+ .....+ . ....+....+.+++.+|++++|++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 000000 0 000122356899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=284.91 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=209.1
Q ss_pred hccCccc-eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec----
Q 047901 505 TKDFDAK-YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH---- 577 (786)
Q Consensus 505 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~---- 577 (786)
+++|.+. ++||-|-.|.|..+..+ +++++|+|++.. .....+|++..-.. .|||||.+++++++
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 4566654 47999999999999765 788999999863 13445788875555 69999999998854
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEe
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVS 654 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~ 654 (786)
.....+|||.|+||.|+..++.+ ....+++.++.+|+.||+.|+.|||+. +|+||||||+|+|.+. +..+||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 45677999999999999999887 456799999999999999999999999 9999999999999964 4679999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
|||+|+.... .....+.+-|+.|.|| |+....+|+...|+||+||+||-|++|.+||........
T Consensus 207 DfGFAK~t~~-~~~L~TPc~TPyYvaP----------evlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---- 271 (400)
T KOG0604|consen 207 DFGFAKETQE-PGDLMTPCFTPYYVAP----------EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---- 271 (400)
T ss_pred ccccccccCC-CccccCCcccccccCH----------HHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC----
Confidence 9999987653 3445667899999999 777778899999999999999999999999986554221
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......++.......|...+...++...++|+.+|+.+|.+|-|+.++++
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 12233445556667788888888999999999999999999999999874
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=306.86 Aligned_cols=260 Identities=18% Similarity=0.293 Sum_probs=194.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|++|+||+|..+ +++.||||.+...... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57889999999999999999865 6789999998653211 1224567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 82 ~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999985 999988754 24688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC--------CCcch
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS--------SSSSI 735 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~--------~~~~~ 735 (786)
.........++..|+|| |...+ ..++.++||||+||++|||++|+.||........ .....
T Consensus 156 ~~~~~~~~~~~~~~~aP----------E~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (291)
T cd07844 156 PSKTYSNEVVTLWYRPP----------DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT 225 (291)
T ss_pred CCccccccccccccCCc----------HHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence 22222334578899999 54443 4578899999999999999999999864331000 00000
Q ss_pred hhhhhhh------ccCCCC--CCChhH---HHH--HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAM------LDHRLP--HPSLDV---QEK--LISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~------~~~~~~--~~~~~~---~~~--~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+... ...... .+.... ... .....+++..|++.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000000 000000 001 145779999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.38 Aligned_cols=263 Identities=18% Similarity=0.235 Sum_probs=195.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCe---
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRH--- 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~--- 580 (786)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+++++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 36888999999999999999865 688999999865322 1223456888999999995 6999999999876555
Q ss_pred --eeEEEeccCCCCHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEec
Q 047901 581 --SFVVYEYINRGSLATVLSNNFA--SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSD 655 (786)
Q Consensus 581 --~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~D 655 (786)
.|+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 7999999986 89998865422 24689999999999999999999999 9999999999999998 89999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC--
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-- 732 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-- 732 (786)
||.++.............+++.|+|| |...+ ..++.++||||||+++|||++|..||..........
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aP----------E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAP----------EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred cccceecCCCccccCCcccccCCCCh----------HHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99998765433333344678899999 54433 457899999999999999999999986432211000
Q ss_pred -----cchhhhhhhh---cc----CCCC--CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 -----SSINIEFNAM---LD----HRLP--HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 -----~~~~~~~~~~---~~----~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... .. .... ............+.+++..||.++|.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00 0000 000001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.40 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=200.1
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCC--chhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPND--QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
+|+..+.||+|++|.||+|.. .+++.||+|++....... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999975 578899999986532211 12245688999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~ 662 (786)
||||+++++|.+++.+. +.+++..+..++.|++.|+.|||+. +++||||+|+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999999754 4688999999999999999999999 999999999999998775 6999999999876
Q ss_pred CCCCC----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 663 KPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 663 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
..... ......++..|+|| |......++.++||||+|+++|+|++|..||...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~P----------E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~ 219 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAP----------EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLAL 219 (268)
T ss_pred ccccccCCccccccccccceeCH----------hHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHH
Confidence 54321 11234688899999 5666677889999999999999999999998642210 11111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......... ...........+.+++.+||..+|.+|||+.|+++
T Consensus 220 ~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 IFKIASATT--APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHhccCC--CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111111111 11112233456889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.41 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=198.4
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCC------chhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPND------QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
+|...+.||+|+||.||+|... +++.||+|.+..+.... .....+.+.+|+++++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999754 68899999886432111 1112356888999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++|+|.+++... +.+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999764 5688999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhc--CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 660 KLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTM--KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 660 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~--~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
+....... ......|+..|+|| |..... .++.++||||||+++||+++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------- 217 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAP----------EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------- 217 (272)
T ss_pred ccccccccccccccccCCccccCH----------HHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--------
Confidence 86543211 12234688999999 554443 378899999999999999999999764221
Q ss_pred hhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... ....+.....+.+..+.+++..||.++|.+|||+++|++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111111 111122222233456899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.47 Aligned_cols=368 Identities=25% Similarity=0.354 Sum_probs=198.9
Q ss_pred CCCcEEECCCCCcc-ccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEc
Q 047901 26 PHLAYLDLSINGFF-GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISL 104 (786)
Q Consensus 26 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L 104 (786)
|-++-+|+++|.+. +..|.....++++++|-|...++. ..|+.++.+.+|+.|.+++|++..+...+..++.|+.+.+
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIV 85 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhh
Confidence 33444444444444 334444444444555544444444 3444444444455555555544444444444444444444
Q ss_pred cCCcCc--ccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCC-cCCCCCCcEEEccCcccc
Q 047901 105 HNNKLS--GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLT 181 (786)
Q Consensus 105 ~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~-l~~l~~L~~L~L~~N~l~ 181 (786)
.+|++. ++++ .+-.|..|+.|+||+|+++ ..|..+....++-.|+|++|+|..+|.. +.+++.|..|+|++|++.
T Consensus 86 R~N~LKnsGiP~-diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPT-DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCc-hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 444443 2222 2223444444555555444 3444444444444445555544444433 344455555555555554
Q ss_pred cccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccC-CCCCccccCCccccEEEeecccccccCCCCc
Q 047901 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT-GRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260 (786)
Q Consensus 182 ~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 260 (786)
.+ |+....+.+|++|+|++|.+.-..-..+..+++|+.|.+++.+-+ .-+|.++.++.+|..+|||.|++. .+|..+
T Consensus 164 ~L-PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 ML-PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred hc-CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 32 333444555555555555443322233334445555555554422 234555555556666666666555 555555
Q ss_pred ccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCC-CcchHHhhhcCcC
Q 047901 261 GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ-EIPEDLALLAHLS 339 (786)
Q Consensus 261 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 339 (786)
.++.+|+.|+||+|+|+. ..-..+...+|+.|+||.|+++. .|++++.+++|+.|++.+|+++- -+|..++.|..|+
T Consensus 242 y~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le 319 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE 319 (1255)
T ss_pred hhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH
Confidence 556666666666666552 22233444555666666666553 34555556666666666665542 2566777777888
Q ss_pred eeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCC
Q 047901 340 ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN 402 (786)
Q Consensus 340 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 402 (786)
.+..++|.+. ..|..++.+.+|+.|.|++|++- .+|+.+.-++.|+.||+..|+=--.+|.
T Consensus 320 vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 320 VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 8888888776 77778888888888888888776 4677777778888888888765544443
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.01 Aligned_cols=261 Identities=18% Similarity=0.228 Sum_probs=194.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
+++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+++++.++||||+++++++..++..|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 467999999999999999999754 688999999865321 1223466789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||++ +++.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred EEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 999996 6888777543 24577888899999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC--------Ccc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS--------SSS 734 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~--------~~~ 734 (786)
..........++..|+||| ...+ ..++.++|||||||++|||++|+.||+........ ...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPD----------VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP 224 (291)
T ss_pred CCCCCCCCccccccccCCc----------eeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence 4333334456789999995 3332 34678999999999999999999998743310000 000
Q ss_pred hhhh---hhh---hccCCCC--CCChh-----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIE---FNA---MLDHRLP--HPSLD-----VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~---~~~---~~~~~~~--~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ... ....... .+... .......+.+++.+|+..||++|||++|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 000 0000000 00000 0001345789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=311.47 Aligned_cols=197 Identities=22% Similarity=0.324 Sum_probs=171.8
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-C-----CcccceeeEEecCC
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-H-----RNIVKFYGFCSHVR 579 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~l~~~~~~~~ 579 (786)
+|.+.+.||+|+||.|-+|.. ++++.||||+++. ......+-..|+.++..++ | -|+|++++|+...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 799999999999999999974 4799999999975 2344556678999999996 4 38999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC--CcEEEeccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE--YEARVSDFG 657 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfg 657 (786)
+.|||+|.++. +|+++++.+. ...++...++.|+.||+.||.+||+. +|||+||||+|||+..- ..+||+|||
T Consensus 262 HlciVfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999966 9999999884 45699999999999999999999999 99999999999999754 479999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLS 726 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~ 726 (786)
.|....+.-. ...-+..|.|| |++.+.+|+.+.||||||||++||++|.+-|.+.+
T Consensus 337 SSc~~~q~vy---tYiQSRfYRAP----------EVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 337 SSCFESQRVY---TYIQSRFYRAP----------EVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccccCCcce---eeeeccccccc----------hhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 9987764322 44667899999 88999999999999999999999999988776533
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.39 Aligned_cols=255 Identities=28% Similarity=0.386 Sum_probs=201.4
Q ss_pred hccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
+-++..+.+||.|.||.||-|. ..+|+-.|||.+...... ....+...+|+.++..+.|||+|+++|+-.+.+..+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 4567788899999999999997 457888999998764332 3445677899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
.||||++|+|.+.++.. .-.++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999753 3456666677889999999999999 99999999999999999999999999999887
Q ss_pred CCCCc----ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 664 PNSSN----WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 664 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
.+... ....+||+.|||||++... .+..-..++||||+|||+.||+||+.||+..+. .-...+
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t-------~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy 1452 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGT-------KGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMY 1452 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhccc-------ccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHh
Confidence 65322 2346899999999644221 112345689999999999999999999764321 111111
Q ss_pred hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.-......+.|.. .+.+-.+++..|+..||++|+++.|+++
T Consensus 1453 ~V~~gh~Pq~P~~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPER----LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHhccCCCCCchh----hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1111222233433 4456789999999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=282.26 Aligned_cols=265 Identities=20% Similarity=0.343 Sum_probs=212.9
Q ss_pred HHHHHHHhccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEE
Q 047901 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFC 575 (786)
Q Consensus 498 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~ 575 (786)
+++..+-++ +.+|+|+|+.|--+. ..+|.++|||++.+. ....+++..+|++++.+.+ |+||+++++||
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 345544443 369999999999886 668999999999762 2345678889999999984 99999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC---cEE
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY---EAR 652 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~k 652 (786)
+++...|+|||-|.||.|...|+.+ .-+++.++.+++.+||.||.|||.+ ||.|||+||+|||-.... -+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence 9999999999999999999999865 6789999999999999999999999 999999999999987553 589
Q ss_pred EeccccceecCC--CC-----CcceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 653 VSDFGTAKLLKP--NS-----SNWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 653 l~Dfg~a~~~~~--~~-----~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
|+||.++.-... +- ....+.+|+..|||||+. +++.+ ..|+.+.|.||+|||+|-|++|.+||.
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV-------d~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV-------DVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHH-------hhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 999998754321 11 123456899999999753 22222 348889999999999999999999996
Q ss_pred cccc----ccCC---CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 724 FLSL----FSSS---SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 724 ~~~~----~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..=. |... ....+..+..+-+.+...|...+...+.+..+++...+..|+.+|-++..+++
T Consensus 293 G~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 293 GHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 5332 2221 11233345566667788899999998999999999999999999999988764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.47 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=200.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK--MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh--ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 4788899999999999999865 67899999986521 11234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. +++|+||||+||++++++ .+||+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999999764 234579999999999999999999998 999999999999999885 579999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........|+..|+|| |......++.++||||||+++|||++|..||..... .........
T Consensus 155 ~~~~~~~~~~~~~~~ap----------e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~ 216 (257)
T cd08225 155 SMELAYTCVGTPYYLSP----------EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQ 216 (257)
T ss_pred CcccccccCCCccccCH----------HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhc
Confidence 43333345689999999 666667788999999999999999999999764221 112222222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .......+.+++.+||..+|++|||+.|+++
T Consensus 217 ~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 217 GYFAPI---SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ccCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 222110 1112335889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.56 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=196.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+..+.||+|+||+||+|... +++.||+|++.... .......+.+.+|+++++.++||||+++.+++...+..++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45888899999999999999865 68899999986422 12233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++ |++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 5787777643 24689999999999999999999998 999999999999999999999999999976643
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. ....++..|+|||++.. .....++.++||||||+++|||+||+.||...... ........
T Consensus 168 ~----~~~~~~~~y~aPE~~~~-------~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~ 228 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILA-------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQ 228 (307)
T ss_pred C----CCccCCccccCceeeec-------cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhc
Confidence 3 23467889999964311 12355788999999999999999999997643211 11111111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... +.......+..+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 229 NDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCC--CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111 11112223456899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.08 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=207.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
...|.+...||+|.|++|..|+.. ++..||||.+.... .+......+.+|+++|+.++|||||+++.+.+.....|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 456888999999999999999865 78999999887532 223344558899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+.+|.+++|+..+ +......+..++.|+..|++|||++ .|||||||++|||++.+..+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999876 4455588889999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. ....+.+|++.|.|| |++.+.+|+ +++|+||+|+++|.|+.|..||+..... +...++
T Consensus 207 ~~-~~lqt~cgsppyAaP----------El~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~Lr~rv 267 (596)
T KOG0586|consen 207 YG-LMLQTFCGSPPYAAP----------ELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------ELRPRV 267 (596)
T ss_pred cc-ccccccCCCCCccCh----------HhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------cccchh
Confidence 43 445667999999999 666666655 7899999999999999999999964432 222334
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+..++..|..... +..+++++++..+|.+|++++++.+
T Consensus 268 l~gk~rIp~~ms~----dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 LRGKYRIPFYMSC----DCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeeecccceeec----hhHHHHHHhhccCccccCCHHHhhh
Confidence 4445544433322 2568899999999999999999875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.45 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=202.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.+.|+..+.+|+|++|.||+|... +++.|++|++.... . ..+.+.+|+++++.++||||+++++++......++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK----Q-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc----h-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 456888889999999999999876 68899999986521 1 45678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|+||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999998652 4789999999999999999999998 99999999999999999999999999987665
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........++..|+|| |...+..++.++|||||||++|+|++|+.||..... ........
T Consensus 168 ~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~ 229 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAP----------EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLIT 229 (286)
T ss_pred cchhhhccccCCcccCCH----------hHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 433333345688899999 666667789999999999999999999999764221 11111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... +.......+..+.+++.+||+.+|.+|||+.++++
T Consensus 230 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 230 TKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11111 11111123456889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=304.93 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=195.1
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||.|++|.||+|... +++.||+|++..... .......+.+|+++++.++|||++++++++.+.+..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 567789999999999999864 789999999865321 12234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|++ ++|.+++.... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 79 FLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred ccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 995 68999987652 24689999999999999999999998 99999999999999999999999999997664333
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------Ccchhhh
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------SSSINIE 738 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~~~~~~~ 738 (786)
.......++..|+|||+ ..+ ..++.++||||||+++|+|++|+.||......... .......
T Consensus 154 ~~~~~~~~~~~~~aPE~----------~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 154 RTYTHEVVTLWYRAPEI----------LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred cccCccccccCCCCCce----------eecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 22333467889999953 333 34688999999999999999999998643211000 0000000
Q ss_pred ---------h-hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 ---------F-NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ---------~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. .....................+.+++.+||+++|++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000000001112245889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.39 Aligned_cols=259 Identities=18% Similarity=0.211 Sum_probs=183.4
Q ss_pred ccCccceeeccccCceEEEEEcCCC----CEEEEEEcCCCCCCCchhh-------HHHHHHHHHHHhhcCCCcccceeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSG----DKIAVKKFNSPFPNDQMSD-------QKEFLNEIKALTKIRHRNIVKFYGF 574 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~hpniv~l~~~ 574 (786)
++|.+.+.||+|+||+||+|...++ ..+|+|+..........+. ......+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999986543 4566665432111100000 0112233445566789999999997
Q ss_pred EecCC----eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 575 CSHVR----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 575 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
+.... ..++++|++.. ++.+.+... ...++..+..++.|++.|++|||+. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 75443 34678887754 666666542 2356788899999999999999998 9999999999999999999
Q ss_pred EEEeccccceecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 651 ARVSDFGTAKLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
+||+|||+|+....... ......||+.|+|| |...+..++.++|||||||++|||++|+.||.
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap----------e~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL----------DAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCH----------HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999987643221 11234699999999 78888889999999999999999999999987
Q ss_pred ccccccCCCcchhh-hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 724 FLSLFSSSSSSINI-EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 724 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.............. ....+.......+ ..+..+.+++..||..+|++||+++++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 235 GFGHNGNLIHAAKCDFIKRLHEGKIKIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccccchHHHHHhHHHHHHHhhhhhhccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 54211100000000 1111222222211 2234588999999999999999999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.12 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=194.3
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
.+||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 56999999999999864 7889999987541 223456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcce
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 670 (786)
++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+...........
T Consensus 102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 999998753 3578999999999999999999999 999999999999999999999999999876654333333
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (786)
...|+..|+|| |......++.++||||+|+++|||++|..||...... ................
T Consensus 175 ~~~~~~~y~~p----------E~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~- 238 (292)
T cd06657 175 SLVGTPYWMAP----------ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAMKMIRDNLPPKLKN- 238 (292)
T ss_pred ccccCccccCH----------HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhhCCcccCC-
Confidence 45688999999 6666667889999999999999999999997642210 0001111111111111
Q ss_pred ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 751 SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+..+.+++.+||+.+|.+||++.++++
T Consensus 239 ---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1122345789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.27 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=193.7
Q ss_pred CccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
|++.+.||+|+||+||+|.+. .++.||||++.... ......+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 566788999999999999753 36789999986532 22334667889999999999999999999885432
Q ss_pred --eeeEEEeccCCCCHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 --HSFVVYEYINRGSLATVLSNNF---ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 --~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..++++||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 2478999999999998875321 123578899999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCC
Q 047901 655 DFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSS 731 (786)
Q Consensus 655 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~ 731 (786)
|||.++........ .....++..|++| |......++.++|||||||++|||++ |+.||.....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLAL----------ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---- 221 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCH----------hHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----
Confidence 99999876433221 1223456789999 66667778899999999999999999 8888764221
Q ss_pred CcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 SSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......... ....+. ..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ----~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 222 ----SEIYNYLIKGNRLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred ----HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111222221 111111 1234589999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.56 Aligned_cols=263 Identities=19% Similarity=0.278 Sum_probs=195.1
Q ss_pred cCccceeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Cee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHS 581 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~ 581 (786)
+|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+.+|+++++.++||||+++++++.+. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4788899999999999999864 478999999876321 1122345678899999999999999999999887 789
Q ss_pred eEEEeccCCCCHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC----CCcEEEec
Q 047901 582 FVVYEYINRGSLATVLSNNFA--SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL----EYEARVSD 655 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~----~~~~kl~D 655 (786)
++||||+++ ++.+++..... ...+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999975 77777753322 23688999999999999999999999 9999999999999999 89999999
Q ss_pred cccceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 656 FGTAKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 656 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
||+++....... ......++..|+|| |...+ ..++.++|||||||++|||++|++||.........
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 225 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAP----------ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225 (316)
T ss_pred CccccccCCCcccccccCCccccccccCH----------HHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence 999987654322 22345678899999 55544 45788999999999999999999998754321100
Q ss_pred -Ccchhhhhh---hhc-----------------------cCCCCCCChhHH-------HHHHHHHHHHHhccCCCCCCCC
Q 047901 732 -SSSINIEFN---AML-----------------------DHRLPHPSLDVQ-------EKLISIMEVALLCLDGCPNSRP 777 (786)
Q Consensus 732 -~~~~~~~~~---~~~-----------------------~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RP 777 (786)
......... +.+ ......+..... .....+.+++.+|++.||++||
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 305 (316)
T cd07842 226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI 305 (316)
T ss_pred cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence 000000000 000 000011100000 1234588999999999999999
Q ss_pred CHHHHHH
Q 047901 778 TMQTVCQ 784 (786)
Q Consensus 778 t~~ev~~ 784 (786)
|+.|+++
T Consensus 306 s~~eil~ 312 (316)
T cd07842 306 TAEEALE 312 (316)
T ss_pred CHHHHhc
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.70 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=203.3
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|++.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+.+|++++++++||||+++++++..+...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4788899999999999999865 688999999865321 12234678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999754 5788999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc-
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD- 744 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~- 744 (786)
. ......|+..|+|| |......++.++||||+|+++|+|++|..||...... ..........
T Consensus 154 ~-~~~~~~~~~~y~~P----------E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 216 (258)
T cd05578 154 T-LTTSTSGTPGYMAP----------EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET 216 (258)
T ss_pred c-cccccCCChhhcCH----------HHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc
Confidence 2 23345688899999 7777777899999999999999999999998743310 1111222222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM--QTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~ev~~ 784 (786)
.....+.. .+..+.+++.+||+.||.+||++ +|+++
T Consensus 217 ~~~~~~~~----~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ADVLYPAT----WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccccCccc----CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 22222222 23458899999999999999999 88764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.62 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=192.6
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv 584 (786)
+|+..+.||+|+||.||++... +++.||+|++.... .......+.+|+.++.++. ||||+++++++..++..+++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc---ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4566678999999999999865 68899999986522 1244567889999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 585 YEYINRGSLATVL---SNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 585 ~e~~~~g~L~~~l---~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|||++. ++.++. ... ....+++..+..++.+++.|++|||+. .+++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 999864 555433 222 235689999999999999999999974 2899999999999999999999999999976
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhc---CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM---KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~---~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
...... .....|+..|+||| ..... .++.++||||+||++|||++|+.||.... .....
T Consensus 158 ~~~~~~-~~~~~~~~~y~aPE----------~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~ 219 (288)
T cd06616 158 LVDSIA-KTRDAGCRPYMAPE----------RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQ 219 (288)
T ss_pred hccCCc-cccccCccCccCHH----------HhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHH
Confidence 543321 23346889999994 44443 68899999999999999999999986422 11111
Q ss_pred hhhhccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+...... ..+.......+..+.+++.+||+++|++|||+++|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 220 LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222221111 1111111224456899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=291.84 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=201.9
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+++++.++||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4788899999999999999875 688999999975321 35678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999999998764 25689999999999999999999998 9999999999999999999999999999877654
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
.. .....++..|+|| |......++.++||||||+++|+|++|+.||..... ..........
T Consensus 152 ~~-~~~~~~~~~~~~P----------E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~ 212 (253)
T cd05122 152 KA-RNTMVGTPYWMAP----------EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIATN 212 (253)
T ss_pred cc-ccceecCCcccCH----------HHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHhc
Confidence 32 3445788999999 666667788999999999999999999999764321 0111111111
Q ss_pred -CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 -RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+. .......+.+++.+||+.||++|||+.|+++
T Consensus 213 ~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 213 GPPGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCcCc--ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 1111345889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.96 Aligned_cols=247 Identities=24% Similarity=0.257 Sum_probs=193.1
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|+||+||+|... +++.||+|.+..... ........+..|+++++.++||||+++++++...+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999754 688999999864221 122334567789999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 672 (786)
|.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+...... ......
T Consensus 80 L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGR 154 (277)
T ss_pred HHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Cccccc
Confidence 999997652 24689999999999999999999999 9999999999999999999999999999765432 222334
Q ss_pred ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCCh
Q 047901 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSL 752 (786)
Q Consensus 673 ~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (786)
.++..|+|| |...+..++.++||||+||++|+|++|+.||....... ................+.
T Consensus 155 ~~~~~y~~P----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~- 219 (277)
T cd05577 155 AGTPGYMAP----------EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLEMAVEYPD- 219 (277)
T ss_pred cCCCCcCCH----------HHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhccccccccCCc-
Confidence 678899999 66666678899999999999999999999986432210 111111111111222221
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 753 DVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 220 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 ---KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2234588999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.33 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=197.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|... +++.||||++..... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36889999999999999999865 578999999865321 223456889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++++.+..+... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 79 FEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 999998777665543 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCC------cchh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS------SSIN 736 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~------~~~~ 736 (786)
... ......++..|+||| +.... .++.++||||||+++|+|++|+.||.......... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~PE----------~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 222 (288)
T cd07833 153 RPASPLTDYVATRWYRAPE----------LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP 222 (288)
T ss_pred CccccccCcccccCCcCCc----------hhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 432 233456889999995 44455 78899999999999999999999986432100000 0000
Q ss_pred hhhhhhcc--C-----CCCCC--Ch-----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAMLD--H-----RLPHP--SL-----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~--~-----~~~~~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ . ..... .. .....+..+.+++++||..+|++|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 0 00000 00 00112456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.82 Aligned_cols=244 Identities=23% Similarity=0.253 Sum_probs=186.7
Q ss_pred eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHH-hhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 512 YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL-TKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
+.||+|+||.||+|... +++.||||.+..... ........+..|..++ ...+|||++++++++..++..|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999864 688999999864211 1112223445555544 44589999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcc
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 669 (786)
+++|.+++... +.+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||.++.... .
T Consensus 81 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 81 GGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 99999999754 4678999999999999999999998 999999999999999999999999999876543 2
Q ss_pred eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCC
Q 047901 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH 749 (786)
Q Consensus 670 ~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (786)
....++..|+|| |...+..++.++||||+|+++|||++|..||..... ......+.......
T Consensus 151 ~~~~~~~~y~~p----------e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 212 (260)
T cd05611 151 KKFVGTPDYLAP----------ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRINW 212 (260)
T ss_pred ccCCCCcCccCh----------hhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcccCC
Confidence 234688899999 555566688999999999999999999999864321 11222222222222
Q ss_pred CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 750 PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.......+..+.+++.+||..+|++|||+.++.+
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 22112223456899999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=298.68 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=193.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHH-HhhcCCCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA-LTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+..|+.+ ++..+||||+++++++..++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 36888999999999999999865 689999999865321 1233455666665 566689999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||++ |+|.+++... .....+++..+..++.|++.|++|||++ .+++||||||+||+++.++.+||+|||.+...
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999997 5888888643 2235689999999999999999999985 28999999999999999999999999999866
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... ......++..|+|||.+... .....++.++|||||||++|||++|+.||..... ..+.....
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~------~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~ 220 (283)
T cd06617 155 VDSV-AKTIDAGCKPYMAPERINPE------LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-------PFQQLKQV 220 (283)
T ss_pred cccc-ccccccCCccccChhhcCCc------ccccccCccccchhhHHHHHHHHhCCCCCCcccc-------CHHHHHHH
Confidence 4321 22334688999999643211 0124568899999999999999999999863211 11112222
Q ss_pred ccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... ..+. ...+..+.+++..||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEEPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HhcCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22111 1111 122345889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=302.44 Aligned_cols=262 Identities=24% Similarity=0.285 Sum_probs=195.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Cee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~ 581 (786)
.++|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++... +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 457999999999999999999864 6899999998653221 12223466899999999999999999998654 568
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++ +|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999999975 898888754 25689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc-------
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS------- 733 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~------- 733 (786)
............++..|+||| ...+ ..++.++||||+||++|||++|+.||...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPE----------LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227 (309)
T ss_pred cCCccCCCCcccccccccChh----------hhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 765433334445688899995 4433 4578899999999999999999999875432110000
Q ss_pred chhhh---hhhhcc-CCCC---CCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIE---FNAMLD-HRLP---HPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~---~~~~~~-~~~~---~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... ...... .... .+.... ......+.++|..|+++||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000 0000 000000 112455789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=314.37 Aligned_cols=380 Identities=30% Similarity=0.391 Sum_probs=295.7
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
..+++++|.+. ++++ ++..+-+++.||..+|+|. ..|+.+..+.+|..|++.+|+++...|+.+. ++.|+.||...
T Consensus 117 ~~l~~s~n~~~-el~~-~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~ 192 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPD-SIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNS 192 (565)
T ss_pred hhhhcccccee-ecCc-hHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccch
Confidence 45667777776 4555 4666777777777777774 5566677777777777777777754444444 78888888888
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhh-ccCccceeecccccccCCCC
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNIC-RSGLLEILTVNDNHFLGSIP 162 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~L~~L~l~~N~l~~~~~ 162 (786)
|-++.+|+.++.+.+|.-|+|.+|+|.. .| .|.++..|++|+++.|+|. .+|.+.+ .++++.+|||.+|+++..|.
T Consensus 193 N~L~tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pd 269 (565)
T KOG0472|consen 193 NLLETLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPD 269 (565)
T ss_pred hhhhcCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCch
Confidence 8888788888888888888888888874 44 7888888888888888887 5666655 78888888888888888888
Q ss_pred CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccC---------------------------------
Q 047901 163 NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS--------------------------------- 209 (786)
Q Consensus 163 ~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~--------------------------------- 209 (786)
++.-+++|.+|++++|.|++ .|..++++ .|+.|-+.+|.+.++-.
T Consensus 270 e~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~ 347 (565)
T KOG0472|consen 270 EICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETA 347 (565)
T ss_pred HHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccccc
Confidence 87778888888888888885 45677777 88888888887642210
Q ss_pred -----cC---ccCCCCccEEEccCcccCCCCCccccCCcc---ccEEEeecccccccCCCCccccccccc-ccccccccC
Q 047901 210 -----SN---WGKCHRLGTLIVSGNNITGRIPPEIGNSSQ---LHVLDLSSNHIAGEIPMELGRLISLNK-LILRGNQLS 277 (786)
Q Consensus 210 -----~~---~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~i~~~~~~~~~~l~~L~~-L~L~~N~l~ 277 (786)
.. .....+.+.|++++-+++. +|+....... .+..+++.|++. ..|..+..+..+.+ +.+++|.+.
T Consensus 348 ~t~~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is 425 (565)
T KOG0472|consen 348 MTLPSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS 425 (565)
T ss_pred CCCCCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc
Confidence 01 1124467888888888884 5554443333 789999999998 77888877776655 556666665
Q ss_pred CCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccc
Q 047901 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC 357 (786)
Q Consensus 278 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 357 (786)
.+|..++.+++|..|+|++|.+..++.+. ..+-.|+.|+++.|++. ..|..+-.+..|+.+-.++|++....|+.+.
T Consensus 426 -fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~-~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~ 502 (565)
T KOG0472|consen 426 -FVPLELSQLQKLTFLDLSNNLLNDLPEEM-GSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLK 502 (565)
T ss_pred -cchHHHHhhhcceeeecccchhhhcchhh-hhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhh
Confidence 88889999999999999999999876554 55666999999999997 6788888888888888888999988888899
Q ss_pred cccccceeccccccccccCCcccccCCCceEEeccCCcccc
Q 047901 358 NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRG 398 (786)
Q Consensus 358 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 398 (786)
++.+|..|||.+|.|. .+|..+++|.+|++|++.||+++-
T Consensus 503 nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 503 NMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred hhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 9999999999999998 567789999999999999999993
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.08 Aligned_cols=251 Identities=24% Similarity=0.271 Sum_probs=204.5
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..+.|+.-++||+|+||.||-++.+ +|+.+|+|++.+.. ............|-.|+++++.|.||.+-..++..+..|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR-iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR-IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH-HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456888899999999999999865 78899999886522 122334456678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+|+..|.||||.-+|.+.+ ...++++.+.-++.+|+-||++||+. +||+||+||+|||+|++|+++|+|.|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999998763 46799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....+||.+|||| |++..+.|+...|.||+||++|||+.|+.||..- ...+ ... -
T Consensus 338 ~~g~-~~~~rvGT~GYMAP----------Evl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~------KeKv--k~e-E 397 (591)
T KOG0986|consen 338 PEGK-PIRGRVGTVGYMAP----------EVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR------KEKV--KRE-E 397 (591)
T ss_pred CCCC-ccccccCcccccCH----------HHHcCCcccCCccHHHHHhHHHHHHcccCchhhh------hhhh--hHH-H
Confidence 7543 23445999999999 7888888999999999999999999999998631 1111 111 2
Q ss_pred ccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 743 LDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 743 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
+|.+ ...+.......+.+..++....|.+||++|--.
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2222 223344444555667888889999999999654
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=297.59 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=191.5
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecC--CeeeE
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHV--RHSFV 583 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~--~~~~l 583 (786)
|++.+.||+|+||.||+|... +++.||+|++...... .......+|+.++.++. ||||+++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 567889999999999999854 6889999998653221 12223457888899885 99999999999877 88999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||++ |++.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++...
T Consensus 78 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 999997 4888888653 24689999999999999999999999 9999999999999999 999999999998764
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------Ccchhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------SSSINI 737 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------~~~~~~ 737 (786)
.... .....++..|+||| .......++.++||||+||++|||++|..||...+..... ......
T Consensus 151 ~~~~-~~~~~~~~~y~aPE---------~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07831 151 SKPP-YTEYISTRWYRAPE---------CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220 (282)
T ss_pred cCCC-cCCCCCCcccCChh---------HhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence 3322 23346789999995 2233455788999999999999999999998754321100 000000
Q ss_pred hhhhhccC----CCCCCCh-------hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDH----RLPHPSL-------DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~----~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ ....+.. .....+..+.+++.+||+++|++|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 0001100 01123467999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.31 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=194.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|++.+.||+|+||.||+|... +++.||||++... ........+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF---EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc---ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 457999999999999999999754 7889999998641 1223456688899999999999999999987543
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++|+||+++ ++.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 357999999975 88887753 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---cceeeccCccccCCCCCCCCchHHHHh-hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC----
Q 047901 659 AKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELA-YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS---- 730 (786)
Q Consensus 659 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~-~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~---- 730 (786)
+........ ......|+..|+|| |.. ....++.++||||+||++|+|++|+.||........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~ 222 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAP----------EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccCh----------HHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 987643222 11234688999999 443 335678899999999999999999999865332100
Q ss_pred ---CCcchhhhhhhhccCC-------CC-CCCh----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ---SSSSINIEFNAMLDHR-------LP-HPSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ---~~~~~~~~~~~~~~~~-------~~-~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+....+.... .+ .+.. ..+..+..+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000001111111100 00 0000 01122456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.35 Aligned_cols=243 Identities=26% Similarity=0.326 Sum_probs=196.8
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||.|++|.||+|+.. +++.||+|++..... ......+.+.+|+++++.++||||+++++++.++...++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999865 588999999865321 222345679999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 672 (786)
|.+++.+. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+....... .....
T Consensus 80 L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~ 152 (262)
T cd05572 80 LWTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF 152 (262)
T ss_pred HHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence 99999754 4588999999999999999999998 99999999999999999999999999998775432 22234
Q ss_pred ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CCCCCC
Q 047901 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHP 750 (786)
Q Consensus 673 ~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 750 (786)
.++..|+|| |......++.++|+||+|+++|+|++|..||..... ........+.. .....|
T Consensus 153 ~~~~~~~~P----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05572 153 CGTPEYVAP----------EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFP 216 (262)
T ss_pred cCCcCccCh----------hHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCC
Confidence 688999999 666667788999999999999999999999864321 11222233332 222223
Q ss_pred ChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 751 SLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
... ...+.+++.+||.++|++||| +.|+++
T Consensus 217 ~~~----~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYI----DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccc----CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222 446899999999999999999 888775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.75 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=202.7
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|++|.||+|... +++.|++|.+.... ......+.+.+|++++++++|||++++++++......++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK--IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc--cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 4788899999999999999765 67899999997632 11245678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999999754 5789999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........++..|+|| |......++.++||||+|+++|+|++|+.||..... ..........
T Consensus 153 ~~~~~~~~~~~~y~~p----------e~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~ 214 (254)
T cd06627 153 SKDDASVVGTPYWMAP----------EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--------MAALFRIVQD 214 (254)
T ss_pred cccccccccchhhcCH----------hhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcc
Confidence 4433455789999999 555555688899999999999999999999764221 1111111111
Q ss_pred CC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. ..+. ..+..+.+++.+||..+|++|||+.+++.
T Consensus 215 ~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPE----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCC----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 1121 12345889999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.59 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=194.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|++|+||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++......++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 46889999999999999999865 688999999865321 123345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~ 663 (786)
|||++ +++.+++... .....++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||++....
T Consensus 80 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 80 FEYLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred Eeccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 99996 4888887654 233467888899999999999999999 9999999999999985 5679999999998664
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-------cch
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SSI 735 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~~ 735 (786)
..........+++.|+|| |...+ ..++.++||||+||++|+|+||+.||.......... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~P----------E~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAP----------EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred CCccccccCceeecccCH----------HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 433333445678899999 55544 357889999999999999999999986432110000 000
Q ss_pred hhhhh--------hhccCCCCCC--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFN--------AMLDHRLPHP--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~--------~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+. .....+.... .......+.++.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0000000000 0001112345789999999999999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.39 Aligned_cols=200 Identities=33% Similarity=0.496 Sum_probs=173.2
Q ss_pred CccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC------Ce
Q 047901 508 FDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV------RH 580 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~ 580 (786)
|...+.+|+|+||.||+|+. .+|+.||||.++... .....+...+|+++|+++.|||||+++++-+.. +.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 45567799999999999995 489999999998633 334566788999999999999999999976443 45
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC--CCC--cEEEecc
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD--LEY--EARVSDF 656 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~--~~kl~Df 656 (786)
..+|||||.+|||..++.+......+++.+.+.+..+++.||.|||++ +||||||||.||++- .+| .-||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 689999999999999998766667899999999999999999999999 999999999999983 333 4699999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
|.|+..++++ .....+||..|.+| |+.. ...|+..+|.|||||++||++||..||..
T Consensus 169 G~Arel~d~s-~~~S~vGT~~YLhP----------el~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNS-LFTSLVGTEEYLHP----------ELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCC-eeeeecCchhhcCh----------HHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999998665 56778999999999 5555 47888999999999999999999999864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.59 Aligned_cols=243 Identities=23% Similarity=0.237 Sum_probs=185.4
Q ss_pred eeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHh---hcCCCcccceeeEEecCCeeeEEEecc
Q 047901 513 CIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT---KIRHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~---~l~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
.||+|+||.||+|... +++.||+|.+........ .....+.+|..+++ ..+||||+.+++++...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999864 688999998865322211 22233444444333 347999999999999889999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 668 (786)
++|+|.+++... +.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 80 NGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999998754 5689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc-CC
Q 047901 669 WTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD-HR 746 (786)
Q Consensus 669 ~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~ 746 (786)
.....|+..|+|| |... +..++.++||||+||++|||++|..||..... ........... ..
T Consensus 152 ~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~ 215 (279)
T cd05633 152 PHASVGTHGYMAP----------EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT------KDKHEIDRMTLTVN 215 (279)
T ss_pred ccCcCCCcCccCH----------HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC------cCHHHHHHHhhcCC
Confidence 2234689999999 4443 45578999999999999999999999864321 11111111111 11
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
...+ ...+..+.+++..||+.||++|| |++|+++
T Consensus 216 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 216 VELP----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCCc----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1112 22334588999999999999999 5999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.48 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=195.6
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|+||.||+|+.. +++.||+|++..... ........+.+|+++++.++|||++++++++..+...++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 777888999999999999854 688999999865322 223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++ ++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 787777543 34689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
....|+..|+|||.+.. .....++.++|||||||++|||++|+.||.... .......+....
T Consensus 179 ---~~~~~~~~y~aPE~~~~-------~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~ 240 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILA-------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE 240 (317)
T ss_pred ---ccccCCccccChhhhhc-------CCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhcc
Confidence 23468889999953210 123567889999999999999999999976421 111122222222
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.... .....+..+.+++.+||+.+|.+|||+.++++.
T Consensus 241 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 241 SPTL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CCCC--CCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 1111 112233458899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.69 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=203.5
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--CeeeE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHSFV 583 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~l 583 (786)
+|+..+.||+|++|.||+|... +++.|++|++..... .....+.+.+|++++++++||||+++++++... +..++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4778889999999999999876 788999999875322 134567889999999999999999999999888 88999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 79 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999999764 3789999999999999999999998 99999999999999999999999999998876
Q ss_pred CCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 664 PNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 664 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.... ......++..|+|| |.......+.++||||||+++|+|++|..||.... ........
T Consensus 153 ~~~~~~~~~~~~~~~~y~~p----------E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~ 215 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAP----------EVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYK 215 (260)
T ss_pred cccccccccCCCCCccccCH----------hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHh
Confidence 5432 13445788999999 66666668899999999999999999999987432 01111111
Q ss_pred hcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... .....+. ..+..+.+++.+|+..+|++|||+.|+++
T Consensus 216 ~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 216 IGSSGEPPEIPE----HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccccCCCcCCCc----ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111 1111121 22456899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=289.02 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=204.6
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+.+|+++++.++|||++++.+.+...+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 4788899999999999999865 68899999986532 22345667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++.... ....+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999997642 236789999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.........|++.|+|| |......++.++||||+|+++|+|++|+.||+... ..........
T Consensus 156 ~~~~~~~~~~~~~y~~p----------e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~ 217 (258)
T cd08215 156 TVDLAKTVVGTPYYLSP----------ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILK 217 (258)
T ss_pred CcceecceeeeecccCh----------hHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhc
Confidence 43333445788999999 55666678899999999999999999999986432 1112222222
Q ss_pred CCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... .+. .....+.+++.+||..+|++|||+.|+++
T Consensus 218 ~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 218 GQYPPIPS----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2221 121 22345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=282.19 Aligned_cols=244 Identities=25% Similarity=0.277 Sum_probs=203.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.+|+|.||.|.+++.+ +++.+|+|+++++.... .++...-..|-.+++..+||.+..+-..+...++.|.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457888999999999999999865 78899999998755433 2344555678899999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||..||.|...+.+. ..+++...+-+..+|+.||.|||++ +||+||+|.+|.|+|.||++||+|||+++...
T Consensus 246 VMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999988764 5688888899999999999999999 99999999999999999999999999998766
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.......+++||+.|.|| |++....|+.++|.|.+||+||||++|+.||...+ .+..+.-+.
T Consensus 320 ~~g~t~kTFCGTPEYLAP----------EVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--------h~kLFeLIl 381 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAP----------EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--------HEKLFELIL 381 (516)
T ss_pred cccceeccccCChhhcCc----------hhhccccccceeehhhhhHHHHHHHhccCcccccc--------hhHHHHHHH
Confidence 555667788999999999 77888899999999999999999999999987422 122222233
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 777 (786)
-..+..|....++ ...++...+.+||++|-
T Consensus 382 ~ed~kFPr~ls~e----AktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 MEDLKFPRTLSPE----AKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhhccCCccCCHH----HHHHHHHHhhcChHhhc
Confidence 3344444433333 66788889999999995
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.37 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=196.8
Q ss_pred cCccceeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
+|++.+.||+|++|.||+|+. .+++.||||.+............+.+.+|++++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377889999999999999874 356789999986432222233456788999999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998753 4688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcC--cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 662 LKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMK--ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~--~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
....... .....|+..|+|| |...+.. .+.++||||||+++|||++|..||...... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~ 220 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAP----------EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEI 220 (288)
T ss_pred cccccccccccccCCccccCH----------HHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHH
Confidence 6543221 1234688999999 4444433 678999999999999999999998532110 011111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...+.......+.. ....+.+++.+||+.+|++|||+.++.+.
T Consensus 221 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 221 SRRILKSKPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred HHHHHccCCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 12222222222222 22358899999999999999998777554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.80 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=195.7
Q ss_pred cCccceeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
.|++.+.||+|+||.||+|+. .+|+.||+|++............+.+.+|+.+++++ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999975 368899999986532222233456788899999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999999754 4678899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC-cceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 662 LKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
...... ......|+..|+||| .... ..++.++||||||+++|+|++|+.||..... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~ 220 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPD----------IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEI 220 (290)
T ss_pred cccccccccccccCCcccCChh----------hccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHH
Confidence 643321 222456899999995 3332 3467899999999999999999999863211 1111111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
...........+. .....+.+++.+||+.+|++|| +++++++
T Consensus 221 ~~~~~~~~~~~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 SRRILKSEPPYPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHhhccCCCCCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1222222222221 1234588999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=284.72 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=193.3
Q ss_pred cceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhh-cCCCcccceeeEEecCCeeeEEEec
Q 047901 510 AKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
....||.|+||+|++..++ .|+..|||+++... ...+++++..|.+...+ -..||||+++|.+..++.-|+-||.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3456999999999999865 78999999998632 24566788899886544 4799999999999999999999999
Q ss_pred cCCCCHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 588 INRGSLATVLSNNF--ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 588 ~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
|.- ++..+-..-+ ....+++.-.-.|....+.||.||.+. ..|+|||+||+|||++..|.+||||||.+-.+.++
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 965 6654332111 234677777778888899999999987 38999999999999999999999999998766532
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
...+.-.|-.+|||||.+... +..|+.+|||||+|+.|||+.||+.|+...+. ..+....++..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~--------~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~g 285 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPS--------DKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIG 285 (361)
T ss_pred -HHhhhccCCccccChhccCCc--------cCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcC
Confidence 233445788999999854321 22589999999999999999999999764221 22223333333
Q ss_pred CCC--CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLP--HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+ .......+...++..+|..|+.+|-.+||.+.++.+
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 222 233333445667999999999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=303.08 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=195.8
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC----
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV---- 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~---- 578 (786)
..++|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+++++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3567999999999999999999854 788999999865322 223445677899999999999999999988543
Q ss_pred --CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecc
Q 047901 579 --RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDF 656 (786)
Q Consensus 579 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 656 (786)
...|+||||+++ +|.+++.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999965 88888753 278889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-----
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----- 731 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----- 731 (786)
|.++...... ......++..|+|| |...+..++.++||||+||++|+|++|+.||...+.....
T Consensus 163 g~~~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 163 GLARTAGTSF-MMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred ccceeCCCCC-CCCCCcccccccCH----------HHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9998764332 22334688999999 6777788999999999999999999999998643311000
Q ss_pred --Ccch-------hhhhhhhccCCCC--------------CCChh---HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 --SSSI-------NIEFNAMLDHRLP--------------HPSLD---VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 --~~~~-------~~~~~~~~~~~~~--------------~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ........+.+.. .+... .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0000000110000 00000 1122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.25 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=206.0
Q ss_pred HHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.-..++|.+.+.||+|+||.|..++.+ +++.||+|++.+. ..-......-|+.|-.+|..-..+-|++++..|.++++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~-eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW-EMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH-HHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 334678999999999999999999976 5778899998651 11122344578999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+|||||+||||...+... ..+++..++-++..|+-||.-+|+. |+|||||||+|||+|..|++||+|||.+.
T Consensus 150 LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred eEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999865 3789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 661 LLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 661 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.+..+.. .....+|||.|++||++. ..-.+ +.|++.+|.||+||++|||+.|..||..-. ..+.
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLq------s~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveT 289 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQ------SQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVET 289 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHH------hhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHH
Confidence 8874433 345679999999996543 11123 678999999999999999999999987322 2344
Q ss_pred hhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 047901 739 FNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT---MQTVC 783 (786)
Q Consensus 739 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~ 783 (786)
+..+... .+..|. ..+.+....++|.+.+. +|+.|-. ++++.
T Consensus 290 Y~KIm~hk~~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 290 YGKIMNHKESLSFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHhchhhhcCCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 5555555 445552 22345567788877664 6777776 66654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.91 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=202.5
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|++.+.||+|+||.||++... +++.+|+|++..... .......+.+|+++++.++||||+++++++......++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 4788899999999999999754 778999999865221 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++.+.. ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999999987532 235689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. ......++..|+|| |...+..++.++|+||+|+++|||++|+.||..... .........
T Consensus 156 ~--~~~~~~~~~~~~~P----------e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~ 215 (256)
T cd08530 156 N--MAKTQIGTPHYMAP----------EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKVQR 215 (256)
T ss_pred C--CcccccCCccccCH----------HHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc
Confidence 4 22334688899999 777777888999999999999999999999864321 111111222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .......+.+++.+||..+|++|||+.|+++
T Consensus 216 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 GKYPPI---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCC---chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 222211 1134456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.42 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=203.7
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~l 583 (786)
++|...+.||+|+||.||+|... +++.||+|++..... ......+.+..|.+++++++ ||||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 36888999999999999999865 789999999865221 12234567889999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++... +.+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 80 VLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999999754 4799999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCC--------------------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 664 PNSS--------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 664 ~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
.... ......++..|+|| |......++.++||||+|++++++++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P----------e~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP----------ELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCH----------HHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 3321 12234678899999 66666678899999999999999999999987
Q ss_pred ccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 047901 724 FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM----QTVCQ 784 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~ev~~ 784 (786)
... .......+.......+... +..+.+++.+||+.+|.+|||+ +++++
T Consensus 224 ~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 224 GSN--------EYLTFQKILKLEYSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Ccc--------HHHHHHHHHhcCCCCCCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 432 1222333333333333322 3348899999999999999999 88875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.95 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=195.0
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|+||.||+|+.. +++.||+|.+..... ......+.+.+|++++++++||||+++++.+...+..|+||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999876 589999999865321 123456678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC-----
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS----- 667 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----- 667 (786)
|.+++.+. +.+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 80 L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 80 LASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99999764 3689999999999999999999998 999999999999999999999999999876543321
Q ss_pred ---cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 668 ---NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 668 ---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
......++..|+|| |.......+.++||||||+++||+++|..||.... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~P----------e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~ 215 (265)
T cd05579 154 DEKEDKRIVGTPDYIAP----------EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN 215 (265)
T ss_pred ccccccCcccCccccCH----------HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc
Confidence 22345678899999 66666678889999999999999999999986422 1222222332
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH---HHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM---QTVC 783 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~---~ev~ 783 (786)
.....+... ..+..+.+++.+||+.+|++|||+ .+++
T Consensus 216 ~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 216 GKIEWPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCcCCCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 233322221 123458899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.83 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=196.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|...+.||+|+||+||+|+.. +++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 357899999999999999999854 688999999875322 223345677899999999999999999987543
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...|+||||+. ++|.+++... +.+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35799999996 6899888753 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCcccccc--------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS-------- 729 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~-------- 729 (786)
++.............++..|+|| |.... ..++.++|||||||++|+|++|+.||...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 224 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAP----------ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224 (337)
T ss_pred ccccCCCcccccccccccCccCh----------HHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 98765443333445688999999 54443 458889999999999999999999986532100
Q ss_pred --CCC-----cchhhhhhhhccCCC--CCC--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 730 --SSS-----SSINIEFNAMLDHRL--PHP--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 730 --~~~-----~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ...........+... ..+ .......+..+.+++.+||+.+|++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000 000000000110000 000 0011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.68 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=199.3
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|++|.||+|... +++.+++|++..... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 567788999999999999865 788999999875332 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++ ++.+++... ...+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 79 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 79 FMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred ccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9975 888888764 25789999999999999999999999 99999999999999999999999999998776543
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-------cchhhh
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SSINIE 738 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~~~~~ 738 (786)
.......++..|+|| |...+. .++.++||||+|+++|+|+||+.||...+...... ......
T Consensus 153 ~~~~~~~~~~~~~~P----------E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd05118 153 RPYTHYVVTRWYRAP----------ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222 (283)
T ss_pred ccccCccCcccccCc----------HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence 233345688899999 555444 68899999999999999999999986543211000 000000
Q ss_pred hhhhcc-----------CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLD-----------HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+ .............+..+.+++..||++||.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0000001112234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.98 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=195.2
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--CeeeEE
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHSFVV 584 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv 584 (786)
|++.+.||+|++|.||+|... +++.+|+|++.... ........+.+|+++++.++|||++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 567889999999999999866 57899999997632 1223446788999999999999999999999887 889999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++ +|.+++... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 79 FEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred eccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999975 898888654 25789999999999999999999998 999999999999999999999999999987754
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-------cchh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SSIN 736 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~~~ 736 (786)
... ......++..|+|||.+ .....+++++||||||+++|||++|+.||+......... ....
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~---------~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELL---------LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223 (287)
T ss_pred CCcccccccccccccCCceee---------EccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 421 22334678899999532 122357889999999999999999999986433110000 0000
Q ss_pred hhh--------hhhccCCCCCCCh---hHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEF--------NAMLDHRLPHPSL---DVQE-KLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~--------~~~~~~~~~~~~~---~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+ ..........+.. .... .+..+.+++.+||+.+|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0000000000000 0001 1456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.09 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=196.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCC-CCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Cee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFP-NDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~ 581 (786)
.+|+..+.||+|+||.||+|+.. +++.||+|++..... .........+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999864 688999998754221 12233456888999999999999999999998654 467
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++++|.+++... +.+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999999754 4578889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC---CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 662 LKPNS---SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 662 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
..... .......++..|+|| |...+..++.++|||||||++|||++|+.||..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~ 217 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSP----------EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--------MAA 217 (264)
T ss_pred cccccccCccccccCCcccccCH----------hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------HHH
Confidence 54311 112234688999999 666666788999999999999999999999864221 111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... ...+......+.+++.+||. +|..|||+.+++.
T Consensus 218 ~~~~~~~~~~--~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQPTK--PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCCCC--CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 2222211111 11112233458999999999 5799999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=304.66 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=195.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec----CCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH----VRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~ 580 (786)
++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 67999999999999999999854 689999999875321 22345677789999999999999999998753 356
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+. |+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 799999996 5899988653 4589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----
Q 047901 661 LLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS---- 731 (786)
Q Consensus 661 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~---- 731 (786)
....... ......|+..|+||| .... ..++.++|||||||++|||++|+.||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE----------~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPE----------LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225 (334)
T ss_pred eecccCcCCCcccccccccccccChH----------HhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH
Confidence 7643221 122347889999994 4433 45789999999999999999999999754321000
Q ss_pred ---Ccc--------hhhhhhhhcc---CCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ---SSS--------INIEFNAMLD---HRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ---~~~--------~~~~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ......+..+ .....+ .......+..+.+++..||+.+|.+|||++++++
T Consensus 226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 0000111111 011110 0001223456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=318.83 Aligned_cols=266 Identities=18% Similarity=0.192 Sum_probs=185.1
Q ss_pred hccCccceeeccccCceEEEEEcCC--CCEEEEEEcCC-------------CCCCCchhhHHHHHHHHHHHhhcCCCccc
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS--GDKIAVKKFNS-------------PFPNDQMSDQKEFLNEIKALTKIRHRNIV 569 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~-------------~~~~~~~~~~~~~~~e~~~l~~l~hpniv 569 (786)
.++|++.+.||+|+||+||++..+. +..+++|.+.. ............+.+|+++++.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 22222221100 00011122345688999999999999999
Q ss_pred ceeeEEecCCeeeEEEeccCCCCHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFA--SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 570 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
++++++...+..|+|+|++. +++.+++..... ........+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 478887754311 12334567788999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC-CCcc
Q 047901 648 EYEARVSDFGTAKLLKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-GDFL 725 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P-f~~~ 725 (786)
++.+||+|||+++........ .....||..|+|| |++.+..++.++|||||||++|||++|..| +...
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSP----------EILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCc----------hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 999999999999877543322 2245799999999 666777899999999999999999998754 3321
Q ss_pred ccccC---------CC------cchhhhhhhhccC-CCCCCChhHH------HHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 726 SLFSS---------SS------SSINIEFNAMLDH-RLPHPSLDVQ------EKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 726 ~~~~~---------~~------~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
..... .. ..........++. .+........ .....+.+++.+|++.||++|||+.|++
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 11000 00 0000000000000 0000000000 0123467789999999999999999998
Q ss_pred H
Q 047901 784 Q 784 (786)
Q Consensus 784 ~ 784 (786)
+
T Consensus 453 ~ 453 (501)
T PHA03210 453 A 453 (501)
T ss_pred h
Confidence 5
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=305.38 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=193.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecC--Ce
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHV--RH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~--~~ 580 (786)
.++|+..+.||+|+||.||+|... +++.||||++..... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 457888999999999999999865 678999999864322 223345677899999999 999999999988643 46
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||++ ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 799999997 4999988642 678889999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC-----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----
Q 047901 661 LLKPNSS-----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS---- 731 (786)
Q Consensus 661 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~---- 731 (786)
....... ......|+..|+|||.+ .....++.++||||||+++|+|++|+.||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEIL---------LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred ccccccccccCcchhcccccccccCceee---------eccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 7654321 22334689999999632 22345778999999999999999999998643211000
Q ss_pred ---Ccchhhh--------hhhhcc----CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ---SSSINIE--------FNAMLD----HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ---~~~~~~~--------~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....... ...+.+ .............+..+.+++..||+.+|++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0000000 000000 0000001111112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.99 Aligned_cols=258 Identities=23% Similarity=0.302 Sum_probs=194.8
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC---
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR--- 579 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--- 579 (786)
..++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 4567999999999999999999875 688999999875321 1223456778999999999999999999986654
Q ss_pred -------eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEE
Q 047901 580 -------HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR 652 (786)
Q Consensus 580 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 652 (786)
..++|+||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 787777653 34689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC-cceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 653 VSDFGTAKLLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
|+|||.+........ ......++..|+||| ... ...++.++|||||||++|||++|++||........
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE----------~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~ 226 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPE----------LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChH----------HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999987654332 222335678899995 333 33568899999999999999999999874322100
Q ss_pred CCcchhhhhhhhccCC--------------------CCC-C--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 SSSSINIEFNAMLDHR--------------------LPH-P--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~--------------------~~~-~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........... ... . .......+..+.+++..||+.+|.+|||+.++++
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 227 -----LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred -----HHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000 000 0 0000112346899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=320.88 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=196.4
Q ss_pred HHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV-- 578 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-- 578 (786)
.+...+|+..+.+|+||||.||+++.+ ||+.||||++.... .......+.+|+..++++.|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 355678888899999999999999977 89999999998743 334567788999999999999999997431000
Q ss_pred --------------------------------------------------------------------------------
Q 047901 579 -------------------------------------------------------------------------------- 578 (786)
Q Consensus 579 -------------------------------------------------------------------------------- 578 (786)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 047901 579 -------------------------------------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621 (786)
Q Consensus 579 -------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~ 621 (786)
...||=||||+...+.++++++.... .....++++++|+.|
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEG 709 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHH
Confidence 02378899999988888887652211 466788999999999
Q ss_pred HHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC------------------CCCCcceeeccCccccCCCC
Q 047901 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK------------------PNSSNWTELVGTFGYVAPAH 683 (786)
Q Consensus 622 l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~ 683 (786)
|.|+|++ |||||||||.||+++++..|||+|||+|+... .+....+..+||.-|+|||.
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998721 01113456789999999964
Q ss_pred CCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHH
Q 047901 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIME 763 (786)
Q Consensus 684 ~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 763 (786)
+... ....|+.|+||||+|||++||+. ||...+ ..........+..++.+.....+....=..
T Consensus 787 l~~~-------~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 787 LSDT-------SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------ERASILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred hccc-------ccccccchhhhHHHHHHHHHHhc---cCCchH-------HHHHHHHhcccCCCCCCcccccccchHHHH
Confidence 4221 12369999999999999999985 454211 011223344455555553334444455578
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 047901 764 VALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 764 li~~cl~~~p~~RPt~~ev~~ 784 (786)
+|.+++++||.+||||.|+++
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.03 Aligned_cols=366 Identities=24% Similarity=0.333 Sum_probs=320.2
Q ss_pred eEEEEcCCCCCcc-cCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 3 VNSINLTSTGLKG-TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 3 ~~~l~l~~~~l~~-~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
|+.+|+|+|..+| ..|+ +...+.++++|-|...++ ..+|+.++.|.+|+.|.+++|++. ...+.++.|+.|+.+++
T Consensus 9 VrGvDfsgNDFsg~~FP~-~v~qMt~~~WLkLnrt~L-~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPH-DVEQMTQMTWLKLNRTKL-EQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eecccccCCcCCCCcCch-hHHHhhheeEEEechhhh-hhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 6788999999995 4555 678899999999999998 478899999999999999999998 56678899999999999
Q ss_pred CCccCc--ccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccC
Q 047901 82 SLNQFS--GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG 159 (786)
Q Consensus 82 s~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 159 (786)
.+|++. |+|+.+..+..|+.||||+|+++ ..|..+...+++-.|+||+|+|..++-..|.+++-|-.|+|++|++..
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~ 164 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM 164 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh
Confidence 999884 77888999999999999999998 678889999999999999999996666677889999999999999999
Q ss_pred CCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccc-cccCcCccCCCCccEEEccCcccCCCCCccccC
Q 047901 160 SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY-GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGN 238 (786)
Q Consensus 160 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 238 (786)
.||....+..|+.|.|++|-+....-..+-.+++|+.|.+++.+=+ .-+|..+.++.+|..+|||.|++. +.|+.+.+
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~ 243 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYK 243 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhh
Confidence 9999999999999999999887766666667888999999986533 356778889999999999999999 88999999
Q ss_pred CccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccc-cchhhhhcccCCcEE
Q 047901 239 SSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN-SILEALGFMFKLFYL 317 (786)
Q Consensus 239 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L 317 (786)
+++|+.|+||+|+|+ ..........+|++|+||.|+++ ..|.++..+++|+.|++.+|+++- -.|..++.+.+|+.+
T Consensus 244 l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF 321 (1255)
T ss_pred hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence 999999999999998 45555666789999999999998 788999999999999999999762 235567888899999
Q ss_pred EecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCC
Q 047901 318 NFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIP 377 (786)
Q Consensus 318 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 377 (786)
..++|.+. ..|+.+..+..|+.|.|++|++- ++|..+.-|+.|+.||+.+|+-.--+|
T Consensus 322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred Hhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 99999996 89999999999999999999998 889999999999999999998653333
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.28 Aligned_cols=257 Identities=20% Similarity=0.245 Sum_probs=188.8
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCC
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINR 590 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 590 (786)
++.+|.|+++.||++.. +++.||||++.... ......+.+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 33445555555555544 68899999987531 2234567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC---
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS--- 667 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--- 667 (786)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998652 34588899999999999999999999 999999999999999999999999999876543211
Q ss_pred ----cceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh-----
Q 047901 668 ----NWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN----- 736 (786)
Q Consensus 668 ----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~----- 736 (786)
......++..|+|| |.... ..++.++|||||||++|||++|+.||..............
T Consensus 160 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSP----------EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229 (314)
T ss_pred ccccccccccccccccCH----------HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcc
Confidence 12234577889999 44433 3578899999999999999999999875331100000000
Q ss_pred --------hhhhhhc-------cCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 --------IEFNAML-------DHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 --------~~~~~~~-------~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+. +.. ...+..........+.+++.+||..||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000000 000 00011111223456889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=291.25 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=194.1
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc---CCCcccceeeEEecCCe---
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCSHVRH--- 580 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~~--- 580 (786)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .......+.+|+++++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 567889999999999999976 588999999975332 122234566788777666 59999999999987766
Q ss_pred --eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 581 --SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 581 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
.+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999975 8999887642 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
+....... ......++..|+|| |...+..++.++|||||||++|||++|++||...... +.
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~~P----------E~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--------~~ 214 (287)
T cd07838 154 ARIYSFEM-ALTSVVVTLWYRAP----------EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--------DQ 214 (287)
T ss_pred ceeccCCc-ccccccccccccCh----------HHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--------HH
Confidence 98765432 22334578899999 6667777899999999999999999999998743210 00
Q ss_pred hhhhcc----------------------CCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLD----------------------HRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~----------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.+ ... ..+.....+....+.+++.+||+.||.+||++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 215 LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 000 0111111233456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=296.23 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=194.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|+..+.||+|+||.||+|+.. +++.+|+|.+..... ......+++.+|+++++.++|||++++++++......++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4777788999999999999864 678899999864211 12234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+. |++.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5888877543 24588999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhh---hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAY---TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~---~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
....++..|+|| |... ...++.++|||||||++|||++|..||..... .......
T Consensus 169 ----~~~~~~~~y~aP----------E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~ 226 (308)
T cd06634 169 ----NXFVGTPYWMAP----------EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHI 226 (308)
T ss_pred ----ccccCCccccCH----------HHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHH
Confidence 234688899999 5543 34578899999999999999999999754221 1111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+ ..........+.+++.+||+++|++|||++++++
T Consensus 227 ~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 227 AQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred hhcCCC--CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 111111 1111223456889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=276.82 Aligned_cols=204 Identities=20% Similarity=0.326 Sum_probs=170.2
Q ss_pred hccCccceeeccccCceEEEEEcC---C--CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-C
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP---S--GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-V 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~ 578 (786)
...|+....||+|.||.||+|... + .+.+|+|+++.+...+ .......+|+..++.++||||+.+..++.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 346899999999999999999532 2 2378999997643322 233466799999999999999999998865 8
Q ss_pred CeeeEEEeccCCCCHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC----CcEE
Q 047901 579 RHSFVVYEYINRGSLATVLSNNF--ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE----YEAR 652 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~k 652 (786)
..+|+++||.+. ||.+.|+-+. ....++...+..|..||+.|++|||++ =|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 889999999988 9999886442 345789999999999999999999999 89999999999999887 8999
Q ss_pred EeccccceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 653 VSDFGTAKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
|+|||+|+.+..+-. .....+-|.+|.|| |.+.+ ..||++.||||.|||+.||+|-++-|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAP----------ELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAP----------ELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecCh----------HHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999998876533 33557889999999 55544 5699999999999999999998877754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.81 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=193.4
Q ss_pred hccCccceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|+..+.||+|+||.||+|..++ ++.||||++.... .......+..|++++.+. .||||+++++++......|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3568889999999999999999764 8899999986522 123345667788777766 4999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++ ++.+.+... ...+++..+..++.|++.|++|||+. .+|+||||+|+||+++.++.+||+|||.+...
T Consensus 91 ~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999864 777776543 34789999999999999999999973 18999999999999999999999999999766
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... ......++..|+|||.+.... ....++.++||||||+++|||++|+.||..... ..+.....
T Consensus 166 ~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~ 231 (296)
T cd06618 166 VDSK-AKTRSAGCAAYMAPERIDPPD------PNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKI 231 (296)
T ss_pred cCCC-cccCCCCCccccCHhhcCCCC------CccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHH
Confidence 4322 223346788999996432110 023478899999999999999999999863211 11122222
Q ss_pred ccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .+. ....+.++.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 232 LQEEPPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred hcCCCCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222211 111 1122345899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=279.20 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=203.4
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe-
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS- 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~- 576 (786)
...+++..-.+.+|.||.||+|.|+ +.+.|.||.++.. ...-+...+..|.-.+..+.|||+..+.+++.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3445666677899999999999654 3456788888652 33445667889999999999999999999874
Q ss_pred cCCeeeEEEeccCCCCHHHHhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 577 HVRHSFVVYEYINRGSLATVLS-----NNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
+.+.+++++.++..|+|..|+. +......++..+...++.|++.|++|||++ +|||.||.++|++|++..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeE
Confidence 5567899999999999999998 222344577888899999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|=.+++.+-+.++.. ........||+| |.+....|+.++|||||||+||||+| |+.|+...+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl----------Eal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP- 504 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSL----------EALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP- 504 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCH----------HHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-
Confidence 999999999887654431 112345689999 88888999999999999999999998 9999775432
Q ss_pred cCCCcchhhhhhhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 729 SSSSSSINIEFNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+...-..| .|+..|..++++ ++.+|.-||..+|++||++++++.
T Consensus 505 -------fEm~~ylkdGyRlaQP~NCPDe----Lf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 505 -------FEMEHYLKDGYRLAQPFNCPDE----LFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -------HHHHHHHhccceecCCCCCcHH----HHHHHHHHHhcCcccCCCHHHHHH
Confidence 222222333 355666655554 999999999999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=289.04 Aligned_cols=248 Identities=21% Similarity=0.242 Sum_probs=189.9
Q ss_pred HHHHHhccCccceee--ccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 500 EIIRRTKDFDAKYCI--GKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 500 ~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
+.....++|++.+.+ |+|+||.||+++.+ ++..+|+|.+..... .. .|+.....+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~-----~e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----NA-----IEPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc----ch-----hhHHHHHHhhcCCCEEEEEEEE
Confidence 334445667776666 99999999999854 678899998864211 11 122222222 699999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEe
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVS 654 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~ 654 (786)
...+..++||||+++|+|.+++... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 9999999999999999999999764 3789999999999999999999999 999999999999999998 99999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
|||.++...... ...++..|+|| |+..+..++.++||||+|+++|||++|+.||...... ..
T Consensus 153 dfg~~~~~~~~~----~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~~ 214 (267)
T PHA03390 153 DYGLCKIIGTPS----CYDGTLDYFSP----------EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE----EL 214 (267)
T ss_pred cCccceecCCCc----cCCCCCcccCh----------hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc----hh
Confidence 999998765332 23688999999 6666777899999999999999999999998743210 00
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-MQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 784 (786)
...............+ ...+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQQKKLPFI----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhhcccCCcc----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0111111112222212 234456899999999999999996 598875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=297.13 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=188.8
Q ss_pred eeccc--cCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKG--EHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.||+| +||+||+|+.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 46666 89999999864 78999999986532 122345788899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc-
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN- 668 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 668 (786)
+|++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+.........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999988652 34588999999999999999999998 9999999999999999999999999865433221111
Q ss_pred ------ceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC---------
Q 047901 669 ------WTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS--------- 731 (786)
Q Consensus 669 ------~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~--------- 731 (786)
.....++..|+||| +..+ ..++.++||||+||++|||++|+.||.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPE----------LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228 (328)
T ss_pred cccccccccccCccCccChh----------hhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence 01123566799994 4433 34788999999999999999999998753210000
Q ss_pred ---C-cchhhhhh------------------------hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 732 ---S-SSINIEFN------------------------AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 732 ---~-~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
. ........ .+...... ..........+.+++.+||..||++|||++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0 00000000 00000001 111223456689999999999999999999998
Q ss_pred H
Q 047901 784 Q 784 (786)
Q Consensus 784 ~ 784 (786)
+
T Consensus 307 ~ 307 (328)
T cd08226 307 S 307 (328)
T ss_pred h
Confidence 5
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.53 Aligned_cols=262 Identities=18% Similarity=0.200 Sum_probs=191.5
Q ss_pred ccCc-cceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCch----------hhHHHHHHHHHHHhhcCCCcccceee
Q 047901 506 KDFD-AKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQM----------SDQKEFLNEIKALTKIRHRNIVKFYG 573 (786)
Q Consensus 506 ~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~hpniv~l~~ 573 (786)
++|. +.+.||+|+||+||+|... +++.||||++......... .....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3565 3567999999999999854 7889999998653221100 01225778999999999999999999
Q ss_pred EEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 574 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
++...+..++||||++ |+|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5999998753 4688999999999999999999998 9999999999999999999999
Q ss_pred eccccceecCCC--------------CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhC
Q 047901 654 SDFGTAKLLKPN--------------SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKG 718 (786)
Q Consensus 654 ~Dfg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg 718 (786)
+|||.+.....+ ........++..|+||| ...+ ..++.++||||+||++|||++|
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE----------LLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCCh----------hcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999876511 11122335688999995 4433 3468899999999999999999
Q ss_pred CCCCCccccccCCC-------cchhhhhhhhcc-----C-CCCCCChh---HHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 047901 719 KHPGDFLSLFSSSS-------SSINIEFNAMLD-----H-RLPHPSLD---VQEKLISIMEVALLCLDGCPNSRPTMQTV 782 (786)
Q Consensus 719 ~~Pf~~~~~~~~~~-------~~~~~~~~~~~~-----~-~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev 782 (786)
+.||.......... ......+..... . ....+... .......+.+++..||+.+|++|||++|+
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 99987433110000 000000000000 0 00000000 01123458899999999999999999999
Q ss_pred HH
Q 047901 783 CQ 784 (786)
Q Consensus 783 ~~ 784 (786)
+.
T Consensus 311 l~ 312 (335)
T PTZ00024 311 LK 312 (335)
T ss_pred hc
Confidence 75
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=295.78 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=191.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|+..+.||+|+||.||+|... +++.||||++..... .......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 356999999999999999999865 688999999865321 1122345678999999999999999999986543
Q ss_pred ----eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 580 ----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 580 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
..++||||+.+ +|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 45999999975 888888653 34689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 656 FGTAKLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 656 fg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
||.+........ ......++..|+|| |...+ ..++.++||||||+++|||++|+.||........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPP----------ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCc----------HHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999986643321 11234678899999 54443 3467899999999999999999999864321000
Q ss_pred ----------CCcch---hhhhhhhccCCCCCCC-hhHH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ----------SSSSI---NIEFNAMLDHRLPHPS-LDVQ------EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ----------~~~~~---~~~~~~~~~~~~~~~~-~~~~------~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... ............+... .... .....+.++|..||..||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 0000000000000000 0000 01234679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.60 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=194.1
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEEE
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 585 (786)
|++.+.||+|++|+||+|... +++.||||++...... .......+|+..+++++ ||||+++++++..++..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 567789999999999999875 5788999998653221 22334557899999998 999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+ +|+|.+++.... ...+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||.++.....
T Consensus 78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 999 789999887652 34689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------Ccc-
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----------SSS- 734 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----------~~~- 734 (786)
. ......++..|+|||.+ .....++.++||||||+++|||++|+.||......... ...
T Consensus 153 ~-~~~~~~~~~~~~aPE~~---------~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd07830 153 P-PYTDYVSTRWYRAPEIL---------LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222 (283)
T ss_pred C-CcCCCCCcccccCceee---------ecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence 2 22345688899999632 23345788999999999999999999998643321000 000
Q ss_pred --hhhhhhhhccCCCC--CCC---hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 --INIEFNAMLDHRLP--HPS---LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 --~~~~~~~~~~~~~~--~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........+...+ .+. .........+.+++..||+.+|++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000100 000 000011345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.90 Aligned_cols=244 Identities=22% Similarity=0.206 Sum_probs=185.5
Q ss_pred eeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHH---HHhhcCCCcccceeeEEecCCeeeEEEecc
Q 047901 513 CIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIK---ALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
.||+|+||.||+|+.. +++.||+|.+....... ......+..|.. .++...||+|+++.+++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc-chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 3899999999999864 68899999986532211 111222334433 344457999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 668 (786)
++|+|.+++... +.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999988753 5689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCC
Q 047901 669 WTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRL 747 (786)
Q Consensus 669 ~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (786)
.....|+..|+|| |... +..++.++||||+||++|||++|+.||...... ..............
T Consensus 152 ~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~ 216 (278)
T cd05606 152 PHASVGTHGYMAP----------EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMAV 216 (278)
T ss_pred CcCcCCCcCCcCc----------HHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHHHHHhhccCC
Confidence 2335789999999 5554 335889999999999999999999998753211 00111111111112
Q ss_pred CCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
..+.. .+..+.+++.+|+..+|.+|| ++.++++
T Consensus 217 ~~~~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22221 234588999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.54 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=192.8
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|...+.||+|+||+||+|+.. +++.||+|++..... ........+.+|+++++.++|||++++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 666778999999999999864 688999999864322 222344578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+. |++.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+.....
T Consensus 102 ~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 102 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred cCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 996 5888877653 34688999999999999999999999 999999999999999999999999999864432
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
.....|+..|+|||.+.. .....++.++|||||||++|||++|..||...... ..........
T Consensus 174 --~~~~~~~~~y~aPE~~~~-------~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~ 236 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILA-------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQND 236 (313)
T ss_pred --CCCccccccccChhhccc-------cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcC
Confidence 224578899999963211 12356788999999999999999999997643211 1111111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+ ..........+.+++.+||+++|++|||+.++++
T Consensus 237 ~~--~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 SP--TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111122345889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.03 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=196.3
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+|.+.+.||+|+||.||++... .+..+++|.++..... ........+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999865 3444566665432111 1222344677899999999999999999999988999999
Q ss_pred EeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||+++++|.+++... .....+++..+..++.|++.|+.|||+. +++|+||+|+||+++. +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 1245789999999999999999999998 9999999999999975 569999999998775
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........|+..|+|| |......++.++||||||+++|+|++|..||.... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~ 218 (260)
T cd08222 157 GSCDLATTFTGTPYYMSP----------EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIV 218 (260)
T ss_pred CCcccccCCCCCcCccCH----------HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH
Confidence 544434445688899999 66666778889999999999999999999986322 111112222
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+. .....+.++.++|.+||+.+|++||++.|+++
T Consensus 219 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 EGPTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cCCCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 221111 11233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=284.00 Aligned_cols=242 Identities=26% Similarity=0.323 Sum_probs=198.1
Q ss_pred eccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|+||.||++... +++.+|+|.+..... ........+..|+++++.++||||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999865 588999999875322 222356688899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 672 (786)
|.+++... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 80 L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 80 LFSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99999754 3689999999999999999999998 99999999999999999999999999998775443333445
Q ss_pred ccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCCh
Q 047901 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSL 752 (786)
Q Consensus 673 ~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (786)
.++..|+|| |...+...+.++|+||||+++||+++|..||...+ .......+.......+..
T Consensus 154 ~~~~~~~~P----------e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~ 215 (250)
T cd05123 154 CGTPEYLAP----------EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--------RKEIYEKILKDPLRFPEF 215 (250)
T ss_pred cCCccccCh----------HHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHhcCCCCCCCC
Confidence 788899999 66666678889999999999999999999986422 122233333344444433
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCCCH---HHHHH
Q 047901 753 DVQEKLISIMEVALLCLDGCPNSRPTM---QTVCQ 784 (786)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~~p~~RPt~---~ev~~ 784 (786)
. +..+.+++++||..||++|||+ +++.+
T Consensus 216 ~----~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 216 L----SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred C----CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2 2348899999999999999999 67654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=299.67 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=197.4
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-----e
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR-----H 580 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~ 580 (786)
+|++.+.||+|++|.||+|+.. +++.||||++.... ......+.+.+|+++++.++||||+++.+++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4788899999999999999865 58899999987532 12344567889999999999999999999987765 7
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 8999999984 899988754 4789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC---CcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccC------
Q 047901 661 LLKPNS---SNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS------ 730 (786)
Q Consensus 661 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~------ 730 (786)
...... .......++..|+||| ...+. .++.++||||+|+++|+|++|+.||........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE----------~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPE----------LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred eecccccccccccccccccCcCCce----------eeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 876543 1233456889999995 44444 688899999999999999999999875432100
Q ss_pred ----CCcc-----hhhhhhhhccCCCCCCChh----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ----SSSS-----INIEFNAMLDHRLPHPSLD----VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ----~~~~-----~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ........+.......... ....+..+.+++.+||+++|.+|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000 0000000000000000000 0112345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=295.84 Aligned_cols=262 Identities=22% Similarity=0.286 Sum_probs=191.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 467999999999999999999865 68899999986532211 1234567899999999999999999987443
Q ss_pred ---CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 579 ---RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 579 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
...++||||+++ ++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 346999999975 777777643 34689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC-----------cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 656 FGTAKLLKPNSS-----------NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 656 fg~a~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
||+++....... ......+++.|+|| |...+ ..++.++|||||||++|||++|++||.
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP----------ELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCCh----------HHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 999986543211 11234678889999 54433 457889999999999999999999986
Q ss_pred ccccccCC----------Ccchhhhhh---hhccCC--CCCCChh---HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 724 FLSLFSSS----------SSSINIEFN---AMLDHR--LPHPSLD---VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 724 ~~~~~~~~----------~~~~~~~~~---~~~~~~--~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ ......... ...+.. ...+... .......+.+++.+|+..+|++|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 229 GKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 43321000 000000000 000000 0000000 0111245889999999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.90 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=189.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV------ 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------ 578 (786)
.+|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 57999999999999999999864 68899999986532 23456788999999999999999999876543
Q ss_pred --------CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CC
Q 047901 579 --------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EY 649 (786)
Q Consensus 579 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~ 649 (786)
...++||||++ ++|.+++.. ..+++..+..++.|++.|+.|||+. +|+||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 589888853 3588999999999999999999999 9999999999999974 56
Q ss_pred cEEEeccccceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 047901 650 EARVSDFGTAKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFL 725 (786)
Q Consensus 650 ~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~ 725 (786)
.+|++|||.++....... ......++..|+|| |... ...++.++|||||||++|||++|+.||...
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP----------RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCH----------HHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 789999999986643211 11234678899999 5433 345788999999999999999999998754
Q ss_pred ccccCC----------Ccchhhhh-----hhhc-cCC-CCCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 726 SLFSSS----------SSSINIEF-----NAML-DHR-LPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 726 ~~~~~~----------~~~~~~~~-----~~~~-~~~-~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... ........ ..+. ... ...+.. .......++.+++..||..||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 321000 00000000 0000 000 000000 00112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.17 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=197.5
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|++|.||+|... +++.||+|++.... ......+.+..|+++++.++|||++++++++...+..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 556778999999999999865 58999999987633 122344677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|++ ++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||.++......
T Consensus 79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 998 59999997642 4689999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------Ccchhhh
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------SSSINIE 738 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~~~~~~~ 738 (786)
.......++..|+|| |..... .++.++|||||||++||+++|+.||......... .......
T Consensus 153 ~~~~~~~~~~~~~aP----------E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 153 RTYTHEVVTLWYRAP----------EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222 (282)
T ss_pred cccCccccCcCcCCh----------HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence 333344567889999 555444 7889999999999999999999998653211000 0000000
Q ss_pred hhhhc-----cCCCCC----CC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAML-----DHRLPH----PS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~-----~~~~~~----~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+..+. +...+. .. .........+.+++.+||..+|++|||+.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 000100 00 001112346899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.80 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=214.2
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
+.+...++.|++.+.||.|.+|.||+++. ++++..|||+..... +..+++..|.++++.. .|||++.++|++.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 33444567799999999999999999984 478899999986532 2334566888898888 5999999999884
Q ss_pred -----cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 577 -----HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 577 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
.++..|+|||||.+|+..|.++.-. +..+.|..+..|+.+++.|+.+||.. .++|||||-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 4678999999999999999998764 77899999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 652 RVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
|++|||++..++.......+..||+.|||||+..+. --....|+.++|+||+|++..||.-|.+|+.++..
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~-----e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---- 233 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD-----ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---- 233 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecc-----cCCCCCcccccchhhccceeehhcCCCCCccCcch----
Confidence 999999999887766667788999999999866443 22345688899999999999999999999886653
Q ss_pred CcchhhhhhhhccCCC-CCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 SSSINIEFNAMLDHRL-PHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.+++.... +.|.. .+.....+|.++|..|+.+|.+.||++.++++
T Consensus 234 -------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 -------MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 333333222 22211 23455677999999999999999999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.38 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=190.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
..+|...+.||+|+||.||+|... +++.||||++..+... ......+.+|+++++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 468999999999999999999854 6899999998754321 22345678999999999999999999988654
Q ss_pred -CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 579 -RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 579 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
...++|+||+.. ++..+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 346899999975 7776652 3578999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc---
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS--- 733 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~--- 733 (786)
+++..... .....++..|+||| ...+ ..++.++|||||||++|||++|+.||...........
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE----------~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 163 LARHADAE---MTGYVVTRWYRAPE----------VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred CCcCCCCC---CCCceeeecccChh----------hhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99765322 22346788999995 4433 4578899999999999999999999875331100000
Q ss_pred ---chhhhh---------hhhccCCCCCCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 ---SINIEF---------NAMLDHRLPHPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ---~~~~~~---------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... ..........+.... ......+.+++.+||++||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 000000000010000 112345789999999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.37 Aligned_cols=245 Identities=23% Similarity=0.323 Sum_probs=205.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
..+|....+||+|+||.|.+|..+ +.+.+|||+++......+. +.+--+.|-.++.-- +-|.++++..++..-+..|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 457899999999999999999866 4567999999875433221 222233455555544 5789999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
.||||+.||+|-..++.- +.+.+..+.-+|.+||-||-|||++ +|++||||.+|||++.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999988754 6788889999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
--+.....+.+||+.|+|| |++...+|+..+|.|||||+||||+.|++||+. ....+.++++
T Consensus 501 i~~~~TTkTFCGTPdYiAP----------EIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--------eDE~elF~aI 562 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAP----------EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--------EDEDELFQAI 562 (683)
T ss_pred ccCCcceeeecCCCccccc----------ceEEecccccchhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHH
Confidence 6555666788999999999 788899999999999999999999999999985 3356677888
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 778 (786)
.+.....|..... +..++.+..+.+.|.+|--
T Consensus 563 ~ehnvsyPKslSk----EAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHNVSYPKSLSK----EAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHccCcCcccccH----HHHHHHHHHhhcCCccccC
Confidence 8888777755443 4678888889999999854
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=293.47 Aligned_cols=265 Identities=19% Similarity=0.285 Sum_probs=196.6
Q ss_pred cHHHHHHHhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEE
Q 047901 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFC 575 (786)
Q Consensus 497 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~ 575 (786)
..+++...+++|+..+.||+|+||.||+|.. .+++.||+|++..+.. .....+.+.+|++++++++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3456667788999999999999999999975 4788999999875321 223345688899999999999999999987
Q ss_pred ecC------CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC
Q 047901 576 SHV------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649 (786)
Q Consensus 576 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 649 (786)
... ...+++++++ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 543 3467888877 7799888753 3588999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccc
Q 047901 650 EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLF 728 (786)
Q Consensus 650 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~ 728 (786)
.+||+|||+++..... .....++..|+|| |...+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~kl~dfg~~~~~~~~---~~~~~~~~~y~aP----------E~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 158 ELKILDFGLARHTDDE---MTGYVATRWYRAP----------EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred CEEEeccccccccccc---ccccccCCCccCH----------HHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999865432 2334678899999 54433 46788999999999999999999998643211
Q ss_pred cCCC-------cchhhh--------hhhhccCCCCCCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 729 SSSS-------SSINIE--------FNAMLDHRLPHPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 729 ~~~~-------~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ...... ...........+.... ......+.+++.+|++.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000 000000 0000000000000000 012345789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.91 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=194.1
Q ss_pred HHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-CCe
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-VRH 580 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~ 580 (786)
..+++|+..+.||+|+||.||+|... +++.||||++..+.. .....+.+.+|+++++.++||||+++.+++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 45678999999999999999999754 788999999865332 22344677899999999999999999998865 567
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+ +++|.+++.. ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 4689888863 3578888889999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------C
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------S 732 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------~ 732 (786)
..... .....++..|+||| ...+ ..++.++|||||||++|+|++|+.||......... .
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE----------~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 223 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPE----------IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223 (328)
T ss_pred ccCCC---cCCCcccccccCce----------eeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 65322 22346788999995 3323 46788999999999999999999998653310000 0
Q ss_pred cchhhhhhhh-----------ccCCCCCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 SSINIEFNAM-----------LDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+..... .......+.. ........+.++|.+||+.+|++|||+++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0000011100 01112356899999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=247.09 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=196.8
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|+..++||+|.||+||+|+.+ +++-||+|+++... ++........+|+-+++.++|.|||+++++...+....+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd--ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC--CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4666788999999999999855 67889999998743 33344567889999999999999999999998889999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
|||.. +|..|...- .+.++.+.++.++.|+++|+.|+|++ ++.|||+||.|.+++.+|+.|++|||+|+-..-+
T Consensus 81 e~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 99976 899888753 47789999999999999999999999 9999999999999999999999999999977655
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHh-CCCCCCccccccC----------CCc
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSS----------SSS 733 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~----------~~~ 733 (786)
-.-+...+-|.+|.+| +++.+ .-|+...|+||.||++.|+.. |++-|...+...+ ...
T Consensus 155 vrcysaevvtlwyrpp----------dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPP----------DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred eEeeeceeeeeeccCc----------ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 4445566789999999 55544 348889999999999999996 6666665432110 001
Q ss_pred chhhhhhhhccCCC-C--CCChhHHHHH----HHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEFNAMLDHRL-P--HPSLDVQEKL----ISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~~~~~~~~~-~--~~~~~~~~~~----~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+....|.+. + .+...+.... ..-.+++...+.-+|..|.++++.++
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11111111112111 0 1111122221 22356777777778999999998875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=292.31 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=194.1
Q ss_pred HHHhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR- 579 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~- 579 (786)
+...++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|++++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34467899999999999999999974 478899999986432 12233456889999999999999999999886543
Q ss_pred -----eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 -----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 458999999 6799888753 4688999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS- 732 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~- 732 (786)
|||.+...... .....++..|+|| |...+ ..++.++||||+||++|++++|+.||..........
T Consensus 161 dfg~~~~~~~~---~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 161 DFGLARQTDSE---MTGYVVTRWYRAP----------EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred ecccccccccC---ccccccCCcccCH----------HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999865432 2234678899999 55443 457889999999999999999999987432110000
Q ss_pred -----cchhhhhhhhcc--------CCCC--CCC---hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 -----SSINIEFNAMLD--------HRLP--HPS---LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 -----~~~~~~~~~~~~--------~~~~--~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+...+. ...+ .+. .........+.+++.+|+..||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000 000 000122345789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=315.57 Aligned_cols=148 Identities=26% Similarity=0.357 Sum_probs=131.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|.+.++||+|+||+||+|... +++.||||++..... ........+..|+.+++.++||||+++++++......|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999866 688999999875321 2233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
|||+++++|.+++... +.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999754 4578899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=294.91 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=193.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe---
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--- 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--- 580 (786)
.++|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+.+|+.++++++||||+++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 567999999999999999999875 67899999986532 122344667889999999999999999998765554
Q ss_pred ---eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 581 ---SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 581 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699998864 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---- 732 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---- 732 (786)
.+...... .....++..|+|| |.... ..++.++||||+||++||+++|+.||..........
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aP----------E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAP----------EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred cccccccc---ccCCcccccccCH----------HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99866432 2334678899999 55443 367889999999999999999999986433210000
Q ss_pred ---cchhhhh--------hhhccCC--CCCCC--hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ---SSINIEF--------NAMLDHR--LPHPS--LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ---~~~~~~~--------~~~~~~~--~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....... ....... ...+. ......+..+.+++.+||+++|++|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000 0000000 00000 000112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.30 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=204.9
Q ss_pred ceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 511 KYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.+.+|+|.||+||-|.++ +|+.||||++.+-.... ...++...|++|++.++||.||.+...|+..+..|+|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 457999999999999754 89999999987632222 334688899999999999999999999999999999999997
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEeccccceecCCCC
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~ 666 (786)
|.-|+-.+.. ..+++++....-++.||+.||.|||.+ +|+|+||||+|||+.+. -++||||||+|+.....
T Consensus 647 GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 647 GDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred chHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 7555555544 357888888888999999999999999 99999999999999755 58999999999988754
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCC
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 746 (786)
......+||+.|.|| |++....|...-|+||.|||+|.-++|..||.- ++..-..+-...
T Consensus 721 sFRrsVVGTPAYLaP----------EVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----------dEdIndQIQNAa 780 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAP----------EVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----------DEDINDQIQNAA 780 (888)
T ss_pred hhhhhhcCCccccCH----------HHHhhccccccccceeeeEEEEEEecccccCCC----------ccchhHHhhccc
Confidence 345667999999999 888899999999999999999999999999862 122223333455
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
+..|...+.+......++|...++..-.+|-|.+.-+
T Consensus 781 FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 781 FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 6677777888888899999999999999998887644
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=290.65 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=190.2
Q ss_pred cCccceeeccccCceEEEEEcC-C--CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec----C
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-S--GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH----V 578 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~----~ 578 (786)
+|+..+.||+|+||.||+++.. . +..||+|++..... .....+.+.+|+++++++ .||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4778899999999999999865 3 67899999864321 223356788899999999 59999999987532 2
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++++||++ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 45788999986 5899988643 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC--
Q 047901 659 AKLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-- 731 (786)
Q Consensus 659 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-- 731 (786)
++....... ......|+..|+|| |...+ ..++.++||||+||++|+|++|++||...+.....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aP----------E~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~ 221 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAP----------EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221 (332)
T ss_pred ceecccccccccccccCcccCccccCc----------HHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHH
Confidence 987653221 12334789999999 54433 46789999999999999999999998753310000
Q ss_pred -----Ccchhhhhhhh--------ccCCCCCCC----hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 -----SSSINIEFNAM--------LDHRLPHPS----LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 -----~~~~~~~~~~~--------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..........+ .......+. .........+.+++.+|++.+|++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 222 ILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 000000000 000112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=290.94 Aligned_cols=239 Identities=22% Similarity=0.275 Sum_probs=192.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
+..|.....+|.|+|+.|-.+... +++..+||++..... +-.+|+.++... .||||+++.+.+.+..+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 456778888999999999999754 678899999976411 223677676666 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee-CCCCcEEEecccccee
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL-DLEYEARVSDFGTAKL 661 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-~~~~~~kl~Dfg~a~~ 661 (786)
+|||.+.+|-+.+.+... +... ..+..|+++++.|+.|||++ ||||||+||+|||+ +..++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 999999999888888654 2233 77888999999999999998 99999999999999 6889999999999987
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...+ ..+.+-|..|.|| |+.....||+++|+||||++||+|++|+.||..-.. ..+....
T Consensus 466 ~~~~---~~tp~~t~~y~AP----------Evl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------~~ei~~~ 525 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAP----------EVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------GIEIHTR 525 (612)
T ss_pred Cchh---hcccchhhcccCh----------hhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------hHHHHHh
Confidence 7654 3345678899999 677788999999999999999999999999874321 1222222
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+...+.. ...+....+++..||+.||++||+|+++..
T Consensus 526 i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2222222 334456889999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=281.02 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=199.5
Q ss_pred hccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCC---chhhHHHHHHHHHHHhhcCCCcccceeeEEe-cCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPND---QMSDQKEFLNEIKALTKIRHRNIVKFYGFCS-HVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~ 579 (786)
.++|-..+.+|+|||+.||+|. +...+.||||+-....... .....+...+|..|.+.++||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567778889999999999996 4467789999865422111 1222446778999999999999999999996 456
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEecc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDF 656 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Df 656 (786)
..|-|.|||+|.+|.-|++.+ +-+++++++.|+.||+.||.||.+. .|+|+|-||||.|||+..+ |.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 678999999999999999865 5688999999999999999999986 5699999999999999644 88999999
Q ss_pred ccceecCCCCCc-------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 657 GTAKLLKPNSSN-------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 657 g~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
|+++.++++++. .....||.+|.+||.|..+... .+.+.|+||||.|||+|..++|+.||.....-.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkeP------PKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEP------PKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCC------CccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 999999876543 1245799999999877666533 368899999999999999999999987532110
Q ss_pred CCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 730 SSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
..-....++.. ....|.. +....+...+|++|+..--++|....++.
T Consensus 692 -----dILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -----DILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----HHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00001111111 1222221 12234578999999999999998877764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=264.80 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=194.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------ 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------ 577 (786)
.+.|....+||+|.||.||+|+.+ ++++||+|++.-+. +.........+|+.++..+.|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 456777788999999999999865 67889998875421 122234466799999999999999999998842
Q ss_pred --CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 578 --VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 578 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
....|+|+++|+. ||.-.+... ..+++..++.+++.++..||.|+|+. .|+|||+||.||||+.++.+||+|
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 2357999999988 899888764 35789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCC----CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccc---
Q 047901 656 FGTAKLLKPNS----SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF--- 728 (786)
Q Consensus 656 fg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~--- 728 (786)
||+|+.+..+. ..++..+-|.+|.+|| -++....|+++.|||+.||||.||+||.+-+......
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppE---------llLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPE---------LLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHH---------HhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 99997654322 1245567899999995 3445677999999999999999999999887642210
Q ss_pred -------------cCCCcchhhhhhhhccCCCCCC-ChhHHHH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 729 -------------SSSSSSINIEFNAMLDHRLPHP-SLDVQEK------LISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 729 -------------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.|.....-+.+..+--..++.. .....+. .....+++..++..||.+||++++++.
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0011111111111111101000 0000111 124678999999999999999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=270.67 Aligned_cols=219 Identities=20% Similarity=0.186 Sum_probs=173.1
Q ss_pred ccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCCHHH
Q 047901 517 GEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLAT 595 (786)
Q Consensus 517 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 595 (786)
|.+|.||+++.. +++.||+|++.... .+..|...+....||||+++++++...+..++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999864 78899999986521 22344555555679999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccC
Q 047901 596 VLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675 (786)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 675 (786)
++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+....... ....++
T Consensus 75 ~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~ 145 (237)
T cd05576 75 HISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVE 145 (237)
T ss_pred HHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcC
Confidence 99754 4589999999999999999999998 99999999999999999999999999887654321 223567
Q ss_pred ccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHH
Q 047901 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQ 755 (786)
Q Consensus 676 ~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (786)
..|+||| ......+++++||||+|+++|||++|+.|+...... ... ...+..|..
T Consensus 146 ~~y~aPE----------~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~--~~~~~~~~~--- 200 (237)
T cd05576 146 NMYCAPE----------VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INT--HTTLNIPEW--- 200 (237)
T ss_pred ccccCCc----------ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------ccc--ccccCCccc---
Confidence 7899994 455567888999999999999999999886532100 000 011112221
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 047901 756 EKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 756 ~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
....+.+++.+|++.||++|||+
T Consensus 201 -~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 201 -VSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -CCHHHHHHHHHHccCCHHHhcCC
Confidence 23458899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=259.27 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=203.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
..+|+..++||+|+|+.|..++++ +.+-+|+|+++++...++ +..+=...|-.+..+. +||.+|-+..++..+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 457999999999999999999976 567889999887543322 2233344566666666 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
.|.||++||+|--..++. ..++++.++-+..+|.-||.|||++ ||++||+|.+|||+|.+|++|+.|+|.++.-
T Consensus 328 fvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999997776643 6789999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
-.+.....+++||+.|+|| |++.+..|...+|.|++||+|+||+.|+.||+.............-.++-+
T Consensus 402 l~~gd~tstfcgtpnyiap----------eilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi 471 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAP----------EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI 471 (593)
T ss_pred CCCCcccccccCCCcccch----------hhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence 6555666788999999999 788889999999999999999999999999985432111222222334555
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 778 (786)
+...+..|.... .....+++.-+.+||.+|-.
T Consensus 472 lekqiriprsls----vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 472 LEKQIRIPRSLS----VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhhcccccceee----hhhHHHHHHhhcCCcHHhcC
Confidence 555555553322 23567888999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=245.21 Aligned_cols=208 Identities=22% Similarity=0.336 Sum_probs=169.1
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhh-cCCCcccceeeEEecCCee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~~ 581 (786)
..++......||+|++|.|-+.++. +|+..|||++..... ....++..+|+.+..+ ..+|.+|+++|...+.+..
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3345556677999999999988865 788999999976332 3455677788887554 5799999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 582 FVVYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
|+.||.|.. +|..|-..- ..++..++...=+|+..+++||.|||++ ..++|||+||+|||++.+|++|+||||.+-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999976 777665432 2346678888889999999999999998 489999999999999999999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
.+.++ ...+...|-..|||||.++.+. ....|+.||||||+|+.+.||.+++.||+.
T Consensus 198 ~L~dS-iAkt~daGCkpYmaPEri~~e~------n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDS-IAKTMDAGCKPYMAPERINPEL------NQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhh-hHHHHhcCCCccCChhhcCccc------Ccccceeehhhhhhhhhhhhhhhccccccc
Confidence 77644 2223346888999998776543 234799999999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=278.54 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=198.8
Q ss_pred ccCccceeeccccCceEEEEEcCCCC-EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGD-KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+++....+|-|+||.|=++..+... .+|+|.+++...- +..+.+.+..|-.||...+.|.||++|.-|.+...+|++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34556667999999999999866433 4788888764332 334566788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||-|-||.++..++.+ +.++..++.-++..+++|++|||++ +||+|||||+|.+++.+|-+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999999865 6788888889999999999999999 999999999999999999999999999999986
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
+... -+++||+.|.|| |++.....+.++|.||+|+++|||++|.+||...+.+. .+..++.
T Consensus 573 g~KT-wTFcGTpEYVAP----------EIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------tYn~ILk 633 (732)
T KOG0614|consen 573 GRKT-WTFCGTPEYVAP----------EIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------TYNLILK 633 (732)
T ss_pred CCce-eeecCCcccccc----------hhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--------HHHHHHh
Confidence 6544 457999999999 78888888999999999999999999999998654321 1222222
Q ss_pred C--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC
Q 047901 745 H--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778 (786)
Q Consensus 745 ~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 778 (786)
. .+..|. .......++|++.++.+|.+|--
T Consensus 634 Gid~i~~Pr----~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 634 GIDKIEFPR----RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhhhccc----ccchhHHHHHHHHHhcCcHhhhc
Confidence 1 122221 22334778999999999999965
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=261.45 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=191.2
Q ss_pred cCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCCHHHH
Q 047901 518 EHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATV 596 (786)
Q Consensus 518 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 596 (786)
+||.||+|... +++.+|+|++...... ...+.+.+|++.+++++|+||+++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999876 4889999998753221 1157899999999999999999999999998999999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCc
Q 047901 597 LSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF 676 (786)
Q Consensus 597 l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 676 (786)
+... ..+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 78 ~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 150 (244)
T smart00220 78 LKKR---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP 150 (244)
T ss_pred HHhc---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence 9754 2388999999999999999999999 99999999999999999999999999998776432 233456888
Q ss_pred cccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHH
Q 047901 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQE 756 (786)
Q Consensus 677 ~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (786)
.|+|| |......+++++||||+|+++|++++|..||.... ................... ...
T Consensus 151 ~~~~p----------E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-~~~ 212 (244)
T smart00220 151 EYMAP----------EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIGKPKPPFPPP-EWK 212 (244)
T ss_pred CCCCH----------HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCccc-ccc
Confidence 99999 66667778899999999999999999999976421 1111122222222211110 000
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 757 KLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 757 ~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.+++.+||..+|++||++.++++
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 3345889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-33 Score=304.83 Aligned_cols=402 Identities=27% Similarity=0.318 Sum_probs=251.0
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
+.|+++.|-+. ..|-....+--.|+.|||++|++ +..|..+..+.+|+.|+++.|.|. ..|.+...+.+|++|.|.+
T Consensus 24 ~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 24 QILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred Hhhhccccccc-cCchHHhhheeeeEEeecccccc-ccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence 44566666555 22211112223377788887777 466777777777888888888777 5667777777788888888
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccc-------------------cccccCChhhhcc
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN-------------------QFTGQLPRNICRS 144 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-------------------~l~~~~~~~~~~~ 144 (786)
|++..+|.++..+.+|++|+++.|++. ..|..+..++.+..+..++| .+.+.++..+..+
T Consensus 101 n~l~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l 179 (1081)
T KOG0618|consen 101 NRLQSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNL 179 (1081)
T ss_pred chhhcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhh
Confidence 777777777777777778888887776 44445555555555555544 4444444444444
Q ss_pred CccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCc------------------ccCCCCCCCEEeccCCcccc
Q 047901 145 GLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISE------------------DFGIYPNLKFLDLSHNNFYG 206 (786)
Q Consensus 145 ~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~------------------~f~~l~~L~~L~L~~N~i~~ 206 (786)
+. .|+|.+|.+. .-++.++..|+.+++..|++..+... .-..-.+|+++++++|+++.
T Consensus 180 ~~--~ldLr~N~~~--~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~ 255 (1081)
T KOG0618|consen 180 TH--QLDLRYNEME--VLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSN 255 (1081)
T ss_pred he--eeecccchhh--hhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhc
Confidence 44 4888888776 23455556666666666665532110 00112467777777777775
Q ss_pred ccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccc-
Q 047901 207 EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALG- 285 (786)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~- 285 (786)
++ +++..+.+|+.++..+|+++ .+|..+..+.+|+.|++.+|.+. -+|....++++|++|+|..|+|...++..|.
T Consensus 256 lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v 332 (1081)
T KOG0618|consen 256 LP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAV 332 (1081)
T ss_pred ch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhh
Confidence 54 77777777777777777775 44544445555555555555554 3344445555555566655555532222111
Q ss_pred ------------------------cCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCee
Q 047901 286 ------------------------LLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSEL 341 (786)
Q Consensus 286 ------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 341 (786)
.++.|+.|++.+|.+++-....+.++.+|+.|+|++|+|...+...+.++..|++|
T Consensus 333 ~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL 412 (1081)
T KOG0618|consen 333 LNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEEL 412 (1081)
T ss_pred hhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHH
Confidence 12345566666666666666666677777778888887776555677777777778
Q ss_pred eccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCccccc-CCCCCccccCCCccccCCCC
Q 047901 342 DLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGP-IPNSTVFRNAPRESFLGNNF 419 (786)
Q Consensus 342 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~n~~ 419 (786)
+||+|+++ .+|..+.++..|++|...+|+|. ..| .+..+++|+.+|++-|+|+-. +|..-.+++..-..+.||.+
T Consensus 413 ~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 413 NLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 88888777 66777777777777777777776 445 677777888888888877543 23222224455556666653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=281.15 Aligned_cols=275 Identities=16% Similarity=0.222 Sum_probs=182.9
Q ss_pred hccCccceeeccccCceEEEEEc-----------------CCCCEEEEEEcCCCCCCCch----------hhHHHHHHHH
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-----------------PSGDKIAVKKFNSPFPNDQM----------SDQKEFLNEI 557 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~----------~~~~~~~~e~ 557 (786)
.++|++.++||+|+||+||+|.. .+++.||||++......... ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999963 23567999998642110000 0112334567
Q ss_pred HHHhhcCCCc-----ccceeeEEec--------CCeeeEEEeccCCCCHHHHhhcCCC---------------------C
Q 047901 558 KALTKIRHRN-----IVKFYGFCSH--------VRHSFVVYEYINRGSLATVLSNNFA---------------------S 603 (786)
Q Consensus 558 ~~l~~l~hpn-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~ 603 (786)
.++.+++|.+ +++++++|.. .+..|+||||+++|+|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 7777776654 4677887743 3568999999999999999864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC-cceeeccCccccCCC
Q 047901 604 EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS-NWTELVGTFGYVAPA 682 (786)
Q Consensus 604 ~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE 682 (786)
...++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2346788899999999999999998 999999999999999999999999999976543221 111224578999998
Q ss_pred CCCCCchHH------------HHhhhcCcCcccchHHHHHHHHHHHhCCC-CCCccccccCCCc---chhhhhhhhccCC
Q 047901 683 HGNIGLHLA------------ELAYTMKITEKCDVYSFGVLALEVIKGKH-PGDFLSLFSSSSS---SINIEFNAMLDHR 746 (786)
Q Consensus 683 ~~~~~~~~~------------e~~~~~~~~~~sDvwslGvil~elltg~~-Pf~~~~~~~~~~~---~~~~~~~~~~~~~ 746 (786)
.+......+ ..........+.||||+||++|+|++|.. ||.....+..... .....+.......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 653221000 00001112235799999999999999886 7654332211111 1111111122222
Q ss_pred CCCCChhHHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 047901 747 LPHPSLDVQEKLISIMEVALLCLDGCP---NSRPTMQTVCQ 784 (786)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~ev~~ 784 (786)
...+ ..........+++..++.++| .+|+|++|+++
T Consensus 461 ~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 2221 122234557899999998765 68999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=284.03 Aligned_cols=243 Identities=24% Similarity=0.343 Sum_probs=184.8
Q ss_pred CccceeeccccCc-eEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEE
Q 047901 508 FDAKYCIGKGEHR-SVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 508 ~~~~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 585 (786)
|...+++|.|+.| .||+|.. +++.||||++.. +..+...+|+..++.- +|||||++++.-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4445578999887 5899988 488999999864 3344567899999988 5999999999989999999999
Q ss_pred eccCCCCHHHHhhcCCCCC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---C--CcEEEeccccc
Q 047901 586 EYINRGSLATVLSNNFASE-DFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---E--YEARVSDFGTA 659 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~--~~~kl~Dfg~a 659 (786)
|.|.. +|.++++...... ...-...+.+..|++.|+++||+. +||||||||.||||+. + ..++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99975 9999998641111 111144577889999999999998 9999999999999976 2 57999999999
Q ss_pred eecCCCCCcc---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcch
Q 047901 660 KLLKPNSSNW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 660 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~ 735 (786)
+.+..+.... ....||-+|+|| |.+....-+.++||||+|||+|+.++ |..||.+.-
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~AP----------E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--------- 719 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAP----------EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--------- 719 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCH----------HHHhccccCcccchhhcCceEEEEecCCccCCCchH---------
Confidence 9987654432 356799999999 56666666779999999999999998 589987421
Q ss_pred hhhhhhhccCCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
++-..++........ ....++ ...++|.+|++++|..||++.+|+.
T Consensus 720 -~R~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 720 -ERQANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -HhhhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111222222211000 001111 4779999999999999999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=261.23 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=196.0
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC--CCc----ccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR--HRN----IVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--hpn----iv~l~~~~~ 576 (786)
...+|.+...+|+|.||.|-.+..+ .+..||||+++.. ....+.-+-|++++.++. .|+ +|.+.+|+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3678999999999999999998644 4789999999752 234456678999999993 233 788888999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---------
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL--------- 647 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--------- 647 (786)
..++.|+|+|.+ |-++.+|+..+ ...+++...++.|++|++++++|||+. +++|-||||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence 999999999988 45999999876 456789999999999999999999999 9999999999999842
Q ss_pred -----------CCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHH
Q 047901 648 -----------EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI 716 (786)
Q Consensus 648 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ell 716 (786)
+..+|++|||.|++..... ...+.|..|.|| |++.+-.++.++||||+||||+|+.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAP----------EViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAP----------EVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCc----------hheeccCcCCccCceeeeeEEEEee
Confidence 2358999999998765332 567899999999 7888889999999999999999999
Q ss_pred hCCCCCCccccccC------C-Ccchhhhhhhh-----cc-CCCCCCCh---------------------hHHHHHHHHH
Q 047901 717 KGKHPGDFLSLFSS------S-SSSINIEFNAM-----LD-HRLPHPSL---------------------DVQEKLISIM 762 (786)
Q Consensus 717 tg~~Pf~~~~~~~~------~-~~~~~~~~~~~-----~~-~~~~~~~~---------------------~~~~~~~~l~ 762 (786)
||..-|..-+.... . .......+.+. .. .++.+++. ....+-..+.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 99988764321100 0 00000000000 00 01110100 1112334699
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 047901 763 EVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 763 ~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+|++.|+..||.+|+|+.|+++
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=288.18 Aligned_cols=270 Identities=17% Similarity=0.203 Sum_probs=169.8
Q ss_pred HhccCccceeeccccCceEEEEEcC-C----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeE----
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-S----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGF---- 574 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~---- 574 (786)
..++|...+.||+|+||.||+|+.. + +..||||++.... ..+....| .+....+.+++.+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3568999999999999999999865 4 6899999875411 11111111 1112222233322221
Q ss_pred --EecCCeeeEEEeccCCCCHHHHhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 047901 575 --CSHVRHSFVVYEYINRGSLATVLSNNFAS-----------------EDFDWRKRMNVITGVADALSYMHHDCFPPIVH 635 (786)
Q Consensus 575 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 635 (786)
+..+...++||||+++++|.+++...... .......+..++.|++.||+|||+. +|+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 24567889999999999999998653110 0112344567999999999999998 9999
Q ss_pred cCCCCCceeeCC-CCcEEEeccccceecCCCC-CcceeeccCccccCCCCCCCCchHH------------HHhhhcCcCc
Q 047901 636 RDISSNNVLLDL-EYEARVSDFGTAKLLKPNS-SNWTELVGTFGYVAPAHGNIGLHLA------------ELAYTMKITE 701 (786)
Q Consensus 636 rdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~------------e~~~~~~~~~ 701 (786)
|||||+|||++. ++.+||+|||+|+...... .......+++.|+|||.+.....-+ .......++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 5899999999998664332 2234567899999997432111000 0011123556
Q ss_pred ccchHHHHHHHHHHHhCCCCCCcccc-cc---CCCcchhhhhhhhccCCCCCCChh----HHHHHHHHHHHHHhccCCCC
Q 047901 702 KCDVYSFGVLALEVIKGKHPGDFLSL-FS---SSSSSINIEFNAMLDHRLPHPSLD----VQEKLISIMEVALLCLDGCP 773 (786)
Q Consensus 702 ~sDvwslGvil~elltg~~Pf~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p 773 (786)
++||||+||++|||+++..|++.... +. .........+......+....... .........+++.+|++.||
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 78999999999999998877542110 00 000000111111222111100000 00011234589999999999
Q ss_pred CCCCCHHHHHH
Q 047901 774 NSRPTMQTVCQ 784 (786)
Q Consensus 774 ~~RPt~~ev~~ 784 (786)
++|||+.|+++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999986
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-32 Score=273.76 Aligned_cols=376 Identities=24% Similarity=0.264 Sum_probs=254.5
Q ss_pred EcCCCCCcccCCcCccCCC-CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC-c
Q 047901 7 NLTSTGLKGTLQEFSFSSF-PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL-N 84 (786)
Q Consensus 7 ~l~~~~l~~~l~~~~f~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N 84 (786)
+=+..|+. .+|. ++ +..+.++|..|+|+.+++.+|+.+++||.||||+|.|+.|.|++|.+|.+|.+|-+-+ |
T Consensus 52 dCr~~GL~-eVP~----~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 52 DCRGKGLT-EVPA----NLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred EccCCCcc-cCcc----cCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 33444554 3444 23 3567888888888888888888888888888888888888888888888877776655 7
Q ss_pred cCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccC----
Q 047901 85 QFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG---- 159 (786)
Q Consensus 85 ~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~---- 159 (786)
+|+.++.. |.+|..|+.|.+.-|++..+..++|..|++|..|.+..|.+..+.-..|..+..++.+.+..|.+..
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 88877764 7788888888888888888888888888888888888888874444477888888888877776321
Q ss_pred ---------CCCCcCCCCCCcEEEccCcccc-------------------------cc-cCcccCCCCCCCEEeccCCcc
Q 047901 160 ---------SIPNLRNCRSLVRAHLGRNNLT-------------------------GN-ISEDFGIYPNLKFLDLSHNNF 204 (786)
Q Consensus 160 ---------~~~~l~~l~~L~~L~L~~N~l~-------------------------~~-~~~~f~~l~~L~~L~L~~N~i 204 (786)
.+..+++.+...-..+.++++. .+ +...|..+++|++|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 0111222222222222222222 22 223577788888888888888
Q ss_pred ccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCC-----
Q 047901 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH----- 279 (786)
Q Consensus 205 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----- 279 (786)
+.+.+++|.++..+++|.|..|+|..+....|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+.--
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w 366 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW 366 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence 888888888888888888888888777777788888888888888888877888888888888888777776310
Q ss_pred Ccc-----------ccccCCcCceeccccccccccc---hhhhh---------cccCCc-EEEecccccCCCcchHHhhh
Q 047901 280 LPR-----------ALGLLTELEYFDLSSNRLNNSI---LEALG---------FMFKLF-YLNFSHNQFSQEIPEDLALL 335 (786)
Q Consensus 280 ~~~-----------~~~~l~~L~~L~L~~N~l~~~~---~~~~~---------~l~~L~-~L~L~~N~l~~~~~~~~~~l 335 (786)
..+ --+.-..++.+.++.+.+.... ++..+ ..+-+. ...-|+..++ ..|..+.
T Consensus 367 l~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP-- 443 (498)
T KOG4237|consen 367 LGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP-- 443 (498)
T ss_pred HHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--
Confidence 000 0112234556666665543321 11110 111222 2223333333 3333221
Q ss_pred cCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCC
Q 047901 336 AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394 (786)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 394 (786)
..-.+|++.+|.++ .+|.. .+.+| .+++++|+|+......|.++++|.+|-|++|
T Consensus 444 ~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 444 VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 35578899999998 56665 66778 8999999999888888999999999998887
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=262.83 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=170.0
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
-|...+.||-|+||.|.+++.. +...+|+|.+++.... ...+....+.|-.|+...+.+-||++|..|.+.+..|.||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4677788999999999999744 4567899998763221 2234456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC--
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK-- 663 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~-- 663 (786)
||++|||+-..|-+. +-+.+.-++-++.+++.|+++.|.. |+|||||||+|||||.+|++||.|||+++-+.
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999988754 6788888999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCc-----------------c-----------------------eeeccCccccCCCCCCCCchHHHHhhhcCcCccc
Q 047901 664 PNSSN-----------------W-----------------------TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKC 703 (786)
Q Consensus 664 ~~~~~-----------------~-----------------------~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~s 703 (786)
++..+ + ...+||+.|+|| |++....|+.-+
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiap----------evl~r~g~~q~c 852 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAP----------EVLARTGYTQLC 852 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccCh----------HHhcccCccccc
Confidence 11000 0 024799999999 778888899999
Q ss_pred chHHHHHHHHHHHhCCCCCCc
Q 047901 704 DVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 704 DvwslGvil~elltg~~Pf~~ 724 (786)
|.||.|||||||+.|++||-.
T Consensus 853 dwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccC
Confidence 999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=273.69 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=202.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+|+....+|.|.||.||||+.. .++..|||.++.+. ....+.+.+|+-+++..+|||||.++|.+...+..|+.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 47899999999999999999864 78899999998732 23455677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||.+|+|.+.-+ ..+.+++.++..+++...+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999998765 357899999999999999999999999 999999999999999999999999999877665
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.-.....+.||+.|||||+. .+...+.|..++|||+.|+...|+-.-++|--+... .....-|-+
T Consensus 165 ti~KrksfiGtpywmapEva-------averkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTk 229 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVA-------AVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTK 229 (829)
T ss_pred hhhhhhcccCCccccchhHH-------HHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhc
Confidence 44445667899999999753 334556788999999999999999988888222111 011111112
Q ss_pred CCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+..|. .+.......+.++++.|+.++|++|||++-+++
T Consensus 230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2222111 112233456999999999999999999987654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=234.38 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=191.9
Q ss_pred HhccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecC--C
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHV--R 579 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~--~ 579 (786)
..++|++.+++|+|.|+.|+.|. ..+.++++||+++. ...+.+.+|+.|+..++ ||||++++++..+. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 35679999999999999999997 45788999999975 35678999999999997 99999999998654 5
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEecccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGT 658 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~ 658 (786)
.+.+|+||+++.+....- +.++...++.++.++++||.|+|++ ||+|||+||.||++|.. ...+|+|||+
T Consensus 109 tpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred CchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecch
Confidence 667999999987766544 3567778899999999999999999 99999999999999966 6799999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc-ccC-------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL-FSS------- 730 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~-~~~------- 730 (786)
|.++.+. ..+...+.+..|..||.+ ...+.|+..-|+|||||++..|+..+.||-.... ..+
T Consensus 180 AEFYHp~-~eYnVRVASRyfKGPELL---------Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 180 AEFYHPG-KEYNVRVASRYFKGPELL---------VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred HhhcCCC-ceeeeeeehhhcCCchhe---------eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 9988654 445667888999999633 2345678889999999999999999999743221 000
Q ss_pred ------------CCcchhhhhhhhccCCCCC------CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ------------SSSSINIEFNAMLDHRLPH------PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ------------~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........+..++...... +.....-..++..+++...+..|..+|||+.|.++
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000011111111111000 00000011245789999999999999999999764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=293.64 Aligned_cols=397 Identities=29% Similarity=0.352 Sum_probs=314.8
Q ss_pred EEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCcc
Q 047901 6 INLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ 85 (786)
Q Consensus 6 l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 85 (786)
+|++.+.+. -||..-|.+-. ++.|++++|-+...+-+...+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~-~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEA-LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHH-HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 577888776 77876666655 999999999987655566666667999999999998 688899999999999999999
Q ss_pred CcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccccc---------
Q 047901 86 FSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH--------- 156 (786)
Q Consensus 86 l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~--------- 156 (786)
|..++.+..++.+|++|.|.+|++. ..|..+..+.+|++|++++|++. ..|..+..++.++.+..++|.
T Consensus 80 i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ 157 (1081)
T KOG0618|consen 80 IRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTS 157 (1081)
T ss_pred HhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcccc
Confidence 9999988999999999999999998 78999999999999999999998 788888888888888877772
Q ss_pred ----------ccC-CCCCcCCCCCCcEEEccCcccccccCcccCCCCC--------------------CCEEeccCCccc
Q 047901 157 ----------FLG-SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPN--------------------LKFLDLSHNNFY 205 (786)
Q Consensus 157 ----------l~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~--------------------L~~L~L~~N~i~ 205 (786)
+.+ ++.++.++.. .|+|.+|.+... +...+++ |+.|+.++|.++
T Consensus 158 ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~ 232 (1081)
T KOG0618|consen 158 IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLT 232 (1081)
T ss_pred chhhhhhhhhcccchhcchhhhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcce
Confidence 111 1112223333 488888887722 2333444 444444444444
Q ss_pred cccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccc
Q 047901 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALG 285 (786)
Q Consensus 206 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 285 (786)
.+.+ -....+|+++++++|+++. .|.++..+.+|+.|+..+|+++ .+|..+...++|+.|.+..|.+. .+|....
T Consensus 233 ~~~~--~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le 307 (1081)
T KOG0618|consen 233 TLDV--HPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLE 307 (1081)
T ss_pred eecc--ccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccc
Confidence 2211 1123578999999999994 5689999999999999999996 78888888999999999999998 4556678
Q ss_pred cCCcCceeccccccccccchhhhhc-------------------------ccCCcEEEecccccCCCcchHHhhhcCcCe
Q 047901 286 LLTELEYFDLSSNRLNNSILEALGF-------------------------MFKLFYLNFSHNQFSQEIPEDLALLAHLSE 340 (786)
Q Consensus 286 ~l~~L~~L~L~~N~l~~~~~~~~~~-------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 340 (786)
+++.|+.|+|..|.|...+...|.. ++.|+.|++.+|.++...-+.+.+.++|+.
T Consensus 308 ~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKV 387 (1081)
T KOG0618|consen 308 GLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKV 387 (1081)
T ss_pred ccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceee
Confidence 8999999999999998876544332 335788999999998877778899999999
Q ss_pred eeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCC
Q 047901 341 LDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF 419 (786)
Q Consensus 341 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 419 (786)
|+|++|+|...+...+.+++.|++|+||+|+++ .+|.+...+..|++|...+|++... |............+..|+.
T Consensus 388 LhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-Pe~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 388 LHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-PELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred eeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-hhhhhcCcceEEecccchh
Confidence 999999999666678899999999999999998 5678999999999999999999864 3555555555556666654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=244.97 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=190.5
Q ss_pred CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----Cee
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV-----RHS 581 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~ 581 (786)
.+-.+.||-|+||+||..... +|+.||.|++.... ......+.+.+|++++..++|.||+..+++..-. .+.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 444567999999999999764 89999999986532 3345567888999999999999999998876433 246
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+|+|.|.. ||...|-. ...++...+.-+.+||++||.|||+. +|.||||||-|.|++++...||+|||+|+.
T Consensus 133 YV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 789999965 88888764 35677788888999999999999999 999999999999999999999999999997
Q ss_pred cCCCC-CcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC---------
Q 047901 662 LKPNS-SNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS--------- 730 (786)
Q Consensus 662 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~--------- 730 (786)
.+.+. ..++..+-|..|.|| |++++ ..|+.+.||||.|||+.|++..+.-|.......+
T Consensus 206 ee~d~~~hMTqEVVTQYYRAP----------EiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAP----------ELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred cchhhhhhhHHHHHHHHhccH----------HHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 76543 344556789999999 55554 5699999999999999999998888765332110
Q ss_pred ---CCcc---hhhhhhhhccCCCCCCCh-------hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ---SSSS---INIEFNAMLDHRLPHPSL-------DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ---~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.. -+.....+.......|.. .......+-..+...++..||.+|.+..+.++
T Consensus 276 TPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 276 TPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred CCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 0000 000011112222211110 00111223567777899999999999887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=260.18 Aligned_cols=202 Identities=22% Similarity=0.292 Sum_probs=170.6
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchh----hHHHHHHHHHHHhhcC---CCcccceeeEE
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMS----DQKEFLNEIKALTKIR---HRNIVKFYGFC 575 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~---hpniv~l~~~~ 575 (786)
...+|+..+.+|+|+||.|+.|.++ +...|+||.+.++....+.. ..-....||+||..+. |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457899999999999999999876 45678888887643221111 1224668999999996 99999999999
Q ss_pred ecCCeeeEEEec-cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 576 SHVRHSFVVYEY-INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 576 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
++++.+|++||- -++-||++||..+ ..+++.++..|+.||+.|+++||+. +|||||||-+||.++.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 999999999997 4667999999865 6799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCc-ccchHHHHHHHHHHHhCCCCCC
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITE-KCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~-~sDvwslGvil~elltg~~Pf~ 723 (786)
|||.|.....+ ....++||..|.|| |++.+.+|-- .-||||+|+++|.++....||.
T Consensus 713 dfgsaa~~ksg--pfd~f~gtv~~aap----------evl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG--PFDVFVGTVDYAAP----------EVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC--Ccceeeeeccccch----------hhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999877643 45678999999999 5666666553 4899999999999999999965
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=234.52 Aligned_cols=212 Identities=33% Similarity=0.558 Sum_probs=182.4
Q ss_pred eccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCC
Q 047901 514 IGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGS 592 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 592 (786)
||+|++|.||++...+ ++.+++|++...... ...+.+.+|++.++.++|++|+++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999998764 889999999763211 135678999999999999999999999999899999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEeccccceecCCCCCccee
Q 047901 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSDFGTAKLLKPNSSNWTE 671 (786)
Q Consensus 593 L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 671 (786)
|.+++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+............
T Consensus 78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 999997542 4688999999999999999999999 9999999999999999 899999999999877654322334
Q ss_pred eccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCC
Q 047901 672 LVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750 (786)
Q Consensus 672 ~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (786)
..+...|++| |..... .++.++|+|++|++++++
T Consensus 153 ~~~~~~~~~p----------e~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAP----------EVLLGKGYYSEKSDIWSLGVILYEL----------------------------------- 187 (215)
T ss_pred ccCCCCccCh----------hHhcccCCCCchhhhHHHHHHHHHH-----------------------------------
Confidence 5678899999 444444 778899999999999999
Q ss_pred ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 751 SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+.+++..|++.+|++|||+.++++.+
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3488999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=243.28 Aligned_cols=133 Identities=23% Similarity=0.366 Sum_probs=112.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-----CC---cccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-----HR---NIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----hp---niv~l~~~~ 575 (786)
.++|.+.++||=|.|+|||+|... +.+.||+|+.+. .....+..+.||.++++++ |+ .||++++.|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 468999999999999999999744 678899999975 2234456778999999983 33 599999998
Q ss_pred e----cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC
Q 047901 576 S----HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 576 ~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 646 (786)
. ++.++|||+|+. |.+|..+|... .-+.++...+.+|++||+.||.|||+.| +|+|-||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 5 466899999998 56999999765 3467899999999999999999999997 999999999999993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=236.24 Aligned_cols=257 Identities=22% Similarity=0.307 Sum_probs=192.4
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
..+|...+.+|.|.- .|..|.. -.++.||+|+...+... ....++..+|...+..+.|+||++++.++...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 346777788999988 5666643 36889999999887433 34456777999999999999999999998543
Q ss_pred -CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 579 -RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 579 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
...|+|||+|.. +|...+. -.++..++..+..|++.|+.|||+. +|+||||||+||++..++.+||.|||
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 356999999965 9998887 3477888999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------ 731 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------ 731 (786)
+|+..... -..+..+.|..|.|| |++-+..+.+.+||||.||++.||++|+.-|.+.....+.
T Consensus 164 ~ar~e~~~-~~mtpyVvtRyyrap----------evil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 164 LARTEDTD-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred hhcccCcc-cccCchhheeeccCc----------hheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 99877644 345667899999999 6666666999999999999999999999887653321100
Q ss_pred ----Ccc--------------hhhhhhhhc-cCCCC---CCCh--hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ----SSS--------------INIEFNAML-DHRLP---HPSL--DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ----~~~--------------~~~~~~~~~-~~~~~---~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ..+.....- ...++ .+.. ...-...-..+++.+||..+|++|.+++++++
T Consensus 233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 000000000 00000 0000 00011223678999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-30 Score=254.78 Aligned_cols=293 Identities=21% Similarity=0.194 Sum_probs=228.7
Q ss_pred cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccC-
Q 047901 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHN- 106 (786)
Q Consensus 29 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~- 106 (786)
..+|-++-.++. +|..+- ..-..++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+.+ +|.++++|.+|-+-+
T Consensus 49 ~~VdCr~~GL~e-VP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 49 GIVDCRGKGLTE-VPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred ceEEccCCCccc-CcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 345666666653 333332 357889999999999999999999999999999999998866 599999988877766
Q ss_pred CcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCC-CcCCCCCCcEEEccCcc------
Q 047901 107 NKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNN------ 179 (786)
Q Consensus 107 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~l~~l~~L~~L~L~~N~------ 179 (786)
|+|+.++.++|++|..|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+.. .+..+.+++.+++..|.
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 99999999999999999999999999999999999999999999999999998776 58999999999999998
Q ss_pred ------cccccCcccCCCCCCCEEeccCCccccccCcCccCC-CCcc-EEEccCcccCCCCC-ccccCCccccEEEeecc
Q 047901 180 ------LTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKC-HRLG-TLIVSGNNITGRIP-PEIGNSSQLHVLDLSSN 250 (786)
Q Consensus 180 ------l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~-~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N 250 (786)
+-...+-.+++..-..-..|.++++..+.+..|... ..+. .+....+... +-| ..|..+++|+.|+|++|
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~-~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS-ICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC-cChHHHHhhcccceEeccCCC
Confidence 333445567777777777777777776666665432 1221 1222222233 333 36777788888888888
Q ss_pred cccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccC
Q 047901 251 HIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 251 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 325 (786)
+|+.+.+.+|.++..++.|+|..|+|..+....|.++..|+.|+|.+|+|+.+.+.+|..+.+|..|+|-.|.+.
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 888777777888888888888888887777777778888888888888888777788887777888877777663
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=224.51 Aligned_cols=246 Identities=20% Similarity=0.322 Sum_probs=181.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeE-EecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGF-CSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~-~~~~~~~ 581 (786)
.+.|++.+.+|+|.||.+-+++++ ..+.+|+|.+..+. ...++|.+|..---.+ .|.||+.-++. |+..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 346999999999999999999987 56789999987643 4567899998865556 48999988774 5667788
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee-CCC-CcEEEeccccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL-DLE-YEARVSDFGTA 659 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-~~~-~~~kl~Dfg~a 659 (786)
+.++||++.|||.+-+.. ..+.+.....++.|++.|+.|||++ ++||||||.+|||| +.| ..+||||||.+
T Consensus 98 vF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 899999999999988754 3566777788999999999999999 99999999999998 333 58999999999
Q ss_pred eecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 660 KLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 660 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
+..+. ......-+..|.|||.. +.... -...+.+|||.||+++|.++||..||... +.......
T Consensus 171 ~k~g~---tV~~~~~~~~y~~pe~~-------~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka----~~~d~~Y~ 236 (378)
T KOG1345|consen 171 RKVGT---TVKYLEYVNNYHAPELC-------DTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA----SIMDKPYW 236 (378)
T ss_pred cccCc---eehhhhhhcccCCcHHH-------hhccccceEecccccchheeeeeeeeecCCCcchhh----hccCchHH
Confidence 86542 22233456689999632 11111 23567899999999999999999997621 12222333
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCC
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 776 (786)
.+........+.-+.......+..+++.++-+.++|++|
T Consensus 237 ~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 237 EWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred HHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 333333333332222223334567788888999999988
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=243.15 Aligned_cols=200 Identities=22% Similarity=0.293 Sum_probs=172.8
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC------CCcccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR------HRNIVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~l~~~~~ 576 (786)
-..+|.+....|+|-|++|.+|... .|+.||||++.. .....+.=.+|+++++++. --|+++++..|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3568999999999999999999754 578999999975 2334556678999999994 248999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEec
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSD 655 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~D 655 (786)
...+.|+|+|-+.. +|.+.+...+..-.+....+..+++|+.-||..|... +|+|.||||+||||++. ..+||||
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeecc
Confidence 99999999998755 9999999887777899999999999999999999998 99999999999999987 5689999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
||.|.....+. .+...-+..|.|| |++.+..|+...|+||.||+|||+.||+.-|.+
T Consensus 581 fGSA~~~~ene--itPYLVSRFYRaP----------EIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 581 FGSASFASENE--ITPYLVSRFYRAP----------EIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred Ccccccccccc--ccHHHHHHhccCc----------ceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 99998876543 3344567789999 788899999999999999999999999987765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=228.52 Aligned_cols=199 Identities=29% Similarity=0.474 Sum_probs=170.2
Q ss_pred CccceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
|+..+.||+|++|+||+|...+ ++.+|+|.+...... ...+.+.+|++.+..++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 5667889999999999998764 889999998753211 256788999999999999999999999998899999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
|+++++|.+++.... ..+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 78 YCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred ccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999999997642 1278999999999999999999999 99999999999999999999999999998776442
Q ss_pred -CcceeeccCccccCCCCCCCCchHHHHh-hhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 667 -SNWTELVGTFGYVAPAHGNIGLHLAELA-YTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 667 -~~~~~~~gt~~y~aPE~~~~~~~~~e~~-~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
.......++..|++|| .. ....++.++|||+||++++||++|+.||+.
T Consensus 153 ~~~~~~~~~~~~~~~pe----------~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPE----------VLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHh----------HhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1223456788999994 44 556777899999999999999999999863
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-25 Score=267.54 Aligned_cols=341 Identities=23% Similarity=0.271 Sum_probs=195.2
Q ss_pred cCCcCccCCCCCCcEEECCCCC------ccccCchhccCCC-CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcc
Q 047901 16 TLQEFSFSSFPHLAYLDLSING------FFGTLPPQVRNLS-KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSG 88 (786)
Q Consensus 16 ~l~~~~f~~l~~L~~L~L~~n~------i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 88 (786)
.+...+|.++++|+.|.+..+. +....|..|..++ +|+.|++.+|.++ ..|..| ...+|+.|+|++|++..
T Consensus 548 ~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~ 625 (1153)
T PLN03210 548 HIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK 625 (1153)
T ss_pred eecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc
Confidence 3556678888888888886553 2234566666664 5888888888887 566666 46888888888888887
Q ss_pred cCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCC
Q 047901 89 TFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCR 168 (786)
Q Consensus 89 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~ 168 (786)
++..+..+++|++|+|++|......| .+..+++|++|+|++|.....+|..+..+++|+.|++++|.....+|.-.+++
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~ 704 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLK 704 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCC
Confidence 77777788888888888765433444 37778888888888876656778888888888888888754333333323667
Q ss_pred CCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCC-------CCCccccCCcc
Q 047901 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG-------RIPPEIGNSSQ 241 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-------~~~~~~~~l~~ 241 (786)
+|+.|++++|......|. ..++|++|+|++|.+..+ |..+ .+++|++|++.++.... ..+..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIEEF-PSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCcccccc---ccCCcCeeecCCCccccc-cccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 777777777653333222 235677777777776643 3222 45666666666533211 11111222345
Q ss_pred ccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecc
Q 047901 242 LHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSH 321 (786)
Q Consensus 242 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 321 (786)
|+.|+|++|.....+|..+.++++|+.|+|++|...+.+|... .+++|+.|++++|..-...+. ...+|++|+|++
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~---~~~nL~~L~Ls~ 855 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSR 855 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc---cccccCEeECCC
Confidence 5555555554444455555555555555555543222333322 345555555554432111111 123444444444
Q ss_pred cccCCCcchHHhhhcCcCeeeccCC-ccCCCCCcccccccccceeccccc
Q 047901 322 NQFSQEIPEDLALLAHLSELDLSHN-LFKGSIPSRICNLESLEKLNLSHN 370 (786)
Q Consensus 322 N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N 370 (786)
|.++ .+|..+..+++|+.|+|++| +++ .+|..+..+++|+.|++++|
T Consensus 856 n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 856 TGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 4443 23444444444444444442 222 33333444444444444444
|
syringae 6; Provisional |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=228.30 Aligned_cols=198 Identities=24% Similarity=0.350 Sum_probs=164.0
Q ss_pred HHhccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEec
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSH 577 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~ 577 (786)
...+.|..+++||+|.|++||+|... ..+.||+|.+.. .+...++..|++++..+. +.||+++.+++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~------ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR------TSSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc------ccCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 34567999999999999999999743 467899999965 234567889999999995 8999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEecc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDF 656 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Df 656 (786)
++.+.+|+||++..+..++.. .++...+..++..+..||+++|.. |||||||||.|++.+.. +.-.|.||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999888875 356888999999999999999999 99999999999999865 66789999
Q ss_pred ccceecCCCC---------------------------------Ccc-----------eeeccCccccCCCCCCCCchHHH
Q 047901 657 GTAKLLKPNS---------------------------------SNW-----------TELVGTFGYVAPAHGNIGLHLAE 692 (786)
Q Consensus 657 g~a~~~~~~~---------------------------------~~~-----------~~~~gt~~y~aPE~~~~~~~~~e 692 (786)
|+|...+... .+. ....||++|.||| -
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE---------v 248 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE---------V 248 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH---------H
Confidence 9987321000 000 0136999999995 3
Q ss_pred HhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 693 LAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 693 ~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
....+..++++||||.|||+..+++++.||-.
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred HhhccCcCCccceeeccceeehhhcccccccc
Confidence 34456788999999999999999999999743
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=262.80 Aligned_cols=340 Identities=17% Similarity=0.174 Sum_probs=268.4
Q ss_pred ccCchhccCCCCCCEEeCcCCc------ccccCCccccCCC-CCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCccc
Q 047901 40 GTLPPQVRNLSKLKYLDLSENE------LSGKIPPEIGLLT-HLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGS 112 (786)
Q Consensus 40 ~~~~~~~~~l~~L~~L~L~~N~------l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~ 112 (786)
.+.+.+|.++.+|+.|.+.+++ +....|..|..++ +|+.|++.+|.++.+|..+ .+.+|++|+|.+|+|. .
T Consensus 548 ~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 548 HIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred eecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccc-c
Confidence 3567789999999999997764 3334677777765 6999999999999887776 5789999999999998 4
Q ss_pred CchhhcccCCcceeccccccccccCChhhhccCccceeecccccc-cCCCCCcCCCCCCcEEEccCcc-cccccCcccCC
Q 047901 113 IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHF-LGSIPNLRNCRSLVRAHLGRNN-LTGNISEDFGI 190 (786)
Q Consensus 113 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l-~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~f~~ 190 (786)
.+..+..+++|+.|+|++|.....+|. +..+++|+.|+|++|.. ...+..+.++++|+.|++++|. ++.+ |..+ .
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~L-p~~i-~ 702 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEIL-PTGI-N 702 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCcc-CCcC-C
Confidence 566788999999999998765446664 78899999999998754 4456678999999999999964 5544 4333 7
Q ss_pred CCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccccc-------ccCCCCcccc
Q 047901 191 YPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIA-------GEIPMELGRL 263 (786)
Q Consensus 191 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~-------~~~~~~~~~l 263 (786)
+++|++|+|++|......|.. ..+|++|+|++|.+. .+|..+ .+++|+.|++.++... ...+..+...
T Consensus 703 l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 703 LKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred CCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcc
Confidence 899999999998765455543 468999999999998 456554 5789999999875432 1222233345
Q ss_pred cccccccccccccCCCCccccccCCcCceecccccc-ccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeee
Q 047901 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR-LNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELD 342 (786)
Q Consensus 264 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 342 (786)
++|+.|+|++|.....+|..++++++|+.|++++|. +..++.. . .+++|+.|++++|......|.. ..+|+.|+
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~-~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~ 852 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG-I-NLESLESLDLSGCSRLRTFPDI---STNISDLN 852 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC-C-CccccCEEECCCCCcccccccc---ccccCEeE
Confidence 789999999998877889999999999999999874 5554433 2 6889999999998665555543 36899999
Q ss_pred ccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCc
Q 047901 343 LSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNE 395 (786)
Q Consensus 343 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 395 (786)
|++|.|+ .+|..+..+++|+.|++++|+-...+|..+..+++|+.+++++|.
T Consensus 853 Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 853 LSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 9999998 678899999999999999954434567778889999999999885
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=249.67 Aligned_cols=262 Identities=23% Similarity=0.211 Sum_probs=122.3
Q ss_pred CCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccc
Q 047901 76 LFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN 155 (786)
Q Consensus 76 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N 155 (786)
-..|+|++|.++.+|+.+. ++|+.|++.+|+|+.++. ..++|++|+|++|+|+. +|.. .++|+.|++++|
T Consensus 203 ~~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCCcCCcchh--cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence 3344444444444433332 244444444444443221 12444444444444442 2221 123444444444
Q ss_pred cccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCcc
Q 047901 156 HFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPE 235 (786)
Q Consensus 156 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 235 (786)
.++.++.. ..+|+.|++++|+|+.++. .+++|++|+|++|+|+++.+ . ..+|+.|++++|+|++ +|..
T Consensus 273 ~L~~Lp~l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~-LP~l 340 (788)
T PRK15387 273 PLTHLPAL---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTS-LPTL 340 (788)
T ss_pred chhhhhhc---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC-C---cccccccccccCcccc-cccc
Confidence 44332221 1345556666666664432 23566667777666665422 1 2345666666666663 3321
Q ss_pred ccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCc
Q 047901 236 IGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF 315 (786)
Q Consensus 236 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 315 (786)
..+|+.|+|++|+|++ +|... .+|+.|++++|+|+.+ |.. ..+|+.|++++|+|+.++.. ..+|+
T Consensus 341 ---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP~l----~s~L~ 405 (788)
T PRK15387 341 ---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSLPVL----PSELK 405 (788)
T ss_pred ---ccccceEecCCCccCC-CCCCC---cccceehhhccccccC-ccc---ccccceEEecCCcccCCCCc----ccCCC
Confidence 1356666666666663 33221 3455566666666542 221 23455555555555543321 23455
Q ss_pred EEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcc
Q 047901 316 YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPAC 379 (786)
Q Consensus 316 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 379 (786)
.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..
T Consensus 406 ~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 406 ELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred EEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 55555555543 2221 123444555555554 34444555555555555555555444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=265.53 Aligned_cols=194 Identities=18% Similarity=0.181 Sum_probs=138.9
Q ss_pred hcCC-CcccceeeEE-------ecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 047901 562 KIRH-RNIVKFYGFC-------SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633 (786)
Q Consensus 562 ~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~i 633 (786)
.++| +||+++++++ ...+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3456 6888888887 2334567788987 55999999753 35689999999999999999999998 99
Q ss_pred EEcCCCCCceeeCC-------------------CCcEEEeccccceecCCCC----------------CcceeeccCccc
Q 047901 634 VHRDISSNNVLLDL-------------------EYEARVSDFGTAKLLKPNS----------------SNWTELVGTFGY 678 (786)
Q Consensus 634 vHrdlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y 678 (786)
+||||||+|||++. ++.+|++|||+++...... ......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556677777765432100 001123588999
Q ss_pred cCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHH
Q 047901 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKL 758 (786)
Q Consensus 679 ~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 758 (786)
||| |+..+..++.++|||||||++|||++|.+|+.... ........... +... ....
T Consensus 182 ~AP----------E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~~~~--~~~~-~~~~ 238 (793)
T PLN00181 182 TSP----------EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRHRVL--PPQI-LLNW 238 (793)
T ss_pred ECh----------hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHHhhc--Chhh-hhcC
Confidence 999 66667789999999999999999999998865211 01111111111 1111 1112
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 759 ISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 759 ~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....++..||+++|.+||||.|+++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhh
Confidence 33568888999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=246.05 Aligned_cols=263 Identities=22% Similarity=0.209 Sum_probs=150.7
Q ss_pred CCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccc
Q 047901 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN 131 (786)
Q Consensus 52 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 131 (786)
-..|+|++|.|+ .+|..+. ++|+.|++++|+|+.++.. +++|++|+|++|+|+.++ .. .++|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~LtsLP-~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLTSLP-VL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCCC---CCCCcEEEecCCccCccc-Cc---ccccceeeccCC
Confidence 344555555554 2333332 2455555555555443321 344555555555555332 11 234555555555
Q ss_pred cccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcC
Q 047901 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN 211 (786)
Q Consensus 132 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~ 211 (786)
.++ .+|..+ .+|+.|++++|+++.++.. .++|+.|+|++|+|++++. ...+|+.|++++|+|++++.
T Consensus 273 ~L~-~Lp~lp---~~L~~L~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~Lp~----lp~~L~~L~Ls~N~L~~LP~-- 339 (788)
T PRK15387 273 PLT-HLPALP---SGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSLPT-- 339 (788)
T ss_pred chh-hhhhch---hhcCEEECcCCcccccccc---ccccceeECCCCccccCCC----CcccccccccccCccccccc--
Confidence 554 222211 3344555555555543321 2456666666666665432 12356666777777765332
Q ss_pred ccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCc
Q 047901 212 WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291 (786)
Q Consensus 212 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 291 (786)
...+|+.|+|++|+|++ +|.. ..+|+.|++++|+|.. +|.. ..+|+.|+|++|+|+.++ .. .++|+
T Consensus 340 --lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP-~l---~s~L~ 405 (788)
T PRK15387 340 --LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLP-VL---PSELK 405 (788)
T ss_pred --cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCC-Cc---ccCCC
Confidence 12367777777777774 3332 2456677777777763 4432 246777777888777533 22 35678
Q ss_pred eeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCccc
Q 047901 292 YFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI 356 (786)
Q Consensus 292 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 356 (786)
.|++++|+++.++.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+..+
T Consensus 406 ~LdLS~N~LssIP~l----~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 406 ELMVSGNRLTSLPML----PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred EEEccCCcCCCCCcc----hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 888888888775431 346778888888887 567888888999999999999987666555
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=206.15 Aligned_cols=163 Identities=21% Similarity=0.258 Sum_probs=122.6
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcce
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 670 (786)
|+|.+++..+ ...+++..++.++.|++.||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999754 35699999999999999999999998 5 999999999999999 99998765432
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (786)
..||+.|+|| |+..+..+++++|||||||++|||+||+.||....... .........+.. .....
T Consensus 64 -~~g~~~y~aP----------E~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~-~~~~~ 128 (176)
T smart00750 64 -SRVDPYFMAP----------EVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGMPA-DDPRD 128 (176)
T ss_pred -CCCcccccCh----------HHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHhcc-CCccc
Confidence 2689999999 77777889999999999999999999999986432211 001111111111 11100
Q ss_pred ChhHHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 751 SLDVQEKLI--SIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 751 ~~~~~~~~~--~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
......... .+.+++.+||..+|++|||+.|+++.
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHH
Confidence 011122222 58999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=219.95 Aligned_cols=183 Identities=19% Similarity=0.164 Sum_probs=135.3
Q ss_pred HhccCccceeeccccCceEEEEEcC--CCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP--SGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
..++|+..+.||+|+||+||+|+++ +++.||||++...... ......+.|.+|++++++++|+|+++.+..+ +.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 4567999999999999999999764 5677899987532110 1223456799999999999999998644322 45
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC-CCCceeeCCCCcEEEeccccc
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDI-SSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfg~a 659 (786)
.|+||||++|++|... .. .+ ...++.++++||.|||+. ||+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 7999999999999632 11 11 145788999999999999 9999999 999999999999999999999
Q ss_pred eecCCCCCc--------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchH
Q 047901 660 KLLKPNSSN--------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVY 706 (786)
Q Consensus 660 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvw 706 (786)
+........ .....+++.|+|||.+... |.......+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~----~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR----ERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh----hhccccccccccCcE
Confidence 977643311 1345788899999865433 222223333446655
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=203.95 Aligned_cols=245 Identities=20% Similarity=0.269 Sum_probs=181.4
Q ss_pred ccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEecc
Q 047901 509 DAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
...-+|.+...|..|+|+|. |..+++|++.... -......+|..|.-.++.+.||||.+++|.|....+..++..||
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~--~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVRE--VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCccccccccc-Ccchhhhhhhhhh--cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34446888999999999996 5667778775421 11223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe--ccccceecCCCC
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS--DFGTAKLLKPNS 666 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~--Dfg~a~~~~~~~ 666 (786)
+.|+|+..++.. ..-..+..++.+++.++|+|++|||+.. |-|.---+.++.|++|++.+++|+ |--++...
T Consensus 270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe---- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---- 343 (448)
T ss_pred cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence 999999999876 4456788899999999999999999973 334444689999999999998875 32222111
Q ss_pred CcceeeccCccccCCCCCCCCchHHHHhhhcCc---CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 667 SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI---TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 667 ~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~---~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
....-.+.||+|| .+...+. -+++|+|||++++||+.|...||++.... ....-.+.-
T Consensus 344 ---~gr~y~pawmspe----------alqrkped~n~raadmwsfaillwel~trevpfadlspm------ecgmkiale 404 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPE----------ALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM------ECGMKIALE 404 (448)
T ss_pred ---cccccCcccCCHH----------HHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch------hhhhhhhhc
Confidence 1123367899994 4444332 25799999999999999999999864432 111111222
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
..+...|+... ..+.++|.-|...||.+||.++.|+-+
T Consensus 405 glrv~ippgis----~hm~klm~icmnedpgkrpkfdmivpi 442 (448)
T KOG0195|consen 405 GLRVHIPPGIS----RHMNKLMNICMNEDPGKRPKFDMIVPI 442 (448)
T ss_pred cccccCCCCcc----HHHHHHHHHHhcCCCCcCCCcceehhh
Confidence 22333444332 348899999999999999999988754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=194.60 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=199.0
Q ss_pred HhccCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-CcccceeeEEecCCee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKFYGFCSHVRHS 581 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~ 581 (786)
..+.|.++++||.|+||.+|.|. ..+|.+||||.-.... ...++..|..+...+++ ..|..+..|..+.+.-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 35689999999999999999996 5689999999876532 22356688899998874 6788888888888888
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEecccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDFGT 658 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~ 658 (786)
.+|||.. |.+|++.+.-. ...++.++++-++-|++.-++|+|.+ +++||||||+|+|++-+ ..+.++|||+
T Consensus 87 vlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 9999988 66999988643 46789999999999999999999999 99999999999999765 4688999999
Q ss_pred ceecCCCCCc-------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 659 AKLLKPNSSN-------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 659 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
|+.+.+.... .....||..|.+- ..+.+...+.+.|+-|+|.++.++--|..||......
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASi----------nAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~--- 227 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASI----------NAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA--- 227 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhh----------hhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh---
Confidence 9987654332 1234799999887 6677777788999999999999999999998764321
Q ss_pred CcchhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 732 SSSINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.-......+...+...+ +..+...+.++.-.+..|-..--++-|....+.+.
T Consensus 228 --tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 228 --TKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred --hHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 11223333334444433 22234445678888999999999999998877664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=214.21 Aligned_cols=253 Identities=20% Similarity=0.228 Sum_probs=185.2
Q ss_pred cCccceeeccccCceEEEEEcCCC--CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC----CcccceeeEE-ecCC
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSG--DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH----RNIVKFYGFC-SHVR 579 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----pniv~l~~~~-~~~~ 579 (786)
+|.+.+.||+|+||.||.+..... ..+|+|....... .....+..|+.++..+.. +++..+++.. ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~----~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG----SKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc----CCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 799999999999999999986543 4788888754211 111156778888888862 6888999888 5777
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-----CcEEEe
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-----YEARVS 654 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-----~~~kl~ 654 (786)
..|+||+.+ |.+|.+...... .+.++..++..++.|++.+|++||+. |++||||||.|+.++.. ..+.+.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 889999977 679999886653 67899999999999999999999999 99999999999999865 469999
Q ss_pred ccccce--ecCCCCC--------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 655 DFGTAK--LLKPNSS--------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 655 Dfg~a~--~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
|||+|+ ....... ......||..|+++ .++.+...+++.|+||++.++.|+..|..||..
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~----------~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI----------NVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccH----------HHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence 999998 3221111 12235699999999 889999999999999999999999999999754
Q ss_pred cccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 725 LSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...... ...+........... .....+..+.++...+-..+..++|....+.+.
T Consensus 240 ~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 240 LEMTDL-----KSKFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccch-----HHHHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 332111 111111111111110 001111235555555555789999998887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=196.21 Aligned_cols=252 Identities=16% Similarity=0.231 Sum_probs=201.2
Q ss_pred cCccceeeccccCceEEEEE-cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 584 (786)
.|.++++||+|.||+++.|. +-+++.||||.-... ....++..|....+.+ ..++|..++.+...+.+-.+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 59999999999999999997 457999999976542 2334566788888877 479999999888888888899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-----CcEEEeccccc
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-----YEARVSDFGTA 659 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-----~~~kl~Dfg~a 659 (786)
+|.. |-+|+|.+.-. +..++.+++..+|.|++.-++|+|++ .+|.|||||+|+||+.. ..+.++|||+|
T Consensus 103 idLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9988 66999988754 46799999999999999999999999 99999999999999754 45899999999
Q ss_pred eecCCCCCcc-------eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 660 KLLKPNSSNW-------TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 660 ~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
+.+.++.... ....||.+||+- .-+.+.+-+.+.|+-|+|-++++.+-|..||.... .
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSI----------NTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK-----A 241 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSI----------NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-----A 241 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEe----------eccccchhhhhhhHHHhhhhhhhhccCCCcccccc-----C
Confidence 9987765422 245799999998 77788888999999999999999999999987543 2
Q ss_pred cchhhhhhhhccCCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 733 SSINIEFNAMLDHRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
....+.+..+-+.+...|. ..+...+.++...+...-+.+-.+-|..+-+...
T Consensus 242 ~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~L 295 (449)
T KOG1165|consen 242 DTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKL 295 (449)
T ss_pred cchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 2344555555555554442 2334455677777777777788888988766543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=234.72 Aligned_cols=259 Identities=21% Similarity=0.231 Sum_probs=190.9
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEe
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 586 (786)
+|...+.+|++.|=.|.+|+.+.|. |+||++.+...........+-..|++ ...++|||++++.-+...++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777888999999999999998776 99999987544444444444444555 555689999999988888888899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC---
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK--- 663 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~--- 663 (786)
|... +|+|.+..+ ..+...+..-|+.|++.|+..+|.. ||+|||||.+||||+.-.-+.|+||..-+...
T Consensus 102 yvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9976 999999743 5677788888999999999999999 99999999999999999999999998765432
Q ss_pred CCCCccee----eccCccccCCCCCCCCchHHHHhhhcC-cCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 664 PNSSNWTE----LVGTFGYVAPAHGNIGLHLAELAYTMK-ITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 664 ~~~~~~~~----~~gt~~y~aPE~~~~~~~~~e~~~~~~-~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
++...+.. ......|+|||.|..+........... .+++.||||+||+++|+++ |++||+....+...... .
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~--~ 252 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN--A 252 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC--c
Confidence 22223332 344458999997764331111222223 7889999999999999998 89998864433211110 1
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...++.-..+.. ..+..++..|++.||.+|-++++.++.
T Consensus 253 ~~~e~~Le~Ied---------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIED---------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcC---------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111112221 237789999999999999999999874
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=228.50 Aligned_cols=120 Identities=25% Similarity=0.339 Sum_probs=55.1
Q ss_pred CccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccc
Q 047901 217 RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLS 296 (786)
Q Consensus 217 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 296 (786)
+|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+. +|..+ .++|+.|+|+
T Consensus 305 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs 375 (754)
T PRK15370 305 GITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVS 375 (754)
T ss_pred hHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECC
Confidence 34444444444442 222221 344555555555442 233222 345555555555542 22222 1345555555
Q ss_pred cccccccchhhhhcccCCcEEEecccccCCCcchHH----hhhcCcCeeeccCCccC
Q 047901 297 SNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL----ALLAHLSELDLSHNLFK 349 (786)
Q Consensus 297 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~ 349 (786)
+|+++.+++... ..|+.|++++|+|+. +|..+ ..++.+..|+|.+|.++
T Consensus 376 ~N~Lt~LP~~l~---~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 376 RNALTNLPENLP---AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCCCCCHhHH---HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 555554443322 235555566666552 33322 22355666666666665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=228.65 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=151.7
Q ss_pred CCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccc
Q 047901 75 HLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND 154 (786)
Q Consensus 75 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~ 154 (786)
+...|+|++++++.+|..+. ++|+.|+|++|+|+.++...+ ++|++|++++|+++ .+|..
T Consensus 179 ~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lt-sLP~~-------------- 238 (754)
T PRK15370 179 NKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLT-SIPAT-------------- 238 (754)
T ss_pred CceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccc-cCChh--------------
Confidence 34555555555554443332 345555555555553332222 24555555555554 22322
Q ss_pred ccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCc
Q 047901 155 NHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPP 234 (786)
Q Consensus 155 N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 234 (786)
+. ++|+.|+|++|+|+.++. .+ .++|++|+|++|+|+.+ |..+. ++|+.|+|++|+++. +|.
T Consensus 239 ---------l~--~~L~~L~Ls~N~L~~LP~-~l--~s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~-LP~ 300 (754)
T PRK15370 239 ---------LP--DTIQEMELSINRITELPE-RL--PSALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRT-LPA 300 (754)
T ss_pred ---------hh--ccccEEECcCCccCcCCh-hH--hCCCCEEECcCCccCcc-ccccC--CCCcEEECCCCcccc-Ccc
Confidence 21 245555556665554322 22 24677777777777754 33332 467888888888874 444
Q ss_pred cccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCC
Q 047901 235 EIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKL 314 (786)
Q Consensus 235 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 314 (786)
.+. ++|+.|++++|+++. +|..+. ++|+.|++++|.++.+ |..+. ++|+.|++++|+|+.++.. + .++|
T Consensus 301 ~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~~LP~~-l--p~~L 369 (754)
T PRK15370 301 HLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSL-PASLP--PELQVLDVSKNQITVLPET-L--PPTI 369 (754)
T ss_pred cch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccC-Chhhc--CcccEEECCCCCCCcCChh-h--cCCc
Confidence 433 478888899998884 444332 5788888999988864 44443 6888899999988865432 2 3578
Q ss_pred cEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCccc----ccccccceecccccccc
Q 047901 315 FYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI----CNLESLEKLNLSHNNIS 373 (786)
Q Consensus 315 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~ 373 (786)
++|+|++|+|+. +|..+. ..|+.|++++|+|+ .+|..+ ..++++..|++.+|+++
T Consensus 370 ~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 370 TTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 889999998885 444443 36888889999888 455443 34477888899998886
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-20 Score=200.11 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=194.2
Q ss_pred CccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCC-cccceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR-NIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e 586 (786)
|...+.+|.|+||.||++... ..+++|.+........ .....+.+|+.+++.+.|+ +++++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667788999999999999876 7899999876433221 2467899999999999988 79999999977777899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEeccccceecCCC
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLKPN 665 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 665 (786)
++.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997776542113688899999999999999999999 999999999999999988 7999999999866543
Q ss_pred CC------cceeeccCccccCCCCCCCCchHHHHhhh---cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 666 SS------NWTELVGTFGYVAPAHGNIGLHLAELAYT---MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 666 ~~------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~---~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
.. ......|+..|+|| |.... ..++...|+||+|++++++++|..||...... ....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~p----------e~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~ 221 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAP----------EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATS 221 (384)
T ss_pred CccccccccccccccccccCCH----------HHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHH
Confidence 32 23567899999999 55555 57888999999999999999999996643211 0001
Q ss_pred hhhhhhccCC---CC--CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 737 IEFNAMLDHR---LP--HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 737 ~~~~~~~~~~---~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
.....+.... .. ............+.+++..|+..+|..|.++.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred HHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 1111111111 11 00000011123578999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-22 Score=223.63 Aligned_cols=254 Identities=19% Similarity=0.232 Sum_probs=184.1
Q ss_pred ccceeeccccCceEEEEEcC-CCCEEEEEEcCCC--CCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 509 DAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSP--FPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
...+.+|.|++|.|+.+... ..+..+.|.++.. ...........+..|.-+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34567999999988877533 4444555544321 11111112222667888888899999988887776666555569
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
|||++ ||+.++... ..++..++..++.|+..|+.|||+. ||.|||+|++|++++.+|.+||+|||.+....-+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999999754 4688889999999999999999999 9999999999999999999999999999765432
Q ss_pred C----CcceeeccCccccCCCCCCCCchHHHHhhhcCcCc-ccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 666 S----SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITE-KCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 666 ~----~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~-~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
. ......+|+.+|+|| |.....+|++ ..||||.|++++.|.+|+.||.......... ...
T Consensus 474 ~e~~~~~~~g~~gS~pY~ap----------E~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~ 538 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAP----------EVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTN 538 (601)
T ss_pred cchhhhhhcCcccCCcCcCc----------ccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhh
Confidence 2 234567899999999 5566667776 4999999999999999999976433211100 000
Q ss_pred hhccC-CC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDH-RL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~-~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... .. ..+.......+..-..++.+++++||.+|-|+++|++
T Consensus 539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00010 11 1222223344556778999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=181.54 Aligned_cols=145 Identities=17% Similarity=0.207 Sum_probs=110.8
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchh----------------------hHHHHHHHHHHHhhcCCCcc
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMS----------------------DQKEFLNEIKALTKIRHRNI 568 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~hpni 568 (786)
...||+|+||.||+|...+|+.||||+++......... .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997642211110 01122459999999988877
Q ss_pred cceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEcCCCCCceeeCC
Q 047901 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM-HHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 569 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrdlk~~Nill~~ 647 (786)
.....+... ..++||||++++++...... ...++...+..++.|++.++.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 544333222 23899999999877654322 24688999999999999999999 688 999999999999998
Q ss_pred CCcEEEeccccceecCC
Q 047901 648 EYEARVSDFGTAKLLKP 664 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~ 664 (786)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=184.35 Aligned_cols=173 Identities=13% Similarity=0.158 Sum_probs=133.8
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHH------HHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKE------FLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|+..+.+|.|+||.||.+.. ++..+|||.+........ ...+. +.+|+..+.++.||+|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~-~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE-RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH-HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 67899999999999999999866 577899999976543322 22222 67899999999999999998885532
Q ss_pred --------CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 579 --------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 579 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
+..++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999988732 222 2456899999999999 999999999999999988
Q ss_pred EEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHH
Q 047901 651 ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI 716 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ell 716 (786)
++++|||.......... . . .+.....+..++|+||||+.+.-..
T Consensus 173 i~liDfg~~~~~~e~~a-~-----------d----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA-K-----------D----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh-H-----------H----------HHHHHhHhcccccccceeEeehHHH
Confidence 99999998865532111 0 0 3344455667999999999876543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=173.82 Aligned_cols=187 Identities=10% Similarity=0.041 Sum_probs=138.8
Q ss_pred ccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEEEec
Q 047901 509 DAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
.+...+++|+||+||.+.. ++.+++.+.+..............|.+|+++|+++. |++|++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998876 677888777754211111112236889999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC-CCCceeeCCCCcEEEeccccceecCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDI-SSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
++|.+|.+.... + ...++.|++.++.++|+. ||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998754321 1 134778999999999999 9999999 7999999999999999999998655433
Q ss_pred Cc-----c--------eeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCC
Q 047901 667 SN-----W--------TELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPG 722 (786)
Q Consensus 667 ~~-----~--------~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf 722 (786)
.. . .....++.|++|+ |.-.-...+ .+.+.++-|.-+|.++|++.|+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~---------~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPV---------ERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHH---------HHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 21 0 0123577888884 333222333 5678889999999999999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=176.09 Aligned_cols=145 Identities=17% Similarity=0.226 Sum_probs=112.7
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCch----------------------hhHHHHHHHHHHHhhcCCCcc
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQM----------------------SDQKEFLNEIKALTKIRHRNI 568 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~hpni 568 (786)
.+.||+|++|.||+|+..+|+.||||+++........ .....+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999878999999999864211000 001234578999999999988
Q ss_pred cceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCC
Q 047901 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 569 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~ 647 (786)
.....+... ..++||||++++++...... ...++......++.+++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 655544333 24899999998865443221 2456788899999999999999999 8 999999999999999
Q ss_pred CCcEEEeccccceecCC
Q 047901 648 EYEARVSDFGTAKLLKP 664 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~ 664 (786)
++.++|+|||+|+....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.2e-20 Score=183.31 Aligned_cols=196 Identities=21% Similarity=0.263 Sum_probs=134.7
Q ss_pred CCCcccceeeEEec---------------------------CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHH
Q 047901 564 RHRNIVKFYGFCSH---------------------------VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT 616 (786)
Q Consensus 564 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~ 616 (786)
+|||||+++++|.+ ....|+||..++. +|.+|+..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 69999999987633 2356999999876 999999754 345566677899
Q ss_pred HHHHHHHHHhhCCCCCeEEcCCCCCceee--CCC--CcEEEeccccceecCCC------CCcceeeccCccccCCCCCCC
Q 047901 617 GVADALSYMHHDCFPPIVHRDISSNNVLL--DLE--YEARVSDFGTAKLLKPN------SSNWTELVGTFGYVAPAHGNI 686 (786)
Q Consensus 617 ~ia~~l~~LH~~~~~~ivHrdlk~~Nill--~~~--~~~kl~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~ 686 (786)
|+++|+.|||.+ ||.|||+|++|||+ ++| -...|+|||++--.+.. .......-|...-||||+++.
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999998 344 35789999998543221 112233467889999965431
Q ss_pred CchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHH
Q 047901 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVA 765 (786)
Q Consensus 687 ~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 765 (786)
---.. ...-..|+|.|+.|.+.||+++...||.......-. .+......++ .|... +.-+.+++
T Consensus 426 ~PGp~----avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-------~r~Yqe~qLPalp~~v----pp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPN----AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-------TRTYQESQLPALPSRV----PPVARQLV 490 (598)
T ss_pred CCCCc----eeeccchhhhhhhhhhHHHHhccCCcccccchheec-------hhhhhhhhCCCCcccC----ChHHHHHH
Confidence 10000 011235899999999999999999998752211101 1111112222 22222 23378999
Q ss_pred HhccCCCCCCCCCHHHH
Q 047901 766 LLCLDGCPNSRPTMQTV 782 (786)
Q Consensus 766 ~~cl~~~p~~RPt~~ev 782 (786)
...+++||.+||+..-.
T Consensus 491 ~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIA 507 (598)
T ss_pred HHHhcCCccccCCccHH
Confidence 99999999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=181.83 Aligned_cols=237 Identities=17% Similarity=0.222 Sum_probs=150.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC----------CcccceeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH----------RNIVKFYGF 574 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------pniv~l~~~ 574 (786)
..+..++.||.|+++.||.++.. +++++|||++..+. .......+++.+|.-....+.+ -.++-.++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 34567789999999999999865 68999999998755 3444556777777765555432 112222222
Q ss_pred E---------ecC---C-----eeeEEEeccCCCCHHHHhhc---C-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 047901 575 C---------SHV---R-----HSFVVYEYINRGSLATVLSN---N-FASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633 (786)
Q Consensus 575 ~---------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~i 633 (786)
. ... . ..+++|+-+. +||.+++.. . ..........+..+..|+++.+++||+. |+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 1 111 1 2367888775 488887652 1 1112344555667778999999999999 99
Q ss_pred EEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh--------cCcCcccch
Q 047901 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT--------MKITEKCDV 705 (786)
Q Consensus 634 vHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--------~~~~~~sDv 705 (786)
+|+||+|+|++++.+|.++|+||+........ ......+..|.+|| .... ..++.+.|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe----------~~~~~~~~~~~~~~~t~~~Da 233 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPE----------LESCAGQFGQNNAPYTFATDA 233 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HH----------HHHHHTSCHHSEEEE-HHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChh----------hhhhhcccCcccceeeeccCH
Confidence 99999999999999999999999888765421 11134456788884 3332 358889999
Q ss_pred HHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCC
Q 047901 706 YSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776 (786)
Q Consensus 706 wslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 776 (786)
|++|+++|.|++|+.||+.......... .+. . +.+.+..+.++|..+++++|.+|
T Consensus 234 W~LG~~ly~lWC~~lPf~~~~~~~~~~~------------~f~---~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 234 WQLGITLYSLWCGRLPFGLSSPEADPEW------------DFS---R-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHSS-STCCCGGGSTSGG------------GGT---T-SS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHHccCCCCCCCccccccc------------cch---h-cCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999885432111110 111 0 11334568999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=194.50 Aligned_cols=214 Identities=25% Similarity=0.444 Sum_probs=160.4
Q ss_pred HhhcCCCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EEcCC
Q 047901 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI-VHRDI 638 (786)
Q Consensus 560 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~i-vHrdl 638 (786)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.-...++.+++.||.|+|.. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 35678999999999999999999999999999999999863 46788999999999999999999997 44 99999
Q ss_pred CCCceeeCCCCcEEEeccccceecCCC--CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHH
Q 047901 639 SSNNVLLDLEYEARVSDFGTAKLLKPN--SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI 716 (786)
Q Consensus 639 k~~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ell 716 (786)
+++|+++|..+.+|++|||+....... ........-..-|.|||.+....... .....+.+.||||||++++|++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~---~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS---LESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc---ccccccccCCeehHHHHHHHHH
Confidence 999999999999999999998877431 11222234566899997655432111 1123577899999999999999
Q ss_pred hCCCCCCccccccCCCcchhhhhhhhcc-CC-CCCCChhHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 717 KGKHPGDFLSLFSSSSSSINIEFNAMLD-HR-LPHPSLDVQ-EKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 717 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
+.+.||+........ .+....+.+ .. ...|..... +....+..+++.||..+|++||+++.|-..
T Consensus 153 ~r~~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred hccCccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 999998753321111 222222222 11 123333322 334468999999999999999999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=200.53 Aligned_cols=226 Identities=24% Similarity=0.275 Sum_probs=180.4
Q ss_pred eccccCceEEEEE----cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEEEecc
Q 047901 514 IGKGEHRSVYRAK----LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 514 ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
+|+|+||.|+.++ .+.+..+|+|..+.......... ....|..++..++ ||.+|++...++.+...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 6899999999764 33467788888876433222222 4556888888886 999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 668 (786)
.+|++...+... ..++......+...+|-+++++|.. +++|||+|++||+++.+|++|+.|||+++..-....
T Consensus 80 rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 80 RGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred ccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999999888643 5677778888889999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCC
Q 047901 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLP 748 (786)
Q Consensus 669 ~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (786)
.+||..|||| |++. ....++|.||||++++||+||..||.. +.+..+......
T Consensus 153 ---~cgt~eymAp----------EI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~ 205 (612)
T KOG0603|consen 153 ---ACGTYEYRAP----------EIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELE 205 (612)
T ss_pred ---cccchhhhhh----------Hhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccC
Confidence 2899999999 5555 456789999999999999999999873 345555555666
Q ss_pred CCChhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 047901 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779 (786)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 779 (786)
.|.... ....+++..+..++|..|--.
T Consensus 206 ~p~~l~----~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELS----AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred Cchhhh----HHHHHHHHHHHhhCHHHHhcc
Confidence 554433 346677778888888887544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.6e-18 Score=165.86 Aligned_cols=137 Identities=18% Similarity=0.280 Sum_probs=104.6
Q ss_pred CccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-----CCCcccceeeEEecCC---
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-----RHRNIVKFYGFCSHVR--- 579 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~l~~~~~~~~--- 579 (786)
....+.||+|+||.||. ++.....+||++.... ....+.+.+|+.+++.+ .||||++++|+++++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 34456899999999996 4433334799886521 22456789999999999 5799999999998763
Q ss_pred eee-EEEec--cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEEcCCCCCceeeCC----CCcE
Q 047901 580 HSF-VVYEY--INRGSLATVLSNNFASEDFDWRKRMNVITGVADAL-SYMHHDCFPPIVHRDISSNNVLLDL----EYEA 651 (786)
Q Consensus 580 ~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l-~~LH~~~~~~ivHrdlk~~Nill~~----~~~~ 651 (786)
..+ +|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 434 78999 5689999999653 34444 34567777777 999999 9999999999999974 3489
Q ss_pred EEeccccc
Q 047901 652 RVSDFGTA 659 (786)
Q Consensus 652 kl~Dfg~a 659 (786)
+|+||+-+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-20 Score=199.46 Aligned_cols=280 Identities=24% Similarity=0.250 Sum_probs=138.7
Q ss_pred EEECCCCCcc-ccCchhccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCcccC-------CCCCCCC
Q 047901 30 YLDLSINGFF-GTLPPQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSGTF-------PPICNLS 97 (786)
Q Consensus 30 ~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~-------~~~~~l~ 97 (786)
.|+|..+.+. ......|..+.+|+.|++++|.++.. ++..+...++|++|++++|.+.+.+ ..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777775 33445566677777888887777432 3344556666777777777665211 1234455
Q ss_pred CCcEEEccCCcCcccCchhhcccCC---cceeccccccccccCChhhhccCccceeecccccccCCCCCcCCC-CCCcEE
Q 047901 98 NLKYISLHNNKLSGSIPEEIGNLMK---LSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC-RSLVRA 173 (786)
Q Consensus 98 ~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l-~~L~~L 173 (786)
+|++|+|++|.+....+..|..+.+ |++|++++|+++......+ ...+..+ ++|+.|
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l-------------------~~~l~~~~~~L~~L 142 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL-------------------AKGLKDLPPALEKL 142 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH-------------------HHHHHhCCCCceEE
Confidence 6666666666665444444444444 5555555555542110000 0011222 344444
Q ss_pred EccCcccccc----cCcccCCCCCCCEEeccCCccccc----cCcCccCCCCccEEEccCcccCCCCCccccCCccccEE
Q 047901 174 HLGRNNLTGN----ISEDFGIYPNLKFLDLSHNNFYGE----ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245 (786)
Q Consensus 174 ~L~~N~l~~~----~~~~f~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 245 (786)
++++|.+++. ....|..+++|++|+|++|.+++. .+..+..+++|+.|+|++|.+++....
T Consensus 143 ~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~----------- 211 (319)
T cd00116 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS----------- 211 (319)
T ss_pred EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH-----------
Confidence 4444444411 122334444555555555555421 111222333444444444444321110
Q ss_pred EeecccccccCCCCcccccccccccccccccCCCCcccc-----ccCCcCceeccccccccccc----hhhhhcccCCcE
Q 047901 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRAL-----GLLTELEYFDLSSNRLNNSI----LEALGFMFKLFY 316 (786)
Q Consensus 246 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~ 316 (786)
..+..+..+++|+.|++++|.++......+ ...++|+.|++++|.++... ...+..+++|++
T Consensus 212 ---------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~ 282 (319)
T cd00116 212 ---------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282 (319)
T ss_pred ---------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence 111223334445555555555443111111 12356777777777765221 234445567778
Q ss_pred EEecccccCCC----cchHHhhh-cCcCeeeccCCcc
Q 047901 317 LNFSHNQFSQE----IPEDLALL-AHLSELDLSHNLF 348 (786)
Q Consensus 317 L~L~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l 348 (786)
+++++|.++.. ....+... +.|++|++.+|++
T Consensus 283 l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 283 LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 88888887744 23334444 6788888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-20 Score=198.69 Aligned_cols=279 Identities=23% Similarity=0.230 Sum_probs=150.4
Q ss_pred EEEccCCcCc-ccCchhhcccCCcceecccccccccc----CChhhhccCccceeecccccccCCCCCcCCCCCCcEEEc
Q 047901 101 YISLHNNKLS-GSIPEEIGNLMKLSYLMLDTNQFTGQ----LPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHL 175 (786)
Q Consensus 101 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L 175 (786)
.|+|.++.++ ......|..+.+|++|++++|.++.. ++..+...+.++.++++++.+......+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~----------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGL----------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHH-----------
Confidence 5788888887 34456677888899999999988532 3334444555666666665543201000
Q ss_pred cCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCC---ccEEEccCcccCC----CCCccccCC-ccccEEEe
Q 047901 176 GRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHR---LGTLIVSGNNITG----RIPPEIGNS-SQLHVLDL 247 (786)
Q Consensus 176 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L 247 (786)
...+..|..+++|++|++++|.+....+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|
T Consensus 71 ------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L 144 (319)
T cd00116 71 ------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144 (319)
T ss_pred ------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc
Confidence 112233444555566666555555433333333333 6666666655542 111223344 56666666
Q ss_pred eccccccc----CCCCcccccccccccccccccCCC----CccccccCCcCceeccccccccccch----hhhhcccCCc
Q 047901 248 SSNHIAGE----IPMELGRLISLNKLILRGNQLSGH----LPRALGLLTELEYFDLSSNRLNNSIL----EALGFMFKLF 315 (786)
Q Consensus 248 s~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~ 315 (786)
++|.+++. .+..+..+++|++|+|++|.+++. .+..+..+++|+.|++++|.+.+... ..+..+++|+
T Consensus 145 ~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~ 224 (319)
T cd00116 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLE 224 (319)
T ss_pred CCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCC
Confidence 66665521 222344445566666666666531 12233444566666666666654332 2334455677
Q ss_pred EEEecccccCCCcchHHhh-----hcCcCeeeccCCccCC----CCCcccccccccceecccccccccc----CCccccc
Q 047901 316 YLNFSHNQFSQEIPEDLAL-----LAHLSELDLSHNLFKG----SIPSRICNLESLEKLNLSHNNISGQ----IPACFIG 382 (786)
Q Consensus 316 ~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~ 382 (786)
+|++++|.++......+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++.. ....+..
T Consensus 225 ~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~ 304 (319)
T cd00116 225 VLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLE 304 (319)
T ss_pred EEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhh
Confidence 7777777665432333222 2567777777776652 1233444556677777777777643 2333334
Q ss_pred C-CCceEEeccCCcc
Q 047901 383 M-SGLLSIDISYNEL 396 (786)
Q Consensus 383 l-~~L~~L~l~~N~l 396 (786)
. +.|+++++.+|++
T Consensus 305 ~~~~~~~~~~~~~~~ 319 (319)
T cd00116 305 PGNELESLWVKDDSF 319 (319)
T ss_pred cCCchhhcccCCCCC
Confidence 4 5666677666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-20 Score=165.27 Aligned_cols=156 Identities=28% Similarity=0.389 Sum_probs=78.4
Q ss_pred CCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecc
Q 047901 49 LSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLML 128 (786)
Q Consensus 49 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 128 (786)
+++++.|-||+|+++ ..|..++.|.+|+.|++++|+|..++.+++.+++|+.|+++-|++. +.|..|+.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 344444445555554 3333444455555555555555544444555555555555555544 44445555555555555
Q ss_pred ccccccc-cCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccc
Q 047901 129 DTNQFTG-QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGE 207 (786)
Q Consensus 129 ~~N~l~~-~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~ 207 (786)
.+|++.. .+|+.|+.++.|+.|+|++|.+.-.+++++++++|+.|.+..|.+-. .|..++.+..|++|.+++|+++.+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqgnrl~vl 188 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQGNRLTVL 188 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhcccceeeec
Confidence 5554442 34555555555555555555555555555555555555555555442 344455555555555555555533
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-18 Score=192.91 Aligned_cols=196 Identities=22% Similarity=0.259 Sum_probs=159.7
Q ss_pred HHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC---CCcccceeeEEecCC
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR---HRNIVKFYGFCSHVR 579 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~ 579 (786)
.....|.+.+.||+|+||+||+|...+|+.||+|+-+.+... +|.-=.+++.+++ -+-|+.+..++...+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 345678889999999999999999888999999998764322 1222334445554 244555666566667
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-------CCcEE
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-------EYEAR 652 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-------~~~~k 652 (786)
..++|+||.+.|+|.+++. ..+..+|.-++.++.|+++.+++||.. +|||+||||+|.|+.. ...++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 7889999999999999998 347789999999999999999999999 9999999999999953 25699
Q ss_pred EeccccceecC--CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC
Q 047901 653 VSDFGTAKLLK--PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721 (786)
Q Consensus 653 l~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P 721 (786)
|+|||.|..+. ++.......++|-.+-.+ |+..+...+.++|-|.++.+++.|+.|+.-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~----------EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCI----------EMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhH----------HHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999998764 333456677889899888 888899999999999999999999998854
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-20 Score=163.78 Aligned_cols=158 Identities=27% Similarity=0.410 Sum_probs=116.4
Q ss_pred CCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEE
Q 047901 24 SFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYIS 103 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 103 (786)
.+.+++.|-||+|+++ ..|..+..|.+|+.|++++|+|+ ..|..++.+++|+.|+++.|++.-.+.+|+.++.|+.||
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levld 108 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLD 108 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhh
Confidence 4556677777777775 44555777777777777777777 567777777777777777777776677777777777777
Q ss_pred ccCCcCc-ccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccccc
Q 047901 104 LHNNKLS-GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTG 182 (786)
Q Consensus 104 L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~ 182 (786)
|.+|++. ...|+.|-.|+.|+-|+|+.|.+. .+|..+..+++|++|.+.+|.+...+.+++.+..|++|++++|+++.
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeee
Confidence 7777776 356777777777777777777776 67777777777777777777777777777777777777777777775
Q ss_pred cc
Q 047901 183 NI 184 (786)
Q Consensus 183 ~~ 184 (786)
++
T Consensus 188 lp 189 (264)
T KOG0617|consen 188 LP 189 (264)
T ss_pred cC
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=164.80 Aligned_cols=150 Identities=19% Similarity=0.239 Sum_probs=114.3
Q ss_pred HhccCccceeeccccCceEEEEE--cCCCCEEEEEEcCCCCCCCc--------------------hhhHHHHHHHHHHHh
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAK--LPSGDKIAVKKFNSPFPNDQ--------------------MSDQKEFLNEIKALT 561 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~~~e~~~l~ 561 (786)
...-|.+.+.||+|++|.||+|. ..+|+.||||+++....... ......+..|++.+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33458888999999999999998 56899999999875321100 001124568999999
Q ss_pred hcCCC--cccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEcCC
Q 047901 562 KIRHR--NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP-IVHRDI 638 (786)
Q Consensus 562 ~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrdl 638 (786)
++.+. .+.+++++ ...++||||++++++..+.... .......+..++.|++.++++||+. + |+||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di 175 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDL 175 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence 99753 34444443 2358999999998887654322 3455666788999999999999999 9 999999
Q ss_pred CCCceeeCCCCcEEEeccccceecCC
Q 047901 639 SSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 639 k~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||+||+++ ++.++|+|||.|.....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999 88999999999876543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=159.24 Aligned_cols=149 Identities=21% Similarity=0.229 Sum_probs=113.5
Q ss_pred HHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCc-h-----------------hhHHHHHHHHHHHh
Q 047901 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQ-M-----------------SDQKEFLNEIKALT 561 (786)
Q Consensus 500 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~-----------------~~~~~~~~e~~~l~ 561 (786)
++.+....|...+.||+|+||.||+|..++|+.||||++........ . .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444444888899999999999999988899999998765321000 0 01123667888999
Q ss_pred hcCCC--cccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 047901 562 KIRHR--NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639 (786)
Q Consensus 562 ~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 639 (786)
.+.|+ .+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+. +|+|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 98877 44444442 345899999999998765421 23457889999999999998 99999999
Q ss_pred CCceeeCCCCcEEEeccccceecCC
Q 047901 640 SNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 640 ~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|+||+++.++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=160.08 Aligned_cols=138 Identities=17% Similarity=0.284 Sum_probs=114.8
Q ss_pred eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCc----hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 512 YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQ----MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
+.||+|++|.||+|++ .+..|++|+......... ......+.+|++++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 577899998654221111 11234678899999999999998888887777888999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++|++|.+++... .+ .+..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998643 11 7788999999999999999 999999999999999 88999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=156.21 Aligned_cols=134 Identities=21% Similarity=0.338 Sum_probs=108.5
Q ss_pred eccccCceEEEEEcCCCCEEEEEEcCCCCC-CC---chhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccC
Q 047901 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFP-ND---QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
||+|+||+||+|.+ ++..|++|+...... .. ......++.+|++++..++|+++.....++...+..++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 79999999999986 578899998654221 11 11223567889999999998876666666666667789999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
|++|.+++... .. .++.+++.++.+||+. +++|||++|+||+++ ++.++++|||.+...
T Consensus 81 g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEG---ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhc---HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999987542 11 6899999999999999 999999999999999 899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=179.35 Aligned_cols=141 Identities=19% Similarity=0.284 Sum_probs=113.4
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEc-CCCCCCC---chhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKF-NSPFPND---QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
..|...+.||+|+||+||+|.+.+.. +++|+. ....... .....+.+.+|+++++.++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566789999999999999876444 444433 2211111 112345788999999999999999888888777788
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++++|.+++. ....++.+++.++.|||+. +++||||||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 3467899999999999999 99999999999999 678999999999976
Q ss_pred c
Q 047901 662 L 662 (786)
Q Consensus 662 ~ 662 (786)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-17 Score=171.36 Aligned_cols=174 Identities=20% Similarity=0.341 Sum_probs=137.5
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..|+.|++|...+|.+|+.++......++.....++.|++.|+.| + +.+|||+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877777888999999999999999999 5 8999999999999999999999999999
Q ss_pred eecCCCC------CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCC
Q 047901 660 KLLKPNS------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSS 732 (786)
Q Consensus 660 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~ 732 (786)
....... ...+..+||..||+| |-+.+..|+.|+||||+|++++|+++ -..+|+..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsP----------EQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSP----------EQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCH----------HHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------
Confidence 8776544 123456899999999 77788899999999999999999997 44443321
Q ss_pred cchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
.....+.+..+ |+....+.+. =+.++.+++...|.+||++.++.
T Consensus 467 ----~t~~d~r~g~i--p~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 467 ----ATLTDIRDGII--PPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ----HhhhhhhcCCC--ChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence 11222333333 3333333332 35788899999999999776653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-16 Score=178.02 Aligned_cols=207 Identities=23% Similarity=0.290 Sum_probs=144.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
..+|+.++.|..|+||.||..+++ ..+++|+ ++... ..+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq---------~lilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ---------NLILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-ccccc---------chhhhc--cccccCCccee--------------
Confidence 357999999999999999999887 4567888 44320 011111 23333344433
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||=...++.. +.++.. .+.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++..-
T Consensus 136 -------gDc~tllk~~---g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------GDCATLLKNI---GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------chhhhhcccC---CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 3333333322 222221 27889999999 99999999999999999999999999987432
Q ss_pred CCC----C-----------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccc
Q 047901 664 PNS----S-----------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF 728 (786)
Q Consensus 664 ~~~----~-----------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~ 728 (786)
-.. + .....+||+.|+|| |++....|...+|.|++|+|+||.+-|..||...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP----------eVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--- 261 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP----------EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--- 261 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccCh----------hhhhhhccCCCccHHHHHHHHHHHheeeeeccCC---
Confidence 110 0 01235899999999 7888888999999999999999999999998642
Q ss_pred cCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC
Q 047901 729 SSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 777 (786)
-.++.+..++...+.+|+. ......+..+++.+.++++|.+|-
T Consensus 262 -----tpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 262 -----TPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -----CHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1234444455545555544 233345688999999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-15 Score=144.95 Aligned_cols=141 Identities=18% Similarity=0.246 Sum_probs=99.3
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhH--------------------HHHHHHHHHHhhcCCC--cc
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQ--------------------KEFLNEIKALTKIRHR--NI 568 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~hp--ni 568 (786)
.+.||+|+||+||+|...+++.||||++............ .....|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753211110000 0113456666666433 24
Q ss_pred cceeeEEecCCeeeEEEeccCCCCHHHH-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeC
Q 047901 569 VKFYGFCSHVRHSFVVYEYINRGSLATV-LSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 569 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~ 646 (786)
.+.+++ ...++||||++++++... +... ... ..+..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 245899999999654321 1111 001 5677899999999999999 7 999999999999999
Q ss_pred CCCcEEEeccccceecCC
Q 047901 647 LEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 647 ~~~~~kl~Dfg~a~~~~~ 664 (786)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 99999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=137.07 Aligned_cols=136 Identities=17% Similarity=0.169 Sum_probs=113.8
Q ss_pred cceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC--CcccceeeEEecCCeeeEEEec
Q 047901 510 AKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH--RNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~ 587 (786)
..+.+|+|.++.||++...+ ..+++|....... ...+..|+.+++.++| +.+++++++....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 34679999999999999754 7899999865221 4578899999999976 5899999988888889999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
++++.+..+ +......++.+++.+++++|.....+++|+|++|+||+++.++.++++|||.++..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 998776543 45566778999999999999875457999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-14 Score=143.68 Aligned_cols=140 Identities=14% Similarity=0.210 Sum_probs=107.0
Q ss_pred ceeec-cccCceEEEEEcCCCCEEEEEEcCCCCC-----C----CchhhHHHHHHHHHHHhhcCCCcc--cceeeEEecC
Q 047901 511 KYCIG-KGEHRSVYRAKLPSGDKIAVKKFNSPFP-----N----DQMSDQKEFLNEIKALTKIRHRNI--VKFYGFCSHV 578 (786)
Q Consensus 511 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~hpni--v~l~~~~~~~ 578 (786)
...+| .|+.|+||.+... +..++||.+..+.. . ........+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999875 67899998854210 0 011234578899999999998875 6677764332
Q ss_pred -C---eeeEEEeccCC-CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 579 -R---HSFVVYEYINR-GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 579 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
. ..++||||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6999888542 34433 357899999999999 9999999999999999999999
Q ss_pred eccccceec
Q 047901 654 SDFGTAKLL 662 (786)
Q Consensus 654 ~Dfg~a~~~ 662 (786)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.5e-16 Score=173.91 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=184.2
Q ss_pred cCccceeeccccCceEEEEEcC--CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP--SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~l 583 (786)
.|...+.||+|+|+.|-.+... ....+|+|.+..+. ...........|..+-+.+. |+|++.+++.....+..++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4777778999999999988753 33456777665432 23334455566788777776 9999999999999999999
Q ss_pred EEeccCCCCHHHHh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEcCCCCCceeeCCCC-cEEEeccccce
Q 047901 584 VYEYINRGSLATVL-SNNFASEDFDWRKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~ 660 (786)
+.+|..++++.+.+ ... ....+...+-.+..|+..++.|+| .. ++.||||||+|.+++..+ ..|++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999988 432 113445556678999999999999 77 999999999999999999 99999999998
Q ss_pred ecCC-CCC--cceeecc-CccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 661 LLKP-NSS--NWTELVG-TFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 661 ~~~~-~~~--~~~~~~g-t~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
.+.. ... .....+| ++.|+|||. ..+ ....+..|+||.|+++..+++|..|++......
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~----------~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------ 237 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEH----------LSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------ 237 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCccc----------ccchhhcCCCcccccccccccccccCCCCcccccccc------
Confidence 8765 222 2345578 999999963 333 234568999999999999999999976533211
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
..+......+.......+........++...++..+|..|.+.+++.
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 238 -GRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -ccceeecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11111222211101111222233467788888889999999988764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.4e-14 Score=154.66 Aligned_cols=200 Identities=30% Similarity=0.385 Sum_probs=132.8
Q ss_pred EEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCC-CCcEEEccCCcCcccCchhhcccCCcceecccccc
Q 047901 54 YLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLS-NLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132 (786)
Q Consensus 54 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 132 (786)
.|+++.|++. ........++.++.|++.+|.++.+++....++ +|+.|++++|++.. .|..++.+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchhh-hhhhhhccccccccccCCch
Confidence 5677777664 233445555667777777777776666655553 77777777777763 33556677777777777777
Q ss_pred ccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCc
Q 047901 133 FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNW 212 (786)
Q Consensus 133 l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~ 212 (786)
++ .+|......+.|+.|++++|++..+++.......|+++.+++|++.. .+..+..+.++..|.+++|++..+ +..+
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~-~~~~~~~~~~l~~l~l~~n~~~~~-~~~~ 251 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDL-PESI 251 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCccee-cchhhhhcccccccccCCceeeec-cchh
Confidence 76 45555556667777777777777666554455567777777775332 344566777777777777777642 5566
Q ss_pred cCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCc
Q 047901 213 GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260 (786)
Q Consensus 213 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 260 (786)
+.++++++|++++|.++.+.. +..+.+++.|++++|.+....+...
T Consensus 252 ~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 252 GNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 777778888888888875433 7777888888888887775555443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.7e-13 Score=144.37 Aligned_cols=144 Identities=17% Similarity=0.245 Sum_probs=100.8
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchh------------------------------------hHHHHH
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMS------------------------------------DQKEFL 554 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~------------------------------------~~~~~~ 554 (786)
.+.||.|++|.||+|++++|+.||||+.+......-.. .+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532110000 001355
Q ss_pred HHHHHHhhc----C-CCcccceeeEE-ecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 047901 555 NEIKALTKI----R-HRNIVKFYGFC-SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD-ALSYMHH 627 (786)
Q Consensus 555 ~e~~~l~~l----~-hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~-~l~~LH~ 627 (786)
+|...+.++ + +++| .+-.++ ......++||||++|++|.++..... ...+ ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHh
Confidence 566655555 2 3333 222222 33455789999999999988765321 1122 3346666665 4678898
Q ss_pred CCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 628 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-13 Score=152.47 Aligned_cols=138 Identities=38% Similarity=0.498 Sum_probs=68.7
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLN 267 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 267 (786)
...+++|+.|++++|++..+.+ ..+.++.|+.|++++|+++ .+|........|++|++++|.+. ..+..+.++.++.
T Consensus 159 ~~~l~~L~~L~l~~N~l~~l~~-~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~ 235 (394)
T COG4886 159 LRNLPNLKNLDLSFNDLSDLPK-LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235 (394)
T ss_pred hhccccccccccCCchhhhhhh-hhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccc
Confidence 3344444444444444443222 1113444445555555554 23333333344555555555433 3444455555555
Q ss_pred cccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchH
Q 047901 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED 331 (786)
Q Consensus 268 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 331 (786)
.|.+.+|++.. .+..++.+++++.|++++|.++.+.. +..+.+++.|++++|.+....+..
T Consensus 236 ~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 236 GLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 55555555542 24455555566666666666665544 555566666666666665544443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.5e-15 Score=154.68 Aligned_cols=195 Identities=33% Similarity=0.501 Sum_probs=100.5
Q ss_pred EccCcccccccCcccC-CCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccc
Q 047901 174 HLGRNNLTGNISEDFG-IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252 (786)
Q Consensus 174 ~L~~N~l~~~~~~~f~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i 252 (786)
.|.+-++...+.+++. .+..-...||+.|++. ..|..+..+..|+.+.|..|.|. .+|..+.++..|+.|||+.|++
T Consensus 56 ~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nql 133 (722)
T KOG0532|consen 56 LLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQL 133 (722)
T ss_pred ccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchh
Confidence 3444444443333332 2333344555555555 34444555555555555555555 4455555555555555555555
Q ss_pred cccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHH
Q 047901 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL 332 (786)
Q Consensus 253 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 332 (786)
. ..|..++.+ -|+.|-+++|+++ ..|..++.+..|..||.+. |.+. ..|..+
T Consensus 134 S-~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~------------------------nei~-slpsql 185 (722)
T KOG0532|consen 134 S-HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK------------------------NEIQ-SLPSQL 185 (722)
T ss_pred h-cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhh------------------------hhhh-hchHHh
Confidence 5 344444444 2455555555554 3333344444444555444 4443 344455
Q ss_pred hhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCC
Q 047901 333 ALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIP 401 (786)
Q Consensus 333 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 401 (786)
+++.+|+.|++..|++. .+|..+..| .|..||++.|+++ .+|.+|..|..|++|.|.+|+|++++.
T Consensus 186 ~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 186 GYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred hhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 55566666666666665 444555533 3556666666665 455566666666666666666655443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-14 Score=153.16 Aligned_cols=193 Identities=32% Similarity=0.396 Sum_probs=153.0
Q ss_pred EEcCCCCCccc-CCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCc
Q 047901 6 INLTSTGLKGT-LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84 (786)
Q Consensus 6 l~l~~~~l~~~-l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 84 (786)
|.|++..++.- .+... .++......||+.|++ ..+|..+..+..|+.|.|.+|.|. .+|..+..|..|+.|||+.|
T Consensus 55 l~Ls~rrlk~fpr~a~~-~~ltdt~~aDlsrNR~-~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAAS-YDLTDTVFADLSRNRF-SELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred cccccchhhcCCCcccc-ccccchhhhhcccccc-ccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 44555555421 11222 4566778899999999 477888888889999999999998 78889999999999999999
Q ss_pred cCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCc
Q 047901 85 QFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNL 164 (786)
Q Consensus 85 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l 164 (786)
+++.++..++.| -|+.|-+++|+++ ..|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++...++++
T Consensus 132 qlS~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El 208 (722)
T KOG0532|consen 132 QLSHLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEEL 208 (722)
T ss_pred hhhcCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHH
Confidence 999888888776 5899999999998 66777888899999999999998 77888888889999998888888877777
Q ss_pred CCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc
Q 047901 165 RNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206 (786)
Q Consensus 165 ~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~ 206 (786)
..+ .|.+|+++.|+++. +|-.|..|..|++|-|.+|.+++
T Consensus 209 ~~L-pLi~lDfScNkis~-iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 209 CSL-PLIRLDFSCNKISY-LPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hCC-ceeeeecccCceee-cchhhhhhhhheeeeeccCCCCC
Confidence 643 47777777777774 45567777777777777777763
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.8e-14 Score=155.95 Aligned_cols=157 Identities=28% Similarity=0.289 Sum_probs=73.8
Q ss_pred CCCCCEEeccCCccccccC-cCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccc
Q 047901 191 YPNLKFLDLSHNNFYGEIS-SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269 (786)
Q Consensus 191 l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 269 (786)
+++|+.+++++|++..+.+ . ...+.+++.+++.+|.+..+ ..+..+..+..+++..|.++.+.+-.......|+.+
T Consensus 161 l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l 237 (414)
T KOG0531|consen 161 LKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLREL 237 (414)
T ss_pred chhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccCcccchhHHHHHH
Confidence 4444444444444443333 1 23444555555555555422 223333444444555555543322111111125566
Q ss_pred cccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCC---cchH-HhhhcCcCeeeccC
Q 047901 270 ILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE---IPED-LALLAHLSELDLSH 345 (786)
Q Consensus 270 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~-~~~l~~L~~L~L~~ 345 (786)
++++|++... +..+..+..+..|++.+|++..+. .+.....+..+.+..|.+... .... ......++.+.+..
T Consensus 238 ~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (414)
T KOG0531|consen 238 YLSGNRISRS-PEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLEL 314 (414)
T ss_pred hcccCccccc-cccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhcccccccccccccccccc
Confidence 6666665522 234455556666666666655432 233334445555555555421 1111 34456777778888
Q ss_pred CccCCCCC
Q 047901 346 NLFKGSIP 353 (786)
Q Consensus 346 N~l~~~~~ 353 (786)
|.+....+
T Consensus 315 ~~~~~~~~ 322 (414)
T KOG0531|consen 315 NPIRKISS 322 (414)
T ss_pred Cccccccc
Confidence 77765443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.6e-13 Score=130.91 Aligned_cols=202 Identities=22% Similarity=0.322 Sum_probs=135.5
Q ss_pred HHHhhcCCCcccceeeEEecC-----CeeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 047901 558 KALTKIRHRNIVKFYGFCSHV-----RHSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFP 631 (786)
Q Consensus 558 ~~l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~ 631 (786)
.-+-++.|.|+|+++.|+.+. .....+.|||+.|++..++++.. ....+....-.+|+.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 344556799999999998543 34678899999999999998642 234566666778999999999999994 78
Q ss_pred CeEEcCCCCCceeeCCCCcEEEeccccceecCC-CC---CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHH
Q 047901 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP-NS---SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYS 707 (786)
Q Consensus 632 ~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~-~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvws 707 (786)
+|+|+++.-+-|++..++-+|+.--.-...... .. .......+-++|.||| +-.....+.++|||+
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~----------sg~~tn~~~a~dIy~ 267 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE----------SGTTTNTTGASDIYK 267 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCC----------cCcccccccchhhhh
Confidence 999999999999999999998753211111100 00 0011124567999994 334445567899999
Q ss_pred HHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 708 FGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 708 lGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
||.+..||..|..--.... .....++.....+.. .+... =..++..|+...|..||+|.+++.
T Consensus 268 fgmcAlemailEiq~tnse----S~~~~ee~ia~~i~~----len~l------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 268 FGMCALEMAILEIQSTNSE----SKVEVEENIANVIIG----LENGL------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred hhHHHHHHHHheeccCCCc----ceeehhhhhhhheee----ccCcc------ccCcCcccccCCCCCCcchhhhhc
Confidence 9999999998876511100 111111111111111 11111 136778999999999999998763
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-13 Score=150.94 Aligned_cols=199 Identities=31% Similarity=0.312 Sum_probs=92.2
Q ss_pred cCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcccc
Q 047901 164 LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLH 243 (786)
Q Consensus 164 l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 243 (786)
+..+.+|..|++.+|+|..+.. .+..+++|++|+|++|+|+.+.+ +..++.|+.|++++|.|+.+ ..+..++.|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhh
Confidence 4444555555555555554322 14445556666666666554422 34444455555555555533 3344455555
Q ss_pred EEEeecccccccCC-CCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEeccc
Q 047901 244 VLDLSSNHIAGEIP-MELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHN 322 (786)
Q Consensus 244 ~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 322 (786)
.+++++|.+..+.+ . ...+.+|+.+++.+|.+..+ ..+..+..+..+++..|+++.+..-....+.+|+.+++++|
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n 242 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGN 242 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccC
Confidence 55666655553332 1 34445555555555555422 22233333444455555554332111111112445555555
Q ss_pred ccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccccc
Q 047901 323 QFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373 (786)
Q Consensus 323 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (786)
.+.. .+..+..+..+..|++.+|++... ..+.....+..+.+..|.+.
T Consensus 243 ~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 243 RISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 5542 113344445555555555555432 22333344455555555543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.8e-12 Score=138.97 Aligned_cols=148 Identities=18% Similarity=0.195 Sum_probs=94.8
Q ss_pred hccCccceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCC-------------------------c-h----hhHH--
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPND-------------------------Q-M----SDQK-- 551 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------------------------~-~----~~~~-- 551 (786)
..+|+. +.+|+|++|.||+|++++ |+.||||+.++..... + . +..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999887 9999999997532100 0 0 1111
Q ss_pred ----HHHHHHHHHhhcC----CCcccceeeEEe-cCCeeeEEEeccCCCCHHHHh--hcCC-CCCCCCHHHHHHHHHHHH
Q 047901 552 ----EFLNEIKALTKIR----HRNIVKFYGFCS-HVRHSFVVYEYINRGSLATVL--SNNF-ASEDFDWRKRMNVITGVA 619 (786)
Q Consensus 552 ----~~~~e~~~l~~l~----hpniv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~~~~~~~~~i~~~ia 619 (786)
+|.+|+..+.+++ +...+.+-.++. .....++||||++|+.+.++- ...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2444544444442 333333333332 245568999999999997742 2211 00112222233333333
Q ss_pred HHHHHHhhCCCCCeEEcCCCCCceeeCCCC----cEEEeccccceecC
Q 047901 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEY----EARVSDFGTAKLLK 663 (786)
Q Consensus 620 ~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg~a~~~~ 663 (786)
... |++|+|++|.||+++.++ .+++.|||++..+.
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 445 999999999999999888 99999999998775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4e-12 Score=136.87 Aligned_cols=246 Identities=25% Similarity=0.248 Sum_probs=178.1
Q ss_pred cCccceeecc--ccCceEEEEEc---CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCe
Q 047901 507 DFDAKYCIGK--GEHRSVYRAKL---PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 507 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~ 580 (786)
.|...+.+|. |.+|.||.++. .++..+|+|+-+.+...... ...=.+|+.....+ .|++.++.+..++..+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~--~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD--SKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc--cccccchhhcccccCccccccccCcccccCCc
Confidence 4666778999 99999999986 36788999986554432111 11223566666666 49999998888999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEec
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD----ALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSD 655 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~----~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~D 655 (786)
.++=+|++. .+|.++.+... ..++....+....+..+ |+.++|+. +++|-|+||.||+...+ ..+++.|
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 999999885 68888876532 22455566666667777 99999999 99999999999999999 8999999
Q ss_pred cccceecCCCCCcce----e-eccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcc--ccc
Q 047901 656 FGTAKLLKPNSSNWT----E-LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL--SLF 728 (786)
Q Consensus 656 fg~a~~~~~~~~~~~----~-~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~--~~~ 728 (786)
||+...+.+...... . ..|...|++|| .. .+.++.++||||+|.+..+..+|..+.... ..|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke----------~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE----------LL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChh----------hh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 999988876542221 1 26888999994 33 456788999999999999999987775432 222
Q ss_pred cCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 729 SSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... +... .+...+..-..++...+..+++.+|..|+++++++.
T Consensus 336 ~~~------------r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQL------------RQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc------------cccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 211 1111 222222222334555888999999999999998764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.9e-12 Score=146.25 Aligned_cols=111 Identities=28% Similarity=0.440 Sum_probs=89.9
Q ss_pred CCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEecc
Q 047901 313 KLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDIS 392 (786)
Q Consensus 313 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 392 (786)
.+..|+|++|.+++..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36788899999988888888889999999999999988888888889999999999999988888888889999999999
Q ss_pred CCcccccCCCCCc--cccCCCccccCCCCCCCCCC
Q 047901 393 YNELRGPIPNSTV--FRNAPRESFLGNNFSTFYGT 425 (786)
Q Consensus 393 ~N~l~~~~p~~~~--~~~~~~~~~~~n~~~~~~~~ 425 (786)
+|++++.+|..-. ........+.+|+. .|+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~--lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAG--LCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcc--ccCC
Confidence 9999888886421 11223456677776 6664
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.9e-13 Score=129.90 Aligned_cols=131 Identities=29% Similarity=0.324 Sum_probs=69.4
Q ss_pred CCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccc
Q 047901 190 IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269 (786)
Q Consensus 190 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 269 (786)
.+..|++||||+|.|+. +.....-.|.++.|++|+|.|..+ ..+..+++|+.||||+|.++ ...++-.++-++++|
T Consensus 282 TWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 34456666666666653 233444455555566666655532 22555555555555555555 223333444455555
Q ss_pred cccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcc-hHHhhhcCcCeeeccCCcc
Q 047901 270 ILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIP-EDLALLAHLSELDLSHNLF 348 (786)
Q Consensus 270 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l 348 (786)
.|++|.|. .+ ..+..+.+|.+||+++|+|..... ..++.++.|+.|.|.+|.+
T Consensus 358 ~La~N~iE------------------------~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 358 KLAQNKIE------------------------TL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred ehhhhhHh------------------------hh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 55555554 21 123334445555555555543211 2466777888888888888
Q ss_pred CC
Q 047901 349 KG 350 (786)
Q Consensus 349 ~~ 350 (786)
.+
T Consensus 412 ~~ 413 (490)
T KOG1259|consen 412 AG 413 (490)
T ss_pred cc
Confidence 74
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=3e-12 Score=120.42 Aligned_cols=127 Identities=31% Similarity=0.318 Sum_probs=53.5
Q ss_pred cCCCCCCcEEECCCCCccccCchhcc-CCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCC-CCCCCC
Q 047901 22 FSSFPHLAYLDLSINGFFGTLPPQVR-NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPI-CNLSNL 99 (786)
Q Consensus 22 f~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~l~~L 99 (786)
+.+...+++|+|++|+|+.+. .+. .+.+|+.|+|++|+|+.+. .+..+++|++|++++|+|+.+.+.+ ..+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 455667899999999997654 354 5789999999999999653 5888999999999999998775544 358999
Q ss_pred cEEEccCCcCcccCc-hhhcccCCcceeccccccccccCCh----hhhccCccceeecc
Q 047901 100 KYISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQLPR----NICRSGLLEILTVN 153 (786)
Q Consensus 100 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~~~~L~~L~l~ 153 (786)
++|+|++|+|..... ..++.+++|++|+|.+|.++.. +. .+..+++|+.||-.
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 999999999986433 5678899999999999999843 33 47788899988754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.6e-12 Score=119.88 Aligned_cols=142 Identities=29% Similarity=0.257 Sum_probs=47.4
Q ss_pred ECCCCCccccCchhccCCCCCCEEeCcCCcccccCCcccc-CCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCc
Q 047901 32 DLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIG-LLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLS 110 (786)
Q Consensus 32 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~ 110 (786)
.|..+.|+.+ ..+.+..++++|+|++|+|+.+. .++ .+.+|+.|+|++|+|+.+ +.+..++.|++|+|++|+|+
T Consensus 3 ~lt~~~i~~~--~~~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 3 RLTANMIEQI--AQYNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp -------------------------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---
T ss_pred cccccccccc--ccccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC
Confidence 3455556432 23556667899999999998653 455 588999999999999865 45778899999999999998
Q ss_pred ccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccC---cc
Q 047901 111 GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS---ED 187 (786)
Q Consensus 111 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~---~~ 187 (786)
.+.+.....+++|++|+|++|+|..... ...+..+++|+.|+|.+|-++.... ..
T Consensus 78 ~i~~~l~~~lp~L~~L~L~~N~I~~l~~----------------------l~~L~~l~~L~~L~L~~NPv~~~~~YR~~v 135 (175)
T PF14580_consen 78 SISEGLDKNLPNLQELYLSNNKISDLNE----------------------LEPLSSLPKLRVLSLEGNPVCEKKNYRLFV 135 (175)
T ss_dssp S-CHHHHHH-TT--EEE-TTS---SCCC----------------------CGGGGG-TT--EEE-TT-GGGGSTTHHHHH
T ss_pred ccccchHHhCCcCCEEECcCCcCCChHH----------------------hHHHHcCCCcceeeccCCcccchhhHHHHH
Confidence 7654434578899999999998873211 1124455666666666666654321 23
Q ss_pred cCCCCCCCEEecc
Q 047901 188 FGIYPNLKFLDLS 200 (786)
Q Consensus 188 f~~l~~L~~L~L~ 200 (786)
+..+|+|+.||-.
T Consensus 136 i~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 136 IYKLPSLKVLDGQ 148 (175)
T ss_dssp HHH-TT-SEETTE
T ss_pred HHHcChhheeCCE
Confidence 4568888888844
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-12 Score=126.70 Aligned_cols=131 Identities=28% Similarity=0.270 Sum_probs=81.2
Q ss_pred CCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEe
Q 047901 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247 (786)
Q Consensus 168 ~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 247 (786)
..|++++|++|.|+.+ .++..-+|.++.|++|+|.|..+. .+..+++|+.||||+|.++ ....+-..+-+++.|.|
T Consensus 284 q~LtelDLS~N~I~~i-DESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLITQI-DESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchhhh-hhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 4455566666666542 445555666677777777666442 2566666777777777666 33444445667777777
Q ss_pred ecccccccCCCCcccccccccccccccccCCCC-ccccccCCcCceeccccccccccc
Q 047901 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHL-PRALGLLTELEYFDLSSNRLNNSI 304 (786)
Q Consensus 248 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~ 304 (786)
+.|.|... ..+.++-+|..|++++|+|.... -..++++|-|+.+.|-+|++..++
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 77776522 44666667777777777776332 235667777777777777776544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.6e-11 Score=116.34 Aligned_cols=131 Identities=21% Similarity=0.200 Sum_probs=95.5
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCccc-ceeeEEecCCeeeEEEeccC
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV-KFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~ 589 (786)
.+.++.|.++.||+++.. ++.|++|....... ....+.+|+.+++.+.+.+++ +++++.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 356899999999999875 77899998754211 122456888888888655544 4554433 34579999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC--FPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|.++.+. . . .....+.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~-~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE-D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc-c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9877543 0 0 11235678999999999982 12369999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.6e-12 Score=133.11 Aligned_cols=208 Identities=22% Similarity=0.182 Sum_probs=118.0
Q ss_pred CCCCCcEEECCCCCccccCc--hhccCCCCCCEEeCcCCcccccCC--ccccCCCCCCEEeCCCccCcccCCC--CCCCC
Q 047901 24 SFPHLAYLDLSINGFFGTLP--PQVRNLSKLKYLDLSENELSGKIP--PEIGLLTHLFSLDLSLNQFSGTFPP--ICNLS 97 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~l~ 97 (786)
++..|+++.|.+..+. ..+ .....+++++.||||+|-+....+ .-...|++|+.|+||.|++.....+ -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4556777777777664 333 356667777777777777663221 2235677777777777776533222 22466
Q ss_pred CCcEEEccCCcCcccC-chhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEcc
Q 047901 98 NLKYISLHNNKLSGSI-PEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLG 176 (786)
Q Consensus 98 ~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~ 176 (786)
+|+.|.|+.|.|+.-. .......++|+.|+|..|...........-+..|+.|+|++|++.....
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~-------------- 263 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQ-------------- 263 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccc--------------
Confidence 7777777777776322 2234566777777777774222333333334455555555555543221
Q ss_pred CcccccccCcccCCCCCCCEEeccCCccccccCcCc------cCCCCccEEEccCcccCCCC-CccccCCccccEEEeec
Q 047901 177 RNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNW------GKCHRLGTLIVSGNNITGRI-PPEIGNSSQLHVLDLSS 249 (786)
Q Consensus 177 ~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~------~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~ 249 (786)
....+.++.|..|+++.+.|.++..... ..+++|+.|+++.|+|.... -..+..+++|+.|.+..
T Consensus 264 --------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 264 --------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred --------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 1233445555555555555554432222 34567777777777775321 13455667778888888
Q ss_pred ccccc
Q 047901 250 NHIAG 254 (786)
Q Consensus 250 N~i~~ 254 (786)
|.+..
T Consensus 336 n~ln~ 340 (505)
T KOG3207|consen 336 NYLNK 340 (505)
T ss_pred ccccc
Confidence 88763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.4e-13 Score=132.02 Aligned_cols=36 Identities=28% Similarity=0.346 Sum_probs=20.6
Q ss_pred CCCCCcEEECCCCCccc----cCchhccCCCCCCEEeCcC
Q 047901 24 SFPHLAYLDLSINGFFG----TLPPQVRNLSKLKYLDLSE 59 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~ 59 (786)
.+..+++|+||+|-+.. .+...+...++|+..++|+
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd 67 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD 67 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh
Confidence 34556667777766632 2334455566666666655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=125.56 Aligned_cols=168 Identities=18% Similarity=0.256 Sum_probs=125.2
Q ss_pred EcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCC
Q 047901 526 KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED 605 (786)
Q Consensus 526 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 605 (786)
+..++.+|.|....... . .......+-++.++.++||||++++..++.++..|+|+|.+. -|..++.+.
T Consensus 33 ~k~~~~~vsVF~~~~~~---~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSN---G-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----- 101 (690)
T ss_pred eeccCCceEEEEEeCCC---c-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----
Confidence 34478889988886521 1 334566778889999999999999999999999999999875 577777653
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCC
Q 047901 606 FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685 (786)
Q Consensus 606 ~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 685 (786)
....+..-+.||+.||.|||+.+ +++|+++.-+.|+|+..|..||++|.++.....-........--..|..|+
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~--- 175 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE--- 175 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChh---
Confidence 24556667899999999999764 999999999999999999999999998865543221111112223456663
Q ss_pred CCchHHHHhhhcCcCcccchHHHHHHHHHHHhCC
Q 047901 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719 (786)
Q Consensus 686 ~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~ 719 (786)
| +. +-+-..|.|-||++++|++.|.
T Consensus 176 ------~-~~--~s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 176 ------E-ID--PSEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ------h-cC--ccccchhhhhHHHHHHHHhCcc
Confidence 1 11 1113469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.1e-10 Score=109.12 Aligned_cols=142 Identities=18% Similarity=0.256 Sum_probs=101.8
Q ss_pred eeeccccCceEEEEEcCC-------CCEEEEEEcCCCCCC----------C--------chhhHHHHH----HHHHHHhh
Q 047901 512 YCIGKGEHRSVYRAKLPS-------GDKIAVKKFNSPFPN----------D--------QMSDQKEFL----NEIKALTK 562 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~--------~~~~~~~~~----~e~~~l~~ 562 (786)
.+||.|--+.||.|...+ +..+|||+.+..... + .....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997543 478999987653210 0 011233444 78889998
Q ss_pred cC--CCcccceeeEEecCCeeeEEEeccCCCCHHH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEcCC
Q 047901 563 IR--HRNIVKFYGFCSHVRHSFVVYEYINRGSLAT-VLSNNFASEDFDWRKRMNVITGVADALSYM-HHDCFPPIVHRDI 638 (786)
Q Consensus 563 l~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrdl 638 (786)
+. .-++.+++++ ...++||||+.++.+.. .+.. ..++......+..+++.++..| |.. ++||+|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 84 3466666664 45679999997754422 2221 2344456677889999999999 787 9999999
Q ss_pred CCCceeeCCCCcEEEeccccceecCCC
Q 047901 639 SSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 639 k~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
++.||+++ ++.+.++|||-|....++
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 99999997 578999999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.2e-11 Score=136.96 Aligned_cols=111 Identities=32% Similarity=0.396 Sum_probs=102.3
Q ss_pred cCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccc
Q 047901 289 ELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLS 368 (786)
Q Consensus 289 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 368 (786)
.++.|+|++|.+.+..+..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccC-CCceEEeccCCccccc
Q 047901 369 HNNISGQIPACFIGM-SGLLSIDISYNELRGP 399 (786)
Q Consensus 369 ~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~ 399 (786)
+|++++.+|..+..+ .++..+++.+|+..+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccC
Confidence 999999999988764 4677899999986543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.5e-12 Score=130.58 Aligned_cols=209 Identities=24% Similarity=0.217 Sum_probs=99.9
Q ss_pred CCCCCcEEEccCCcCcccCc-hhhcccCCcceeccccccccccC--ChhhhccCccceeecccccccCCCCCc--CCCCC
Q 047901 95 NLSNLKYISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQL--PRNICRSGLLEILTVNDNHFLGSIPNL--RNCRS 169 (786)
Q Consensus 95 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~L~~L~l~~N~l~~~~~~l--~~l~~ 169 (786)
++.+|+.+.|.+..+....- .....+++++.|||++|-+.... -.-...+++|+.|+|+.|++.....+. ..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 45566666666666652221 24455666666666666555322 122344555555555555554322221 12344
Q ss_pred CcEEEccCccccccc-CcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEee
Q 047901 170 LVRAHLGRNNLTGNI-SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248 (786)
Q Consensus 170 L~~L~L~~N~l~~~~-~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 248 (786)
|+.|.|+.|.|+.-. .......|+|+.|+|+.|.... +.......+..|+.|||+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~------------------------~~~~~~~i~~~L~~LdLs 254 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIIL------------------------IKATSTKILQTLQELDLS 254 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccc------------------------eecchhhhhhHHhhcccc
Confidence 445555554444211 1112233444444444443222 222233334445555555
Q ss_pred cccccccC-CCCcccccccccccccccccCCCC-ccc-----cccCCcCceeccccccccccc-hhhhhcccCCcEEEec
Q 047901 249 SNHIAGEI-PMELGRLISLNKLILRGNQLSGHL-PRA-----LGLLTELEYFDLSSNRLNNSI-LEALGFMFKLFYLNFS 320 (786)
Q Consensus 249 ~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~-----~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~ 320 (786)
+|++-... ......++.|..|+++.+.+..+. |+. ...+++|++|+++.|+|.... .+.+..+++|+.|...
T Consensus 255 ~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 255 NNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred CCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence 55443211 123344555555555555554331 121 245567777777777775432 2344556667777777
Q ss_pred ccccCCC
Q 047901 321 HNQFSQE 327 (786)
Q Consensus 321 ~N~l~~~ 327 (786)
.|.++..
T Consensus 335 ~n~ln~e 341 (505)
T KOG3207|consen 335 LNYLNKE 341 (505)
T ss_pred ccccccc
Confidence 7777643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.6e-12 Score=127.19 Aligned_cols=200 Identities=21% Similarity=0.207 Sum_probs=106.6
Q ss_pred hhccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCc----ccC-------CCCCCCCCCcEEEccCCc
Q 047901 44 PQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFS----GTF-------PPICNLSNLKYISLHNNK 108 (786)
Q Consensus 44 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~----~~~-------~~~~~l~~L~~L~L~~N~ 108 (786)
+....+..++.|+||+|.+... +...+...++|+..++|+=--. .++ +.+...++|++|+||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 3456677888999999988632 2344567778888888764211 111 223456688888888888
Q ss_pred CcccCch----hhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccccccc
Q 047901 109 LSGSIPE----EIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNI 184 (786)
Q Consensus 109 l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~ 184 (786)
+..-.+. .++++++|++|+|.+|.+...--..++. .|..|. .|+. ..+-+.|+.+..++|++..-.
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk------~~~~~~Lrv~i~~rNrlen~g 173 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK------AASKPKLRVFICGRNRLENGG 173 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc------cCCCcceEEEEeecccccccc
Confidence 7643333 3456777888888888765211111111 122222 2221 123355666777777665322
Q ss_pred ----CcccCCCCCCCEEeccCCccccc----cCcCccCCCCccEEEccCcccCCC----CCccccCCccccEEEeecccc
Q 047901 185 ----SEDFGIYPNLKFLDLSHNNFYGE----ISSNWGKCHRLGTLIVSGNNITGR----IPPEIGNSSQLHVLDLSSNHI 252 (786)
Q Consensus 185 ----~~~f~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i 252 (786)
...|...+.|+.+.++.|.|... ...+|..+++|+.|||.+|-++.. +..+++.+++|+.|+++++.+
T Consensus 174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll 253 (382)
T KOG1909|consen 174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL 253 (382)
T ss_pred HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence 23455556666666666666421 112344455555555555544421 112333444444444444444
Q ss_pred c
Q 047901 253 A 253 (786)
Q Consensus 253 ~ 253 (786)
.
T Consensus 254 ~ 254 (382)
T KOG1909|consen 254 E 254 (382)
T ss_pred c
Confidence 3
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-09 Score=100.71 Aligned_cols=135 Identities=20% Similarity=0.320 Sum_probs=99.2
Q ss_pred eeccccCceEEEEEcCCCCEEEEEE-cCCCCCCCchh---hHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEecc
Q 047901 513 CIGKGEHRSVYRAKLPSGDKIAVKK-FNSPFPNDQMS---DQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 513 ~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
.+++|+-+.+|.+.+.+.. +++|. +.+.+.....+ ...+-.+|..++.+++--.|....=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999886444 44443 22223322222 2345678999999887666665555666777788999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+|..|.+++... ...++..+=.-+.-||.. +|+|+|+.++||.+..+. +.++|||++..-
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999898754 133556666667789999 999999999999998655 999999999743
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.4e-11 Score=138.36 Aligned_cols=127 Identities=28% Similarity=0.304 Sum_probs=64.0
Q ss_pred CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCc--ccccCCccccCCCCCCEEeCCCcc-CcccCCCCCCCCCCcEE
Q 047901 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENE--LSGKIPPEIGLLTHLFSLDLSLNQ-FSGTFPPICNLSNLKYI 102 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~l~~L~~L 102 (786)
...+.+.+-+|.+..+ +....+ ++|++|-+.+|. +..+..+.|..++.|+.||||+|. +..+|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~~-~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHI-AGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhhc-cCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 3445555555555322 222221 245555555554 443444445555555555555552 34444445555555555
Q ss_pred EccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccc
Q 047901 103 SLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN 155 (786)
Q Consensus 103 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N 155 (786)
+|++..++ ..|..+.+|.+|.+|+++.+.-...+|...+.+.+|++|.+..-
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 55555555 44555555555555555555443344555555555555555433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-10 Score=125.99 Aligned_cols=247 Identities=19% Similarity=0.198 Sum_probs=170.0
Q ss_pred HHhccCccceeeccccCceEEEEEc--CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCC
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKL--PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVR 579 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~ 579 (786)
....+|..+..||.|.|+.|+.... .++..+++|......... ..+ ..-..|+.+...+ .|.+++++...+...+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-ASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch-Hhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3456788999999999999998763 367788999876533211 111 1113455555555 5899999888777778
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEecccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGT 658 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~ 658 (786)
..|+--||+++++....+. ....++...++.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 8889999999999887763 234567777888999999999999998 99999999999999886 8899999999
Q ss_pred ceecCCCCCcceeeccCcccc-CCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYV-APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
++.+.-.. ....++-+++ .+| .......+-.+.|++|||.-+.|.++|..--....
T Consensus 414 ~t~~~~~~---~~~~~~~r~~p~~~---------~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------- 470 (524)
T KOG0601|consen 414 WTRLAFSS---GVFHHIDRLYPIAE---------ILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------- 470 (524)
T ss_pred ccccceec---ccccccccccccch---------hhccccccccccccccccccccccccCcccCcccc-----------
Confidence 97533211 1112222333 232 34444556789999999999999999876411111
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+..+............ ..+..+.+-+..+++..||.+.++..
T Consensus 471 ~~~~i~~~~~p~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 471 QSLTIRSGDTPNLPGLK----LQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred cceeeecccccCCCchH----HhhhhhhhhhcCCccccchhhhhhcc
Confidence 11112222222211111 23667778888999999999887643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-09 Score=109.79 Aligned_cols=143 Identities=20% Similarity=0.263 Sum_probs=108.7
Q ss_pred eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC--CcccceeeEEecC---CeeeEEEe
Q 047901 512 YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH--RNIVKFYGFCSHV---RHSFVVYE 586 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e 586 (786)
+.++.|..+.||+++..+|+.+++|........ .....+..|.++++.+.+ ..+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998876789999987642211 123467899999999965 4467778877654 36689999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC------------------------------------- 629 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------------------------------------- 629 (786)
|++|+++.+.+.. ..++......++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9999888765421 34666777778888888888888531
Q ss_pred ----------------CCCeEEcCCCCCceeeCC--CCcEEEecccccee
Q 047901 630 ----------------FPPIVHRDISSNNVLLDL--EYEARVSDFGTAKL 661 (786)
Q Consensus 630 ----------------~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~ 661 (786)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 67789999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-10 Score=90.57 Aligned_cols=61 Identities=41% Similarity=0.496 Sum_probs=47.6
Q ss_pred CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccC
Q 047901 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQF 86 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 86 (786)
|+|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.+++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5677788888888777777788888888888888888777777777777787777777765
|
... |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.6e-09 Score=96.31 Aligned_cols=147 Identities=18% Similarity=0.298 Sum_probs=105.6
Q ss_pred cceeeccccCceEEEEEcCCCCEEEEEE-cCCCCCCCc---hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 510 AKYCIGKGEHRSVYRAKLPSGDKIAVKK-FNSPFPNDQ---MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
....+-+|+-+.|+++.+. |+...||. +.+.+.... .-..++..+|+.++.+++--.|....=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999985 66655554 333332221 122456778999998886555555555555656667999
Q ss_pred eccCC-CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC---cEEEecccccee
Q 047901 586 EYINR-GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY---EARVSDFGTAKL 661 (786)
Q Consensus 586 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfg~a~~ 661 (786)
||++| .++.+|+......+..+ .....++..|=+.+.-||.. +|+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47888887653333222 23367888888899999999 999999999999997664 458999999864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.3e-10 Score=86.51 Aligned_cols=59 Identities=34% Similarity=0.394 Sum_probs=32.3
Q ss_pred CCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc
Q 047901 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 227 (786)
+|+.|++++|+|+.+.++.|.++++|++|++++|+|+.+.+++|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34555555555555555555555555555555555555555555555555555555554
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.8e-10 Score=128.80 Aligned_cols=250 Identities=21% Similarity=0.245 Sum_probs=168.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.+.+...+.+.+|.++.++.+.-. .|...+.|...... .-.....+....+-.+.-..++|-+++...-+......++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap-~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAP-KIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccch-hhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 345666667889999999987643 23223333322110 0011111222223333333355666665555556677899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|++|..+++|...++.. +..+..-++.....+..+.+|||.. .+.|||++|.|.+...++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999988754 3445555666788899999999998 79999999999999999999999998433211
Q ss_pred C------C---------------C----------CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHH
Q 047901 664 P------N---------------S----------SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLA 712 (786)
Q Consensus 664 ~------~---------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil 712 (786)
. . . .......||+.|.|| |...+......+|.|+.|+++
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP----------e~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP----------EILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC----------cccccccCCCcchhhhhhhhh
Confidence 0 0 0 001235789999999 566677788899999999999
Q ss_pred HHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 047901 713 LEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780 (786)
Q Consensus 713 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 780 (786)
+|.++|.+||.... ....++.+....+++|.. ..+...+..+++...+..+|.+|-.|.
T Consensus 1026 ~e~l~g~pp~na~t--------pq~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAET--------PQQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhcCCCCCCCcc--------hhhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999987432 223344455555554432 333445678888889999999997765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-09 Score=127.50 Aligned_cols=129 Identities=20% Similarity=0.153 Sum_probs=84.6
Q ss_pred CCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCc--CcccCchhhcccCCcceeccccccccccCChhhhccCccceee
Q 047901 74 THLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNK--LSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILT 151 (786)
Q Consensus 74 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~ 151 (786)
...+...+-+|++....... ..++|++|-+..|. +..+..+.|..++.|++|||++|.=-+.+|..++++-+|++|+
T Consensus 523 ~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred hheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 45556666666654433332 23467777777775 5556666677777777777777665556777777777777777
Q ss_pred cccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCc
Q 047901 152 VNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNN 203 (786)
Q Consensus 152 l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~ 203 (786)
+++..+...|..+.++..|..|++..+.-....++....+++|++|.+..-.
T Consensus 602 L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 602 LSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 7777777666677777777777777666444446666667777777776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.4e-08 Score=101.34 Aligned_cols=169 Identities=18% Similarity=0.276 Sum_probs=125.8
Q ss_pred CceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe----cCCeeeEEEeccCC-CC
Q 047901 519 HRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS----HVRHSFVVYEYINR-GS 592 (786)
Q Consensus 519 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~----~~~~~~lv~e~~~~-g~ 592 (786)
-.+.|++.. .||..|++|+++.. ..........-+++.+++.|+|||++.+++. .+...++||+|+++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~----r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGD----RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccc----cccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 457899974 48999999999431 1111112335678899999999999998875 34567899999876 57
Q ss_pred HHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 593 LATVLSNNF------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 593 L~~~l~~~~------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
|.++--... .....++...|.++.|++.||.++|+. |...+=+.+++|+++.+.+++|+.-|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 766442211 123467899999999999999999999 99999999999999999999999888776
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P 721 (786)
....+. .+|- |.. .+-|.-.||.++..|.||..-
T Consensus 442 vl~~d~------------~~~l---------e~~------Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDP------------TEPL---------ESQ------QQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCC------------Ccch---------hHH------hhhhHHHHHHHHHHHhhcccc
Confidence 665432 1220 111 246899999999999999543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.3e-08 Score=98.76 Aligned_cols=143 Identities=22% Similarity=0.205 Sum_probs=99.0
Q ss_pred eccccCceEEEEEcCCCCEEEEEEcCCCCCC---Cc----hhhHHHHHHHHHHHhhcCCCc--ccceeeEEec-----CC
Q 047901 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN---DQ----MSDQKEFLNEIKALTKIRHRN--IVKFYGFCSH-----VR 579 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~~~~e~~~l~~l~hpn--iv~l~~~~~~-----~~ 579 (786)
+-......|.+..+ +|+.|.||+....... .. ......+.+|...+.++..-+ +++.+++.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 34344444667766 5778999977432100 00 001114778888888774333 3444555543 23
Q ss_pred eeeEEEeccCCC-CHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-------CCcE
Q 047901 580 HSFVVYEYINRG-SLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-------EYEA 651 (786)
Q Consensus 580 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-------~~~~ 651 (786)
..++|||++++. +|.+++.... ..+.+...+..++.+++..+.-||.. ||+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 578999999886 8999885321 23455667778999999999999999 9999999999999975 4689
Q ss_pred EEecccccee
Q 047901 652 RVSDFGTAKL 661 (786)
Q Consensus 652 kl~Dfg~a~~ 661 (786)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2e-07 Score=95.89 Aligned_cols=260 Identities=14% Similarity=0.197 Sum_probs=159.0
Q ss_pred CccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE------ecCC-
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC------SHVR- 579 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~------~~~~- 579 (786)
...++.+|+|+.+.+|-.-.- ...+.|++..+..... .+.++.|... .||-+-.=+.|= .+..
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~-------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ-------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecchh--hchhheeecCCCchHH-------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 345677999999999965321 1235566665432111 1234444444 566544312221 1222
Q ss_pred eeeEEEeccCCC-CHHHHh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 580 HSFVVYEYINRG-SLATVL---SNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 580 ~~~lv~e~~~~g-~L~~~l---~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
...+.|..+++. -...+. .+++.-....|.-.++.++.+|.+.+-||+. |.+-+|+.++|+|+++++.+.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 256778777664 122222 1222345678999999999999999999999 999999999999999999999998
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC-CCCCCccccccCCCcc
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG-KHPGDFLSLFSSSSSS 734 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg-~~Pf~~~~~~~~~~~~ 734 (786)
-..-... .........+|...|.+||.-+.+ .+.+-.-++.+|-|.+||++++++.| +.||+....-......
T Consensus 161 sDsfqi~-~ng~~~~cpVg~~eftPPElQ~~~-----sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 161 SDSFQIN-ANGTLHLCPVGVSEFTPPELQTLP-----SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred ccceeec-cCCceEecccCccccCCHHHhccc-----cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 7654433 233444556899999999632211 12344567789999999999999985 9999876542221111
Q ss_pred hhhhh-----hhhccC---CCCCCCh-hHHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHh
Q 047901 735 INIEF-----NAMLDH---RLPHPSL-DVQEKLISIMEVALLCLDGC--PNSRPTMQTVCQL 785 (786)
Q Consensus 735 ~~~~~-----~~~~~~---~~~~~~~-~~~~~~~~l~~li~~cl~~~--p~~RPt~~ev~~~ 785 (786)
.+... .-..+. ..+.|.. ...-...++..+..+|+... +.-|||++..+..
T Consensus 235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 11011 000111 1111111 11222345777788888543 5689999887654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.5e-08 Score=94.67 Aligned_cols=131 Identities=23% Similarity=0.341 Sum_probs=83.3
Q ss_pred eEEEEEcCCCCEEEEEEcCCCCCC----------------------CchhhHHHHHHHHHHHhhcCCC--cccceeeEEe
Q 047901 521 SVYRAKLPSGDKIAVKKFNSPFPN----------------------DQMSDQKEFLNEIKALTKIRHR--NIVKFYGFCS 576 (786)
Q Consensus 521 ~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~e~~~l~~l~hp--niv~l~~~~~ 576 (786)
-||.|...+|..+|||..+..... ..........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888999999987653210 0011133567899999999755 566666553
Q ss_pred cCCeeeEEEeccC--CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 577 HVRHSFVVYEYIN--RGSLATVLSNNFASEDFDWRKRMNVITGVADALSY-MHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 577 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~-LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
.-++||||++ |..+....... ++......++.+++..+.. +|.. |++|+|+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3469999998 54444332211 1123345577777776665 4677 99999999999999977 9999
Q ss_pred eccccceecCC
Q 047901 654 SDFGTAKLLKP 664 (786)
Q Consensus 654 ~Dfg~a~~~~~ 664 (786)
+|||.|....+
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-09 Score=106.91 Aligned_cols=108 Identities=25% Similarity=0.277 Sum_probs=68.8
Q ss_pred CCcEEECCCCCccccCc-hhc-cCCCCCCEEeCcCCcccc--cCCccccCCCCCCEEeCCCccCcccCCCC-CCCCCCcE
Q 047901 27 HLAYLDLSINGFFGTLP-PQV-RNLSKLKYLDLSENELSG--KIPPEIGLLTHLFSLDLSLNQFSGTFPPI-CNLSNLKY 101 (786)
Q Consensus 27 ~L~~L~L~~n~i~~~~~-~~~-~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~l~~L~~ 101 (786)
.++.|-+.++.|..+-. ..| ...+.++.|||.+|+|+. .+...+.+++.|+.|+|+.|+++.....+ ..+.+|+.
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 44455555555532211 123 235678888888888873 22233467888888888888887665554 35678888
Q ss_pred EEccCCcCccc-CchhhcccCCcceecccccccc
Q 047901 102 ISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 102 L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 134 (786)
|-|.+..+... ....+..+++++.|.++.|.+.
T Consensus 126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r 159 (418)
T KOG2982|consen 126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR 159 (418)
T ss_pred EEEcCCCCChhhhhhhhhcchhhhhhhhccchhh
Confidence 88888877633 2334567777788888777543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-10 Score=124.44 Aligned_cols=188 Identities=27% Similarity=0.298 Sum_probs=105.3
Q ss_pred CCCCCCCCcEEEccCCcCcccCchhhcccC-CcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCC
Q 047901 92 PICNLSNLKYISLHNNKLSGSIPEEIGNLM-KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSL 170 (786)
Q Consensus 92 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L 170 (786)
.+...++|+.|.|.++.|.. ...+..+. .|++|... |.++ .+...|.... +.+.+-.--..|
T Consensus 104 ~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~-Al~~v~ascg-------------gd~~ns~~Wn~L 166 (1096)
T KOG1859|consen 104 SIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLD-ALRHVFASCG-------------GDISNSPVWNKL 166 (1096)
T ss_pred eeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHH-HHHHHHHHhc-------------cccccchhhhhH
Confidence 46677889999999888874 22233332 35555332 3333 1111111110 000000112345
Q ss_pred cEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecc
Q 047901 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSN 250 (786)
Q Consensus 171 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 250 (786)
...+.++|.+. ....++.-++.|+.|||++|+++.+. .+..+++|++|||++|.++.+.--...+. .|+.|.|++|
T Consensus 167 ~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrnN 242 (1096)
T KOG1859|consen 167 ATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRNN 242 (1096)
T ss_pred hhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeeeeccc
Confidence 55666666666 34556666777777777777776543 56677777777777777774322233333 3777777777
Q ss_pred cccccCCCCcccccccccccccccccCCCCc-cccccCCcCceeccccccccc
Q 047901 251 HIAGEIPMELGRLISLNKLILRGNQLSGHLP-RALGLLTELEYFDLSSNRLNN 302 (786)
Q Consensus 251 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 302 (786)
.++.. ..+.+|.+|+.||+++|-|.+.-. ..+..+..|+.|+|.||++--
T Consensus 243 ~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 243 ALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred HHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 77633 346667777777777777763311 123455667777777777653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4e-09 Score=114.56 Aligned_cols=39 Identities=15% Similarity=0.100 Sum_probs=23.0
Q ss_pred CCCCCEEeccCCcccccc-CcCccCCCCccEEEccCcccC
Q 047901 191 YPNLKFLDLSHNNFYGEI-SSNWGKCHRLGTLIVSGNNIT 229 (786)
Q Consensus 191 l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~ 229 (786)
+++++.|.+-.-.=.+-. |-.+..+.+|+.|.|.++.|.
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~ 122 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLS 122 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchh
Confidence 455555554433222111 334556778999999999886
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.9e-08 Score=98.53 Aligned_cols=85 Identities=20% Similarity=0.250 Sum_probs=38.1
Q ss_pred CCCCcEEEccCcccccc--cCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCC-CCCccccCCcccc
Q 047901 167 CRSLVRAHLGRNNLTGN--ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG-RIPPEIGNSSQLH 243 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~--~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 243 (786)
++.++.++|.+|+|+.- +...+..+|.|++|+|+.|++...+...-..+.+|++|.|.+..+.= .....+..+|.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 44555555666655532 12233455566666666665553322221233445555555444431 1112233444444
Q ss_pred EEEeeccc
Q 047901 244 VLDLSSNH 251 (786)
Q Consensus 244 ~L~Ls~N~ 251 (786)
.|.+|.|+
T Consensus 150 elHmS~N~ 157 (418)
T KOG2982|consen 150 ELHMSDNS 157 (418)
T ss_pred hhhhccch
Confidence 44444443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.8e-07 Score=87.92 Aligned_cols=140 Identities=24% Similarity=0.268 Sum_probs=97.3
Q ss_pred CccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCC--------------C--c--hhhHHHHHHHHHHHhhcCCC--c
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN--------------D--Q--MSDQKEFLNEIKALTKIRHR--N 567 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~--~--~~~~~~~~~e~~~l~~l~hp--n 567 (786)
..++.+||-|--+.||.|....|.++|||.=+..... . + ........+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566789999999999999999999999964322100 0 0 01133567899999999644 6
Q ss_pred ccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 568 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
|.+.+++ +...+||||++|--|...- ++......++..|+.-+...-.. ||||+|+.+=||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7777765 3456999999985554321 12223333444555555544455 9999999999999999
Q ss_pred CCcEEEeccccceec
Q 047901 648 EYEARVSDFGTAKLL 662 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~ 662 (786)
||.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999655443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.5e-06 Score=82.29 Aligned_cols=143 Identities=16% Similarity=0.161 Sum_probs=104.2
Q ss_pred eccccCceEEEEEcCCCCEEEEEEcCCCCCCC-c-hhhHHHHHHHHHHHhhcCC--CcccceeeEEe-c----CCeeeEE
Q 047901 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND-Q-MSDQKEFLNEIKALTKIRH--RNIVKFYGFCS-H----VRHSFVV 584 (786)
Q Consensus 514 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~-~----~~~~~lv 584 (786)
-|+||-+.|++.... |+.+-+|+-....... . .-....|.+|+..+..+.. -.+.++. ++. . .-..++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477888999998875 4478899865211111 1 2356789999999998842 2255555 332 1 1235799
Q ss_pred EeccCC-CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc--EEEecccccee
Q 047901 585 YEYINR-GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE--ARVSDFGTAKL 661 (786)
Q Consensus 585 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfg~a~~ 661 (786)
+|-+++ -+|.+++... ...+.+...+..+..++++++.-||.. |+.|+|+.+.||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5898888654 234567777889999999999999999 9999999999999986666 99999976654
Q ss_pred c
Q 047901 662 L 662 (786)
Q Consensus 662 ~ 662 (786)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4e-08 Score=107.73 Aligned_cols=149 Identities=21% Similarity=0.258 Sum_probs=100.9
Q ss_pred HHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc----ce-----eeccCccccCCCCCCC
Q 047901 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN----WT-----ELVGTFGYVAPAHGNI 686 (786)
Q Consensus 616 ~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----~~-----~~~gt~~y~aPE~~~~ 686 (786)
.+++.|+.|+|.. +++||++|.|++|.++..+..||+.|+.+.....+..+ ++ -......|.||
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap----- 178 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP----- 178 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc-----
Confidence 3455999999987 59999999999999999999999999998766543221 11 12345689999
Q ss_pred CchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHH
Q 047901 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVA 765 (786)
Q Consensus 687 ~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 765 (786)
|+......++++|+||+||++|.+.. |+.-++.......+ .......+....... .+.+.++.+=+
T Consensus 179 -----E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~~~~~~~~~~~~s---~~~p~el~~~l 245 (700)
T KOG2137|consen 179 -----EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFSRNLLNAGAFGYS---NNLPSELRESL 245 (700)
T ss_pred -----hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhhhccccccccccc---ccCcHHHHHHH
Confidence 66666778899999999999999995 55444432211100 000111111111111 22233577778
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 047901 766 LLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 766 ~~cl~~~p~~RPt~~ev~~ 784 (786)
.+++..++..||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 8899999999998887754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-06 Score=86.19 Aligned_cols=108 Identities=17% Similarity=0.267 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhhcCC--CcccceeeEEecC----CeeeEEEeccCCC-CHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 047901 550 QKEFLNEIKALTKIRH--RNIVKFYGFCSHV----RHSFVVYEYINRG-SLATVLSNNFASEDFDWRKRMNVITGVADAL 622 (786)
Q Consensus 550 ~~~~~~e~~~l~~l~h--pniv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l 622 (786)
.....+|...+..+.. =.+.+.+++.+.. ...++|+|++++. +|.+++.... ..+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 3467788887777743 2355666666542 2458999999884 8999987531 255667788999999999
Q ss_pred HHHhhCCCCCeEEcCCCCCceeeCCCC---cEEEeccccceecC
Q 047901 623 SYMHHDCFPPIVHRDISSNNVLLDLEY---EARVSDFGTAKLLK 663 (786)
Q Consensus 623 ~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~ 663 (786)
.-||+. ||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 999999999999999887 89999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.7e-08 Score=96.13 Aligned_cols=18 Identities=17% Similarity=0.263 Sum_probs=12.4
Q ss_pred ccCCcCceeccccccccc
Q 047901 285 GLLTELEYFDLSSNRLNN 302 (786)
Q Consensus 285 ~~l~~L~~L~L~~N~l~~ 302 (786)
..++-|..|.+.+|+++.
T Consensus 300 ~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 300 DAVPLLVDLERNGNRIKE 317 (388)
T ss_pred cccHHHHHHHHccCcchh
Confidence 356667777777777765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 786 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-36 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-36 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 8e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 8e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3vq1_A | 606 | Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE | 2e-04 | ||
| 2z64_A | 599 | Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp | 2e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606 | Back alignment and structure |
|
| >pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 786 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-129 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-116 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-114 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-113 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-97 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-71 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-15 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-74 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-70 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-54 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-34 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-07 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-75 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-75 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-71 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-71 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-67 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-71 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-64 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-45 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-33 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-70 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-69 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-64 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-60 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-40 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-34 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-65 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-60 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-57 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-35 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-30 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-14 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-63 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-62 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-57 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-57 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-41 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-38 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-34 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-63 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-57 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-57 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-53 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-52 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-49 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-31 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-29 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-56 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-18 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-50 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-50 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-08 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-51 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-51 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-48 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-47 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-43 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-42 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-35 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-36 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-27 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-27 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-11 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-08 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-45 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-07 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-35 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-27 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-43 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-39 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-35 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-33 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-11 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-19 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-41 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-40 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-40 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-20 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-40 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-19 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-36 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-34 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-35 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-17 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-12 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-31 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-34 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 7e-33 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-28 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-25 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-09 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-16 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-28 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-28 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-28 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-28 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-27 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-27 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-27 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-27 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-25 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-04 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-27 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-26 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-26 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-26 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-26 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-26 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-26 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-26 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-26 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-26 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-26 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-26 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 8e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-21 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-25 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-25 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-25 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-25 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-25 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-25 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-25 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-25 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-25 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-18 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 7e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-25 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-22 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-24 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-24 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 7e-19 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-23 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-23 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-23 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-23 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-23 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-23 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-23 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-23 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-23 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-23 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-22 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-22 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-22 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-22 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-22 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-22 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-22 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-22 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-22 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-21 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-06 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-21 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-21 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-21 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-09 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-21 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-21 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-21 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-12 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-21 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-21 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-21 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-21 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-21 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-21 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-21 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 9e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-20 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-20 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-20 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-20 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-20 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-20 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-20 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-20 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-20 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-20 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-20 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 7e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-19 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-19 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-19 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-19 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-19 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-19 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-19 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-19 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-19 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 8e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-06 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-04 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-18 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-18 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-18 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-18 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-18 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-18 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-18 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-18 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-18 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-10 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-17 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 9e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-16 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-13 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-16 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-04 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-14 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-14 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-06 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-13 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-13 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-13 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-13 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-12 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-12 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-12 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-12 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-12 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-12 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-12 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 9e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-05 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-11 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-06 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-11 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-11 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-11 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-05 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-10 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-10 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-04 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-04 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-05 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-09 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-09 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-09 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-04 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-09 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-09 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-09 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-09 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-08 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-08 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-08 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-08 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 8e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 1e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-07 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 9e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-04 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-06 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-05 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 8e-05 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 2e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-04 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-04 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-04 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-04 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-129
Identities = 140/420 (33%), Positives = 196/420 (46%), Gaps = 11/420 (2%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLS-KLKYLDLSENELS 63
S+ L+S G L + L LDLS N F G LP + NLS L LDLS N S
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 64 GKIPPEIG--LLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNL 120
G I P + L L L N F+G PP + N S L + L N LSG+IP +G+L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 121 MKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNN 179
KL L L N G++P+ + LE L ++ N G IP+ L NC +L L N
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 180 LTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS 239
LTG I + G NL L LS+N+F G I + G C L L ++ N G IP +
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGN--QLSGHLPRALGLLTELEYFDLSS 297
S +++N IAG+ + + + GN + G L L+ +++S
Sbjct: 562 S----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 298 NRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC 357
+ +L+ S+N S IP+++ + +L L+L HN GSIP +
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677
Query: 358 NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGN 417
+L L L+LS N + G+IP ++ L ID+S N L GPIP F P FL N
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-116
Identities = 142/427 (33%), Positives = 208/427 (48%), Gaps = 15/427 (3%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
+ ++ + G + S +L +LD+S N F +P + + S L++LD+S N+LSG
Sbjct: 182 HLAISGNKISGDV---DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237
Query: 65 KIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKL 123
I T L L++S NQF G PP L +L+Y+SL NK +G IP+ + G L
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 124 SYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLT 181
+ L L N F G +P LLE L ++ N+F G +P L R L L N +
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 182 GNISEDFG-IYPNLKFLDLSHNNFYGEISSNWGKCHR--LGTLIVSGNNITGRIPPEIGN 238
G + E + +L LDLS NNF G I N + + L L + N TG+IPP + N
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 239 SSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSN 298
S+L L LS N+++G IP LG L L L L N L G +P+ L + LE L N
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 299 RLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICN 358
L I L L +++ S+N+ + EIP+ + L +L+ L LS+N F G+IP+ + +
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 359 LESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN 418
SL L+L+ N +G IPA S I+ N + G +E N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 419 FSTFYGT 425
F G
Sbjct: 593 LLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-114
Identities = 129/417 (30%), Positives = 184/417 (44%), Gaps = 19/417 (4%)
Query: 1 GRVNSINLTSTGLKGTLQEF--SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLS 58
+V SI+L+S L S S L L LS + G++ + + L LDLS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 59 ENELSGKIPP--EIGLLTHLFSLDLSLNQFSGT--FPPICNLSNLKYISLHNNKLSGSIP 114
N LSG + +G + L L++S N L++L+ + L N +SG+
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 115 EEI---GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLV 171
+L +L + N+ +G + + R LE L V+ N+F IP L +C +L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQ 226
Query: 172 RAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR 231
+ N L+G+ S LK L++S N F G I L L ++ N TG
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 232 IPPEI-GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTE 289
IP + G L LDLS NH G +P G L L L N SG LP L +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 290 LEYFDLSSNRLNNSILEALGFM-FKLFYLNFSHNQFSQEIPEDL--ALLAHLSELDLSHN 346
L+ DLS N + + E+L + L L+ S N FS I +L L EL L +N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 347 LFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
F G IP + N L L+LS N +SG IP+ +S L + + N L G IP
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-113
Identities = 129/408 (31%), Positives = 196/408 (48%), Gaps = 13/408 (3%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVR---NLSKLKYLDLSENE 61
+N++S L + L LDLS N G +LK+L +S N+
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189
Query: 62 LSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
+SG + + +L LD+S N FS P + + S L+++ + NKLSG I
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 122 KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNN 179
+L L + +NQF G +P +S L+ L++ +N F G IP+ C +L L N+
Sbjct: 248 ELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 180 LTGNISEDFGIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEIGN 238
G + FG L+ L LS NNF GE+ + K L L +S N +G +P + N
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 239 -SSQLHVLDLSSNHIAGEIPMELGR--LISLNKLILRGNQLSGHLPRALGLLTELEYFDL 295
S+ L LDLSSN+ +G I L + +L +L L+ N +G +P L +EL L
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL 425
Query: 296 SSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSR 355
S N L+ +I +LG + KL L N EIP++L + L L L N G IPS
Sbjct: 426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485
Query: 356 ICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
+ N +L ++LS+N ++G+IP + L + +S N G IP
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = 8e-97
Identities = 125/425 (29%), Positives = 189/425 (44%), Gaps = 50/425 (11%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
++++ L G + S+ L L++S N F G +PP L L+YL L+EN+ +G
Sbjct: 227 HLDISGNKLSGDFSR-AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283
Query: 65 KIPPEI-GLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEE-IGNLM 121
+IP + G L LDLS N F G PP + S L+ ++L +N SG +P + + +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 122 KLSYLMLDTNQFTGQLPRNICR-SGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180
L L L N+F+G+LP ++ S L L ++ N+F G I +L +N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL----------PNLCQNPK 393
Query: 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240
L+ L L +N F G+I C L +L +S N ++G IP +G+ S
Sbjct: 394 N-----------TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300
+L L L N + GEIP EL + +L LIL N L+G +P L T L + LS+NRL
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 301 NNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLE 360
I + +G + L L S+N FS IP +L L LDL+ NLF G+IP+ +
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
Query: 361 SLEKLNLSHNNI----------------------SGQIPACFIGMSGLLSIDISYNELRG 398
N G +S +I+ G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 399 PIPNS 403
+
Sbjct: 623 HTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 2e-87
Identities = 116/391 (29%), Positives = 167/391 (42%), Gaps = 25/391 (6%)
Query: 48 NLSKLKYLDLSENELS---GKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISL 104
K+ +DLS L+ + + LT L SL LS + +G+ ++L + L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107
Query: 105 HNNKLSGSIPE--EIGNLMKLSYLMLDTNQFTGQLPR-NICRSGLLEILTVNDNHFLGSI 161
N LSG + +G+ L +L + +N + LE+L ++ N G+
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 162 P----NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHR 217
C L + N ++G++ NL+FLD+S NNF I G C
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSA 224
Query: 218 LGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
L L +SGN ++G I ++L +L++SSN G IP L SL L L N+ +
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFT 282
Query: 278 GHLPRAL-GLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-LALL 335
G +P L G L DLS N ++ G L L S N FS E+P D L +
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 336 AHLSELDLSHNLFKGSIPSRICNL-ESLEKLNLSHNNISGQIPA--CFIGMSGLLSIDIS 392
L LDLS N F G +P + NL SL L+LS NN SG I C + L + +
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 393 YNELRGPIPNSTVFRNAPRESFL---GNNFS 420
N G IP + N L N S
Sbjct: 403 NNGFTGKIPPT--LSNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-71
Identities = 100/322 (31%), Positives = 153/322 (47%), Gaps = 18/322 (5%)
Query: 94 CNLSNLKYISLHNNKLS---GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEIL 150
C + I L + L+ ++ + +L L L L + G + S L L
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSL 105
Query: 151 TVNDNHFLGSIP---NLRNCRSLVRAHLGRNNLTGNISEDFGI-YPNLKFLDLSHNNFYG 206
++ N G + +L +C L ++ N L G+ +L+ LDLS N+ G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 207 EISSNW---GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL 263
W C L L +SGN I+G + + L LD+SSN+ + IP LG
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDC 222
Query: 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ 323
+L L + GN+LSG RA+ TEL+ ++SSN+ I + L YL+ + N+
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENK 280
Query: 324 FSQEIPEDLA-LLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIG 382
F+ EIP+ L+ L+ LDLS N F G++P + LE L LS NN SG++P +
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 383 -MSGLLSIDISYNELRGPIPNS 403
M GL +D+S+NE G +P S
Sbjct: 341 KMRGLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-15
Identities = 32/88 (36%), Positives = 43/88 (48%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
S P+L L+L N G++P +V +L L LDLS N+L G+IP + LT L +D
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNK 108
LS N SG P + NN
Sbjct: 711 LSNNNLSGPIPEMGQFETFPPAKFLNNP 738
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-81
Identities = 94/300 (31%), Positives = 150/300 (50%), Gaps = 26/300 (8%)
Query: 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
E+ + +F K +G+G VY+ +L G +AVK+ Q + +F E+
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGE-LQFQTEV 78
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED-FDWRKRMNVIT 616
+ ++ HRN+++ GFC +VY Y+ GS+A+ L S+ DW KR +
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-WTELVGT 675
G A L+Y+H C P I+HRD+ + N+LLD E+EA V DFG AKL+ ++ T + GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
G++AP E T K +EK DV+ +GV+ LE+I G+ D L + +
Sbjct: 199 IGHIAP----------EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 736 ---------NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ A++D L + +E + +++VALLC P RP M V ++L
Sbjct: 249 LDWVKGLLKEKKLEALVDVDL-QGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-75
Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 7/270 (2%)
Query: 154 DNHFLGSIPN-LRNCRSLVRAHLGRNNLTG--NISEDFGIYPNLKFLDLSH-NNFYGEIS 209
+ +LG + + + L NL I P L FL + NN G I
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 210 SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269
K +L L ++ N++G IP + L LD S N ++G +P + L +L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 270 ILRGNQLSGHLPRALGLLTEL-EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI 328
GN++SG +P + G ++L +S NRL I + L +++ S N +
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 329 PEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLS 388
+ ++ L+ N + + ++L L+L +N I G +P + L S
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 389 IDISYNELRGPIPNSTVFRNAPRESFLGNN 418
+++S+N L G IP + ++ N
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 8e-74
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 9/275 (3%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG--KIPPEIGLLTHLFSLDLS-LNQFS 87
D + G L ++ LDLS L IP + L +L L + +N
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 88 GTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
G PP I L+ L Y+ + + +SG+IP+ + + L L N +G LP +I
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 147 LEILTVNDNHFLGSIPN-LRNCRSLVRA-HLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
L +T + N G+IP+ + L + + RN LTG I F NL F+DLS N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRNML 209
Query: 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
G+ S +G + ++ N++ + ++G S L+ LDL +N I G +P L +L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR 299
L+ L + N L G +P G L + ++N+
Sbjct: 269 FLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-70
Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 32/287 (11%)
Query: 1 GRVNSINLTSTGLKGTLQ-EFSFSSFPHLAYLDLS-INGFFGTLPPQVRNLSKLKYLDLS 58
RVN+++L+ L S ++ P+L +L + IN G +PP + L++L YL ++
Sbjct: 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109
Query: 59 ENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEI 117
+SG IP + + L +LD S N SGT PP I +L NL I+ N++SG+IP+
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 118 GNLMKLS-YLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLG 176
G+ KL + + N+ TG++P + NL +L L
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPP--------------------TFANL----NLAFVDLS 205
Query: 177 RNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI 236
RN L G+ S FG N + + L+ N+ ++ G L L + N I G +P +
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 237 GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQL--SGHLP 281
LH L++S N++ GEIP + G L + N+ LP
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 5/209 (2%)
Query: 197 LDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR--IPPEIGNSSQLHVLDLSS-NHIA 253
D + + G + + +R+ L +SG N+ IP + N L+ L + N++
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 254 GEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK 313
G IP + +L L+ L + +SG +P L + L D S N L+ ++ ++ +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 314 LFYLNFSHNQFSQEIPEDLALLAHLSE-LDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372
L + F N+ S IP+ + L + +S N G IP NL +L ++LS N +
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209
Query: 373 SGQIPACFIGMSGLLSIDISYNELRGPIP 401
G F I ++ N L +
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 21 SFSSFPHLA-YLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
S+ SF L + +S N G +PP NL+ L ++DLS N L G G + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
L+ N + + NL + L NN++ G++P+ + L L L + N G++P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 140 N-ICRSGLLEILTVNDNHFLGSIPNLRNC 167
+ ++ +N L P L C
Sbjct: 287 GGNLQR--FDVSAYANNKCLCGSP-LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 19/84 (22%), Positives = 33/84 (39%), Gaps = 3/84 (3%)
Query: 323 QFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ--IPACF 380
Q +++ L + L D + + G + + L+LS N+ IP+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 381 IGMSGLLSIDIS-YNELRGPIPNS 403
+ L + I N L GPIP +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPA 96
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 5e-75
Identities = 65/457 (14%), Positives = 143/457 (31%), Gaps = 44/457 (9%)
Query: 1 GRVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFG----TLPPQVRNLSKLKYLD 56
GRV ++L G G + + + L L L +G P + +
Sbjct: 81 GRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 57 LSENELSGKIPPEIGLL--THLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSI 113
+ L ++ + + I +N ++ +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 114 PEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVR 172
+ + L KL + + F + + E + N + L
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTD 253
Query: 173 AHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF--------YGEISSNWGKCHRLGTLIVS 224
+ + P ++ ++++ N + ++ ++ + +
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 225 GNNI-TGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
NN+ T + + +L +L+ N + G++P G I L L L NQ++
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANF 372
Query: 284 LGLLTELEYFDLSSNRLNN-SILEALGFMFKLFYLNFSHNQFS-------QEIPEDLALL 335
G ++E + N+L + + + ++FS+N+ +
Sbjct: 373 CGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 336 AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG-------QIPACFIGMSGLLS 388
++S ++LS+N L +NL N ++ F L S
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 389 IDISYNELRGPIPNSTVFRNAPRESFL---GNNFSTF 422
ID+ +N+L + + P + N+FS F
Sbjct: 493 IDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKF 528
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 8e-75
Identities = 60/415 (14%), Positives = 122/415 (29%), Gaps = 41/415 (9%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+ L + + F + +Y + + L L ++
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVE 255
Query: 81 LSLNQFSGTFPP-ICNLSNLKYISLHNNKL--------SGSIPEEIGNLMKLSYLMLDTN 131
+ P + L ++ I++ N+ + K+ + + N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 132 QF-TGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGI 190
T + ++ + L +L N G +P + L +L N +T + G
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 191 YPNLKFLDLSHNNFYG-EISSNWGKCHRLGTLIVSGNNITG-------RIPPEIGNSSQL 242
++ L +HN + + + S N I + P +
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 243 HVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG-------HLPRALGLLTELEYFDL 295
++LS+N I+ L+ + L GN L+ L DL
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 296 SSNRLNNSILE-ALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNL------F 348
N+L + + L ++ S+N FS + P + L + +
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 349 KGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
P I SL +L + N+I + + +DI N +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 1e-71
Identities = 67/431 (15%), Positives = 129/431 (29%), Gaps = 40/431 (9%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLA---YLDLSINGFFGTLPPQV--RNLSKLKYLDLSE 59
+ L S G K + F + T + S L ++
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168
Query: 60 NELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGN 119
+ I + + N + + L+ L+ + N+ E
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
Query: 120 LMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRN 178
Y Q L + V + L +P L+ + ++ N
Sbjct: 229 NENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 179 NLT--------GNISEDFGIYPNLKFLDLSHNNF-YGEISSNWGKCHRLGTLIVSGNNIT 229
D + ++ + + +NN + ++ K +LG L N +
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 230 GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL--L 287
G P G+ +L L+L+ N I G + L N+L +P +
Sbjct: 344 G-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSV 401
Query: 288 TELEYFDLSSNRLN-------NSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSE 340
+ + D S N + + + + +N S+NQ S+ E + + LS
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 341 LDLSHNLFKG-------SIPSRICNLESLEKLNLSHNNISGQIPACFIG-MSGLLSIDIS 392
++L N+ N L ++L N ++ + L+ ID+S
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLS 521
Query: 393 YNELRGPIPNS 403
YN P
Sbjct: 522 YNSFSK-FPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 5e-71
Identities = 66/423 (15%), Positives = 142/423 (33%), Gaps = 55/423 (13%)
Query: 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL- 62
+ N T + + L +++ LP ++ L +++ ++++ N
Sbjct: 228 ENENSEYAQQYKTEDL-KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 63 -------SGKIPPEIGLLTHLFSLDLSLNQF-SGTFPP-ICNLSNLKYISLHNNKLSGSI 113
+ + + + + + N + + + L + N+L G +
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 114 PEEIGNLMKLSYLMLDTNQFTGQLPRNIC-RSGLLEILTVNDNHFLGSIPN---LRNCRS 169
P G+ +KL+ L L NQ T +P N C + +E L+ N L IPN ++
Sbjct: 347 PA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNK-LKYIPNIFDAKSVSV 403
Query: 170 LVRAHLGRNNLTGNISEDFGIYP-------NLKFLDLSHNNFYGEISSNWGKCHRLGTLI 222
+ N + ++F N+ ++LS+N + L ++
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 223 VSGNNITG-------RIPPEIGNSSQLHVLDLSSNHIAGEIP-MELGRLISLNKLILRGN 274
+ GN +T N+ L +DL N + L L + L N
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYN 523
Query: 275 QLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLAL 334
S P + L+ F + + + N+ +E PE + L
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITL 564
Query: 335 LAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
L++L + N + + +I ++ L++ N + + Y+
Sbjct: 565 CPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
Query: 395 ELR 397
+ +
Sbjct: 622 KTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-67
Identities = 55/420 (13%), Positives = 133/420 (31%), Gaps = 36/420 (8%)
Query: 12 GLKGTLQEFSFSSFPHLA--YLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPE 69
L G A + ++ + + + ++ L L SG++P
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA 100
Query: 70 IGLLTHLFSLDLSLNQFSGTFPP-----ICNLSNLKYISLHNNKLSGSIPEEIG--NLMK 122
IG LT L L L + I + + + + +
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160
Query: 123 LSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLT 181
L ++++ + ++ + + N+ + + + L + ++G +
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN-ITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ 241
I + + + Y W L + V ++P + +
Sbjct: 220 AEN-----ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274
Query: 242 LHVLDLSSNHI--------AGEIPMELGRLISLNKLILRGNQL-SGHLPRALGLLTELEY 292
+ +++++ N + + + + + N L + + +L + +L
Sbjct: 275 MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGM 334
Query: 293 FDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSI 352
+ N+L L A G KL LN ++NQ ++ + L +HN K I
Sbjct: 335 LECLYNQL-EGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YI 392
Query: 353 PSR--ICNLESLEKLNLSHNNISG-------QIPACFIGMSGLLSIDISYNELRGPIPNS 403
P+ ++ + ++ S+N I + + SI++S N++
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-66
Identities = 55/387 (14%), Positives = 117/387 (30%), Gaps = 53/387 (13%)
Query: 21 SFSSFPHLAYLDLSINGF--------FGTLPPQVRNLSKLKYLDLSENEL-SGKIPPEIG 71
+ P + ++++ N K++ + + N L + + +
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 72 LLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN 131
+ L L+ NQ G P + L ++L N+++ G ++ L N
Sbjct: 328 KMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 132 QFTGQLPRNICRSGL--LEILTVNDNHFLGSIPN--------LRNCRSLVRAHLGRNNLT 181
+ +P + + + + N ++ +L N ++
Sbjct: 388 KLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
Query: 182 GNISEDFGIYPNLKFLDLSHNNF-------YGEISSNWGKCHRLGTLIVSGNNITGRIPP 234
E F L ++L N + + N+ + L ++ + N +T +
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505
Query: 235 EI--GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEY 292
+ L +DLS N + P + +L +R +
Sbjct: 506 DFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQR----------------- 547
Query: 293 FDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSI 352
D NR E + L L N ++ E + ++S LD+ N
Sbjct: 548 -DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE--KITPNISVLDIKDNPNISID 603
Query: 353 PSRICNLESLEKLNLSHNNISGQIPAC 379
S +C L ++ I C
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ-DIRGC 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-71
Identities = 89/424 (20%), Positives = 149/424 (35%), Gaps = 24/424 (5%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
+ +NLT L+ L +F+ + L LD+ N P + L LK L+L NEL
Sbjct: 27 ITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
S T+L L L N P NL + L +N LS + L
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 122 KLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRN 178
L L+L N+ + L+ L ++ N P L L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 179 NLTGNISEDFGIY---PNLKFLDLSHNNFYGEISSNWGKCH--RLGTLIVSGNNITGRIP 233
L +++E + +++ L LS++ ++ + L L +S NN+
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 234 PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHL---------PRAL 284
QL L N+I L L ++ L L+ + + +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 285 GLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLAL----LAHLSE 340
L LE+ ++ N + + L YL+ S++ S + + L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 341 LDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDISYNELRGP 399
L+L+ N L LE L+L N I ++ + G+ + I +SYN+
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 400 IPNS 403
NS
Sbjct: 446 TRNS 449
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 3e-69
Identities = 74/410 (18%), Positives = 129/410 (31%), Gaps = 22/410 (5%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
L + ++ L+L+ N S+L LD+ N +S P L L
Sbjct: 16 LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 77 FSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
L+L N+ S +NL + L +N + L L L N +
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPN---LRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
+ L+ L +++N + SL + L N + F
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 193 NLKFLDLSHNNFYGEISSNWG---KCHRLGTLIVSGNNITGRIPPEIGN--SSQLHVLDL 247
L L L++ ++ + L +S + ++ + L +LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSN--------- 298
S N++ L L L N + +L L + Y +L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 299 RLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI-- 356
L + ++ L +LN N L +L L LS++ +
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 357 --CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNST 404
L LNL+ N IS F + L +D+ NE+ +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 4e-69
Identities = 94/443 (21%), Positives = 147/443 (33%), Gaps = 31/443 (6%)
Query: 2 RVNSINLTSTGLKGTLQE--FSFSSFPHLAYLDLSINGFFGTLPPQVRNL--SKLKYLDL 57
R+ + L + L +L E + + L LS + T L + L LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 58 SENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNN--------- 107
S N L+ L L L N F + L N++Y++L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167
L L L +L ++ N G L+ L+++++
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 168 RSLVRA-----HLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTL 221
SL + +L +N ++ S+ F +L+ LDL N E++ W + +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 222 IVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG--EIPMELGRLISLNKLILRGNQLSGH 279
+S N L L L + P L +L L L N ++
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 280 LPRALGLLTELEYFDLSSNRLN--------NSILEALGFMFKLFYLNFSHNQFSQEIPED 331
L L +LE DL N L + L + L LN N F + E
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 332 LALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACF-IGMSGLLSID 390
L L +DL N S N SL+ LNL N I+ F L +D
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615
Query: 391 ISYNELRGPIPNSTVFRNAPRES 413
+ +N + F N E+
Sbjct: 616 MRFNPFDCTCESIAWFVNWINET 638
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-64
Identities = 86/389 (22%), Positives = 137/389 (35%), Gaps = 25/389 (6%)
Query: 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLS 110
+ D S +L+ ++P L T++ L+L+ NQ S L + + N +S
Sbjct: 6 HEVADCSHLKLT-QVPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 111 GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRS 169
PE L L L L N+ + + L L + N N ++
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 170 LVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS--NWGKCHRLGTLIVSGNN 227
L+ L N L+ NL+ L LS+N S + L L +S N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELG---RLISLNKLILRGNQLSGHLPRAL 284
I P +L L L++ + + +L S+ L L +QLS
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 285 GLL--TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELD 342
L T L DLS N LN ++ ++ +L Y +N L L ++ L+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 343 LSHNLFKGSI---------PSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISY 393
L + K SI L+ LE LN+ N+I G F G+ L + +S
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 394 NELRGPIPNSTVFRNAPRES----FLGNN 418
+ + F + L N
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKN 391
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-56
Identities = 86/408 (21%), Positives = 132/408 (32%), Gaps = 32/408 (7%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSEN---------ELSGKI 66
+ SF+ P L Y L N + L ++YL+L + L
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 67 PPEIGLLTHLFSLDLSLNQFSGTFPPI-CNLSNLKYISLHNNKLSGSIPEEIG----NLM 121
L L L++ N G + L NLKY+SL N+ S
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
Query: 122 KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNN 179
L L L N+ + G LE+L + N + R ++ +L N
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 180 LTGNISEDFGIYPNLKFLDLSHNNFYG--EISSNWGKCHRLGTLIVSGNNITGRIPPEIG 237
F + P+L+ L L S + L L +S NNI +
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
Query: 238 NSSQLHVLDLSSNHI--------AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTE 289
+L +LDL N++ G L L L+ L L N L E
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 290 LEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLA-LLAHLSELDLSHNLF 348
L+ DL N LN L LN N + + +L+ELD+ N F
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
Query: 349 KGSIPSRICNLESLEKLNLSHNNISGQI----PACFIGMSGLLSIDIS 392
+ S + + + + + +S P + G + D S
Sbjct: 622 DCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP-VRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-45
Identities = 66/289 (22%), Positives = 105/289 (36%), Gaps = 18/289 (6%)
Query: 147 LEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
E+ + L +P+ N L +L N L + +F Y L LD+ N
Sbjct: 6 HEVADCSHLK-LTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 205 YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
K L L + N ++ + L L L SN I +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMF--KLFYLNFSHN 322
+L L L N LS L L+ LS+N++ E L L L S N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 323 QFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC---NLESLEKLNLSHNNISGQIPAC 379
Q + P + L L L++ S+ ++C S+ L+LS++ +S
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 380 FIGM--SGLLSIDISYNELRGPIPNSTVFRNAPRESFL---GNNFSTFY 423
F+G+ + L +D+SYN L +S F P+ + NN +
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDS--FAWLPQLEYFFLEYNNIQHLF 288
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-33
Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 6/193 (3%)
Query: 214 KCH-RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILR 272
KC S +T ++P ++ + + VL+L+ N + R L L +
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPDDLPTN--ITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 273 GNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL 332
N +S P L L+ +L N L+ + F L L+ N +
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 333 ALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACF--IGMSGLLSID 390
+L LDLSHN + LE+L++L LS+N I S L ++
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 391 ISYNELRGPIPNS 403
+S N+++ P
Sbjct: 178 LSSNQIKEFSPGC 190
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-70
Identities = 91/337 (27%), Positives = 147/337 (43%), Gaps = 49/337 (14%)
Query: 470 SQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPS 529
S+ + +S ND + V ++ ++ T +FD K+ IG G VY+ L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 530 GDKIAVKKFNSPFPNDQMSDQ--KEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587
G K+A+K+ S Q +EF EI+ L+ RH ++V GFC ++Y+Y
Sbjct: 63 GAKVALKRRT------PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116
Query: 588 INRGSLATVLS-NNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646
+ G+L L ++ + W +R+ + G A L Y+H I+HRD+ S N+LLD
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD 173
Query: 647 LEYEARVSDFGTAKLLKPNSSNW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKC 703
+ +++DFG +K T + GT GY+ P E ++TEK
Sbjct: 174 ENFVPKITDFGISKKG-TELDQTHLSTVVKGTLGYIDP----------EYFIKGRLTEKS 222
Query: 704 DVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI-----------EFNAMLDHRLPHPSL 752
DVYSFGV+ EV+ + S +N+ + ++D P+L
Sbjct: 223 DVYSFGVVLFEVLCARSAIV----QSLPREMVNLAEWAVESHNNGQLEQIVD-----PNL 273
Query: 753 DVQ---EKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ E L + A+ CL RP+M V L
Sbjct: 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-69
Identities = 65/457 (14%), Positives = 131/457 (28%), Gaps = 63/457 (13%)
Query: 17 LQEFSFSSFPHLAYLDLS-INGFFGTLPPQVRNLSKLKYLDLSENELSG----------- 64
++ S L + + + ++ L+KL+ + + + +
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473
Query: 65 --------KIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSG---- 111
L L ++L P + +L L+ +++ N+
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 112 -----SIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSIPNL 164
+ ++ K+ + N P + + L +L N + +
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNK-VRHLEAF 591
Query: 165 RNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG-EISSNWGKCHRLGTLIV 223
L L N + + ++ L SHN N + +G++
Sbjct: 592 GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDF 651
Query: 224 SGNNITGRIPPEIG------NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
S N I I + LS N I ++ +IL N ++
Sbjct: 652 SYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
Query: 278 -------GHLPRALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEI 328
L DL N+L S+ + + L ++ S+N FS
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SF 768
Query: 329 PEDLALLAHLSELDLSHNL------FKGSIPSRICNLESLEKLNLSHNNISGQIPACFIG 382
P + L + H P+ I SL +L + N+I +
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL-- 825
Query: 383 MSGLLSIDISYNEL-RGPIPNSTVFRNAPRESFLGNN 418
L +DI+ N + + + A L +
Sbjct: 826 TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-64
Identities = 64/420 (15%), Positives = 138/420 (32%), Gaps = 56/420 (13%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG-- 64
+ + +E S+S+ L ++L LP + +L +L+ L+++ N
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 65 -------KIPPEIGLLTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPE 115
++ + + + N + + L + +NK+ E
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLE 589
Query: 116 EIGNLMKLSYLMLDTNQFTGQLPRNICR-SGLLEILTVNDNHFLGSIPN---LRNCRSLV 171
G +KL+ L LD NQ ++P + C + +E L + N L IPN ++ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK-LKYIPNIFNAKSVYVMG 647
Query: 172 RAHLGRNNLTGNISEDFGIYP-----NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGN 226
N + N + LS+N + + + T+I+S N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 227 NIT-------GRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL--GRLISLNKLILRGNQLS 277
+T N+ L +DL N + + + L L+ + + N S
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS 766
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAH 337
P ++L+ F + + N+ ++ P +
Sbjct: 767 -SFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPS 807
Query: 338 LSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
L +L + N + + ++ L L+++ N + Y++ +
Sbjct: 808 LIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-60
Identities = 68/402 (16%), Positives = 140/402 (34%), Gaps = 36/402 (8%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLT------ 74
+ + L L+ G G +P + L++LK L + + G
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFGDEELTPDMS 376
Query: 75 --HLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132
+ + + + NLS+L +++ N I ++ +K + + TN+
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 133 FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
T + + I R L+I+ ++ F + A+ N +
Sbjct: 437 ITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEELSWSNLK 491
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG---------RIPPEIGNSSQLH 243
+L ++L + ++ L +L ++ N R+ + ++
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 244 VLDLSSNHIAGEIPME--LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301
+ + N++ E P L +++ L L N++ HL A G +L L N++
Sbjct: 552 IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE 608
Query: 302 NSILEALGFMFKLFYLNFSHNQFSQEIPEDLAL--LAHLSELDLSHNLFKG-----SIPS 354
+ F ++ L FSHN+ IP + + +D S+N S
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 355 RICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
+ + LS+N I F S + +I +S N +
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 4e-40
Identities = 60/325 (18%), Positives = 101/325 (31%), Gaps = 38/325 (11%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
+ L+ S L LD N KL L L N++
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE 609
Query: 65 KIPPEIG-LLTHLFSLDLSLNQFSGTFPP---ICNLSNLKYISLHNNKLSGSIPEEIG-- 118
IP + + L S N+ P ++ + + NK+ S I
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCS 666
Query: 119 ----NLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN---------LR 165
+ S + L N+ + + +++N + SIP +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL-MTSIPENSLKPKDGNYK 725
Query: 166 NCRSLVRAHLGRNNLTGNISEDFGI--YPNLKFLDLSHNNFYGEISSNWGKCHRLGTL-- 221
N L L N LT +S+DF P L +D+S+N F + +L
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGI 783
Query: 222 ----IVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
GN I + P I L L + SN I ++ +L L L + N
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNI 840
Query: 278 GHLPRALGLLTELEYFDLSSNRLNN 302
++ E + L ++ +
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-34
Identities = 35/261 (13%), Positives = 83/261 (31%), Gaps = 22/261 (8%)
Query: 163 NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLI 222
+L N + L G + + G LK L ++ +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 223 VSGNNITGRIPPEIGNSSQ-LHVLDLSSNHI-----AGEIPMELGRLISLNKLILRGNQL 276
+ I + Q L++ DL + I I + + ++ N++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 277 SGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLA 336
+ + +A+ LT+L+ +++ + N + + + + L
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLK 491
Query: 337 HLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG---------QIPACFIGMSGLL 387
L++++L + +P + +L L+ LN++ N ++ +
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 388 SIDISYNELRGPIPNSTVFRN 408
+ YN L P S +
Sbjct: 552 IFYMGYNNLEE-FPASASLQK 571
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-65
Identities = 88/421 (20%), Positives = 147/421 (34%), Gaps = 16/421 (3%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
+ E +F S L L L+ N + LK+L + +S +
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 76 LFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ-F 133
L SL L N S P LK + NN + E++ +L + + L L+ N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 134 TGQLPRNICRSGLLEILTVNDNHFLG-SIPNLRNC--RSLVRAHLGRNNLTGNISEDFGI 190
+ S + + L L L+N +SL + F
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 191 YP--NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248
+++ ++L + F+ S+ + L L ++ +++ +P + S L L LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHL-PRALGLLTELEYFDLSSNRLNNSILEA 307
+N + SL L ++GN L L L L DLS + + S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 308 LGF--MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIP-SRICNLESLEK 364
L + L LN S+N+ E L LDL+ K S NL L+
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIP-NSTVFRNAPRESFL---GNNFS 420
LNLSH+ + F G+ L +++ N + + R L + S
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 421 T 421
+
Sbjct: 490 S 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-60
Identities = 87/440 (19%), Positives = 143/440 (32%), Gaps = 44/440 (10%)
Query: 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELS 63
+++ LT+ L + E + S L +L G + N L+ L L N +S
Sbjct: 84 DTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 64 GKIPPEIGLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEIGN 119
P+ L LD N + +NL ++L+ N ++ I +
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIA-GIEPGAFD 200
Query: 120 LMKLSYLMLDTNQFTGQLPRNICRSGL----------------------------LEILT 151
L Q + + + S + +E +
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 152 VNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210
+ ++F N L L +L+ + LK L LS N F
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 211 NWGKCHRLGTLIVSGNNITGRIPPE-IGNSSQLHVLDLSSNHIA--GEIPMELGRLISLN 267
+ L L + GN + + N L LDLS + I ++L L L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILE-ALGFMFKLFYLNFSHNQFSQ 326
L L N+ A +LE DL+ RL + + L LN SH+
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 327 EIPEDLALLAHLSELDLSHNLFKGSI---PSRICNLESLEKLNLSHNNISGQIPACFIGM 383
+ L L L+L N F + + L LE L LS ++S F +
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 384 SGLLSIDISYNELRGPIPNS 403
+ +D+S+N L +
Sbjct: 500 KMMNHVDLSHNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-57
Identities = 76/396 (19%), Positives = 137/396 (34%), Gaps = 18/396 (4%)
Query: 16 TLQEFSFSSFPHLAYLDLSING-FFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGL-- 72
L + SS L L++NG + P + + + L+ + I +
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 73 LTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLML 128
+ L+ F +C + +++ I+L + L L L
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 129 DTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISED 187
+ +LP + L+ L ++ N F N SL + N +
Sbjct: 286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
Query: 188 -FGIYPNLKFLDLSHNNFY--GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHV 244
NL+ LDLSH++ + L +L +S N QL +
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 245 LDLSSNHIAG-EIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNS 303
LDL+ + + L L L L + L + L L++ +L N
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 304 ILEALGF---MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLE 360
++ + +L L S S L ++ +DLSHN S + +L+
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 361 SLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
+ LNL+ N+IS +P+ +S +I++ N L
Sbjct: 525 GIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-55
Identities = 80/404 (19%), Positives = 136/404 (33%), Gaps = 16/404 (3%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
L E + L+ S N L L +LDL+ ++ L
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 77 FSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
+L L+ N + LK++ +S + N L L L +N +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 136 QLPRNICRSGLLEILTVNDNHF----LGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIY 191
+ L++L +N + +L+ +L +L N++ G I
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-LNLNGNDIAG-IEPGAFDS 201
Query: 192 PNLKFLDLSHNNFYGEISSNWGKCH--RLGTLIVSGNNITGRIPPEIGNSSQLHV--LDL 247
+ L+ I L + P ++ V ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEA 307
++ L +L L LS LP L L+ L+ LS+N+ N +
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 308 LGFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLFKGSIPSR--ICNLESLEK 364
L +L+ N E+ L L +L ELDLSH+ + S + NL L+
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRN 408
LNLS+N F L +D+++ L+ S F+N
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS-PFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-51
Identities = 69/371 (18%), Positives = 128/371 (34%), Gaps = 33/371 (8%)
Query: 13 LKGTLQEFSFSSFPHLAYLDLS---INGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPE 69
L + S+ L + + +S ++ ++L ++
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNT 273
Query: 70 IGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLD 129
+ L LDL+ S + LS LK + L NK N L++L +
Sbjct: 274 FHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333
Query: 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLT--GNISED 187
N +L L N +L L +++ +
Sbjct: 334 GNTKRLELGTGC----------------------LENLENLRELDLSHDDIETSDCCNLQ 371
Query: 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
+L+ L+LS+N + + +C +L L ++ + + N L VL+
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 247 LSSNHIAGEIPMELGRLISLNKLILRGNQLSG---HLPRALGLLTELEYFDLSSNRLNNS 303
LS + + L +L L L+GN +L L LE LS L++
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 304 ILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLE 363
A + + +++ SHN+ + E L+ L + L+L+ N +PS + L
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQR 550
Query: 364 KLNLSHNNISG 374
+NL N +
Sbjct: 551 TINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 55/326 (16%), Positives = 97/326 (29%), Gaps = 38/326 (11%)
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNL 194
++P + S E L + N +L L R + + F L
Sbjct: 26 EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 195 KFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254
L L+ N + L L I+ + N L L L SNHI+
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 255 EIPMELGRLISLNKLILRGNQLSG-------------------------HLPRALGLLTE 289
+ L L + N + +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 290 LEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDLALLAHLS--ELDLSH 345
+ + + I + L + L+ F P L +S ++L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 346 NLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTV 405
+ F + L++L+L+ ++S ++P+ +G+S L + +S N+ S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS-- 320
Query: 406 FRNAPRESFL---GNNFSTFYGTSDL 428
N P + L GN GT L
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCL 346
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 40/235 (17%), Positives = 72/235 (30%), Gaps = 8/235 (3%)
Query: 173 AHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRI 232
+ L I + + + L+ S N ++ + + L L ++ I
Sbjct: 17 YNCENLGLN-EIPGT--LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 233 PPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEY 292
+ +L L L++N + L +L L +S L LE
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 293 FDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS--ELDLSHNLFKG 350
L SN +++ L KL L+F +N ED++ L + L+L+ N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA- 192
Query: 351 SIPSRICNLESLEKLNLSHNNISGQIPA--CFIGMSGLLSIDISYNELRGPIPNS 403
I + + LN I + L + P
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 42/203 (20%), Positives = 65/203 (32%), Gaps = 5/203 (2%)
Query: 220 TLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH 279
T + IP + NS L+ S N + RLI+L L L Q+
Sbjct: 16 TYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 280 LPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS 339
L+ L++N L AL L +L F S L L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 340 ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGL--LSIDISYNELR 397
L L N + E L+ L+ +N I + LS++++ N++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 398 GPIPNSTVFRNAPRESFLGNNFS 420
G P + +F G
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNL 215
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 29/134 (21%), Positives = 53/134 (39%), Gaps = 4/134 (2%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLS---INGFFGTLPPQVRNLSKLKYLDLSENE 61
+NL+ + L E F P L +L+L ++ L +L+ L LS +
Sbjct: 429 VLNLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 62 LSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
LS L + +DLS N+ + + + Y++L +N +S +P + L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILS 547
Query: 122 KLSYLMLDTNQFTG 135
+ + L N
Sbjct: 548 QQRTINLRQNPLDC 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-63
Identities = 86/461 (18%), Positives = 147/461 (31%), Gaps = 50/461 (10%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL-S 63
++ LT ++ L +FS L L + +L LK L+++ N + S
Sbjct: 80 TLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 64 GKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKY----ISLHNNKLSGSIPEEIG 118
K+P LT+L LDLS N+ + + L + + L N ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 119 NLMKLSYLMLDTNQFTGQLPRNICRS-GLLEILTVNDNHFLG-------SIPNLRNCRSL 170
++L L L N + + + + LE+ + F L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 171 VRAHLGRNNL---TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
L +I + F N+ L E ++ L +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCK 315
Query: 228 IT-------------------GRIPPEIGNSSQLHVLDLSSNHIA--GEIPMELGRLISL 266
G + L LDLS N ++ G SL
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI-LEALGFMFKLFYLNFSHNQFS 325
L L N + + L +LE+ D + L + L YL+ SH
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRI-CNLESLEKLNLSHNNISGQIPACFIGMS 384
L+ L L ++ N F+ + I L +L L+LS + P F +S
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 385 GLLSIDISYNELRGPIPNSTVFRNAPRESFL---GNNFSTF 422
L +++S+N ++ L N+ T
Sbjct: 495 SLQVLNMSHNNFFSLDTFP--YKCLNSLQVLDYSLNHIMTS 533
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 7e-62
Identities = 78/402 (19%), Positives = 128/402 (31%), Gaps = 27/402 (6%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKY----LDLSENELSGKIPPEIGLLTHL 76
FS+ +L +LDLS N +R L ++ LDLS N ++ I P L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 77 FSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGS------IPEEIGNLMKLSYLML 128
L L N S I L+ L+ L + + L L+
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 129 DTNQ---FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS 185
+ + + ++ + + + L +
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT-IERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT--GRIPPEIGNSSQLH 243
L F N + E+ L L +S N ++ G ++ L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVD-----LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 244 VLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNN 302
LDLS N + + L L L + + L L L Y D+S
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 303 SILEALGFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLFKGSIPSRICNLES 361
+ + L L + N F + D L +L+ LDLS + P+ +L S
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 362 LEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
L+ LN+SHNN + ++ L +D S N +
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-57
Identities = 90/412 (21%), Positives = 139/412 (33%), Gaps = 34/412 (8%)
Query: 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGT---LPPQVRNLSKLKYLDLS 58
R++ + L + + + L L + F L L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 59 ENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIG 118
E L+ LD L+ F L+N+ SL + +
Sbjct: 261 EFRLA--------------YLDYYLDDIIDLF---NCLTNVSSFSLVSVTIERVKD--FS 301
Query: 119 NLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRN 178
+L L +F Q P +S L+ LT N + + + SL L RN
Sbjct: 302 YNFGWQHLELVNCKFG-QFPTLKLKS--LKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRN 357
Query: 179 NLT--GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI 236
L+ G S+ +LK+LDLS N +SSN+ +L L +N+ +
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 237 -GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHL-PRALGLLTELEYFD 294
+ L LD+S H L SL L + GN + P L L + D
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 295 LSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPS 354
LS +L A + L LN SHN F L L LD S N S
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 355 RICNLE-SLEKLNLSHNNISGQIPAC-FIG-MSGLLSIDISYNELRGPIPNS 403
+ + SL LNL+ N+ + F+ + + + + P+
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-57
Identities = 78/413 (18%), Positives = 129/413 (31%), Gaps = 29/413 (7%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
+ + LDLS N + +L+ LDLS E+ L+HL
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 77 FSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
+L L+ N LS+L+ + L+ IG+L L L + N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 136 -QLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSL----VRAHLGRNNLTGNISEDFG 189
+LP LE L ++ N LR + + L N + F
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 190 IYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRI---PPEIGNSSQLHVL 245
L L L +N + L + + L L
Sbjct: 199 E-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 246 DLSSNHI------AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR 299
+ + +I L +++ L + ++ +L + +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCK 315
Query: 300 LNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN--LFKGSIPSRIC 357
L L L F+ N+ L L LDLS N FKG
Sbjct: 316 FGQFPTLKLK---SLKRLTFTSNKGG--NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 358 NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAP 410
SL+ L+LS N + + + F+G+ L +D ++ L+ S VF +
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS-VFLSLR 421
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-41
Identities = 64/390 (16%), Positives = 107/390 (27%), Gaps = 61/390 (15%)
Query: 91 PPICNL--------------------SNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDT 130
P + + + K + L N L + +L L L
Sbjct: 2 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 131 NQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFG 189
+ L L + N SL + NL + G
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 190 IYPNLKFLDLSHNNF-YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHV---- 244
LK L+++HN ++ + L L +S N I ++ Q+ +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNNS 303
LDLS N + I + I L+KL LR N S ++ + + L LE L N
Sbjct: 182 LDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 304 ILEA---LGFMFKLFYLNFSHNQFSQ------EIPEDLALLAHLSELDLSHNLFKGSIPS 354
+ L L + + +I + L ++S L +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299
Query: 355 RICNLESLEKLNLSHNNIS-------------------GQIPACFIGMSGLLSIDISYNE 395
+ L L + G + + L +D+S N
Sbjct: 300 -FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 396 LRGPIPNSTVFRNAPRESFL---GNNFSTF 422
L S +L N T
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITM 388
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 54/253 (21%), Positives = 88/253 (34%), Gaps = 11/253 (4%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248
+ + K LDLS N S ++ L L +S I + S L L L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN-SILEA 307
N I L SL KL+ L+ +G L L+ +++ N + + + E
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS----ELDLSHNLFKGSIPSRICNLESLE 363
+ L +L+ S N+ DL +L + LDLS N P + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203
Query: 364 KLNLSHNNISGQIPA-CFIGMSGLLSIDISYNELRG----PIPNSTVFRNAPRESFLGNN 418
KL L +N S + C G++GL + E R + + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 419 FSTFYGTSDLLSH 431
+ D +
Sbjct: 264 LAYLDYYLDDIID 276
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 50/239 (20%), Positives = 87/239 (36%), Gaps = 9/239 (3%)
Query: 20 FSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLTHLFS 78
S L YLDLS NG T+ L +L++LD + L + L +L
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 79 LDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSI-PEEIGNLMKLSYLMLDTNQFTGQ 136
LD+S F LS+L+ + + N + P+ L L++L L Q
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 137 LPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFG-IYPNL 194
P L++L ++ N+F + SL N++ + ++ +L
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 545
Query: 195 KFLDLSHNNFYGEISSNW--GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNH 251
FL+L+ N+F L+V + P + L L+++
Sbjct: 546 AFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNITCQM 603
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-63
Identities = 87/310 (28%), Positives = 139/310 (44%), Gaps = 46/310 (14%)
Query: 498 YEEIIRRTKDFDAKYC------IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQ- 550
+ E+ T +FD + +G+G VY+ + +AVKK + D +++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAM--VDITTEEL 73
Query: 551 -KEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWR 609
++F EIK + K +H N+V+ GF S +VY Y+ GSL LS + W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 610 KRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP--NSS 667
R + G A+ ++++H + +HRDI S N+LLD + A++SDFG A+ + +
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF--- 724
+ +VGT Y+AP E A +IT K D+YSFGV+ LE+I G D
Sbjct: 191 MTSRIVGTTAYMAP----------E-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 725 --------LSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776
+ + +D ++ E + VA CL N R
Sbjct: 240 PQLLLDIKEEIEDEEKT-----IEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKR 291
Query: 777 PTMQTVCQLL 786
P ++ V QLL
Sbjct: 292 PDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 69/316 (21%), Positives = 118/316 (37%), Gaps = 45/316 (14%)
Query: 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
E + ++ +G V++A+L + +AVK F D+ S Q E+ E+
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF---PIQDKQSWQNEY--EV 69
Query: 558 KALTKIRHRNIVKFYGFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMN 613
+L ++H NI++F G +++ + +GSL+ L N W + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCH 125
Query: 614 VITGVADALSYMHHDCF-------PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666
+ +A L+Y+H D P I HRDI S NVLL A ++DFG A +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 667 SNW--TELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPG 722
S VGT Y+AP G I + D+Y+ G++ E+
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINF-------QRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 723 D-----FLSLFSSSSSSINIEFNAMLDH------RLPHP-SLDVQEKLISIMEVALLCLD 770
D ++ F + M + R + + E C D
Sbjct: 239 DGPVDEYMLPFEEEIGQ-HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 771 GCPNSRPTMQTVCQLL 786
+R + V + +
Sbjct: 298 HDAEARLSAGCVGERI 313
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-57
Identities = 85/441 (19%), Positives = 137/441 (31%), Gaps = 50/441 (11%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFG-TLPPQVRNLSKLKYLDLSENELS 63
++ T L L+ F L L+++ N LP NL+ L ++DLS N +
Sbjct: 108 NLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 64 G---------------------------KIPPEIGLLTHLFSLDLSLNQFSGTFPPIC-- 94
I + L L L N S C
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
Query: 95 NLSNLKYISL------HNNKLSGSIPEEIGNLMKLSYLMLD--TNQFTGQLPRNICRSGL 146
NL+ L L L P + L ++
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
+ +++ + + ++ + R L + D P LK L L+ N G
Sbjct: 287 VSAMSLAGVS-IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNK--G 340
Query: 207 EISSNWGKCHRLGTLIVSGNNIT--GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
IS L L +S N ++ G ++ L LDLS N + L
Sbjct: 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLE 399
Query: 265 SLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ 323
L L + + L A L +L Y D+S + L L + N
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459
Query: 324 FSQEIPED-LALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIG 382
F + A +L+ LDLS + L L+ LN+SHNN+ + +
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519
Query: 383 MSGLLSIDISYNELRGPIPNS 403
+ L ++D S+N +
Sbjct: 520 LYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-53
Identities = 77/431 (17%), Positives = 127/431 (29%), Gaps = 40/431 (9%)
Query: 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLK----YLDLSE 59
+N+ + FS+ +L ++DLS N ++ L + LD+S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 60 NELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPIC--NLSNLKYISL------HNNKLSG 111
N + I + L L L N S C NL+ L L L
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 112 SIPEEIGNLMKLSYLMLD--TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRS 169
P + L ++ + +++ + + ++
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS-IKYLEDVPKHFK 308
Query: 170 LVRAHLGRNNLT-------------------GNISEDFGIYPNLKFLDLSHNNFY--GEI 208
+ R L G+IS P+L +LDLS N G
Sbjct: 309 WQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 209 SSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLN 267
S + + L L +S N + +L LD + + L L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQFSQ 326
L + LT L ++ N ++ L L +L+ S Q Q
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 327 EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGL 386
L L L++SHN S L SL L+ S N I L
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL 547
Query: 387 LSIDISYNELR 397
+++ N +
Sbjct: 548 AFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-52
Identities = 78/420 (18%), Positives = 139/420 (33%), Gaps = 32/420 (7%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
++ LT ++ SFS L L + L LK L+++ N +
Sbjct: 84 NLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 65 -KIPPEIGLLTHLFSLDLSLNQFSG----TFPPICNLS-NLKYISLHNNKLSGSIPEEIG 118
K+P LT+L +DLS N + + + N + I ++
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201
Query: 119 NLMKLSYLMLDTNQFTGQLPRNICRS-GLLEILTVNDNHFLGSIP----------NLRNC 167
+KL L L N + + + ++ L + + F L +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
L N + F N+ + L+ + + + K + +L +
Sbjct: 262 TIDEF-RLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQ 318
Query: 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287
+ P + L L L+ N I + L SL+ L L N LS + L
Sbjct: 319 LKQ-FPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 288 --TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLS 344
L + DLS N + + +L +L+F H+ + L L LD+S
Sbjct: 374 GTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 345 HNLFKGSIPSRICNLESLEKLNLSHNNISGQIPAC-FIGMSGLLSIDISYNELRGPIPNS 403
+ K L SL L ++ N+ + F + L +D+S +L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-49
Identities = 85/391 (21%), Positives = 126/391 (32%), Gaps = 46/391 (11%)
Query: 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84
+DLS N N S+L++LDLS E+ L HL +L L+ N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 85 QFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICR 143
P L++L+ + KL+ IG L+ L L + N
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-------- 142
Query: 144 SGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF----LDL 199
N +LV L N + D LD+
Sbjct: 143 --------------CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 200 SHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS-SQLHVLDLSSNHIAGEIPM 258
S N I + +L L + GN + I + + LHV L E +
Sbjct: 189 SLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 259 E------LGRLISLNKLILR--GNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF 310
E + L + R L + L+ + LE +
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPK 305
Query: 311 MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHN 370
FK L+ Q Q D L L L L+ N KGSI + L SL L+LS N
Sbjct: 306 HFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRN 360
Query: 371 NISGQIPACF--IGMSGLLSIDISYNELRGP 399
+S + +G + L +D+S+N
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM 391
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-42
Identities = 70/388 (18%), Positives = 131/388 (33%), Gaps = 28/388 (7%)
Query: 40 GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSG-TFPPICNLSN 98
G+L P + + + + +LS K+P + + ++DLS N N S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 99 LKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFL 158
L+++ L ++ + L LS L+L N P + LE L +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 159 GSIPN-LRNCRSLVRAHLGRNNLTG-NISEDFGIYPNLKFLDLSHNNF----YGEISSNW 212
+ +L + ++ N + + F NL +DLS+N ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 213 GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR-LISLNKLIL 271
+L +S N I I + +LH L L N + I + L L+ L
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 272 RGNQLSGHL------PRALGLLTEL--EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ 323
+ P + L ++ + F L+ + + + + ++ +
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 324 FSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGM 383
ED+ L + K P+ +L L+ L L+ N S I + +
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGS--ISFKKVAL 349
Query: 384 SGLLSIDISYNELRGPIPNSTVFRNAPR 411
L +D+S N L S
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-31
Identities = 53/272 (19%), Positives = 91/272 (33%), Gaps = 14/272 (5%)
Query: 159 GSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRL 218
GS+ + L+ + +D I + K +DLS N S ++ L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDD--IPSSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 219 GTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG 278
L +S I L L L+ N I P L SL L+ +L+
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 279 HLPRALGLLTELEYFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQFSQEIPEDLALLAH 337
+G L L+ +++ N +++ L + L +++ S+N DL L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 338 LS----ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDIS 392
LD+S N I + L +L L N S I C ++GL +
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 393 YNELRG----PIPNSTVFRNAPRESFLGNNFS 420
E + I ++ + +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-29
Identities = 52/240 (21%), Positives = 82/240 (34%), Gaps = 16/240 (6%)
Query: 197 LDLSHNNFY---GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIA 253
+I S+ + +S N + N S+L LDLS I
Sbjct: 16 YQCMDQKLSKVPDDIPSS------TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 254 GEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK 313
L L+ LIL GN + P + LT LE +L + +G +
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 314 LFYLNFSHNQFSQ-EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLE----SLEKLNLS 368
L LN +HN ++P + L +L +DLS+N + + + L L++S
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 369 HNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDL 428
N I F G+ L + + N I T +N F +L
Sbjct: 190 LNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIM-KTCLQNLAGLHVHRLILGEFKDERNL 247
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-56
Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 496 IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
I Y+EI +G+G V +AK +A+K+ S S++K F+
Sbjct: 5 IDYKEIEVEEV-------VGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIV 50
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E++ L+++ H NIVK YG C + +V EY GSL VL + M+
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE-ARVSDFGTAKLLKPNSSNWTELVG 674
+ ++Y+H ++HRD+ N+LL ++ DFGTA ++ ++ T G
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKG 165
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734
+ ++AP E+ +EKCDV+S+G++ EVI + P D + +
Sbjct: 166 SAAWMAP----------EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI-----GGPA 210
Query: 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
I + R P ++ + + S+M C P+ RP+M+ + +++
Sbjct: 211 FRIMWAVHNGTRPPLIK-NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-55
Identities = 76/350 (21%), Positives = 155/350 (44%), Gaps = 23/350 (6%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
+L++ L + ++ L + L ++ + + + I L+NL+Y++L+ N
Sbjct: 20 DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGN 76
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167
+++ P + NL+KL+ L + TN+ T + L L +N+++ + I L N
Sbjct: 77 QITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDN-ISDISPLANL 131
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
+ +LG N+ ++S L +L ++ + + + L +L ++ N
Sbjct: 132 TKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQ 188
Query: 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287
I + + + LH N I P + + LN L + N+++ P L L
Sbjct: 189 IED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANL 242
Query: 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNL 347
++L + ++ +N++++ + A+ + KL LN NQ S L L+ L+ L L++N
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQ 298
Query: 348 FKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
I L +L L LS N+I+ P +S + S D + ++
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 19/306 (6%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+L YL+L+ N T + NL KL L + N+++ + LT+L L
Sbjct: 61 GIEYLTNLEYLNLNGNQI--TDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN 140
L+ + S P+ NL+ + ++L N S + N+ L+YL + ++
Sbjct: 117 LNEDNISD-ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTP 172
Query: 141 ICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLS 200
I L L++N N + I L + SL N +T L L +
Sbjct: 173 IANLTDLYSLSLNYNQ-IEDISPLASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIG 229
Query: 201 HNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260
+N S +L L + N I+ + + ++L +L++ SN I+ +I L
Sbjct: 230 NNKI--TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DIS-VL 283
Query: 261 GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320
L LN L L NQL +G LT L LS N + + + L + K+ +F+
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFA 341
Query: 321 HNQFSQ 326
+ +
Sbjct: 342 NQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-31
Identities = 56/255 (21%), Positives = 94/255 (36%), Gaps = 18/255 (7%)
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
L + I + +RA L + ++T ++ L ++
Sbjct: 2 AATLATLPAP-INQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV-- 56
Query: 207 EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266
L L ++GN IT + N +L L + +N I L L +L
Sbjct: 57 ASIQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNL 112
Query: 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ 326
+L L + +S L LT++ +L +N S L L M L YL + ++
Sbjct: 113 RELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 327 EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGL 386
P +A L L L L++N + P + +L SL N I+ P M+ L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 387 LSIDISYNELRGPIP 401
S+ I N++ P
Sbjct: 224 NSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 30/158 (18%), Positives = 65/158 (41%), Gaps = 12/158 (7%)
Query: 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI 304
L I P L + +L+ ++ + L + ++ ++ +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEK 364
++ + ++ L YLN + NQ + P L+ L L+ L + N + S + NL +L +
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRE 114
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN 402
L L+ +NIS P ++ + S+++ N +
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 87/321 (27%), Positives = 145/321 (45%), Gaps = 32/321 (9%)
Query: 467 KRDSQSQGSCSSKNDTRGIFHSVLDFDG-KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRA 525
F +D D I + ++ + K IG G +V+RA
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK-------IGAGSFGTVHRA 56
Query: 526 KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585
+ G +AVK + + EFL E+ + ++RH NIV F G + + +V
Sbjct: 57 EW-HGSDVAVKILMEQDFHAER--VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL 645
EY++RGSL +L + A E D R+R+++ VA ++Y+H+ PPIVHR++ S N+L+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLV 172
Query: 646 DLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDV 705
D +Y +V DFG ++L + GT ++AP E+ EK DV
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP----------EVLRDEPSNEKSDV 222
Query: 706 YSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVA 765
YSFGV+ E+ + P + + + + + RL P ++ ++ +I+E
Sbjct: 223 YSFGVILWELATLQQP------WGNLNPAQVVAAVGFKCKRLEIPR-NLNPQVAAIIE-- 273
Query: 766 LLCLDGCPNSRPTMQTVCQLL 786
C P RP+ T+ LL
Sbjct: 274 -GCWTNEPWKRPSFATIMDLL 293
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-53
Identities = 91/382 (23%), Positives = 158/382 (41%), Gaps = 29/382 (7%)
Query: 20 FSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
F+ ++ L T+ +L ++ L + + L +L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
+ S NQ + P+ NL+ L I ++NN+++ P + NL L+ L L NQ T
Sbjct: 74 NFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--ID 128
Query: 140 NICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDL 199
+ L L ++ N + I L SL + G N +T + L+ LD+
Sbjct: 129 PLKNLTNLNRLELSSNT-ISDISALSGLTSLQQLSFG-NQVTD--LKPLANLTTLERLDI 184
Query: 200 SHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME 259
S N S K L +LI + N I+ I P +G + L L L+ N + +I
Sbjct: 185 SSNKVSDI--SVLAKLTNLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLK-DIG-T 238
Query: 260 LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNF 319
L L +L L L NQ+S P L LT+L L +N+++N + L + L L
Sbjct: 239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLEL 294
Query: 320 SHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPAC 379
+ NQ P ++ L +L+ L L N P + +L L++L +N +S +
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSS 348
Query: 380 FIGMSGLLSIDISYNELRGPIP 401
++ + + +N++ P
Sbjct: 349 LANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-50
Identities = 90/383 (23%), Positives = 150/383 (39%), Gaps = 27/383 (7%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+L ++ S N + P ++NL+KL + ++ N+++ + LT+L L
Sbjct: 63 GVEYLNNLTQINFSNN-QLTDITP-LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLT 118
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN 140
L NQ + P+ NL+NL + L +N +S + L L L NQ T P
Sbjct: 119 LFNNQITD-IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLA 174
Query: 141 ICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLS 200
+ LE L ++ N + I L +L N ++ GI NL L L+
Sbjct: 175 NLTT--LERLDISSNK-VSDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLN 229
Query: 201 HNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260
N + L L ++ N I+ + ++L L L +N I+ P L
Sbjct: 230 GNQL--KDIGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--L 283
Query: 261 GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320
L +L L L NQL + L L Y L N +++ + + + KL L F
Sbjct: 284 AGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFY 339
Query: 321 HNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACF 380
+N+ S LA L +++ L HN P + NL + +L L+ +
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYK 395
Query: 381 IGMSGLLSIDISYNELRGPIPNS 403
+S ++ L P S
Sbjct: 396 ANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-50
Identities = 87/400 (21%), Positives = 155/400 (38%), Gaps = 29/400 (7%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
+ L + ++ N + NL+ L L L N+++ + LT+L L+L
Sbjct: 86 LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLEL 141
Query: 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI 141
S N S + L++L+ +S N + + NL L L + +N+ + +
Sbjct: 142 SSNTISD-ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVL 195
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201
+ LE L +N + I L +L L N L +I NL LDL++
Sbjct: 196 AKLTNLESLIATNNQ-ISDITPLGILTNLDELSLNGNQLK-DIGT-LASLTNLTDLDLAN 252
Query: 202 NNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELG 261
N + +L L + N I+ + + L L+L+ N + P +
Sbjct: 253 NQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--IS 306
Query: 262 RLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSH 321
L +L L L N +S P + LT+L+ +N++++ + +L + + +L+ H
Sbjct: 307 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGH 362
Query: 322 NQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFI 381
NQ S P LA L +++L L+ + + + N+ N N I I
Sbjct: 363 NQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP---NTVKNVTGALIAPATI 417
Query: 382 GMSGLLS-IDISYNELRGPIPNSTVFRNAPRESFLGNNFS 420
G + DI++N S F FS
Sbjct: 418 SDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-36
Identities = 75/358 (20%), Positives = 123/358 (34%), Gaps = 69/358 (19%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
++ L LD+S N + + L+ L+ L + N++S I P +G+LT+L L
Sbjct: 172 PLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISD-ITP-LGILTNLDELS 227
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN 140
L+ NQ + +L+NL + L NN++S P + L KL+ L L NQ +
Sbjct: 228 LNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS------ 278
Query: 141 ICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLS 200
+I L +L L N L NL +L L
Sbjct: 279 -------------------NISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLY 317
Query: 201 HNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260
NNI+ P + + ++L L +N + L
Sbjct: 318 F------------------------NNISDISP--VSSLTKLQRLFFYNNKV--SDVSSL 349
Query: 261 GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320
L ++N L NQ+S P L LT + L+ N+ + + N
Sbjct: 350 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA---NVSIPNTV 404
Query: 321 HNQFSQEI-PEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIP 377
N I P ++ +E D++ NL + SG +
Sbjct: 405 KNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 19/144 (13%), Positives = 41/144 (28%), Gaps = 28/144 (19%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
SS L L N + + NL+ + +L N++S + LT + L
Sbjct: 326 PVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLG 381
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ-------- 132
L+ ++ ++ + P I + + + N
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVS 440
Query: 133 ---------------FTGQLPRNI 141
F+G + + +
Sbjct: 441 YTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 42/299 (14%)
Query: 496 IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
I + E+ IG G VYRA GD++AVK D +
Sbjct: 4 IDFAELTLEEI-------IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E K ++H NI+ G C + +V E+ G L VLS +N
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWA 111
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR--------VSDFGTAKLLKPNSS 667
+A ++Y+H + PI+HRD+ S+N+L+ + E ++DFG A+ +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727
G + ++AP E+ ++ DV+S+GVL E++ G+ P
Sbjct: 172 --MSAAGAYAWMAP----------EVIRASMFSKGSDVWSYGVLLWELLTGEVP------ 213
Query: 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
F AM LP PS E +ME C + P+SRP+ + L
Sbjct: 214 FRGIDGLAVAYGVAMNKLALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-51
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 514 IGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQ---KEFLNEIKALTKIRHRNIV 569
IGKG V++ +L +A+K + +EF E+ ++ + H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
K YG +V E++ G L L + + W ++ ++ +A + YM +
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 630 FPPIVHRDISSNNVLLDLEYE-----ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
PPIVHRD+ S N+ L E A+V+DFG ++ +S + L+G F ++AP
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSV--SGLLGNFQWMAP--- 195
Query: 685 NIGLHLAELAYTMKI--TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742
E + TEK D YSF ++ ++ G+ P D S ++ E
Sbjct: 196 -------ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-- 246
Query: 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
R P D +L +++E LC G P RP + + L
Sbjct: 247 --LRPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 56/299 (18%), Positives = 110/299 (36%), Gaps = 39/299 (13%)
Query: 496 IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
I +E++ IGKG VY + G+ +A++ + N+ K F
Sbjct: 30 IPFEQLEIGEL-------IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQ--LKAFKR 78
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E+ A + RH N+V F G C H ++ +L +V+ + D K +
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIA 136
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-----LKPNSSNWT 670
+ + Y+H I+H+D+ S NV D + ++DFG +
Sbjct: 137 QEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR 192
Query: 671 ELVGTFGYVAP---AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727
G ++AP + +L + ++ DV++ G + E+ + P
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPF----SKHSDVFALGTIWYELHAREWP------ 242
Query: 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
F + + I + + + + +++ I+ C RPT + +L
Sbjct: 243 FKTQPAE-AIIWQMGTGMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDML 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 54/296 (18%), Positives = 110/296 (37%), Gaps = 42/296 (14%)
Query: 496 IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
I ++++ TK + + +++ + G+ I VK + + S ++F
Sbjct: 7 IDFKQLNFLTK-------LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKS--RDFNE 56
Query: 556 EIKALTKIRHRNIVKFYGFCSH--VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN 613
E L H N++ G C H ++ ++ GSL VL + D + +
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVK 115
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELV 673
+A ++++H P I ++S +V++D + AR+S + +
Sbjct: 116 FALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRM 169
Query: 674 GTFGYVAPAHGNIGLHLAEL---AYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
+VAP E D++SF VL E++ + P F+
Sbjct: 170 YAPAWVAP----------EALQKKPEDTNRRSADMWSFAVLLWELVTREVP------FAD 213
Query: 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
S+ A+ R P + + +M+ +C++ P RP + +L
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP-GISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 64/305 (20%), Positives = 116/305 (38%), Gaps = 48/305 (15%)
Query: 496 IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
++I +GKG + ++ V K F + + FL
Sbjct: 7 FRPSDLIHGEV-------LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLK 56
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E+K + + H N++KF G + + EYI G+L ++ + + W +R++
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFA 114
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL------------- 662
+A ++Y+H I+HRD++S+N L+ V+DFG A+L+
Sbjct: 115 KDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 663 -KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
KP+ +VG ++AP E+ EK DV+SFG++ E+I +
Sbjct: 172 KKPDRKKRYTVVGNPYWMAP----------EMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
Query: 722 GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQT 781
+++ N P + I + C D P RP+
Sbjct: 222 DPDY-----LPRTMDFGLNVRGFLDRYCPP-NCPPSFFPIT---VRCCDLDPEKRPSFVK 272
Query: 782 VCQLL 786
+ L
Sbjct: 273 LEHWL 277
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-45
Identities = 77/432 (17%), Positives = 153/432 (35%), Gaps = 71/432 (16%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
+ L+L+ G +LP L+ L S N L+ ++P L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT-ELPELPQSLKS 115
Query: 76 LFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
L + +L S L+Y+ + NN+L +PE + N L + +D N
Sbjct: 116 LLVDNNNLKALSD------LPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK- 166
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLK 195
+LP LE + +N L +P L+N L + N+L + + +L+
Sbjct: 167 KLPDLPPS---LEFIAAGNNQ-LEELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLE 218
Query: 196 FLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255
+ +N E L T+ N + +P + L L++ N++ +
Sbjct: 219 SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT-D 271
Query: 256 IPMELGRLISLNKLILRGNQLSG-------------HLPRALGLLTELEYFDLSSNRLNN 302
+P L L+ + LS + L LE ++S+N+L
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 330
Query: 303 SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLE-- 360
+ +L L S N + E+PE L +L +L + +N + P ++E
Sbjct: 331 ELPALPP---RLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 382
Query: 361 --------------SLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVF 406
+L++L++ N + + P + + ++ + P +
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEFAHET 438
Query: 407 RNAPRESFLGNN 418
+ + ++
Sbjct: 439 TDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-43
Identities = 82/383 (21%), Positives = 138/383 (36%), Gaps = 63/383 (16%)
Query: 41 TLPPQVRNLSKLKYLDLSENELSGKIPPEIG-------------LLTHLFSLDLSLNQFS 87
+P + N+ + +E PP G L L+L+ S
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 88 GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL 147
+ P +L+ + N L+ +PE +L L + + P LL
Sbjct: 85 -SLPE--LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LL 133
Query: 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGE 207
E L V++N L +P L+N L + N+L + + P+L+F+ +N E
Sbjct: 134 EYLGVSNNQ-LEKLPELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQL--E 186
Query: 208 ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLN 267
L + N++ ++P + L + +N + E+P EL L L
Sbjct: 187 ELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE-ELP-ELQNLPFLT 240
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI--LEAL-----------GFMFKL 314
+ N L LP L L D L L L L
Sbjct: 241 TIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 299
Query: 315 FYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374
+YLN S N+ + + L L EL++S+N +P+ LE+L S N+++
Sbjct: 300 YYLNASSNEIR-SLCD---LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA- 350
Query: 375 QIPACFIGMSGLLSIDISYNELR 397
++P L + + YN LR
Sbjct: 351 EVPE---LPQNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-42
Identities = 82/366 (22%), Positives = 123/366 (33%), Gaps = 61/366 (16%)
Query: 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ 85
P L YL +S N LP ++N S LK +D+ N L K+P L + NQ
Sbjct: 131 PLLEYLGVSNN-QLEKLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQ 184
Query: 86 FSGTFPPICNLSNLKYISLHNNKLSG------------------SIPEEIGNLMKLSYLM 127
P + NL L I NN L E+ NL L+ +
Sbjct: 185 LE-ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 243
Query: 128 LDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187
D N LP LE L V DN+ ++ L + + L+
Sbjct: 244 ADNNLLK-TLPDLPPS---LEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP--- 296
Query: 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247
PNL +L+ S N + L L VS N + +P L L
Sbjct: 297 ----PNLYYLNASSNEI-RSLCDLPPS---LEELNVSNNKLI-ELPALPPR---LERLIA 344
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEA 307
S NH+A E+P L L+ + N L P + +L R+N+ + E
Sbjct: 345 SFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDL--------RMNSHLAEV 391
Query: 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNL 367
L L+ N E P+ + + +L ++ + LE
Sbjct: 392 PELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDVF 447
Query: 368 SHNNIS 373
H++
Sbjct: 448 EHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 65/347 (18%), Positives = 115/347 (33%), Gaps = 54/347 (15%)
Query: 66 IPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLM--- 121
I P T L + + P N+ + ++ + P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 122 ----------KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSL 170
+ L L+ + LP LE L + N L +P ++ +SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNS-LTELPELPQSLKSL 116
Query: 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG 230
+ + L+ P L++L +S+N E L + V N++
Sbjct: 117 LVDNNNLKALSDLP-------PLLEYLGVSNNQL--EKLPELQNSSFLKIIDVDNNSLK- 166
Query: 231 RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTEL 290
++P + L + +N + E+P EL L L + N L LP L +
Sbjct: 167 KLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI 220
Query: 291 EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKG 350
+N L L L + L + +N +P+ L L L++ N
Sbjct: 221 ---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLT- 270
Query: 351 SIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
+P +L L+ + +S P L ++ S NE+R
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR 310
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 67/335 (20%), Positives = 112/335 (33%), Gaps = 57/335 (17%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+ L +D+ N LP L+++ N+L PE+ L L ++
Sbjct: 148 ELQNSSFLKIIDVDNN-SLKKLPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIY 201
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN 140
N P +L+ I NN L E+ NL L+ + D N LP
Sbjct: 202 ADNNSLK-KLPD--LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL 255
Query: 141 ICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTG-------------NISED 187
LE L V DN+ ++ L + + L+ I
Sbjct: 256 PPS---LEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL 312
Query: 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247
+ P+L+ L++S+N E+ + + L LI S N++ +P N L L +
Sbjct: 313 CDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQN---LKQLHV 364
Query: 248 SSNHIAGEIPMELGRLISLN----------------KLILRGNQLSGHLPRALGLLTELE 291
N + E P + L +L + N L P + +L
Sbjct: 365 EYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL- 421
Query: 292 YFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ 326
++S R+ + A KL F H+
Sbjct: 422 --RMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 65/326 (19%), Positives = 117/326 (35%), Gaps = 46/326 (14%)
Query: 91 PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI--------- 141
P + + L+ H++ L+ +P E N+ + +++ P
Sbjct: 5 PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 142 ----CRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF 196
C L +N+ L S+P + SL N+LT + E +L
Sbjct: 64 RLRDCLDRQAHELELNNLG-LSSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLV 118
Query: 197 LDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI 256
+ + L L VS N + PE+ NSS L ++D+ +N + ++
Sbjct: 119 DNNNLKALSDLPPL-------LEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KL 168
Query: 257 PMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFY 316
P L + NQL LP L L L +N L L
Sbjct: 169 PDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLP----DLPLSLES 219
Query: 317 LNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQI 376
+ +N + +L L L+ + +NL K ++P +LE+ LN+ N ++ +
Sbjct: 220 IVAGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRDNYLT-DL 272
Query: 377 PACFIGMSGLLSIDISYNELRGPIPN 402
P ++ L + ++ L PN
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPPN 298
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-45
Identities = 69/402 (17%), Positives = 132/402 (32%), Gaps = 42/402 (10%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
+ ++ + L ++ +K LDLS N LS ++ T L L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI 141
S N + +LS L+ + L+NN + E+ + L N + ++ +
Sbjct: 66 SSNVLY-ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201
+ + + +L N +T D G +++LDL
Sbjct: 119 GQG--KKNI-----------------------YLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 202 NNFYG-EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260
N + L L + N I + ++ ++L LDLSSN +A + E
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEF 210
Query: 261 GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320
+ + LR N+L + +AL LE+FDL N + L F +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVA 268
Query: 321 HNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG----QI 376
+ ++ + + L +L++ + + G ++
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328
Query: 377 PACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN 418
+ ID + R I T+ + A
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-41
Identities = 61/397 (15%), Positives = 128/397 (32%), Gaps = 25/397 (6%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
S ++ LDLS N + +KL+ L+LS N L ++ L+
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 76 LFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
L +LDL+ N + +++ + NN +S + + L N+ T
Sbjct: 82 LRTLDLNNNYVQE----LLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM 134
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPN---LRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
+ ++ L + N + ++ + +L +L N + ++
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNE-IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-A 191
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
LK LDLS N + + + + + N + I + S L DL N
Sbjct: 192 KLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 253 AGEIPMEL-GRLISLNKLILRGNQ-LSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF 310
+ + + + + + L+G + T Y L + L
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309
Query: 311 M--FKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLS 368
+ + L+ ++ + + + A E+D ++ I ++ L
Sbjct: 310 LKRKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 369 HNNISGQIPACFIGMSGL---LSIDISYNELRGPIPN 402
+ Q+ + L L + EL+
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-36
Identities = 50/287 (17%), Positives = 101/287 (35%), Gaps = 17/287 (5%)
Query: 112 SIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSL 170
+I E N + + + L + ++ L ++ N L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG 230
+L N L + D L+ LDL++N + TL + NNI+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 231 RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG-HLPRALGLLTE 289
R+ G + L++N I ++ G + L L+ N++ +
Sbjct: 113 RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 290 LEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFK 349
LE+ +L N + ++ KL L+ S N+ + + + A ++ + L +N
Sbjct: 171 LEHLNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 350 GSIPSRICNLESLEKLNLSHNNIS-GQIPACFIGMSGLLSIDISYNE 395
I + ++LE +L N G + F + ++ +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 56/336 (16%), Positives = 103/336 (30%), Gaps = 32/336 (9%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQ--VRNLSKLKYLDLSENELSGKIPPEIGLL 73
L++ + YLDL +N T+ + L++L+L N + + ++ +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLN-EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 74 THLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQF 133
L +LDLS N+ + P + + + +ISL NNKL I + + L + L N F
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 134 TGQLPRNICRSGLLEILTVNDNHFLG-SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
R+ S + TV + N C H G
Sbjct: 250 HCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE---DLPAPFAD 305
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
L L + L+ + T R+ E N ++ +D
Sbjct: 306 RLIALKRKEHA-----------------LLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN--SILEALGF 310
I R + L + L + EL+ + E
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
Query: 311 MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346
+ L + + + E + + D+ +
Sbjct: 409 LQLLRAIVKRYEEMYVEQQ--SVQNNAIRDWDMYQH 442
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 42/215 (19%), Positives = 87/215 (40%), Gaps = 13/215 (6%)
Query: 184 ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLH 243
I E K ++ ++ ++S + L +SGN ++ ++ ++L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 244 VLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNS 303
+L+LSSN + E +L L +L L L N + L + +E ++N ++
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114
Query: 304 ILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKG-SIPSRICNLESL 362
+ ++N+ + D + + LDL N + + ++L
Sbjct: 115 SCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 363 EKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
E LNL +N I + + + L ++D+S N+L
Sbjct: 172 EHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 303 SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESL 362
+I E + + + Q + ++ ELDLS N + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 363 EKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
E LNLS N + + +S L ++D++ N +
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 14/74 (18%), Positives = 31/74 (41%)
Query: 328 IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLL 387
I E ++ + K ++ S + ++++L+LS N +S A + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 388 SIDISYNELRGPIP 401
+++S N L +
Sbjct: 62 LLNLSSNVLYETLD 75
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 3e-45
Identities = 76/326 (23%), Positives = 123/326 (37%), Gaps = 54/326 (16%)
Query: 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNE- 556
E + IG+G + +VY+ L +AVK F+ ++++ F+NE
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF-------ANRQNFINEK 56
Query: 557 -IKALTKIRHRNIVKFYGFCSHVRHS-----FVVYEYINRGSLATVLSNNFASEDFDWRK 610
I + + H NI +F V +V EY GSL LS + DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112
Query: 611 RMNVITGVADALSYMHHD------CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
+ V L+Y+H + P I HRD++S NVL+ + +SDFG + L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 665 NSSNW--------TELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGVLALE 714
N VGT Y+AP G + L E A ++ D+Y+ G++ E
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL-----KQVDMYALGLIYWE 227
Query: 715 VI---KGKHPGDFLSLFS---SSSSSINIEFNAMLD------HRLPHPS--LDVQEKLIS 760
+ PG+ + + + + F M R P + + S
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 761 IMEVALLCLDGCPNSRPTMQTVCQLL 786
+ E C D +R T Q + +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERM 313
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 32/293 (10%)
Query: 496 IMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
I +I + IG G +VY+ K GD +AVK N P Q + F N
Sbjct: 21 IPDGQITVGQR-------IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQ--LQAFKN 69
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E+ L K RH NI+ F G+ + + + V ++ SL L + F+ +K +++
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHAS--ETKFEMKKLIDIA 126
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK--PNSSNWTELV 673
A + Y+H I+HRD+ SNN+ L + ++ DFG A S + +L
Sbjct: 127 RQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 674 GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733
G+ ++AP + + + + + DVY+FG++ E++ G+ P + ++ +
Sbjct: 184 GSILWMAP-------EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI 234
Query: 734 SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ ++ S + +++ +M CL + RP+ + +
Sbjct: 235 IEMVGRGSLSPDLSKVRS-NCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-44
Identities = 93/413 (22%), Positives = 156/413 (37%), Gaps = 29/413 (7%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGF-FGTLPPQVRNLSKLKYLDLSENELS 63
+ T L +L+ F L L+++ N LP NL+ L++LDLS N++
Sbjct: 104 KLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 64 GKIPPEIGLLTHL----FSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEE-IG 118
++ +L + SLDLSLN + P L ++L NN S ++ + I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 119 NLMKLSYLMLDTNQFTGQ---------LPRNICRSGLLEILTVNDNHFLGSIPNL-RNCR 168
L L L +F + +C + E +++L I +L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228
++ L + +DF + L+L + F + K L L + N
Sbjct: 283 NVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKG 337
Query: 229 TGRIPPEIGNSSQLHVLDLSSNHIA--GEIPMELGRLISLNKLILRGNQLSGHLPRALGL 286
E+ S L LDLS N ++ G SL L L N + +
Sbjct: 338 GN-AFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 287 LTELEYFDLSSNRLNN-SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSH 345
L +LE+ D + L S + L YL+ SH L+ L L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 346 NLFKGSIPSRI-CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
N F+ + I L +L L+LS + P F +S L ++++ N+L+
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-43
Identities = 91/438 (20%), Positives = 157/438 (35%), Gaps = 50/438 (11%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
T+++ ++ S HL+ L L+ N +L LS L+ L E L+ IG L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGN-PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 75 HLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSY----LML 128
L L+++ N P NL+NL+++ L +NK+ ++ L ++ L L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 129 DTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP--------NLRNCRSLVRAHLGRNNL 180
N + + L LT+ +N ++ L R ++ NL
Sbjct: 185 SLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 181 TGNISEDFGIYPNLKFLDLSHN---NFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIG 237
NL + + +I + + + + I R+
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY 302
Query: 238 NSS--------------------QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
N L L +SN G E+ L SL L L N LS
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG-GNAFSEVD-LPSLEFLDLSRNGLS 360
Query: 278 --GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-LAL 334
G ++ T L+Y DLS N + ++ + +L +L+F H+ Q
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 335 LAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDISY 393
L +L LD+SH + + L SLE L ++ N+ F + L +D+S
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 394 NELRGPIPNSTVFRNAPR 411
+L + + F +
Sbjct: 480 CQLEQ-LSPT-AFNSLSS 495
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-39
Identities = 81/407 (19%), Positives = 132/407 (32%), Gaps = 41/407 (10%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKY----LDLSEN 60
+N+ ++ FS+ +L +LDLS N +R L ++ LDLS N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 61 ELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISL------HNNKLSGS 112
++ I P L L L N S I L+ L+ L + L
Sbjct: 188 PMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 113 IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND--NHFLGSIPNLRNCRSL 170
+ L L+ L I L ++ + + + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW 306
Query: 171 VRAHLGRN--------------------NLTGNISEDFGIYPNLKFLDLSHN--NFYGEI 208
L N GN + + P+L+FLDLS N +F G
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCC 365
Query: 209 SSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLN 267
S + L L +S N + + QL LD +++ L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQFSQ 326
L + L+ LE ++ N + L + + L +L+ S Q Q
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 327 EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373
P L+ L L+++ N K L SL+K+ L N
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-37
Identities = 84/391 (21%), Positives = 127/391 (32%), Gaps = 51/391 (13%)
Query: 25 FPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83
LDLS N L + +L+ LDLS E+ L+HL +L L+
Sbjct: 27 PFSTKNLDLSFN-PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85
Query: 84 NQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI 141
N + LS+L+ + L+ IG+L L L + N
Sbjct: 86 NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ------- 137
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF----L 197
N +L L N + D + + L
Sbjct: 138 ---------------SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 198 DLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPE-IGNSSQLHVLDLSSNHIAGEI 256
DLS N I K RL L + N + + I + L V L E
Sbjct: 183 DLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 257 PME------LGRLISLNKLILRGNQLSG---HLPRALGLLTELEYFDLSSNRLNNSILEA 307
+E L L +L R L + LT + F L S + ++
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKD 299
Query: 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNL 367
+ F +L + +F Q P L L L + N + +L SLE L+L
Sbjct: 300 FSYNFGWQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDL 354
Query: 368 SHNNIS--GQIPACFIGMSGLLSIDISYNEL 396
S N +S G G + L +D+S+N +
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 81/385 (21%), Positives = 125/385 (32%), Gaps = 57/385 (14%)
Query: 16 TLQEFSFSSFPHLAY----LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPE-I 70
++ + LDLS+N + P +L L L N S + I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLN-PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 71 GLLTHLFSLDLSLNQF----------SGTFPPICNLS----------------------- 97
L L L L +F +CNL+
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 98 -NLKYISLHNNKLSGSIPEEIG--NLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND 154
N+ SL + + + + L + QF ++ L+ LT
Sbjct: 282 TNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKS------LKRLTFTS 334
Query: 155 NHFLGSIPNLRNCRSLVRAHLGRNNLT--GNISEDFGIYPNLKFLDLSHNNFYGEISSNW 212
N G+ + + SL L RN L+ G S+ +LK+LDLS N +SSN+
Sbjct: 335 NK-GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 213 GKCHRLGTLIVSGNNITGRIPPEI--GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLI 270
+L L +N+ ++ + L LD+S H L SL L
Sbjct: 393 LGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 271 LRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIP 329
+ GN + L L + DLS +L A + L LN + NQ
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511
Query: 330 EDLALLAHLSELDLSHNLFKGSIPS 354
L L ++ L N + S P
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-24
Identities = 56/305 (18%), Positives = 108/305 (35%), Gaps = 24/305 (7%)
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPN 193
++P N+ S + L ++ N L + + + L L R + + +
Sbjct: 21 KIPDNLPFS--TKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 194 LKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIA 253
L L L+ N + L L+ N+ IG+ L L+++ N I
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 254 -GEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYF----DLSSNRLNNSILEAL 308
++P L +L L L N++ L +L ++ DLS N +N A
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 309 GFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLFKG---------SIPSRICN 358
+ +L L +N S + + + LA L L F+ S +CN
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 359 LESLEKLNLSHNNISG-QIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGN 417
L ++E+ L++ + I F ++ + S + + + + + +
Sbjct: 257 L-TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNC 314
Query: 418 NFSTF 422
F F
Sbjct: 315 KFGQF 319
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 54/247 (21%), Positives = 87/247 (35%), Gaps = 17/247 (6%)
Query: 192 PNLKFLDLSHNNFY---GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248
PN+ + NFY + + L +S N + + +L VLDLS
Sbjct: 8 PNITY-QCMELNFYKIPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEAL 308
I L L+ LIL GN + A L+ L+ L + +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 309 GFMFKLFYLNFSHNQF-SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLE---- 363
G + L LN +HN S ++PE + L +L LDLS N + + + L +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 364 KLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFY 423
L+LS N ++ P F + L + + N + T + F
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVM-KTCIQGLAGLEVHRLVLGEFR 238
Query: 424 GTSDLLS 430
+L
Sbjct: 239 NEGNLEK 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 6/109 (5%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGK 65
+ + F+ +L +LDLS L P +LS L+ L+++ N+L
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMASNQLK-S 508
Query: 66 IPPEI-GLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSI 113
+P I LT L + L N + + P I LS +++ ++ K GS
Sbjct: 509 VPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR--WLNKNSQKEQGSA 555
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 57/342 (16%), Positives = 104/342 (30%), Gaps = 27/342 (7%)
Query: 39 FGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSN 98
G+ + S + L + + ++ D + + N +N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA---NSNN 57
Query: 99 LKYISLHNNKLSGSIPEEIGNL--MKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH 156
+ + L + + + + L L + Q P R L+ +T++
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 157 FLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKC 215
L +P+ ++ L L RN L + L+ L + E+
Sbjct: 116 -LMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 216 HRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQ 275
E L L L I +P + L +L L +R +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 276 LSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALL 335
LS L A+ L +LE DL + G L L +P D+ L
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 336 AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIP 377
L +LDL + +PS I L + + + + +
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 48/321 (14%), Positives = 98/321 (30%), Gaps = 23/321 (7%)
Query: 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87
L + + + D + + + + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK 69
Query: 88 GTFPPI--CNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG 145
T + + L + L P++ L L ++ +D +LP + +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 146 LLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYP---------NLK 195
LE LT+ N L ++P + + L + + E NL+
Sbjct: 128 GLETLTLARNP-LRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 196 FLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255
L L + ++ L +L + + ++ + P I + +L LDL
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244
Query: 256 IPMELGRLISLNKLILRG-NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKL 314
P G L +LIL+ + L LP + LT+LE DL + + + +
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 315 FYLNFSHNQFSQEIPEDLALL 335
+ + +Q
Sbjct: 304 CIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 43/270 (15%), Positives = 86/270 (31%), Gaps = 24/270 (8%)
Query: 147 LEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
E L + L + L + A R + + N ++
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----NNPQIETRTGRAL 68
Query: 206 GEISSNWGKCHRLG--TLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL 263
+ + G L + + + P + S L + + + + E+P + +
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSS-NRL--------NNSILEALGFMFKL 314
L L L N L LP ++ L L + + L + + L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 315 FYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374
L + +P +A L +L L + ++ ++ I +L LE+L+L
Sbjct: 186 QSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 375 QIPACFIGMSGLLSIDIS-YNELRGPIPNS 403
P F G + L + + + L +P
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLT-LPLD 272
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 77/406 (18%), Positives = 135/406 (33%), Gaps = 53/406 (13%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSL 79
+ + + + + L+ K + + + K+P + + L
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74
Query: 80 DLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFT 134
+L+ Q F ++ + + N + +P + N+ L+ L+L+ N +
Sbjct: 75 NLNDLQIEEIDTYAFA---YAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 135 GQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNL 194
LPR I N L + NNL + F +L
Sbjct: 131 -SLPRGI----------------------FHNTPKLTTLSMSNNNLERIEDDTFQATTSL 167
Query: 195 KFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254
+ L LS N + L VS N ++ + + LD S N I
Sbjct: 168 QNLQLSSNRL-THVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN- 218
Query: 255 EIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKL 314
+ + + L L L+ N L+ L L DLS N L + M +L
Sbjct: 219 VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274
Query: 315 FYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374
L S+N+ + + L LDLSHN + + LE L L HN+I
Sbjct: 275 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 331
Query: 375 QIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFS 420
+ L ++ +S+N+ +FRN R + +
Sbjct: 332 TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-38
Identities = 68/339 (20%), Positives = 118/339 (34%), Gaps = 34/339 (10%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGL-L 73
L SF + L+L+ + ++ L + N + +PP + +
Sbjct: 59 KLPAALLDSFRQVELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 116
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLML 128
L L L N S G F N L +S+ NN L I ++ L L L
Sbjct: 117 PLLTVLVLERNDLSSLPRGIF---HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 172
Query: 129 DTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDF 188
+N+ T + ++ S L V+ N L ++ L N++ +
Sbjct: 173 SSNRLT-HVDLSLIPS--LFHANVSYNL-LSTLAIPIAVEEL---DASHNSIN-VVRG-- 222
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDL 247
+ L L L HNN ++ L + +S N + +I +L L +
Sbjct: 223 PVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 279
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEA 307
S+N + + + + +L L L N L H+ R LE L N + ++
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTL--K 334
Query: 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346
L L L SHN + AL +++ +
Sbjct: 335 LSTHHTLKNLTLSHNDWD--CNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 58/301 (19%), Positives = 113/301 (37%), Gaps = 20/301 (6%)
Query: 101 YISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGS 160
Y I + + +D +I+T ++ +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRK 59
Query: 161 IPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRL 218
+P L + R + +L + + F ++ L + N + L
Sbjct: 60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119
Query: 219 GTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELGR-LISLNKLILRGNQL 276
L++ N+++ +P I N+ +L L +S+N++ I + + SL L L N+L
Sbjct: 120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL 177
Query: 277 SGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLA 336
+ H+ L L+ L + ++S N L+ L + L+ SHN + + +
Sbjct: 178 T-HVD--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPV--NV 226
Query: 337 HLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
L+ L L HN + N L +++LS+N + + F+ M L + IS N L
Sbjct: 227 ELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
Query: 397 R 397
Sbjct: 285 V 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 47/302 (15%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNE--IKALTKIRHRNIVK 570
C+GKG + V+R G+ +AVK F+S D+K + E + +RH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 571 FYGFCSHVRHSFVVY----EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
F RHS Y GSL L D + ++ +A L+++H
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLH 122
Query: 627 HDCF-----PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS----NWTELVGTFG 677
+ F P I HRD+ S N+L+ + ++D G A + +++ VGT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS---SSSSS 734
Y+AP + + + ++ D+++FG++ EV + + +
Sbjct: 183 YMAPEVLDETIQVDCFDS----YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 735 INIEFNAMLD------HRLPHP----SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ F M R P S L +M+ C P++R T + +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKK 295
Query: 785 LL 786
L
Sbjct: 296 TL 297
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-42
Identities = 93/453 (20%), Positives = 157/453 (34%), Gaps = 46/453 (10%)
Query: 6 INLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSG 64
+ L S T+ + +F + P+L LDL + L P + L L L L LS
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 65 KIPPEIGL--LTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPEEIGNL 120
+ + L L LDLS NQ + L++LK I +N++ E+ L
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
Query: 121 --MKLSYLMLDTNQFTGQLPRNICRSG------LLEILTVNDNHFLGSIPN--------- 163
LS+ L N ++ + + +LEIL V+ N + I
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 164 ----LRNCRSLVRAHLGRNNLTGNISEDFG--IYPNLKFLDLSHNNFYGEISSNWGKCHR 217
L ++ A G +N+ F +++ LDLSH + S +
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 218 LGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
L L ++ N I L VL+LS N + L + + L+ N ++
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAH 337
+ L +L+ DL N L + F+ + + S N+ +L
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLVTLPKINLT---- 402
Query: 338 LSELDLSHNLFKG-SIPSRICNLESLEKLNLSHNNISG-QIPACFIGMSGLLSIDISYNE 395
+ + LS N + I + + L+ L L+ N S L + + N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 396 LRGPIPNS---TVFRNAPRESFL---GNNFSTF 422
L+ VF L N ++
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL 495
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-39
Identities = 80/380 (21%), Positives = 133/380 (35%), Gaps = 35/380 (9%)
Query: 47 RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQFSGTFPP--ICNLSNLKYIS 103
+ L+ + L LS N + + L L L+L T NL NL+ +
Sbjct: 21 QVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHF--LG 159
L ++K+ P+ L L L L + + ++ L L L ++ N L
Sbjct: 80 LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 160 SIPNLRNCRSLVRAHLGRNNLTGNISEDFG--IYPNLKFLDLSHNNFYGEISSNWGKCH- 216
P+ SL N + + L F L+ N+ Y +S +WGKC
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 217 -----RLGTLIVSGNNITGRIP------------PEIGNSSQLHVLDLSSNHIAGEIPME 259
L L VSGN T I + + + ++I
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 260 LGRL--ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYL 317
L S+ L L + R L +L+ +L+ N++N EA + L L
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVL 319
Query: 318 NFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIP 377
N S+N + + L ++ +DL N LE L+ L+L N ++
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT---- 375
Query: 378 ACFIGMSGLLSIDISYNELR 397
+ + I +S N+L
Sbjct: 376 -TIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-35
Identities = 83/441 (18%), Positives = 146/441 (33%), Gaps = 68/441 (15%)
Query: 20 FSFSSFPHLAYLDLSIN-------GFFGTLPPQVRNLSKLKYLDLSENELSGKIP----- 67
L++ L+ N +G RN+ L+ LD+S N + I
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV-LEILDVSGNGWTVDITGNFSN 226
Query: 68 -------PEIGLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEE 116
+ L H+ + TF + S+++++ L + +
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR-SSVRHLDLSHGFVFSLNSRV 285
Query: 117 IGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLG 176
L L L L N+ + D F +L +L
Sbjct: 286 FETLKDLKVLNLAYNKIN----------------KIADEAF-------YGLDNLQVLNLS 322
Query: 177 RNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI 236
N L S +F P + ++DL N+ + +L TL + N +T I
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TI 377
Query: 237 GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA-LGLLTELEYFDL 295
+ + LS N + + L + N + L N+L L + L+ L
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 296 SSNRLNNSILEAL-GFMFKLFYLNFSHNQFSQEIPEDLAL-----LAHLSELDLSHNLFK 349
+ NR ++ + L L N +L L+HL L L+HN
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 350 GSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNA 409
P +L +L L+L+ N ++ + + + L +DIS N+L P P+ F +
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL-PANLEILDISRNQLLAPNPDV--FVSL 549
Query: 410 PRESFLGNNFSTFYGTSDLLS 430
N F S ++
Sbjct: 550 SVLDITHNKFICECELSTFIN 570
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-33
Identities = 59/348 (16%), Positives = 116/348 (33%), Gaps = 34/348 (9%)
Query: 79 LDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLP 138
+ L+ + + L N + L +L L L + +
Sbjct: 9 AFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 139 RNICRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISED--FGIYPN 193
+ R+ L IL + + + + + L L L+ + +D F
Sbjct: 66 KEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 194 LKFLDLSHNNFYG-EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS---SQLHVLDLSS 249
L LDLS N + ++GK + L ++ S N I + L L++
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAA 183
Query: 250 NHIAGEIPMELG------RLISLNKLILRGNQLSGHLPRA------------LGLLTELE 291
N + + ++ G R + L L + GN + + L L +
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 292 YFDLSSNRLNNSILEALGFMFK--LFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFK 349
+ + + + + + +L+ SH L L L+L++N
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 350 GSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
L++L+ LNLS+N + + F G+ + ID+ N +
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 24/119 (20%), Positives = 36/119 (30%), Gaps = 5/119 (4%)
Query: 294 DLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIP 353
L + + L L S N L L L+L +I
Sbjct: 10 FYRFCNLT-QVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 354 SRIC-NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPR 411
NL +L L+L + I P F G+ L + + + L + FRN
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 17/211 (8%)
Query: 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV--RNLSKLKYLDLSENE 61
N I+L+ L+ + PHL L L+ N F + L+ L L EN
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQN-RFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 62 LSGKIPPEIGL-----LTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIP 114
L E+ L+HL L L+ N + + PP +L+ L+ +SL++N+L+ +
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 115 EEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAH 174
L L + NQ ++ S L +L + N F+ L +
Sbjct: 521 HND-LPANLEILDISRNQLL-APNPDVFVS--LSVLDITHNKFICECELSTFINWLNHTN 576
Query: 175 LGRNNLTGNISEDF-GIYPNLKFLDLSHNNF 204
+ +I + + + LS
Sbjct: 577 VTIAGPPADIYCVYPDSFSGVSLFSLSTEGC 607
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 68/300 (22%), Positives = 114/300 (38%), Gaps = 43/300 (14%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG + V+ K G+K+AVK F + ++ S +E EI +RH NI+ F
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRE--TEIYQTVLMRHENILGFI 97
Query: 573 GFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
S +++ +Y GSL L + D + + + L ++H +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 629 CF-----PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW----TELVGTFGYV 679
F P I HRD+ S N+L+ ++D G A +++ VGT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLS---LFSSSSSSIN 736
P + L+ D+YSFG++ EV + G + L +
Sbjct: 214 PPEVLDESLNRNHFQS----YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 737 IEFNAMLD------HRLPHPSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ M + R P+ + ++ +M C P SR T V + L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTL 326
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 65/350 (18%), Positives = 119/350 (34%), Gaps = 40/350 (11%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
+ ++ + L ++ +K LDLS N LS ++ T L L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI 141
S N + +LS L+ + L+NN + E+ + L N + ++ +
Sbjct: 66 SSNVLY-ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201
+ + + +L N +T D G +++LDL
Sbjct: 119 GQG--KKNI-----------------------YLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 202 NNFYG-EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260
N + L L + N I + ++ + L LDLSSN +A + E
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEF 210
Query: 261 GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320
+ + LR N+L + +AL LE+FDL N + L F +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVA 268
Query: 321 HNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSH 369
+++ + L +P+ L +L + H
Sbjct: 269 KQTV-KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 50/308 (16%), Positives = 102/308 (33%), Gaps = 39/308 (12%)
Query: 112 SIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLV 171
+I E N + + + Q ++ ++ ++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASL----------------------RQSAWNVK 37
Query: 172 RAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR 231
L N L+ + D + L+ L+LS N Y + + L TL ++ N +
Sbjct: 38 ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-- 93
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291
E+ + L ++N+I+ + G+ + L N+++ G + ++
Sbjct: 94 ---ELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 292 YFDLSSNRLNN-SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKG 350
Y DL N ++ + E L +LN +N ++ + A L LDLS N
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA- 204
Query: 351 SIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAP 410
+ + + ++L +N + I L D+ N F
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQ 262
Query: 411 RESFLGNN 418
R +
Sbjct: 263 RVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 40/192 (20%), Positives = 72/192 (37%), Gaps = 13/192 (6%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQ--VRNLSKLKYLDLSENELSGKIPPEIGLL 73
L++ + YLDL +N T+ + L++L+L N + + ++ +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLN-EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 74 THLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQF 133
L +LDLS N+ + P + + + +ISL NNKL I + + L + L N F
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 134 TGQLPRNICRSGLLEILTVNDNHFLG-SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
S + TV + N C H G ++ F
Sbjct: 250 H-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG-AYCCEDLPAPFA--- 304
Query: 193 NLKFLDLSHNNF 204
+ + L H++
Sbjct: 305 -DRLIALGHHHH 315
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-41
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 51/304 (16%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNE--IKALTKIRHRNIVK 570
IGKG V+R K G+++AVK F+S +++ + E I +RH NI+
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 100
Query: 571 FYGFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
F + + ++V +Y GSL L+ + + A L+++H
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLH 156
Query: 627 HDCF-----PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS----NWTELVGTFG 677
+ P I HRD+ S N+L+ ++D G A + VGT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 678 YVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLS---LFSSSS 732
Y+AP +I + E ++ D+Y+ G++ E+ + G L
Sbjct: 217 YMAPEVLDDSINMKHFE------SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 733 SSINIEFNAMLD------HRLPHP----SLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ M R P S + + IM C +R T +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRI 327
Query: 783 CQLL 786
+ L
Sbjct: 328 KKTL 331
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-40
Identities = 71/404 (17%), Positives = 144/404 (35%), Gaps = 36/404 (8%)
Query: 25 FPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLS 82
+ LDLS N + R + L+ L L + ++ I + L L LDLS
Sbjct: 25 TAAMKSLDLSFN-KITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLS 82
Query: 83 LNQFSGTFPPIC--NLSNLKYISLHNNKLSG-SIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
N S + LS+LKY++L N + NL L L + + ++ R
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 140 NICRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF 196
L L + L + + L++ R + L + + I ++++
Sbjct: 142 IDFAGLTSLNELEIKALS-LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 197 LDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG----------RIPPEIGNSSQLHVLD 246
L+L N S + + ++ I S++ D
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 247 LSSNHIAG------EIPMELGRL--ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSN 298
+ N + ++ ELG++ +++ +L + L L LL +++ + ++
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 299 RLNNSILEALGFMFKLFYLNFSHNQFSQEIPED---LALLAHLSELDLSHNLFK--GSIP 353
++ + L +L+ S N +E ++ L L LS N +
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 354 SRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
+ L++L L++S N +P + +++S +R
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-40
Identities = 79/447 (17%), Positives = 154/447 (34%), Gaps = 49/447 (10%)
Query: 6 INLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSG 64
++L+ L +L F L YL+L N + + NL+ L+ L + E
Sbjct: 79 LDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 65 KIPPE-IGLLTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPEEIGNLM 121
+I LT L L++ + + ++ ++ +++LH ++ + + L
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 122 KLSYLMLDTNQ--------FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRA 173
+ YL L + + + D F + LR L
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
Query: 174 HLGRNNLTGNISEDFGI-----------YPNLKFLDLSHNNFYGEISSNWGKCHRLGTLI 222
L G + ++ L + + ++S+ + ++ +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 223 VSGNNITGRIPPEIGNS-SQLHVLDLSSNHIAGEIPME---LGRLISLNKLILRGNQLSG 278
V + + +P L LDLS N + E G SL L+L N L
Sbjct: 317 VENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR- 374
Query: 279 HLPRALGL---LTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALL 335
+ + + L L D+S N + + ++ + K+ +LN S + +
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--P 430
Query: 336 AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNE 395
L LD+S+N S L L++L +S N + +P + LL + IS N+
Sbjct: 431 QTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQ 484
Query: 396 LRGPIPNSTVFRNAPRESFL---GNNF 419
L+ +F + N +
Sbjct: 485 LKSVPDG--IFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-34
Identities = 71/395 (17%), Positives = 140/395 (35%), Gaps = 39/395 (9%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELS 63
++ + + ++ F+ L L++ Q +++ + +L L +E +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKAL-SLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 64 GKIPPEIGLLTHLFSLDLSLNQ----FSGTFPPICNLSNLKYISLHNNKLS----GSIPE 115
+ +L+ + L+L P S +K ++ + L+ + +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 116 EIGNLMKLSYLMLDTNQFTGQL------PRNICRSGLLEILTVNDNHF----LGSIPN-- 163
+ +++LS + D G + G +E +T+ H L +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 164 LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNW---GKCHRLGT 220
+ R + + + +L+FLDLS N E N G L T
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 221 LIVSGNNITGRIPPEIG---NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
L++S N++ + L LD+S N +P + L L +
Sbjct: 366 LVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR 423
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAH 337
+ + LE D+S+N L++ L F+ +L L S N+ +P+ +L
Sbjct: 424 -VVKT--CIPQTLEVLDVSNNNLDSFSL----FLPRLQELYISRNKLKT-LPDA-SLFPV 474
Query: 338 LSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372
L + +S N K L SL+K+ L N
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 64/410 (15%), Positives = 137/410 (33%), Gaps = 53/410 (12%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLH 105
+ D + IP GL + SLDLS N+ + + +NL+ + L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILK 58
Query: 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLR 165
+++++ + +L L +L L N + L +
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW----------------------FG 95
Query: 166 NCRSLVRAHLGRNNLTG-NISEDFGIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIV 223
SL +L N ++ F NL+ L + + + EI L L +
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
++ + + +H L L + A + + L S+ L LR L+
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP 215
Query: 284 LGLLTELEYFDLSSNRLN-------NSILEALGFMFKLFYLNFSHNQFSQ---------E 327
L + + R + N +L+ L ++ +L + F + +
Sbjct: 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
Query: 328 IPEDLALL--AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
+ +L + + L + + + LE ++++ + ++ + + +
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335
Query: 386 LLSIDISYNEL-RGPIPNSTVFRNAPRESFL---GNNFSTFYGTSDLLSH 431
L +D+S N + + NS P L N+ + T ++L
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 49/289 (16%), Positives = 89/289 (30%), Gaps = 35/289 (12%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
L E F D + + ++ L + + L + LL +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 77 FSLDLSLNQFSGTFPPIC-NLSNLKYISLHNNKLSGSIPEE---IGNLMKLSYLMLDTNQ 132
+ + ++ +L +L+++ L N + + G L L+L N
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 133 FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
L + L L+N SL + RN + +
Sbjct: 373 --------------LRSMQKTGEILL----TLKNLTSL---DISRNTFH-PMPDSCQWPE 410
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
++FL+LS L L VS NN+ + +L L +S N +
Sbjct: 411 KMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKL 463
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301
+P + L + + NQL LT L+ L +N +
Sbjct: 464 K-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-20
Identities = 41/210 (19%), Positives = 76/210 (36%), Gaps = 16/210 (7%)
Query: 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQ---VRNLSKLKYLDLS 58
+V I + ++ + + L +LDLS N L+ L LS
Sbjct: 311 KVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 59 ENELSGKIPPEIGL---LTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPE 115
+N L + + L +L SLD+S N F +++++L + + +
Sbjct: 370 QNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKT 427
Query: 116 EIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHL 175
I L L + N + R L+ L ++ N L ++P+ L+ +
Sbjct: 428 CI--PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNK-LKTLPDASLFPVLLVMKI 480
Query: 176 GRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
RN L F +L+ + L N +
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-40
Identities = 86/446 (19%), Positives = 150/446 (33%), Gaps = 57/446 (12%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKI 66
N+ + + + + + + + L+ K + + + K+
Sbjct: 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KL 66
Query: 67 PPEI-GLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNL 120
P + + L+L+ Q F ++ + + N + +P + N+
Sbjct: 67 PAALLDSFRQVELLNLNDLQIEEIDTYAFA---YAHTIQKLYMGFNAIR-YLPPHVFQNV 122
Query: 121 MKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180
L+ L+L+ N + LPR I N L + NNL
Sbjct: 123 PLLTVLVLERNDLS-SLPRGI----------------------FHNTPKLTTLSMSNNNL 159
Query: 181 TGNISED-FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS 239
I +D F +L+ L LS N + + L VS N ++ +
Sbjct: 160 E-RIEDDTFQATTSLQNLQLSSNRL-THVDLSL--IPSLFHANVSYNLLS-----TLAIP 210
Query: 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR 299
+ LD S N I + + + L L L+ N L+ L L DLS N
Sbjct: 211 IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNE 265
Query: 300 LNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNL 359
L + M +L L S+N+ + + L LDLSHN +
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323
Query: 360 ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGN-- 417
+ LE L L HN+I + L ++ +S+N+ +FRN R +
Sbjct: 324 DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQ 379
Query: 418 NFSTFYGTSDLLSHKEASKKTPFLIL 443
+ Y L KE+ K +L
Sbjct: 380 HCKIDYQLEHGLCCKESDKPYLDRLL 405
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 5e-19
Identities = 48/300 (16%), Positives = 96/300 (32%), Gaps = 27/300 (9%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
L S P L + ++S N + ++ LD S N ++ + + L
Sbjct: 183 LTHVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVEL 234
Query: 77 FSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTG 135
L L N + + N L + L N+L I + +L L + N+
Sbjct: 235 TILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV- 291
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLK 195
L L++L ++ NH L N L +L N++ + + LK
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLK 348
Query: 196 FLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS----------SQLHVL 245
L LSHN++ + V + +I ++ + +
Sbjct: 349 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
++ + ++ GR + + + + + L E + N L +
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 55/357 (15%), Positives = 111/357 (31%), Gaps = 15/357 (4%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
++P L +DLS N + + +L+ L +S N L + + L L
Sbjct: 249 WLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
DLS N L+ + L +N + ++ + L L L N + R
Sbjct: 307 DLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLR 363
Query: 140 NICRSGLLEILTVNDNHFLGSIPNLRN--CRSLVRAHLGRNNLTGNISEDFGIYPNLKFL 197
+ R+ + D H C+ + +L R ++
Sbjct: 364 ALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALT-SVVEKVQRAQG 422
Query: 198 DLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS-SQLHVLDLSSNHIAGEI 256
S + + S + G + + GN E+ QL + + +
Sbjct: 423 RCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGL 482
Query: 257 PMELGRLISLNKLILRG-NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF 315
E+ + +L G + S +L + L E + F L EA +
Sbjct: 483 HAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRET--QARRTEADAKQKETE 540
Query: 316 YLNFSHNQFSQEI-PEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
L + +++ + E L K + ++ +++ H++
Sbjct: 541 DLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ-LEAKKNRNPDTRRVSHHHHH 596
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-39
Identities = 67/330 (20%), Positives = 117/330 (35%), Gaps = 44/330 (13%)
Query: 49 LSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNK 108
+ L++ E+ L+ +P + H+ +L + N + + P L+ + + N+
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA--LPPELRTLEVSGNQ 92
Query: 109 LSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNC 167
L+ S+P L++LS LP L L + N L S+P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLP-ALPSG------LCKLWIFGNQ-LTSLPVLPPGL 143
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
+ L + N L ++ L L +N + L L VS N
Sbjct: 144 QEL---SVSDNQLA-SLPALPS---ELCKLWAYNNQL-TSLPMLPSG---LQELSVSDNQ 192
Query: 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287
+ +P L+ L +N + +P L +LI+ GN+L+ LP L
Sbjct: 193 LA-SLPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPSEL 243
Query: 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNL 347
EL +S NRL S+ L L+ NQ + +PE L L+ + ++L N
Sbjct: 244 KEL---MVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 348 FKGSIPSRICNLESLEKLNLSHNNISGQIP 377
+ + S +
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-37
Identities = 67/307 (21%), Positives = 114/307 (37%), Gaps = 45/307 (14%)
Query: 92 PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILT 151
C + +++ + L+ ++P+ + ++ L++ N T LP L L
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLE 87
Query: 152 VNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210
V+ N L S+P L +L S L L + N +
Sbjct: 88 VSGNQ-LTSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSLPV 138
Query: 211 NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLI 270
L L VS N + +P L L +N + +PM L L+
Sbjct: 139 LPPG---LQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQELS--- 187
Query: 271 LRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPE 330
+ NQL+ LP L +L +NRL S+ L L S N+ + +P
Sbjct: 188 VSDNQLA-SLPTLPSELYKLW---AYNNRL-TSLPALPS---GLKELIVSGNRLT-SLPV 238
Query: 331 DLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSID 390
L + L EL +S N S+P L S L++ N ++ ++P I +S +++
Sbjct: 239 ---LPSELKELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 391 ISYNELR 397
+ N L
Sbjct: 291 LEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-35
Identities = 75/346 (21%), Positives = 116/346 (33%), Gaps = 47/346 (13%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
L H+ L + N +LP +L+ L++S N+L+ +P L L
Sbjct: 52 LTTLPDCLPAHITTLVIPDNNL-TSLPA---LPPELRTLEVSGNQLT-SLPVLPPGLLEL 106
Query: 77 FSLDLSLNQFSGTFPPICNL--------------SNLKYISLHNNKLSGSIPEEIGNLMK 122
L +C L L+ +S+ +N+L+ S+P L K
Sbjct: 107 SIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCK 165
Query: 123 LSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLT 181
L NQ T LP L+ L+V+DN L S+P L + +L
Sbjct: 166 LW---AYNNQLT-SLPMLPSG---LQELSVSDNQ-LASLPTLPSELYKLWAYNNRLTSLP 217
Query: 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ 241
S LK L +S N + + L L+VSGN +T +P
Sbjct: 218 ALPS-------GLKELIVSGNRL-TSLPVLPSE---LKELMVSGNRLT-SLPMLPSG--- 262
Query: 242 LHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301
L L + N + +P L L S + L GN LS +AL +T + R +
Sbjct: 263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
Query: 302 NSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNL 347
+ A L + + A N
Sbjct: 322 MAGASAPRETRALHLAAA--DWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-36
Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 22/313 (7%)
Query: 25 FPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLS 82
LDL N TL + L+ L+L+EN +S + P L +L +L L
Sbjct: 31 PTETRLLDLGKN-RIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLR 88
Query: 83 LNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQL 137
N+ G F LSNL + + NK+ + + + +L L L + N +
Sbjct: 89 SNRLKLIPLGVFT---GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YI 143
Query: 138 PRNICRSGL--LEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPN 193
SGL LE LT+ + L SIP L + L+ L N+ F
Sbjct: 144 SHR-AFSGLNSLEQLTLEKCN-LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 194 LKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPE-IGNSSQLHVLDLSSNHI 252
LK L++SH + ++ N L +L ++ N+T +P + + L L+LS N I
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMF 312
+ L L+ L ++ L G QL+ P A L L ++S N+L +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG 320
Query: 313 KLFYLNFSHNQFS 325
L L N +
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 62/298 (20%), Positives = 103/298 (34%), Gaps = 22/298 (7%)
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISED-FGIYP 192
+P I +L + N + ++ + L L N ++ + F
Sbjct: 25 AVPEGIPTE--TRLLDLGKNR-IKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLF 80
Query: 193 NLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSN 250
NL+ L L N I L L +S N I + + + L L++ N
Sbjct: 81 NLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN 138
Query: 251 HIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALG 309
+ I L SL +L L L+ AL L L L +N +
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
Query: 310 FMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLS 368
+++L L SH + + + +L+ L ++H ++P +L L LNLS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256
Query: 369 HNNISGQIPAC-FIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFL---GNNFSTF 422
+N IS I + L I + +L + FR L GN +T
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPYA-FRGLNYLRVLNVSGNQLTTL 311
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 36/149 (24%), Positives = 60/149 (40%), Gaps = 13/149 (8%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPE-IGLLT 74
++++SF L L++S + T+ P L L ++ L+ +P + L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248
Query: 75 HLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLD 129
+L L+LS N S L L+ I L +L+ + L L L +
Sbjct: 249 YLRFLNLSYNPISTIEGSMLH---ELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVS 304
Query: 130 TNQFTGQLPRNICRS-GLLEILTVNDNHF 157
NQ T L ++ S G LE L ++ N
Sbjct: 305 GNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-36
Identities = 69/381 (18%), Positives = 132/381 (34%), Gaps = 41/381 (10%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
S L LD + T + L+ L L + N ++ ++ T+L
Sbjct: 33 TDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNITT---LDLSQNTNL 87
Query: 77 FSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQ 136
L N+ + + L+ L Y++ NKL+ + + L+YL N T +
Sbjct: 88 TYLACDSNKLTNL--DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-E 141
Query: 137 LPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF 196
+ + L L + N + + ++ L N +T D L
Sbjct: 142 IDVSHNTQ--LTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKIT---ELDVSQNKLLNR 195
Query: 197 LDLSHNNFYGEISS-NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255
L+ NN I+ + + +L L S N +T I + +QL D S N + E
Sbjct: 196 LNCDTNN----ITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-E 247
Query: 256 IPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF 315
+ + L L L L + L T+L YF R + + +L+
Sbjct: 248 LD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLY 300
Query: 316 YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375
L+ ++ DL+ L L L++ + + + L+ L+ + +I
Sbjct: 301 LLDCQAAGITE---LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-D 353
Query: 376 IPACFIGMSGLLSIDISYNEL 396
+ + L + + +
Sbjct: 354 FSS-VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 78/371 (21%), Positives = 128/371 (34%), Gaps = 37/371 (9%)
Query: 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ 85
+ A + T L+ L LD + ++ I LT L L + N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75
Query: 86 FSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG 145
T + +NL Y++ +NKL+ ++ + L KL+YL DTN+ T +L +
Sbjct: 76 I--TTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPL- 128
Query: 146 LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
L L N L I + + L N + D L LD S N
Sbjct: 129 -LTYLNCARNT-LTEID-VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI- 182
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
+ + L L NNIT ++ + QL LD SSN + EI + L
Sbjct: 183 --TELDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325
L N L+ L + L++L L L +L Y +
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNT---QLIYFQAEGCRKI 288
Query: 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385
+E+ D+ L LD + + L L L++ ++ ++ +
Sbjct: 289 KEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS--HNTK 340
Query: 386 LLSIDISYNEL 396
L S+ +
Sbjct: 341 LKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 73/394 (18%), Positives = 138/394 (35%), Gaps = 43/394 (10%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
+ S +L YL N L V L+KL YL+ N+L+ K+ + L
Sbjct: 76 ITTLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLL 129
Query: 77 FSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQ 136
L+ + N T + + + L + H NK + + +L+ L N+ T +
Sbjct: 130 TYLNCARNTL--TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-E 184
Query: 137 LPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF 196
L + ++ LL L + N+ + + L L N LT D L +
Sbjct: 185 LD--VSQNKLLNRLNCDTNN-ITKLD-LNQNIQLTFLDCSSNKLT---EIDVTPLTQLTY 237
Query: 197 LDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI 256
D S N + +L TL ++ I + +++QL E+
Sbjct: 238 FDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL 291
Query: 257 PMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFY 316
++ L L + ++ L L +L Y L++ L + L+ + KL
Sbjct: 292 --DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL--TELD-VSHNTKLKS 343
Query: 317 LNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESL------EKLNLSHN 370
L+ + + + + L+ + ++P SL + L+ N
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGN 400
Query: 371 NISGQIPACFIGMSGLLSIDISYNELRGPIPNST 404
++ I G+ + I++ L P T
Sbjct: 401 PMN--IEPGDGGVYDQATNTITWENLSTDNPAVT 432
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 86/404 (21%), Positives = 140/404 (34%), Gaps = 32/404 (7%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVR--NLSKLKYLDLSENELSGKIPPEIGLLT 74
L + S +L +LDLS N F LP N+S+LK+L LS L K
Sbjct: 81 LVKISCHPTVNLKHLDLSFN-AFDALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHL 138
Query: 75 HLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT 134
++ + L L + G L + SLH + I ++ + L+ +
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 135 GQLPRNICRSGLLEILTVNDNHF---------------LGSIPNLRNCRSLVRAHLGRNN 179
L N C L + + N I L ++ +
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
Query: 180 LTGNISEDFGIYPN-----LKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPP 234
L G + Y L + + F S + + + +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318
Query: 235 EIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL---LTELE 291
S LD S+N + + G L L LIL+ NQL L + + + L+
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQ 377
Query: 292 YFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKG 350
D+S N ++ + L LN S N + I L + LDL N K
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK- 434
Query: 351 SIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
SIP ++ LE+L++LN++ N + F ++ L I + N
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 81/407 (19%), Positives = 142/407 (34%), Gaps = 34/407 (8%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
L S L L +S N L V + +L+YLDLS N+L KI
Sbjct: 35 ELWTSDILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTV 90
Query: 75 HLFSLDLSLNQFS--GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNL-MKLSYLMLDTN 131
+L LDLS N F N+S LK++ L L S I +L + L+L
Sbjct: 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIY 191
+ P + + V + + + A+L +N+ + ++ Y
Sbjct: 151 YGEKEDPEGLQDFNTESLHIVFPTN--KEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 192 -----------PNLKFLDLSHNNFYGEISSNWGKCHRLGTLI---VSGNNITGRIPPEIG 237
P L L L++ + T+ +S + G++
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 238 NSS-----QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEY 292
+ S L + + S+ ++N + ++ +
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 293 FDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS--QEIPEDLALLAHLSELDLSHNLFKG 350
D S+N L +++ E G + +L L NQ +I E + L +LD+S N
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 351 SIPSRIC-NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
C +SL LN+S N ++ I C + +D+ N++
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 67/385 (17%), Positives = 117/385 (30%), Gaps = 17/385 (4%)
Query: 26 PHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSL 83
L++S N L +LSKL+ L +S N + + + L LDLS
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSH 78
Query: 84 NQFSGTFPPICNLSNLKYISLHNNKLSGSIPE--EIGNLMKLSYLMLDTNQFTGQLPRNI 141
N+ NLK++ L N ++P E GN+ +L +L L T I
Sbjct: 79 NKLVKI--SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201
+ ++L V + + L T +L
Sbjct: 136 AHLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 202 NNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELG 261
+N + N + N + + + S I +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-----TLNNIETTWNSFIRILQLVWHTTV 249
Query: 262 RLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSH 321
S++ + L+G + L L + S+ + NF+
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 322 NQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS--GQIPAC 379
+ + ++ LD S+NL ++ +L LE L L N + +I
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 380 FIGMSGLLSIDISYNELRGPIPNST 404
M L +DIS N +
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-18
Identities = 58/344 (16%), Positives = 111/344 (32%), Gaps = 27/344 (7%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHL 76
++ L I + ++S +L + + K E ++
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI--KCVLEDNKCSYF 209
Query: 77 FSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQ 136
S+ L LSNL ++ S ++ + Y + + GQ
Sbjct: 210 LSILAKLQTN-------PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ 262
Query: 137 LPRNI-------CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG 189
L ++ + + + F S ++ + +
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI-YEIFSNMNIKNFTVSGTRMVHMLCPS 321
Query: 190 IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIG---NSSQLHVLD 246
LD S+N + N G L TLI+ N + + L LD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380
Query: 247 LSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
+S N ++ + SL L + N L+ + R L ++ DL SN++ SI
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP 437
Query: 306 EALGFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLF 348
+ + + L LN + NQ + +P+ L L ++ L N +
Sbjct: 438 KQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 7e-17
Identities = 39/195 (20%), Positives = 77/195 (39%), Gaps = 10/195 (5%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
Q + + F ++ + +++G +S +LD S N L+ + G LT
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 76 LFSLDLSLNQFSGTFPPIC----NLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDT 130
L +L L +NQ I + +L+ + + N +S + L L + +
Sbjct: 350 LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 131 NQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFG 189
N T + R C +++L ++ N + SIP + +L ++ N L F
Sbjct: 409 NILTDTIFR--CLPPRIKVLDLHSNK-IKSIPKQVVKLEALQELNVASNQLKSVPDGIFD 465
Query: 190 IYPNLKFLDLSHNNF 204
+L+ + L N +
Sbjct: 466 RLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 45/232 (19%), Positives = 78/232 (33%), Gaps = 16/232 (6%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
S N + +P ++ + +L++S N+I+ ++ L L LI+ N++
Sbjct: 8 SKNGLI-HVPKDLSQKTT--ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLAL--LAHLSEL 341
ELEY DLS N+L L +L+ S N F +P ++ L L
Sbjct: 65 FKFNQELEYLDLSHNKLVKISCHPTV---NLKHLDLSFNAF-DALPICKEFGNMSQLKFL 120
Query: 342 DLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIP 401
LS + S I +L + L + + + S+ I + P
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF-------P 173
Query: 402 NSTVFRNAPRESFLGNNFSTFYGTSDLLSHKEASKKTPFLILFPLLGALALL 453
+ F S +L + S L L+ L
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 38/209 (18%), Positives = 75/209 (35%), Gaps = 8/209 (3%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDL 247
+ L++S N +S+ +L LI+S N I + + + +L LDL
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDL 76
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQL-SGHLPRALGLLTELEYFDLSSNRLNNSILE 306
S N + +I ++L L L N + + + G +++L++ LS+ L S +
Sbjct: 77 SHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 307 ALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLN 366
+ + L + ++ ED L + L I ++ N
Sbjct: 134 PIAHLNISKVLLVLGETYGEK--EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 367 LSHNNISGQIPACFIGMSGLLSIDISYNE 395
L +NI + + + N
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-34
Identities = 81/391 (20%), Positives = 136/391 (34%), Gaps = 42/391 (10%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELS 63
++L+ + L E SFS L +L + + R LS L L L N+
Sbjct: 34 YVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92
Query: 64 GKIPPEI-GLLTHLFSLDLSLNQFSGTFPPI---CNLSNLKYISLHNNKLSGSIPEEI-G 118
++ L +L L L+ G L++L+ + L +N + P
Sbjct: 93 -QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 119 NLMKLSYLMLDTNQFTGQLPRNI---CRSGLLEILTVNDNHFL---------GSIPNLRN 166
N+ + L L N+ + + +L ++ N
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 167 CRSLVRAHLGRNNLTGNISEDF-GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSG 225
S+ L N ++++ F K L +N Y N G
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY-----NMGSSFGHTNFKDPD 265
Query: 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPRAL 284
N + S + DLS + I + + L +L L N+++ A
Sbjct: 266 NFTFKGLEA-----SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319
Query: 285 GLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDL-ALLAHLSEL 341
LT L +LS N L +++ F + KL L+ S+N + + + L +L EL
Sbjct: 320 WGLTHLLKLNLSQNFL--GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKEL 376
Query: 342 DLSHNLFKGSIPSRI-CNLESLEKLNLSHNN 371
L N K S+P I L SL+K+ L N
Sbjct: 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 74/394 (18%), Positives = 126/394 (31%), Gaps = 65/394 (16%)
Query: 26 PHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSL 83
H+ Y+DLS+N L L L++L + + I L+ L L L
Sbjct: 30 AHVNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 84 NQFS----GTFPPICNLSNLKYISLHNNKL-SGSIPEEI-GNLMKLSYLMLDTNQFTGQL 137
NQF G F L+NL+ ++L L + L L L+L N
Sbjct: 89 NQFLQLETGAFN---GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145
Query: 138 PRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFL 197
P + N R L N + ED + F
Sbjct: 146 PASF----------------------FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183
Query: 198 DLS-HNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI 256
L + +++ W + G ++ + LDLS N +
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPF---------------KNTSITTLDLSGNGFKESM 228
Query: 257 PMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFY 316
I+ K+ S ++ + G + + + L S ++
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK---------T 279
Query: 317 LNFSHNQFSQEIPEDL-ALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISG 374
+ S ++ + + + + L +L L+ N I L L KLNLS N +
Sbjct: 280 CDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS 337
Query: 375 QIPACFIGMSGLLSIDISYNELRGPIPNSTVFRN 408
F + L +D+SYN +R + + F
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIRA-LGDQ-SFLG 369
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 40/226 (17%), Positives = 86/226 (38%), Gaps = 33/226 (14%)
Query: 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNL---SKLKYLDLSEN 60
++ + G + + + LDLS NGF ++ + + +K++ L LS +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 61 ELSGKIPPEIGL------------LTHLFSLDLSLNQFS----GTFPPICNLSNLKYISL 104
G + + + DLS ++ F + ++L+ ++L
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFS---HFTDLEQLTL 306
Query: 105 HNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSI 161
N+++ I + L L L L N + + L LE+L ++ NH + ++
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFE-NLDKLEVLDLSYNH-IRAL 362
Query: 162 PN--LRNCRSLVRAHLGRNNLTGNISED-FGIYPNLKFLDLSHNNF 204
+ +L L N L ++ + F +L+ + L N +
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 57/289 (19%)
Query: 514 IGKGEHRSVYRAKLPSGD-KIAVKKFNSPFPNDQMSDQK-EFLNEIKALTKIRHRNIVKF 571
IG+G V+ +L + + +AVK D K +FL E + L + H NIV+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
G C+ + ++V E + G T L + + ++ A + Y+ C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKCC- 234
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-----------WTELVGTFGYVA 680
+HRD+++ N L+ + ++SDFG ++ WT A
Sbjct: 235 --IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT---------A 283
Query: 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEF 739
P E + + + DV+SFG+L E G P LS N +
Sbjct: 284 P----------EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---------NQQT 324
Query: 740 NAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
++ RLP P + + +M C P RP+ T+ Q L
Sbjct: 325 REFVEKGGRLPCPE-LCPDAVFRLM---EQCWAYEPGQRPSFSTIYQEL 369
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-32
Identities = 74/381 (19%), Positives = 132/381 (34%), Gaps = 58/381 (15%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGF--FGTLPPQVRNLSKLKYLDLSENEL 62
S N + GT ++ FS++ L +L + +++ L L+ L
Sbjct: 14 SQNSFYNTISGTYADY-FSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNL 71
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMK 122
S +P + + L+++ N + P ++L+Y+ +N+LS ++PE +L
Sbjct: 72 S-SLPDNLP--PQITVLEITQNALI-SLPE--LPASLEYLDACDNRLS-TLPELPASLKH 124
Query: 123 LSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTG 182
L +D NQ T LP LLE + ++N L +P L SL + N LT
Sbjct: 125 LD---VDNNQLT-MLPELP---ALLEYINADNNQ-LTMLPEL--PTSLEVLSVRNNQLTF 174
Query: 183 NISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQL 242
+ E +L+ LD+S N L +L P +
Sbjct: 175 -LPELPE---SLEALDVSTN--------------LLESL-----------PAVPVRNHHS 205
Query: 243 ----HVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSN 298
N I IP + L +IL N LS + +L T +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 299 RLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICN 358
+ S + L F + D++ + H E + N F + R+ +
Sbjct: 265 YFSMSDGQQNTLHRPLADA--VTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSD 321
Query: 359 LESLEKLNLSHNNISGQIPAC 379
S + ++ +
Sbjct: 322 TVSARNTSGFREQVAAWLEKL 342
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-28
Identities = 62/321 (19%), Positives = 107/321 (33%), Gaps = 40/321 (12%)
Query: 126 LMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS 185
+ML N L +N + + + + RN +
Sbjct: 3 IMLPINNNF-SLSQNSFYNTISGTY----ADYFSAWDKWEK---QALPGENRNEAVSLLK 54
Query: 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245
E + L L+ N + N ++ L ++ N + +P + L L
Sbjct: 55 E--CLINQFSELQLNRLNL-SSLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYL 105
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
D N ++ +P L L+ + NQL+ LP LL + + +N+L +
Sbjct: 106 DACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYI---NADNNQLT-MLP 156
Query: 306 EALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEK- 364
E L L+ +NQ +PE L L LD+S NL + S+P+ E+
Sbjct: 157 ELPT---SLEVLSVRNNQL-TFLPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEET 208
Query: 365 ---LNLSHNNISGQIPACFIGMSGLLSIDISYNELRG-PIPNSTVFRNAPRESFLGNNFS 420
N I+ IP + + +I + N L + + P FS
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
Query: 421 TFYGTSDLLSHKEASKKTPFL 441
G + L A T +
Sbjct: 268 MSDGQQNTLHRPLADAVTAWF 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 513 CIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
IG+G ++VY+ + ++A + + + F E + L ++H NIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER---QRFKEEAEMLKGLQHPNIVR 89
Query: 571 FYGFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
FY +V E + G+L T L + + + + L ++H
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH 146
Query: 627 HDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
PPI+HRD+ +N+ + ++ D G A L + + + ++GT ++AP
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAP---- 199
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745
E+ Y K E DVY+FG+ LE+ ++P +S ++ I
Sbjct: 200 ------EM-YEEKYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGV 246
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ ++ I+E C+ + R ++ LL
Sbjct: 247 KPASFDKVAIPEVKEIIE---GCIRQNKDERY---SIKDLL 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 38/289 (13%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMS--DQKEFLNEIKALTK 562
+F + IG+G+ VYRA L G +A+KK D M + + + EI L +
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF---DLMDAKARADCIKEIDLLKQ 88
Query: 563 IRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL-----SNNFASEDFDWRKRMNVITG 617
+ H N++K+Y +V E + G L+ ++ E W
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQ 144
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
+ AL +MH ++HRDI NV + ++ D G + ++ LVGT
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI-N 736
Y++P E + K D++S G L E+ + P F ++ +
Sbjct: 202 YMSP----------ERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYS 245
Query: 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785
+ P PS E+L ++ +C++ P RP + V +
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/309 (18%), Positives = 120/309 (38%), Gaps = 58/309 (18%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
R DF+ C+G+G V+ AK A+K+ P ++ +++ + E+KAL
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALA 58
Query: 562 KIRHRNIVKFYGFC------------SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWR 609
K+ H IV+++ S + ++ + + +L ++ E+ +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 610 KRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK------ 663
+++ +A+A+ ++H ++HRD+ +N+ ++ +V DFG +
Sbjct: 119 VCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 664 ------PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717
P + T VGT Y++P E + + K D++S G++ E++
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSP----------EQIHGNSYSHKVDIFSLGLILFELL- 224
Query: 718 GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQE--KLISIMEVALLCLDGCPNS 775
+P FS+ + + P + ++ M L P
Sbjct: 225 --YP------FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDM----LSPS--PME 270
Query: 776 RPTMQTVCQ 784
RP + +
Sbjct: 271 RPEAINIIE 279
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 51/300 (17%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
+++ F + +L L L N + P L KL+ L LS+N+L ++P +
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPK 121
Query: 75 HLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKL-SGSIPEEI-GNLMKLSYLML 128
L L + N+ + F L+ + + L N L S I + KLSY+ +
Sbjct: 122 TLQELRVHENEITKVRKSVFN---GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 129 DTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDF 188
T +P+ + S L L HL N +T +
Sbjct: 179 ADTNIT-TIPQGLPPS--LTEL-----------------------HLDGNKITKVDAASL 212
Query: 189 GIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247
NL L LS N+ + + L L ++ N + ++P + + + V+ L
Sbjct: 213 KGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270
Query: 248 SSNHI------AGEIPMELGRLISLNKLILRGNQLSGHL--PRALGLLTELEYFDLSSNR 299
+N+I P + S + + L N + P + L + +
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 71/331 (21%), Positives = 111/331 (33%), Gaps = 67/331 (20%)
Query: 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSG 111
LDL N+++ +I F NL NL + L NNK+S
Sbjct: 54 TALLDLQNNKIT-EIKD---------------GDFK-------NLKNLHTLILINNKIS- 89
Query: 112 SIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP--NLRNCR 168
I L+KL L L NQ +LP + ++ L+ L V++N + +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENE-ITKVRKSVFNGLN 145
Query: 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228
++ LG N L GI F + +L + ++ NI
Sbjct: 146 QMIVVELGTNPLK-----SSGIENGA-FQGMK----------------KLSYIRIADTNI 183
Query: 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLL 287
T IP G L L L N I ++ L L +L KL L N +S +L
Sbjct: 184 T-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239
Query: 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ------EIPEDLALLAHLSEL 341
L L++N+L + L + + +N S P A S +
Sbjct: 240 PHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 342 DLSHN-LFKGSIPSRI-CNLESLEKLNLSHN 370
L N + I + + L +
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 14/214 (6%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
+ P+ LDL +N EI L TLI+ N I+ +I P +L L
Sbjct: 49 DLPPDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLY 106
Query: 247 LSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILE 306
LS N + E+P ++ +L +L + N+++ L ++ +L +N L +S +E
Sbjct: 107 LSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 307 ALGF--MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI-CNLESLE 363
F M KL Y+ + + IP+ L L+EL L N + + L +L
Sbjct: 164 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLA 219
Query: 364 KLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
KL LS N+IS L + ++ N+L
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 71/341 (20%), Positives = 126/341 (36%), Gaps = 50/341 (14%)
Query: 91 PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEIL 150
P C L+ + + L +P+++ + L L N+ T
Sbjct: 26 PFRCQCH-LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKIT---------------- 65
Query: 151 TVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210
+ D F +N ++L L N ++ F L+ L LS N E+
Sbjct: 66 EIKDGDF-------KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 117
Query: 211 NWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHI-AGEIPME-LGRLISLN 267
K L L V N IT ++ + +Q+ V++L +N + + I + L+
Sbjct: 118 KMPK--TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE 327
+ + ++ +P+ GL L L N++ +L + L L S N S
Sbjct: 175 YIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-A 230
Query: 328 IPED-LALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG------QIPACF 380
+ LA HL EL L++N +P + + + ++ + L +NNIS P
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 381 IGMSGLLSIDISYNELR-GPIPNSTVFRNAP--RESFLGNN 418
+ + + N ++ I ST FR LGN
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPST-FRCVYVRAAVQLGNY 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 70/293 (23%), Positives = 127/293 (43%), Gaps = 39/293 (13%)
Query: 504 RTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
R +D++ Y IG G + + + G + K+ + + +++ ++E+ L +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRE 61
Query: 563 IRHRNIVKFYG-FCSHVRHSFVVY-EYINRGSLATVL-----SNNFASEDFDWRKRMNVI 615
++H NIV++Y + + EY G LA+V+ + E+F R V+
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR----VM 117
Query: 616 TGVADALSYMH--HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELV 673
T + AL H D ++HRD+ NV LD + ++ DFG A++L ++S V
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 674 GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733
GT Y++P E M EK D++S G L E+ P S +
Sbjct: 178 GTPYYMSP----------EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227
Query: 734 SINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785
+F R+P+ S ++ E +I+ M L L RP+++ + +
Sbjct: 228 IREGKFR-----RIPYRYSDELNE-IITRM----LNLK--DYHRPSVEEILEN 268
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-29
Identities = 78/405 (19%), Positives = 129/405 (31%), Gaps = 32/405 (7%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
L+ S L L LS N +L V L+YLD+S N L I +
Sbjct: 66 ELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMA 121
Query: 75 HLFSLDLSLNQFSGTFPPIC---NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN 131
L LDLS N F P NL+ L ++ L K + + LS ++LD
Sbjct: 122 SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLV 179
Query: 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIY 191
+ + + H N HL +N+ N +
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM 239
Query: 192 ---------PNLKFLDLSHNNFYGEISSNWGKC---HRLGTLIVSGNNITGRIPPEIGNS 239
P L + L H + S + + L + IT RI E
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 240 S-----QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFD 294
S L + + + +N +L + + + +
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 295 LSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ--EIPEDLALLAHLSELDLSHNLFKGSI 352
+ N +S+ + + +L L N ++ ++ L LD+S N
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 353 PSRICNL-ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
R C ES+ LNLS N ++G + C + +D+ N +
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI 462
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 77/402 (19%), Positives = 140/402 (34%), Gaps = 30/402 (7%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPP--QVRNLSKLKYLDLSENELSGKIPPEIGLLT 74
LQ S L +LDLS N F LP + NL+KL +L LS + ++
Sbjct: 112 LQNISCCPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHL 169
Query: 75 HLFSLDLSLNQFSGTFPPICNLSNLK----YISLHNNKLSGSIPEEIGN------LMKLS 124
HL + L L + +L ++ H N L N L +
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 125 YLMLDTNQFTGQLPRNICRSGLLEILTVNDN---HFLGSIPNLRNCRSLVRAHLGRNNLT 181
+ + L LL + + + R + ++ +T
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 182 GNISEDFGIY-----PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI 236
I + Y +L + + F + + + ++S ++
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 237 GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA---LGLLTELEYF 293
+ S L+ + N + L L LIL+ N L + + ++ LE
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 294 DLSSNRLNNSILEAL-GFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSI 352
D+S N LN+ + + + LN S N + + L + LDL +N SI
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SI 465
Query: 353 PSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
P + +L++L++LN++ N + F ++ L I + N
Sbjct: 466 PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 50/299 (16%), Positives = 89/299 (29%), Gaps = 75/299 (25%)
Query: 3 VNSINLTSTGL-KGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENE 61
+N NLT T +S ++ L + F + +++ LS ++
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 62 LSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPIC-NLSNLKYISLHNNKLSGSIPEEIGNL 120
+ L+ + N F+ + C L L+ + L N L + +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399
Query: 121 MKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180
+S L L S+ +
Sbjct: 400 KNMSSLETLDVS-------------------------LNSLNS----------------- 417
Query: 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240
++ L+LS N ++ +PP
Sbjct: 418 -HAYDRTCAWAESILVLNLSSNMLT--------------------GSVFRCLPP------ 450
Query: 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSN 298
++ VLDL +N I IP ++ L +L +L + NQL +P LT L+Y L N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 61/361 (16%), Positives = 117/361 (32%), Gaps = 27/361 (7%)
Query: 92 PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRS-GLLEIL 150
P K +SL N +S +I L +L L L N+ L ++ LE L
Sbjct: 47 PKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYL 105
Query: 151 TVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTG-NISEDFGIYPNLKFLDLSHNNFYGEIS 209
V+ N L +I SL L N+ + ++FG L FL LS F
Sbjct: 106 DVSHNR-LQNIS-CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR---Q 160
Query: 210 SNWGKCHRLGTLIVSGNNITGRIPP------EIGNSSQLHVLDLSSNHIAGEIPMELGRL 263
+ L + + ++ I +I N++ LH++ ++ + ++ M + L
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 264 ISLNKLILRGNQLSGH----LPRALGLLTELEYFDLSSNRLN-NSILEALGFMF--KLFY 316
L ++ N + L L L ++ F + + Y
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 317 LNFSHNQFSQEIPEDLA-----LLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
LN + ++ I + L L + + +F S + + LS ++
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 372 ISGQIPACFIGMSGLLSIDISYNEL-RGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLLS 430
C S ++ + N + + N F+ + +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 431 H 431
+
Sbjct: 401 N 401
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 40/197 (20%), Positives = 78/197 (39%), Gaps = 14/197 (7%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
+E +S F + LSI+ + S +L+ ++N + + L
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378
Query: 76 LFSLDLSLNQF---SGTFPPICNLSNLKYISLHNNKL-SGSIPEEIGNLMKLSYLMLDTN 131
L +L L N N+S+L+ + + N L S + + L L +N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIP----NLRNCRSLVRAHLGRNNLTGNISED 187
TG + R C +++L +++N + SIP +L+ + L ++ N L
Sbjct: 439 MLTGSVFR--CLPPKVKVLDLHNNR-IMSIPKDVTHLQALQEL---NVASNQLKSVPDGV 492
Query: 188 FGIYPNLKFLDLSHNNF 204
F +L+++ L N +
Sbjct: 493 FDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 39/152 (25%), Positives = 53/152 (34%), Gaps = 33/152 (21%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
S N+T +P ++ + L LS N I+ ++ L L L L N++
Sbjct: 39 SNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV 95
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
+LEY D+S NRL Q I +A L LDL
Sbjct: 96 FLFNQDLEYLDVSHNRL-------------------------QNISCC--PMASLRHLDL 128
Query: 344 SHNLFKGSIP--SRICNLESLEKLNLSHNNIS 373
S N F +P NL L L LS
Sbjct: 129 SFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR 159
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 52/300 (17%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
L++ F HL L L N + + L KL+ L +S+N L +IPP L +
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPS 123
Query: 75 HLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKL-SGSIPEEIGNLMKLSYLMLD 129
L L + N+ G F L N+ I + N L + + +KL+YL +
Sbjct: 124 SLVELRIHDNRIRKVPKGVFS---GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180
Query: 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG 189
+ T +P+++ + L L ++ N + +I ED
Sbjct: 181 EAKLT-GIPKDLPET--LNELHLDHNK-IQAIE----------------------LEDLL 214
Query: 190 IYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248
Y L L L HN I + L L + N ++ R+P + + L V+ L
Sbjct: 215 RYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 249 SNHIAGEIPME-------LGRLISLNKLILRGNQLSGHL--PRALGLLTELEYFDLSSNR 299
+N+I ++ + + N + L N + P +T+ + +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 61/332 (18%), Positives = 108/332 (32%), Gaps = 70/332 (21%)
Query: 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSG 111
LDL N++S ++ + F L +L + L NNK+S
Sbjct: 56 TTLLDLQNNDIS-ELRK---------------DDFK-------GLQHLYALVLVNNKIS- 91
Query: 112 SIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSL 170
I E+ L KL L + N ++P L SL
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIP-----PNLP--------------------SSL 125
Query: 171 VRAHLGRNNLTGNISED-FGIYPNLKFLDLSHNNFY-GEISSNWGKCHRLGTLIVSGNNI 228
V + N + + + F N+ +++ N +L L +S +
Sbjct: 126 VELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLL 287
T IP L+ L L N I I +E L R L +L L NQ+ +L L
Sbjct: 185 T-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-------LALLAHLSE 340
L L +N+L + + L + L + N + ++ + A+ +
Sbjct: 241 PTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 341 LDLSHN-LFKGSIPSRI-CNLESLEKLNLSHN 370
+ L +N + + + + +
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 13/213 (6%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
I P+ LDL +N+ E+ + + L L++ N I+ +I + +L L
Sbjct: 51 EISPDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 247 LSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILE 306
+S NH+ EIP L SL +L + N++ L + ++ N L NS E
Sbjct: 109 ISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 307 ALGFM-FKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI-CNLESLEK 364
F KL YL S + + IP+DL L+EL L HN + +I L +
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYR 221
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
L L HN I + L + + N+L
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 76/413 (18%), Positives = 131/413 (31%), Gaps = 106/413 (25%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+ S P L L + + P L+ + S+ L +P EI LD
Sbjct: 9 TTSGIPDLDSLPPTYSA---MCPFGCHC--HLRVVQCSDLGLK-AVPKEIS--PDTTLLD 60
Query: 81 LSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTG 135
L N S F L +L + L NNK+S I E+ L KL L + N
Sbjct: 61 LQNNDISELRKDDFK---GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV- 115
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED-FGIYPNL 194
++P L SLV + N + + + F N+
Sbjct: 116 EIP-----PNLP--------------------SSLVELRIHDNRIR-KVPKGVFSGLRNM 149
Query: 195 KFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254
+++ N + ++ P + +L+ L +S +
Sbjct: 150 NCIEMGGNP----LENSG-------------------FEPGAFDGLKLNYLRISEAKLT- 185
Query: 255 EIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKL 314
IP +L +LN+L L N++ L ++L L N++
Sbjct: 186 GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM------------ 231
Query: 315 FYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374
+ S L L EL L +N +P+ + +L+ L+ + L NNI+
Sbjct: 232 ----IENGSLSF--------LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 375 QIPA-------CFIGMSGLLSIDISYNELRGPIPNSTVFRNAP--RESFLGNN 418
++ + + I + N + FR GN
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 52/251 (20%), Positives = 90/251 (35%), Gaps = 39/251 (15%)
Query: 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCH-RLGTLIVSGNNITGRIPPEIGNSS 240
+ +E P+L L +++ CH L + S + +P EI S
Sbjct: 4 ASGAETTSGIPDLDSLPPTYSAMCPF------GCHCHLRVVQCSDLGLK-AVPKEI--SP 54
Query: 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300
+LDL +N I+ + L L L+L N++S +A L +L+ +S N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 301 -----------------NNSI--LEALGF--MFKLFYLNFSHNQFSQE-IPEDLALLAHL 338
+N I + F + + + N L
Sbjct: 115 VEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 339 SELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDISYNELR 397
+ L +S IP + E+L +L+L HN I I + S L + + +N++R
Sbjct: 175 NYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR 230
Query: 398 GPIPNSTVFRN 408
I N +
Sbjct: 231 M-IENGS-LSF 239
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 58/284 (20%), Positives = 113/284 (39%), Gaps = 36/284 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
+ + IG+G K G + +K+ N + + +++E E+ L ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMK 81
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLS---NNFASEDFDWRKRMNVITGVADA 621
H NIV++ ++V +Y G L ++ ED + A
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQICLA 137
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
L ++H I+HRDI S N+ L + ++ DFG A++L +GT Y++P
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741
E+ K D+++ G + E+ KH + S+ + I+ F
Sbjct: 195 ----------EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP- 243
Query: 742 MLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ H S D++ L+S + + P RP++ ++ +
Sbjct: 244 ----PVSLHYSYDLRS-LVSQL----FKRN--PRDRPSVNSILE 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 513 CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+GKG + VY + L + +IA+K+ P + + S EI ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLH--EEIALHKHLKHKNIVQY 84
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
G S + E + GSL+ +L + + + + + + L Y+H +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 632 PIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTELVGTFGYVAP---AHGNI 686
IVHRDI +NVL++ Y + SDFGT+K L + GT Y+AP G
Sbjct: 143 -IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
G + D++S G +E+ GK P
Sbjct: 201 GY-----------GKAADIWSLGCTIIEMATGKPP 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 56/294 (19%), Positives = 108/294 (36%), Gaps = 38/294 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
K + +G+G V + L G A+K+ + D++E E
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFN 84
Query: 565 HRNIVKFYGFCSHVRHS----FVVYEYINRGSLATVLSNNFASED-FDWRKRMNVITGVA 619
H NI++ +C R + +++ + RG+L + + + + ++ G+
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN---------WT 670
L +H HRD+ N+LL E + + D G+ + W
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
T Y AP L + I E+ DV+S G + ++ G+ P + +F
Sbjct: 202 AQRCTISYRAP-------ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQK 252
Query: 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
S N + + P S + + L++ M + +D P+ RP + +
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQ-LLNSM----MTVD--PHQRPHIPLLLS 299
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 60/280 (21%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 513 CIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G G++ VY +AVK + + +EFL E + +I+H N+V+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
G C+ +++ E++ G+L L ++ + + T ++ A+ Y+ F
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF- 339
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
+HR++++ N L+ + +V+DFG ++L+ ++ Y A A +
Sbjct: 340 --IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-----------YTAHAGAKFPIKWT 386
Query: 692 --ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HR 746
E K + K DV++FGVL E+ G P + + +L+ +R
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYELLEKDYR 437
Query: 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ P EK+ +M C P+ RP+ + Q
Sbjct: 438 MERPE-GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 473
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 75/313 (23%), Positives = 121/313 (38%), Gaps = 63/313 (20%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
R DF+ +G+G V +A+ A+KK L+E+ L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLA 57
Query: 562 KIRHRNIVKFYGFCSHVRHS-------------FVVYEYINRGSLATVLS--NNFASEDF 606
+ H+ +V++Y R+ F+ EY G+L ++ N D
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 607 DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK--- 663
WR + + +ALSY+H I+HRD+ N+ +D ++ DFG AK +
Sbjct: 118 YWR----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 664 -----------PNSSNWTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVL 711
+S N T +GT YVA E L T EK D+YS G++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVAT----------EVLDGTGHYNEKIDMYSLGII 220
Query: 712 ALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDG 771
E+I G S++IEF + V++K+I ++ + D
Sbjct: 221 FFEMIYPFSTGMERVNILKKLRSVSIEF----PPDFDDNKMKVEKKIIRLL----IDHD- 271
Query: 772 CPNSRPTMQTVCQ 784
PN RP +T+
Sbjct: 272 -PNKRPGARTLLN 283
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 65/286 (22%), Positives = 111/286 (38%), Gaps = 55/286 (19%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IG G+ V+ + DK+A+K + +++F+ E + + K+ H +V+ YG
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
C +V E++ G L+ L F + + V + ++Y+ C
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV--- 125
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSN------WTELVGTFGYVAPAH 683
+HRD+++ N L+ +VSDFG + + + S+ W +P
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------SP-- 174
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAM 742
E+ + + K DV+SFGVL EV +GK P + S N E
Sbjct: 175 --------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVVED 217
Query: 743 LD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ RL P + IM C P RP + + L
Sbjct: 218 ISTGFRLYKPR-LASTHVYQIM---NHCWRERPEDRPAFSRLLRQL 259
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 55/286 (19%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G+ V K +AVK + + EF E + + K+ H +VKFYG
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
CS ++V EYI+ G L L ++ + + + + + V + ++++ F
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSN------WTELVGTFGYVAPAH 683
+HRD+++ N L+D + +VSDFG + + + S W+ AP
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------AP-- 174
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAM 742
E+ + K + K DV++FG+L EV GK P D + N E
Sbjct: 175 --------EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---------NSEVVLK 217
Query: 743 LD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ HRL P + + IM C P RPT Q + +
Sbjct: 218 VSQGHRLYRPH-LASDTIYQIM---YSCWHELPEKRPTFQQLLSSI 259
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 55/299 (18%), Positives = 107/299 (35%), Gaps = 56/299 (18%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
R DF IG G V++AK G +K+ + ++ E+KAL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALA 59
Query: 562 KIRHRNIVKFYGF-------------CSHVRHSFVVY---EYINRGSLATVLSNNFASED 605
K+ H NIV + G S + ++ E+ ++G+L + E
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEK 118
Query: 606 FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665
D + + + + Y+H +++RD+ +N+ L + ++ DFG LK N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-N 174
Query: 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725
T GT Y++P E + ++ D+Y+ G++ E++
Sbjct: 175 DGKRTRSKGTLRYMSP----------EQISSQDYGKEVDLYALGLILAELLHVCDT---- 220
Query: 726 SLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+S + ++ + L+ + L P RP + +
Sbjct: 221 --AFETSKFFTDLRDGIIS---DIFDKKEKT-LLQKL----LSKK--PEDRPNTSEILR 267
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 65/327 (19%), Positives = 116/327 (35%), Gaps = 61/327 (18%)
Query: 474 GSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKI 533
GS S G + + GKI + K +G G ++ + +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCP----------KDVLGHGAEGTIVYRGMFDNRDV 51
Query: 534 AVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINRGS 592
AVK+ E++ L + H N+++++ + ++ E +
Sbjct: 52 AVKRILP-------ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AAT 103
Query: 593 LATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL-----DL 647
L + + + ++ L+++H IVHRD+ +N+L+
Sbjct: 104 LQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHG 158
Query: 648 EYEARVSDFGTAKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAEL---AYTMKITE 701
+ +A +SDFG K L + + GT G++AP E+ T
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP----------EMLSEDCKENPTY 208
Query: 702 KCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNA--MLDHRLPHPSLDVQEK- 757
D++S G + VI +G HP F S LD P DV +
Sbjct: 209 TVDIFSAGCVFYYVISEGSHP------FGKSLQRQANILLGACSLDCLHPEKHEDVIARE 262
Query: 758 LISIMEVALLCLDGCPNSRPTMQTVCQ 784
LI M + +D P RP+ + V +
Sbjct: 263 LIEKM----IAMD--PQKRPSAKHVLK 283
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 39/279 (13%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G V+ ++A+K + FL E + + K+RH +V+ Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
S ++V EY+++GSL L + + +++ +A ++Y+ +
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 301
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA- 691
VHRD+ + N+L+ +V+DFG A+L++ N Y A +
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNE-----------YTARQGAKFPIKWTA 349
Query: 692 -ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HRL 747
E A + T K DV+SFG+L E+ KG+ P + N E ++ +R+
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRM 400
Query: 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
P P + E L +M C P RPT + + L
Sbjct: 401 PCPP-ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 435
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 55/286 (19%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
+G G+ V K +A+K + + EF+ E K + + H +V+ YG
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
C+ R F++ EY+ G L L F ++ + + V +A+ Y+ F
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSN------WTELVGTFGYVAPAH 683
+HRD+++ N L++ + +VSDFG ++ + + S W+ P
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------PP-- 190
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAM 742
E+ K + K D+++FGVL E+ GK P + + N E
Sbjct: 191 --------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSETAEH 233
Query: 743 LD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ RL P EK+ +IM C + RPT + + +
Sbjct: 234 IAQGLRLYRPH-LASEKVYTIM---YSCWHEKADERPTFKILLSNI 275
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 7/214 (3%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR--IPPEIGNSSQLHVLD 246
GI + L+L N + K +L L +S N ++ + ++ L LD
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 247 LSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNNSIL 305
LS N + + L L L + + L L L Y D+S +
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143
Query: 306 EALGFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLFKGSIPSRI-CNLESLE 363
+ L L + N F + D L +L+ LDLS + + +L SL+
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQ 202
Query: 364 KLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
LN+SHNN + ++ L +D S N +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 52/261 (19%), Positives = 96/261 (36%), Gaps = 21/261 (8%)
Query: 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNK 108
+ + L+ +P G+ + L+L N+ G F L+ L +SL +N
Sbjct: 10 TEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFD---KLTQLTKLSLSSNG 63
Query: 109 LS--GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN--- 163
LS G + L YL L N + N LE L ++ L +
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-LKQMSEFSV 121
Query: 164 LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLI 222
+ R+L+ + + + F +L+ L ++ N+F + + + L L
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 223 VSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLP 281
+S + ++ P + S L VL++S N+ L SL L N +
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240
Query: 282 RAL-GLLTELEYFDLSSNRLN 301
+ L + L + +L+ N
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 53/236 (22%), Positives = 85/236 (36%), Gaps = 9/236 (3%)
Query: 97 SNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVND 154
S+ + L +NKL L +L+ L L +N + + + G L+ L ++
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 155 NHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED-FGIYPNLKFLDLSHNNFYGEISSNW- 212
N + N L +NL F NL +LD+SH + +
Sbjct: 88 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIF 146
Query: 213 GKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLI 270
L L ++GN+ P+I L LDLS + ++ L SL L
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 271 LRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK-LFYLNFSHNQFS 325
+ N L L+ D S N + S + L L +LN + N F+
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 60/258 (23%), Positives = 87/258 (33%), Gaps = 43/258 (16%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSING--FFGTLPPQVRNLSKLKYLDLSENEL 62
+ L S L+ +L F L L LS NG F G + LKYLDLS N +
Sbjct: 32 RLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 90
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFS-----GTFPPICNLSNLKYISLHNNKLSGSIPEEI 117
+ L L LD + F +L NL Y+ + + I
Sbjct: 91 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL---SLRNLIYLDISHTHTR-VAFNGI 145
Query: 118 -GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLG 176
L L L + N F +I R+L L
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDI----------------------FTELRNLTFLDLS 183
Query: 177 RNNLTGNISED-FGIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPP 234
+ L +S F +L+ L++SHNNF + + + L L S N+I
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
Query: 235 EI--GNSSQLHVLDLSSN 250
+ S L L+L+ N
Sbjct: 241 QELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 18/199 (9%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLTH 75
S L YLDLS NG T+ L +L++LD + L + L +
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 76 LFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDT 130
L LD+S G F LS+L+ + + N + +I L L++L L
Sbjct: 128 LIYLDISHTHTRVAFNGIF---NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 131 NQFTGQLPRNICRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISED 187
Q QL S L++L ++ N+ S+ + SL N++ +
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNN-FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 188 --FGIYPNLKFLDLSHNNF 204
+L FL+L+ N+F
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 14/73 (19%), Positives = 25/73 (34%), Gaps = 3/73 (4%)
Query: 339 SELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRG 398
+E+ + S+P+ I S +L L N + F ++ L + +S N L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 399 PIPNSTVFRNAPR 411
S
Sbjct: 67 KGCCSQSDFGTTS 79
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
K + IG+G +VY A + +G ++A+++ N Q ++ +NEI + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMREN 74
Query: 564 RHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT-GVAD 620
++ NIV + S++ +VV EY+ GSL V++ E ++ +
Sbjct: 75 KNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVCRECLQ 127
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
AL ++H + ++HRDI S+N+LL ++ +++DFG + P S + +VGT ++A
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P E+ K D++S G++A+E+I+G+ P
Sbjct: 185 P----------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 39/279 (13%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G V+ ++A+K + FL E + + K+RH +V+ Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
S ++V EY+++GSL L + + +++ +A ++Y+ +
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA- 691
VHRD+ + N+L+ +V+DFG A+L++ N Y A +
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNE-----------YTARQGAKFPIKWTA 432
Query: 692 -ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HRL 747
E A + T K DV+SFG+L E+ KG+ P + N E ++ +R+
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRM 483
Query: 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
P P + E L +M C P RPT + + L
Sbjct: 484 PCPP-ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 518
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 61/306 (19%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKL--PSGDKI--AVKKFNSPFPNDQMSDQKEFLN 555
EI + IG G+ V +L P + A+K +++FL+
Sbjct: 45 EIEASRIHIEKI--IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLS 99
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E + + H NI++ G + R + +V EY+ GSL T L + F + + ++
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGML 157
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------- 668
GV + Y+ + VHRD+++ NVL+D +VSDFG +++L+ +
Sbjct: 158 RGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 669 -----WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPG 722
WT AP E + DV+SFGV+ EV+ G+ P
Sbjct: 215 KIPIRWT---------AP----------EAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
Query: 723 DFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
++ N + + ++ +RLP P L +M L C RP
Sbjct: 256 WNMT---------NRDVISSVEEGYRLPAPM-GCPHALHQLM---LDCWHKDRAQRPRFS 302
Query: 781 TVCQLL 786
+ +L
Sbjct: 303 QIVSVL 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 41/297 (13%)
Query: 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDK---IAVKKFNSPFPNDQMSDQKEFLN 555
+ ++R A +G G SV + K +A+K + +D +E +
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMR 59
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E + + ++ + IV+ G C +V E G L L E+ ++
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELL 116
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
V+ + Y+ F VHRD+++ NVLL + A++SDFG +K L + S +T
Sbjct: 117 HQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 676 ---FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSS 731
+ AP E K + + DV+S+GV E + G+ P +
Sbjct: 174 KWPLKWYAP----------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----- 218
Query: 732 SSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E A ++ R+ P + +L ++M C RP TV Q +
Sbjct: 219 ----GPEVMAFIEQGKRMECPP-ECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 38/290 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G+G V + P GD +AVK P + + EI+ L + H NI
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENI 85
Query: 569 VKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
VK+ G C+ + ++ E++ GSL L N + ++++ + + Y+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG 143
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+ VHRD+++ NVL++ E++ ++ DFG K ++ + Y +
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---------YYTVKDDRDS 191
Query: 687 GLH-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSS-----INIE 738
+ A E K DV+SFGV E++ ++LF
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
L RLP P + +++ +M C + P++R + Q + +
Sbjct: 252 LVNTLKEGKRLPCPP-NCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
D+ IG+G V A+ SG ++AVK + + ++ NE+ +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD----LRKQQRRELLFNEVVIMRDY 99
Query: 564 RHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621
+H N+V+ Y S++ +V+ E++ G+L ++S +E+ + V V A
Sbjct: 100 QHFNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQVRLNEE----QIATVCEAVLQA 153
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
L+Y+H ++HRDI S+++LL L+ ++SDFG + + LVGT ++AP
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ + D++S G++ +E++ G+ P
Sbjct: 211 ----------EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
+ F IGKG V++ + +A+K + D++ D EI L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED---IQQEITVLSQC 77
Query: 564 RHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT-GVAD 620
+ K+YG S+++ + +++ EY+ GS +L E + I +
Sbjct: 78 DSPYVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILK 130
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
L Y+H + +HRDI + NVLL E +++DFG A L VGT ++A
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187
Query: 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P E+ K D++S G+ A+E+ +G+ P
Sbjct: 188 P----------EVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 35/283 (12%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN--IVK 570
IG G V++ A+K N + NEI L K++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDC 629
Y + ++ ++V E N L + L + D +R + + +A+ +H H
Sbjct: 93 LYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 630 FPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNW--TELVGTFGYVAP-AHG 684
IVH D+ N L+ + + DFG A ++P++++ VGT Y+ P A
Sbjct: 148 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML- 743
++ KI+ K DV+S G + + GK P F + I+ +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAIIDP 255
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+H + P ++ L +++ L D P R ++ +LL
Sbjct: 256 NHEIEFPD-IPEKDLQDVLK-CCLKRD--PKQRISIP---ELL 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 67/283 (23%), Positives = 110/283 (38%), Gaps = 53/283 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IGKGE V G+K+AVK + + FL E +T++RH N+V+ G
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 574 FCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
+ ++V EY+ +GSL L + + V +A+ Y+ + F
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------WTELVGTFGYVAPAHGNI 686
VHRD+++ NVL+ + A+VSDFG K WT AP
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------AP----- 183
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD- 744
E K + K DV+SFG+L E+ G+ P + + ++
Sbjct: 184 -----EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVEK 229
Query: 745 -HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+++ P + +M C RP+ + + L
Sbjct: 230 GYKMDAPD-GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQL 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 63/280 (22%), Positives = 122/280 (43%), Gaps = 41/280 (14%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G+ V+ A K+AVK + FL E + ++H +VK +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
+ +++ E++ +GSL L ++ K ++ +A+ ++++ +
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYV---APAHGNIGLH 689
+HRD+ + N+L+ +++DFG A+++ + +T G + AP
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP-------- 354
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HR 746
E T K DV+SFG+L +E++ G+ P +S N E L+ +R
Sbjct: 355 --EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---------NPEVIRALERGYR 403
Query: 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+P P + E+L +IM + C P RPT + + +L
Sbjct: 404 MPRPE-NCPEELYNIM---MRCWKNRPEERPTFEYIQSVL 439
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 69/284 (24%), Positives = 111/284 (39%), Gaps = 53/284 (18%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKGE V G+K+AVK + D + FL E +T++RH N+V+
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKN----DAT--AQAFLAEASVMTQLRHSNLVQLL 252
Query: 573 GFCSHVRHSF-VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
G + +V EY+ +GSL L + + V +A+ Y+ + F
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------WTELVGTFGYVAPAHGN 685
VHRD+++ NVL+ + A+VSDFG K WT AP
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------AP---- 355
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E K + K DV+SFG+L E+ G+ P + + ++
Sbjct: 356 ------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVE 400
Query: 745 --HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+++ P + +M C +RPT + + L
Sbjct: 401 KGYKMDAPD-GCPPAVYDVM---KNCWHLDAATRPTFLQLREQL 440
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 64/287 (22%), Positives = 117/287 (40%), Gaps = 55/287 (19%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G+ V+ K+AVK M FL E + +++H+ +V+ Y
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLK----QGSM-SPDAFLAEANLMKQLQHQRLVRLY 74
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
+ +++ EY+ GSL L + K +++ +A+ ++++ +
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSN------WTELVGTFGYVAPA 682
+HRD+ + N+L+ +++DFG A+L++ N WT AP
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------AP- 179
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNA 741
E T K DV+SFG+L E++ G+ P ++ N E
Sbjct: 180 ---------EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQ 221
Query: 742 MLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
L+ +R+ P + E+L +M LC P RPT + +L
Sbjct: 222 NLERGYRMVRPD-NCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 55/287 (19%)
Query: 514 IGKGEHRSVYRAKLPSGD-KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G++ VY +AVK + + +EFL E + +I+H N+V+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
G C+ +++ E++ G+L L ++ + + T ++ A+ Y+ F
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSN------WTELVGTFGYVAPA 682
+HRD+++ N L+ + +V+DFG ++L+ + + WT AP
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP- 181
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNA 741
E K + K DV++FGVL E+ G P + +
Sbjct: 182 ---------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYE 223
Query: 742 MLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+L+ +R+ P EK+ +M C P+ RP+ + Q
Sbjct: 224 LLEKDYRMERPE-GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 266
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 40/291 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+GKG SV + P D +AVKK ++F EI+ L ++H NI
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHDNI 73
Query: 569 VKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
VK+ G C ++ EY+ GSL L + E D K + + + + Y+
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 131
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+ +HRD+++ N+L++ E ++ DFG K+L + + G
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---------FFKVKEPGES 179
Query: 687 GLH-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSI------NI 737
+ A E K + DV+SFGV+ E+ + + F +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 738 EFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+L RLP P +++ IM C + N RP+ + + +
Sbjct: 240 HLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLALRV 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 60/293 (20%)
Query: 514 IGKGEHRSVYRA--KLPSGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
IG GE VY+ K SG +A+K + +FL E + + H NI
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
++ G S + ++ EY+ G+L L +F + + ++ G+A + Y+ +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------------WTELVGTF 676
+ VHRD+++ N+L++ +VSDFG +++L+ + WT
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSI 735
AP E K T DV+SFG++ EV+ G+ P LS
Sbjct: 218 ---AP----------EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------- 255
Query: 736 NIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E ++ RLP P D + +M + C RP + +L
Sbjct: 256 NHEVMKAINDGFRLPTPM-DCPSAIYQLM---MQCWQQERARRPKFADIVSIL 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 63/283 (22%), Positives = 100/283 (35%), Gaps = 42/283 (14%)
Query: 50 SKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLH 105
++ + + LS ++P G+ ++ L+L N TF +L +L+ + L
Sbjct: 54 NQFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFR---HLHHLEVLQLG 107
Query: 106 NNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNL 164
N + I L L+ L L N + + F L
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNW----------------LTVIPSGAFEY----L 146
Query: 165 RNCRSLVRAHLGRNNLTGNISED-FGIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLI 222
R L L N + +I F P+L LDL IS + L L
Sbjct: 147 SKLREL---WLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202
Query: 223 VSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLP 281
+ NI P + L L++S NH EI L SL KL + +Q+S
Sbjct: 203 LGMCNIKD--MPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 282 RALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
A L L +L+ N L++ + + L L+ HN +
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 11/214 (5%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
GI N ++L+L NN I ++ H L L + N+I +I + L+ L+
Sbjct: 72 GIPSNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLE 129
Query: 247 LSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSS-NRLNNSI 304
L N + IP L L +L LR N + A + L DL +L
Sbjct: 130 LFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS 188
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSR-ICNLESLE 363
A +F L YLN ++P +L L L EL++S N F I L SL+
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLK 245
Query: 364 KLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
KL + ++ +S F G++ L+ +++++N L
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 11/232 (4%)
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGN 226
+ +L NN+ ++ F +L+ L L N+ +I + L TL + N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDN 133
Query: 227 NITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLIL-RGNQLSGHLPRA 283
+T IP S+L L L +N I IP R+ SL +L L +L A
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGA 191
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
L L+Y +L + + + L + L L S N F + P L+ L +L +
Sbjct: 192 FEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249
Query: 344 SHNLFKGSIPSR-ICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
++ I L SL +LNL+HNN+S F + L+ + + +N
Sbjct: 250 MNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 11/204 (5%)
Query: 220 TLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGNQLS 277
L + NNI I + + L VL L N I +I + L SLN L L N L+
Sbjct: 79 YLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT 136
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-LALLA 336
A L++L L +N + + A + L L+ + + I E L
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 337 HLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
+L L+L K +P+ + L LE+L +S N+ P F G+S L + + +++
Sbjct: 197 NLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254
Query: 397 RGPIPNSTVFRNAP--RESFLGNN 418
I + F E L +N
Sbjct: 255 SL-IERNA-FDGLASLVELNLAHN 276
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 52/245 (21%), Positives = 78/245 (31%), Gaps = 43/245 (17%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
+Q +F HL L L N + L+ L L+L +N L+ IP L
Sbjct: 89 MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYL 146
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISL-HNNKLSGSIPEEI-GNLMKLSYLM 127
+ L L L N F + +L + L KL I E L L YL
Sbjct: 147 SKLRELWLRNNPIESIPSYAF---NRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLN 202
Query: 128 LDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187
L +PNL L + N+
Sbjct: 203 LGMCNIK-------------------------DMPNLTPLVGLEELEMSGNHFPEIRPGS 237
Query: 188 FGIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVL 245
F +LK L + ++ I N + L L ++ NN++ +P ++ L L
Sbjct: 238 FHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVEL 295
Query: 246 DLSSN 250
L N
Sbjct: 296 HLHHN 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 74/314 (23%), Positives = 121/314 (38%), Gaps = 50/314 (15%)
Query: 499 EEIIRRTKDFDAKYC----IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFL 554
I + +G G +V G +AVK+ L
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIAL 56
Query: 555 NEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINRGSLA-TVLSNNFASEDFDWRKRM 612
EIK LT+ H N++++Y + R ++ E N +L V S N + E+ +K
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEY 115
Query: 613 ---NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-------------YEARVSDF 656
+++ +A ++++H I+HRD+ N+L+ +SDF
Sbjct: 116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 657 GTAKLLKPNSSNWT----ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLA 712
G K L S++ GT G+ AP + L ++T D++S G +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAP---ELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 713 LEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEK-LISIMEVALLCLD 770
++ KGKHP F +S S+ I F+ L SL + LIS M + D
Sbjct: 230 YYILSKGKHP--FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM----IDHD 283
Query: 771 GCPNSRPTMQTVCQ 784
P RPT V +
Sbjct: 284 --PLKRPTAMKVLR 295
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 58/321 (18%), Positives = 108/321 (33%), Gaps = 54/321 (16%)
Query: 470 SQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LP 528
++ Q D G+ + Y E + +G+G V+R K
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP---RVGRGSFGEVHRMKDKQ 81
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588
+G + AVK ++ + + E+ A + IV YG + E +
Sbjct: 82 TGFQCAVK---------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648
GSL ++ + + + + L Y+H I+H D+ ++NVLL +
Sbjct: 133 EGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSD 186
Query: 649 -YEARVSDFGTAKLLKPNSSNWTE-----LVGTFGYVAPAHGNIGLHLAELAYTMKITEK 702
A + DFG A L+P+ + + GT ++AP E+ K
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP----------EVVMGKPCDAK 236
Query: 703 CDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM----LDHRLPHPSLDVQEKL 758
D++S + L ++ G HP ++ P P ++
Sbjct: 237 VDIWSSCCMMLHMLNGCHP--------------WTQYFRGPLCLKIASEPPPIREIPPSC 282
Query: 759 ISIM-EVALLCLDGCPNSRPT 778
+ + L P R +
Sbjct: 283 APLTAQAIQEGLRKEPVHRAS 303
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 59/292 (20%)
Query: 514 IGKGEHRSVYRA--KLPSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G GE V KLPS +I A+K +++FL E + + H NI+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
+ G + + +V EY+ GSL + L + F + + ++ G+A + Y+
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------------WTELVGTFG 677
+ VHRD+++ N+L++ +VSDFG ++L+ + WT
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT------- 217
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSIN 736
+P E K T DV+S+G++ EV+ G+ P +S N
Sbjct: 218 --SP----------EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---------N 256
Query: 737 IEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ +D RLP P D L +M L C N+RP + + +L
Sbjct: 257 QDVIKAVDEGYRLPPPM-DCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 40/291 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+GKG SV + P D +AVKK ++F EI+ L ++H NI
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHDNI 104
Query: 569 VKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
VK+ G C ++ EY+ GSL L + E D K + + + + Y+
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 162
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+ +HRD+++ N+L++ E ++ DFG K+L + Y G
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---------YYKVKEPGES 210
Query: 687 GLH-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSI------NI 737
+ A E K + DV+SFGV+ E+ + + F +
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 738 EFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+L RLP P +++ IM C + N RP+ + + +
Sbjct: 271 HLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLALRV 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 45/230 (19%), Positives = 86/230 (37%), Gaps = 30/230 (13%)
Query: 505 TKDFDAKYCIGKGEHR--SVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
++ IGKG +V A+ P+G+ + V++ N E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSK 81
Query: 562 KIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621
H NIV + +VV ++ GS ++ +F + + ++ GV A
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKA 140
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG-----TAKLLKPNSSN--WTELVG 674
L Y+HH VHR + ++++L+ ++ + +S + + + V
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 675 TFGYVAP---AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+++P G Y K D+YS G+ A E+ G P
Sbjct: 198 VLPWLSPEVLQQNLQG-------Y----DAKSDIYSVGITACELANGHVP 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 59/306 (19%), Positives = 111/306 (36%), Gaps = 61/306 (19%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDK-----IAVKKFNSPFPNDQMSDQKEFL 554
I++ T +F +G G +VY+ + +A+K+ KE L
Sbjct: 10 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 65
Query: 555 NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
+E + + + ++ + G C ++ + + G L + + ++ + +N
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNW 122
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS------- 667
+A ++Y+ VHRD+++ NVL+ +++DFG AKLL
Sbjct: 123 CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 668 ----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPG 722
W A E T + DV+S+GV E++ G P
Sbjct: 180 KVPIKWM---------AL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 723 DFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
D + E +++L+ RLP P + IM C +SRP +
Sbjct: 221 DGIP---------ASEISSILEKGERLPQPP-ICTIDVYMIM---RKCWMIDADSRPKFR 267
Query: 781 TVCQLL 786
+
Sbjct: 268 ELIIEF 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G+G V P+ D +AVK + + + EI L + H +I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 569 VKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
+K+ G C + +V EY+ GSL L + + + + + ++Y+H
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH 151
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+ +HRD+++ NVLLD + ++ DFG AK + Y G+
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---------YYRVREDGDS 199
Query: 687 GLH-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSS-----INIE 738
+ A E K DV+SFGV E++ + F +
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+L+ RLP P ++ +M C + + RPT + + +L
Sbjct: 260 LTELLERGERLPRPD-KCPAEVYHLM---KNCWETEASFRPTFENLIPIL 305
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 41/295 (13%)
Query: 501 IIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDK---IAVKKFNSPFPNDQMSDQKEFLNEI 557
++R A +G G SV + K +A+K + +D +E + E
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREA 387
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
+ + ++ + IV+ G C +V E G L L E+ ++
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQ 444
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT-- 675
V+ + Y+ F VHR++++ NVLL + A++SDFG +K L + S +T
Sbjct: 445 VSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 676 -FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSS 733
+ AP E K + + DV+S+GV E + G+ P +
Sbjct: 502 PLKWYAP----------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------- 544
Query: 734 SINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E A ++ R+ P + +L ++M C RP TV Q +
Sbjct: 545 --GPEVMAFIEQGKRMECPP-ECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 593
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 52/298 (17%), Positives = 108/298 (36%), Gaps = 68/298 (22%)
Query: 514 IGKGEHRSVYRAKLPSGD--------KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+G+G +++ ++ +K + + + F ++K+ H
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNYSESFFEAASMMSKLSH 71
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
+++V YG C + +V E++ GSL T L N + ++ V +A A+ ++
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFL 129
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEAR--------VSDFGTAKLLKPNSS-----NWTEL 672
+ +H ++ + N+LL E + + +SD G + + P W
Sbjct: 130 EENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV-- 184
Query: 673 VGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSS 730
P E + + D +SFG E+ G P L
Sbjct: 185 -------PP----------ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD---- 223
Query: 731 SSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ + H+LP P +L +++ C+D P+ RP+ + + + L
Sbjct: 224 -----SQRKLQFYEDRHQLPAPKAA---ELANLI---NNCMDYEPDHRPSFRAIIRDL 270
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 39/290 (13%)
Query: 514 IGKGEHRSVYRAKL-PSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+GKG SV + P GD +AVK+ + Q++F EI+ L + I
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREIQILKALHSDFI 86
Query: 569 VKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
VK+ G +V EY+ G L L + D + + + + + Y+
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG 144
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
VHRD+++ N+L++ E +++DFG AKLL + YV G
Sbjct: 145 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---------YYVVREPGQS 192
Query: 687 GLH-LA-ELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSI-----NIE 738
+ A E + + DV+SFGV+ E+ + F
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+L+ RLP P ++ +M LC P RP+ + L
Sbjct: 253 LLELLEEGQRLPAPP-ACPAEVHELM---KLCWAPSPQDRPSFSALGPQL 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 60/288 (20%), Positives = 113/288 (39%), Gaps = 32/288 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+ + IG G V++ A+K N + NEI L K++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 566 --RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
I++ Y + ++ ++V E N L + L + D +R + + +A+
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVH 122
Query: 624 YMH-HDCFPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNW--TELVGTFGY 678
+H H IVH D+ N L+ + + DFG A ++P++++ VGT Y
Sbjct: 123 TIHQHG----IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 679 VAP-AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737
+ P A ++ KI+ K DV+S G + + GK P F + I+
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISK 229
Query: 738 EFNAML-DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ +H + P ++ L +++ L D P R ++ +
Sbjct: 230 LHAIIDPNHEIEFPD-IPEKDLQDVLK-CCLKRD--PKQRISIPELLA 273
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 11/232 (4%)
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGN 226
+ +L N + F +L+ L LS N+ I L TL + N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDN 122
Query: 227 NITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLIL-RGNQLSGHLPRA 283
+T IP S+L L L +N I IP R+ SL +L L +LS A
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
L+ L Y +L+ L + L + KL L+ S N S P L HL +L +
Sbjct: 181 FEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 344 SHNLFKGSIPSR-ICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
+ + I NL+SL ++NL+HNN++ F + L I + +N
Sbjct: 239 IQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 62/288 (21%), Positives = 104/288 (36%), Gaps = 42/288 (14%)
Query: 43 PPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS----GTFPPICNLSN 98
P ++ + L ++P G+ T+ L+L NQ +F +L +
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPD--GISTNTRLLNLHENQIQIIKVNSFK---HLRH 89
Query: 99 LKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHF 157
L+ + L N + +I L L+ L L N+ T T+ + F
Sbjct: 90 LEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT----------------TIPNGAF 132
Query: 158 LGSIPNLRNCRSLVRAHLGRNNLTGNISED-FGIYPNLKFLDLSHNNFYGEISSNW-GKC 215
+ L + L L N + +I F P+L+ LDL IS
Sbjct: 133 VY----LSKLKEL---WLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 216 HRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGN 274
L L ++ N+ P + +L LDLS NH++ I L+ L KL + +
Sbjct: 185 SNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQS 241
Query: 275 QLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHN 322
Q+ A L L +L+ N L + + L ++ HN
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 60/214 (28%), Positives = 85/214 (39%), Gaps = 11/214 (5%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
GI N + L+L N I N L L +S N+I I + L+ L+
Sbjct: 61 GISTNTRLLNLHENQI-QIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118
Query: 247 LSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSS-NRLNNSI 304
L N + IP L L +L LR N + A + L DL RL+
Sbjct: 119 LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS 177
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI-CNLESLE 363
A + L YLN + EIP +L L L ELDLS N +I L L+
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQ 234
Query: 364 KLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
KL + + I F + L+ I++++N L
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 11/204 (5%)
Query: 220 TLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRGNQLS 277
L + N I I + L +L LS NHI I + L +LN L L N+L+
Sbjct: 68 LLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT 125
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-LALLA 336
A L++L+ L +N + + A + L L+ + I E L+
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185
Query: 337 HLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
+L L+L+ + IP+ + L L++L+LS N++S P F G+ L + + +++
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 397 RGPIPNSTVFRNAP--RESFLGNN 418
+ I + F N E L +N
Sbjct: 244 QV-IERNA-FDNLQSLVEINLAHN 265
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 55/245 (22%), Positives = 83/245 (33%), Gaps = 43/245 (17%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
++ SF HL L LS N T+ L+ L L+L +N L+ IP L
Sbjct: 78 IIKVNSFKHLRHLEILQLSRNH-IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYL 135
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISL-HNNKLSGSIPEEI-GNLMKLSYLM 127
+ L L L N F + +L+ + L +LS I E L L YL
Sbjct: 136 SKLKELWLRNNPIESIPSYAF---NRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLN 191
Query: 128 LDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187
L IPNL L L N+L+
Sbjct: 192 LAMCNLR-------------------------EIPNLTPLIKLDELDLSGNHLSAIRPGS 226
Query: 188 FGIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEIGNS-SQLHVL 245
F +L+ L + + I N + L + ++ NN+T +P ++ L +
Sbjct: 227 FQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERI 284
Query: 246 DLSSN 250
L N
Sbjct: 285 HLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
T++ +F+ +L L+L N T+P LSKLK L L N + IP +
Sbjct: 102 TIEIGAFNGLANLNTLELFDN-RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159
Query: 74 THLFSLDLS-LNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLML 128
L LDL L + S G F LSNL+Y++L L IP + L+KL L L
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFE---GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214
Query: 129 DTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNI 184
N + + + GL L+ L + + + I N +SLV +L NNLT +
Sbjct: 215 SGNHLS-AIRPGSFQ-GLMHLQKLWMIQSQ-IQVIERNAFDNLQSLVEINLAHNNLT-LL 270
Query: 185 SED-FGIYPNLKFLDLSHNNF 204
D F +L+ + L HN +
Sbjct: 271 PHDLFTPLHHLERIHLHHNPW 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 45/284 (15%)
Query: 514 IGKGEHRSVYRAKLPSGD---KIAVK--KFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G G +V + +AVK K + P + + E L E + ++ + I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYI 80
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
V+ G C +V E G L L N + + ++ V+ + Y+
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 136
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---FGYVAPAHGN 685
F VHRD+++ NVLL ++ A++SDFG +K L+ + + + + AP
Sbjct: 137 NF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP---- 189
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E K + K DV+SFGVL E G+ P + E AML+
Sbjct: 190 ------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLE 234
Query: 745 H--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
R+ P+ ++ +M LC +RP V L
Sbjct: 235 KGERMGCPA-GCPREMYDLM---NLCWTYDVENRPGFAAVELRL 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 59/289 (20%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
+ FD +G+G + SVY+A +G +A+K+ SD +E + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEIIKEISIMQQC 81
Query: 564 RHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMN------VI 615
++VK+YG S+ +++ ++V EY GS++ ++ K + ++
Sbjct: 82 DSPHVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIIRLR--------NKTLTEDEIATIL 131
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
L Y+H +HRDI + N+LL+ E A+++DFG A L + ++GT
Sbjct: 132 QSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 188
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735
++AP E+ + D++S G+ A+E+ +GK P
Sbjct: 189 PFWMAP----------EVIQEIGYNCVADIWSLGITAIEMAEGKPP-------------- 224
Query: 736 NIEFNAM----LDHRLPHPSLDVQEKLISIME--VALLCLDGCPNSRPT 778
+ + M + P P+ E V CL P R T
Sbjct: 225 YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK-QCLVKSPEQRAT 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 32/295 (10%)
Query: 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
E I + + + IG G V++ A+K N + NEI
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--LEEADNQTLDSYRNEIA 106
Query: 559 ALTKIRH--RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT 616
L K++ I++ Y + ++ ++V E N L + L + D +R +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWK 162
Query: 617 GVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTE-- 671
+ +A+ +H H IVH D+ N L+ + + DFG A ++P++++ +
Sbjct: 163 NMLEAVHTIHQHG----IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 672 LVGTFGYVAP-AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
VG Y+ P A ++ KI+ K DV+S G + + GK P F
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQ 269
Query: 731 SSSSINIEFNAML-DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ I+ + +H + P ++ L +++ L D P R ++ +
Sbjct: 270 IINQISKLHAIIDPNHEIEFPD-IPEKDLQDVLK-CCLKRD--PKQRISIPELLA 320
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 63/366 (17%), Positives = 119/366 (32%), Gaps = 78/366 (21%)
Query: 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84
+ + + + + S L+ IP GL + SLDLS N
Sbjct: 6 WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNN 62
Query: 85 QFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPR 139
+ + NL+ + L +N ++ +I E+ +L L +L L N
Sbjct: 63 RITYISNSDLQ---RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY------- 111
Query: 140 NICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISED--FGIYPNLK 195
L ++ + + SL +L N + E F L+
Sbjct: 112 ------------------LSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152
Query: 196 FLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254
L + + + + +I L L + +++ P+
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKS------------------ 193
Query: 255 EIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEAL------ 308
L + +++ LIL Q L + + + +E +L L+ L
Sbjct: 194 -----LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 309 --GFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKL 365
F + + ++ + L ++ L EL+ S N K S+P I L SL+K+
Sbjct: 249 SLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKI 306
Query: 366 NLSHNN 371
L N
Sbjct: 307 WLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 50/271 (18%), Positives = 94/271 (34%), Gaps = 27/271 (9%)
Query: 50 SKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISL 104
+K LDLS N ++ I +L +L L+ N + +F +L +L+++ L
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSF---SSLGSLEHLDL 107
Query: 105 HNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSI 161
N LS ++ L L++L L N + L S L L+IL V + I
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 162 PN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLG 219
L + ++L + N+ L L + +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 220 TLIVSGNNITGRIPPEI--------GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271
L + ++ E+ + ++ + ++ L ++ L +L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 272 RGNQLSGHLPR-ALGLLTELEYFDLSSNRLN 301
NQL +P LT L+ L +N +
Sbjct: 285 SRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 45/242 (18%), Positives = 86/242 (35%), Gaps = 27/242 (11%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI--GL 72
T++E SFSS L +LDLS N + L + LS L +L+L N +
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYN-YLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
Query: 73 LTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLD 129
LT L L + L+ L+ + + + L S + ++ +S+L+L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILH 206
Query: 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG 189
Q L + + +E L + D + L+ +
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDL---------------DTFHFSELSTGETNSLI 251
Query: 190 IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLS 248
+ + ++ + + ++ + L L S N + +P I + L + L
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLH 309
Query: 249 SN 250
+N
Sbjct: 310 TN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 16/222 (7%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDL 247
G+ +K LDLS+N +S+ +C L L+++ N I I + + L LDL
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107
Query: 248 SSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPRAL-GLLTELEYFDLSSNRLNNSI- 304
S N+++ + L SL L L GN +L LT+L+ + + I
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRI-CNLESLE 363
+ + L L + P+ L + ++S L L + S+E
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVE 225
Query: 364 KLNLSHNNISG----QIPAC----FIGMSGLLSIDISYNELR 397
L L ++ ++ I ++ I+ L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 41/185 (22%), Positives = 75/185 (40%), Gaps = 7/185 (3%)
Query: 215 CHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGN 274
C R G S ++ IP + + + LDLS+N I +L R ++L L+L N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 275 QLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED--L 332
++ + L LE+ DLS N L+N + L +LN N + + + E
Sbjct: 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLF 145
Query: 333 ALLAHLSELDLSHNLFKGSIPSRI-CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDI 391
+ L L L + + I + L LE+L + +++ P + + + +
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 392 SYNEL 396
+
Sbjct: 206 HMKQH 210
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 48/259 (18%), Positives = 93/259 (35%), Gaps = 20/259 (7%)
Query: 20 FSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
F + + + + T +L + L ++ I + L +L L
Sbjct: 13 FPDPALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
+L NQ + P+ NL+ + + L N L I L + L L + Q T P
Sbjct: 69 ELKDNQIT-DLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 140 NICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDL 199
+ L++L ++ N + +I L +L +G ++ +++ L L
Sbjct: 126 AGLSN--LQVLYLDLNQ-ITNISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKA 180
Query: 200 SHNNFYGEIS--SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP 257
N IS S L + + N I+ + P + N+S L ++ L++ I +
Sbjct: 181 DDNK----ISDISPLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTNQTITNQPV 234
Query: 258 MELGRLISLNKLILRGNQL 276
L+ N +
Sbjct: 235 FYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 18/236 (7%)
Query: 161 IPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGT 220
I + ++ G++N+T ++ + L + L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIG 67
Query: 221 LIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHL 280
L + N IT + P + N +++ L+LS N + + + L S+ L L Q++
Sbjct: 68 LELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD-- 121
Query: 281 PRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSE 340
L L+ L+ L N++ N + L + L YL+ + Q S P LA L+ L+
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177
Query: 341 LDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
L N I + +L +L +++L +N IS P S L + ++ +
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 54/259 (20%), Positives = 97/259 (37%), Gaps = 21/259 (8%)
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
+ ++ + + + +T I NL L+L N
Sbjct: 21 AIKIAAGKSN-VTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ--- 74
Query: 207 EIS--SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
I+ + ++ L +SGN + + I + LDL+S I P L L
Sbjct: 75 -ITDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLS 129
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
+L L L NQ++ ++ L LT L+Y + + ++++ L L + KL L N+
Sbjct: 130 NLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKI 185
Query: 325 SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMS 384
S +I LA L +L E+ L +N P + N +L + L++ I+ Q +
Sbjct: 186 S-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241
Query: 385 GLLSIDISYNELRGPIPNS 403
+ P S
Sbjct: 242 VPNVVKGPSGAPIAPATIS 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 58/299 (19%), Positives = 114/299 (38%), Gaps = 49/299 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G +V+R + +GD A+K FN+ + + E + L K+ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNN---ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 573 GF--CSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
+ RH ++ E+ GSL TVL + + + V+ V ++++ +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 631 PPIVHRDISSNNVLLDLEYEAR----VSDFGTAKLLKPNSSNWTELVGTFGYVAPA--HG 684
IVHR+I N++ + + + ++DFG A+ L+ + + L GT Y+ P
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALE-----------------------VIKGKHP 721
+ + Y D++S GV +I GK
Sbjct: 190 AVLRKDHQKKY----GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 722 GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
G + + + I+ + + L + +++ + L D
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI----LEAD--QEKCWGFD 298
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-----AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G G +VY A+ D I A+K P + + ++ F E+ +++ H+NI
Sbjct: 19 LGGGGMSTVYLAE----DTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNI 73
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
V ++V EYI +L+ + ++ +N + D + + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM 130
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT-ELVGTFGYVAPAHGNIG 687
IVHRDI N+L+D ++ DFG AK L S T ++GT Y +P
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP------ 181
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GD 723
E A E D+YS G++ E++ G+ P G+
Sbjct: 182 ----EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 58/299 (19%), Positives = 114/299 (38%), Gaps = 49/299 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G +V+R + +GD A+K FN+ + + E + L K+ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNN---ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 573 GF--CSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
+ RH ++ E+ GSL TVL + + + V+ V ++++ +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 631 PPIVHRDISSNNVLLDLEYEAR----VSDFGTAKLLKPNSSNWTELVGTFGYVAP--AHG 684
IVHR+I N++ + + + ++DFG A+ L+ + + L GT Y+ P
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALE-----------------------VIKGKHP 721
+ + Y D++S GV +I GK
Sbjct: 190 AVLRKDHQKKY----GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 722 GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
G + + + I+ + + L + +++ + L D
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI----LEAD--QEKCWGFD 298
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/260 (21%), Positives = 91/260 (35%), Gaps = 29/260 (11%)
Query: 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH--LFSLDLSLN 84
L I +V +S L+ L L E++G PP + T L L+L
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 85 QFSGTFPPICNLSN-----LKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
++ + L LK +S+ E++ LS L L N G+
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG- 190
Query: 140 NICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDL 199
+ P L + L + G +G S L+ LDL
Sbjct: 191 ------------LISALCPLKFPTL---QVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 200 SHNNFYGEI-SSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPM 258
SHN+ + + +L +L +S + ++P + ++L VLDLS N + P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNP- 290
Query: 259 ELGRLISLNKLILRGNQLSG 278
L + L L+GN
Sbjct: 291 SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 52/320 (16%), Positives = 95/320 (29%), Gaps = 65/320 (20%)
Query: 95 NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICR----SGLLEIL 150
S + + + +I + L L + + ++ R SGL E L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE-L 100
Query: 151 TVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210
T+ + G+ P P+L L+L + ++ +
Sbjct: 101 TLENLEVTGTAP---------------------PPLLEATGPDLNILNLRNVSWATRDAW 139
Query: 211 NWG----KCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME----LGR 262
L L ++ + ++ L LDLS N GE + +
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 263 LISLNKLILRGNQ---LSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNF 319
+L L LR SG +L+ DLS N L ++
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA--------------- 244
Query: 320 SHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPAC 379
+ L+ L+LS K +P L L+LS+N + P+
Sbjct: 245 --------GAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLDR-NPS- 291
Query: 380 FIGMSGLLSIDISYNELRGP 399
+ + ++ + N
Sbjct: 292 PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 36/185 (19%), Positives = 57/185 (30%), Gaps = 13/185 (7%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKI 66
N++ L E P L L ++ QVR L LDLS+N G+
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 67 PPEIGL----LTHLFSLDLSLNQFSGTFPPIC----NLSNLKYISLHNNKLSGSIPEEIG 118
L L L L L+ + L +N L +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 119 NLM-KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGR 177
+ +L+ L L Q+P+ + L +L ++ N L P+ + L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLPAK--LSVLDLSYNR-LDRNPSPDELPQVGNLSLKG 305
Query: 178 NNLTG 182
N
Sbjct: 306 NPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 41/200 (20%), Positives = 67/200 (33%), Gaps = 16/200 (8%)
Query: 221 LIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNK---LILRGNQLS 277
L +I S L L + + I I R++ ++ L L +++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 278 GHLPRALGLLT--ELEYFDLSSNRLNNSILEALGFMFKLF----YLNFSHNQFSQEIPED 331
G P L T +L +L + L L+ + E
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 332 LALLAHLSELDLSHNLFKG--SIPSRIC--NLESLEKLNLSHNN---ISGQIPACFIGMS 384
+ + LS LDLS N G + S +C +L+ L L + SG A
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 385 GLLSIDISYNELRGPIPNST 404
L +D+S+N LR +
Sbjct: 229 QLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 24/174 (13%), Positives = 55/174 (31%), Gaps = 13/174 (7%)
Query: 237 GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL---TELEYF 293
G S ++L ++ + +SL +L +R ++ + + + L+
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 294 DLSSNRLNNSILEALGFMF--KLFYLNFSHNQFSQEIPEDLAL----LAHLSELDLSHNL 347
L + + + L L LN + ++ L L L ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 348 FKGSIPSRICNLESLEKLNLSHNNISGQIP----ACFIGMSGLLSIDISYNELR 397
++ +L L+LS N G+ C + L + + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 27/93 (29%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
++ L LDLS N S+L L+LS L ++P GL L L
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLSVL 279
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGS 112
DLS N+ P L + +SL N S
Sbjct: 280 DLSYNRLD-RNPSPDELPQVGNLSLKGNPFLDS 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/291 (20%), Positives = 105/291 (36%), Gaps = 60/291 (20%)
Query: 514 IGKGEHRSVYRAKL--PSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G+G VY G+KI AVK + + ++++F++E + + H +IV
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 570 KFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
K G +++ E G L L N + + A++Y+
Sbjct: 77 KLIGIIE--EEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN----------WTELVGTFGY 678
VHRDI+ N+L+ ++ DFG ++ ++ W
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-------- 181
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINI 737
+P E + T DV+ F V E++ GK P +L N
Sbjct: 182 -SP----------ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE---------NK 221
Query: 738 EFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ +L+ RLP P L ++M C D P+ RP + L
Sbjct: 222 DVIGVLEKGDRLPKPD-LCPPVLYTLM---TRCWDYDPSDRPRFTELVCSL 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 68/287 (23%), Positives = 109/287 (37%), Gaps = 47/287 (16%)
Query: 514 IGKGEHRSVYRA--KLPSGDKI--AVKKFNSPFPNDQMSDQK---EFLNEIKALTKIRHR 566
+G G V R PSG + AVK D +S + +F+ E+ A+ + HR
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLK----PDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
N+++ YG +V E GSL L + F VA+ + Y+
Sbjct: 82 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT---FGYVAPAH 683
F +HRD+++ N+LL ++ DFG + L N ++ F + AP
Sbjct: 139 SKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP-- 193
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAM 742
E T + D + FGV E+ G+ P L+ +
Sbjct: 194 --------ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---------GSQILHK 236
Query: 743 LD---HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+D RLP P D + + ++M + C P RPT + L
Sbjct: 237 IDKEGERLPRPE-DCPQDIYNVM---VQCWAHKPEDRPTFVALRDFL 279
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 48/279 (17%), Positives = 94/279 (33%), Gaps = 21/279 (7%)
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
+ + S+ + +++ ++ + PN+ L L+ N
Sbjct: 23 TIKDNLKKKS-VTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK--- 76
Query: 207 EIS--SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
++ LG L + N I + + + +L L L N I+ +I L L
Sbjct: 77 -LTDIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLVHLP 131
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
L L L N+++ L LT+L+ L N++++ + L + KL L S N
Sbjct: 132 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHI 187
Query: 325 SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMS 384
S ++ LA L +L L+L + NL + + ++ P
Sbjct: 188 S-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDG 243
Query: 385 GLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFY 423
++ ++ S +F F
Sbjct: 244 DYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV 282
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (259), Expect = 3e-23
Identities = 65/330 (19%), Positives = 110/330 (33%), Gaps = 66/330 (20%)
Query: 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSG 111
+ + +I P +L + L+++ I +N+ +
Sbjct: 1 MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIK- 56
Query: 112 SIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLV 171
S+ + I L ++ L L+ N+ L I L N ++L
Sbjct: 57 SV-QGIQYLPNVTKLFLNGNK-------------------------LTDIKPLTNLKNLG 90
Query: 172 RAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR 231
L N + ++ LK L L HN IS +I G
Sbjct: 91 WLFLDENKIK-DL-SSLKDLKKLKSLSLEHNG----IS-----------------DING- 126
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291
+ + QL L L +N I +I L RL L+ L L NQ+S + L LT+L+
Sbjct: 127 ----LVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 178
Query: 292 YFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGS 351
LS N +++ L AL + L L + + + L + + +
Sbjct: 179 NLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-- 234
Query: 352 IPSRICNLESLEKLNLSHNNISGQIPACFI 381
P I + EK N+ + FI
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 7e-19
Identities = 43/232 (18%), Positives = 93/232 (40%), Gaps = 14/232 (6%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+ + + + + + ++ ++ L + L L+ N+L+ I P + L +L L
Sbjct: 38 TQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLF 93
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN 140
L N+ + +L LK +SL +N +S I + +L +L L L N+ T
Sbjct: 94 LDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITV 148
Query: 141 ICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLS 200
+ R L+ L++ DN + I L L +L +N+++ ++ NL L+L
Sbjct: 149 LSRLTKLDTLSLEDNQ-ISDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELF 205
Query: 201 HNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
+ ++ T+ + ++ P I + ++ +
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP 255
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 59/306 (19%), Positives = 112/306 (36%), Gaps = 61/306 (19%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDK-----IAVKKFNSPFPNDQMSDQKEFL 554
I++ T +F +G G +VY+ + +A+K+ KE L
Sbjct: 10 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 65
Query: 555 NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
+E + + + ++ + G C ++ + + G L + + ++ + +N
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNW 122
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS------- 667
+A ++Y+ VHRD+++ NVL+ +++DFG AKLL
Sbjct: 123 CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 668 ----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPG 722
W A E T + DV+S+GV E++ G P
Sbjct: 180 KVPIKWM---------AL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 723 DFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
D + E +++L+ RLP P + IM + C +SRP +
Sbjct: 221 DGIP---------ASEISSILEKGERLPQPP-ICTIDVYMIM---VKCWMIDADSRPKFR 267
Query: 781 TVCQLL 786
+
Sbjct: 268 ELIIEF 273
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 25/220 (11%)
Query: 514 IGKGEHRSVYRAKLPSGD-KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G VY A+ + +A+K + +D + + E + +++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-RTRMQREARTAGRLQEPHVVPIH 100
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
F +V IN LA +L + + ++ + AL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE---LVGTFGYVAPAHGNIGLH 689
HRD+ N+L+ + A + DFG A T+ VGT Y+AP
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP-------- 204
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GDFLSL 727
E T + D+Y+ + E + G P GD LS+
Sbjct: 205 --ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 514 IGKGEHRSVYRAKLPSGDKI-----AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G G V+ A+ D AVK + D + F E + + H I
Sbjct: 20 LGFGGMSEVHLAR----DLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAI 74
Query: 569 VKFY--GF--CSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
V Y G ++V EY++ +L ++ ++ + VI AL++
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNF 131
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE---LVGTFGYVAP 681
H + I+HRD+ N+++ +V DFG A+ + + ++ T+ ++GT Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--GD 723
E A + + DVYS G + EV+ G+ P GD
Sbjct: 189 ----------EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 63/290 (21%), Positives = 109/290 (37%), Gaps = 58/290 (20%)
Query: 514 IGKGEHRSVYRAKLPSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG+G+ V++ S + +A+K S +++FL E + + H +IV
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
K G + +++ E G L + L D + ++ AL+Y+
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR 136
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN----SSN------WTELVGTFGYV 679
F VHRDI++ NVL+ ++ DFG ++ ++ + +S W
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--------- 184
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIE 738
AP E + T DV+ FGV E++ G P + N +
Sbjct: 185 AP----------ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NND 225
Query: 739 FNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
++ RLP P + L S+M C P+ RP + L
Sbjct: 226 VIGRIENGERLPMPP-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 58/310 (18%), Positives = 112/310 (36%), Gaps = 66/310 (21%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
R T +F IG GE SV++ K G A+K+ S P D++ L E+ A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHA 65
Query: 562 KI-RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED-FDWRKRMNVITGVA 619
+ +H ++V+++ + H + EY N GSLA +S N+ F + +++ V
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLD-------------------LEYEARVSDFGTAK 660
L Y+H +VH DI +N+ + + ++ D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 661 LLKPNSSNWTELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG 718
+ S+ G ++A N + K D+++ + +
Sbjct: 183 RI----SSPQVEEGDSRFLANEVLQENYT-------H----LPKADIFALALTVVCAAGA 227
Query: 719 KHPGDFLSLFSSSSSSINIEFNAMLDHRLP----HPSLDVQEKLISIMEVALLCLDGCPN 774
+ + +++ + RLP S + E L+ + + P
Sbjct: 228 EPL------PRNGD-----QWHEIRQGRLPRIPQVLSQEFTE-LLK------VMIHPDPE 269
Query: 775 SRPTMQTVCQ 784
RP+ + +
Sbjct: 270 RRPSAMALVK 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 50/293 (17%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKAL 560
R + + +GKG + + + A K S ++ EI
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIH 69
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN------V 614
+ H+++V F+GF FVV E R SL + RK +
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYY 120
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ + Y+H + ++HRD+ N+ L+ + E ++ DFG A ++ + L G
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734
T Y+AP E+ + + DV+S G + ++ GK P + +S
Sbjct: 178 TPNYIAP----------EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSC 219
Query: 735 INIEFN--AMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ + ++ +P H + LI M L P +RPT+ +
Sbjct: 220 LKETYLRIKKNEYSIPKHINPVAA-SLIQKM------LQTDPTARPTINELLN 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 40/228 (17%)
Query: 503 RRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVK-----KFNSPFPNDQMSDQKE 552
T F Y +G+G V R P+ + AVK S + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 553 FLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW--- 608
L E+ L K+ H NI++ F+V++ + +G L FD+
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL------------FDYLTE 117
Query: 609 ------RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
++ ++ + + + +H IVHRD+ N+LLD + +++DFG + L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
P E+ GT Y+AP I + + ++ D++S GV
Sbjct: 175 DPGEK-LREVCGTPSYLAP---EI-IECSMNDNHPGYGKEVDMWSTGV 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 50/293 (17%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKAL 560
R + + +GKG + + + A K S ++ EI
Sbjct: 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIH 95
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN------V 614
+ H+++V F+GF FVV E R SL + RK +
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYY 146
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ + Y+H + ++HRD+ N+ L+ + E ++ DFG A ++ + L G
Sbjct: 147 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734
T Y+AP E+ + + DV+S G + ++ GK P + +S
Sbjct: 204 TPNYIAP----------EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSC 245
Query: 735 INIEFN--AMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ + ++ +P H + LI M L P +RPT+ +
Sbjct: 246 LKETYLRIKKNEYSIPKHINPVAA-SLIQKM------LQTDPTARPTINELLN 291
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 36/238 (15%), Positives = 73/238 (30%), Gaps = 38/238 (15%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK------LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
+K + +G+G VY A + K +K P + ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF----YIGTQLME 119
Query: 559 ALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLS--NNFASEDFDWRKRMNVIT 616
L +KFY S +V E + G+L ++ N + ++
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA-----------RVSDFGTAKLLK-- 663
+ + +H I+H DI +N +L + + D G + +K
Sbjct: 180 RMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
P + +T T G+ E+ + D + ++ G +
Sbjct: 237 PKGTIFTAKCETSGFQCV----------EMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 47/231 (20%), Positives = 97/231 (41%), Gaps = 41/231 (17%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
+ ++ +G G VY+AK +G A K + ++++ EI+ L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYIVEIEILATC 73
Query: 564 RHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMN------VI 615
H IVK G ++ +++ E+ G++ ++ + + V
Sbjct: 74 DHPYIVKLLG--AYYHDGKLWIMIEFCPGGAVDAIMLEL--------DRGLTEPQIQVVC 123
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
+ +AL+++H I+HRD+ + NVL+ LE + R++DFG + +GT
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 721
++AP E+ + + K D++S G+ +E+ + + P
Sbjct: 181 PYWMAP----------EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 55/298 (18%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKF 571
+ +G VY A+ + SG + A+K+ S + + + E+ + K+ H NIV+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 572 YGFCSHVRHS-------FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
S + F++ + +G L L + + + A+ +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------------WTEL 672
MH PPI+HRD+ N+LL + ++ DFG+A +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
T Y P + +L I EK D+++ G + + +HP F +
Sbjct: 211 NTTPMYRTP-------EIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP------FEDGA 257
Query: 733 SSINIEFNAMLDHRLPHPSLDVQ----EKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+++ + P D Q LI M L ++ P R ++ V L
Sbjct: 258 ------KLRIVNGKYSIPPHDTQYTVFHSLIRAM----LQVN--PEERLSIAEVVHQL 303
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 43/230 (18%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
K F IG G +VY A+ + + + +A+KK + ++ + E++ L K+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKL 111
Query: 564 RHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMN------VI 615
RH N +++ G ++R ++V EY GS + +L + +K + V
Sbjct: 112 RHPNTIQYRG--CYLREHTAWLVMEYCL-GSASDLLEVH--------KKPLQEVEIAAVT 160
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG-TAKLLKPNSSNWTELVG 674
G L+Y+H ++HRD+ + N+LL ++ DFG + + NS VG
Sbjct: 161 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVG 212
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITE---KCDVYSFGVLALEVIKGKHP 721
T ++AP E+ M + K DV+S G+ +E+ + K P
Sbjct: 213 TPYWMAP----------EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 36/280 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKI 563
+DF+ +GKG+ +VY A+ S +A+K + + Q E++ + +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
RH NI++ YG+ +++ EY G++ L FD ++ IT +A+ALS
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALS 123
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
Y H ++HRDI N+LL E +++DFG + P+S L GT Y+ P
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLDYLPP-- 176
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
E+ EK D++S GVL E + GK P F +++ + + +
Sbjct: 177 --------EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP------FEANTYQETYKRISRV 222
Query: 744 DHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ P + + LIS LL + P+ RP ++ V
Sbjct: 223 EFTFPDFVTEGAR-DLIS----RLLKHN--PSQRPMLREV 255
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 42/235 (17%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
D++ + IG G V A P +K+A+K+ N M + L EI+A+++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE---LLKEIQAMSQCH 71
Query: 565 HRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMN------VIT 616
H NIV +Y S V ++V + ++ GS+ ++ + A + ++ ++
Sbjct: 72 HPNIVSYY--TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-SGVLDESTIATILR 128
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL---- 672
V + L Y+H + +HRD+ + N+LL + +++DFG + L
Sbjct: 129 EVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 673 -VGTFGYVAP-----AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
VGT ++AP G Y K D++SFG+ A+E+ G P
Sbjct: 186 FVGTPCWMAPEVMEQVRG----------Y----DFKADIWSFGITAIELATGAAP 226
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/288 (18%), Positives = 94/288 (32%), Gaps = 43/288 (14%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
+ F +G G + V++ G AVK+ SPF + D+ L E+ +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHE 111
Query: 562 KI-RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
K+ +H V+ ++ E SL AS + +
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS--LPEAQVWGYLRDTLL 168
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680
AL+++H +VH D+ N+ L ++ DFG L + + G Y+A
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGDPRYMA 224
Query: 681 PAHGNIGLHLAEL---AYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737
P EL +Y DV+S G+ LEV
Sbjct: 225 P----------ELLQGSY----GTAADVFSLGLTILEVACNMEL-------PHGGEGWQQ 263
Query: 738 EFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
L S +++ ++ + L+ P R T + +
Sbjct: 264 LRQGYLPPEFTAGLSSELRS-VLV------MMLEPDPKLRATAEALLA 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 59/295 (20%), Positives = 102/295 (34%), Gaps = 51/295 (17%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G V R +G+++A+K+ +++ + EI+ + K+ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQ---ELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 573 ------GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
+ + EY G L L+ +++ ++ AL Y+H
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEAR---VSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
+ I+HRD+ N++L + + D G AK L VGT Y+AP
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAP-- 192
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP------------------GDFL 725
EL K T D +SFG LA E I G P + +
Sbjct: 193 --------ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 726 SLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
++ + ++ + L E+ + M L R T
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM----LMWH--QRQRGTDP 293
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 69/294 (23%), Positives = 107/294 (36%), Gaps = 61/294 (20%)
Query: 514 IGKGEHRSVYRAKLPSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG+G VY L D AVK N + + +FL E + H N++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 570 KFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
G C S VV Y+ G L + N + + + + VA + Y+
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL-------KPNSSN------WTELVGT 675
F VHRD+++ N +LD ++ +V+DFG A+ + N + W
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----- 199
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSS 734
A E T K T K DV+SFGVL E++ +G P ++
Sbjct: 200 ----AL----------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------- 237
Query: 735 INIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ L RL P + L +M L C RP+ + +
Sbjct: 238 -TFDITVYLLQGRRLLQPE-YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 286
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 31/311 (9%), Positives = 69/311 (22%), Gaps = 68/311 (21%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+ G+ V+ + + + A+K F N S+ + A ++ + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARLLGESPEEAR 128
Query: 573 GFC--------------------------SHVRHSFVVYEYINRGSLATVLSNNF----A 602
V + ++ L + S
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 603 SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662
D + + + + +VH + +N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPG 722
+ Y L+ + + T + + G+ V P
Sbjct: 242 WKVGTRGPASSVPVTYAPREF----LNASTATF----THALNAWQLGLSIYRVWCLFLP- 292
Query: 723 DFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQE---------KLISIMEVALLCLDGCP 773
F + I + SL LI L D
Sbjct: 293 -----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG----RFLNFD--R 341
Query: 774 NSRPTMQTVCQ 784
R +
Sbjct: 342 RRRLLPLEAME 352
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-22
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 37/230 (16%)
Query: 501 IIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVK---------KFNSPFPNDQ 546
+ ++ Y G G + V K + A+K S +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASED 605
+E NEI L + H NI+K + ++ ++V E+ G L +++ + E
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE- 145
Query: 606 FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAKLL 662
N++ + + Y+H IVHRDI N+LL + ++ DFG +
Sbjct: 146 ---CDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLA 712
+ + +GT Y+AP E K EKCDV+S GV+
Sbjct: 200 SKDYK-LRDRLGTAYYIAP----------E-VLKKKYNEKCDVWSCGVIM 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 61/294 (20%)
Query: 514 IGKGEHRSVYRAKLPSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG+G VY L D AVK N + + +FL E + H N++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 570 KFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
G C S VV Y+ G L + N + + + + VA + ++
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-------------WTELVGT 675
F VHRD+++ N +LD ++ +V+DFG A+ + + W
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----- 263
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSS 734
A E T K T K DV+SFGVL E++ +G P ++
Sbjct: 264 ----AL----------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------- 301
Query: 735 INIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ L RL P + L +M L C RP+ + +
Sbjct: 302 -TFDITVYLLQGRRLLQPE-YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 350
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-22
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 30/230 (13%)
Query: 501 IIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
I + Y G G + V + + + A+K + S + L
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT--SVSTSSNSKLLE 85
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNV 614
E+ L + H NI+K Y F R+ ++V E G L ++ +E +
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE----VDAAVI 141
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAKLLKPNSSNWTE 671
I V ++Y+H IVHRD+ N+LL + + ++ DFG + + + E
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKE 197
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+GT Y+AP E+ K EKCDV+S GV+ ++ G P
Sbjct: 198 RLGTAYYIAP----------EV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-22
Identities = 75/409 (18%), Positives = 131/409 (32%), Gaps = 63/409 (15%)
Query: 50 SKLKYLDLSENELSGKIPPEIG-LLTHLFSLDLSLNQFSGTF-PPIC----NLSNLKYIS 103
++ LD+ ELS E+ LL + L + I L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 104 LHNNKLSGSIPEEIGNLMK-----LSYLMLDTNQFTGQ----LPRNICRSGLLEILTVND 154
L +N+L + ++ + L L TG L + L+ L ++D
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 155 NHF-------LGSIPNLRNCRSLVRAHLGRNNLT----GNISEDFGIYPNLKFLDLSHNN 203
N L L L + L +L+ ++ P+ K L +S+N+
Sbjct: 123 NLLGDAGLQLLCEG-LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 204 FYGE----ISSNWGKCH-RLGTLIVSGNNITGR----IPPEIGNSSQLHVLDLSSNHIAG 254
+ +L L + +T + + + + L L L SN +
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 255 EIPMELGRLI-----SLNKLILRGNQLS----GHLPRALGLLTELEYFDLSSNRLNNSIL 305
EL + L L + ++ G L R L L+ L+ N L +
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301
Query: 306 EALGFMFK-----LFYLNFSHNQFS----QEIPEDLALLAHLSELDLSHNLFKGSIPSRI 356
L L L F+ LA L EL +S+N + + +
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361
Query: 357 C-----NLESLEKLNLSHNNISGQ----IPACFIGMSGLLSIDISYNEL 396
C L L L+ ++S + A + L +D+S N L
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-21
Identities = 76/418 (18%), Positives = 125/418 (29%), Gaps = 69/418 (16%)
Query: 23 SSFPHLAYLDLSINGF----FGTLPPQVRNLSKLKYLDLSENELSGKIPPEI--GLL--- 73
+ L G + +R L L+L NEL + GL
Sbjct: 25 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 84
Query: 74 THLFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKLSGSIPEEIGNLM-----KL 123
+ L L +G + L L+ + L +N L + + + + +L
Sbjct: 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 124 SYLMLDTNQFTGQLPRNICRSGL-----LEILTVNDNHF-------LGSIPNLRNCRSLV 171
L L+ + + S L + LTV++N L C L
Sbjct: 145 EKLQLEYCSLSAASCEPLA-SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC-QLE 202
Query: 172 RAHLGRNNLT----GNISEDFGIYPNLKFLDLSHNNFYGE----ISSNWGKCH-RLGTLI 222
L +T ++ +L+ L L N + RL TL
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 223 VSGNNITGR----IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI-----SLNKLILRG 273
+ IT + + + L L L+ N + E L + L L ++
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 274 NQLSG----HLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK-----LFYLNFSHNQF 324
+ H L L +S+NRL ++ + L L L +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 325 SQEIPEDLALL----AHLSELDLSHNLFKGSIPSRIC-----NLESLEKLNLSHNNIS 373
S LA L ELDLS+N + ++ LE+L L S
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 68/364 (18%), Positives = 117/364 (32%), Gaps = 58/364 (15%)
Query: 27 HLAYLDLSINGF----FGTLPPQVRNLSKLKYLDLSENELSGKIPPEI--GLL---THLF 77
+ L L G L +R L L+ L LS+N L + GLL L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 78 SLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKLSGSIPEEIG-----NLMKLSYLM 127
L L S + + K +++ NN ++ + + + +L L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 128 LDTNQFTGQ----LPRNICRSGLLEILTVNDNHF-------LGSIPNLRNCRSLVRAHLG 176
L++ T L + L L + N L + L +
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS-RLRTLWIW 264
Query: 177 RNNLT----GNISEDFGIYPNLKFLDLSHNNFYGE----ISSNWGKCH-RLGTLIVSGNN 227
+T G++ +LK L L+ N E + + +L +L V +
Sbjct: 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324
Query: 228 ITGR----IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI-----SLNKLILRGNQLS- 277
T + + L L +S+N + EL + + L L L +S
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384
Query: 278 ---GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK-----LFYLNFSHNQFSQEIP 329
L L L DLS+N L ++ + L + L L +S+E+
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 444
Query: 330 EDLA 333
+ L
Sbjct: 445 DRLQ 448
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 50/295 (16%), Positives = 89/295 (30%), Gaps = 53/295 (17%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLS--------KLKYLDLSENELSGK----IPPE 69
+ P L +S N VR L +L+ L L ++ +
Sbjct: 166 LRAKPDFKELTVSNNDI---NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 70 IGLLTHLFSLDLSLNQFSGTF------PPICNLSNLKYISLHNNKLS----GSIPEEIGN 119
+ L L L N+ + S L+ + + ++ G + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 120 LMKLSYLMLDTNQFTGQLPRNICRSGL-----LEILTVNDNHF-------LGSIPNLRNC 167
L L L N+ + R +C + L LE L V F S+ L
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV--LAQN 340
Query: 168 RSLVRAHLGRNNLTG----NISEDFGIY-PNLKFLDLSHNNF----YGEISSNWGKCHRL 218
R L+ + N L + + G L+ L L+ + +++ H L
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400
Query: 219 GTLIVSGNNITGRIPPEIG-----NSSQLHVLDLSSNHIAGEIPMELGRLISLNK 268
L +S N + ++ L L L + + E+ L L
Sbjct: 401 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 455
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 65/308 (21%), Positives = 108/308 (35%), Gaps = 61/308 (19%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGD----KIAVKKFNSPFPNDQMSDQKEFLN 555
I + IGKG VY + + A+K + +M + FL
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLR 71
Query: 556 EIKALTKIRHRNIVKFYGFCSHVR-HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
E + + H N++ G V+ Y+ G L + + + + ++
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISF 129
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN------ 668
VA + Y+ F VHRD+++ N +LD + +V+DFG A+ +
Sbjct: 130 GLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 669 -------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKH 720
WT A E T + T K DV+SFGVL E++ +G
Sbjct: 187 HARLPVKWT---------AL----------ESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
Query: 721 PGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
P + + L RLP P + L +M C + P RPT
Sbjct: 228 PYRHID---------PFDLTHFLAQGRRLPQPE-YCPDSLYQVM---QQCWEADPAVRPT 274
Query: 779 MQTVCQLL 786
+ + +
Sbjct: 275 FRVLVGEV 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 65/295 (22%), Positives = 103/295 (34%), Gaps = 55/295 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G G VY ++ +AVK D+ +FL E ++K H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVL----SNNFASEDFDWRKRMNVITGVADALS 623
IV+ G F++ E + G L + L ++V +A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARV---SDFGTAKLLKPNSSNWTELVGTFGYV- 679
Y+ + F +HRDI++ N LL RV DFG A+ + +++ G +
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR-KGGCAMLP 208
Query: 680 ----APAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSS 733
P E T K D +SFGVL E+ G P + S S
Sbjct: 209 VKWMPP----------EAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP------YPSKS- 250
Query: 734 SINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E + R+ P + + IM C P RP + + +
Sbjct: 251 --NQEVLEFVTSGGRMDPPK-NCPGPVYRIM---TQCWQHQPEDRPNFAIILERI 299
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 45/217 (20%), Positives = 80/217 (36%), Gaps = 36/217 (16%)
Query: 513 CIGKGEHRSVYRAK---LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
CI G +Y A + +G + +K D Q + E + L ++ H +IV
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHS--GDA-EAQAMAMAERQFLAEVVHPSIV 142
Query: 570 KFYGFCSHVRHS-----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
+ + F H ++V EY+ SL + + + + + ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+H +V+ D+ N++L E + ++ D G + L GT G+ AP
Sbjct: 198 LHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAP--- 246
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ T T D+Y+ G +
Sbjct: 247 -------EIVRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 50/226 (22%)
Query: 503 RRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
+T + + G G V+ K +G A+K NEI
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK----SPAFRDSSLENEI 57
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW--------- 608
L KI+H NIV H ++V + ++ G L FD
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL------------FDRILERGVYTE 105
Query: 609 RKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLL-DLEYEARV--SDFGTAKLLKP 664
+ VI V A+ Y+H + IVHRD+ N+L E +++ +DFG +K+ +
Sbjct: 106 KDASLVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
+ GT GYVAP + LA+ Y ++ D +S GV
Sbjct: 162 GI--MSTACGTPGYVAP---EV---LAQKPY----SKAVDCWSIGV 195
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 45/226 (19%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 503 RRTKDFDAKYC----IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
F +Y +GKG V R + +G + A N+ D ++ E
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK--KLSARDHQKLEREA 61
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW--------- 608
+ ++H NIV+ + S H +++++ + G L F+
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL------------FEDIVAREYYSE 109
Query: 609 RKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKP 664
+ I + +A+ + H +VHR++ N+LL + + +++DFG A ++
Sbjct: 110 ADASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
W GT GY++P + L + Y + D+++ GV
Sbjct: 166 EQQAWFGFAGTPGYLSP---EV---LRKDPY----GKPVDLWACGV 201
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 52/259 (20%), Positives = 91/259 (35%), Gaps = 42/259 (16%)
Query: 20 FSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
FS +F +L T L+ + + + +++ + I L ++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPR 139
L+ N+ + P+ NL NL ++ L NK+ + + +L KL L L+ N +
Sbjct: 74 FLNGNKLT-DIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS----- 125
Query: 140 NICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDL 199
I L + L +LG N +T +I+ L L L
Sbjct: 126 --------------------DINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSL 163
Query: 200 SHNNFYGEIS--SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP 257
N IS +L L +S N+I+ + + L VL+L S +
Sbjct: 164 EDNQ----ISDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPI 217
Query: 258 MELGRLISLNKLILRGNQL 276
L+ N + L
Sbjct: 218 NHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 20/245 (8%)
Query: 161 IPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS--NWGKCHRL 218
I + ++ +L + ++T ++ + ++++ I S +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSD----IKSVQGIQYLPNV 70
Query: 219 GTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG 278
L ++GN +T I P + N L L L N + ++ L L L L L N +S
Sbjct: 71 TKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS- 125
Query: 279 HLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHL 338
+ L L +LE L +N++ + + L + KL L+ NQ S +I LA L L
Sbjct: 126 DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKL 180
Query: 339 SELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRG 398
L LS N S + L++L+ L L + + ++ + L
Sbjct: 181 QNLYLSKN--HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
Query: 399 PIPNS 403
P S
Sbjct: 239 PEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 43/228 (18%), Positives = 85/228 (37%), Gaps = 19/228 (8%)
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
+ + S+ + +++ ++ + PN+ L L+ N
Sbjct: 26 TIKDNLKKKS-VTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK--- 79
Query: 207 EIS--SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264
++ LG L + N + + + + +L L L N I+ +I L L
Sbjct: 80 -LTDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLVHLP 134
Query: 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
L L L N+++ L LT+L+ L N++++ + L + KL L S N
Sbjct: 135 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHI 190
Query: 325 SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372
S ++ LA L +L L+L + NL + + ++
Sbjct: 191 S-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 33/134 (24%), Positives = 49/134 (36%), Gaps = 7/134 (5%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
P L L L N + + L+KL L L +N++S I P + LT L +L L
Sbjct: 130 LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 185
Query: 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI 141
S N S + L NL + L + + NL+ + + P I
Sbjct: 186 SKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEII 242
Query: 142 CRSGLLEILTVNDN 155
G E V +
Sbjct: 243 SDDGDYEKPNVKWH 256
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 65/299 (21%), Positives = 123/299 (41%), Gaps = 61/299 (20%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKAL 560
+ +DF +GKG VYRA+ + +G ++A+K + M + NE+K
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIH 65
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN------V 614
+++H +I++ Y + + ++V E + G + L N K +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--------VKPFSENEARHF 117
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ + + Y+H I+HRD++ +N+LL +++DFG A LK L G
Sbjct: 118 MHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174
Query: 675 TFGYVAP------AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF 728
T Y++P AHG + DV+S G + ++ G+ P D
Sbjct: 175 TPNYISPEIATRSAHG----------------LESDVWSLGCMFYTLLIGRPPFD----- 213
Query: 729 SSSSSSINIEFN--AMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ ++ N + D+ +P S++ + LI + L P R ++ +V
Sbjct: 214 ---TDTVKNTLNKVVLADYEMPSFLSIEAK-DLIHQL------LRRNPADRLSLSSVLD 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 53/237 (22%), Positives = 91/237 (38%), Gaps = 45/237 (18%)
Query: 496 IMYEEIIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN----SPFPNDQ 546
+ ++ K +Y + G G V A + K+A++ + + +
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDF 606
EI+ L K+ H I+K F + ++V E + G L F
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL------------F 227
Query: 607 DW---RKRMN------VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVS 654
D KR+ + A+ Y+H + I+HRD+ NVLL + E +++
Sbjct: 228 DKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
DFG +K+L S L GT Y+AP + + + Y D +S GV+
Sbjct: 285 DFGHSKILGETSL-MRTLCGTPTYLAP---EVLVSVGTAGY----NRAVDCWSLGVI 333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 65/295 (22%), Positives = 102/295 (34%), Gaps = 55/295 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G G VY ++ +AVK D+ +FL E ++K H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVL----SNNFASEDFDWRKRMNVITGVADALS 623
IV+ G F++ E + G L + L ++V +A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARV---SDFGTAKLLKPNSSNWTELVGTFGYV- 679
Y+ + F +HRDI++ N LL RV DFG A+ + + + G +
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAMLP 249
Query: 680 ----APAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSS 733
P E T K D +SFGVL E+ G P + S S
Sbjct: 250 VKWMPP----------EAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP------YPSKS- 291
Query: 734 SINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E + R+ P + + IM C P RP + + +
Sbjct: 292 --NQEVLEFVTSGGRMDPPK-NCPGPVYRIM---TQCWQHQPEDRPNFAIILERI 340
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 52/258 (20%), Positives = 94/258 (36%), Gaps = 31/258 (12%)
Query: 464 RRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCI----GKGEH 519
R + D Q + + + V D + + + + Y I G G
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 520 RSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578
V+R +G+ A K SD++ EI+ ++ +RH +V +
Sbjct: 171 GVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 579 RHSFVVYEYINRGSL--ATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHR 636
++YE+++ G L +N SE + + + V L +MH + VH
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQVCKGLCHMHEN---NYVHL 279
Query: 637 DISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELA 694
D+ N++ + + DFG L P + GT + AP E+A
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAP----------EVA 328
Query: 695 YTMKITEKCDVYSFGVLA 712
+ D++S GVL+
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 53/238 (22%), Positives = 97/238 (40%), Gaps = 48/238 (20%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
F+ +G G + VY+ + + +G A+K + +++E EI L K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIKQEINMLKKY 77
Query: 564 -RHRNIVKFYGFCSHVRHSF--------VVYEYINRGSLATVLSNNFASEDFDWRKRMN- 613
HRNI +YG + ++ + +V E+ GS+ ++ N +
Sbjct: 78 SHHRNIATYYG--AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKE 128
Query: 614 -----VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
+ + LS++H ++HRDI NVLL E ++ DFG + L
Sbjct: 129 EWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 721
+GT ++AP E+ + + K D++S G+ A+E+ +G P
Sbjct: 186 RNTFIGTPYWMAP----------EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 19/200 (9%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
+ SF + +L L L N + L+ L+ LDLS+N + P L
Sbjct: 46 HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLML 128
L +L L G F L+ L+Y+ L +N L ++P++ +L L++L L
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFR---GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFL 160
Query: 129 DTNQFTGQLPRNICRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNIS 185
N+ + +P R L+ L ++ N + + R+ L+ +L NNL+ +
Sbjct: 161 HGNRIS-SVPERAFRGLHSLDRLLLHQNR-VAHVHPHAFRDLGRLMTLYLFANNLS-ALP 217
Query: 186 ED-FGIYPNLKFLDLSHNNF 204
+ L++L L+ N +
Sbjct: 218 TEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 7/182 (3%)
Query: 220 TLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG 278
+ + GN I+ +P L +L L SN +A L L +L L N
Sbjct: 36 RIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 279 HLP-RALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED-LALLA 336
+ L L L L + L YL N Q +P+D L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLG 153
Query: 337 HLSELDLSHNLFKGSIPSRI-CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNE 395
+L+ L L N S+P R L SL++L L N ++ P F + L+++ + N
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 396 LR 397
L
Sbjct: 213 LS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 50/236 (21%), Positives = 79/236 (33%), Gaps = 11/236 (4%)
Query: 94 CNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVN 153
C S L ++P I + L N+ + + L IL ++
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 154 DNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISED-FGIYPNLKFLDLSHNNFYGEISS 210
N L I L + L N ++ F L L L E+
Sbjct: 65 SNV-LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGP 122
Query: 211 NW-GKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELGRLISLNK 268
L L + N + +P + + L L L N I+ L SL++
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 269 LILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
L+L N+++ P A L L L +N L+ EAL + L YL + N +
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 31/138 (22%), Positives = 52/138 (37%), Gaps = 7/138 (5%)
Query: 285 GLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLS 344
G+ + L NR+++ + L L N ++ LA L +LDLS
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 345 HNLFKGSIPSRI-CNLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDISYNELRGPIPN 402
N S+ L L L+L + ++ F G++ L + + N L+ +P
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LP- 145
Query: 403 STVFRNAP--RESFLGNN 418
FR+ FL N
Sbjct: 146 DDTFRDLGNLTHLFLHGN 163
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 43/229 (18%)
Query: 503 RRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNE 556
F+ Y IGKG V R +G + AVK + + F + ++ E
Sbjct: 17 DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHSFVVYEY----------INRGSLATVLSNNFASEDF 606
++H +IV+ S ++V+E+ + R V S AS
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH-- 134
Query: 607 DWRKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLL 662
+ + +AL Y H ++ I+HRD+ + VLL + + ++ FG A L
Sbjct: 135 -------YMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
+ VGT ++AP + + Y + DV+ GV+
Sbjct: 184 GESGLVAGGRVGTPHFMAP---EV---VKREPY----GKPVDVWGCGVI 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 31/231 (13%)
Query: 501 IIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFL 554
+ T F +Y GKG V K +G + AVK + D++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT--DKESLL 74
Query: 555 NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMN 613
E++ L ++ H NI+K Y F + ++V E G L ++S SE
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE----VDAAR 130
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAKLLKPNSSNWT 670
+I V ++YMH + IVHRD+ N+LL + R+ DFG + + +
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ +GT Y+AP E+ EKCDV+S GV+ ++ G P
Sbjct: 187 DKIGTAYYIAP----------EV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 503 RRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFN----SPFPNDQMSDQKEF 553
K+F KY IG+G V R +G + AVK P ++
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 554 LNEIKALTKIR-HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---- 608
E L ++ H +I+ F+V++ + +G L FD+
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL------------FDYLTEK 194
Query: 609 -----RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663
++ +++ + +A+S++H + IVHRD+ N+LLD + R+SDFG + L+
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
P EL GT GY+AP + Y ++ D+++ GV
Sbjct: 252 PGEK-LRELCGTPGYLAPEILKCSMDETHPGY----GKEVDLWACGV 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 58/292 (19%), Positives = 103/292 (35%), Gaps = 60/292 (20%)
Query: 514 IGKGEHRSVYRAKLPSGDK-----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
+G G +V++ + + +K + + + A+ + H +I
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIE---DKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
V+ G C +V +Y+ GSL + + + +N +A + Y+
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS-----------NWTELVGTFG 677
VHR++++ NVLL + +V+DFG A LL P+ W
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM------- 184
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSIN 736
A E + K T + DV+S+GV E++ G P L
Sbjct: 185 --AL----------ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR---------L 223
Query: 737 IEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
E +L+ RL P + +M + C N RPT + +
Sbjct: 224 AEVPDLLEKGERLAQPQ-ICTIDVYMVM---VKCWMIDENIRPTFKELANEF 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 83/395 (21%), Positives = 143/395 (36%), Gaps = 69/395 (17%)
Query: 428 LLSHKEASKKTPFLILFPLLG---ALALLIV-YVVMV------FMFRRWKRDSQSQGSCS 477
+L K A P + P L +A LI Y +V F+ R K ++ S
Sbjct: 285 MLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIP 344
Query: 478 SK--NDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKY---------------CIGKGEHR 520
N+ +G+ + Y EII + CIG+G+
Sbjct: 345 KLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFG 404
Query: 521 SVYRA--KLPSGDKI--AVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS 576
V++ P + A+K S +++FL E + + H +IVK G +
Sbjct: 405 DVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461
Query: 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHR 636
+++ E G L + L D + ++ AL+Y+ F VHR
Sbjct: 462 E-NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKRF---VHR 515
Query: 637 DISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA--ELA 694
DI++ NVL+ ++ DFG ++ ++ ++ Y + G + + E
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDST-----------YYKASKGKLPIKWMAPESI 564
Query: 695 YTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPS 751
+ T DV+ FGV E++ G P + N + ++ RLP P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NNDVIGRIENGERLPMPP 615
Query: 752 LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ L S+M C P+ RP + L
Sbjct: 616 -NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 646
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 50/220 (22%), Positives = 76/220 (34%), Gaps = 38/220 (17%)
Query: 503 RRTKDFDAKYCIGK----GEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
D + Y + G V A + + A KK + D F EI
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK----YFVEDVDRFKQEI 57
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVIT 616
+ + + H NI++ Y ++V E G L V+ E ++
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDAARIMK 113
Query: 617 GVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSSNWTEL 672
V A++Y H + + HRD+ N L + ++ DFG A KP
Sbjct: 114 DVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTK 168
Query: 673 VGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGV 710
VGT YV+P G G +CD +S GV
Sbjct: 169 VGTPYYVSPQVLEGLYG-------------PECDEWSAGV 195
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 65/300 (21%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G VY K +A+K N M ++ EFLNE + + +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVL-------SNNFASEDFDWRKRMNVITGVAD 620
+V+ G S + + V+ E + RG L + L +NN K + + +AD
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL------KPNSSN-----W 669
++Y++ + F VHRD+++ N ++ ++ ++ DFG + + + W
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLF 728
+P E T DV+SFGV+ E+ + P LS
Sbjct: 207 M---------SP----------ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-- 245
Query: 729 SSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N + + L P + + L +M +C P RP+ + +
Sbjct: 246 -------NEQVLRFVMEGGLLDKPD-NCPDMLFELM---RMCWQYNPKMRPSFLEIISSI 294
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 505 TKDFDAKYCI----GKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
+ F Y + GKG V R +G + A K N+ D ++ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQKLEREARI 58
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL--ATVLSNNFASEDFDWRKRMNVITG 617
K++H NIV+ + ++V++ + G L V + SE + I
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SE----ADASHCIQQ 113
Query: 618 VADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSSNWTELV 673
+ ++++Y H + IVHR++ N+LL + + +++DFG A + + + W
Sbjct: 114 ILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA 168
Query: 674 GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
GT GY++P + L + Y ++ D+++ GV
Sbjct: 169 GTPGYLSP---EV---LKKDPY----SKPVDIWACGV 195
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 54/226 (23%), Positives = 85/226 (37%), Gaps = 45/226 (19%)
Query: 506 KDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN----SPFPNDQMSDQKEFLNE 556
K +Y + G G V A + K+A+K + + + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRM- 612
I+ L K+ H I+K F + ++V E + G L FD KR+
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL------------FDKVVGNKRLK 112
Query: 613 -----NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKP 664
+ A+ Y+H + I+HRD+ NVLL + E +++DFG +K+L
Sbjct: 113 EATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
S L GT Y+AP L + D +S GV
Sbjct: 170 TSL-MRTLCGTPTYLAPE------VLVSVGTA-GYNRAVDCWSLGV 207
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 29/279 (10%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
DF+ +G G V++ PSG +A K + + + + + + E++ L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQVLHECN 89
Query: 565 HRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADAL 622
IV FYG + + E+++ GSL VL + V V L
Sbjct: 90 SPYIVGFYG--AFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGL 144
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
+Y+ I+HRD+ +N+L++ E ++ DFG + L +S + VGT Y++P
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPE 200
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP----GDFLSLFSSSSSSINIE 738
L Y++ + D++S G+ +E+ G++P
Sbjct: 201 ------RLQGTHYSV----QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
Query: 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777
R P L+ LD N P
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 74/307 (24%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G V+ A+ + +AVK + ++ +K+F E + LT ++H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAELLTNLQHEH 78
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR-------------MNV 614
IVKFYG C +V+EY+ G L L + + +++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL------KPNSSN 668
+ +A + Y+ F VHRD+++ N L+ ++ DFG ++ + +
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 669 -----WTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLALEVI-KGKHP 721
W P E + Y K T + DV+SFGV+ E+ GK P
Sbjct: 196 MLPIRWM---------PP----------ESIMYR-KFTTESDVWSFGVILWEIFTYGKQP 235
Query: 722 GDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779
LS N E + L P +++ +M L C P R +
Sbjct: 236 WFQLS---------NTEVIECITQGRVLERPR-VCPKEVYDVM---LGCWQREPQQRLNI 282
Query: 780 QTVCQLL 786
+ + ++L
Sbjct: 283 KEIYKIL 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 41/255 (16%), Positives = 97/255 (38%), Gaps = 38/255 (14%)
Query: 542 FPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNF 601
+P S +I+ + +N V S + ++ + + +L ++
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 602 ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661
+ ED + +++ +A+A+ ++H ++HRD+ +N+ ++ +V DFG
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 662 LK------------PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709
+ P + T VGT Y++P E + + K D++S G
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP----------EQIHGNNYSHKVDIFSLG 263
Query: 710 VLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCL 769
++ E++ + FS+ + I + + + P + +++ +L
Sbjct: 264 LILFELL---YS------FSTQMERVRI-ITDVRNLKFPLLFTQKYPQEHMMVQ-DMLSP 312
Query: 770 DGCPNSRPTMQTVCQ 784
P RP + +
Sbjct: 313 S--PTERPEATDIIE 325
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 73/306 (23%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+G V+ A+ + +AVK S +++F E + LT ++H++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTMLQHQH 104
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR------------MNVI 615
IV+F+G C+ R +V+EY+ G L L ++ + V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL------KPNSSN- 668
+ VA + Y+ F VHRD+++ N L+ ++ DFG ++ + +
Sbjct: 165 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 669 ----WTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPG 722
W P E + Y K T + DV+SFGV+ E+ GK P
Sbjct: 222 LPIRWM---------PP----------ESILYR-KFTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 723 DFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
LS N E + L P ++ +IM C P R +++
Sbjct: 262 YQLS---------NTEAIDCITQGRELERPR-ACPPEVYAIM---RGCWQREPQQRHSIK 308
Query: 781 TVCQLL 786
V L
Sbjct: 309 DVHARL 314
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 36/224 (16%)
Query: 499 EEIIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKE 552
E + F +Y I GKG V + K + + AVK N + N D
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTST 67
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKR 611
L E++ L K+ H NI+K + ++V E G L ++ SE
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDA 123
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSSN 668
+I V ++YMH IVHRD+ N+LL+ + + ++ DFG + + N+
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179
Query: 669 WTELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGV 710
+ +GT Y+AP G Y EKCDV+S GV
Sbjct: 180 MKDRIGTAYYIAPEVLRGT---------Y----DEKCDVWSAGV 210
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 34/274 (12%), Positives = 66/274 (24%), Gaps = 58/274 (21%)
Query: 513 CIGKGEHRSVYRA---KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
G ++A L ++A+ + +E L+ L++I +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPD-DVLQETLSRTLRLSRIDKPGVA 94
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
+ VV E+I GSL V + + +A A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 630 FPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLH 689
+ + V VS G L + A
Sbjct: 149 --GVALSIDHPSRVR--------VSIDGDVVL------------AYPATMPDA------- 179
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF-NAMLDHRLP 748
+ D+ G ++ + P + + +
Sbjct: 180 ----------NPQDDIRGIGASLYALLVNRWP------LPEAGVRSGLAPAERDTAGQPI 223
Query: 749 HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
P+ ++ I VA + G R +
Sbjct: 224 EPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 64/300 (21%)
Query: 514 IGKGEHRSVYRAKLPSGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+GKGE SV A+L D K+AVK + D +EFL E + + H ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88
Query: 570 KFYGFCS------HVRHSFVVYEYINRGSLATVLSNNFASED---FDWRKRMNVITGVAD 620
K G + V+ ++ G L L + E+ + + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS-----------NW 669
+ Y+ F +HRD+++ N +L + V+DFG ++ + W
Sbjct: 149 GMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLF 728
A E T DV++FGV E++ +G+ P +
Sbjct: 206 L---------AL----------ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-- 244
Query: 729 SSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E L +RL P + E++ +M C P RP+ + L
Sbjct: 245 -------NAEIYNYLIGGNRLKQPP-ECMEEVYDLM---YQCWSADPKQRPSFTCLRMEL 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 499 EEIIRRTKDFDAKY----CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEF 553
E ++ + F Y +GKG V R +G + A K N+ D ++
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQKL 75
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL--ATVLSNNFASEDFDWRKR 611
E + K++H NIV+ + ++V++ + G L V + SE
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SE----ADA 130
Query: 612 MNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSS 667
+ I + ++++Y H + IVHR++ N+LL + + +++DFG A + + +
Sbjct: 131 SHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
W GT GY++P + L + Y ++ D+++ GV
Sbjct: 187 -WHGFAGTPGYLSP---EV---LKKDPY----SKPVDIWACGV 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKIR 564
DFD +GKG+ +VY A+ + +A+K S + + Q EI+ + +R
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLR 72
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H NI++ Y + + +++ E+ RG L L + FD ++ + +ADAL Y
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHY 129
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
H ++HRDI N+L+ + E +++DFG + P+ T + GT Y+ P
Sbjct: 130 CHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYLPP--- 181
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ EK D++ GVL E + G P
Sbjct: 182 -------EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 67/299 (22%), Positives = 108/299 (36%), Gaps = 63/299 (21%)
Query: 514 IGKGEHRSVYRAKLPSGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
+G+GE SV L D K+AVK + + + +EFL+E + H N++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99
Query: 570 KFYGFCS-----HVRHSFVVYEYINRGSLATVL---SNNFASEDFDWRKRMNVITGVADA 621
+ G C + V+ ++ G L T L + + + + +A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS-----------NWT 670
+ Y+ + F +HRD+++ N +L + V+DFG +K + W
Sbjct: 160 MEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFS 729
A E T K DV++FGV E+ +G P +
Sbjct: 217 ---------AI----------ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ--- 254
Query: 730 SSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
N E L HRL P D ++L IM C P RPT + L
Sbjct: 255 ------NHEMYDYLLHGHRLKQPE-DCLDELYEIM---YSCWRTDPLDRPTFSVLRLQL 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 499 EEIIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEF 553
E + F +Y I GKG V + K + + AVK N ++ D
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTI 68
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRM 612
L E++ L K+ H NI+K + ++V E G L ++ SE
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAA 124
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAKLLKPNSSNW 669
+I V ++YMH IVHRD+ N+LL + + + ++ DFG + + N+
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-M 180
Query: 670 TELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGV 710
+ +GT Y+AP G EKCDV+S GV
Sbjct: 181 KDRIGTAYYIAPEVLRGTYD-------------EKCDVWSAGV 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 47/235 (20%), Positives = 87/235 (37%), Gaps = 35/235 (14%)
Query: 489 VLDFDGKIMYEEIIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFP 543
D K + + + + Y I G G V+R +G K N+
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--- 86
Query: 544 NDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFA 602
D+ NEI + ++ H ++ + ++ E+++ G L + + ++
Sbjct: 87 -PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 145
Query: 603 -SEDFDWRKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARV--SDFGT 658
SE + +N + + L +MH H IVH DI N++ + + + V DFG
Sbjct: 146 MSE----AEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
A L P+ T + AP E + + D+++ GVL
Sbjct: 198 ATKLNPD-EIVKVTTATAEFAAP----------EIVDREP-VGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 50/267 (18%), Positives = 97/267 (36%), Gaps = 51/267 (19%)
Query: 466 WKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKY------CIGKGEH 519
W ++ T + + + + + ++ Y +G G
Sbjct: 43 WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102
Query: 520 RSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578
V++ + +G K+A K + M D++E NEI + ++ H N+++ Y
Sbjct: 103 GQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158
Query: 579 RHSFVVYEYINRGSLATVLSNNFASEDFDW----------RKRMNVITGVADALSYMHHD 628
+V EY++ G L FD + + + + + +MH
Sbjct: 159 NDIVLVMEYVDGGEL------------FDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 629 CFPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
I+H D+ N+L ++ DFG A+ KP GT ++AP
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAP----- 257
Query: 687 GLHLAE-LAYTMKITEKCDVYSFGVLA 712
E + Y ++ D++S GV+A
Sbjct: 258 -----EVVNYD-FVSFPTDMWSVGVIA 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 51/225 (22%), Positives = 84/225 (37%), Gaps = 49/225 (21%)
Query: 503 RRTKDFDAKYCIGK----GEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
+ + G VYR K + A+K + D+K EI
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK------KTVDKKIVRTEI 99
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW--------- 608
L ++ H NI+K +V E + G L FD
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL------------FDRIVEKGYYSE 147
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL-DLEYEARV--SDFGTAKLLKPN 665
R + + + +A++Y+H + IVHRD+ N+L +A + +DFG +K+++
Sbjct: 148 RDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGV 710
+ GT GY AP I L AY + D++S G+
Sbjct: 205 VL-MKTVCGTPGYCAP---EI---LRGCAY----GPEVDMWSVGI 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 41/227 (18%)
Query: 500 EIIRRTKDFDAKYCIGK----GEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFL 554
E + D + + G V+ + SG + +K N + ++
Sbjct: 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK---DRSQVPMEQIE 68
Query: 555 NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-----ATVLSNNFASEDFDWR 609
EI+ L + H NI+K + + ++V E G L + SE
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE----G 124
Query: 610 KRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPN 665
++ + +AL+Y H +VH+D+ N+L ++ DFG A+L K +
Sbjct: 125 YVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 666 SSNWTELVGTFGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGV 710
T GT Y+AP ++ KCD++S GV
Sbjct: 181 EH-STNAAGTALYMAPEVFKRDVT-------------FKCDIWSAGV 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 64/300 (21%), Positives = 121/300 (40%), Gaps = 59/300 (19%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G G V A K +AVK +++ ++E+K ++ + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVL--SNNFASEDFDWRKRMNVITG------- 617
NIV G C+H V+ EY G L L + D + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 618 --VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
VA ++++ +HRD+++ NVLL + A++ DFG A+ + +S+
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-------- 219
Query: 676 FGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLF 728
Y+ + + + + + YT+ + DV+S+G+L E+ G +P
Sbjct: 220 --YIVKGNARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFSLGLNP------- 266
Query: 729 SSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+N +F ++ +++ P+ + + SIM C P RPT Q +C L
Sbjct: 267 -YPGILVNSKFYKLVKDGYQMAQPA-FAPKNIYSIM---QACWALEPTHRPTFQQICSFL 321
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IR 564
D IG+G + SV + PSG +AVK+ S +QK+ L ++ + +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---TVDEKEQKQLLMDLDVVMRSSD 79
Query: 565 HRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFASEDFDWRKRMN-----VIT- 616
IV+FYG + R ++ E ++ S ++ D + IT
Sbjct: 80 CPYIVQFYG--ALFREGDCWICMELMS-TSFDKFYKYVYSVLD----DVIPEEILGKITL 132
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF 676
AL+++ + I+HRDI +N+LLD ++ DFG + L +S T G
Sbjct: 133 ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCR 189
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+AP I + Y + DV+S G+ E+ G+ P
Sbjct: 190 PYMAPER--IDPSASRQGY----DVRSDVWSLGITLYELATGRFP 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 43/222 (19%), Positives = 89/222 (40%), Gaps = 32/222 (14%)
Query: 504 RTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN--SPFPNDQMSDQKEFLNE 556
+ + + Y I G G+ V + + +G + A K + + ++E E
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVI 615
+ L ++ H N++ + + ++ E ++ G L + SE + + I
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFI 121
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLL-DLEYEA---RVSDFGTAKLLKPNSSNWTE 671
+ D ++Y+H I H D+ N++L D ++ DFG A ++ +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177
Query: 672 LVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
+ GT +VAP E + Y + + D++S GV+
Sbjct: 178 IFGTPEFVAP----------EIVNYE-PLGLEADMWSIGVIT 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 2e-19
Identities = 37/315 (11%), Positives = 80/315 (25%), Gaps = 57/315 (18%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
E+ R + +G+ + + A +G+ V + K+ E+
Sbjct: 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-NAIKQMKEEVL 130
Query: 559 ALTKIR----------------------HRNIVKFYGFCSHVRHSFVVYEYI----NRGS 592
L +R K R +V+ + + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 593 LATVLSNNFA----SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648
L T + + R+ + V L+ +HH +VH + +++LD
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 247
Query: 649 YEARVSDFGTAKLL-KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYS 707
++ F S A + + +T D ++
Sbjct: 248 GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAER-----MLPFGQHHPTLMTFAFDTWT 302
Query: 708 FGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL 767
G+ + P + ++ E+ +P P L+ L
Sbjct: 303 LGLAIYWIWCADLP------NTDDAALGGSEWIFRSCKNIPQPVRA----LLE----GFL 348
Query: 768 CLDGCPNSRPTMQTV 782
R
Sbjct: 349 RYP--KEDRLLPLQA 361
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 40/226 (17%)
Query: 499 EEIIRRTKDFDAKY----CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEF 553
+++ R + F Y IG G + R + + AVK + D E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTE- 64
Query: 554 LNEIKALTK-IRHRNIVKFYGFCSHVRHSFVVYEYINRGSL--ATVLSNNFASEDFDWRK 610
EI+ L + +H NI+ ++ +VV E + G L + F SE R+
Sbjct: 65 --EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-SE----RE 117
Query: 611 RMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA----RVSDFGTAKLLKPN 665
V+ + + Y+H +VHRD+ +N+L E R+ DFG AK L+
Sbjct: 118 ASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
+ T +VAP + L Y CD++S GVL
Sbjct: 174 NGLLMTPCYTANFVAP---EV---LERQGY----DAACDIWSLGVL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 52/269 (19%), Positives = 85/269 (31%), Gaps = 60/269 (22%)
Query: 493 DGKIMYEEIIRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQ 546
G+ + KY + G+G + V A + A+K N +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 547 MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL------------- 593
D + E++ + K+ H NI + Y ++ +V E + G L
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 594 ------------------------ATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC 629
+ + N++ + AL Y+H+
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187
Query: 630 FPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSN----WTELVGTFGYVAPAH 683
I HRDI N L + DFG +K ++ T GT +VAP
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE- 244
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLA 712
L+ +Y KCD +S GVL
Sbjct: 245 ---VLNTTNESY----GPKCDAWSAGVLL 266
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 41/225 (18%), Positives = 88/225 (39%), Gaps = 34/225 (15%)
Query: 502 IRRTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN--SPFPNDQMSDQKEFL 554
+ R ++ D Y G G+ V + + +G + A K + + +++
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 555 NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMN 613
E+ L +I+H N++ + + ++ E + G L + +E +
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE----EEATE 118
Query: 614 VITGVADALSYMH-HDCFPPIVHRDISSNNVLL-DLEYEA---RVSDFGTAKLLKPNSSN 668
+ + + + Y+H I H D+ N++L D ++ DFG A + +
Sbjct: 119 FLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 669 WTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
+ + GT +VAP E + Y + + D++S GV+
Sbjct: 174 FKNIFGTPEFVAP----------EIVNYE-PLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 43/222 (19%), Positives = 88/222 (39%), Gaps = 32/222 (14%)
Query: 504 RTKDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN--SPFPNDQMSDQKEFLNE 556
+ + + Y I G G+ V + + +G + A K + + ++E E
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVI 615
+ L ++ H NI+ + + ++ E ++ G L + SE + + I
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFI 121
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLL----DLEYEARVSDFGTAKLLKPNSSNWTE 671
+ D ++Y+H I H D+ N++L ++ DFG A ++ +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177
Query: 672 LVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
+ GT +VAP E + Y + + D++S GV+
Sbjct: 178 IFGTPEFVAP----------EIVNYE-PLGLEADMWSIGVIT 208
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 48/306 (15%), Positives = 103/306 (33%), Gaps = 57/306 (18%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFN-------------SPFPNDQMSDQKEFLNEIKAL 560
+ +G+ + + A+KK+ + S +F NE++ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNF-----ASEDFDWRKRMNVI 615
T I++ + G ++ +++YEY+ S+ F + + +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGT 675
V ++ SY+H+ I HRD+ +N+L+D ++SDFG ++ + GT
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGT 213
Query: 676 FGYVAP--AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP----GDFLSLF- 728
+ ++ P + K D++S G+ + P + LF
Sbjct: 214 YEFMPPEFFSNESSYN----------GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 729 ----------SSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
+ + N S + + + L + P R T
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI-DFLKLF----LRKN--PAERIT 316
Query: 779 MQTVCQ 784
+ +
Sbjct: 317 SEDALK 322
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 49/223 (21%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IR 564
D + +G+G + V + + +PSG +AVK+ + +QK L ++ + +
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA---TVNSQEQKRLLMDLDISMRTVD 64
Query: 565 HRNIVKFYGFCSHVRHSFV--VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA--- 619
V FYG + R V E ++ SL +++ +A
Sbjct: 65 CPFTVTFYG--ALFREGDVWICMELMD-TSLDKFYKQVIDKGQ---TIPEDILGKIAVSI 118
Query: 620 -DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
AL ++H ++HRD+ +NVL++ + ++ DFG + L + G Y
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPY 175
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+AP I L + Y++ K D++S G+ +E+ + P
Sbjct: 176 MAPER--INPELNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 65/310 (20%), Positives = 110/310 (35%), Gaps = 84/310 (27%)
Query: 514 IGKGEHRSVYRAKLPSGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIV 569
IG+G V +A++ A+K+ D ++F E++ L K+ H NI+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 570 KFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI-------------T 616
G C H + ++ EY G+L L + E N
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 617 GVADALSY---MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG------------TAKL 661
VA + Y +HRD+++ N+L+ Y A+++DFG +L
Sbjct: 150 DVARGMDYLSQKQ------FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 662 -LKPNSSNWTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLALEVI-KG 718
++ W A E L Y+ T DV+S+GVL E++ G
Sbjct: 204 PVR-----WM---------AI----------ESLNYS-VYTTNSDVWSYGVLLWEIVSLG 238
Query: 719 KHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776
P ++ E L +RL P + +++ +M C P R
Sbjct: 239 GTPYCGMT---------CAELYEKLPQGYRLEKPL-NCDDEVYDLM---RQCWREKPYER 285
Query: 777 PTMQTVCQLL 786
P+ + L
Sbjct: 286 PSFAQILVSL 295
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 67/303 (22%), Positives = 112/303 (36%), Gaps = 62/303 (20%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G+G V A DK +AVK S+ + ++E+K L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 567 NIVKFYGFCSHV-RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG-------- 617
N+V G C+ V+ E+ G+L+T L + ++
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 618 -----VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL 672
VA + ++ +HRD+++ N+LL + ++ DFG A+ + +
Sbjct: 152 CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----- 203
Query: 673 VGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFL 725
YV + L + + YT+ + DV+SFGVL E+ G P
Sbjct: 204 -----YVRKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIFSLGASP---- 250
Query: 726 SLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783
I+ EF L R+ P ++ M L C G P+ RPT +
Sbjct: 251 ----YPGVKIDEEFCRRLKEGTRMRAPD-YTTPEMYQTM---LDCWHGEPSQRPTFSELV 302
Query: 784 QLL 786
+ L
Sbjct: 303 EHL 305
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 44/218 (20%), Positives = 83/218 (38%), Gaps = 16/218 (7%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-I 563
D + +G G V++ + +G IAVK+ + + K L ++ + K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR---SGNKEENKRILMDLDVVLKSH 81
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
IV+ +G F+ E + + R + + AL
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ---GPIPERILGKMTVAIVKALY 138
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
Y+ ++HRD+ +N+LLD + ++ DFG + L + G Y+AP
Sbjct: 139 YLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPER 195
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ + Y + DV+S G+ +E+ G+ P
Sbjct: 196 ID-PPDPTKPDY----DIRADVWSLGISLVELATGQFP 228
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 65/306 (21%), Positives = 116/306 (37%), Gaps = 67/306 (21%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G G V A K +AVK P+ +++++ ++E+K L+ + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG--------- 617
NIV G C+ + V+ EY G L L S +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 618 ------VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
VA ++++ +HRD+++ N+LL ++ DFG A+ +K +S+
Sbjct: 148 LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSN---- 200
Query: 672 LVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-KGKHP--G 722
YV + + + + YT + DV+S+G+ E+ G P G
Sbjct: 201 ------YVVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWELFSLGSSPYPG 250
Query: 723 DFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
++ +F M+ R+ P ++ IM C D P RPT +
Sbjct: 251 ----------MPVDSKFYKMIKEGFRMLSPE-HAPAEMYDIM---KTCWDADPLKRPTFK 296
Query: 781 TVCQLL 786
+ QL+
Sbjct: 297 QIVQLI 302
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 23/158 (14%), Positives = 59/158 (37%), Gaps = 9/158 (5%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
++ L Y+ L+ ++ + I ++ L ++ + + PI LSNL+ + +
Sbjct: 42 QMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRIMGK 98
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSIPNLR 165
++ + L L+ L + + + I + L + + ++ N + I L+
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI--NTLPKVNSIDLSYNGAITDIMPLK 156
Query: 166 NCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNN 203
L ++ + + + +P L L
Sbjct: 157 TLPELKSLNIQFDGVH-DYR-GIEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 36/211 (17%), Positives = 73/211 (34%), Gaps = 38/211 (18%)
Query: 166 NCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS--SNWGKCHRLGTLIV 223
++ + LG+++ +L ++ L++ N ++ + H + L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANIN----VTDLTGIEYAHNIKDLTI 73
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
+ + T P I S L L + G ++
Sbjct: 74 NNIHATN-YNP-ISGLSNLERLRIM------------------------GKDVTSDKIPN 107
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
L LT L D+S + ++SIL + + K+ ++ S+N +I L L L L++
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166
Query: 344 SHNLFKGSIPSRICNLESLEKLNLSHNNISG 374
+ I + L +L I G
Sbjct: 167 QFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 34/208 (16%), Positives = 63/208 (30%), Gaps = 32/208 (15%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
L ++ + + L + L+ + I N+K ++++N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNI 76
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167
+ P I L L L + T IPNL
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSD-----------------------KIPNLSGL 111
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
SL + + +I P + +DLS+N +I L +L + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDG 170
Query: 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGE 255
+ I + +L+ L S I G+
Sbjct: 171 VHD-YRG-IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 27/152 (17%), Positives = 61/152 (40%), Gaps = 8/152 (5%)
Query: 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI 304
L + A + ++ SL + L ++ L + ++ +++ N
Sbjct: 28 GLLGQSSTA---NITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN-- 80
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEK 364
+ + L L + + +L+ L L+ LD+SH+ SI ++I L +
Sbjct: 81 YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 365 LNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
++LS+N I + L S++I ++ +
Sbjct: 141 IDLSYNGAITDIMP-LKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 31/200 (15%), Positives = 68/200 (34%), Gaps = 30/200 (15%)
Query: 79 LDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLP 138
L+ L Q S +++L YI+L N ++ + I + L ++ T
Sbjct: 26 LNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT---- 79
Query: 139 RNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLD 198
+ + +L R + ++T + + +L LD
Sbjct: 80 ---------------------NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 199 LSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPM 258
+SH+ I + ++ ++ +S N I P + +L L++ + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG- 176
Query: 259 ELGRLISLNKLILRGNQLSG 278
+ LN+L + G
Sbjct: 177 -IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 2/114 (1%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
S +L L + P + L+ L LD+S + I +I L + S+DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
S N P+ L LK +++ + + I + KL+ L + G
Sbjct: 144 SYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 20/91 (21%), Positives = 38/91 (41%), Gaps = 2/91 (2%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
+ S L LD+S + ++ ++ L K+ +DLS N I P + L L SL+
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLN 165
Query: 81 LSLNQFSGTFPPICNLSNLKYISLHNNKLSG 111
+ + + I + L + + + G
Sbjct: 166 IQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 16/93 (17%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 311 MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHN 370
M L Y+ ++ + ++ + ++ +L +++ P I L +LE+L +
Sbjct: 43 MNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 371 NISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
+++ G++ L +DIS++ I
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 50/215 (23%), Positives = 79/215 (36%), Gaps = 14/215 (6%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
+ + K LDLS N + S + L L +S I I + S L L
Sbjct: 25 NLPFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 247 LSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
L+ N I + + L SL KL+ L+ +G L L+ +++ N + + L
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 306 -EALGFMFKLFYLNFSHNQFSQEIPEDL-----ALLAHLSELDLSHNLFKGSIPSRICNL 359
E + L +L+ S N+ Q I + LDLS N I
Sbjct: 142 PEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 360 ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
L++L L N + F ++ L I + N
Sbjct: 200 IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 60/208 (28%), Positives = 85/208 (40%), Gaps = 18/208 (8%)
Query: 174 HLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS----NWGKCHRLGTLIVSGNNIT 229
L N L S F +P L+ LDLS I + + L TLI++GN I
Sbjct: 34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCE----IQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 230 GRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQL-SGHLPRALGLL 287
+ S L L ++A +G L +L +L + N + S LP L
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 288 TELEYFDLSSNRLNNSILEALGFMFKL----FYLNFSHNQFSQEIPEDLALLAHLSELDL 343
T LE+ DLSSN++ + L + ++ L+ S N I L EL L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELAL 207
Query: 344 SHNLFKGSIPSRIC-NLESLEKLNLSHN 370
N K S+P I L SL+K+ L N
Sbjct: 208 DTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 45/201 (22%), Positives = 70/201 (34%), Gaps = 22/201 (10%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
L +SF SFP L LDLS T+ ++LS L L L+ N + + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGL 99
Query: 74 THLFSLDLSLNQF----SGTFPPICNLSNLKYISLHNNKLSGSIPEE--IGNLMKLSYLM 127
+ L L + +L LK +++ +N + S NL L +L
Sbjct: 100 SSLQKLVAVETNLASLENFPI---GHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLD 155
Query: 128 LDTNQFTGQLPRNICRS-----GLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLT 181
L +N+ + R L L ++ N + I L L N L
Sbjct: 156 LSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLKELALDTNQLK 213
Query: 182 GNISEDFGIYPNLKFLDLSHN 202
F +L+ + L N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 57/252 (22%), Positives = 81/252 (32%), Gaps = 56/252 (22%)
Query: 30 YLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQFS 87
LDLS N L + +L+ LDLS E+ I L+HL +L L+ N
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 88 ----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNIC 142
G F LS+L+ + L+ S+ G+L L L + N
Sbjct: 90 SLALGAFS---GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP-- 142
Query: 143 RSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHN 202
NL N L L N + D + + L+LS
Sbjct: 143 ----------------EYFSNLTNLEHL---DLSSNKIQSIYCTDLRVLHQMPLLNLS-- 181
Query: 203 NFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR 262
L +S N + I P +L L L +N + R
Sbjct: 182 ------------------LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDR 222
Query: 263 LISLNKLILRGN 274
L SL K+ L N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 18/136 (13%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGK 65
T L +L+ F L L+++ N P+ NL+ L++LDLS N++
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-S 163
Query: 66 IPPEI-----GLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEE 116
I + SLDLSLN + G F I LK ++L N+L S+P+
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI----RLKELALDTNQLK-SVPDG 218
Query: 117 I-GNLMKLSYLMLDTN 131
I L L + L TN
Sbjct: 219 IFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 20/83 (24%), Positives = 27/83 (32%), Gaps = 2/83 (2%)
Query: 316 YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISG 374
L+ S N L LDLS + +I +L L L L+ N I
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 375 QIPACFIGMSGLLSIDISYNELR 397
F G+S L + L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA 113
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 72/367 (19%), Positives = 130/367 (35%), Gaps = 79/367 (21%)
Query: 464 RRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKY----------- 512
R+ ++S S +S I + M + D K+
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 513 CIGKGEHRSVYRAKLPSGDK--------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI- 563
+G+G V A+ DK +AVK + D + ++E++ + I
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIG 144
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG------ 617
+H+NI+ G C+ +V+ EY ++G+L L V
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 618 -------VADALSYM--HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
+A + Y+ +HRD+++ NVL+ +++DFG A+ +
Sbjct: 205 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY- 258
Query: 669 WTELVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-KGKHP 721
Y +G + + L + YT + DV+SFGVL E+ G P
Sbjct: 259 ---------YKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSP 305
Query: 722 GDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM 779
+ E +L HR+ P+ + +L +M C P+ RPT
Sbjct: 306 YPGIP---------VEELFKLLKEGHRMDKPA-NCTNELYMMM---RDCWHAVPSQRPTF 352
Query: 780 QTVCQLL 786
+ + + L
Sbjct: 353 KQLVEDL 359
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 58/308 (18%), Positives = 112/308 (36%), Gaps = 75/308 (24%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+ VY+ L +A+K + ++EF +E +++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR-------------MNV 614
+V G + + +++ Y + G L L D +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 615 ITGVADALSYM--HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL------KPNS 666
+ +A + Y+ HH +VH+D+++ NVL+ + ++SD G + + K
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 667 SN-----WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKH 720
++ W AP E K + D++S+GV+ EV G
Sbjct: 189 NSLLPIRWM---------AP----------EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 721 PGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
P S N + M+ LP P D + ++M + C + P+ RP
Sbjct: 230 PYCGYS---------NQDVVEMIRNRQVLPCPD-DCPAWVYALM---IECWNEFPSRRPR 276
Query: 779 MQTVCQLL 786
+ + L
Sbjct: 277 FKDIHSRL 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 64/304 (21%)
Query: 514 IGKGEHRSVYRAKLPSGDK--------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-R 564
+G+G V A+ DK +AVK + D + ++E++ + I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG------- 617
H+NI+ G C+ +V+ EY ++G+L L V
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 618 ------VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+A + Y+ +HRD+++ NVL+ +++DFG A+ +
Sbjct: 160 VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDY---- 212
Query: 672 LVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDF 724
Y +G + + L + YT + DV+SFGVL E+ G P
Sbjct: 213 ------YKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSPYPG 262
Query: 725 LSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ E +L HR+ P+ + +L +M C P+ RPT + +
Sbjct: 263 IP---------VEELFKLLKEGHRMDKPA-NCTNELYMMM---RDCWHAVPSQRPTFKQL 309
Query: 783 CQLL 786
+ L
Sbjct: 310 VEDL 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 39/222 (17%)
Query: 504 RTKDFDAKY-------CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLN 555
+ F Y +G+G + S AVK + +
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQK 54
Query: 556 EIKALTKIR-HRNIVKFYGFCSHVRHSFVVYEYINRGSL--ATVLSNNFASEDFDWRKRM 612
EI AL H NIVK + H+F+V E +N G L +F SE +
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF-SE----TEAS 109
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSSNW 669
++ + A+S+MH +VHRD+ N+L E + ++ DFG A+L P++
Sbjct: 110 YIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
T Y AP + L + Y E CD++S GV+
Sbjct: 167 KTPCFTLHYAAP---EL---LNQNGY----DESCDLWSLGVI 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 38/300 (12%), Positives = 86/300 (28%), Gaps = 54/300 (18%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVK--KFNSPFPNDQMSDQKEFLNEIKALTKIRH----- 565
+G+ + + A +G+ V F P++ + KE + ++ L I++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 566 --------RNIVKFYGFCSHVR----------HSFVVYEYINRGSLATVLSNNFA----S 603
++VK +R S + +L T +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 604 EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663
+ R+ + V L+ +HH +VH + +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPG 722
+ G+ P ++ + T D ++ G++ + P
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 723 DFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ ++ E+ +P P L+ L R
Sbjct: 313 -----ITKDAALGGSEWIFRSCKNIPQPVRA----LLE----GFLRYP--KEDRLLPLQA 357
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 36/218 (16%)
Query: 506 KDFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL 560
K+ KY I G+GE V+R S K F + +DQ EI L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISIL 55
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL--ATVLSNNFASEDFDWRKRMNVITGV 618
RHRNI+ + + +++E+I+ + S +E R+ ++ + V
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE----REIVSYVHQV 111
Query: 619 ADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTELVGT 675
+AL ++H H+ I H DI N++ + + +FG A+ LKP N+ L
Sbjct: 112 CEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTA 166
Query: 676 FGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
Y AP E + + ++ D++S G L
Sbjct: 167 PEYYAP----------EVHQHDV-VSTATDMWSLGTLV 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 64/304 (21%)
Query: 514 IGKGEHRSVYRAKLPSGDK--------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-R 564
+G+G V A+ DK +AVK + D + ++E++ + I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG------- 617
H+NI+ G C+ +V+ EY ++G+L L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 618 ------VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
VA + Y+ +HRD+++ NVL+ + +++DFG A+ +
Sbjct: 194 VSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---- 246
Query: 672 LVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDF 724
Y +G + + L + YT + DV+SFGVL E+ G P
Sbjct: 247 ------YKKTTNGRLPVKWMAPEALFDRIYTH----QSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 725 LSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782
+ E +L HR+ PS + +L +M C P+ RPT + +
Sbjct: 297 VP---------VEELFKLLKEGHRMDKPS-NCTNELYMMM---RDCWHAVPSQRPTFKQL 343
Query: 783 CQLL 786
+ L
Sbjct: 344 VEDL 347
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 501 IIRRTKDFDAKYCI-----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFL 554
+ ++F+ Y + G+G+ V + +G + A K + E L
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEIL 76
Query: 555 NEIKALTKIRHR-NIVKFYGFCSHVRHSFVVYEYINRGSL----ATVLSNNFASEDFDWR 609
+EI L + ++ + + ++ EY G + L+ SE
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV-SE----N 131
Query: 610 KRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNS 666
+ +I + + + Y+H + IVH D+ N+LL Y ++ DFG ++ +
Sbjct: 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 667 SNWTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
E++GT Y+AP E L Y IT D+++ G++A
Sbjct: 189 E-LREIMGTPEYLAP----------EILNYD-PITTATDMWNIGIIA 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 42/219 (19%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 507 DFDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFN--SPFPNDQMSDQKEFLNEIKA 559
+ Y + G G+ V + + +G + A K + + ++E E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVITGV 618
L +IRH NI+ + + ++ E ++ G L + +E + + +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE----DEATQFLKQI 117
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA----RVSDFGTAKLLKPNSSNWTELVG 674
D + Y+H I H D+ N++L + ++ DFG A ++ + + + G
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFG 173
Query: 675 TFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
T +VAP E + Y + + D++S GV+
Sbjct: 174 TPEFVAP----------EIVNYE-PLGLEADMWSIGVIT 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 47/227 (20%), Positives = 88/227 (38%), Gaps = 38/227 (16%)
Query: 505 TKDFDAKY-----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK 558
+ F+ Y +G+G H V L + + AVK + E++
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE----KQPGHIRSRVFREVE 62
Query: 559 ALTKIR-HRNIVKFYGFCSHVRHSFVVYEYINRGSLAT-VLSNNFASEDFDWRKRMNVIT 616
L + + HRN+++ F ++V+E + GS+ + + +E + V+
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE----LEASVVVQ 118
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSS------ 667
VA AL ++H I HRD+ N+L + + ++ DF +K N
Sbjct: 119 DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 668 -NWTELVGTFGYVAPAHGNI--GLHLAELAYTMKITEKCDVYSFGVL 711
G+ Y+AP + Y ++CD++S GV+
Sbjct: 176 PELLTPCGSAEYMAP---EVVEAFSEEASIY----DKRCDLWSLGVI 215
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 73/311 (23%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G+GE V +A +AVK N S+ ++ L+E L ++ H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG---------- 617
++K YG CS ++ EY GSL L + + +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 618 -----------VADALSYM--HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
++ + Y+ +VHRD+++ N+L+ + ++SDFG ++ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-K 717
S YV + G I + L + YT + DV+SFGVL E++
Sbjct: 203 EDS----------YVKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIVTL 248
Query: 718 GKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNS 775
G +P + +L HR+ P + E++ +M L C P+
Sbjct: 249 GGNPYPGIP---------PERLFNLLKTGHRMERPD-NCSEEMYRLM---LQCWKQEPDK 295
Query: 776 RPTMQTVCQLL 786
RP + + L
Sbjct: 296 RPVFADISKDL 306
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 85.6 bits (211), Expect = 2e-17
Identities = 58/339 (17%), Positives = 103/339 (30%), Gaps = 15/339 (4%)
Query: 12 GLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIG 71
L G + H++ + ++ F + L + P+
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 72 L------LTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSY 125
L L + L+ TF I S+ + + + +L
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 126 LMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS 185
L + T L E+ N L I +R L+ + +
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245
D +LD + F E S + + L ++ ++T + + + L
Sbjct: 414 VDP---MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHL 468
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN-SI 304
DLS N + +P L L L L N L ++ + L L+ L +NRL +
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAA 525
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
++ L +L LN N QE L L +
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.5 bits (177), Expect = 3e-13
Identities = 37/221 (16%), Positives = 76/221 (34%), Gaps = 30/221 (13%)
Query: 199 LSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI-- 256
+ + + +L +S T + E+ + +L L+ + I
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 257 -PMELGRLISLNKLILRGNQLSG------------------HLPRALGLLTELEYFDLSS 297
L L+ + + + L ++ L+
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450
Query: 298 NRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC 357
L ++L L + + +L+ SHN+ +P LA L L L S N + ++ +
Sbjct: 451 KDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VA 505
Query: 358 NLESLEKLNLSHNNISGQIPA--CFIGMSGLLSIDISYNEL 396
NL L++L L +N + Q A + L+ +++ N L
Sbjct: 506 NLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 34/225 (15%), Positives = 62/225 (27%), Gaps = 28/225 (12%)
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
+L L+ W ++ + + QL +LS
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCELSVEKS 361
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN---------- 302
+ EL L +L + + L L Y + +
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 303 -----------SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGS 351
+ L+ +H + L L ++ LDLSHN + +
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-A 477
Query: 352 IPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396
+P + L LE L S N + + + L + + N L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 34/186 (18%), Positives = 63/186 (33%), Gaps = 29/186 (15%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
AYLD + F + ++ L L+ +L+ + + L
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLL 464
Query: 76 LFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
+ LDLS N+ P + L L+ + +N L ++ + NL +L L+L N+
Sbjct: 465 VTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ 522
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED---FGIYP 192
+I L +C LV +L N+L + P
Sbjct: 523 ----------------------SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560
Query: 193 NLKFLD 198
++ +
Sbjct: 561 SVSSIL 566
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 14/207 (6%)
Query: 220 TLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKL-ILRGNQL 276
L + I L +++S N + I + L L+++ I + N L
Sbjct: 34 ELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92
Query: 277 SGHLPRALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDL-- 332
P A L L+Y +S+ + L + + L+ N I +
Sbjct: 93 LYINPEAFQNLPNLQYLLISNTGI--KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 333 ALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDI 391
L L L+ N + I + N L++LNLS NN ++P F G SG + +DI
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 392 SYNELRGPIPNSTVFRNAPRESFLGNN 418
S + +P S N +
Sbjct: 210 SRTRIH-SLP-SYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 41/207 (19%), Positives = 75/207 (36%), Gaps = 13/207 (6%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSE-NEL 62
+ T L+ +Q+ +FS F L +++S N + V NL KL + + + N L
Sbjct: 34 ELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92
Query: 63 SGKIPPEI-GLLTHLFSLDLSLNQFSGTFPPI--CNLSNLKYISLHNNKLSGSIPEEI-- 117
I PE L +L L +S P + + + + +N +I
Sbjct: 93 L-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 118 GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN--LRNCRSLVRAHL 175
G + L L+ N ++ + L+ L ++DN+ L +PN V +
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 176 GRNNLTGNISEDFGIYPNLKFLDLSHN 202
R + S L+ +
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 57/360 (15%), Positives = 95/360 (26%), Gaps = 111/360 (30%)
Query: 25 FPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83
+ L + + L+ +++S+N++ I
Sbjct: 29 PRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEA--------------- 72
Query: 84 NQFSGTFPPICNLSNLKYISL-HNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNI 141
F NL L I + N L I E NL L YL++
Sbjct: 73 ----DVFS---NLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK------- 117
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201
+P++ SL LD+
Sbjct: 118 ------------------HLPDVHKIHSL----------------------QKVLLDIQD 137
Query: 202 NNFYGEISSNW--GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME 259
N I N G L ++ N I I N +QL L+LS N
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN--------- 187
Query: 260 LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNF 319
N L + D+S R+++ L + KL +
Sbjct: 188 --------------NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233
Query: 320 SHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPAC 379
+ +++P L L L E L++ PS C + + + I +
Sbjct: 234 YNL---KKLP-TLEKLVALMEASLTY-------PSHCCAFANWRRQISELHPICNKSILR 282
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 39/214 (18%), Positives = 73/214 (34%), Gaps = 10/214 (4%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
+ N L I + L + +S N++ I ++ N +LH +
Sbjct: 27 DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85
Query: 247 LS-SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL-LTELEYFDLSSNRLNNSI 304
+ +N++ P L +L L++ + HLP + + D+ N ++I
Sbjct: 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTI 144
Query: 305 LEAL--GFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC-NLES 361
G F+ L + N QEI L EL+LS N +P+ +
Sbjct: 145 ERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203
Query: 362 LEKLNLSHNNISGQIPACFIGMSGLLSIDISYNE 395
L++S I + L + +
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 35/183 (19%), Positives = 64/183 (34%), Gaps = 13/183 (7%)
Query: 243 HVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN 302
V + + EIP +L + +L +L A +LE ++S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 303 SI-LEALGFMFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLFKGSIPSRI-CNL 359
I + + KL + I + L +L L +S+ K +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 360 ESLEKLNLSHNNISGQIPA-CFIGMSGLL-SIDISYNELRGPIPNSTVFRNAPRES--FL 415
L++ N I F+G+S + ++ N ++ I NS F +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSA-FNGTQLDELNLS 185
Query: 416 GNN 418
NN
Sbjct: 186 DNN 188
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 72/311 (23%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G G V A K +AVK S+++ ++E+K +T++ H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG--------- 617
NIV G C+ ++++EY G L L + D + N
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 618 -----------VADALSYM--HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
VA + ++ VHRD+++ NVL+ ++ DFG A+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLH------LAELAYTMKITEKCDVYSFGVLALEVI-K 717
+S+ YV + + + L E YT+ K DV+S+G+L E+
Sbjct: 225 DSN----------YVVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYGILLWEIFSL 270
Query: 718 GKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNS 775
G +P ++ F ++ ++ P E++ IM C
Sbjct: 271 GVNP--------YPGIPVDANFYKLIQNGFKMDQPF-YATEEIYIIM---QSCWAFDSRK 318
Query: 776 RPTMQTVCQLL 786
RP+ + L
Sbjct: 319 RPSFPNLTSFL 329
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 59/317 (18%), Positives = 113/317 (35%), Gaps = 85/317 (26%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
IG+G V++A+ P +AVK Q +F E + + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG---------- 617
IVK G C+ + +++EY+ G L L +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 618 -----------VADALSYM--HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL-- 662
VA ++Y+ VHRD+++ N L+ +++DFG ++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 663 ----KPNSSN-----WTELVGTFGYVAPAHGNIGLHLAE-LAYTMKITEKCDVYSFGVLA 712
K + ++ W P E + Y + T + DV+++GV+
Sbjct: 227 ADYYKADGNDAIPIRWM---------PP----------ESIFYN-RYTTESDVWAYGVVL 266
Query: 713 LEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCL 769
E+ G P ++ + E + + L P + +L ++M LC
Sbjct: 267 WEIFSYGLQPYYGMA---------HEEVIYYVRDGNILACPE-NCPLELYNLM---RLCW 313
Query: 770 DGCPNSRPTMQTVCQLL 786
P RP+ ++ ++L
Sbjct: 314 SKLPADRPSFCSIHRIL 330
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
N+T +PP++ +L LS N + L L +L L +L+ L
Sbjct: 18 DKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-V 72
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELD 342
G L L DLS N+L S+ + L L+ S N+ +P L L EL
Sbjct: 73 DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELY 130
Query: 343 LSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDISYNELRGPI 400
L N K ++P + LEKL+L++NN++ ++PA G+ L ++ + N L I
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-I 187
Query: 401 PNSTVFRNAPRESFLGNN 418
P + +FL N
Sbjct: 188 PKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 41/154 (26%), Positives = 61/154 (39%), Gaps = 15/154 (9%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
T + + L L+L T L L LDLS N+L +P L
Sbjct: 45 TFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
Query: 76 LFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDT 130
L LD+S N+ + G L L+ + L N+L ++P + KL L L
Sbjct: 102 LTVLDVSFNRLTSLPLGAL---RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLAN 157
Query: 131 NQFTGQLPRNICRS-GLLEILTVNDNHFLGSIPN 163
N T +LP + L+ L + +N L +IP
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENS-LYTIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 41/140 (29%), Positives = 58/140 (41%), Gaps = 13/140 (9%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLD 80
+ P L LDLS N +LP + L L LD+S N L+ +P L L L
Sbjct: 73 DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 81 LSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTG 135
L N+ G P L+ +SL NN L+ +P + L L L+L N
Sbjct: 131 LKGNELKTLPPGLLTP---TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT 186
Query: 136 QLPRNICRSGLLEILTVNDN 155
+P+ S LL ++ N
Sbjct: 187 -IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 50/184 (27%), Positives = 74/184 (40%), Gaps = 14/184 (7%)
Query: 25 FPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83
L LS N T ++L L+L EL+ K+ + L L +LDLS
Sbjct: 30 PKDTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT-LPVLGTLDLSH 86
Query: 84 NQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNI 141
NQ + P L L + + N+L+ S+P L +L L L N+ LP +
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 142 CRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLD 198
LE L++ +N+ L +P L +L L N+L I + F L F
Sbjct: 144 LTPTPKLEKLSLANNN-LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 199 LSHN 202
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 53/276 (19%), Positives = 76/276 (27%), Gaps = 103/276 (37%)
Query: 97 SNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH 156
+ + L N L + +L+ L LD +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE------------------------ 66
Query: 157 FLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCH 216
L + G P L LDLSHN ++ S
Sbjct: 67 -LTKLQV------------------------DGTLPVLGTLDLSHN----QLQS------ 91
Query: 217 RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQ 275
+P L VLD+S N + +P+ L L +L L+GN+
Sbjct: 92 ---------------LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE 135
Query: 276 LSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-AL 334
L P L +LE L++N L E+P L
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNL-------------------------TELPAGLLNG 170
Query: 335 LAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHN 370
L +L L L N +IP L L N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 43/178 (24%), Positives = 69/178 (38%), Gaps = 17/178 (9%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME--LGRLISLNKLILRGNQLSGHLP 281
S + +P + S +LDLS N+++ + E RL +L+ L+L N L+
Sbjct: 26 SKQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISS 81
Query: 282 RALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPED-LALLAHL 338
A + L Y DLSSN L L+ F + L L +N + + +A L
Sbjct: 82 EAFVPVPNLRYLDLSSNHL--HTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQL 138
Query: 339 SELDLSHNLFKGSIPSRI----CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDIS 392
+L LS N P + L L L+LS N + + + +
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 47/192 (24%), Positives = 69/192 (35%), Gaps = 37/192 (19%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCH--RLGTLIVSGNNITGRIPPEI-GNSSQLHVL 245
+ LDLSHNN + + W L +L++S N++ I E L L
Sbjct: 36 SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93
Query: 246 DLSSNHIAGEIPME-LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI 304
DLSSNH+ + L +L L+L N + A + +L+ LS N++
Sbjct: 94 DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI---- 148
Query: 305 LEALGFMFKLFYLNFSHNQFSQEIPED----LALLAHLSELDLSHNLFKGSIPSRICNLE 360
P + L L LDLS N K + + L
Sbjct: 149 ---------------------SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187
Query: 361 SLEKLNLS-HNN 371
+ K L HNN
Sbjct: 188 AWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 32/126 (25%), Positives = 52/126 (41%), Gaps = 16/126 (12%)
Query: 19 EFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHL 76
E++ + +L L LS N + + + L+YLDLS N L + + L L
Sbjct: 57 EWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQAL 114
Query: 77 FSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI----GNLMKLSYLML 128
L L N F +++ L+ + L N++S P E+ L KL L L
Sbjct: 115 EVLLLYNNHIVVVDRNAFE---DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170
Query: 129 DTNQFT 134
+N+
Sbjct: 171 SSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 9e-14
Identities = 45/188 (23%), Positives = 64/188 (34%), Gaps = 35/188 (18%)
Query: 25 FPHLAYLDLSINGFFGTLPPQV--RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDL 81
+ A LDLS N L + L+ L L LS N L+ I E + +L LDL
Sbjct: 38 PSYTALLDLSHN-NLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDL 95
Query: 82 SLNQF----SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQ 136
S N F +L L+ + L+NN + + ++ +L L L NQ + +
Sbjct: 96 SSNHLHTLDEFLFS---DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-R 150
Query: 137 LPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKF 196
P I + L+ L N L D P
Sbjct: 151 FPV-------------------ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 197 LDLS-HNN 203
L HNN
Sbjct: 192 NGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 33/127 (25%), Positives = 46/127 (36%), Gaps = 10/127 (7%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
+ +F P+L YLDLS N TL + +L L+ L L N + + +
Sbjct: 78 FISSEAFVPVPNLRYLDLSSN-HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLS--YLM 127
L L LS NQ S L L + L +NKL ++ L L
Sbjct: 136 AQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
Query: 128 LDTNQFT 134
L N
Sbjct: 196 LHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 55 LDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS-----GTFPPICNLSNLKYISLHNNKL 109
L S+ +L +P L ++ LDLS N S T L+NL + L +N L
Sbjct: 23 LSCSKQQLP-NVPQ--SLPSYTALLDLSHNNLSRLRAEWTP---TRLTNLHSLLLSHNHL 76
Query: 110 SGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSIPN--L 164
+ I E + L YL L +N L + L LE+L + +NH + +
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFS-DLQALEVLLLYNNH-IVVVDRNAF 132
Query: 165 RNCRSLVRAHLGRNNLT---GNISEDFGIYPNLKFLDLSHNNF 204
+ L + +L +N ++ + +D P L LDLS N
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 18/183 (9%)
Query: 30 YLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQF- 86
LDL N +LP + L+KL+ L L++N+L +P I L +L +L ++ N+
Sbjct: 41 KLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
Query: 87 ---SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNIC 142
G F L NL + L N+L S+P + +L KL+YL L N+ LP+ +
Sbjct: 99 ALPIGVFD---QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 143 RS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDL 199
L+ L + +N L +P L L N L F LK L L
Sbjct: 154 DKLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 200 SHN 202
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 18/173 (10%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
+L +F L L L+ N TLP + + L L+ L +++N+L +P + L
Sbjct: 51 SLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQL 108
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLML 128
+L L L NQ F +L+ L Y+SL N+L S+P+ + L L L L
Sbjct: 109 VNLAELRLDRNQLKSLPPRVFD---SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 129 DTNQFTGQLPRNICRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRN 178
NQ ++P L+ L +++N L +P + L L N
Sbjct: 165 YNNQLK-RVPEGAFDKLTELKTLKLDNNQ-LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 7/176 (3%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
S +T IP I + LDL SN ++ RL L L L N+L
Sbjct: 24 SSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI 80
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELD 342
L LE ++ N+L + + L L NQ + +P + L L+ L
Sbjct: 81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLS 139
Query: 343 LSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
L +N + S+P + L SL++L L +N + F ++ L ++ + N+L+
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 12/180 (6%)
Query: 221 LIVSGNNITGRIPPEIGNS-SQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQLSG 278
L + N ++ +P + + ++L +L L+ N + +P + L +L L + N+L
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA 99
Query: 279 HLPRALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDL-ALL 335
L L L N+L + L F + KL YL+ +N+ Q +P+ + L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS--LPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKL 156
Query: 336 AHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
L EL L +N K +P L L+ L L +N + F + L + + N
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 61/237 (25%), Positives = 92/237 (38%), Gaps = 43/237 (18%)
Query: 94 CNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRS-GLLEILTV 152
CN +N + + KL+ +IP I L L +N+ + LP L +L +
Sbjct: 14 CN-NNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYL 68
Query: 153 NDNHFLGSIP-----NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGE 207
NDN L ++P L+N +L + N L F NL L L N +
Sbjct: 69 NDNK-LQTLPAGIFKELKNLETL---WVTDNKLQALPIGVFDQLVNLAELRLDRN----Q 120
Query: 208 ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS-SQLHVLDLSSNHIAGEIPMEL-GRLIS 265
+ S +PP + +S ++L L L N + +P + +L S
Sbjct: 121 LKS---------------------LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHN 322
L +L L NQL A LTEL+ L +N+L A + KL L N
Sbjct: 159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 57/288 (19%), Positives = 91/288 (31%), Gaps = 62/288 (21%)
Query: 168 RSLVRAHLGRNNLTG----NISEDFGIYPNLKFLDLSHNNFYGE----ISSNWGKCHRLG 219
S+ L + +T ++ ++K + LS N E +S N L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 220 TLIVSGNNITGRIPPEIG-----------NSSQLHVLDLSSNHIAGEIPMELGRLISLNK 268
S GR+ EI +LH + LS N L +S +
Sbjct: 64 IAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 269 ----LILRGNQLS-------------GHLPRALGLLTELEYFDLSSNRLNNSILEALGFM 311
L L N L + + L NRL N ++
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182
Query: 312 FK----LFYLNFSHNQFSQE-----IPEDLALLAHLSELDLSHNLF--KG--SIPSRICN 358
F+ L + N E + E LA L LDL N F G ++ + +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 359 LESLEKLNLSHNNIS--GQIPACFIGM-------SGLLSIDISYNELR 397
+L +L L+ +S G A + GL ++ + YNE+
Sbjct: 243 WPNLRELGLNDCLLSARG---AAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 53/335 (15%), Positives = 98/335 (29%), Gaps = 61/335 (18%)
Query: 76 LFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKLSG----SIPEEIGNLMKLSYL 126
+ L L+ + F + ++K I L N + + E I + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN--- 183
FTG++ ++ L +L L C L L N
Sbjct: 66 EFSDI-FTGRV-KDEIPEALRLLLQA-----------LLKCPKLHTVRLSDNAFGPTAQE 112
Query: 184 -ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQL 242
+ + + L+ L L +N G + ++ + + N+ L
Sbjct: 113 PLIDFLSKHTPLEHLYLHNNGL-GPQA-----GAKIARALQELAVNK-----KAKNAPPL 161
Query: 243 HVLDLSSNHI----AGEIPMELGRLISLNKLILRGNQL-----SGHLPRALGLLTELEYF 293
+ N + E L+ + + N + L L EL+
Sbjct: 162 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL 221
Query: 294 DLSSNRLNN----SILEALGFMFKLFYLNFSHNQFS----QEIPEDLALLAH--LSELDL 343
DL N + ++ AL L L + S + + + L + L L L
Sbjct: 222 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281
Query: 344 SHNLFKGSIPSRIC-----NLESLEKLNLSHNNIS 373
+N + + + L L L+ N S
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 63/344 (18%), Positives = 101/344 (29%), Gaps = 73/344 (21%)
Query: 47 RNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSGTFPPI--------- 93
+K + LS N + + + I L + S I
Sbjct: 29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88
Query: 94 --CNLSNLKYISLHNNKLSGSIPEEIGNLMK----LSYLMLDTNQFTGQLPRNICRSGLL 147
L + L +N + E + + + L +L L N Q I R+ L
Sbjct: 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--L 146
Query: 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN----ISEDFGIYPNLKFLDLSHNN 203
+ L VN +N L GRN L ++ F + L + + N
Sbjct: 147 QELAVNK--------KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198
Query: 204 FYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI----AGEIPME 259
E G H L + +L VLDL N + + +
Sbjct: 199 IRPE-----GIEHLLLEG--------------LAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 260 LGRLISLNKLILRGNQLSG----HLPRALGLL--TELEYFDLSSNRLNNSILEALGFMFK 313
L +L +L L LS + A L L+ L N + + L +
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 314 -----LFYLNFSHNQFS------QEIPEDLALLAHLSELDLSHN 346
L +L + N+FS EI E + +L
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 343
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 45/228 (19%), Positives = 81/228 (35%), Gaps = 51/228 (22%)
Query: 504 RTKDFDAKY-----CIGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
+ Y +G G + V +G K A+K + D + E+
Sbjct: 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---------LLYDSPKARQEV 72
Query: 558 KALTKI-RHRNIVKFYGFCSHVRHS----FVVYEYINRGSLATVLSNNF------ASEDF 606
+ +IV ++ H ++ E + G L F + F
Sbjct: 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAF 125
Query: 607 DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLK 663
R+ ++ + A+ ++H I HRD+ N+L + + +++DFG AK
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
N+ T YVAP E+ K + CD++S GV+
Sbjct: 183 QNA--LQTPCYTPYYVAP----------EVLGPEKYDKSCDMWSLGVI 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 45/213 (21%)
Query: 514 IGKGEHRSVYRA-KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKF 571
+G G + V + + +K A+K + D + E++ + + +IV+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 120
Query: 572 YGFC----SHVRHSFVVYEYINRGSLATVLSNNF------ASEDFDWRKRMNVITGVADA 621
+ + +V E ++ G L F + F R+ ++ + +A
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAKLLKPNSSNWTELVGTFGY 678
+ Y+H I HRD+ N+L + +++DFG AK ++S T T Y
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYY 229
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711
VAP E+ K + CD++S GV+
Sbjct: 230 VAP----------EVLGPEKYDKSCDMWSLGVI 252
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 36/216 (16%), Positives = 81/216 (37%), Gaps = 43/216 (19%)
Query: 160 SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS--SNWGKCHR 217
+ + V+ +LG+ ++T ++ ++ + ++N I +
Sbjct: 11 QVFPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSN----IQSLAGMQFFTN 64
Query: 218 LGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
L L +S N I+ + P + + ++L L ++ N + + L++L L N+L
Sbjct: 65 LKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELR 119
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAH 337
+L L LE + +N+L + + LGF+ KL L+ N+ + +
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNE-----------ITN 164
Query: 338 LSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373
L L+ + ++L+
Sbjct: 165 TGGLT---------------RLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 35/224 (15%), Positives = 77/224 (34%), Gaps = 41/224 (18%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
L+ +L + ++ + L+ + + + + + + +NLK + L +N
Sbjct: 17 GLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHN 73
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167
++S + + +L KL L ++ N+ ++ + +
Sbjct: 74 QIS-DL-SPLKDLTKLEELSVNRNRLK-------------------------NLNGIPSA 106
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS--SNWGKCHRLGTLIVSG 225
L R L N L + NL+ L + +N + G +L L + G
Sbjct: 107 -CLSRLFLDNNELR-DTD-SLIHLKNLEILSIRNNK----LKSIVMLGFLSKLEVLDLHG 159
Query: 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269
N IT + +++ +DL+ E L N +
Sbjct: 160 NEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 52/285 (18%), Positives = 86/285 (30%), Gaps = 70/285 (24%)
Query: 92 PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILT 151
P L+N +L ++ L + D +
Sbjct: 14 PDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ----------------- 54
Query: 152 VNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS-- 209
S+ ++ NLK L LSHN IS
Sbjct: 55 --------SLAGMQFF------------------------TNLKELHLSHNQ----ISDL 78
Query: 210 SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269
S +L L V+ N + + S+ L L L +N + L L +L L
Sbjct: 79 SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRDTDS--LIHLKNLEIL 133
Query: 270 ILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIP 329
+R N+L + LG L++LE DL N + N L + K+ +++ + + E
Sbjct: 134 SIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPV 189
Query: 330 EDLALLAHLSEL-DLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373
+ L + + D P I N S +
Sbjct: 190 KYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 33/177 (18%), Positives = 67/177 (37%), Gaps = 15/177 (8%)
Query: 221 LIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHL 280
I I ++ P + +L + + L + + + L
Sbjct: 2 SIQRPTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL 56
Query: 281 PRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSE 340
+ T L+ LS N++++ L L + KL L+ + N+ + LS
Sbjct: 57 A-GMQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLKN--LNGIPSA-CLSR 110
Query: 341 LDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
L L +N + + +L++LE L++ +N + I +S L +D+ NE+
Sbjct: 111 LFLDNN--ELRDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 41/182 (22%), Positives = 64/182 (35%), Gaps = 36/182 (19%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
F +L L LS N L P +++L+KL+ L ++ N L + L L L
Sbjct: 59 MQFFTNLKELHLSHNQI-SDLSP-LKDLTKLEELSVNRNRLK-NLNGIPSA--CLSRLFL 113
Query: 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI 141
N+ + +L NL+ +S+ NNKL SI +G L KL L L N+ T
Sbjct: 114 DNNELR-DTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT------- 163
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201
+ L + + L +E P L +
Sbjct: 164 ------------------NTGGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVK 202
Query: 202 NN 203
+
Sbjct: 203 DP 204
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 41/222 (18%), Positives = 81/222 (36%), Gaps = 17/222 (7%)
Query: 158 LGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNW-GKCH 216
+ IP+L S L +L S F PN+ + +S + ++ S+
Sbjct: 23 IQRIPSLP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 217 RLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIP--MELGRLISLNKLILRG 273
++ + + I P+ L L + + + P ++ L +
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139
Query: 274 NQLSGHLPRAL--GLLTELEYFDLSSNRLNNSILEALGFMF-KLFYLNFSHNQFSQEIPE 330
N +P GL E L +N + ++ F KL + + N++ I +
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFTS--VQGYAFNGTKLDAVYLNKNKYLTVIDK 197
Query: 331 DL--ALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHN 370
D + + S LD+S ++PS+ LE L++L +
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/207 (19%), Positives = 76/207 (36%), Gaps = 33/207 (15%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELS 63
++ L T L+ T+ +FS+ P+++ + +SI+ L NLSK+ ++++
Sbjct: 35 TLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93
Query: 64 GKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEE--IGNLM 121
I P L LK++ + N L P+ + +
Sbjct: 94 TYIDP-------------------DALK---ELPLLKFLGIFNTGLK-MFPDLTKVYSTD 130
Query: 122 KLSYLMLDTNQFTGQLPRNICR--SGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRN 178
L + N + +P N + L + +N S+ N L +L +N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG-FTSVQGYAFNGTKLDAVYLNKN 189
Query: 179 NLTGNISED--FGIYPNLKFLDLSHNN 203
I +D G+Y LD+S +
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTS 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 34/216 (15%), Positives = 69/216 (31%), Gaps = 39/216 (18%)
Query: 96 LSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGL--LEILTV 152
+ + + L L +IP NL +S + + + QL + L + + +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHS-FYNLSKVTHIEI 87
Query: 153 NDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIY--PNLKFLDLSHNNFYGEI 208
+ L I L+ L + L + +Y L+++ N + I
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 209 SSN--WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266
N G C+ TL + N T + N ++L + L+ N
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN---------------- 189
Query: 267 NKLILRGNQLSGHLPRAL--GLLTELEYFDLSSNRL 300
L+ + + G+ + D+S +
Sbjct: 190 -------KYLT-VIDKDAFGGVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 30/167 (17%), Positives = 57/167 (34%), Gaps = 17/167 (10%)
Query: 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNR 299
Q ++ I IP S L L L A L + +S
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI-- 64
Query: 300 LNNSI--LEALGF--MFKLFYLNFSHNQFSQEIPED-LALLAHLSELDLSHNLFKGSIP- 353
+ ++ LE+ F + K+ ++ + + I D L L L L + + K P
Sbjct: 65 -DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 354 -SRICNLESLEKLNLSHNNISGQIPA-CFIGMSGLL-SIDISYNELR 397
+++ + + L ++ N IP F G+ ++ + N
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/129 (16%), Positives = 47/129 (36%), Gaps = 9/129 (6%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSK-LKYLDLSENEL 62
+ + +TGLK S L+++ N + ++P + L L L N
Sbjct: 109 FLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFSGTFPPIC--NL-SNLKYISLHNNKLSGSIPEEIGN 119
+ + T L ++ L+ N++ + S + + ++ ++P +
Sbjct: 169 T-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG-- 224
Query: 120 LMKLSYLML 128
L L L+
Sbjct: 225 LEHLKELIA 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 65/289 (22%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVK-----KFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
IGKG V A+ + +G ++A+K + N + ++ E++ + + H N
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-------TSLQKLFREVRIMKILNHPN 75
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMNVITG------V 618
IVK + + +++ EY + G + FD+ RM +
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEV------------FDYLVAHGRMKEKEARSKFRQI 123
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
A+ Y H IVHRD+ + N+LLD + +++DFG + G Y
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPY 179
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
AP Y + DV+S GV+ ++ G P D ++
Sbjct: 180 AAPE------LFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFD--------GQNLKEL 222
Query: 739 FNAMLD--HRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+L +R+P + S D E L+ L L+ P R T++ + +
Sbjct: 223 RERVLRGKYRIPFYMSTDC-ENLLKRF----LVLN--PIKRGTLEQIMK 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 41/242 (16%)
Query: 498 YEEIIRRTK-------DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSD 549
Y++ I + + D++ IG+G V + S K+ A+K + +M
Sbjct: 54 YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS----KFEMIK 109
Query: 550 QKE---FLNEIKALTKIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED 605
+ + F E + +V+ FY F R+ ++V EY+ G L ++SN E
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLMSNYDVPEK 168
Query: 606 FDWRKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
R V AL +H +HRD+ +N+LLD +++DFGT +
Sbjct: 169 ---WARF-YTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 665 NSSNWTE-LVGTFGYVAP----AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ VGT Y++P + G G + +CD +S GV E++ G
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYY----------GRECDWWSVGVFLYEMLVGD 270
Query: 720 HP 721
P
Sbjct: 271 TP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 49/234 (20%), Positives = 89/234 (38%), Gaps = 50/234 (21%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALT 561
+DF +G+G +V A+ + + A+K + + + E ++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMS 85
Query: 562 KIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKR 611
++ H VK Y + Y G L + + +E
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE------- 138
Query: 612 MNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-- 668
+ AL Y+H I+HRD+ N+LL+ + +++DFGTAK+L P S
Sbjct: 139 ------IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 669 -WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ VGT YV+P EL + D+++ G + +++ G P
Sbjct: 189 ANS-FVGTAQYVSP----------ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 30/239 (12%)
Query: 498 YEEIIRRTK-------DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSD 549
E I+ R K DF+ IG+G V K+ ++ A+K N M
Sbjct: 46 AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN----KWDMLK 101
Query: 550 QKE---FLNEIKALTKIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFA--S 603
+ E F E L R I + + F + ++V EY G L T+LS
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLHFAFQDE-NYLYLVMEYYVGGDLLTLLSKFGERIP 160
Query: 604 EDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663
+ R + + A+ +H VHRDI +N+LLD R++DFG+ L+
Sbjct: 161 AE---MARF-YLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 664 PNSSNWTE-LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ + + VGT Y++P I + T +CD ++ GV A E+ G+ P
Sbjct: 214 ADGTVRSLVAVGTPDYLSP---EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 34/125 (27%), Positives = 56/125 (44%), Gaps = 13/125 (10%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLL 73
+ +FS + L +DLS N L P + L L L L N+++ ++P + L
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNN-QISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL 103
Query: 74 THLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLML 128
L L L+ N+ + F +L NL +SL++NKL +I + L + + L
Sbjct: 104 FSLQLLLLNANKINCLRVDAFQ---DLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHL 159
Query: 129 DTNQF 133
N F
Sbjct: 160 AQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 33/144 (22%), Positives = 55/144 (38%), Gaps = 12/144 (8%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291
IP + + + L N I P L ++ L NQ+S P A L L
Sbjct: 26 IPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 292 YFDLSSNRL---NNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNL 347
L N++ S+ E L L L + N+ + D L +L+ L L N
Sbjct: 84 SLVLYGNKITELPKSLFEGLF---SLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNK 139
Query: 348 FKGSIPSRI-CNLESLEKLNLSHN 370
+ +I L +++ ++L+ N
Sbjct: 140 LQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 32/178 (17%), Positives = 60/178 (33%), Gaps = 54/178 (30%)
Query: 31 LDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGT 89
+ L N +PP KL+ +DLS N++S ++ P
Sbjct: 37 IRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAP-------------------DA 75
Query: 90 FPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGLLE 148
F L +L + L+ NK++ +P+ + L L L+L+ N+
Sbjct: 76 FQ---GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK---------------- 115
Query: 149 ILTVNDNHFLGSIPN--LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF 204
+ + ++ +L L N L F ++ + L+ N F
Sbjct: 116 ---------INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 20/135 (14%)
Query: 174 HLGRNNLTGNISEDFGIYPNLKFLDLSHNN--------FYGEISSNWGKCHRLGTLIVSG 225
L +N + F Y L+ +DLS+N F G L +L++ G
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG--------LRSLNSLVLYG 89
Query: 226 NNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPRA 283
N IT +P + L +L L++N I + ++ L +LN L L N+L
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 284 LGLLTELEYFDLSSN 298
L ++ L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/140 (22%), Positives = 53/140 (37%), Gaps = 8/140 (5%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSN-WGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLD 246
+ + + L N I + +L + +S N I+ + P+ L+ L
Sbjct: 29 NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86
Query: 247 LSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNNSI 304
L N I E+P L L SL L+L N+++ L A L L L N+L
Sbjct: 87 LYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 305 LEALGFMFKLFYLNFSHNQF 324
+ + ++ + N F
Sbjct: 145 KGTFSPLRAIQTMHLAQNPF 164
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 54/293 (18%), Positives = 102/293 (34%), Gaps = 72/293 (24%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVK-----KFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567
+G G V+ A ++ VK K + K L EI L+++ H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMNVITG------V 618
I+K + +V E G + F + R++ +
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGL-----------DLFAFIDRHPRLDEPLASYIFRQL 139
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
A+ Y+ I+HRDI N+++ ++ ++ DFG+A L+ +T GT Y
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEY 195
Query: 679 VAPAHGNIGLHLAEL----AYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734
AP E+ Y + +++S GV ++ ++P
Sbjct: 196 CAP----------EVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC----------- 231
Query: 735 INIEFNAMLDHRL---PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
E ++ + S ++ L+S + L P R T++ +
Sbjct: 232 ---ELEETVEAAIHPPYLVSKEL-MSLVSGL------LQPVPERRTTLEKLVT 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 40/183 (21%), Positives = 69/183 (37%), Gaps = 30/183 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G+G + V + + AVK + + EI+ L ++RH+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 573 GFCSHV--RHSFVVYEYINRGSLATVLSNNFASEDFDW--RKRMNVITGVA------DAL 622
+ + ++V EY G E D KR V D L
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM----------QEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF----GY 678
Y+H IVH+DI N+LL ++S G A+ L P +++ + T +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSPAF 177
Query: 679 VAP 681
P
Sbjct: 178 QPP 180
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 53/229 (23%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFN------------SPFPNDQMSDQKEFLN----- 555
IGKG + V A A+K + P P +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 556 -----EIKALTKIRHRNIVKFYGFCSHV------RHSFVVYEYINRGSLATVLSNNFASE 604
EI L K+ H N+VK V H ++V+E +N+G + V + SE
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 605 DFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
D ++I G+ Y+H+ I+HRDI +N+L+ + +++DFG + K
Sbjct: 137 DQARFYFQDLIKGI----EYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT---EKCDVYSFGV 710
+ + + VGT ++AP E + + DV++ GV
Sbjct: 190 SDALLSNTVGTPAFMAP----------ESLSETRKIFSGKALDVWAMGV 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 47/172 (27%), Positives = 70/172 (40%), Gaps = 17/172 (9%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G + + + +AVK + + + EI +RH NIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQ--REIINHRSLRHPNIVRFK 82
Query: 573 GFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
H ++ EY + G L + + SED +++GV SY H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV----SYCHSMQ-- 136
Query: 632 PIVHRDISSNNVLLDLEYEAR--VSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
I HRD+ N LLD R + DFG +K +S + VGT Y+AP
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAP 186
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 51/187 (27%), Positives = 74/187 (39%), Gaps = 44/187 (23%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-EIKALTKIRHRNIVKF 571
+G+G + V A + + +AVK + + D E + EI + H N+VKF
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMN----------VITGV 618
YG ++ EY + G L FD M ++ GV
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL----VG 674
Y+H I HRDI N+LLD ++SDFG A + + N+ L G
Sbjct: 119 ----VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--RLLNKMCG 169
Query: 675 TFGYVAP 681
T YVAP
Sbjct: 170 TLPYVAP 176
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 21/175 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G G V + +G K+AVK N + + + + EI+ L RH +I+K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 572 YGFCSHVRHSFVVYEYINRGSL-ATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
Y S F+V EY++ G L + + E R +++ V Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCHRHM- 131
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF----GYVAP 681
+VHRD+ NVLLD A+++DFG + ++ E + T Y AP
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-----EFLRTSCGSPNYAAP 179
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 48/250 (19%), Positives = 94/250 (37%), Gaps = 41/250 (16%)
Query: 165 RNCRSLVRAHLGRNNLTGNISEDFG-----IYPNLKFLDLSHNNFYGE----ISSNWGKC 215
S+ +L N+L S++ I N+ L+LS N + +
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 216 H-RLGTLIVSGNNITGRIPPEIG-----NSSQLHVLDLSSNHIAGEIPMELGRLI----- 264
+ L + N+ + + E + + L+L N + + EL +++
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 265 SLNKLILRGNQLS----GHLPRALGLL-TELEYFDLSSNRLNNSILEALGFMFK-----L 314
++N L LRGN L+ L + L + + DLS+N L L ++F +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227
Query: 315 FYLNFSHNQFSQEIPEDLALL----AHLSELDLSHNLFKG-------SIPSRICNLESLE 363
LN N E+L LL HL + L +++ K ++ + N++ +
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 364 KLNLSHNNIS 373
++ + I
Sbjct: 288 LVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 47/245 (19%), Positives = 90/245 (36%), Gaps = 39/245 (15%)
Query: 192 PNLKFLDLSHNNFYGE----ISSNWGKCH-RLGTLIVSGNNITGRIPPEIG-----NSSQ 241
+ LDLS NN Y + + + +L +SGN++ + E+ +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 242 LHVLDLSSNHIAGEIPMELGRLI-----SLNKLILRGNQLSG----HLPRALGLL-TELE 291
+ L+LS N ++ + EL + + ++ L L N S +A L +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 292 YFDLSSNRLNNSILEALGFMFK-----LFYLNFSHNQFSQEIPEDLALL-----AHLSEL 341
+L N L + L + + LN N + + +LA A ++ L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201
Query: 342 DLSHNLFKGSIPSRIC-----NLESLEKLNLSHNNISGQ----IPACFIGMSGLLSIDIS 392
DLS NL + + + LNL N + G + + L ++ +
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 393 YNELR 397
Y+ ++
Sbjct: 262 YDIVK 266
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 57/354 (16%), Positives = 108/354 (30%), Gaps = 74/354 (20%)
Query: 47 RNLSKLKYLDLSENELSGKIPPEIG-----LLTHLFSLDLSLNQFS-------GTFPPIC 94
+ LDLS N L E+ + SL+LS N
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78
Query: 95 NLSNLKYISLHNNKLSGSIPEEIGNLMK-----LSYLMLDTNQFTGQLPRNICRSGLLEI 149
+N+ ++L N LS +E+ + ++ L L N F+ + ++
Sbjct: 79 P-ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA----- 132
Query: 150 LTVNDNHFLGSIPNLRNC-RSLVRAHLGRNNLTGN----ISEDFGIYP-NLKFLDLSHNN 203
N S+ +L N+L + + P N+ L+L NN
Sbjct: 133 --------------FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 204 FYGE----ISSNWGKCHR-LGTLIVSGNNITGRIPPEIG-----NSSQLHVLDLSSNHIA 253
+ ++ + +L +S N + + E+ + + L+L N +
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
Query: 254 GEIPMELGRLISLNK----LILRGNQLSG-------HLPRALGLLTELEYFDLSSNRLNN 302
G L L K + L + + L A + ++ D + ++
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298
Query: 303 SILEALGFMFK----------LFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346
S + + + L Q Q EDL + L E +
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 52/354 (14%), Positives = 115/354 (32%), Gaps = 76/354 (21%)
Query: 74 THLFSLDLSLNQFSGT-FPPIC-----NLSNLKYISLHNNKLSGSIPEEIGNLMK----- 122
+ SLDLSLN + +++ ++L N L +E+ ++
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 123 LSYLMLDTNQFTGQ--------LPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAH 174
++ L L N + + L + +L + N F + ++ +A
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFT---ITVLDLGWNDF-----SSKSSSEFKQA- 132
Query: 175 LGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGE----ISSNWGKCH-RLGTLIVSGNNIT 229
+ + L+L N+ + + + +L + GNN+
Sbjct: 133 FSNLPAS------------ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 230 GRIPPEIG-----NSSQLHVLDLSSNHIAGEIPMELGRLI-----SLNKLILRGNQLSG- 278
+ E+ + + LDLS+N + + EL + + L L N L G
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 279 ---HLPRALGLLTELEYFDLSSNRLNN-------SILEALGFMFKLFYLNFSHNQFSQEI 328
+L L L+ L + + N ++ A + K+ ++ + +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300
Query: 329 PEDLA-----LLAHLSELDLSHN--LFKGSIPSRICNL---ESLEKLNLSHNNI 372
++ L L + +F + I +L + L + + +
Sbjct: 301 SIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 25/138 (18%), Positives = 51/138 (36%), Gaps = 20/138 (14%)
Query: 279 HLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK-----LFYLNFSHNQFSQEIPEDLA 333
+ + + DLS N L + L F + LN S N + ++L
Sbjct: 13 PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72
Query: 334 LL-----AHLSELDLSHNLFKGSIPSRICNL-----ESLEKLNLSHNNISGQIPACFIGM 383
+ A+++ L+LS N + ++ L+L N+ S + + F
Sbjct: 73 QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA 132
Query: 384 -----SGLLSIDISYNEL 396
+ + S+++ N+L
Sbjct: 133 FSNLPASITSLNLRGNDL 150
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 29/213 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G V A +A+KK + PF N + K E+ + + H+NI+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 573 ------GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
+ ++V E + L E R + + + ++H
Sbjct: 128 NVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQMLC-GIKHLH 181
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
I+HRD+ +N+++ + ++ DFG A+ S T V T Y AP
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP----- 232
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
E+ M E D++S G + E+++ K
Sbjct: 233 -----EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 29/222 (13%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
+ +G G + +V A +G K+A+KK PF + K E++ L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHM 81
Query: 564 RHRNIVKFY------GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
RH N++ ++V ++ L ++ + ED ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDR----IQFLVYQ 136
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
+ L Y+H I+HRD+ N+ ++ + E ++ DFG A + S T V T
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRW 190
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
Y AP + L + YT + D++S G + E+I GK
Sbjct: 191 YRAPE-----VILNWMRYTQTV----DIWSVGCIMAEMITGK 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 51/187 (27%), Positives = 74/187 (39%), Gaps = 44/187 (23%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-EIKALTKIRHRNIVKF 571
+G+G + V A + + +AVK + + D E + EI + H N+VKF
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMN----------VITGV 618
YG ++ EY + G L FD M ++ GV
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTEL----VG 674
Y+H I HRDI N+LLD ++SDFG A + + N+ L G
Sbjct: 119 ----VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--RLLNKMCG 169
Query: 675 TFGYVAP 681
T YVAP
Sbjct: 170 TLPYVAP 176
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 52/249 (20%)
Query: 498 YEEIIRRTK-------DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSD 549
+ + K DF+ IG+G V KL + DK+ A+K N +M
Sbjct: 59 AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLK 114
Query: 550 QKE---FLNEIKALTKIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN----- 600
+ E F E L + I Y F + ++V +Y G L T+LS
Sbjct: 115 RAETACFREERDVLVNGDSKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLSKFEDRLP 173
Query: 601 ------FASEDFDWRKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARV 653
+ +E + A+ +H VHRDI +N+L+D+ R+
Sbjct: 174 EEMARFYLAE-------------MVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRL 216
Query: 654 SDFGTAKLLKPNSSNWTE-LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLA 712
+DFG+ L + + + VGT Y++P + A + +CD +S GV
Sbjct: 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPE-----ILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 713 LEVIKGKHP 721
E++ G+ P
Sbjct: 272 YEMLYGETP 280
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 61/293 (20%), Positives = 100/293 (34%), Gaps = 70/293 (23%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFN--SPFPNDQMSDQKEFLNEIKALTKIR----HR 566
+GKG +V+ L ++A+K +SD E+ L K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMNVITG------ 617
+++ + +V E + FD+ + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ-----------DLFDYITEKGPLGEGPSRCFFGQ 147
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLKPNSSNWTELVGTF 676
V A+ + H +VHRDI N+L+DL A++ DFG+ LL +T+ GT
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTR 202
Query: 677 GYVAPAHGNIGLHLAEL----AYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
Y P E Y V+S G+L +++ G P F
Sbjct: 203 VYSPP----------EWISRHQYHAL---PATVWSLGILLYDMVCGDIP------FERDQ 243
Query: 733 SSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ E P H S D LI L P+SRP+++ +
Sbjct: 244 EILEAEL------HFPAHVSPDCC-ALIRRC------LAPKPSSRPSLEEILL 283
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 6e-12
Identities = 50/187 (26%), Positives = 77/187 (41%), Gaps = 45/187 (24%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G G V K +G K+AVK N + + + EI+ L RH +I+K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMN----------VITGV 618
Y S F+V EY++ G L FD+ R++ +++GV
Sbjct: 82 YQVISTPSDIFMVMEYVSGGEL------------FDYICKNGRLDEKESRRLFQQILSGV 129
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF-- 676
Y H +VHRD+ NVLLD A+++DFG + ++ E + T
Sbjct: 130 D----YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-----EFLRTSCG 177
Query: 677 --GYVAP 681
Y AP
Sbjct: 178 SPNYAAP 184
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 45/255 (17%)
Query: 477 SSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKY----CIGKGEHRSVYRAK-LPSGD 531
S++ F+SV EI T +Y IG G V A
Sbjct: 2 GSRSKRDNNFYSV----------EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER 51
Query: 532 KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY------GFCSHVRHSFVVY 585
+A+KK + PF N + K E+ + + H+NI+ + ++V
Sbjct: 52 NVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109
Query: 586 EYINRGSLATVLSNNFASEDFDWRKRMNVIT-GVADALSYMHHDCFPPIVHRDISSNNVL 644
E ++ +L V+ E RM+ + + + ++H I+HRD+ +N++
Sbjct: 110 ELMD-ANLCQVIQMELDHE------RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 159
Query: 645 LDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCD 704
+ + ++ DFG A+ S T V T Y AP E+ M E D
Sbjct: 160 VKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP----------EVILGMGYKENVD 208
Query: 705 VYSFGVLALEVIKGK 719
++S G + E+IKG
Sbjct: 209 IWSVGCIMGEMIKGG 223
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 19/174 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-----EIKALTKIRHRN 567
+G+G + V + + +G +A+KKF SD + + EIK L ++RH N
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+V C + ++V+E+++ ++ L D++ + + + + + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
I+HRDI N+L+ ++ DFG A+ L + + V T Y AP
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 53/234 (22%)
Query: 514 IGKGEHRSVYRAKL-PSGDKIAVKK-FNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK- 570
G+G +V K +G +A+KK P + L ++ L + H NIV+
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDP------RFRNRELQIMQDLAVLHHPNIVQL 84
Query: 571 FYGFCSHVRHSF------VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG------V 618
F + VV EY+ +L N + + I +
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQL 138
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFG 677
++ +H + HRDI +NVL++ ++ DFG+AK L P+ N + +
Sbjct: 139 IRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRY 196
Query: 678 YVAPAHGNIGLHLAEL-----AYTMKITEKCDVYSFG-VLALEVIKGKH--PGD 723
Y AP EL YT + D++S G + A E++ G+ GD
Sbjct: 197 YRAP----------ELIFGNQHYTTAV----DIWSVGCIFA-EMMLGEPIFRGD 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 19/174 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-----EIKALTKIRHRN 567
IG+G + V++ + +G +A+KKF S+ + EI+ L +++H N
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+V R +V+EY + ++ L ++ A+++ H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
+HRD+ N+L+ ++ DFG A+LL S + + V T Y +P
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G + SV A SG+K+A+KK + PF + K E+ L ++H N++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 573 ------GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
+ ++V ++ L ++ F+ E + ++ + L Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIH 143
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+VHRD+ N+ ++ + E ++ DFG A + + T V T Y AP
Sbjct: 144 S---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPE---- 193
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ L+ + Y + D++S G + E++ GK
Sbjct: 194 -VILSWMHYNQTV----DIWSVGCIMAEMLTGK 221
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 1e-11
Identities = 114/715 (15%), Positives = 193/715 (26%), Gaps = 230/715 (32%)
Query: 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGK-------IPPEIGLLTHLFSL 79
Y D+ ++ F V N D+ ++ LS + + LF
Sbjct: 15 QYQYKDI-LSVF---EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 80 DLSLNQFSGT--FPPICNLSNLKYI--SLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135
L Q F N K++ + + S+ + + L D F
Sbjct: 71 -LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI-EQRDRLYNDNQVFA- 127
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAH----LGRNNLTGNISEDFGIY 191
N+ R L L LR ++++ G+ + ++ + +
Sbjct: 128 --KYNVSRLQPYLKLR---QALL----ELRPAKNVL-IDGVLGSGKTWVALDVCLSYKV- 176
Query: 192 PNLKFLDLSHNNFYGEISSNW---GKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248
+I W C+ T++ + +I P N + D S
Sbjct: 177 ---------QCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP---NWTSR--SDHS 220
Query: 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL------TELEYFDLSSNRL-- 300
SN I + + + + + +L+ L +L F+LS L
Sbjct: 221 SN-----IKLRIHSIQAELRRLLKSKP----YENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 301 --NNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLA---HLSELDLSH---------- 345
+ + L +++ H+ + E +LL DL
Sbjct: 272 TRFKQVTDFLSAA-TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 346 NLFKGSIPSRICNLESLEKLNLS-HNNISGQIPACFIGMSGLLSIDISYNELRGPIPNST 404
++ SI + ++ + +N I I+ S N L P
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTI----------------IESSLNVLE---PAEY 371
Query: 405 VFRNAPRESFLGNNFSTFYGTSDLLSHKEASKKTPFLILFPLLGALALL----IVYVVMV 460
R+ F + S F S P L+L+ I VMV
Sbjct: 372 ------RKMF--DRLSVF----------PPSAHIP-------TILLSLIWFDVIKSDVMV 406
Query: 461 FM--FRRWKRDSQSQGSCSSKNDTRGIFHSV-LDFDGKIMYEEIIRRTKDFDAKYCIGKG 517
+ + S K T I S+ L+ K+ E +
Sbjct: 407 VVNKLHK-----YSLVEKQPKESTISI-PSIYLELKVKLENEYAL--------------- 445
Query: 518 EHRSV---YRA--KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
HRS+ Y S D P DQ Y
Sbjct: 446 -HRSIVDHYNIPKTFDSDDL-------IPPYLDQ-------------------------Y 472
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW--RKRMNVITGVADALSYMHHDCF 630
F SH+ H E+ R +L F DF + +K + HD
Sbjct: 473 -FYSHIGHHLKNIEHPERMTL---FRMVFL--DFRFLEQK--------------IRHDST 512
Query: 631 PPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
I N L L+ Y+ + D N + LV P
Sbjct: 513 AWNASGSI--LNTLQQLKFYKPYICD---------NDPKYERLVNAILDFLPKIE 556
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 3e-09
Identities = 54/343 (15%), Positives = 111/343 (32%), Gaps = 83/343 (24%)
Query: 477 SSKNDTRGIFHSVLDFDGKIMY---EEIIRRTKDFD------AKYCIGKGEHRSVY---R 524
+ + T +F ++L +++ EE++R ++ +Y R
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLR--INYKFLMSPIKTEQRQPSMMTRMYIEQR 116
Query: 525 AKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGF---------- 574
+L + N F +S + +L +AL ++R V G
Sbjct: 117 DRLYND--------NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL 168
Query: 575 --CS----HVRHSFVVYEYINRG-------------SLATVLSNNFASE-DFDWRKRMNV 614
C + F ++ ++N L + N+ S D ++
Sbjct: 169 DVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR- 226
Query: 615 ITGVADALSY-----MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669
I + L + +C +V ++ + ++ LL
Sbjct: 227 IHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKI-------LLTTRFKQV 277
Query: 670 TELVG--TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727
T+ + T +++ H ++ L E + K L EV+ +P LS+
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDLPREVLTT-NP-RRLSI 332
Query: 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLD 770
+ S + A D H + D KL +I+E +L L+
Sbjct: 333 IAESIR----DGLATWD-NWKHVNCD---KLTTIIESSLNVLE 367
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-05
Identities = 60/431 (13%), Positives = 122/431 (28%), Gaps = 161/431 (37%)
Query: 46 VRNLSKLKYLDLS------------ENELSGKIPPEIGLLTHL--FSLDLSLNQFSGTFP 91
V+N +LS + LS I L H + D +
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL---- 308
Query: 92 PICNLSNLKYISLHNNKLSGSIPEEI--GNLMKLSYL------MLDTNQFTGQLPRNICR 143
KY+ L P E+ N +LS + L T +++
Sbjct: 309 --------KYLDCRPQDL----PREVLTTNPRRLSIIAESIRDGLATWDNW----KHVNC 352
Query: 144 SGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP-NLKFLDLSHN 202
L I+ S+ L + R + ++P +
Sbjct: 353 DKLTTIIES-------SLNVLEP--AEYRKMF----------DRLSVFPPSAH------- 386
Query: 203 NFYGEISSN-----WG------------KCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245
I + W K H+ L+ ++ + +
Sbjct: 387 -----IPTILLSLIWFDVIKSDVMVVVNKLHKYS-LVEKQPK---------ESTISIPSI 431
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
L E+ ++L +L++ I+ + + +P+ + DL L+
Sbjct: 432 YL-------ELKVKLENEYALHRSIV--DHYN--IPKTF------DSDDLIPPYLDQYFY 474
Query: 306 EALGF------------MFKLFYLNFSHNQFSQE--IPEDLALLAHLSELDLSHNL--FK 349
+G +F++ +L+F F ++ + A A S L+ L +K
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFR---FLEQKIRHDSTAWNASGSILNTLQQLKFYK 531
Query: 350 GSI------PSRICNLESLEK--LNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIP 401
I R+ + ++ + N I + + LL I +
Sbjct: 532 PYICDNDPKYERL--VNAILDFLPKIEENLICSK-------YTDLLRIALMA-------E 575
Query: 402 NSTVFRNAPRE 412
+ +F A ++
Sbjct: 576 DEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 9e-05
Identities = 42/313 (13%), Positives = 97/313 (30%), Gaps = 91/313 (29%)
Query: 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFF--GT-LPPQVRNLSKLKYLDLS 58
VN LT+ ++ +L + + + + LS+ F +P + LS + + D+
Sbjct: 349 HVNCDKLTTI-IESSLNVLEPAEYRKM-FDRLSV---FPPSAHIPTIL--LSLI-WFDVI 400
Query: 59 ENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIG 118
+++ + H +SL + T IS+ + L + E
Sbjct: 401 KSD-----VMVVVNKLHKYSL-VEKQPKEST------------ISIPSIYLELKVKLE-- 440
Query: 119 NLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN---HFLGSIPNLRNCRSLVRAHL 175
N L ++D + +P+ L+ D +G HL
Sbjct: 441 NEYALHRSIVD--HY--NIPKTFDSDDLI--PPYLDQYFYSHIGH-------------HL 481
Query: 176 GRNNLTGNISEDFGIYPNLKFLD--LSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIP 233
++ ++ + +FL+ + H+ S+ W +
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHD------STAWNASGSILNT------------ 523
Query: 234 PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA-------LGL 286
L L +I P + ++ + + + +L + + L
Sbjct: 524 --------LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE---NLICSKYTDLLRIAL 572
Query: 287 LTELEYFDLSSNR 299
+ E E +++
Sbjct: 573 MAEDEAIFEEAHK 585
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 57/233 (24%)
Query: 514 IGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G VY+AKL SG+ +A+KK + D++ E++ + K+ H NIV+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 573 GFCSHVRHSF------VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG------VAD 620
F +V +Y+ ++ V + + ++ + VI +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFR 167
Query: 621 ALSYMH-HDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
+L+Y+H I HRDI N+LLD + ++ DFG+AK L N + + Y
Sbjct: 168 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYY 222
Query: 679 VAPAHGNIGLHLAEL-----AYTMKITEKCDVYSFG-VLALEVIKGKH--PGD 723
AP EL YT I DV+S G VLA E++ G+ PGD
Sbjct: 223 RAP----------ELIFGATDYTSSI----DVWSAGCVLA-ELLLGQPIFPGD 260
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 27/222 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALT 561
F +GKG V ++ + K+ A KK ++ +K LNE + L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE----KKRIKKRKGEAMALNEKQILE 239
Query: 562 KIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG-VA 619
K+ R +V Y + + V+ +N G L + + F R +
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVL-TLMNGGDLKFHIYHM-GQAGFP-EARAVFYAAEIC 296
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYV 679
L +H + IV+RD+ N+LLD R+SD G A + + VGT GY+
Sbjct: 297 CGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYM 352
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
AP + + YT D ++ G L E+I G+ P
Sbjct: 353 AP---EV---VKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 61/295 (20%), Positives = 103/295 (34%), Gaps = 76/295 (25%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN------EIKALTKIRHR 566
+G G SVY + +A+K D++SD E N E+ L K+
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE----KDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 567 --NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMNVITG---- 617
+++ + ++ E + FD+ R +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQ-----------DLFDFITERGALQEELARSFF 155
Query: 618 --VADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLKPNSSNWTELVG 674
V +A+ + H+ ++HRDI N+L+DL E ++ DFG+ LLK + +T+ G
Sbjct: 156 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDG 210
Query: 675 TFGYVAPAHGNIGLHLAEL----AYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
T Y P E Y + V+S G+L +++ G P F
Sbjct: 211 TRVYSPP----------EWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP------FEH 251
Query: 731 SSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
I + S + Q LI L P+ RPT + +
Sbjct: 252 DEEIIRGQV------FFRQRVSSECQ-HLIRWC------LALRPSDRPTFEEIQN 293
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 47/214 (21%), Positives = 91/214 (42%), Gaps = 29/214 (13%)
Query: 513 CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G G + SV A +G ++AVKK + PF + + K E++ L ++H N++
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGL 93
Query: 572 Y------GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
++V + L ++ ++D +I + L Y+
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDH----VQFLIYQILRGLKYI 148
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
H I+HRD+ +N+ ++ + E ++ DFG A + + T V T Y AP
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPE--- 199
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
+ L + Y + D++S G + E++ G+
Sbjct: 200 --IMLNWMHYNQTV----DIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 35/215 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKF 571
+G+G++ V+ A + + +K+ VK P +K+ EIK L +R NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-PV------KKKKIKREIKILENLRGGPNIITL 96
Query: 572 YGFCSHVRHSFV---VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-H 627
S V+E++N + D+D R M I AL Y H
Sbjct: 97 AD-IVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEIL---KALDYCHSM 149
Query: 628 DCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
I+HRD+ +NV++D E+ + R+ D+G A+ P + V + + P
Sbjct: 150 G----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPE---- 200
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L + Y + D++S G + +I K P
Sbjct: 201 -LLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 29/138 (21%), Positives = 55/138 (39%), Gaps = 20/138 (14%)
Query: 31 LDLSINGFFGTLPPQV--RNLSKLKYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQ 85
L L+ N F L + L +L+ ++ S N+++ I G + + + L+ N+
Sbjct: 37 LRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEE--GAFEGASGVNEILLTSNR 92
Query: 86 F----SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRN 140
F L +LK + L +N+++ + + L + L L NQ T +
Sbjct: 93 LENVQHKMFK---GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 141 ICRS-GLLEILTVNDNHF 157
+ L L + N F
Sbjct: 148 AFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 27/120 (22%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
++E +F + + L+ N + ++ + L LK L L N ++ +
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGN------ 122
Query: 75 HLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQF 133
+F LS+++ +SL++N+++ ++ L LS L L N F
Sbjct: 123 -------------DSFI---GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 30/155 (19%), Positives = 49/155 (31%), Gaps = 31/155 (20%)
Query: 220 TLIVSGNNITGRIPPEIG--NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277
L ++ N T + QL ++ S+N I +N+++L N+L
Sbjct: 36 ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLA 336
+ L L+ L SNR+ + D L+
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRI-------------------------TCVGNDSFIGLS 129
Query: 337 HLSELDLSHNLFKGSIPSRI-CNLESLEKLNLSHN 370
+ L L N ++ L SL LNL N
Sbjct: 130 SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 285 GLLTELEYFDLSSNRLNNSILEALGF---MFKLFYLNFSHNQFSQEIPED-LALLAHLSE 340
+ L++N ++LEA G + +L +NFS+N+ +I E + ++E
Sbjct: 29 HIPQYTAELRLNNNEF--TVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNE 85
Query: 341 LDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQIPA-CFIGMSGLLSIDISYNELR 397
+ L+ N + ++ ++ LESL+ L L N I+ + FIG+S + + + N++
Sbjct: 86 ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 31/166 (18%), Positives = 55/166 (33%), Gaps = 31/166 (18%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPM-ELGRLISLNKLILRGNQLSGHLPRALGLLTEL 290
IP I + L L++N +L L K+ N+++ A + +
Sbjct: 26 IPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 291 EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNLFK 349
L+SNRL + + + L L L L N
Sbjct: 84 NEILLTSNRL-------------------------ENVQHKMFKGLESLKTLMLRSNRIT 118
Query: 350 GSIPSRI-CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
+ + L S+ L+L N I+ P F + L ++++ N
Sbjct: 119 -CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 32/147 (21%), Positives = 60/147 (40%), Gaps = 15/147 (10%)
Query: 66 IPPEIGLLTHLFSLDLSLNQFSGTFPPIC--NLSNLKYISLHNNKLSGSIPEEI-GNLMK 122
IP + + L L+ N+F+ L L+ I+ NNK++ I E
Sbjct: 26 IPE--HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 123 LSYLMLDTNQFTGQLPRNICRSGL--LEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRN 178
++ ++L +N+ + + + GL L+ L + N + + N S+ L N
Sbjct: 83 VNEILLTSNRLEN-VQHKMFK-GLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDN 139
Query: 179 NLTGNISED-FGIYPNLKFLDLSHNNF 204
+T ++ F +L L+L N F
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 16/111 (14%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQFS 87
L L N F +P ++ N L +DLS N +S + +T L +L LS N+
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNMTQLLTLILSYNRLR 91
Query: 88 ----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQF 133
TF L +L+ +SLH N +S +PE +L LS+L + N
Sbjct: 92 CIPPRTFD---GLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 25/105 (23%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 78 SLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQ 136
L L NQF+ + N +L I L NN++S ++ + N+ +L L+L N+
Sbjct: 35 ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 137 LPRNICRS-GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRN 178
+P L +L+++ N + +P + +L +G N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGND-ISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 9/107 (8%)
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFS 325
+L L GNQ + +P+ L L DLS+NR+ S L F M +L L S+N+
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRI--STLSNQSFSNMTQLLTLILSYNRL- 90
Query: 326 QEIPEDL-ALLAHLSELDLSHNLFKGSIPSRI-CNLESLEKLNLSHN 370
+ IP L L L L N +P +L +L L + N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 38/280 (13%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALT 561
F +G+G V+ ++ + K+ A KK N ++ +K + + E K L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN----KKRLKKRKGYQGAMVEKKILA 240
Query: 562 KIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED-FDWRKRMNVITG-V 618
K+ R IV Y F + V+ +N G + + N F R T +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVM-TIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQI 298
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
L ++H I++RD+ NVLLD + R+SD G A LK + GT G+
Sbjct: 299 VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
+AP + L Y + D ++ GV E+I + P F + + +
Sbjct: 356 MAP---EL---LLGEEYDFSV----DYFALGVTLYEMIAARGP------FRARGEKVENK 399
Query: 739 --FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSR 776
+L+ + +P E ALL D P R
Sbjct: 400 ELKQRVLEQAVTYPD-KFSPASKDFCE-ALLQKD--PEKR 435
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 47/183 (25%), Positives = 71/183 (38%), Gaps = 38/183 (20%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFN-SPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF 571
+G+G V A + K+A+K + M + E EI L +RH +I+K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW---RKRMNVITGVA------DAL 622
Y + +V EY G L FD+ +KRM G A+
Sbjct: 75 YDVITTPTDIVMVIEYAG-GEL------------FDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF----GY 678
Y H IVHRD+ N+LLD +++DFG + ++ + T Y
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-----NFLKTSCGSPNY 173
Query: 679 VAP 681
AP
Sbjct: 174 AAP 176
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 69/346 (19%), Positives = 112/346 (32%), Gaps = 98/346 (28%)
Query: 514 IGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G+G V A DK +AVK S+ + ++E+K L I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 86
Query: 567 NIVKFYG--------------FCSH-------VRHSFVVYEYINRGSLATVLSNNFASED 605
N+V G FC Y +G+ + +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 606 FDWRKRMNVITG---------------------------------VADALSY-------M 625
D ++R++ IT + + Y M
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
+HRD+++ N+LL + ++ DFG A+ + + YV
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----------YVRKGDAR 256
Query: 686 IGL-HLA-ELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742
+ L +A E + T + DV+SFGVL E+ G P I+ EF
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKIDEEFCRR 308
Query: 743 LD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
L R+ P ++ M L C G P+ RPT + + L
Sbjct: 309 LKEGTRMRAPD-YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-11
Identities = 27/143 (18%), Positives = 44/143 (30%), Gaps = 17/143 (11%)
Query: 161 IPNLRNCRSLVRAHLGRNNLT--GNISEDFGIYPNLKFLDLSHNNFYGEISS--NWGKCH 216
N L + N+ +D S N EI +
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDN----EIRKLDGFPLLR 64
Query: 217 RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIA--GEIPMELGRLISLNKLILRGN 274
RL TL+V+ N I L L L++N + G++ L L SL L + N
Sbjct: 65 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
Query: 275 ---QLSGHLPRALGLLTELEYFD 294
+ + + ++ D
Sbjct: 124 PVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-10
Identities = 26/133 (19%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 244 VLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS--GHLPRALGLLTELEYFDLSSNRLN 301
++ L++ I + + + +L LRG ++ +L L + + D S N +
Sbjct: 1 MVKLTAELIE-QAA-QYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDNEIR 55
Query: 302 NSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKG-SIPSRICNLE 360
L+ + +L L ++N+ + L L+EL L++N + +L+
Sbjct: 56 K--LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113
Query: 361 SLEKLNLSHNNIS 373
SL L + N ++
Sbjct: 114 SLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 8/133 (6%)
Query: 197 LDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI 256
+ L+ E ++ + R L + G I I Q +D S N I
Sbjct: 2 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---R 55
Query: 257 PME-LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN-SILEALGFMFKL 314
++ L L L++ N++ L +L L++N L L+ L + L
Sbjct: 56 KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 315 FYLNFSHNQFSQE 327
YL N + +
Sbjct: 116 TYLCILRNPVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 30/163 (18%), Positives = 51/163 (31%), Gaps = 37/163 (22%)
Query: 44 PQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYIS 103
Q N + + LDL ++ I L ++D S N+ L LK +
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLL 70
Query: 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT--------GQLPRNICRSGLLEILTVNDN 155
++NN++ L L+ L+L N L L L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS-------LTYLCILRN 123
Query: 156 HFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLD 198
+ N ++ R V + P ++ LD
Sbjct: 124 ----PVTNKKHYRLYVIYKV----------------PQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 8/89 (8%)
Query: 23 SSFPHLAYLDLSINGF--FGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80
++ +D S N P L +LK L ++ N + L L L
Sbjct: 39 ATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94
Query: 81 LSLNQFS--GTFPPICNLSNLKYISLHNN 107
L+ N G P+ +L +L Y+ + N
Sbjct: 95 LTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 15/107 (14%), Positives = 34/107 (31%), Gaps = 11/107 (10%)
Query: 294 DLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIP 353
L++ + + + L+ + I A L +D S N +
Sbjct: 3 KLTAELIEQA--AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR---- 55
Query: 354 SRICNLES---LEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
++ L+ L +++N I + L + ++ N L
Sbjct: 56 -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 50/244 (20%)
Query: 498 YEEIIRRTK-DFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQK 551
E++R D +Y IG+G + V A + ++A+KK + PF + + +
Sbjct: 14 GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PF--EHQTYCQ 70
Query: 552 EFLNEIKALTKIRHRNIVKFYG-FCSHVRHSF----VVYEYINRGSLATVLSNNFASED- 605
L EIK L + RH NI+ + +V + + L +L S D
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDH 129
Query: 606 ---FDW---RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659
F + R L Y+H ++HRD+ +N+LL+ + ++ DFG A
Sbjct: 130 ICYFLYQILR-----------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 660 KLLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG-VLALEV 715
++ P+ + TE V T Y AP + L YT I D++S G +LA E+
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPE-----IMLNSKGYTKSI----DIWSVGCILA-EM 225
Query: 716 IKGK 719
+ +
Sbjct: 226 LSNR 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 59/261 (22%), Positives = 99/261 (37%), Gaps = 51/261 (19%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALTK 562
F+ IGKG V + K+ A+K N + ++ E E++ +
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN----KQKCVERNEVRNVFKELQIMQG 71
Query: 563 IRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKR 611
+ H +V +Y F VV + + G L L N F E
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVV-DLLLGGDLRYHLQQNVHFKEETVKLFICE------- 123
Query: 612 MNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670
+ AL Y+ I+HRD+ +N+LLD ++DF A +L + T
Sbjct: 124 ------LVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
+ GT Y+AP + Y+ + D +S GV A E+++G+ P +
Sbjct: 174 -MAGTKPYMAP---EMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--Y---HIR 220
Query: 731 SSSSINIEFNAMLDHRLPHPS 751
SS+S + + +PS
Sbjct: 221 SSTSSKEIVHTFETTVVTYPS 241
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 39/109 (35%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 30 YLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQF- 86
L L N L P V +L LK L L N+L +P + LT L LDL NQ
Sbjct: 44 ILYLHDNQI-TKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 87 ---SGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132
S F L +LK + + NKL+ +P I L L++L LD NQ
Sbjct: 102 VLPSAVFD---RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 47/144 (32%), Positives = 65/144 (45%), Gaps = 12/144 (8%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRAL-GLLTEL 290
+P I ++Q +L L N I P LI+L +L L NQL LP + LT+L
Sbjct: 34 VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQL 90
Query: 291 EYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLF 348
DL +N+L ++L + F + L L N+ E+P + L HL+ L L N
Sbjct: 91 TVLDLGTNQL--TVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
Query: 349 KGSIPSRIC-NLESLEKLNLSHNN 371
K SIP L SL L N
Sbjct: 148 K-SIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 11/116 (9%)
Query: 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQF----SGTFPPICNLSNLKYISLHNNK 108
+ L L +N+++ P L +L L L NQ G F +L+ L + L N+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQLTVLDLGTNQ 99
Query: 109 LSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN 163
L+ +P + L+ L L + N+ T LPR I R L L ++ N L SIP+
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ-LKSIPH 152
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 16/157 (10%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQF--- 86
LDL G R L+KL +L+L N+L + + LT L +L L+ NQ
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 87 -SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRS 144
G F +L+ L + L N+L S+P + L KL L L+TNQ +P
Sbjct: 99 PLGVFD---HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 145 -GLLEILTVNDNHFLGSIPN--LRNCRSLVRAHLGRN 178
L+ L+++ N L S+P+ L L N
Sbjct: 154 LTNLQTLSLSTNQ-LQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291
+P I ++ LDL S +A L L L L NQL LTEL
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 292 YFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNLF 348
L++N+L + L F + +L L NQ + +P + L L EL L+ N
Sbjct: 87 TLGLANNQLAS--LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQL 143
Query: 349 KGSIPSRICN-LESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
+ SIP+ + L +L+ L+LS N + F + L +I + N
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 48/173 (27%), Positives = 66/173 (38%), Gaps = 19/173 (10%)
Query: 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS----GTFPPICNLSNLKYISLHNNK 108
+ LDL L+ LT L L+L NQ G F +L+ L + L NN+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD---DLTELGTLGLANNQ 94
Query: 109 LSGSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNICRS-GLLEILTVNDNHFLGSIPN--L 164
L+ S+P + +L +L L L NQ LP + L+ L +N N L SIP
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQ-LQSIPAGAF 151
Query: 165 RNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS-----SNW 212
+L L N L F L+ + L N F S W
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQW 204
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 10/135 (7%)
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFS 325
KL L+ L+ LT+L + +L N+L L A F + +L L ++NQ
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL--QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 326 QEIPEDL-ALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQIPA-CFIG 382
+P + L L +L L N K S+PS + L L++L L+ N + IPA F
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 383 MSGLLSIDISYNELR 397
++ L ++ +S N+L+
Sbjct: 154 LTNLQTLSLSTNQLQ 168
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 14/112 (12%)
Query: 30 YLDLSINGFFGTLPPQ--VRNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQF 86
L L+ N G + L L L+L N+L+ I P +H+ L L N+
Sbjct: 33 ELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 87 S----GTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQF 133
F L LK ++L++N++S + +L L+ L L +N F
Sbjct: 91 KEISNKMFL---GLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 9/103 (8%)
Query: 65 KIPPEIGLLTHLFSLDLSLNQFSGTFPPIC--NLSNLKYISLHNNKLSGSIPEEI-GNLM 121
+IP +I L T L L+ N+ L +L + L N+L+ I
Sbjct: 22 EIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 122 KLSYLMLDTNQFTGQLPRNICRS-GLLEILTVNDNHFLGSIPN 163
+ L L N+ ++ + L+ L + DN + +
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQ-ISCVMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 36/142 (25%), Positives = 53/142 (37%), Gaps = 31/142 (21%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPRALGLLTEL 290
IP +I + L L+ N + L GRL L KL L+ NQL+G P A + +
Sbjct: 23 IPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 291 EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNLFK 349
+ L N++ +EI + L L L+L N
Sbjct: 81 QELQLGENKI-------------------------KEISNKMFLGLHQLKTLNLYDNQIS 115
Query: 350 GSIPSRIC-NLESLEKLNLSHN 370
+ +L SL LNL+ N
Sbjct: 116 -CVMPGSFEHLNSLTSLNLASN 136
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 64/279 (22%)
Query: 469 DSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLP 528
++ G + D VL DGK + I + IG G V++AKL
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKLV 62
Query: 529 SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK----FYGFCSHVRHSFV- 583
D++A+KK + D++ E++ + ++H N+V FY F+
Sbjct: 63 ESDEVAIKKV--------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 584 -VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV---------ADALSYMHHDCFPPI 633
V EY+ ++ + K + + +L+Y+H I
Sbjct: 115 LVLEYVPE-TVYRASR--------HYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---I 162
Query: 634 VHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
HRDI N+LLD ++ DFG+AK+L N + + Y AP E
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAP----------E 211
Query: 693 L-----AYTMKITEKCDVYSFG-VLALEVIKGK--HPGD 723
L YT I D++S G V+A E+++G+ PG+
Sbjct: 212 LIFGATNYTTNI----DIWSTGCVMA-ELMQGQPLFPGE 245
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 62.3 bits (150), Expect = 2e-10
Identities = 19/162 (11%), Positives = 51/162 (31%), Gaps = 21/162 (12%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL----- 286
+ P + L+ L + + + +L L + L + +
Sbjct: 164 LSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 287 LTELEYFDLSSNRLNNSILEAL------GFMFKLFYLNFSHNQFSQEIPEDLA---LLAH 337
L +L + + + + L +L + + E +L
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 338 LSELDLSHNLFKGS----IPSRICNLESLEKLNLSHNNISGQ 375
L +D+S + + + ++ L+ +N+ +N +S +
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 1e-07
Identities = 26/179 (14%), Positives = 53/179 (29%), Gaps = 37/179 (20%)
Query: 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS-- 239
++S P L L + N +S L +L + + + +I S
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 240 SQLHVLDL---SSNHIAGEIPMEL------GRLISLNKLILRGNQLSGHLPRALG---LL 287
L L L ++ R +L L + + + +L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346
+LE D+S+ L + L + + + HL +++ +N
Sbjct: 279 PQLETMDISAGVLTDEGARLL--------------------LDHVDKIKHLKFINMKYN 317
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 4e-06
Identities = 37/326 (11%), Positives = 87/326 (26%), Gaps = 26/326 (7%)
Query: 39 FGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSN 98
F + + KL + + + LS ++ + +
Sbjct: 43 FSSAGEAEKAAGKLIAEKTKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKILK 102
Query: 99 LKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFL 158
K + G E + ++ +++ + E ++ +
Sbjct: 103 DKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQV 162
Query: 159 GSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHR- 217
P L L + N N+S PNLK L++ + +
Sbjct: 163 DLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP 219
Query: 218 --------LGTLIVSGNNITGRIPPEIGNSS--QLHVLDLSSNHIAGEIPMELGR---LI 264
+G + P L L + + L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 265 SLNKLILRGNQLSG----HLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320
L + + L+ L + + L++ ++ N L++ + + L L
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS-----LPMK 334
Query: 321 HNQFSQEIPEDLALLAHLSELDLSHN 346
+ + +D ++EL+ H+
Sbjct: 335 IDVSDSQEYDDDYSYPMITELEHHHH 360
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 7e-06
Identities = 22/125 (17%), Positives = 48/125 (38%), Gaps = 17/125 (13%)
Query: 17 LQEFSFSSFPHLAYLDLSI-------NGFFGTLPP--QVRNLSKLKYLDLSENELSGKIP 67
+++ S P+L L L + +G P LK+L + + E +
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269
Query: 68 PEIG---LLTHLFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKLSGSIPEEIGN 119
+L L ++D+S + + + +LK+I++ N LS + +E+
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
Query: 120 LMKLS 124
+ +
Sbjct: 330 SLPMK 334
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 17/103 (16%), Positives = 39/103 (37%), Gaps = 15/103 (14%)
Query: 11 TGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPP---QVRNLSKLKYLDLSENELSGK-- 65
+ FS FP+L +L + + + L +L+ +D+S L+ +
Sbjct: 237 GDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296
Query: 66 --IPPEIGLLTHLFSLDLSLNQFSG--------TFPPICNLSN 98
+ + + HL +++ N S + P ++S+
Sbjct: 297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSD 339
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 57/250 (22%)
Query: 497 MYEEIIRRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQK 551
M + I + + + +G+G + V A P+G+ +A+KK PF
Sbjct: 1 MPKRI---VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDK--PLFAL 54
Query: 552 EFLNEIKALTKIRHRNIVKFYG-FCSHVRHSF----VVYEYINRGSLATVLSNNFASED- 605
L EIK L +H NI+ + +F ++ E + L V+S S+D
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH 113
Query: 606 ---FDW---RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659
F + R A+ +H ++HRD+ +N+L++ + +V DFG A
Sbjct: 114 IQYFIYQTLR-----------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 660 KLLKPNSSN----------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG 709
+++ ++++ E V T Y AP + L Y+ + DV+S G
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPE-----VMLTSAKYSRAM----DVWSCG 210
Query: 710 VLALEVIKGK 719
+ E+ +
Sbjct: 211 CILAELFLRR 220
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 19/133 (14%), Positives = 35/133 (26%), Gaps = 16/133 (12%)
Query: 41 TLPPQVRNLSKLKYLDLSENELSGKIPPE-IGLLTHLFSLDLSLNQFS----GTFPPICN 95
+ L L + + + + L L +L + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH---F 78
Query: 96 LSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN 155
L ++L N L S+ + + L L+L N C L + +
Sbjct: 79 TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH-------CSCALRWLQRWEEE 130
Query: 156 HFLGSIPNLRNCR 168
G C
Sbjct: 131 GLGGVPEQKLQCH 143
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 19/99 (19%), Positives = 37/99 (37%), Gaps = 2/99 (2%)
Query: 321 HNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSR-ICNLESLEKLNLSHNNISGQIPAC 379
+ + L +L+EL + + + R + L L L + + + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 380 FIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNN 418
F L +++S+N L + TV + +E L N
Sbjct: 76 FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 21/111 (18%), Positives = 33/111 (29%), Gaps = 3/111 (2%)
Query: 215 CHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME-LGRLISLNKLILRG 273
H L + + + + L L + + + + L L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 274 NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324
+ L P A L +LS N L S+ L L S N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 24/93 (25%), Positives = 33/93 (35%), Gaps = 2/93 (2%)
Query: 255 EIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDLSSNRLNNSILEALGFMFK 313
+ L +L +L + Q HL L L EL + + L +A F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 314 LFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346
L LN S N + L EL LS N
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 21/123 (17%), Positives = 36/123 (29%), Gaps = 24/123 (19%)
Query: 142 CR-SGLLEILTVNDNHF--LGSIPNLRNCRSLVRAHLGRNNLTGNI-SEDFGIYPNLKFL 197
C G + D L +P N L ++ ++ D L+ L
Sbjct: 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTEL---YIENQQHLQHLELRDLRGLGELRNL 61
Query: 198 DLSHNN--------FYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSS 249
+ + F+ RL L +S N + + + L L LS
Sbjct: 62 TIVKSGLRFVAPDAFHF--------TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSG 112
Query: 250 NHI 252
N +
Sbjct: 113 NPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 16/72 (22%), Positives = 24/72 (33%), Gaps = 3/72 (4%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGLLT 74
L+ L L + +G + P +L L+LS N L + +
Sbjct: 46 HLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL 103
Query: 75 HLFSLDLSLNQF 86
L L LS N
Sbjct: 104 SLQELVLSGNPL 115
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 5e-10
Identities = 42/173 (24%), Positives = 82/173 (47%), Gaps = 18/173 (10%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRNI 568
IG+G + VY+A+ G+ A+KK ++ + E + EI L +++H NI
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
VK Y + +V+E++++ L +L + + + + + ++Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
++HRD+ N+L++ E E +++DFG A+ +T + T Y AP
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 49/256 (19%), Positives = 83/256 (32%), Gaps = 58/256 (22%)
Query: 493 DGKIMYEEIIRRTKDFDAKY----CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMS 548
G+ ++I + Y I G + +V G +A+K+ + + +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 549 -------DQKEFLNEIKALTKIRHRNIVKFYG-FCSHVRHSF----VVYEYINRGSLATV 596
K L EI+ L H NI+ F + +V E +
Sbjct: 65 NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-------- 116
Query: 597 LSNNFASEDFDWRKRMNVITGVADALSYMHHDCF-------------PPIVHRDISSNNV 643
D + VI +S H F +VHRD+ N+
Sbjct: 117 --------RTDLAQ---VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 644 LLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKC 703
LL + + DF A+ + +N T V Y AP L + +T +
Sbjct: 166 LLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPE-----LVMQFKGFTKLV---- 215
Query: 704 DVYSFGVLALEVIKGK 719
D++S G + E+ K
Sbjct: 216 DMWSAGCVMAEMFNRK 231
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-10
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 17/112 (15%)
Query: 30 YLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQ 85
L+L N +LP V L++L L LS+N++ +P G+ LT L L L N+
Sbjct: 32 RLELESNKL-QSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--GVFDKLTKLTILYLHENK 87
Query: 86 F----SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQ 132
+G F L+ LK ++L N+L S+P+ I L L + L TN
Sbjct: 88 LQSLPNGVFD---KLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 34/94 (36%), Positives = 42/94 (44%), Gaps = 15/94 (15%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGL---LTHLF 77
F L L LS N +LP V L+KL L L EN+L +P G+ LT L
Sbjct: 48 FDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-SLPN--GVFDKLTQLK 103
Query: 78 SLDLSLNQF----SGTFPPICNLSNLKYISLHNN 107
L L NQ G F L++L+ I LH N
Sbjct: 104 ELALDTNQLKSVPDGIFD---RLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 32/86 (37%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 53 KYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQF----SGTFPPICNLSNLKYISLHNN 107
L+L N+L +P + LT L L LS NQ G F L+ L + LH N
Sbjct: 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD---KLTKLTILYLHEN 86
Query: 108 KLSGSIPEEI-GNLMKLSYLMLDTNQ 132
KL S+P + L +L L LDTNQ
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQ 111
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 36/110 (32%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFS 325
+L L N+L LT+L LS N++ + L F + KL L N+
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS--LPDGVFDKLTKLTILYLHENKL- 88
Query: 326 QEIPE---DLALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNN 371
Q +P D L L EL L N K S+P I L SL+K+ L H N
Sbjct: 89 QSLPNGVFD--KLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWL-HTN 134
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 52/253 (20%), Positives = 86/253 (33%), Gaps = 65/253 (25%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK-- 570
+G G V + SG + A+KK + D + E+ + + H NI+K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 571 --FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD-------- 620
FY + N+ NN + + + +
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 621 --------------------------ALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARV 653
A+ ++H I HRDI N+L++ + ++
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183
Query: 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG-VLA 712
DFG+AK L P+ + + + Y AP L L YT I D++S G V
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRFYRAPE-----LMLGATEYTPSI----DLWSIGCVFG 233
Query: 713 LEVIKGKH--PGD 723
E+I GK G+
Sbjct: 234 -ELILGKPLFSGE 245
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 48/139 (34%), Positives = 65/139 (46%), Gaps = 21/139 (15%)
Query: 7 NLTSTGLKGT-LQEFSFSSFPHLA---YLDLSINGFFGTLPPQVRN-LSKLKYLDLSENE 61
NLT L G LQ F L L L N +LP V + L+ L YL+L+ N+
Sbjct: 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 62 LSGKIPPEIGL---LTHLFSLDLSLNQF----SGTFPPICNLSNLKYISLHNNKLSGSIP 114
L +P G+ LT+L LDLS NQ G F L+ LK + L+ N+L S+P
Sbjct: 145 LQ-SLPK--GVFDKLTNLTELDLSYNQLQSLPEGVFD---KLTQLKDLRLYQNQLK-SVP 197
Query: 115 EEI-GNLMKLSYLMLDTNQ 132
+ + L L Y+ L N
Sbjct: 198 DGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 21 SFSSFPHLAYLDLSIN-----GFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLT 74
P++ YL L N + L+ L YL L+ N+L +P + LT
Sbjct: 58 GIQYLPNVRYLALGGNKLHDISAL-------KELTNLTYLILTGNQLQ-SLPNGVFDKLT 109
Query: 75 HLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTN 131
+L L L NQ + P L+NL Y++L +N+L S+P+ + L L+ L L N
Sbjct: 110 NLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167
Query: 132 QFTGQLPRNIC-RSGLLEILTVNDNHFLGSIPN 163
Q LP + + L+ L + N L S+P+
Sbjct: 168 QLQ-SLPEGVFDKLTQLKDLRLYQNQ-LKSVPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGL---LTHLF 77
+ + + + + + ++ L ++YL L N+L +I LT+L
Sbjct: 36 TQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLT 88
Query: 78 SLDLSLNQFS----GTFPPICNLSNLKYISLHNNKLSGSIPEEIGN-LMKLSYLMLDTNQ 132
L L+ NQ G F L+NLK + L N+L S+P+ + + L L+YL L NQ
Sbjct: 89 YLILTGNQLQSLPNGVFD---KLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144
Query: 133 FTGQLPRNIC-RSGLLEILTVNDNHFLGSIPN 163
LP+ + + L L ++ N L S+P
Sbjct: 145 LQ-SLPKGVFDKLTNLTELDLSYNQ-LQSLPE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 22/159 (13%)
Query: 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGS 112
+L + ++ + L + + + + + I L N++Y++L NKL
Sbjct: 22 IKANLKKKSVT-DAVTQNEL-NSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLH-- 76
Query: 113 IPEEIG---NLMKLSYLMLDTNQFTGQLPRNICRS-GLLEILTVNDNHFLGSIP-----N 163
+I L L+YL+L NQ LP + L+ L + +N L S+P
Sbjct: 77 ---DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ-LQSLPDGVFDK 131
Query: 164 LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHN 202
L N L +L N L F NL LDLS+N
Sbjct: 132 LTNLTYL---NLAHNQLQSLPKGVFDKLTNLTELDLSYN 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 18/144 (12%)
Query: 234 PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL---LTEL 290
+ + + +++ I ++ L ++ L L GN+L + LT L
Sbjct: 35 VTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-----DISALKELTNL 87
Query: 291 EYFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNL 347
Y L+ N+L L F + L L NQ Q +P+ + L +L+ L+L+HN
Sbjct: 88 TYLILTGNQL--QSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 348 FKGSIPSRIC-NLESLEKLNLSHN 370
+ S+P + L +L +L+LS+N
Sbjct: 145 LQ-SLPKGVFDKLTNLTELDLSYN 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 47/227 (20%), Positives = 77/227 (33%), Gaps = 60/227 (26%)
Query: 78 SLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQL 137
+L + L+++ I +N+ + S+ I L + YL L N+
Sbjct: 23 KANLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHD-- 77
Query: 138 PRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFL 197
+ ++ L N L L N L + F NLK L
Sbjct: 78 --------------------ISALKELTNLTYL---ILTGNQLQSLPNGVFDKLTNLKEL 114
Query: 198 DLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS-SQLHVLDLSSNHIAGEI 256
L N +L +L P + + + L L+L+ N +
Sbjct: 115 VLVEN--------------QLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSLP 149
Query: 257 PMELGRLISLNKLILRGNQLSGHLPRALGL---LTELEYFDLSSNRL 300
+L +L +L L NQL LP G+ LT+L+ L N+L
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKDLRLYQNQL 193
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 11/109 (10%)
Query: 30 YLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQF-- 86
YLDL N L+ L L L N+L +P + LT L L+LS NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 87 --SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYLMLDTNQ 132
+G F L+ LK ++L+ N+L S+P+ + L +L L L NQ
Sbjct: 91 LPNGVFD---KLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 232 IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291
+P I + LDL +N + L SL +L L GN+L LT L
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 292 YFDLSSNRLNNSILEALGF--MFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNLF 348
Y +LS+N+L + L F + +L L + NQ Q +P+ + L L +L L N
Sbjct: 80 YLNLSTNQLQS--LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 349 KGSIPSRIC-NLESLEKLNLSHNN 371
K S+P + L SL+ + L H+N
Sbjct: 137 K-SVPDGVFDRLTSLQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 36/115 (31%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP--ICNLSNLKYISLHNNKLS 110
YLDL N L LT L L L N+ + P L++L Y++L N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 111 GSIPEEI-GNLMKLSYLMLDTNQFTGQLPRNIC-RSGLLEILTVNDNHFLGSIPN 163
S+P + L +L L L+TNQ LP + + L+ L + N L S+P+
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ-LKSVPD 141
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 15/94 (15%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGL---LTHLF 77
F+ L YL+LS N +LP V L++LK L L+ N+L +P G+ LT L
Sbjct: 72 FNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLTQLK 127
Query: 78 SLDLSLNQF----SGTFPPICNLSNLKYISLHNN 107
L L NQ G F L++L+YI LH+N
Sbjct: 128 DLRLYQNQLKSVPDGVFD---RLTSLQYIWLHDN 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 37/180 (20%), Positives = 59/180 (32%), Gaps = 41/180 (22%)
Query: 174 HLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIP 233
H + + K L LS NN +I S+ L L + N I +I
Sbjct: 31 HGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIE 86
Query: 234 PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYF 293
+ L L +S N I LSG + L L
Sbjct: 87 NLDAVADTLEELWISYNQI---------------------ASLSG-----IEKLVNLRVL 120
Query: 294 DLSSNRLNN-SILEALGFMFKLFYLNFSHNQFSQEIPED----------LALLAHLSELD 342
+S+N++ N ++ L + KL L + N + E+ + L +L +LD
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE 327
+L + + L L ++ LS+N + + +L M L L+ N +
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK-K 84
Query: 328 IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373
I A+ L EL +S+N S+ S I L +L L +S+N I+
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 31/139 (22%), Positives = 51/139 (36%), Gaps = 17/139 (12%)
Query: 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLS---GHLPRALGLLTELEYFDLSSNRLN 301
L I ++ L L + L L N + L + L L N +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLI- 82
Query: 302 NSILEALGFMF-KLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFK--GSIPSRICN 358
+E L + L L S+NQ + + + L +L L +S+N G I ++
Sbjct: 83 -KKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAA 138
Query: 359 LESLEKLNLSHNNISGQIP 377
L+ LE L L+ N +
Sbjct: 139 LDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 24/127 (18%), Positives = 46/127 (36%), Gaps = 7/127 (5%)
Query: 78 SLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQL 137
L + + L K+++L N + I + + L L L N ++
Sbjct: 29 ELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 138 PRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISE--DFGIYPNLK 195
+ LE L ++ N + S+ + +L ++ N +T N E L+
Sbjct: 86 ENLDAVADTLEELWISYNQ-IASLSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLE 143
Query: 196 FLDLSHN 202
L L+ N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 37/176 (21%), Positives = 57/176 (32%), Gaps = 33/176 (18%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTF 90
L I + + L K+L LS N + KI + + +L L L N
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIKKIE 86
Query: 91 PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT-----GQLPRNICRSG 145
L+ + + N+++ S+ I L+ L L + N+ T +L
Sbjct: 87 NLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDK--- 141
Query: 146 LLEILTVNDN---HFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLD 198
LE L + N + R V L PNLK LD
Sbjct: 142 -LEDLLLAGNPLYNDYKENNATSEYRIEVVKRL----------------PNLKKLD 180
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 18/173 (10%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLN-----EIKALTKIRHRNI 568
+G+G + VY+AK G +A+K+ + + E + EI L ++ H NI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR-------LDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
V R +V+E++ + L VL N + + + +++ H
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
I+HRD+ N+L++ + +++DFG A+ ++T V T Y AP
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 30/224 (13%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALT 561
DF IG+G VY + K+ A+K + ++ ++ LNE L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD----KKRIKMKQGETLALNERIMLS 244
Query: 562 KI---RHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
+ IV Y F + + + +N G L LS F
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAE 300
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
+ L +MH+ +V+RD+ N+LLD R+SD G A + VGT G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASVGTHG 355
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+AP + +AY D +S G + ++++G P
Sbjct: 356 YMAPE-----VLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALTK 562
+F+ +GKG V K + + A+K + + + E L E + L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK----KEVIVAKDEVAHTLTENRVLQN 204
Query: 563 IRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN--FASEDFDWRKRMNVITGVA 619
RH + Y F +H R FV+ EY N G L LS F SED R R +
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVF-SED---RARF-YGAEIV 258
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGY 678
AL Y+H + +V+RD+ N++LD + +++DFG K +K ++ T GT Y
Sbjct: 259 SALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEY 315
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+AP + L + Y + D + GV+ E++ G+ P
Sbjct: 316 LAP---EV---LEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 4e-09
Identities = 37/174 (21%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-----EIKALTKIRHRN 567
IG+G + +V++AK + + +A+K+ ++ D E + EI L +++H+N
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
IV+ + + +V+E+ ++ L + + D D + + + L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
++HRD+ N+L++ E ++++FG A+ ++ V T Y P
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 68/395 (17%), Positives = 123/395 (31%), Gaps = 57/395 (14%)
Query: 24 SFPHLAYLDLSINGFFGT--LPPQVRNLSKLKYLDLSENELSGKIPPEIGLL----THLF 77
SF + L LS F T L LK LDL E+++ + T L
Sbjct: 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187
Query: 78 SLDLSLNQFSGTFPPICNLS----NLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQF 133
SL++S +F + L NLK + L+ + + +L L
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGT----- 242
Query: 134 TGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPN 193
+ V + + G L C+ L + + + + +
Sbjct: 243 ------GGYTA------EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR 290
Query: 194 LKFLDLSHNNFYGE-ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS-SQLHVLDLSSNH 251
L L+LS+ + +C +L L V + I + ++ L L + +
Sbjct: 291 LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL-DYIEDAGLEVLASTCKDLRELRVFPSE 349
Query: 252 IAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFM 311
ME ++ L+ +S P+ LE ++ N+ L +
Sbjct: 350 ---PFVMEPNVALTEQGLV----SVSMGCPK-------LESVLYFCRQMTNAALITIARN 395
Query: 312 ------FKLFYLNFSHNQFSQEIPEDLALLA------HLSELDLSHNLFKGSIPSRICNL 359
F+L + + P D+ A L L LS L
Sbjct: 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYA 455
Query: 360 ESLEKLNLSHNNISGQ-IPACFIGMSGLLSIDISY 393
+ +E L+++ S + G L ++I
Sbjct: 456 KKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 46/272 (16%), Positives = 91/272 (33%), Gaps = 29/272 (10%)
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIY------PNLKFLDLS 200
L+ + V D+ L I ++ ++ L S G+ NLK LDL
Sbjct: 112 LKRMVVTDDC-LELI--AKSFKNFKVLVLSSCE---GFS-TDGLAAIAATCRNLKELDLR 164
Query: 201 HNNFYGEISSNW-----GKCHRLGTLIVSG--NNITGR-IPPEIGNSSQLHVLDLSSNHI 252
++ ++S +W L +L +S + ++ + + L L L+
Sbjct: 165 ESDV-DDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVP 223
Query: 253 AGEIPMELGRLISLNKLILRG------NQLSGHLPRALGLLTELEYFDLSSNRLNNSILE 306
++ L R L +L G + L AL EL + + +
Sbjct: 224 LEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283
Query: 307 ALGFMFKLFYLNFSHNQFS-QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKL 365
+L LN S+ ++ + L L L + + + + L +L
Sbjct: 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL 343
Query: 366 NLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
+ + P + GL+S+ + +L
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 36/234 (15%), Positives = 64/234 (27%), Gaps = 26/234 (11%)
Query: 163 NLRNCRSLVRAHLGRNNLTGNISEDFGI----YPNLKFLDLSH----NNFYGEISSNWGK 214
L+ +L + G + Y L+ + L ++ I+ +
Sbjct: 72 ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKS--- 128
Query: 215 CHRLGTLIVSG-NNITGRIPPEIG-NSSQLHVLDLSSNHIAG-------EIPMELGRLIS 265
L++S + I L LDL + + P L+S
Sbjct: 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188
Query: 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKL------FYLNF 319
LN L L R + L+ L+ + L +L Y
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE 248
Query: 320 SHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373
+ L+ L L + +P+ L LNLS+ +
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 36/179 (20%), Positives = 75/179 (41%), Gaps = 25/179 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRN 567
+G+G + VY+A + + +A+K+ + ++E + E+ L +++HRN
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
I++ H +++EY L + N D R + + + + +++ H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHS 150
Query: 628 DCFPPIVHRDISSNNVLLDLEYEAR-----VSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
+HRD+ N+LL + + + DFG A+ +T + T Y P
Sbjct: 151 RR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 50/230 (21%), Positives = 87/230 (37%), Gaps = 49/230 (21%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALTK 562
FD +G G V K A+K + ++ K+ LNE + L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----QKVVKLKQIEHTLNEKRILQA 97
Query: 563 IRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKRM 612
+ +VK + ++V EY+ G + + L +A++
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------- 149
Query: 613 NVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
+ Y+H D +++RD+ N+L+D + +V+DFG AK + WT
Sbjct: 150 -----IVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT- 197
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L GT +AP E+ + + D ++ GVL E+ G P
Sbjct: 198 LCGTPEALAP----------EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 42/236 (17%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-F----LNE 556
++ IG+G V++A+ +G K+A+KK M ++KE F L E
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALRE 66
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHS--------FVVYEYINRGSLATVLSNNFASEDFDW 608
IK L ++H N+V C ++V+++ LA +LSN F
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTL 123
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL----LKP 664
+ V+ + + L Y+H + I+HRD+ + NVL+ + +++DFG A+
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG-VLALEVIKGK 719
+ +T V T Y P L L E Y I D++ G ++A E+
Sbjct: 181 QPNRYTNRVVTLWYRPPE-----LLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 8e-09
Identities = 41/174 (23%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN-----EIKALTKIRHRN 567
IG+G + VY+A+ +G+ +A+KK ++ + E + EI L ++ H N
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPN 63
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
IVK ++V+E++++ L + + A + + + L++ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
++HRD+ N+L++ E +++DFG A+ +T V T Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 32/213 (15%)
Query: 490 LDFDGKIMYEEIIRRTKDFDAK--YCIGKGEHRSVYRAK---LPSGDKIAVKKFNSPFPN 544
+D+D K+ R +D +G+G + VY+AK A+K+
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---- 58
Query: 545 DQMSDQKEFLNEIKALTKIRHRNIVKFYG-FCSHVRHS-FVVYEYINRGSLATVLSNNFA 602
+S EI L +++H N++ F SH +++++Y L ++ + A
Sbjct: 59 TGISMSA--CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA 115
Query: 603 SEDFDWRKRMNVITG------VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR---- 652
S+ ++ + D + Y+H + ++HRD+ N+L+ E R
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172
Query: 653 VSDFGTAKL----LKPNSSNWTELVGTFGYVAP 681
++D G A+L LKP + +V TF Y AP
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVV-TFWYRAP 204
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 42/214 (19%), Positives = 76/214 (35%), Gaps = 33/214 (15%)
Query: 464 RRWKRDSQSQGSCSSKNDTRGIFHSVLDFDGKIMYEEIIRRTKDF--DAKY----CIGKG 517
+ G+ + + ++ + R D+ +Y IG G
Sbjct: 5 EAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTG 64
Query: 518 EHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG-FC 575
+ V A +A+KK F + + D K L EI L ++ H ++VK
Sbjct: 65 SYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 576 SHVRHSF----VVYEYINRGSLATVL-SNNFASED----FDWRKRMNVITGVADALSYMH 626
F VV E + + + + +E + N++ G + Y+H
Sbjct: 123 PKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLY----NLLVG----VKYVH 173
Query: 627 -HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659
I+HRD+ N L++ + +V DFG A
Sbjct: 174 SAG----ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 36/174 (20%), Positives = 76/174 (43%), Gaps = 20/174 (11%)
Query: 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRN 567
+G+G + +VY+ K + + +A+K+ + +E + E+ L ++H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRL--------EHEEGAPCTAIREVSLLKDLKHAN 61
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
IV + + +V+EY+++ L L + + + + L+Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
++HRD+ N+L++ E +++DFG A+ + + V T Y P
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 40/225 (17%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G + V+ A ++A+KK + K L EIK + ++ H NIVK +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKI--VLTD--PQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 573 ----------GFCSHVRHSF----VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV 618
+V EY+ LA VL E+ + +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEH----ARLFMYQL 129
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSN---WTELVG 674
L Y+H ++HRD+ N+ ++ E ++ DFG A+++ P+ S+ +E +
Sbjct: 130 LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719
T Y +P L L+ YT I D+++ G + E++ GK
Sbjct: 187 TKWYRSPR-----LLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 32/126 (25%), Positives = 47/126 (37%), Gaps = 12/126 (9%)
Query: 176 GRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS--NWGKCHRLGTLIVSGNNITGRIP 233
+ G I + NL+FL L + + S N K +L L +S N I G +
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKLELSENRIFGGLD 88
Query: 234 PEIGNSSQLHVLDLSSNHIA--GEIPMELGRLISLNKLILRGN---QLSGHLPRALGLLT 288
L L+LS N + + L +L L L L L+ + LL
Sbjct: 89 MLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP 147
Query: 289 ELEYFD 294
+L Y D
Sbjct: 148 QLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 31/122 (25%), Positives = 50/122 (40%), Gaps = 17/122 (13%)
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMF 312
+G M++ R I L LR + + EL L + + N+ +E L F
Sbjct: 3 SGSSGMDMKRRI---HLELRNRTPAA--------VREL---VLDNCKSNDGKIEGLTAEF 48
Query: 313 -KLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
L +L+ + + +L L L +L+LS N G + L +L LNLS N
Sbjct: 49 VNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 372 IS 373
+
Sbjct: 107 LK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
V + L + E + F +L +L L G + L KLK L+LSEN +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRI 83
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFS--GTFPPICNLSNLKYISLHNN 107
G + L +L L+LS N+ T P+ L LK + L N
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 26/137 (18%), Positives = 45/137 (32%), Gaps = 27/137 (19%)
Query: 95 NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND 154
+ ++ + L N K + + G + L E L++ +
Sbjct: 22 TPAAVRELVLDNCKSN--DGKIEGLTAEFVNL---------------------EFLSLIN 58
Query: 155 NHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNF--YGEISSNW 212
L S+ NL L + L N + G + PNL L+LS N +
Sbjct: 59 VG-LISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPL 116
Query: 213 GKCHRLGTLIVSGNNIT 229
K L +L + +T
Sbjct: 117 KKLECLKSLDLFNCEVT 133
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 29/126 (23%), Positives = 48/126 (38%), Gaps = 10/126 (7%)
Query: 175 LGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS--NWGKCHRLGTLIVSGNNITGRI 232
+ G + + L+FL + ++S N K ++L L +S N ++G +
Sbjct: 25 DNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKLELSDNRVSGGL 80
Query: 233 PPEIGNSSQLHVLDLSSNHIAG-EIPMELGRLISLNKLILRGN---QLSGHLPRALGLLT 288
L L+LS N I L +L +L L L L+ + LL
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140
Query: 289 ELEYFD 294
+L Y D
Sbjct: 141 QLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 287 LTELEYFDLSSNRLNNSILEALGFMF-KLFYLNFSHNQFSQEIPEDLALLAHLSELDLSH 345
++++ L ++R N LE L F +L +L+ + + I +L L L +L+LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 346 NLFKGSIPSRICNLESLEKLNLSHNNISG-QIPACFIGMSGLLSIDISYNEL 396
N G + +L LNLS N I + L S+D+ E+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENEL 62
V + L ++ E F L +L G T + L+KLK L+LS+N +
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRV 76
Query: 63 SGKIPPEIGLLTHLFSLDLSLNQFS--GTFPPICNLSNLKYISLHNN 107
SG + +L L+LS N+ T P+ L NLK + L N
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 316 YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375
L+ S + ++ L L + SI + + L L+KL LS N +SG
Sbjct: 23 VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79
Query: 376 IPACFIGMSGLLSIDISYNELR 397
+ L +++S N+++
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 28/136 (20%), Positives = 46/136 (33%), Gaps = 25/136 (18%)
Query: 95 NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND 154
S++K + L N++ + + G + L E L+ +
Sbjct: 15 TPSDVKELVLDNSRSN--EGKLEGLTDEFEEL---------------------EFLSTIN 51
Query: 155 NHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG-EISSNWG 213
L SI NL L + L N ++G + PNL L+LS N
Sbjct: 52 VG-LTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK 110
Query: 214 KCHRLGTLIVSGNNIT 229
K L +L + +T
Sbjct: 111 KLENLKSLDLFNCEVT 126
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 40/203 (19%)
Query: 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEF-- 553
M ++ R K ++ +G+G+ +VY+A+ + +A+KK ++ + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-------KLGHRSEAKD 53
Query: 554 ------LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFD 607
L EIK L ++ H NI+ H + +V++++ L ++
Sbjct: 54 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---------- 102
Query: 608 WRKRMNVITGVADALSYMH---------HDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658
K +++ + +YM H + I+HRD+ NN+LLD +++DFG
Sbjct: 103 --KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 659 AKLLKPNSSNWTELVGTFGYVAP 681
AK + +T V T Y AP
Sbjct: 159 AKSFGSPNRAYTHQVVTRWYRAP 181
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 63/398 (15%), Positives = 126/398 (31%), Gaps = 41/398 (10%)
Query: 17 LQEFSFSSFPHLAYLDLSINGFFGT--LPPQVRNLSKLKYLDLSENELSGKIPPEIGLL- 73
L + + L L L F T L V + K+K L + E+ S K + L
Sbjct: 129 LDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188
Query: 74 ---THLFSLDLSLNQFSG-TFPPIC----NLSNLKYISLHNNKLS--GSIPEEIGNLMKL 123
T L L+ + +F+ + + N +L + + + ++ + NL +
Sbjct: 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEF 248
Query: 124 SYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGR-NNLTG 182
L+ + + N+ L L ++ + + L T
Sbjct: 249 CGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE 308
Query: 183 NISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIG----- 237
+ PNL+ L+ + + C +L L + + E G
Sbjct: 309 DHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368
Query: 238 -------NSSQLHVLDLSSNHI----AGEIPMELGRLISLNKLILRGNQLSGHLPRALGL 286
+L + + + I I L L ++L + LP G+
Sbjct: 369 GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428
Query: 287 ------LTELEYFDLSSN--RLNNSILEALGFMFK-LFYLNFSHNQFSQEIPEDLAL-LA 336
+L F L + L +G + ++ + S E + +
Sbjct: 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP 488
Query: 337 HLSELDLSHNLF-KGSIPSRICNLESLEKLNLSHNNIS 373
+L +L++ F + +I + + L SL L + S
Sbjct: 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 33/179 (18%), Positives = 69/179 (38%), Gaps = 40/179 (22%)
Query: 502 IRRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNE 556
I++ D +G G + V + + +K A+K + D + E
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARRE 60
Query: 557 IKALTKI-RHRNIVKFYGFC----SHVRHSFVVYEYINRGSLATVLSNNF------ASED 605
++ + + +IV+ + + +V E ++ G L F +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQA 113
Query: 606 FDWRKRMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEA---RVSDFGTAK 660
F R+ ++ + +A+ Y+H + I HRD+ N+L + +++DFG AK
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 36/177 (20%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKALTKIRHRN 567
+G G + +VY+ +G +A+K+ D +E + EI + +++H N
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKL--------DSEEGTPSTAIREISLMKELKHEN 64
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN---FASEDFDWRKRMNVITGVADALSY 624
IV+ Y +V+E+++ L + + + + L++
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
H + I+HRD+ N+L++ + ++ DFG A+ + ++ V T Y AP
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 30/154 (19%), Positives = 55/154 (35%), Gaps = 18/154 (11%)
Query: 238 NSSQLHVLDLSSNHIAGEIPMELGR-LISLNKLILRGNQLSGHLPRALGLL-----TELE 291
L ++L+S + L + KL L+ N L + L L ++
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQIT 158
Query: 292 YFDLSSNRLNNSILEALGFMFK----LFYLNFSHNQFS----QEIPEDLALLAHLSELDL 343
LS+N L + + L + +L+ H + + L L EL++
Sbjct: 159 TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218
Query: 344 SHNLFKGS----IPSRICNLESLEKLNLSHNNIS 373
++N + + SLE L+L N +S
Sbjct: 219 AYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 45/311 (14%), Positives = 85/311 (27%), Gaps = 64/311 (20%)
Query: 96 LSNLKYISLHNNKLSGSIPEEIGNLMK-----LSYLMLDTNQFTGQLPRNICRSGLLEIL 150
LS+L+ ++L +++ + ++ L + L + Q GL +L
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPA--------GLRTLL 122
Query: 151 TVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN----ISEDFGIYP-NLKFLDLSHNNFY 205
V R L L N+L + + + L LS+N
Sbjct: 123 PV-----------FLRARKL---GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT 168
Query: 206 GE----ISSNWGKCHRLGTLIVSGNNITGR----IPPEIGNSSQLHVLDLSSNHIAGEIP 257
+ + L + + + ++ + QL L+++ N
Sbjct: 169 AAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA 228
Query: 258 MELGRLI----SLNKLILRGNQLS-------GHLPRALGLLTELEYFDLSSNRLNNSILE 306
+ L R SL L L N+LS L A + ++
Sbjct: 229 LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSV 288
Query: 307 ALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNL----ESL 362
L + + + L L DL + P R L +
Sbjct: 289 ILSEVQR-------NLNSWDRARVQRHL--ELLLRDLEDSRGATLNPWRKAQLLRVEGEV 339
Query: 363 EKLNLSHNNIS 373
L +
Sbjct: 340 RALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 38/313 (12%), Positives = 86/313 (27%), Gaps = 65/313 (20%)
Query: 49 LSKLKYLDLSENELSGKIPPEIGLL--------THLFSLDLSLNQFS--GTFPPICNLSN 98
LS L+ L+L+ ++ P + ++ L ++L+ Q G +
Sbjct: 71 LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR 127
Query: 99 LKYISLHNNKLSGSIPEEIGNLMK-----LSYLMLDTNQFTGQLPRNICRSGLLEILTVN 153
+ + L N L +++ +L+ ++ L L N T +
Sbjct: 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEG--------- 178
Query: 154 DNHFLGSIPNLRNCRSLVRAHLGRNNLTGN----ISEDFGIYPNLKFLDLSHNNFYGE-- 207
L S+ L L ++ L+ L++++N
Sbjct: 179 ----------LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA 228
Query: 208 --ISSNWGKCHRLGTLIVSGNNIT-------GRIPPEIGNSSQLHVLDLSSNHIAGEIPM 258
++ + L L + N ++ + +++ V ++ +
Sbjct: 229 LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSV 288
Query: 259 ELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN----SILEALGFMFKL 314
L + R EL DL +R + L ++
Sbjct: 289 ILSEVQRNLNSWDRARVQRH---------LELLLRDLEDSRGATLNPWRKAQLLRVEGEV 339
Query: 315 FYLNFSHNQFSQE 327
L
Sbjct: 340 RALLEQLGSSGSP 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 41/175 (23%), Positives = 75/175 (42%), Gaps = 25/175 (14%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
++ K+ IG+G + VY A + +A+KK N F + + D K L EI L ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRL 82
Query: 564 RHRNIVKFYG-FCSHVRHSF----VVYEYINRGSLATVL-SNNFASED----FDWRKRMN 613
+ I++ Y F +V E + L + + F +E+ + N
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILY----N 137
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
++ G +++H I+HRD+ N LL+ + +V DFG A+ +
Sbjct: 138 LLLG----ENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 39/190 (20%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI-AVKKFNSPFPNDQMSDQKEF---LNEIKALTK 562
DF +G G V+ + + A+K + + K+ +E L+
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK----EIVVRLKQVEHTNDERLMLSI 62
Query: 563 IRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKRM 612
+ H I++ +G + F++ +YI G L ++L + +A+E
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-------- 114
Query: 613 NVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
V AL Y+H D I++RD+ N+LLD +++DFG AK +T
Sbjct: 115 -----VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYT- 162
Query: 672 LVGTFGYVAP 681
L GT Y+AP
Sbjct: 163 LCGTPDYIAP 172
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 15/86 (17%)
Query: 30 YLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQ 85
L L N L P V L++L LDL N+L+ +P G+ LT L L L+ NQ
Sbjct: 34 VLYLYDNQI-TKLEPGVFDRLTQLTRLDLDNNQLT-VLPA--GVFDKLTQLTQLSLNDNQ 89
Query: 86 F----SGTFPPICNLSNLKYISLHNN 107
G F NL +L +I L NN
Sbjct: 90 LKSIPRGAFD---NLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 50 SKLKYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQF----SGTFPPICNLSNLKYI 102
+ + L L +N+++ K+ P G+ LT L LDL NQ +G F L+ L +
Sbjct: 30 TTTQVLYLYDNQIT-KLEP--GVFDRLTQLTRLDLDNNQLTVLPAGVFD---KLTQLTQL 83
Query: 103 SLHNNKLSGSIPEEI-GNLMKLSYLMLDTN 131
SL++N+L SIP NL L+++ L N
Sbjct: 84 SLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 22/72 (30%), Positives = 32/72 (44%), Gaps = 11/72 (15%)
Query: 66 IPPEIGLLTHLFSLDLSLNQF----SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNL 120
+P I T L L NQ G F L+ L + L NN+L+ +P + L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFD---RLTQLTRLDLDNNQLT-VLPAGVFDKL 77
Query: 121 MKLSYLMLDTNQ 132
+L+ L L+ NQ
Sbjct: 78 TQLTQLSLNDNQ 89
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 15/86 (17%)
Query: 30 YLDLSINGFFGTLPPQV-RNLSKLKYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQ 85
L L+ N L P V +L L+ L + N+L+ IP G+ LT L LDL+ N
Sbjct: 37 RLWLNNNQI-TKLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLTQLTQLDLNDNH 92
Query: 86 F----SGTFPPICNLSNLKYISLHNN 107
G F NL +L +I L+NN
Sbjct: 93 LKSIPRGAFD---NLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 15/87 (17%)
Query: 53 KYLDLSENELSGKIPPEIGL---LTHLFSLDLSLNQF----SGTFPPICNLSNLKYISLH 105
+ L L+ N+++ K+ P G+ L +L L + N+ +G F L+ L + L+
Sbjct: 36 QRLWLNNNQIT-KLEP--GVFDHLVNLQQLYFNSNKLTAIPTGVFD---KLTQLTQLDLN 89
Query: 106 NNKLSGSIPEEI-GNLMKLSYLMLDTN 131
+N L SIP NL L+++ L N
Sbjct: 90 DNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 11/72 (15%)
Query: 66 IPPEIGLLTHLFSLDLSLNQF----SGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNL 120
+P I T L L+ NQ G F +L NL+ + ++NKL+ +IP + L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFD---HLVNLQQLYFNSNKLT-AIPTGVFDKL 80
Query: 121 MKLSYLMLDTNQ 132
+L+ L L+ N
Sbjct: 81 TQLTQLDLNDNH 92
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 30/185 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLN--------EI---KALT 561
IG G + +VY+A+ SG +A+K + + E+ + L
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVR-------VPNGGGGGGGLPISTVREVALLRRLE 69
Query: 562 KIRHRNIVKFYGFCSHVRHS-----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT 616
H N+V+ C+ R +V+E++++ L T L +++
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA-PPPGLPAETIKDLMR 127
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTF 676
L ++H +C IVHRD+ N+L+ +++DFG A++ T +V T
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTL 183
Query: 677 GYVAP 681
Y AP
Sbjct: 184 WYRAP 188
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDKI----AVKKFNSPFPNDQMSDQKEF---LNEIKA 559
DFD +GKG V + + + ++K + + + E + E +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-------EVIIAKDEVAHTVTESRV 58
Query: 560 LTKIRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN--FASEDFDWRKRMNVIT 616
L RH + Y F +H R FV+ EY N G L LS F +E+ R R
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVF-TEE---RARF-YGA 112
Query: 617 GVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVG 674
+ AL Y+H D +V+RDI N++LD + +++DFG K + ++ T G
Sbjct: 113 EIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCG 167
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
T Y+AP + L + Y + D + GV+ E++ G+ P
Sbjct: 168 TPEYLAP---EV---LEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 60/239 (25%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKF 571
+GKG + V+++ +G+ +AVKK F +D + EI LT++ H NIV
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 572 YGFC--SHVRHSFVVYEYINRGSLATVLSNNFASED----FDW---RKRMNVITGVADAL 622
+ R ++V++Y+ L V+ N + + +
Sbjct: 75 LNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIK-----------VI 122
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA---------------------KL 661
Y+H ++HRD+ +N+LL+ E +V+DFG + +
Sbjct: 123 KYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFG-VLALEVIKGK 719
+ T+ V T Y AP + L YT I D++S G +L E++ GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPE-----ILLGSTKYTKGI----DMWSLGCILG-EILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 2e-05
Identities = 27/212 (12%), Positives = 52/212 (24%), Gaps = 61/212 (28%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFP----NDQMSDQKEFLNEIKALTKI------ 563
IG+G V++ +A+K P +E L EI ++
Sbjct: 28 IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 564 ---RHRNIVKFYGFCSHVR-------------------------------HSFVVYEYIN 589
R + V+ F+V E+
Sbjct: 87 VCNRTEGFIGLNS-VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649
G ++ +++ + +L+ HRD+ NVLL
Sbjct: 146 GGIDL----EQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTS 199
Query: 650 EARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
++ K + + G
Sbjct: 200 LKKLHYTLNGKSST---------IPSCGLQVS 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 5e-05
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 48/232 (20%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSG---DKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
F+ +G+G V+ K SG ++ A+K + D+ E L +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVE 82
Query: 563 IRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKR 611
+ H IVK Y F + + ++ +++ G L T LS + +E
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAE------- 134
Query: 612 MNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNW 669
+A AL ++H I++RD+ N+LLD E +++DFG +K + +
Sbjct: 135 ------LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
+ GT Y+AP E+ T+ D +SFGVL E++ G P
Sbjct: 185 S-FCGTVEYMAP----------EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 50/263 (19%), Positives = 91/263 (34%), Gaps = 72/263 (27%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-------- 564
+G G +V+ AK + + +A+K + ++ E EIK L ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAED--EIKLLQRVNDADNTKED 81
Query: 565 ---HRNIVKFYGFCSH----VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKR------ 611
+I+K +H H +V+E VL N K+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE---------VLGENL----LALIKKYEHRGI 128
Query: 612 -MNVITGVA----DALSYMHHDCFPPIVHRDISSNNVLLDLE------YEARVSDFGTAK 660
+ + ++ L YMH C I+H DI NVL+++ + +++D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH 720
++T + T Y +P E+ D++S L E+I G
Sbjct: 187 W---YDEHYTNSIQTREYRSP----------EVLLGAPWGCGADIWSTACLIFELITGDF 233
Query: 721 PGDFLSLFSSSSSSINIEFNAML 743
LF + + +
Sbjct: 234 ------LFEPDEGHSYTKDDDHI 250
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 23/107 (21%), Positives = 34/107 (31%), Gaps = 14/107 (13%)
Query: 282 RALGLLTELEYFDLSSNRLNNSILEALGFMFK----LFYLNFSHNQFS----QEIPEDLA 333
AL T ++ F + R N+ + AL M K L LN N S + E L
Sbjct: 59 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQ 118
Query: 334 LLAHLSELDLSHNLFK------GSIPSRICNLESLEKLNLSHNNISG 374
L EL + + I + + +L K
Sbjct: 119 SNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 31/162 (19%), Positives = 69/162 (42%), Gaps = 27/162 (16%)
Query: 514 IGKGEHRSVYRAK--LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEI---KALTKI 563
IG+G + V++A+ G +A+K+ + +E + E+ + L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVAVLRHLETF 71
Query: 564 RHRNIVK----FYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGV 618
H N+V+ + +V+E++++ L T L + +++ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQL 129
Query: 619 ADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660
L ++H +VHRD+ N+L+ + +++DFG A+
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 41/246 (16%), Positives = 87/246 (35%), Gaps = 19/246 (7%)
Query: 139 RNICRSGLL-EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFL 197
+ L + L + + + + ++ R+ + ++E F ++ +
Sbjct: 40 YRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHM 98
Query: 198 DLSHNNF-YGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEI 256
DLS++ + +C +L L + G ++ I + +S L L+LS E
Sbjct: 99 DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 158
Query: 257 PME--LGRLISLNKLILRG------NQLSGHLPRALGLLTELEYFDLS--SNRLNNSILE 306
++ L L++L L + + +T+L +LS L S L
Sbjct: 159 ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL---NLSGYRKNLQKSDLS 215
Query: 307 ALGFMF-KLFYLNFSH-NQFSQEIPEDLALLAHLSELDLSH-NLFKGSIPSRICNLESLE 363
L L +L+ S + ++ L +L L LS + + +L+
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 275
Query: 364 KLNLSH 369
L +
Sbjct: 276 TLQVFG 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 35/172 (20%), Positives = 68/172 (39%), Gaps = 37/172 (21%)
Query: 514 IGKGEHRSVYRAK---------LPSGDKIAVK--KFNSPFPNDQMSDQKEF----LNEIK 558
+ +Y A P K ++K + N+Q Q+ +N+ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 559 ALTKIRHRNIVKFYGFCSHV-RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
L I GF H ++ F+V + R SL + L D + ++ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL-------DVSPKHVLSERS- 160
Query: 618 VA-------DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV--SDFGTAK 660
V DAL ++H + + VH ++++ N+ +D E +++V + +G A
Sbjct: 161 VLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 618 VADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGT 675
+A AL Y+H + IV+RD+ N+LLD + ++DFG K ++ NS+ T GT
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGT 202
Query: 676 FGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+AP + L + Y + D + G + E++ G P
Sbjct: 203 PEYLAP---EV---LHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 15/105 (14%)
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTF 676
+A L ++ I++RD+ +NV+LD E +++DFG K + + T GT
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTP 506
Query: 677 GYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
Y+AP I +A Y + D ++FGVL E++ G+ P
Sbjct: 507 DYIAP---EI---IAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 22/136 (16%)
Query: 621 ALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGY 678
AL+Y+H I++RD+ +NVLLD E +++D+G K L+P + T GT Y
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 176
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
+AP I L Y + D ++ GVL E++ G+ P F + SS + N E
Sbjct: 177 IAP---EI---LRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTE 224
Query: 739 ---FNAMLDHRLPHPS 751
F +L+ ++ P
Sbjct: 225 DYLFQVILEKQIRIPR 240
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 46/232 (19%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSG---DKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
F+ +GKG + V++ + +G KI A+K D E L +
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 563 IRHRNIVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRKR 611
++H IV Y F + + ++ EY++ G L L + +E
Sbjct: 78 VKHPFIVDLIYAFQTGGKLYLIL-EYLSGGELFMQLEREGIFMEDTACFYLAE------- 129
Query: 612 MNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNW 669
++ AL ++H I++RD+ N++L+ + +++DFG K + +
Sbjct: 130 ------ISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
T GT Y+AP E+ D +S G L +++ G P
Sbjct: 180 T-FCGTIEYMAP----------EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 22/136 (16%)
Query: 621 ALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL-LKPNSSNWTELVGTFGY 678
AL+Y+H I++RD+ +NVLLD E +++D+G K L+P + T GT Y
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 219
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
+AP I L Y + D ++ GVL E++ G+ P F + SS + N E
Sbjct: 220 IAP---EI---LRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTE 267
Query: 739 ---FNAMLDHRLPHPS 751
F +L+ ++ P
Sbjct: 268 DYLFQVILEKQIRIPR 283
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 54/266 (20%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSG---DKI-AVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
+F+ +G G + V+ + SG K+ A+K + + E + L
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 563 IRHRN-IVK-FYGFCSHVRHSFVVYEYINRGSLATVLSNN----------FASEDFDWRK 610
IR +V Y F + + ++ +YIN G L T LS + E
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLIL-DYINGGELFTHLSQRERFTEHEVQIYVGE------ 167
Query: 611 RMNVITGVADALSYMH-HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK--LLKPNSS 667
+ AL ++H I++RDI N+LLD ++DFG +K +
Sbjct: 168 -------IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727
+ GT Y+AP +I + + + D +S GVL E++ G P
Sbjct: 217 AYD-FCGTIEYMAP---DI-VRGGDSGHDK----AVDWWSLGVLMYELLTGASP------ 261
Query: 728 FSSSSSSINIE--FNAMLDHRLPHPS 751
F+ + +L P+P
Sbjct: 262 FTVDGEKNSQAEISRRILKSEPPYPQ 287
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 43/279 (15%), Positives = 84/279 (30%), Gaps = 82/279 (29%)
Query: 508 FDAKYCI----GKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
F+ +Y + G G +V+ + + +A+K S + L+EI+ L
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKS 89
Query: 563 IRHRNIV-KFYGFCSHVRHSFV-----------VYEYINRGSLATVLSNNFASEDFDWRK 610
+R+ + + F V+E + L + + +
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPC 147
Query: 611 RMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---------------------- 648
+I V L Y+H C I+H DI N+LL +
Sbjct: 148 VKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 649 -------------------YEARVSDFGTAKLLKPNSSNW-----TELVGTFGYVAPAHG 684
E + ++ K+ ++ W TE + T Y +
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL--- 262
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723
E+ D++S +A E+ G + +
Sbjct: 263 -------EVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 786 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.81 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.44 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.59 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.22 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.53 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.42 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.02 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.42 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-54 Score=509.02 Aligned_cols=418 Identities=36% Similarity=0.579 Sum_probs=329.9
Q ss_pred eEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCC-CCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNL-SKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
++.|+|++|.+.+.++.. .+++|++|+|++|++++..|..+..+ ++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 249 L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 325 (768)
T 3rgz_A 249 LKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325 (768)
T ss_dssp CCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEEC
T ss_pred CCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEEC
Confidence 344444444444444432 44555555555555554555555443 66666666666666666666666666666666
Q ss_pred CCccCcccCC-C-CCCCCCCcEEEccCCcCcccCchhhcccC-CcceeccccccccccCChhhhc--cCccceeeccccc
Q 047901 82 SLNQFSGTFP-P-ICNLSNLKYISLHNNKLSGSIPEEIGNLM-KLSYLMLDTNQFTGQLPRNICR--SGLLEILTVNDNH 156 (786)
Q Consensus 82 s~N~l~~~~~-~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~--~~~L~~L~l~~N~ 156 (786)
++|++++..+ . +..+++|++|+|++|++++..|..+.+++ +|++|++++|++++..|..++. +++|+.|++++|.
T Consensus 326 ~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~ 405 (768)
T 3rgz_A 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405 (768)
T ss_dssp CSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSE
T ss_pred CCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCc
Confidence 6666653333 2 56666666666666666666666666665 6666666666666666666655 5667777777777
Q ss_pred ccCCCC-CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCcc
Q 047901 157 FLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPE 235 (786)
Q Consensus 157 l~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 235 (786)
+++.++ .+.++++|+.|++++|++++..|..|..+++|++|+|++|++.+..|..|..+++|++|+|++|++++..|..
T Consensus 406 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 485 (768)
T 3rgz_A 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485 (768)
T ss_dssp EEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred cccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHH
Confidence 775444 4778888888888888888888888888888888888888888888888888888999999999888888888
Q ss_pred ccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchh---------
Q 047901 236 IGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILE--------- 306 (786)
Q Consensus 236 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------- 306 (786)
+.++++|+.|+|++|++++.+|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++.+..+.
T Consensus 486 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~ 565 (768)
T 3rgz_A 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI 565 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCB
T ss_pred HhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchh
Confidence 88889999999999999888888888899999999999999888888888999999999999888743332
Q ss_pred -------------------------------------------------------------hhhcccCCcEEEecccccC
Q 047901 307 -------------------------------------------------------------ALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 307 -------------------------------------------------------------~~~~l~~L~~L~L~~N~l~ 325 (786)
.|..+++|++|+|++|+++
T Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~ 645 (768)
T 3rgz_A 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645 (768)
T ss_dssp CCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCB
T ss_pred hhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccc
Confidence 2334577999999999999
Q ss_pred CCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCc
Q 047901 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTV 405 (786)
Q Consensus 326 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 405 (786)
+.+|..|+.++.|+.|+|++|++++.+|..|.++++|+.|+|++|+++|.+|..|..+++|+.||+++|+++|.+|....
T Consensus 646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~ 725 (768)
T 3rgz_A 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSS
T ss_pred ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccCCCCCCCCCC
Q 047901 406 FRNAPRESFLGNNFSTFYGT 425 (786)
Q Consensus 406 ~~~~~~~~~~~n~~~~~~~~ 425 (786)
+..++..+|.||+. +||.
T Consensus 726 ~~~~~~~~~~gN~~--Lcg~ 743 (768)
T 3rgz_A 726 FETFPPAKFLNNPG--LCGY 743 (768)
T ss_dssp GGGSCGGGGCSCTE--EEST
T ss_pred hccCCHHHhcCCch--hcCC
Confidence 99999999999997 8875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=438.05 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=208.6
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
++|.+.+.||+|+||+||+|++. ++..||||+++. ......++|.+|+++|++++|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC----CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 46888999999999999999864 467899999975 23455678999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC
Q 047901 580 HSFVVYEYINRGSLATVLSNNF----------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 649 (786)
..|+|||||++|+|.++++... ....++|.++..|+.|||.||+|||++ +|+||||||+|||++.++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 9999999999999999997542 245799999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccc
Q 047901 650 EARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLS 726 (786)
Q Consensus 650 ~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~ 726 (786)
.+||+|||+|+........ .....||+.|||| |++.+..|+.++|||||||++|||+| |+.||....
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP----------E~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP----------ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCH----------HHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999876543322 1235799999999 88889999999999999999999999 999987533
Q ss_pred cccCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 727 LFSSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+....+.... ...|... +.++.++|.+||+.||++||||+||.+.|
T Consensus 236 --------~~~~~~~i~~~~~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 236 --------NNEVIECITQGRVLQRPRTC----PQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp --------HHHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------HHHHHHHHHcCCCCCCCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 122233333333 3334333 34589999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=439.66 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=203.4
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
++|...++||+|+||+||+|+++ +++.||||+++. ......++|.+|+++|++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46788899999999999999864 467899999975 33456678999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 580 HSFVVYEYINRGSLATVLSNNFA------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
..|+|||||++|+|.++++.... ..+++|.+++.|+.|||.||+|||++ +|+||||||+|||++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 99999999999999999976422 24689999999999999999999998 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCc
Q 047901 648 EYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDF 724 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~ 724 (786)
++.+||+|||+|+....... ......||+.|||| |++.+..|+.++|||||||++|||+| |+.||..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP----------E~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP----------ESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccCh----------hhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 99999999999987654332 22346799999999 88889999999999999999999999 9999875
Q ss_pred cccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 725 LSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... .+....+... +...|... +..+.++|.+||++||++||||+||++.|
T Consensus 264 ~~~--------~~~~~~i~~g~~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 264 LSN--------TEAIDCITQGRELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp SCH--------HHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred CCH--------HHHHHHHHcCCCCCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 331 2222333332 33444433 34589999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=436.68 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=208.0
Q ss_pred ccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.+++..++||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 35677889999999999999863 45789999997532 2334578999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC
Q 047901 580 HSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD 646 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 646 (786)
..++|||||++|+|.+++..... ...++|..+..|+.|||.||+|||++ +||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 99999999999999999965321 24589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCC
Q 047901 647 LEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGD 723 (786)
Q Consensus 647 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~ 723 (786)
+++++||+|||+|+....... ......||+.|||| |++.++.|+.++|||||||++|||+| |+.||.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP----------E~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP----------EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCH----------HHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 999999999999987653322 23446899999999 88889999999999999999999998 899987
Q ss_pred ccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 724 FLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.... .+....+... +.+.|.. ++..+.++|.+||+.||++||||.||++.|
T Consensus 250 ~~~~--------~~~~~~i~~~~~~~~p~~----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 250 GYSN--------QDVVEMIRNRQVLPCPDD----CPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp TCCH--------HHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCH--------HHHHHHHHcCCCCCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 5321 2222223332 2333433 334589999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=438.30 Aligned_cols=251 Identities=20% Similarity=0.321 Sum_probs=206.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.|.+|++++++++|||||++++++.+++..|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH--CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 57999999999999999999864 78999999997532 2334567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||+||+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999999764 345678999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
........+||+.|||| |++.+..|+.++||||+||++|||+||+.||.... ....+..+..
T Consensus 178 ~~~~~~~~~GT~~YmAP----------E~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~ 239 (350)
T 4b9d_A 178 TVELARACIGTPYYLSP----------EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIIS 239 (350)
T ss_dssp HHHHHHHHHSCCTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH
T ss_pred CcccccccCCCccccCH----------HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHc
Confidence 33333456899999999 88888899999999999999999999999987432 2233344444
Q ss_pred CCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+ .+.. .+..+.++|.+||.+||++|||++|+++
T Consensus 240 ~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 240 GSFPPVSLH----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4332 2222 2345889999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=429.73 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=200.5
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.+++++.++||+|+||+||+|+++ ..||||+++... ......+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 357888999999999999999975 369999986532 334556789999999999999999999999865 568999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||++|+|.+++... ...+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999754 35799999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CcceeeccCccccCCCCCCCCchHHHHhhh---cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 665 NS--SNWTELVGTFGYVAPAHGNIGLHLAELAYT---MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 665 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~---~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
.. ......+||+.|||| |++.+ ..|+.++|||||||++|||+||+.||..... ....
T Consensus 185 ~~~~~~~~~~~GT~~ymAP----------E~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~ 246 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAP----------EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQI 246 (307)
T ss_dssp ---------CCCCTTSCCH----------HHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHH
T ss_pred CCcceeecccccCCCccCH----------HHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHH
Confidence 22 223456899999999 66653 4589999999999999999999999875321 1111
Q ss_pred hhhccCCCCCC--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 740 NAMLDHRLPHP--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 740 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+......| .....+++..+.++|.+||++||++||||.||++.|
T Consensus 247 ~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 247 IFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 22222211111 111223345689999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=437.66 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=209.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
..|+..++||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+++..|+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45999999999999999999865 78999999996521 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||++|+|.+++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 150 mEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp ECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 999999999999975 3589999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
........+||+.|||| |++.+..|+.++||||+||++|||++|+.||..... ...+..+.+
T Consensus 223 ~~~~~~~~~GTp~YmAP----------Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~ 284 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAP----------ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD 284 (346)
T ss_dssp SSCCBCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred CCCcccccccCcCcCCH----------HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc
Confidence 55556678999999999 888888999999999999999999999999874321 122222222
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ........+.++.+++.+||.+||++|||++|+++
T Consensus 285 ~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 285 NLPP-RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SSCC-CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC-CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111 11112233456899999999999999999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=479.04 Aligned_cols=414 Identities=31% Similarity=0.464 Sum_probs=326.3
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|.+.+.++. |..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|.. .+++|++|+|
T Consensus 201 ~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L 276 (768)
T 3rgz_A 201 NLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276 (768)
T ss_dssp TCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEEC
T ss_pred cCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEEC
Confidence 467788888888776665 788888888888888888788888888888888888888877655543 5666666666
Q ss_pred CCccCccc-CCCCCC-CCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChh-hhccCccceeeccccccc
Q 047901 82 SLNQFSGT-FPPICN-LSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN-ICRSGLLEILTVNDNHFL 158 (786)
Q Consensus 82 s~N~l~~~-~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~~L~~L~l~~N~l~ 158 (786)
++|++++. +..+.. +++|++|+|++|++++..|..|+++++|++|+|++|++++.+|.. +..+++|+.|++++|.++
T Consensus 277 ~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~ 356 (768)
T 3rgz_A 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356 (768)
T ss_dssp CSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEE
T ss_pred cCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccC
Confidence 66666533 333443 366666666666666666666666666666666666665555543 555555555555555554
Q ss_pred CCC--------------------------CCcCC--CCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCc
Q 047901 159 GSI--------------------------PNLRN--CRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210 (786)
Q Consensus 159 ~~~--------------------------~~l~~--l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 210 (786)
+.. +.+.. +++|+.|++++|++++..+..|..+++|++|+|++|++++..|.
T Consensus 357 ~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 436 (768)
T 3rgz_A 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436 (768)
T ss_dssp ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH
Confidence 222 22222 56788888888888888888888899999999999999988899
Q ss_pred CccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcC
Q 047901 211 NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTEL 290 (786)
Q Consensus 211 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 290 (786)
.|..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|..|.++++|+.|+|++|++++..|..|+.+++|
T Consensus 437 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 516 (768)
T 3rgz_A 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred HHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCC
Confidence 99999999999999999998889999999999999999999998899999999999999999999998999999999999
Q ss_pred ceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHh-------------------------------------
Q 047901 291 EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLA------------------------------------- 333 (786)
Q Consensus 291 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------------------- 333 (786)
+.|+|++|++.+..+..+..+++|++|++++|.+++.+|..+.
T Consensus 517 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (768)
T 3rgz_A 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596 (768)
T ss_dssp CEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEEC
T ss_pred CEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccc
Confidence 9999999999988889999999999999999999877765442
Q ss_pred ---------------------------------hhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCccc
Q 047901 334 ---------------------------------LLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACF 380 (786)
Q Consensus 334 ---------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 380 (786)
.+++|+.|||++|++++.+|..+.++++|+.|+|++|++++.+|..|
T Consensus 597 ~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l 676 (768)
T 3rgz_A 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676 (768)
T ss_dssp TTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred ccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHH
Confidence 24678899999999999999999999999999999999999999999
Q ss_pred ccCCCceEEeccCCcccccCCCC-CccccCCCccccCCCC
Q 047901 381 IGMSGLLSIDISYNELRGPIPNS-TVFRNAPRESFLGNNF 419 (786)
Q Consensus 381 ~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 419 (786)
.++++|+.|||++|+++|.+|.. ..+.......+.+|+.
T Consensus 677 ~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp GGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 99999999999999999988864 2234444556666664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=427.55 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=212.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|++++++++|||||++++++++++..|+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 357999999999999999999864 789999999864110 112345679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
|||||+||+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 110 vmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999999864 5799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCC--CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 664 PNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 664 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
... ......+||+.|||| |++.+..|+.++||||+||++|||+||+.||...+ .......
T Consensus 184 ~~~~~~~~~~~~GTp~YmAP----------Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~ 245 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSP----------ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAK 245 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCH----------HHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred CCCCcccccCcccCcccCCH----------HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 432 234567899999999 88888999999999999999999999999987422 2334455
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 782 (786)
+.......|.... .++.+++.+||.+||++|||++|+
T Consensus 246 i~~~~~~~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 246 IIKLEYDFPEKFF----PKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp HHHTCCCCCTTCC----HHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred HHcCCCCCCcccC----HHHHHHHHHHccCCHhHCcChHHH
Confidence 5555555554333 348899999999999999999986
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=464.85 Aligned_cols=420 Identities=19% Similarity=0.160 Sum_probs=263.8
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
.++.|+|++|.+. .++..+|.++++|++|+|++|+++++.|.+|.++++|++|+|++|+++++.|.+|+.+++|++|+|
T Consensus 34 ~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 34 STECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TCCEEECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred cCcEEEccCCccC-cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 3567777777776 344446777777777777777777777777777777777777777777666667777777777777
Q ss_pred CCccCcccC-CCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhcc----------------
Q 047901 82 SLNQFSGTF-PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRS---------------- 144 (786)
Q Consensus 82 s~N~l~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~---------------- 144 (786)
++|+++++. ..+..+++|++|+|++|+++++....+.++++|++|++++|++++..|..+..+
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 777666542 235555555555555555554433333334555555555554443333333333
Q ss_pred --------------------------------------------------------------------------------
Q 047901 145 -------------------------------------------------------------------------------- 144 (786)
Q Consensus 145 -------------------------------------------------------------------------------- 144 (786)
T Consensus 193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence
Q ss_pred -----CccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc-ccCcCccCCCCc
Q 047901 145 -----GLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG-EISSNWGKCHRL 218 (786)
Q Consensus 145 -----~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L 218 (786)
++|+.|++++|.++.++..+.++++|+.|++++|+++++.+..|..+++|++|++++|.+.+ +.+..|..+++|
T Consensus 273 ~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 352 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352 (606)
T ss_dssp TTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred HhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcC
Confidence 34444444444444444444444445555555555544444444455555555555554442 223335555666
Q ss_pred cEEEccCcccCCCC--CccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCcc-ccccCCcCceecc
Q 047901 219 GTLIVSGNNITGRI--PPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR-ALGLLTELEYFDL 295 (786)
Q Consensus 219 ~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L 295 (786)
++|++++|++++.. +..+..+++|+.|++++|++.+..|..|..+++|+.|++++|++++..+. .|..+++|+.|++
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 66666666665443 45566666666666666666666666677777777777777777655443 3667777777777
Q ss_pred ccccccccchhhhhcccCCcEEEecccccCCC---cchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccc
Q 047901 296 SSNRLNNSILEALGFMFKLFYLNFSHNQFSQE---IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372 (786)
Q Consensus 296 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (786)
++|.+....+..|..+++|++|++++|.+++. .+..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc
Confidence 77777776677777777777777777777652 224577777777777777777777777777777888888888888
Q ss_pred cccCCcccccCCCceEEeccCCcccccCCCC-CccccCCCccccCCCCCCCC
Q 047901 373 SGQIPACFIGMSGLLSIDISYNELRGPIPNS-TVFRNAPRESFLGNNFSTFY 423 (786)
Q Consensus 373 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~~~~ 423 (786)
++..|..|.+++.| .|++++|++++.+|.. ..+.......+.+|++.|.|
T Consensus 513 ~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 513 TSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred CcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 77777777777777 7888888877665542 23445566777888885554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=413.18 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=195.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|+++++.++|||||++++++.+++..|+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL-AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc-CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 368999999999999999999865 789999999975332 223345679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+ +|+|.+++..+ +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999 67999999764 5799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
+. ......+||+.|||| |++.+..+ +.++||||+||++|||+||+.||.... .......+
T Consensus 164 ~~-~~~~~~~GT~~Y~AP----------E~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i 224 (275)
T 3hyh_A 164 DG-NFLKTSCGSPNYAAP----------EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNI 224 (275)
T ss_dssp ------------CTTSCH----------HHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred CC-CccCCeeECcccCCh----------hhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH
Confidence 43 233457899999999 77777776 579999999999999999999987422 22333444
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......|... +..+.+++.+||++||++|||++|+++
T Consensus 225 ~~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 225 SNGVYTLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHTCCCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 44445444433 235889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=438.69 Aligned_cols=246 Identities=25% Similarity=0.363 Sum_probs=209.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+..++||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+++..|+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT----CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 46999999999999999999865 78999999997532 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||+||+|.+++.. +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999999975 3589999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
........+||+.|||| |++.+..|+.++||||+||++|||++|+.||..... ...+..+..
T Consensus 300 ~~~~~~~~~GTp~YmAP----------Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~ 361 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAP----------ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD 361 (423)
T ss_dssp SCCCBCCCEECTTTCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred CCccccccccCcCcCCH----------HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc
Confidence 55556678999999999 888888999999999999999999999999874321 112222222
Q ss_pred C---CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 H---RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. .+..+ ...+..+.+|+.+||.+||++|||++|+++
T Consensus 362 ~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 362 NLPPRLKNL----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCCCCCSCT----TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 22222 122345889999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=416.86 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=197.7
Q ss_pred ccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec----CCeeeE
Q 047901 509 DAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH----VRHSFV 583 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~l 583 (786)
+..++||+|+||+||+|++. +++.||||++.... ......+.|.+|++++++++|||||++++++.. ++..|+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 56678999999999999865 68899999986532 223456789999999999999999999999864 356799
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~ 662 (786)
|||||++|+|.+++.+. +.+++..+..++.||+.||+|||++ .++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 107 vmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999999864 5789999999999999999999998 113999999999999984 799999999999864
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. ......+||+.|||| |++. +.|+.++|||||||++|||+||+.||..... .......+
T Consensus 183 ~~--~~~~~~~GTp~YmAP----------E~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i 242 (290)
T 3fpq_A 183 RA--SFAKAVIGTPEFMAP----------EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRV 242 (290)
T ss_dssp CT--TSBEESCSSCCCCCG----------GGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHH
T ss_pred CC--CccCCcccCccccCH----------HHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHH
Confidence 32 334567899999999 5554 4699999999999999999999999864221 11112222
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... |.......+.++.++|.+||.+||++|||++|+++
T Consensus 243 ~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 243 TSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22211 11112222345889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=425.95 Aligned_cols=246 Identities=22% Similarity=0.230 Sum_probs=200.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+..++||+|+||+||+|+.+ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46888889999999999999865 689999999975211 23699999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~ 663 (786)
||||+||+|.++++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 129 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999999864 5799999999999999999999999 999999999999999987 69999999999876
Q ss_pred CCCC-----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 664 PNSS-----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 664 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.... .....+||+.|||| |++.+..|+.++||||+||++|||+||+.||...... ..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAP----------E~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~ 264 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAP----------EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PL 264 (336)
T ss_dssp -----------CCCCCCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CC
T ss_pred CCCcccceecCCccccCccccCH----------HHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HH
Confidence 4322 12345799999999 8888889999999999999999999999999753321 11
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...+.....+. ...+...+..+.+++.+||.+||++|||+.|+++.
T Consensus 265 ~~~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 265 CLKIASEPPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp HHHHHHSCCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12222221110 00111233458899999999999999999999864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=474.72 Aligned_cols=418 Identities=22% Similarity=0.222 Sum_probs=274.6
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCc-cccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEe
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGF-FGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 80 (786)
+++.|+|++|.+. .+...+|.++++|++|||++|.+ ..+.|.+|.++++|++|+|++|+|+++.|.+|..+++|++|+
T Consensus 25 ~l~~LdLs~N~i~-~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 25 TTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TCCEEEEESCCCC-EECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CcCEEECCCCcCC-ccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 5789999999987 45555899999999999999954 445688999999999999999999988899999999999999
Q ss_pred CCCccCccc-CCC--CCCCCCCcEEEccCCcCcccCc-hhhcccCCcceeccccccccccCChhhhcc--Cccceeeccc
Q 047901 81 LSLNQFSGT-FPP--ICNLSNLKYISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQLPRNICRS--GLLEILTVND 154 (786)
Q Consensus 81 Ls~N~l~~~-~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~--~~L~~L~l~~ 154 (786)
|++|++++. +.. +..+++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|+++.
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 999999873 333 8899999999999999987755 579999999999999999988888888776 6666666666
Q ss_pred ccccCCCC-CcCCC------------------------------------------------------------------
Q 047901 155 NHFLGSIP-NLRNC------------------------------------------------------------------ 167 (786)
Q Consensus 155 N~l~~~~~-~l~~l------------------------------------------------------------------ 167 (786)
|.+.+..+ .+..+
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 66654322 12222
Q ss_pred --CCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEE
Q 047901 168 --RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245 (786)
Q Consensus 168 --~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 245 (786)
++|+.|++++|.++++.+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.|..|.++++|+.|
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 343 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343 (844)
T ss_dssp TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence 345555555555555555556666666666666666666556666666666666666666665555566666666666
Q ss_pred EeecccccccCCCCcccccccccccccccccCCCCc----------------------------------------cccc
Q 047901 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLP----------------------------------------RALG 285 (786)
Q Consensus 246 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----------------------------------------~~~~ 285 (786)
+|++|.+.+..+..|..+++|+.|+|++|.++++.. ..+.
T Consensus 344 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~ 423 (844)
T 3j0a_A 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLL 423 (844)
T ss_dssp ECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHT
T ss_pred ECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhh
Confidence 666666655555556666666666666665553211 0011
Q ss_pred cCCcCceeccccccccccchh-hhhcccCCcEEEecccccC-----CCcchHHhhhcCcCeeeccCCccCCCCCcccccc
Q 047901 286 LLTELEYFDLSSNRLNNSILE-ALGFMFKLFYLNFSHNQFS-----QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNL 359 (786)
Q Consensus 286 ~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 359 (786)
.+++|+.|+|++|+++.+... .+..+++|+.|+|++|.++ +..+..|..+++|+.|+|++|+|++..|..|.++
T Consensus 424 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 503 (844)
T 3j0a_A 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503 (844)
T ss_dssp TCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSC
T ss_pred cCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccch
Confidence 222333333333333222111 1222333333344444333 1222345556666666666666666666666666
Q ss_pred cccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCCCCCCC
Q 047901 360 ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYG 424 (786)
Q Consensus 360 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~ 424 (786)
++|+.|+|++|+|+++.|..+. ++|+.||+++|++++..|.. +.......+.+|++.|.|.
T Consensus 504 ~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 504 TALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred hhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 6666666666666665555554 56666666666666666544 5566677888999977664
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=421.38 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=202.6
Q ss_pred ccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|++.+.||+|+||+||+|+.. .++.||||++..... .......+.+|++++++++|||||++++++.+++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL--KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE--EEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc--ChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 57999999999999999999752 467899999975321 112234678899999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+|||||+||+|.+++.+. +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999999865 5799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...........+||+.|||| |++.+..|+.++||||+||++|||+||+.||...+ ..+....
T Consensus 176 ~~~~~~~~~~~~GT~~YmAP----------E~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~ 237 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAP----------EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTM 237 (304)
T ss_dssp -----CCCCSCCCCGGGCCH----------HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred ccCCCccccccccCcccCCH----------HHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHH
Confidence 66554555567899999999 88888999999999999999999999999987432 2333444
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM-----QTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 784 (786)
+.......|... +.++.+++.+||.+||++|||+ +|+++
T Consensus 238 i~~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 238 ILKAKLGMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHCCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHcCCCCCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 555555555433 3358899999999999999995 57654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=424.16 Aligned_cols=262 Identities=23% Similarity=0.356 Sum_probs=212.0
Q ss_pred HHHHHHHhccCccceeeccccCceEEEEEcCC------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-Ccccc
Q 047901 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPS------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVK 570 (786)
Q Consensus 498 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~ 570 (786)
..+|+...++|++.+.||+|+||+||+|++.. ++.||||++... ......+.|.+|+++|++++| ||||+
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~---~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34555556789999999999999999998542 357999999752 233456789999999999975 99999
Q ss_pred eeeEEec-CCeeeEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 047901 571 FYGFCSH-VRHSFVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHR 636 (786)
Q Consensus 571 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHr 636 (786)
++|+|.. ++..++|||||++|+|.++++... ....+++.++..++.|||.||+|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 9999965 456899999999999999997532 134589999999999999999999999 99999
Q ss_pred CCCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHH
Q 047901 637 DISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALE 714 (786)
Q Consensus 637 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~e 714 (786)
||||+|||++.++.+||+|||+|+........ .....||+.|||| |++.+..|+.++|||||||++||
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP----------E~l~~~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP----------ETIFDRVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH----------HHHhcCCCCCcccEeehHHHHHH
Confidence 99999999999999999999999977654332 2346799999999 88889999999999999999999
Q ss_pred HHh-CCCCCCccccccCCCcchhhhhhhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 715 VIK-GKHPGDFLSLFSSSSSSINIEFNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 715 llt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|+| |+.||..... .......+.+ .+...|.... .++.++|..||+.||++||||+||++.|
T Consensus 280 l~t~G~~Pf~~~~~-------~~~~~~~i~~g~~~~~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 280 IFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HTTTSCCSSTTCCC-------SHHHHHHHHHTCCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhCCCCCCCCCCH-------HHHHHHHHHcCCCCCCCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 998 9999875321 1111122222 2334444333 3588999999999999999999999764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=454.70 Aligned_cols=419 Identities=21% Similarity=0.136 Sum_probs=342.2
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|.+. .++...|.++++|++|+|++|+++++.|.+|.++++|++|+|++|+|+++.|.+|+.+++|++|+|
T Consensus 33 ~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 33 STKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CcCEEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 5889999999998 566668999999999999999999999999999999999999999999888999999999999999
Q ss_pred CCccCcccCC-CCCCCCCCcEEEccCCcCccc-CchhhcccCCcceeccccccccccCChhhhccCccc----eeecccc
Q 047901 82 SLNQFSGTFP-PICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLE----ILTVNDN 155 (786)
Q Consensus 82 s~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~----~L~l~~N 155 (786)
++|++++.++ .+.++++|++|+|++|+++++ .|..|+++++|++|++++|++++..|..+..+.+|+ .|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999998774 599999999999999999864 588999999999999999999988887777666544 4666666
Q ss_pred cccCCCCCcC----------------------------------------------------------------------
Q 047901 156 HFLGSIPNLR---------------------------------------------------------------------- 165 (786)
Q Consensus 156 ~l~~~~~~l~---------------------------------------------------------------------- 165 (786)
.++++++...
T Consensus 192 ~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 271 (606)
T 3vq2_A 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271 (606)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCC
T ss_pred CcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccc
Confidence 5554333221
Q ss_pred -----------CCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccccc-------------------CcCccCC
Q 047901 166 -----------NCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEI-------------------SSNWGKC 215 (786)
Q Consensus 166 -----------~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~-------------------~~~~~~l 215 (786)
.+++|+.|++++|.++.+. .+..+++|++|++++|++..++ +..+..+
T Consensus 272 ~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l 349 (606)
T 3vq2_A 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVAL 349 (606)
T ss_dssp TTCCGGGGSCGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCC
T ss_pred ccccccccccccCCCCCEEEecCccchhhh--hccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccC
Confidence 2233333333333333221 3444445555555555543221 1245677
Q ss_pred CCccEEEccCcccCCC--CCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCc-cccccCCcCce
Q 047901 216 HRLGTLIVSGNNITGR--IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLP-RALGLLTELEY 292 (786)
Q Consensus 216 ~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~ 292 (786)
++|++|++++|++++. .|..+..+++|+.|+|++|.+.+ .|..|..+++|+.|++++|++.+..+ ..|..+++|+.
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 7888888888888765 37788888999999999999885 55889999999999999999998877 68999999999
Q ss_pred eccccccccccchhhhhcccCCcEEEecccccCC-CcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccc
Q 047901 293 FDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ-EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371 (786)
Q Consensus 293 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (786)
|++++|.+....+..|..+++|++|++++|.+++ ..|..|..+++|+.|+|++|++++..|..|.++++|+.|++++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 9999999999999999999999999999999987 478889999999999999999998889999999999999999999
Q ss_pred ccccCCcccccCCCceEEeccCCcccccCCCCCccc-cCCCccccCCCCCCCCC
Q 047901 372 ISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFR-NAPRESFLGNNFSTFYG 424 (786)
Q Consensus 372 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~~~~~ 424 (786)
+++..|..|.++++|+.|++++|++++.++....+. ......+.+|++.|.|.
T Consensus 509 l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999999999999999999999996554433332 35567889999966664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=449.97 Aligned_cols=389 Identities=20% Similarity=0.188 Sum_probs=284.8
Q ss_pred EEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCc
Q 047901 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84 (786)
Q Consensus 5 ~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 84 (786)
.++.++.++. .+|.. + -+++++|||++|.|+++.|..|.++++|++|+|++|+|+++.|.+|+.+++|++|+|++|
T Consensus 16 ~~~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGT-L--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp EEECTTSCCS-SCCTT-S--CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEECCCCCcc-cCcCC-C--CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 5778888887 67763 2 247999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCC
Q 047901 85 QFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN 163 (786)
Q Consensus 85 ~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 163 (786)
++++..+ .|..+++|++|+|++|+++++.+..|.++++|++|++++|++++..+..+..+++|+.|++++|.+++..+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 9998765 599999999999999999998889999999999999999999976656666799999999999999876543
Q ss_pred -cCCCCCCc--EEEccCcccccccCcccCCC-------------------------------------------------
Q 047901 164 -LRNCRSLV--RAHLGRNNLTGNISEDFGIY------------------------------------------------- 191 (786)
Q Consensus 164 -l~~l~~L~--~L~L~~N~l~~~~~~~f~~l------------------------------------------------- 191 (786)
+..+++|+ .|++++|.++++.+..|...
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 66777777 77788887777666555321
Q ss_pred --CCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccc
Q 047901 192 --PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269 (786)
Q Consensus 192 --~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 269 (786)
.+|++|++++|+++++.+..|..+++|++|++++|+++ .+|..+..+++|++|++++|.+++..|..+..+++|+.|
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 04566666666666666666666666666666666666 455566666666666666666666656666666666666
Q ss_pred cccccccCCC-CccccccCCcCceeccccccccccc--hhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCC
Q 047901 270 ILRGNQLSGH-LPRALGLLTELEYFDLSSNRLNNSI--LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346 (786)
Q Consensus 270 ~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 346 (786)
++++|.+.+. .+..+..+++|+.|++++|.+..+. +..+..+++|++|++++|.+++..|..|..+++|+.|++++|
T Consensus 331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 410 (606)
T 3t6q_A 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410 (606)
T ss_dssp ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred ECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence 6666666533 2334666666666666666666554 455566666666666666666555556666666666666666
Q ss_pred ccCCCCCc-ccccccccceeccccccccccCCcccccCCCceEEeccCCcccc
Q 047901 347 LFKGSIPS-RICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRG 398 (786)
Q Consensus 347 ~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 398 (786)
++++..+. .|..+++|+.|++++|.+++..|..|.++++|+.|++++|++.+
T Consensus 411 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 463 (606)
T 3t6q_A 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463 (606)
T ss_dssp CEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGG
T ss_pred cCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCc
Confidence 66544432 35556666666666666665556566666666666666666554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=415.89 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=196.5
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHH--HHHHHHhhcCCCcccceeeEEecCC----
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFL--NEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
++|...++||+|+||+||+|++ +|+.||||++.. ...+.+. .|+..+.+++|||||+++|+|.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~-------~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECc-------cchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 4688889999999999999998 488999999854 1223333 4555567889999999999997653
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD-----CFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..|+|||||++|+|.++++.. .++|..+.+++.|+|.||+|||++ ..++|+||||||+|||++.++++||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 579999999999999999753 589999999999999999999976 24589999999999999999999999
Q ss_pred ccccceecCCCCCc----ceeeccCccccCCCCCCCCchHHHHhhhc------CcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 655 DFGTAKLLKPNSSN----WTELVGTFGYVAPAHGNIGLHLAELAYTM------KITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 655 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~------~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
|||+|+........ ....+||+.|||| |++.+. .++.|+|||||||++|||+||++||..
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAP----------E~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAP----------EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCH----------HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred eCCCCccccCCCCceeeecccccccccccCH----------HHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 99999887644322 2345899999999 555432 478899999999999999999988754
Q ss_pred cccccC-------CCcchhhhhhhhccCCCC--CCChh-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 725 LSLFSS-------SSSSINIEFNAMLDHRLP--HPSLD-VQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 725 ~~~~~~-------~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...... ...........+...... .|... ..+....+.++|.+||+.||++||||.||++.|
T Consensus 221 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred cccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 332111 011112222222333222 22221 224556789999999999999999999999864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=456.37 Aligned_cols=217 Identities=24% Similarity=0.210 Sum_probs=156.0
Q ss_pred cCcCccCCCCccEEEccCcccCCCCC-ccccCCccccEEEeecccccccCCCCcccccccccccccccccC--CCCcccc
Q 047901 208 ISSNWGKCHRLGTLIVSGNNITGRIP-PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS--GHLPRAL 284 (786)
Q Consensus 208 ~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~ 284 (786)
.+.+|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +..|..|
T Consensus 397 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~ 476 (680)
T 1ziw_A 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTT
T ss_pred ChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccc
Confidence 33344444444444444444433222 34444444444444444444444445555555555555555554 3466778
Q ss_pred ccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcc--------hHHhhhcCcCeeeccCCccCCCCCccc
Q 047901 285 GLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIP--------EDLALLAHLSELDLSHNLFKGSIPSRI 356 (786)
Q Consensus 285 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~ 356 (786)
..+++|+.|++++|+++.+++..|..+++|++|+|++|++++..+ ..|..+++|+.|+|++|+++...+..|
T Consensus 477 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 556 (680)
T 1ziw_A 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHc
Confidence 888899999999999999888889999999999999999986432 237888999999999999996666679
Q ss_pred ccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCC--ccccCCCccccCCCCCCCCC
Q 047901 357 CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNST--VFRNAPRESFLGNNFSTFYG 424 (786)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~~~~~~ 424 (786)
.++++|+.|+|++|+|+++.+..|.++++|+.|++++|++++..|..- .+.......+.+|+|.|.|.
T Consensus 557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 999999999999999998888889999999999999999998766432 34566778899999966664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=410.34 Aligned_cols=251 Identities=20% Similarity=0.387 Sum_probs=193.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|+..+.||+|+||+||+|+.+ +++.||||++... ......+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC---SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 356999999999999999999865 7899999998652 23345578999999999999999999999986543
Q ss_pred --------eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 580 --------HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 580 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
..|+|||||++|+|.+++.........++..++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 3689999999999999998765555667888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc------------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCC
Q 047901 652 RVSDFGTAKLLKPNSSN------------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK 719 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~ 719 (786)
||+|||+|+........ ....+||+.|||| |++.+..|+.++||||+||++|||++
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP----------E~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP----------EQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCH----------HHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCH----------HHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 99999999877543221 2335799999999 88888899999999999999999996
Q ss_pred CCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
||.... ............. .|+ ..........+++.+||++||++|||+.|+++
T Consensus 226 -Pf~~~~-------~~~~~~~~~~~~~--~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 -PFSTQM-------ERVRTLTDVRNLK--FPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -CCSSHH-------HHHHHHHHHHTTC--CCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCcc-------HHHHHHHHHhcCC--CCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 765311 1111112222222 222 23344456788999999999999999999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=452.53 Aligned_cols=410 Identities=20% Similarity=0.257 Sum_probs=289.1
Q ss_pred CCeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCcc------c---------------------------cCchhcc
Q 047901 1 GRVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFF------G---------------------------TLPPQVR 47 (786)
Q Consensus 1 g~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~------~---------------------------~~~~~~~ 47 (786)
|+|+.|+|+++++.|+++. +|..+++|++|||++|.+. + ..|..+.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CCEEEEECTTSCCEEEECG-GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred CCEEEEEecCcccCCcCCh-HHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHH
Confidence 7899999999999999997 8999999999999999651 1 0000000
Q ss_pred -------------------CCCCCCEEeCc--CCcccccCCccccCCCCCCEEeCCCccCcc------------------
Q 047901 48 -------------------NLSKLKYLDLS--ENELSGKIPPEIGLLTHLFSLDLSLNQFSG------------------ 88 (786)
Q Consensus 48 -------------------~l~~L~~L~L~--~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------------------ 88 (786)
....++.+.+. +|++++ +|.+|+.+++|++|+|++|++++
T Consensus 160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ 238 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence 11122222222 567776 67777777777777777777777
Q ss_pred cCCCCC--CCCCCcEEEccCCcCcccCchhhcccCCcceecccccc-ccc-cCChhhhcc------Cccceeeccccccc
Q 047901 89 TFPPIC--NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ-FTG-QLPRNICRS------GLLEILTVNDNHFL 158 (786)
Q Consensus 89 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~~------~~L~~L~l~~N~l~ 158 (786)
++..+. ++++|++|+|++|++.+..|..|.++++|++|+|++|+ +++ .+|..+..+ ++|+.|++++|.++
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 566666 77777777777777777777777777777777777776 776 677777665 77777777777777
Q ss_pred CCCC--CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCC-ccEEEccCcccCCCCCcc
Q 047901 159 GSIP--NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHR-LGTLIVSGNNITGRIPPE 235 (786)
Q Consensus 159 ~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~ 235 (786)
.++. .+.++++|+.|++++|++++..| .|..+++|++|+|++|+++ ..|..|..+++ |++|++++|+++ .+|..
T Consensus 319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~ 395 (636)
T 4eco_A 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNI 395 (636)
T ss_dssp SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSC
T ss_pred ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchh
Confidence 5555 57777777777777777775555 7777777777777777777 45556777777 777777777777 55666
Q ss_pred ccCCc--cccEEEeecccccccCCCCcc-------cccccccccccccccCCCCccccccCCcCceeccccccccccchh
Q 047901 236 IGNSS--QLHVLDLSSNHIAGEIPMELG-------RLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILE 306 (786)
Q Consensus 236 ~~~l~--~L~~L~Ls~N~i~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 306 (786)
+..++ +|+.|+|++|.+.+..|..|. .+++|+.|+|++|+++.+++..+..+++|+.|+|++|+++.++..
T Consensus 396 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~ 475 (636)
T 4eco_A 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475 (636)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSS
T ss_pred hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHH
Confidence 65544 777777777777777777666 666777777777777766666666677777777777777766666
Q ss_pred hhhccc-------CCcEEEecccccCCCcchHHh--hhcCcCeeeccCCccCCCCCcccccccccceecc------cccc
Q 047901 307 ALGFMF-------KLFYLNFSHNQFSQEIPEDLA--LLAHLSELDLSHNLFKGSIPSRICNLESLEKLNL------SHNN 371 (786)
Q Consensus 307 ~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------~~N~ 371 (786)
.+.... +|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+| ++|+
T Consensus 476 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~ 553 (636)
T 4eco_A 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553 (636)
T ss_dssp SSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCB
T ss_pred HhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCc
Confidence 555443 7777777777777 4555554 77777777777777775 6777777777777777 4566
Q ss_pred ccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCC
Q 047901 372 ISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF 419 (786)
Q Consensus 372 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 419 (786)
+.+.+|..|..+++|+.|++++|++ +.+|.. .+.......+.+|++
T Consensus 554 l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l 599 (636)
T 4eco_A 554 TLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPN 599 (636)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTT
T ss_pred ccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCC
Confidence 7777777777777777777777777 444543 224555566666665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=440.40 Aligned_cols=396 Identities=25% Similarity=0.275 Sum_probs=264.9
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+|+.|+|++|++. .++...|.++++|++|||++|.++++.|..|.++++|++|+|++|+|+.+.+.+|+.+++|++|+|
T Consensus 26 ~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 26 NITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TCSEEECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCcEEECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 5788999999887 466667899999999999999998888888999999999999999998777778899999999999
Q ss_pred CCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhh--ccCccceeeccccccc
Q 047901 82 SLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNIC--RSGLLEILTVNDNHFL 158 (786)
Q Consensus 82 s~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~~~~L~~L~l~~N~l~ 158 (786)
++|+++++++ .|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..+. .+++|+.|++++|.++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 9999888775 488889999999999998888888888888888888888888876666554 3467777777777776
Q ss_pred CCCCC----------------------------------------------------cCCCC--CCcEEEccCccccccc
Q 047901 159 GSIPN----------------------------------------------------LRNCR--SLVRAHLGRNNLTGNI 184 (786)
Q Consensus 159 ~~~~~----------------------------------------------------l~~l~--~L~~L~L~~N~l~~~~ 184 (786)
+..+. +.+++ +|+.|++++|+++++.
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 54432 22222 2666666666666666
Q ss_pred CcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCC---------CCCccccCCccccEEEeeccccccc
Q 047901 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG---------RIPPEIGNSSQLHVLDLSSNHIAGE 255 (786)
Q Consensus 185 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~---------~~~~~~~~l~~L~~L~Ls~N~i~~~ 255 (786)
+..|..+++|++|+|++|++.++.+..|.++++|+.|++++|...+ +....|..+++|+.|++++|.+.+.
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~ 344 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC
Confidence 6666666666666666666666555544444433333333322110 0011334444555555555555554
Q ss_pred CCCCccccccccc----------------------------ccccccccCCCCccccccCCcCceeccccccccc-cchh
Q 047901 256 IPMELGRLISLNK----------------------------LILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN-SILE 306 (786)
Q Consensus 256 ~~~~~~~l~~L~~----------------------------L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~ 306 (786)
.+..|.++++|+. |++++|+++++.|..|..+++|+.|++++|.+.+ ++..
T Consensus 345 ~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 424 (680)
T 1ziw_A 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSG
T ss_pred ChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcc
Confidence 4444444444333 3344445555556667777777777777777764 3445
Q ss_pred hhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccC--CCCCcccccccccceeccccccccccCCcccccCC
Q 047901 307 ALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFK--GSIPSRICNLESLEKLNLSHNNISGQIPACFIGMS 384 (786)
Q Consensus 307 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 384 (786)
.|..+++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..|.++++|+.|++++|+|+++.+..|.+++
T Consensus 425 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 504 (680)
T 1ziw_A 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504 (680)
T ss_dssp GGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred cccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccc
Confidence 6667777777777777766655556666666666666666554 34455556666666666666666655555555666
Q ss_pred CceEEeccCCcccc
Q 047901 385 GLLSIDISYNELRG 398 (786)
Q Consensus 385 ~L~~L~l~~N~l~~ 398 (786)
+|+.|++++|++++
T Consensus 505 ~L~~L~Ls~N~l~~ 518 (680)
T 1ziw_A 505 KLEILDLQHNNLAR 518 (680)
T ss_dssp TCCEEECCSSCCGG
T ss_pred ccCEEeCCCCCccc
Confidence 66666666666554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=437.14 Aligned_cols=417 Identities=21% Similarity=0.198 Sum_probs=334.8
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
.++.|+|++|++. .++..+|.++++|++|||++|+++++.+..|.++++|++|+|++|+++.+.|.+|..+++|++|+|
T Consensus 29 ~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred cccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 4789999999998 566668999999999999999999999999999999999999999999888899999999999999
Q ss_pred CCccCcccCC-CCCCCCCCcEEEccCCcCccc-CchhhcccCCcceeccccccccccCChhhhccCcc----ceeecccc
Q 047901 82 SLNQFSGTFP-PICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL----EILTVNDN 155 (786)
Q Consensus 82 s~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L----~~L~l~~N 155 (786)
++|+++++++ .+..+++|++|+|++|+++++ .|..|.++++|++|++++|++++..+..+..+.+| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999998876 589999999999999999975 58999999999999999999998888888888888 88899998
Q ss_pred cccCCCCCcCCCCCCcEEEccCc---------------------------------------------------------
Q 047901 156 HFLGSIPNLRNCRSLVRAHLGRN--------------------------------------------------------- 178 (786)
Q Consensus 156 ~l~~~~~~l~~l~~L~~L~L~~N--------------------------------------------------------- 178 (786)
.+.+..+......+|+.|++++|
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred CceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 88765544222224444444443
Q ss_pred -ccccccCcccCCCCCCCEEeccCCccccccCcCccC--------------------CCCccEEEccCcccCCCCCcccc
Q 047901 179 -NLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGK--------------------CHRLGTLIVSGNNITGRIPPEIG 237 (786)
Q Consensus 179 -~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~--------------------l~~L~~L~L~~N~l~~~~~~~~~ 237 (786)
.+.+..+..|..+++|++|++++|.+.. .|..+.. +++|+.|++++|.+.+..+. .
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~--~ 344 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--V 344 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC--C
T ss_pred hhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccc--c
Confidence 2222233444445555555555555543 3333333 44455555555554433332 5
Q ss_pred CCccccEEEeecccccccC--CCCcccccccccccccccccCCCCccccccCCcCceeccccccccccch-hhhhcccCC
Q 047901 238 NSSQLHVLDLSSNHIAGEI--PMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL-EALGFMFKL 314 (786)
Q Consensus 238 ~l~~L~~L~Ls~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L 314 (786)
.+++|+.|++++|.+++.. +..+..+++|+.|++++|.+.+..+. +..+++|+.|++++|.+....+ ..|..+++|
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence 6788888888888887554 56778888999999999998866555 8889999999999999887755 578889999
Q ss_pred cEEEecccccCCCcchHHhhhcCcCeeeccCCccC-CCCCcccccccccceeccccccccccCCcccccCCCceEEeccC
Q 047901 315 FYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFK-GSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISY 393 (786)
Q Consensus 315 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 393 (786)
++|++++|.+++..|..|..+++|+.|+|++|.++ +.+|..|..+++|+.|++++|++++..|..|..+++|+.|++++
T Consensus 424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 99999999999888889999999999999999997 56888999999999999999999999899999999999999999
Q ss_pred CcccccCCCC-CccccCCCccccCCCCCCCC
Q 047901 394 NELRGPIPNS-TVFRNAPRESFLGNNFSTFY 423 (786)
Q Consensus 394 N~l~~~~p~~-~~~~~~~~~~~~~n~~~~~~ 423 (786)
|++++.+|.. ..+.......+.+|++.+.|
T Consensus 504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 9999877653 34456666788899985555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=445.51 Aligned_cols=409 Identities=21% Similarity=0.239 Sum_probs=308.8
Q ss_pred CCeEEEEcCCCCCcccCCcCccCCCCCCcEEEC-CCCCccccCchh----------------------------------
Q 047901 1 GRVNSINLTSTGLKGTLQEFSFSSFPHLAYLDL-SINGFFGTLPPQ---------------------------------- 45 (786)
Q Consensus 1 g~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L-~~n~i~~~~~~~---------------------------------- 45 (786)
|+|+.|+|+++++.|.+|+ +|.++++|++||| ++|.+.+..+-.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s 401 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401 (876)
T ss_dssp SCEEEEECTTTCCEEEECG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred CCEEEEECccCCCCCcCch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhh
Confidence 6899999999999999997 7999999999999 888775542211
Q ss_pred -----------------ccCCCCCCEEeCcC--CcccccCCccccCCCCCCEEeCCCccCcc------------------
Q 047901 46 -----------------VRNLSKLKYLDLSE--NELSGKIPPEIGLLTHLFSLDLSLNQFSG------------------ 88 (786)
Q Consensus 46 -----------------~~~l~~L~~L~L~~--N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------------------ 88 (786)
......++.+.+.. |++++ +|..|+.+++|++|+|++|+|++
T Consensus 402 ~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence 01122334444443 77776 67788888888888888888887
Q ss_pred cCCCCC--CCCCCcEEEccCCcCcccCchhhcccCCcceecccccc-ccc-cCChhhhccC-------ccceeecccccc
Q 047901 89 TFPPIC--NLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ-FTG-QLPRNICRSG-------LLEILTVNDNHF 157 (786)
Q Consensus 89 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~~~-------~L~~L~l~~N~l 157 (786)
+|+.++ ++++|++|+|++|++.+..|..|.++++|++|+|++|+ +++ .+|..+..+. +|+.|+|++|.+
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 666666 88888888888888887888888888888888888887 776 6777776665 888888888888
Q ss_pred cCCCC--CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCC-ccEEEccCcccCCCCCc
Q 047901 158 LGSIP--NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHR-LGTLIVSGNNITGRIPP 234 (786)
Q Consensus 158 ~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 234 (786)
+.++. .+.++++|+.|+|++|+|+.+ | .|..+++|++|+|++|+++ ..|..+..+++ |+.|+|++|+++ .+|.
T Consensus 561 ~~ip~~~~l~~L~~L~~L~Ls~N~l~~l-p-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 561 EEFPASASLQKMVKLGLLDCVHNKVRHL-E-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp CBCCCHHHHTTCTTCCEEECTTSCCCBC-C-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred CccCChhhhhcCCCCCEEECCCCCcccc-h-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 86665 578888888888888888844 3 7888888888888888888 56666778887 888888888888 5677
Q ss_pred cccCCcc--ccEEEeecccccccCCCCc---c--cccccccccccccccCCCCccccccCCcCceeccccccccccchhh
Q 047901 235 EIGNSSQ--LHVLDLSSNHIAGEIPMEL---G--RLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEA 307 (786)
Q Consensus 235 ~~~~l~~--L~~L~Ls~N~i~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 307 (786)
.+..++. |+.|+|++|++.+.+|... . .+++|+.|+|++|+++.+++..+..+++|+.|+|++|+++.++...
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~ 716 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence 7766654 8888888888876655322 2 3347888888888888666566667888888888888888776666
Q ss_pred hhcc-------cCCcEEEecccccCCCcchHHh--hhcCcCeeeccCCccCCCCCcccccccccceecccc------ccc
Q 047901 308 LGFM-------FKLFYLNFSHNQFSQEIPEDLA--LLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSH------NNI 372 (786)
Q Consensus 308 ~~~l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~------N~l 372 (786)
+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++ |++
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l 794 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBC
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccc
Confidence 5543 37888888888887 5566665 78888888888888885 677777888888888865 777
Q ss_pred cccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCC
Q 047901 373 SGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF 419 (786)
Q Consensus 373 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 419 (786)
.+.+|..|.++++|+.|+|++|++ +.+|.. .+.......+.+|+.
T Consensus 795 ~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l 839 (876)
T 4ecn_A 795 LRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPN 839 (876)
T ss_dssp CCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTT
T ss_pred cccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCC
Confidence 778888888888888888888888 555554 234555556666665
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=438.94 Aligned_cols=388 Identities=18% Similarity=0.205 Sum_probs=319.0
Q ss_pred CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCcccc----------------------------------
Q 047901 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIG---------------------------------- 71 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------------- 71 (786)
.+++.|+|++|++.+.+|.+|.+|++|++|+|++|.+. ..+..++
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHH
Confidence 57899999999999999999999999999999999762 1111111
Q ss_pred -------------------CCCCCCEEeCC--CccCcccCCCCCCCCCCcEEEccCCcCccc-----------------C
Q 047901 72 -------------------LLTHLFSLDLS--LNQFSGTFPPICNLSNLKYISLHNNKLSGS-----------------I 113 (786)
Q Consensus 72 -------------------~l~~L~~L~Ls--~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------~ 113 (786)
....++.+.+. .|++++++..++++++|++|+|++|++++. .
T Consensus 160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHHhhcCccccccccccccchhhhhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 11123333333 578888777789999999999999999984 7
Q ss_pred chhhc--ccCCcceeccccccccccCChhhhccCccceeeccccc-ccC--CCCCcCCC------CCCcEEEccCccccc
Q 047901 114 PEEIG--NLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH-FLG--SIPNLRNC------RSLVRAHLGRNNLTG 182 (786)
Q Consensus 114 ~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~-l~~--~~~~l~~l------~~L~~L~L~~N~l~~ 182 (786)
|..+. ++++|++|+|++|++.+.+|..+..+++|+.|++++|+ +++ ++..+.++ ++|+.|++++|+++.
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ 319 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSS
T ss_pred chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCc
Confidence 78888 99999999999999999999999999999999999998 876 44445554 899999999999994
Q ss_pred ccCc--ccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcc-ccEEEeecccccccCCCC
Q 047901 183 NISE--DFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ-LHVLDLSSNHIAGEIPME 259 (786)
Q Consensus 183 ~~~~--~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~i~~~~~~~ 259 (786)
.|. .|+.+++|++|+|++|++++..| .|..+++|++|+|++|+++ .+|..+..+++ |+.|+|++|.++ .+|..
T Consensus 320 -ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~ 395 (636)
T 4eco_A 320 -FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNI 395 (636)
T ss_dssp -CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSC
T ss_pred -cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchh
Confidence 455 89999999999999999997777 8999999999999999999 67888999998 999999999998 67777
Q ss_pred ccccc--ccccccccccccCCCCccccc-------cCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcch
Q 047901 260 LGRLI--SLNKLILRGNQLSGHLPRALG-------LLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPE 330 (786)
Q Consensus 260 ~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 330 (786)
+..+. +|+.|++++|++++..|..|. .+++|+.|+|++|+++.++...+..+++|++|+|++|+++.+.+.
T Consensus 396 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~ 475 (636)
T 4eco_A 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475 (636)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSS
T ss_pred hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHH
Confidence 77654 899999999999988888888 788999999999999988888888899999999999999855544
Q ss_pred HHhhhc-------CcCeeeccCCccCCCCCcccc--cccccceeccccccccccCCcccccCCCceEEec------cCCc
Q 047901 331 DLALLA-------HLSELDLSHNLFKGSIPSRIC--NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDI------SYNE 395 (786)
Q Consensus 331 ~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l------~~N~ 395 (786)
.+.... +|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|++ ++|+
T Consensus 476 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~ 553 (636)
T 4eco_A 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553 (636)
T ss_dssp SSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCB
T ss_pred HhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCc
Confidence 554433 8999999999998 6777776 89999999999999997 7888889999999999 5677
Q ss_pred ccccCCCC-CccccCCCccccCCCCC
Q 047901 396 LRGPIPNS-TVFRNAPRESFLGNNFS 420 (786)
Q Consensus 396 l~~~~p~~-~~~~~~~~~~~~~n~~~ 420 (786)
+.+.+|.. ..+.......+.+|...
T Consensus 554 l~~~~p~~l~~l~~L~~L~Ls~N~l~ 579 (636)
T 4eco_A 554 TLREWPEGITLCPSLTQLQIGSNDIR 579 (636)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCCC
T ss_pred ccccChHHHhcCCCCCEEECCCCcCC
Confidence 77777743 23455566677777763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=434.50 Aligned_cols=397 Identities=19% Similarity=0.129 Sum_probs=334.4
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|.+. .++..+|.++++|++|+|++|.++++.|..|.++++|++|+|++|+++++.+..|+.+++|++|+|
T Consensus 57 ~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 57 ELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred cCcEEeCCCCccc-ccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 5789999999998 455558999999999999999999999999999999999999999999888889999999999999
Q ss_pred CCccCcc--cCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcc----eeccccccccccCChhhhc------------
Q 047901 82 SLNQFSG--TFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLS----YLMLDTNQFTGQLPRNICR------------ 143 (786)
Q Consensus 82 s~N~l~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~------------ 143 (786)
++|++++ ++..+.++++|++|+|++|+++++.+..|+.+++|+ +|++++|++++..+..+..
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~ 215 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNF 215 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCc
Confidence 9999986 355699999999999999999999888888777665 6777777776544433322
Q ss_pred --------------------------------------------------------------------cCccceeecccc
Q 047901 144 --------------------------------------------------------------------SGLLEILTVNDN 155 (786)
Q Consensus 144 --------------------------------------------------------------------~~~L~~L~l~~N 155 (786)
+++|+.|++++|
T Consensus 216 ~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~ 295 (606)
T 3vq2_A 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295 (606)
T ss_dssp SCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESC
T ss_pred cchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCc
Confidence 222333333333
Q ss_pred cccCCCCCcCCCCCCcEEEccCccccccc-------------------CcccCCCCCCCEEeccCCcccccc--CcCccC
Q 047901 156 HFLGSIPNLRNCRSLVRAHLGRNNLTGNI-------------------SEDFGIYPNLKFLDLSHNNFYGEI--SSNWGK 214 (786)
Q Consensus 156 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~-------------------~~~f~~l~~L~~L~L~~N~i~~~~--~~~~~~ 214 (786)
.+...+ .+..+++|+.|++++|+++.++ +..+..+++|++|+|++|+++++. +..+..
T Consensus 296 ~~~~l~-~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 374 (606)
T 3vq2_A 296 SIKYLE-DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374 (606)
T ss_dssp CCCCCC-CCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHC
T ss_pred cchhhh-hccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhcc
Confidence 332222 4444445555555555443221 225667889999999999998774 788999
Q ss_pred CCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCC-CCcccccccccccccccccCCCCccccccCCcCcee
Q 047901 215 CHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP-MELGRLISLNKLILRGNQLSGHLPRALGLLTELEYF 293 (786)
Q Consensus 215 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 293 (786)
+++|++|++++|.+++ .|..|..+++|+.|++++|++.+..+ ..|..+++|+.|++++|.+++..|..|..+++|+.|
T Consensus 375 ~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 453 (606)
T 3vq2_A 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453 (606)
T ss_dssp CSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence 9999999999999995 56899999999999999999998877 689999999999999999999999999999999999
Q ss_pred ccccccccc-cchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccc
Q 047901 294 DLSSNRLNN-SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372 (786)
Q Consensus 294 ~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (786)
++++|++.+ +.+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|+.|++++|+|
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 533 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence 999999998 5788899999999999999999999999999999999999999999998899999999999999999999
Q ss_pred cccCCcccccCC-CceEEeccCCcccccCCC
Q 047901 373 SGQIPACFIGMS-GLLSIDISYNELRGPIPN 402 (786)
Q Consensus 373 ~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~ 402 (786)
+. +|..+..++ +|+.|++++|++.+..+.
T Consensus 534 ~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 534 ET-SKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 95 555688887 599999999999876553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=447.36 Aligned_cols=395 Identities=23% Similarity=0.230 Sum_probs=339.8
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCcc--ccCCCCCCEE
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPE--IGLLTHLFSL 79 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L 79 (786)
+++.|+|++|+..+.++..+|.++++|++|+|++|.+.++.|..|.++++|++|+|++|++++..|.. |..+++|++|
T Consensus 49 ~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L 128 (844)
T 3j0a_A 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128 (844)
T ss_dssp SCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEE
T ss_pred cCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEE
Confidence 57899999998888998889999999999999999999999999999999999999999999765554 9999999999
Q ss_pred eCCCccCcccCC--CCCCCCCCcEEEccCCcCcccCchhhccc--CCcceeccccccccc--------------------
Q 047901 80 DLSLNQFSGTFP--PICNLSNLKYISLHNNKLSGSIPEEIGNL--MKLSYLMLDTNQFTG-------------------- 135 (786)
Q Consensus 80 ~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~-------------------- 135 (786)
+|++|++++..+ .|.++++|++|+|++|+++++.+..|..+ ++|+.|+|++|.+++
T Consensus 129 ~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~ 208 (844)
T 3j0a_A 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208 (844)
T ss_dssp EEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSE
T ss_pred ECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeE
Confidence 999999988754 48899999999999999998888877766 455555555544443
Q ss_pred ----------cCChhhhc--------------------------------------cCccceeecccccccCCCC-CcCC
Q 047901 136 ----------QLPRNICR--------------------------------------SGLLEILTVNDNHFLGSIP-NLRN 166 (786)
Q Consensus 136 ----------~~~~~~~~--------------------------------------~~~L~~L~l~~N~l~~~~~-~l~~ 166 (786)
..+..+.. .++|+.|++++|.+.+..+ .+.+
T Consensus 209 L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~ 288 (844)
T 3j0a_A 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288 (844)
T ss_dssp EBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSS
T ss_pred EecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhc
Confidence 33333222 1467778888888776554 4788
Q ss_pred CCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEE
Q 047901 167 CRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLD 246 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 246 (786)
+++|+.|+|++|+|+++.+..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|+++.+.+..|.++++|+.|+
T Consensus 289 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 368 (844)
T 3j0a_A 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368 (844)
T ss_dssp CCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEE
T ss_pred CCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999988888999999999999
Q ss_pred eecccccccCC------------------C----------------------CcccccccccccccccccCCCCcc-ccc
Q 047901 247 LSSNHIAGEIP------------------M----------------------ELGRLISLNKLILRGNQLSGHLPR-ALG 285 (786)
Q Consensus 247 Ls~N~i~~~~~------------------~----------------------~~~~l~~L~~L~L~~N~l~~~~~~-~~~ 285 (786)
|++|.+++... . .+.++++|+.|+|++|++++..+. .+.
T Consensus 369 Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 448 (844)
T 3j0a_A 369 LRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448 (844)
T ss_dssp EETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSC
T ss_pred CCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccc
Confidence 99999875321 0 123678999999999999876544 466
Q ss_pred cCCcCceeccccccccc-----cchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCccccccc
Q 047901 286 LLTELEYFDLSSNRLNN-----SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLE 360 (786)
Q Consensus 286 ~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 360 (786)
.+++|+.|+|++|.++. ..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+. +
T Consensus 449 ~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~ 526 (844)
T 3j0a_A 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--A 526 (844)
T ss_dssp SCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--S
T ss_pred cCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--c
Confidence 78999999999999974 4456788999999999999999999999999999999999999999987777776 8
Q ss_pred ccceeccccccccccCCcccccCCCceEEeccCCcccccCC
Q 047901 361 SLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIP 401 (786)
Q Consensus 361 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 401 (786)
+|+.|+|++|+|++..|..|. +|+.|++++|++.+..+
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred cccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence 999999999999999998764 78899999999987554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=425.36 Aligned_cols=395 Identities=21% Similarity=0.170 Sum_probs=334.5
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|.+. .++...|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++.+.+..|+.+++|++|+|
T Consensus 53 ~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 53 ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CceEEECCCCcCC-ccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 5789999999988 566668999999999999999999999999999999999999999999877778999999999999
Q ss_pred CCccCccc--CCCCCCCCCCcEEEccCCcCcccCchhhcccCCc----ceeccccccccccCChhhhc------------
Q 047901 82 SLNQFSGT--FPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKL----SYLMLDTNQFTGQLPRNICR------------ 143 (786)
Q Consensus 82 s~N~l~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~------------ 143 (786)
++|++++. +..+.++++|++|++++|+++++.+..|+.+++| +.|++++|.+++..|..+..
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~ 211 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEeccccc
Confidence 99999873 5568999999999999999999999999999998 88999999888666655443
Q ss_pred ---------------------------------------------------------------------cCccceeeccc
Q 047901 144 ---------------------------------------------------------------------SGLLEILTVND 154 (786)
Q Consensus 144 ---------------------------------------------------------------------~~~L~~L~l~~ 154 (786)
+++|+.|++++
T Consensus 212 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~ 291 (570)
T 2z63_A 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291 (570)
T ss_dssp SCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEES
T ss_pred ccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecC
Confidence 34444444444
Q ss_pred ccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCC--
Q 047901 155 NHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRI-- 232 (786)
Q Consensus 155 N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-- 232 (786)
|.+..++..+..+ +|+.|++++|.++.++. ..+++|++|++++|.+....+. ..+++|++|++++|++++..
T Consensus 292 ~~l~~l~~~~~~~-~L~~L~l~~n~~~~l~~---~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~ 365 (570)
T 2z63_A 292 VTIERVKDFSYNF-GWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCC 365 (570)
T ss_dssp CEECSCCBCCSCC-CCSEEEEESCBCSSCCB---CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEE
T ss_pred ccchhhhhhhccC-CccEEeeccCcccccCc---ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccc
Confidence 4444443334444 55555555555553322 2455666666666666544443 67899999999999998654
Q ss_pred CccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCc-cccccCCcCceeccccccccccchhhhhcc
Q 047901 233 PPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLP-RALGLLTELEYFDLSSNRLNNSILEALGFM 311 (786)
Q Consensus 233 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 311 (786)
+..+.++++|+.|++++|.+.+..+. +..+++|+.|++++|.+.+..+ ..|..+++|+.|++++|.+....+..|..+
T Consensus 366 ~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 444 (570)
T 2z63_A 366 SQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444 (570)
T ss_dssp EHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred cccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcC
Confidence 67888999999999999999976655 9999999999999999997766 578999999999999999999999999999
Q ss_pred cCCcEEEecccccC-CCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEe
Q 047901 312 FKLFYLNFSHNQFS-QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSID 390 (786)
Q Consensus 312 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 390 (786)
++|++|++++|.++ +..|..|..+++|+.|+|++|++++..|..|.++++|+.|++++|++++..|..|.++++|+.|+
T Consensus 445 ~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 524 (570)
T 2z63_A 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524 (570)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEE
Confidence 99999999999997 56888999999999999999999988899999999999999999999999999999999999999
Q ss_pred ccCCcccccCCCCC
Q 047901 391 ISYNELRGPIPNST 404 (786)
Q Consensus 391 l~~N~l~~~~p~~~ 404 (786)
+++|++++..|...
T Consensus 525 l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 525 LHTNPWDCSCPRID 538 (570)
T ss_dssp CCSSCBCCCTTTTH
T ss_pred ecCCcccCCCcchH
Confidence 99999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=401.53 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=199.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------C
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------V 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~ 578 (786)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ......+.+.+|+++|+.++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 47999999999999999999864 78999999997532 233456788999999999999999999998753 3
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
+..|+|||||+ |+|.+++... +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 67899999996 6899999754 6799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCC----CCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCC--
Q 047901 659 AKLLKPN----SSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-- 731 (786)
Q Consensus 659 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-- 731 (786)
|+.+... .......+||+.|||| |++.+. .++.++||||+||++|||++|++||...+.....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~AP----------Ev~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~ 274 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAP----------ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL 274 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCH----------HHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCH----------HHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9876432 1233457899999999 776654 5689999999999999999999999753321000
Q ss_pred -------------CcchhhhhhhhccCCCCCCChhHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 -------------SSSINIEFNAMLDHRLPHPSLDVQ----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 -------------~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........................ ..+..+.+|+.+||.+||++|||++|+++
T Consensus 275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000000000011 12345789999999999999999999975
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=412.96 Aligned_cols=404 Identities=19% Similarity=0.187 Sum_probs=325.0
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
+.||++++++. .+|...+ ++|++|||++|+++++.|..|.++++|++|+|++|+|+++.|.+|+.+++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC---TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc---ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 57999999998 6887433 8999999999999988889999999999999999999988899999999999999999
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCccc-CchhhcccCCcceeccccccccccCChhhhccCcc--ceeecccccc--c
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL--EILTVNDNHF--L 158 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L--~~L~l~~N~l--~ 158 (786)
|+|++++.. .+++|++|+|++|+++++ .|..|+++++|++|++++|++++ ..+..+++| +.|++++|.+ .
T Consensus 79 N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 79 NKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp SCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred CceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999987766 899999999999999974 67899999999999999999985 467777777 9999999988 3
Q ss_pred CCCC-CcC--------------------------CCCCCcEEEccCcc-------cccccCcccCC--------------
Q 047901 159 GSIP-NLR--------------------------NCRSLVRAHLGRNN-------LTGNISEDFGI-------------- 190 (786)
Q Consensus 159 ~~~~-~l~--------------------------~l~~L~~L~L~~N~-------l~~~~~~~f~~-------------- 190 (786)
+..+ .+. ++++|+.+++++|. +.+..+ .|..
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 3222 222 24455555555553 222111 1222
Q ss_pred -------------CCCCCEEeccCCccccccCcCc-----cCCCCccEEEccCcccCCCCCccccCC---ccccEEEeec
Q 047901 191 -------------YPNLKFLDLSHNNFYGEISSNW-----GKCHRLGTLIVSGNNITGRIPPEIGNS---SQLHVLDLSS 249 (786)
Q Consensus 191 -------------l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~ 249 (786)
.++|++|++++|++++..|..+ ..+++|+.+++++|.+ .+.+..+..+ .+|+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~ 311 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSG 311 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEES
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCC
Confidence 3478888889999987788877 8999999999999999 3333455544 6799999999
Q ss_pred ccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccc--hhhhhcccCCcEEEecccccCCC
Q 047901 250 NHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI--LEALGFMFKLFYLNFSHNQFSQE 327 (786)
Q Consensus 250 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~ 327 (786)
|.+.... .+..+++|++|++++|++++..|..+..+++|+.|++++|+++++. +..+..+++|++|++++|.+++.
T Consensus 312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 389 (520)
T 2z7x_B 312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389 (520)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence 9886432 2367889999999999999888888999999999999999998754 36788999999999999999874
Q ss_pred cch-HHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCC-CCc
Q 047901 328 IPE-DLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN-STV 405 (786)
Q Consensus 328 ~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~ 405 (786)
.|. .+..+++|++|+|++|++++..|..+. ++|+.|++++|+|+ .+|..+..+++|+.|++++|++++.++. ...
T Consensus 390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 466 (520)
T 2z7x_B 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466 (520)
T ss_dssp GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhcc
Confidence 554 588889999999999999877766654 68999999999998 5677667999999999999999865444 334
Q ss_pred cccCCCccccCCCCCCCC
Q 047901 406 FRNAPRESFLGNNFSTFY 423 (786)
Q Consensus 406 ~~~~~~~~~~~n~~~~~~ 423 (786)
+.......+.+|++.|.|
T Consensus 467 l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 467 LTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp CTTCCEEECCSSCBCCCH
T ss_pred CCcccEEECcCCCCcccC
Confidence 556666788899985555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=423.03 Aligned_cols=410 Identities=20% Similarity=0.176 Sum_probs=320.6
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|++.+ ++...|.++++|++|+|++|+++++.|.+|.++++|++|+|++|+++++.|..|+.+++|++|+|
T Consensus 27 ~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 27 AMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TCCEEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CccEEECcCCccCc-cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 58899999999874 44457999999999999999999999999999999999999999999888888999999999999
Q ss_pred CCccCccc--CCCCCCCCCCcEEEccCCc-CcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccccccc
Q 047901 82 SLNQFSGT--FPPICNLSNLKYISLHNNK-LSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFL 158 (786)
Q Consensus 82 s~N~l~~~--~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 158 (786)
++|++++. +..+..+++|++|+|++|+ +..+++..|.++++|++|++++|++++..|..+..+++|+.|+++.|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 99999854 4568899999999999998 66666678999999999999999999888998888888888888877765
Q ss_pred CCCCC-cCCCCCCcEEEccCccccccc---CcccCCCCCCCEEeccCC----------------------------cccc
Q 047901 159 GSIPN-LRNCRSLVRAHLGRNNLTGNI---SEDFGIYPNLKFLDLSHN----------------------------NFYG 206 (786)
Q Consensus 159 ~~~~~-l~~l~~L~~L~L~~N~l~~~~---~~~f~~l~~L~~L~L~~N----------------------------~i~~ 206 (786)
..+.. +..+++|+.|++++|++++.. ......+++|++|++++| .+.+
T Consensus 186 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~ 265 (549)
T 2z81_A 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265 (549)
T ss_dssp THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence 44333 245677777777777777642 112223344444444443 3332
Q ss_pred ccC-----------------------------------cCccCCCCccEEEccCcccCCCCCccc-cCCccccEEEeecc
Q 047901 207 EIS-----------------------------------SNWGKCHRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSN 250 (786)
Q Consensus 207 ~~~-----------------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N 250 (786)
+.. ..+...++|++|++++|++. .+|..+ ..+++|+.|+|++|
T Consensus 266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N 344 (549)
T 2z81_A 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344 (549)
T ss_dssp CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSS
T ss_pred cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCC
Confidence 110 00122357899999999998 456555 57999999999999
Q ss_pred cccccCC---CCcccccccccccccccccCCCCc--cccccCCcCceeccccccccccchhhhhcccCCcEEEecccccC
Q 047901 251 HIAGEIP---MELGRLISLNKLILRGNQLSGHLP--RALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 251 ~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 325 (786)
++++..| ..+..+++|+.|+|++|+++++.+ ..+..+++|+.|++++|+++.+ +..+..+++|++|++++|+++
T Consensus 345 ~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~~~~L~~L~Ls~N~l~ 423 (549)
T 2z81_A 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPM-PDSCQWPEKMRFLNLSSTGIR 423 (549)
T ss_dssp CCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCC-CSCCCCCTTCCEEECTTSCCS
T ss_pred ccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccC-ChhhcccccccEEECCCCCcc
Confidence 9987653 457888999999999999987653 5688999999999999999865 456778899999999999997
Q ss_pred CCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCC-CC
Q 047901 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN-ST 404 (786)
Q Consensus 326 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~ 404 (786)
.. |..+ .++|+.|+|++|++++.+ ..+++|+.|+|++|+|+. +|. ...+++|+.|++++|++++.+|. ..
T Consensus 424 ~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~ 494 (549)
T 2z81_A 424 VV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFD 494 (549)
T ss_dssp CC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGG
T ss_pred cc-cchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHh
Confidence 54 3332 268999999999998643 578899999999999984 454 45789999999999999987775 34
Q ss_pred ccccCCCccccCCCCCCCC
Q 047901 405 VFRNAPRESFLGNNFSTFY 423 (786)
Q Consensus 405 ~~~~~~~~~~~~n~~~~~~ 423 (786)
.+.......+.+|++.+.|
T Consensus 495 ~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 495 RLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp GCTTCCEEECCSSCBCCCH
T ss_pred cCcccCEEEecCCCccCCC
Confidence 4566667788899985544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=412.15 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=213.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +|+.||||++.. ......+.+.+|+++|+.++|||||++++++.+.+..|+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec----cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999865 789999999875 2344567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC--CcEEEeccccceec
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE--YEARVSDFGTAKLL 662 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfg~a~~~ 662 (786)
||||+||+|.+++... .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999999999653 35689999999999999999999999 99999999999999854 89999999999988
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......+||+.|||| |++.+..|+.++||||+||++|||++|+.||.... ..+.+..+
T Consensus 308 ~~~-~~~~~~~GT~~y~AP----------Ev~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i 368 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAP----------EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNV 368 (573)
T ss_dssp CTT-SEEEEECSSGGGCCH----------HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHH
T ss_pred cCC-CceeeeEECccccCH----------HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHH
Confidence 644 334567899999999 88888899999999999999999999999987432 22333444
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+..+.+||.+||.+||++|||+.|+++
T Consensus 369 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 369 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 444444443333444556889999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=390.50 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=170.2
Q ss_pred HHHHHhccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeE
Q 047901 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGF 574 (786)
Q Consensus 500 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~ 574 (786)
.+....++|++.+.||+|+||+||+|+.+ .++.||||++... ....++.+|+++++.+ +|||||+++++
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 33344678999999999999999999742 4678999998642 2345678999999998 69999999999
Q ss_pred EecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEE
Q 047901 575 CSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARV 653 (786)
Q Consensus 575 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl 653 (786)
+.+.++.|+||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999999983 488999999999999999999999 99999999999999877 89999
Q ss_pred eccccceecCCCCC----------------------------cceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccc
Q 047901 654 SDFGTAKLLKPNSS----------------------------NWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCD 704 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sD 704 (786)
+|||+|+...+... .....+||+.|||| |++.+. .|+.++|
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP----------E~l~~~~~y~~~~D 229 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP----------EVLTKCPNQTTAID 229 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCH----------HHHTTCSCCCTHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCH----------HHHcCCCCCCCccc
Confidence 99999986643211 12335799999999 777654 5899999
Q ss_pred hHHHHHHHHHHHhCCCCCCc
Q 047901 705 VYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 705 vwslGvil~elltg~~Pf~~ 724 (786)
|||+||++|||++|+.||..
T Consensus 230 iWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 230 MWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHHHHHTCSSSSC
T ss_pred hhhhHHHHHHHHHCCCCCCC
Confidence 99999999999999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=406.43 Aligned_cols=253 Identities=21% Similarity=0.198 Sum_probs=203.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCC--CCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFP--NDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ............++++++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 357999999999999999999865 789999999864210 01111122233446677788999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999865 5699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... ....+||+.|||| |++. +..|+.++||||+||++|||++|++||..... ........
T Consensus 342 ~~~~~--~~t~~GTp~YmAP----------Evl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~~~i~~ 404 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAP----------EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDR 404 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCH----------HHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCHHHHHH
T ss_pred cCCCC--CCCccCCcCccCH----------HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence 75432 3456999999999 7775 45799999999999999999999999974321 11122333
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
.........|... +..+.++|..||.+||++|++ ++||++
T Consensus 405 ~i~~~~~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 405 MTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHCCCCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred hhcCCCCCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 4444445444433 334889999999999999998 677754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=410.33 Aligned_cols=419 Identities=22% Similarity=0.192 Sum_probs=329.9
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
.++.|||++|.+. .++..+|.++++|++|||++|+|+++.+.+|.++++|++|+|++|+|+++.+.+|.++++|++|+|
T Consensus 53 ~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 4789999999998 788889999999999999999999999999999999999999999999888889999999999999
Q ss_pred CCccCcccCCC-CCCCCCCcEEEccCCcCccc-CchhhcccCCcceeccccccccccCChhhhccCccc----eeecccc
Q 047901 82 SLNQFSGTFPP-ICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLE----ILTVNDN 155 (786)
Q Consensus 82 s~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~----~L~l~~N 155 (786)
++|+|+++++. |.++++|++|+|++|+++++ .|..+..+++|++|+|++|++++..+..+..+..++ .++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 99999988774 89999999999999999865 578889999999999999999988888877665443 4555666
Q ss_pred cccCCCCCcCCCC-------------------------------------------------------------------
Q 047901 156 HFLGSIPNLRNCR------------------------------------------------------------------- 168 (786)
Q Consensus 156 ~l~~~~~~l~~l~------------------------------------------------------------------- 168 (786)
.+..+.+......
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence 5544333222222
Q ss_pred ---------------CCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcC-------------------ccC
Q 047901 169 ---------------SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN-------------------WGK 214 (786)
Q Consensus 169 ---------------~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~-------------------~~~ 214 (786)
++..+.+.+|.+..+ ..+....+|+.|++++|.+..+.+.. +..
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~ 369 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 369 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCB
T ss_pred cccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccc
Confidence 222333333333222 12334456666666666655443322 223
Q ss_pred CCCccEEEccCcccCC--CCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCC-ccccccCCcCc
Q 047901 215 CHRLGTLIVSGNNITG--RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHL-PRALGLLTELE 291 (786)
Q Consensus 215 l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~ 291 (786)
+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|...... ...|..+++++
T Consensus 370 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~ 448 (635)
T 4g8a_A 370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 448 (635)
T ss_dssp CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred ccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccc
Confidence 5566666666666642 23444555666777777776665 34556788889999999888776543 45788999999
Q ss_pred eeccccccccccchhhhhcccCCcEEEeccccc-CCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccc
Q 047901 292 YFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF-SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHN 370 (786)
Q Consensus 292 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 370 (786)
.++++.|.+..+.+..+..++.|+.|+|++|.+ ....|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 449 ~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N 528 (635)
T 4g8a_A 449 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 528 (635)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCC
Confidence 999999999999999999999999999999975 4457788999999999999999999988999999999999999999
Q ss_pred cccccCCcccccCCCceEEeccCCcccccCCCCCc-c-ccCCCccccCCCCCCCCC
Q 047901 371 NISGQIPACFIGMSGLLSIDISYNELRGPIPNSTV-F-RNAPRESFLGNNFSTFYG 424 (786)
Q Consensus 371 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~-~~~~~~~~~~n~~~~~~~ 424 (786)
+|+++.|..|.++++|+.|||++|+|++.+|..-. + .......+.+|+|.|.|.
T Consensus 529 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 529 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred cCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999999999999999998876421 2 345567889999977764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=398.10 Aligned_cols=381 Identities=21% Similarity=0.232 Sum_probs=285.0
Q ss_pred EEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCccc-ccCCccccCCCCCCEEeCCC
Q 047901 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELS-GKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 5 ~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~ 83 (786)
.++.+++++. .+|. + .++|++|||++|.++++.|..|.++++|++|+|++|++. .+.+..|..+++|++|+|++
T Consensus 14 ~~~c~~~~l~-~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 14 NAICINRGLH-QVPE--L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp EEECCSSCCS-SCCC--C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred ccCcCCCCcc-cCCC--C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 4566777776 5665 2 267888888888888888888888888888888888886 35567788888888888888
Q ss_pred ccCcccCC-CCCCCCCCcEEEccCCcCcccCchh--hcccCCcceeccccccccccCChh-hhccCccceeecccccccC
Q 047901 84 NQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEE--IGNLMKLSYLMLDTNQFTGQLPRN-ICRSGLLEILTVNDNHFLG 159 (786)
Q Consensus 84 N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~~L~~L~l~~N~l~~ 159 (786)
|++++..+ .+..+++|++|+|++|++++..+.. |.++++|++|+|++|++++..|.. +..+++|+.|++++|.+.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 88887644 5788888888888888887644443 888888888888888888776665 6777788888888887776
Q ss_pred CCCC-cCCC--CCCcEEEccCcccccccCccc--------CCCCCCCEEeccCCccccccCcCccCC---CCccEEEccC
Q 047901 160 SIPN-LRNC--RSLVRAHLGRNNLTGNISEDF--------GIYPNLKFLDLSHNNFYGEISSNWGKC---HRLGTLIVSG 225 (786)
Q Consensus 160 ~~~~-l~~l--~~L~~L~L~~N~l~~~~~~~f--------~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~ 225 (786)
..+. +.++ .+|+.|++++|.++.+.+..+ ..+++|++|+|++|++++..+..+... ++|+.|++++
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~ 248 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence 5543 4433 567777777777776554332 245667777777777666555554433 5666666666
Q ss_pred cccCCCCCccccCCccccEEEeecccccccCCCCcccc--cccccccccccccCCCCccccccCCcCceecccccccccc
Q 047901 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL--ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNS 303 (786)
Q Consensus 226 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 303 (786)
|.+.+.. +..+.+....+..+..+ ++|+.|++++|.+++..|..|+.+++|+.|++++|++.++
T Consensus 249 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 314 (455)
T 3v47_A 249 SYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314 (455)
T ss_dssp CTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred ccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc
Confidence 6554321 11122222333334433 5788888888888888888888888888888888888888
Q ss_pred chhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccC
Q 047901 304 ILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGM 383 (786)
Q Consensus 304 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 383 (786)
.+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|+.|++++|+|+++.+..|..+
T Consensus 315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 394 (455)
T 3v47_A 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccC
Confidence 88888888888888888888887778888888899999999999987778888889999999999999988877788888
Q ss_pred CCceEEeccCCcccccCCCCC
Q 047901 384 SGLLSIDISYNELRGPIPNST 404 (786)
Q Consensus 384 ~~L~~L~l~~N~l~~~~p~~~ 404 (786)
++|+.|++++|++++..|...
T Consensus 395 ~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 395 TSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp TTCCEEECCSSCBCCCTTTTH
T ss_pred CcccEEEccCCCcccCCCcch
Confidence 999999999999988777543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=411.65 Aligned_cols=401 Identities=20% Similarity=0.199 Sum_probs=301.6
Q ss_pred EEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCcc
Q 047901 6 INLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ 85 (786)
Q Consensus 6 l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 85 (786)
.+.+++++. .+|...+ ++|++|||++|+++++.|..|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|+
T Consensus 10 c~~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 85 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85 (549)
T ss_dssp EECTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence 678888887 7887433 789999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCC-CCCCCCCcEEEccCCcCccc-CchhhcccCCcceecccccc-ccccCChhhhccCccceeecccccccCCC-
Q 047901 86 FSGTFPP-ICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQ-FTGQLPRNICRSGLLEILTVNDNHFLGSI- 161 (786)
Q Consensus 86 l~~~~~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~L~~L~l~~N~l~~~~- 161 (786)
+++.++. +..+++|++|+|++|+++++ .+..|+++++|++|++++|+ ++...+..+..+++|+.|++++|.+++..
T Consensus 86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 165 (549)
T 2z81_A 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165 (549)
T ss_dssp CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence 9988876 89999999999999999974 46789999999999999998 55555578999999999999999999854
Q ss_pred CCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccccc--C-cCccCCCCccEEEccCcccCCCCCc----
Q 047901 162 PNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEI--S-SNWGKCHRLGTLIVSGNNITGRIPP---- 234 (786)
Q Consensus 162 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~~~---- 234 (786)
..+.++++|+.|+++.|.+..+....+..+++|++|++++|++++.. + .....+++|+.|++++|.+++..+.
T Consensus 166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 245 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245 (549)
T ss_dssp TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence 46899999999999999998776666678999999999999998753 1 2223445555555555554321110
Q ss_pred c------------------------------cc-----------------------------CCccccEEEeeccccccc
Q 047901 235 E------------------------------IG-----------------------------NSSQLHVLDLSSNHIAGE 255 (786)
Q Consensus 235 ~------------------------------~~-----------------------------~l~~L~~L~Ls~N~i~~~ 255 (786)
. +. ...+|+.|++++|.+. .
T Consensus 246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ 324 (549)
T 2z81_A 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-L 324 (549)
T ss_dssp GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-C
T ss_pred HhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-c
Confidence 0 11 1234556666666665 3
Q ss_pred CCCCc-ccccccccccccccccCCCCc---cccccCCcCceeccccccccccch--hhhhcccCCcEEEecccccCCCcc
Q 047901 256 IPMEL-GRLISLNKLILRGNQLSGHLP---RALGLLTELEYFDLSSNRLNNSIL--EALGFMFKLFYLNFSHNQFSQEIP 329 (786)
Q Consensus 256 ~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~ 329 (786)
+|..+ ..+++|+.|+|++|++++..| ..++.+++|+.|++++|+++.++. ..+..+++|++|++++|+++ .+|
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 403 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCC
T ss_pred CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCC
Confidence 34333 456677777777777765442 235666777777777777766543 45666777777777777776 455
Q ss_pred hHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCccccC
Q 047901 330 EDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNA 409 (786)
Q Consensus 330 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 409 (786)
..+..+++|+.|+|++|++++ +|..+. ++|+.|++++|+|++.. ..+++|+.|++++|+++. +|....+...
T Consensus 404 ~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~-ip~~~~l~~L 475 (549)
T 2z81_A 404 DSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLKT-LPDASLFPVL 475 (549)
T ss_dssp SCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS-CCCGGGCTTC
T ss_pred hhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccCc-CCCcccCccC
Confidence 566666777777777777763 333221 46777777777776542 478999999999999984 5655556666
Q ss_pred CCccccCCCCC
Q 047901 410 PRESFLGNNFS 420 (786)
Q Consensus 410 ~~~~~~~n~~~ 420 (786)
....+.+|...
T Consensus 476 ~~L~Ls~N~l~ 486 (549)
T 2z81_A 476 LVMKISRNQLK 486 (549)
T ss_dssp CEEECCSSCCC
T ss_pred CEEecCCCccC
Confidence 67777888764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=405.09 Aligned_cols=404 Identities=19% Similarity=0.169 Sum_probs=291.3
Q ss_pred eEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCC
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLS 82 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 82 (786)
.+.++++++++. .+|...+ ++|++|||++|+|+++.+..|.++++|++|+|++|+|+++.|++|..+++|++|+|+
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CcEEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 367999999998 5887433 899999999999999999999999999999999999999999999999999999999
Q ss_pred CccCcccCCCCCCCCCCcEEEccCCcCcccC-chhhcccCCcceeccccccccccCChhhhccCcc--ceeecccccc--
Q 047901 83 LNQFSGTFPPICNLSNLKYISLHNNKLSGSI-PEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL--EILTVNDNHF-- 157 (786)
Q Consensus 83 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L--~~L~l~~N~l-- 157 (786)
+|+|+.++.. .+++|++|+|++|+++++. |..|+++++|++|+|++|++++. .+..++.| +.|++++|.+
T Consensus 109 ~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 109 HNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp TSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9999987766 8999999999999999854 68999999999999999999853 45555666 9999999988
Q ss_pred cCCCCC-cC--------------------------CCCCCcEEEccCcc----------------------------cc-
Q 047901 158 LGSIPN-LR--------------------------NCRSLVRAHLGRNN----------------------------LT- 181 (786)
Q Consensus 158 ~~~~~~-l~--------------------------~l~~L~~L~L~~N~----------------------------l~- 181 (786)
++..+. +. ++++|+.+++++|+ ++
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 543332 32 34556666666653 11
Q ss_pred ----cccCcccCCCCCCCEEeccCCccccccCcCc-----cCCCCccEEEccCcccCCCCCccccCC---ccccEEEeec
Q 047901 182 ----GNISEDFGIYPNLKFLDLSHNNFYGEISSNW-----GKCHRLGTLIVSGNNITGRIPPEIGNS---SQLHVLDLSS 249 (786)
Q Consensus 182 ----~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~ 249 (786)
++.+ ....++|++|++++|++++..|..+ ..++.|+.++++.|.+. +.+..+..+ .+|+.|++++
T Consensus 264 ~~~~~~~~--~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~-~p~~~~~~~~~~~~L~~L~l~~ 340 (562)
T 3a79_B 264 KCSVKLFQ--FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISD 340 (562)
T ss_dssp HHHHHHHH--HHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCS-SCHHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHH--hhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceee-cChhhhhhhhccCcceEEEccC
Confidence 0000 1112488899999999987777766 66666666666666661 221222222 4577777777
Q ss_pred ccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccc--hhhhhcccCCcEEEecccccCC-
Q 047901 250 NHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI--LEALGFMFKLFYLNFSHNQFSQ- 326 (786)
Q Consensus 250 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~- 326 (786)
|.+.... .+..+++|+.|++++|++++..|..|..+++|+.|++++|+++++. +..|..+++|++|++++|++++
T Consensus 341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 418 (562)
T 3a79_B 341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418 (562)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSC
T ss_pred CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCc
Confidence 7765321 1256677777777777777767777777777777777777777654 3456777777777777777776
Q ss_pred CcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCC-CCc
Q 047901 327 EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN-STV 405 (786)
Q Consensus 327 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~ 405 (786)
..+..+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+|+. +|..+.++++|+.|++++|++++.++. ...
T Consensus 419 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 495 (562)
T 3a79_B 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDR 495 (562)
T ss_dssp CSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTT
T ss_pred cChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhc
Confidence 3334566777777777777777655544433 577777777777774 444444777777777777777754443 333
Q ss_pred cccCCCccccCCCCCCCC
Q 047901 406 FRNAPRESFLGNNFSTFY 423 (786)
Q Consensus 406 ~~~~~~~~~~~n~~~~~~ 423 (786)
+.......+.+|++.|.|
T Consensus 496 l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 496 LTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CTTCCCEECCSCCBCCCH
T ss_pred CCCCCEEEecCCCcCCCc
Confidence 445555667777775444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=394.14 Aligned_cols=362 Identities=21% Similarity=0.194 Sum_probs=310.1
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCcc-ccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEe
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFF-GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLD 80 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 80 (786)
+++.|+|++|.+.+ +....|.++++|++|+|++|.+. .+.+..|.++++|++|+|++|+++++.|..|+.+++|++|+
T Consensus 31 ~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 31 HVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TCCEEECCSSCCCE-ECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred ccCEEEecCCccCc-CChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 58999999999985 54558999999999999999997 45678899999999999999999999999999999999999
Q ss_pred CCCccCccc-CCC--CCCCCCCcEEEccCCcCcccCchh-hcccCCcceeccccccccccCChhhhcc--Cccceeeccc
Q 047901 81 LSLNQFSGT-FPP--ICNLSNLKYISLHNNKLSGSIPEE-IGNLMKLSYLMLDTNQFTGQLPRNICRS--GLLEILTVND 154 (786)
Q Consensus 81 Ls~N~l~~~-~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~--~~L~~L~l~~ 154 (786)
|++|++++. +.. +..+++|++|+|++|+++++.|.. |.++++|++|++++|++++..+..+..+ ..|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 999999863 223 889999999999999999987776 8999999999999999999999988887 7899999999
Q ss_pred ccccCCCCC---------cCCCCCCcEEEccCcccccccCcccCCC---CCCCEEeccCCccccccCcCccCCCCccEEE
Q 047901 155 NHFLGSIPN---------LRNCRSLVRAHLGRNNLTGNISEDFGIY---PNLKFLDLSHNNFYGEISSNWGKCHRLGTLI 222 (786)
Q Consensus 155 N~l~~~~~~---------l~~l~~L~~L~L~~N~l~~~~~~~f~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 222 (786)
|.+....+. +..+++|+.|++++|++++..+..|... ++|+.|++++|.+.+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------------- 255 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------------- 255 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence 999876543 3467899999999999998877766544 89999999999876431
Q ss_pred ccCcccCCCCCccccCC--ccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccc
Q 047901 223 VSGNNITGRIPPEIGNS--SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300 (786)
Q Consensus 223 L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 300 (786)
+..+.+.+..+..+.++ ++|+.|++++|.+.+..|..|..+++|+.|+|++|+++++.+..|.++++|+.|+|++|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 22333443444444443 6888888888888888888888888888888888888888888888889999999999999
Q ss_pred cccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCc
Q 047901 301 NNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA 378 (786)
Q Consensus 301 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 378 (786)
..+.+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++++..|.
T Consensus 336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 888888888899999999999999888888899999999999999999977777888999999999999999887763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=418.13 Aligned_cols=391 Identities=19% Similarity=0.203 Sum_probs=325.4
Q ss_pred CCcEEECCC--CCccccCchhccCCCCCCEEeCcCCcccc-----------------cCCcccc--CCCCCCEEeCCCcc
Q 047901 27 HLAYLDLSI--NGFFGTLPPQVRNLSKLKYLDLSENELSG-----------------KIPPEIG--LLTHLFSLDLSLNQ 85 (786)
Q Consensus 27 ~L~~L~L~~--n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~ 85 (786)
.++.+.+.. |++++ +|..|.++++|++|+|++|+|++ .+|..++ .+++|++|+|++|+
T Consensus 424 ~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred chhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 344445544 88887 78899999999999999999997 2788877 99999999999999
Q ss_pred CcccCC-CCCCCCCCcEEEccCCc-Ccc-cCchhhcccC-------CcceeccccccccccCCh--hhhccCccceeecc
Q 047901 86 FSGTFP-PICNLSNLKYISLHNNK-LSG-SIPEEIGNLM-------KLSYLMLDTNQFTGQLPR--NICRSGLLEILTVN 153 (786)
Q Consensus 86 l~~~~~-~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~--~~~~~~~L~~L~l~ 153 (786)
+.+..+ .+.++++|++|+|++|+ +++ ..|..|..++ +|++|+|++|+++ .+|. .+..+++|+.|+|+
T Consensus 503 l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls 581 (876)
T 4ecn_A 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCV 581 (876)
T ss_dssp TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECT
T ss_pred CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECC
Confidence 877655 58999999999999998 887 6787777766 9999999999999 7888 99999999999999
Q ss_pred cccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCC-CCEEeccCCccccccCcCccCCCC--ccEEEccCcccCC
Q 047901 154 DNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPN-LKFLDLSHNNFYGEISSNWGKCHR--LGTLIVSGNNITG 230 (786)
Q Consensus 154 ~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~--L~~L~L~~N~l~~ 230 (786)
+|.++.++ .+.++++|+.|+|++|+|+ ..|..|..+++ |++|+|++|+|+ ..|..+..++. |+.|+|++|++.+
T Consensus 582 ~N~l~~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g 658 (876)
T 4ecn_A 582 HNKVRHLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658 (876)
T ss_dssp TSCCCBCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred CCCcccch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCC
Confidence 99999554 8999999999999999999 55667899999 999999999999 55777777654 9999999999987
Q ss_pred CCCccc---c--CCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccC-------CcCceeccccc
Q 047901 231 RIPPEI---G--NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL-------TELEYFDLSSN 298 (786)
Q Consensus 231 ~~~~~~---~--~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~L~~N 298 (786)
.+|... . .+++|+.|+|++|+++.+.+..+..+++|+.|+|++|+|+.+++..+... ++|+.|+|++|
T Consensus 659 ~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N 738 (876)
T 4ecn_A 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738 (876)
T ss_dssp TSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSS
T ss_pred ccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCC
Confidence 665332 2 34589999999999995444455689999999999999996666666543 39999999999
Q ss_pred cccccchhhh-hcccCCcEEEecccccCCCcchHHhhhcCcCeeeccC------CccCCCCCcccccccccceecccccc
Q 047901 299 RLNNSILEAL-GFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSH------NLFKGSIPSRICNLESLEKLNLSHNN 371 (786)
Q Consensus 299 ~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (786)
+++.++...+ ..+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..|.++++|+.|+|++|+
T Consensus 739 ~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~ 817 (876)
T 4ecn_A 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817 (876)
T ss_dssp CCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred CCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCC
Confidence 9997654443 489999999999999997 688899999999999976 88888999999999999999999999
Q ss_pred ccccCCcccccCCCceEEeccCCcccccCCCCCc-cccCCCccccCCCCCCCCCCC
Q 047901 372 ISGQIPACFIGMSGLLSIDISYNELRGPIPNSTV-FRNAPRESFLGNNFSTFYGTS 426 (786)
Q Consensus 372 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~~~ 426 (786)
| +.+|..+. ++|+.|||++|++....+..-. ........+..|+....++|+
T Consensus 818 L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~ 870 (876)
T 4ecn_A 818 I-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870 (876)
T ss_dssp C-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred C-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence 9 57777765 6999999999999865543211 122334556677776666663
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.93 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=208.1
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG----GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 45799999999999999999985 47899999998652 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999753 588999999999999999999999 99999999999999999999999999998877
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||+.|+|| |...+..+++++||||+||++|||++|+.||...... ..........
T Consensus 168 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~ 232 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNG 232 (297)
T ss_dssp STTCCBCCCCSCGGGCCH----------HHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHC
T ss_pred CcccccCCccCCcCccCh----------hhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC
Confidence 655555667899999999 8888889999999999999999999999998643211 0000111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+. ..+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 233 TPELQNPE----KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCCCSCGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCcc----ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11222222 23345889999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.54 Aligned_cols=278 Identities=33% Similarity=0.598 Sum_probs=224.0
Q ss_pred ccccHHHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceee
Q 047901 494 GKIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573 (786)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~ 573 (786)
..++..++....++|+..+.||+|+||+||+|+..+++.||||++...... .....+.+|+++++.++||||+++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEE
Confidence 456778898999999999999999999999999888999999999763221 12236889999999999999999999
Q ss_pred EEecCCeeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEE
Q 047901 574 FCSHVRHSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR 652 (786)
Q Consensus 574 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 652 (786)
++...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998653 234589999999999999999999998777999999999999999999999
Q ss_pred EeccccceecCCCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 653 VSDFGTAKLLKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
|+|||+++........ .....||+.|+|| |...+..++.++|||||||++|||++|+.||+........
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP----------EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCH----------HHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred eccCccccccCcccccccccccCCcCccCH----------HHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 9999999887544332 3345699999999 7888888999999999999999999999998632211111
Q ss_pred Ccchhhh---------hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 SSSINIE---------FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....... ...+.+.... .....+....+.+++..||+.||++|||+.||++.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhHHHHHHHHhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 1111111 1111122211 223455667899999999999999999999999864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=394.05 Aligned_cols=379 Identities=19% Similarity=0.220 Sum_probs=315.0
Q ss_pred cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccCC
Q 047901 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNN 107 (786)
Q Consensus 29 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N 107 (786)
++||+++|+++. +|..+. ++|++|+|++|+|+++.|.+|..+++|++|+|++|+|++..+ .|..+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 589999999985 455454 899999999999998888999999999999999999998855 6999999999999999
Q ss_pred cCcccCchhhcccCCcceeccccccccc-cCChhhhccCccceeecccccccCCCCCcCCCCCC--cEEEccCccc--cc
Q 047901 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTG-QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSL--VRAHLGRNNL--TG 182 (786)
Q Consensus 108 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L--~~L~L~~N~l--~~ 182 (786)
+|+.+++. .+++|++|+|++|++++ ..|..|..+++|+.|++++|.+.+ ..+..+++| +.|++++|.+ ++
T Consensus 80 ~l~~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 80 KLVKISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CCCEEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ceeecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEeecccccccc
Confidence 99965544 89999999999999997 468999999999999999999986 356777888 9999999999 55
Q ss_pred ccCcccCC--------------------------CCCCCEEeccCCc-------cccccCcCccC---------------
Q 047901 183 NISEDFGI--------------------------YPNLKFLDLSHNN-------FYGEISSNWGK--------------- 214 (786)
Q Consensus 183 ~~~~~f~~--------------------------l~~L~~L~L~~N~-------i~~~~~~~~~~--------------- 214 (786)
..+..|.. +++|+.|++++|. +.+..+ .+..
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 55555544 6677777777775 322222 2222
Q ss_pred ------------CCCccEEEccCcccCCCCCccc-----cCCccccEEEeecccccccCCCCcccc---ccccccccccc
Q 047901 215 ------------CHRLGTLIVSGNNITGRIPPEI-----GNSSQLHVLDLSSNHIAGEIPMELGRL---ISLNKLILRGN 274 (786)
Q Consensus 215 ------------l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~i~~~~~~~~~~l---~~L~~L~L~~N 274 (786)
.++|++|++++|++++.+|..+ ..+++|+.+++++|.+ ......+..+ .+|+.|++++|
T Consensus 234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n 312 (520)
T 2z7x_B 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGT 312 (520)
T ss_dssp HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCC
Confidence 2378888889999988888888 8999999999999999 2332455555 67999999999
Q ss_pred ccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCC--CcchHHhhhcCcCeeeccCCccCCCC
Q 047901 275 QLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ--EIPEDLALLAHLSELDLSHNLFKGSI 352 (786)
Q Consensus 275 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~ 352 (786)
.+.... .+..+++|+.|++++|++++..+..+..+++|++|+|++|++++ ..|..+..+++|+.|+|++|++++.+
T Consensus 313 ~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l 390 (520)
T 2z7x_B 313 RMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390 (520)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCG
T ss_pred cccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccc
Confidence 987543 23789999999999999999888999999999999999999987 45578999999999999999999745
Q ss_pred Cc-ccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCCCC
Q 047901 353 PS-RICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFST 421 (786)
Q Consensus 353 ~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~ 421 (786)
|. .+..+++|+.|++++|++++..|..+. ++|+.|++++|+++..++....+.......+.+|....
T Consensus 391 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~ 458 (520)
T 2z7x_B 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKS 458 (520)
T ss_dssp GGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC
T ss_pred ccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCc
Confidence 54 588999999999999999988877664 79999999999999544444455666667788887753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=365.37 Aligned_cols=255 Identities=32% Similarity=0.454 Sum_probs=200.9
Q ss_pred HhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
...+|++.+.||+|+||+||+|+. +++.||||++.... ......+.+.+|++++++++||||+++++++...+..++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 356899999999999999999987 57899999987532 233456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
||||+++|+|.+++........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999998653334589999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
............||+.|+|| |...+..++.++|||||||++|||++|+.||..... ......
T Consensus 189 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~ 250 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAP----------EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAA 250 (309)
T ss_dssp -------------CCTTSCH----------HHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHH
T ss_pred ccccccccccCCCCccccCh----------hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 65443334556899999999 788888899999999999999999999999874321 111111
Q ss_pred h--ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 M--LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+ ...+...+... +..+.+++..||+.||++|||++++++.|
T Consensus 251 ~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 251 VGFKCKRLEIPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp HHHSCCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcCCCCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 22223333322 23588999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=366.04 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=210.2
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+.+|+++++.++||||+++++++...+..|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 45799999999999999999986 578999999986532 123456678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999764 5689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. ......+||+.|+|| |.+.+..++ +++||||+||++|||++|+.||+... .......+
T Consensus 166 ~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i 226 (328)
T 3fe3_A 166 VG-GKLDAFCGAPPYAAP----------ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERV 226 (328)
T ss_dssp SS-CGGGTTSSSGGGCCH----------HHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred CC-CccccccCCcceeCc----------ccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 43 234456899999999 777777765 79999999999999999999987532 22333444
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......|.... ..+.+++.+||..||.+|||++|+++
T Consensus 227 ~~~~~~~p~~~s----~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 227 LRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHCCCCCCTTSC----HHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 444444444333 34789999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.36 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=206.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|...+.||+|+||+||+|+.. +++.||+|++.. ......+.|.+|+++++.++||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 457999999999999999999865 688999999854 344567789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999999864 35689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcc--------------eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 664 PNSSNW--------------TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 664 ~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
...... ....||+.|+|| |.+.+..++.++||||||+++|||++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP----------EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp --------------------CCCCSCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cccccccccccccccccccccccCCCcceeCH----------HHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 432211 145799999999 78888889999999999999999999999976432211
Q ss_pred CCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 730 SSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..... ......+...+ .. .+..+.+++.+||+.||++|||+.|+++.|
T Consensus 230 ~~~~~---~~~~~~~~~~~--~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 230 MDFGL---NVRGFLDRYCP--PN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp TTSSB---CHHHHHHHTCC--TT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhh---hhhccccccCC--CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11111 11111111111 11 112488999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.02 Aligned_cols=255 Identities=18% Similarity=0.253 Sum_probs=212.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc--hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ--MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.+.|++.+.||+|+||+||+|+.. +++.||||++........ ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357999999999999999999865 689999999976432211 12356889999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC----cEEEeccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY----EARVSDFG 657 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 657 (786)
++||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999753 5789999999999999999999999 999999999999998876 79999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
+++...... ......||+.|+|| |+..+..++.++||||+||++|+|++|..||.... ...
T Consensus 165 ~a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~ 225 (361)
T 2yab_A 165 LAHEIEDGV-EFKNIFGTPEFVAP----------EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQE 225 (361)
T ss_dssp SCEECCTTC-CCCCCCSCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHH
T ss_pred CceEcCCCC-ccccCCCCccEECc----------hHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHH
Confidence 998876532 33456899999999 78888889999999999999999999999986422 223
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.......+...+...+..+.+++..||.+||++|||+.|+++
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 33444444444443333344556899999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.42 Aligned_cols=266 Identities=31% Similarity=0.502 Sum_probs=214.8
Q ss_pred HHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
...+++|+..+.||+|+||+||+|+.++++.||||++... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 3456789999999999999999999888999999998652 234567899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 582 FVVYEYINRGSLATVLSNNFA-SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999975432 23689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch---
Q 047901 661 LLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI--- 735 (786)
Q Consensus 661 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~--- 735 (786)
....... ......||+.|+|| |...+..++.++|||||||++|||++|+.||.............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDP----------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCH----------HHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred ccccccccccccccCCCccccCH----------HHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 7643221 22345689999999 78888889999999999999999999999987533211110000
Q ss_pred ----hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 736 ----NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 736 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......++.... .....+.+..+.+++.+||+.||++|||+.|+++.|
T Consensus 258 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHTTTCCCSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccccccHHHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0001111222221 122345667899999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=362.58 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=212.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 357999999999999999999865 6788999998642 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC--CCcEEEecccccee
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL--EYEARVSDFGTAKL 661 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~ 661 (786)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999999753 34689999999999999999999999 9999999999999987 78999999999998
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.... .......||+.|+|| |...+..+++++||||+||++|||++|..||.... .......
T Consensus 154 ~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~ 214 (321)
T 1tki_A 154 LKPG-DNFRLLFTAPEYYAP----------EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIEN 214 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCH----------HHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred CCCC-CccccccCChhhcCc----------HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHH
Confidence 7643 334556899999999 77777788999999999999999999999986422 2333444
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.......+.......+..+.+++.+||..||++|||+.|+++
T Consensus 215 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4444444443333344567899999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.69 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=212.6
Q ss_pred cccHHHHHHHhcc----------CccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc
Q 047901 495 KIMYEEIIRRTKD----------FDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563 (786)
Q Consensus 495 ~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l 563 (786)
.++++++..+++. |+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.+
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDY 99 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhC
Confidence 4566777666653 677789999999999999876 79999999987522 23456788999999999
Q ss_pred CCCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCce
Q 047901 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNV 643 (786)
Q Consensus 564 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 643 (786)
+||||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 999999999999999999999999999999999864 4689999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 644 LLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 644 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
+++.++.+||+|||+++.............||+.|+|| |...+..++.++|||||||++|||++|+.||.
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP----------EVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCH----------hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999998876544444556899999999 77888889999999999999999999999986
Q ss_pred ccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 724 FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ......+.....+.. ......+..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 243 SDSP--------VQAMKRLRDSPPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TSCH--------HHHHHHHHHSSCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCH--------HHHHHHHhcCCCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4321 112222222211111 011122345889999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=375.70 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=212.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 567999999999999999999754 78899999987532 223445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC---CCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD---LEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+|+
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999999864 5689999999999999999999999 999999999999998 46889999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
.............||+.|+|| |+..+..++.++||||+||++|+|++|..||.... ......
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~AP----------E~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~ 223 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSP----------EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQ 223 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHH
T ss_pred EecCCCceeecccCCcccCCH----------HHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHH
Confidence 876655545567899999999 78888889999999999999999999999986422 223334
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+...+...+..+.+++..||+.||++|||+.|+++
T Consensus 224 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 44444444333333334456899999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=363.95 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=209.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.+ +++.||||++..... ........+.+|+.+++.++||||+++++++...+..|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 357999999999999999999865 689999999864210 012345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999999764 5689999999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.........+||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .......+.
T Consensus 157 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~ 218 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELIL 218 (337)
T ss_dssp CTTCCBCCCEECGGGCCG----------GGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred cCCCcccccccChhhCCh----------hhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHH
Confidence 444445567899999999 66677789999999999999999999999986422 222333344
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
......|... +..+.+++..||++||++|| +++|+++
T Consensus 219 ~~~~~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 219 MEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HCCCCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCCCCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 4444444332 23488999999999999999 8999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=366.12 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=207.4
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
.++|++.+.||+|+||+||+|+.. ++..||||++... ......+.+.+|+++++.+ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 357999999999999999999752 3457999999752 2344567899999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..|+||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999986532 24589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
||++.++.+||+|||+|+........ .....+|+.|+|| |+..+..++.++|||||||++|||++ |+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DvwslG~il~ellt~g~ 303 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP----------EALFDRVYTHQSDVWSFGVLMWEIFTLGG 303 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH----------HHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECH----------hHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999977543321 2234678899999 78888889999999999999999999 99
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||..... ......+... +...+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 304 ~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 304 SPYPGIPV--------EELFKLLKEGHRMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp CSSTTCCG--------GGHHHHHHTTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCH--------HHHHHHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99875321 1122222222 1222322 233588999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.46 Aligned_cols=275 Identities=31% Similarity=0.482 Sum_probs=221.6
Q ss_pred ccccHHHHHHHhccCccc------eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc
Q 047901 494 GKIMYEEIIRRTKDFDAK------YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN 567 (786)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 567 (786)
..+.++++...++.|... +.||+|+||+||+|.. +++.||||++............+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457788999999888877 8999999999999987 588999999976443334455678999999999999999
Q ss_pred ccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 568 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
|+++++++...+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997654456799999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 047901 648 EYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~ 725 (786)
++.+||+|||+++........ .....||+.|+|| |...+ .++.++||||||+++|||++|+.||...
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP----------E~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP----------EALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH----------HHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCCh----------HHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 999999999999876543222 2235789999999 65543 5789999999999999999999998754
Q ss_pred ccccCCCcc------hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 726 SLFSSSSSS------INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 726 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......... ........++..+.. .....+..+.+++..||+.||++|||+.+|++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp BSSSBTTHHHHHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cchHHHHHHHHHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 321111000 001112223333321 2344556799999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=367.61 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=205.3
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
..++|++.+.||+|+||+||+|+.+ +++.||||++..... ........+.+|..+++.+ +||||+++++++.+.+..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3568999999999999999999865 688999999864110 1123455678899999988 699999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+||||+++|+|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999999764 5689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...........+||+.|+|| |++.+..++.++||||+||++|||++|+.||.... .......
T Consensus 174 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~ 235 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAP----------EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEA 235 (353)
T ss_dssp SCC---------CCGGGCCH----------HHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred cccCCccccccCCCcCeECh----------hhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 55444445567899999999 78888889999999999999999999999987432 2334455
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM------QTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~ 784 (786)
+.......|.... ..+.+++..||.+||++||++ +|+++
T Consensus 236 i~~~~~~~p~~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDEVVYPTWLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCCCCCCTTSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCCCCCCCCCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 5555555554333 348899999999999999998 66654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=385.30 Aligned_cols=383 Identities=18% Similarity=0.187 Sum_probs=308.0
Q ss_pred CCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcE
Q 047901 23 SSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKY 101 (786)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 101 (786)
..+...+++|+++|+++++ |..+. ++|++|+|++|+|+++.|.+|..+++|++|+|++|+|+++.+ .|..+++|++
T Consensus 28 ~~~~~~~~l~ls~~~L~~i-p~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 104 (562)
T 3a79_B 28 FSNELESMVDYSNRNLTHV-PKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104 (562)
T ss_dssp -----CCEEECTTSCCCSC-CTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred cccCCCcEEEcCCCCCccC-CCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence 3445568999999999864 44443 799999999999998888999999999999999999998865 5899999999
Q ss_pred EEccCCcCcccCchhhcccCCcceecccccccccc-CChhhhccCccceeecccccccCCCCCcCCCCCC--cEEEccCc
Q 047901 102 ISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQ-LPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSL--VRAHLGRN 178 (786)
Q Consensus 102 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L--~~L~L~~N 178 (786)
|+|++|+|+.+++. .+++|++|+|++|++++. .|..|..+++|+.|++++|.++. ..+..+++| +.|++++|
T Consensus 105 L~Ls~N~l~~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~L~~n 179 (562)
T 3a79_B 105 LDVSHNRLQNISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ--LDLLPVAHLHLSCILLDLV 179 (562)
T ss_dssp EECTTSCCCEECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT--TTTGGGTTSCEEEEEEEES
T ss_pred EECCCCcCCccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc--CchhhhhhceeeEEEeecc
Confidence 99999999976655 899999999999999974 46899999999999999999986 345556666 99999999
Q ss_pred cc--ccccCcccCC--------------------------CCCCCEEeccCCcc--------------------------
Q 047901 179 NL--TGNISEDFGI--------------------------YPNLKFLDLSHNNF-------------------------- 204 (786)
Q Consensus 179 ~l--~~~~~~~f~~--------------------------l~~L~~L~L~~N~i-------------------------- 204 (786)
++ ++..+..|.. +++|+.|++++|+.
T Consensus 180 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~ 259 (562)
T 3a79_B 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259 (562)
T ss_dssp SCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEE
T ss_pred cccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCC
Confidence 99 6666666554 44666667666631
Q ss_pred --c-----cccCcCccCCCCccEEEccCcccCCCCCccc-----cCCccccEEEeecccccccCC-CCcccc---ccccc
Q 047901 205 --Y-----GEISSNWGKCHRLGTLIVSGNNITGRIPPEI-----GNSSQLHVLDLSSNHIAGEIP-MELGRL---ISLNK 268 (786)
Q Consensus 205 --~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~i~~~~~-~~~~~l---~~L~~ 268 (786)
. ++.+ ....++|++|++++|++++.+|..+ ..++.|+.++++.|.+ .+| ..+..+ .+|+.
T Consensus 260 ~l~~~~~~~~~~--~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~ 335 (562)
T 3a79_B 260 ETTWKCSVKLFQ--FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKM 335 (562)
T ss_dssp EECHHHHHHHHH--HHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSE
T ss_pred cCcHHHHHHHHH--hhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceE
Confidence 0 0000 1122489999999999998888877 7788888888888877 233 333332 57999
Q ss_pred ccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCc--chHHhhhcCcCeeeccCC
Q 047901 269 LILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI--PEDLALLAHLSELDLSHN 346 (786)
Q Consensus 269 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N 346 (786)
|++++|.+.... ....+++|+.|++++|++++..+..+..+++|++|+|++|++++.. |..|..+++|+.|+|++|
T Consensus 336 L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N 413 (562)
T 3a79_B 336 LSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413 (562)
T ss_dssp EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTS
T ss_pred EEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCC
Confidence 999999987432 2378899999999999999988999999999999999999999744 466899999999999999
Q ss_pred ccCCCCC-cccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCCCC
Q 047901 347 LFKGSIP-SRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFST 421 (786)
Q Consensus 347 ~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~ 421 (786)
++++.+| ..+..+++|+.|++++|++++..|..+. ++|+.|++++|+++..++............+.+|....
T Consensus 414 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp CCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCC
T ss_pred cCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCC
Confidence 9998344 5688999999999999999987776654 79999999999999765555555666677788888753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.15 Aligned_cols=258 Identities=20% Similarity=0.245 Sum_probs=210.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCC-CCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPF-PNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||+||+|+.+ +++.||||++.... ........+.+.+|+++++.++||||+++++++...+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999864 78999999985311 0011123567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc---EEEecccc
Q 047901 583 VVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE---ARVSDFGT 658 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg~ 658 (786)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886432 234589999999999999999999999 9999999999999986654 99999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
++.............||+.|+|| |...+..++.++||||+||++|||++|+.||.... ...
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~ 240 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAP----------EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERL 240 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHH
T ss_pred eeEecCCCeeecCCcCCcCccCH----------HHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHH
Confidence 99876554444556899999999 78888889999999999999999999999986421 223
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.......+...+...+..+.+++.+||..||++|||+.|+++
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3344444444333223334556899999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=359.23 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=210.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCC--chhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPND--QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.+.|+..+.||+|+||+||+|+.. +++.||||++....... .....+.+.+|+++++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346999999999999999999865 68999999987643221 112467899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC----cEEEeccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY----EARVSDFG 657 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 657 (786)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999753 5689999999999999999999999 999999999999999887 89999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
+++...... ......||+.|+|| |+..+..++.++|||||||++|||++|+.||.... ...
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~ 224 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAP----------EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQE 224 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHH
T ss_pred CCeECCCCC-ccccccCCcCcCCc----------eeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHH
Confidence 998875432 23446799999999 77888889999999999999999999999986422 122
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.......+.......+..+.+++..||..||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22333333333332222333456889999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=367.47 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=208.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||+||+|+.+ +++.||||++...... .....+.+..|..++.++ +||||+++++++.+.+..|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 457999999999999999999865 6788999998753221 122334677899999887 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++|+|.+++... +.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999999864 5689999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-cchhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-SSINIEFNA 741 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~ 741 (786)
..........+||+.|+|| |++.+..++.++||||+||++|||++|+.||.......... .........
T Consensus 204 ~~~~~~~~~~~gt~~Y~aP----------E~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAP----------EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ccCCCccccccCCcccCCc----------hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 4444445567899999999 88888899999999999999999999999996432211111 111223344
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM------QTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~ 784 (786)
+.......|.... ..+.+++..||++||++||++ +|+++
T Consensus 274 i~~~~~~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 274 ILEKQIRIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHHCCCCCCTTSC----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred HhccccCCCCcCC----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 4455555554333 348899999999999999996 56654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=363.80 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=211.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|..+ +++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 467999999999999999999865 689999999975322 23455678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999999754 5689999999999999999999999 99999999999999865 459999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ......||+.|+|| |+..+..++.++||||+||++|||++|+.||.... ......
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~ 240 (362)
T 2bdw_A 180 EVNDSE-AWHGFAGTPGYLSP----------EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYA 240 (362)
T ss_dssp CCTTCC-SCCCSCSCTTTCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred EecCCc-ccccCCCCccccCH----------HHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 776432 33456899999999 77888889999999999999999999999986422 122333
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+...+...+..+.+++.+||..||++|||+.|+++
T Consensus 241 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33444444343333344556899999999999999999999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.96 Aligned_cols=348 Identities=25% Similarity=0.351 Sum_probs=305.1
Q ss_pred CCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEE
Q 047901 24 SFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYIS 103 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 103 (786)
.+++++.|++++|.+..+ | .+..+++|++|+|++|+++++.+ |..+++|++|+|++|++++.++ +..+++|++|+
T Consensus 44 ~l~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~ 118 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLT 118 (466)
T ss_dssp HHHTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred HhccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEE
Confidence 467899999999999754 3 38889999999999999986654 8999999999999999987766 88999999999
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN 183 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~ 183 (786)
|++|+++++.+ |.++++|++|++++|++++. + .+..+++|+.|+++ |.+.... .+.++++|+.|++++|.++.+
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~-~~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK-PLANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG-GGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch-hhccCCCCCEEECcCCcCCCC
Confidence 99999997654 89999999999999999853 3 58889999999996 5555443 488999999999999999876
Q ss_pred cCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccc
Q 047901 184 ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL 263 (786)
Q Consensus 184 ~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 263 (786)
..+..+++|++|++++|++.++.+ +..+++|++|++++|+++++ +.+..+++|+.|++++|.+.+..+ +..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 264 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 264 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred --hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC
Confidence 358899999999999999998766 78899999999999999864 578899999999999999987655 8899
Q ss_pred cccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeec
Q 047901 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343 (786)
Q Consensus 264 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 343 (786)
++|+.|++++|.+++..+ +..+++|+.|++++|++.++.+ +..+++|++|++++|++++..| +..+++|+.|++
T Consensus 265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 338 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence 999999999999997655 8899999999999999998765 8899999999999999998766 789999999999
Q ss_pred cCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccC
Q 047901 344 SHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPI 400 (786)
Q Consensus 344 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 400 (786)
++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|++++.+
T Consensus 339 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 339 YNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred CCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence 99999965 578999999999999999998887 889999999999999998743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.71 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=198.5
Q ss_pred hccCccceeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|++.+.||+|+||+||+|+. .+++.||+|++..............+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 47889999999764322233345568899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999764 4688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
.............||+.|+|| |...+..++.++|||||||++|||++|+.||.... ......
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~ 231 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAP----------EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTID 231 (327)
T ss_dssp ---------CTTSSCCTTSCH----------HHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHH
T ss_pred ccccCCccccccCCCcCccCH----------hhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 654443334456799999999 77878889999999999999999999999987432 223334
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.+.......|.... ..+.+++.+||..||++|| ++.|+++
T Consensus 232 ~i~~~~~~~p~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 232 KILKCKLNLPPYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHTCCCCCTTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHhCCCCCCCCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 44444444443322 3488999999999999999 7778765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=357.90 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=204.2
Q ss_pred hccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|++.+.||+|+||+||+|+.. .+..||||++... ......+.|.+|+++++.++||||+++++++.+.+.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 357889999999999999999864 3345999999752 234456789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999754 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 661 LLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 661 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
........ .....+|+.|+|| |...+..++.++|||||||++|||++ |+.||..... .
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~ 261 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAP----------EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------R 261 (325)
T ss_dssp ECC----CCEECC---CCGGGSCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------H
T ss_pred ccccCccceeeccCCCCcccccCH----------hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------H
Confidence 87644322 1223567789999 78888889999999999999999999 9999864321 1
Q ss_pred hhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+... +...+.. .+..+.+++..||..||++|||+.||++.|
T Consensus 262 ~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 262 DVISSVEEGYRLPAPMG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp HHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCC----cCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 222222222 2222222 234588999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=358.72 Aligned_cols=251 Identities=20% Similarity=0.370 Sum_probs=204.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 467999999999999999999876 78999999997532 2345678999999999999999999999885433
Q ss_pred -----------------------------------------------------eeeEEEeccCCCCHHHHhhcCCCCCCC
Q 047901 580 -----------------------------------------------------HSFVVYEYINRGSLATVLSNNFASEDF 606 (786)
Q Consensus 580 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~ 606 (786)
..++||||+++|+|.+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999877655667
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC------------cceeecc
Q 047901 607 DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS------------NWTELVG 674 (786)
Q Consensus 607 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~g 674 (786)
++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 8888999999999999999999 999999999999999999999999999998765421 1233579
Q ss_pred CccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhH
Q 047901 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDV 754 (786)
Q Consensus 675 t~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (786)
|+.|+|| |...+..++.++|||||||++|||++|..|+.. ............. +...
T Consensus 239 t~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~~~~---~~~~ 295 (332)
T 3qd2_B 239 TKLYMSP----------EQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRNLKF---PLLF 295 (332)
T ss_dssp CGGGSCH----------HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHTTCC---CHHH
T ss_pred CcCccCh----------HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhccCC---Cccc
Confidence 9999999 788888899999999999999999999887321 1111122222221 2233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 755 QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 755 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.+++..||+.||++|||++|+++
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 444566889999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=359.40 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=209.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|+..+.||+|+||.||+|+.+ +++.||||++..... ......+.+.+|..+++++ +||||+++++++.+.+..|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 357999999999999999999865 688999999975322 2234456788999999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++|+|.+++... +.+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999999764 4689999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-cchhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-SSINIEFNA 741 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~ 741 (786)
..........+||+.|+|| |+..+..++.++||||+||++|||++|+.||.......... .........
T Consensus 161 ~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAP----------EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred cCCCCcccccCCCccccCc----------cccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 4444445567899999999 78888889999999999999999999999996432111111 111222333
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM------QTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~ 784 (786)
+.......|... +..+.+++.+||+.||++||++ +|+++
T Consensus 231 i~~~~~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 231 ILEKQIRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHHCCCCCCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HHcCCCCCCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 444444444332 2348899999999999999996 56653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.06 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=202.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.. +++.||+|++..... ......+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 57999999999999999999854 788999999865332 3344567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999765 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... ......||+.|+|| |...+..++.++||||+|+++|||++|+.||..... ........
T Consensus 164 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~ 225 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSP----------EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHI 225 (294)
T ss_dssp -----------CCSSCCH----------HHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHH
T ss_pred ccccccCccccCccccCH----------hHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHh
Confidence 322 22345799999999 788888899999999999999999999999875321 11112222
Q ss_pred cCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHh
Q 047901 744 DHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRP-TMQTVCQL 785 (786)
Q Consensus 744 ~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~ 785 (786)
....+.. .......+..+.+++.+||.+||++|| +++++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHH
T ss_pred hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHH
Confidence 2222110 001112234588999999999999999 88887764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=355.74 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=207.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC--eee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR--HSF 582 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~ 582 (786)
++|.+.+.||+|+||+||+|+.. +++.||||++... ......+.+.+|++++++++||||+++++++.... ..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI---SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGG---GGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccc---cccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 57999999999999999999865 5899999998642 12234567889999999999999999999987655 779
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee----CCCCcEEEecccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL----DLEYEARVSDFGT 658 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfg~ 658 (786)
+||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999998764445599999999999999999999999 99999999999999 7888999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh--------hcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY--------TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~--------~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
|+...... ......||+.|+|| |+.. +..++.++|||||||++|||++|+.||.......
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~- 230 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHP----------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR- 230 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCH----------HHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG-
T ss_pred ceecCCCC-ceeecccCCCccCH----------HHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc-
Confidence 99876543 23445799999999 5554 4678999999999999999999999986432111
Q ss_pred CCcchhhhhhhhccC---------------------CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 731 SSSSINIEFNAMLDH---------------------RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
........+... ..+.+..........+.+++..||+.||++|||++|+++.
T Consensus 231 ---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 231 ---RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp ---GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ---hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 111111111111 1122222335566678999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=355.31 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=197.9
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhh--cCCCcccceeeEEec----C
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK--IRHRNIVKFYGFCSH----V 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~----~ 578 (786)
.++|+..+.||+|+||+||+|+. +++.||||++.. .....+..|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46799999999999999999988 588999999854 234566677777766 799999999998644 3
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEcCCCCCceeeCCCCc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH--------HDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
...++||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 568999999999999999953 46899999999999999999999 77 9999999999999999999
Q ss_pred EEEeccccceecCCCCCc----ceeeccCccccCCCCCCCCchHHHHhhhc------CcCcccchHHHHHHHHHHHhC--
Q 047901 651 ARVSDFGTAKLLKPNSSN----WTELVGTFGYVAPAHGNIGLHLAELAYTM------KITEKCDVYSFGVLALEVIKG-- 718 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~------~~~~~sDvwslGvil~elltg-- 718 (786)
+||+|||+|+........ .....||+.|+|| |...+. .+++++|||||||++|||+||
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~ 221 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP----------EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCH----------HHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeCh----------hhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence 999999999876544332 2234799999999 666554 456799999999999999999
Q ss_pred --------CCCCCccccccCCCcchhhhhhhhcc---CCCCCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 719 --------KHPGDFLSLFSSSSSSINIEFNAMLD---HRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 719 --------~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.||....... ........... .+...+.. .....+..+.+++..||+.||++|||+.||++.|
T Consensus 222 ~~~~~~~~~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 222 SNGIVEDYKPPFYDVVPND----PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp BTTBCCCCCCTTTTTSCSS----CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CccccccccccccccCCCC----cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 77765322111 11111222211 11222221 2234566799999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=353.50 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=201.9
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|+..+++.||||++.... ......+.+.+|+++++.++||||+++++++...+..++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc--ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 36799999999999999999998889999999997532 2223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 98 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 888888754 35689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.........||+.|+|| |...+ ..++.++||||+||++|||++|+.||....... .........
T Consensus 172 ~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~ 236 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAP----------DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QLPKIFSIL 236 (311)
T ss_dssp CCC---CCCCCCTTCCH----------HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HHHHHHHHH
T ss_pred CcccccCCcccCCcCCH----------HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHH
Confidence 54455566899999999 66654 568999999999999999999999987533210 000000000
Q ss_pred c------------------CCCCC-CChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 D------------------HRLPH-PSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~------------------~~~~~-~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. ..... ..... .....++.+++.+||..||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00000 00000 112245889999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=368.22 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=206.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|...+.||+|+||+||+|++. +++.||||++... ......+.|.+|++++++++||||+++++++...+..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 467999999999999999999976 7899999998752 223345578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 190 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999754 34689999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCcc--eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhh
Q 047901 664 PNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 664 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ....++..|+|| |......++.++|||||||++|||+| |..||..... ....
T Consensus 265 ~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~ 325 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAP----------EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTR 325 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHH
T ss_pred CCceeecCCCCCCCcCcCCH----------hHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH
Confidence 332111 122457789999 78888889999999999999999998 9999875321 1122
Q ss_pred hhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 741 AMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 741 ~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+. .+.+.|... +..+.++|..||+.||++|||++++++.|
T Consensus 326 ~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 326 EFVEKGGRLPCPELC----PDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp HHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 2222 223333322 23588999999999999999999999864
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.46 Aligned_cols=344 Identities=26% Similarity=0.358 Sum_probs=308.1
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+|+.|+++++++. .++. |..+++|++|||++|.++++.+ |.++++|++|+|++|+++++.+ |..+++|++|+|
T Consensus 47 ~l~~L~l~~~~i~-~l~~--~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 47 QVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp TCCEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred cccEEecCCCCCc-cCcc--hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 5789999999987 5765 7889999999999999987765 9999999999999999997655 999999999999
Q ss_pred CCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCC
Q 047901 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSI 161 (786)
Q Consensus 82 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~ 161 (786)
++|++++.++ +..+++|++|+|++|+++++. .+.++++|++|+++ |.+.+.. .+..+++|+.|++++|.+...
T Consensus 120 ~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~- 192 (466)
T 1o6v_A 120 FNNQITDIDP-LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI- 192 (466)
T ss_dssp CSSCCCCCGG-GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-
T ss_pred CCCCCCCChH-HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-
Confidence 9999998765 889999999999999999653 59999999999997 5665433 389999999999999999875
Q ss_pred CCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcc
Q 047901 162 PNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ 241 (786)
Q Consensus 162 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 241 (786)
+.+..+++|+.|++++|+++++.+ ++.+++|++|++++|+++++ ..+..+++|+.|++++|.+++..+ +..+++
T Consensus 193 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 266 (466)
T 1o6v_A 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTK 266 (466)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCC
Confidence 458899999999999999998765 78899999999999999875 468899999999999999997644 899999
Q ss_pred ccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecc
Q 047901 242 LHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSH 321 (786)
Q Consensus 242 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 321 (786)
|+.|++++|.+++..+ +..+++|+.|++++|+++++.+ +..+++|+.|++++|+++++.+ +..+++|++|++++
T Consensus 267 L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 340 (466)
T 1o6v_A 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340 (466)
T ss_dssp CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred CCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCC
Confidence 9999999999997654 8899999999999999997655 8899999999999999998765 78999999999999
Q ss_pred cccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccccccc
Q 047901 322 NQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375 (786)
Q Consensus 322 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 375 (786)
|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 341 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 341 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp SCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred CccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 999876 478999999999999999997766 89999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.29 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=189.0
Q ss_pred ceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEEEecc
Q 047901 511 KYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
.+.||+|+||+||+|+.. +++.||||++.. .....+.+|+.+++.+. ||||+++++++.+....|+||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 478999999999999865 689999999853 24467789999999997 999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC---cEEEeccccceecCCC
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY---EARVSDFGTAKLLKPN 665 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~~~ 665 (786)
++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 89 NGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999999864 5789999999999999999999999 999999999999997665 8999999999987655
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
........||+.|+|| |...+..++.++||||+||++|||++|+.||....... ...........+...
T Consensus 163 ~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAP----------ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKG 231 (325)
T ss_dssp -------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTT
T ss_pred CCcccccCCCcCccCH----------HHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcC
Confidence 5555567899999999 66667789999999999999999999999987543211 111223334445555
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+...+...+..+.+++..||..||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 555555444555667999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.93 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=207.7
Q ss_pred HHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCe
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~ 580 (786)
...++|+..+.||+|+||+||+|+.+ +++.||||++..... ......+.+..|..++..+ +||||+++++++.+.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34578999999999999999999875 688999999864210 0112345678899999877 89999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999999764 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
............+||+.|+|| |+..+..++.++||||+||++|||++|+.||.... ......
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~ 228 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAP----------EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFH 228 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred hcccCCCcccCCCCCcccCCh----------hhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHH
Confidence 755444445567899999999 78888889999999999999999999999987432 122333
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ-TVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~ 784 (786)
.+.......|... +..+.+++.+||..||++||++. |+++
T Consensus 229 ~i~~~~~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 229 SIRMDNPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHCCCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHhCCCCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 3333333333322 23588999999999999999997 6653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.27 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=206.8
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|+.+++..||||++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-----TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-----CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 4679999999999999999999988889999999652 12346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999999764 34589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....+|+.|+|| |...+..++.++||||+|+++|||++ |+.||+.... ......+
T Consensus 157 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~ 218 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAP----------EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKV 218 (268)
T ss_dssp TCEEECCSCCCCGGGCCH----------HHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHH
T ss_pred hhhhcccCCCcCcccCCH----------HHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHH
Confidence 4321 2234567789999 78888889999999999999999999 9999874321 1122222
Q ss_pred ccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.... ...+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 219 ~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 219 SQGHRLYRPHLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HTTCCCCCCTTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCCCcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2222 2222222 23488999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.98 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=208.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 357999999999999999999865 6889999998652 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC--CCcEEEecccccee
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL--EYEARVSDFGTAKL 661 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~ 661 (786)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 126 v~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999999999753 34689999999999999999999999 9999999999999974 47899999999998
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
..... ......||+.|+|| |+..+..++.++|||||||++|||++|+.||..... ......
T Consensus 201 ~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~ 261 (387)
T 1kob_A 201 LNPDE-IVKVTTATAEFAAP----------EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQN 261 (387)
T ss_dssp CCTTS-CEEEECSSGGGCCH----------HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH
T ss_pred cCCCc-ceeeeccCCCccCc----------hhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 76432 33456899999999 788888899999999999999999999999874321 222233
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.......+.......+..+.+++..||..||++|||+.|+++
T Consensus 262 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 262 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 3333322222222233446899999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.31 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=206.8
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|+..+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-----SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-----ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 4579999999999999999999888899999999752 12346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999754 35689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......+|+.|+|| |......+++++||||+|+++|||++ |+.||.... .......+
T Consensus 159 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~ 220 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASP----------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDI 220 (269)
T ss_dssp HHHHSTTSTTCCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHH
T ss_pred cccccccCcccccccCCH----------HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHH
Confidence 211 12234567889999 78888889999999999999999999 999987432 11222222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 221 STGFRLYKPRLA----STHVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp HTTCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCccCCCCCcC----CHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 222 22222222 23488999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=362.78 Aligned_cols=252 Identities=24% Similarity=0.435 Sum_probs=194.6
Q ss_pred hccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
..+|+..+.||+|+||+||+|+.. ++..||||++... ......+.|.+|+.++++++||||+++++++...+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 357999999999999999999864 5678999999753 233456789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999764 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 661 LLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 661 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
........ .....++..|+|| |...+..++.++|||||||++|||++ |+.||..... .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~ 257 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSP----------EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------Q 257 (373)
T ss_dssp ------------------CTTSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------H
T ss_pred ccccCCccceeccCCCcCCCccCh----------hhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 77543221 1122457789999 88888899999999999999999998 9999864321 1
Q ss_pred hhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+... +.+.+.. .+..+.+++..||+.||++|||+.+|++.|
T Consensus 258 ~~~~~i~~~~~~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 258 DVIKAVDEGYRLPPPMD----CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp HHHHHHHTTEECCCCTT----CBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCcc----ccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 111222111 1222222 234588999999999999999999998864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.19 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=208.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 357999999999999999999865 789999999864210 111235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999999864 5689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ....+||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .......+.
T Consensus 158 ~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~ 216 (318)
T 1fot_A 158 DV---TYTLCGTPDYIAP----------EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKIL 216 (318)
T ss_dssp SC---BCCCCSCTTTCCH----------HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred Cc---cccccCCccccCH----------hHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 32 2346899999999 78888889999999999999999999999986432 223344444
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
......|.... ..+.+++.+||..||++|| +++|+++
T Consensus 217 ~~~~~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 217 NAELRFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HCCCCCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hCCCCCCCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 55554444332 3488999999999999999 8888874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.64 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=201.9
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----e
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR----H 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~ 580 (786)
.++|+..+.||+|+||+||+|+.. ++.||||++.. .......+..|+.++++++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI-----QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeec-----CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 468999999999999999999875 78999999864 2233445667888999999999999999997644 4
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEEcCCCCCceeeCCCCcEEE
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC-------FPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+.. .++|+||||||+||+++.++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 69999999999999999753 4899999999999999999999861 238999999999999999999999
Q ss_pred eccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhh-----cCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 047901 654 SDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYT-----MKITEKCDVYSFGVLALEVIKGKHPGDFLS 726 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~-----~~~~~~sDvwslGvil~elltg~~Pf~~~~ 726 (786)
+|||+|+........ .....||+.|+|| |...+ ..++.++|||||||++|||+||+.||....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAP----------EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCH----------HHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccCccccccCccCccccCH----------hhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999877643322 2335799999999 55554 356678999999999999999999987533
Q ss_pred cccCCC-------cchhhhhhhhc-cCCCC--CCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 727 LFSSSS-------SSINIEFNAML-DHRLP--HPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 727 ~~~~~~-------~~~~~~~~~~~-~~~~~--~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...... ........... ..... .+.. .....+..+.+++.+||+.||++|||+.||++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 211000 00111111111 11111 1111 1123455699999999999999999999999864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=384.56 Aligned_cols=395 Identities=21% Similarity=0.175 Sum_probs=327.4
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+|++|.+. .+++.+|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|+.+++|++|+|
T Consensus 77 ~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 77 ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 5889999999998 688889999999999999999999999999999999999999999999888889999999999999
Q ss_pred CCccCcccC--CCCCCCCCCcEEEccCCcCcccCchhhcccCCcc----eeccccccccccCChhhhc------------
Q 047901 82 SLNQFSGTF--PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLS----YLMLDTNQFTGQLPRNICR------------ 143 (786)
Q Consensus 82 s~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~------------ 143 (786)
++|++++.. ..+..+++|++|+|++|+|+++.+..|..+.+++ .++++.|.++...+..+..
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccc
Confidence 999998653 3478899999999999999999999988777655 5677777776433332211
Q ss_pred ------------cCc---------------------------------------------------------cceeeccc
Q 047901 144 ------------SGL---------------------------------------------------------LEILTVND 154 (786)
Q Consensus 144 ------------~~~---------------------------------------------------------L~~L~l~~ 154 (786)
+.. ++.+.+.+
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence 111 11111111
Q ss_pred ccccCCCCCcCCCCCCcEEEccCcccccccCc-------------------ccCCCCCCCEEeccCCcccc--ccCcCcc
Q 047901 155 NHFLGSIPNLRNCRSLVRAHLGRNNLTGNISE-------------------DFGIYPNLKFLDLSHNNFYG--EISSNWG 213 (786)
Q Consensus 155 N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-------------------~f~~l~~L~~L~L~~N~i~~--~~~~~~~ 213 (786)
|.+... ..+....+|+.|++.+|.+..+... .+..+++|+.|++++|.+.. ..+..+.
T Consensus 316 ~~~~~~-~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 316 VTIERV-KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp CEEEEC-GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred cccccc-cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence 111111 1233345566666666665544332 23457899999999999864 3455667
Q ss_pred CCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCC-CCcccccccccccccccccCCCCccccccCCcCce
Q 047901 214 KCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP-MELGRLISLNKLILRGNQLSGHLPRALGLLTELEY 292 (786)
Q Consensus 214 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 292 (786)
.+.+|+.|+++.|.+.. .+..+..+++|+.++++.|......+ ..|..+.+++.+++++|.+....+..+..+++|+.
T Consensus 395 ~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~ 473 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 473 (635)
T ss_dssp SCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred hhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 88999999999999984 56678899999999999998776554 56899999999999999999999999999999999
Q ss_pred eccccccc-cccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccc
Q 047901 293 FDLSSNRL-NNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371 (786)
Q Consensus 293 L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (786)
|++++|.+ ..+.++.|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~ 553 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 553 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence 99999984 55678899999999999999999999999999999999999999999998889999999999999999999
Q ss_pred ccccCCcccccC-CCceEEeccCCccccc
Q 047901 372 ISGQIPACFIGM-SGLLSIDISYNELRGP 399 (786)
Q Consensus 372 l~~~~p~~~~~l-~~L~~L~l~~N~l~~~ 399 (786)
|++..|..|..+ ++|+.|++++|++.+.
T Consensus 554 l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 554 IMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999998 6899999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.26 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=208.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 57999999999999999999865 789999999854110 1123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999864 4689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. ....+||+.|+|| |+..+..++.++|||||||++|||++|+.||.... .......+..
T Consensus 194 ~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~ 252 (350)
T 1rdq_E 194 R---TWTLCGTPEALAP----------EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVS 252 (350)
T ss_dssp C---BCCCEECGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred C---cccccCCccccCH----------HHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHc
Confidence 3 2346899999999 78888889999999999999999999999987422 2333444445
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
.....|.... ..+.+++.+||+.||++||+ ++|+++
T Consensus 253 ~~~~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 253 GKVRFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 5555444332 34889999999999999998 888864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=360.26 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=201.6
Q ss_pred ccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 509 DAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
...+.||+|+||.||+|+.. +++.||+|++.. ......+.+.+|++++++++||||+++++++...+..++||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEEC----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc----cccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 34678999999999999854 789999999975 2234567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee--CCCCcEEEeccccceecCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL--DLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill--~~~~~~kl~Dfg~a~~~~~~ 665 (786)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 168 ~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 168 VDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9999999998753 34689999999999999999999999 99999999999999 66789999999999987643
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 745 (786)
. ......||+.|+|| |+.....++.++|||||||++|||++|+.||.... .......+...
T Consensus 243 ~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~ 303 (373)
T 2x4f_A 243 E-KLKVNFGTPEFLAP----------EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILAC 303 (373)
T ss_dssp C-BCCCCCSSCTTCCH----------HHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT
T ss_pred c-ccccccCCCcEeCh----------hhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 3 23345799999999 77778889999999999999999999999987432 22333444444
Q ss_pred CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.......+..+.+++..||+.||++|||+.|+++
T Consensus 304 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 304 RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 444333333334456899999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=359.41 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=200.7
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|.+.+.||+|+||+||+|+. .+++.||||++..... ........+.+|+++++.++||||+++++++...+..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35799999999999999999986 5789999999854110 011223578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+ +|+|.+++... +.+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 67999998754 5689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. ......+||+.|+|| |...+..+ ++++||||+||++|+|++|+.||+..... .....+
T Consensus 160 ~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i 220 (336)
T 3h4j_B 160 DG-NFLKTSCGSPNYAAP----------EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP--------NLFKKV 220 (336)
T ss_dssp TS-BTTCCCTTSTTTSCG----------GGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST--------TCBCCC
T ss_pred CC-cccccccCCcCcCCH----------HHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH--------HHHHHH
Confidence 43 233456899999999 45545454 68999999999999999999998753211 111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......|... +..+.+++.+||..||.+|||++|+++
T Consensus 221 ~~~~~~~p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSCVYVMPDFL----SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSCCCCCTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcCCCCCcccC----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12222223222 234889999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=351.64 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=196.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc----------------------hhhHHHHHHHHHHHh
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ----------------------MSDQKEFLNEIKALT 561 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~ 561 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++........ ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999854 688999999875321110 112356889999999
Q ss_pred hcCCCcccceeeEEec--CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 047901 562 KIRHRNIVKFYGFCSH--VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDIS 639 (786)
Q Consensus 562 ~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk 639 (786)
.++||||+++++++.+ .+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999976 568899999999999988653 35789999999999999999999999 99999999
Q ss_pred CCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcC---cCcccchHHHHHHHHHHH
Q 047901 640 SNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMK---ITEKCDVYSFGVLALEVI 716 (786)
Q Consensus 640 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~---~~~~sDvwslGvil~ell 716 (786)
|+||+++.++.+||+|||+++.............||+.|+||| ...+.. ++.++|||||||++|||+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE----------~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE----------SLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGG----------GCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChh----------hhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999999999998765544445568999999995 443333 477899999999999999
Q ss_pred hCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 717 KGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 717 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+|+.||..... ......+.......+.. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 235 FGQCPFMDERI--------MCLHSKIKSQALEFPDQ--PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HSSCSSCCSSH--------HHHHHHHHHCCCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HCCCCCCCccH--------HHHHHHHhcccCCCCCc--cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99999874321 11122222222222210 112235889999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=358.79 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=209.1
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
..++|+..+.||+|+||+||+|+.+ +++.||||++..... ......+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3568999999999999999999876 578899999864210 0123356788999999988 799999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+||||+++|+|.+++... +.+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 97 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999999864 4689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...........+||+.|+|| |+..+..++.++|||||||++|||++|+.||.... .......
T Consensus 171 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~ 232 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAP----------EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQS 232 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCH----------HHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred cccCCcccccccCCccccCh----------hhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHH
Confidence 54444444567899999999 78888889999999999999999999999987422 2334444
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
+.......|... +..+.+++..||.+||++||+ ++|+++
T Consensus 233 i~~~~~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 IMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHCCCCCCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHhCCCCCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 555555544432 335889999999999999995 467654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.40 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=205.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||+||+|+.+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 567999999999999999999865 688999999975321 234688888888 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC----CcEEEecccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE----YEARVSDFGT 658 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~ 658 (786)
+||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||++..+ +.+||+|||+
T Consensus 93 lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 999999999999999754 5689999999999999999999999 99999999999998543 3599999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
++............+||+.|+|| |+..+..++.++||||+||++|||++|+.||.... .....+.
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~ 231 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAP----------EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEI 231 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCH----------HHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHH
T ss_pred cccCcCCCCceeccCCCccccCH----------HHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHH
Confidence 99876554445567899999999 77777778999999999999999999999987421 1122233
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.......+...+...+..+.+++..||..||++|||+.|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3344444444333223334456889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.32 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=202.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 357999999999999999999865 789999999865321 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999999743 5689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC--CcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 664 PNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 664 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
... .......||+.|+|| |...+..+ +.++||||+||++|||++|+.||..... ......
T Consensus 157 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~ 219 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAP----------ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYS 219 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCH----------HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT-------TSHHHH
T ss_pred cCCcccccCCCccCcCccCc----------HHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHH
Confidence 322 223456899999999 77766665 7789999999999999999999874321 111122
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........+. .......+.+++.+||..||++|||++|+++
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 220 DWKEKKTYLNP--WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHTTCTTSTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcccccCCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 22222221111 1223345789999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.82 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=191.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 457999999999999999999876 5789999999752 133567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999999754 5689999999999999999999999 9999999999999975 8999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... .......||+.|+|| |...+..++.++|||||||++|||++|+.||.... .......
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~ 261 (349)
T 2w4o_A 200 IVEHQ-VLMKTVCGTPGYCAP----------EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-------GDQFMFR 261 (349)
T ss_dssp --------------CGGGSCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-------CHHHHHH
T ss_pred ccCcc-cccccccCCCCccCH----------HHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-------ccHHHHH
Confidence 76533 223446799999999 78888889999999999999999999999986422 1122233
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+.......+..+.+++.+||..||++|||+.|+++
T Consensus 262 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 262 RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 33333333222222233456889999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.32 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=205.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 357999999999999999999865 688999999854110 112335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999999854 5689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......+||+.|+|||++.. ..+..++.++|||||||++|||++|+.||..... .........+.
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~ 233 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSS-------RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTFE 233 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCC-------CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHHH
T ss_pred CC-CceeccCCCccccCCeeecc-------CCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHh
Confidence 43 33455689999999953321 0134588999999999999999999999864221 11222233333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-MQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 784 (786)
......|.... ..+.+++..||..||++||+ ++++.+
T Consensus 234 ~~~~~~p~~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HCCCCCCTTSC----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hcccCCCCcCC----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 33344443322 34889999999999999998 777754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=349.90 Aligned_cols=261 Identities=22% Similarity=0.313 Sum_probs=198.5
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|+..+.||+|+||+||+|+..+++.||||++.... ......+.+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc--cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 4789999999999999999998889999999997532 12223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++ +|.+++... .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99986 999998754 35689999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------Ccc
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----------SSS 734 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----------~~~ 734 (786)
........||+.|+|| |...+ ..++.++||||+||++|||++|+.||......... ...
T Consensus 154 ~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAP----------DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (288)
T ss_dssp --------CCCTTCCH----------HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCc----------hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh
Confidence 4444556789999999 66654 45899999999999999999999998753311000 000
Q ss_pred hhhhhhh--hccCCCC--CC---ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNA--MLDHRLP--HP---SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~--~~~~~~~--~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....... ..+.... .+ .......+..+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000000 00 0000112345889999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.92 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=201.1
Q ss_pred hccCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-- 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-- 577 (786)
.++|++.+.||+|+||+||+|++ .+++.||||++.. ......+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 45799999999999999999983 3678999999875 234556789999999999999999999999854
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 35689999999999999999764 34589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccc-----c
Q 047901 658 TAKLLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF-----S 729 (786)
Q Consensus 658 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~-----~ 729 (786)
+++........ .....++..|+|| |...+..++.++||||||+++|||+||..||...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 229 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAP----------ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229 (295)
T ss_dssp SCC-------------CTTCGGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHC
T ss_pred ccccccCCcceeeeccCCCCccceeCc----------HHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhc
Confidence 99877543221 2234577789999 8888889999999999999999999999997643210 0
Q ss_pred C--CCcchhhhhhhhcc--CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 730 S--SSSSINIEFNAMLD--HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 730 ~--~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. ............+. .+.+.+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 230 NDKQGQMIVFHLIELLKNNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CccccchhHHHHHHHHhccCcCCCCcC----cCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 0 00000001111111 12222322 234589999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.44 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=193.5
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|++. ++.||||++............+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357999999999999999999975 8899999987643333334467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC--------CCcEEEecc
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL--------EYEARVSDF 656 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--------~~~~kl~Df 656 (786)
|||+++++|.+++.. ..+++..+..++.|++.|++|||+....+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999853 46899999999999999999999992222999999999999986 678999999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
|.++...... .....||+.|+|| |...+..+++++||||||+++|||++|+.||..... .
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~ 220 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAP----------EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------L 220 (271)
T ss_dssp CC---------------CCGGGSCH----------HHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------H
T ss_pred Cccccccccc--ccCCCCccceeCH----------HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 9998765432 2245799999999 788888899999999999999999999999875321 1
Q ss_pred hhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......... ...+.. .+..+.+++.+||+.||++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 221 AVAYGVAMNKLALPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp HHHHHHHTSCCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhhhcCCCCCCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 1112222222 222222 233588999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.22 Aligned_cols=255 Identities=18% Similarity=0.258 Sum_probs=210.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc--hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ--MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++........ ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456999999999999999999865 688999999876432221 12467899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC----cEEEeccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY----EARVSDFG 657 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 657 (786)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999753 5689999999999999999999999 999999999999999887 79999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
+++...... ......||+.|+|| |...+..++.++||||||+++|||++|+.||.... ...
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~ 225 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAP----------EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQE 225 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHH
T ss_pred cceecCccc-cccccCCCCCccCc----------ccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHH
Confidence 998776432 23445799999999 77888889999999999999999999999986422 122
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.......+.......+..+.+++..||..||++|||++|+++
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 226 TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23333333333332222233456899999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.21 Aligned_cols=255 Identities=21% Similarity=0.380 Sum_probs=207.9
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
..++|+..+.||+|+||.||+|+.. +++.||||++... ......+.+.+|+++++.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3578999999999999999999864 3478999999752 233456789999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA---------------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHR 636 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHr 636 (786)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9999999999999999999976421 25689999999999999999999999 99999
Q ss_pred CCCCCceeeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHH
Q 047901 637 DISSNNVLLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALE 714 (786)
Q Consensus 637 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~e 714 (786)
||||+||+++.++.+||+|||+++....... ......+|+.|+|| |...+..++.++||||||+++||
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP----------ESIFYNRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh----------hhhccCCcCcccccHHHHHHHHH
Confidence 9999999999999999999999987643221 22345688999999 78888889999999999999999
Q ss_pred HHh-CCCCCCccccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 715 VIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 715 llt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|++ |..||.... .......+.+.... .+.. .+..+.+++..||+.||++|||+.++++.|
T Consensus 269 l~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 269 IFSYGLQPYYGMA--------HEEVIYYVRDGNILACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHTTTCCTTTTSC--------HHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcCCCcCCCCC--------hHHHHHHHhCCCcCCCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 999 999986432 12222233333322 2222 223588999999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.11 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=208.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF----VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 457999999999999999999865 57789999986522 2345688999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee---CCCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 660 (786)
||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||++ +.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 99999999999998764 4689999999999999999999999 99999999999999 788999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ......||+.|+|| |...+ .+++++||||+|+++|||++|+.||.... ......
T Consensus 158 ~~~~~~-~~~~~~~t~~y~aP----------E~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~ 217 (277)
T 3f3z_A 158 RFKPGK-MMRTKVGTPYYVSP----------QVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVML 217 (277)
T ss_dssp ECCTTS-CBCCCCSCTTTCCH----------HHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred eccCcc-chhccCCCCCccCh----------HHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 776432 33456799999999 66544 48999999999999999999999987432 223334
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+.......+..+.+++..||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 218 KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 44444444443333334566899999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.16 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=204.6
Q ss_pred hccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|++.+.||+|+||+||+|++. +++.||||++... ........+.+|+.++++++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 357999999999999999999843 4568999998642 2334556788999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC---cE
Q 047901 579 RHSFVVYEYINRGSLATVLSNNF----ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY---EA 651 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~ 651 (786)
...++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997642 224589999999999999999999999 999999999999999554 59
Q ss_pred EEeccccceecCCCC--CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|||+|+...... .......||+.|+|| |.+.+..++.++|||||||++|||++ |..||....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-- 291 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP----------EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-- 291 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred EECCCccccccccccccccCCCcCCcccEECH----------HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 999999998653221 122345789999999 88888899999999999999999998 999987432
Q ss_pred cCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......+.... ...+.. .+..+.+++..||+.||++|||+.||++.|
T Consensus 292 ------~~~~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 292 ------NQEVLEFVTSGGRMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp ------HHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------HHHHHHHHHcCCCCCCCcc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 122222222222 222222 223588999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=357.67 Aligned_cols=254 Identities=16% Similarity=0.206 Sum_probs=204.5
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 583 (786)
++|++.+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+++++.+ +||||+++++++...+..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 5799999999999999999985 5788999999865321 23577999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc-----EEEecccc
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE-----ARVSDFGT 658 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfg~ 658 (786)
||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 89999999864 35799999999999999999999999 9999999999999998887 99999999
Q ss_pred ceecCCCCCc-------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 659 AKLLKPNSSN-------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 659 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
|+........ .....||+.|+|| |.+.+..++.++|||||||++|||++|+.||.....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~---- 222 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSI----------NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA---- 222 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----
T ss_pred ceeeecCCCCccccccccCCcCCCccccCh----------HHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----
Confidence 9976543321 2356899999999 888888899999999999999999999999875321
Q ss_pred CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.........+...+...+........+.+.+++..||+.||.+|||+++|.+.|
T Consensus 223 -~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 223 -DTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp -SSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred -ccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 111222222222222212111111112689999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.37 Aligned_cols=254 Identities=19% Similarity=0.277 Sum_probs=201.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC--CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 47999999999999999999865 68899999997533 2334457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++ ++.+++... .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 999986 666666543 35799999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcC-cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMK-ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~-~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.........||+.|+|| |...+.. ++.++||||+||++|||++|..||..... .......+.
T Consensus 154 ~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-------~~~~~~~i~ 216 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPP----------DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIF 216 (292)
T ss_dssp CCSCCCSCCSCGGGCCH----------HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-------HHHHHHHHH
T ss_pred ccccccCCccccCCcCh----------HHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-------HHHHHHHHH
Confidence 55555566899999999 6666555 79999999999999999998888532111 000011100
Q ss_pred c------------------CC-C------CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 D------------------HR-L------PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~------------------~~-~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. .. . ..........+..+.+++..||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00 0 0000001122345889999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.89 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=208.2
Q ss_pred HHHHHHHhccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccc
Q 047901 498 YEEIIRRTKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVK 570 (786)
Q Consensus 498 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~ 570 (786)
...+....++|++.+.||+|+||.||+|++ .+++.||||++... ......+.+.+|+++++++ +||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345555678899999999999999999973 34578999999752 2334557899999999999 7999999
Q ss_pred eeeEEecCC-eeeEEEeccCCCCHHHHhhcCCC-----------------------------------------------
Q 047901 571 FYGFCSHVR-HSFVVYEYINRGSLATVLSNNFA----------------------------------------------- 602 (786)
Q Consensus 571 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 602 (786)
+++++...+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987754 48999999999999999976422
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCC
Q 047901 603 ----------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666 (786)
Q Consensus 603 ----------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 666 (786)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288999999999999999999999 99999999999999999999999999998765433
Q ss_pred C--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 667 S--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 667 ~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
. ......||+.|+|| |...+..++.++|||||||++|||+| |+.||..... .......+.
T Consensus 248 ~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~ 310 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAP----------ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLK 310 (359)
T ss_dssp TCEEC--CEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-------SHHHHHHHH
T ss_pred cchhccccCCCceeECh----------hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-------hHHHHHHHH
Confidence 2 22345789999999 88888899999999999999999998 9999874321 111111111
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. ....+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 311 ~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 311 EGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp HTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 11 22222222 23488999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.19 Aligned_cols=263 Identities=19% Similarity=0.293 Sum_probs=189.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+++++.++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 457999999999999999999865 68899999997532 22234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNF---ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
||||++ |+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999998 59999986431 234689999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC--------
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------- 731 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------- 731 (786)
.............||+.|+|| |+..+ ..++.++|||||||++|||++|+.||.........
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 226 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAP----------DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCH----------HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecCCCcccCCCCcccccccCc----------hHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 876544444556899999999 66654 46899999999999999999999998753321000
Q ss_pred --Ccchhhhhhhhcc--CCCC-CCChhH---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 --SSSINIEFNAMLD--HRLP-HPSLDV---------QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 --~~~~~~~~~~~~~--~~~~-~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
............. .... .+.... ...+..+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000000000 0000 000000 012245889999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.76 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=203.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|++.++..||||++... ....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-----SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-----CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 4679999999999999999999988889999999752 12346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 98 TEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp ECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999999763 35689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......+|+.|+|| |...+..++.++||||+|+++|||+| |+.||..... ......+
T Consensus 173 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~ 234 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPP----------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHI 234 (283)
T ss_dssp HHHHSTTSTTSCGGGCCH----------HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHH
T ss_pred cccccccCCccCcccCCH----------HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHH
Confidence 211 12234567889999 78888889999999999999999998 9999874321 1122222
Q ss_pred ccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.... ...+... +..+.+++..||+.||++|||++|+++.|
T Consensus 235 ~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 235 AQGLRLYRPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HTTCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred hcccCCCCCCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 2221 1122222 23488999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=371.14 Aligned_cols=250 Identities=22% Similarity=0.418 Sum_probs=205.3
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|+++++..||||++... ....+.|.+|+.+++.++||||+++++++. .+..++|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-----SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-----CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 5679999999999999999999988889999999752 134678999999999999999999999987 5678999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999754 223578999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......++..|+|| |......++.++|||||||++|||+| |+.||..... .+....+
T Consensus 337 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i 398 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAP----------EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRAL 398 (454)
T ss_dssp HHHHTTCSSSSCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHH
T ss_pred CceeccCCCcccccccCH----------HHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 211 11233567899999 78888899999999999999999999 9999875321 1111222
Q ss_pred cc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. .+.+.|... +..+.++|..||+.||++|||+++|++.|
T Consensus 399 ~~~~~~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 399 ERGYRMPRPENC----PEELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp HHTCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 11 223333322 34589999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=358.17 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=207.2
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
.++|.+.+.||+|+||+||+|+.. .+..||||++... ......+.+.+|+++++.+ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 457999999999999999999842 2357999999753 2344567899999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999986532 24589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||+|+....... ......+|+.|+|| |...+..++.++|||||||++|||++ |.
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP----------EALFDRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH----------HHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH----------HHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999987654322 22334678899999 78888889999999999999999999 99
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||.... .......+... +...+... +..+.+++..||+.||++|||++||++.|
T Consensus 292 ~p~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 292 SPYPGVP--------VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp CSSTTCC--------HHHHHHHHHTTCCCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCC--------HHHHHHHHHcCCCCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9986432 11222222222 12222222 23588999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=342.77 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=208.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 467999999999999999999865 68899999986532 123445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc---EEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE---ARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++. +||+|||.+.
T Consensus 83 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999998764 5689999999999999999999999 9999999999999986655 9999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ......||+.|+|| |...+..++.++||||+|+++|+|++|+.||.... ......
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~ 217 (284)
T 3kk8_A 157 EVNDSE-AWHGFAGTPGYLSP----------EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYA 217 (284)
T ss_dssp ECCSSC-BCCCSCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred EcccCc-cccCCCCCcCCcCc----------hhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHH
Confidence 775432 23446799999999 78888889999999999999999999999986432 122223
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+.......+..+.+++..||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 218 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 33333333232222233445889999999999999999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=366.50 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=207.5
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|.+.+.||+|+||+||+|+.. +|+.||||++..... ........+.+|+++++.++||||+++++++...+..++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 57999999999999999999865 789999999864110 1112356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999753 5699999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
. ......+||+.|+|| |+..+..+ ++++||||+||++|||++|+.||+... .......+.
T Consensus 169 ~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~ 229 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAP----------EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKIC 229 (476)
T ss_dssp T-CCBCCCCSCSTTCCH----------HHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHH
T ss_pred c-ccccccCCCcCeECh----------hhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHh
Confidence 3 233456899999999 77766655 689999999999999999999987432 122333444
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.....|.... ..+.+++..||..||++|||++|+++
T Consensus 230 ~~~~~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 230 DGIFYTPQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TTCCCCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCcCCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 44444443322 34889999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=343.53 Aligned_cols=251 Identities=20% Similarity=0.321 Sum_probs=210.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|...+.||+|+||+||+|+.. +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 457999999999999999999865 578899999865322 223456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999998754 4689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||+.|+|| |...+..++.++||||+|+++|||++|+.||.... .......+.
T Consensus 167 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~ 228 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAP----------EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIK 228 (294)
T ss_dssp STTCCBCCCCSCCSSCCH----------HHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred cCccccccccCCCCcCCc----------chhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh
Confidence 544444556799999999 77778889999999999999999999999987432 122233333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.... ..+.+++..||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 229 KNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTCCCCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccCCCccccC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 33333333222 34889999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.10 Aligned_cols=247 Identities=23% Similarity=0.256 Sum_probs=197.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHH-HhhcCCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA-LTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
.++|+..+.||+|+||+||+|+.+ +++.||||++...... .......+..|..+ ++.++||||+++++++.+.+..|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 357999999999999999999865 6788999998753211 12234456677776 56789999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++|+|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999999764 4688999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
..........+||+.|+|| |++.+..++.++|||||||++|||++|+.||.... .......+
T Consensus 190 ~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i 251 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAP----------EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNI 251 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHH
T ss_pred ccCCCccccccCCccccCH----------HHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHH
Confidence 4444445567899999999 78888889999999999999999999999987432 23334444
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 780 (786)
.......+.... ..+.+++..||++||++||++.
T Consensus 252 ~~~~~~~~~~~~----~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 252 LNKPLQLKPNIT----NSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHSCCCCCSSSC----HHHHHHHHHHTCSSGGGSTTTT
T ss_pred HhcccCCCCCCC----HHHHHHHHHHcccCHHhCCCCC
Confidence 554444443322 3488999999999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=371.24 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=207.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
..+|+..+.||+|+||.||+|+++ ++..||||++... ....+.|.+|++++++++||||++++++|...+..++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-----ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 457899999999999999999876 4789999998642 2245789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999865 345689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhh
Q 047901 664 PNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 664 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
..... .....++..|+|| |.+....++.++|||||||++|||+| |..||..... .....
T Consensus 370 ~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---------~~~~~ 430 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAP----------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYE 430 (495)
T ss_dssp TCCEECCTTCCCCGGGCCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------GGHHH
T ss_pred CCceeecCCCcCCcceeCH----------hHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---------HHHHH
Confidence 43221 1233567899999 78888889999999999999999999 9999875331 11112
Q ss_pred hccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 MLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.+.. +...+... +..+.++|..||+.||++|||+.+|++.|
T Consensus 431 ~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 431 LLEKDYRMERPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp HHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCC----CHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 2222 22233322 33588999999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.28 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=185.3
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45799999999999999999986 4789999999854110 111234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999754 35689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||+.|+|| |...+..++.++||||||+++|||++|+.||...... .......
T Consensus 164 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~ 225 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISP----------EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVV 225 (278)
T ss_dssp --------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC
T ss_pred CCCCcceeccCCCCcCCc----------chhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHh
Confidence 443333456799999999 5555667889999999999999999999998753321 1111122
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+... +..+.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADYEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2222223222 234889999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=365.41 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=201.8
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-eeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR-HSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~l 583 (786)
.++|+..+.||+|+||.||+|.+. ++.||||+++.. ...+.|.+|++++++++||||+++++++...+ ..++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 467899999999999999999985 779999999752 13467999999999999999999999987654 7899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999865 233478999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. .....++..|+|| |...+..++.++|||||||++|||+| |+.||..... ......+
T Consensus 341 ~~---~~~~~~~~~y~aP----------E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i 399 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAP----------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV 399 (450)
T ss_dssp ---------CCCTTTSCH----------HHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--------TTHHHHH
T ss_pred cc---ccCCCCCcceeCH----------HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 32 1233678899999 88888899999999999999999998 9999875432 1111122
Q ss_pred cc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. .+...|... +..+.++|..||+.||++|||+.++++.|
T Consensus 400 ~~~~~~~~p~~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 400 EKGYKMDAPDGC----PPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp HTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 12 123333322 34589999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=347.02 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=206.9
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|.+.+.||+|+||.||+|+. .+++.||||++... ......+.+.+|+++++.++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 46799999999999999999975 24578999999752 2345567899999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFA---------------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRD 637 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 637 (786)
+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999986532 13489999999999999999999999 999999
Q ss_pred CCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 638 ISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 638 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
|||+||+++.++.+||+|||+++........ .....+|+.|+|| |...+..++.++||||+||++|||
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el 245 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI----------ESLFDHIYTTQSDVWSFGVLLWEI 245 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH----------HHHHHCEECHHHHHHHHHHHHHHH
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh----------hhhcCCCcCchhhHHHHHHHHHHH
Confidence 9999999999999999999999877543322 2234678899999 778888899999999999999999
Q ss_pred Hh-CCCCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 716 IK-GKHPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 716 lt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
++ |+.||..... ......+... ....+.. .+..+.+++.+||+.||++|||+.|+++.|
T Consensus 246 ~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 246 VTLGGNPYPGIPP--------ERLFNLLKTGHRMERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp HTTSCCSSTTCCG--------GGHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhCCCCCCCCCCH--------HHHHHHhhcCCcCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99 9999874321 1111111111 1122222 234588999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=370.55 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=199.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ........+.+|+.+++.++||||+++++++...+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 467999999999999999999854 789999999864211 112234567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999999764 568999999999999999999998 7 9999999999999999999999999999875
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
..........+||+.|+|| |++.+..++.++|||||||++|||++|+.||.... .......+
T Consensus 300 ~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i 361 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELI 361 (446)
T ss_dssp CC-----CCSSSCGGGCCH----------HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred cCCCcccccccCCccccCH----------hhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHH
Confidence 5444445567899999999 88888899999999999999999999999986432 22233333
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.......|.... ..+.+++..||++||++|| |++|+++
T Consensus 362 ~~~~~~~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 LMEEIRFPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHCCCCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhCCCCCCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 444444443322 3488999999999999999 9999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=354.36 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=197.4
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe---
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--- 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--- 580 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ........+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 35799999999999999999985 5788999999976332 233456688999999999999999999999876543
Q ss_pred -eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 581 -SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 581 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
.|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999764 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
+....... ......||+.|+|| |...+..++.++|||||||++|||++|+.||..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~ 225 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSP----------EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------V 225 (311)
T ss_dssp ------------------CCTTCCH----------HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------H
T ss_pred ccccccccccccccccCcCcccCCH----------HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------H
Confidence 87654322 22345799999999 788888899999999999999999999999874321 1
Q ss_pred hhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.............+.......+..+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 226 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 112222222222111111123446889999999999999998877764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.10 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=203.5
Q ss_pred hccCccceeeccc--cCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 505 TKDFDAKYCIGKG--EHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
.++|++.+.||+| +||+||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 4679999999999 99999999865 78999999997532 2234567788999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999765 335689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC-------CcceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 662 LKPNS-------SNWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 662 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
..... .......||+.|+|| |++.+ ..++.++||||+||++|||++|+.||..........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSP----------EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCH----------HHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred eccccccccccccccccccccccccCH----------HHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 53221 112234789999999 66665 578999999999999999999999997533211000
Q ss_pred cchhhhhhhhccC---------------------------CCCC-------CChhHHHHHHHHHHHHHhccCCCCCCCCC
Q 047901 733 SSINIEFNAMLDH---------------------------RLPH-------PSLDVQEKLISIMEVALLCLDGCPNSRPT 778 (786)
Q Consensus 733 ~~~~~~~~~~~~~---------------------------~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt 778 (786)
...........+. .... ........+..+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 0000000000000 0000 00011122346889999999999999999
Q ss_pred HHHHHH
Q 047901 779 MQTVCQ 784 (786)
Q Consensus 779 ~~ev~~ 784 (786)
++|+++
T Consensus 328 a~ell~ 333 (389)
T 3gni_B 328 ASTLLN 333 (389)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.07 Aligned_cols=261 Identities=23% Similarity=0.248 Sum_probs=204.7
Q ss_pred HHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCC-CCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFP-NDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
...++|++.+.||+|+||+||+|+.. +++.||+|++..... .......+.+.+|+++++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 44667999999999999999999864 678999999854210 0122345789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 047901 581 SFVVYEYINRGSLATVLSNNF-------------------------------------ASEDFDWRKRMNVITGVADALS 623 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~ia~~l~ 623 (786)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999999985210 0112357778899999999999
Q ss_pred HHhhCCCCCeEEcCCCCCceeeCCCC--cEEEeccccceecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhh-
Q 047901 624 YMHHDCFPPIVHRDISSNNVLLDLEY--EARVSDFGTAKLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYT- 696 (786)
Q Consensus 624 ~LH~~~~~~ivHrdlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~- 696 (786)
|||+. +|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|| |.+.+
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~ 249 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP----------EVLNTT 249 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH----------HHHTCS
T ss_pred HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc----------hhhccC
Confidence 99999 999999999999998776 899999999987643221 23456799999999 66654
Q ss_pred -cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCC
Q 047901 697 -MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNS 775 (786)
Q Consensus 697 -~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 775 (786)
..++.++|||||||++|||++|+.||.... .......+.......+.......+..+.+++..||..||++
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 678899999999999999999999987432 22333444444444333333334456899999999999999
Q ss_pred CCCHHHHHH
Q 047901 776 RPTMQTVCQ 784 (786)
Q Consensus 776 RPt~~ev~~ 784 (786)
|||+.|+++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=350.63 Aligned_cols=250 Identities=22% Similarity=0.421 Sum_probs=197.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.++|+..+.||+|+||+||+|++. +++ +||+|.+... ......+.|.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 357999999999999999999854 444 4688888642 22344578999999999999999999999998754
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
.++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 78999999999999999864 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
+........ .....+|+.|+|| |...+..++.++|||||||++|||+| |+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------- 225 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMAL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------- 225 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---------
T ss_pred eEccCCcccccccCCCccccccCh----------HHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---------
Confidence 877544322 2234568899999 88888899999999999999999999 9999874321
Q ss_pred hhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. +...+... ...+.+++..||+.||++|||+.|+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 226 SEISSILEKGERLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTB----CHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccC----CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 112222222 22223222 33588999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.46 Aligned_cols=251 Identities=20% Similarity=0.321 Sum_probs=210.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 457999999999999999999865 578899999865321 223456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999998754 5689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||..|+|| |...+..++.++||||||+++|||++|+.||.... .......+.
T Consensus 193 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~ 254 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAP----------EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIK 254 (335)
T ss_dssp STTCCBCCCCSCCSSCCH----------HHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred cCcccccccCCCccccCH----------HHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHh
Confidence 544444556899999999 77888889999999999999999999999987432 122223333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.... ..+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 255 KNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HTCCCCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCCCCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333333222 34889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=367.66 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=204.2
Q ss_pred HHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 501 IIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 501 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
+....++|+..+.||+|+||+||+|+.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3344678999999999999999999865 688999999853100 00112234788999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999999999753 588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhcC----cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 660 KLLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMK----ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 660 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~----~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
+....... .....+||+.|+|| |++.... ++.++|||||||++|||++|+.||....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~AP----------E~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------- 277 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISP----------EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------- 277 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCH----------HHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------
T ss_pred EeeccCCcccccCCcCCccccCH----------HHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------
Confidence 87754432 22356899999999 6666544 7899999999999999999999987432
Q ss_pred hhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 047901 735 INIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNS--RPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~ 784 (786)
.......+... ....|.. ...+..+.+++.+||..+|.+ ||+++||++
T Consensus 278 ~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 278 LVGTYSKIMNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHHHHTHHHHCCCCTT--CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred hhhHHHHHHhccccccCCCc--ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 12222233221 1222210 112235889999999999988 999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.12 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=200.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhh---HHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSD---QKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++........... .+.+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 357999999999999999999864 789999999976433322222 267899999999999999999999987654
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeCCCCc-----EEE
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLDLEYE-----ARV 653 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~-----~kl 653 (786)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 6999999999999998754 35789999999999999999999998 7 999999999999988776 999
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~ 733 (786)
+|||+++.... ......||+.|+|||++.. ....+++++||||+||++|||++|+.||.....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~--------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------ 233 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGA--------EEESYTEKADTYSFAMILYTILTGEGPFDEYSY------ 233 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSC--------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------
T ss_pred CCCCccccccc---cccccCCCccccCchhhcc--------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------
Confidence 99999985443 2345679999999953311 234578899999999999999999999874321
Q ss_pred chhhhhhhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 734 SINIEFNAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 734 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
........+..... ..+.. .+..+.+++..||+.||++|||++|+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 234 GKIKFINMIREEGLRPTIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CHHHHHHHHHHSCCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHhccCCCCCCCcc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 11111122222221 22222 234589999999999999999999999864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.98 Aligned_cols=320 Identities=20% Similarity=0.164 Sum_probs=206.7
Q ss_pred CCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccc
Q 047901 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDT 130 (786)
Q Consensus 52 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 130 (786)
-+.++.++++++ .+|..+ .++|+.|+|++|+|+++.+ .|..+++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TTEEECCSCCCS-SCCSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 457888888887 445544 3578888888888887755 477888888888888888888888888888888888888
Q ss_pred ccccccCChhhhccCccceeecccccccCCCC-CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccC
Q 047901 131 NQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS 209 (786)
Q Consensus 131 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~ 209 (786)
|+++...+..|..+++|+.|+|++|.+....+ .+.++++|+.|++++|.++++.+..|..+++|++|+|++|+++++.+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 88886665666666666666666666665443 35566666666666666666666666666666666666666665555
Q ss_pred cCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCc
Q 047901 210 SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTE 289 (786)
Q Consensus 210 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 289 (786)
..|..+++|+.|+|++|.+.++.+..|..+++|+.|++++|.+.+.++.......+|+.|+|++|+++.+.+..|..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 55666666666666666666555556666666666666666555444444444445666666666665554455556666
Q ss_pred CceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccc
Q 047901 290 LEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSH 369 (786)
Q Consensus 290 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 369 (786)
|+.|+|++|+++.+.+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 329 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCS
T ss_pred cCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccC
Confidence 66666666666655555555555666666666666555555555555566666666655554445555555555555555
Q ss_pred ccccc
Q 047901 370 NNISG 374 (786)
Q Consensus 370 N~l~~ 374 (786)
|++.+
T Consensus 330 N~l~c 334 (477)
T 2id5_A 330 NPLAC 334 (477)
T ss_dssp SCEEC
T ss_pred CCccC
Confidence 55543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.10 Aligned_cols=317 Identities=22% Similarity=0.190 Sum_probs=198.0
Q ss_pred EEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCc
Q 047901 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84 (786)
Q Consensus 5 ~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 84 (786)
.++.+++++. .+|.. + .+++++|||++|+|+++.+..|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~-~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEG-I--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSC-C--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCC-C--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4566666665 56652 2 256788888888887777777888888888888888887777778888888888888888
Q ss_pred cCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCC
Q 047901 85 QFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN 163 (786)
Q Consensus 85 ~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 163 (786)
+++++++. |.++++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+++.++.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 88776664 67778888888888888777777777888888888888877766666666666666666666666554432
Q ss_pred -cCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccc
Q 047901 164 -LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQL 242 (786)
Q Consensus 164 -l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 242 (786)
+.++++|+.|++++|.++++.+..|..+++|++|++++|.+.+..+.......+|++|+|++|+++.+.+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 4555555555555555555555555555555555555554444333333333455555555555554333445555555
Q ss_pred cEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEeccc
Q 047901 243 HVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHN 322 (786)
Q Consensus 243 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 322 (786)
+.|+|++|.+++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|+++.+++..|..+++|++|+|++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 55555555555554555555555555555555555555555555555555555555555555545555555555555555
Q ss_pred ccC
Q 047901 323 QFS 325 (786)
Q Consensus 323 ~l~ 325 (786)
.++
T Consensus 331 ~l~ 333 (477)
T 2id5_A 331 PLA 333 (477)
T ss_dssp CEE
T ss_pred Ccc
Confidence 544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.69 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=193.0
Q ss_pred hccCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|++.+.||+|+||+||+|+... +..||+|++... ......+.+.+|+.++++++||||+++++++. ++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4579999999999999999998643 346999998652 23345678999999999999999999999985 467
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 89999999999999999764 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhh
Q 047901 661 LLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 661 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 738 (786)
....... ......+++.|+|| |......++.++||||||+++|||++ |..||..... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~ 226 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAP----------ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDV 226 (281)
T ss_dssp --------------CCGGGCCH----------HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGH
T ss_pred ccCcccccccccCCCcccccCh----------hhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHH
Confidence 7754322 12334577899999 78888889999999999999999997 9999874321 112
Q ss_pred hhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 739 FNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 739 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+... ....+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 227 ~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 227 IGRIENGERLPMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp HHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2222222 1222222 234588999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=367.24 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=200.2
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|.+.++..||||++.... ...+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 45789999999999999999999888889999997522 234679999999999999999999999876 678999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999753 224589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......++..|+|| |......++.++|||||||++|||++ |+.||..... .+....+
T Consensus 333 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i 394 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAP----------EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV 394 (452)
T ss_dssp ----------CCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH
T ss_pred CceecccCCcccccccCH----------hHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 322 12234577899999 78888899999999999999999999 9999874321 1112222
Q ss_pred cc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. .+.+.|.. .+..+.++|..||+.||++|||++++++.|
T Consensus 395 ~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 395 ERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp HTTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22 12333332 234588999999999999999999998764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.12 Aligned_cols=342 Identities=19% Similarity=0.163 Sum_probs=258.9
Q ss_pred ccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCc
Q 047901 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLK 100 (786)
Q Consensus 21 ~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 100 (786)
+|..+++|++|||++|.++++ | .|..+++|++|+|++|+|+++ | |+.+++|++|+|++|++++++ +..+++|+
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~ 109 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD--VTPLTKLT 109 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC--CTTCTTCC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee--cCCCCcCC
Confidence 566778888888888888765 3 577788888888888888764 3 777888888888888887653 77788888
Q ss_pred EEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccc
Q 047901 101 YISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180 (786)
Q Consensus 101 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l 180 (786)
+|+|++|+++++ + |+.+++|++|++++|++++. + +..+++|+.|++++|...+.. .+..+++|+.|++++|+|
T Consensus 110 ~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 110 YLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp EEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSSCC
T ss_pred EEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-ccccCCcCCEEECCCCcc
Confidence 888888888765 2 77788888888888888763 2 677778888888888544433 466778888888888888
Q ss_pred ccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCc
Q 047901 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260 (786)
Q Consensus 181 ~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 260 (786)
+++. +..+++|++|++++|+++++ .+..+++|+.|++++|++++ +| +..+++|+.|++++|++++..+..+
T Consensus 183 ~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l 253 (457)
T 3bz5_A 183 TELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL 253 (457)
T ss_dssp CCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred ceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence 8753 77778888888888888765 37777888888888888886 34 7777888888888888887665555
Q ss_pred cccc-------ccccccccccccCCCCccccccCCcCceeccccccccccchh--------hhhcccCCcEEEecccccC
Q 047901 261 GRLI-------SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILE--------ALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 261 ~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~ 325 (786)
.++. +|+.|++++|.+.+..| ++.+++|+.|++++|...+..+. .+..+++|++|++++|+++
T Consensus 254 ~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~ 331 (457)
T 3bz5_A 254 SKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT 331 (457)
T ss_dssp TTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCS
T ss_pred CCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccc
Confidence 5554 55677777777665554 56778888888888874332221 3556688999999999999
Q ss_pred CCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCC
Q 047901 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403 (786)
Q Consensus 326 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 403 (786)
+. + +..+++|+.|++++|+|++ ++.|..|++++|.++|. ..+..|..+++++|+++|.+|..
T Consensus 332 ~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 332 EL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred cc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 75 3 8889999999999999984 35678889999999876 24566778899999999998864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=342.10 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=202.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++.... .........+.+|+++++.++||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 467999999999999999999865 67789999985411 0112234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999999764 5689999999999999999999998 99999999999999999999999999986554
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......||+.|+|| |...+..++.++||||+|+++|+|++|+.||.... .......+.
T Consensus 161 ~~--~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~ 220 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPP----------EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRIS 220 (279)
T ss_dssp ---------CCCCTTCCH----------HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred cc--cccccCCCCCccCH----------hHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHH
Confidence 32 22345789999999 77888888999999999999999999999987432 122233333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.... ..+.+++..||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 221 RVEFTFPDFVT----EGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HTCCCCCTTSC----HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCcCC----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 33333333222 34889999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.11 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=194.4
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|++. ++.||||++.. ....+.|.+|++++++++||||+++++++.+ ..++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 357899999999999999999885 78899999864 2345789999999999999999999998874 47899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc-EEEeccccceecC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE-ARVSDFGTAKLLK 663 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-~kl~Dfg~a~~~~ 663 (786)
|||+++|+|.+++........+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999986644446789999999999999999999932229999999999999988876 7999999997654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. .....||+.|+|| |...+..++.++||||||+++|||++|+.||+.... ..........
T Consensus 158 ~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~ 218 (307)
T 2eva_A 158 TH---MTNNKGSAAWMAP----------EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVH 218 (307)
T ss_dssp ----------CCTTSSCH----------HHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHH
T ss_pred cc---cccCCCCCceECh----------hhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHh
Confidence 32 2334699999999 778888899999999999999999999999874321 1111111111
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...+. ..+..+.+++.+||+.||++|||++|+++.|
T Consensus 219 ~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 219 NGTRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp TTCCCCCBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 11 111111 1233588999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.19 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=190.1
Q ss_pred hccCccceeeccccCceEEEEEcCCCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|+..+.||+|+||+||+|+..... .||||++..... .....+.+.+|++++++++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 457999999999999999999876432 799999975321 23456789999999999999999999999987665
Q ss_pred e------eEEEeccCCCCHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 581 S------FVVYEYINRGSLATVLSNNF---ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 581 ~------~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
. ++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999996432 122589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|||+|+....... ......+++.|+|| |...+..++.++|||||||++|||++ |+.||.....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~- 245 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLAL----------ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN- 245 (323)
T ss_dssp EECCCCC-----------------CCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-
T ss_pred EEeeccccccccccccccccccccCcccccCc----------hhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-
Confidence 9999999987654322 12234578899999 78888889999999999999999999 9999875321
Q ss_pred cCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.... ...+.. .+..+.+++..||+.||++|||+.++++.|
T Consensus 246 -------~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 246 -------AEIYNYLIGGNRLKQPPE----CMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp -------GGHHHHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -------HHHHHHHhcCCCCCCCCc----cCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 12222222222 222222 223588999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.73 Aligned_cols=254 Identities=19% Similarity=0.291 Sum_probs=205.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCC--chhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPND--QMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
++|++.+.||+|+||+||+|+.. +++.||||++....... .....+.+.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46999999999999999999876 68999999987543221 1224678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC----cEEEecccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY----EARVSDFGT 658 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg~ 658 (786)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||.
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999754 5689999999999999999999999 999999999999998877 899999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
+....... ......|++.|+|| |...+..++.++||||||+++|||++|+.||.... ....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~ 219 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAP----------EIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQET 219 (283)
T ss_dssp CEECC---------CCCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHH
T ss_pred ceeccCCC-cccccCCCcCccCc----------ceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHH
Confidence 98775432 23345799999999 77778889999999999999999999999987432 1222
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.......+.......+..+.+++.+||..||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2223333332222222233456889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.86 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=194.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 457999999999999999999865 78899999997522 123567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc--EEEecccccee
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE--ARVSDFGTAKL 661 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfg~a~~ 661 (786)
||||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+|+.
T Consensus 94 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999999999999754 4689999999999999999999999 9999999999999987765 99999999975
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcc-cchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEK-CDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~-sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
.... .......||+.|+|| |.+.+..++.+ +||||+||++|||++|+.||...... ........
T Consensus 168 ~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~ 232 (361)
T 3uc3_A 168 SVLH-SQPKSTVGTPAYIAP----------EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQ 232 (361)
T ss_dssp --------------CTTSCH----------HHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHH
T ss_pred cccc-CCCCCCcCCCCcCCh----------hhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHH
Confidence 4322 223345799999999 77777777655 99999999999999999998753321 11222233
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+.. ...+..+.+++.+||..||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 233 RILSVKYSIPDD--IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHTTCCCCCTT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhcCCCCCCCc--CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 333333332221 011235889999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=349.77 Aligned_cols=246 Identities=20% Similarity=0.312 Sum_probs=203.5
Q ss_pred HhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCc----hhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQ----MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
..++|+..+.||+|+||+||+|+. .+++.||||++........ ....+.+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999985 4788999999976432111 11234577899999999999999999999999
Q ss_pred CeeeEEEeccCCC-CHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 579 RHSFVVYEYINRG-SLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 579 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 999999754 5689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
+++...... ......||+.|+|| |...+..+ +.++|||||||++|||++|+.||.....
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------- 235 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAP----------EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------- 235 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCH----------HHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred cceECCCCC-ceeccCCCccccCh----------hhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence 998876543 23456799999999 77776666 7899999999999999999999864221
Q ss_pred hhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........+... +..+.+++..||++||++|||++|+++
T Consensus 236 -----~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 236 -----TVEAAIHPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -----GTTTCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHhhccCCCccc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111222222222 234889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.00 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=200.0
Q ss_pred ccCccc-eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 506 KDFDAK-YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 506 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
+.|++. +.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC----SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC----cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 467774 78999999999999854 7899999999753 223456788999999985 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc---EEEeccccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE---ARVSDFGTA 659 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg~a 659 (786)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 999999999999999764 4689999999999999999999999 9999999999999998765 999999999
Q ss_pred eecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhh-----cCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 047901 660 KLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYT-----MKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727 (786)
Q Consensus 660 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-----~~~~~~sDvwslGvil~elltg~~Pf~~~~~ 727 (786)
........ ......||+.|+|| |.... ..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAP----------EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp C-------------------CCSGGGCCH----------HHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cccccCCccccccccccccccCCcCccCh----------HHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 86542211 12234699999999 55543 5588999999999999999999999875432
Q ss_pred ccCCCc-------chhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 728 FSSSSS-------SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 728 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... ........+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp SCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 110000 011122333334444443222233456899999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.07 Aligned_cols=199 Identities=23% Similarity=0.299 Sum_probs=175.4
Q ss_pred HhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-----CCcccceeeEEec
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-----HRNIVKFYGFCSH 577 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~l~~~~~~ 577 (786)
..++|++.+.||+|+||+||+|+. .+++.||||++.. .......+..|+++++.++ ||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 356899999999999999999986 4788999999863 2344567788999999986 9999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC----------
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---------- 647 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---------- 647 (786)
.+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccch
Confidence 99999999999 88999999865 334689999999999999999999999 9999999999999975
Q ss_pred ---------------CCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHH
Q 047901 648 ---------------EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLA 712 (786)
Q Consensus 648 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil 712 (786)
++.+||+|||+|+..... .....||+.|+|| |+..+..++.++||||+||++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAP----------EVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCH----------HHHTTCCCCTTHHHHHHHHHH
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCc----------HHHcCCCCCCccchHHHHHHH
Confidence 789999999999876532 2345799999999 788888899999999999999
Q ss_pred HHHHhCCCCCCcc
Q 047901 713 LEVIKGKHPGDFL 725 (786)
Q Consensus 713 ~elltg~~Pf~~~ 725 (786)
|||++|+.||...
T Consensus 250 ~ell~g~~pf~~~ 262 (360)
T 3llt_A 250 AELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHSSCSCCCS
T ss_pred HHHHHCCCCCCCC
Confidence 9999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.69 Aligned_cols=246 Identities=21% Similarity=0.238 Sum_probs=195.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 583 (786)
++|+..++||+|+||+||+|+.. +++.||||++..... .......+..|+..+..+ +||||+++++++.+.+..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 57999999999999999999876 789999999865322 223344556666666655 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 66999988765 35699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... ......||+.|+|| |+..+ .++.++|||||||++|||++|..|+.... ....+.
T Consensus 209 ~~~-~~~~~~gt~~y~aP----------E~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~ 265 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAP----------ELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLR 265 (311)
T ss_dssp -------CCCCCGGGCCG----------GGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHT
T ss_pred cCC-CCcccCCCccccCH----------hHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHh
Confidence 432 23345799999999 55544 68999999999999999999977654211 122222
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... +.......+..+.+++..||++||++|||++|+++
T Consensus 266 ~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 QGYL--PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTCC--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCC--CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2221 11122223456899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.85 Aligned_cols=258 Identities=22% Similarity=0.250 Sum_probs=210.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|...+.||+|+||+||+|+.+ +++.||||++..... ........+.+|+.+++.++||||+++++++...+..|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 357899999999999999999875 689999999864210 111234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNFA-SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||+++|+|.+++..... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999976422 35699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
..........+||+.|+|| |++.+..++.++|||||||++|||++|+.||..... ..........+
T Consensus 340 ~~~~~~~~~~~GT~~Y~AP----------E~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i 405 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAP----------ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRV 405 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHH
T ss_pred cCCCcccccccCCccccCh----------hhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHH
Confidence 6554444456899999999 788888899999999999999999999999875321 11122333344
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM-----QTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 784 (786)
.......|... +..+.+++..||.+||++||++ +++++
T Consensus 406 ~~~~~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 406 LEQAVTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHCCCCCCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hhcccCCCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 44444444332 3358899999999999999975 56653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.04 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=197.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|++++++++||||+++++++...+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 57999999999999999999865 58999999986532 2334466788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 81 ~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999999988743 5689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----------c
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS----------S 733 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~----------~ 733 (786)
.........||+.|+|| |...+ ..++.++||||+|+++|||++|+.||.......... .
T Consensus 155 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSP----------ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp -----------GGGCCH----------HHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccccCCCcCCccccCh----------HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 54445566899999999 66654 668999999999999999999999987533210000 0
Q ss_pred chhhhh--hh-hccCCCCCCCh------hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEF--NA-MLDHRLPHPSL------DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~--~~-~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .. ......+.+.. .....+..+.+++..||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00 00001111100 00122345889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.68 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=210.7
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc----hhhHHHHHHHHHHHhhc-CCCccccee
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ----MSDQKEFLNEIKALTKI-RHRNIVKFY 572 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~ 572 (786)
+......++|+..+.||+|+||.||+|+.. +|+.||||++........ ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344445678999999999999999999875 789999999876432211 12245788999999999 799999999
Q ss_pred eEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEE
Q 047901 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR 652 (786)
Q Consensus 573 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 652 (786)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999754 5689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh------cCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 047901 653 VSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT------MKITEKCDVYSFGVLALEVIKGKHPGDFLS 726 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~------~~~~~~sDvwslGvil~elltg~~Pf~~~~ 726 (786)
|+|||++....... ......||+.|+|| |+..+ ..++.++|||||||++|||++|+.||....
T Consensus 241 l~DfG~~~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE-KLRELCGTPGYLAP----------EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECCCTTCEECCTTC-CBCCCCSCGGGCCH----------HHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCcccccCCCc-ccccCCCCCCccCh----------hhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 99999998876432 33456899999999 55542 358899999999999999999999986422
Q ss_pred cccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 727 LFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+...+...+..+.+++..||..||++|||+.|+++
T Consensus 310 --------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 --------QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --------HHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12222233333333222222233456899999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.32 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=208.0
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|+..+.||+|+||+||+|+.. ++..||+|++.. .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-----CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3567999999999999999999876 578899999864 2235678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999865 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhh
Q 047901 663 KPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 663 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... ......+|+.|+|| |...+..++.++||||+|+++|+|++ |..||..... .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~~~~ 223 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAP----------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYE 223 (288)
T ss_dssp CSSSSEEETTEEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHH
T ss_pred cCCccccccCCccccCcCCh----------hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 54332 22334678899999 78888889999999999999999999 9999874321 11111
Q ss_pred hhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 741 AMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 741 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.+... +...+... +..+.+++..||+.||++|||++|+++.|
T Consensus 224 ~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 224 LLEKDYRMERPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp HHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhccCCCCCCCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 11111 12222222 33588999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.68 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=203.4
Q ss_pred ccCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV-- 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-- 578 (786)
+.|+..+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4588999999999999999983 367899999997532 223456789999999999999999999999876
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 6689999999999999999654 35689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccc------c
Q 047901 659 AKLLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF------S 729 (786)
Q Consensus 659 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~------~ 729 (786)
++........ .....||..|+|| |...+..++.++||||+|+++|||++|+.|+...... .
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAP----------ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred cccccCCCcceeccCCCCCCccccCC----------eeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 9887654321 2345688899999 8888888999999999999999999999986432110 0
Q ss_pred CCCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 730 SSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
................ +...+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGKRLPCPPN----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp CCGGGHHHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cccccCHHHHHHHHhccCCCCCCCC----CCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 0011111111222221 1222222 234588999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.54 Aligned_cols=255 Identities=22% Similarity=0.394 Sum_probs=204.4
Q ss_pred HhccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
..++|+..+.||+|+||+||+|+. .++..||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 356899999999999999999985 245679999997532 223446789999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFAS--------------------EDFDWRKRMNVITGVADALSYMHHDCFPPIVHR 636 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHr 636 (786)
..+..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999765321 3479999999999999999999999 99999
Q ss_pred CCCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHH
Q 047901 637 DISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALE 714 (786)
Q Consensus 637 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~e 714 (786)
||||+||+++.++.+||+|||+++........ .....||+.|+|| |...+..++.++|||||||++||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~e 266 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP----------ESLFEGIYTIKSDVWSYGILLWE 266 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH----------HHhccCCCChhHhHHHHHHHHHH
Confidence 99999999999999999999999876543322 2345678899999 78888889999999999999999
Q ss_pred HHh-CCCCCCccccccCCCcchhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 715 VIK-GKHPGDFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 715 llt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
|+| |..||..... .......+... ...+... +..+.+++..||+.||.+|||+.|+++.|
T Consensus 267 l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 267 IFSLGVNPYPGIPV--------DANFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HTTTSCCSSTTCCC--------SHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCCCCcccCCc--------HHHHHHHHhcCCCCCCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 998 9999875321 11122222222 1222222 33588999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.92 Aligned_cols=254 Identities=23% Similarity=0.399 Sum_probs=205.3
Q ss_pred hccCccceeeccccCceEEEEEcC--------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
.++|++.+.||+|+||+||+|+.. ++..||||++... ......+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC---CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 468999999999999999999853 4678999999752 2334567899999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999986532 23489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||+++........ .....+|+.|+|| |...+..++.++||||||+++|||++ |+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~ 257 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP----------EALFDRVYTHQSDVWSFGVLMWEIFTLGG 257 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeCh----------HHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999877643321 2234578899999 77788889999999999999999999 99
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||..... ......+... +...+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 258 ~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 258 SPYPGIPV--------EELFKLLKEGHRMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp CSSTTCCH--------HHHHHHHHHTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcCcCCH--------HHHHHHHhcCCCCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99864321 1111222221 1222222 223588999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=359.06 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=206.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC--ee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR--HS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~ 581 (786)
.++|.+.+.||+|+||+||+|+.. +++.||||++... ......+.+.+|++++++++||||+++++++...+ ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI---SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGG---GGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccc---cccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 357999999999999999999865 5899999998642 22234567889999999999999999999997654 77
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee----CCCCcEEEeccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL----DLEYEARVSDFG 657 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfg 657 (786)
++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999998654444599999999999999999999999 99999999999999 778889999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh--------cCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT--------MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--------~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
+|+...... ......||+.|+|| |+... ..++.++|||||||++|||++|+.||.......
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 162 AARELEDDE-QFVSLYGTEEYLHP----------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp GCEECCCGG-GSSCSSSCCTTCCH----------HHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred CceEccCCC-ccccccCCccccCH----------HHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 998875432 23345799999999 55543 567889999999999999999999986432111
Q ss_pred CCCcchhhhhhhhccC---------------------CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 730 SSSSSINIEFNAMLDH---------------------RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
.....+..+... ..+.+..........+.+++..||..||++|||++|+++.
T Consensus 231 ----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 231 ----RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ----TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ----chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111111111111 1111222235566778999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=358.44 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=191.8
Q ss_pred ccCccc-eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhh-cCCCcccceeeEEec----C
Q 047901 506 KDFDAK-YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IRHRNIVKFYGFCSH----V 578 (786)
Q Consensus 506 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~----~ 578 (786)
++|... +.||+|+||+||+|+.. +++.||||++.. ...+.+|++++.+ .+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 457665 68999999999999865 688999999853 1356688888754 489999999998865 5
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEec
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVSD 655 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 655 (786)
...|+||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 6789999999999999999864 234689999999999999999999999 9999999999999998 78999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||+++..... ......+||+.|+|| |++.+..++.++|||||||++|||++|+.||..........
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--- 273 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAP----------EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--- 273 (400)
T ss_dssp CTTCEECC------------CTTCCG----------GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---
T ss_pred cccccccCCC-CccccCCCCCCccCH----------hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---
Confidence 9999876533 223456899999999 66667789999999999999999999999997543221111
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+.......+...+...+..+.+++..||..||++|||+.|+++
T Consensus 274 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 274 -GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111222222222222222233456899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.18 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=206.2
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
.++....++|+..+.||+|+||+||+|+.+ +++.||||++..... ........+.+|+.++..++||||+++++++.+
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh-hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 334445678999999999999999999876 578899999853100 011122347899999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
.+..|+||||+++|+|.+++... .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999763 35689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc-ceeeccCccccCCCCCCCCchHHHHhh-----hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 658 TAKLLKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAY-----TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 658 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~-----~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
+|+........ ....+||+.|+|| |++. ...++.++|||||||++|||++|+.||....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~AP----------E~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~----- 285 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISP----------EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----- 285 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCH----------HHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----
T ss_pred hhhhcccCCCcccccccCCcCeeCh----------HHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-----
Confidence 99877544332 2346899999999 6665 4568999999999999999999999987432
Q ss_pred CcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 047901 732 SSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNS--RPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~ 784 (786)
.......+... +...|.. ....+..+.+++.+|+..+|++ ||+++|+++
T Consensus 286 ---~~~~~~~i~~~~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 286 ---LVETYGKIMNHKERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---HHHHHHHHHTHHHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---hhHHHHhhhhccccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 12222222221 1222221 0112335889999999988888 999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.37 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=205.4
Q ss_pred HhccCccceeeccccCceEEEEEcCC-C-----CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLPS-G-----DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
..++|+..+.||+|+||+||+|.... + ..||+|++... ......+.+.+|+.+++.+ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 35689999999999999999998542 2 47999999752 2334567899999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNF-----------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL 645 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 645 (786)
..+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 9999999999999999999997531 134579999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCC
Q 047901 646 DLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPG 722 (786)
Q Consensus 646 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf 722 (786)
+.++.+||+|||+++........ .....+|+.|+|| |...+..++.++|||||||++|||+| |..||
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP----------ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCH----------HHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999876543221 2334678899999 77888889999999999999999998 99998
Q ss_pred CccccccCCCcchhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 723 DFLSLFSSSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..... ........... ...+... +..+.+++..||+.||.+|||+.|+++.|
T Consensus 268 ~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 268 PGILV--------NSKFYKLVKDGYQMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp TTCCS--------SHHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccch--------hHHHHHHHhcCCCCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 74321 11112222211 1122222 23588999999999999999999998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.45 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=206.0
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 45799999999999999999998888899999997522 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999999999764 35689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......++..|+|| |...+..++.++||||+|+++|||++ |+.||.... .......+
T Consensus 157 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i 218 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASP----------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDI 218 (267)
T ss_dssp HHHHSTTSTTCCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHH
T ss_pred ccccccccccccccccCh----------hhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHH
Confidence 211 11234577899999 78888889999999999999999999 899987432 11222222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 219 ~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 219 STGFRLYKPRLA----STHVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp HTTCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCcCCCCccC----cHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 222 11222222 23588999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.41 Aligned_cols=254 Identities=23% Similarity=0.416 Sum_probs=207.1
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|+..+.||+|+||+||+|+. .+++.||||++... ......+.+.+|+++++++ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 46799999999999999999974 35678999999752 2334567899999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA---------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999976532 12589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+||+|||+++........ .....+|+.|+|| |...+..++.++||||||+++|||+| |+
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP----------ESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh----------HHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999877654332 2234678899999 77888889999999999999999999 99
Q ss_pred CCCCccccccCCCcchhhhhhhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.||..... .......+.... ..+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 246 ~p~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 246 SPYPGMPV--------DSKFYKMIKEGFRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp CSSTTCCS--------SHHHHHHHHHTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccc--------hhHHHHHhccCCCCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99875321 111122222111 11221 233588999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.37 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=198.0
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC--CcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH--RNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||+||+|...+++.||||++.... ......+.+.+|+++++.++| |||+++++++...+..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 35699999999999999999998889999999987532 233456789999999999976 99999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||| +.+|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+|+..
T Consensus 86 lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 5678999999864 5689999999999999999999999 999999999999997 688999999999877
Q ss_pred CCCCC--cceeeccCccccCCCCCCCCchHHHHhhh-----------cCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 663 KPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 663 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-----------~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
..... ......||+.|+|| |++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--- 224 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPP----------EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--- 224 (343)
T ss_dssp ------------CCCCSSCCH----------HHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC---
T ss_pred CcccccccCCCCcCCcCcCCH----------HHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh---
Confidence 54332 22356799999999 55543 678899999999999999999999986421
Q ss_pred CCCcchhhhhhhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 730 SSSSSINIEFNAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........++... ..+.... ..+.+++..||..||++|||+.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 225 ----NQISKLHAIIDPNHEIEFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ----SHHHHHHHHHCTTSCCCCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----hHHHHHHHHhcCCcccCCcccCC----HHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11122333333222 2222222 34889999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.64 Aligned_cols=248 Identities=19% Similarity=0.273 Sum_probs=201.2
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC--Ceee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV--RHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~ 582 (786)
.++|+..+.||+|+||+||+|+.+ ++.||||++.... ......+.+.+|+.++++++||||+++++++... +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 357999999999999999999985 8899999997632 2334567899999999999999999999999876 7889
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999999865 234689999999999999999999998 7 9999999999999999999999999876
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC---cccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT---EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~---~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
..... ...||+.|+|| |...+..++ .++||||||+++|||++|+.||..... ..
T Consensus 162 ~~~~~-----~~~~t~~y~aP----------E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~ 218 (271)
T 3kmu_A 162 SFQSP-----GRMYAPAWVAP----------EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------ME 218 (271)
T ss_dssp TTSCT-----TCBSCGGGSCH----------HHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HH
T ss_pred eeccc-----CccCCccccCh----------hhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HH
Confidence 54322 34789999999 666654444 389999999999999999999874321 11
Q ss_pred hhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
........ +...+.. .+..+.+++..||+.||++|||++|+++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 219 IGMKVALEGLRPTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp HHHHHHHSCCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11222221 1222222 233589999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.61 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=191.5
Q ss_pred ccCccceeeccccCceEEEEEcC--CC--CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe-cCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP--SG--DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS-HVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~~ 580 (786)
..|+..+.||+|+||+||+|++. ++ ..||||.+... ......+.|.+|+.++++++||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 35777889999999999999853 22 36899998642 33455678999999999999999999999875 4567
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 89999999999999999754 35688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcch
Q 047901 661 LLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 661 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~ 735 (786)
....... ......+|+.|+|| |...+..++.++|||||||++|||+| |.+||......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~------- 303 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMAL----------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------- 303 (373)
T ss_dssp -----------------CCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-------
T ss_pred cccccccccccccCCCCCcccccCh----------HHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-------
Confidence 7643321 12334678899999 88888899999999999999999999 67787643211
Q ss_pred hhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 736 NIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 736 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+... +...|... +..+.+++..||+.||++|||+.|+++.|
T Consensus 304 -~~~~~~~~~~~~~~p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 304 -DITVYLLQGRRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp -CHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHHHHcCCCCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111112222 22223222 23588999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.89 Aligned_cols=256 Identities=22% Similarity=0.232 Sum_probs=207.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||.||+|+.+ +++.||||++..... ........+.+|+++++.++||||+++++++.+.+..|+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 457999999999999999999865 789999999854110 112234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999765 234589999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... .....+||+.|+|| |++.+..++.++|||||||++|||++|+.||..... ..........+.
T Consensus 338 ~~~-~~~~~~GT~~Y~AP----------Evl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~----~~~~~~i~~~i~ 402 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAP----------EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERLVK 402 (576)
T ss_dssp TTC-CEECCCSCGGGCCH----------HHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS----CCCHHHHHHHHH
T ss_pred cCc-cccccCCCccccCH----------HHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc----chhHHHHHHHhh
Confidence 432 23446899999999 788888899999999999999999999999875321 011111222222
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
......+... +..+.+++..||.+||++|| +++|+++
T Consensus 403 ~~~~~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 EVPEEYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HCCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cccccCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 2233333222 33588999999999999999 7888875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=345.42 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=197.0
Q ss_pred HHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc--CCCcccceeeEEecC--
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI--RHRNIVKFYGFCSHV-- 578 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~l~~~~~~~-- 578 (786)
...++|++.+.||+|+||+||+|+.. ++.||||++.. .....+..|.+++... +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT-------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec-------cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34568999999999999999999885 88999999853 2334556667766655 899999999999876
Q ss_pred --CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEcCCCCCceeeCCCCcE
Q 047901 579 --RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC-----FPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 579 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrdlk~~Nill~~~~~~ 651 (786)
...++||||+++|+|.+++... .+++..+..++.|++.||+|||+.. .++|+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6889999999999999999753 5899999999999999999999762 3489999999999999999999
Q ss_pred EEeccccceecCCCCCc----ceeeccCccccCCCCCCCCchHHHHhhhcCcCcc------cchHHHHHHHHHHHhC---
Q 047901 652 RVSDFGTAKLLKPNSSN----WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEK------CDVYSFGVLALEVIKG--- 718 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~------sDvwslGvil~elltg--- 718 (786)
||+|||+|+........ .....||+.|+|| |...+..++.+ +|||||||++|||+||
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP----------EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCH----------HHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeCh----------hhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 99999999876543322 1245799999999 66666555554 9999999999999999
Q ss_pred -------CCCCCccccccCCCcchhhhhhhhccC-C--CCCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 719 -------KHPGDFLSLFSSSSSSINIEFNAMLDH-R--LPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 719 -------~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.||...... ............. . ...+.. ...+++..+.+++..||+.||++|||+.||++.|
T Consensus 252 ~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPS----DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp TTBCCCCCCTTTTTSCS----SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccccccccHhhhcCC----CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 4454322111 1111122222211 1 112211 1235567799999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.82 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=198.5
Q ss_pred cCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
+|.....||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 355566899999999999985 46889999998752 2234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-CCcEEEeccccceecCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-EYEARVSDFGTAKLLKP 664 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~ 664 (786)
||+++++|.+++........+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||.++....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999998764445678999999999999999999999 9999999999999987 89999999999988764
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhc--CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM--KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~--~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.........||+.|+|| |...+. .++.++||||||+++|||++|+.||..... ..........
T Consensus 176 ~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~ 240 (295)
T 2clq_A 176 INPCTETFTGTLQYMAP----------EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMFKVGM 240 (295)
T ss_dssp -----CCCCCCGGGCCH----------HHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHHHHHH
T ss_pred CCCcccccCCCccccCh----------hhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHHhhcc
Confidence 43334456799999999 666553 378999999999999999999999864221 0000011111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+... +..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 241 FKVHPEIPESM----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HCCCCCCCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11122222222 235889999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.66 Aligned_cols=256 Identities=24% Similarity=0.320 Sum_probs=197.8
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCC-CchhhHHHHHHHHHHHhhc---CCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPN-DQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~ 579 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++...... ........+.+|+++++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999986 47889999998643211 1112234566777777766 4999999999997654
Q ss_pred -----eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 -----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5789999997 5999999865 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
|||+|+..... .......||+.|+|| |...+..++.++||||+||++|||++|+.||......
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------ 225 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAP----------EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------ 225 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCH----------HHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH------
T ss_pred eCccccccCCC-cccCCccccccccCc----------hHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 99999866533 233456899999999 7888888999999999999999999999998753321
Q ss_pred hhhhhhhhcc----------------------CCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLD----------------------HRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~----------------------~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+.+ .....+ .....+....+.+++.+||+.||++|||+.|+++
T Consensus 226 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 226 --DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp --HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 01111100 000000 0000112346889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.82 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=200.6
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+..+.||+|+||+||+|+. .+++.||||++..... ......+.+.+|+++++.++||||+++++++...+..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 4589999999999999999985 5788999999875321 2334456889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++ |++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5888888643 35689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh---hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY---TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~---~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
. ....||+.|+|| |... ...++.++|||||||++|||++|+.||..... ......
T Consensus 207 ~----~~~~gt~~y~aP----------E~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~ 264 (348)
T 1u5q_A 207 A----NSFVGTPYWMAP----------EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYH 264 (348)
T ss_dssp B----CCCCSCGGGCCH----------HHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH
T ss_pred C----CcccCCcceeCH----------hhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH
Confidence 2 345799999999 6653 46789999999999999999999999864321 111122
Q ss_pred hccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.....+ ... ...+..+.+++..||+.||++|||++++++
T Consensus 265 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 265 IAQNESPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHSCCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 2222111 111 112335889999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.64 Aligned_cols=260 Identities=24% Similarity=0.270 Sum_probs=205.1
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
+++....++|+..+.||+|+||+||+|+.+ +++.||||++..... ......+.+.+|..++..++||||+++++++.+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-LKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 334444678999999999999999999875 789999999853100 011223457889999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
.+..|+||||+++|+|.+++.+. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999764 24689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc-ceeeccCccccCCCCCCCCchHHHHhh-------hcCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 658 TAKLLKPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAY-------TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 658 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~-------~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
+|+........ ....+||+.|+|| |++. ...++.++|||||||++|||++|+.||....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~AP----------E~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--- 274 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSP----------EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--- 274 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCH----------HHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---
T ss_pred hheeccCCCccccceeccccCcCCH----------HHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---
Confidence 99887644332 2345899999999 6665 3568999999999999999999999987432
Q ss_pred CCCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 047901 730 SSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSR---PTMQTVCQ 784 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~ 784 (786)
.......+... ....|. .....+..+.+++.+||. +|++| |+++|+++
T Consensus 275 -----~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 275 -----TAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -----HHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -----HHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 12222222221 122221 011223458899999999 99998 69999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.00 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=196.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|...+.||+|+||+||+|+.. ++..||+|++.... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 56999999999999999999864 68899999987532 223457889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee---CCCCcEEEeccccce
Q 047901 585 YEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAK 660 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 660 (786)
|||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999986431 235689999999999999999999999 99999999999999 456889999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ......||+.|+|| |... ..++.++||||+|+++|||++|+.||..... .....
T Consensus 176 ~~~~~~-~~~~~~~t~~y~aP----------E~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~ 235 (285)
T 3is5_A 176 LFKSDE-HSTNAAGTALYMAP----------EVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQ 235 (285)
T ss_dssp C-----------CTTGGGCCH----------HHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred ecCCcc-cCcCcccccCcCCh----------HHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHh
Confidence 765432 23445799999999 6554 4688999999999999999999999874321 11111
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........+. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 236 KATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111110 00012235889999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=349.04 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=197.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCE----EEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
++|+..+.||+|+||+||+|++. +++. ||+|.+..... ......+.+|+.+++.++||||+++++++. ++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 47999999999999999999864 4443 88888754321 122345678999999999999999999986 456
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 88999999999999999764 35688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... ......||..|+|| |...+..++.++|||||||++|||+| |+.||..... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~ 225 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMAL----------ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------AE 225 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------TH
T ss_pred ccCcccccccccCCCCcccccCh----------HHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--------HH
Confidence 7754432 23445788899999 88888899999999999999999999 9999875321 11
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+... +...+... +..+.+++..||..||++|||+.|+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 226 VPDLLEKGERLAQPQIC----TIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp HHHHHHTTCBCCCCTTB----CTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcC----cHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111111 22222222 22478999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.80 Aligned_cols=255 Identities=16% Similarity=0.220 Sum_probs=204.0
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++.+ +|||++++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 35799999999999999999985 578999999986522 123577899999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc-----EEEeccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE-----ARVSDFG 657 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfg 657 (786)
+||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 99999999864 34689999999999999999999999 9999999999999987766 9999999
Q ss_pred cceecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 658 TAKLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 658 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
+++....... ......||+.|+|| |...+..+++++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 223 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSI----------NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA--- 223 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS---
T ss_pred cccccccccccccccccCccCCCCCcccCCc----------hhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc---
Confidence 9998765432 12345799999999 788888899999999999999999999999875321
Q ss_pred CCcchhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 SSSSINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.........+.......+ .......+..+.+++..||+.||++|||+++|++.|
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 224 --ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp --CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred --cccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 111111222211111111 000112234689999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.81 Aligned_cols=251 Identities=26% Similarity=0.446 Sum_probs=198.1
Q ss_pred ccCccceeeccccCceEEEEEcCC-----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS-----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+|+..+.||+|+||+||+|+... +..||||++... ........+.+|+++++.++||||+++++++...+.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 467888999999999999998542 235999999753 233455679999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999764 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 661 LLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 661 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
........ .....+|+.|+|| |...+..++.++|||||||++|||++ |+.||.... ..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~ 257 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAP----------EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NH 257 (333)
T ss_dssp ---------------CCCGGGSCH----------HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred hhccccccccccCCCCccccccCc----------hhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HH
Confidence 76543221 1223567899999 77888889999999999999999999 999986432 11
Q ss_pred hhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+.+. +.+.+.. .+..+.+++.+||+.||++|||+.++++.|
T Consensus 258 ~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 258 EVMKAINDGFRLPTPMD----CPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp HHHHHHHTTCCCCCCTT----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHCCCcCCCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 222222222 2222222 234588999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=350.91 Aligned_cols=260 Identities=17% Similarity=0.246 Sum_probs=192.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|...+.||+|+||+||+|+.. +++.||||++...... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999865 7889999999753211 1112345799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 99998 5999998764 35689999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------------
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------------ 731 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------------ 731 (786)
.........||+.|+|| |...+ ..++.++||||+||++|||++|+.||.........
T Consensus 153 ~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPP----------DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222 (324)
T ss_dssp ----------CGGGCCH----------HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred CccccccccCcccccCh----------hhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 44445556889999999 66654 56899999999999999999999998753311000
Q ss_pred ----CcchhhhhhhhccCCCCCCC--hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ----SSSINIEFNAMLDHRLPHPS--LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ----~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.................... .........+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000000000 000112345789999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.43 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=196.6
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|+.+++.++||||+++++++...+..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3578999999999999999999865 688999999865221 22334578899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++++|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999864 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 663 KPNS-SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 663 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.... .......|++.|+|| |...+..++.++||||||+++|||++|+.||..... .....
T Consensus 185 ~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~ 245 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAP----------ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGA 245 (309)
T ss_dssp ------------CCGGGCCG----------GGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHH
T ss_pred cccccccccccCCCcCccCH----------HHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHH
Confidence 5432 223345799999999 556666788999999999999999999999874321 12222
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHhC
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-TMQTVCQLL 786 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L 786 (786)
.+......+.......+..+.+++.+||+.||++|| |++++++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 246 HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 222222212111222334588999999999999999 999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.15 Aligned_cols=260 Identities=18% Similarity=0.255 Sum_probs=205.9
Q ss_pred HHHHHhccCccc-eeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEe
Q 047901 500 EIIRRTKDFDAK-YCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCS 576 (786)
Q Consensus 500 ~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~ 576 (786)
......++|.+. +.||+|+||+||+|+.. +++.||||++..... .......+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 334445678877 88999999999999865 689999999875322 2234568899999999995 699999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEE
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARV 653 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl 653 (786)
..+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998654 346789999999999999999999999 9999999999999998 789999
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~ 733 (786)
+|||+++...... ......||+.|+|| |...+..++.++|||||||++|||++|+.||....
T Consensus 176 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------- 237 (327)
T 3lm5_A 176 VDFGMSRKIGHAC-ELREIMGTPEYLAP----------EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED------- 237 (327)
T ss_dssp CCGGGCEEC----------CCCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------
T ss_pred eeCccccccCCcc-ccccccCCcCccCC----------eeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 9999998775432 23446799999999 78888889999999999999999999999986432
Q ss_pred chhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+.......+..+.+++..||+.||++|||++|+++
T Consensus 238 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 238 -NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 12222222222222222222233445889999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.02 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=210.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|++++++++||||+++++++...+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV-KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc-ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 357999999999999999999865 789999999865322 223456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee---CCCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999754 5689999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ......||+.|+|| |+..+ .++.++||||+||++|+|++|++||.... ......
T Consensus 178 ~~~~~~-~~~~~~gt~~y~aP----------E~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 237 (484)
T 3nyv_A 178 HFEASK-KMKDKIGTAYYIAP----------EVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILK 237 (484)
T ss_dssp HBCCCC-SHHHHTTGGGTCCH----------HHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred Eccccc-ccccCCCCccccCc----------eeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 775443 33445799999999 66654 68999999999999999999999987432 223334
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+...+...+..+.+++..||.+||++|||+.|+++
T Consensus 238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 44444444333333444566899999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=352.47 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=198.6
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC--CCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR--HRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~l 583 (786)
.+|++.+.||+|+||+||+|...+++.||||++.... ......+.+.+|+++++.++ ||||+++++++...+..|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4699999999999999999998889999999987532 23345678999999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||| +.+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 134 v~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 5678999999865 4688999999999999999999999 999999999999996 6899999999998775
Q ss_pred CCCC--cceeeccCccccCCCCCCCCchHHHHhhh-----------cCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 664 PNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 664 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-----------~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
.... .....+||+.|+|| |++.+ ..++.++|||||||++|||++|+.||....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---- 271 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPP----------EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---- 271 (390)
T ss_dssp --------CCSCCCGGGCCH----------HHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----
T ss_pred CCCccccCCCCCcCCCccCh----------HHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh----
Confidence 4322 22345799999999 55543 468899999999999999999999986421
Q ss_pred CCcchhhhhhhhccCCCC--CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 SSSSINIEFNAMLDHRLP--HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........+++.... .+... ...+.+++..||..||++|||+.|+++
T Consensus 272 ---~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 272 ---NQISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ---CHHHHHHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHhCccccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 112223334433222 22222 234889999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.20 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=204.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe--cCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS--HVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~ 581 (786)
.++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+.+.+|++++++++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc--CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 468999999999999999999865 78999999997532 22345678999999999999999999999874 46788
Q ss_pred eEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEEcCCCCCceeeCCCCcEEEec
Q 047901 582 FVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPP-----IVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivHrdlk~~Nill~~~~~~kl~D 655 (786)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 99999999999999997532 234589999999999999999999998 7 99999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||.++.............||+.|+|| |...+..++.++||||||+++|||++|+.||.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------- 221 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSP----------EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------- 221 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCH----------HHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred CchheeeccccccccccCCCccccCh----------HHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------
Confidence 99998775443333445789999999 777788899999999999999999999999874321
Q ss_pred hhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 736 NIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 736 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
......+...... .+.. .+..+.+++.+||+.||++|||++|+++.
T Consensus 222 ~~~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 222 KELAGKIREGKFRRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHHHHHHHTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhhcccccCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1122222222221 2222 23358899999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.67 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=195.8
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .........+.+|+.+++.++||||+++++++...+..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS-SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 35799999999999999999985 478999999997522 2234456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999996421 245689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
...........|++.|+|| |...+..++.++||||||+++|||++|+.||..... ........+
T Consensus 187 ~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~ 250 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSP----------ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKI 250 (310)
T ss_dssp ------------CCSSCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHH
T ss_pred cCCCccccccCCCeeEeCh----------HHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHh
Confidence 6544334456799999999 777788899999999999999999999999864211 111112222
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+.. .....+..+.+++..||+.||++|||+.+|++.|
T Consensus 251 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 251 EQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp HTTCSCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcccCCCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 22222111 0111234588999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=364.31 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=206.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc---------hhhHHHHHHHHHHHhhcCCCcccceeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ---------MSDQKEFLNEIKALTKIRHRNIVKFYGF 574 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~hpniv~l~~~ 574 (786)
.++|.+.+.||+|+||+||+|+.. +++.||||++........ ....+.+.+|+++++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999865 678999999875322110 1335678999999999999999999999
Q ss_pred EecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC---cE
Q 047901 575 CSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY---EA 651 (786)
Q Consensus 575 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~ 651 (786)
+.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999999764 5689999999999999999999999 999999999999998775 69
Q ss_pred EEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 652 RVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
||+|||+|+..... .......||+.|+|| |+.. ..++.++||||+||++|+|++|..||....
T Consensus 189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aP----------E~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----- 251 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAP----------EVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN----- 251 (504)
T ss_dssp EECCCTTCEECCTT-SCBCCCCSCTTTCCH----------HHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred EEEECCCCEEcCCC-CccccccCCcCCCCH----------HHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 99999999877543 233456899999999 6655 468999999999999999999999987432
Q ss_pred CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+...+...+..+.+++..||.+||.+|||++|+++
T Consensus 252 ---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 252 ---DQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ---HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22334444444444333333334566899999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.60 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=202.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 457999999999999999999865 78999999997522 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee---CCCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 660 (786)
||||+++++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||.++
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 99999999999999754 4689999999999999999999999 99999999999999 778999999999997
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... ......||+.|+||| ...+..++.++||||+|+++|||++|+.||.... ......
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE----------~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~ 217 (304)
T 2jam_A 158 MEQNG--IMSTACGTPGYVAPE----------VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFE 217 (304)
T ss_dssp CCCCB--TTHHHHSCCCBCCTT----------TBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHH
T ss_pred ecCCC--ccccccCCCCccChH----------HhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 65432 233457999999995 5556678999999999999999999999986422 112222
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+.......+..+.+++..||..||++|||++|+++
T Consensus 218 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 218 KIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33333222222222223446899999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=337.62 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=206.5
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.+.|+..+.||+|+||+||+|+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT---CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 34699999999999999999985 478899999997532 22346789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++.. +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 98 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999999964 4689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||+.|+|| |...+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 171 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~ 232 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAP----------EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIP 232 (303)
T ss_dssp TTBCCBCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH
T ss_pred ccccccCccCCCcCccCH----------HHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhh
Confidence 554444556899999999 778888899999999999999999999999874321 11111111
Q ss_pred cCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... .+.. .+..+.+++..||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 233 KNNPPTLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HSCCCCCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCCCCCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1111 2234889999999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.55 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=206.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 357999999999999999999865 677899999854110 011234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999764 4689999999999999999999999 99999999999999999999999999997765
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......|++.|+|| |...+..++.++||||||+++|||++|+.||.... .......+.
T Consensus 166 ~~--~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~ 225 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPP----------EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIV 225 (284)
T ss_dssp SS--CBCCCCSCGGGCCH----------HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred cc--ccccccCCCCcCCH----------HHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHh
Confidence 32 22345799999999 77888889999999999999999999999987432 122233333
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+... +..+.+++..||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 226 NVDLKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTCCCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 3333333322 234889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=363.62 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=204.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. ++..||||++...... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346999999999999999999865 7889999999763221 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.. +.+||+|||+|+
T Consensus 114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999998754 5689999999999999999999999 99999999999999764 569999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... .......||+.|+|| |+.. ..++.++||||+||++|+|++|+.||.... ......
T Consensus 188 ~~~~~-~~~~~~~gt~~y~aP----------E~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 247 (494)
T 3lij_A 188 VFENQ-KKMKERLGTAYYIAP----------EVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILR 247 (494)
T ss_dssp ECBTT-BCBCCCCSCTTTCCH----------HHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred ECCCC-ccccccCCCcCeeCH----------HHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 77643 233456899999999 6654 468999999999999999999999987432 223334
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+...+...+..+.+++..||..||++|||+.|+++
T Consensus 248 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 248 KVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 44444444333333344556899999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=343.65 Aligned_cols=246 Identities=21% Similarity=0.397 Sum_probs=198.1
Q ss_pred hccCccceeeccccCceEEEEEcCC-C-------CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS-G-------DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS 576 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~ 576 (786)
.++|...+.||+|+||+||+|+... + ..||+|++.. ......+.+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG----GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc----ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 3579999999999999999998652 3 4699999864 23445678999999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc------
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE------ 650 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~------ 650 (786)
..+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999999864 34489999999999999999999999 9999999999999998887
Q ss_pred --EEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCC-CCCccc
Q 047901 651 --ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKH-PGDFLS 726 (786)
Q Consensus 651 --~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~-Pf~~~~ 726 (786)
+||+|||.+...... ....||+.|+|| |...+ ..++.++|||||||++|||++|.. ||....
T Consensus 158 ~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK----DILQERIPWVPP----------ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CEEEECCCCSCTTTSCH----HHHHHTTTTSCH----------HHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceeeeccCcccccccCc----cccCCcCcccCH----------HHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 999999998755322 335689999999 66665 678999999999999999999554 443211
Q ss_pred cccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 727 LFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..............+... +..+.+++..||+.||++|||++|+++.|
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 224 ---------SQRKLQFYEDRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp ---------HHHHHHHHHTTCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ---------hHHHHHHhhccCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111111222222222211 12378999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.14 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=202.5
Q ss_pred ccCccce-eeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKY-CIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|.+.+ .||+|+||+||+|... ++..||||++... ......+.+.+|+++++.++||||+++++++ ..+..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4566665 8999999999999753 5678999999753 2345567899999999999999999999999 45668
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999999999753 35689999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 662 LKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 662 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... .....+|+.|+|| |...+..++.++||||||+++|||++ |+.||..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~ 221 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAP----------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PE 221 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HH
T ss_pred eccCcceeeccccccccccccCH----------HHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HH
Confidence 7543322 1233568899999 77888889999999999999999998 9999874321 11
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+... +...+.. .+..+.+++..||+.||++|||+.++++.|
T Consensus 222 ~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 222 VMAFIEQGKRMECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCcCCCCCC----cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11222221 1222222 234588999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.33 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=207.5
Q ss_pred HHHhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEE
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFC 575 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~ 575 (786)
....++|+..+.||+|+||+||+|+.. +++.||||++... ........+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334678999999999999999999754 3678999998752 2334556789999999999999999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNF-------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 648 (786)
.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999997531 124578999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcc
Q 047901 649 YEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFL 725 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~ 725 (786)
+.+||+|||+++....... ......+|+.|+|| |...+..++.++||||||+++|||++ |+.||...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP----------ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccCh----------hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999986643321 12234678899999 78888889999999999999999999 89998643
Q ss_pred ccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 726 SLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. .......+...... .+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 245 ~--------~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 245 S--------NEQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp C--------HHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C--------HHHHHHHHHcCCcCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 2 12222222222222 2222 233588999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.81 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=198.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+++++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 457999999999999999999865 58899999986532 233445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999998887643 5689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----------
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---------- 732 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---------- 732 (786)
..........||+.|+|| |...+. .++.++||||+||++|||++|+.||..........
T Consensus 176 ~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAP----------ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245 (331)
T ss_dssp --------CCCCCTTCCH----------HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CCccccCCCcCCccccCc----------ccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence 544444556899999999 666554 68899999999999999999999987533210000
Q ss_pred cchhhh------hhhhccCCCCCCCh---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 SSINIE------FNAMLDHRLPHPSL---DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... .............. .....+..+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00000000000000 00122356899999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=343.89 Aligned_cols=250 Identities=22% Similarity=0.416 Sum_probs=195.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.++|+..+.||+|+||+||+|++. +++ +||+|.+... ......+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC---SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc---cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 357999999999999999999854 444 3588877542 22345678999999999999999999999998754
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
.++|+||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 78999999999999999864 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
+....... ......+|+.|+|| |...+..++.++|||||||++|||++ |+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------- 225 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMAL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------- 225 (327)
T ss_dssp ---------------CCCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---------
T ss_pred eEccCccccccccCCCccccccCH----------HHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---------
Confidence 87654322 22334568899999 88888899999999999999999999 9999875321
Q ss_pred hhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. ....+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 226 SEISSILEKGERLPQPPIC----TIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 112222222 22223222 23488999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.39 Aligned_cols=250 Identities=22% Similarity=0.413 Sum_probs=203.3
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|+..+.||+|+||+||+|+..+++.||||++.... ...+.+.+|+++++.++||||+++++++.. +..++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 46799999999999999999998888899999986521 235678999999999999999999999874 568999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999999753 123689999999999999999999999 999999999999999999999999999988764
Q ss_pred CCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.... .....++..|+|| |...+..++.++||||||+++|||++ |+.||..... ......+
T Consensus 162 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~ 223 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAP----------EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNL 223 (279)
T ss_dssp SCEECCTTCCCCTTTSCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH
T ss_pred cccccccCCCCccCccCh----------hhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHH
Confidence 3221 1234567899999 77788889999999999999999999 9999864321 1122222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+.. .+..+.+++..||+.||++|||++++++.|
T Consensus 224 ~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 224 ERGYRMVRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp HTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcccCCCCccc----ccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 221 1122222 233588999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.71 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=191.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|+.. ..||||++.... ......+.|.+|++++++++||||+++++++ .....++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 467999999999999999999874 369999997532 2344567899999999999999999999976 45668999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999654 35689999999999999999999999 999999999999999999999999999986643
Q ss_pred C--CCcceeeccCccccCCCCCCCCchHHHHhh---hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 665 N--SSNWTELVGTFGYVAPAHGNIGLHLAELAY---TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 665 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~---~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
. ........||+.|+|| |... ...++.++||||||+++|||++|+.||..... ....
T Consensus 173 ~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~ 234 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAP----------EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQI 234 (289)
T ss_dssp -----------CCCTTCCH----------HHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--------HHHH
T ss_pred ccccccccccCCCccccCc----------hhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--------HHHH
Confidence 2 2223445799999999 6554 56688899999999999999999999874321 1111
Q ss_pred hhhc-cCCCCC-CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 740 NAML-DHRLPH-PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 740 ~~~~-~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+ ...... ........+..+.+++..||+.||++|||+.|+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 235 IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp HHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1111 111111 1111122334589999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=344.73 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=205.6
Q ss_pred hccCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe--c
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS--H 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~ 577 (786)
.++|+..+.||+|+||+||+|++ .+++.||||++.. ......+.+.+|++++++++||||+++++++. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc----CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 45799999999999999999983 3678999999975 23455677999999999999999999999886 4
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence 56789999999999999999764 24689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc-----
Q 047901 658 TAKLLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS----- 729 (786)
Q Consensus 658 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~----- 729 (786)
+++........ .....||..|+|| |...+..+++++||||||+++|||++|+.||.......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~ 242 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAP----------ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC
T ss_pred cceecccCCccceeeccCCccccccCH----------HHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc
Confidence 99987544321 2234688889999 78888889999999999999999999999976432100
Q ss_pred -CCCcchhhhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 730 -SSSSSINIEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 730 -~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.............+... ...+.. .+..+.+++..||+.||++|||++|+++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 243 CERDVPALSRLLELLEEGQRLPAPPA----CPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp ----CCHHHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccccccHHHHHHHhhcccCCCCCCc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00000111112222221 122222 234589999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=336.75 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=199.2
Q ss_pred hccCccceeeccccCceEEEEEcCCC----CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe-cCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSG----DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS-HVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~ 579 (786)
..+|+..+.||+|+||+||+|+..+. ..||+|++.. .......+.+.+|+.++++++||||+++++++. .++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT---CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc---CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 35688899999999999999985422 2589999865 233455678999999999999999999999864 556
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 789999999999999999753 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcc
Q 047901 660 KLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 660 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~ 734 (786)
+....... ......+|+.|+|| |...+..+++++||||+|+++|||++ |.+||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------- 238 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMAL----------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------- 238 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-------
T ss_pred ccccccchhccccccCCCCCccccCh----------HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-------
Confidence 87654321 12344678899999 78888899999999999999999999 5566553221
Q ss_pred hhhhhhhhccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 735 INIEFNAMLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 735 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
............ ..+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 239 -~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 239 -FDITVYLLQGRRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp -TTHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHHHHhcCCCCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111112222221 222222 23488999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=353.01 Aligned_cols=203 Identities=27% Similarity=0.428 Sum_probs=163.9
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecC--C
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHV--R 579 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~--~ 579 (786)
..++|++.+.||+|+||+||+|... +++.||||++.... ......+.+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3568999999999999999999854 78999999986532 23445667889999999997 99999999999654 3
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..|+|||||+ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 7899999998 599999875 3688999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCC---------------------CCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHh
Q 047901 660 KLLKPN---------------------SSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 660 ~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~ellt 717 (786)
+..... .......+||+.|+|| |++.+ ..++.++||||+||++|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwSlG~il~ell~ 226 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP----------EILLGSTKYTKGIDMWSLGCILGEILC 226 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCH----------HHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCH----------HHhcCCCCCCChhhHHHHHHHHHHHHh
Confidence 876431 1112345899999999 66655 678999999999999999999
Q ss_pred CCCCCCccc
Q 047901 718 GKHPGDFLS 726 (786)
Q Consensus 718 g~~Pf~~~~ 726 (786)
|++||....
T Consensus 227 g~~pf~~~~ 235 (388)
T 3oz6_A 227 GKPIFPGSS 235 (388)
T ss_dssp SSCSCCCSS
T ss_pred CCCCCCCCC
Confidence 999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.63 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=196.7
Q ss_pred HHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc-hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ-MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
...++|+..+.||+|+||+||+|+.. +++.||||++........ ....+.+.+|+++++.++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 689999999975322111 1123467899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 899988754 35688889999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
.............||+.|+|| |...+ ..++.++|||||||++|||++|.+||...... ...
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--------~~~ 222 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAP----------ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQL 222 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCH----------HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred eccCCcccCCcccccccccCc----------hHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHH
Confidence 776554445566899999999 66654 45889999999999999999999998753311 011
Q ss_pred hhhccC-------C----------C---CCCChh----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 NAMLDH-------R----------L---PHPSLD----VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~-------~----------~---~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+... . . ..+... ....+..+.+++..||..||++|||++|+++
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111000 0 0 000000 0112346899999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=334.38 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=199.6
Q ss_pred hccCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|+..+.||+|+||+||+|+... +..||||++... ......+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD---CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT---SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc---cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4679999999999999999998532 235999998752 233456789999999999999999999999875 45
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 68999999999999999764 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhh
Q 047901 661 LLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 661 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 738 (786)
....... ......+++.|+|| |...+..++.++||||||+++|||++ |+.||..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~ 223 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSP----------ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDV 223 (281)
T ss_dssp CC---------CCCCCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGH
T ss_pred ccccccccccccCCCCcceeCc----------hhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHH
Confidence 7654322 22334678899999 77888889999999999999999998 9999864321 111
Q ss_pred hhhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 739 FNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 739 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+.. ...+.+... +..+.+++.+||+.||++|||+.|+++.|
T Consensus 224 ~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 224 IGVLEKGDRLPKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp HHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 111111 122222222 23488999999999999999999998764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.02 Aligned_cols=346 Identities=24% Similarity=0.249 Sum_probs=213.7
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCC-------------CEEeCcCCcccccCCc
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKL-------------KYLDLSENELSGKIPP 68 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~~~ 68 (786)
++++|++++|++ +.+|+ +|..+++|++|++++|++.+..|..+..+.+| ++|++++|+++++ |.
T Consensus 12 ~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred cchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 478899999999 79998 68999999999999999998999999988864 8999999998854 33
Q ss_pred cccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccc
Q 047901 69 EIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLE 148 (786)
Q Consensus 69 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 148 (786)
..++|++|+|++|++++++.. +++|++|++++|+++++... .++|++|++++|++++ +| .+..+++|+
T Consensus 89 ---~~~~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~ 156 (454)
T 1jl5_A 89 ---LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLK 156 (454)
T ss_dssp ---CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCC
T ss_pred ---CcCCCCEEEccCCcCCccccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCC
Confidence 247888888888888875543 36788888888887754321 1578888888888875 55 477778888
Q ss_pred eeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCccc
Q 047901 149 ILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228 (786)
Q Consensus 149 ~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 228 (786)
.|++++|++++++..+ .+|+.|++++|++++++ .|..+++|++|++++|+++++.. . .++|++|++++|++
T Consensus 157 ~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~l~~-~---~~~L~~L~l~~n~l 227 (454)
T 1jl5_A 157 IIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKKLPD-L---PLSLESIVAGNNIL 227 (454)
T ss_dssp EEECCSSCCSCCCCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSSCCC-C---CTTCCEEECCSSCC
T ss_pred EEECCCCcCcccCCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCcCCC-C---cCcccEEECcCCcC
Confidence 8888888877644332 47778888888887743 57778888888888887776432 1 24777788888877
Q ss_pred CCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhh
Q 047901 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEAL 308 (786)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 308 (786)
+ .+| .+..+++|+.|++++|++++ +|.. +++|+.|++++|++++++ .. +++|+.|++++|++++++..
T Consensus 228 ~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~-~~---~~~L~~L~ls~N~l~~l~~~-- 295 (454)
T 1jl5_A 228 E-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLP-EL---PQSLTFLDVSENIFSGLSEL-- 295 (454)
T ss_dssp S-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSEESCC--
T ss_pred C-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccC-cc---cCcCCEEECcCCccCcccCc--
Confidence 7 345 37777778888888777774 3332 257777777777777532 22 36677777777776654311
Q ss_pred hcccCCcEEEecccccCCCcchHHhhh-cCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCce
Q 047901 309 GFMFKLFYLNFSHNQFSQEIPEDLALL-AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLL 387 (786)
Q Consensus 309 ~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 387 (786)
.++|++|++++|++++.. .+ ++|+.|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|+
T Consensus 296 --~~~L~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~ 360 (454)
T 1jl5_A 296 --PPNLYYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLK 360 (454)
T ss_dssp --CTTCCEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCC
T ss_pred --CCcCCEEECcCCcCCccc-----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhcc
Confidence 145555555555554321 11 355555555555553 3322 3455555555555553 232 245555
Q ss_pred EEeccCCcccc
Q 047901 388 SIDISYNELRG 398 (786)
Q Consensus 388 ~L~l~~N~l~~ 398 (786)
.|++++|++++
T Consensus 361 ~L~L~~N~l~~ 371 (454)
T 1jl5_A 361 QLHVEYNPLRE 371 (454)
T ss_dssp EEECCSSCCSS
T ss_pred EEECCCCCCCc
Confidence 55555555555
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.81 Aligned_cols=259 Identities=21% Similarity=0.236 Sum_probs=193.4
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC----CchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN----DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
..++|.+.+.||+|+||+||+|... +++.||||++...... ........+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3568999999999999999999854 6889999998652111 111223357899999999999999999999864
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEec
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSD 655 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~D 655 (786)
+..++||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 5579999999999999998754 5689999999999999999999999 99999999999999754 4599999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||+|+..... .......||+.|+|||++.. .....++.++|||||||++|||++|+.||..... .
T Consensus 286 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-------~ 350 (419)
T 3i6u_A 286 FGHSKILGET-SLMRTLCGTPTYLAPEVLVS-------VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-------Q 350 (419)
T ss_dssp SSTTTSCC------------CTTCCTTTTC-----------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-------S
T ss_pred cccceecCCC-ccccccCCCCCccCceeeec-------CCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-------h
Confidence 9999876533 22345689999999964321 1235678899999999999999999999874221 1
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus 351 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 351 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111222223333222222334456899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.43 Aligned_cols=262 Identities=17% Similarity=0.258 Sum_probs=191.3
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+++++.++||||+++++++...+..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3568999999999999999999854 78899999997532 22233456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee-----CCCCcEEEeccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL-----DLEYEARVSDFG 657 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-----~~~~~~kl~Dfg 657 (786)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 999999865 4689999999999999999999999 99999999999999 455669999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---- 732 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---- 732 (786)
+|+.............||+.|+|| |+..+ ..++.++|||||||++|||++|+.||..........
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPP----------EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp HHHHHC-----------CCTTCCH----------HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccccCCcccccCCCcCCccccCH----------HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 998776544445556889999999 66665 448999999999999999999999987533210000
Q ss_pred ------cchhhhhhhhc--cCCCC-CCChhHH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ------SSINIEFNAML--DHRLP-HPSLDVQ-----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ------~~~~~~~~~~~--~~~~~-~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........... ....+ ....... .....+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000 00000 0000000 02345889999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=343.92 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=201.6
Q ss_pred HHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhh--cCCCcccceeeEEecCC
Q 047901 502 IRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK--IRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 502 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~~ 579 (786)
....++|++.+.||+|+||+||+|+. +++.||||++.. .....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34456899999999999999999988 488999999853 234677889999887 68999999999998765
Q ss_pred ----eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEcCCCCCceeeCC
Q 047901 580 ----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH--------HDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 580 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrdlk~~Nill~~ 647 (786)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 789999999999999999753 5899999999999999999999 66 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCc----ceeeccCccccCCCCCCCCchHHHHhhhc------CcCcccchHHHHHHHHHHHh
Q 047901 648 EYEARVSDFGTAKLLKPNSSN----WTELVGTFGYVAPAHGNIGLHLAELAYTM------KITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~------~~~~~sDvwslGvil~ellt 717 (786)
++.+||+|||+++........ .....||+.|+|| |...+. .++.++|||||||++|||+|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP----------EVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCH----------HHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCH----------hhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 999999999999877654322 2345799999999 555443 34478999999999999999
Q ss_pred C----------CCCCCccccccCCCcchhhhhhhhccCCCC--CCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 718 G----------KHPGDFLSLFSSSSSSINIEFNAMLDHRLP--HPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 718 g----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
| ..||...... ..........+...... .+.. ...+....+.+++.+||+.||++|||+.||++
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPS---DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCS---SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCcCCcccccccCccccCcC---cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9 6676542211 11111112222222221 2211 12345567999999999999999999999998
Q ss_pred hC
Q 047901 785 LL 786 (786)
Q Consensus 785 ~L 786 (786)
.|
T Consensus 330 ~L 331 (342)
T 1b6c_B 330 TL 331 (342)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=354.79 Aligned_cols=261 Identities=17% Similarity=0.210 Sum_probs=195.5
Q ss_pred hccCccceeeccccCceEEEEEcCC------CCEEEEEEcCCCCCCCch-------hhHHHHHHHHHHHhhcCCCcccce
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS------GDKIAVKKFNSPFPNDQM-------SDQKEFLNEIKALTKIRHRNIVKF 571 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~l 571 (786)
.++|++.+.||+|+||+||+|.+.. ++.||||++......... .....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998754 478999998652110000 001123445666778889999999
Q ss_pred eeEEecC----CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-
Q 047901 572 YGFCSHV----RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD- 646 (786)
Q Consensus 572 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~- 646 (786)
++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9998764 4579999999 99999999764 35799999999999999999999999 999999999999999
Q ss_pred -CCCcEEEeccccceecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC
Q 047901 647 -LEYEARVSDFGTAKLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG 718 (786)
Q Consensus 647 -~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg 718 (786)
.++.+||+|||+|+.+..... ......||+.|+|| |.+.+..++.++|||||||++|||+||
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~~l~el~~g 257 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI----------DAHNGVAPSRRGDLEILGYCMIQWLTG 257 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH----------HHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 889999999999987653321 11334699999999 888888899999999999999999999
Q ss_pred CCCCCccccccCCCc----chhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 719 KHPGDFLSLFSSSSS----SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 719 ~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+.||........... ..........+..+.. ...+..+.+++..||+.+|++|||+++|++.|
T Consensus 258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CCCccccccCHHHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 999874221000000 0000111111111110 01134589999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.75 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=202.7
Q ss_pred CccceeeccccCceEEEEEcC-----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLP-----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRH 580 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~ 580 (786)
|+..+.||+|+||+||++.+. +++.||||++... ......+.+.+|+++++.++||||+++++++.+ ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 489999999999999988642 5788999999753 233456789999999999999999999999987 467
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999999754 489999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccc-----cCC-
Q 047901 661 LLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF-----SSS- 731 (786)
Q Consensus 661 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~-----~~~- 731 (786)
........ .....+|..|+|| |...+..++.++||||||+++|||++|+.||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAP----------ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred cccccccccccccCCCCCceeeCh----------HHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 87654322 2334678899999 7888888999999999999999999999997642210 000
Q ss_pred CcchhhhhhhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 732 SSSINIEFNAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...........+.... ..+.. .+..+.+++..||+.||++|||++|+++.|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDK----CPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHHHHHhcccCCCCCcc----ccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0001111222222222 22222 234589999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=363.70 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=205.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ........+.+|++++++++||||+++++++.+....++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHH--HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 457999999999999999999865 78999999985421 112245678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC---CCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD---LEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+|+
T Consensus 99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999998764 5689999999999999999999999 999999999999995 45689999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... .......||+.|+|| |+..+ .++.++||||+||++|+|++|+.||.... ......
T Consensus 173 ~~~~~-~~~~~~~gt~~y~aP----------E~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 232 (486)
T 3mwu_A 173 CFQQN-TKMKDRIGTAYYIAP----------EVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILK 232 (486)
T ss_dssp TBCCC-----CCTTGGGGCCG----------GGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred ECCCC-CccCCCcCCCCCCCH----------HHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 76543 233456899999999 55443 58999999999999999999999986432 223333
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.......+...+...+..+.+++..||..||++|||+.|+++
T Consensus 233 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 44444444333333344556899999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=357.85 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=195.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 467999999999999999999854 68899999997532 2334567888999999999999999999999654
Q ss_pred -CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 579 -RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 579 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
...|+||||+++ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 457999999986 5777664 2488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC-----
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS----- 732 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~----- 732 (786)
+|+..... ......+||+.|+|| |++.+..++.++||||+||++|||++|+.||...+......
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 210 LARTAGTS-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp CC-----C-CCC----CCCTTCCH----------HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eeeecCCC-cccCCCcccccccCH----------HHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99876543 234556899999999 78888899999999999999999999999997543210000
Q ss_pred ---------cchhhhhhhhccCCCC----------------CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ---------SSINIEFNAMLDHRLP----------------HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ---------~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..........+..... ............+.+++.+||..||++|||++|+++
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000011111111111 111112223556899999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=333.37 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=202.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 467999999999999999999865 78999999986422 22345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999998643 5689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC--CcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 664 PNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 664 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
... .......||+.|+|| |...+..+ +.++||||||+++|||++|+.||..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~ 219 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAP----------ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYS 219 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCG----------GGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT-------TSHHHH
T ss_pred CCcchhcccCCccccCccCh----------HHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch-------HHHHHH
Confidence 322 123445799999999 55555444 6789999999999999999999875321 011112
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........+. ....+..+.+++..||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 220 DWKEKKTYLNP--WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHTTCTTSTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhcccccCc--hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 22221111111 1223345889999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.37 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=200.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||.||+|... +++.||||++... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT------SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch------HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 567999999999999999999865 6899999999752 123578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 102 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999999743 35689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||+.|+|| |...+..++.++||||||+++|||++|+.||....... .........
T Consensus 177 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~ 241 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAP----------EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPTNP 241 (314)
T ss_dssp TTBSCBCCCCSCGGGCCH----------HHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSC
T ss_pred hhccccCccCCCCCccCh----------hhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCC
Confidence 544444556899999999 77777889999999999999999999999987432110 000001111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+. ..+..+.+++..||..||++|||+.++++
T Consensus 242 ~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 242 PPTFRKPE----LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCCSSGG----GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CcccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111111 12345889999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.99 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=198.3
Q ss_pred cCccceeeccccCceEEEEEcC-CC---CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee-
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SG---DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS- 581 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~- 581 (786)
.|...+.||+|+||+||+|++. ++ ..||+|++.. .......+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT---CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc---cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 5667789999999999999853 22 2699999865 23344567899999999999999999999999766555
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999999763 35689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC----CcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC-CCccccccCCCcchh
Q 047901 662 LKPNS----SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-GDFLSLFSSSSSSIN 736 (786)
Q Consensus 662 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P-f~~~~~~~~~~~~~~ 736 (786)
..... .......+++.|+|| |...+..+++++||||||+++|||++|..| |..... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--------~ 235 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTAL----------ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--------F 235 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--------G
T ss_pred ccCCcccccccCcCCCCCccccCh----------hhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--------H
Confidence 64321 122345678999999 788888899999999999999999996555 432211 1
Q ss_pred hhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+... ....+... +..+.+++..||+.||.+|||+.++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 236 DLTHFLAQGRRLPQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp GHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111111111 12222222 23588999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.76 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=202.1
Q ss_pred hccCccceeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~ 579 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++............+.+.+|+++++.+ .||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999986 368899999986422111122334567899999999 6999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999764 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
+....... ......||+.|+|| |+..+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~ 272 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAP----------DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQA 272 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCH----------HHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHH
T ss_pred eecccCCCCcccCcccCcCccCh----------hhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHH
Confidence 87643322 23345799999999 66654 3478899999999999999999999864321 11112
Q ss_pred hhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 737 IEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.............+... +..+.+++.+||..||++|| |++|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 273 EISRRILKSEPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHhccCCCCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 22223333333333222 23488999999999999999 9999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=369.26 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=204.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|++.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..++|
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 46789999999999999999999888889999997522 234679999999999999999999999876 678999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999753 224589999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......++..|+|| |.+....++.++|||||||++|||++ |+.||..... .+....+
T Consensus 416 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i 477 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAP----------EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV 477 (535)
T ss_dssp HHHHTTCSTTSCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHH
T ss_pred CceecccCCcCcccccCH----------HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 211 11233567899999 78888899999999999999999999 9999874321 1122222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+... +..+.++|..||+.||++|||+++|++.|
T Consensus 478 ~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 478 ERGYRMPCPPEC----PESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp HTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 221 22333322 34588999999999999999999998864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=373.77 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=211.9
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
..++|++.+.||+|+||+||+|+.+ +++.||||++..... ......+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4568999999999999999999865 678899999864210 0122345678899999988 699999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+||||+++|+|.+++... +.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999999864 5689999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...........+||+.|+|| |++.+..++.++|||||||++|||++|+.||.... ..+....
T Consensus 492 ~~~~~~~~~~~~GT~~Y~AP----------E~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~ 553 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAP----------EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQS 553 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCH----------HHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred cccCCcccccccCCCcccCH----------hhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHH
Confidence 65444455667899999999 88888899999999999999999999999987432 3344555
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM-----QTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 784 (786)
+.......|.... ..+.+++..||.+||++||++ +||++
T Consensus 554 i~~~~~~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 554 IMEHNVAYPKSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHSSCCCCCTTSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHhCCCCCCccCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 6666665554333 358899999999999999998 77654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=340.99 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=207.6
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccce
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKF 571 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l 571 (786)
.++....++|++.+.||+|+||+||+|+. .+++.||||++... ......+.+.+|+.+++.+ +||||+++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34444567899999999999999999973 35678999999753 2334556889999999999 69999999
Q ss_pred eeEEecCC-eeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 047901 572 YGFCSHVR-HSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRD 637 (786)
Q Consensus 572 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 637 (786)
++++...+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987654 58999999999999999986532 12378999999999999999999999 999999
Q ss_pred CCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 638 ISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 638 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
|||+||+++.++.+||+|||+++........ .....||+.|+|| |...+..++.++||||||+++|||
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l 243 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP----------ETIFDRVYTIQSDVWSFGVLLWEI 243 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc----------hhhccccccchhHHHHHHHHHHHH
Confidence 9999999999999999999999876543322 2345688999999 788888899999999999999999
Q ss_pred Hh-CCCCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 716 IK-GKHPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 716 lt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+| |+.||..... .......+... ....+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 244 ~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 244 FSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HTTSCCSSTTCCC-------SHHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhCCCCCCcccch-------hHHHHHHhccCccCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 98 9999864321 11111111111 12222222 23488999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=337.90 Aligned_cols=255 Identities=17% Similarity=0.250 Sum_probs=198.5
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEE-ecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFC-SHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~ 582 (786)
.++|+..+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+++++.++|++++..++++ ...+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 56899999999999999999985 5788999998754221 23477899999999988877777665 6677889
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee---CCCCcEEEeccccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTA 659 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a 659 (786)
+||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 89999999753 35689999999999999999999999 99999999999999 78899999999999
Q ss_pred eecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 660 KLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 660 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
+....... ......||+.|+|| |...+..++.++|||||||++|||++|+.||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~- 224 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASI----------NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR- 224 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-
T ss_pred eeccCcccCccCCCCcccccCCCccccch----------HHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-
Confidence 88764432 12345799999999 7888888999999999999999999999999754322111
Q ss_pred cchhhhhhhhccCCCCCCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 733 SSINIEFNAMLDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.............+.. .....+..+.+++..||+.||++|||++++++.|
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 225 ----QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp ----SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred ----hhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 1111111111111100 0011234589999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=368.71 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=197.3
Q ss_pred cCccce-eeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 507 DFDAKY-CIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 507 ~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
++...+ .||+|+||+||+|.++ ++..||||+++.. ......+.|.+|++++++++|||||++++++.. +..+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC---CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344444 7999999999999753 4567999999753 223456789999999999999999999999976 5689
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 412 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999999754 45689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcc---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhh
Q 047901 663 KPNSSNW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 663 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 738 (786)
....... ....+++.|+|| |++....++.++|||||||++|||++ |+.||..... .+.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~AP----------E~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~ 548 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAP----------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEV 548 (613)
T ss_dssp C--------------CCTTSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHH
T ss_pred cCCCceeeeccCCCCccceeCH----------hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHH
Confidence 5432211 223456899999 88888899999999999999999998 9999875331 111
Q ss_pred hhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 739 FNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 739 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+... +...|... +..+.++|..||+.||++|||+.+|++.|
T Consensus 549 ~~~i~~~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 549 MAFIEQGKRMECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp HHHHHTTCCCCCCTTC----CHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 2222222 23333322 34589999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.21 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=194.8
Q ss_pred HhccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
..++|...+.||+|+||+||+|+.. .+..||||++.... ......+.+.+|+.++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3568999999999999999999753 34479999987532 23345678999999999999999999999997654
Q ss_pred -----eeeEEEeccCCCCHHHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 580 -----HSFVVYEYINRGSLATVLSNN---FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 580 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 349999999999999998532 1345689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|||+++....... ......+++.|+|| |...+..+++++||||||+++|||++ |..||.....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 255 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI----------ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN- 255 (313)
T ss_dssp EECSCSCC----------------CCGGGSCH----------HHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred EEeecCcceecccccccCcccccCCCccccCc----------hhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-
Confidence 9999999987654322 12334678899999 78888889999999999999999999 8899864321
Q ss_pred cCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+... +...+.. .+..+.+++..||..||++|||+.++++.|
T Consensus 256 -------~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 256 -------HEMYDYLLHGHRLKQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp -------GGHHHHHHTTCCCCCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -------HHHHHHHHcCCCCCCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1122222222 2222222 233589999999999999999999998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=358.46 Aligned_cols=194 Identities=25% Similarity=0.374 Sum_probs=155.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-----CC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-----VR 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-----~~ 579 (786)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+++++.++||||+++++++.. ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 57999999999999999999865 78999999996532 334556789999999999999999999999843 35
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 7899999985 6999999753 5699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---------------------------cceeeccCccccCCCCCCCCchHHHHh-hhcCcCcccchHHHHHH
Q 047901 660 KLLKPNSS---------------------------NWTELVGTFGYVAPAHGNIGLHLAELA-YTMKITEKCDVYSFGVL 711 (786)
Q Consensus 660 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~-~~~~~~~~sDvwslGvi 711 (786)
+....... .....+||+.|+|| |++ ....++.++|||||||+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP----------E~~~~~~~~~~~~DiwSlG~i 273 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP----------ELILLQENYTEAIDVWSIGCI 273 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCH----------HHHTTCCCCCTHHHHHHHHHH
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccCh----------HHhhCCCCCCcHhHHHHHHHH
Confidence 87653211 22345789999999 654 55679999999999999
Q ss_pred HHHHHhC
Q 047901 712 ALEVIKG 718 (786)
Q Consensus 712 l~elltg 718 (786)
+|||++|
T Consensus 274 l~elltg 280 (458)
T 3rp9_A 274 FAELLNM 280 (458)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9999993
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.68 Aligned_cols=246 Identities=22% Similarity=0.360 Sum_probs=199.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 582 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++..... .......+.+|+.++..+ +||||+++++++.+.+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 567999999999999999999865 789999999976432 233456788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-------------
Q 047901 583 VVYEYINRGSLATVLSNNFA-SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE------------- 648 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~------------- 648 (786)
+||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999975421 25689999999999999999999999 99999999999999844
Q ss_pred ------CcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCC
Q 047901 649 ------YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHP 721 (786)
Q Consensus 649 ------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~P 721 (786)
..+||+|||.+....... ...||+.|+|| |...+. .+++++|||||||++|||++|.+|
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLAN----------EVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCH----------HHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccCCceEEEEcccccccccCCcc----ccCCCccccCh----------hHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999998876432 24699999999 665544 566899999999999999999988
Q ss_pred CCccccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 722 GDFLSLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 722 f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.... ....+.....+ .+... +..+.+++..||+.||++|||+.|+++
T Consensus 231 ~~~~~-----------~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 231 PRNGD-----------QWHEIRQGRLPRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CSSSH-----------HHHHHHTTCCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Ccchh-----------HHHHHHcCCCCCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 54321 12222222222 22222 235889999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.81 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=200.5
Q ss_pred hccCccce-eeccccCceEEEEEc---CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKY-CIGKGEHRSVYRAKL---PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|++.+ .||+|+||+||+|.+ .+++.||||++.... ......+.+.+|+++++.++||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 45788887 999999999999953 246789999997532 2233467899999999999999999999999 5567
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++++|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 89999999999999999864 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcc---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 661 LLKPNSSNW---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 661 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
......... ....+++.|+|| |...+..++.++||||||+++|||++ |+.||..... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~ 227 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAP----------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------S 227 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------H
T ss_pred eeccCCCcccccccCCCCceeeCh----------HHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------H
Confidence 876543321 223467899999 77778889999999999999999999 9999874321 1
Q ss_pred hhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+... +...+.. .+..+.+++..||+.||++|||+.++++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 228 EVTAMLEKGERMGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp HHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111112121 1222222 234589999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.88 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=200.8
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|++.+.||+|+||+||+|++ .+++.||||++... ........+.+|+.++++++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 46799999999999999999984 24678999999642 2334566889999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcE
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFA----SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEA 651 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~ 651 (786)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999986532 24589999999999999999999999 9999999999999984 4569
Q ss_pred EEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~ 728 (786)
||+|||+++....... ......||+.|+|| |...+..++.++||||||+++|||+| |+.||....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-- 250 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPP----------EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-- 250 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred EECccccccccccccccccCCCcCCCcceeCH----------hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--
Confidence 9999999986543322 22345688999999 77888889999999999999999998 999986422
Q ss_pred cCCCcchhhhhhhhccCC-CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDHR-LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.......+.... ...+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 251 ------~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 251 ------NQEVLEFVTSGGRMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp ------HHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------HHHHHHHHhcCCCCCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111222222221 122222 223588999999999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.70 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=207.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCC-----chhhHHHHHHHHHHHhhcC-CCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPND-----QMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~ 577 (786)
.++|+..+.||+|+||.||+|+.. +++.||||++....... .....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467999999999999999999865 68899999987532111 1123567889999999996 9999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999764 5689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh------hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY------TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~------~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
.+....... ......|++.|+|| |... ...++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----- 233 (298)
T 1phk_A 170 FSCQLDPGE-KLREVCGTPSYLAP----------EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----- 233 (298)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCH----------HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred chhhcCCCc-ccccccCCccccCH----------HHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----
Confidence 998775432 23445799999999 5553 4568899999999999999999999986422
Q ss_pred CcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 SSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+.......+..+.+++..||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 ---QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 12222333333333222222334456899999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.85 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=195.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|.+.+.||+|+||.||+|+.. +++.||||++.... .......+.+.+|+++++.++||||+++++++...+..++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 57999999999999999999865 78999999985411 01122356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999764 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......|++.|+|| |...+..+ +.++||||||+++|+|++|+.||.... .......+.
T Consensus 164 ~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~ 224 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAP----------EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIR 224 (276)
T ss_dssp --------------CCT----------GGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred Cc-ceecccCCccccCH----------HHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhh
Confidence 32 23345789999999 55555444 689999999999999999999986422 112222233
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+... ...+.+++..||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 225 GGVFYIPEYL----NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcccCchhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 3333333322 234889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.05 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=197.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++...+..++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 457999999999999999999875 5889999998652 23345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999998753 35689999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHh-----hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELA-----YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~-----~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
..........||+.|+|| |.. ....++.++||||||+++|||++|+.||..... ...
T Consensus 169 ~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~ 230 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAP----------EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRV 230 (302)
T ss_dssp HHHHC-----CCGGGCCH----------HHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHH
T ss_pred ccccccccccCChhhcCC----------eeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHH
Confidence 221122345799999999 555 356788999999999999999999999874321 111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
............ ......+..+.+++..||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 231 LLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 122222211110 011122345889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.06 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=198.1
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------ 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------ 577 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++..... .......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35799999999999999999986 4789999999866432 22234567899999999999999999999876
Q ss_pred --CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 578 --VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 578 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
.+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 4568999999985 888877654 35689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCC----CcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 656 FGTAKLLKPNS----SNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 656 fg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
||+|+...... .......||+.|+|| |...+ ..++.++|||||||++|||++|+.||........
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPP----------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCH----------HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred chhcccccccccccccccCCcccccCccCc----------hhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99998765321 223445789999999 66654 4589999999999999999999999875321000
Q ss_pred ----------CC-----cchhhhhhhhccCCCCCCChhHHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ----------SS-----SSINIEFNAMLDHRLPHPSLDVQE-----KLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ----------~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. ........................ ....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 000000000000000000000000 1245889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.71 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=200.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEE--ecCCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFC--SHVRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~--~~~~~~ 581 (786)
.++|++.+.||+|+||.||+|... +++.||||++............+.+.+|+++++.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999865 68899999986421111123456899999999999999999999998 445678
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||++++ |.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999886 77777654 346789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CcceeeccCccccCCCCCCCCchHHHHhhhcC--cCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 662 LKPNS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMK--ITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 662 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~--~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
..... .......||+.|+|| |...+.. ++.++||||||+++|||++|+.||.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~ 220 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPP----------EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYK 220 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCH----------HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHH
T ss_pred cCccccccccccCCCCCCCcCh----------hhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHH
Confidence 75432 222345799999999 6665433 4779999999999999999999987432 122
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.......+.... ..+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~i~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 221 LFENIGKGSYAIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHHCCCCCCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHhcCCCCCCCccC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22333333333333322 34889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.46 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=199.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCE--EEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDK--IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
++|+..+.||+|+||.||+|+.. ++.. ||||++.... .....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 57999999999999999999865 4554 4999886422 223445788999999999 899999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC
Q 047901 582 FVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 648 (786)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999997642 234789999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 047901 649 YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSL 727 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~ 727 (786)
+.+||+|||+++..... .......+++.|+|| |...+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAI----------ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccCh----------hhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 99999999999754321 112334678899999 77788889999999999999999998 9999874321
Q ss_pred ccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+... +...+... +..+.+++.+||..||++|||++|+++.|
T Consensus 248 --------~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 248 --------AELYEKLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp --------HHHHHHGGGTCCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------HHHHHHhhcCCCCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1122222222 12222222 23588999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=336.67 Aligned_cols=255 Identities=17% Similarity=0.258 Sum_probs=200.9
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEE-ecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFC-SHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~ 582 (786)
.++|+..+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++.++|++++..++++ ...+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS------SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc------chhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45799999999999999999985 578999999986532 123578999999999998877766655 5677889
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC---CCCcEEEeccccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD---LEYEARVSDFGTA 659 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a 659 (786)
+||||+ +++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 89999999753 35689999999999999999999999 999999999999994 7899999999999
Q ss_pred eecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 660 KLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 660 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
+....... ......||+.|+|| |...+..++.++|||||||++|||++|+.||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 223 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASI----------NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-- 223 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--
T ss_pred ccccccccccccccccccccccccccCCh----------hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--
Confidence 88765432 12345799999999 788888899999999999999999999999875432111
Q ss_pred cchhhhhhhhccCCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 733 SSINIEFNAMLDHRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.......+. ......+..+.+++..||+.||++|||+++|++.|
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 224 ---RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp ---SSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred ---hhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 1111111111111110 00111234589999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.33 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=193.8
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|+..+.||+|+||+||+|.. .+++.||||++.... ......+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 35799999999999999999986 478999999996533 23345678899999999999999999999997653
Q ss_pred --eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 580 --HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 580 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 7899999975 3588999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---- 732 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---- 732 (786)
+|+..... .....+|+.|+|| |...+ ..++.++||||+||++|||++|+.||..........
T Consensus 174 ~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 174 LARQADSE---MTGYVVTRWYRAP----------EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp TCEECCSS---CCSSCSCGGGCCT----------HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccc---cCcCcCCCCcCCH----------HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99876532 3345789999999 66655 679999999999999999999999987543210000
Q ss_pred --------------cchhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 --------------SSINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 --------------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+..........+ ..........+.+++.+||..||++|||++|+++
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000000000000 0001112345889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.39 Aligned_cols=255 Identities=22% Similarity=0.267 Sum_probs=197.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC----CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN----DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.++|.+.+.||+|+||.||+|+.. +++.||||++...... ........+.+|+++++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457999999999999999999865 6789999998753211 11223346889999999999999999999987655
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc---EEEecc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE---ARVSDF 656 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Df 656 (786)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 89999999999999999753 5789999999999999999999999 9999999999999987654 999999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh---hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY---TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~---~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~ 733 (786)
|+++..... .......||+.|+|| |... ...++.++|||||||++|||++|+.||......
T Consensus 162 g~~~~~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 225 (322)
T 2ycf_A 162 GHSKILGET-SLMRTLCGTPTYLAP----------EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 225 (322)
T ss_dssp TTCEECCCC-HHHHHHHSCCTTCCH----------HHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-----
T ss_pred ccceecccc-cccccccCCcCccCc----------hhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-----
Confidence 999877532 222345799999999 5543 466889999999999999999999998743211
Q ss_pred chhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+...............+..+.+++.+||..||++|||++|+++
T Consensus 226 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 --VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0111112222222222222233456899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.75 Aligned_cols=245 Identities=14% Similarity=0.124 Sum_probs=189.3
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHH---HHhhcCCCccccee-------e
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK---ALTKIRHRNIVKFY-------G 573 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~hpniv~l~-------~ 573 (786)
.++|+..+.||+|+||+||+|+. .+++.||||++..... ......+.+.+|++ +++.++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 45788999999999999999996 4689999999975322 22345678999994 55556899999998 6
Q ss_pred EEecCC-----------------eeeEEEeccCCCCHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 047901 574 FCSHVR-----------------HSFVVYEYINRGSLATVLSNNFA----SEDFDWRKRMNVITGVADALSYMHHDCFPP 632 (786)
Q Consensus 574 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ 632 (786)
++...+ ..|+||||+ +|+|.+++..... ...+++..+..++.|++.||+|||+. +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 278999999 5799999975411 12344688889999999999999999 9
Q ss_pred eEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhc-----------CcCc
Q 047901 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-----------KITE 701 (786)
Q Consensus 633 ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-----------~~~~ 701 (786)
|+||||||+|||++.++.+||+|||+|+.... ......| +.|+|| |+..+. .++.
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aP----------E~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPP----------ELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCH----------HHHHHHTSTHHHHCCEEECCH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccCh----------hhhcccccccccccccccCCh
Confidence 99999999999999999999999999986432 2344567 999999 777766 7999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 047901 702 KCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQT 781 (786)
Q Consensus 702 ~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 781 (786)
++|||||||++|||++|+.||....... ....+... .. . .+..+.+++.+||..||++|||+.|
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~--------~~~~~~~~-~~---~----~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALG--------GSEWIFRS-CK---N----IPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------C--------CSGGGGSS-CC---C----CCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCccccccc--------chhhhhhh-cc---C----CCHHHHHHHHHHcCCCchhCCCHHH
Confidence 9999999999999999999987533211 11111111 11 1 1234889999999999999999999
Q ss_pred HHH
Q 047901 782 VCQ 784 (786)
Q Consensus 782 v~~ 784 (786)
+++
T Consensus 357 ~l~ 359 (377)
T 3byv_A 357 AME 359 (377)
T ss_dssp HHT
T ss_pred Hhh
Confidence 985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.86 Aligned_cols=245 Identities=16% Similarity=0.144 Sum_probs=196.9
Q ss_pred hccCccceeeccccCceEEEEE------cCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC---CCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAK------LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR---HRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~ 575 (786)
.++|.+.+.||+|+||+||+|. ..+++.||||++.. ....++..|+++++.++ |+||+++++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-------ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-------CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-------CChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 4679999999999999999994 44688999999864 23456778888888886 99999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC------
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNF--ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL------ 647 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~------ 647 (786)
...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 99999999999999999999997431 245799999999999999999999999 9999999999999998
Q ss_pred -----CCcEEEeccccceecCC--CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCC
Q 047901 648 -----EYEARVSDFGTAKLLKP--NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH 720 (786)
Q Consensus 648 -----~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~ 720 (786)
++.+||+|||+|+.+.. ........+||+.|+|| |+..+..++.++|||||||++|||+||+.
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV----------EMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH----------HHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh----------HHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 89999999999986542 22234456899999999 88888889999999999999999999999
Q ss_pred CCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHh
Q 047901 721 PGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSR-PTMQTVCQL 785 (786)
Q Consensus 721 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~ev~~~ 785 (786)
||...... ............ . ...+.+++..|++.+|.+| |+++++.+.
T Consensus 284 pf~~~~~~-----------~~~~~~~~~~~~--~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 284 MKVKNEGG-----------ECKPEGLFRRLP--H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp CCEEEETT-----------EEEECSCCTTCS--S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ccccCCCC-----------ceeechhccccC--c---HHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 97532210 000111111111 1 2247788999999999999 566666553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.49 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=197.6
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec----CCee
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH----VRHS 581 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~ 581 (786)
.|...+.||+|+||+||+|... ++..||+|++.... ......+.+.+|+.+++.++||||+++++++.. ....
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh--hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4778889999999999999864 67889999986422 223456789999999999999999999998864 4568
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeC-CCCcEEEecccc
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLD-LEYEARVSDFGT 658 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~-~~~~~kl~Dfg~ 658 (786)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999999764 5689999999999999999999998 7 99999999999998 789999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
+...... ......||+.|+|| |... ..++.++||||+|+++|+|++|+.||..... ....
T Consensus 179 ~~~~~~~--~~~~~~~t~~y~aP----------E~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~ 238 (290)
T 1t4h_A 179 ATLKRAS--FAKAVIGTPEFMAP----------EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQI 238 (290)
T ss_dssp GGGCCTT--SBEESCSSCCCCCG----------GGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHH
T ss_pred ccccccc--ccccccCCcCcCCH----------HHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHH
Confidence 9755432 33456799999999 5444 4589999999999999999999999864221 1111
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+..... +.......+..+.+++..||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 239 YRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 222222111 11111122245899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=333.60 Aligned_cols=246 Identities=27% Similarity=0.402 Sum_probs=193.5
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-CeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV-RHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++... +..++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 467999999999999999999875 789999998642 2456789999999999999999999987544 57899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999754 122378999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. .....+++.|+|| |...+..+++++||||||+++|||+| |+.||..... ......+
T Consensus 169 ~~---~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~ 227 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAP----------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV 227 (278)
T ss_dssp ----------CCTTTSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHH
T ss_pred cc---ccCCCccccccCH----------HHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 32 2234678899999 78888889999999999999999998 9999874321 1111112
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 228 ~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 228 EKGYKMDAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp TTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCCCCCccc----CCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 111 1222222 234588999999999999999999998864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.07 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=168.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 457999999999999999999865 67889999997532 3345567899999999999999999999998765
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...|+||||++ |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57899999997 5999999753 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC----------------------cceeeccCccccCCCCCCCCchHHHHh-hhcCcCcccchHHHHHHHHHH
Q 047901 659 AKLLKPNSS----------------------NWTELVGTFGYVAPAHGNIGLHLAELA-YTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 659 a~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~~~~~~e~~-~~~~~~~~sDvwslGvil~el 715 (786)
|+....... .....+||++|+|| |++ ....++.++||||+||++|||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP----------E~~~~~~~~~~~~DiwSlG~il~el 245 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP----------ELILLQENYTKSIDIWSTGCIFAEL 245 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCH----------HHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCH----------HHHhcCCCCCcccccchHHHHHHHH
Confidence 997754321 12456899999999 654 556799999999999999999
Q ss_pred HhCCCCCC
Q 047901 716 IKGKHPGD 723 (786)
Q Consensus 716 ltg~~Pf~ 723 (786)
++|..||.
T Consensus 246 l~g~~p~~ 253 (432)
T 3n9x_A 246 LNMLQSHI 253 (432)
T ss_dssp HTTCTTTC
T ss_pred Hhcccccc
Confidence 98766654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=343.13 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=191.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHH--hhcCCCcccceeeEEe-----c
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL--TKIRHRNIVKFYGFCS-----H 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l--~~l~hpniv~l~~~~~-----~ 577 (786)
.++|++.+.||+|+||+||+|+. +++.||||++.. .....+..|.+++ ..++||||+++++++. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF-------ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeec-------cchhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 45799999999999999999987 588999999864 2334455555554 4579999999998553 2
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEcCCCCCceeeCCCCcE
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC------FPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrdlk~~Nill~~~~~~ 651 (786)
....++||||+++|+|.+++... ..++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 33568999999999999999754 3588999999999999999999863 2389999999999999999999
Q ss_pred EEeccccceecCCCCC--------cceeeccCccccCCCCCCCCchHHHHhhh-------cCcCcccchHHHHHHHHHHH
Q 047901 652 RVSDFGTAKLLKPNSS--------NWTELVGTFGYVAPAHGNIGLHLAELAYT-------MKITEKCDVYSFGVLALEVI 716 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-------~~~~~~sDvwslGvil~ell 716 (786)
||+|||+|+....... ......||+.|+|| |...+ ..+++++|||||||++|||+
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP----------EVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCH----------HHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCc----------hhhcCCcccccccccccccchHHHHHHHHHHH
Confidence 9999999987754321 12234799999999 55544 45678999999999999999
Q ss_pred hCCCCCCccccccCCCcc---------hhhhhhhhccC---CCCCCCh--hHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 047901 717 KGKHPGDFLSLFSSSSSS---------INIEFNAMLDH---RLPHPSL--DVQEKLISIMEVALLCLDGCPNSRPTMQTV 782 (786)
Q Consensus 717 tg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~---~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 782 (786)
+|..||............ ........+.. +...+.. .....+..+.+++.+||+.||++|||++|+
T Consensus 230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 997775432211111000 01111111111 1111111 112345569999999999999999999999
Q ss_pred HHhC
Q 047901 783 CQLL 786 (786)
Q Consensus 783 ~~~L 786 (786)
++.|
T Consensus 310 l~~L 313 (336)
T 3g2f_A 310 EERM 313 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.29 Aligned_cols=259 Identities=19% Similarity=0.215 Sum_probs=194.2
Q ss_pred hccCccceeeccccCceEEEEEcC----CCCEEEEEEcCCCCCCCch-------hhHHHHHHHHHHHhhcCCCcccceee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP----SGDKIAVKKFNSPFPNDQM-------SDQKEFLNEIKALTKIRHRNIVKFYG 573 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~l~~ 573 (786)
.++|++.+.||+|+||+||+|+.. ++..||||++......... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999865 5678999998753211000 01224667888999999999999999
Q ss_pred EEec----CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC
Q 047901 574 FCSH----VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY 649 (786)
Q Consensus 574 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 649 (786)
++.. ....|+||||+ +++|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9877 67889999999 99999999765 3789999999999999999999999 999999999999998887
Q ss_pred --cEEEeccccceecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCC
Q 047901 650 --EARVSDFGTAKLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH 720 (786)
Q Consensus 650 --~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~ 720 (786)
.+||+|||+|+....... ......||+.|+|| |...+..++.++|||||||++|||++|+.
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL----------DAHKGVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH----------HHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCH----------HHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999987643211 12345799999999 88888889999999999999999999999
Q ss_pred CCCccccccCCCcchhhhhhhhccCCCCCCChhHH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 721 PGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQ-----EKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 721 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
||..... ...............+ +..... ..+..+.+++..||..||++|||+++|++.|
T Consensus 259 pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 259 PWEQNLK----DPVAVQTAKTNLLDEL--PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp TTGGGTT----CHHHHHHHHHHHHHTT--THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred Ccccccc----ccHHHHHHHHhhcccc--cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 9853211 0000001111111111 110000 1234689999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.23 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=203.9
Q ss_pred hccCccceeeccccCceEEEEEc-----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
.++|++.+.||+|+||.||+|++ .+++.||||++.. ......+.+.+|+++++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS----CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 45689999999999999999983 3688999999975 23345678999999999999999999999986544
Q ss_pred --eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 580 --HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 580 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 789999999999999999865 34689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc-c----c
Q 047901 658 TAKLLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL-F----S 729 (786)
Q Consensus 658 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~-~----~ 729 (786)
+++........ .....++..|+|| |...+..++.++||||||+++|||+||..||..... + .
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~ 260 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAP----------ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred chhhccccccccccccCCCCceeEECc----------hhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence 99987654322 1234577889999 777888899999999999999999999999753210 0 0
Q ss_pred CCC--cchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 730 SSS--SSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 730 ~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... ..........+.. +.+.+.. .+..+.+++..||+.||++|||+.|+++.|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 261 NDKQGQMIVFHLIELLKNNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cccchhhhHHHHHHHhhcCCCCCCCCc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 000 0000111122221 2222222 234589999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=346.35 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=202.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||+|++... ......+.+.+|+.+++.++||||+++++++..++..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 357999999999999999999865 7889999999753 233456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999764 46899999999999999999999831 89999999999999999999999999997653
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC-------------
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS------------- 730 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~------------- 730 (786)
.. ......||+.|+|| |...+..++.++|||||||++|||++|+.||........
T Consensus 184 ~~--~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSP----------ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251 (360)
T ss_dssp HH--C----CCCCTTCCH----------HHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred cc--cccCCCCCCCeECH----------HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence 22 12345799999999 788888899999999999999999999999875321000
Q ss_pred ---------------------CCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ---------------------SSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ---------------------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.................. .+. ...+..+.+++..||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------------------CCCHHHHHHHHHHSCCCCCCT---TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCc---ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000001111111111 111 112335889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=349.14 Aligned_cols=198 Identities=19% Similarity=0.286 Sum_probs=172.5
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc------CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI------RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~l~~~~~~ 577 (786)
..+|++.+.||+|+||+||+|+.. +++.||||++.. .......+.+|+.+++.+ .||||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 346999999999999999999755 688999999964 233456777888888877 57799999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc--EEEec
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE--ARVSD 655 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~D 655 (786)
.+..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CCeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999996 5999999865 334589999999999999999999999 9999999999999999887 99999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~ 725 (786)
||+|+..... .....||+.|+|| |++.+..++.++|||||||++|||++|++||...
T Consensus 246 FG~a~~~~~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 246 FGSSCYEHQR---VYTYIQSRFYRAP----------EVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCH----------HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceecCCc---ccccCCCCCccCh----------HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999876433 2345899999999 8888888999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=341.24 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=193.8
Q ss_pred HhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec----
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH---- 577 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~---- 577 (786)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 356899999999999999999986 478899999986521 2345788999999999 79999999999876
Q ss_pred --CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 578 --VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 578 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999864 235689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhh-----hcCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-----TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-----~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
||++..............||+.|+|| |... ...++.++|||||||++|||++|+.||.....
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--- 239 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAP----------EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--- 239 (326)
T ss_dssp CTTTC-------------CCGGGCCH----------HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred CcCceecCcCccccccccCCccccCh----------hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---
Confidence 99998765443334456799999999 5554 46688999999999999999999999864321
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.....+.. .....+..+.+++.+||..||++|||++++++
T Consensus 240 -----~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 -----MRALFLIPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHHHHHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHhhcCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111111100 00111235889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=340.21 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=192.4
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 357999999999999999999854 68899999997532 23345677889999999999999999999997654
Q ss_pred --eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 580 --HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 580 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999975 7888885 3488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------ 731 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------ 731 (786)
+|+..... .......||+.|+|| |+..+..++.++||||+||++|||++|+.||.........
T Consensus 173 ~a~~~~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 173 LARTAGTS-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp C-----------------CTTCCH----------HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred cccccccc-cccCCceecCCccCH----------HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99876532 223446899999999 7888888999999999999999999999998754321000
Q ss_pred -Ccc-------hhhhhhhhccCC----------------CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 -SSS-------INIEFNAMLDHR----------------LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 -~~~-------~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ............ .+............+.+++.+||..||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 000000000000 01111112233567899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.08 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=185.0
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh---cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3568999999999999999999864 68899999986532 1234567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 583 VVYEYINRGSLATVLSNN-----FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
+||||+++|+|.+++... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998641 1245689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC-----cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 658 TAKLLKPNSS-----NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 658 ~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
.+........ ......||+.|+|| |.... ..++.++||||||+++|||++|+.||......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 233 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAP----------EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--- 233 (303)
T ss_dssp HHHHCC---------------CCCTTCCH----------HHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---
T ss_pred chheeccCCCccchhhhcccCCCccccCH----------HHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---
Confidence 9976643211 12345799999999 66654 56899999999999999999999998753321
Q ss_pred CcchhhhhhhhccCCCCC-CC-----hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 SSSINIEFNAMLDHRLPH-PS-----LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
............. +. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 234 -----KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----GHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----hHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0111111111100 00 000112235889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.02 Aligned_cols=243 Identities=22% Similarity=0.378 Sum_probs=200.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------ 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------ 577 (786)
..+|+..+.||+|+||.||+|+.. +++.||||++.... +.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 457999999999999999999875 78999999997521 246689999999999999999998854
Q ss_pred ----------CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC
Q 047901 578 ----------VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 578 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 647 (786)
....++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 44579999999999999999754 235689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 047901 648 EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727 (786)
Q Consensus 648 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~ 727 (786)
++.+||+|||++....... ......||+.|+|| |...+..++.++||||||+++|||++|..||...
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-- 224 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSP----------EQISSQDYGKEVDLYALGLILAELLHVCDTAFET-- 224 (284)
T ss_dssp TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCH----------HHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--
T ss_pred CCCEEECcchhheeccccc-cccccCCcccccCh----------hhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--
Confidence 9999999999998876542 23345799999999 7788888999999999999999999999985421
Q ss_pred ccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...........+. ... +..+.+++..||+.||++|||+.|+++.|
T Consensus 225 --------~~~~~~~~~~~~~--~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 225 --------SKFFTDLRDGIIS--DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp --------HHHHHHHHTTCCC--TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------HHHHHHhhccccc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111222222222 111 23478999999999999999999998763
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.96 Aligned_cols=333 Identities=18% Similarity=0.186 Sum_probs=146.8
Q ss_pred eEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCC
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLS 82 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 82 (786)
++.|++++|++.+ ++ .|..+++|++|+|++|+++++ | +..+++|++|+|++|+|+++ + |+.+++|++|+|+
T Consensus 44 L~~L~Ls~n~l~~-~~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 44 LTSLDCHNSSITD-MT--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCD 114 (457)
T ss_dssp CCEEECCSSCCCC-CT--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECC
T ss_pred CCEEEccCCCccc-Ch--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECC
Confidence 4445555554442 22 244445555555555554433 1 44445555555555555432 1 4445555555555
Q ss_pred CccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCC
Q 047901 83 LNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP 162 (786)
Q Consensus 83 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~ 162 (786)
+|++++++ +..+++|++|+|++|+++++ .++++++|++|++++|+..+.+ .+..+++|+.|++++|++++++
T Consensus 115 ~N~l~~l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~- 186 (457)
T 3bz5_A 115 TNKLTKLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD- 186 (457)
T ss_dssp SSCCSCCC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC-
T ss_pred CCcCCeec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec-
Confidence 55544431 44445555555555555443 1444445555555555322222 2444444555555555544432
Q ss_pred CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCc--
Q 047901 163 NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS-- 240 (786)
Q Consensus 163 ~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-- 240 (786)
+..+++|+.|++++|+++++ .|..+++|++|+|++|+++++ | +..+++|+.|++++|++++..+..+..+.
T Consensus 187 -l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L 259 (457)
T 3bz5_A 187 -VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL 259 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEE
T ss_pred -cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEE
Confidence 44444555555555554443 244445555555555555442 2 44444555555555555443322222222
Q ss_pred -----cccEEEeecccccccCCCCcccccccccccccccccCCCCcc--------ccccCCcCceeccccccccccchhh
Q 047901 241 -----QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPR--------ALGLLTELEYFDLSSNRLNNSILEA 307 (786)
Q Consensus 241 -----~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~~~~ 307 (786)
+|+.|++++|.+.+.+| +..+++|+.|++++|...+..|. .++++++|+.|++++|+++++ .
T Consensus 260 ~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~ 334 (457)
T 3bz5_A 260 HCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---D 334 (457)
T ss_dssp ECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---C
T ss_pred eccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---c
Confidence 22223333333222222 23344455555555443322221 133334445555555555443 1
Q ss_pred hhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCC
Q 047901 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIP 377 (786)
Q Consensus 308 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 377 (786)
+..+++|+.|++++|++++ ++.|..|++++|.+++. ..+..|+.+++++|+++|.+|
T Consensus 335 l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip 391 (457)
T 3bz5_A 335 VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVS 391 (457)
T ss_dssp CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECC
T ss_pred cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcC
Confidence 4444445555555555443 13344444555544432 233444444555555544444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=365.64 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=195.0
Q ss_pred eeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEecc
Q 047901 512 YCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
+.||+|+||+||+|.+. .++.||||+++... ......+++.+|++++++++|||||++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999642 45789999997521 223446789999999999999999999999975 5578999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 668 (786)
++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 452 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 452 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999999754 5689999999999999999999999 9999999999999999999999999999877544321
Q ss_pred ---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhcc
Q 047901 669 ---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 669 ---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
.....+|+.|+|| |++....++.++|||||||++|||++ |+.||..... ......+..
T Consensus 526 ~~~~~~~~~t~~y~AP----------E~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~ 587 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAP----------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEK 587 (635)
T ss_dssp ---------CGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT
T ss_pred cccccCCCCceeeeCh----------hhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc
Confidence 2234567899999 88888899999999999999999998 9999875321 111222222
Q ss_pred C-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 H-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 ~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. +...+.. .+..+.++|..||+.||++|||+++|++.|
T Consensus 588 ~~~~~~p~~----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 588 GERMGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp TCCCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCCCC----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2 2223332 234589999999999999999999998864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.49 Aligned_cols=257 Identities=10% Similarity=0.023 Sum_probs=182.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc--CCCccccee-------eE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI--RHRNIVKFY-------GF 574 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~l~-------~~ 574 (786)
..+|+..+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|+.+++.+ +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 345899999999999999999865 788999999986422 2334556778885554444 699988754 44
Q ss_pred EecC-----------------CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCC
Q 047901 575 CSHV-----------------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKR------MNVITGVADALSYMHHDCFP 631 (786)
Q Consensus 575 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~ia~~l~~LH~~~~~ 631 (786)
+... ...|+||||++ |+|.+++.... ..+++..+ ..++.|++.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 4332 33799999999 89999997641 23344445 67889999999999999
Q ss_pred CeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHH
Q 047901 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFG 709 (786)
Q Consensus 632 ~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslG 709 (786)
+|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|| |...+ ..++.++||||||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPR----------EFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCH----------HHHTCSEEECCHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcCh----------hhccCCCCCcCccccHHHHH
Confidence 9999999999999999999999999999876432 2245678999999 77766 6789999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 710 VLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 710 vil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
|++|||++|+.||............ ..............+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGSWK-RPSLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTCCC-BCCTTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHhCCCCCCCcCcccccchh-hhhhhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999998754321100000 0000111111111111 1122345889999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.07 Aligned_cols=259 Identities=19% Similarity=0.299 Sum_probs=197.9
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe----cCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS----HVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~----~~~ 579 (786)
.++|++.+.||+|+||.||+|+. .+++.||||++.. ......+.+.+|+++++.++||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 46799999999999999999986 5789999999864 23455678999999999999999999999986 345
Q ss_pred eeeEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 7899999999999999997531 245789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc---------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 659 AKLLKPNSSN---------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 659 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
+......... .....||+.|+|||.+... ....+++++||||||+++|||++|+.||.......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-------SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-------SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccC-------CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 8865421110 1234579999999533211 12236889999999999999999999986321100
Q ss_pred CCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 730 SSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......... ....+.+.. .+..+.+++.+||+.||++|||+.|+++.|
T Consensus 254 ---~~~~~~~~~--~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 254 ---DSVALAVQN--QLSIPQSPR----HSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp ---SCHHHHHHC--C--CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---chhhHHhhc--cCCCCcccc----CCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 000111111 111121111 233588999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=331.43 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=194.6
Q ss_pred hccCccceeeccccCceEEEEEcC--CCC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP--SGD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.++|++.+.||+|+||+||+|++. +++ .||||++..... ......+.+.+|+++++.++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 357999999999999999999853 333 689999875322 22345678999999999999999999999998755
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 88999999999999999764 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchh
Q 047901 661 LLKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 661 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 736 (786)
........ .....+|..|+|| |...+..++.++||||||+++|||++ |+.||.... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~ 231 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAP----------ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GS 231 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred cccccccchhhhccCCCCceeeCc----------hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HH
Confidence 87654322 2234678899999 77888889999999999999999999 999987432 12
Q ss_pred hhhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+.... ...+.. .+..+.+++..||+.||++|||+.++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 232 QILHKIDKEGERLPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp HHHHHHHTSCCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHccCCCCCCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 2222222222 222222 234589999999999999999999998864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.56 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=203.5
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCc-------------hhhHHHHHHHHHHHhhcCCCcccce
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQ-------------MSDQKEFLNEIKALTKIRHRNIVKF 571 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~~~~e~~~l~~l~hpniv~l 571 (786)
.++|++.+.||+|+||+||+|+. +++.||||++........ ....+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35799999999999999999998 899999999864211110 0112789999999999999999999
Q ss_pred eeEEecCCeeeEEEeccCCCCHHHH------hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCcee
Q 047901 572 YGFCSHVRHSFVVYEYINRGSLATV------LSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVL 644 (786)
Q Consensus 572 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nil 644 (786)
++++.+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||.|||+ . +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999999 5432 24679999999999999999999999 8 9999999999999
Q ss_pred eCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCc-ccchHHHHHHHHHHHhCCCCC
Q 047901 645 LDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITE-KCDVYSFGVLALEVIKGKHPG 722 (786)
Q Consensus 645 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~-~sDvwslGvil~elltg~~Pf 722 (786)
++.++.+||+|||.+...... ......||..|+|| |...+. .++. ++||||||+++|||++|+.||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPP----------EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCG----------GGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCc----------hhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999876543 33445799999999 555544 5655 999999999999999999998
Q ss_pred CccccccCCCcchhhhhhhhccCCCCCCCh---------------hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 723 DFLSLFSSSSSSINIEFNAMLDHRLPHPSL---------------DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..... .......+.......+.. .....+..+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKIS-------LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSC-------SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCc-------HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 74321 012222222222222210 00223346899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.46 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=184.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEe------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCS------ 576 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~------ 576 (786)
..+|++.+.||+|+||+||+|+.. +++.||||++.. ......+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE----SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC----CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 357999999999999999999864 789999999854 23445678899999999996 999999999983
Q ss_pred --cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeCCCCcEE
Q 047901 577 --HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLDLEYEAR 652 (786)
Q Consensus 577 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~k 652 (786)
.....++||||++ |+|.+++......+.+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 3445789999996 69999987643456799999999999999999999998 7 99999999999999999999
Q ss_pred EeccccceecCCCCCc------------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCC
Q 047901 653 VSDFGTAKLLKPNSSN------------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKH 720 (786)
Q Consensus 653 l~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~ 720 (786)
|+|||+++........ .....||+.|+|||++. ...+..+++++|||||||++|||++|+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID-------LYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp BCCCTTCBCCSSCC--------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh-------ccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 9999999876543221 11346899999995431 1145678899999999999999999999
Q ss_pred CCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 721 PGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 721 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
||...... .........+.. ......+.+++..||+.||++|||+.|+++.|
T Consensus 252 p~~~~~~~------------~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 252 PFEDGAKL------------RIVNGKYSIPPH--DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp CC------------------------CCCCTT--CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCcchhHH------------HhhcCcccCCcc--cccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 98743221 111111111100 01112378999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.77 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=193.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------ 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------ 577 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.. .....+.+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 567999999999999999999864 789999999853 23456788999999999999999999998754
Q ss_pred -------CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc
Q 047901 578 -------VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE 650 (786)
Q Consensus 578 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 650 (786)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 45679999999999999999864 35678899999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCC--------------CcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHH
Q 047901 651 ARVSDFGTAKLLKPNS--------------SNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 651 ~kl~Dfg~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~el 715 (786)
+||+|||.++...... .......||+.|+|| |...+ ..++.++|||||||++|||
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l 224 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT----------EVLDGTGHYNEKIDMYSLGIIFFEM 224 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCH----------HHHTSCSCCCTHHHHHHHHHHHHHH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc----------ccccCCCCCcchhhHHHHHHHHHHH
Confidence 9999999998764321 122345789999999 66654 3688999999999999999
Q ss_pred HhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 716 IKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 716 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
++ ||.... ........+.......+.......+..+.+++..||+.||++|||++|+++
T Consensus 225 ~~---p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 225 IY---PFSTGM-------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HS---CCSSHH-------HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hh---ccCCch-------hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 98 543211 111122222222222232222333445889999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.08 Aligned_cols=254 Identities=17% Similarity=0.226 Sum_probs=197.7
Q ss_pred ccCccceeeccccCceEEEEEcCC---------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccc------
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS---------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK------ 570 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~------ 570 (786)
++|++.+.||+|+||+||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 579999999999999999998763 789999998642 35779999999999999998
Q ss_pred ---------eeeEEec-CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCC
Q 047901 571 ---------FYGFCSH-VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISS 640 (786)
Q Consensus 571 ---------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 640 (786)
+++++.. ++..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5677765 77889999999 99999999864 235799999999999999999999999 999999999
Q ss_pred CceeeCCCC--cEEEeccccceecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHH
Q 047901 641 NNVLLDLEY--EARVSDFGTAKLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711 (786)
Q Consensus 641 ~Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvi 711 (786)
+||+++.++ .+||+|||+++....... ......||+.|+|| |...+..++.++|||||||+
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~i 257 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM----------DLHKGCGPSRRSDLQSLGYC 257 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH----------HHHTTCCCCHHHHHHHHHHH
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH----------HHHccCCCCchhhHHHHHHH
Confidence 999999998 999999999987653221 12334799999999 78888889999999999999
Q ss_pred HHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCC--hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 712 ALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPS--LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 712 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+|||++|+.||...... ..................+. ......+..+.+++..||+.||++|||++++++.|
T Consensus 258 l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 258 MLKWLYGFLPWTNCLPN---TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHHSCCTTGGGTTC---HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHhCCCCcccCCcC---HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 99999999998753210 00011111111111111000 00011124589999999999999999999998864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.86 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=204.9
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 3568999999999999999999865 788999999865321 1234568899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC---CcEEEeccccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE---YEARVSDFGTA 659 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a 659 (786)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999998754 4689999999999999999999999 99999999999999754 47999999999
Q ss_pred eecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 660 KLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 660 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
....... ......||+.|+|| |...+ .++.++||||||+++|+|++|+.||..... ....
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aP----------E~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~ 231 (287)
T 2wei_A 172 TCFQQNT-KMKDRIGTAYYIAP----------EVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDIL 231 (287)
T ss_dssp GTBCCCS-SCSCHHHHHTTCCH----------HHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred eeecCCC-ccccccCcccccCh----------HHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 8765432 22345689999999 65544 488999999999999999999999874321 1222
Q ss_pred hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+.......+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 233333333222222233456899999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.81 Aligned_cols=271 Identities=20% Similarity=0.242 Sum_probs=199.2
Q ss_pred cHHHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCC-------chhhHHHHHHHHHHHhhcCCCccc
Q 047901 497 MYEEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND-------QMSDQKEFLNEIKALTKIRHRNIV 569 (786)
Q Consensus 497 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~hpniv 569 (786)
...++....++|+..+.||+|+||+||+|...+++.||||++....... .....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4566777789999999999999999999998889999999986533221 112247899999999999999999
Q ss_pred ceeeEEec-----CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCcee
Q 047901 570 KFYGFCSH-----VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644 (786)
Q Consensus 570 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 644 (786)
++++++.. ....|+||||++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99999843 346799999998 5898888753 35789999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 645 LDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 645 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
++.++.+||+|||+++...... ......||+.|+|| |...+ ..++.++||||+||++|||++|+.||.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAP----------ELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCH----------HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EcCCCCEEEEecCccccccccc-ccceecccceecCc----------HHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 9999999999999998654332 23445789999999 66655 678999999999999999999999987
Q ss_pred ccccccCCCc--------c-------hhhhhhhhccCCCC-CCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 724 FLSLFSSSSS--------S-------INIEFNAMLDHRLP-HPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 724 ~~~~~~~~~~--------~-------~~~~~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
.......... . .............. .+.... ......+.+++..||+.||++|||+.|++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 5331100000 0 00000001111111 111111 11234588999999999999999999998
Q ss_pred H
Q 047901 784 Q 784 (786)
Q Consensus 784 ~ 784 (786)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.61 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=191.4
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR----- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----- 579 (786)
..+|+..+.||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3579999999999999999999877777999998652211 126999999999999999999985433
Q ss_pred -eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-CCCcEEEeccc
Q 047901 580 -HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-LEYEARVSDFG 657 (786)
Q Consensus 580 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg 657 (786)
..++||||++++.+............+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998754433332222346789999999999999999999999 999999999999999 78999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---- 732 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---- 732 (786)
+|+....... .....||+.|+|| |.+.+ ..++.++||||+||++|||++|+.||..........
T Consensus 188 ~a~~~~~~~~-~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 188 SAKILIAGEP-NVSYICSRYYRAP----------ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp TCEECCTTCC-CCSSCSCGGGCCH----------HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccccCCCC-CcccccCcCccCH----------HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9988754332 2345789999999 66654 458999999999999999999999997543210000
Q ss_pred ---cchhhhhhh----hccCCCCC-CChhH-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ---SSINIEFNA----MLDHRLPH-PSLDV-----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ---~~~~~~~~~----~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.... ......+. ..... ...+..+.+++.+||..||++|||+.|+++
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000 00111110 00000 112346899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=339.12 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=198.8
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.. .......+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc---ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 457999999999999999999854 678899999964 22344557889999999999999999999998654
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++||||+++ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 468999999985 99999875 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc-
Q 047901 659 AKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS- 733 (786)
Q Consensus 659 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~- 733 (786)
++....... ......||+.|+|| |... ...++.++||||+||++|||++|+.||...........
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 244 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAP----------EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCH----------HHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred eEecCCCCCccccccccccccCCCCC----------HHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence 987754322 12445899999999 6544 44589999999999999999999999875432110000
Q ss_pred ------chhhhh--------hhhcc---CCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 ------SINIEF--------NAMLD---HRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ------~~~~~~--------~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...... ..... .....+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000 000000 0000112345889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=341.72 Aligned_cols=257 Identities=19% Similarity=0.301 Sum_probs=182.2
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|+..+.||+|+||+||+|.. .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 46799999999999999999985 478899999997532 2334567888999999999999999999998654
Q ss_pred -CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 579 -RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 579 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
...++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 6799998864 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC----
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS---- 732 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~---- 732 (786)
+++..... .....||+.|+|| |...+ ..++.++||||+||++|||++|+.||..........
T Consensus 178 ~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 178 LARHTADE---MTGYVATRWYRAP----------EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp ----------------CCCTTCCH----------HHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccc---CCCcCcCcCccCh----------HHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99876432 3346899999999 66655 678999999999999999999999997543210000
Q ss_pred ---cc--------hhhhhhhhccCCCCCCChhHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ---SS--------INIEFNAMLDHRLPHPSLDVQ----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ---~~--------~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. ........+..-...+..... .....+.+++.+||..||++|||+.|+++
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 000000111100011111111 12345889999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.01 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=196.6
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEec--CCe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSH--VRH 580 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~--~~~ 580 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++.. ...+.+.+|+++++.++ ||||+++++++.. ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 36799999999999999999975 5789999999864 23467889999999997 9999999999987 667
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEeccccc
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTA 659 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a 659 (786)
.++||||+++++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+|
T Consensus 108 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 899999999999999884 378899999999999999999999 999999999999999776 8999999999
Q ss_pred eecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc----
Q 047901 660 KLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS---- 734 (786)
Q Consensus 660 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~---- 734 (786)
+...... ......||..|+|| |...+ ..++.++||||+||++|||++|+.||............
T Consensus 179 ~~~~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 179 EFYHPGQ-EYNVRVASRYFKGP----------ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp EECCTTC-CCCSCCSCGGGCCH----------HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred eEcCCCC-ccccccccccccCh----------hhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 8775433 23455799999999 66655 67899999999999999999999998432110000000
Q ss_pred -hhhhhhhhc-cCCCCC--------------------CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 -INIEFNAML-DHRLPH--------------------PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 -~~~~~~~~~-~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........+ ...... +.......+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 000000 00001112456899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=343.77 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=199.3
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC--------CCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR--------HRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~l~~~~ 575 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++.. .....+.+.+|+++++.++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 36799999999999999999985 4688999999964 2345567889999999985 78899999998
Q ss_pred e----cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC--
Q 047901 576 S----HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-- 649 (786)
Q Consensus 576 ~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-- 649 (786)
. .....++||||+ ++++.+++... ....+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 7 566889999999 56777777654 2356899999999999999999999853 899999999999999775
Q ss_pred -----------------------------------------------cEEEeccccceecCCCCCcceeeccCccccCCC
Q 047901 650 -----------------------------------------------EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682 (786)
Q Consensus 650 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE 682 (786)
.+||+|||.|+..... .....||+.|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aP- 262 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSL- 262 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCH-
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCC-
Confidence 7999999999877533 3345799999999
Q ss_pred CCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc--CC--------------
Q 047901 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD--HR-------------- 746 (786)
Q Consensus 683 ~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~-------------- 746 (786)
|++.+..++.++|||||||++|||++|+.||.......... .......+.. ..
T Consensus 263 ---------E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 331 (397)
T 1wak_A 263 ---------EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR--DEDHIALIIELLGKVPRKLIVAGKYSKE 331 (397)
T ss_dssp ---------HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH--HHHHHHHHHHHHCSCCHHHHHHCTTGGG
T ss_pred ---------hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc--hHHHHHHHHHhcCCCChHHhhccccccc
Confidence 88888889999999999999999999999997533211000 0000000000 00
Q ss_pred ----------CC--CC----------ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 747 ----------LP--HP----------SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 747 ----------~~--~~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+. .+ .....+....+.+++.+||+.||++|||++|+++
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00 0012345567899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=332.20 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=190.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe-------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS------- 576 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~------- 576 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.. ......+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL----TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec----CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 357999999999999999999876 588999999865 23455678899999999999999999999873
Q ss_pred -------cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-CC
Q 047901 577 -------HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-LE 648 (786)
Q Consensus 577 -------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~ 648 (786)
.....++||||++ |+|.+++.. +.+++..+..++.|++.||+|||+. +|+||||||+||+++ .+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999998 599999963 4689999999999999999999999 999999999999997 56
Q ss_pred CcEEEeccccceecCCCC---CcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 649 YEARVSDFGTAKLLKPNS---SNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
+.+||+|||+++...... .......+|..|+|| |.... ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP----------RLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCH----------HHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCc----------HHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 799999999998765321 122345679999999 55543 6789999999999999999999999875
Q ss_pred cccccCC-------Ccchhhhhhhhcc-------CCCCCCCh----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 725 LSLFSSS-------SSSINIEFNAMLD-------HRLPHPSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 725 ~~~~~~~-------~~~~~~~~~~~~~-------~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....... .........++.. .....+.. .....+..+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 4321000 0000000000000 00000000 00112346899999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=336.67 Aligned_cols=309 Identities=19% Similarity=0.178 Sum_probs=205.0
Q ss_pred CCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEE
Q 047901 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYIS 103 (786)
Q Consensus 25 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~ 103 (786)
++++++|++++|.++.+.+..|.++++|++|+|++|+|+.+.+.+|..+++|++|+|++|+++++++. +..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 46777777777777766666677777777777777777777667777777777777777777766554 66777777777
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN 183 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~ 183 (786)
|++|+++.+++..|.++++|++|++++|++++..|..+..+++|+.|++++|.++. +
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~ 180 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-----------------------V 180 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-----------------------C
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc-----------------------c
Confidence 77777776666667777777777777777776555555555555555555555543 3
Q ss_pred cCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccc
Q 047901 184 ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL 263 (786)
Q Consensus 184 ~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 263 (786)
.+..+++|++|++++|.++++ ...++|++|++++|.+... |.. ..++|+.|++++|.+++. ..+..+
T Consensus 181 ---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l 247 (390)
T 3o6n_A 181 ---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNY 247 (390)
T ss_dssp ---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGC
T ss_pred ---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCC
Confidence 133345555555555555432 1223555566666655533 221 135666666666666643 456666
Q ss_pred cccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeec
Q 047901 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343 (786)
Q Consensus 264 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 343 (786)
++|+.|+|++|.++++.|..|..+++|+.|+|++|+++.++. .+..+++|++|+|++|+++ ..|..+..+++|+.|+|
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNL-YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEEC-SSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCc-ccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 777777777777776667777777777777777777766432 3355677777777777776 44556777788888888
Q ss_pred cCCccCCCCCcccccccccceeccccccccc
Q 047901 344 SHNLFKGSIPSRICNLESLEKLNLSHNNISG 374 (786)
Q Consensus 344 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (786)
++|+++.. + +..+++|+.|++++|++.+
T Consensus 326 ~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 326 DHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 88888743 2 5566677777777777764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.38 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=199.6
Q ss_pred hccCccceeeccccCceEEEEEc--CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCC------cccceeeEEe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL--PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR------NIVKFYGFCS 576 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp------niv~l~~~~~ 576 (786)
.++|++.+.||+|+||+||+|.. .+++.||||++.. .....+.+.+|+++++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 35799999999999999999985 3678999999864 234456788999999988665 4999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---------
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL--------- 647 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--------- 647 (786)
..+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 999999999999 88999999865 234689999999999999999999999 9999999999999987
Q ss_pred ----------CCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh
Q 047901 648 ----------EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 648 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt 717 (786)
++.+||+|||.++..... .....||+.|+|| |...+..++.++|||||||++|||++
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAP----------EVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCH----------HHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccCh----------HHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 668999999999875432 2345799999999 78888889999999999999999999
Q ss_pred CCCCCCccccccCCCcchhhhhhhhcc------------------CCCCCC-------------------ChhHHHHHHH
Q 047901 718 GKHPGDFLSLFSSSSSSINIEFNAMLD------------------HRLPHP-------------------SLDVQEKLIS 760 (786)
Q Consensus 718 g~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~-------------------~~~~~~~~~~ 760 (786)
|+.||....... .......... .....+ ..........
T Consensus 230 g~~pf~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 230 GFTVFPTHDSKE-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp SSCSCCCSCHHH-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CCCCCCCCChHH-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 999987532100 0000000000 000000 0001223456
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 047901 761 IMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 761 l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.+++.+||+.||++|||++|+++
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhCcCcccccCHHHHhc
Confidence 899999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.62 Aligned_cols=266 Identities=19% Similarity=0.205 Sum_probs=186.3
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH 577 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 577 (786)
++.....++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.++++.++.++||||+++++++..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 455667789999999999999999999864 68999999986522 122345678888888999999999999865
Q ss_pred CCe-------eeEEEeccCCCCHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEEcCCCCCceeeCC
Q 047901 578 VRH-------SFVVYEYINRGSLATVLSN-NFASEDFDWRKRMNVITGVADALSYMH--HDCFPPIVHRDISSNNVLLDL 647 (786)
Q Consensus 578 ~~~-------~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~ia~~l~~LH--~~~~~~ivHrdlk~~Nill~~ 647 (786)
.+. .++||||+++ +|.+.+.. ......+++..+..++.|++.|+.||| +. +|+||||||+||+++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE 166 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence 333 7899999987 55544432 223467899999999999999999999 77 9999999999999997
Q ss_pred -CCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 047901 648 -EYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFL 725 (786)
Q Consensus 648 -~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~ 725 (786)
++.+||+|||+++...... ......||+.|+|| |...+ ..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aP----------E~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAP----------ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCH----------HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcEEEeeCCCceecCCCC-CcccccCCcceeCH----------HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 8999999999998775432 23345789999999 66654 44899999999999999999999998753
Q ss_pred ccccCCC-------cchhhhhhhhccCCCC-----CCChhHH--------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 726 SLFSSSS-------SSINIEFNAMLDHRLP-----HPSLDVQ--------EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 726 ~~~~~~~-------~~~~~~~~~~~~~~~~-----~~~~~~~--------~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....... .........+...... .....+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 3210000 0000000000000000 0000000 12446899999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.44 Aligned_cols=259 Identities=22% Similarity=0.245 Sum_probs=192.1
Q ss_pred HHhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec----
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH---- 577 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~---- 577 (786)
...++|+..+.||+|+||+||+|+. .+++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3456899999999999999999985 5789999999865221 12379999999999999999999843
Q ss_pred ----------------------------------CCeeeEEEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHH
Q 047901 578 ----------------------------------VRHSFVVYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADAL 622 (786)
Q Consensus 578 ----------------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l 622 (786)
....++||||+++ +|.+.+... .....+++..+..++.|++.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3347899999984 887777532 1345789999999999999999
Q ss_pred HHHhhCCCCCeEEcCCCCCceeeC-CCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcC
Q 047901 623 SYMHHDCFPPIVHRDISSNNVLLD-LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKIT 700 (786)
Q Consensus 623 ~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~ 700 (786)
+|||+. +|+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|| |...+ ..++
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aP----------E~~~~~~~~~ 220 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAP----------ELMLGATEYT 220 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCH----------HHHTTCSSCC
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCH----------HHhcCCCCCC
Confidence 999999 999999999999997 68999999999999775433 23345789999999 66655 4589
Q ss_pred cccchHHHHHHHHHHHhCCCCCCccccccCCC-------cchhhhhhhhc----cCCCC-CCChhH-----HHHHHHHHH
Q 047901 701 EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS-------SSINIEFNAML----DHRLP-HPSLDV-----QEKLISIME 763 (786)
Q Consensus 701 ~~sDvwslGvil~elltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~----~~~~~-~~~~~~-----~~~~~~l~~ 763 (786)
.++||||+||++|||++|+.||.......... ....+....+. ....+ .....+ ...+..+.+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 99999999999999999999987533210000 00000000000 00000 000000 112345889
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 047901 764 VALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 764 li~~cl~~~p~~RPt~~ev~~ 784 (786)
++.+||..||++|||+.|+++
T Consensus 301 li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.91 Aligned_cols=259 Identities=21% Similarity=0.275 Sum_probs=197.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV----- 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 578 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.. .........+.+|+++++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc---cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 357999999999999999999865 688999999964 23334566788999999999999999999988654
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999997 599999875 3689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc----------ceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 047901 659 AKLLKPNSSN----------WTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727 (786)
Q Consensus 659 a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~ 727 (786)
++........ .....||+.|+|| |... ...++.++|||||||++|||++|+.||.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAP----------EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCH----------HHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccCccccccchhhccccccccCC----------eeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9877532211 1234789999999 6554 46789999999999999999999999875431
Q ss_pred ccC----------------CCcchhhhhhhhccCCCCCCCh----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 728 FSS----------------SSSSINIEFNAMLDHRLPHPSL----DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 728 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
... ...................+.. .....+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000000011111110000100 00122345889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.15 Aligned_cols=255 Identities=17% Similarity=0.264 Sum_probs=200.5
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-CcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+++++.++| ++|..+..++...+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 35799999999999999999985 5789999998765321 1247789999999987 55666666777888899
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee---CCCCcEEEeccccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL---DLEYEARVSDFGTA 659 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a 659 (786)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 89999999753 35699999999999999999999999 99999999999999 57899999999999
Q ss_pred eecCCCCCc-------ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 660 KLLKPNSSN-------WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 660 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
+........ .....||+.|+|| |.+.+..++.++|||||||++|||++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP----------E~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----- 218 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASV----------NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----- 218 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----
T ss_pred eeccCCccccccccccccccCCCccccCH----------HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----
Confidence 987654321 1256799999999 888888899999999999999999999999875332
Q ss_pred cchhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 733 SSINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+..+........ .......+.++.+++..||+.+|++||++++|++.|
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred hhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111111222211111111 001112234689999999999999999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.11 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=187.1
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+. .+++.||||++.... ......+.+.++...++.++||||+++++++.+.+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 46799999999999999999986 478899999997532 222233344455556888899999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||+++ +|.+++... .....+++..+..++.|++.|++|||++ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999985 888877542 1245799999999999999999999984 28999999999999999999999999999876
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHh----hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELA----YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~----~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
.... ......||+.|+|| |.. ....++.++||||+||++|||++|+.||.... .....
T Consensus 161 ~~~~-~~~~~~~t~~y~aP----------E~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~ 222 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAP----------ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-------TPFQQ 222 (290)
T ss_dssp ----------CCCCCCSCH----------HHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-------CHHHH
T ss_pred cccc-cccccCCCccccCh----------hhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-------chHHH
Confidence 5432 22334799999999 553 45678899999999999999999999986421 11222
Q ss_pred hhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... .+. ...+..+.+++..||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEEPSPQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHSCCCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhccCCCCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 2222222222 111 112345889999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=358.96 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=201.0
Q ss_pred HhccCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
..++|++.+.||+|+||+||+|.+.. +..||||++... ......+.|.+|+.++++++||||+++++++.+ +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 34678899999999999999998642 457999998652 233455789999999999999999999999854 5
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 689999999999999999764 34689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 660 KLLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 660 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
+....... ......+|+.|+|| |...+..++.++|||||||++|||++ |..||..... ..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~ 600 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAP----------ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------ND 600 (656)
T ss_dssp CSCCC----------CCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred eecCCCcceeccCCCCCcceeCH----------HHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HH
Confidence 87754322 12234577899999 78888899999999999999999997 9999874321 12
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+... +...+... +..+.+++..||+.||++|||+.|+++.|
T Consensus 601 ~~~~i~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 601 VIGRIENGERLPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp HHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22222222 22233322 34588999999999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.60 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=194.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee--
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS-- 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~-- 581 (786)
.++|...+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 457999999999999999999854 68899999997532 2334567889999999999999999999999876654
Q ss_pred ----eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 582 ----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 582 ----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 58888874 3489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc--
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS-- 734 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~-- 734 (786)
+++..... .....||+.|+|| |...+ ..++.++|||||||++|||++|+.||............
T Consensus 190 ~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 190 LARHADAE---MTGYVVTRWYRAP----------EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp CC-----------CTTCCCTTSCH----------HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccC---cCCcccCccccCH----------HHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99866432 2345789999999 66655 67899999999999999999999999754321000000
Q ss_pred -------------hhhhhhhhccCCCCCCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 -------------INIEFNAMLDHRLPHPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 -------------~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...............+.... ...+..+.+++..||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000000000010001 112356899999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.76 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=172.3
Q ss_pred hccCccce-eeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHH-HHHhhcCCCcccceeeEEec----
Q 047901 505 TKDFDAKY-CIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEI-KALTKIRHRNIVKFYGFCSH---- 577 (786)
Q Consensus 505 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~hpniv~l~~~~~~---- 577 (786)
.++|.+.+ .||+|+||+||+|+.. +++.||||++.. .. ...+|+ ..++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SP----KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES-----SH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC-----cH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 46788854 6999999999999866 789999999854 11 122333 33566789999999999865
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEe
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVS 654 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~ 654 (786)
....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 45589999999999999999865 335799999999999999999999999 9999999999999976 4569999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcc
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~ 734 (786)
|||+++..... ......||+.|+|| |......++.++|||||||++|+|++|+.||.........
T Consensus 174 Dfg~~~~~~~~--~~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 238 (336)
T 3fhr_A 174 DFGFAKETTQN--ALQTPCYTPYYVAP----------EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--- 238 (336)
T ss_dssp CCTTCEEC----------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred ccccceecccc--ccccCCCCcCccCh----------hhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---
Confidence 99999876533 23345789999999 5555667888999999999999999999998653321100
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.......+.......+..+.+++..||+.||++|||++|+++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 239 -PGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -hhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001111111111121111223445889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.08 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=196.3
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC--CCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR--HRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~ 582 (786)
.++|++.+.||+|+||.||+|+..+++.||||++.... ......+.+.+|++++++++ ||||+++++++...+..+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 56799999999999999999998889999999997532 23345678999999999997 599999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||| +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++ ++.+||+|||+++..
T Consensus 105 lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999 5678999999864 5689999999999999999999999 999999999999996 589999999999876
Q ss_pred CCCCC--cceeeccCccccCCCCCCCCchHHHHhhh-----------cCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 047901 663 KPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729 (786)
Q Consensus 663 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-----------~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~ 729 (786)
..... ......||+.|+|| |.... ..++.++||||||+++|||++|+.||....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--- 243 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPP----------EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--- 243 (313)
T ss_dssp -------------CCGGGCCH----------HHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC---
T ss_pred cCccccccccCCCCCCCcCCH----------HHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH---
Confidence 54322 12345799999999 55443 468889999999999999999999986422
Q ss_pred CCCcchhhhhhhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 730 SSSSSINIEFNAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..........+... ..+... +..+.+++..||+.||++|||+.|+++
T Consensus 244 ----~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 244 ----NQISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ----SHHHHHHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHHHHHhcccccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11122233333222 222222 234889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.98 Aligned_cols=199 Identities=21% Similarity=0.363 Sum_probs=153.3
Q ss_pred ccCcc-ceeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEe--cCC
Q 047901 506 KDFDA-KYCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCS--HVR 579 (786)
Q Consensus 506 ~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~ 579 (786)
+.|+. +++||+|+||+||+|+.+ +++.||||++... .....+.+|+++++.++||||+++++++. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT------GISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS------SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC------CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 34666 457999999999999865 5788999999642 12246789999999999999999999994 467
Q ss_pred eeeEEEeccCCCCHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee----CCCC
Q 047901 580 HSFVVYEYINRGSLATVLSNN------FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL----DLEY 649 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~ 649 (786)
..++||||+++ +|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 89999999975 888887532 1223589999999999999999999999 99999999999999 6779
Q ss_pred cEEEeccccceecCCCC---CcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 650 EARVSDFGTAKLLKPNS---SNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 650 ~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
.+||+|||+|+...... ......+||+.|+|| |++.+ ..++.++||||+||++|||++|+.||..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP----------ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCH----------HHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCc----------hhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999998765432 223456899999999 66665 4589999999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.67 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=197.3
Q ss_pred HhccCccceeeccccCceEEEEEc--CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc---CCCcccceeeEEe--
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL--PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCS-- 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~-- 576 (786)
..++|++.+.||+|+||+||+|+. .+++.||||++....... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 356899999999999999999986 467889999986532211 1122455777776666 8999999999987
Q ss_pred ---cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 577 ---HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 577 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
.....++||||++ |+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence 5567899999998 5999999865 234589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~ 733 (786)
+|||.++..... .......||+.|+|| |...+..++.++|||||||++|||++|+.||......
T Consensus 162 ~Dfg~~~~~~~~-~~~~~~~~~~~y~aP----------E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 225 (326)
T 1blx_A 162 ADFGLARIYSFQ-MALTSVVVTLWYRAP----------EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----- 225 (326)
T ss_dssp CSCCSCCCCCGG-GGGCCCCCCCTTCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----
T ss_pred ecCcccccccCC-CCccccccccceeCH----------HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----
Confidence 999999866432 223446789999999 7777888999999999999999999999998753321
Q ss_pred chhhhhhhhc----------------------cCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEFNAML----------------------DHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~~~~~----------------------~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+. ......+ .......+..+.+++.+||..||++|||+.|+++
T Consensus 226 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 ---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp ---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000000 0001122345889999999999999999999985
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=328.58 Aligned_cols=307 Identities=23% Similarity=0.314 Sum_probs=204.4
Q ss_pred cCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcE
Q 047901 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKY 101 (786)
Q Consensus 22 f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 101 (786)
+..+++|++|++++|.+..+ + .+..+++|++|+|++|+++.+.+ |..+++|++|+|++|+++.+ +.+..+++|++
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~~ 114 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-SALQNLTNLRE 114 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSE
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-hHHcCCCcCCE
Confidence 34556666666666666543 2 26666666666666666664433 66666666666666666543 34556666666
Q ss_pred EEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccc
Q 047901 102 ISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLT 181 (786)
Q Consensus 102 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~ 181 (786)
|+|++|+++++.+ +..+++|++|++++|... ..++.+..+++|+.|++++|.++
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~------------------------~~~~~~~~l~~L~~L~l~~~~~~ 168 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNL------------------------SDLSPLSNMTGLNYLTVTESKVK 168 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTC------------------------CCCGGGTTCTTCCEEECCSSCCC
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCc------------------------ccccchhhCCCCcEEEecCCCcC
Confidence 6666666664433 556666666666666433 22333455566666666666665
Q ss_pred cccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcc
Q 047901 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELG 261 (786)
Q Consensus 182 ~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 261 (786)
++.+ +..+++|++|++++|++.++.+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +.
T Consensus 169 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~ 240 (347)
T 4fmz_A 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA 240 (347)
T ss_dssp CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT
T ss_pred Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hh
Confidence 5433 6666777777777777765544 6667777777777777765433 6667777777777777765433 67
Q ss_pred cccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCee
Q 047901 262 RLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSEL 341 (786)
Q Consensus 262 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 341 (786)
.+++|+.|++++|.++++ ..+..+++|+.|++++|+++.+ ..+..+++|++|++++|.+++..+..|..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 241 NLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred cCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 777777777777777754 4577778888888888888775 457778888888888888887777888888888888
Q ss_pred eccCCccCCCCCcccccccccceecccccccc
Q 047901 342 DLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373 (786)
Q Consensus 342 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (786)
+|++|++++..| +..+++|+.|++++|+|+
T Consensus 317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888886555 777888888888888875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.07 Aligned_cols=307 Identities=24% Similarity=0.343 Sum_probs=252.0
Q ss_pred ccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcce
Q 047901 46 VRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSY 125 (786)
Q Consensus 46 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 125 (786)
+..+++|++|++++|.++.+ + .|..+++|++|+|++|+++++++ +..+++|++|+|++|+++.+ ..|.++++|++
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~ 114 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRE 114 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCE
Confidence 45667777777777777643 2 36777777777777777776554 66777777777777777653 24666777777
Q ss_pred eccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccc
Q 047901 126 LMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205 (786)
Q Consensus 126 L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~ 205 (786)
|++++|++++ .++ +.++++|+.|++++|...... ..+..+++|++|++++|.+.
T Consensus 115 L~l~~n~i~~------------------------~~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~ 168 (347)
T 4fmz_A 115 LYLNEDNISD------------------------ISP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK 168 (347)
T ss_dssp EECTTSCCCC------------------------CGG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred EECcCCcccC------------------------chh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcC
Confidence 7777766652 222 567788999999999655433 34899999999999999998
Q ss_pred cccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccc
Q 047901 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALG 285 (786)
Q Consensus 206 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 285 (786)
.+.+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +.
T Consensus 169 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~ 240 (347)
T 4fmz_A 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA 240 (347)
T ss_dssp CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT
T ss_pred Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hh
Confidence 7655 8899999999999999996543 8899999999999999986554 8899999999999999997655 89
Q ss_pred cCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCccccccccccee
Q 047901 286 LLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKL 365 (786)
Q Consensus 286 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 365 (786)
.+++|+.|++++|.++.+ ..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++..+..|.++++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 241 NLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred cCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 999999999999999986 5688999999999999999875 468999999999999999998888999999999999
Q ss_pred ccccccccccCCcccccCCCceEEeccCCccc
Q 047901 366 NLSHNNISGQIPACFIGMSGLLSIDISYNELR 397 (786)
Q Consensus 366 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 397 (786)
++++|++++..| +..+++|+.|++++|+++
T Consensus 317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999998877 889999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.93 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=185.1
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~-------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG-------GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH-------HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 3555688999999999877666799999999854 2345678999999886 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-------------
Q 047901 586 EYINRGSLATVLSNNFASED----FDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE------------- 648 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~----~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~------------- 648 (786)
||++ |+|.+++........ .++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 599999976522111 13334578999999999999999 99999999999999654
Q ss_pred CcEEEeccccceecCCCCCc----ceeeccCccccCCCCCCCCchHHHHhhh-------cCcCcccchHHHHHHHHHHHh
Q 047901 649 YEARVSDFGTAKLLKPNSSN----WTELVGTFGYVAPAHGNIGLHLAELAYT-------MKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~e~~~~-------~~~~~~sDvwslGvil~ellt 717 (786)
+.+||+|||+|+........ .....||+.|+|| |+..+ ..++.++|||||||++|||+|
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP----------ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCH----------HHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCH----------HHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence 48999999999987654321 2345799999999 55543 678999999999999999999
Q ss_pred -CCCCCCccccccCCCcchhhhhhhhccCCCCC---CChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 718 -GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPH---PSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 718 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
|+.||..... .. ..+....... +.......+..+.+++.+||+.||++|||+.||++
T Consensus 235 ~g~~Pf~~~~~------~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 235 KGKHPFGDKYS------RE----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TSCCTTCSTTT------HH----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCchh------hH----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9999864211 11 1111111111 11112344567899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=334.08 Aligned_cols=200 Identities=20% Similarity=0.265 Sum_probs=170.7
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CC-----cccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HR-----NIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~l~~~~~~ 577 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++.. .......+..|+.+++.++ |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 468999999999999999999865 678899999964 2334567788999888885 55 49999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC--CCCcEEEec
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD--LEYEARVSD 655 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~D 655 (786)
.+..++||||+++ +|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999964 999999865 235689999999999999999999952 12999999999999995 468899999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~ 725 (786)
||+|+..... .....||+.|+|| |+..+..++.++|||||||++|||++|+.||...
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSP----------EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc---cccccCCccccCh----------HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999887533 2345799999999 7888888999999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.01 Aligned_cols=256 Identities=24% Similarity=0.279 Sum_probs=190.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV------ 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------ 578 (786)
.+|+..+.||+|+||+||+|+.. +++.||||++..... .+.+|+++++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 46999999999999999999875 689999999865211 123799999999999999999988432
Q ss_pred CeeeEEEeccCCCCHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEecc
Q 047901 579 RHSFVVYEYINRGSLATVLSNN-FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDF 656 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Df 656 (786)
...++||||+++ ++.+.+... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence 236799999986 676665431 1346789999999999999999999999 99999999999999965 67899999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCC---
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS--- 732 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~--- 732 (786)
|+|+....... .....||+.|+|| |++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 202 G~a~~~~~~~~-~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 202 GSAKQLVRGEP-NVSYICSRYYRAP----------ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp TTCEECCTTCC-CCSCCSCTTSCCH----------HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hhhhhcccCCC-ceeeeeCCCcCCH----------HHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99997754322 2345789999999 66655 478999999999999999999999987543210000
Q ss_pred ----cchhhhhhhhcc--CCCCCC---ChhHH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ----SSINIEFNAMLD--HRLPHP---SLDVQ-----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ----~~~~~~~~~~~~--~~~~~~---~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+.+..+.. .....+ ...+. ..+..+.+++.+||..||++|||+.|+++
T Consensus 271 ~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000001111100 000111 00011 12345889999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.75 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=198.7
Q ss_pred HhccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCc--hhhHHHHHHHHHHHhhcC--CCcccceeeEEecC
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQ--MSDQKEFLNEIKALTKIR--HRNIVKFYGFCSHV 578 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~ 578 (786)
..++|++.+.||+|+||+||+|+. .+++.||||++........ ....+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 356799999999999999999985 4788999999875322110 112245668999999996 59999999999999
Q ss_pred CeeeEEEeccCC-CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-CCCcEEEecc
Q 047901 579 RHSFVVYEYINR-GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-LEYEARVSDF 656 (786)
Q Consensus 579 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Df 656 (786)
+..++|||++.+ ++|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 8999999764 5689999999999999999999999 999999999999999 7799999999
Q ss_pred ccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 657 GTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 657 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
|+++..... ......||+.|+|| |...+..+ +.++|||||||++|||++|+.||....
T Consensus 195 g~~~~~~~~--~~~~~~gt~~y~aP----------E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------- 253 (320)
T 3a99_A 195 GSGALLKDT--VYTDFDGTRVYSPP----------EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 253 (320)
T ss_dssp TTCEECCSS--CBCCCCSCGGGSCH----------HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred ccccccccc--cccCCCCCccCCCh----------HHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence 999877543 23345799999999 66666665 688999999999999999999986421
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. ........+... +..+.+++.+||+.||++|||++|+++
T Consensus 254 -~----~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 -E----IIRGQVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -H----HHHCCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -h----hhcccccccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111112222211 234889999999999999999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=330.61 Aligned_cols=352 Identities=22% Similarity=0.222 Sum_probs=264.3
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCC-------------cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCc
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHL-------------AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPP 68 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L-------------~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 68 (786)
+++.|+++.|.+.|.+|. +|..+.+| ++|++++|+++++.. -.++|++|+|++|++++ .|.
T Consensus 35 ~L~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~----~~~~L~~L~l~~n~l~~-lp~ 108 (454)
T 1jl5_A 35 SKTEYYNAWSEWERNAPP-GNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSLTE-LPE 108 (454)
T ss_dssp CHHHHHHHHHHHHHTSCT-TSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSS-CCC
T ss_pred chhhhhccCCcccccCCc-ccccchhcchhhhhhhhccCCCEEEecCCccccCCC----CcCCCCEEEccCCcCCc-ccc
Confidence 355678888888888887 57777764 999999999976443 23789999999999986 554
Q ss_pred cccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccc
Q 047901 69 EIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLE 148 (786)
Q Consensus 69 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 148 (786)
. +++|++|++++|++++++.. .++|++|+|++|+++++ | .|+++++|++|++++|++++ +|..+ .+|+
T Consensus 109 ~---~~~L~~L~l~~n~l~~l~~~---~~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~ 176 (454)
T 1jl5_A 109 L---PQSLKSLLVDNNNLKALSDL---PPLLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLE 176 (454)
T ss_dssp C---CTTCCEEECCSSCCSCCCSC---CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCC
T ss_pred c---cCCCcEEECCCCccCcccCC---CCCCCEEECcCCCCCCC-c-ccCCCCCCCEEECCCCcCcc-cCCCc---cccc
Confidence 3 48899999999999875432 26899999999999974 4 59999999999999999985 55433 5899
Q ss_pred eeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCccc
Q 047901 149 ILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228 (786)
Q Consensus 149 ~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 228 (786)
.|++++|++++.+ .+.++++|+.|++++|++++++. ..++|++|++++|+++.+ | .|..+++|++|++++|++
T Consensus 177 ~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~n~l~~l-p-~~~~l~~L~~L~l~~N~l 249 (454)
T 1jl5_A 177 FIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILEEL-P-ELQNLPFLTTIYADNNLL 249 (454)
T ss_dssp EEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCC
T ss_pred EEECcCCcCCcCc-cccCCCCCCEEECCCCcCCcCCC----CcCcccEEECcCCcCCcc-c-ccCCCCCCCEEECCCCcC
Confidence 9999999998854 78899999999999999987543 236899999999999854 4 488999999999999999
Q ss_pred CCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhh
Q 047901 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEAL 308 (786)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 308 (786)
++ +|.. +++|+.|++++|++++ +|.. .++|+.|++++|+++++.. -.++|+.|++++|+++++..
T Consensus 250 ~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~----~~~~L~~L~l~~N~l~~i~~--- 314 (454)
T 1jl5_A 250 KT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSLCD--- 314 (454)
T ss_dssp SS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEECC---
T ss_pred Cc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccC----cCCcCCEEECcCCcCCcccC---
Confidence 85 4432 4789999999999986 4443 3689999999999986321 12689999999999887431
Q ss_pred hcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccc--cCCcccccC---
Q 047901 309 GFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG--QIPACFIGM--- 383 (786)
Q Consensus 309 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l--- 383 (786)
..++|++|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|+.|++++|++++ .+|..+..+
T Consensus 315 -~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n 385 (454)
T 1jl5_A 315 -LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMN 385 (454)
T ss_dssp -CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECC
T ss_pred -CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhc
Confidence 12589999999999986 4433 5889999999999984 555 46889999999999998 678888777
Q ss_pred ----------CCceEEeccCCcccc--cCCC
Q 047901 384 ----------SGLLSIDISYNELRG--PIPN 402 (786)
Q Consensus 384 ----------~~L~~L~l~~N~l~~--~~p~ 402 (786)
++|+.||+++|++++ .+|.
T Consensus 386 ~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 386 SHLAEVPELPQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp C------------------------------
T ss_pred ccccccccccCcCCEEECCCCcCCccccchh
Confidence 889999999999997 5554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=327.27 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=191.9
Q ss_pred HHhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc--hhhHHHHHHHHHHHhhc----CCCcccceeeEE
Q 047901 503 RRTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ--MSDQKEFLNEIKALTKI----RHRNIVKFYGFC 575 (786)
Q Consensus 503 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l----~hpniv~l~~~~ 575 (786)
...++|+..+.||+|+||.||+|+.. +++.||||++........ ......+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999999999999864 788999999975322111 11233456789999888 899999999999
Q ss_pred ecCCeeeEEEec-cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC-CCCcEEE
Q 047901 576 SHVRHSFVVYEY-INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-LEYEARV 653 (786)
Q Consensus 576 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl 653 (786)
...+..++|||| +++++|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 7899999999864 4689999999999999999999999 999999999999999 8899999
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcC-cccchHHHHHHHHHHHhCCCCCCccccccCCC
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKIT-EKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~-~~sDvwslGvil~elltg~~Pf~~~~~~~~~~ 732 (786)
+|||+++..... ......||..|+|| |...+..+. .++||||||+++|||++|+.||....
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aP----------E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------ 243 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPP----------EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------ 243 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCH----------HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred EEcchhhhcccC--cccccCCcccccCc----------eeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------
Confidence 999999877543 23445799999999 666666654 58999999999999999999986421
Q ss_pred cchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........+... ...+.+++.+||+.||++|||++|+++
T Consensus 244 --------~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --------EILEAELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --------HHHHTCCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------HHhhhccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112222222222 234889999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.22 Aligned_cols=305 Identities=19% Similarity=0.139 Sum_probs=210.1
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+++.|+++.+.+. .++...|..+++|++|+|++|.++++.+..|.++++|++|+|++|+|+++.|..|+.+++|++|+|
T Consensus 46 ~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 5788999999876 788878999999999999999999999999999999999999999999998999999999999999
Q ss_pred CCccCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCC
Q 047901 82 SLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGS 160 (786)
Q Consensus 82 s~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~ 160 (786)
++|+++.+++. |..+++|++|+|++|+++++.+..|.++++|++|++++|++++. .+..+++|+.|++++|.+.+.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 99999988876 68999999999999999999999999999999999999999864 245566777777777766532
Q ss_pred CCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCc
Q 047901 161 IPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240 (786)
Q Consensus 161 ~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 240 (786)
...++|+.|++++|.++.+... ..++|++|+|++|++++. ..+..+++|++|+|++|.++++.|..|..++
T Consensus 202 ----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (390)
T 3o6n_A 202 ----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272 (390)
T ss_dssp ----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCS
T ss_pred ----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccc
Confidence 2234555666666665554322 134555555555555543 3445555555555555555554455555555
Q ss_pred cccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEec
Q 047901 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320 (786)
Q Consensus 241 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 320 (786)
+|+.|+|++|++++ +|..+..+++|+.|+|++|+++. .|..+..+++|+.|++++|+++.++ +..+++|++|+++
T Consensus 273 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~ 347 (390)
T 3o6n_A 273 RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLS 347 (390)
T ss_dssp SCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECC
T ss_pred cCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEEEcC
Confidence 55555555555543 23333444445555555554442 2223344444444444444444332 2333344444444
Q ss_pred cccc
Q 047901 321 HNQF 324 (786)
Q Consensus 321 ~N~l 324 (786)
+|.+
T Consensus 348 ~N~~ 351 (390)
T 3o6n_A 348 HNDW 351 (390)
T ss_dssp SSCE
T ss_pred CCCc
Confidence 4444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.02 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=193.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe----
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH---- 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~---- 580 (786)
++|...+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 57999999999999999999864 68899999997532 233456788999999999999999999999977654
Q ss_pred --eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 581 --SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 581 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
.++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 58888774 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------ 731 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------ 731 (786)
++..... .....||+.|+|| |...+ ..++.++||||+||++|||++|+.||.........
T Consensus 173 ~~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 173 ARHADAE---MTGYVVTRWYRAP----------EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp TTC-----------CCSBCCSCH----------HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred ccCCCCC---ccccccCcCcCCH----------HHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9865432 2345789999999 66655 67889999999999999999999998754321000
Q ss_pred ------------Ccchhhhh-hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ------------SSSINIEF-NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ------------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ ..+...............+..+.+++.+||..||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000000000011122345899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.97 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=194.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|+.++ .||+|++...... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN--EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC--CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC--HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 5679999999999999999998753 5999998754321 22334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999764 34688999999999999999999999 999999999999998 78999999999876532
Q ss_pred C-----CCcceeeccCccccCCCCCCCCchHHHHhhh---------cCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 665 N-----SSNWTELVGTFGYVAPAHGNIGLHLAELAYT---------MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 665 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~---------~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
. ........||+.|+|| |.... ..++.++||||||+++|||++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aP----------E~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--- 248 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAP----------EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--- 248 (319)
T ss_dssp ------CCSCBCCSGGGGTSCH----------HHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---
T ss_pred ccccccccccccCCCcccccCh----------HHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 1 1122345689999999 55442 4578899999999999999999999874321
Q ss_pred CCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.....+... ....+..+.+++..||..||++|||+.++++.|
T Consensus 249 -----~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 249 -----EAIIWQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp -----HHHHHHHHTTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred -----HHHHHHhccCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 1111222221111100 001123488999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=329.58 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=197.3
Q ss_pred hccCccceeeccccCceEEEEEcC-CC-CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc------ccceeeEEe
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SG-DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN------IVKFYGFCS 576 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~l~~~~~ 576 (786)
.++|++.+.||+|+||+||+|+.. ++ +.||||++.. .....+.+.+|+++++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 357999999999999999999864 34 6899999864 2344567889999999997765 899999999
Q ss_pred cCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceee-----------
Q 047901 577 HVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLL----------- 645 (786)
Q Consensus 577 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----------- 645 (786)
..+..++||||+ ++++.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 999999999999 66788877654 235689999999999999999999999 99999999999999
Q ss_pred --------CCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh
Q 047901 646 --------DLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717 (786)
Q Consensus 646 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt 717 (786)
+.++.+||+|||+++..... .....||+.|+|| |...+..++.++|||||||++|||++
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPP----------EVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCC----------eeeecCCCCCccchHHHHHHHHHHHh
Confidence 56789999999999875433 2345799999999 78888889999999999999999999
Q ss_pred CCCCCCccccccCCCcchhhhhhhhcc------------------CCCCCCC-------------------hhHHHHHHH
Q 047901 718 GKHPGDFLSLFSSSSSSINIEFNAMLD------------------HRLPHPS-------------------LDVQEKLIS 760 (786)
Q Consensus 718 g~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~-------------------~~~~~~~~~ 760 (786)
|+.||....... .......... .....+. .........
T Consensus 235 g~~pf~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 235 GFTLFQTHENRE-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp SSCSCCCSSHHH-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CCCCCCCCCHHH-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 999987533110 0000000000 0000000 001122446
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 047901 761 IMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 761 l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.+++.+||+.||++|||++|+++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCcCHHHHhc
Confidence 889999999999999999999975
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=348.05 Aligned_cols=310 Identities=20% Similarity=0.175 Sum_probs=192.8
Q ss_pred CCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEE
Q 047901 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYIS 103 (786)
Q Consensus 25 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~ 103 (786)
+++++.|++++|.+..+++..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|.|+++++. |.++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34566666666666655555566666666666666666665555666666666666666666655543 45666666666
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN 183 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~ 183 (786)
|++|+|+++++..|.++++|++|+|++|.+++..|..|..+++|+.|++++|. |+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-----------------------l~~~ 186 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR-----------------------LTHV 186 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSC-----------------------CSBC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCC-----------------------CCCc
Confidence 66666665555556666666666666666665555555555555555555554 4443
Q ss_pred cCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccc
Q 047901 184 ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRL 263 (786)
Q Consensus 184 ~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 263 (786)
. +..+++|++|++++|.++++ ...++|+.|++++|.++.+.+.. .++|+.|+|++|.+++ +..+..+
T Consensus 187 ~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l 253 (597)
T 3oja_B 187 D---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNY 253 (597)
T ss_dssp C---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGC
T ss_pred C---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccC
Confidence 2 33345555666666555532 22345666666666665332221 1466777777777664 3556677
Q ss_pred cccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeec
Q 047901 264 ISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343 (786)
Q Consensus 264 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 343 (786)
++|+.|+|++|.++++.|..|..+++|+.|+|++|.+++++ ..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L 331 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALN-LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEE-CSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCC-cccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEEC
Confidence 77777777777777777777777777777777777777653 33455677777777777776 45666777788888888
Q ss_pred cCCccCCCCCcccccccccceecccccccccc
Q 047901 344 SHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375 (786)
Q Consensus 344 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 375 (786)
++|++++. + +..+++|+.|++++|++.+.
T Consensus 332 ~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 332 DHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 88887743 2 45556677777777776543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=333.15 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=197.0
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-----------CCccccee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-----------HRNIVKFY 572 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~l~ 572 (786)
.++|++.+.||+|+||+||+|+. .+++.||||++.. .....+.+.+|+.++++++ ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 35799999999999999999985 4788999999864 2334567889999999886 89999999
Q ss_pred eEEecCC----eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC--
Q 047901 573 GFCSHVR----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD-- 646 (786)
Q Consensus 573 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-- 646 (786)
+++...+ ..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 9987544 789999999 88999999865 2356899999999999999999999952 899999999999994
Q ss_pred ----CCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCC
Q 047901 647 ----LEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPG 722 (786)
Q Consensus 647 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf 722 (786)
..+.+||+|||+++..... .....||+.|+|| |...+..++.++|||||||++|||++|+.||
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSP----------EVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCH----------HHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCc----------HHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 4458999999999877533 2345799999999 7888888999999999999999999999999
Q ss_pred CccccccCCCcchhhhhhhhc------------------------------------------cCCCCCCChhHHHHHHH
Q 047901 723 DFLSLFSSSSSSINIEFNAML------------------------------------------DHRLPHPSLDVQEKLIS 760 (786)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~ 760 (786)
......... ........+. ..... ........
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 309 (373)
T 1q8y_A 236 EPDEGHSYT--KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK----FSKDEAKE 309 (373)
T ss_dssp -----------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC----CCHHHHHH
T ss_pred CCCcccccC--ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc----CCcchHHH
Confidence 753321100 0001111110 00111 12345567
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 047901 761 IMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 761 l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.+++..||+.||++|||++|+++
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHhccCccccCCHHHHhh
Confidence 899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=340.57 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=183.8
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 583 (786)
..+|...+.||+|+||+||.....+++.||||++.... ...+.+|+++++.+ +||||+++++++.+....|+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 34688999999999999765555678999999996521 11345899999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-----CCcEEEecccc
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-----EYEARVSDFGT 658 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfg~ 658 (786)
||||++ |+|.+++.... ....+..+..++.|++.||+|||+. +|+||||||+||+++. ...+||+|||+
T Consensus 96 v~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999997 59999998652 2344445678999999999999999 9999999999999953 24688999999
Q ss_pred ceecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcc
Q 047901 659 AKLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSS 734 (786)
Q Consensus 659 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~ 734 (786)
|+....... ......||+.|+|||++... ....++.++||||+||++|||++ |..||....
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-------- 234 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-------CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-------- 234 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC----------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT--------
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcc-------cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh--------
Confidence 987754321 23346799999999533210 13567789999999999999999 999975321
Q ss_pred hhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.........................+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 235 -QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -THHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111111111000111223345789999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=353.29 Aligned_cols=262 Identities=24% Similarity=0.283 Sum_probs=198.2
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------ 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------ 577 (786)
.++|++.+.||+|+||+||+|... +++.||||++... ......+.+.+|+++++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 367999999999999999999864 6889999998652 234456789999999999999999999998765
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCc---EEEe
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYE---ARVS 654 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~ 654 (786)
.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999998764445788999999999999999999999 9999999999999997664 9999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCcccc---ccCC
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL---FSSS 731 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~---~~~~ 731 (786)
|||.++...... ......||+.|+||| ...+..++.++||||+||++|||++|+.||..... +...
T Consensus 167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE----------~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~ 235 (676)
T 3qa8_A 167 DLGYAKELDQGE-LCTEFVGTLQYLAPE----------LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235 (676)
T ss_dssp SCCCCCBTTSCC-CCCCCCSCCTTCSSC----------SSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT
T ss_pred cccccccccccc-ccccccCCcccCChH----------HhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh
Confidence 999998775443 234468999999995 44566789999999999999999999999864211 0000
Q ss_pred Ccc---hhhhhhh------hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 732 SSS---INIEFNA------MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 732 ~~~---~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
... ....... ......+.+.......+..+.+++..||.+||++|||+.|++
T Consensus 236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000 0000000 011111222222333456799999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.97 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=179.1
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHH-HHhhcCCCcccceeeEEecCCeee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIK-ALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
.++|+..+.||+|+||.||+|... +++.||||++.... .......+..|+. +++.++||||+++++++...+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 357999999999999999999865 78899999997532 2234455666666 677789999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 583 VVYEYINRGSLATVLSNN--FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
+||||+++ +|.+++... .....+++..+..++.|++.|+.|||+. ++|+||||||+||+++.++.+||+|||+++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999986 888877531 1246789999999999999999999985 389999999999999999999999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
...... ......||+.|+|||.+... ..+..++.++|||||||++|||++|+.||...... .....
T Consensus 175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~ 240 (327)
T 3aln_A 175 QLVDSI-AKTRDAGCRPYMAPERIDPS------ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLT 240 (327)
T ss_dssp C-------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C
T ss_pred eccccc-ccccCCCCccccCceeeccc------cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHH
Confidence 765432 22334799999999643210 13556889999999999999999999998753211 01111
Q ss_pred hhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ .+.......+..+.+++..||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111 111011112345889999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.63 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=179.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+..+..+++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 457999999999999999999875 78999999997532 122223344455557888899999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||+ ++.+..+.... ...+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 44555555432 3568999999999999999999998 5 8999999999999999999999999999776
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHh-----hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELA-----YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~-----~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
.... ......||+.|+|| |.. ....++.++|||||||++|||++|+.||.... ....
T Consensus 176 ~~~~-~~~~~~~~~~y~aP----------E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~ 237 (318)
T 2dyl_A 176 VDDK-AKDRSAGCAAYMAP----------ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFE 237 (318)
T ss_dssp ------------CCTTCCH----------HHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHH
T ss_pred cCCc-cccccCCCccccCh----------hhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHH
Confidence 5432 22345799999999 555 35568899999999999999999999987422 1122
Q ss_pred hhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
....+...... .+.. ...+..+.+++..||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 238 VLTKVLQEEPPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHSCCCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhccCCCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 22222222221 1110 012235889999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.67 Aligned_cols=229 Identities=14% Similarity=0.095 Sum_probs=181.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 57999999999999999999865 588999999976432 2234567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++... ....++..++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999532 35567889999999999999999 99999999999999999999998543
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
|++| ++.++|||||||++|||+||+.||............ .....
T Consensus 175 -------------~~~~-----------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----~~~~~ 219 (286)
T 3uqc_A 175 -------------TMPD-----------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----ERDTA 219 (286)
T ss_dssp -------------CCTT-----------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----CBCTT
T ss_pred -------------ccCC-----------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----HHHhc
Confidence 4444 577999999999999999999999864432111000 00011
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+.......+..+.+++.+||++||++| |+.|+++.|
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 11111111111223458999999999999999 999999864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.23 Aligned_cols=294 Identities=19% Similarity=0.184 Sum_probs=169.9
Q ss_pred eEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCC
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLS 82 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 82 (786)
++.++++++++. .+|.. + .++|++|+|++|+++++.+..|.++++|++|+|++|+|+++.|..|..+++|++|+|+
T Consensus 33 l~~l~~~~~~l~-~lp~~-~--~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp TTEEECTTSCCC-SCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CeEEEecCCCcc-ccCcc-C--CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 455666666665 44442 1 2566677777777766666666777777777777777766666667777777777777
Q ss_pred CccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccc--cCChhhhccCccceeecccccccCC
Q 047901 83 LNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTG--QLPRNICRSGLLEILTVNDNHFLGS 160 (786)
Q Consensus 83 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~~~~L~~L~l~~N~l~~~ 160 (786)
+|+++.++..+. ++|++|++++|+++++.+..|.++++|++|++++|+++. ..+..+..+++|+.|++++|.++.+
T Consensus 109 ~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l 186 (330)
T 1xku_A 109 KNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186 (330)
T ss_dssp SSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence 777665555443 567777777777766666666677777777777776642 4555566666666666666666554
Q ss_pred CCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCc
Q 047901 161 IPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240 (786)
Q Consensus 161 ~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 240 (786)
+..+. ++|+.|++++|+++++.+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|+++ .+|..+..++
T Consensus 187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 263 (330)
T 1xku_A 187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263 (330)
T ss_dssp CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence 44332 45555555555555555555555555555555555555555555555555555555555555 3444455555
Q ss_pred cccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccc--cchhhhhcccCCcEEE
Q 047901 241 QLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN--SILEALGFMFKLFYLN 318 (786)
Q Consensus 241 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ 318 (786)
+|+.|+|++|+|+++.+..|+... .....+.|+.|++++|++.. +.+..|..+.+++.++
T Consensus 264 ~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~ 325 (330)
T 1xku_A 264 YIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325 (330)
T ss_dssp SCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred CcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCcccccccCccccccccceeEEE
Confidence 555555555555544444443220 00012455566666666543 4455666666666666
Q ss_pred ecccc
Q 047901 319 FSHNQ 323 (786)
Q Consensus 319 L~~N~ 323 (786)
|++|+
T Consensus 326 L~~N~ 330 (330)
T 1xku_A 326 LGNYK 330 (330)
T ss_dssp C----
T ss_pred ecccC
Confidence 66653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.58 Aligned_cols=286 Identities=18% Similarity=0.169 Sum_probs=156.9
Q ss_pred CCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEcc
Q 047901 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLH 105 (786)
Q Consensus 27 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~ 105 (786)
+++.+++++|.++.+ |..+. ++|++|+|++|+|+.+.|..|..+++|++|+|++|+++++.+ .+..+++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~~i-p~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAV-PKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCSSC-CSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcccc-CCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 455555555555322 22221 345555555555554444455555555555555555554432 34455555555555
Q ss_pred CCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccC--C-CCCcCCCCCCcEEEccCccccc
Q 047901 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG--S-IPNLRNCRSLVRAHLGRNNLTG 182 (786)
Q Consensus 106 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~--~-~~~l~~l~~L~~L~L~~N~l~~ 182 (786)
+|+++.+++..+ ++|++|++++|+++...+..|..+++|+.|++++|.++. . +..+..+ +|+.|++++|++++
T Consensus 111 ~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCCSCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCCccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 555553333222 455555555555554444445555555555555555532 2 1223444 55555666666555
Q ss_pred ccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccc
Q 047901 183 NISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR 262 (786)
Q Consensus 183 ~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 262 (786)
++...+ ++|++|+|++|+++++.+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|+++ .+|..+..
T Consensus 187 l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 IPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp CCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred cCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 433222 46666666666666666666666666666666666666555556666666666666666666 45555666
Q ss_pred ccccccccccccccCCCCcccccc------CCcCceecccccccc--ccchhhhhcccCCcEEEecccc
Q 047901 263 LISLNKLILRGNQLSGHLPRALGL------LTELEYFDLSSNRLN--NSILEALGFMFKLFYLNFSHNQ 323 (786)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 323 (786)
+++|+.|++++|+|+++.+..|.. ..+|+.|++++|++. .+.+..|..+++|+.|++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 666666666666666655555543 355777777777776 5666777777777777777764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=315.22 Aligned_cols=230 Identities=20% Similarity=0.280 Sum_probs=179.6
Q ss_pred ccCccc-eeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHH-hhcCCCcccceeeEEec----C
Q 047901 506 KDFDAK-YCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL-TKIRHRNIVKFYGFCSH----V 578 (786)
Q Consensus 506 ~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~l~~~~~~----~ 578 (786)
++|.+. +.||+|+||+||+|.. .+++.||||++.. ...+.+|++++ +..+||||+++++++.. .
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 467776 7799999999999986 4788999999853 13566888887 55689999999999876 6
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEec
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVSD 655 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 655 (786)
...++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 7789999999999999999875 335689999999999999999999999 9999999999999998 78999999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||++..... ..++.++||||+||++|||++|+.||..........
T Consensus 164 fg~a~~~~~--------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--- 208 (299)
T 3m2w_A 164 FGFAKETTG--------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--- 208 (299)
T ss_dssp CTTCEECTT--------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---
T ss_pred ccccccccc--------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---
Confidence 999865431 235678999999999999999999986533211000
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.............+.......+..+.+++..||+.||++|||++|+++
T Consensus 209 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 -GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000111111222222112233456899999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=341.50 Aligned_cols=346 Identities=21% Similarity=0.167 Sum_probs=278.1
Q ss_pred CCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCccee
Q 047901 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYL 126 (786)
Q Consensus 48 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 126 (786)
.+.+++.|++++|.++.+.+..|..+++|++|+|++|.|+++++ .|..+++|++|+|++|.|++++|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 35678888888888887777777888888888888888887765 57778888888888888887777777888888888
Q ss_pred ccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc
Q 047901 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206 (786)
Q Consensus 127 ~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~ 206 (786)
+|++|.+++.++.. +.++++|+.|+|++|.|+++.+..|..+++|++|+|++|++++
T Consensus 129 ~L~~n~l~~l~~~~-----------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 129 VLERNDLSSLPRGI-----------------------FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp ECCSSCCCCCCTTT-----------------------TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred EeeCCCCCCCCHHH-----------------------hccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 88887776433332 3566777888888888888888899999999999999999997
Q ss_pred ccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCcccccc
Q 047901 207 EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL 286 (786)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 286 (786)
+. +..+++|+.|++++|.+++. ...++|+.|++++|.+....+..+ ++|+.|+|++|.+++. ..+..
T Consensus 186 ~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~--~~l~~ 252 (597)
T 3oja_B 186 VD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT--AWLLN 252 (597)
T ss_dssp CC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC--GGGGG
T ss_pred cC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC--hhhcc
Confidence 63 56788999999999999853 345789999999999986554433 5899999999999864 67899
Q ss_pred CCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceec
Q 047901 287 LTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLN 366 (786)
Q Consensus 287 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 366 (786)
+++|+.|+|++|.+.++.+..|..+++|++|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence 9999999999999999999999999999999999999986 5666778999999999999999 6778889999999999
Q ss_pred cccccccccCCcccccCCCceEEeccCCcccccCCCCCccccCCCccccCCCCCCCCCCCccccccccccC
Q 047901 367 LSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTFYGTSDLLSHKEASKK 437 (786)
Q Consensus 367 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~ 437 (786)
|++|+|++.. +..+++|+.|++++|++.+..+. ..+.......+.++.. .|+.........|++.
T Consensus 331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~--~C~~~~~~~~~~cc~~ 395 (597)
T 3oja_B 331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQ--HCKIDYQLEHGLCCKE 395 (597)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCC--CCCTTCEEETTEEEEC
T ss_pred CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccc--cCCcchhccCCccccC
Confidence 9999998763 66788999999999999864321 2244455555666665 5654333334444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.86 Aligned_cols=287 Identities=24% Similarity=0.282 Sum_probs=168.0
Q ss_pred CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccc
Q 047901 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLD 129 (786)
Q Consensus 51 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 129 (786)
+++.+++++|.++ .+|..+ .++|+.|+|++|+++++++ .|.++++|++|+|++|+|+++.|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5677777777766 344433 2466666666666665544 36666666666666666666666666666666666666
Q ss_pred cccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc--c
Q 047901 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG--E 207 (786)
Q Consensus 130 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~--~ 207 (786)
+|+++ .++..+. ++|+.|++++|+|+.+.+..|..+++|++|++++|.++. +
T Consensus 111 ~n~l~------------------------~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 164 (332)
T 2ft3_A 111 KNHLV------------------------EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164 (332)
T ss_dssp SSCCC------------------------SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGS
T ss_pred CCcCC------------------------ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCC
Confidence 66655 2222222 455566666666665555556666666666666666642 4
Q ss_pred cCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccC
Q 047901 208 ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287 (786)
Q Consensus 208 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 287 (786)
.+..|..+ +|+.|++++|++++ +|.. +. ++|+.|++++|+++++.+..|..+
T Consensus 165 ~~~~~~~l-~L~~L~l~~n~l~~-l~~~------------------------~~--~~L~~L~l~~n~i~~~~~~~l~~l 216 (332)
T 2ft3_A 165 EPGAFDGL-KLNYLRISEAKLTG-IPKD------------------------LP--ETLNELHLDHNKIQAIELEDLLRY 216 (332)
T ss_dssp CTTSSCSC-CCSCCBCCSSBCSS-CCSS------------------------SC--SSCSCCBCCSSCCCCCCTTSSTTC
T ss_pred CcccccCC-ccCEEECcCCCCCc-cCcc------------------------cc--CCCCEEECCCCcCCccCHHHhcCC
Confidence 44444444 55555555555543 2222 21 345555555555555555555555
Q ss_pred CcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCccccc------ccc
Q 047901 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICN------LES 361 (786)
Q Consensus 288 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~ 361 (786)
++|+.|++++|+++.+.+..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|.. ..+
T Consensus 217 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 295 (332)
T 2ft3_A 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295 (332)
T ss_dssp TTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCC
T ss_pred CCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccccccccc
Confidence 55555666666555555555566666666666666665 44555666666777777777666555555544 255
Q ss_pred cceecccccccc--ccCCcccccCCCceEEeccCCc
Q 047901 362 LEKLNLSHNNIS--GQIPACFIGMSGLLSIDISYNE 395 (786)
Q Consensus 362 L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~ 395 (786)
|+.|++++|++. ++.|..|..+++|+.+++++|.
T Consensus 296 l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 777777777776 5666777777777777777764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=345.78 Aligned_cols=233 Identities=23% Similarity=0.319 Sum_probs=188.0
Q ss_pred ccCccceeeccccCceEEEEEcC--CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe---
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP--SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH--- 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--- 580 (786)
++|++.+.||+|+||+||+|... +++.||||++... ........+.+|++++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 57999999999999999999864 5889999998642 233456688999999999999999999999987655
Q ss_pred --eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 581 --SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 581 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
.|+||||+++++|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987643 689999999999999999999999 99999999999999975 999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
++..... ....||+.|+|| |...+. ++.++|||||||++|||++|..||.....
T Consensus 228 a~~~~~~----~~~~gt~~y~aP----------E~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~----------- 281 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAP----------EIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV----------- 281 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCT----------THHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC-----------
T ss_pred chhcccC----CccCCCccccCH----------HHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc-----------
Confidence 9877543 345799999999 455443 48899999999999999999998663211
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
..+. ...........+.+++.+||++||++||+..+.+
T Consensus 282 ------~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 282 ------DGLP-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp ------SSCC-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred ------cccc-ccccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence 0011 0111222345688999999999999999655443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.59 Aligned_cols=291 Identities=19% Similarity=0.159 Sum_probs=190.7
Q ss_pred CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEc
Q 047901 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISL 104 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L 104 (786)
.+++.++++++.++.+ |..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+++++.+ .+..+++|++|+|
T Consensus 31 c~l~~l~~~~~~l~~l-p~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcccc-CccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 3567777777766533 33332 466677777777766666666677777777777777666533 4666667777777
Q ss_pred cCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccccccc
Q 047901 105 HNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNI 184 (786)
Q Consensus 105 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~ 184 (786)
++|+++.++...+ ++|++|++++|++++..+..+..+++|+.|++++|.+.. .++.
T Consensus 108 s~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---------------------~~~~ 163 (330)
T 1xku_A 108 SKNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS---------------------SGIE 163 (330)
T ss_dssp CSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG---------------------GGBC
T ss_pred CCCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc---------------------cCcC
Confidence 7776664433332 466666666666665555555555555555554444431 1244
Q ss_pred CcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccc
Q 047901 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 185 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
+..|..+++|++|++++|+++.+....+ ++|++|++++|++++..|..|..+++|+.|+|++|.+++..+..|..++
T Consensus 164 ~~~~~~l~~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 240 (330)
T 1xku_A 164 NGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240 (330)
T ss_dssp TTGGGGCTTCCEEECCSSCCCSCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred hhhccCCCCcCEEECCCCccccCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCC
Confidence 5566666677777777776665433322 5677777777777766666777777777777777777766666777777
Q ss_pred ccccccccccccCCCCccccccCCcCceeccccccccccchhhhhc------ccCCcEEEecccccCC--CcchHHhhhc
Q 047901 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF------MFKLFYLNFSHNQFSQ--EIPEDLALLA 336 (786)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~ 336 (786)
+|+.|+|++|+++ ..|..+..+++|+.|++++|+++.++...|.. ...|+.|++++|.+.. +.|..|..+.
T Consensus 241 ~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~ 319 (330)
T 1xku_A 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319 (330)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred CCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccccc
Confidence 7777777777776 44556777777777777777777777766654 3678999999999964 6778999999
Q ss_pred CcCeeeccCCc
Q 047901 337 HLSELDLSHNL 347 (786)
Q Consensus 337 ~L~~L~L~~N~ 347 (786)
+++.++|++|+
T Consensus 320 ~l~~l~L~~N~ 330 (330)
T 1xku_A 320 VRAAVQLGNYK 330 (330)
T ss_dssp CGGGEEC----
T ss_pred ceeEEEecccC
Confidence 99999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=322.56 Aligned_cols=245 Identities=14% Similarity=0.128 Sum_probs=181.2
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-Cccccee----------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKFY---------- 572 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~---------- 572 (786)
...|...+.||+|+||+||+|++ .+++.||||++..... ......+.+.+|+.+++.++| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34578889999999999999984 5789999999874322 222345679999999999987 3222111
Q ss_pred -----------eEEec-----CCeeeEEEeccCCCCHHHHhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 047901 573 -----------GFCSH-----VRHSFVVYEYINRGSLATVLSN----NFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632 (786)
Q Consensus 573 -----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ 632 (786)
.++.. ....+++|+++ +++|.++++. ......+++..+..++.|++.||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 11111 22356777765 5799998852 11245678889999999999999999999 9
Q ss_pred eEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHh----------hhcCcCcc
Q 047901 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELA----------YTMKITEK 702 (786)
Q Consensus 633 ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~----------~~~~~~~~ 702 (786)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|| |+. ....++.+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aP----------E~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPP----------ETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCH----------HHHHHHTSTTGGGCCEEECHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCc----------hhhhccccccccccCcCCCch
Confidence 999999999999999999999999999876432 344577 999999 555 44568889
Q ss_pred cchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 047901 703 CDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTV 782 (786)
Q Consensus 703 sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 782 (786)
+|||||||++|||++|+.||....... ....+.......+ ..+.+++..||+.||++|||+.++
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~--------~~~~~~~~~~~~~--------~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALG--------GSEWIFRSCKNIP--------QPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGS--------CSGGGGSSCCCCC--------HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhh--------hHHHHHhhcccCC--------HHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999999999987543211 1111222111111 348899999999999999999888
Q ss_pred HH
Q 047901 783 CQ 784 (786)
Q Consensus 783 ~~ 784 (786)
++
T Consensus 362 l~ 363 (413)
T 3dzo_A 362 ME 363 (413)
T ss_dssp TT
T ss_pred Hh
Confidence 64
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.97 Aligned_cols=243 Identities=15% Similarity=0.143 Sum_probs=185.7
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCC----CchhhHHHHHHHHHHHhhcC---------CCcccce
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN----DQMSDQKEFLNEIKALTKIR---------HRNIVKF 571 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------hpniv~l 571 (786)
.++|++.+.||+|+||+||+|+. +++.||||++...... ......+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35799999999999999999988 6899999999764321 12234577889999998886 6666665
Q ss_pred eeE-----------------Eec-------------CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 047901 572 YGF-----------------CSH-------------VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621 (786)
Q Consensus 572 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~ 621 (786)
.++ +.. .+..|+||||+++|++.+.+.+ ..+++..+..++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 332 6789999999999987777643 458999999999999999
Q ss_pred HHHHh-hCCCCCeEEcCCCCCceeeCCCC--------------------cEEEeccccceecCCCCCcceeeccCccccC
Q 047901 622 LSYMH-HDCFPPIVHRDISSNNVLLDLEY--------------------EARVSDFGTAKLLKPNSSNWTELVGTFGYVA 680 (786)
Q Consensus 622 l~~LH-~~~~~~ivHrdlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~a 680 (786)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 9999999999877532 3589999999
Q ss_pred CCCCCCCchHHHHhhhcCcCcccchHHHHHH-HHHHHhCCCCCCccccccCCCcchhhhhhhhc---cCCCCCCChhHHH
Q 047901 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVL-ALEVIKGKHPGDFLSLFSSSSSSINIEFNAML---DHRLPHPSLDVQE 756 (786)
Q Consensus 681 PE~~~~~~~~~e~~~~~~~~~~sDvwslGvi-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 756 (786)
| |++.+.. +.++||||+|++ .+++++|..||..... .......+. ......+......
T Consensus 246 P----------E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (336)
T 2vuw_A 246 E----------DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-------LHYLTDKMLKQMTFKTKCNTPAMKQ 307 (336)
T ss_dssp S----------GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-------HHHHHHHHHHTCCCSSCCCSHHHHH
T ss_pred h----------hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-------hhHHHHhhhhhhccCcccchhhhhh
Confidence 9 5555444 789999998776 7888899999753110 000111111 1122223334556
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 757 KLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 757 ~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
.+..+.+++.+||.+| |++|++
T Consensus 308 ~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cCHHHHHHHHHHhccC-----CHHHHH
Confidence 6778999999999865 999998
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=297.37 Aligned_cols=247 Identities=30% Similarity=0.464 Sum_probs=184.0
Q ss_pred CCCcEEECCCCCccc--cCchhccCCCCCCEEeCcC-CcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcE
Q 047901 26 PHLAYLDLSINGFFG--TLPPQVRNLSKLKYLDLSE-NELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKY 101 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 101 (786)
.+++.|+|++|++.+ ..|..|.++++|++|+|++ |++.+..|..|..+++|++|+|++|++++..+ .+..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578888888888887 7888888888899999985 88888888888888889999998888885444 5888888999
Q ss_pred EEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccC-ccceeecccccccCCCC-CcCCCCCCcEEEccCcc
Q 047901 102 ISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG-LLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNN 179 (786)
Q Consensus 102 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~L~~L~l~~N~l~~~~~-~l~~l~~L~~L~L~~N~ 179 (786)
|+|++|++++..|..|.++++|++|+|++|++++..|..+..+. .|+.|++++|.+++..+ .+..++ |+.|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999988888888888889999999999988888888777776 67777777776664333 345454 6666666666
Q ss_pred cccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCC
Q 047901 180 LTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME 259 (786)
Q Consensus 180 l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 259 (786)
+++..+..|..+++|++|+|++|++++..+. +..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 6666666666777777777777776655444 556666666666666666666666666666666666666666665554
Q ss_pred cccccccccccccccc
Q 047901 260 LGRLISLNKLILRGNQ 275 (786)
Q Consensus 260 ~~~l~~L~~L~L~~N~ 275 (786)
..+++|+.|++++|.
T Consensus 288 -~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNK 302 (313)
T ss_dssp -TTGGGSCGGGTCSSS
T ss_pred -ccccccChHHhcCCC
Confidence 556666666666665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=343.60 Aligned_cols=155 Identities=17% Similarity=0.169 Sum_probs=72.9
Q ss_pred eEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccc----cCchhccCCCCCCEEeCcCCcccccCCccc-cCCC---
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFG----TLPPQVRNLSKLKYLDLSENELSGKIPPEI-GLLT--- 74 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~--- 74 (786)
++.|+|+++++...-....|..+++|++|+|++|+++. ..+..+..+++|++|+|++|+|+...+..+ ..++
T Consensus 5 l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 84 (461)
T 1z7x_W 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 84 (461)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred ceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCC
Confidence 45555555555432222224555555555555555542 224445555555555555555553322222 2233
Q ss_pred -CCCEEeCCCccCcc-----cCCCCCCCCCCcEEEccCCcCcccCchhhc-----ccCCcceeccccccccccC----Ch
Q 047901 75 -HLFSLDLSLNQFSG-----TFPPICNLSNLKYISLHNNKLSGSIPEEIG-----NLMKLSYLMLDTNQFTGQL----PR 139 (786)
Q Consensus 75 -~L~~L~Ls~N~l~~-----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----~~ 139 (786)
+|++|+|++|+++. ++..+..+++|++|+|++|++++..+..+. ..++|++|+|++|++++.. +.
T Consensus 85 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 164 (461)
T 1z7x_W 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHH
Confidence 45555555555542 122344555555555555555433232222 1334555555555555322 23
Q ss_pred hhhccCccceeecccccc
Q 047901 140 NICRSGLLEILTVNDNHF 157 (786)
Q Consensus 140 ~~~~~~~L~~L~l~~N~l 157 (786)
.+..+++|+.|++++|.+
T Consensus 165 ~l~~~~~L~~L~L~~n~i 182 (461)
T 1z7x_W 165 VLRAKPDFKELTVSNNDI 182 (461)
T ss_dssp HHHHCTTCCEEECCSSBC
T ss_pred HHhhCCCCCEEECcCCCc
Confidence 333344444444444444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.80 Aligned_cols=374 Identities=19% Similarity=0.140 Sum_probs=296.7
Q ss_pred CCCCcEEECCCCCccccCchh-ccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCcccCC-C-CCCCC
Q 047901 25 FPHLAYLDLSINGFFGTLPPQ-VRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSGTFP-P-ICNLS 97 (786)
Q Consensus 25 l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~-~-~~~l~ 97 (786)
.++|++|||++|+++...... |..+++|++|+|++|+++.. .+..+..+++|++|+|++|+++.... . +..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 367999999999997665444 88999999999999999853 46678889999999999999975322 1 22334
Q ss_pred ----CCcEEEccCCcCcc----cCchhhcccCCcceeccccccccccCChhhhc-----cCccceeecccccccCCC---
Q 047901 98 ----NLKYISLHNNKLSG----SIPEEIGNLMKLSYLMLDTNQFTGQLPRNICR-----SGLLEILTVNDNHFLGSI--- 161 (786)
Q Consensus 98 ----~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----~~~L~~L~l~~N~l~~~~--- 161 (786)
+|++|+|++|+|+. ..+..|..+++|++|+|++|+++...+..++. .++|+.|++++|.++...
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 79999999999985 45888999999999999999998665555544 457999999999998632
Q ss_pred --CCcCCCCCCcEEEccCcccccccCcccC-----CCCCCCEEeccCCccccc----cCcCccCCCCccEEEccCcccCC
Q 047901 162 --PNLRNCRSLVRAHLGRNNLTGNISEDFG-----IYPNLKFLDLSHNNFYGE----ISSNWGKCHRLGTLIVSGNNITG 230 (786)
Q Consensus 162 --~~l~~l~~L~~L~L~~N~l~~~~~~~f~-----~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~ 230 (786)
..+..+++|+.|++++|.++......+. ..++|++|+|++|+++.. .+..+..+++|++|+|++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 2356789999999999999876554443 367999999999999874 36667789999999999999875
Q ss_pred CC-----CccccCCccccEEEeeccccccc----CCCCcccccccccccccccccCCCCcccccc-----CCcCceeccc
Q 047901 231 RI-----PPEIGNSSQLHVLDLSSNHIAGE----IPMELGRLISLNKLILRGNQLSGHLPRALGL-----LTELEYFDLS 296 (786)
Q Consensus 231 ~~-----~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~ 296 (786)
.. +..+..+++|+.|+|++|.++.. ++..+..+++|+.|+|++|.++...+..+.. .++|+.|+++
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 32 23344689999999999999864 5667778999999999999997544444432 3799999999
Q ss_pred cccccccc----hhhhhcccCCcEEEecccccCCCcchHHhh-----hcCcCeeeccCCccCC----CCCcccccccccc
Q 047901 297 SNRLNNSI----LEALGFMFKLFYLNFSHNQFSQEIPEDLAL-----LAHLSELDLSHNLFKG----SIPSRICNLESLE 363 (786)
Q Consensus 297 ~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~ 363 (786)
+|.++... +..+..+++|++|+|++|.++...+..+.. .++|+.|+|++|.+++ .+|..+..+++|+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 99998764 455667899999999999998765655554 5699999999999985 6788888899999
Q ss_pred eeccccccccccCCcccc-----cCCCceEEeccCCcccc
Q 047901 364 KLNLSHNNISGQIPACFI-----GMSGLLSIDISYNELRG 398 (786)
Q Consensus 364 ~L~L~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~ 398 (786)
.|++++|++++.-...+. ...+|+.|++.++....
T Consensus 402 ~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred EEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 999999999864222221 23467777777776653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=295.37 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=184.6
Q ss_pred CCCcEEEccCccccc--ccCcccCCCCCCCEEeccC-CccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccE
Q 047901 168 RSLVRAHLGRNNLTG--NISEDFGIYPNLKFLDLSH-NNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHV 244 (786)
Q Consensus 168 ~~L~~L~L~~N~l~~--~~~~~f~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 244 (786)
.+++.|+|++|++++ ..+..|..+++|++|+|++ |.+.+..|..|..+++|++|+|++|++++..|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 456667777777766 5666777777777777774 7777677777777777777777777777667777777777777
Q ss_pred EEeecccccccCCCCcccccccccccccccccCCCCccccccCC-cCceeccccccccccchhhhhcccCCcEEEecccc
Q 047901 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLT-ELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ 323 (786)
Q Consensus 245 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 323 (786)
|+|++|.+++..|..|..+++|++|+|++|++++..|..+..++ +|+.|++++|++++..+..|..+. |++|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 77777777777777777777777777777777766677777776 777777777777766667777665 7777777777
Q ss_pred cCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCC
Q 047901 324 FSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403 (786)
Q Consensus 324 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 403 (786)
+++..|..|..+++|+.|+|++|++++.+|. +..+++|++|++++|+|++..|..|..+++|+.|++++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 7777777777777777777777777755444 667777777777777777777777777777777777777777777776
Q ss_pred CccccCCCccccCCCCCCCCC
Q 047901 404 TVFRNAPRESFLGNNFSTFYG 424 (786)
Q Consensus 404 ~~~~~~~~~~~~~n~~~~~~~ 424 (786)
..+.......+.+|++ .||
T Consensus 288 ~~l~~L~~l~l~~N~~--lc~ 306 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKC--LCG 306 (313)
T ss_dssp TTGGGSCGGGTCSSSE--EES
T ss_pred ccccccChHHhcCCCC--ccC
Confidence 6666666677777775 665
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.73 Aligned_cols=278 Identities=22% Similarity=0.229 Sum_probs=149.3
Q ss_pred CEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEEccCCcCcccC--chhhcccCCcceeccc
Q 047901 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSI--PEEIGNLMKLSYLMLD 129 (786)
Q Consensus 53 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~ 129 (786)
+.++++++.++. .|..+ .++|++|+|++|+++.+++. |..+++|++|+|++|+++.+. +..+.++++|++|+|+
T Consensus 10 ~~l~c~~~~l~~-ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCccc-CCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 456667776663 34333 24666666666666655554 556666666666666665332 4455556666666666
Q ss_pred cccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccC-cccCCCCCCCEEeccCCcccccc
Q 047901 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS-EDFGIYPNLKFLDLSHNNFYGEI 208 (786)
Q Consensus 130 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~i~~~~ 208 (786)
+|.++. +|..+ .++++|+.|++++|+++++.+ ..|..+++|++|++++|++.++.
T Consensus 87 ~n~i~~-l~~~~-----------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 142 (306)
T 2z66_A 87 FNGVIT-MSSNF-----------------------LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142 (306)
T ss_dssp SCSEEE-EEEEE-----------------------ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred CCcccc-Chhhc-----------------------CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence 666552 23333 334444444455555444433 34555555666666666555555
Q ss_pred CcCccCCCCccEEEccCcccCC-CCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccC
Q 047901 209 SSNWGKCHRLGTLIVSGNNITG-RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287 (786)
Q Consensus 209 ~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 287 (786)
+..|..+++|++|+|++|.+++ ..|..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|+++++.+..|..+
T Consensus 143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 222 (306)
T 2z66_A 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222 (306)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence 5555555555555555555554 345555555556666666665555555555555555555555555555555555555
Q ss_pred CcCceeccccccccccchhhhhccc-CCcEEEecccccCCCcc--hHHhhhcCcCeeeccCCccCCCCCcccc
Q 047901 288 TELEYFDLSSNRLNNSILEALGFMF-KLFYLNFSHNQFSQEIP--EDLALLAHLSELDLSHNLFKGSIPSRIC 357 (786)
Q Consensus 288 ~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 357 (786)
++|+.|++++|++.+..+..+..++ +|++|+|++|.+++..+ .....+...+.+.+..+.+....|..+.
T Consensus 223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 5555555555555555555555442 55555555555543321 1122333344444444444444444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.98 Aligned_cols=246 Identities=24% Similarity=0.203 Sum_probs=168.6
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccC--CccccCCCCCCEEeC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKI--PPEIGLLTHLFSLDL 81 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L 81 (786)
+.++.+++++. .+|... .++|++|+|++|+++.+.+..|.++++|++|+|++|+|+.+. +..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 35777777776 566532 267888888888887777777888888888888888887432 566777888888888
Q ss_pred CCccCcccCCCCCCCCCCcEEEccCCcCcccCc-hhhcccCCcceeccccccccccCChhhhccCccceeecccccccC-
Q 047901 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG- 159 (786)
Q Consensus 82 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~- 159 (786)
++|++++++..+..+++|++|+|++|+++++.+ ..|.++++|++|++++|++++..+..+..+++|+.|++++|.+.+
T Consensus 86 s~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp CSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 888888776667788888888888888887665 678888888888888888887777766666666666666666654
Q ss_pred -CCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccC
Q 047901 160 -SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGN 238 (786)
Q Consensus 160 -~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 238 (786)
.+..+..+++|+.|++++|+|+++.+..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 2334555555666666666555555555555555666666655555555555555555555555555555555555555
Q ss_pred Cc-cccEEEeeccccc
Q 047901 239 SS-QLHVLDLSSNHIA 253 (786)
Q Consensus 239 l~-~L~~L~Ls~N~i~ 253 (786)
++ +|+.|+|++|.+.
T Consensus 246 ~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFA 261 (306)
T ss_dssp CCTTCCEEECTTCCEE
T ss_pred hhccCCEEEccCCCee
Confidence 53 5555555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.80 Aligned_cols=189 Identities=20% Similarity=0.218 Sum_probs=84.4
Q ss_pred cCCCCCCCEEeccCCccccccC-cCccCCCCccEEEccCc-ccCCCCCccccCCccccEEEeecccccccCCCCcccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEIS-SNWGKCHRLGTLIVSGN-NITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~ 265 (786)
|..+++|++|+|++|+++.+.+ ..|..+++|++|++++| .+..+.+..|.++++|+.|++++|.+++..|..|..+++
T Consensus 120 ~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 199 (353)
T 2z80_A 120 FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199 (353)
T ss_dssp HTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred hCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcccc
Confidence 3334444444444444443333 23444444444444444 233333334444444444444444444444444444444
Q ss_pred cccccccccccCCCCccccccCCcCceeccccccccccchhhhh---cccCCcEEEecccccCC----CcchHHhhhcCc
Q 047901 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALG---FMFKLFYLNFSHNQFSQ----EIPEDLALLAHL 338 (786)
Q Consensus 266 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L 338 (786)
|+.|++++|++..+....+..+++|+.|++++|++++.....+. ....++.++|++|.+++ .+|..+..+++|
T Consensus 200 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L 279 (353)
T 2z80_A 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL 279 (353)
T ss_dssp EEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTC
T ss_pred CCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCC
Confidence 44444444444333222333344444444444444433322211 23344555555555443 234455556666
Q ss_pred CeeeccCCccCCCCCcccccccccceeccccccccccC
Q 047901 339 SELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQI 376 (786)
Q Consensus 339 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 376 (786)
+.|+|++|+++...+..|.++++|+.|++++|++.+..
T Consensus 280 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 280 LELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 66666666666333333455666666666666655443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=286.83 Aligned_cols=245 Identities=20% Similarity=0.161 Sum_probs=161.7
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHN 106 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~ 106 (786)
...++.+++.++.+ |..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++++ .|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~i-P~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSEV-PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCcc-CCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 45566666665433 32222 456666666666665556666666666666666666665543 355566666666666
Q ss_pred CcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccc-cccCCCC-CcCCCCCCcEEEccCccccccc
Q 047901 107 NKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN-HFLGSIP-NLRNCRSLVRAHLGRNNLTGNI 184 (786)
Q Consensus 107 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N-~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~ 184 (786)
|+|+.+++..|.++++|++|+|++|+++...+..|..+++|+.|++++| .+..+.+ .+.++++|+.|+|++|+|+++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP 212 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc
Confidence 6666555555666666666666666666555555666666666666653 3333333 2566777777777777777652
Q ss_pred CcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccc
Q 047901 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 185 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
.+..+++|++|+|++|+|+++.+..|.++++|+.|+|++|+++++.+..|.++++|+.|+|++|+|++..+..|..++
T Consensus 213 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 213 --NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp --CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred --cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 466777777778877777777777777777788888888877777777777778888888888888777777777788
Q ss_pred ccccccccccccC
Q 047901 265 SLNKLILRGNQLS 277 (786)
Q Consensus 265 ~L~~L~L~~N~l~ 277 (786)
+|+.|+|++|.+.
T Consensus 291 ~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 291 YLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEccCCCcC
Confidence 8888888888775
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=286.47 Aligned_cols=280 Identities=15% Similarity=0.136 Sum_probs=233.0
Q ss_pred CCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEc
Q 047901 96 LSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHL 175 (786)
Q Consensus 96 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L 175 (786)
++.....++++|.++.++.. +. ++|++|++++|++++..+. .+.++++|+.|++
T Consensus 30 C~~~~~c~~~~~~l~~iP~~-~~--~~L~~L~l~~n~i~~~~~~-----------------------~~~~l~~L~~L~L 83 (353)
T 2z80_A 30 CDRNGICKGSSGSLNSIPSG-LT--EAVKSLDLSNNRITYISNS-----------------------DLQRCVNLQALVL 83 (353)
T ss_dssp ECTTSEEECCSTTCSSCCTT-CC--TTCCEEECTTSCCCEECTT-----------------------TTTTCTTCCEEEC
T ss_pred CCCCeEeeCCCCCccccccc-cc--ccCcEEECCCCcCcccCHH-----------------------HhccCCCCCEEEC
Confidence 44555567777777754432 22 3566666666666643332 3566778888888
Q ss_pred cCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCC-ccccCCccccEEEeecc-ccc
Q 047901 176 GRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIP-PEIGNSSQLHVLDLSSN-HIA 253 (786)
Q Consensus 176 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~i~ 253 (786)
++|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+++++.+ ..|..+++|+.|++++| .+.
T Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~ 163 (353)
T 2z80_A 84 TSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163 (353)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC
T ss_pred CCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc
Confidence 8888888888899999999999999999998888789999999999999999996655 58999999999999999 588
Q ss_pred ccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHh
Q 047901 254 GEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLA 333 (786)
Q Consensus 254 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 333 (786)
...+..|.++++|+.|++++|++++..|..|..+++|+.|++++|++..++...+..+++|++|++++|.+++..+..+.
T Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 243 (353)
T 2z80_A 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243 (353)
T ss_dssp EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc
Confidence 77788999999999999999999999899999999999999999999988888888899999999999999987655443
Q ss_pred ---hhcCcCeeeccCCccCC----CCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCC
Q 047901 334 ---LLAHLSELDLSHNLFKG----SIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIP 401 (786)
Q Consensus 334 ---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 401 (786)
....++.++|++|.+++ .+|..+..+++|+.|++++|+|+.+.+..|.++++|+.|++++|++.+..|
T Consensus 244 ~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 35678888898888875 367788899999999999999997666667999999999999999988665
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=284.86 Aligned_cols=245 Identities=20% Similarity=0.142 Sum_probs=158.2
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHN 106 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~ 106 (786)
...++.++++++.+ |..+. ++++.|+|++|+|+.+.+..|..+++|++|+|++|+|+++.+ .|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~i-P~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLREV-PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSSC-CSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCcC-CCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 44555655555433 32222 355666666666665555566666666666666666655443 355566666666666
Q ss_pred CcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccc-cccCCCC-CcCCCCCCcEEEccCccccccc
Q 047901 107 NKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN-HFLGSIP-NLRNCRSLVRAHLGRNNLTGNI 184 (786)
Q Consensus 107 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N-~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~ 184 (786)
|+|+.+.+..|.++++|++|+|++|+++...+..|..+++|+.|++++| .+..+.+ .+.++++|+.|+|++|+|+.++
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 201 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP 201 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence 6666555555666666666666666666555555666666666666653 2333332 3566677777777777776553
Q ss_pred CcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccc
Q 047901 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 185 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
.+..+++|++|+|++|+|+++.+..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..|..++
T Consensus 202 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 202 --NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp --CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred --ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 466777777777777777777777777777777777777777777777777777788888888877777777777777
Q ss_pred ccccccccccccC
Q 047901 265 SLNKLILRGNQLS 277 (786)
Q Consensus 265 ~L~~L~L~~N~l~ 277 (786)
+|+.|+|++|.+.
T Consensus 280 ~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 280 HLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEcCCCCcc
Confidence 8888888888775
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=287.06 Aligned_cols=248 Identities=21% Similarity=0.175 Sum_probs=189.7
Q ss_pred cceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCc
Q 047901 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGN 226 (786)
Q Consensus 147 L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 226 (786)
...++++++.++.++..+. ++++.|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 3455666666665555444 56777788888887777777888888888888888888777777888888888888888
Q ss_pred ccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccc-cccCCCCccccccCCcCceeccccccccccch
Q 047901 227 NITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRG-NQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305 (786)
Q Consensus 227 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 305 (786)
+|+.+.+..|.++++|+.|+|++|+|+.+.+..|.++++|+.|+|++ |.+..+.+..|.++++|+.|+|++|+++.++
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~- 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP- 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC-
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc-
Confidence 88776666777788888888888888777777777888888888877 5555555667777888888888888877653
Q ss_pred hhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCC
Q 047901 306 EALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385 (786)
Q Consensus 306 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 385 (786)
.+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 4667778888888888888777778888888888888888888777777888888888888888888777777777888
Q ss_pred ceEEeccCCcccc
Q 047901 386 LLSIDISYNELRG 398 (786)
Q Consensus 386 L~~L~l~~N~l~~ 398 (786)
|+.|+|++|++.+
T Consensus 292 L~~L~L~~Np~~C 304 (452)
T 3zyi_A 292 LVELHLHHNPWNC 304 (452)
T ss_dssp CCEEECCSSCEEC
T ss_pred CCEEEccCCCcCC
Confidence 8888888887754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=286.40 Aligned_cols=248 Identities=23% Similarity=0.195 Sum_probs=192.3
Q ss_pred cceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCc
Q 047901 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGN 226 (786)
Q Consensus 147 L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 226 (786)
...++++++.++.++..+. ++++.|+|++|+|+.+.+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 4456666666666655554 56777888888888777777888888888888888888777777888888888888888
Q ss_pred ccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccc-cccCCCCccccccCCcCceeccccccccccch
Q 047901 227 NITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRG-NQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305 (786)
Q Consensus 227 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 305 (786)
+|+.+.+..|..+++|+.|+|++|.|+.+.+..|.++++|+.|+|++ |.+..+.+..|.++++|+.|+|++|.++.++
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~- 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP- 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-
Confidence 88876666778888888888888888777777788888888888877 4555555667788888888888888887664
Q ss_pred hhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCC
Q 047901 306 EALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSG 385 (786)
Q Consensus 306 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 385 (786)
.+..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+++.+..|..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 4677778888888888888777778888888888888888888777778888888888888888888777777888888
Q ss_pred ceEEeccCCcccc
Q 047901 386 LLSIDISYNELRG 398 (786)
Q Consensus 386 L~~L~l~~N~l~~ 398 (786)
|+.|+|++|++.+
T Consensus 281 L~~L~L~~Np~~C 293 (440)
T 3zyj_A 281 LERIHLHHNPWNC 293 (440)
T ss_dssp CCEEECCSSCEEC
T ss_pred CCEEEcCCCCccC
Confidence 8888888888754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-30 Score=266.24 Aligned_cols=170 Identities=23% Similarity=0.218 Sum_probs=78.8
Q ss_pred ccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccccc
Q 047901 187 DFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266 (786)
Q Consensus 187 ~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 266 (786)
.|..+++|++|+|++|+++++.+..|..+++|++|++++|+++++.+..|..+++|+.|+|++|++++..+..|..+++|
T Consensus 100 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 179 (285)
T 1ozn_A 100 TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179 (285)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred HhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCcccc
Confidence 34444444444444444444444444444444444444444444333344444444444444444444444444444444
Q ss_pred ccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCC
Q 047901 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346 (786)
Q Consensus 267 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 346 (786)
+.|+|++|++++..|..|..+++|+.|++++|+++.+++..|..+++|++|++++|.+....+.. ..+..++.+..+.|
T Consensus 180 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~ 258 (285)
T 1ozn_A 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSS 258 (285)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEEC
T ss_pred CEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccC
Confidence 44444444444444444444555555555555555444444444555555555555554322211 11223444445555
Q ss_pred ccCCCCCcccc
Q 047901 347 LFKGSIPSRIC 357 (786)
Q Consensus 347 ~l~~~~~~~~~ 357 (786)
.+....|..+.
T Consensus 259 ~~~c~~p~~l~ 269 (285)
T 1ozn_A 259 EVPCSLPQRLA 269 (285)
T ss_dssp CCBEEESGGGT
T ss_pred ccccCCchHhC
Confidence 55555555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=263.06 Aligned_cols=235 Identities=22% Similarity=0.175 Sum_probs=144.6
Q ss_pred CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCcc-CcccCC-CCCCCCCCcEEE
Q 047901 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ-FSGTFP-PICNLSNLKYIS 103 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~-~~~~l~~L~~L~ 103 (786)
++|++|+|++|+++++.+..|..+++|++|+|++|+|+++.|.+|..+++|++|+|++|+ ++.+.+ .+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 445555555555555444555555555555555555554445555555555555555554 444422 244455555555
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCC-cCCCCCCcEEEccCccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTG 182 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~-l~~l~~L~~L~L~~N~l~~ 182 (786)
|++|+++++.+..|.++++|++|++++|+++ ..++. +.++++|+.|++++|+|++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~ 167 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQ------------------------ALPDDTFRDLGNLTHLFLHGNRISS 167 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCccc------------------------ccCHhHhccCCCccEEECCCCcccc
Confidence 5555555444444445555555555544444 43333 5566777777777777777
Q ss_pred ccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccc
Q 047901 183 NISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR 262 (786)
Q Consensus 183 ~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 262 (786)
+.+..|..+++|++|+|++|+++++.|..|..+++|+.|+|++|+++++.+..+..+++|+.|+|++|.+....+. ..-
T Consensus 168 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~ 246 (285)
T 1ozn_A 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHH
T ss_pred cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHH
Confidence 7777788888888888888888888888888888888888888888876666788888888888888887633221 112
Q ss_pred ccccccccccccccCCCCccccc
Q 047901 263 LISLNKLILRGNQLSGHLPRALG 285 (786)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~ 285 (786)
...++.+..+.+.+....|..+.
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGGT
T ss_pred HHHHHhcccccCccccCCchHhC
Confidence 23456666666766655555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=285.05 Aligned_cols=94 Identities=26% Similarity=0.251 Sum_probs=47.9
Q ss_pred CCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccC
Q 047901 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHN 106 (786)
Q Consensus 27 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~ 106 (786)
+++.|++++|.++. +|..+. ++|++|+|++|+|+.+ |. .+++|++|+|++|+|++++. .+++|++|+|++
T Consensus 41 ~l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 41 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECS
T ss_pred CCcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcC
Confidence 35566666666542 233332 4556666666665532 22 34555555555555554443 345555555555
Q ss_pred CcCcccCchhhcccCCcceecccccccc
Q 047901 107 NKLSGSIPEEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 107 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 134 (786)
|+|++++. .+++|++|++++|+++
T Consensus 111 N~l~~l~~----~l~~L~~L~L~~N~l~ 134 (622)
T 3g06_A 111 NPLTHLPA----LPSGLCKLWIFGNQLT 134 (622)
T ss_dssp CCCCCCCC----CCTTCCEEECCSSCCS
T ss_pred CcCCCCCC----CCCCcCEEECCCCCCC
Confidence 55554332 3344555555555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-29 Score=282.74 Aligned_cols=248 Identities=22% Similarity=0.186 Sum_probs=116.8
Q ss_pred CCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecc
Q 047901 74 THLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVN 153 (786)
Q Consensus 74 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~ 153 (786)
++|++|+|++|+|+.++. .+++|++|+|++|+|+++++ .+++|++|+|++|++++. |. .+++|+.|+++
T Consensus 61 ~~L~~L~L~~N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~ 129 (622)
T 3g06_A 61 AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIF 129 (622)
T ss_dssp TTCSEEEECSCCCSCCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECC
T ss_pred CCCcEEEecCCCCCCCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECC
Confidence 344444444444443332 23444444444444443222 334444444444444422 11 23344444444
Q ss_pred cccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCC
Q 047901 154 DNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIP 233 (786)
Q Consensus 154 ~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 233 (786)
+|+++.++.. +++|+.|++++|+|++++. .+++|+.|++++|+|+++. ..+++|+.|+|++|+|+++ |
T Consensus 130 ~N~l~~lp~~---l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~----~~~~~L~~L~Ls~N~l~~l-~ 197 (622)
T 3g06_A 130 GNQLTSLPVL---PPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSLP----MLPSGLQELSVSDNQLASL-P 197 (622)
T ss_dssp SSCCSCCCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSCC-C
T ss_pred CCCCCcCCCC---CCCCCEEECcCCcCCCcCC----ccCCCCEEECCCCCCCCCc----ccCCCCcEEECCCCCCCCC-C
Confidence 4444433321 2344444444444443221 2234444455554444332 2234455555555555432 2
Q ss_pred ccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccC
Q 047901 234 PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK 313 (786)
Q Consensus 234 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 313 (786)
.. +++|+.|++++|.++. +|.. +++|+.|+|++|+|++++ ..+++|+.|+|++|+|+.++. .+++
T Consensus 198 ~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~~lp~----~~~~ 262 (622)
T 3g06_A 198 TL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLTSLPM----LPSG 262 (622)
T ss_dssp CC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSCCCC----CCTT
T ss_pred Cc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCCcCCc----cccc
Confidence 21 2445555555555542 2221 245555555555555432 334556666666666665443 3456
Q ss_pred CcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCccccccc
Q 047901 314 LFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLE 360 (786)
Q Consensus 314 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 360 (786)
|+.|+|++|+|+ .+|..|..+++|+.|+|++|++++..|..+..++
T Consensus 263 L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 666666666666 4455666677777777777777665555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-31 Score=278.47 Aligned_cols=256 Identities=20% Similarity=0.139 Sum_probs=167.6
Q ss_pred eEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCC
Q 047901 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLS 82 (786)
Q Consensus 3 ~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 82 (786)
++.++++.+++...+ ...|..+++|++|+|++|+++++.|..|.++++|++|+|++|++++..+ |..+++|++|+|+
T Consensus 12 l~i~~ls~~~l~~~~-~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLKQAL-ASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHHHHH-HHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchhhhH-HHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 455667777766333 3356777788888888888887777888888888888888888876544 7888888888888
Q ss_pred CccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCC
Q 047901 83 LNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP 162 (786)
Q Consensus 83 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~ 162 (786)
+|++++++. .++|++|++++|+++++.+.. +++|++|++++|++++..+..+..+++|+.|++++|.+++..+
T Consensus 89 ~n~l~~l~~----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 89 NNYVQELLV----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SSEEEEEEE----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred CCccccccC----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 888876543 378888888888888765543 5678888888888877666667667777777777766665433
Q ss_pred C-c-CCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCc
Q 047901 163 N-L-RNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSS 240 (786)
Q Consensus 163 ~-l-~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 240 (786)
. + ..+++|+.|+|++|+|+++.. ...+++|++|+|++|+|+++.+. |..+++|+.|+|++|+|++ +|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~~-l~~~~~~l~ 237 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQ 237 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred HHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCcccc-hhhHhhcCC
Confidence 2 2 345666666666666665522 22356666666666666554333 5555666666666666653 344555555
Q ss_pred cccEEEeeccccc-ccCCCCccccccccccccc
Q 047901 241 QLHVLDLSSNHIA-GEIPMELGRLISLNKLILR 272 (786)
Q Consensus 241 ~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~L~ 272 (786)
+|+.|+|++|.+. +..+..+..+++|+.|+++
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 6666666666555 4444455555555555555
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=266.52 Aligned_cols=234 Identities=18% Similarity=0.192 Sum_probs=135.2
Q ss_pred CCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEcc
Q 047901 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLH 105 (786)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~ 105 (786)
++++.|+|++|+++ .+|..+..+++|++|+|++|+|+ .+|..|+.+++|++|+|++|+++.++..+..+++|++|+|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIR 158 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECC
Confidence 45556666666654 33444555556666666666655 45555555556666666666555444445555555555555
Q ss_pred CCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccC
Q 047901 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS 185 (786)
Q Consensus 106 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 185 (786)
+|++.+..|..+... ..+..+..+++|+.|++++|.++.++..+.++++|+.|++++|++++++
T Consensus 159 ~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~- 222 (328)
T 4fcg_A 159 ACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALG- 222 (328)
T ss_dssp EETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCC-
T ss_pred CCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCc-
Confidence 555554444443320 0000011244455555555555444444555555666666666666433
Q ss_pred cccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccc
Q 047901 186 EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265 (786)
Q Consensus 186 ~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~ 265 (786)
..|..+++|++|+|++|++.+..|..|..+++|++|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+.++++
T Consensus 223 ~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence 34666666666666666666666666666666777777666666666666666777777777776666666777777777
Q ss_pred cccccccccccC
Q 047901 266 LNKLILRGNQLS 277 (786)
Q Consensus 266 L~~L~L~~N~l~ 277 (786)
|+.+++..|.+.
T Consensus 303 L~~l~l~~~~~~ 314 (328)
T 4fcg_A 303 NCIILVPPHLQA 314 (328)
T ss_dssp TCEEECCGGGSC
T ss_pred ceEEeCCHHHHH
Confidence 777766666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=276.26 Aligned_cols=264 Identities=20% Similarity=0.199 Sum_probs=132.4
Q ss_pred EEeCCCccCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccccc
Q 047901 78 SLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH 156 (786)
Q Consensus 78 ~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~ 156 (786)
.++++.+.+...+.. +..+++|++|+|++|+|+++.+..|.++++|++|+|++|++++..+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~------------------ 75 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD------------------ 75 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE------------------
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh------------------
Confidence 345555555433322 2344556666666666665555556666666666666665553221
Q ss_pred ccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccc
Q 047901 157 FLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEI 236 (786)
Q Consensus 157 l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 236 (786)
+..+++|+.|++++|+|+++.+ .++|++|++++|+|+++.+.. +++|++|++++|+++++.+..+
T Consensus 76 -------~~~l~~L~~L~Ls~n~l~~l~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~ 140 (317)
T 3o53_A 76 -------LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDE 140 (317)
T ss_dssp -------ETTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCT
T ss_pred -------hhhcCCCCEEECcCCccccccC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhh
Confidence 3333444444444444443321 245555555555555443322 2344444444444444333344
Q ss_pred cCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcE
Q 047901 237 GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFY 316 (786)
Q Consensus 237 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 316 (786)
..+++|+.|+|++|.+++..+..+. ..+++|+.|+|++|.++.++.. ..+++|++
T Consensus 141 ~~l~~L~~L~Ls~N~l~~~~~~~~~-----------------------~~l~~L~~L~L~~N~l~~~~~~--~~l~~L~~ 195 (317)
T 3o53_A 141 GCRSRVQYLDLKLNEIDTVNFAELA-----------------------ASSDTLEHLNLQYNFIYDVKGQ--VVFAKLKT 195 (317)
T ss_dssp GGGSSEEEEECTTSCCCEEEGGGGG-----------------------GGTTTCCEEECTTSCCCEEECC--CCCTTCCE
T ss_pred hccCCCCEEECCCCCCCcccHHHHh-----------------------hccCcCCEEECCCCcCcccccc--cccccCCE
Confidence 4444444444444444433333321 2344455555555554444221 12455555
Q ss_pred EEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccccc-ccCCcccccCCCceEEeccC-C
Q 047901 317 LNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS-GQIPACFIGMSGLLSIDISY-N 394 (786)
Q Consensus 317 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~-N 394 (786)
|+|++|++++.. ..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ +..|..+..+++|+.+++++ +
T Consensus 196 L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~ 273 (317)
T 3o53_A 196 LDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273 (317)
T ss_dssp EECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred EECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCch
Confidence 555555555333 23556666666666666666 34555666666666666666666 45556666666666666663 3
Q ss_pred cccccCC
Q 047901 395 ELRGPIP 401 (786)
Q Consensus 395 ~l~~~~p 401 (786)
.+++..|
T Consensus 274 ~l~~~~~ 280 (317)
T 3o53_A 274 KLTGQNE 280 (317)
T ss_dssp HHHSSSS
T ss_pred hccCCch
Confidence 3444433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=263.85 Aligned_cols=240 Identities=19% Similarity=0.226 Sum_probs=206.6
Q ss_pred CCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceec
Q 047901 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLM 127 (786)
Q Consensus 48 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 127 (786)
...+++.|+|++|+|+ .+|..+..+++|++|+|++|+++.++..+..+++|++|+|++|+++ ..|..|.++++|++|+
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 3478899999999998 5677788899999999999998877777888899999999999988 5577788889999999
Q ss_pred cccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccc
Q 047901 128 LDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGE 207 (786)
Q Consensus 128 L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~ 207 (786)
|++|++.+.+|..+... . ....+.++++|+.|++++|+|+. .|..|..+++|++|+|++|+++++
T Consensus 157 L~~n~~~~~~p~~~~~~-----------~---~~~~~~~l~~L~~L~L~~n~l~~-lp~~l~~l~~L~~L~L~~N~l~~l 221 (328)
T 4fcg_A 157 IRACPELTELPEPLAST-----------D---ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSAL 221 (328)
T ss_dssp EEEETTCCCCCSCSEEE-----------C----CCCEEESTTCCEEEEEEECCCC-CCGGGGGCTTCCEEEEESSCCCCC
T ss_pred CCCCCCccccChhHhhc-----------c---chhhhccCCCCCEEECcCCCcCc-chHhhcCCCCCCEEEccCCCCCcC
Confidence 99888777777755431 1 12236678999999999999994 567799999999999999999975
Q ss_pred cCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccC
Q 047901 208 ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287 (786)
Q Consensus 208 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 287 (786)
|..|..+++|++|+|++|++.+.+|..|.++++|+.|+|++|.+.+.+|..+.++++|+.|+|++|.+.+.+|..+..+
T Consensus 222 -~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L 300 (328)
T 4fcg_A 222 -GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300 (328)
T ss_dssp -CGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred -chhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence 4569999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCceeccccccccccch
Q 047901 288 TELEYFDLSSNRLNNSIL 305 (786)
Q Consensus 288 ~~L~~L~L~~N~l~~~~~ 305 (786)
++|+.+++..|.+..+..
T Consensus 301 ~~L~~l~l~~~~~~~l~~ 318 (328)
T 4fcg_A 301 PANCIILVPPHLQAQLDQ 318 (328)
T ss_dssp CTTCEEECCGGGSCC---
T ss_pred cCceEEeCCHHHHHHHhh
Confidence 999999999888765443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=271.74 Aligned_cols=252 Identities=18% Similarity=0.171 Sum_probs=185.2
Q ss_pred hhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccC-----
Q 047901 115 EEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG----- 189 (786)
Q Consensus 115 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~----- 189 (786)
+.+.+.++|++|++++|.+ .+|..+... |+.|++++|.+... ..+..+.
T Consensus 37 ~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~----------------------~~~~~~~~~~~~ 90 (312)
T 1wwl_A 37 ELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAA----------------------RIPSRILFGALR 90 (312)
T ss_dssp EEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEE----------------------ECBHHHHHHHHH
T ss_pred EEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCC----------------------CcCHHHHHHHHH
Confidence 3456777888888888888 566666554 77777777766421 1112221
Q ss_pred --CCCCCCEEeccCCccccccCcCc--cCCCCccEEEccCcccCCCCCccccCC-----ccccEEEeecccccccCCCCc
Q 047901 190 --IYPNLKFLDLSHNNFYGEISSNW--GKCHRLGTLIVSGNNITGRIPPEIGNS-----SQLHVLDLSSNHIAGEIPMEL 260 (786)
Q Consensus 190 --~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~i~~~~~~~~ 260 (786)
.+++|++|+|++|++++..|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|+|.+..+..|
T Consensus 91 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~ 169 (312)
T 1wwl_A 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169 (312)
T ss_dssp HHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTC
T ss_pred hcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHh
Confidence 46667777777777766666554 6677777777777777755 6666665 777777777777777666777
Q ss_pred ccccccccccccccccCCC--Ccccc--ccCCcCceeccccccccc---cchhhhhcccCCcEEEecccccCCCcc-hHH
Q 047901 261 GRLISLNKLILRGNQLSGH--LPRAL--GLLTELEYFDLSSNRLNN---SILEALGFMFKLFYLNFSHNQFSQEIP-EDL 332 (786)
Q Consensus 261 ~~l~~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~ 332 (786)
.++++|+.|+|++|++.+. .+..+ ..+++|+.|+|++|+++. +....+..+++|++|+|++|++++..| ..+
T Consensus 170 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 249 (312)
T 1wwl_A 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249 (312)
T ss_dssp CCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCC
T ss_pred ccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhh
Confidence 7777777777777776543 22233 778888888888888884 334556678899999999999987664 456
Q ss_pred hhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccc
Q 047901 333 ALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRG 398 (786)
Q Consensus 333 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 398 (786)
..+++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 250 ~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 67899999999999998 6677666 8999999999999977 65 8899999999999999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-30 Score=270.49 Aligned_cols=247 Identities=22% Similarity=0.227 Sum_probs=131.3
Q ss_pred CCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccc-cCCcccc-------CCCCCCEEeCCCccCcccCC-CC
Q 047901 23 SSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG-KIPPEIG-------LLTHLFSLDLSLNQFSGTFP-PI 93 (786)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~-~~ 93 (786)
.+.++|++|++++|.+ ..|..+... |+.|+|++|+++. ..|..+. .+++|++|+|++|++++..+ .+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3444555555555555 333333322 5555555555532 2333333 45555555555555554322 22
Q ss_pred --CCCCCCcEEEccCCcCcccCchhhccc-----CCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCC
Q 047901 94 --CNLSNLKYISLHNNKLSGSIPEEIGNL-----MKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRN 166 (786)
Q Consensus 94 --~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~ 166 (786)
..+++|++|+|++|+++++ |..|.++ ++|++|+|++|++++..|..|. +
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~-----------------------~ 171 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR-----------------------V 171 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC-----------------------C
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc-----------------------c
Confidence 4555555555555555544 4555554 5555555555555544444444 4
Q ss_pred CCCCcEEEccCcccccc--cCcc--cCCCCCCCEEeccCCcccc---ccCcCccCCCCccEEEccCcccCCCCC-ccccC
Q 047901 167 CRSLVRAHLGRNNLTGN--ISED--FGIYPNLKFLDLSHNNFYG---EISSNWGKCHRLGTLIVSGNNITGRIP-PEIGN 238 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~--~~~~--f~~l~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~ 238 (786)
+++|+.|+|++|++.+. .+.. |..+++|++|+|++|+|++ +....+..+++|++|+|++|++++..| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 45555555555554332 1112 2555666666666666652 222334455666666666666665443 34445
Q ss_pred CccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccc
Q 047901 239 SSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN 302 (786)
Q Consensus 239 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 302 (786)
+++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 566666666666666 4444444 5666666666666655 33 6666667777777766654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-30 Score=289.61 Aligned_cols=188 Identities=21% Similarity=0.209 Sum_probs=132.8
Q ss_pred eccccCceEEEEE-cCCCCEEEEEEcCCCCCCC------chhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCeeeEEE
Q 047901 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPND------QMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 514 ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 585 (786)
.+.|++|.+..++ ..-|+.+|||++....... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666554 2358899999997643211 122345799999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||++|++|.++|.+. ++++.. +|+.||+.||+|+|++ |||||||||+|||++.++.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999864 455554 4889999999999999 9999999999999999999999999999987665
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P 721 (786)
.......+||+.|||| |...+ .+..++|+||+|++++++.++..|
T Consensus 393 ~~~~~t~vGTp~YmAP----------E~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVN----------ELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHH----------HHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccH----------HHhCC-CCCCcccccccccchhhhccccch
Confidence 5555667899999999 55543 456789999999998888766544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-30 Score=300.74 Aligned_cols=372 Identities=14% Similarity=0.034 Sum_probs=277.0
Q ss_pred CCCCCcEEECCCCCccccCchhccCC--CCCCEEeCcCCc-ccc-cCCccccCCCCCCEEeCCCccCcccCC-----CCC
Q 047901 24 SFPHLAYLDLSINGFFGTLPPQVRNL--SKLKYLDLSENE-LSG-KIPPEIGLLTHLFSLDLSLNQFSGTFP-----PIC 94 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~N~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~-----~~~ 94 (786)
.+++|++|+|++|.+++..+..+... .+|++|+|++|. ++. ..+.....+++|++|+|++|.+++... .+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 68899999999998877666666653 459999999987 221 122233478999999999998865421 134
Q ss_pred CCCCCcEEEccCCcCcccC----chhhcccCCcceeccccccccccCChhhhccCccceeeccccccc----CCCCCcCC
Q 047901 95 NLSNLKYISLHNNKLSGSI----PEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFL----GSIPNLRN 166 (786)
Q Consensus 95 ~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~----~~~~~l~~ 166 (786)
.+++|++|+|++|.++++. +..+.++++|++|+|++|.+.+ +|..+..+++|+.|+++.+... .....+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 6889999999999997433 4456788999999999999885 6788999999999999864332 12335778
Q ss_pred CCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccC-cCccCCCCccEEEccCcccCC-CCCccccCCccccE
Q 047901 167 CRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS-SNWGKCHRLGTLIVSGNNITG-RIPPEIGNSSQLHV 244 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~ 244 (786)
+++|+.|.+.++... ..+..+..+++|++|+|++|.++.... ..+..+++|++|+++ |.+.+ ..+..+..+++|+.
T Consensus 269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKR 346 (592)
T ss_dssp CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCE
T ss_pred cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCE
Confidence 889999999886544 345677888999999999999765433 336789999999999 44442 23334466789999
Q ss_pred EEee-----------cccccccCCC-CcccccccccccccccccCCCCcccccc-CCcCceeccc----cccccccc---
Q 047901 245 LDLS-----------SNHIAGEIPM-ELGRLISLNKLILRGNQLSGHLPRALGL-LTELEYFDLS----SNRLNNSI--- 304 (786)
Q Consensus 245 L~Ls-----------~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~~--- 304 (786)
|+|+ .|.++..... .+..+++|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++.+
T Consensus 347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~ 426 (592)
T 3ogk_B 347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426 (592)
T ss_dssp EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence 9999 3666643222 2455789999999999998665555654 8899999996 67787642
Q ss_pred --hhhhhcccCCcEEEeccc--ccCCCcchHHhh-hcCcCeeeccCCccCC-CCCcccccccccceecccccccccc-CC
Q 047901 305 --LEALGFMFKLFYLNFSHN--QFSQEIPEDLAL-LAHLSELDLSHNLFKG-SIPSRICNLESLEKLNLSHNNISGQ-IP 377 (786)
Q Consensus 305 --~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~~-l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~-~p 377 (786)
...+..+++|++|++++| .++......+.. +++|+.|+|++|.+++ .++..+.++++|+.|++++|++++. ++
T Consensus 427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 506 (592)
T 3ogk_B 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIA 506 (592)
T ss_dssp HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHH
T ss_pred HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHH
Confidence 334677899999999854 366555555544 7899999999999875 3345567889999999999998754 34
Q ss_pred cccccCCCceEEeccCCcccc
Q 047901 378 ACFIGMSGLLSIDISYNELRG 398 (786)
Q Consensus 378 ~~~~~l~~L~~L~l~~N~l~~ 398 (786)
..+..+++|+.|++++|+++.
T Consensus 507 ~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 507 AAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHHHCSSCCEEEEESCBCCT
T ss_pred HHHHhcCccCeeECcCCcCCH
Confidence 445678999999999999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=275.88 Aligned_cols=237 Identities=21% Similarity=0.173 Sum_probs=146.7
Q ss_pred CCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEE
Q 047901 24 SFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYIS 103 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 103 (786)
.+++|++|+|++|.++++.|..|.++++|++|+|++|+|++..| |..+++|++|+|++|+|+++++. ++|++|+
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~ 105 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLH 105 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEE
Confidence 44578888888888888878888888888888888888876554 88888888888888888766542 7888888
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN 183 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~ 183 (786)
|++|+|+++++. .+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++ +
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----------------------~ 159 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-----------------------V 159 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE-----------------------E
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC-----------------------c
Confidence 888888876654 34678888888888877666666666666666666665554 3
Q ss_pred cCcccC-CCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccc
Q 047901 184 ISEDFG-IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR 262 (786)
Q Consensus 184 ~~~~f~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 262 (786)
.+..|. .+++|++|+|++|.|+++.+ +..+++|+.|+|++|+|+++ |+.|..+++|+.|+|++|.|++ +|..+..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhcc
Confidence 333332 34444444444444444422 12244455555555555432 2224445555555555555543 3344455
Q ss_pred ccccccccccccccC-CCCccccccCCcCceeccc
Q 047901 263 LISLNKLILRGNQLS-GHLPRALGLLTELEYFDLS 296 (786)
Q Consensus 263 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 296 (786)
+++|+.|++++|.+. +..|..+..++.|+.++++
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 555555555555554 3344445555555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-30 Score=297.82 Aligned_cols=390 Identities=15% Similarity=0.066 Sum_probs=289.3
Q ss_pred CeEEEEcCCCCCcccCCcCccCC-CCC-CcEEECCCCC-ccc-cCchhccCCCCCCEEeCcCCcccccC----CccccCC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSS-FPH-LAYLDLSING-FFG-TLPPQVRNLSKLKYLDLSENELSGKI----PPEIGLL 73 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~-l~~-L~~L~L~~n~-i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l 73 (786)
+++.|+|++|.+.+.... .+.. ++. |++|+|++|. +.. ..+..+.++++|++|+|++|.+++.. +..+..+
T Consensus 113 ~L~~L~L~~~~i~~~~~~-~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~ 191 (592)
T 3ogk_B 113 QLKSVHFRRMIVSDLDLD-RLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191 (592)
T ss_dssp TCCEEEEESCBCCHHHHH-HHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHC
T ss_pred CCCeEEeeccEecHHHHH-HHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcC
Confidence 477888888866543322 2333 445 9999999987 221 12334458899999999999987653 3345788
Q ss_pred CCCCEEeCCCccCcccC-----CCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccccccc---ccCChhhhccC
Q 047901 74 THLFSLDLSLNQFSGTF-----PPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT---GQLPRNICRSG 145 (786)
Q Consensus 74 ~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~~~ 145 (786)
++|++|+|++|++++.. ..+.++++|++|+|++|.+.+ .+..+.++++|++|+++++... ...+..+..++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 99999999999997332 224578999999999999986 5688999999999999864433 23445677788
Q ss_pred ccceeecccccccCCCCCcCCCCCCcEEEccCcccccccC-cccCCCCCCCEEeccCCcccc-ccCcCccCCCCccEEEc
Q 047901 146 LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS-EDFGIYPNLKFLDLSHNNFYG-EISSNWGKCHRLGTLIV 223 (786)
Q Consensus 146 ~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L 223 (786)
+|+.|+++++.....+..+..+++|+.|++++|.++.... ..+..+++|++|+|+ |.+.. ..+..+..+++|++|+|
T Consensus 271 ~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L 349 (592)
T 3ogk_B 271 KLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRI 349 (592)
T ss_dssp TCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEE
T ss_pred cccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEe
Confidence 9999999987555555557789999999999999875443 346889999999999 54443 33334467899999999
Q ss_pred c-----------CcccCCCC-CccccCCccccEEEeecccccccCCCCccc-cccccccccc----ccccCCC-----Cc
Q 047901 224 S-----------GNNITGRI-PPEIGNSSQLHVLDLSSNHIAGEIPMELGR-LISLNKLILR----GNQLSGH-----LP 281 (786)
Q Consensus 224 ~-----------~N~l~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~ 281 (786)
+ .|.+++.. +..+..+++|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++. .+
T Consensus 350 ~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~ 429 (592)
T 3ogk_B 350 ERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVR 429 (592)
T ss_dssp ECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHH
T ss_pred ecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHH
Confidence 9 36666332 222456899999999999998776666665 8899999996 7788764 33
Q ss_pred cccccCCcCceeccccc--cccccchhhhh-cccCCcEEEecccccCCC-cchHHhhhcCcCeeeccCCccCCC-CCccc
Q 047901 282 RALGLLTELEYFDLSSN--RLNNSILEALG-FMFKLFYLNFSHNQFSQE-IPEDLALLAHLSELDLSHNLFKGS-IPSRI 356 (786)
Q Consensus 282 ~~~~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~ 356 (786)
..+.++++|+.|+++.+ .++......+. .+++|++|++++|++++. .+..+..+++|+.|+|++|.+++. ++..+
T Consensus 430 ~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 509 (592)
T 3ogk_B 430 SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAV 509 (592)
T ss_dssp HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHH
T ss_pred HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHH
Confidence 34678999999999753 36655444444 488999999999999753 344567889999999999998744 34445
Q ss_pred ccccccceeccccccccccCCccc-ccCCCceEEeccCC
Q 047901 357 CNLESLEKLNLSHNNISGQIPACF-IGMSGLLSIDISYN 394 (786)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N 394 (786)
..+++|+.|++++|+++..-...+ ..++.+....+..+
T Consensus 510 ~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 510 TKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 678999999999999986533333 35677766655554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=274.62 Aligned_cols=235 Identities=24% Similarity=0.203 Sum_probs=137.4
Q ss_pred CCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccc
Q 047901 50 SKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLD 129 (786)
Q Consensus 50 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 129 (786)
++|++|+|++|+|+++.|..|..+++|++|+|++|.+++.++ +..+++|++|+|++|+|+++++ .++|++|+++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 377888888888877777777777777777777777776554 6667777777777777765432 2556666666
Q ss_pred cccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccC
Q 047901 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS 209 (786)
Q Consensus 130 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~ 209 (786)
+|.+++..+. .+++|+.|+|++|.|+++.+..|+.+++|++|+|++|.|+++.|
T Consensus 108 ~N~l~~~~~~--------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (487)
T 3oja_A 108 NNNISRVSCS--------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (487)
T ss_dssp SSCCCCEEEC--------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEG
T ss_pred CCcCCCCCcc--------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcCh
Confidence 6655532111 12455566666666665555566666666666666666666555
Q ss_pred cCcc-CCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCC
Q 047901 210 SNWG-KCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLT 288 (786)
Q Consensus 210 ~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 288 (786)
..|. .+++|+.|+|++|.|+++. .+..+++|+.|+|++|.|++.+| .|..+++|+.|+|++|.|++ +|..+
T Consensus 162 ~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l---- 233 (487)
T 3oja_A 162 AELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKAL---- 233 (487)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTC----
T ss_pred HHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhh----
Confidence 5554 4566666666666665441 12235555555555555553322 24455555555555555543 23334
Q ss_pred cCceeccccccccccchhhhhcccCCcEEEecccccC-CCcchHHhhhcCcCeeecc
Q 047901 289 ELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS-QEIPEDLALLAHLSELDLS 344 (786)
Q Consensus 289 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 344 (786)
..+++|+.|++++|.+. +..|..+..++.|+.|+++
T Consensus 234 --------------------~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 --------------------RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp --------------------CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred --------------------ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 44445555555555554 3445556666667777765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-27 Score=242.62 Aligned_cols=209 Identities=24% Similarity=0.198 Sum_probs=136.4
Q ss_pred CCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccccccccccc
Q 047901 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILR 272 (786)
Q Consensus 193 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 272 (786)
+|++|+|++|+++++.+..|..+++|++|+|++|+++++.+..|.++++|+.|+|++|.+++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555555555555555555555555555554444455555555555555555555555555555566666666
Q ss_pred ccccCCCCccccccCCcCceeccccccccccc-hhhhhcccCCcEEEecccccCCCcchHHhhhcCcC----eeeccCCc
Q 047901 273 GNQLSGHLPRALGLLTELEYFDLSSNRLNNSI-LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS----ELDLSHNL 347 (786)
Q Consensus 273 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~ 347 (786)
+|.+.++.+..+..+++|+.|++++|.++.+. +..|..+++|++|+|++|++++..+..|..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 66665555555666666666666666666543 55666666777777777777666666676666666 78888888
Q ss_pred cCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCC
Q 047901 348 FKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN 402 (786)
Q Consensus 348 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 402 (786)
+++..+..+.. .+|+.|++++|++++..+..|..+++|+.|++++|++.+..|.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 88655555544 4788999999998888777788889999999999998876554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=241.99 Aligned_cols=225 Identities=27% Similarity=0.280 Sum_probs=191.3
Q ss_pred eecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccC
Q 047901 150 LTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT 229 (786)
Q Consensus 150 L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 229 (786)
.+..+..+..++..+. ++|+.|++++|+|+++.+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|+++
T Consensus 12 ~~c~~~~l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 12 YQCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp EECTTSCCSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EEecCCCccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 3445555555555554 57888999999999888888999999999999999999888888999999999999999998
Q ss_pred CCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCC-CccccccCCcCceeccccccccccchhhh
Q 047901 230 GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH-LPRALGLLTELEYFDLSSNRLNNSILEAL 308 (786)
Q Consensus 230 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 308 (786)
++.+..|.++++|+.|++++|.+.+..+..+..+++|++|++++|++++. .|..|..+++|+.|++++|+++.+.+..|
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 88888899999999999999999877777889999999999999999875 48889999999999999999999888888
Q ss_pred hcccCCc----EEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCC
Q 047901 309 GFMFKLF----YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIP 377 (786)
Q Consensus 309 ~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 377 (786)
..+.+|+ .|++++|.+++..+..+.. .+|+.|+|++|++++..+..|.++++|+.|++++|++++..|
T Consensus 170 ~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp HHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred hhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8888777 8999999998766665554 489999999999997777778999999999999999986544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-29 Score=291.19 Aligned_cols=369 Identities=15% Similarity=0.105 Sum_probs=211.0
Q ss_pred CCCCCCcEEECCCCCccccCchhcc-CCCCCCEEeCcCC-ccccc-CCccccCCCCCCEEeCCCccCcccCC-----CCC
Q 047901 23 SSFPHLAYLDLSINGFFGTLPPQVR-NLSKLKYLDLSEN-ELSGK-IPPEIGLLTHLFSLDLSLNQFSGTFP-----PIC 94 (786)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~-----~~~ 94 (786)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. .+..+..+++|++|+|++|.+++... ...
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3567778888887777665555554 5777888888777 45432 33334467788888888877654221 123
Q ss_pred CCCCCcEEEccCCcCcccCchhh----cccCCcceeccccc-cccccCChhhhccCccceeecccc-------cccCCCC
Q 047901 95 NLSNLKYISLHNNKLSGSIPEEI----GNLMKLSYLMLDTN-QFTGQLPRNICRSGLLEILTVNDN-------HFLGSIP 162 (786)
Q Consensus 95 ~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~L~~L~l~~N-------~l~~~~~ 162 (786)
.+++|++|+|++|. ..+....+ .++++|++|+|++| .++ .++..+..+++|+.|++..+ .+.+.++
T Consensus 182 ~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~ 259 (594)
T 2p1m_B 182 TYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259 (594)
T ss_dssp TCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred cCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence 56778888887776 22222223 34577888888777 444 36666777777777774433 3333333
Q ss_pred CcCCCCCCcEE-EccCcccccccCcccCCCCCCCEEeccCCccccccC-cCccCCCCccEEEccCcccCCC-CCccccCC
Q 047901 163 NLRNCRSLVRA-HLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS-SNWGKCHRLGTLIVSGNNITGR-IPPEIGNS 239 (786)
Q Consensus 163 ~l~~l~~L~~L-~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l 239 (786)
.+.++++|+.| .+.+.... ..+..+..+++|++|+|++|.++.... ..+..+++|++|++++| +.+. .+.....+
T Consensus 260 ~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~ 337 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTC 337 (594)
T ss_dssp HHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHC
T ss_pred HHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhC
Confidence 45566666666 23222211 122233356777777777777553222 12446677777777766 3311 11122246
Q ss_pred ccccEEEeec---------ccccccCCCCcc-cccccccccccccccCCCCccccc-cCCcCceeccc--c----ccccc
Q 047901 240 SQLHVLDLSS---------NHIAGEIPMELG-RLISLNKLILRGNQLSGHLPRALG-LLTELEYFDLS--S----NRLNN 302 (786)
Q Consensus 240 ~~L~~L~Ls~---------N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~ 302 (786)
++|+.|+|++ |.+++.....+. .+++|+.|.+..|.++......+. .+++|+.|+++ + |.++.
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 6777777733 344322222222 356677777777776644333333 46777777777 3 44543
Q ss_pred cch-----hhhhcccCCcEEEecccccCCCcchHHhh-hcCcCeeeccCCccCCCCCccc-ccccccceecccccccccc
Q 047901 303 SIL-----EALGFMFKLFYLNFSHNQFSQEIPEDLAL-LAHLSELDLSHNLFKGSIPSRI-CNLESLEKLNLSHNNISGQ 375 (786)
Q Consensus 303 ~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~ 375 (786)
.+. ..+..+++|+.|+|++ .++......+.. +++|+.|+|++|.+++..+..+ .++++|+.|+|++|++++.
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 221 1245566777777765 555444444444 6677777777777654433333 4567777777777777543
Q ss_pred CCc-ccccCCCceEEeccCCcc
Q 047901 376 IPA-CFIGMSGLLSIDISYNEL 396 (786)
Q Consensus 376 ~p~-~~~~l~~L~~L~l~~N~l 396 (786)
... ....+++|+.|++++|++
T Consensus 497 ~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 497 ALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHhCCCCCEEeeeCCCC
Confidence 332 334467777777777766
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=231.85 Aligned_cols=201 Identities=23% Similarity=0.238 Sum_probs=115.0
Q ss_pred CCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEee
Q 047901 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 248 (786)
..+.+++++|+++.++.. + .++|++|+|++|+|+++.+..|..+++|++|+|++|+++.+.+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~ip~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSN-I--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSSCCSC-C--CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCccCCC-C--CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 456677777777764432 2 2567777777777776666667777777777777777765555556666666666666
Q ss_pred cccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCc
Q 047901 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI 328 (786)
Q Consensus 249 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 328 (786)
+|++++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|+++.+++..|..+++|++|+|++|+++...
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 66666555555666666666666666666555555555555555555555555555444555555555555555544444
Q ss_pred chHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccc
Q 047901 329 PEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372 (786)
Q Consensus 329 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (786)
+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 44444444444444444444433333344444444444444444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=231.17 Aligned_cols=204 Identities=21% Similarity=0.200 Sum_probs=171.1
Q ss_pred ccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccC
Q 047901 146 LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSG 225 (786)
Q Consensus 146 ~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 225 (786)
..+.+++++|.++.++..+. ++++.|++++|+|+++.+..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 34556666666665554444 5788888888888888888888888899999988888888888888888899999998
Q ss_pred cccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccch
Q 047901 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305 (786)
Q Consensus 226 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 305 (786)
|+++++.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|+++.+++
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 88887777788888899999999998888888888888899999999999988887788888999999999999988888
Q ss_pred hhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCC
Q 047901 306 EALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGS 351 (786)
Q Consensus 306 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 351 (786)
..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++...
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 8888889999999999999877777788899999999999988754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=231.83 Aligned_cols=203 Identities=19% Similarity=0.167 Sum_probs=117.0
Q ss_pred ccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccce
Q 047901 70 IGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEI 149 (786)
Q Consensus 70 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~ 149 (786)
++.+++|+++++++|+++.++..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+. ..+++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~--- 78 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPV--- 78 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTT---
T ss_pred ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCc---
Confidence 4556666666666666666655543 5677777777777766667777777777777777776643221 23333
Q ss_pred eecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccC
Q 047901 150 LTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT 229 (786)
Q Consensus 150 L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 229 (786)
|+.|++++|+|+.+ +..+..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|+
T Consensus 79 --------------------L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 79 --------------------LGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp --------------------CCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred --------------------CCEEECCCCcCCcC-chhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence 44444444444422 234445555555555555555555555555555555555555555
Q ss_pred CCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccc
Q 047901 230 GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301 (786)
Q Consensus 230 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 301 (786)
++.+..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|+.+ |..+..+.+|+.|+|++|++.
T Consensus 138 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCCCSEEECCSCCBC
T ss_pred ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCcc-ChhhcccccCCeEEeCCCCcc
Confidence 55445555555566666666666555555555566666666666666533 333444556777777777665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-25 Score=229.01 Aligned_cols=203 Identities=22% Similarity=0.164 Sum_probs=127.9
Q ss_pred ccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCc
Q 047901 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLK 100 (786)
Q Consensus 21 ~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 100 (786)
.+.++++++.+++++|+++.+++. +. +++++|+|++|+|+++.+..|..+++|++|+|++|+|++++.. ..+++|+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~-~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~ 80 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG 80 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred cccccCCccEEECCCCCCCcCCCC-CC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence 466788888899988888755443 32 5788888888888888888888888888888888888876543 6777888
Q ss_pred EEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccc
Q 047901 101 YISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180 (786)
Q Consensus 101 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l 180 (786)
+|+|++|+|+ ..|..+.++++|++|+|++|+|++..+..| .++++|+.|+|++|+|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~-----------------------~~l~~L~~L~L~~N~l 136 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL-----------------------RGLGELQELYLKGNEL 136 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTT-----------------------TTCTTCCEEECTTSCC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHH-----------------------cCCCCCCEEECCCCCC
Confidence 8888888877 344566666777777777666664333322 3334444444444444
Q ss_pred ccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccc
Q 047901 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252 (786)
Q Consensus 181 ~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i 252 (786)
+++++..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+
T Consensus 137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 4444445555555555555555555555555555555555555555555 3344444444555555555544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=233.61 Aligned_cols=207 Identities=21% Similarity=0.194 Sum_probs=129.3
Q ss_pred CCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEE
Q 047901 166 NCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245 (786)
Q Consensus 166 ~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 245 (786)
.+++|+.|++.+|.++.+ ..+..+++|++|+|++|+++++ ..+..+++|++|+|++|.++++.+..|..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 344555555555555533 2355566666666666666543 245566666666666666665555556666666666
Q ss_pred EeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccC
Q 047901 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 246 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 325 (786)
+|++|++++..+..|.++++|+.|+|++|+++++.+..|..+++|+.|++++|+++.+++..|..+++|++|++++|+++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 66666666555555666666666666666666666656666666666666666666666666666666666666666666
Q ss_pred CCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccC
Q 047901 326 QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGM 383 (786)
Q Consensus 326 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 383 (786)
+..+..|..+++|+.|+|++|.+.+. +++|+.|++..|.++|.+|..+..+
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 66666666677777777777766532 3456777777777777777665544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=233.02 Aligned_cols=228 Identities=17% Similarity=0.175 Sum_probs=180.1
Q ss_pred CcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccC
Q 047901 122 KLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSH 201 (786)
Q Consensus 122 ~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~ 201 (786)
++..+++.++.+... ..+..+++|+.|++++|.+.. ++.+..+++|+.|++++|+++++ ..+..+++|++|+|++
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 344555555555432 234455566666666666553 33466777888888888888764 4678888888888888
Q ss_pred CccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCc
Q 047901 202 NNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLP 281 (786)
Q Consensus 202 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 281 (786)
|+++++.+..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|+++++.+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 88888888888888888888888888887777778888888888888888887777778888889999999998888888
Q ss_pred cccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccc
Q 047901 282 RALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLES 361 (786)
Q Consensus 282 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 361 (786)
..|..+++|+.|++++|+++++++..|..+++|++|++++|.+.+. +++|+.|+++.|.+++.+|..++.+..
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 8888889999999999999888888888899999999999988754 457889999999999999988877655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-28 Score=282.22 Aligned_cols=391 Identities=18% Similarity=0.126 Sum_probs=281.4
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCC-Ccccc-CchhccCCCCCCEEeCcCCcccccCCcccc----CCCC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSIN-GFFGT-LPPQVRNLSKLKYLDLSENELSGKIPPEIG----LLTH 75 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~ 75 (786)
+++.|+|+++.+.+.....-...+++|++|+|++| .++.. .+..+.++++|++|+|++|.+++..+..+. .+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 57889999988765444322226899999999999 55432 455566899999999999999876555454 6779
Q ss_pred CCEEeCCCcc--Cccc-CCC-CCCCCCCcEEEccCC-cCcccCchhhcccCCcceecccc-------ccccccCChhhhc
Q 047901 76 LFSLDLSLNQ--FSGT-FPP-ICNLSNLKYISLHNN-KLSGSIPEEIGNLMKLSYLMLDT-------NQFTGQLPRNICR 143 (786)
Q Consensus 76 L~~L~Ls~N~--l~~~-~~~-~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-------N~l~~~~~~~~~~ 143 (786)
|++|+|++|. ++.. ... +..+++|++|+|++| .+.+ .+..+..+++|++|+++. |.+.+ ++..+.+
T Consensus 186 L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~ 263 (594)
T 2p1m_B 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSG 263 (594)
T ss_dssp CCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHT
T ss_pred CcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhc
Confidence 9999999997 3210 111 235799999999999 4544 778889999999999554 44553 4457888
Q ss_pred cCcccee-ecccccccCCCCCcCCCCCCcEEEccCcccccccC-cccCCCCCCCEEeccCCcccccc-CcCccCCCCccE
Q 047901 144 SGLLEIL-TVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS-EDFGIYPNLKFLDLSHNNFYGEI-SSNWGKCHRLGT 220 (786)
Q Consensus 144 ~~~L~~L-~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~ 220 (786)
+++|+.| .+.+......+..+..+++|+.|++++|.++.... ..+..+++|++|++++| +.... +.....+++|++
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 8999998 44443332222234478999999999999775432 23568999999999998 44222 222335889999
Q ss_pred EEccC---------cccCCCCCccc-cCCccccEEEeecccccccCCCCcc-ccccccccccc--c----cccCCCCc--
Q 047901 221 LIVSG---------NNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELG-RLISLNKLILR--G----NQLSGHLP-- 281 (786)
Q Consensus 221 L~L~~---------N~l~~~~~~~~-~~l~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~~-- 281 (786)
|++++ +.+++.....+ .++++|+.|+++.|.+++.....+. .+++|+.|+++ + |.++....
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 422 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence 99944 45553222223 3478999999999999866555554 58899999999 4 56663322
Q ss_pred ---cccccCCcCceeccccccccccchhhhhc-ccCCcEEEecccccCCCcchHH-hhhcCcCeeeccCCccCCCCCc-c
Q 047901 282 ---RALGLLTELEYFDLSSNRLNNSILEALGF-MFKLFYLNFSHNQFSQEIPEDL-ALLAHLSELDLSHNLFKGSIPS-R 355 (786)
Q Consensus 282 ---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~-~ 355 (786)
..+..+++|+.|++++ .++......+.. +++|+.|+|++|.+++.....+ ..+++|+.|+|++|.+++.... .
T Consensus 423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~ 501 (594)
T 2p1m_B 423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN 501 (594)
T ss_dssp HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT
T ss_pred HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH
Confidence 2367789999999987 676655555555 8899999999999976555555 6789999999999999644333 4
Q ss_pred cccccccceeccccccccccCCccc-ccCCCceEEeccCCcc
Q 047901 356 ICNLESLEKLNLSHNNISGQIPACF-IGMSGLLSIDISYNEL 396 (786)
Q Consensus 356 ~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l 396 (786)
...+++|+.|++++|+++..-...+ ..++.|+...+..+.-
T Consensus 502 ~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 502 ASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp GGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred HHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 4568999999999999964433334 5578887776666643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=224.03 Aligned_cols=199 Identities=15% Similarity=0.136 Sum_probs=96.8
Q ss_pred CCcEEEccCcccccccCcccCCCCCCCEEeccCCc-cccccCcCccCCCCccEEEccC-cccCCCCCccccCCccccEEE
Q 047901 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNN-FYGEISSNWGKCHRLGTLIVSG-NNITGRIPPEIGNSSQLHVLD 246 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 246 (786)
+|+.|++++|+|+++.+..|..+++|++|+|++|+ ++.+.+.+|.++++|++|+|++ |+++++.+..|.++++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555555555555555555555555554 5555544555555555555554 555544444455555555555
Q ss_pred eecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccc-cccccchhhhhcccCCc-EEEeccccc
Q 047901 247 LSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSN-RLNNSILEALGFMFKLF-YLNFSHNQF 324 (786)
Q Consensus 247 Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l 324 (786)
+++|++++ +|. |..+++|+ .|+.|++++| .++.+++..|..+++|+ +|++++|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~---------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCC---------------------SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CCCCCCcc-ccc-cccccccc---------------------cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 55555543 222 44444444 0004444444 44444444444444444 455555544
Q ss_pred CCCcchHHhhhcCcCeeeccCCc-cCCCCCcccccc-cccceeccccccccccCCcccccCCCceEEeccCC
Q 047901 325 SQEIPEDLALLAHLSELDLSHNL-FKGSIPSRICNL-ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394 (786)
Q Consensus 325 ~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 394 (786)
+.+.+..|.. ++|+.|+|++|+ +++..+..|.++ ++|+.|++++|+|+++.+. .+++|+.|+++++
T Consensus 169 ~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 169 TSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred cccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 4333333333 455555555553 554444455555 5555555555555543332 3445555555544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=254.07 Aligned_cols=187 Identities=15% Similarity=0.215 Sum_probs=146.1
Q ss_pred ccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCc----hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 509 DAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQ----MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
...+.||+|+||+||+|+. .++.+++|+......... ....+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999965 478899998755322111 11245689999999999999999777777677788999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++++|.+++.. +..++.|++.||+|||++ +|+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999864 457999999999999999 9999999999999998 999999999998864
Q ss_pred CCCc-------ceeeccCccccCCCCCCCCchHHHHhhh--cCcCcccchHHHHHHHHHHHhCCCCC
Q 047901 665 NSSN-------WTELVGTFGYVAPAHGNIGLHLAELAYT--MKITEKCDVYSFGVLALEVIKGKHPG 722 (786)
Q Consensus 665 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~e~~~~--~~~~~~sDvwslGvil~elltg~~Pf 722 (786)
.... .....||+.|||| |++.. ..|+.++|+||..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~AP----------Ev~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFD----------EIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHH----------HHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCH----------HHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 1356899999999 66655 56788899999999888888887775
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=219.77 Aligned_cols=193 Identities=16% Similarity=0.116 Sum_probs=140.7
Q ss_pred CCCCEEeccCCccccccCcCccCCCCccEEEccCcc-cCCCCCccccCCccccEEEeec-ccccccCCCCcccccccccc
Q 047901 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN-ITGRIPPEIGNSSQLHVLDLSS-NHIAGEIPMELGRLISLNKL 269 (786)
Q Consensus 192 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~L~~L 269 (786)
++|++|+|++|+|+++.+..|.++++|++|++++|+ ++.+.+..|.++++|+.|+|++ |+++++.+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 367777777777777666667777777777777775 6655555666666666666666 66665555555555555555
Q ss_pred cccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCc---EEEeccc-ccCCCcchHHhhhcCcC-eeecc
Q 047901 270 ILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF---YLNFSHN-QFSQEIPEDLALLAHLS-ELDLS 344 (786)
Q Consensus 270 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~ 344 (786)
++++|+++ .++. |..+++|+ +|++++| .++...+..|..+++|+ .|+++
T Consensus 111 ~l~~n~l~------------------------~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 111 GIFNTGLK------------------------MFPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp EEEEECCC------------------------SCCC--CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred eCCCCCCc------------------------cccc--cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 55555554 3222 44455555 9999999 99988888899999999 99999
Q ss_pred CCccCCCCCcccccccccceecccccc-ccccCCcccccC-CCceEEeccCCcccccCCCCCccccCCCcc
Q 047901 345 HNLFKGSIPSRICNLESLEKLNLSHNN-ISGQIPACFIGM-SGLLSIDISYNELRGPIPNSTVFRNAPRES 413 (786)
Q Consensus 345 ~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~ 413 (786)
+|+++...+..|.. ++|+.|++++|+ ++++.+..|.++ ++|+.|++++|++++.++. .+.......
T Consensus 165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~ 232 (239)
T 2xwt_C 165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELI 232 (239)
T ss_dssp SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEE
T ss_pred CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceee
Confidence 99999544555555 899999999995 998888999999 9999999999999975544 345444333
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=230.00 Aligned_cols=242 Identities=16% Similarity=0.132 Sum_probs=193.6
Q ss_pred ceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc-ccCcCccCCCCccE-EEccC
Q 047901 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG-EISSNWGKCHRLGT-LIVSG 225 (786)
Q Consensus 148 ~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~-L~L~~ 225 (786)
+.++.++++++.+|.++. +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+ +.+.+|.+++++.+ +++++
T Consensus 12 ~~v~C~~~~Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCCSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCCccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 456777777777766663 678899999999999888899999999999999999855 55678899988775 66777
Q ss_pred cccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccc-cccCCCCccccccCC-cCceecccccccccc
Q 047901 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRG-NQLSGHLPRALGLLT-ELEYFDLSSNRLNNS 303 (786)
Q Consensus 226 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~ 303 (786)
|+|+.+.|..|.++++|+.|++++|+|+...+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+.+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i 169 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence 999988888999999999999999999877777888888888888855 678877777887775 588899999999988
Q ss_pred chhhhhcccCCcEEEecc-cccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCccccc
Q 047901 304 ILEALGFMFKLFYLNFSH-NQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIG 382 (786)
Q Consensus 304 ~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 382 (786)
+...|.. .+|+.|++++ |.++.+.+..|..+++|+.|+|++|+|+...+..|.++.+|+.+++ ++++ .+| .+..
T Consensus 170 ~~~~f~~-~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~ 244 (350)
T 4ay9_X 170 HNSAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEK 244 (350)
T ss_dssp CTTSSTT-EEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTT
T ss_pred Chhhccc-cchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cchh
Confidence 8887764 5788899874 7777666678899999999999999999666666776666666555 3343 455 3778
Q ss_pred CCCceEEeccCCcc
Q 047901 383 MSGLLSIDISYNEL 396 (786)
Q Consensus 383 l~~L~~L~l~~N~l 396 (786)
+++|+.++++++.-
T Consensus 245 l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 245 LVALMEASLTYPSH 258 (350)
T ss_dssp CCSCCEEECSCHHH
T ss_pred CcChhhCcCCCCcc
Confidence 88999998876543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=243.07 Aligned_cols=128 Identities=23% Similarity=0.217 Sum_probs=65.8
Q ss_pred EEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCc----hhccCCC-CCCEEeCcCCcccccCCccccCC-----CC
Q 047901 6 INLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLP----PQVRNLS-KLKYLDLSENELSGKIPPEIGLL-----TH 75 (786)
Q Consensus 6 l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~ 75 (786)
.+|+.+++.+.+++ .+...++|++|||++|.+++..+ ..|.+++ +|++|+|++|+|+...+..|..+ ++
T Consensus 3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35555666555554 12333336666666666655554 5555555 56666666666655555555443 55
Q ss_pred CCEEeCCCccCcccCCC-----CCCC-CCCcEEEccCCcCcccCchhhcc-----cCCcceecccccccc
Q 047901 76 LFSLDLSLNQFSGTFPP-----ICNL-SNLKYISLHNNKLSGSIPEEIGN-----LMKLSYLMLDTNQFT 134 (786)
Q Consensus 76 L~~L~Ls~N~l~~~~~~-----~~~l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~ 134 (786)
|++|+|++|++++.... +..+ ++|++|+|++|+|++..+..|.. .++|++|+|++|+++
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 55555555555543321 2223 45555555555555444433322 135555555555554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=238.35 Aligned_cols=250 Identities=16% Similarity=0.126 Sum_probs=202.9
Q ss_pred EEECCCCCccccCchhccCCCCCCEEeCcCCcccccCC----ccccCCC-CCCEEeCCCccCcccCC-CCCCC-----CC
Q 047901 30 YLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIP----PEIGLLT-HLFSLDLSLNQFSGTFP-PICNL-----SN 98 (786)
Q Consensus 30 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~-~~~~l-----~~ 98 (786)
+++|++|.+++..|..+...++|++|+|++|+|+...+ .+|..++ +|++|+|++|+|++... .+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999998888888888889999999999997777 7888999 99999999999987543 24443 89
Q ss_pred CcEEEccCCcCcccCchhhccc-----CCcceeccccccccccCChhhhc-----cCccceeecccccccCCCC-----C
Q 047901 99 LKYISLHNNKLSGSIPEEIGNL-----MKLSYLMLDTNQFTGQLPRNICR-----SGLLEILTVNDNHFLGSIP-----N 163 (786)
Q Consensus 99 L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~-----~~~L~~L~l~~N~l~~~~~-----~ 163 (786)
|++|+|++|++++..+..+... ++|++|+|++|++++..+..++. .++|+.|+|++|.+..... .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999998887765544 89999999999999777766655 3699999999999985322 2
Q ss_pred cCCCC-CCcEEEccCcccccccCccc----CCC-CCCCEEeccCCcccccc----CcCccC-CCCccEEEccCcccCCCC
Q 047901 164 LRNCR-SLVRAHLGRNNLTGNISEDF----GIY-PNLKFLDLSHNNFYGEI----SSNWGK-CHRLGTLIVSGNNITGRI 232 (786)
Q Consensus 164 l~~l~-~L~~L~L~~N~l~~~~~~~f----~~l-~~L~~L~L~~N~i~~~~----~~~~~~-l~~L~~L~L~~N~l~~~~ 232 (786)
+..++ +|+.|+|++|+|++..+..+ ... ++|++|+|++|+|+... +..+.. .++|++|+|++|+|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34454 99999999999998776544 445 59999999999998732 334444 459999999999999754
Q ss_pred C----ccccCCccccEEEeeccccccc-------CCCCcccccccccccccccccCCC
Q 047901 233 P----PEIGNSSQLHVLDLSSNHIAGE-------IPMELGRLISLNKLILRGNQLSGH 279 (786)
Q Consensus 233 ~----~~~~~l~~L~~L~Ls~N~i~~~-------~~~~~~~l~~L~~L~L~~N~l~~~ 279 (786)
+ ..+..+++|+.|+|++|.+.++ ++..+..+++|+.|++++|.+...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 4 3457789999999999995533 334678899999999999999855
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=229.30 Aligned_cols=225 Identities=16% Similarity=0.152 Sum_probs=174.4
Q ss_pred CCcEEEccCcccccccC---cccCCCCCCCEEeccCCccccccCcCc--cCCCCccEEEccCcccCCCCC----ccccCC
Q 047901 169 SLVRAHLGRNNLTGNIS---EDFGIYPNLKFLDLSHNNFYGEISSNW--GKCHRLGTLIVSGNNITGRIP----PEIGNS 239 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~---~~f~~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l 239 (786)
.++.+.+.++.++.... ..+..+++|++|+|++|++.+..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 45666666666543211 112234678888888888888888877 888888888888888886544 344568
Q ss_pred ccccEEEeecccccccCCCCcccccccccccccccccCC---CC-ccccccCCcCceeccccccccccchh---hhhccc
Q 047901 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG---HL-PRALGLLTELEYFDLSSNRLNNSILE---ALGFMF 312 (786)
Q Consensus 240 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~ 312 (786)
++|+.|+|++|++.+..+..|..+++|++|+|++|++.+ .. +..+..+++|++|+|++|+++.+... .+..++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 889999999999988888888889999999999998764 22 23346788999999999999765443 457789
Q ss_pred CCcEEEecccccCCCcchHHhhh---cCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEE
Q 047901 313 KLFYLNFSHNQFSQEIPEDLALL---AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSI 389 (786)
Q Consensus 313 ~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 389 (786)
+|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 99999999999998777776666 69999999999999 5666664 7999999999999875 33 6788999999
Q ss_pred eccCCcccc
Q 047901 390 DISYNELRG 398 (786)
Q Consensus 390 ~l~~N~l~~ 398 (786)
++++|+++.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=223.85 Aligned_cols=194 Identities=22% Similarity=0.318 Sum_probs=120.7
Q ss_pred CCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEE
Q 047901 23 SSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYI 102 (786)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L 102 (786)
..+++|++|++++|.++.+ + .+..+++|++|+|++|+|+.+.+ |..+++|++|+|++|++++. +.+..+++|++|
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L 112 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-SAIAGLQSIKTL 112 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEE
T ss_pred HHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEE
Confidence 3455566666666655433 2 35555666666666666654333 55556666666666655543 235555555555
Q ss_pred EccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccccc
Q 047901 103 SLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTG 182 (786)
Q Consensus 103 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~ 182 (786)
+|++|+++++.+ |..+++|++|++++|+++ +..+ +.++++|+.|++++|++++
T Consensus 113 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~------------------------~~~~-l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQIT------------------------NISP-LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp ECTTSCCCCCGG--GTTCTTCCEEECCSSCCC------------------------CCGG-GGGCTTCCEEECCSSCCCC
T ss_pred ECCCCCCCCchh--hcCCCCCCEEECCCCccC------------------------cCcc-ccCCCCccEEEccCCcCCC
Confidence 555555554322 555555555555555554 3322 4556666677777777766
Q ss_pred ccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccc
Q 047901 183 NISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254 (786)
Q Consensus 183 ~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 254 (786)
+.+ +..+++|++|+|++|+++++.+ +..+++|+.|+|++|++++.. .+..+++|+.|+|++|++++
T Consensus 166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 544 7777788888888888776654 777788888888888887554 37778888888888888874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=222.85 Aligned_cols=213 Identities=20% Similarity=0.245 Sum_probs=163.0
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N 107 (786)
+..+.+..+.+++..+ +..+++|++|++++|+++.+ + .+..+++|++|+|++|+++++++ +..+++|++|+|++|
T Consensus 21 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n 95 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGN 95 (308)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSC
T ss_pred HHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCC
Confidence 3344555555544332 44566777777777777643 3 46777777777777777776555 667777777777777
Q ss_pred cCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcc
Q 047901 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187 (786)
Q Consensus 108 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 187 (786)
+++++ ..|..+++|++|++++|+++ +. +.+..+++|+.|++++|+++++.+
T Consensus 96 ~l~~~--~~~~~l~~L~~L~l~~n~l~------------------------~~-~~l~~l~~L~~L~l~~n~l~~~~~-- 146 (308)
T 1h6u_A 96 PLKNV--SAIAGLQSIKTLDLTSTQIT------------------------DV-TPLAGLSNLQVLYLDLNQITNISP-- 146 (308)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCCC------------------------CC-GGGTTCTTCCEEECCSSCCCCCGG--
T ss_pred cCCCc--hhhcCCCCCCEEECCCCCCC------------------------Cc-hhhcCCCCCCEEECCCCccCcCcc--
Confidence 77654 24666666666666666665 22 236678899999999999998755
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLN 267 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 267 (786)
+..+++|++|+|++|+++++.+ +..+++|+.|+|++|+++++.+ +..+++|+.|+|++|++++.. .+..+++|+
T Consensus 147 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~ 220 (308)
T 1h6u_A 147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLF 220 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCC
T ss_pred ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCC
Confidence 8999999999999999998765 8999999999999999997643 889999999999999999665 389999999
Q ss_pred cccccccccCCCC
Q 047901 268 KLILRGNQLSGHL 280 (786)
Q Consensus 268 ~L~L~~N~l~~~~ 280 (786)
.|+|++|++++..
T Consensus 221 ~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 221 IVTLTNQTITNQP 233 (308)
T ss_dssp EEEEEEEEEECCC
T ss_pred EEEccCCeeecCC
Confidence 9999999998643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=228.46 Aligned_cols=239 Identities=18% Similarity=0.111 Sum_probs=142.1
Q ss_pred cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCccc-CC-CCCCCCCCcE-EEcc
Q 047901 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGT-FP-PICNLSNLKY-ISLH 105 (786)
Q Consensus 29 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~-~~~~l~~L~~-L~L~ 105 (786)
+.++.++|+++.+ |..+ .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. ++ .|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt~i-P~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVTEI-PSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCCSC-CTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCCcc-CcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 4455566666433 3323 23566666666666655555666666666666666665432 22 2555655543 4455
Q ss_pred CCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccc-ccccCCCCC-cCCC-CCCcEEEccCccccc
Q 047901 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND-NHFLGSIPN-LRNC-RSLVRAHLGRNNLTG 182 (786)
Q Consensus 106 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~-N~l~~~~~~-l~~l-~~L~~L~L~~N~l~~ 182 (786)
+|+|+.+.++.|.++++|++|++++|+++...+..+.....+..|++.+ |++..+++. +..+ ..++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 5666666666666666666666666666655555555555666666644 344444332 4444 356677777777777
Q ss_pred ccCcccCCCCCCCEEeccC-CccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcc
Q 047901 183 NISEDFGIYPNLKFLDLSH-NNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELG 261 (786)
Q Consensus 183 ~~~~~f~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 261 (786)
+.+..|.. .+|++|++++ |.++.+.+++|.++++|++|+|++|+|+.+.+..|.++++|+.+++ +.++ ..| .+.
T Consensus 169 i~~~~f~~-~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~ 243 (350)
T 4ay9_X 169 IHNSAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLE 243 (350)
T ss_dssp ECTTSSTT-EEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTT
T ss_pred CChhhccc-cchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cch
Confidence 76666643 5677777764 6677776777777777888888877777655545544444433332 2333 444 367
Q ss_pred cccccccccccccc
Q 047901 262 RLISLNKLILRGNQ 275 (786)
Q Consensus 262 ~l~~L~~L~L~~N~ 275 (786)
++++|+.++++++.
T Consensus 244 ~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 244 KLVALMEASLTYPS 257 (350)
T ss_dssp TCCSCCEEECSCHH
T ss_pred hCcChhhCcCCCCc
Confidence 77777777776554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=213.51 Aligned_cols=178 Identities=22% Similarity=0.198 Sum_probs=103.6
Q ss_pred CCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEee
Q 047901 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 248 (786)
+.+.++++++.++.++.... ++|++|+|++|+++++.+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCccccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 45566777777765543222 466667777777666666666666666666666666666655566666666666666
Q ss_pred cccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCc
Q 047901 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI 328 (786)
Q Consensus 249 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 328 (786)
+|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+++.+++..|..+++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66666555555556666666666666665555555555555555555555555555444555555555555555554444
Q ss_pred chHHhhhcCcCeeeccCCccC
Q 047901 329 PEDLALLAHLSELDLSHNLFK 349 (786)
Q Consensus 329 ~~~~~~l~~L~~L~L~~N~l~ 349 (786)
+..|..+++|+.|+|++|+++
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBC
T ss_pred HHHHhCCCCCCEEEeeCCcee
Confidence 444444444444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.1e-23 Score=209.13 Aligned_cols=180 Identities=22% Similarity=0.202 Sum_probs=158.8
Q ss_pred ccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccC
Q 047901 146 LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSG 225 (786)
Q Consensus 146 ~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 225 (786)
..+.++++++.++.++..+. ++++.|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 45566677776666665555 5788999999999988888899999999999999999998888899999999999999
Q ss_pred cccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccch
Q 047901 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305 (786)
Q Consensus 226 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 305 (786)
|+++++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|+++.+++
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 99998888888999999999999999998878888999999999999999998888889999999999999999999998
Q ss_pred hhhhcccCCcEEEecccccCCC
Q 047901 306 EALGFMFKLFYLNFSHNQFSQE 327 (786)
Q Consensus 306 ~~~~~l~~L~~L~L~~N~l~~~ 327 (786)
..|..+++|++|+|++|.++..
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHhCCCCCCEEEeeCCceeCC
Confidence 8999999999999999999865
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=221.94 Aligned_cols=223 Identities=17% Similarity=0.158 Sum_probs=179.0
Q ss_pred CeEEEEcCCCCCcccC-C-cCccCCCCCCcEEECCCCCccccCchhc--cCCCCCCEEeCcCCcccccCC----ccccCC
Q 047901 2 RVNSINLTSTGLKGTL-Q-EFSFSSFPHLAYLDLSINGFFGTLPPQV--RNLSKLKYLDLSENELSGKIP----PEIGLL 73 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l-~-~~~f~~l~~L~~L~L~~n~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l 73 (786)
+++.+.+..+.+...- . -..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|+|++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 3567777777664210 0 0113345779999999999999999888 899999999999999987544 445679
Q ss_pred CCCCEEeCCCccCcccCC-CCCCCCCCcEEEccCCcCcc---cC-chhhcccCCcceeccccccccccCCh----hhhcc
Q 047901 74 THLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSG---SI-PEEIGNLMKLSYLMLDTNQFTGQLPR----NICRS 144 (786)
Q Consensus 74 ~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~~ 144 (786)
++|++|+|++|++++.++ .+..+++|++|+|++|++.+ +. +..+..+++|++|+|++|+++. ++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 999999999999988776 48899999999999999864 22 2345789999999999999973 333 35778
Q ss_pred CccceeecccccccCC-CCCcCCC---CCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccE
Q 047901 145 GLLEILTVNDNHFLGS-IPNLRNC---RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGT 220 (786)
Q Consensus 145 ~~L~~L~l~~N~l~~~-~~~l~~l---~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 220 (786)
++|+.|+|++|++.+. ++.+..+ ++|+.|+|++|+|+.++. .+. ++|++|+|++|+|+++ |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~-~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPK-GLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCS-CCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhh-hhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 9999999999999987 4455555 799999999999997644 342 8999999999999976 32 788999999
Q ss_pred EEccCcccCC
Q 047901 221 LIVSGNNITG 230 (786)
Q Consensus 221 L~L~~N~l~~ 230 (786)
|+|++|++++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999974
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-25 Score=233.92 Aligned_cols=101 Identities=16% Similarity=0.217 Sum_probs=49.9
Q ss_pred CCEEeCcCCcccccCCccccCC--CCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCccc-CchhhcccCCcceecc
Q 047901 52 LKYLDLSENELSGKIPPEIGLL--THLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLML 128 (786)
Q Consensus 52 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L 128 (786)
++.|++++|.+. +..+..+ ++++.|++++|.+++..+.+..+++|++|+|++|.+++. .+..+..+++|++|+|
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L 125 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 125 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeC
Confidence 455555555443 2334444 555555555555555444444555555555555555433 4444555555555555
Q ss_pred ccccccccCChhhhccCccceeecccc
Q 047901 129 DTNQFTGQLPRNICRSGLLEILTVNDN 155 (786)
Q Consensus 129 ~~N~l~~~~~~~~~~~~~L~~L~l~~N 155 (786)
++|++++..+..+..+++|+.|++++|
T Consensus 126 ~~~~l~~~~~~~l~~~~~L~~L~L~~~ 152 (336)
T 2ast_B 126 EGLRLSDPIVNTLAKNSNLVRLNLSGC 152 (336)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred cCcccCHHHHHHHhcCCCCCEEECCCC
Confidence 555555444444444444444444433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-25 Score=244.21 Aligned_cols=258 Identities=19% Similarity=0.163 Sum_probs=129.5
Q ss_pred CCEEeCcCCcccccCCccccCCCCCCEEeCCCccCccc-----CCCCCCCCCCcEEEccCCcCc---ccCchhh------
Q 047901 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKLS---GSIPEEI------ 117 (786)
Q Consensus 52 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~L~~N~l~---~~~~~~~------ 117 (786)
|+...++...+. ..+..+..+++|++|+|++|+|+.. ...+..+++|++|+|++|.+. +..|..+
T Consensus 11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~ 89 (386)
T 2ca6_A 11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89 (386)
T ss_dssp CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH
T ss_pred cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHH
Confidence 344444444554 4566777788888888888888653 234667788888888886443 3334333
Q ss_pred -cccCCcceeccccccccc----cCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccC---
Q 047901 118 -GNLMKLSYLMLDTNQFTG----QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG--- 189 (786)
Q Consensus 118 -~~l~~L~~L~L~~N~l~~----~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~--- 189 (786)
..+++|++|+|++|+++. .+|..+..+++|+.|+|++|.+. ...+..+.
T Consensus 90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~-----------------------~~~~~~l~~~l 146 (386)
T 2ca6_A 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG-----------------------PQAGAKIARAL 146 (386)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH-----------------------HHHHHHHHHHH
T ss_pred HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC-----------------------HHHHHHHHHHH
Confidence 566667777777766664 23334444444444444444332 11111111
Q ss_pred -CC---------CCCCEEeccCCcccc-ccC---cCccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccccccc
Q 047901 190 -IY---------PNLKFLDLSHNNFYG-EIS---SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255 (786)
Q Consensus 190 -~l---------~~L~~L~L~~N~i~~-~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 255 (786)
.+ ++|++|+|++|+|+. -.+ ..+..+++|++|+|++|+|+... +...
T Consensus 147 ~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g-------------------~~~l 207 (386)
T 2ca6_A 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG-------------------IEHL 207 (386)
T ss_dssp HHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHH-------------------HHHH
T ss_pred HHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhH-------------------HHHH
Confidence 11 455555555555431 111 12333444444444444443100 0001
Q ss_pred CCCCcccccccccccccccccC----CCCccccccCCcCceecccccccccc----chhhhhc--ccCCcEEEecccccC
Q 047901 256 IPMELGRLISLNKLILRGNQLS----GHLPRALGLLTELEYFDLSSNRLNNS----ILEALGF--MFKLFYLNFSHNQFS 325 (786)
Q Consensus 256 ~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~--l~~L~~L~L~~N~l~ 325 (786)
.+..+..+++|+.|+|++|.++ ..+|..+..+++|+.|+|++|+++.. .+..+.. +++|++|+|++|.++
T Consensus 208 ~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp HHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred HHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence 2223444444444444444442 23344455555555555555555543 1223322 566666666666665
Q ss_pred C----CcchHH-hhhcCcCeeeccCCccCCCC
Q 047901 326 Q----EIPEDL-ALLAHLSELDLSHNLFKGSI 352 (786)
Q Consensus 326 ~----~~~~~~-~~l~~L~~L~L~~N~l~~~~ 352 (786)
. .+|..+ ..+++|+.|+|++|++++..
T Consensus 288 ~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 4 244444 44566677777777666544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-24 Score=231.20 Aligned_cols=251 Identities=14% Similarity=0.171 Sum_probs=119.7
Q ss_pred CcEEEccCCcCcccCchhhccc--CCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEcc
Q 047901 99 LKYISLHNNKLSGSIPEEIGNL--MKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLG 176 (786)
Q Consensus 99 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~ 176 (786)
++.|++++|.+. +..+..+ ++++.|++++|.++ +.++.+..+++|+.|+++
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~------------------------~~~~~~~~~~~L~~L~L~ 101 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMD------------------------QPLAEHFSPFRVQHMDLS 101 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEEC------------------------SCCCSCCCCBCCCEEECT
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCcccc------------------------ccchhhccCCCCCEEEcc
Confidence 555566555544 3344444 45555555555444 333334445566666666
Q ss_pred Ccccccc-cCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCc-ccCCC-CCccccCCccccEEEeecc-cc
Q 047901 177 RNNLTGN-ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGN-NITGR-IPPEIGNSSQLHVLDLSSN-HI 252 (786)
Q Consensus 177 ~N~l~~~-~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~i 252 (786)
+|.++.. .+..+..+++|++|+|++|++++..+..+..+++|++|+|++| .+++. .+..+.++++|+.|+|++| .+
T Consensus 102 ~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l 181 (336)
T 2ast_B 102 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 181 (336)
T ss_dssp TCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred CCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCc
Confidence 6665543 4445566666666666666666555555555666666666666 44431 3333445555555555555 55
Q ss_pred ccc-CCCCccccc-ccccccccccccCCCCccccccCCcCceecccccccc-ccchhhhhcccCCcEEEecccc-cCCCc
Q 047901 253 AGE-IPMELGRLI-SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN-NSILEALGFMFKLFYLNFSHNQ-FSQEI 328 (786)
Q Consensus 253 ~~~-~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~ 328 (786)
++. ++..+..++ +|++|++++|.+ .++ ...+..+..+++|++|++++|. ++...
T Consensus 182 ~~~~~~~~~~~l~~~L~~L~l~~~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~ 239 (336)
T 2ast_B 182 TEKHVQVAVAHVSETITQLNLSGYRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 239 (336)
T ss_dssp CHHHHHHHHHHSCTTCCEEECCSCGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGG
T ss_pred ChHHHHHHHHhcccCCCEEEeCCCcc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHH
Confidence 432 233334444 444444444421 122 1122233444445555555554 33334
Q ss_pred chHHhhhcCcCeeeccCCc-cCCCCCcccccccccceeccccccccccCCcccccC-CCceEEeccCCcccccCCC
Q 047901 329 PEDLALLAHLSELDLSHNL-FKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGM-SGLLSIDISYNELRGPIPN 402 (786)
Q Consensus 329 ~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~ 402 (786)
+..+..+++|+.|++++|. +.......+.++++|+.|++++| ++ ...+..+ ..+..|++++|++++..|.
T Consensus 240 ~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 240 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp GGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred HHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCC
Confidence 4444455555555555553 11111113444555555555555 22 1122222 1233444555555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-25 Score=242.33 Aligned_cols=235 Identities=21% Similarity=0.277 Sum_probs=172.8
Q ss_pred cCCCCCCcEEEccCcccccccC----cccCCCCCCCEEeccCCccc---cccCcCc-------cCCCCccEEEccCcccC
Q 047901 164 LRNCRSLVRAHLGRNNLTGNIS----EDFGIYPNLKFLDLSHNNFY---GEISSNW-------GKCHRLGTLIVSGNNIT 229 (786)
Q Consensus 164 l~~l~~L~~L~L~~N~l~~~~~----~~f~~l~~L~~L~L~~N~i~---~~~~~~~-------~~l~~L~~L~L~~N~l~ 229 (786)
+..+++|+.|+|++|+|+...+ ..|..+++|++|+|++|.+. +..|..+ ..+++|++|+|++|.++
T Consensus 28 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 107 (386)
T 2ca6_A 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107 (386)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCC
Confidence 4445556666666666655422 33666777777777775433 3333333 56778888888888877
Q ss_pred C----CCCccccCCccccEEEeecccccccCCCCccc----c---------cccccccccccccC-CCCc---cccccCC
Q 047901 230 G----RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR----L---------ISLNKLILRGNQLS-GHLP---RALGLLT 288 (786)
Q Consensus 230 ~----~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~----l---------~~L~~L~L~~N~l~-~~~~---~~~~~l~ 288 (786)
+ .+|..+..+++|+.|+|++|.++...+..+.. + ++|++|+|++|+++ ...+ ..+..++
T Consensus 108 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~ 187 (386)
T 2ca6_A 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187 (386)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCC
Confidence 5 35566777888888888888886444433333 3 78889999999887 2333 4667888
Q ss_pred cCceeccccccccc-----cchhhhhcccCCcEEEecccccC----CCcchHHhhhcCcCeeeccCCccCCC----CCcc
Q 047901 289 ELEYFDLSSNRLNN-----SILEALGFMFKLFYLNFSHNQFS----QEIPEDLALLAHLSELDLSHNLFKGS----IPSR 355 (786)
Q Consensus 289 ~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~ 355 (786)
+|+.|+|++|++.. +.+..+..+++|++|+|++|.++ ..+|..+..+++|+.|+|++|.|++. ++..
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 267 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHH
Confidence 99999999999873 23337788899999999999996 56777888999999999999999865 4556
Q ss_pred cc--cccccceeccccccccc----cCCccc-ccCCCceEEeccCCcccc
Q 047901 356 IC--NLESLEKLNLSHNNISG----QIPACF-IGMSGLLSIDISYNELRG 398 (786)
Q Consensus 356 ~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~ 398 (786)
+. .+++|+.|+|++|.|++ .+|..+ .++++|+.|++++|++++
T Consensus 268 l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 63 38999999999999998 467666 668999999999999875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=208.89 Aligned_cols=146 Identities=20% Similarity=0.224 Sum_probs=116.3
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCc-----h---------hhHHHHHHHHHHHhhcC
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQ-----M---------SDQKEFLNEIKALTKIR 564 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~---------~~~~~~~~e~~~l~~l~ 564 (786)
..+......|.+.+.||+|+||.||+|+..+++.||||+++....... . .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455667778899999999999999987789999999965321110 0 13567899999999999
Q ss_pred CCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCcee
Q 047901 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVL 644 (786)
Q Consensus 565 hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 644 (786)
| +++.+++.. +..|+||||+++|+|.+ +.. .....++.|++.|+.|||+. +|+||||||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 666665544 55699999999999988 421 12446999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccceec
Q 047901 645 LDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 645 l~~~~~~kl~Dfg~a~~~ 662 (786)
++ ++.+||+|||+|+..
T Consensus 226 l~-~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV 242 (282)
T ss_dssp EE-TTEEEECCCTTCEET
T ss_pred EE-CCcEEEEECCCCeEC
Confidence 99 999999999999744
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.04 Aligned_cols=178 Identities=19% Similarity=0.180 Sum_probs=94.3
Q ss_pred EEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccc
Q 047901 172 RAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNH 251 (786)
Q Consensus 172 ~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 251 (786)
.+++.++.++.++... .++|++|+|++|+++++.+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|+
T Consensus 11 ~v~c~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCccCCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 3444555554443221 2456666666666665555555566666666666666655544455555666666666666
Q ss_pred ccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchH
Q 047901 252 IAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED 331 (786)
Q Consensus 252 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 331 (786)
+++..+..|.++++|+.|+|++|+++++.+..|..+++|+.|++++|+++.+++..|..+++|++|++++|.+.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~---- 163 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT---- 163 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC----
Confidence 5544444555555555555555555555555555555555555555555554444444455555555555544321
Q ss_pred HhhhcCcCeeeccCCccCCCCCcccccc
Q 047901 332 LALLAHLSELDLSHNLFKGSIPSRICNL 359 (786)
Q Consensus 332 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l 359 (786)
+++|+.|+++.|++++.+|..++.+
T Consensus 164 ---~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 164 ---CPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp ---TTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred ---CCCHHHHHHHHHhCCceeeccCccc
Confidence 2344445555555555444444433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=193.08 Aligned_cols=190 Identities=20% Similarity=0.134 Sum_probs=156.2
Q ss_pred ceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc
Q 047901 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227 (786)
Q Consensus 148 ~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 227 (786)
+.++++++.++.++..+. ++|+.|++++|+++++.+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|+
T Consensus 10 ~~v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCccCCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 345566666665554443 578888999999988888888899999999999999998888888899999999999999
Q ss_pred cCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhh
Q 047901 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEA 307 (786)
Q Consensus 228 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 307 (786)
++++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|++++|.+..
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----- 162 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----- 162 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-----
Confidence 997777778899999999999999998777788999999999999999998888888999999999999998763
Q ss_pred hhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCC
Q 047901 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKG 350 (786)
Q Consensus 308 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 350 (786)
.+++|++|+++.|++++.+|..++.++. ++..|...+
T Consensus 163 --~~~~l~~L~~~~n~~~g~ip~~~~~l~~----~~~~C~~~~ 199 (208)
T 2o6s_A 163 --TCPGIRYLSEWINKHSGVVRNSAGSVAP----DSAKCSGSG 199 (208)
T ss_dssp --CTTTTHHHHHHHHHCTTTBBCTTSSBCT----TCSBBTTTC
T ss_pred --CCCCHHHHHHHHHhCCceeeccCccccC----CccccccCC
Confidence 4567899999999999999988776554 444554443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.9e-22 Score=222.31 Aligned_cols=186 Identities=24% Similarity=0.236 Sum_probs=95.2
Q ss_pred CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccc
Q 047901 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDT 130 (786)
Q Consensus 51 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 130 (786)
+|+.|+|++|+|++ +|..+ .++|++|+|++|+|+.++ ..+++|++|+|++|+|++++. |.+ +|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch--hhc--CCCEEECCC
Confidence 56666666666654 33333 255666666666665444 234566666666666655332 433 566666666
Q ss_pred ccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCc
Q 047901 131 NQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210 (786)
Q Consensus 131 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 210 (786)
|+|++ +|. .+++|+.|++++|.+++++. .+++|+.|+|++|+|++++. |. ++|++|+|++|+|+.+++
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~~lp~- 197 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLESLPA- 197 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCSSCCC-
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCCchhh-
Confidence 66554 333 34455555555555544332 34555555555555555333 33 556666666665553333
Q ss_pred CccCCCCc-------cEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccc
Q 047901 211 NWGKCHRL-------GTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR 262 (786)
Q Consensus 211 ~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 262 (786)
|.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..
T Consensus 198 -~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 198 -VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp -CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred -HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 332 44 55555555555 23444444555555555555555554444443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=221.77 Aligned_cols=200 Identities=20% Similarity=0.153 Sum_probs=116.6
Q ss_pred cccCCC-----CCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhc
Q 047901 69 EIGLLT-----HLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICR 143 (786)
Q Consensus 69 ~~~~l~-----~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 143 (786)
.|..++ +|+.|+|++|+|++++..+. ++|++|+|++|+|+.++ ..+++|++|+|++|+|++ +|. +..
T Consensus 49 ~~~~l~~C~~~~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~ 120 (571)
T 3cvr_A 49 AVSLLKECLINQFSELQLNRLNLSSLPDNLP--PQITVLEITQNALISLP----ELPASLEYLDACDNRLST-LPE-LPA 120 (571)
T ss_dssp HHHHHHHHHHTTCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSC-CCC-CCT
T ss_pred hhhhccccccCCccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCcccc----cccCCCCEEEccCCCCCC-cch-hhc
Confidence 566665 89999999999998776663 78999999999998554 457889999999998886 555 443
Q ss_pred cCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEc
Q 047901 144 SGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIV 223 (786)
Q Consensus 144 ~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 223 (786)
+|+.|+|++|.+++++. .+++|+.|+|++|+|++++. .+++|++|+|++|+|+++++ |. ++|+.|+|
T Consensus 121 --~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~L 187 (571)
T 3cvr_A 121 --SLKHLDVDNNQLTMLPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDV 187 (571)
T ss_dssp --TCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC--CC--TTCCEEEC
T ss_pred --CCCEEECCCCcCCCCCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCCcch--hh--CCCCEEEC
Confidence 66666666666665433 44555555555555554332 34555555555555554322 33 45555555
Q ss_pred cCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccccc
Q 047901 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNS 303 (786)
Q Consensus 224 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 303 (786)
++|+|+ .+|. |.. +| +...+.|+.|+|++|+|+. +|..+..+++|+.|+|++|++++.
T Consensus 188 s~N~L~-~lp~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 188 STNLLE-SLPA-VPV--RN-----------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp CSSCCS-SCCC-CC---------------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHH
T ss_pred cCCCCC-chhh-HHH--hh-----------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCc
Confidence 555555 2232 322 33 0000111555555555553 233333455555555555555555
Q ss_pred chhhhhcc
Q 047901 304 ILEALGFM 311 (786)
Q Consensus 304 ~~~~~~~l 311 (786)
.+..+..+
T Consensus 246 ~p~~l~~l 253 (571)
T 3cvr_A 246 IRESLSQQ 253 (571)
T ss_dssp HHHHHHHH
T ss_pred CHHHHHHh
Confidence 55554443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.2e-21 Score=200.28 Aligned_cols=189 Identities=22% Similarity=0.276 Sum_probs=110.5
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N 107 (786)
+..+.+..+.+++..+ +..+++|++|++++|.|+.+ + .+..+++|++|+|++|++++.++ +..+++|++|+|++|
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCC
Confidence 3344455555543322 34566666666666666643 2 36666666666666666665544 666666666666666
Q ss_pred cCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcc
Q 047901 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187 (786)
Q Consensus 108 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 187 (786)
+++++ ..+..+++|++|+|++|++++. .. +..+++|+.|++++|+++++ ..
T Consensus 101 ~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~-----------------------l~~l~~L~~L~l~~n~l~~~--~~ 151 (291)
T 1h6t_A 101 KVKDL--SSLKDLKKLKSLSLEHNGISDI--NG-----------------------LVHLPQLESLYLGNNKITDI--TV 151 (291)
T ss_dssp CCCCG--GGGTTCTTCCEEECTTSCCCCC--GG-----------------------GGGCTTCCEEECCSSCCCCC--GG
T ss_pred cCCCC--hhhccCCCCCEEECCCCcCCCC--hh-----------------------hcCCCCCCEEEccCCcCCcc--hh
Confidence 66643 2366666666666666666531 12 33344455555555555544 34
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 254 (786)
|..+++|++|+|++|+|+++.+ +..+++|+.|+|++|+|+++ + .+..+++|+.|++++|++..
T Consensus 152 l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 152 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred hccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 5566666666666666665544 66666666666666666643 2 36666677777777776664
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4.5e-21 Score=199.98 Aligned_cols=173 Identities=20% Similarity=0.186 Sum_probs=132.2
Q ss_pred cCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcE
Q 047901 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKY 101 (786)
Q Consensus 22 f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 101 (786)
+..+++|+.|++++|.+..+. .+..+++|++|+|++|+|+++.+ +..+++|++|+|++|++++.+ .+..+++|++
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG-GGTTCTTCCE
T ss_pred hhhcCcccEEEccCCCcccCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCCh-hhccCCCCCE
Confidence 457889999999999997663 48999999999999999997655 999999999999999998754 4889999999
Q ss_pred EEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccc
Q 047901 102 ISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLT 181 (786)
Q Consensus 102 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~ 181 (786)
|+|++|+++++ ..+..+++|++|++++|++++. ..+..+++| +.|++++|+|+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L-----------------------~~L~L~~N~l~ 169 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKL-----------------------DTLSLEDNQIS 169 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTC-----------------------SEEECCSSCCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCC-----------------------CEEEccCCccc
Confidence 99999999975 5689999999999999999853 445444444 44555555555
Q ss_pred cccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCC
Q 047901 182 GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG 230 (786)
Q Consensus 182 ~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 230 (786)
++.+ +..+++|++|+|++|+|+++. .+..+++|+.|++++|+++.
T Consensus 170 ~~~~--l~~l~~L~~L~L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 170 DIVP--LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred cchh--hcCCCccCEEECCCCcCCCCh--hhccCCCCCEEECcCCcccC
Confidence 4433 555666666666666666542 35666666666666666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=203.48 Aligned_cols=162 Identities=27% Similarity=0.198 Sum_probs=90.3
Q ss_pred eeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccC-CCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc
Q 047901 149 ILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG-IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227 (786)
Q Consensus 149 ~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 227 (786)
.+++++|.++.++..+. +.++.|+|++|+|+++.+..|. .+++|++|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus 22 ~l~c~~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 22 ILSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp EEECCSSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 44555555554444333 2355666666666666665565 66666666666666666666666666666666666666
Q ss_pred cCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCcccc---ccCCcCceeccccccccccc
Q 047901 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRAL---GLLTELEYFDLSSNRLNNSI 304 (786)
Q Consensus 228 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~ 304 (786)
|+.+.+..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|+.+.+..| ..+++|+.|+|++|+|+.++
T Consensus 100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 179 (361)
T 2xot_A 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCC
T ss_pred CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccC
Confidence 665555556666666666666666665555555555555555555555555444444 33444555555555444444
Q ss_pred hhhhhccc
Q 047901 305 LEALGFMF 312 (786)
Q Consensus 305 ~~~~~~l~ 312 (786)
...|..++
T Consensus 180 ~~~~~~l~ 187 (361)
T 2xot_A 180 LTDLQKLP 187 (361)
T ss_dssp HHHHHHSC
T ss_pred HHHhhhcc
Confidence 44444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=216.02 Aligned_cols=190 Identities=21% Similarity=0.271 Sum_probs=93.7
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N 107 (786)
+..+.|+.+.+..+.+ +..|++|+.|+|++|.|+.+ + .|..+++|+.|+|++|+|+++++ +..+++|+.|+|++|
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCC
Confidence 3444455555443332 34455555555555555532 2 35555555555555555554433 455555555555555
Q ss_pred cCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcc
Q 047901 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187 (786)
Q Consensus 108 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 187 (786)
+|+++. .|..+++|++|+|++|++++. ..+ ..+++|+.|+|++|+|+++ ..
T Consensus 98 ~l~~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l-----------------------~~l~~L~~L~Ls~N~l~~l--~~ 148 (605)
T 1m9s_A 98 KIKDLS--SLKDLKKLKSLSLEHNGISDI--NGL-----------------------VHLPQLESLYLGNNKITDI--TV 148 (605)
T ss_dssp CCCCCT--TSTTCTTCCEEECTTSCCCCC--GGG-----------------------GGCTTCSEEECCSSCCCCC--GG
T ss_pred CCCCCh--hhccCCCCCEEEecCCCCCCC--ccc-----------------------cCCCccCEEECCCCccCCc--hh
Confidence 555321 355555555555555555421 122 3333444444444444433 34
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 255 (786)
|..+++|++|+|++|+|.++.| +..+++|+.|+|++|+|+++ +.+..+++|+.|+|++|++.+.
T Consensus 149 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 149 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 4455555555555555554444 55555555555555555543 2455555555555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=215.07 Aligned_cols=205 Identities=22% Similarity=0.276 Sum_probs=162.6
Q ss_pred CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccc
Q 047901 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDT 130 (786)
Q Consensus 51 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 130 (786)
++..+.|+.+.+..+.+ +..|++|+.|+|++|.|+.++ .+..+++|+.|+|++|+|+++.+ |..+++|+.|+|++
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 35556677777775543 567788888888888887653 57778888888888888876655 77777788888777
Q ss_pred ccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCc
Q 047901 131 NQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210 (786)
Q Consensus 131 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 210 (786)
|+|++ ++.+..+++|+.|+|++|+|+++ ..|..+++|+.|+|++|+|+++ .
T Consensus 97 N~l~~-------------------------l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~ 147 (605)
T 1m9s_A 97 NKIKD-------------------------LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--T 147 (605)
T ss_dssp SCCCC-------------------------CTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--G
T ss_pred CCCCC-------------------------ChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--h
Confidence 77762 22466778888888888888875 4688999999999999999987 6
Q ss_pred CccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcC
Q 047901 211 NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTEL 290 (786)
Q Consensus 211 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 290 (786)
.+..+++|+.|+|++|+|+++.| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+...+...+..+..+
T Consensus 148 ~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~ 223 (605)
T 1m9s_A 148 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223 (605)
T ss_dssp GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEE
T ss_pred hhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEec
Confidence 79999999999999999997755 99999999999999999965 468999999999999999987655555554444
Q ss_pred cee
Q 047901 291 EYF 293 (786)
Q Consensus 291 ~~L 293 (786)
..+
T Consensus 224 ~~l 226 (605)
T 1m9s_A 224 NTV 226 (605)
T ss_dssp CCC
T ss_pred ccc
Confidence 433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=202.80 Aligned_cols=177 Identities=24% Similarity=0.210 Sum_probs=155.8
Q ss_pred cEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCcc-CCCCccEEEccCcccCCCCCccccCCccccEEEeec
Q 047901 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWG-KCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSS 249 (786)
Q Consensus 171 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 249 (786)
..+++++|+|+.++... .+.++.|+|++|+|+++.+..|. .+++|+.|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSSCCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCccCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57899999999865432 35689999999999999999898 999999999999999988888999999999999999
Q ss_pred ccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhh---hcccCCcEEEecccccCC
Q 047901 250 NHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEAL---GFMFKLFYLNFSHNQFSQ 326 (786)
Q Consensus 250 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 326 (786)
|+|+++.+..|.++++|+.|+|++|+|+.+.+..|.++++|+.|+|++|+|+.++...| ..+++|+.|+|++|+|+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888889999999999999999998888999999999999999999999888887 568899999999999988
Q ss_pred CcchHHhhhcC--cCeeeccCCccCC
Q 047901 327 EIPEDLALLAH--LSELDLSHNLFKG 350 (786)
Q Consensus 327 ~~~~~~~~l~~--L~~L~L~~N~l~~ 350 (786)
..+..|..++. |+.|+|++|++..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 77778888877 4888999998874
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=184.08 Aligned_cols=150 Identities=22% Similarity=0.247 Sum_probs=81.3
Q ss_pred eeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCccc
Q 047901 149 ILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228 (786)
Q Consensus 149 ~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 228 (786)
.+++++|.++.++..+. ++|+.|++++|+|+++.+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|
T Consensus 15 ~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 15 IVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 34445555544444333 4555556666666555555565566666666666666555555555555555555555555
Q ss_pred CCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccc
Q 047901 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300 (786)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 300 (786)
+.+.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 544444455555555555555555555555555555555555555555544444454444555444444444
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.9e-20 Score=182.62 Aligned_cols=150 Identities=21% Similarity=0.223 Sum_probs=111.6
Q ss_pred EEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCc
Q 047901 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84 (786)
Q Consensus 5 ~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 84 (786)
.++++++++. .+|... .++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~iP~~l---~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNL---PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EEECTTSCCS-SCCSSC---CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred EEEcCCCCcC-cCCCcc---CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 4677777776 566532 257788888888887777777888888888888888887777778888888888888888
Q ss_pred cCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeeccccccc
Q 047901 85 QFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFL 158 (786)
Q Consensus 85 ~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 158 (786)
+|+.+++. |..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|+.|++++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 88777665 567788888888888888777777878888888888888877666666666666666666666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.8e-21 Score=195.00 Aligned_cols=168 Identities=20% Similarity=0.279 Sum_probs=89.4
Q ss_pred CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccc
Q 047901 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDT 130 (786)
Q Consensus 51 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 130 (786)
++..+++++|.++.+. .+..+++|+.|++++|+|+.++ .+..+++|++|+|++|+|+++.+ |.++++|++|+|++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 3444445555554322 3444555555555555554333 34445555555555555554433 55555555555555
Q ss_pred ccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCc
Q 047901 131 NQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS 210 (786)
Q Consensus 131 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 210 (786)
|++++. |. +.. ++|+.|+|++|+|+++ +.|..+++|++|+|++|+|+++.
T Consensus 95 N~l~~l-~~------------------------~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~-- 144 (263)
T 1xeu_A 95 NRLKNL-NG------------------------IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV-- 144 (263)
T ss_dssp SCCSCC-TT------------------------CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--
T ss_pred CccCCc-Cc------------------------ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--
Confidence 555421 11 111 3444445555554443 23556666666666666666542
Q ss_pred CccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccccccc
Q 047901 211 NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255 (786)
Q Consensus 211 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 255 (786)
.+..+++|+.|+|++|+|++. ..+..+++|+.|++++|.+...
T Consensus 145 ~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 466666666666666666654 5566666777777777766644
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=7e-20 Score=182.56 Aligned_cols=151 Identities=19% Similarity=0.198 Sum_probs=82.7
Q ss_pred eeecccccccCCCCCcCCCCCCcEEEccCcccccccC-cccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc
Q 047901 149 ILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS-EDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227 (786)
Q Consensus 149 ~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 227 (786)
.+++++|.++.++..+. ..++.|+|++|+|+++.+ ..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+
T Consensus 15 ~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 92 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92 (220)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCc
Confidence 44444444444433332 234556666666655532 345566666666666666665555556666666666666666
Q ss_pred cCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccc
Q 047901 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301 (786)
Q Consensus 228 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 301 (786)
|+++.+..|.++++|++|+|++|+|+++.|..|..+++|+.|+|++|+|+++.|..|..+++|+.|+|++|++.
T Consensus 93 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred cCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 65555555555555555555555555555555555555555555555555555555555555555555555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-20 Score=200.38 Aligned_cols=222 Identities=11% Similarity=0.031 Sum_probs=157.8
Q ss_pred CCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc----cCCCCCccccCCccc
Q 047901 167 CRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN----ITGRIPPEIGNSSQL 242 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L 242 (786)
|++|+.+.|.+ +++.+...+|.++++|++|++++|.+..+.+.+|.++.++..+.++.+. ...+.+.+|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 67777777777 7777777888888888888888888877888888887777777666532 233445566666666
Q ss_pred c-EEEeeccc-ccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEec
Q 047901 243 H-VLDLSSNH-IAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFS 320 (786)
Q Consensus 243 ~-~L~Ls~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 320 (786)
+ .+.+.... +............++..+.+.++-...........+++|+.|+|++|.++.++..+|.++.+|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 6 45554321 111111111223455555555542211111111237889999999988998888999999999999998
Q ss_pred ccccCCCcchHHhhhcCcC-eeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEec
Q 047901 321 HNQFSQEIPEDLALLAHLS-ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDI 391 (786)
Q Consensus 321 ~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 391 (786)
+| ++.+.+.+|.++.+|+ .|++.+ .++.+.+..|.++++|+.|++++|+++.+.+.+|.++++|+.++.
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 88 7777778899999998 999988 777677789999999999999999998888889999999988764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.7e-20 Score=182.26 Aligned_cols=153 Identities=22% Similarity=0.184 Sum_probs=86.8
Q ss_pred cEEEccCcccCCCCCccccCCccccEEEeecccccccCC-CCcccccccccccccccccCCCCccccccCCcCceecccc
Q 047901 219 GTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP-MELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSS 297 (786)
Q Consensus 219 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 297 (786)
+++++++|.++. +|..+. ..++.|+|++|+|++..+ ..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 467777777774 444443 345677777777765533 3456666666666666666655555566666666666666
Q ss_pred ccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccc
Q 047901 298 NRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374 (786)
Q Consensus 298 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (786)
|+++.+.+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 66555555555555555555555555555445555555555555555555554444455555555555555555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-18 Score=188.31 Aligned_cols=265 Identities=12% Similarity=0.111 Sum_probs=178.4
Q ss_pred CCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEE
Q 047901 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYIS 103 (786)
Q Consensus 25 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~ 103 (786)
+..++.+.+- |.++.+...+|.+. +|+.+.|.+| ++.+...+|.+ .+|+.+.|.. .++.+.. .|.++++|+.++
T Consensus 112 ~~~l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEEC-CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 3555555554 34555555555553 4666665554 55455555555 3466666654 4444433 355556666666
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCC-cCCCCCCcEEEccCccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTG 182 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~-l~~l~~L~~L~L~~N~l~~ 182 (786)
|.+|+++.+...+|. ..+|+.+.|..+ ++.....+|.++.+|+.+++.+| ++.+... |.+ .+|+.+.+ .|.++.
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence 666666655555555 355666666533 55455555666666666666553 3332222 444 57777777 456777
Q ss_pred ccCcccCCCCCCCEEeccCCccc-----cccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCC
Q 047901 183 NISEDFGIYPNLKFLDLSHNNFY-----GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP 257 (786)
Q Consensus 183 ~~~~~f~~l~~L~~L~L~~N~i~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~ 257 (786)
+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. +.++.+...+|.++.+|+.++|..| ++.+..
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 88888888888999888888775 6788889999999999998 4577777888888899999999655 776778
Q ss_pred CCcccccccccccccccccCCCCccccccCC-cCceeccccccccc
Q 047901 258 MELGRLISLNKLILRGNQLSGHLPRALGLLT-ELEYFDLSSNRLNN 302 (786)
Q Consensus 258 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 302 (786)
.+|.++ +|+.+++.+|.+..+.+..|.+++ +++.|++..+.+..
T Consensus 340 ~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 340 SAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK 384 (401)
T ss_dssp TSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred HhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence 889888 899999999988888888888885 68888888877654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=191.64 Aligned_cols=171 Identities=20% Similarity=0.300 Sum_probs=119.5
Q ss_pred CCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEE
Q 047901 24 SFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYIS 103 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 103 (786)
.+.++..+++++|.++++. .+..+++|++|++++|+|+.+ + .+..+++|++|+|++|+|+++++ +..+++|++|+
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~ 91 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEE
Confidence 3556777788888886554 577888888888888888754 3 67888888888888888887766 77888888888
Q ss_pred ccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccc
Q 047901 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN 183 (786)
Q Consensus 104 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~ 183 (786)
|++|+++++.+ +.. ++|++|+|++|++++. ..+ .++++|+.|++++|+|+++
T Consensus 92 L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l-----------------------~~l~~L~~L~Ls~N~i~~~ 143 (263)
T 1xeu_A 92 VNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSL-----------------------IHLKNLEILSIRNNKLKSI 143 (263)
T ss_dssp CCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGG-----------------------TTCTTCCEEECTTSCCCBC
T ss_pred CCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhh-----------------------cCcccccEEECCCCcCCCC
Confidence 88888886543 222 7788888888887742 123 3445555555555555544
Q ss_pred cCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCC
Q 047901 184 ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR 231 (786)
Q Consensus 184 ~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 231 (786)
. .+..+++|++|+|++|+|+++ ..+..+++|+.|++++|++...
T Consensus 144 ~--~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 144 V--MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp G--GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 2 466667777777777777665 5566777777777777777643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.8e-20 Score=196.15 Aligned_cols=260 Identities=15% Similarity=0.066 Sum_probs=173.5
Q ss_pred CCCCcEEECCCCCcc--ccCchhccCCCCCCEEeCcCCcccccCCccccC--------CCCCCEEeCCCccCcccCCC-C
Q 047901 25 FPHLAYLDLSINGFF--GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGL--------LTHLFSLDLSLNQFSGTFPP-I 93 (786)
Q Consensus 25 l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~~-~ 93 (786)
+++|++|||++|+|. ...+..+. .++.+.+..|. +.+.+|.+ +++|+.|+|++ .++.+.+. |
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCcccccc---ccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 788999999999997 33333333 25666677773 45677888 99999999998 88877664 8
Q ss_pred CCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccc----cccCChhhhccCccc-eeeccccccc-C-CCCCcCC
Q 047901 94 CNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQF----TGQLPRNICRSGLLE-ILTVNDNHFL-G-SIPNLRN 166 (786)
Q Consensus 94 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l----~~~~~~~~~~~~~L~-~L~l~~N~l~-~-~~~~l~~ 166 (786)
.++++|++|+|++|.+..+.+.+|.++.++..+.+..+.. ......+|.+...|+ .+.+....-. . ....-..
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 8899999999999999888889999888888887776422 223444565555655 3333321100 0 0000112
Q ss_pred CCCCcEEEccCcccccccCccc-CCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcccc-E
Q 047901 167 CRSLVRAHLGRNNLTGNISEDF-GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLH-V 244 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~~~~~f-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~ 244 (786)
..++..+.+.++-.. .....+ ..+++|++|+|++|+++.+.+.+|.++++|++|+|++| ++.+.+.+|.++++|+ .
T Consensus 201 ~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 201 PRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp GGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred ccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence 344455555443211 111111 23677777777777777777777777777777777776 6666677777777777 7
Q ss_pred EEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceec
Q 047901 245 LDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFD 294 (786)
Q Consensus 245 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 294 (786)
|++.+ .++.+.+.+|.++++|+.|++++|.++.+.+.+|.++++|+.++
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 77777 66666677777777777777777777777777777777777765
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.5e-19 Score=177.31 Aligned_cols=135 Identities=24% Similarity=0.274 Sum_probs=73.5
Q ss_pred CCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccc
Q 047901 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271 (786)
Q Consensus 192 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 271 (786)
++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+.+.+..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 44555555555555555555555555555555555555444444555555555555555555444444555555555555
Q ss_pred cccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCC
Q 047901 272 RGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE 327 (786)
Q Consensus 272 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 327 (786)
++|+|+ .+|..+..+++|+.|+|++|+|+.+++..|..+++|+.|+|++|.+...
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 555555 3344455555566666666665555555555566666666666666543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-22 Score=226.28 Aligned_cols=204 Identities=17% Similarity=0.135 Sum_probs=150.5
Q ss_pred CCCCCCcEEEccCCcCcccCchhhcccCCcceecccccc-------------ccccCChhhhccCccceee-cccccccC
Q 047901 94 CNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ-------------FTGQLPRNICRSGLLEILT-VNDNHFLG 159 (786)
Q Consensus 94 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~~~~L~~L~-l~~N~l~~ 159 (786)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+..|..+..+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 44666666777777766 446666777777777766654 4456667777777777777 666654
Q ss_pred CCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCC
Q 047901 160 SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNS 239 (786)
Q Consensus 160 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 239 (786)
.+|..+.+.+|.|+.+.+ ..|+.|+|++|+|+++ |. |..+++|+.|+|++|+|+ .+|..|.++
T Consensus 423 --------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp --------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred --------chhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 345556677777776543 2478888888888875 44 888888888888888888 567788888
Q ss_pred ccccEEEeecccccccCCCCcccccccccccccccccCCCC-ccccccCCcCceeccccccccccchh---hhhcccCCc
Q 047901 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHL-PRALGLLTELEYFDLSSNRLNNSILE---ALGFMFKLF 315 (786)
Q Consensus 240 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~ 315 (786)
++|+.|+|++|+|++ +| .|..+++|+.|+|++|+|+++. |..|..+++|+.|+|++|++++.++. .+..+++|+
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~ 563 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence 888888888888886 45 7888888888888888888776 88888888888888888888876543 345578888
Q ss_pred EEEe
Q 047901 316 YLNF 319 (786)
Q Consensus 316 ~L~L 319 (786)
.|++
T Consensus 564 ~L~l 567 (567)
T 1dce_A 564 SILT 567 (567)
T ss_dssp EEEC
T ss_pred ccCC
Confidence 8864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-21 Score=221.94 Aligned_cols=203 Identities=21% Similarity=0.173 Sum_probs=119.7
Q ss_pred cccCCcceeccccccccccCChhhhccCccceeecccccc-------------cCCCC-CcCCCCCCcEEE-ccCccccc
Q 047901 118 GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHF-------------LGSIP-NLRNCRSLVRAH-LGRNNLTG 182 (786)
Q Consensus 118 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l-------------~~~~~-~l~~l~~L~~L~-L~~N~l~~ 182 (786)
...++|+.|+|++|+++ .+|..+..++.|+.|++++|.. .+.++ .+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45566777777777776 5677777777777777755531 11111 122333333333 2222221
Q ss_pred ccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccc
Q 047901 183 NISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGR 262 (786)
Q Consensus 183 ~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 262 (786)
+|+.+.+++|.|+.+.+ ..|+.|+|++|+|++ +|. |..+++|+.|+|++|.|+ .+|..|.+
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 22333344444443322 136677777777775 344 667777777777777776 55666777
Q ss_pred ccccccccccccccCCCCccccccCCcCceeccccccccccc-hhhhhcccCCcEEEecccccCCCcch---HHhhhcCc
Q 047901 263 LISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI-LEALGFMFKLFYLNFSHNQFSQEIPE---DLALLAHL 338 (786)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L 338 (786)
+++|+.|+|++|+|+++ | .|+.+++|+.|+|++|+|+++. +..+..+++|+.|+|++|.+++.+|. .+..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 77777777777777653 3 5667777777777777777665 66677777777777777777655442 23446666
Q ss_pred Ceeec
Q 047901 339 SELDL 343 (786)
Q Consensus 339 ~~L~L 343 (786)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 66653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-18 Score=186.55 Aligned_cols=267 Identities=11% Similarity=0.034 Sum_probs=212.2
Q ss_pred ccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcc
Q 047901 46 VRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLS 124 (786)
Q Consensus 46 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 124 (786)
+.....++.+.+.++ ++.+...+|.+. +|+.+.|..| ++.+... |.+ .+|+.+.|.+ .++.+...+|.++++|+
T Consensus 109 ~~~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~ 183 (401)
T 4fdw_A 109 TEILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLK 183 (401)
T ss_dssp EEECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCC
T ss_pred EEecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCC
Confidence 445678888888764 666888888874 7999998877 6666553 656 4788998885 77778888899999999
Q ss_pred eeccccccccccCChhhhccCccceeecccccccCCCC-CcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCc
Q 047901 125 YLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIP-NLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNN 203 (786)
Q Consensus 125 ~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~ 203 (786)
.+++++|+++.....+|. ..+|+.+.+..+ ++.+.. .|.+|++|+.+.+..| ++.+...+|.+ .+|+.+.| .|.
T Consensus 184 ~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~ 258 (401)
T 4fdw_A 184 KADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNG 258 (401)
T ss_dssp EEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETT
T ss_pred eeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCC
Confidence 999998888866666666 578888888755 555443 4788888999998875 77788888888 78999998 466
Q ss_pred cccccCcCccCCCCccEEEccCcccC-----CCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCC
Q 047901 204 FYGEISSNWGKCHRLGTLIVSGNNIT-----GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG 278 (786)
Q Consensus 204 i~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 278 (786)
++.+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. +.++.+...+|.++++|+.+.|..| ++.
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~ 336 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQ 336 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCE
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccE
Confidence 77788888999999999998888765 4667788888999999998 4577777888888889999998655 777
Q ss_pred CCccccccCCcCceeccccccccccchhhhhccc-CCcEEEecccccC
Q 047901 279 HLPRALGLLTELEYFDLSSNRLNNSILEALGFMF-KLFYLNFSHNQFS 325 (786)
Q Consensus 279 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 325 (786)
+...+|.++ +|+.+++++|.+..+....|..++ .++.|++..+.+.
T Consensus 337 I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 337 INFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 788888888 899999999988888888888874 6788888877664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-18 Score=175.40 Aligned_cols=151 Identities=21% Similarity=0.165 Sum_probs=77.6
Q ss_pred ceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc
Q 047901 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227 (786)
Q Consensus 148 ~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 227 (786)
+.++++++.++.++..+. ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+.+.+..|..+++|+.|+|++|+
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 344555555544444333 445555555555555555555555555555555555555444455555555555555555
Q ss_pred cCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccc
Q 047901 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301 (786)
Q Consensus 228 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 301 (786)
|+++.+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++.
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 55444444555555555555555555 34444555555555555555555444444555555555555555544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.1e-19 Score=172.66 Aligned_cols=107 Identities=15% Similarity=0.260 Sum_probs=60.6
Q ss_pred cCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCccee
Q 047901 47 RNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYL 126 (786)
Q Consensus 47 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 126 (786)
..+++|++|++++|+|+. .| .+..+++|++|++++|.++.. +.+..+++|++|+|++|++++..+..|.++++|++|
T Consensus 41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 445556666666666652 23 456666666666666655432 245556666666666666665555556666666666
Q ss_pred ccccccccccCChhhhccCccceeeccccc
Q 047901 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNH 156 (786)
Q Consensus 127 ~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~ 156 (786)
++++|++++..|..+..+++|+.|++++|.
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 666666665445555444444444444443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=177.68 Aligned_cols=143 Identities=17% Similarity=0.204 Sum_probs=108.7
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCE--EEEEEcCCCCCCC--------------------chhhHHHHHHHHHHHhh
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDK--IAVKKFNSPFPND--------------------QMSDQKEFLNEIKALTK 562 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~--------------------~~~~~~~~~~e~~~l~~ 562 (786)
.-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... .......+.+|+.++..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467888999999999999987 67888 9999976531110 00112367899999999
Q ss_pred cCCCcc--cceeeEEecCCeeeEEEeccCC-C----CHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeE
Q 047901 563 IRHRNI--VKFYGFCSHVRHSFVVYEYINR-G----SLATVLSNNFASEDFDWRKRMNVITGVADALSYMH-HDCFPPIV 634 (786)
Q Consensus 563 l~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH-~~~~~~iv 634 (786)
+.|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. +|+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 988864 334432 356899999942 4 67666432 123456789999999999999 88 999
Q ss_pred EcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 635 HRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 635 Hrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||||+|||++. .++|+|||+|....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999998 99999999998664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-17 Score=180.36 Aligned_cols=331 Identities=12% Similarity=0.024 Sum_probs=170.8
Q ss_pred CCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCC
Q 047901 17 LQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICN 95 (786)
Q Consensus 17 l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~ 95 (786)
|.+.+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+.. .|.+
T Consensus 62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence 5556666666677776653 365666666666666777766544 55466666666666666665544 222222 2444
Q ss_pred CCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEc
Q 047901 96 LSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHL 175 (786)
Q Consensus 96 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L 175 (786)
+..++.... +.+..+...+|.++++|+.+.+..+. +.....+|.+..+|+.+.+..|
T Consensus 139 ~~~~~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-------------------- 195 (394)
T 4fs7_A 139 CDFKEITIP--EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-------------------- 195 (394)
T ss_dssp CCCSEEECC--TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT--------------------
T ss_pred ccccccccC--ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC--------------------
Confidence 433222221 22223444556666666666665432 2244444444444554444433
Q ss_pred cCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccccccc
Q 047901 176 GRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGE 255 (786)
Q Consensus 176 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 255 (786)
++.+...+|.+...|+.+.+..+... +. +.+....+|+.+.+..+ ++.+....|.+...|+.+.+..+... +
T Consensus 196 ----~~~I~~~~F~~~~~L~~i~~~~~~~~-i~-~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i 267 (394)
T 4fs7_A 196 ----LKIIRDYCFAECILLENMEFPNSLYY-LG-DFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-I 267 (394)
T ss_dssp ----CCEECTTTTTTCTTCCBCCCCTTCCE-EC-TTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-E
T ss_pred ----ceEeCchhhccccccceeecCCCceE-ee-hhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-e
Confidence 33344445555555555554443322 21 12222344555555432 22233445555555555555544332 4
Q ss_pred CCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhh
Q 047901 256 IPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALL 335 (786)
Q Consensus 256 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 335 (786)
...+|.....++.+.+..+.+ ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++
T Consensus 268 ~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c 342 (394)
T 4fs7_A 268 GGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC 342 (394)
T ss_dssp CSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred eccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence 444555555555555544432 2234555556666555443 55555556666666666666433 444455566666
Q ss_pred cCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEE
Q 047901 336 AHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSI 389 (786)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 389 (786)
.+|+.+++..| ++.+...+|.++.+|+.+++..+ ++. ...+|.+.++|+.+
T Consensus 343 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~~-~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 343 TSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LEQ-YRYDFEDTTKFKWI 393 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GGG-GGGGBCTTCEEEEE
T ss_pred CCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CEE-hhheecCCCCCcEE
Confidence 66666666555 55455566666666776666544 332 23456666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=169.25 Aligned_cols=152 Identities=17% Similarity=0.191 Sum_probs=79.0
Q ss_pred CCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccccccc
Q 047901 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNK 268 (786)
Q Consensus 189 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~ 268 (786)
..+++|++|++++|.|+.+. .+..+++|++|++++|.++. +..+..+++|+.|++++|.+++..+..|..+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 33456666666666666333 35556666666666665542 235556666666666666666555555555555555
Q ss_pred ccccccccCCCCccccccCCcCceecccccc-ccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCc
Q 047901 269 LILRGNQLSGHLPRALGLLTELEYFDLSSNR-LNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNL 347 (786)
Q Consensus 269 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 347 (786)
|+|++|++++..+..+..+++|+.|++++|+ +..++ .+..+++|++|++++|.+++.. .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 5555555554444555555555555555554 44332 3444444444444444443321 33444444444444444
Q ss_pred c
Q 047901 348 F 348 (786)
Q Consensus 348 l 348 (786)
|
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-19 Score=208.38 Aligned_cols=197 Identities=19% Similarity=0.150 Sum_probs=83.9
Q ss_pred CCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEc
Q 047901 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISL 104 (786)
Q Consensus 25 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L 104 (786)
-+.++.|+|.+|.+..+ +. ..|+.++|++|.|.. ++++.|++...+..+..+++|+.|+|
T Consensus 172 ~~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 172 TPLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSIDE--------------DDDIENRMVMPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CCccceEEeeCCCCCcc-hh-----hHhhcCccCcccccC--------------ccccccceecChhhhccCCCCcEEEC
Confidence 35566677766666542 21 124445555555442 23444554433334566666666666
Q ss_pred cCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCccccccc
Q 047901 105 HNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNI 184 (786)
Q Consensus 105 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~ 184 (786)
++|+|..+++ .+.++++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|+.++..+.++++|+.|+|++|.|+.+
T Consensus 232 s~n~l~~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~l- 308 (727)
T 4b8c_D 232 SNLQIFNISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTTL- 308 (727)
T ss_dssp TTSCCSCCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCCCC-
T ss_pred CCCCCCCCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCCcc-
Confidence 6666664333 3336666777777777666 556666666666666666666665544566666666666666666644
Q ss_pred CcccCCCCCCCEEeccCCccccccCcCccCCCC-ccEEEccCcccCCCCCccccCCccccEEEeecc
Q 047901 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHR-LGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSN 250 (786)
Q Consensus 185 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 250 (786)
|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|. .|..|+++.|
T Consensus 309 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 309 PWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp CSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred ChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence 334666777777777777776666665544321 22356666666655543 3344455554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-17 Score=179.89 Aligned_cols=318 Identities=10% Similarity=0.002 Sum_probs=225.8
Q ss_pred ccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhh
Q 047901 38 FFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEI 117 (786)
Q Consensus 38 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 117 (786)
++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|..| ++.+...+|
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~------------------------l~~I~~~aF 113 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS------------------------VKMIGRCTF 113 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT------------------------CCEECTTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC------------------------ceEccchhh
Confidence 44445555555555555555432 44455555555555555555433 333444444
Q ss_pred cccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEE
Q 047901 118 GNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFL 197 (786)
Q Consensus 118 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L 197 (786)
.++.+|+.+.+..+ ++.....+|.+...++.......... ....+.++++|+.+.+..+ +..+....|.++++|+.+
T Consensus 114 ~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~~~i-~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i 190 (394)
T 4fs7_A 114 SGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGVTVI-GDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSI 190 (394)
T ss_dssp TTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTCCEE-CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBC
T ss_pred cccccchhhcccCc-eeeecceeeecccccccccCcccccc-chhhhcccCCCcEEecCCc-cceeccccccCCCCceEE
Confidence 44444444444332 22233334443332222222111111 1224677888888888755 455888999999999999
Q ss_pred eccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccC
Q 047901 198 DLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLS 277 (786)
Q Consensus 198 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 277 (786)
++..| ++.+...+|.++..|+.+.+..+... + ...+....+|+.+.+..+ ++.+...+|.....|+.+.+..+...
T Consensus 191 ~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~ 266 (394)
T 4fs7_A 191 KLPRN-LKIIRDYCFAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR 266 (394)
T ss_dssp CCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE
T ss_pred EcCCC-ceEeCchhhccccccceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce
Confidence 99887 77788999999999999999877654 3 344455678999999754 44477788999999999999888654
Q ss_pred CCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccc
Q 047901 278 GHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC 357 (786)
Q Consensus 278 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 357 (786)
+....|..+..++.+....+. +....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++.+....|.
T Consensus 267 -i~~~~F~~~~~l~~~~~~~~~---i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 340 (394)
T 4fs7_A 267 -IGGSLFYNCSGLKKVIYGSVI---VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFR 340 (394)
T ss_dssp -ECSCTTTTCTTCCEEEECSSE---ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTT
T ss_pred -eeccccccccccceeccCcee---eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhcc
Confidence 778899999999999887765 45678999999999999865 76677789999999999999755 7767778999
Q ss_pred cccccceeccccccccccCCcccccCCCceEEeccCC
Q 047901 358 NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394 (786)
Q Consensus 358 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 394 (786)
++.+|+.+++..| ++.+-..+|.++.+|+.+++..+
T Consensus 341 ~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 341 GCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 9999999999877 88888899999999999999765
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.4e-19 Score=207.11 Aligned_cols=189 Identities=21% Similarity=0.200 Sum_probs=100.5
Q ss_pred ccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCC
Q 047901 199 LSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG 278 (786)
Q Consensus 199 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 278 (786)
++.|++. +.++.|..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|.++++|+.|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3334444 45666777777777777777777 45555557777777777777777 56677777777777777777777
Q ss_pred CCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcC-cCeeeccCCccCCCCCcccc
Q 047901 279 HLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAH-LSELDLSHNLFKGSIPSRIC 357 (786)
Q Consensus 279 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~ 357 (786)
.+|..|..+++|+.|+|++|.|+.++.. |..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVTTLPWE-FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCCCCCSS-TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred ccChhhcCCCCCCEEECCCCCCCccChh-hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence 4466677777777777777777765443 777777777788888777777777655432 234778888888766653
Q ss_pred cccccceeccccc--------cccccCCcccccCCCceEEeccCCcccc
Q 047901 358 NLESLEKLNLSHN--------NISGQIPACFIGMSGLLSIDISYNELRG 398 (786)
Q Consensus 358 ~l~~L~~L~L~~N--------~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 398 (786)
|+.|++++| .|.+..+..+..+..+....+++|-+..
T Consensus 361 ----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 361 ----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ---------------------------------------------CCCG
T ss_pred ----cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 445566666 3444444455556666666777777654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-17 Score=158.96 Aligned_cols=127 Identities=24% Similarity=0.213 Sum_probs=58.2
Q ss_pred cEEEccCcccccccCcccCCCCCCCEEeccCCccccccCc-CccCCCCccEEEccCcccCCCCCccccCCccccEEEeec
Q 047901 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS-NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSS 249 (786)
Q Consensus 171 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 249 (786)
+.+++++|+|+.++...+ ++|++|+|++|+|+++.+. .|..+++|++|+|++|+|+++.|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 345555555554433221 2455555555555544443 244455555555555555544444444444444444444
Q ss_pred ccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccc
Q 047901 250 NHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300 (786)
Q Consensus 250 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 300 (786)
|+|++..+..|.++++|+.|+|++|+|+++.|..|..+++|+.|+|++|++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 138 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCc
Confidence 444444444444444444444444444444344444444443333333333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=161.27 Aligned_cols=128 Identities=17% Similarity=0.199 Sum_probs=63.9
Q ss_pred CEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCc-cccCCccccEEEeecccccccCCCCcccccccccccccc
Q 047901 195 KFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPP-EIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRG 273 (786)
Q Consensus 195 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 273 (786)
+++++++|+++.++...+ .+|++|+|++|+|+++.+. .|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 556666666654332221 1555555555555544432 255555555555555555555455555555555555555
Q ss_pred cccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccC
Q 047901 274 NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 274 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 325 (786)
|+|+++.+..|.++++|+.|+|++|+++++.+..|..+++|++|+|++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 5555444444544555555555555444444444444444444444444443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=155.92 Aligned_cols=137 Identities=22% Similarity=0.130 Sum_probs=108.2
Q ss_pred CCCCCcEEECCCCCcc-ccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcE
Q 047901 24 SFPHLAYLDLSINGFF-GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKY 101 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~ 101 (786)
..++|++|+|++|+++ +..|..|..+++|++|+|++|+|+.+ ..|..+++|++|+|++|++++..+. +..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3477888888888886 46677788888888888888888865 6788888888888888888875444 455888888
Q ss_pred EEccCCcCcccCc-hhhcccCCcceeccccccccccCC---hhhhccCccceeecccccccCCCC
Q 047901 102 ISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQLP---RNICRSGLLEILTVNDNHFLGSIP 162 (786)
Q Consensus 102 L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~L~~L~l~~N~l~~~~~ 162 (786)
|+|++|+|+++.. ..|..+++|++|++++|++++..+ ..+..+++|+.|++++|.+...+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 8888888886543 678888888888888888886655 478888888888888888776544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3e-16 Score=152.62 Aligned_cols=125 Identities=28% Similarity=0.347 Sum_probs=81.8
Q ss_pred EEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCc
Q 047901 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84 (786)
Q Consensus 5 ~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 84 (786)
.++++++++. .+|... .++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~~---~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGI---PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSCC---CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCCC---CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4566666665 555432 246677777777765 34466667777777777777776666666777777777777777
Q ss_pred cCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceecccccccc
Q 047901 85 QFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 85 ~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 134 (786)
+|+++++. |..+++|++|+|++|+|+.+++..|..+++|++|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 77666553 666667777777777776666666666667777777766665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=151.39 Aligned_cols=132 Identities=22% Similarity=0.183 Sum_probs=58.6
Q ss_pred CCCCEEeccCCccc-cccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccccccccc
Q 047901 192 PNLKFLDLSHNNFY-GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLI 270 (786)
Q Consensus 192 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 270 (786)
++|++|+|++|+++ +..|..+..+++|+.|+|++|.|+++ ..+..+++|+.|+|++|+++
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~----------------- 84 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIF----------------- 84 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCC-----------------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCc-----------------
Confidence 45555555555554 23333344444444444444444432 33444444444444444443
Q ss_pred ccccccCCCCccccccCCcCceeccccccccccch-hhhhcccCCcEEEecccccCCCcc---hHHhhhcCcCeeeccCC
Q 047901 271 LRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQFSQEIP---EDLALLAHLSELDLSHN 346 (786)
Q Consensus 271 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N 346 (786)
+.+|..+..+++|+.|++++|+++.++. ..+..+++|++|++++|.+++..+ ..+..+++|+.|++++|
T Consensus 85 -------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n 157 (168)
T 2ell_A 85 -------GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157 (168)
T ss_dssp -------SCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred -------hHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence 3333333344444444444444444322 334444444444444444443333 24444555555555555
Q ss_pred ccC
Q 047901 347 LFK 349 (786)
Q Consensus 347 ~l~ 349 (786)
.+.
T Consensus 158 ~~~ 160 (168)
T 2ell_A 158 EDQ 160 (168)
T ss_dssp TSC
T ss_pred Chh
Confidence 444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=8.5e-17 Score=149.63 Aligned_cols=129 Identities=22% Similarity=0.170 Sum_probs=101.3
Q ss_pred CCCCCcEEECCCCCcc-ccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcE
Q 047901 24 SFPHLAYLDLSINGFF-GTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKY 101 (786)
Q Consensus 24 ~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 101 (786)
..++|+.|++++|.++ +..|..+..+++|++|+|++|+|+++ ..|..+++|++|+|++|++++..+ .+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3477888888888886 56677788888888888888888865 678888888888888888887444 3556888888
Q ss_pred EEccCCcCccc-CchhhcccCCcceeccccccccccCC---hhhhccCccceeeccc
Q 047901 102 ISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLP---RNICRSGLLEILTVND 154 (786)
Q Consensus 102 L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~L~~L~l~~ 154 (786)
|+|++|+++++ .+..|.++++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88888888864 34778888888888888888886665 5788888888888763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.6e-16 Score=149.29 Aligned_cols=129 Identities=23% Similarity=0.215 Sum_probs=100.2
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
+.++++++++. .++... .++|++|+|++|+++++.+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 46777877776 455432 36788888888888777777788888888888888888877777778888888888888
Q ss_pred ccCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCcceecccccccccc
Q 047901 84 NQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQ 136 (786)
Q Consensus 84 N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 136 (786)
|+|+++++. +..+++|++|+|++|+|+++++..|..+++|++|+|++|++++.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 888877665 67788888888888888877777778888888888888887743
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-16 Score=148.23 Aligned_cols=124 Identities=27% Similarity=0.331 Sum_probs=61.3
Q ss_pred eEEEEcCCCCCc-ccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 3 VNSINLTSTGLK-GTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 3 ~~~l~l~~~~l~-~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
++.|++++|++. +.++. .|..+++|++|+|++|.++++ ..|..+++|++|+|++|+|++..|..+..+++|++|+|
T Consensus 19 l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 19 VKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp CSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred CeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 445555555554 34443 344555555555555555443 44555555555555555555444444444555555555
Q ss_pred CCccCcccC--CCCCCCCCCcEEEccCCcCcccCc---hhhcccCCcceeccc
Q 047901 82 SLNQFSGTF--PPICNLSNLKYISLHNNKLSGSIP---EEIGNLMKLSYLMLD 129 (786)
Q Consensus 82 s~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~ 129 (786)
++|++++.+ ..+..+++|++|++++|+++++++ ..|..+++|++|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555554432 334445555555555555554443 345555555555543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.3e-16 Score=150.29 Aligned_cols=126 Identities=24% Similarity=0.176 Sum_probs=74.0
Q ss_pred EEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeeccc
Q 047901 172 RAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNH 251 (786)
Q Consensus 172 ~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 251 (786)
.+++++|+|+.++... .++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~~ip~~~---~~~l~~L~L~~n~i~~i-p~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLKVLPKGI---PRDVTELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCSSCCSCC---CTTCCEEECCSSCCCSC-CGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCCcCCCCC---CCCCCEEECCCCcCchh-HHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3444444444433221 13555666666665532 3555566666666666666665555556666666666666666
Q ss_pred ccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccc
Q 047901 252 IAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301 (786)
Q Consensus 252 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 301 (786)
|+++.+..|.++++|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66555556666666666666666666555556666667777777777665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.64 E-value=5e-15 Score=161.45 Aligned_cols=333 Identities=8% Similarity=0.066 Sum_probs=188.9
Q ss_pred cCCcCccCCCC-CCcEEECCCCCccccCchhccCCCCCCEEeCcCCc---ccccCCccccCCCCCCEEeCCCccCcccCC
Q 047901 16 TLQEFSFSSFP-HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENE---LSGKIPPEIGLLTHLFSLDLSLNQFSGTFP 91 (786)
Q Consensus 16 ~l~~~~f~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 91 (786)
.|.+.+|.+.. .|+.+.+-. .++.+...+|.++.+|+.+.++.|. ++.+...+|..+.+|+.+.+..+ ++.+..
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~ 130 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS 130 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred EcCHhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence 46667788774 588888864 4777888888888888888887764 66677778888888888777655 444443
Q ss_pred -CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCC
Q 047901 92 -PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSL 170 (786)
Q Consensus 92 -~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L 170 (786)
.|..+.+|+.+.+..+ +..+....|.++.+|+.+.+..+ ++.....+|.+ ..|+.+.+..+...-....+.++.++
T Consensus 131 ~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~i~~~af~~c~~l 207 (394)
T 4gt6_A 131 EAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTRIGTNAFSECFAL 207 (394)
T ss_dssp TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCEECTTTTTTCTTC
T ss_pred hhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccccccchhhhcccc
Confidence 4777888888888654 44577778888888888887655 44344444543 45666666554333222334555555
Q ss_pred cEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecc
Q 047901 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSN 250 (786)
Q Consensus 171 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 250 (786)
.......+....+....+........-. ..+.....+..+.+.. .++.+...+|.++.+|+.+.+..+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~ 275 (394)
T 4gt6_A 208 STITSDSESYPAIDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDS 275 (394)
T ss_dssp CEEEECCSSSCBSSSCEEEECTTSCEEE-----------EECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTT
T ss_pred ceecccccccccccceeecccccccccc-----------cccccccccceEEcCC-cceEcccceeeecccccEEecccc
Confidence 5555544443322211111110000000 0011112233333322 223344455666666666666544
Q ss_pred cccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcch
Q 047901 251 HIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPE 330 (786)
Q Consensus 251 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 330 (786)
... +...+|.+..+|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.+...
T Consensus 276 ~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~ 351 (394)
T 4gt6_A 276 VVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPES 351 (394)
T ss_dssp CCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGG
T ss_pred cce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHh
Confidence 332 555566666666666664 3444455666666666776666543 56666667777777777777543 5555566
Q ss_pred HHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccc
Q 047901 331 DLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372 (786)
Q Consensus 331 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (786)
+|.++.+|+.+++.+|... . ..|....+|+.+.+..|.+
T Consensus 352 aF~~C~~L~~i~~~~~~~~-~--~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 352 AFSNCTALNNIEYSGSRSQ-W--NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GGTTCTTCCEEEESSCHHH-H--HTCBCCCCC----------
T ss_pred HhhCCCCCCEEEECCceee-h--hhhhccCCCCEEEeCCCCE
Confidence 7777777777777766543 1 3555666777777666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=168.16 Aligned_cols=152 Identities=11% Similarity=0.107 Sum_probs=105.4
Q ss_pred HHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCC-----Cc-----hhhHHH--------HHHHHHHHh
Q 047901 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPN-----DQ-----MSDQKE--------FLNEIKALT 561 (786)
Q Consensus 500 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~-----~~~~~~--------~~~e~~~l~ 561 (786)
.+.....-|.+.++||+|++|.||+|...+|+.||||+++..... .. ...... ..+|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 344444459999999999999999999889999999987642110 00 000111 234556666
Q ss_pred hcCCCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 047901 562 KIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSN 641 (786)
Q Consensus 562 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 641 (786)
++.++++....-+.. ...++||||++|++|.+.... .....++.|++.++.|||+. |||||||||.
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence 664443322111111 123799999999888665321 12356889999999999998 9999999999
Q ss_pred ceeeCCCC----------cEEEeccccceecCCC
Q 047901 642 NVLLDLEY----------EARVSDFGTAKLLKPN 665 (786)
Q Consensus 642 Nill~~~~----------~~kl~Dfg~a~~~~~~ 665 (786)
|||+++++ .+.|+||+-+....++
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence 99998776 3899999988766543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=146.37 Aligned_cols=111 Identities=23% Similarity=0.209 Sum_probs=60.6
Q ss_pred CCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccc
Q 047901 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271 (786)
Q Consensus 192 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 271 (786)
++|++|++++|+++++.+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 34555555555555544444555555555555555555444444555555555555555555444445555555555555
Q ss_pred cccccCCCCccccccCCcCceeccccccccc
Q 047901 272 RGNQLSGHLPRALGLLTELEYFDLSSNRLNN 302 (786)
Q Consensus 272 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 302 (786)
++|+++++++..|..+++|+.|++++|++..
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5555555555555555666666666665554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=8.8e-16 Score=147.12 Aligned_cols=133 Identities=20% Similarity=0.191 Sum_probs=98.0
Q ss_pred ccCCCCCCcEEECCCCCccccCchhccCC-CCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCC-CCCCC
Q 047901 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNL-SKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPI-CNLSN 98 (786)
Q Consensus 21 ~f~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~l~~ 98 (786)
.|...++|++|+|++|+++.+ +. +..+ ++|++|+|++|+|+++ ..|..+++|++|+|++|+|+++++.+ ..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 467778888888888888754 44 4444 4888888888888865 57788888888888888888776653 67888
Q ss_pred CcEEEccCCcCcccCc-hhhcccCCcceeccccccccccCCh----hhhccCccceeeccccccc
Q 047901 99 LKYISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQLPR----NICRSGLLEILTVNDNHFL 158 (786)
Q Consensus 99 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~~~~L~~L~l~~N~l~ 158 (786)
|++|+|++|+|+.+++ ..|.++++|++|++++|+++. .|. .+..+++|+.|++++|.+.
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8888888888875443 367788888888888888873 444 3677777777777776653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.7e-14 Score=154.52 Aligned_cols=322 Identities=12% Similarity=0.086 Sum_probs=193.0
Q ss_pred ccccCchhccCCC-CCCEEeCcCCcccccCCccccCCCCCCEEeCCCcc---CcccCC-CCCCCCCCcEEEccCCcCccc
Q 047901 38 FFGTLPPQVRNLS-KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ---FSGTFP-PICNLSNLKYISLHNNKLSGS 112 (786)
Q Consensus 38 i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~-~~~~l~~L~~L~L~~N~l~~~ 112 (786)
++.+...+|.+.. .|+.+.+..+ ++.+...+|.++++|+.+.++.|. ++.+.. +|..+.+|+.+.+..+ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 4455556666653 4666666544 555666666666666666666553 333322 2455555555554433 3335
Q ss_pred CchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCC
Q 047901 113 IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192 (786)
Q Consensus 113 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~ 192 (786)
...+|.++.+|+.+.+..+ ++...... +.++.+|+.+.+..+ ++.+...+|.. .
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~-----------------------F~~c~~L~~i~~~~~-~~~I~~~aF~~-~ 182 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VTSVADGM-----------------------FSYCYSLHTVTLPDS-VTAIEERAFTG-T 182 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTT-----------------------TTTCTTCCEEECCTT-CCEECTTTTTT-C
T ss_pred hhhhhhhhcccccccccce-eeeecccc-----------------------eecccccccccccce-eeEeccccccc-c
Confidence 5555555555555555432 22222333 445555655555443 44455566654 4
Q ss_pred CCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCcc-------------ccCCccccEEEeecccccccCCCC
Q 047901 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPE-------------IGNSSQLHVLDLSSNHIAGEIPME 259 (786)
Q Consensus 193 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~i~~~~~~~ 259 (786)
+|+.+.+..+- ..+...+|..+.+++......+......... +.....+..+.+. +.++.+...+
T Consensus 183 ~l~~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~a 260 (394)
T 4gt6_A 183 ALTQIHIPAKV-TRIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHA 260 (394)
T ss_dssp CCSEEEECTTC-CEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTT
T ss_pred ceeEEEECCcc-cccccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccce
Confidence 56666665443 3355666666666666666555443211111 1122334444443 3344466678
Q ss_pred cccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcC
Q 047901 260 LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLS 339 (786)
Q Consensus 260 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 339 (786)
|.+...|+.+.+.++... +...+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+
T Consensus 261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~ 337 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE 337 (394)
T ss_dssp TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred eeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence 888888888888766554 777788888889988885 5677888888988889999888765 6656677888888899
Q ss_pred eeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcc
Q 047901 340 ELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNEL 396 (786)
Q Consensus 340 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 396 (786)
.+.+..+ ++.+....|.++.+|+.+++.+|.... ..|....+|+.+.+..|.+
T Consensus 338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred EEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 8888654 665667788888889988888876542 4566777888877766654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=146.29 Aligned_cols=137 Identities=20% Similarity=0.169 Sum_probs=101.0
Q ss_pred hhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCc
Q 047901 44 PQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKL 123 (786)
Q Consensus 44 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 123 (786)
..|.++.+|++|+|++|+|+.+ |......++|++|+|++|+|+++ +.+..+++|++|+|++|+|+++++..|.++++|
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred HhcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4577888899999999999854 54333344899999999999876 678888899999999999988877777888888
Q ss_pred ceeccccccccccCCh--hhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCc---ccCCCCCCCEEe
Q 047901 124 SYLMLDTNQFTGQLPR--NICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISE---DFGIYPNLKFLD 198 (786)
Q Consensus 124 ~~L~L~~N~l~~~~~~--~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~---~f~~l~~L~~L~ 198 (786)
++|+|++|+|+. +|. .+. ++++|+.|++++|.++.++.. .+..+++|++||
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~-----------------------~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld 146 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLA-----------------------SLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGG-----------------------GCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CEEECCCCcCCc-chhhHhhh-----------------------cCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeC
Confidence 888888888863 333 343 445555566666666544332 467788888888
Q ss_pred ccCCcccc
Q 047901 199 LSHNNFYG 206 (786)
Q Consensus 199 L~~N~i~~ 206 (786)
+++|.+..
T Consensus 147 ~~~n~~~~ 154 (176)
T 1a9n_A 147 FQKVKLKE 154 (176)
T ss_dssp TEECCHHH
T ss_pred CCcCCHHH
Confidence 88887653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=7.5e-17 Score=157.83 Aligned_cols=130 Identities=22% Similarity=0.208 Sum_probs=61.5
Q ss_pred CCCCCEEeccCCccccccCc------CccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccc
Q 047901 191 YPNLKFLDLSHNNFYGEISS------NWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 191 l~~L~~L~L~~N~i~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
.+.++.++++.|.+.+..|. .|..+++|++|+|++|++++ +| .+..+++|+.|+|++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 44555555555555544333 44445555555555555553 23 4455555555555555554 3334444444
Q ss_pred ccccccccccccCCCCccccccCCcCceeccccccccccch-hhhhcccCCcEEEecccccC
Q 047901 265 SLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQFS 325 (786)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 325 (786)
+|+.|+|++|+++++ | .+..+++|+.|++++|+++.+.. ..+..+++|++|++++|.++
T Consensus 94 ~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 94 TLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred cCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 555555555555432 2 34444444444444444444332 33444444444444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=7e-17 Score=158.05 Aligned_cols=153 Identities=22% Similarity=0.221 Sum_probs=82.0
Q ss_pred CCCCccEEEccCcccCCCCCc------cccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccC
Q 047901 214 KCHRLGTLIVSGNNITGRIPP------EIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287 (786)
Q Consensus 214 ~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 287 (786)
....++.++++.+.+.+..|. .|..+++|+.|+|++|.+++ +| .+.++++|+.|++++|+++
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~---------- 83 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK---------- 83 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC----------
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc----------
Confidence 344555555555555544443 45555555555555555543 23 4444555555555555544
Q ss_pred CcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCC-cccccccccceec
Q 047901 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIP-SRICNLESLEKLN 366 (786)
Q Consensus 288 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ 366 (786)
.++ ..+..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|+
T Consensus 84 --------------~l~-~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T 1ds9_A 84 --------------KIE-NLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp --------------SCS-SHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred --------------ccc-chhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence 322 233444555555555555553 22 45556666666666666653222 3555666666666
Q ss_pred cccccccccCCc----------ccccCCCceEEeccCCccc
Q 047901 367 LSHNNISGQIPA----------CFIGMSGLLSIDISYNELR 397 (786)
Q Consensus 367 L~~N~l~~~~p~----------~~~~l~~L~~L~l~~N~l~ 397 (786)
+++|++++..|. .+..+++|+.|| +|+++
T Consensus 147 l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 147 LAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 666666655443 266677777765 56554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=3.5e-14 Score=134.85 Aligned_cols=106 Identities=25% Similarity=0.255 Sum_probs=79.0
Q ss_pred CCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEEcc
Q 047901 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLH 105 (786)
Q Consensus 27 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~ 105 (786)
..+.|++++|+++.+ |..+ .++|++|+|++|+|+++.|..|..+++|++|+|++|+|+++++. |..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~i-p~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLASV-PTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCcc-CccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 356778888877654 3333 26778888888888777777788888888888888888777665 5677888888888
Q ss_pred CCcCcccCchhhcccCCcceeccccccccc
Q 047901 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTG 135 (786)
Q Consensus 106 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 135 (786)
+|+|+++++..|.++++|++|+|++|+++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 888887777778888888888888887763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-12 Score=142.29 Aligned_cols=302 Identities=10% Similarity=0.031 Sum_probs=194.2
Q ss_pred cCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcE
Q 047901 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKY 101 (786)
Q Consensus 22 f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 101 (786)
|....+|+.+.+. ..++.+...+|.++.+|+.+.|..+ ++.+...+|.+. +|+.+.+..+ ++.+........+|+.
T Consensus 42 ~~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~~L~~ 117 (379)
T 4h09_A 42 YKDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGTDLDD 117 (379)
T ss_dssp GGGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTCCCSE
T ss_pred cccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccCCccc
Confidence 4444566777665 3466666667777777777777544 555666667665 5666666543 4434333222236777
Q ss_pred EEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccC-------------CCCCcCCCC
Q 047901 102 ISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG-------------SIPNLRNCR 168 (786)
Q Consensus 102 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~-------------~~~~l~~l~ 168 (786)
+.+..+ +..+...+|.+. +|+.+.+-.+ ++......|.....++...+..+.... ....+..+.
T Consensus 118 i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (379)
T 4h09_A 118 FEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAK 194 (379)
T ss_dssp EECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTC
T ss_pred ccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccc
Confidence 776654 333555555553 4555544432 333445556666666665554432211 111233445
Q ss_pred CCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEee
Q 047901 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 248 (786)
.+..+.+..+ ...+....|....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+...+|.+..+|+.+.+.
T Consensus 195 ~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~ 271 (379)
T 4h09_A 195 TGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFY 271 (379)
T ss_dssp CCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccccccccc-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccc
Confidence 5555555443 33355667777888888888654 55577778888888888888766 565667788888888888886
Q ss_pred cccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCc
Q 047901 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI 328 (786)
Q Consensus 249 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 328 (786)
.+ +..+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+.
T Consensus 272 ~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~ 348 (379)
T 4h09_A 272 AK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIE 348 (379)
T ss_dssp CC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEEC
T ss_pred cc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEc
Confidence 54 55566778888888888888888887777888888888888888654 77788888888888888888655 65555
Q ss_pred chHHhhhc
Q 047901 329 PEDLALLA 336 (786)
Q Consensus 329 ~~~~~~l~ 336 (786)
..+|.+..
T Consensus 349 ~~aF~~c~ 356 (379)
T 4h09_A 349 SGAFEGSS 356 (379)
T ss_dssp TTTTTTSS
T ss_pred hhHhhCCC
Confidence 66776653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.8e-14 Score=132.92 Aligned_cols=104 Identities=18% Similarity=0.229 Sum_probs=80.6
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEEccC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHN 106 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~ 106 (786)
-+.+++++|+++.+ |..+. ++|++|+|++|+|+++.|..|..+++|++|+|++|+|+++++. |..+++|++|+|++
T Consensus 14 ~~~l~~~~n~l~~i-P~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLASV-PAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCcc-CCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 36788888888543 44443 6788888888888877778888888888888888888877765 56788888888888
Q ss_pred CcCcccCchhhcccCCcceecccccccc
Q 047901 107 NKLSGSIPEEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 107 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 134 (786)
|+|+++++..|.++++|++|+|++|++.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 8888777777888888888888888876
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=130.57 Aligned_cols=104 Identities=16% Similarity=0.104 Sum_probs=52.0
Q ss_pred ceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcc
Q 047901 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227 (786)
Q Consensus 148 ~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 227 (786)
+.+++++|.++.++..+. ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+
T Consensus 12 ~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 12 TTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 344444444444333332 445555555555555555555555555555555555555555555555555555555555
Q ss_pred cCCCCCccccCCccccEEEeeccccc
Q 047901 228 ITGRIPPEIGNSSQLHVLDLSSNHIA 253 (786)
Q Consensus 228 l~~~~~~~~~~l~~L~~L~Ls~N~i~ 253 (786)
|+++.+..|..+++|+.|+|++|.+.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 55444444555555555555555444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.9e-13 Score=128.96 Aligned_cols=86 Identities=22% Similarity=0.206 Sum_probs=40.7
Q ss_pred CCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccc
Q 047901 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271 (786)
Q Consensus 192 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 271 (786)
++|++|+|++|+|+++.|..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444444444444444444433334444444555555555444443334444555555555
Q ss_pred cccccC
Q 047901 272 RGNQLS 277 (786)
Q Consensus 272 ~~N~l~ 277 (786)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 555544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.9e-12 Score=138.80 Aligned_cols=303 Identities=7% Similarity=-0.036 Sum_probs=175.5
Q ss_pred hccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEEEccCCcCcccCchhhcccCCc
Q 047901 45 QVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKL 123 (786)
Q Consensus 45 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 123 (786)
.|....+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.+... |.++ +|+.+.+..+ ++.+...+|.+. +|
T Consensus 41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 4555566777777543 55566667777777777777544 5544443 5554 5666666533 555666666653 67
Q ss_pred ceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccc------------cCcccCCC
Q 047901 124 SYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGN------------ISEDFGIY 191 (786)
Q Consensus 124 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~------------~~~~f~~l 191 (786)
+.+.+..+ ++.....+|.+. .|+.+.+..+--.-....+.++..++.+.+..+..... ....|...
T Consensus 116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp SEEECCTT-CCEECTTTTTTC-CCCEEEECTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred ccccCCCc-cccccccccccc-eeeeeeccceeeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 77777654 332333344333 44444444332111122355566666665554432211 11234444
Q ss_pred CCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccc
Q 047901 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271 (786)
Q Consensus 192 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 271 (786)
..+..+.+..+. ..+...+|....+|+.+.+..+ +..+...+|.+...|+.+.+..+ ++.+...+|.+..+|+.+.+
T Consensus 194 ~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 194 KTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp CCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 555555554432 2355566666677777776544 33355566677777777777655 55455666777777777776
Q ss_pred cccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCC
Q 047901 272 RGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGS 351 (786)
Q Consensus 272 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 351 (786)
..+ +..+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I 347 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLI 347 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred ccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence 543 44455666777777777777777777777777777777777777544 55455566777777777777554 5544
Q ss_pred CCccccccc
Q 047901 352 IPSRICNLE 360 (786)
Q Consensus 352 ~~~~~~~l~ 360 (786)
...+|.++.
T Consensus 348 ~~~aF~~c~ 356 (379)
T 4h09_A 348 ESGAFEGSS 356 (379)
T ss_dssp CTTTTTTSS
T ss_pred chhHhhCCC
Confidence 456666654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.6e-12 Score=136.34 Aligned_cols=102 Identities=20% Similarity=0.206 Sum_probs=51.3
Q ss_pred EEcCCC-CCcccCCcCccCCCCCCcEEECCC-CCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 6 INLTST-GLKGTLQEFSFSSFPHLAYLDLSI-NGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 6 l~l~~~-~l~~~l~~~~f~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
++++++ ++. .+|. |..+++|++|+|++ |+|+++.+..|.+|++|++|+|++|+|+++.|..|..|++|++|+|++
T Consensus 13 v~~~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp EECCSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEcCCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 344444 443 3444 55555555555553 555555555555555555555555555555555555555555555555
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCc
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLS 110 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~ 110 (786)
|+|+++++.+.....|++|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCcc
Confidence 555554443222222555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-14 Score=154.46 Aligned_cols=165 Identities=19% Similarity=0.146 Sum_probs=80.1
Q ss_pred CCCCCEEeccCCccccccCcCccCC-----CCccEEEccCcccCCCCCccc-cCCccccEEEeecccccccCCCCccccc
Q 047901 191 YPNLKFLDLSHNNFYGEISSNWGKC-----HRLGTLIVSGNNITGRIPPEI-GNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 191 l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
+++|++|+|++|.|+......+... ++|++|+|++|.|++.....+ ..+++|+.|+|++|.|+......++.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~-- 148 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD-- 148 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH--
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH--
Confidence 4567778888877765433333222 456666666666543211111 22344555555555544222121110
Q ss_pred ccccccccccccCCCCcccc-ccCCcCceeccccccccccchh----hhhcccCCcEEEecccccCCCc----chHHhhh
Q 047901 265 SLNKLILRGNQLSGHLPRAL-GLLTELEYFDLSSNRLNNSILE----ALGFMFKLFYLNFSHNQFSQEI----PEDLALL 335 (786)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l 335 (786)
.+ ...++|+.|+|++|.|+..... .+...++|++|+|++|.|+... +..+...
T Consensus 149 ------------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~ 210 (372)
T 3un9_A 149 ------------------LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN 210 (372)
T ss_dssp ------------------HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred ------------------HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence 01 1234555555555555443222 2244555666666666554321 2334445
Q ss_pred cCcCeeeccCCccCCC----CCcccccccccceecccccccccc
Q 047901 336 AHLSELDLSHNLFKGS----IPSRICNLESLEKLNLSHNNISGQ 375 (786)
Q Consensus 336 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 375 (786)
++|+.|+|++|.|+.. ++..+...++|+.|+|++|.|+..
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 5666666666666532 122233345666666666666543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.1e-14 Score=154.38 Aligned_cols=165 Identities=17% Similarity=0.066 Sum_probs=104.7
Q ss_pred CCCCcEEEccCcccccccCcccCC-----CCCCCEEeccCCccccccCcCc-cCCCCccEEEccCcccCCCCCccc----
Q 047901 167 CRSLVRAHLGRNNLTGNISEDFGI-----YPNLKFLDLSHNNFYGEISSNW-GKCHRLGTLIVSGNNITGRIPPEI---- 236 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~~~~~f~~-----l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~---- 236 (786)
++.|+.|+|++|.|+......+.. .++|++|+|++|.|+......+ ..+++|++|+|++|+|++.....+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 367999999999998755444433 3799999999999975443333 356789999999999985433333
Q ss_pred -cCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccc----hhhhhcc
Q 047901 237 -GNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI----LEALGFM 311 (786)
Q Consensus 237 -~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l 311 (786)
...++|+.|+|++|.|+......+ +..+...++|+.|+|++|.|.... ...+...
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l--------------------~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~ 210 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVL--------------------MEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN 210 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHH--------------------HHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred HhcCCccceeeCCCCCCChHHHHHH--------------------HHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence 235678888888887763211111 122334445555555555554432 2334455
Q ss_pred cCCcEEEecccccCCC----cchHHhhhcCcCeeeccCCccCCC
Q 047901 312 FKLFYLNFSHNQFSQE----IPEDLALLAHLSELDLSHNLFKGS 351 (786)
Q Consensus 312 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 351 (786)
++|+.|+|++|.|+.. +...+...++|++|+|++|.|+..
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 5666666666666542 223344557788888888877643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=6.1e-12 Score=134.49 Aligned_cols=103 Identities=17% Similarity=0.085 Sum_probs=82.2
Q ss_pred eeecccc-cccCCCCCcCCCCCCcEEEccC-cccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCc
Q 047901 149 ILTVNDN-HFLGSIPNLRNCRSLVRAHLGR-NNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGN 226 (786)
Q Consensus 149 ~L~l~~N-~l~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 226 (786)
.++++++ .++.++. +..+++|+.|+|++ |+|+++.+..|..+++|++|+|++|+|+++.|..|.++++|+.|+|++|
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 3466666 6766666 77778888888885 8888888888888888888888888888888888888888888888888
Q ss_pred ccCCCCCccccCCccccEEEeeccccc
Q 047901 227 NITGRIPPEIGNSSQLHVLDLSSNHIA 253 (786)
Q Consensus 227 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 253 (786)
+|+++.+..|..++ |+.|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 88876666666665 888888888876
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.6e-11 Score=124.02 Aligned_cols=147 Identities=12% Similarity=0.094 Sum_probs=113.9
Q ss_pred HHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCC
Q 047901 501 IIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVR 579 (786)
Q Consensus 501 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~ 579 (786)
+......|+.....+.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++...+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 3344567888888999999999999864 68999999864211 11235778999999884 677889999999888
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC------------------------------ 629 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------------------------------ 629 (786)
..|+||||++|.++.+.... ......++.++++++..||+..
T Consensus 84 ~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred ceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 99999999999999876321 1123467889999999999821
Q ss_pred --------------------------CCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 630 --------------------------FPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 630 --------------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.+.++|+|++|.||+++.+..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667899998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=118.92 Aligned_cols=137 Identities=15% Similarity=0.122 Sum_probs=100.4
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc--ccceeeEEecCCeeeEE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN--IVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~~~~~~~~~~~lv 584 (786)
.+......+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 34443333456669999998877888999997542 1134678999998885444 56688888888889999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC----------------------------------- 629 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~----------------------------------- 629 (786)
|||++|.++. ... .+ ...++.++++.+..||+..
T Consensus 94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998874 211 11 2356778888888888752
Q ss_pred --------------------CCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 630 --------------------FPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 630 --------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
.+.++|+|++|.||+++.++.++|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998777778999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.6e-09 Score=116.10 Aligned_cols=144 Identities=14% Similarity=0.234 Sum_probs=107.8
Q ss_pred cceeeccccCceEEEEEcCCCCEEEEEEcC--CCCCCCchhhHHHHHHHHHHHhhcC--CCcccceeeEEecC---Ceee
Q 047901 510 AKYCIGKGEHRSVYRAKLPSGDKIAVKKFN--SPFPNDQMSDQKEFLNEIKALTKIR--HRNIVKFYGFCSHV---RHSF 582 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~---~~~~ 582 (786)
..+.++.|.++.||+....+ ..+++|+.. ... .......+.+|.++++.+. +..+.++++++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~---~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK---LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC---CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 45678999999999998764 678888875 311 1112346778999999886 45688899988776 4589
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC--------------------------------- 629 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~--------------------------------- 629 (786)
+||||++|..+.+.. ...++...+..++.+++++|..||+..
T Consensus 118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999997774421 234678888889999999999999731
Q ss_pred ----------------------CCCeEEcCCCCCceeeCCCC--cEEEeccccceec
Q 047901 630 ----------------------FPPIVHRDISSNNVLLDLEY--EARVSDFGTAKLL 662 (786)
Q Consensus 630 ----------------------~~~ivHrdlk~~Nill~~~~--~~kl~Dfg~a~~~ 662 (786)
.+.++|||+++.||+++.++ .+.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 24799999999999999775 3699999998754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.7e-10 Score=120.07 Aligned_cols=58 Identities=22% Similarity=0.192 Sum_probs=26.8
Q ss_pred ccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhc--ccCCcceeccc
Q 047901 70 IGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIG--NLMKLSYLMLD 129 (786)
Q Consensus 70 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~ 129 (786)
+..+++|+.|+|++|.-..++ .+ .+++|++|+|..|.+.......+. .+++|++|+|+
T Consensus 168 l~~~P~L~~L~L~g~~~l~l~-~~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLSIG-KK-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHTCTTCCEEEEECCBTCBCC-SC-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HhcCCCCcEEEEeCCCCceec-cc-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 345556666666555211111 12 255566666655555432222232 45555555553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.7e-09 Score=112.98 Aligned_cols=191 Identities=18% Similarity=0.211 Sum_probs=122.5
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCc--ccceeeEEecCC---eeeEE
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRN--IVKFYGFCSHVR---HSFVV 584 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv 584 (786)
.+.++.|....||+.. +.+++|+-.. ......+.+|.++++.+. +.. +.++++.....+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999873 5688988643 134567889999998883 332 445555543333 45899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC----------------------------------- 629 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~----------------------------------- 629 (786)
||+++|.++.+... ..++..++..++.++++.+..||+..
T Consensus 95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999988865332 23566777788888888888888621
Q ss_pred --------------------CCCeEEcCCCCCceeeCC--CCcEEEeccccceecCCCCCcceeeccCccc---cCCCCC
Q 047901 630 --------------------FPPIVHRDISSNNVLLDL--EYEARVSDFGTAKLLKPNSSNWTELVGTFGY---VAPAHG 684 (786)
Q Consensus 630 --------------------~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y---~aPE~~ 684 (786)
.+.++|+|++|.||+++. +..+.|+||+.+....+. .... ....+ ..|+..
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~---~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFI---SLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHH---TTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHH---HHHhhccccCHHHH
Confidence 135899999999999998 566899999998765321 1000 00000 111000
Q ss_pred C------CCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCC
Q 047901 685 N------IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPG 722 (786)
Q Consensus 685 ~------~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf 722 (786)
. .....++.... .....+.|++|.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00000011111 122368999999999999999884
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=6.6e-10 Score=118.16 Aligned_cols=83 Identities=17% Similarity=0.304 Sum_probs=40.6
Q ss_pred ccCCcEEEecccccCCCcchHHh---hhcCcCeeeccCCccCCC----CCcccccccccceeccccccccccCCccccc-
Q 047901 311 MFKLFYLNFSHNQFSQEIPEDLA---LLAHLSELDLSHNLFKGS----IPSRICNLESLEKLNLSHNNISGQIPACFIG- 382 (786)
Q Consensus 311 l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~- 382 (786)
+++|++|+|.+|.+....+..+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 44555555555555432222222 245566666666665532 1222234566666666666665432222322
Q ss_pred CCCceEEeccCCc
Q 047901 383 MSGLLSIDISYNE 395 (786)
Q Consensus 383 l~~L~~L~l~~N~ 395 (786)
+ ...+++++|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 1 2346666666
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.60 E-value=3e-09 Score=107.10 Aligned_cols=105 Identities=27% Similarity=0.218 Sum_probs=53.0
Q ss_pred cCCCCCCcE--EECCCCCcc---ccCchhccCCCCCCEEeCcCCcccccC--CccccCCCCCCEEeCCCccCcccCC--C
Q 047901 22 FSSFPHLAY--LDLSINGFF---GTLPPQVRNLSKLKYLDLSENELSGKI--PPEIGLLTHLFSLDLSLNQFSGTFP--P 92 (786)
Q Consensus 22 f~~l~~L~~--L~L~~n~i~---~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~--~ 92 (786)
|...|.|.. ++++.|+.. ...+....++++|+.|+|++|+|+++. |..+..+++|+.|+|++|+|++... .
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~ 216 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 216 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhh
Confidence 444445554 555555332 111222245566666666666666532 3445566666666666666654411 1
Q ss_pred CCCCCCCcEEEccCCcCcccCc-------hhhcccCCcceec
Q 047901 93 ICNLSNLKYISLHNNKLSGSIP-------EEIGNLMKLSYLM 127 (786)
Q Consensus 93 ~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~ 127 (786)
+..+ +|++|+|++|.+.+..| ..+..+++|+.||
T Consensus 217 l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 217 IKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 2222 56666666666654322 2244555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.59 E-value=9.8e-09 Score=98.44 Aligned_cols=113 Identities=12% Similarity=0.113 Sum_probs=61.4
Q ss_pred cCCCCCCcEEECCCC-Ccccc----CchhccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCcc----
Q 047901 22 FSSFPHLAYLDLSIN-GFFGT----LPPQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSG---- 88 (786)
Q Consensus 22 f~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~---- 88 (786)
+...+.|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|+|+.
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 445566666666666 66431 234455556666666666666532 12334445566666666666653
Q ss_pred -cCCCCCCCCCCcEEEc--cCCcCcccC----chhhcccCCcceecccccccc
Q 047901 89 -TFPPICNLSNLKYISL--HNNKLSGSI----PEEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 89 -~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 134 (786)
+...+...++|++|+| ++|.|.... ...+...++|++|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2233445556666666 556665322 223334455666666666554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=3.6e-08 Score=99.26 Aligned_cols=105 Identities=23% Similarity=0.215 Sum_probs=72.9
Q ss_pred cccCCcCce--eccccccccccc---hhhhhcccCCcEEEecccccCCC--cchHHhhhcCcCeeeccCCccCCCCCccc
Q 047901 284 LGLLTELEY--FDLSSNRLNNSI---LEALGFMFKLFYLNFSHNQFSQE--IPEDLALLAHLSELDLSHNLFKGSIPSRI 356 (786)
Q Consensus 284 ~~~l~~L~~--L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 356 (786)
|...+.|+. ++++.|+...+. ......+++|+.|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 555556665 667777543322 22335678888888888888874 346777888999999999988854 334
Q ss_pred cccc--ccceeccccccccccCCc-------ccccCCCceEEe
Q 047901 357 CNLE--SLEKLNLSHNNISGQIPA-------CFIGMSGLLSID 390 (786)
Q Consensus 357 ~~l~--~L~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~ 390 (786)
..+. +|++|+|++|++++..|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 888889999988875552 366788888775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.45 E-value=3.2e-08 Score=94.81 Aligned_cols=96 Identities=16% Similarity=0.129 Sum_probs=68.4
Q ss_pred ccCchhccCCCCCCEEeCcCC-ccccc----CCccccCCCCCCEEeCCCccCccc-----CCCCCCCCCCcEEEccCCcC
Q 047901 40 GTLPPQVRNLSKLKYLDLSEN-ELSGK----IPPEIGLLTHLFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKL 109 (786)
Q Consensus 40 ~~~~~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~L~~N~l 109 (786)
..+...+...++|++|+|++| .|... +...+...++|++|+|++|+|+.. ...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 345566788889999999999 88642 334556678899999999988641 22344567888888888888
Q ss_pred ccc----CchhhcccCCcceecc--ccccccc
Q 047901 110 SGS----IPEEIGNLMKLSYLML--DTNQFTG 135 (786)
Q Consensus 110 ~~~----~~~~~~~l~~L~~L~L--~~N~l~~ 135 (786)
... ....+...++|++|+| ++|.|+.
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 753 2345566677888888 7787764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-06 Score=88.86 Aligned_cols=135 Identities=16% Similarity=0.162 Sum_probs=97.9
Q ss_pred eeccccCc-eEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHR-SVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.+..|..| .||+.... ++..+++|+-.. .....+.+|.++++.+. +--|.++++++.+.+..|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 44556555 69998765 567899998643 23456788999998884 3347788999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC---------------------------------------- 629 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------- 629 (786)
|.++.+..... ......++.+++..+..||+..
T Consensus 104 G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 104 GKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp SEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 98887755321 1122345666677777777531
Q ss_pred ---------------CCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 630 ---------------FPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 630 ---------------~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
.+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11389999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.2e-06 Score=87.92 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=95.0
Q ss_pred ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCC---cccceeeEEe-cCCeeeEEEe
Q 047901 511 KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR---NIVKFYGFCS-HVRHSFVVYE 586 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e 586 (786)
.+.++.|....||+. ++.+++|+-.. ......+.+|.++++.+.+. .|.+++.++. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888888899988 56788887432 23456788999999999642 3666777764 4566789999
Q ss_pred ccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 047901 587 YINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD-------------------------------------- 628 (786)
Q Consensus 587 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~-------------------------------------- 628 (786)
|++|..+.+... ..++......++.++++.+..||+.
T Consensus 94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999988765321 1223344444455555555544432
Q ss_pred -------------------CCCCeEEcCCCCCceeeCC---CCc-EEEeccccceecC
Q 047901 629 -------------------CFPPIVHRDISSNNVLLDL---EYE-ARVSDFGTAKLLK 663 (786)
Q Consensus 629 -------------------~~~~ivHrdlk~~Nill~~---~~~-~kl~Dfg~a~~~~ 663 (786)
..+.++|+|++|.||+++. ++. +.|+||+.+....
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2235799999999999997 344 5899999887543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=8.9e-06 Score=86.71 Aligned_cols=83 Identities=5% Similarity=0.009 Sum_probs=54.5
Q ss_pred ceee-ccccCceEEEEEcC-------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-C--CcccceeeEEecC-
Q 047901 511 KYCI-GKGEHRSVYRAKLP-------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-H--RNIVKFYGFCSHV- 578 (786)
Q Consensus 511 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--pniv~l~~~~~~~- 578 (786)
.+.+ +.|....+|+.... +++.+++|+........ ......+.+|.++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 3567 88888999998754 25678888764321000 000134567888888774 3 3577788887655
Q ss_pred --CeeeEEEeccCCCCHH
Q 047901 579 --RHSFVVYEYINRGSLA 594 (786)
Q Consensus 579 --~~~~lv~e~~~~g~L~ 594 (786)
+..|+||||++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 4578999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=4e-05 Score=82.90 Aligned_cols=79 Identities=13% Similarity=0.043 Sum_probs=49.6
Q ss_pred ceeeccccCceEEEEEcC-CCCEEEEEEcCCCCC---CCchhhHHHHHHHHHHHhhcCC--Cc-ccceeeEEecCCeeeE
Q 047901 511 KYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFP---NDQMSDQKEFLNEIKALTKIRH--RN-IVKFYGFCSHVRHSFV 583 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h--pn-iv~l~~~~~~~~~~~l 583 (786)
.+.+|.|..+.||++... +++.++||....... ........++..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999764 467899998653211 0001123456778888887742 43 4455554 3445689
Q ss_pred EEeccCCC
Q 047901 584 VYEYINRG 591 (786)
Q Consensus 584 v~e~~~~g 591 (786)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=6.2e-05 Score=79.53 Aligned_cols=141 Identities=20% Similarity=0.282 Sum_probs=79.1
Q ss_pred eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-----CCccccee-e--EEecCCeeeE
Q 047901 512 YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-----HRNIVKFY-G--FCSHVRHSFV 583 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~l~-~--~~~~~~~~~l 583 (786)
+.++.|..+.||+....++ .+++|+... .. ..+..|.++++.+. .|.++... | +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-----PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-----CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-----CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4466677899999987654 589998864 11 22334455544442 24443311 1 1234667899
Q ss_pred EEeccCCCCHH--------------HHhhc---CCC-C-------CCCCHHHH---------------------------
Q 047901 584 VYEYINRGSLA--------------TVLSN---NFA-S-------EDFDWRKR--------------------------- 611 (786)
Q Consensus 584 v~e~~~~g~L~--------------~~l~~---~~~-~-------~~~~~~~~--------------------------- 611 (786)
||||++|..+. ..++. ... . ....|...
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 11111 000 0 01123211
Q ss_pred ----HHHHHHHHHHHHHHhh----------CCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 612 ----MNVITGVADALSYMHH----------DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 612 ----~~i~~~ia~~l~~LH~----------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
..+...+..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666653 1235899999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.0001 Score=76.19 Aligned_cols=139 Identities=18% Similarity=0.194 Sum_probs=93.0
Q ss_pred cceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC---CCcccceeeEEecCCeeeEEEe
Q 047901 510 AKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR---HRNIVKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e 586 (786)
..+.++.|....+|+... +++.+++|+... .....+..|.+.++.+. ...+.++++++...+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 346789999999999987 467888998643 23567888999888883 3678889999888888999999
Q ss_pred ccCCCCHHH-----------HhhcCCCCC-------------------CCCHHHHH---HHHH----------------H
Q 047901 587 YINRGSLAT-----------VLSNNFASE-------------------DFDWRKRM---NVIT----------------G 617 (786)
Q Consensus 587 ~~~~g~L~~-----------~l~~~~~~~-------------------~~~~~~~~---~i~~----------------~ 617 (786)
|+++..+.. .++...... .-+|.... ++.. .
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 999876421 122211100 12454322 1111 1
Q ss_pred HHHH-HHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 618 VADA-LSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 618 ia~~-l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
++.. ...|.. ...|.++|+|+.+.|++++.++ +.|.||+
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 223422 2346899999999999999887 8899984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.71 E-value=1.2e-05 Score=74.95 Aligned_cols=83 Identities=11% Similarity=0.082 Sum_probs=40.2
Q ss_pred cCceeccccccccccchhhhhcccCCcEEEecccc-cCCCcchHHhhh----cCcCeeeccCCc-cCCCCCccccccccc
Q 047901 289 ELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ-FSQEIPEDLALL----AHLSELDLSHNL-FKGSIPSRICNLESL 362 (786)
Q Consensus 289 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~L 362 (786)
+|+.||++++.|+......+..+++|+.|+|++|. |+..--..+..+ ++|++|+|++|. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555555444445555555566665553 432211222221 245566666553 443222334455556
Q ss_pred ceecccccc
Q 047901 363 EKLNLSHNN 371 (786)
Q Consensus 363 ~~L~L~~N~ 371 (786)
+.|+++++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666665553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.66 E-value=2.4e-05 Score=72.89 Aligned_cols=35 Identities=14% Similarity=0.079 Sum_probs=19.5
Q ss_pred ccccEEEeecccccccCCCCccccccccccccccc
Q 047901 240 SQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGN 274 (786)
Q Consensus 240 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N 274 (786)
.+|+.|||+++.|+..--..+.++++|+.|+|++|
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 45777777776665443333444555555555555
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0004 Score=75.58 Aligned_cols=78 Identities=12% Similarity=0.166 Sum_probs=46.2
Q ss_pred cceeeccccCceEEEEEcCCCCEEEEEEcCCCCC--CCc---hhhHHHHHHHHHHHh-hcCCCcccceeeEEecCCeeeE
Q 047901 510 AKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFP--NDQ---MSDQKEFLNEIKALT-KIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~---~~~~~~~~~e~~~l~-~l~hpniv~l~~~~~~~~~~~l 583 (786)
..+.+|.|..+.||++.. +++.++||....... ... ......+..|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 346789999999999975 467899995332111 000 012223333433322 22234566777765 466789
Q ss_pred EEecc-CC
Q 047901 584 VYEYI-NR 590 (786)
Q Consensus 584 v~e~~-~~ 590 (786)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00017 Score=74.01 Aligned_cols=79 Identities=16% Similarity=0.218 Sum_probs=56.3
Q ss_pred cCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC---CcccceeeEEecCCeeeE
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH---RNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---pniv~l~~~~~~~~~~~l 583 (786)
+....+.+|.|..+.||+.+..||+.|+||+-.... ......|..|.+.|+.+.- --+.+++++. ..++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 455667899999999999999999999999865421 1222357789998888842 2345555542 3478
Q ss_pred EEeccCCCCH
Q 047901 584 VYEYINRGSL 593 (786)
Q Consensus 584 v~e~~~~g~L 593 (786)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.53 E-value=3.7e-05 Score=72.99 Aligned_cols=83 Identities=12% Similarity=0.052 Sum_probs=38.9
Q ss_pred CCCCcEEECCCC-Cccc----cCchhccCCCCCCEEeCcCCcccccC----CccccCCCCCCEEeCCCccCcc-----cC
Q 047901 25 FPHLAYLDLSIN-GFFG----TLPPQVRNLSKLKYLDLSENELSGKI----PPEIGLLTHLFSLDLSLNQFSG-----TF 90 (786)
Q Consensus 25 l~~L~~L~L~~n-~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~-----~~ 90 (786)
-+.|+.|+|++| +|.. .+-+++..-+.|+.|+|++|+|.... ..++..-+.|++|+|++|+|+. +.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 345555566553 4432 12333444455555555555554221 2223344555555555555542 11
Q ss_pred CCCCCCCCCcEEEccCC
Q 047901 91 PPICNLSNLKYISLHNN 107 (786)
Q Consensus 91 ~~~~~l~~L~~L~L~~N 107 (786)
..+..-+.|++|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 22334445555555543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0011 Score=69.63 Aligned_cols=142 Identities=16% Similarity=0.147 Sum_probs=74.5
Q ss_pred eeccccCc-eEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-C-CcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEHR-SVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-H-RNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-pniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.++.|+.. ++|+....+++.+++|....... ..+..|+++++.+. + -.+.+++.+....+ ++|||++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 45555444 37787764467777776543110 12335666666553 2 23556776654433 78999998
Q ss_pred CCCHHHHhhcC---------------------CC--CCCCCHHHHH-------H-H------------HHHHHHHHHHHh
Q 047901 590 RGSLATVLSNN---------------------FA--SEDFDWRKRM-------N-V------------ITGVADALSYMH 626 (786)
Q Consensus 590 ~g~L~~~l~~~---------------------~~--~~~~~~~~~~-------~-i------------~~~ia~~l~~LH 626 (786)
+..+.+++... .. ...++..... . + ...+...+..+.
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 76665444211 00 0112211100 0 0 011112222221
Q ss_pred h---CCCCCeEEcCCCCCceeeCCC----CcEEEeccccceecC
Q 047901 627 H---DCFPPIVHRDISSNNVLLDLE----YEARVSDFGTAKLLK 663 (786)
Q Consensus 627 ~---~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~a~~~~ 663 (786)
. ...+.++|||+.+.||+++.+ +.+.|+||+.+....
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1 123479999999999999875 689999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0016 Score=67.09 Aligned_cols=143 Identities=15% Similarity=0.097 Sum_probs=76.1
Q ss_pred CccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcc-cceeeEEecCCeeeEEEe
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI-VKFYGFCSHVRHSFVVYE 586 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e 586 (786)
+...+.++.|....+|+. +.+++|+........ -...+|..+++.+....+ .+++++. .+.-++|+|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 333678999999999999 568888876421110 112357777766632222 4555543 334578999
Q ss_pred cc-CCCCHHH------------------HhhcCCC--CCCCC-HHHHHHHHHH--------------HHHHH----HHHh
Q 047901 587 YI-NRGSLAT------------------VLSNNFA--SEDFD-WRKRMNVITG--------------VADAL----SYMH 626 (786)
Q Consensus 587 ~~-~~g~L~~------------------~l~~~~~--~~~~~-~~~~~~i~~~--------------ia~~l----~~LH 626 (786)
|+ ++.++.. .++.... ..... +.....+... +.+.+ ..+.
T Consensus 88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 99 6544421 0111100 00011 1111111100 11111 1111
Q ss_pred h-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 627 H-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 627 ~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
. ...+.++|+|+.+.||+ ..++.+.++||..+....
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 1 12245899999999999 556778999999887543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00046 Score=61.13 Aligned_cols=55 Identities=16% Similarity=0.156 Sum_probs=39.6
Q ss_pred EEeCCCccCc--ccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccccccc
Q 047901 78 SLDLSLNQFS--GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 78 ~L~Ls~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 134 (786)
.++.+++.++ .++..+. ++|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666777766 5554432 46778888888888777777888888888888888764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.21 E-value=9.4e-05 Score=70.19 Aligned_cols=15 Identities=13% Similarity=0.038 Sum_probs=7.5
Q ss_pred CCCCCCCEEeccCCc
Q 047901 189 GIYPNLKFLDLSHNN 203 (786)
Q Consensus 189 ~~l~~L~~L~L~~N~ 203 (786)
..-+.|++|+++.|.
T Consensus 154 ~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 154 EENESLLRVGISFAS 168 (197)
T ss_dssp HHCSSCCEEECCCCC
T ss_pred HhCCCcCeEeccCCC
Confidence 334455555555444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0049 Score=64.31 Aligned_cols=143 Identities=11% Similarity=0.155 Sum_probs=81.3
Q ss_pred eeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCC--cccceeeE-----EecCCeeeEE
Q 047901 512 YCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR--NIVKFYGF-----CSHVRHSFVV 584 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~l~~~-----~~~~~~~~lv 584 (786)
..++ |....||+....+|+.+++|...... .....+..|.+++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3566 88889999887777789999986321 1234566777777776321 24444432 2234566889
Q ss_pred EeccCCCCHH-----HH---------hhcC---CC---CCCCCHHHH----HHH---------------HHHHHHHHHHH
Q 047901 585 YEYINRGSLA-----TV---------LSNN---FA---SEDFDWRKR----MNV---------------ITGVADALSYM 625 (786)
Q Consensus 585 ~e~~~~g~L~-----~~---------l~~~---~~---~~~~~~~~~----~~i---------------~~~ia~~l~~L 625 (786)
|||++|..+. .+ ++.. .. ....++... ..+ ...+...+..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 10 1110 00 011222111 001 11111222233
Q ss_pred hhC----CCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 626 HHD----CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 626 H~~----~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
... ..+.++|+|+++.||+++ + .+.++||+.+...
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 221 234689999999999999 5 8999999887644
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0039 Score=64.87 Aligned_cols=157 Identities=10% Similarity=0.130 Sum_probs=85.1
Q ss_pred HHHHHHHhccCcc-----ceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc--ccc
Q 047901 498 YEEIIRRTKDFDA-----KYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN--IVK 570 (786)
Q Consensus 498 ~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~ 570 (786)
.+++......|.. .+.++.|....+|+....++ .+++|...... ....+..|.+++..+.... +.+
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3455555555654 23567788889999987655 68899886421 1123446677666653111 333
Q ss_pred eeeE------EecCCeeeEEEeccCCCCHHH--------------HhhcC---CCCCC------CCHHHHHH--------
Q 047901 571 FYGF------CSHVRHSFVVYEYINRGSLAT--------------VLSNN---FASED------FDWRKRMN-------- 613 (786)
Q Consensus 571 l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~---~~~~~------~~~~~~~~-------- 613 (786)
++.. ....+..++||+|++|..+.. .++.. ..... ..|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 123456789999999864311 11111 00000 11222110
Q ss_pred ----HHHHHHHHHHHHhhC----CCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 614 ----VITGVADALSYMHHD----CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 614 ----i~~~ia~~l~~LH~~----~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
+...+.+.++++++. ..++++|+|+.+.||+++.++.+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234445555432 124799999999999999876678999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0032 Score=66.83 Aligned_cols=142 Identities=15% Similarity=0.229 Sum_probs=83.3
Q ss_pred eeeccccCceEEEEEcCC--------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCeee
Q 047901 512 YCIGKGEHRSVYRAKLPS--------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~ 582 (786)
+.+..|-...+|+....+ ++.+++|+... .........+|..+++.+. +.-..++++++.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-----~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-----ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-----ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 457778888999998752 47899988532 1122345568988888774 3334667776654 2
Q ss_pred EEEeccCCCCHHHH-----------------hhcCC--CCCCCC--HHHHHHHHHHHHH-------------------HH
Q 047901 583 VVYEYINRGSLATV-----------------LSNNF--ASEDFD--WRKRMNVITGVAD-------------------AL 622 (786)
Q Consensus 583 lv~e~~~~g~L~~~-----------------l~~~~--~~~~~~--~~~~~~i~~~ia~-------------------~l 622 (786)
+||||++|..+..- ++... ..+... +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999998554310 11110 011222 4555555544322 12
Q ss_pred HH----HhhC-CCCCeEEcCCCCCceeeCCC----CcEEEeccccceec
Q 047901 623 SY----MHHD-CFPPIVHRDISSNNVLLDLE----YEARVSDFGTAKLL 662 (786)
Q Consensus 623 ~~----LH~~-~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~a~~~ 662 (786)
.+ |... ....++|+|+.+.||+++.+ +.+.++||..|...
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 22 2221 22469999999999999876 78999999988643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0012 Score=58.51 Aligned_cols=55 Identities=22% Similarity=0.112 Sum_probs=34.2
Q ss_pred EEEccCcccc--cccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccC
Q 047901 172 RAHLGRNNLT--GNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT 229 (786)
Q Consensus 172 ~L~L~~N~l~--~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 229 (786)
.++.+++.++ .++.. + .++|++|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555 33321 1 235777777777777777777777777777777777654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0018 Score=70.42 Aligned_cols=73 Identities=21% Similarity=0.295 Sum_probs=49.0
Q ss_pred ceeeccccCceEEEEEcCC--------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCee
Q 047901 511 KYCIGKGEHRSVYRAKLPS--------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~ 581 (786)
.+.|+.|....+|+....+ ++.+++|+...+ . ....+..|..+++.+. +.-..++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----E--TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----C--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 3568888889999998653 478999987431 1 1134557888888874 3334567776543
Q ss_pred eEEEeccCCCCH
Q 047901 582 FVVYEYINRGSL 593 (786)
Q Consensus 582 ~lv~e~~~~g~L 593 (786)
.+|+||++|.++
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999986433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.011 Score=64.50 Aligned_cols=74 Identities=19% Similarity=0.190 Sum_probs=46.5
Q ss_pred ceeeccccCceEEEEEcCC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcc-cceeeEEecCCeeeEEEecc
Q 047901 511 KYCIGKGEHRSVYRAKLPS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI-VKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~ 588 (786)
.+.|+.|-...+|+....+ ++.+++|+...... ..-. -..|..+++.+...++ .++++++.. ..||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~id---R~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIIN---REREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSC---HHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcC---HHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 3568888889999998764 47888988743211 1111 1478888888864444 567776632 2599999
Q ss_pred CCCCH
Q 047901 589 NRGSL 593 (786)
Q Consensus 589 ~~g~L 593 (786)
+|.++
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.015 Score=60.80 Aligned_cols=33 Identities=27% Similarity=0.335 Sum_probs=28.8
Q ss_pred CCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 631 ~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
+.++|+|+.+.||+++.++.+.++||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 479999999999999988889999998876543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0046 Score=65.74 Aligned_cols=73 Identities=8% Similarity=0.154 Sum_probs=42.4
Q ss_pred eeeccccCceEEEEEcCC---------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc-ccceeeEEecCCee
Q 047901 512 YCIGKGEHRSVYRAKLPS---------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN-IVKFYGFCSHVRHS 581 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~~~ 581 (786)
+.++.|....+|+....+ ++.+++|+..... ........|.++++.+...+ +.++++... -
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 457788888999998654 2688888865311 11112346777777774223 446665442 3
Q ss_pred eEEEeccCCCCH
Q 047901 582 FVVYEYINRGSL 593 (786)
Q Consensus 582 ~lv~e~~~~g~L 593 (786)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.17 E-value=0.047 Score=51.96 Aligned_cols=103 Identities=16% Similarity=0.093 Sum_probs=64.7
Q ss_pred CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCcce
Q 047901 591 GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT 670 (786)
Q Consensus 591 g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 670 (786)
-+|.+.|+.. ..++++.+++.++.|.+.+|.-+-.... + ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 4789999875 5789999999999999999877622111 1 1223356888999899887764 1111
Q ss_pred eeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC
Q 047901 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721 (786)
Q Consensus 671 ~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P 721 (786)
.....+.|||.. ....+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~-----------~~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLG-----------YSQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCS-----------SSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhc-----------cccchHHHHHHHHHHHHHHHhhcCCC
Confidence 122346678532 12345678899999999998854333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.15 Score=54.75 Aligned_cols=142 Identities=11% Similarity=0.115 Sum_probs=82.2
Q ss_pred ceeeccccCceEEEEEcCC--------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCee
Q 047901 511 KYCIGKGEHRSVYRAKLPS--------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~ 581 (786)
.+.+..|-...+|+....+ ++.+++|+...... ... .-.+|..+++.+. +.-..++++.+. -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~i---dR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFY---DSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCC---CHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhc---CHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 3467778888999998653 57899988644211 111 1236777777764 333455665432 2
Q ss_pred eEEEeccCCCCHHH--------------Hh---hcC-------C---CCCCCCHHHHHHHHHHH----------------
Q 047901 582 FVVYEYINRGSLAT--------------VL---SNN-------F---ASEDFDWRKRMNVITGV---------------- 618 (786)
Q Consensus 582 ~lv~e~~~~g~L~~--------------~l---~~~-------~---~~~~~~~~~~~~i~~~i---------------- 618 (786)
+.||||++|..+.. .+ +.. . ...+.-+.++.++..++
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 78999999865321 00 100 0 11111244443333222
Q ss_pred ---HHHHHHHhh---------------------CCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 619 ---ADALSYMHH---------------------DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 619 ---a~~l~~LH~---------------------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
...+.+|.+ .....++|+|+.+.||+ +.++.+.++||..|...
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 122233321 11236899999999999 77889999999988743
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.42 E-value=0.65 Score=49.55 Aligned_cols=31 Identities=23% Similarity=0.297 Sum_probs=26.1
Q ss_pred CeEEcCCCCCceee------CCCCcEEEeccccceec
Q 047901 632 PIVHRDISSNNVLL------DLEYEARVSDFGTAKLL 662 (786)
Q Consensus 632 ~ivHrdlk~~Nill------~~~~~~kl~Dfg~a~~~ 662 (786)
.++|+|+.+.||++ +++..++++||-+|..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 46899999999999 45678999999988743
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.37 E-value=0.33 Score=32.92 Aligned_cols=29 Identities=31% Similarity=0.385 Sum_probs=14.7
Q ss_pred eehhhHHHHHHHHHHHHHHHhheeeeccc
Q 047901 441 LILFPLLGALALLIVYVVMVFMFRRWKRD 469 (786)
Q Consensus 441 ~i~~~~~~~~~~~~~~~~~~~~~~r~~~~ 469 (786)
.|+..++++++++++++..+++++|+++.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 46666666555554444444444444333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.02 E-value=1 Score=42.81 Aligned_cols=117 Identities=7% Similarity=0.081 Sum_probs=79.6
Q ss_pred CCCcccceeeEEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCce
Q 047901 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNV 643 (786)
Q Consensus 564 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 643 (786)
.||+.++. .+-..++.+.+.++.-+. ...|-. -...+...+++++..|+....+++.+ +|--+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 58888876 566666666555554432 222221 13467889999999999988777765 8889999999
Q ss_pred eeCCCCcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCC
Q 047901 644 LLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGD 723 (786)
Q Consensus 644 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~ 723 (786)
+++.++.+++.=.|+-..+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l-----------------~P~---------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-----------------DPL---------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB-----------------SCC---------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC-----------------CCC---------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999977764322 331 01111112346778889999998876
Q ss_pred c
Q 047901 724 F 724 (786)
Q Consensus 724 ~ 724 (786)
.
T Consensus 159 ~ 159 (215)
T 4ann_A 159 A 159 (215)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.42 E-value=0.8 Score=30.95 Aligned_cols=27 Identities=26% Similarity=0.432 Sum_probs=12.4
Q ss_pred eehhhHHHHHHHHHHHHHHHhheeeec
Q 047901 441 LILFPLLGALALLIVYVVMVFMFRRWK 467 (786)
Q Consensus 441 ~i~~~~~~~~~~~~~~~~~~~~~~r~~ 467 (786)
.|+..++++++++++++..+++++|++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 355555554554444444433444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 786 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-16 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-55
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 25/275 (9%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IG G +VY+ K +AVK N P Q + F NE+ L K RH NI+ F G
Sbjct: 16 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
+ + +V ++ SL L F+ K +++ A + Y+H I
Sbjct: 72 YSTA-PQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLA 691
+HRD+ SNN+ L + ++ DFG A + S + + +L G+ ++AP +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP-------EVI 178
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPS 751
+ + + DVY+FG++ E++ G+ P +S+ ++ I F + P S
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLS 232
Query: 752 LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
++ + CL + RP + +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-51
Identities = 56/282 (19%), Positives = 109/282 (38%), Gaps = 31/282 (10%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+ +G G+ V+ K+AVK FL E + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
+ +V+ Y + +++ EY+ GSL L + K +++ +A+ ++++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI 125
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW-TELVGTFGYVAPAHG 684
+HRD+ + N+L+ +++DFG A+L++ N + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA- 181
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
T K DV+SFG+L E++ ++ + N
Sbjct: 182 ---------INYGTFTIKSDVWSFGILLTEIVTHGRI------PYPGMTNPEVIQNLERG 226
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+R+ P + E+L +M LC P RPT + +L
Sbjct: 227 YRMVRPD-NCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 55/282 (19%), Positives = 107/282 (37%), Gaps = 31/282 (10%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+ IG G+ V+ + DK+A+K + +++F+ E + + K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 59
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
+V+ YG C +V+E++ G L+ L F + + V + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGM--- 114
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE-LVGTFGYVAPAHG 684
+ ++HRD+++ N L+ +VSDFG + + + + + +P
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP--- 171
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E+ + + K DV+SFGVL EV + S+ + +
Sbjct: 172 -------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKI------PYENRSNSEVVEDISTG 218
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RL P L + ++ C P RP + + L
Sbjct: 219 FRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 63/287 (21%), Positives = 124/287 (43%), Gaps = 29/287 (10%)
Query: 504 RTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
R +D++ Y IG G + + + G + K+ + + +++ ++E+ L +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRE 59
Query: 563 IRHRNIVKFYGFCSHVRHS--FVVYEYINRGSLATVLSNNFAS-EDFDWRKRMNVITGVA 619
++H NIV++Y ++ ++V EY G LA+V++ + D + V+T +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 620 DALSYMH--HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
AL H D ++HRD+ NV LD + ++ DFG A++L ++S VGT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY 179
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737
Y++P E M EK D++S G L E+ P ++ S
Sbjct: 180 YMSP----------EQMNRMSYNEKSDIWSLGCLLYELCALMPP--------FTAFSQKE 221
Query: 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ + + ++L I+ L+ RP+++ + +
Sbjct: 222 LAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-47
Identities = 59/283 (20%), Positives = 114/283 (40%), Gaps = 33/283 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
KD +G G+ V K +A+K + + EF+ E K + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 58
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
+V+ YG C+ R F++ EY+ G L L F ++ + + V +A+ Y+
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-SSNWTELVGTFGYVAPAHG 684
+HRD+++ N L++ + +VSDFG ++ + + ++ + P
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP--- 170
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAML 743
E+ K + K D+++FGVL E+ GK P + ++ +
Sbjct: 171 -------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQ 216
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RL P L ++ + + C + RPT + + +
Sbjct: 217 GLRLYRPHLASEK----VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-47
Identities = 62/288 (21%), Positives = 113/288 (39%), Gaps = 33/288 (11%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKA 559
EI R + + +G+G V+ ++A+K + FL E +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQV 65
Query: 560 LTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
+ K+RH +V+ Y S ++V EY+++GSL + + +++ +A
Sbjct: 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIA 123
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN-SSNWTELVGTFGY 678
++Y+ VHRD+ + N+L+ +V+DFG A+L++ N + +
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
AP A + T K DV+SFG+L E+ + +
Sbjct: 181 TAPEA----------ALYGRFTIKSDVWSFGILLTELTTKGRV------PYPGMVNREVL 224
Query: 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+R+P P + E L +M C P RPT + + L
Sbjct: 225 DQVERGYRMPCPP-ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-47
Identities = 59/314 (18%), Positives = 114/314 (36%), Gaps = 53/314 (16%)
Query: 504 RTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
+ DF+ +G G V++ PSG +A K + + + + + + E++ L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHE 60
Query: 563 IRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADAL 622
IV FYG + E+++ GSL VL + V V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGL 117
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPA 682
+Y+ I+HRD+ +N+L++ E ++ DFG + L + + VGT Y++P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSP- 172
Query: 683 HGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP--------------------- 721
E + + D++S G+ +E+ G++P
Sbjct: 173 ---------ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
Query: 722 ---------GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL--CLD 770
S + +LD+ + P + + S+ + CL
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 771 GCPNSRPTMQTVCQ 784
P R ++ +
Sbjct: 284 KNPAERADLKQLMV 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 35/282 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
K+ IGKGE V G+K+AVK + + + FL E +T++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRH 59
Query: 566 RNIVKFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
N+V+ G + ++V EY+ +GSL L + + V +A+ Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEY 118
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+ VHRD+++ NVL+ + A+VSDFG K SS + AP
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP--- 169
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E K + K DV+SFG+L E+ ++
Sbjct: 170 -------EALREKKFSTKSDVWSFGILLWEIYSFGRV------PYPRIPLKDVVPRVEKG 216
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+++ P + +M C RP+ + + L
Sbjct: 217 YKMDAPD-GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 8e-46
Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 48/308 (15%)
Query: 498 YEEIIRRTKDFDAKY---------CIGKGEHRSVYRAKLPSGDK----IAVKKFNSPFPN 544
+E+ ++F + IG GE V L K +A+K S +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 545 DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASE 604
Q +++FL+E + + H N++ G + ++ E++ GSL + L N
Sbjct: 69 KQ---RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124
Query: 605 DFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664
F + + ++ G+A + Y+ VHRD+++ N+L++ +VSDFG ++ L+
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 665 NSSNWTE-----LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KG 718
++S+ T + AP K T DV+S+G++ EV+ G
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQ----------YRKFTSASDVWSYGIVMWEVMSYG 230
Query: 719 KHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
+ P + ++ + NA+ P +D L +M L C N RP
Sbjct: 231 ERP-----YWDMTNQDV---INAIEQDYRLPPPMDCPSALHQLM---LDCWQKDRNHRPK 279
Query: 779 MQTVCQLL 786
+ L
Sbjct: 280 FGQIVNTL 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-45
Identities = 59/298 (19%), Positives = 109/298 (36%), Gaps = 39/298 (13%)
Query: 513 CIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IGKG V+R K G+++AVK F+S + EI +RH NI+ F
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFI 63
Query: 573 GFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
+ + ++V +Y GSL L+ + + A L+++H +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHME 119
Query: 629 CF-----PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW----TELVGTFGYV 679
P I HRD+ S N+L+ ++D G A + VGT Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739
AP + +++ ++ D+Y+ G++ E+ + G + +
Sbjct: 180 APEVLDDSINMKHFES----FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 740 NAM-----------LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
++ L +P E L + ++ C +R T + + L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-45
Identities = 65/282 (23%), Positives = 99/282 (35%), Gaps = 37/282 (13%)
Query: 514 IGKGEHRSVYRAKLPSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIV 569
IG+G VY L D AVK N + + +FL E + H N++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 570 KFYGFCSHVRHS-FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
G C S VV Y+ G L + N + + M
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS----SNWTELVGTFGYVAPAHG 684
VHRD+++ N +LD ++ +V+DFG A+ + N T ++A
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL--- 203
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E T K T K DV+SFGVL E++ P ++ +I +
Sbjct: 204 -------ESLQTQKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQG 250
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RL P + EV L C RP+ + +
Sbjct: 251 RRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-44
Identities = 56/277 (20%), Positives = 114/277 (41%), Gaps = 34/277 (12%)
Query: 514 IGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G ++VY+ + ++A + +++ F E + L ++H NIV+FY
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 573 GFCSHV----RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
+ +V E + G+L T L + + + + L ++H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 629 CFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIG 687
PPI+HRD+ +N+ + ++ D G A L + + + ++GT ++AP
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAP------ 182
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRL 747
E+ Y K E DVY+FG+ LE+ ++P +S ++ I +
Sbjct: 183 ----EM-YEEKYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKP 231
Query: 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
++ I+E C+ + R +++ +
Sbjct: 232 ASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 27/291 (9%)
Query: 498 YEEIIRRTK---DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEF 553
YE + R ++ +G G VY+A+ + A K + + +++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDY 56
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN 613
+ EI L H NIVK + + +++ E+ G++ V+ +
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQV 114
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELV 673
V DAL+Y+H I+HRD+ + N+L L+ + +++DFG + +
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 674 GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733
GT ++AP + + E + K DV+S G+ +E+ + + P L+
Sbjct: 172 GTPYWMAP-----EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226
Query: 734 SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
E L PS ++ CL+ ++R T + Q
Sbjct: 227 IAKSEP-----PTLAQPS-RWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-44
Identities = 69/297 (23%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 499 EEIIRRTK------DFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQM 547
EEI+ + + D KY IG+G +VY A + +G ++A+++ N Q
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN----LQQQ 58
Query: 548 SDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFD 607
++ +NEI + + ++ NIV + +VV EY+ GSL V++ D
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MD 114
Query: 608 WRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667
+ V AL ++H + ++HRDI S+N+LL ++ +++DFG + P S
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSL 727
+ +VGT ++AP E+ K D++S G++A+E+I+G+ P
Sbjct: 172 KRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP------ 215
Query: 728 FSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ + + + A + + CLD R + + + Q
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 2e-44
Identities = 59/281 (20%), Positives = 120/281 (42%), Gaps = 29/281 (10%)
Query: 505 TKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
K F IG G +VY A+ + + + +A+KK + ++ + E++ L K+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKL 72
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
RH N +++ G +++V EY + + + + + V G L+
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLA 129
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
Y+H ++HRD+ + N+LL ++ DFG+A ++ P +S VGT ++AP
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAP-- 180
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
+ + K DV+S G+ +E+ + K P + ++++ ++
Sbjct: 181 -----EVILAMDEGQYDGKVDVWSLGITCIELAERKPP-------LFNMNAMSALYHIAQ 228
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ S E + ++ CL P RPT + + +
Sbjct: 229 NESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 32/280 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
+DF+ +GKG+ +VY A+ S +A+K + + E++ + +R
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLR 64
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H NI++ YG+ +++ EY G++ L FD ++ IT +A+ALSY
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
H ++HRDI N+LL E +++DFG + SS T L GT Y+ P
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLCGTLDYLPP--- 173
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E+ EK D++S GVL E + GK P +++ + +
Sbjct: 174 -------EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--------FEANTYQETYKRISR 218
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
P V E ++ L P+ RP ++ V +
Sbjct: 219 VEFTFPD-FVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 61/280 (21%), Positives = 105/280 (37%), Gaps = 37/280 (13%)
Query: 514 IGKGEHRSVYRAKLPSGDK---IAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
+G G SV + K +A+K + +D +E + E + + ++ + IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G C +V E G L L E+ ++ V+ + Y+
Sbjct: 74 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE---LVGTFGYVAPAHGNIG 687
VHRD+++ NVLL + A++SDFG +K L + S +T + AP
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP------ 181
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746
E K + + DV+S+GV E + G+ P + R
Sbjct: 182 ----ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-------KMKGPEVMAFIEQGKR 230
Query: 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ P + +L ++M C RP TV Q +
Sbjct: 231 MECPP-ECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 5e-44
Identities = 58/283 (20%), Positives = 112/283 (39%), Gaps = 31/283 (10%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
D K+ +G G++ VY +AVK + + +EFL E + +I+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 71
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H N+V+ G C+ +++ E++ G+L L ++ + + T ++ A+ Y
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEY 130
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN-WTELVGTFGYVAPAH 683
+ +HRD+++ N L+ + +V+DFG ++L+ ++ + AP
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
K + K DV++FGVL E+ +
Sbjct: 188 ----------LAYNKFSIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEK 231
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
D+R+ P EK+ +M C P+ RP+ + Q
Sbjct: 232 DYRMERPE-GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-43
Identities = 61/280 (21%), Positives = 105/280 (37%), Gaps = 37/280 (13%)
Query: 514 IGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVK 570
+G G +V + +AVK + + + + E L E + ++ + IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL--KDELLAEANVMQQLDNPYIVR 72
Query: 571 FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCF 630
G C +V E G L L N + + ++ V+ + Y+
Sbjct: 73 MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 631 PPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW---TELVGTFGYVAPAHGNIG 687
VHRD+++ NVLL ++ A++SDFG +K L+ + + + T + AP
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP------ 179
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINIEFNAMLDHR 746
E K + K DV+SFGVL E G+ P + R
Sbjct: 180 ----ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR-------GMKGSEVTAMLEKGER 228
Query: 747 LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ P+ ++ +M LC +RP V L
Sbjct: 229 MGCPA-GCPREMYDLM---NLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 36/281 (12%)
Query: 514 IGKGEHRSVYRAKLPSGD-----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNI 568
IG GE VY+ L + +A+K + + Q + +FL E + + H NI
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDFLGEAGIMGQFSHHNI 71
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
++ G S + ++ EY+ G+L L +F + + ++ G+A + M +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIA---AGMKYL 126
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW---TELVGTFGYVAPAHGN 685
VHRD+++ N+L++ +VSDFG +++L+ + + + AP
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP---- 182
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745
E K T DV+SFG++ EV+ S+ +
Sbjct: 183 ------EAISYRKFTSASDVWSFGIVMWEVMTYGER------PYWELSNHEVMKAINDGF 230
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P D + +M + C RP + +L
Sbjct: 231 RLPTPM-DCPSAIYQLM---MQCWQQERARRPKFADIVSIL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-43
Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 32/283 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
+D+D +G+G + V A + + +AVK + + + EI +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H N+VKFYG ++ EY + G L + + + + Y
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVY 118
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPA 682
+H I HRDI N+LLD ++SDFG A + + N+ ++ GT YVAP
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP- 174
Query: 683 HGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741
EL + E DV+S G++ ++ G+ P + S S +
Sbjct: 175 ---------ELLKRREFHAEPVDVWSCGIVLTAMLAGELP------WDQPSDSCQEYSDW 219
Query: 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+P + ++++ +L + P++R T+ + +
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLH-KILVEN--PSARITIPDIKK 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 1e-42
Identities = 53/309 (17%), Positives = 111/309 (35%), Gaps = 55/309 (17%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL 560
+ + IG+G V++A+ P +AVK Q +F E +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALM 70
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN-------------------- 600
+ + NIVK G C+ + +++EY+ G L L +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 601 -FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659
+++ + VA ++Y+ VHRD+++ N L+ +++DFG +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 660 KLLKPNSSNW--TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717
+ + ++ P E + + T + DV+++GV+ E+
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPP----------ESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 718 GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777
+ + + + L P + +L ++M LC P RP
Sbjct: 238 YGLQ------PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLM---RLCWSKLPADRP 287
Query: 778 TMQTVCQLL 786
+ ++ ++L
Sbjct: 288 SFCSIHRIL 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 56/309 (18%), Positives = 104/309 (33%), Gaps = 54/309 (17%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLPSGDK------IAVKKFNSPFPNDQMSDQKEFLNEIKAL 560
+ + +G G V A K +AVK S+++ ++E+K +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMM 94
Query: 561 TKI-RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNN------------------- 600
T++ H NIV G C+ ++++EY G L L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 601 -FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659
+ + VA + ++ VHRD+++ NVL+ ++ DFG A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 660 KLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK 717
+ + +S+ ++AP E + T K DV+S+G+L E+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAP----------ESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 718 GKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777
+ N ++ P +E I + C RP
Sbjct: 262 LGVN-----PYPGIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRP 312
Query: 778 TMQTVCQLL 786
+ + L
Sbjct: 313 SFPNLTSFL 321
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 58/298 (19%), Positives = 110/298 (36%), Gaps = 44/298 (14%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDK---IAVKKFNSPFPNDQMSDQKEFLNEIKALTK 562
D + IG+G V +A++ A+K+ D D ++F E++ L K
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 66
Query: 563 I-RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED-------------FDW 608
+ H NI+ G C H + ++ EY G+L L + E
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668
++ ++ VA + Y+ +HRD+++ N+L+ Y A+++DFG ++ +
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 669 WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLF 728
++A E T DV+S+GVL E++
Sbjct: 184 TM-GRLPVRWMAI----------ESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------P 226
Query: 729 SSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ + +RL P + +++ +M C P RP+ + L
Sbjct: 227 YCGMTCAELYEKLPQGYRLEKPL-NCDDEVYDLM---RQCWREKPYERPSFAQILVSL 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 61/299 (20%), Positives = 114/299 (38%), Gaps = 53/299 (17%)
Query: 514 IGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHR 566
+G G V A + +AVK P+ +++++ ++E+K L+ + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 567 NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASED---------------FDWRKR 611
NIV G C+ + V+ EY G L L S D
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW-- 669
++ VA ++++ +HRD+++ N+LL ++ DFG A+ +K +S+
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 670 TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729
++AP E + T + DV+S+G+ E+
Sbjct: 205 GNARLPVKWMAP----------ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP----- 249
Query: 730 SSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
++ +F M+ R+ P E + ++ C D P RPT + + QL+
Sbjct: 250 --GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-41
Identities = 63/289 (21%), Positives = 105/289 (36%), Gaps = 35/289 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKLPSGDK----IAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
KD +G G V R + + +AVK + +F+ E+ A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-EAMDDFIREVNAMH 66
Query: 562 KIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621
+ HRN+++ YG +V E GSL L + R VA+
Sbjct: 67 SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEG 123
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW---TELVGTFGY 678
+ Y+ +HRD+++ N+LL ++ DFG + L N ++ F +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSSSINI 737
AP E T + D + FGV E+ G+ P + + S +
Sbjct: 181 CAP----------ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP------WIGLNGSQIL 224
Query: 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
RLP P D + + ++M + C P RPT + L
Sbjct: 225 HKIDKEGERLPRPE-DCPQDIYNVM---VQCWAHKPEDRPTFVALRDFL 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (381), Expect = 1e-40
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 36/294 (12%)
Query: 495 KIMYEEIIRRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEF 553
+I ++ ++ +D +G G V+R +G+ A K +P SD++
Sbjct: 18 EIKHDHVLDH---YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETV 70
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMN 613
EI+ ++ +RH +V + ++YE+++ G L +++ + +
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVE 128
Query: 614 VITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTE 671
+ V L +MH + VH D+ N++ + + DFG L P S
Sbjct: 129 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731
GT + AP E+A + D++S GVL+ ++ G P F
Sbjct: 186 -TGTAEFAAP----------EVAEGKPVGYYTDMWSVGVLSYILLSGLSP------FGGE 228
Query: 732 SSSINIEFNAMLDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ + D + + + E + LL D PN+R T+ +
Sbjct: 229 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR-KLLLAD--PNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 9e-40
Identities = 52/294 (17%), Positives = 103/294 (35%), Gaps = 37/294 (12%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGD-----KIAVKKFNSPFPNDQMSDQKEFL 554
I++ T +F +G G +VY+ +A+K+ KE L
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 59
Query: 555 NEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
+E + + + ++ + G C + L V + ++ + +N
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNW 116
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW--TEL 672
+A ++Y+ +VHRD+++ NVL+ +++DFG AKLL +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
++A E T + DV+S+GV E++
Sbjct: 174 KVPIKWMAL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGI 217
Query: 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ I RLP P + + + + + C +SRP + +
Sbjct: 218 PASEISSILEKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 2e-39
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 32/288 (11%)
Query: 503 RRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEI 557
++ +D Y +G G V A+ + +A+K + NEI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEI 58
Query: 558 KALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITG 617
L KI+H NIV H +++ + ++ G L + + R +I
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQ 115
Query: 618 VADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFG 677
V DA+ Y+H + + LD + + +SDFG +K+ P S T GT G
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPG 174
Query: 678 YVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737
YVAP E+ ++ D +S GV+A ++ G P F + +
Sbjct: 175 YVAP----------EVLAQKPYSKAVDCWSIGVIAYILLCGYPP------FYDENDAKLF 218
Query: 738 EFNAMLDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
E ++ P D+ + + L+ D P R T + Q
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIR-HLMEKD--PEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 61/281 (21%), Positives = 106/281 (37%), Gaps = 32/281 (11%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
+R +DF +G+G +V A+ L + + A+K + + E ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMS 63
Query: 562 KIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADA 621
++ H VK Y + Y G L + FD + A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120
Query: 622 LSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW--TELVGTFGYV 679
L Y+H I+HRD+ N+LL+ + +++DFGTAK+L P S VGT YV
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739
+P EL + D+++ G + +++ G P + + + F
Sbjct: 178 SP----------ELLTEKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIF 219
Query: 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
++ P K ++E LL LD R +
Sbjct: 220 QKIIKLEYDFPE-KFFPKARDLVE-KLLVLD--ATKRLGCE 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (371), Expect = 2e-39
Identities = 52/275 (18%), Positives = 100/275 (36%), Gaps = 33/275 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G V+R +G K N+P+P D+ NEI + ++ H ++ +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLH 92
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
++ E+++ G L ++ + +N + + L +MH
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 633 IVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHL 690
IVH DI N++ + + + V DFG A L P+ T + AP
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAP--------- 197
Query: 691 AELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRLPHP 750
E+ + D+++ GVL ++ G P F+ ++ D
Sbjct: 198 -EIVDREPVGFYTDMWAIGVLGYVLLSGLSP------FAGEDDLETLQNVKRCDWEFDED 250
Query: 751 SL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ V + ++ LL + P R T+ +
Sbjct: 251 AFSSVSPEAKDFIK-NLLQKE--PRKRLTVHDALE 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 38/293 (12%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGD----KIAVKKFNSPFPNDQMSDQKEFLN 555
EI R + + CIG+G+ V++ S + +A+K S +++FL
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQ 57
Query: 556 EIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVI 615
E + + H +IVK G + +++ E G L + L S D +
Sbjct: 58 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYA 114
Query: 616 TGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS-NWTELVG 674
++ AL+Y+ VHRDI++ NVL+ ++ DFG ++ ++ ++ ++
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVI-KGKHPGDFLSLFSSSSS 733
++AP E + T DV+ FGV E++ G P
Sbjct: 172 PIKWMAP----------ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------GVK 214
Query: 734 SINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ ++ RLP P + L S+M C P+ RP + L
Sbjct: 215 NNDVIGRIENGERLPMPP-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (354), Expect = 7e-38
Identities = 55/286 (19%), Positives = 114/286 (39%), Gaps = 28/286 (9%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE-----FLNEIKAL 560
+++ K +G+G V R P+ + AVK + +++ + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 561 TKIR-HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
K+ H NI++ F+V++ + +G L L+ ++ ++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYV 679
+ + +H IVHRD+ N+LLD + +++DFG + L P E+ GT Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739
AP + + ++ D++S GV+ ++ G P F + +
Sbjct: 177 APEI----IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRKQMLMLRM 226
Query: 740 NAMLDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+++ P D + + ++ L + P R T +
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKDLVS-RFLVVQ--PQKRYTAEEALA 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-38
Identities = 56/302 (18%), Positives = 112/302 (37%), Gaps = 43/302 (14%)
Query: 500 EIIRRTKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEF 553
E+ R + +G+G VY ++A+K N M ++ EF
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEF 70
Query: 554 LNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL-------SNNFASEDF 606
LNE + + ++V+ G S + + V+ E + RG L + L +NN
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 607 DWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNS 666
K + + +AD ++Y++ VHRD+++ N ++ ++ ++ DFG + +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 667 S--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724
+ + +++P E T DV+SFGV+ E+
Sbjct: 188 YYRKGGKGLLPVRWMSP----------ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--- 234
Query: 725 LSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
S +++ L + + L +M +C P RP+ +
Sbjct: 235 ----PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIIS 287
Query: 785 LL 786
+
Sbjct: 288 SI 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 58/287 (20%), Positives = 114/287 (39%), Gaps = 38/287 (13%)
Query: 506 KDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKAL 560
K+ KY +G+GE V+R S K + +DQ EI L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISIL 55
Query: 561 TKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
RHRNI+ + + +++E+I+ + ++ + + + + R+ ++ + V +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCE 113
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV--SDFGTAKLLKPNSSNWTELVGTFGY 678
AL ++H I H DI N++ + + +FG A+ LKP + L Y
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEY 169
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738
AP E+ ++ D++S G L ++ G +P F + ++ IE
Sbjct: 170 YAP----------EVHQHDVVSTATDMWSLGTLVYVLLSGINP------FLAETNQQIIE 213
Query: 739 FNAMLDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
++ + ++ + + ++ LL + SR T Q
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVD-RLLVKE--RKSRMTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-36
Identities = 62/297 (20%), Positives = 114/297 (38%), Gaps = 50/297 (16%)
Query: 514 IGKGEHRSVYRAKLPSGDK--------IAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-R 564
+G+G V A+ DK +AVK S D + ++E++ + I +
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGK 77
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVL-------------SNNFASEDFDWRKR 611
H+NI+ G C+ +V+ EY ++G+L L ++ E +
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
++ VA + Y+ +HRD+++ NVL+ + +++DFG A+ +
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 672 LV--GTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFS 729
++AP E + T + DV+SFGVL E+
Sbjct: 195 TNGRLPVKWMAP----------EALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PY 238
Query: 730 SSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ HR+ PS + +L +M C P+ RPT + + + L
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPS-NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (335), Expect = 3e-35
Identities = 57/288 (19%), Positives = 111/288 (38%), Gaps = 34/288 (11%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYG 573
IG+G + VY+A+ G+ A+KK ++ + + EI L +++H NIVK Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLYD 67
Query: 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPI 633
+ +V+E++++ + E + + L+ + + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL------LQLLNGIAYCHDRRV 121
Query: 634 VHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAEL 693
+HRD+ N+L++ E E +++DFG A+ +T + T Y AP L
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP---------DVL 172
Query: 694 AYTMKITEKCDVYSFGVLALEVIKGKHP-------------GDFLSLFSSSSSSINIEFN 740
+ K + D++S G + E++ G L +S + E
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGC----PNSRPTMQTVCQ 784
+ + L + L + E + L PN R T + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-35
Identities = 58/276 (21%), Positives = 102/276 (36%), Gaps = 31/276 (11%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTK-IR 564
DF +GKG V+ A+ + A+K D + + E + L+
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWE 61
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H + + + F V EY+N G L + + FD + + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+H IV+RD+ +N+LLD + +++DFG K + GT Y+AP
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP--- 172
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E+ K D +SFGVL E++ G+ P F M +
Sbjct: 173 -------EILLGQKYNHSVDWWSFGVLLYEMLIGQSP------FHGQDEEELFHSIRMDN 219
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
P ++++ ++ L + P R ++
Sbjct: 220 PFYPR---WLEKEAKDLLV-KLFVRE--PEKRLGVR 249
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (335), Expect = 5e-35
Identities = 54/274 (19%), Positives = 103/274 (37%), Gaps = 33/274 (12%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
+DF +G G V+ + +G A+K + +E L+ +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVT 62
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H I++ +G + F++ +YI G L ++L + + + A+
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA------AEVCLA 116
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+ + I++RD+ N+LLD +++DFG AK + L GT Y+AP
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAP--- 170
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E+ T + D +SFG+L E++ G P S+ + +L+
Sbjct: 171 -------EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILN 215
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT 778
L P E + ++ + + R
Sbjct: 216 AELRFPP-FFNEDVKDLLS---RLITRDLSQRLG 245
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 130 bits (328), Expect = 2e-34
Identities = 59/274 (21%), Positives = 108/274 (39%), Gaps = 35/274 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
+G G V+ A+ L +AVK + D S F E + + H IV Y
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAIVAVY 73
Query: 573 GFCSHVRHS----FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
+ ++V EY++ +L ++ ++ + VI AL++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ- 129
Query: 629 CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE---LVGTFGYVAPAHGN 685
I+HRD+ N+++ +V DFG A+ + + ++ T+ ++GT Y++P
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP---- 183
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745
E A + + DVYS G + EV+ G+ P F+ S + D
Sbjct: 184 ------EQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDP 231
Query: 746 RLPHPSLD-VQEKLISIMEVALLCLDGCPNSRPT 778
P + + L +++ L P +R
Sbjct: 232 IPPSARHEGLSADLDAVVL---KALAKNPENRYQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 51/293 (17%), Positives = 108/293 (36%), Gaps = 38/293 (12%)
Query: 504 RTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPF--PNDQMSDQKEFLNE 556
R ++ D Y +G G+ V + + +G + A K + + +++ E
Sbjct: 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 557 IKALTKIRHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVIT 616
+ L +I+H N++ + + ++ E + G L L+ E + +
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLK 120
Query: 617 GVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEAR----VSDFGTAKLLKPNSSNWTEL 672
+ + + Y+H I H D+ N++L + + DFG A + + + +
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 176
Query: 673 VGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSS 732
GT +VAP E+ + + D++S GV+ ++ G P F +
Sbjct: 177 FGTPEFVAP----------EIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDT 220
Query: 733 SSINIEFNAMLDHRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ + +++ + + LL D P R T+Q Q
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIR-RLLVKD--PKKRMTIQDSLQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (332), Expect = 4e-34
Identities = 56/277 (20%), Positives = 93/277 (33%), Gaps = 29/277 (10%)
Query: 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQ--KEFLNEIKALTKI 563
DF IG+G VY + +G A+K + + + + ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 564 RHRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALS 623
IV + + +N G L LS + F + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLE 121
Query: 624 YMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAH 683
+MH+ +V+RD+ N+LLD R+SD G A + + GT GY+AP
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP-- 174
Query: 684 GNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743
L + D +S G + ++++G P F + E + M
Sbjct: 175 -------EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP------FRQHKTKDKHEIDRMT 221
Query: 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ 780
+L S++E LL D N R
Sbjct: 222 LTMAVELPDSFSPELRSLLE-GLLQRD--VNRRLGCL 255
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 55/292 (18%), Positives = 105/292 (35%), Gaps = 39/292 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSD-QKEFLNEIKALTKIRHRNIVKF 571
+G+G+ +VY+A+ + +A+KK ++ + L EIK L ++ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
H + +V++++ + N+ + M L + +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM------LMTLQGLEYLHQH 119
Query: 632 PIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLA 691
I+HRD+ NN+LLD +++DFG AK + +T V T Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP---------E 170
Query: 692 ELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLS-------------------LFSSSS 732
L D+++ G + E++ S S
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ F + L H + L+ +++ L + P +R T +
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ-GLFLFN--PCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 53/296 (17%), Positives = 107/296 (36%), Gaps = 34/296 (11%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+F IG+G + VY+A+ +G+ +A+KK + + + EI L ++ H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNH 60
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
NIVK ++V+E++++ + ++ K + L +
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
++HRD+ N+L++ E +++DFG A+ +T V T Y AP
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP---- 171
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF----------LSLFSSSSSSI 735
L + D++S G + E++ + + +
Sbjct: 172 -----EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 736 NIEFNAMLDHRLPHPSL---DVQEKLISIMEVALLCLDGC----PNSRPTMQTVCQ 784
+M D++ P D + + + E L PN R + +
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 1e-32
Identities = 41/287 (14%), Positives = 91/287 (31%), Gaps = 42/287 (14%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G +Y + +G+++A+K + + E K ++ +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 573 GFC-SHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
+C + ++ +V E + + F + + + + + Y+H
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 632 PIVHRDISSNNVL---LDLEYEARVSDFGTAKLLKPNSSN-------WTELVGTFGYVAP 681
+HRD+ +N L + DFG AK + ++ L GT Y +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741
++ + + D+ S G + + G P +++ E +
Sbjct: 183 ----------NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG---LKAATKRQKYERIS 229
Query: 742 MLDHRLPHPSL--DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
P L + + + C + +P + QL
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 39/281 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKF 571
+G G + V + + +K A+K + D + E++ + + +IV+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM---------LQDCPKARREVELHWRASQCPHIVRI 70
Query: 572 YGFCSHV----RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
++ + +V E ++ G L + + + + F R+ ++ + +A+ Y+H
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 628 DCFPPIVHRDISSNNVLLDLEYE---ARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
I HRD+ N+L + +++DFG AK ++S T T YVAP
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAP--- 182
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
E+ K + CD++S GV+ ++ G P F S + S M
Sbjct: 183 -------EVLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQ 233
Query: 745 HRLPHPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
+ P+P +V E++ ++ LL + P R T+
Sbjct: 234 YEFPNPEWSEVSEEVKMLIR-NLLKTE--PTQRMTITEFMN 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 48/296 (16%)
Query: 514 IGKGEHRSVYRA------KLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHR- 566
+G+G V A K + +AVK S+ + ++E+K L I H
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 77
Query: 567 NIVKFYGFCSHVRHS-FVVYEYINRGSLATVLSNN-------------FASEDFDWRKRM 612
N+V G C+ V+ E+ G+L+T L + + +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 613 NVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW--T 670
VA + ++ +HRD+++ N+LL + ++ DFG A+ + +
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 671 ELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730
+ ++AP + T + DV+SFGVL E+ +
Sbjct: 195 DARLPLKWMAPET----------IFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPG 239
Query: 731 SSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
R+ P E + + L C G P+ RPT + + L
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 50/277 (18%), Positives = 98/277 (35%), Gaps = 40/277 (14%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPND--QMSDQKEFLNEIKALTKIR--HRNI 568
+G G SVY + +A+K +D ++ + E+ L K+ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 569 VKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD 628
++ + ++ E + + V +A+ + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN- 128
Query: 629 CFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIG 687
++HRDI N+L+DL E ++ DFG+ LLK + +T+ GT Y P
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPP------ 178
Query: 688 LHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDHRL 747
+ Y V+S G+L +++ G P F ++ ++
Sbjct: 179 ---EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------FEHD--------EEIIRGQV 221
Query: 748 PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784
V + ++ CL P+ RPT + +
Sbjct: 222 FFRQ-RVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-31
Identities = 65/303 (21%), Positives = 110/303 (36%), Gaps = 46/303 (15%)
Query: 507 DFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
+ IG G VY+AKL SG+ +A+KK D++ E++ + K+ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDH 72
Query: 566 RNIVKFYGFCSHV------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVA 619
NIV+ F + +V +Y+ + A + + +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 620 DALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGY 678
+L+Y+H I HRDI N+LLD + ++ DFG+AK L N + + + Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYY 188
Query: 679 VAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP----------GDFLSLF 728
AP + T DV+S G + E++ G+ + + +
Sbjct: 189 RAP---------ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 729 SSSSSSINIEFNA-----MLDHRLPHPSLDVQEKLISIMEVALL--CLDGCPNSRPTMQT 781
+ + E N HP V +AL L+ P +R T
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 782 VCQ 784
C
Sbjct: 300 ACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 52/294 (17%), Positives = 103/294 (35%), Gaps = 38/294 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G + V A + ++A+KK + P + + + L EIK L + RH NI+
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
+ Y+ + L ++ + + L Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN---WTELVGTFGYVAPAHGNIGLH 689
++HRD+ +N+LL+ + ++ DFG A++ P+ + TE V T Y AP
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP-------- 181
Query: 690 LAELAYTMKITEKCDVYSFGVLALEVIKGKHP-----------------GDFLSLFSSSS 732
+ + T+ D++S G + E++ + G +
Sbjct: 182 -EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 733 SSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL--CLDGCPNSRPTMQTVCQ 784
++ + + + LL L P+ R ++
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-30
Identities = 50/305 (16%), Positives = 108/305 (35%), Gaps = 39/305 (12%)
Query: 503 RRTKDFDAKYCIGKGEHRSVYRAK--LPSGDKIAVKKFNSPFPNDQMSDQ-KEFLNEIKA 559
R + ++ IG+G + V++A+ G +A+K+ + M + ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 560 LTKIRHRNIVKFYGFCSHVR-----HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNV 614
L H N+V+ + C+ R +V+E++++ + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDM 121
Query: 615 ITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVG 674
+ + L ++H +VHRD+ N+L+ + +++DFG A++ + + +V
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVV 177
Query: 675 TFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP------------- 721
T Y AP D++S G + E+ + K
Sbjct: 178 TLWYRAPEV----------LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 722 GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL--CLDGCPNSRPTM 779
D + L ++ H ++ I + LL CL P R +
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 780 QTVCQ 784
+
Sbjct: 288 YSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 5e-30
Identities = 46/290 (15%), Positives = 102/290 (35%), Gaps = 36/290 (12%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G + +V++AK + + +A+K+ ++ + L EI L +++H+NIV+ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 573 GFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP 632
+ +V+E+ ++ S N V + + L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 633 IVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAE 692
++HRD+ N+L++ E ++++FG A+ ++ V T Y P
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP---------DV 172
Query: 693 LAYTMKITEKCDVYSFGVLALEVIKGKHP--------------GDFLSLFSSSSSSINIE 738
L + D++S G + E+ P L + +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGC----PNSRPTMQTVCQ 784
+ + + + + + L P R + + Q
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-30
Identities = 58/284 (20%), Positives = 96/284 (33%), Gaps = 32/284 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR 564
DFD +GKG V + +G A+K + + + E + L R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTR 63
Query: 565 HRNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
H + V EY N G L LS F + + AL Y
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEY 120
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHG 684
+H +V+RDI N++LD + +++DFG K + + GT Y+AP
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV- 176
Query: 685 NIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744
D + GV+ E++ G+ P + F +L
Sbjct: 177 ---------LEDNDYGRAVDWWGLGVVMYEMMCGRLP--------FYNQDHERLFELILM 219
Query: 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ--TVCQLL 786
+ P + + S++ LL D P R +++
Sbjct: 220 EEIRFPR-TLSPEAKSLLA-GLLKKD--PKQRLGGGPSDAKEVM 259
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (293), Expect = 1e-29
Identities = 41/287 (14%), Positives = 87/287 (30%), Gaps = 40/287 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN-IVKF 571
IG+G ++ L + ++A+K + SD + +E + + I
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 572 YGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFP 631
Y F H+ +V + + + F + + + +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 632 PIVHRDISSNNVLLDLEY-----EARVSDFGTAKLLKPNSSN-------WTELVGTFGYV 679
+V+RDI +N L+ V DFG K + + L GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739
+ + + + D+ + G + + ++G P L ++ I
Sbjct: 181 SI----------NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786
+ E+ M + ++ P + L
Sbjct: 231 KKQSTPLRELCA-GFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 50/304 (16%), Positives = 98/304 (32%), Gaps = 50/304 (16%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG+G V++A+ +G K+A+KK N++ L EIK L ++H N+V
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 573 GFCSHV--------RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSY 624
C ++V+++ + + + ++ M ++ L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 129
Query: 625 MHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS----NWTELVGTFGYVA 680
+++ I+HRD+ + NVL+ + +++DFG A+ + +T V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 681 PAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-----------------GD 723
P L D++ G + E+ G
Sbjct: 190 P---------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 724 FLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL---CLDGCPNSRPTMQ 780
+ + + L D + + L L P R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 781 TVCQ 784
Sbjct: 301 DALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 55/291 (18%), Positives = 105/291 (36%), Gaps = 34/291 (11%)
Query: 506 KDFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT 561
++F+ +G G + V+ + +G A+K + + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 562 KIRHR-NIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVAD 620
IR +V + ++ +YIN G L T LS + + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 621 ALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWT-ELVGTFGYV 679
+ + H I++RDI N+LLD ++DFG +K + + + GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 680 APAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE- 738
AP + D +S GVL E++ G P F+ +
Sbjct: 198 APDI--------VRGGDSGHDKAVDWWSLGVLMYELLTGASP------FTVDGEKNSQAE 243
Query: 739 -FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTM--QTVCQLL 786
+L P+P ++ +++ LL D P R + ++
Sbjct: 244 ISRRILKSEPPYPQ-EMSALAKDLIQ-RLLMKD--PKKRLGCGPRDADEIK 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-27
Identities = 61/312 (19%), Positives = 107/312 (34%), Gaps = 42/312 (13%)
Query: 498 YEEIIRRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE 552
+E+ + + A Y +G G + +V A +G K+A+KK PF ++ K
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF--AKR 63
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYE-YINRGSLATVLSNNFASEDFDWRKR 611
E++ L +RH N++ + + Y+ + T L E +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 612 MNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTE 671
++ + L Y+H HRD+ N+ ++ + E ++ DFG A+ + +
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-- 178
Query: 672 LVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP---------- 721
V T Y AP + M+ T+ D++S G + E+I GK
Sbjct: 179 -VVTRWYRAP---------EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228
Query: 722 -------GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL--CLDGC 772
G + F S + L S + V LL L
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288
Query: 773 PNSRPTMQTVCQ 784
R T
Sbjct: 289 AEQRVTAGEALA 300
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (276), Expect = 1e-26
Identities = 75/383 (19%), Positives = 132/383 (34%), Gaps = 55/383 (14%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
L++ L + ++ + L + +L + + L+NL I+ NN
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNN 76
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG-------- 159
+L+ P + NL KL ++++ NQ P + L N +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 160 --------SIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN 211
+I ++ L + L+ LD+S N
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS--V 192
Query: 212 WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271
K L +LI + N I+ P I + L L L+ N + L L +L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 272 RGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI--------------------LEALGFM 311
NQ+S P L LT+L L +N+++N + + +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 312 FKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
L YL N S P ++ L L L ++N S + NL ++ L+ HN
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 372 ISGQIPACFIGMSGLLSIDISYN 394
IS P ++ + + ++
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 3e-26
Identities = 55/272 (20%), Positives = 90/272 (33%), Gaps = 33/272 (12%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH 565
FD +G G V K SG+ A+K + + LNE + L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNF 100
Query: 566 RNIVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYM 625
+VK + ++V EY+ G + + L F + Y+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYL 157
Query: 626 HHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGN 685
H +++RD+ N+L+D + +V+DFG A K L GT +AP
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAP---- 207
Query: 686 IGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLDH 745
E+ + + D ++ GVL E+ G P F + E
Sbjct: 208 ------EIILSKGYNKAVDWWALGVLIYEMAAGYPP------FFADQPIQIYEKIVSGKV 255
Query: 746 RLPHPSLDVQEKLISIMEVALLCLDGCPNSRP 777
R P L ++ L R
Sbjct: 256 RFPS---HFSSDLKDLLR---NLLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (255), Expect = 3e-24
Identities = 46/220 (20%), Positives = 83/220 (37%), Gaps = 31/220 (14%)
Query: 507 DFDAKYCIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR- 564
D+ +G+G++ V+ A + + +K+ VK +K+ EIK L +R
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRG 88
Query: 565 HRNIVKFYGFCSHV--RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADAL 622
NI+ R +V+E++N + + + AL
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 623 SYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAP 681
Y H I+HRD+ +NV++D E + R+ D+G A+ P + V + + P
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 198
Query: 682 AHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
L D++S G + +I K P
Sbjct: 199 ---------ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-23
Identities = 43/215 (20%), Positives = 82/215 (38%), Gaps = 29/215 (13%)
Query: 514 IGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFY 572
IG G V A +A+KK + PF N K E+ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIISLL 82
Query: 573 GFCSH------VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMH 626
+ + ++V E ++ + D + ++ + + ++H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 136
Query: 627 HDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNI 686
+HRD+ +N+++ + ++ DFG A+ S T V T Y AP
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP----- 187
Query: 687 GLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP 721
E+ M E D++S G + E+++ K
Sbjct: 188 -----EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 6e-23
Identities = 54/316 (17%), Positives = 109/316 (34%), Gaps = 50/316 (15%)
Query: 498 YEEIIRRTKDFDAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKE 552
+E+ + + +Y +G G + SV A +G ++AVKK + PF + K
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKR 63
Query: 553 FLNEIKALTKIRHRNIVKFYGFCSHVR-----HSFVVYEYINRGSLATVLSNNFASEDFD 607
E++ L ++H N++ + R + + ++ L ++
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 608 WRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667
+I + L Y+H HRD+ +N+ ++ + E ++ DFG A+ +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 668 NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP------ 721
+ T Y AP + M + D++S G + E++ G+
Sbjct: 177 GYVA---TRWYRAP---------EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 722 -----------GDFLSLFSSSSSSINIEFNAMLDHRLPHPSLDVQEKLISIMEVALL--C 768
G + SS + ++P + + + V LL
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 769 LDGCPNSRPTMQTVCQ 784
L + R T
Sbjct: 285 LVLDSDKRITAAQALA 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.6 bits (239), Expect = 2e-22
Identities = 62/301 (20%), Positives = 102/301 (33%), Gaps = 16/301 (5%)
Query: 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLS 110
L+ + S+ L K+P ++ LDL N+ + NL NL + L NNK+S
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 111 GSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSL 170
P L+KL L L NQ + L + S+ N N +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG 230
V +G + F L ++ ++ N + G L L + GN IT
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITK 185
Query: 231 RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTEL 290
+ + L L LS N I+ L L +L L N+L P L +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYI 244
Query: 291 EYFDLSSNRLNN------SILEALGFMFKLFYLNFSHN--QFSQEIPEDLALLAHLSELD 342
+ L +N ++ ++ N Q+ + P + + +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
Query: 343 L 343
L
Sbjct: 305 L 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 2e-20
Identities = 52/291 (17%), Positives = 95/291 (32%), Gaps = 33/291 (11%)
Query: 26 PHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQ 85
P A LDL N +NL L L L N++S P
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA-------------- 76
Query: 86 FSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSG 145
L L+ + L N+L + L +L + + + + +
Sbjct: 77 ---------PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 146 LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
++E+ T + + L + N+T + G+ P+L L L N
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKIT 184
Query: 206 GEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLIS 265
+++ + L L +S N+I+ + N+ L L L++N + ++P L
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKY 243
Query: 266 LNKLILRGNQLSG------HLPRALGLLTELEYFDLSSNRLNNSILEALGF 310
+ + L N +S P L SN + ++ F
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.3 bits (220), Expect = 5e-20
Identities = 52/297 (17%), Positives = 92/297 (30%), Gaps = 24/297 (8%)
Query: 97 SNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH 156
+ + L NNK++ + NL L L+L N+ + P LE L ++ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 157 FLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCH 216
+ +R H + + L + G + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 217 RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQL 276
+L + ++ NIT IP G L L L N I L L +L KL L N +
Sbjct: 151 KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 277 SGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLA 336
S +L L L++N+L + + +N S D
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGL-ADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 337 HLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ--IPACFIGMSGLLSIDI 391
+ + S ++L N + P+ F + ++ +
Sbjct: 267 YNT------------------KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 2e-18
Identities = 50/274 (18%), Positives = 98/274 (35%), Gaps = 13/274 (4%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
++L + + +++ F + +L L L N P L KL+ L LS+N+L
Sbjct: 35 LLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 93
Query: 65 KIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLS 124
L L + + + + N + + + K SG + KLS
Sbjct: 94 LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153
Query: 125 YLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGN 183
Y+ + T +P+ + S L L ++ N L+ +L + L N+++
Sbjct: 154 YIRIADTNIT-TIPQGLPPS--LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210
Query: 184 ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG------RIPPEIG 237
+ P+L+ L L++N + + + NNI+ P
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKVPGGLAD-HKYIQVVYLHNNNISAIGSNDFCPPGYNT 269
Query: 238 NSSQLHVLDLSSNHI-AGEIPMELGRLISLNKLI 270
+ + L SN + EI R + + +
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 1e-17
Identities = 49/234 (20%), Positives = 80/234 (34%), Gaps = 4/234 (1%)
Query: 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248
+ P+ LDL +N ++ L TLI+ N I+ P +L L LS
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 249 SNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEAL 308
N + L L ++ + L + +E + + + A
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAF 146
Query: 309 GFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLS 368
M KL Y+ + + IP+ L L+EL L N + + L +L KL LS
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 369 HNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNFSTF 422
N+IS L + ++ N+L + NN S
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (229), Expect = 2e-21
Identities = 55/283 (19%), Positives = 91/283 (32%), Gaps = 9/283 (3%)
Query: 94 CNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVN 153
C S L ++P I + + L N+ + + L IL ++
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 154 DNHFLGSIPNLRNCRSLVRAHLGRN--NLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN 211
N +L+ + L F L L L
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 212 WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271
+ L L + N + + L L L N I+ L SL++L+L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 272 RGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED 331
N+++ P A L L L +N L+ EAL + L YL + N + +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA- 243
Query: 332 LALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374
L A L + S + S+P L + L+ N++ G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (189), Expect = 4e-16
Identities = 49/250 (19%), Positives = 75/250 (30%), Gaps = 6/250 (2%)
Query: 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKY--ISLHNNKL 109
+ + L N +S +L L L N + L N +L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 110 SGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPN-LRNCR 168
P L +L L LD P L+ L + DN + R+
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228
+L L N ++ F +L L L N + RL TL + NN+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALG--L 286
+ + L L L+ N + L K +++ LP+ L
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 287 LTELEYFDLS 296
L L DL
Sbjct: 273 LKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (179), Expect = 6e-15
Identities = 40/193 (20%), Positives = 69/193 (35%), Gaps = 4/193 (2%)
Query: 15 GTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLT 74
++ +F L L L G P R L+ L+YL L +N L L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 75 HLFSLDLSLNQFSGT-FPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQF 133
+L L L N+ S L +L + LH N+++ P +L +L L L N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 134 TGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPN 193
+ + L+ L +NDN ++ L + + + ++ +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA---G 270
Query: 194 LKFLDLSHNNFYG 206
L+ N+ G
Sbjct: 271 RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 42/200 (21%), Positives = 65/200 (32%), Gaps = 1/200 (0%)
Query: 220 TLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH 279
+ + GN I+ L +L L SN +A L L +L L N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 280 L-PRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHL 338
+ P L L L L + L YL N + L +L
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155
Query: 339 SELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRG 398
+ L L N L SL++L L N ++ P F + L+++ + N L
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 399 PIPNSTVFRNAPRESFLGNN 418
+ A + L +N
Sbjct: 216 LPTEALAPLRALQYLRLNDN 235
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (126), Expect = 4e-08
Identities = 31/183 (16%), Positives = 57/183 (31%), Gaps = 4/183 (2%)
Query: 238 NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSS 297
+ + +P+ + + ++ L GN++S + L L S
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 298 NRLNNSILEALGFMFKLFYLNFSHNQFSQEI-PEDLALLAHLSELDLSHNLFKGSIPSRI 356
N L A + L L+ S N + + P L L L L + P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 357 CNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLG 416
L +L+ L L N + F + L + + N + + ++ L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 417 NNF 419
N
Sbjct: 186 QNR 188
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.7 bits (226), Expect = 9e-21
Identities = 59/263 (22%), Positives = 92/263 (34%), Gaps = 5/263 (1%)
Query: 23 SSFPHLAYLDLSINGFFG--TLPPQVRNLSKLKYLDLSENE-LSGKIPPEIGLLTHLFSL 79
+ + LDLS +P + NL L +L + L G IPP I LT L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 80 DLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLP 138
++ SG P + + L + N LSG++P I +L L + D N+ +G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 139 RNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLD 198
+ L + L + N+ +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 199 LSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPM 258
N G L L + N I G +P + LH L++S N++ GEIP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285
Query: 259 ELGRLISLNKLILRGNQLSGHLP 281
+ G L + N+ P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.8 bits (195), Expect = 8e-17
Identities = 58/266 (21%), Positives = 96/266 (36%), Gaps = 30/266 (11%)
Query: 143 RSGLLEILTVNDNHFLGSIP---NLRNCRSLVRAHLGRN-NLTGNISEDFGIYPNLKFLD 198
++ + L ++ + P +L N L ++G NL G I L +L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 199 LSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPM 258
++H N G I + L TL S N ++G +PP I + L + N I+G IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 259 ELGRLISL--------NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGF 310
G L N+L + +L A L+ +S +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 311 MFKLF---------------YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSR 355
+ K L+ +N+ +P+ L L L L++S N G IP
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286
Query: 356 ICNLESLEKLNLSHNNI--SGQIPAC 379
NL+ + ++N +PAC
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.8 bits (182), Expect = 4e-15
Identities = 56/254 (22%), Positives = 97/254 (38%), Gaps = 6/254 (2%)
Query: 170 LVRAHLGRNNLTGN--ISEDFGIYPNLKFLDLSHN-NFYGEISSNWGKCHRLGTLIVSGN 226
+ L NL I P L FL + N G I K +L L ++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 227 NITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGL 286
N++G IP + L LD S N ++G +P + L +L + GN++SG +P + G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 287 LTELEY-FDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSH 345
++L +S NRL I + F + + ++
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS--DKNTQKIHLA 229
Query: 346 NLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNSTV 405
++ ++L L+L +N I G +P + L S+++S+N L G IP
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 406 FRNAPRESFLGNNF 419
+ ++ N
Sbjct: 290 LQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 7e-10
Identities = 21/70 (30%), Positives = 30/70 (42%), Gaps = 2/70 (2%)
Query: 74 THLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132
+L LDL N+ GT P + L L +++ N L G IP+ GNL + N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302
Query: 133 FTGQLPRNIC 142
P C
Sbjct: 303 CLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 37/176 (21%), Positives = 68/176 (38%), Gaps = 25/176 (14%)
Query: 198 DLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGR--IPPEIGNSSQLHVLDLSSNHIAGE 255
D + + G + + +R+ L +SG N+ IP + N L+ L + +
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN---- 87
Query: 256 IPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLF 315
L G +P A+ LT+L Y ++ ++ +I + L + L
Sbjct: 88 -------------------NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 316 YLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
L+FS+N S +P ++ L +L + N G+IP + L N
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.9 bits (94), Expect = 4e-04
Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSEN-EL 62
N ++L + + GTL + + L L++S N G + PQ NL + + N L
Sbjct: 247 NGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCL 304
Query: 63 SGKIPP 68
G P
Sbjct: 305 CGSPLP 310
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 2e-16
Identities = 23/162 (14%), Positives = 47/162 (29%), Gaps = 16/162 (9%)
Query: 514 IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND------QMSDQKEFLNEIKALTKIRHRN 567
+G+G+ +V+ + VK + + F + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 568 IVKFYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH 627
+ K G ++ L + V+ + + ++ +H
Sbjct: 68 LQKLQGLA------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 628 DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSNW 669
IVH D+S NVL+ E + DF + +
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWRE 159
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.2 bits (191), Expect = 6e-16
Identities = 53/267 (19%), Positives = 91/267 (34%), Gaps = 42/267 (15%)
Query: 509 DAKY----CIGKGEHRSVYRAK-LPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI 563
DA+Y +G G +V+ AK + + +A+K + +EIK L ++
Sbjct: 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRV 66
Query: 564 RHRNIVK---------------FYGFCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDW 608
+ K F + H +V+E + LA + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 609 RKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGTAKLLKPNSS 667
K++ + L YMH C I+H DI NVL+++ + A L
Sbjct: 127 VKQI--SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 668 --NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFL 725
++T + T Y +P E+ D++S L E+I G +
Sbjct: 183 DEHYTNSIQTREYRSP----------EVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232
Query: 726 SLFSSSSSSINIEFNAMLDHRLPHPSL 752
S + +I L LP L
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLL 259
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (163), Expect = 6e-13
Identities = 38/232 (16%), Positives = 66/232 (28%), Gaps = 29/232 (12%)
Query: 45 QVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISL 104
+V ++ ++ + L+ +PP++ + + L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-------------------------KDTTILHL 38
Query: 105 HNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNL 164
N L + +L+ L LD + T L L ++ N
Sbjct: 39 SENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPV--LGTLDLSHNQLQSLPLLG 96
Query: 165 RNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVS 224
+ +L + N LT L+ L L N +L L ++
Sbjct: 97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156
Query: 225 GNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQL 276
NN+T + L L L N + IP L L GN
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 42/181 (23%), Positives = 66/181 (36%), Gaps = 4/181 (2%)
Query: 25 FPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLN 84
L LS N + + ++L L+L EL+ L L +LDLS N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGT--LPVLGTLDLSHN 87
Query: 85 QFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRS 144
Q L L + + N+L+ + L +L L L N+ P + +
Sbjct: 88 QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 145 GLLEILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNN 203
LE L++ +N+ L +L L N+L I + F L F L N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206
Query: 204 F 204
+
Sbjct: 207 W 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 43/195 (22%), Positives = 68/195 (34%), Gaps = 25/195 (12%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSG-HLPR 282
N+T +PP++ +L LS N + L L +L L +L+ +
Sbjct: 18 DKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 283 ALGLLTELEYFDLSS--------------------NRLNNSILEALGFMFKLFYLNFSHN 322
L +L L+ NRL + L AL + +L L N
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 323 QFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIG 382
+ P L L +L L++N + LE+L+ L L N++ IP F G
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 383 MSGLLSIDISYNELR 397
L + N
Sbjct: 194 SHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 9e-05
Identities = 21/94 (22%), Positives = 31/94 (32%)
Query: 16 TLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTH 75
+L + L L L N P + KL+ L L+ N L+ + L +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 76 LFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKL 109
L +L L N L + LH N
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 13/58 (22%), Positives = 20/58 (34%), Gaps = 3/58 (5%)
Query: 314 LFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
+N + +P DL + L LS NL + + L +LNL
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.4 bits (147), Expect = 1e-10
Identities = 58/337 (17%), Positives = 105/337 (31%), Gaps = 25/337 (7%)
Query: 50 SKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKL 109
+ L+L+ LS +P L HL SL S N + P + +LK + + NN L
Sbjct: 38 RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNL 90
Query: 110 SGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRS 169
+ +L L + +N +LP L + D S
Sbjct: 91 KA-----LSDLPPLLEYLGVSNNQLEKLPELQN----SSFLKIIDVDNNSLKKLPDLPPS 141
Query: 170 LVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNIT 229
L G N L + + D + ++ + ++ +
Sbjct: 142 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 201
Query: 230 GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTE 289
+ + L + E ++ + + L+E
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261
Query: 290 LEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFK 349
L N +N I L LN S+N+ E+P AL L L S N
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA 317
Query: 350 GSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGL 386
+P ++L++L++ +N + + P + L
Sbjct: 318 -EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 53/340 (15%), Positives = 95/340 (27%), Gaps = 26/340 (7%)
Query: 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQF 86
L+L+ G +LP L+ L S N L+ ++P L L + +L
Sbjct: 39 QAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 87 SGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGL 146
S P L +S + E++ L S+L + L
Sbjct: 94 SDLPP-----------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
I N+ + + A ++ +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202
Query: 207 EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266
+ + N S L L
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ 326
+ N S + L LE ++S+N+L + +L L S N +
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLA- 317
Query: 327 EIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLN 366
E+PE L +L +L + +N + P ++E L ++N
Sbjct: 318 EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 5e-08
Identities = 51/332 (15%), Positives = 100/332 (30%), Gaps = 25/332 (7%)
Query: 72 LLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN 131
L L+L+ S + P + +L+ + N L+ +PE +L L
Sbjct: 36 LDRQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-ELPELPQSLKSLLVDNN--- 88
Query: 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIY 191
L LLE L V++N + + + + + +
Sbjct: 89 ----NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS-----LKKLPDLP 139
Query: 192 PNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNH 251
P+L+F+ +N + +P + + + +
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 252 IAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFM 311
+ + + L S S + +
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 312 FKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371
+L + N S EI L L EL++S+N +P+ LE+L S N+
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNH 315
Query: 372 ISGQIPACFIGMSGLLSIDISYNELRGPIPNS 403
++ ++P L + + YN LR P+
Sbjct: 316 LA-EVPEL---PQNLKQLHVEYNPLRE-FPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 22/104 (21%), Positives = 37/104 (35%), Gaps = 8/104 (7%)
Query: 20 FSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSL 79
FS L +N + L+ L++S N+L ++P L L
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---L 309
Query: 80 DLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKL 123
S N + P + NLK + + N L P+ ++ L
Sbjct: 310 IASFNHLA-EVPEL--PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 8e-05
Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 8/79 (10%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
P L L++S N LP +L+ L S N L+ ++P L +L L +
Sbjct: 280 CDLPPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHLA-EVPE---LPQNLKQLHV 331
Query: 82 SLNQFSGTFPPICNLSNLK 100
N ++ +L+
Sbjct: 332 EYNPLREFPDIPESVEDLR 350
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 3e-10
Identities = 41/228 (17%), Positives = 77/228 (33%), Gaps = 17/228 (7%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
L+ + ++ ++ + L + +L + T + L+NL + L +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167
+++ + NL K++ L L N +S LT + + L N
Sbjct: 74 QIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
+ L I+ + LS N + +L TL N
Sbjct: 132 QVLYLDL-------NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 228 ITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQ 275
I+ P + + L + L +N I+ P L +L + L NQ
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 38/222 (17%), Positives = 65/222 (29%), Gaps = 25/222 (11%)
Query: 162 PNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTL 221
P L N ++ G++N+T +++ + L + L L
Sbjct: 16 PALAN---AIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 222 IVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPM--------------ELGRLISLN 267
+ N IT P + L + I ++
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE 327
+ + L LS S L L + KL L N+ S
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 328 IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSH 369
P LA L +L E+ L +N P + N +L + L++
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 35/254 (13%), Positives = 79/254 (31%), Gaps = 41/254 (16%)
Query: 92 PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILT 151
P L+N I+ + ++ ++ + +L ++ L T
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT----------------- 54
Query: 152 VNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN 211
+I ++ +L+ L N +T D NL + + + +
Sbjct: 55 --------TIEGVQYLNNLIGLELKDNQIT-----DLAPLKNLTKITELELSGNPLKNVS 101
Query: 212 WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLIL 271
+ + + + P G S+ + +I N L
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL-----YLDLNQITNISPLAGLTNLQYL 156
Query: 272 RGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED 331
L L++L N++++ + L + L ++ +NQ S P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP-- 212
Query: 332 LALLAHLSELDLSH 345
LA ++L + L++
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 5/64 (7%)
Query: 22 FSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81
++ L L N P + +L L + L N++S P + ++LF + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 82 SLNQ 85
+ NQ
Sbjct: 225 T-NQ 227
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 7e-10
Identities = 46/307 (14%), Positives = 87/307 (28%), Gaps = 45/307 (14%)
Query: 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSG 64
+++LT L + S + + F + + +++++DLS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRS-FMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 65 KIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLS 124
I + S L+ +SL +LS I + L
Sbjct: 61 STLHGI----------------------LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 125 YLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNI 184
L L + S L ++ +
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSC---------------SRLDELNLSWCFDFTEKHVQVAV 143
Query: 185 SEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGN-NITGRIPPEIGNSSQLH 243
+ L N ++S+ +C L L +S + + E + L
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 244 VLDLSS-NHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNN 302
L LS I E +ELG + +L L + G G L L L ++ +
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTT 260
Query: 303 SILEALG 309
+G
Sbjct: 261 IARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 39/270 (14%), Positives = 86/270 (31%), Gaps = 15/270 (5%)
Query: 146 LLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFY 205
L + L + + + + ++ R+ + ++E F ++ +DLS++
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIE 59
Query: 206 GE-ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME----- 259
+ +C +L L + G ++ I + +S L L+LS E ++
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 260 LGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNF 319
RL LN + + +LS R N + + + L
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 320 SHNQFSQ----EIPEDLALLAHLSELDLSH-NLFKGSIPSRICNLESLEKLNLSHNNISG 374
S + ++ L +L L LS + + +L+ L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 375 QIPACFIGMSGLLSIDISYNELRGPIPNST 404
+ L + I+ + +
Sbjct: 240 TLQLLK---EALPHLQINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 37/272 (13%), Positives = 67/272 (24%), Gaps = 60/272 (22%)
Query: 31 LDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTF 90
LDL+ + ++ + + + + E + +DLS + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 91 PP--ICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLE 148
+ S L+ +SL +LS I + L L L + S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 149 ILTVNDNHFLGSIPNLRNCRSLVRAHLGR------------------------------- 177
+ +N + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 178 ---NNLTGNISEDFGIYPNLKFLDLSHNNFY-GEISSNWGKCHRLGTLIVSG-------- 225
L + ++F L+ L LS E G+ L TL V G
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 226 -------------NNITGRIPPEIGNSSQLHV 244
++ T P IGN +
Sbjct: 243 LLKEALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 8e-07
Identities = 38/305 (12%), Positives = 84/305 (27%), Gaps = 44/305 (14%)
Query: 78 SLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQL 137
+LDL+ + + + + E ++ ++ L +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 138 PRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFL 197
I L C L L L+ I NL L
Sbjct: 63 LHGI----------------------LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
Query: 198 DLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIP 257
+LS + + E + ++ + + + ++ +++G
Sbjct: 101 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG--- 157
Query: 258 MELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL-NNSILEALGFMFKLFY 316
R N L + L + DLS + + N + + L +
Sbjct: 158 -------------YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204
Query: 317 LNFSH-NQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQ 375
L+ S E +L + L L + + G++ E+L L ++ ++ +
Sbjct: 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK---EALPHLQINCSHFTTI 261
Query: 376 IPACF 380
Sbjct: 262 ARPTI 266
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 4e-09
Identities = 29/202 (14%), Positives = 61/202 (30%), Gaps = 14/202 (6%)
Query: 48 NLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107
++ +L + ++ + L + + + + I L N+ + L+ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGN 78
Query: 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167
KL+ L L L + + +++ + I L +
Sbjct: 79 KLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNN 227
L +LG N +T + + +L L +S N+
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPLAGLTKLQNLYLSKNH 189
Query: 228 ITGRIPPEIGNSSQLHVLDLSS 249
I+ + L VL+L S
Sbjct: 190 ISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 33/200 (16%), Positives = 64/200 (32%), Gaps = 16/200 (8%)
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
+L + ++ N + + + +I + ++I I + L L+ N +
Sbjct: 25 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMF 312
P+ L G + S + +N I + G +
Sbjct: 81 TDIKPLA--------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 313 KLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNI 372
+ L+ L L L L N +P + L L+ L LS N+I
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190
Query: 373 SGQIPACFIGMSGLLSIDIS 392
S + A G+ L +++
Sbjct: 191 SD-LRA-LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 33/225 (14%), Positives = 59/225 (26%), Gaps = 38/225 (16%)
Query: 73 LTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132
+L + L+++ I +N+ + I L ++ L L+ N+
Sbjct: 23 FAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 133 FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
T L+ L L + + P
Sbjct: 80 LTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
L+ L L +N + +S + + ++L L LS NHI
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLD----TLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
Query: 253 AGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSS 297
+ RAL L L+ +L S
Sbjct: 191 SD--------------------------LRALAGLKNLDVLELFS 209
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 8e-09
Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 5/107 (4%)
Query: 30 YLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGT 89
L L+ T+ + L + +LDLS N L +PP + L L L S +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQAS-DNALEN 57
Query: 90 FPPICNLSNLKYISLHNNKL-SGSIPEEIGNLMKLSYLMLDTNQFTG 135
+ NL L+ + L NN+L + + + + +L L L N
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 3e-08
Identities = 25/126 (19%), Positives = 49/126 (38%), Gaps = 12/126 (9%)
Query: 244 VLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNS 303
VL L+ + + L +L+ + L L N+L P AL L LE ++
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALE 56
Query: 304 ILEALGFMFKLFYLNFSHNQFSQ-EIPEDLALLAHLSELDLSHNLF------KGSIPSRI 356
++ + + +L L +N+ Q + L L L+L N + + +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 357 CNLESL 362
++ S+
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 6e-08
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 269 LILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI 328
L L L+ L L + + DLS NRL ++ AL + L L S N
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-- 57
Query: 329 PEDLALLAHLSELDLSHN-LFKGSIPSRICNLESLEKLNLSHNNISG 374
+ +A L L EL L +N L + + + + L LNL N++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 6/123 (4%)
Query: 220 TLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGH 279
L ++ ++T + + + LDLS N + P L L L +L+ + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALE 56
Query: 280 LPRALGLLTELEYFDLSSNRLNN-SILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHL 338
+ L L+ L +NRL + ++ L +L LN N QE L L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 339 SEL 341
+
Sbjct: 117 PSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 23/106 (21%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 174 HLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIP 233
HL +LT + + LDLSHN + L + ++
Sbjct: 4 HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEV--LQASDNALENV 58
Query: 234 PEIGNSSQLHVLDLSSNHIAG-EIPMELGRLISLNKLILRGNQLSG 278
+ N +L L L +N + L L L L+GN L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 23/109 (21%), Positives = 45/109 (41%), Gaps = 5/109 (4%)
Query: 100 KYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLG 159
+ + L + L+ + + L+ +++L L N+ P + LE+L +DN
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL-E 56
Query: 160 SIPNLRNCRSLVRAHLGRNNLTGNIS-EDFGIYPNLKFLDLSHNNFYGE 207
++ + N L L N L + + + P L L+L N+ E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 9e-08
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 10/96 (10%)
Query: 239 SSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQLSG----HLPRALGLLTELEYF 293
S + LD+ ++ EL L + L L+ + AL + L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 294 DLSSNRLNNSILEALGFMF-----KLFYLNFSHNQF 324
+L SN L + + + K+ L+ +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 15/116 (12%), Positives = 39/116 (33%), Gaps = 10/116 (8%)
Query: 289 ELEYFDLSSNRLNNSILEALGFMFK-LFYLNFSHNQFS----QEIPEDLALLAHLSELDL 343
+++ D+ L+++ L + + + + ++I L + L+EL+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 344 SHNLFKGSIPSRIC-----NLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
N + ++KL+L + ++G L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 9/86 (10%)
Query: 191 YPNLKFLDLSHNNFYGE----ISSNWGKCHRLGTLIVSGNNITGRIPPEIG-----NSSQ 241
L+ L L+ + +++ H L L +S N + ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 242 LHVLDLSSNHIAGEIPMELGRLISLN 267
L L L + + E+ L L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 6e-07
Identities = 10/92 (10%), Positives = 28/92 (30%), Gaps = 5/92 (5%)
Query: 193 NLKFLDLSHNNFYGE-ISSNWGKCHRLGTLIVSGNNITGR----IPPEIGNSSQLHVLDL 247
+++ LD+ + + + + +T I + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGH 279
SN + + + + ++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/76 (21%), Positives = 25/76 (32%), Gaps = 9/76 (11%)
Query: 311 MFKLFYLNFSHNQFSQE----IPEDLALLAHLSELDLSHNLFKGSIPSRIC-----NLES 361
L L + S + L L ELDLS+N + ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 362 LEKLNLSHNNISGQIP 377
LE+L L S ++
Sbjct: 428 LEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 15/130 (11%), Positives = 35/130 (26%), Gaps = 6/130 (4%)
Query: 52 LKYLDLSENELSGKIPPEI-GLLTHLFSLDLSLNQFSGTFPP-----ICNLSNLKYISLH 105
++ LD+ ELS E+ LL + L + + L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 106 NNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLR 165
+N+L + ++ + L L + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123
Query: 166 NCRSLVRAHL 175
+ ++
Sbjct: 124 LGDAGLQLLC 133
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 19/80 (23%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 265 SLNKLILRGNQLSG----HLPRALGLLTELEYFDLSSNRLNNSILEALGFMFK-----LF 315
L L L +S L L L DLS+N L ++ + L + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 316 YLNFSHNQFSQEIPEDLALL 335
L +S+E+ + L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 6e-06
Identities = 54/407 (13%), Positives = 99/407 (24%), Gaps = 14/407 (3%)
Query: 3 VNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGF----FGTLPPQVRNLSKLKYLDLS 58
+ S+++ L + L G + +R L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 59 ENELSGKIPPEIG-----LLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSI 113
NEL + + L L +G + + + +L LS ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123
Query: 114 PEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRA 173
+ G + +LD +L C + +
Sbjct: 124 LGDAGLQLLC-EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182
Query: 174 HLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIP 233
G L + + LK + + G+N G +
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242
Query: 234 PEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYF 293
LH E + L +++ L L E
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302
Query: 294 DLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIP 353
+ LE+L F + S L +S L +
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362
Query: 354 SRICNLESLEKLNLSHNNISGQ----IPACFIGMSGLLSIDISYNEL 396
L L L+ ++S + A + L +D+S N L
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 15/84 (17%), Positives = 32/84 (38%), Gaps = 9/84 (10%)
Query: 215 CHRLGTLIVSGNNITGR----IPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI-----S 265
L L ++ +++ + + + L LDLS+N + ++L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 266 LNKLILRGNQLSGHLPRALGLLTE 289
L +L+L S + L L +
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 10/97 (10%)
Query: 36 NGFFGTLPPQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSGTFP 91
G + S L+ L L++ ++S + + L LDLS N
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 92 PI------CNLSNLKYISLHNNKLSGSIPEEIGNLMK 122
L+ + L++ S + + + L K
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 18/126 (14%), Positives = 36/126 (28%), Gaps = 25/126 (19%)
Query: 98 NLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNH 156
+++ + + +LS + E + L + + LD T ++I +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50
Query: 157 FLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG-----IYPNLKFLDLSHNNFYGEISSN 211
LR +L +L N L ++ L L + G
Sbjct: 51 -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103
Query: 212 WGKCHR 217
R
Sbjct: 104 LSSTLR 109
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 11/76 (14%), Positives = 24/76 (31%), Gaps = 9/76 (11%)
Query: 337 HLSELDLSHNLFKG----SIPSRICNLESLEKLNLSHNNISGQIPACFIG-----MSGLL 387
L L L+ S+ + + SL +L+LS+N + + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 388 SIDISYNELRGPIPNS 403
+ + + +
Sbjct: 430 QLVLYDIYWSEEMEDR 445
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.4 bits (116), Expect = 3e-07
Identities = 36/167 (21%), Positives = 56/167 (33%), Gaps = 5/167 (2%)
Query: 189 GIYPNLKFLDLSHNNFYGEI-SSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247
I + L L+ N +G+ L L + N +TG P +S + L L
Sbjct: 26 DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85
Query: 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEA 307
N I L L L L NQ+S +P + L L + ++ N
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHL 144
Query: 308 LGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPS 354
F L + + P + + DL H+ FK S +
Sbjct: 145 AWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSEN 188
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 8/182 (4%)
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRGNQLSGHLPR 282
+G + IP +I + L L+ N + L GRL L KL L+ NQL+G P
Sbjct: 16 TGRGLK-EIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 283 ALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELD 342
A + ++ L N++ + + +L LN NQ S +P L L+ L+
Sbjct: 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 343 LSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPN 402
+ E L K +L+ P+ + + D+ ++E + N
Sbjct: 133 -LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSEN 188
Query: 403 ST 404
S
Sbjct: 189 SE 190
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 45.1 bits (105), Expect = 8e-06
Identities = 29/165 (17%), Positives = 53/165 (32%), Gaps = 16/165 (9%)
Query: 49 LSKLKYLDLSENELSGKIPP------EIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYI 102
+ + + EL G IPP + L L LS N + + NL+ +
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRIL 75
Query: 103 SLHNNKL-----SGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHF 157
SL N + ++ + + L + + + + +I +
Sbjct: 76 SLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDK 135
Query: 158 LGSIPNLRNC----RSLVRAHLGRNNLTGNISEDFGIYPNLKFLD 198
L ++ L + L + N + E PNLK LD
Sbjct: 136 LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 8e-06
Identities = 33/325 (10%), Positives = 71/325 (21%), Gaps = 23/325 (7%)
Query: 79 LDLSLNQFSGTFPPICNLSNLKYISLHNNKLSG----SIPEEIGNLMKLSYLMLDTNQFT 134
++ F + ++K I L N + + E I + L
Sbjct: 13 DAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG 72
Query: 135 GQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNL 194
LL + P L R A
Sbjct: 73 RVKDEIPEALRLLLQALLK-------CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125
Query: 195 KFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG 254
+L + I + + + +
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185
Query: 255 EIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKL 314
+ + + + + + L L L + ++ ++++ AL L
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 315 FYLNFSHNQFSQEIPEDLA------LLAHLSELDLSHNLFKGSIPSRIC-----NLESLE 363
L + S + L L L +N + + + L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 364 KLNLSHNNISGQIPACFIGMSGLLS 388
L L+ N + + + S
Sbjct: 306 FLELNGNRF-SEEDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 47/333 (14%), Positives = 89/333 (26%), Gaps = 42/333 (12%)
Query: 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-----ICNLSNLKYISLH 105
LK ++ + + + + + LS N I + +L+
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 106 NN---KLSGSIPEEIGNLMKLSY-LMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSI 161
+ ++ IPE + L++ L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 162 PNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTL 221
+ A + R +++ P L+ + N W K + L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 222 IVSGNNITGRIPPEIGNSSQLHVLD-------------LSSNHIAGEIPMELGRLISLNK 268
+ + + I PE L L ++ + + + L +L +
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 269 LILRGNQLSGHLPRALG------LLTELEYFDLSSNRLNNSILEAL-----GFMFKLFYL 317
L L LS A+ L+ L N + + L M L +L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 318 NFSHNQFSQEIPE--------DLALLAHLSELD 342
+ N+FS+E L ELD
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 35/317 (11%), Positives = 80/317 (25%), Gaps = 36/317 (11%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGF----FGTLPPQVRNLSKLKYLDLSEN-- 60
+T+ K + + LS N L + + L+ + S+
Sbjct: 14 AITTEDEKSVFA--VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 61 -ELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSG-SIPEEIG 118
+ +IP + LL L+ + + I + +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 119 NLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRN 178
L + + + + + L + N L
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 179 NLTGN--------------ISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVS 224
+ N ++ + + + ++ L L ++
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 225 GNNITGRIPPEIGN------SSQLHVLDLSSNHIAGEIPMEL-----GRLISLNKLILRG 273
++ R + + + L L L N I + L ++ L L L G
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 274 NQLSGHLPRALGLLTEL 290
N+ S + + E+
Sbjct: 312 NRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 13/74 (17%), Positives = 23/74 (31%), Gaps = 5/74 (6%)
Query: 48 NLSKLKYLDLSENELSGKIPPEI-----GLLTHLFSLDLSLNQFSGTFPPICNLSNLKYI 102
L+ L L NE+ + + L L+L+ N+FS + + +
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330
Query: 103 SLHNNKLSGSIPEE 116
EE
Sbjct: 331 RGRGELDELDDMEE 344
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 6/78 (7%)
Query: 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQV-----RNLSKLKYLDLSENE 61
L++ G + FS L L L N + + L +L+L+ N
Sbjct: 254 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313
Query: 62 LSGKIPPEIGLLTHLFSL 79
+ + + +FS
Sbjct: 314 F-SEEDDVVDEIREVFST 330
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 1e-05
Identities = 39/197 (19%), Positives = 59/197 (29%), Gaps = 14/197 (7%)
Query: 73 LTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132
L L + T +L + + + SI + + L L+ + NQ
Sbjct: 17 LAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 73
Query: 133 FTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYP 192
T L L + L N +
Sbjct: 74 LTDI-----TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 193 NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHI 252
NL L+LS N S L L S N +T P + N + L LD+SSN +
Sbjct: 129 NLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV 184
Query: 253 AGEIPMELGRLISLNKL 269
+ L +L +L L
Sbjct: 185 SD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 29/202 (14%), Positives = 53/202 (26%), Gaps = 20/202 (9%)
Query: 166 NCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISS--NWGKCHRLGTLIV 223
++ LG+ N+T +S+ + L I S + L +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLG----IKSIDGVEYLNNLTQINF 69
Query: 224 SGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRA 283
S N +T P + +++ + + +
Sbjct: 70 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129
Query: 284 LGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
L L I + + + + LA L L LD+
Sbjct: 130 LNRLELSSNT----------ISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDI 179
Query: 344 SHNLFKGSIPSRICNLESLEKL 365
S N S + L +LE L
Sbjct: 180 SSNKVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 23/145 (15%), Positives = 43/145 (29%), Gaps = 3/145 (2%)
Query: 142 CRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED-FGIYPNLKFLDLS 200
C L + L S+ +L +L ++ ++ L+ L +
Sbjct: 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 201 HNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPME- 259
+ + RL L +S N + + + L L LS N + +
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 260 LGRLISLNKLILRGNQLSGHLPRAL 284
L R + +L H L
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.001
Identities = 20/147 (13%), Positives = 37/147 (25%), Gaps = 4/147 (2%)
Query: 215 CHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL-GRLISLNKLILRG 273
H L + + + + L L + + + + L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 274 NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEI-PEDL 332
+ L P A L +LS N S+ L L S N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 333 ALLAHLSELDLSHNLFKGSIPSRICNL 359
+ + + ++
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 2/104 (1%)
Query: 317 LNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC-NLESLEKLNLSHNNISGQ 375
L + + + L +L+EL + + + R L L L + + +
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 376 IPACFIGMSGLLSIDISYNELRGPIPNSTVFRNAPRESFLGNNF 419
P F L +++S+N L + + GN
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 17/114 (14%), Positives = 32/114 (28%), Gaps = 1/114 (0%)
Query: 68 PEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEI-GNLMKLSYL 126
P+ L + + + + NL + + N + + L +L L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 127 MLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNL 180
+ + P + L L ++ N SL L N L
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 2e-05
Identities = 28/146 (19%), Positives = 51/146 (34%), Gaps = 6/146 (4%)
Query: 271 LRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPE 330
L+ Q+ L + + L L + L LN + + +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAAT-LRI 59
Query: 331 DLALLAHLSELDLSHN--LFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLS 388
+ L L+LS+N + S + +L+ LNLS N + + I L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 389 IDISYNELRGPIPNSTVFRNAPRESF 414
+ + N L + + + +A RE F
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 8e-05
Identities = 23/146 (15%), Positives = 51/146 (34%), Gaps = 6/146 (4%)
Query: 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305
+L + ++ + + + ++ L L L + S+ + ++
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLR 58
Query: 306 EALGFMFKLFYLNFSHNQFS--QEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLE 363
+ +L LN S+N+ ++ + +L L+LS N K LE
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 364 KLNLSHNNISGQIPACFIGMSGLLSI 389
+L L N++S +S +
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 4/146 (2%)
Query: 136 QLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLK 195
QL + + ++ S P+L V + R+++ + P L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL-RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELL 68
Query: 196 FLDLSHNNFYG--EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIA 253
L+LS+N Y ++SS K L L +SGN + + +L L L N ++
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 254 GEIPMELGRLISLNKLILRGNQLSGH 279
+ + ++ + + +L GH
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 4e-05
Identities = 22/134 (16%), Positives = 34/134 (25%), Gaps = 7/134 (5%)
Query: 215 CHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGN 274
R L + G I I Q +D S N I L L L++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 275 QLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPED--- 331
++ L +L L++N L K
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 332 -LALLAHLSELDLS 344
+ + + LD
Sbjct: 134 VIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 21/162 (12%), Positives = 46/162 (28%), Gaps = 31/162 (19%)
Query: 44 PQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYIS 103
Q N + + LDL ++ I L ++D
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAID----------------------- 47
Query: 104 LHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRN-----ICRSGLLEILTVNDNHFL 158
+N++ + L +L L+++ N+ +L ++ + L
Sbjct: 48 FSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL 105
Query: 159 GSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLS 200
+ +L++ L N P ++ LD
Sbjct: 106 DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 9e-04
Identities = 23/144 (15%), Positives = 38/144 (26%), Gaps = 7/144 (4%)
Query: 157 FLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCH 216
+ N L + I +D S N +
Sbjct: 7 LIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLR 63
Query: 217 RLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAG-EIPMELGRLISLNKLILRG-- 273
RL TL+V+ N I L L L++N + L L SL L +
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 274 -NQLSGHLPRALGLLTELEYFDLS 296
+ + + ++ D
Sbjct: 124 VTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 3/87 (3%)
Query: 335 LAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394
ELDL I + L+ + ++ S N I + F + L ++ ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 395 ELRGPIPNSTVFRNAPRESFLGNNFST 421
+ E L NN
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.004
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 5/98 (5%)
Query: 302 NSILEALGF--MFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNL 359
I +A + + L+ + I A L +D S N + L
Sbjct: 6 ELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLL 62
Query: 360 ESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELR 397
L+ L +++N I + L + ++ N L
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 7e-05
Identities = 29/227 (12%), Positives = 62/227 (27%), Gaps = 9/227 (3%)
Query: 55 LDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYISLHNNKLSGSI 113
E++++ +IP L + L L + +L+ I + N + I
Sbjct: 13 FLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 114 PEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDN-----HFLGSIPNLRNCR 168
++ + + + + L + + + H +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 169 SLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228
L+ N T + G+ L L+ N + + + NN+
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 229 TGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQ 275
+S +LD+S I L L L +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 30/207 (14%), Positives = 60/207 (28%), Gaps = 4/207 (1%)
Query: 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSG-- 225
R+ + L F + +L+ +++S N+ I ++ I
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALG 285
NN+ P N L L +S+ I + + L ++ N + R
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 286 LLTELEYFDLS--SNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343
+ E L N + A +N + + + LD+
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 344 SHNLFKGSIPSRICNLESLEKLNLSHN 370
S + NL+ L + +
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 28/237 (11%), Positives = 60/237 (25%), Gaps = 9/237 (3%)
Query: 92 PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNI-----CRSGL 146
IC+ SN + +K++ IP ++ L +
Sbjct: 4 RICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIE 59
Query: 147 LEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG 206
+ V + NL + + + +
Sbjct: 60 ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 119
Query: 207 EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266
++ L + + N T +G S + +L L+ N I
Sbjct: 120 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLD 179
Query: 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQ 323
+ N L + D+S R+++ L + KL + + +
Sbjct: 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 786 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.46 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.71 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.0 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.96 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=409.92 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=210.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +++.||||++.... .......+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 47999999999999999999875 68899999985411 01123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999999864 5689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. ......||+.|||| |++.+..++.++||||+||++|||++|+.||.... .......+..
T Consensus 159 ~--~~~~~~Gt~~Y~AP----------E~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~ 218 (263)
T d2j4za1 159 S--RRTTLCGTLDYLPP----------EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISR 218 (263)
T ss_dssp C--CCEETTEEGGGCCH----------HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHT
T ss_pred C--cccccCCCCcccCH----------HHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHc
Confidence 3 23456899999999 88888889999999999999999999999987432 2233344444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....|... +..+.+++.+||++||++|||++|+++
T Consensus 219 ~~~~~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VEFTFPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 454444433 235889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=413.81 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=208.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG----GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc----cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 46999999999999999999864 7899999998652 223456799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 96 mEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999998865 3589999999999999999999999 999999999999999999999999999998866
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
........+||+.|+|| |+..+..+++++||||+||++|||+||+.||..... ......+..
T Consensus 169 ~~~~~~~~~gt~~Y~aP----------E~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~ 230 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAP----------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIAT 230 (293)
T ss_dssp TTCCBCCCCSCGGGCCH----------HHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred ccccccccccCCCccCh----------hhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHh
Confidence 55555667899999999 788888899999999999999999999999874321 111112221
Q ss_pred C---CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 745 H---RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 745 ~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. .+..+ ...+..+.+++.+||++||++|||++|+++
T Consensus 231 ~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 NGTPELQNP----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HCSCCCSSG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCc----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12222 223345889999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=410.02 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=203.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +++.||||++.... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 57999999999999999999865 78999999987532 122345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999999999743 5799999999999999999999999 999999999999999999999999999997753
Q ss_pred CC--CcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 665 NS--SNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 665 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.. ......+||+.|||| |++.+..+ +.++||||+||++|||+||+.||..... .......
T Consensus 156 ~~~~~~~~~~~GT~~Y~AP----------E~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~~ 218 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAP----------ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYSD 218 (271)
T ss_dssp TTEECCBCCCCSCGGGSCT----------HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST-------TSHHHHH
T ss_pred CCccccccceeeCcCccCH----------hHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh-------HHHHHHH
Confidence 32 223456899999999 77777766 5789999999999999999999864321 1111222
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........+. ....+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 219 WKEKKTYLNP--WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHTTCTTSTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhcCCCCCCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222221111 1223345789999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=406.42 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=196.8
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|+..+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|..++..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 578899999999999999999988889999998642 223467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ...+++..+..++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999999998754 35689999999999999999999999 9999999999999999999999999999877544
Q ss_pred CC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC-CCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG-KHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......||+.|+|| |++.+..++.++|||||||++|||+|+ ++||.... ..+....+.
T Consensus 155 ~~~~~~~~~gt~~y~aP----------E~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~~i~ 216 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASP----------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDIS 216 (263)
T ss_dssp ----------CTTSCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHHHHH
T ss_pred CceeecceecCcccCCh----------HHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHHHHHH
Confidence 32 22345789999999 888888999999999999999999995 55554321 111222222
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...|... +.++.+++..||+.||++||||+||++.|
T Consensus 217 ~~~~~~~p~~~----~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 217 TGFRLYKPRLA----STHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HTCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCCCCcccc----CHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 22 22233322 23588999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=408.62 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=196.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec--CCee
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH--VRHS 581 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~ 581 (786)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... ......+.+.+|++++++++|||||++++++.+ ++..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT--SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh--CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 367999999999999999999864 78999999997632 233456789999999999999999999998864 4568
Q ss_pred eEEEeccCCCCHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 582 FVVYEYINRGSLATVLSNNF-ASEDFDWRKRMNVITGVADALSYMHHDC--FPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
|+||||+++|+|.+++.... ..+.+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999999986432 2457999999999999999999999861 11499999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
|+.............||+.|||| |++.+..+++++|||||||++|||+||+.||..... ...
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~AP----------E~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~ 222 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSP----------EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KEL 222 (269)
T ss_dssp HHHC-----------CCCSCCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH
T ss_pred eeecccCCCccccCCCCcccCCH----------HHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHH
Confidence 99876554445567899999999 788888899999999999999999999999874321 222
Q ss_pred hhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+...... .|.. .+.++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~i~~~~~~~~~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 223 AGKIREGKFRRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCCCcc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2333333332 2222 2335889999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=412.26 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=199.2
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|+++ ..||||+++... ......+.|.+|++++++++|||||+++|++.. +..++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSS--CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 467999999999999999999875 369999997532 233456789999999999999999999998765 568999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ...+++..+..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999999754 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--cceeeccCccccCCCCCCCCchHHHHhhh---cCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 665 NSS--NWTELVGTFGYVAPAHGNIGLHLAELAYT---MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 665 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~---~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
... ......||+.|||| |++.+ ..|+.++|||||||++|||+||+.||..... ....
T Consensus 157 ~~~~~~~~~~~gt~~y~AP----------E~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~ 218 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAP----------EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQI 218 (276)
T ss_dssp ---------CCCCGGGCCH----------HHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHH
T ss_pred cCCcccccccccCcccCCH----------HHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHH
Confidence 322 23456899999999 66643 3588999999999999999999999875321 1111
Q ss_pred hhhccCCCCCC--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 740 NAMLDHRLPHP--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 740 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
...+......| .......+..+.+++.+||+.||++||||+||++.|
T Consensus 219 ~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 11111111111 111122334689999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-49 Score=410.83 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=195.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCC---EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGD---KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|+..+.||+|+||+||+|+++ +++ .||||++... ......+.|.+|++++++++|||||+++|++..++..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46778899999999999999865 332 5899988652 2334567899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++|||||++|+|.+++... .+.+++.++..++.|||+||+|||++ +|+||||||+|||++.++++||+|||+|+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999999998764 35689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-----ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcch
Q 047901 662 LKPNSSN-----WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 662 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~ 735 (786)
....... .....||+.|||| |...+..++.++|||||||++|||+| |+.||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aP----------E~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------- 239 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAP----------EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------- 239 (299)
T ss_dssp ------------------CGGGSCH----------HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------
T ss_pred ccCCCCcceeeecccccCCccccCH----------HHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------
Confidence 7643221 1224678999999 88888899999999999999999998 8999875321
Q ss_pred hhhhhhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 736 NIEFNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 736 ~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
......+.. .+.+.|.. .+..+.+++.+||++||++||||+||++.|
T Consensus 240 ~~~~~~i~~~~~~~~~~~----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 240 QDVINAIEQDYRLPPPMD----CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp HHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 122222222 22333332 234588999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-50 Score=412.84 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=207.8
Q ss_pred HhccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
..++|+..+.||+|+||+||+|+++ +++.||||++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3467999999999999999999875 5888999998642 234567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
+||||+++|+|.+++... ....+++..+..++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999765 346789999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc-ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 663 KPNSSN-WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 663 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
...... .....|++.|+|| |++.+..|+.++|||||||++|||++|..||.... .......
T Consensus 166 ~~~~~~~~~~~~g~~~y~aP----------E~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--------~~~~~~~ 227 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAP----------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYE 227 (287)
T ss_dssp CSSSSEEETTEEECGGGCCH----------HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHH
T ss_pred CCCCceeeccccccccccCh----------HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--------hHHHHHH
Confidence 544322 2334689999999 88888999999999999999999999777643211 1112222
Q ss_pred hccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 MLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.+.. +...|... +..+.+++..||+.||++||||+||++.|
T Consensus 228 ~i~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 228 LLEKDYRMERPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp HHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcCCCCCCCccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2222 22333322 34589999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=409.88 Aligned_cols=250 Identities=21% Similarity=0.388 Sum_probs=204.3
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-----cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 4579999999999999999999988889999999642 2234679999999999999999999998865 567999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....+++..+..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999988654 234689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCC-CCccccccCCCcchhhhhhhh
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHP-GDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~P-f~~~~~~~~~~~~~~~~~~~~ 742 (786)
... ......||+.|+|| |+..+..++.++|||||||++|||+||..| |.... .......+
T Consensus 162 ~~~~~~~~~~gt~~y~AP----------E~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--------~~~~~~~i 223 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAP----------EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNL 223 (272)
T ss_dssp SCEECCTTCCCCTTTSCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHH
T ss_pred CccccccccCCcccccCh----------HHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--------HHHHHHHH
Confidence 432 22345789999999 888888999999999999999999996555 33211 12222222
Q ss_pred ccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
... +...|... +..+.+++.+||+.||++||||+||++.|
T Consensus 224 ~~~~~~~~p~~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 224 ERGYRMVRPDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (272)
T ss_dssp HTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhcCCCCCcccC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 222 22333322 33588999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=410.46 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=205.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 35899999999999999999865 7889999998752 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++.+. .+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999999998754 35699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHh-----hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELA-----YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~-----~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
.........||+.|+|| |++ ....|+.++||||+||++|||+||+.||..... ....
T Consensus 163 ~~~~~~~~~Gt~~y~AP----------E~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~ 224 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAP----------EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVL 224 (288)
T ss_dssp HHHHHTCCCSCCTTCCH----------HHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHH
T ss_pred CcccccccccccccCCH----------HHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHH
Confidence 32233456899999999 554 345689999999999999999999999875321 1222
Q ss_pred hhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 740 NAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..+.....+... .....+.++.+++.+||++||++|||++|+++
T Consensus 225 ~~i~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 LKIAKSEPPTLA-QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHSCCCCCS-SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCCCCCC-ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233332221111 11223446889999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=397.94 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=210.0
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|+..+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-----~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-----SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-----cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 579999999999999999999988889999999752 123467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+++|+|.+++... ...+++..+.+++.|+|+||+|||+. +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 79 Ey~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 79 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp ECCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999999997654 35688999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhc
Q 047901 666 SS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 666 ~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
.. ......||+.|+|| |.+....++.|+|||||||++|||+| |+.||..... .+....+.
T Consensus 154 ~~~~~~~~~~t~~y~aP----------E~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~ 215 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPP----------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIA 215 (258)
T ss_dssp SCCCCCCSCCCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHH
T ss_pred CceeecccCCCCCcCCc----------HHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHH
Confidence 32 23346789999999 88888999999999999999999998 8999875331 12222222
Q ss_pred cC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 DH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. +...|... +..+.+++..||+.||++|||++|+++.|
T Consensus 216 ~~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 216 QGLRLYRPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp TTCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred hCCCCCCcccc----cHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 22 23333332 34589999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=408.21 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=207.6
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|++++++++||||+++++++.+++..|+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 357999999999999999999864 789999999864110 112345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... +.+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+...
T Consensus 86 vmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999999998764 5799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 664 PNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 664 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.... .....+||+.|+|| |++.+..++.++||||+||++|||+||+.||...+ .......
T Consensus 160 ~~~~~~~~~~~~GT~~Y~AP----------E~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~ 221 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSP----------ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQK 221 (288)
T ss_dssp ----------CCCCGGGCCH----------HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred cCCcccccccccCCccccCc----------eeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHH
Confidence 4322 23456899999999 88888899999999999999999999999987432 2233344
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVC 783 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 783 (786)
+.......|.... ..+.++|.+||++||++|||++|++
T Consensus 222 i~~~~~~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 222 IIKLEYDFPEKFF----PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHTTCCCCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHcCCCCCCccCC----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 4454555444333 3488999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-49 Score=409.14 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=193.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|++.+.||+|+||+||+|+.+ +++.||||++...... ...+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999865 6889999999753321 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC---CCCcEEEecccccee
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD---LEYEARVSDFGTAKL 661 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a~~ 661 (786)
||||+||+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||++. .++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999999754 5799999999999999999999999 999999999999995 578999999999987
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
..... .....+||+.|||| |++.+..|++++||||+||++|||++|+.||.... .......
T Consensus 160 ~~~~~-~~~~~~GT~~y~AP----------E~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~ 220 (307)
T d1a06a_ 160 EDPGS-VLSTACGTPGYVAP----------EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQ 220 (307)
T ss_dssp --------------CTTSCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH
T ss_pred ccCCC-eeeeeeeCccccCc----------HHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 65432 23456899999999 88888889999999999999999999999987422 1223333
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.......+.......+..+.+++.+||++||++|||++|+++
T Consensus 221 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 3343333332222333456899999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=400.76 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=203.7
Q ss_pred ccCccce-eeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKY-CIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|...+ +||+|+||+||+|.++ ++..||||++... ......++|.+|++++++++|||||+++|++.. +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 3566666 4999999999999764 3457999999752 234556789999999999999999999999875 467
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+||||+++|+|.+++... ...+++..+..++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999999998653 35789999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 662 LKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 662 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... .....||+.|+|| |++....++.++|||||||++|||+| |+.||..... .+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~ 220 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAP----------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PE 220 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HH
T ss_pred ccccccccccccccccCccccCh----------HHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HH
Confidence 7654322 2234689999999 88888899999999999999999998 9999875321 11
Q ss_pred hhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+... +...|... +.++.++|..||+.||++||||.+|.+.|
T Consensus 221 ~~~~i~~~~~~~~p~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 221 VMAFIEQGKRMECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp HHHHHHTTCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 22222222 23333332 34588999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=397.22 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=196.9
Q ss_pred ccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec----CCeeeE
Q 047901 509 DAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH----VRHSFV 583 (786)
Q Consensus 509 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~l 583 (786)
+..++||+|+||+||+|+.. +++.||+|++.... ......+.|.+|++++++++|||||++++++.. ....|+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 56678999999999999865 68899999986532 123456789999999999999999999999864 356799
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCceeeC-CCCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPP--IVHRDISSNNVLLD-LEYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrdlk~~Nill~-~~~~~kl~Dfg~a~ 660 (786)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++ + |+||||||+|||++ .++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999999764 5689999999999999999999998 6 99999999999996 57899999999998
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
.... ......+||+.|||| |+.. +.++.++||||+||++|||++|+.||..... ......
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aP----------E~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~ 223 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAP----------EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYR 223 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCG----------GGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHH
T ss_pred eccC--CccCCcccCccccCH----------HHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHH
Confidence 6543 233567899999999 5544 3689999999999999999999999864221 111122
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.+.. ... +.......+.++.+++.+||++||++|||++|+++
T Consensus 224 ~i~~-~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 224 RVTS-GVK-PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHTT-TCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHc-CCC-CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2222 111 11112223345889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-48 Score=410.08 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=212.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +|+.||||++.. ......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc----cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 47999999999999999999864 789999999975 2334567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC--CCcEEEeccccceec
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL--EYEARVSDFGTAKLL 662 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~~ 662 (786)
||||++|+|.+++... .+.+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 102 mE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999999653 35699999999999999999999999 9999999999999964 588999999999987
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... .......||+.|||| |++.+..++.++||||+||++|||++|+.||.... ..+.+..+
T Consensus 177 ~~~-~~~~~~~gT~~Y~aP----------Ev~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i 237 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAP----------EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNV 237 (350)
T ss_dssp CTT-SCEEEECSCTTTCCH----------HHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred ccc-cccceecCcccccCH----------HHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 643 334567899999999 88888899999999999999999999999987432 23334444
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+..+.+++.+||.+||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 444444343333344456899999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=410.25 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=205.2
Q ss_pred hccCccceeeccccCceEEEEEcCC-C-----CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS-G-----DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|++.+.||+|+||+||+|++.. + ..||||++.... .......+.+|+.+++++ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3579999999999999999998642 2 269999986532 223456789999999998 89999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFA--------------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRD 637 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 637 (786)
.+..++|||||++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999975421 23589999999999999999999999 999999
Q ss_pred CCCCceeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 638 ISSNNVLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 638 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
|||+||+++.++.+||+|||+|+........ .....||+.|||| |++.+..++.++|||||||++|||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP----------E~l~~~~~~~~~DiwS~Gvil~em 259 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP----------ESLFEGIYTIKSDVWSYGILLWEI 259 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh----------HHHcCCCCCcceeccchhHHHHHH
Confidence 9999999999999999999999877654332 2345789999999 888889999999999999999999
Q ss_pred Hh-CCCCCCccccccCCCcchhhhhhhhccC--CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 716 IK-GKHPGDFLSLFSSSSSSINIEFNAMLDH--RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 716 lt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+| |+.||..... ...+..++.. ++..|... +.++.++|.+||+.||++||||+||++.|
T Consensus 260 lt~g~~Pf~~~~~--------~~~~~~~~~~~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 260 FSLGVNPYPGIPV--------DANFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp TTTSCCSSTTCCC--------SHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhCCCCCCCCCCH--------HHHHHHHHhcCCCCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 98 8999875321 1222333332 23333332 34589999999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=396.58 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=196.9
Q ss_pred eeeccccCceEEEEEcC---CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEecc
Q 047901 512 YCIGKGEHRSVYRAKLP---SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEYI 588 (786)
Q Consensus 512 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 588 (786)
++||+|+||+||+|.++ .++.||||+++... .+....++|.+|++++++++|||||+++|+|.. +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 46999999999999754 34679999996532 233456789999999999999999999999965 4578999999
Q ss_pred CCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCCc
Q 047901 589 NRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSSN 668 (786)
Q Consensus 589 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 668 (786)
++|+|.+++... ..+++..+..++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 90 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 90 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999999864 5689999999999999999999999 9999999999999999999999999999987654332
Q ss_pred c---eeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhhcc
Q 047901 669 W---TELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 669 ~---~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. ....||+.|||| |.+.+..++.++|||||||++|||+| |+.||..... .+....+..
T Consensus 164 ~~~~~~~~gt~~y~AP----------E~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~ 225 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAP----------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEK 225 (277)
T ss_dssp EEC----CCCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT
T ss_pred cccccccCCCceecCc----------hhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHc
Confidence 2 234789999999 88888899999999999999999998 8999875321 111222222
Q ss_pred -CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 745 -HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 745 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.+...|... +.++.++|.+||+.||++||||++|.+.|
T Consensus 226 ~~~~~~p~~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 226 GERMGCPAGC----PREMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp TCCCCCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCCccc----CHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 233334332 34588999999999999999999997653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=400.31 Aligned_cols=254 Identities=18% Similarity=0.266 Sum_probs=212.3
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCC--CchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPN--DQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSF 582 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 582 (786)
++|++.+.||+|+||+||+|+.+ +|+.||||++...... ......+.+.+|++++++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999864 7899999998653322 22234678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC----cEEEecccc
Q 047901 583 VVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY----EARVSDFGT 658 (786)
Q Consensus 583 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg~ 658 (786)
+|||||++|+|.+++... +.+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999865 5799999999999999999999999 999999999999998776 599999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
|+...... ......||+.|+|| |++.+..++.++||||+||++|||++|+.||.... ..+.
T Consensus 164 a~~~~~~~-~~~~~~~t~~y~AP----------E~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~ 224 (293)
T d1jksa_ 164 AHKIDFGN-EFKNIFGTPEFVAP----------EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQET 224 (293)
T ss_dssp CEECTTSC-BCSCCCCCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred hhhcCCCc-cccccCCCCcccCH----------HHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHH
Confidence 99876443 23456899999999 78888889999999999999999999999987432 2223
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.......+.......+..+.+++++||+.||++|||++|+++
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3333444443333333334556889999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.4e-48 Score=408.58 Aligned_cols=251 Identities=19% Similarity=0.249 Sum_probs=211.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999864 7899999998752 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeC--CCCcEEEeccccceec
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLD--LEYEARVSDFGTAKLL 662 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfg~a~~~ 662 (786)
||||++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+..
T Consensus 105 mE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999988653 35699999999999999999999999 999999999999998 5689999999999988
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... .......||+.|+|| |++.+..++.++||||+||++|||+||+.||.... .......+
T Consensus 180 ~~~-~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i 240 (352)
T d1koba_ 180 NPD-EIVKVTTATAEFAAP----------EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNV 240 (352)
T ss_dssp CTT-SCEEEECSSGGGCCH----------HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHH
T ss_pred CCC-CceeeccCcccccCH----------HHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 654 334557899999999 88888899999999999999999999999987432 12233334
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+..+.++|.+||.+||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 343333333223334456899999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=404.83 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=203.0
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
+.|+..+.||+|+||+||+|+. .+++.||||++.... .......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh-ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3599999999999999999985 478899999987532 22334556799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||++|++..++... +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999998776643 5799999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhh---hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAY---TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~---~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
. ....||+.|||| |++. ...|+.++|||||||++|||++|+.||..... ......
T Consensus 168 ~----~~~~GT~~Y~AP----------E~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~ 225 (309)
T d1u5ra_ 168 A----NSFVGTPYWMAP----------EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYH 225 (309)
T ss_dssp B----CCCCSCGGGCCH----------HHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH
T ss_pred C----CccccCccccCH----------HHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 2 345899999999 6654 34689999999999999999999999864321 122222
Q ss_pred hccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 742 MLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
+.....+... ....+..+.+++.+||++||++|||++|+++
T Consensus 226 i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 IAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHSCCCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 3332222111 1112345889999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=397.31 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=198.4
Q ss_pred hccCccceeeccccCceEEEEEcCCC-----CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSG-----DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 579 (786)
+.+|+..+.||+|+||+||+|.+++. ..||||++... .......+|.+|++++++++|||||+++|++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 35688899999999999999986532 36999999652 23344567999999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTA 659 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 659 (786)
..++||||+++|++.+++... ...+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 999999999999999988764 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchh
Q 047901 660 KLLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSIN 736 (786)
Q Consensus 660 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~ 736 (786)
+....... ......||+.|||| |++.+..++.++|||||||++|||++|..|+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~AP----------E~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~ 220 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAP----------EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNH 220 (283)
T ss_dssp ----------------CCCGGGSCH----------HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHH
T ss_pred hcccCCCccceEeccCCCCccccCH----------HHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHH
Confidence 87754322 12334689999999 88888999999999999999999999766643211 112
Q ss_pred hhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 737 IEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 737 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.....+.+. +.+.|.. .+..+.+++.+||+.||++||||.||++.|
T Consensus 221 ~~~~~i~~~~~~~~~~~----~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 221 EVMKAINDGFRLPTPMD----CPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp HHHHHHHTTCCCCCCTT----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHhccCCCCCchh----hHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 222333332 2223322 234589999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=408.97 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=203.9
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 583 (786)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... .....+.+.+|+.++++++|||||++++++.+.+..|+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 568999999999999999999864 78899999997632 23345688999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEeccccceec
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLL 662 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 662 (786)
||||+++|+|.+++.+. +.+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+..
T Consensus 82 VmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999999864 568999999999999999999997 5 8999999999999999999999999999876
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC-------CC---
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS-------SS--- 732 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~-------~~--- 732 (786)
.+. .....+||+.|+|| |++.+..|++++||||+||++|||++|+.||...+.... ..
T Consensus 156 ~~~--~~~~~~GT~~Y~AP----------Evl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 156 IDS--MANSFVGTRSYMSP----------ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp HHH--TC---CCSSCCCCH----------HHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred CCC--ccccccCCccccCc----------hHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence 432 22356899999999 888888999999999999999999999999965321000 00
Q ss_pred ------------------------cchhhhhhhhccCCC-CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 ------------------------SSINIEFNAMLDHRL-PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ------------------------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
............... ..+. ...+.++.+++.+||..||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000000000 0010 011245889999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=403.13 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=212.9
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+. .+++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 5799999999999999999986 4789999999864211 1123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
||||++|+|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999999865 5689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
........+||+.|+|| |+..+..|+.++||||+||++|||++|++||...+ .......+..
T Consensus 158 ~~~~~~~~~GT~~Y~aP----------E~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~ 219 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAP----------EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM 219 (337)
T ss_dssp TTCCBCCCEECGGGCCG----------GGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred CCcccccceeCHHHhhh----------hhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhc
Confidence 55555667999999999 77778889999999999999999999999987532 2333444555
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
..+..|.... .++.++|..||++||++||+ ++|+++
T Consensus 220 ~~~~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 EEIRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 5555554433 34789999999999999995 788764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=395.20 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=198.6
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
.++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-----cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 3579999999999999999999988889999998642 2234679999999999999999999999855 567899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+++|+|.+++... ....++|.+++.++.|||.||+|||+. +|+||||||+|||++.++++||+|||+|+....
T Consensus 90 ~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999999998754 234689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 665 NSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 665 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
... ......||+.|+|| |+...+.++.++|||||||++|||+||..|+.... ...+....+.
T Consensus 166 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~i~ 228 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAP----------EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVE 228 (285)
T ss_dssp ----------CCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHH
T ss_pred CCceeeccccccccccCh----------HHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHHHHHH
Confidence 332 23346799999999 88889999999999999999999999766643211 1122222222
Q ss_pred c-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 744 D-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 744 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
. .+.+.+.. .+.++.+++.+||+.||++||||++|++.|
T Consensus 229 ~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 268 (285)
T d1fmka3 229 RGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTFEYLQAFL 268 (285)
T ss_dssp TTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCCCCCcc----cCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 2 22233332 234589999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-47 Score=388.29 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=209.6
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc-----hhhHHHHHHHHHHHhhcC-CCcccceeeEEecC
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ-----MSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHV 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~ 578 (786)
++|++.+.||+|+||+||+|+.. +++.||||++........ ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999864 788999999876432221 122446889999999997 99999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
+..|+|||||++|+|.+++..+ +.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999764 5799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIE 738 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 738 (786)
|+...... ......||+.|+|||++... +......+++++||||+||++|||+||+.||.... ....
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~----~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~ 223 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECS----MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLM 223 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHH----HCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhcc----ccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHH
Confidence 99876533 33456899999999532110 11123457889999999999999999999987432 1222
Q ss_pred hhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 739 FNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...+.......+.......+.++.+++++||++||++|||++|+++
T Consensus 224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3333433333232223334556899999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-47 Score=394.92 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=208.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ......+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 57999999999999999999864 789999999864210 1123456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||++||+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999998864 5678899999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. ....+||+.|||| |++.+..|+.++||||+||++|||+||+.||...+ ..+....+..
T Consensus 157 ~---~~~~~Gt~~Y~AP----------E~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~ 215 (316)
T d1fota_ 157 V---TYTLCGTPDYIAP----------EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILN 215 (316)
T ss_dssp C---BCCCCSCTTTCCH----------HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH
T ss_pred c---cccccCcccccCH----------HHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHc
Confidence 3 2356899999999 88888889999999999999999999999987432 2233444444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.....|.... ..+.+++.+||.+||.+|| |++|+++
T Consensus 216 ~~~~~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 216 AELRFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCCCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 4555444333 3488999999999999996 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=395.09 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=211.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|... +++.||||++... ......+.+|+++++.++|||||++++++.+++..|+|
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999865 6889999999752 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC--CcEEEeccccceec
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE--YEARVSDFGTAKLL 662 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfg~a~~~ 662 (786)
||||+||+|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999999754 34689999999999999999999999 99999999999999854 58999999999887
Q ss_pred CCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhh
Q 047901 663 KPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 663 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
... .......+|+.|+|| |...+..++.++||||+||++|||++|+.||.... ....+..+
T Consensus 155 ~~~-~~~~~~~~t~~y~ap----------e~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i 215 (321)
T d1tkia_ 155 KPG-DNFRLLFTAPEYYAP----------EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENI 215 (321)
T ss_dssp CTT-CEEEEEESCGGGSCH----------HHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHH
T ss_pred ccC-Ccccccccccccccc----------hhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 543 234556899999999 77888889999999999999999999999987432 22334444
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 743 LDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......+.......+..+.+++..||.+||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 555555444333344556899999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=392.87 Aligned_cols=254 Identities=20% Similarity=0.370 Sum_probs=206.9
Q ss_pred hccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|+..+.||+|+||+||+|+++ +++.||||++... ......++|.+|++++++++||||++++++|...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 467999999999999999999853 3568999998652 2334567899999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 047901 579 RHSFVVYEYINRGSLATVLSNNF---------------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRD 637 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 637 (786)
+..++||||+++|+|.+++.... ....+++..+..++.|+|.||+|||++ +|||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeE
Confidence 99999999999999999996431 123488999999999999999999999 999999
Q ss_pred CCCCceeeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHH
Q 047901 638 ISSNNVLLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEV 715 (786)
Q Consensus 638 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~el 715 (786)
|||+|||++.++.+||+|||+|+...+... ......||+.|+|| |...+..+++++|||||||++|||
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP----------E~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP----------ESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH----------HHHccCCCChhhhhccchhhHHHH
Confidence 999999999999999999999987654322 22345789999999 888899999999999999999999
Q ss_pred HhCC-CCCCccccccCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 716 IKGK-HPGDFLSLFSSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 716 ltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
++|. +||.... ..+....+.+.... .|... +.++.+++.+||+.||++||||.||+++|
T Consensus 236 l~~~~~p~~~~~--------~~e~~~~v~~~~~~~~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 236 FSYGLQPYYGMA--------HEEVIYYVRDGNILACPENC----PLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HTTTCCTTTTSC--------HHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HccCCCCCCCCC--------HHHHHHHHHcCCCCCCCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9985 5666432 22233334443332 33322 33589999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=385.67 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=194.2
Q ss_pred ccCccceeeccccCceEEEEEcCC----CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS----GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|++.+.||+|+||+||+|++.. +..||||++... ......+.|.+|++++++++|||||+++|++.+ +..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 579999999999999999998642 346889988642 234456789999999999999999999999964 678
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999999988754 35789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhh
Q 047901 662 LKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEF 739 (786)
Q Consensus 662 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 739 (786)
...... ......||+.|+|| |.+....++.++|||||||++|||+| |.+||..... .+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~ap----------E~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~ 219 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAP----------ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVI 219 (273)
T ss_dssp -------------CCGGGCCH----------HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHH
T ss_pred ccCCcceeccceecCcccchh----------hHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHH
Confidence 654332 23345789999999 88888999999999999999999998 8999875332 1222
Q ss_pred hhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 740 NAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 740 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+... +.+.|... +..+.++|.+||+.||++|||++||++.|
T Consensus 220 ~~i~~~~~~~~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 220 GRIENGERLPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp HHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 222222 23333332 34589999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=388.38 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=195.7
Q ss_pred ccCccceeeccccCceEEEEEcC--CC--CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP--SG--DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|++.+.||+|+||+||+|++. ++ ..||||++..... ......++|.+|++++++++|||||+++|++.+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 57999999999999999999853 22 3689999875332 233456789999999999999999999999976 467
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
++||||+++|++.+++... .+.+++..++.++.|+|.||.|||++ +|+||||||+||+++.++++||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999988754 35699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc---ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 662 LKPNSSN---WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 662 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... .....|+..|+|| |...+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aP----------E~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~ 222 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAP----------ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQ 222 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCH----------HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHH
T ss_pred cccCCCcceecCccccCcccCCH----------HHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--------HHH
Confidence 7654332 2234678899999 88888899999999999999999998 899987432 122
Q ss_pred hhhhhccCC--CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 738 EFNAMLDHR--LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....+.... .+.+.. .+..+.+++..||+.||++||||+||.+.|
T Consensus 223 ~~~~i~~~~~~~~~~~~----~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 223 ILHKIDKEGERLPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp HHHHHHTSCCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhCCCCCCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 233333332 222222 234588999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-47 Score=389.53 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=201.0
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----e
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR----H 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~ 580 (786)
++|++.+.||+|+||+||+|+. .+++.||||++..... .+....+.|.+|+++++.++|||||++++++...+ .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5799999999999999999985 4789999999976432 23445678999999999999999999999987543 4
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.|+||||+++|+|.+++... +.+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.++++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999998764 5789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... .....+||+.|+|| |...+..+++++||||+||++|||+||+.||..... .+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aP----------E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~ 221 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSP----------EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VS 221 (277)
T ss_dssp ECC----------------TTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HH
T ss_pred hhccccccccccccccCcccccCH----------HHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HH
Confidence 7643322 23456899999999 788888899999999999999999999999874321 12
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHhC
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-TMQTVCQLL 786 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L 786 (786)
.....+......+.......+.++.+++.+||++||++|| |++++++.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 2222222222222222222345689999999999999999 899987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=384.04 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=194.0
Q ss_pred hccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-CCeeeE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-VRHSFV 583 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~l 583 (786)
.++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+..++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 356888999999999999999985 778999999642 234679999999999999999999999854 466899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999999754 223589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhhhhhhh
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINIEFNAM 742 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 742 (786)
.. .....+|..|+|| |+..+..+++++|||||||++|||+| |++||..... ......+
T Consensus 155 ~~---~~~~~~~~~y~aP----------E~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i 213 (262)
T d1byga_ 155 ST---QDTGKLPVKWTAP----------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV 213 (262)
T ss_dssp ----------CCTTTSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHH
T ss_pred CC---CccccccccCCCh----------HHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHH
Confidence 32 2345789999999 88888899999999999999999998 7888764321 1112222
Q ss_pred cc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 743 LD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 743 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
.. .+...|.. .+.++.+++.+||+.||++||||.|+++.|
T Consensus 214 ~~~~~~~~~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 214 EKGYKMDAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp TTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCCcc----CCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 21 22233332 234588999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.34 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=207.8
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHh-hcCCCcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALT-KIRHRNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~hpniv~l~~~~~~~~~~~l 583 (786)
++|++.+.||+|+||+||+|+.+ +++.||||++..... ......+.+..|..++. .++|||||++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 47999999999999999999865 788999999864110 01223456677777765 6899999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecC
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLK 663 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 663 (786)
||||+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 vmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999999865 5689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhc
Q 047901 664 PNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAML 743 (786)
Q Consensus 664 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 743 (786)
..........||+.|+|| |++.+..+++++||||+||++|||+||+.||.... .......+.
T Consensus 155 ~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~ 216 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAP----------EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIR 216 (320)
T ss_dssp CTTCCBCCCCSCGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred cccccccccCCCCCcCCH----------HHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 555555667899999999 88888999999999999999999999999987432 222333344
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 047901 744 DHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQ-TVCQ 784 (786)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~ 784 (786)
......|... +..+.+++.+||.+||++|||+. |+++
T Consensus 217 ~~~~~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 MDNPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HCCCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cCCCCCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 4444444332 33488999999999999999995 6653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=392.13 Aligned_cols=249 Identities=22% Similarity=0.392 Sum_probs=199.2
Q ss_pred ccCccceeeccccCceEEEEEcC-CCC----EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGD----KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~ 580 (786)
.+|+..+.||+|+||+||+|++. +|+ +||||++... ......+.|.+|++++++++|||||+++|+|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 46999999999999999999864 443 6899998652 2233467899999999999999999999999864 5
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.+++|||+.+|+|.+++... ...+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 67889999999999988764 46789999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 737 (786)
........ .....||+.|+|| |.+.++.++.++|||||||++|||+| |.+||+.... .+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~AP----------E~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~ 221 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMAL----------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SE 221 (317)
T ss_dssp HTTTTCC--------CCTTTSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GG
T ss_pred ecccccccccccccccCccccCh----------HHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HH
Confidence 87654332 2334689999999 88888999999999999999999998 7889875321 11
Q ss_pred hhhhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 738 EFNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 738 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
....+.. .+.+.|... +..+.+++.+||+.||++|||+.||++.
T Consensus 222 ~~~~i~~~~~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 222 ISSILEKGERLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHTCCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccc----CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1111212 233344333 2358899999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-46 Score=398.04 Aligned_cols=251 Identities=22% Similarity=0.214 Sum_probs=200.0
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHH---HHHHHHhhcCCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFL---NEIKALTKIRHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~---~e~~~l~~l~hpniv~l~~~~~~~~~~ 581 (786)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ........+. .|+++++.++|||||++++++.+.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc-chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 57999999999999999999865 789999999853110 0111122333 446677778899999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999999865 5688999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhh
Q 047901 662 LKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFN 740 (786)
Q Consensus 662 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 740 (786)
..... .....||+.|+|| |++. +..|++++||||+||++|||+||+.||..... ........
T Consensus 157 ~~~~~--~~~~~GT~~y~AP----------E~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~ 219 (364)
T d1omwa3 157 FSKKK--PHASVGTHGYMAP----------EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDR 219 (364)
T ss_dssp CSSSC--CCSCCSCGGGCCH----------HHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHH
T ss_pred cCCCc--ccccccccccchh----------HHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence 76432 3456899999999 6664 45689999999999999999999999874321 11112222
Q ss_pred hhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 047901 741 AMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPT-----MQTVCQ 784 (786)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 784 (786)
.........|... +..+.++|.+||++||++||| ++|+++
T Consensus 220 ~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSCCCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccCCCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2333333333332 334889999999999999999 688764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-46 Score=394.90 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=209.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ......+.+.+|+.+++.++|||||++++++.+....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47999999999999999999864 789999999853110 1123456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+.+|+|.+++... +.+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999999765 4689999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhhhcc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNAMLD 744 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 744 (786)
. .....||+.|||| |++.+..++.++||||+||++|||+||+.||.... .......+..
T Consensus 194 ~---~~~~~Gt~~Y~AP----------E~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~ 252 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAP----------EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVS 252 (350)
T ss_dssp C---BCCCEECGGGCCH----------HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred c---cccccCccccCCH----------HHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhc
Confidence 3 2346899999999 88888899999999999999999999999987432 2233444444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 745 HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
.....|.... ..+.+++++||.+||.+|+ |++|+++
T Consensus 253 ~~~~~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 GKVRFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 4444444333 3488999999999999994 8999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=392.33 Aligned_cols=251 Identities=20% Similarity=0.268 Sum_probs=200.2
Q ss_pred ccCccce-eeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec----C
Q 047901 506 KDFDAKY-CIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH----V 578 (786)
Q Consensus 506 ~~~~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~----~ 578 (786)
++|.+.+ .||+|+||+||+|+. .+++.||||++.. .+.+.+|++++.++ +|||||++++++.+ +
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 5788765 699999999999985 5789999999853 23567899987655 89999999999865 4
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEec
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVSD 655 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 655 (786)
...|+|||||+||+|.+++... ....+++.+++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 6789999999999999999864 335799999999999999999999999 9999999999999985 46799999
Q ss_pred cccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcch
Q 047901 656 FGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSI 735 (786)
Q Consensus 656 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~ 735 (786)
||+|+...... ......||+.||||| ++.+..|++++||||+||++|||+||+.||........ .
T Consensus 158 FG~a~~~~~~~-~~~~~~gt~~y~aPE----------~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~ 222 (335)
T d2ozaa1 158 FGFAKETTSHN-SLTTPCYTPYYVAPE----------VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----S 222 (335)
T ss_dssp CTTCEECCCCC-CCCCCSCCCSSCCCC----------CCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cceeeeccCCC-ccccccCCcccCCcH----------HHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----H
Confidence 99999876543 334568999999995 45566789999999999999999999999875332110 0
Q ss_pred hhhhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 736 NIEFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
......+.......|.......+.++.+++.+||.+||++|||+.|+++
T Consensus 223 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 223 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111222223333444444555677999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=384.05 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=198.4
Q ss_pred ceeeccccCceEEEEEcCCC----CEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-CCeeeEEE
Q 047901 511 KYCIGKGEHRSVYRAKLPSG----DKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-VRHSFVVY 585 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~ 585 (786)
.++||+|+||+||+|++.++ ..||||++.. .......++|.+|++++++++||||++++|++.. ++..++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc---ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 56899999999999986532 2589999864 2344566889999999999999999999999865 56889999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
|||++|+|.+++... ....++..+.+++.|+|.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999998764 45678899999999999999999999 9999999999999999999999999999977543
Q ss_pred CC----cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhhhhhh
Q 047901 666 SS----NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINIEFNA 741 (786)
Q Consensus 666 ~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 741 (786)
.. ......||+.|+|| |......++.++||||||+++|||+||+.||..... .......
T Consensus 184 ~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~ 246 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMAL----------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVY 246 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHH
T ss_pred ccccceecccccccccccCh----------HHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHH
Confidence 22 12335789999999 888888999999999999999999998877653211 1111122
Q ss_pred hccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 742 MLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 742 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+... +...|... +..+.++|.+||+.||++||||.||++.|
T Consensus 247 i~~g~~~~~p~~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 247 LLQGRRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCCCCCcccC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2222 23333322 23588999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=389.36 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=194.3
Q ss_pred cceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc-hhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEEec
Q 047901 510 AKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ-MSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVYEY 587 (786)
Q Consensus 510 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 587 (786)
..+.||+|+||+||+|+.+ +++.||||++........ ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999965 689999999975332211 11234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCCCC
Q 047901 588 INRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPNSS 667 (786)
Q Consensus 588 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 667 (786)
++++++..+... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 998877766543 35688899999999999999999999 999999999999999999999999999987765554
Q ss_pred cceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC----------Ccchh
Q 047901 668 NWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS----------SSSIN 736 (786)
Q Consensus 668 ~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~----------~~~~~ 736 (786)
.....+||+.|+|| |+.. ...++.++||||+||++|||+||++||......... .....
T Consensus 156 ~~~~~~gt~~y~aP----------E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAP----------ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp CCCCSCCCCTTCCH----------HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccceecChhhccH----------HHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 45566899999999 6554 446799999999999999999999998753321000 00000
Q ss_pred hhhhhhcc-CCC-CCCChhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 737 IEFNAMLD-HRL-PHPSLDV----QEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 737 ~~~~~~~~-~~~-~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
........ ... ..+.... ...+..+.+++.+||..||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000 000 0011001 112345889999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=385.18 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=200.4
Q ss_pred ccCccceeeccccCceEEEEEcCC-CC--EEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEecCCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPS-GD--KIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 581 (786)
++|+..+.||+|+||+||+|++++ +. .||||++.... .....+.|.+|+++++++ +|||||+++|+|.+.+..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 578999999999999999998763 33 47888875422 223456799999999998 799999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC
Q 047901 582 FVVYEYINRGSLATVLSNN-------------FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE 648 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 648 (786)
++||||+++|+|.++++.. .....+++..+..++.|||.||.|||+. +|+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence 9999999999999999754 2346799999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCC-CCCCcccc
Q 047901 649 YEARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK-HPGDFLSL 727 (786)
Q Consensus 649 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~-~Pf~~~~~ 727 (786)
+.+||+|||+|+...... ......||..|+|| |.+.+..++.++|||||||++|||++|. +||....
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aP----------E~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~- 231 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAI----------ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT- 231 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCH----------HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred CceEEccccccccccccc-cccceecCCcccch----------HHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-
Confidence 999999999998654322 22345789999999 7888889999999999999999999975 5665432
Q ss_pred ccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 728 FSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+....+... +...|... +..+.++|.+||+.||++||||+||++.|
T Consensus 232 -------~~~~~~~i~~~~~~~~~~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 232 -------CAELYEKLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp -------HHHHHHHGGGTCCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------HHHHHHHHHhcCCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 12222222222 33333332 33588999999999999999999999753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=383.16 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=194.1
Q ss_pred HhccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEe
Q 047901 504 RTKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCS 576 (786)
Q Consensus 504 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~ 576 (786)
..++|++.+.||+|+||+||+|++. +++.||||++... ......+.+.+|.+++.++ +||||+.+++++.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3467999999999999999999853 2457999998642 2334556788888888877 6899999999886
Q ss_pred c-CCeeeEEEeccCCCCHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 577 H-VRHSFVVYEYINRGSLATVLSNNF-------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 577 ~-~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
. +...++|||||++|+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 5 456899999999999999997542 123589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhC-C
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKG-K 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg-~ 719 (786)
||++.++.+||+|||+|+....... ......||+.|+|| |+..+..++.++|||||||++|||+|| .
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP----------E~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP----------ETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccch----------hHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 9999999999999999987654332 23456799999999 888889999999999999999999996 4
Q ss_pred CCCCccccccCCCcchhhhhhhhcc-CCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLD-HRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+||..... .......+.. .+...|... +.++.+++.+||+.||++||||+||++.|
T Consensus 235 ~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 235 SPYPGVKI-------DEEFCRRLKEGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp CSSTTCCC-------SHHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCH-------HHHHHHHHhcCCCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 57654221 1111111111 122233322 33588999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=383.80 Aligned_cols=254 Identities=23% Similarity=0.418 Sum_probs=207.0
Q ss_pred hccCccceeeccccCceEEEEEc------CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEEec
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL------PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFCSH 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 577 (786)
.++|++.+.||+|+||.||+|++ .+++.||||+++.. ........|.+|+.+++++ +|||||+++|+|.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc---cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 45799999999999999999974 24568999999752 2344566899999999999 69999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNF---------------ASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
.+..++|||||++|+|.+++.... ....+++..+..++.|||.|++|||++ +|+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999997542 123588999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
|+++.++.+|++|||.++........ .....||+.|+|| |...+..++.++|||||||++|||+| |.
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP----------ESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCH----------HHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence 99999999999999999987654332 2345889999999 88888999999999999999999999 55
Q ss_pred CCCCccccccCCCcchhhhhhhhccCCC--CCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDHRL--PHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+||.... ....+.+++.... ..+.. .+..+.++|.+||+.||++||||+||++.|
T Consensus 246 p~~~~~~--------~~~~~~~~i~~~~~~~~~~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 246 SPYPGMP--------VDSKFYKMIKEGFRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp CSSTTCC--------SSHHHHHHHHHTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCC--------HHHHHHHHHhcCCCCCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 5554322 1122333333222 22222 234589999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=380.30 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=202.2
Q ss_pred hccCccceeeccccCceEEEEEcCC--------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc-CCCcccceeeEE
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLPS--------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI-RHRNIVKFYGFC 575 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~ 575 (786)
.++|++.+.||+|+||.||+|+... +..||||++... .......++.+|...+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc---cChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3579999999999999999997532 247999999752 2334567888999999888 799999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCc
Q 047901 576 SHVRHSFVVYEYINRGSLATVLSNNFA-------------SEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNN 642 (786)
Q Consensus 576 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 642 (786)
.+++..++||||+++|+|.+++..... ...+++.+++.++.|+|.||+|||+. +|+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 999999999999999999999975421 24589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccceecCCCCC--cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHh-CC
Q 047901 643 VLLDLEYEARVSDFGTAKLLKPNSS--NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIK-GK 719 (786)
Q Consensus 643 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~ellt-g~ 719 (786)
||++.++.+||+|||+++....... ......||+.|+|| |.+.++.|++++|||||||++|||++ |.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP----------E~l~~~~y~~k~DiwS~Gvvl~ell~~g~ 235 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP----------EALFDRIYTHQSDVWSFGVLLWEIFTLGG 235 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH----------HHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhh----------hHhcCCCCCchhhhHHhHHHHHHhccCCC
Confidence 9999999999999999997754332 22345789999999 88888999999999999999999998 78
Q ss_pred CCCCccccccCCCcchhhhhhhhccC-CCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 720 HPGDFLSLFSSSSSSINIEFNAMLDH-RLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 720 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
+||..... ......+... +...|... +..+.+++.+||++||++||||.||++.|
T Consensus 236 ~p~~~~~~--------~~~~~~i~~~~~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 236 SPYPGVPV--------EELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp CSSTTCCH--------HHHHHHHHTTCCCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCH--------HHHHHHHHcCCCCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 88764321 1222222222 22333332 33589999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=382.48 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=208.7
Q ss_pred hccCccceeeccccCceEEEEEcC------CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecC
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP------SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHV 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~ 578 (786)
.++|+..+.||+|+||+||+|.++ +++.||||+++.. ........|.+|++++++++|||||+++|++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 468999999999999999999763 3568999999642 3344556799999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcE
Q 047901 579 RHSFVVYEYINRGSLATVLSNN-------FASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEA 651 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 651 (786)
+..++||||+++|+|.+++... .....+++..+..++.|+|+||.|||++ +|+||||||+|||++.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 9999999999999999998643 1224578999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc--ceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCC-CCCCccccc
Q 047901 652 RVSDFGTAKLLKPNSSN--WTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGK-HPGDFLSLF 728 (786)
Q Consensus 652 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~-~Pf~~~~~~ 728 (786)
||+|||+|+........ .....||+.|+|| |...+..++.++|||||||++|||+||. +||....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP----------e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-- 240 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP----------ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-- 240 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCH----------HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--
T ss_pred EEeecccceeccCCcceeeccceecccccCCH----------HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999877543322 2334789999999 8888899999999999999999999985 6765422
Q ss_pred cCCCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 729 SSSSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
..+....+.+.... .|... +..+.++|.+||+.+|++||||++|++.|
T Consensus 241 ------~~~~~~~i~~~~~~~~p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 241 ------NEQVLRFVMEGGLLDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp ------HHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------HHHHHHHHHhCCCCCCcccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 23334444443332 33322 34599999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=380.19 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=195.8
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHH--HHhhcCCCcccceeeEEecCC----
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIK--ALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~--~l~~l~hpniv~l~~~~~~~~---- 579 (786)
++|...+.||+|+||+||+|++ +|+.||||++.. ...+.+.+|.+ .++.++|||||+++|++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~-------~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECc-------cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4688889999999999999997 578999999853 12334444544 456789999999999997543
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD-----CFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
..|+|||||++|+|.+++++. .++|..+..++.|+|.||+|+|+. ..++|+||||||+|||++.++.+||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 578999999999999999763 589999999999999999999973 12499999999999999999999999
Q ss_pred ccccceecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhhc------CcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 655 DFGTAKLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYTM------KITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 655 Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~------~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
|||+++....... ......||+.|+|| |++.+. .++.|+|||||||++|||+||..||..
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAP----------EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCH----------HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ecCccccccCCCcceeccccceecccCcCCh----------hhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9999998754432 22346899999999 554432 367899999999999999999988754
Q ss_pred cccccCC-------CcchhhhhhhhccCCCC--CCCh-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHhC
Q 047901 725 LSLFSSS-------SSSINIEFNAMLDHRLP--HPSL-DVQEKLISIMEVALLCLDGCPNSRPTMQTVCQLL 786 (786)
Q Consensus 725 ~~~~~~~-------~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 786 (786)
....... ............+.... .+.. ...+....+.+++.+||+.||++||||.||++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred ccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 3321111 11112222223333322 1221 1234456689999999999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=379.42 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=199.8
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4799999999999999999986 5789999999965321 223356889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
|||+.+ ++.+++... ....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~e~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EECCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred EeecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence 999976 455555433 245699999999999999999999999 999999999999999999999999999988876
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC----------CCc
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS----------SSS 733 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~----------~~~ 733 (786)
+........||+.|+|| |.... ..++.++||||+||++|+|++|+.||...+.... ...
T Consensus 155 ~~~~~~~~~gt~~y~ap----------E~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAP----------EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp CSBCTTCCBCCCTTCCH----------HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred Ccccceeecccceeeeh----------hhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 55555667899999999 55444 4457899999999999999999999975331100 000
Q ss_pred chhhhhhhhccCCCCCC---Chh----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 734 SINIEFNAMLDHRLPHP---SLD----VQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 734 ~~~~~~~~~~~~~~~~~---~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
..........+.....+ ... ....+..+.+++.+||..||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000011111110000 000 0112245889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-45 Score=381.04 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=199.4
Q ss_pred ccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVVY 585 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 585 (786)
++|+..+.||+|+||+||+|+.++++.||||++..... .....+.+.+|+.+|++++|||||++++++..++..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 57999999999999999999998999999999976422 2234578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCCC
Q 047901 586 EYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKPN 665 (786)
Q Consensus 586 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 665 (786)
||+.++.+..+... .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.|......
T Consensus 80 e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 99988776666553 36799999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCcceeeccCccccCCCCCCCCchHHHHhh-hcCcCcccchHHHHHHHHHHHhCCCCCCccccccC----------CCcc
Q 047901 666 SSNWTELVGTFGYVAPAHGNIGLHLAELAY-TMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS----------SSSS 734 (786)
Q Consensus 666 ~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~-~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~----------~~~~ 734 (786)
........|++.|+|| |... ...++.++||||+||++|||++|+.||........ ....
T Consensus 154 ~~~~~~~~~~~~y~~p----------E~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAP----------DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp --------CCCTTCCH----------HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccceecccchhhhH----------HHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence 5545556799999999 4444 45678999999999999999999999975432100 0000
Q ss_pred hhhhhhhhcc------CCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 735 INIEFNAMLD------HRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 735 ~~~~~~~~~~------~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.......... .....+ .......+..+.+++++||++||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 000000 0001112345889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=376.32 Aligned_cols=243 Identities=20% Similarity=0.315 Sum_probs=197.9
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCc--hhhHHHHHHHHHHHhhcC--CCcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQ--MSDQKEFLNEIKALTKIR--HRNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~ 580 (786)
++|++.+.||+|+||+||+|+.. +++.||||++........ .....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999864 789999999865322111 112234668999999986 8999999999999999
Q ss_pred eeEEEeccCC-CCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCC-CcEEEecccc
Q 047901 581 SFVVYEYINR-GSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLE-YEARVSDFGT 658 (786)
Q Consensus 581 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~ 658 (786)
.++||||+.+ +++.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 6888888754 5789999999999999999999999 99999999999999855 7999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCc-CcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKI-TEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~-~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
|+..... ......||+.|+|| |++.+..+ +.++||||+||++|||+||+.||....
T Consensus 158 a~~~~~~--~~~~~~GT~~y~aP----------E~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------- 214 (273)
T d1xwsa_ 158 GALLKDT--VYTDFDGTRVYSPP----------EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 214 (273)
T ss_dssp CEECCSS--CBCCCCSCGGGSCH----------HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred ceecccc--cccccccCCCcCCH----------HHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------
Confidence 9876533 33456899999999 77776665 567999999999999999999987421
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
++.......+... +.++.+++.+||++||++|||++|+++
T Consensus 215 ---~i~~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ---EIIRGQVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---HHHHCCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHhhcccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1222222222222 234889999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=371.13 Aligned_cols=262 Identities=18% Similarity=0.266 Sum_probs=194.0
Q ss_pred hccCccceeeccccCceEEEEEc-CC-CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhc---CCCcccceeeEEec--
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PS-GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKI---RHRNIVKFYGFCSH-- 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~-- 577 (786)
.++|++.+.||+|+||+||+|+. ++ ++.||||++....... .....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 46899999999999999999986 34 5679999986532221 1122455677776655 79999999998853
Q ss_pred ---CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEe
Q 047901 578 ---VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVS 654 (786)
Q Consensus 578 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 654 (786)
....+++|||++++++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence 3567899999998776554443 346789999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC---
Q 047901 655 DFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS--- 731 (786)
Q Consensus 655 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~--- 731 (786)
|||.++..... .......||+.|+|| |++.+..|+.++||||+||++|||++|+.||.........
T Consensus 159 dfg~~~~~~~~-~~~~~~~gT~~Y~AP----------E~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 227 (305)
T d1blxa_ 159 DFGLARIYSFQ-MALTSVVVTLWYRAP----------EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227 (305)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCH----------HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred chhhhhhhccc-ccCCCcccChhhcCc----------chhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999865432 234556899999999 8888889999999999999999999999999754311000
Q ss_pred -------Cc----chhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 -------SS----SINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 -------~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.. ................+ .......+..+.+++.+||++||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000000000000 0011112345789999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=373.29 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=191.1
Q ss_pred cCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------CC
Q 047901 507 DFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------VR 579 (786)
Q Consensus 507 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~~ 579 (786)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|++++++++||||+++++++.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 6889999999999999999865 789999999975321 12379999999999999999999843 23
Q ss_pred eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEecccc
Q 047901 580 HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGT 658 (786)
Q Consensus 580 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~ 658 (786)
+.++|||||++|.+............+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 5789999998764443333222346799999999999999999999999 999999999999999775 899999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC-------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------- 731 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------- 731 (786)
|+...... ......||+.|+||| ++.....++.++||||+||++|||++|+.||.........
T Consensus 170 a~~~~~~~-~~~~~~gt~~y~aPE---------~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~ 239 (350)
T d1q5ka_ 170 AKQLVRGE-PNVSYICSRYYRAPE---------LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239 (350)
T ss_dssp CEECCTTS-CCCSCCSCTTSCCHH---------HHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred hhhccCCc-ccccccccccccChH---------HhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh
Confidence 98875443 234468999999995 4444567899999999999999999999998753321000
Q ss_pred Ccchhhhhhhhc----cCCCCC----C--ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 SSSINIEFNAML----DHRLPH----P--SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ~~~~~~~~~~~~----~~~~~~----~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.....+...... ...... + .......+..+.+++.+||..||++|||+.|+++
T Consensus 240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 001100 0 0001112345889999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=370.04 Aligned_cols=259 Identities=20% Similarity=0.267 Sum_probs=193.4
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----e
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR----H 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~ 580 (786)
.+|++.+.||+|+||+||+|+. .+|+.||||++... ......+.+.+|+++|++++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh---cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4699999999999999999975 58999999999652 23445678999999999999999999999986543 2
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.+++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34556667799999999753 589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---cceeeccCccccCCCCCCCCchHHHHh-hhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC------
Q 047901 661 LLKPNSS---NWTELVGTFGYVAPAHGNIGLHLAELA-YTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS------ 730 (786)
Q Consensus 661 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~e~~-~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~------ 730 (786)
....... .....+||+.|+||| +. ....+++++||||+||++|||++|+.||........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE----------~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~ 227 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPE----------IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGG----------GTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eccCCCccceeeccccccceechHH----------HhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh
Confidence 7654322 234567999999995 44 345678899999999999999999999975432100
Q ss_pred ----CCcc--------hhhhhhhhccCCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ----SSSS--------INIEFNAMLDHRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ----~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.... ...............+. ......+..+.+++.+||..||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000000000000 000111235889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=367.97 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=203.5
Q ss_pred ccCccceeeccccCceEEEEEc----CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-CcccceeeEEecCCe
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL----PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKFYGFCSHVRH 580 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~ 580 (786)
++|++.+.||+|+||+||+|+. .+|+.||||++.......+....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 25789999998653222222334568899999999976 899999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccce
Q 047901 581 SFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAK 660 (786)
Q Consensus 581 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 660 (786)
.++||||+.+|+|.+++... +.+....+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999865 4567889999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-cceeeccCccccCCCCCCCCchHHHHhhhc--CcCcccchHHHHHHHHHHHhCCCCCCccccccCCCcchhh
Q 047901 661 LLKPNSS-NWTELVGTFGYVAPAHGNIGLHLAELAYTM--KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSSSINI 737 (786)
Q Consensus 661 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~--~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~~~~~ 737 (786)
....... ......|++.|+|| |...+. .++.++||||+||++|||+||+.||...... .....
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~p----------e~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~ 243 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAP----------DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAE 243 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCH----------HHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHH
T ss_pred hhcccccccccccccccccchh----------HHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 7754322 33456899999999 555433 4678999999999999999999999754321 12222
Q ss_pred hhhhhccCCCCCCChhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 047901 738 EFNAMLDHRLPHPSLDVQEKLISIMEVALLCLDGCPNSRP-----TMQTVCQ 784 (786)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 784 (786)
............|... +..+.+++.+||++||++|| |++|+++
T Consensus 244 i~~~~~~~~~~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRILKSEPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhcccCCCCCcccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2333334444444332 34588999999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=359.68 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=203.2
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCCeeeEE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVRHSFVV 584 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 584 (786)
++|++.+.||+|+||+||+|+. .+++.||||+++... .......++.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999986 478899999997533 2334567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccccceecCC
Q 047901 585 YEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKLLKP 664 (786)
Q Consensus 585 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 664 (786)
+|++.++++..++... +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999998887654 6788999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcceeeccCccccCCCCCCCCchHHHHhhhc-CcCcccchHHHHHHHHHHHhCCCCCCccccccC-----------CC
Q 047901 665 NSSNWTELVGTFGYVAPAHGNIGLHLAELAYTM-KITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS-----------SS 732 (786)
Q Consensus 665 ~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~-~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~-----------~~ 732 (786)
.........++..|+|| |..... .++.++||||+||++|||++|+.||........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~p----------e~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPP----------DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp CCSCCCSCCSCGGGCCH----------HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CCccceeeccccchhhh----------hHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence 55555556778888888 665544 468999999999999999999999643221000 00
Q ss_pred cchhhhhhhhccCC-------CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 733 SSINIEFNAMLDHR-------LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 733 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
...........+.. ..............+.+++.+||+.||++||||+|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 00000111122345789999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=364.56 Aligned_cols=261 Identities=20% Similarity=0.273 Sum_probs=192.8
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------ 577 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------ 577 (786)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 36899999999999999999986 4789999999876432 22345678899999999999999999998854
Q ss_pred --CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEec
Q 047901 578 --VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSD 655 (786)
Q Consensus 578 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 655 (786)
.+..|+||||++++++..+... ...++...++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence 3467999999988766655443 35788999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC----cceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC
Q 047901 656 FGTAKLLKPNSS----NWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS 730 (786)
Q Consensus 656 fg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~ 730 (786)
||+|+....... .....+||+.|+|| |...+ ..+++++||||+||++|||++|+.||........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aP----------E~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPP----------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCH----------HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhH----------HHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 999987653321 22345799999999 55544 4689999999999999999999999975321100
Q ss_pred C---------------CcchhhhhhhhccCCCCCCChhHHH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 S---------------SSSINIEFNAMLDHRLPHPSLDVQE------KLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ~---------------~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. ............... ........+ ....+.+++.+||++||++|||++|+++
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 231 LALISQLCGSITPEVWPNVDNYELYEKLELV-KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHHCCCCTTTSTTCCCC-------CC-SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcCCCChhhccccchhhhhhhhccc-ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 000000000000000 000111111 1235678999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=368.20 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=192.0
Q ss_pred hccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSHVR---- 579 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---- 579 (786)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 357999999999999999999864 78999999997532 23345678899999999999999999999997654
Q ss_pred --eeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEeccc
Q 047901 580 --HSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFG 657 (786)
Q Consensus 580 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 657 (786)
+.|+||||+ +++|..+.+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 569999999 5578777654 4699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccC------
Q 047901 658 TAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS------ 730 (786)
Q Consensus 658 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~------ 730 (786)
.|+..... .....||+.|+|| |...+ ..++.++||||+||++|||++|+.||........
T Consensus 167 ~a~~~~~~---~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 167 LARQADSE---MTGYVVTRWYRAP----------EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp TCEECCSS---CCSSCSCGGGCCT----------HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ceeccCCc---cccccccccccCH----------HHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 99877543 3456899999999 65554 5678999999999999999999999875432100
Q ss_pred ------------CCcchhhhhhhhccCCCC-CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ------------SSSSINIEFNAMLDHRLP-HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ------------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
.................. ............+.+|+.+||..||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000000 000001112335789999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-41 Score=355.13 Aligned_cols=253 Identities=17% Similarity=0.239 Sum_probs=192.2
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccce-eeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKF-YGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l-~~~~~~~~~~~l 583 (786)
++|++.+.||+|+||+||+|+. .+++.||||++..... .+++..|+++++.++|++++.. .++..+.+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 4699999999999999999986 4688999999865321 1347789999999987765555 555577888899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC---CCcEEEeccccce
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL---EYEARVSDFGTAK 660 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfg~a~ 660 (786)
||||+. |++.+.+... .+.+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999995 5777766543 45799999999999999999999999 9999999999999864 4679999999999
Q ss_pred ecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCCCc
Q 047901 661 LLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSSSS 733 (786)
Q Consensus 661 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~~~ 733 (786)
....... ......||+.|||| |...+..+++++|||||||++|||+||+.||...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASI----------NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCH----------HHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred eccccccccceeccccCCcCCCccccCH----------HHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 8764322 12345799999999 888888899999999999999999999999875432111111
Q ss_pred chhhhhhhhccCCCCCCC-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 734 SINIEFNAMLDHRLPHPS-LDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
...........+. ......+.++.+++..||+.+|++||+++++.+.
T Consensus 225 -----~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~ 272 (299)
T d1ckia_ 225 -----YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272 (299)
T ss_dssp -----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHH
T ss_pred -----HHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1111111111110 0111223458999999999999999999988764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=359.97 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=193.6
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEec--CCee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSH--VRHS 581 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~--~~~~ 581 (786)
++|++.+.||+|+||+||+|+. .+++.||||++.. ...+++.+|+++|+.++ ||||+++++++.. ....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-------~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-------SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-------HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 5799999999999999999986 4788999999864 23467889999999995 9999999999874 4568
Q ss_pred eEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCC-cEEEeccccce
Q 047901 582 FVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEY-EARVSDFGTAK 660 (786)
Q Consensus 582 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~ 660 (786)
++||||+++|+|..+. +.+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+
T Consensus 108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 9999999999987754 3589999999999999999999999 999999999999998654 69999999999
Q ss_pred ecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC--------
Q 047901 661 LLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS-------- 731 (786)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~-------- 731 (786)
...... ......+|+.|+|| |...+ ..++.++||||+||++|||++|+.||.........
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aP----------E~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 179 FYHPGQ-EYNVRVASRYFKGP----------ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp ECCTTC-CCCSCCSCGGGCCH----------HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred eccCCC-cccccccCccccCc----------ccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 876442 33456899999999 55544 45799999999999999999999998643210000
Q ss_pred ------------CcchhhhhhhhccCCCC------CCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ------------SSSINIEFNAMLDHRLP------HPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ------------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
................. .+.......+.++.+++++||.+||++|||++|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000000 001111122345889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-41 Score=353.46 Aligned_cols=253 Identities=15% Similarity=0.207 Sum_probs=199.1
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-CcccceeeEEecCCeeeE
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-RNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~l 583 (786)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|+++++.++| +|++.+++++......++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 57999999999999999999865 688999998865221 1246688899999965 899999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCC-----CCcEEEecccc
Q 047901 584 VYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDL-----EYEARVSDFGT 658 (786)
Q Consensus 584 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfg~ 658 (786)
||||+ +++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99999 67999998764 35689999999999999999999999 9999999999999974 57899999999
Q ss_pred ceecCCCCC-------cceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccCC
Q 047901 659 AKLLKPNSS-------NWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS 731 (786)
Q Consensus 659 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~ 731 (786)
|+....... ......||+.|||| |.+.+..+++++|||||||++|||+||+.||......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aP----------E~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--- 219 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSI----------NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--- 219 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCH----------HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---
T ss_pred eEEcccCccccceeecccCceEEchhhcCH----------HHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch---
Confidence 998754321 22345799999999 8888889999999999999999999999998743321
Q ss_pred CcchhhhhhhhccCCCCCC-ChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHh
Q 047901 732 SSSINIEFNAMLDHRLPHP-SLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQL 785 (786)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 785 (786)
........+...+...+ .......+.++.+++..|+..+|++||+++.+.+.
T Consensus 220 --~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 220 --TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp --CHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred --hHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11111111111111111 00011123458899999999999999999888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=355.35 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=190.4
Q ss_pred ccCccceeeccccCceEEEEEcC-CCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec------C
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH------V 578 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~ 578 (786)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+++.+|+.+++.++|||||++++++.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 47999999999999999999865 68999999997643 234456678999999999999999999999853 4
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...|+||||+.++ +.+.+. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 6789999999765 444443 3578999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCccccccC--------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSS-------- 730 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~-------- 730 (786)
++..... .......+|+.|+|| |.+.+..+++++||||+||++|||++|+.||........
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aP----------E~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~ 234 (355)
T d2b1pa1 166 ARTAGTS-FMMTPYVVTRYYRAP----------EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_dssp ----------------CCTTCCH----------HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred hhccccc-cccccccccccccCh----------hhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 8866543 233456799999999 888888999999999999999999999999864321000
Q ss_pred ------CCcchhhhhhhhccCC----------------CCCCChhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 731 ------SSSSINIEFNAMLDHR----------------LPHPSLDVQEKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 731 ------~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
................ ...........+..+.+|+++||..||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000001111111 11112223345667899999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=360.66 Aligned_cols=258 Identities=19% Similarity=0.275 Sum_probs=193.9
Q ss_pred hccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCcccceeeEEec-----C
Q 047901 505 TKDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRNIVKFYGFCSH-----V 578 (786)
Q Consensus 505 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-----~ 578 (786)
+++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+.+|+++++.++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 45799999999999999999985 479999999997532 334456678999999999999999999999853 3
Q ss_pred CeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEEecccc
Q 047901 579 RHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARVSDFGT 658 (786)
Q Consensus 579 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 658 (786)
...+++|+|+.+|+|.+++.. +.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 345677888889999999954 4699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhh-cCcCcccchHHHHHHHHHHHhCCCCCCccccccCC------
Q 047901 659 AKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYT-MKITEKCDVYSFGVLALEVIKGKHPGDFLSLFSSS------ 731 (786)
Q Consensus 659 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~-~~~~~~sDvwslGvil~elltg~~Pf~~~~~~~~~------ 731 (786)
|..... ......||+.|+|| |...+ ..++.++||||+||++|+|++|+.||...+.....
T Consensus 168 a~~~~~---~~~~~~g~~~y~ap----------E~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~ 234 (348)
T d2gfsa1 168 ARHTDD---EMTGYVATRWYRAP----------EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234 (348)
T ss_dssp --CCTG---GGSSSCHHHHTSCH----------HHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hcccCc---ccccccccccccCc----------hhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 976542 23446799999999 54444 45688999999999999999999999753311000
Q ss_pred ----C-----cchhhhhhhhccCCCCCCChhHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 047901 732 ----S-----SSINIEFNAMLDHRLPHPSLDVQ----EKLISIMEVALLCLDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 732 ----~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 784 (786)
. .................+..... ..+..+.+++.+||..||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 00000000000100111111111 12345789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=323.19 Aligned_cols=258 Identities=19% Similarity=0.229 Sum_probs=188.5
Q ss_pred ccCccceeeccccCceEEEEEc-CCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-----------CCcccceee
Q 047901 506 KDFDAKYCIGKGEHRSVYRAKL-PSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-----------HRNIVKFYG 573 (786)
Q Consensus 506 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~l~~ 573 (786)
++|++.+.||+|+||+||+|+. .+|+.||||+++. .....+.+.+|+.+++.+. ||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~-----~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec-----cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4599999999999999999986 4789999999964 2234467788998888775 578999999
Q ss_pred EEec--CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCC-
Q 047901 574 FCSH--VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEY- 649 (786)
Q Consensus 574 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~- 649 (786)
++.. ....+++|+++..+..............+++..+..++.|++.|++|||+ . +|+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 8754 34566777776555444333333345678999999999999999999998 5 999999999999998664
Q ss_pred -----cEEEeccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHHHHHHHhCCCCCCc
Q 047901 650 -----EARVSDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVLALEVIKGKHPGDF 724 (786)
Q Consensus 650 -----~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvil~elltg~~Pf~~ 724 (786)
.+|++|||.|...... ....+||+.|+|| |......++.++||||+||+++||++|+.||..
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aP----------E~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSP----------EVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCH----------HHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccccceeeEeecccccccccc---cccccccccccCh----------hhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 4999999999866432 2346899999999 788888899999999999999999999999875
Q ss_pred cccccCCCcchh-------------hhh------hhhcc-----CCCCC------------CChhHHHHHHHHHHHHHhc
Q 047901 725 LSLFSSSSSSIN-------------IEF------NAMLD-----HRLPH------------PSLDVQEKLISIMEVALLC 768 (786)
Q Consensus 725 ~~~~~~~~~~~~-------------~~~------~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~c 768 (786)
............ ... ....+ ..+.. ...........+.+++.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 432111100000 000 00000 00000 0011234456789999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 047901 769 LDGCPNSRPTMQTVCQ 784 (786)
Q Consensus 769 l~~~p~~RPt~~ev~~ 784 (786)
+..||.+|||++|+++
T Consensus 312 L~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVN 327 (362)
T ss_dssp GCSSTTTCBCHHHHHT
T ss_pred CCCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.98 E-value=1.5e-31 Score=289.49 Aligned_cols=355 Identities=24% Similarity=0.319 Sum_probs=268.3
Q ss_pred cCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCc
Q 047901 8 LTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFS 87 (786)
Q Consensus 8 l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 87 (786)
++.+++.+.+.. +.+.+|++|++++|+|+.+ +.+..+++|++|+|++|+|+++. .|+.+++|++|+|++|+|+
T Consensus 29 l~~~~~~~~~~~---~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 29 LGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp TTCSSTTSEECH---HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred hCCCCCCCccCH---HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 444555544443 3466788888888888754 35778888888888888888653 3888888888888888887
Q ss_pred ccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCC
Q 047901 88 GTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNC 167 (786)
Q Consensus 88 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l 167 (786)
+++ .+..+++|+.|++++|.+++..+ ......+..+....|.+....+.................. ...+...
T Consensus 102 ~i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 174 (384)
T d2omza2 102 DIT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD----LKPLANL 174 (384)
T ss_dssp CCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC----CGGGTTC
T ss_pred ccc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch----hhhhccc
Confidence 654 47788888888888888876543 4455677777777777664333222222222222221111 1223444
Q ss_pred CCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEe
Q 047901 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247 (786)
Q Consensus 168 ~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 247 (786)
..........|... ....+..+++++.+++++|.++++.+ +...++|++|++++|.+++. +.+..+++|+.|++
T Consensus 175 ~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l 248 (384)
T d2omza2 175 TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDL 248 (384)
T ss_dssp TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred cccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhcc
Confidence 55556666666554 34567788999999999999987755 56678999999999999853 46888999999999
Q ss_pred ecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCC
Q 047901 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE 327 (786)
Q Consensus 248 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 327 (786)
++|.+++.. .+..+++|+.|++++|++++.. .+..++.++.++++.|.+.++. .+..+++++.|++++|++++.
T Consensus 249 ~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~--~~~~~~~l~~L~ls~n~l~~l 322 (384)
T d2omza2 249 ANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDIS--PISNLKNLTYLTLYFNNISDI 322 (384)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG--GGGGCTTCSEEECCSSCCSCC
T ss_pred ccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccccc--ccchhcccCeEECCCCCCCCC
Confidence 999998654 3788899999999999998654 3778899999999999998743 578889999999999999876
Q ss_pred cchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCC
Q 047901 328 IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYN 394 (786)
Q Consensus 328 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 394 (786)
.+ +..+++|+.|++++|+|++ ++ .+.++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 323 ~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 323 SP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred cc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 43 8889999999999999984 44 68999999999999999998765 889999999999998
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3.7e-30 Score=278.43 Aligned_cols=340 Identities=24% Similarity=0.310 Sum_probs=271.8
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeC
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDL 81 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 81 (786)
+|++|+++++++. .++. +..+++|++|||++|+|+++.+ |.++++|++|+|++|+|+++. .++.+++|+.|++
T Consensus 45 ~l~~L~l~~~~I~-~l~g--l~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~ 117 (384)
T d2omza2 45 QVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL 117 (384)
T ss_dssp TCCEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred CCCEEECCCCCCC-Cccc--cccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--ccccccccccccc
Confidence 6899999999997 5653 7789999999999999987654 999999999999999998654 4899999999999
Q ss_pred CCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCC
Q 047901 82 SLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSI 161 (786)
Q Consensus 82 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~ 161 (786)
++|.+++... ......+..+....|.+....................... ...+.............|... ..
T Consensus 118 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~ 190 (384)
T d2omza2 118 FNNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS-DI 190 (384)
T ss_dssp CSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC-CC
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccch-----hhhhccccccccccccccccc-cc
Confidence 9999986544 3456788899999999886655444433333333332222 233444444555555555443 23
Q ss_pred CCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcc
Q 047901 162 PNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ 241 (786)
Q Consensus 162 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 241 (786)
.....++++..+.+++|.++++.+ +...++|++|++++|+++.+ ..+..+++|+.|++++|.+++.. .+..+++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~ 264 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTK 264 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTT
T ss_pred cccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--ccccccc
Confidence 346778899999999999998754 56678999999999999864 46888999999999999998653 4788899
Q ss_pred ccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecc
Q 047901 242 LHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSH 321 (786)
Q Consensus 242 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 321 (786)
|+.|++++|++++.. .+..++.++.+.+++|+++++ ..+..+++++.|++++|+++++. .+..+++|++|++++
T Consensus 265 L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~ 338 (384)
T d2omza2 265 LTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN 338 (384)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred CCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCC
Confidence 999999999998553 477888999999999999864 35788999999999999999875 488899999999999
Q ss_pred cccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccc
Q 047901 322 NQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNN 371 (786)
Q Consensus 322 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (786)
|+|++. + .|..+++|++|+|++|+|++..| +.++++|+.|+|++|.
T Consensus 339 n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 339 NKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp SCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred CCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 999853 3 58999999999999999996544 8899999999999983
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=6.7e-30 Score=268.14 Aligned_cols=246 Identities=30% Similarity=0.463 Sum_probs=166.7
Q ss_pred CCcEEECCCCCccc--cCchhccCCCCCCEEeCcC-CcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCCcEE
Q 047901 27 HLAYLDLSINGFFG--TLPPQVRNLSKLKYLDLSE-NELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNLKYI 102 (786)
Q Consensus 27 ~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L 102 (786)
+++.|||++|.+.+ .+|..+.+|++|++|+|++ |++++.+|.+|+.+++|++|+|++|++.+..+. +..+.+|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 56777777777765 3566777777777777765 677766777777777777777777777765554 6667777777
Q ss_pred EccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCcc-ceeecccccccCCCCC-cCCCCCCcEEEccCccc
Q 047901 103 SLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLL-EILTVNDNHFLGSIPN-LRNCRSLVRAHLGRNNL 180 (786)
Q Consensus 103 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L-~~L~l~~N~l~~~~~~-l~~l~~L~~L~L~~N~l 180 (786)
++++|++....|..|.++++|+++++++|.+++.+|..+..+..+ +.++++.|++++..+. +.++ .+..+++.+|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l-~~~~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC-CCSEEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccc-cccccccccccc
Confidence 777777777777777777777777777777777777766666554 5666666666654443 3333 333566666666
Q ss_pred ccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCc
Q 047901 181 TGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMEL 260 (786)
Q Consensus 181 ~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 260 (786)
.+..+..+..+++|+.|++++|.+.+.++ .+..+++|+.|+|++|++++.+|..|.++++|++|+|++|+|+|.+|. +
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~ 287 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c
Confidence 66666666677777777777777765443 466666777777777777766677777777777777777777766653 4
Q ss_pred ccccccccccccccc
Q 047901 261 GRLISLNKLILRGNQ 275 (786)
Q Consensus 261 ~~l~~L~~L~L~~N~ 275 (786)
.++++|+.+++++|+
T Consensus 288 ~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNK 302 (313)
T ss_dssp TTGGGSCGGGTCSSS
T ss_pred ccCCCCCHHHhCCCc
Confidence 566666667676665
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=4.6e-28 Score=253.02 Aligned_cols=287 Identities=20% Similarity=0.200 Sum_probs=210.7
Q ss_pred EEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 4 NSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 4 ~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
+.+|=++.++. ++|.. + .+++++|||++|+|+.+.+.+|.++++|++|++++|+++.+.|.+|..+++|++|++++
T Consensus 13 ~~~~C~~~~L~-~lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TEEECTTSCCC-SCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCC-ccCCC-C--CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 45666777776 67763 3 26799999999999888888899999999999999999988899999999999999999
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccccccc--ccCChhhhccCccceeecccccccCCC
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFT--GQLPRNICRSGLLEILTVNDNHFLGSI 161 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~~~~L~~L~l~~N~l~~~~ 161 (786)
|+|+.++..+ ...|+.|++.+|.+..+.+..|.....++.++...|... ...+..+..++.|+.+++++|.+...+
T Consensus 89 n~l~~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~ 166 (305)
T d1xkua_ 89 NQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166 (305)
T ss_dssp SCCSBCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCC
T ss_pred CccCcCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccC
Confidence 9998876653 368899999999999888888988888999998888544 344556777777888888887776554
Q ss_pred CCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCcc
Q 047901 162 PNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQ 241 (786)
Q Consensus 162 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 241 (786)
..+ +++|+.|++++|.++...+..|..++.+++|++++|.+.++.+..|.++++|++|+|++|+|+. +|..|..+++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~ 243 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKY 243 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSS
T ss_pred ccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccC
Confidence 433 4667777777777777777777777777777777777777777777777777777777777763 4556677777
Q ss_pred ccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccc--ccchhhhhcccCCcEE
Q 047901 242 LHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN--NSILEALGFMFKLFYL 317 (786)
Q Consensus 242 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L 317 (786)
|++|+|++|+|+.+....|.. +..+..+.+|+.|+|++|+++ .+.+..|..+.....+
T Consensus 244 L~~L~Ls~N~i~~i~~~~f~~------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~ 303 (305)
T d1xkua_ 244 IQVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303 (305)
T ss_dssp CCEEECCSSCCCCCCTTSSSC------------------SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred CCEEECCCCccCccChhhccC------------------cchhcccCCCCEEECCCCcCccCcCCHhHhcccccCccc
Confidence 777777777776544444332 122334556667777777654 3556666655444433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=6.5e-29 Score=260.53 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=160.1
Q ss_pred CCcEEEccCcccccc--cCcccCCCCCCCEEeccC-CccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEE
Q 047901 169 SLVRAHLGRNNLTGN--ISEDFGIYPNLKFLDLSH-NNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245 (786)
Q Consensus 169 ~L~~L~L~~N~l~~~--~~~~f~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 245 (786)
.++.|+|++|.+++. .|..++.+++|++|+|++ |++++.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 355555555555542 345666666666666664 56665566666666666666666666666666666666666666
Q ss_pred EeecccccccCCCCcccccccccccccccccCCCCccccccCCcC-ceeccccccccccchhhhhcccCCcEEEeccccc
Q 047901 246 DLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTEL-EYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQF 324 (786)
Q Consensus 246 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 324 (786)
++++|.+.+.+|..+.+++.|+.+++++|.+.+..|..+..+.++ +.+++++|++++..+..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 666666666666666666666666666666666666666555554 566666666666666666555433 566666666
Q ss_pred CCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCcccccCCCceEEeccCCcccccCCCCC
Q 047901 325 SQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDISYNELRGPIPNST 404 (786)
Q Consensus 325 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 404 (786)
.+..|..+..+++|+.+++++|.+++.+ ..+..+++|+.|+|++|++++.+|..|.++++|+.|||++|+|+|.+|...
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 6666666666666777777777666443 345666667777777777766666666667777777777777766666655
Q ss_pred ccccCCCccccCCCCCCCCC
Q 047901 405 VFRNAPRESFLGNNFSTFYG 424 (786)
Q Consensus 405 ~~~~~~~~~~~~n~~~~~~~ 424 (786)
.+.......+.+|++ +||
T Consensus 289 ~L~~L~~l~l~~N~~--l~g 306 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKC--LCG 306 (313)
T ss_dssp TGGGSCGGGTCSSSE--EES
T ss_pred cCCCCCHHHhCCCcc--ccC
Confidence 555666666666664 555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.7e-27 Score=248.61 Aligned_cols=278 Identities=23% Similarity=0.255 Sum_probs=152.0
Q ss_pred CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC-CCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccc
Q 047901 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP-PICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLD 129 (786)
Q Consensus 51 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 129 (786)
.+++++-++++++. +|..+. +++++|+|++|+|+.+++ .|.++++|++|++++|++..+.|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCc-cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 46778888888874 455543 578888888888887776 47778888888888888887777778888888888888
Q ss_pred cccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc--c
Q 047901 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG--E 207 (786)
Q Consensus 130 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~--~ 207 (786)
+|+++. +|..+ ...+..|.+.+|.+..+.+..|.....+..++...|.... .
T Consensus 88 ~n~l~~-l~~~~-------------------------~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~ 141 (305)
T d1xkua_ 88 KNQLKE-LPEKM-------------------------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141 (305)
T ss_dssp SSCCSB-CCSSC-------------------------CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB
T ss_pred CCccCc-Cccch-------------------------hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC
Confidence 887763 22211 1345555555566655555555556666666666554331 2
Q ss_pred cCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccC
Q 047901 208 ISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLL 287 (786)
Q Consensus 208 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 287 (786)
.+..|..+++|+.+++++|+++.+ |..+ .++|+.|++++|.+. ...+..|.++
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~------------------------~~~~~~~~~~ 194 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKIT------------------------KVDAASLKGL 194 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCC------------------------EECTGGGTTC
T ss_pred CccccccccccCccccccCCcccc-Cccc--CCccCEEECCCCcCC------------------------CCChhHhhcc
Confidence 233344444444444444444421 2111 233444444444333 3333344444
Q ss_pred CcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcc------cccccc
Q 047901 288 TELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSR------ICNLES 361 (786)
Q Consensus 288 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~l~~ 361 (786)
+.++.|++++|.+..+.+..|..+++|++|+|++|+|+. +|.+|..+++|+.|+|++|+|+...... +..+.+
T Consensus 195 ~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~ 273 (305)
T d1xkua_ 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 273 (305)
T ss_dssp TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCC
T ss_pred ccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCC
Confidence 444444444444444444444444444444444444442 2344455555555555555555332222 233456
Q ss_pred cceecccccccc--ccCCcccccCCC
Q 047901 362 LEKLNLSHNNIS--GQIPACFIGMSG 385 (786)
Q Consensus 362 L~~L~L~~N~l~--~~~p~~~~~l~~ 385 (786)
|+.|+|++|+++ .+.|.+|.-+..
T Consensus 274 L~~L~L~~N~~~~~~~~~~~f~~~~~ 299 (305)
T d1xkua_ 274 YSGVSLFSNPVQYWEIQPSTFRCVYV 299 (305)
T ss_dssp CSEEECCSSSSCGGGSCGGGGTTCCC
T ss_pred CCEEECCCCcCccCcCCHhHhccccc
Confidence 666666666654 344555544433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-27 Score=245.59 Aligned_cols=255 Identities=21% Similarity=0.187 Sum_probs=146.8
Q ss_pred EEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccc
Q 047901 78 SLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHF 157 (786)
Q Consensus 78 ~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l 157 (786)
.++.++++++.+|..+. +++++|+|++|+|+.+++..|.++++|++|++++|++....+..+.....++.+...
T Consensus 15 ~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~---- 88 (284)
T d1ozna_ 15 TTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS---- 88 (284)
T ss_dssp EEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----
T ss_pred EEEcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc----
Confidence 34555555655544432 456677777777766666667777777777777777665554444443333333322
Q ss_pred cCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCcccc
Q 047901 158 LGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIG 237 (786)
Q Consensus 158 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 237 (786)
..|.++.+.+..|.++++|++|++++|.+..+.+..+....+|+.+++++|+|+++.+..|.
T Consensus 89 ------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~ 150 (284)
T d1ozna_ 89 ------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150 (284)
T ss_dssp ------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred ------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc
Confidence 22334444455566666666666666666655555566666666666666666655555566
Q ss_pred CCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEE
Q 047901 238 NSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYL 317 (786)
Q Consensus 238 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 317 (786)
.+++|+.|++++|+++++.+.+|.++++|+.+++++|+++++.|..|.++++|+.|++++|++..+++..|..+++|++|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 66666666666666665556666666666666666666666666666666666666666666666666666666666666
Q ss_pred EecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccc
Q 047901 318 NFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRIC 357 (786)
Q Consensus 318 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 357 (786)
+|++|.+...-+. ..-...++.+....+++....|..+.
T Consensus 231 ~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 231 RLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp ECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred EecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHc
Confidence 6666666543221 11122344455555555544454443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.3e-27 Score=243.58 Aligned_cols=222 Identities=20% Similarity=0.161 Sum_probs=130.3
Q ss_pred ecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEcc-CcccC
Q 047901 151 TVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVS-GNNIT 229 (786)
Q Consensus 151 ~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~N~l~ 229 (786)
+++++.++.+|..+. ++++.|+|++|+|+.+.+..|.++++|++|++++|++..+.+..+..+..++.++.. .|.++
T Consensus 17 ~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 17 SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp ECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred EcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 344444444433333 345566666666666655566666666666666666666666666666666665543 44455
Q ss_pred CCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhh
Q 047901 230 GRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALG 309 (786)
Q Consensus 230 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 309 (786)
.+.+..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|+++.+++..|.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~ 174 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc
Confidence 55555566666666666666666555555555556666666666666655555566666666666666666666566666
Q ss_pred cccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccc
Q 047901 310 FMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISG 374 (786)
Q Consensus 310 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (786)
.+++|+++++++|+++++.|..|..+++|+.|++++|++++..+..|.++++|+.|++++|++.+
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 66666666666666665555566666666666666666665555555566666666666666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.7e-24 Score=219.01 Aligned_cols=200 Identities=19% Similarity=0.170 Sum_probs=96.2
Q ss_pred CCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeec
Q 047901 73 LTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTV 152 (786)
Q Consensus 73 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l 152 (786)
...+.+.+.+++.++.+|+.+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+... .+..+++|+.|+|
T Consensus 9 ~~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDL 84 (266)
T ss_dssp STTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEEC
T ss_pred cCCCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccc
Confidence 3344445555555554444332 35556666666665555555666666666666666655221 1222333333333
Q ss_pred ccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCC
Q 047901 153 NDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRI 232 (786)
Q Consensus 153 ~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 232 (786)
++|+++..+. .|..+++|++|++++|.+.++.+..+..+.++++|++++|.++.+.
T Consensus 85 s~N~l~~~~~------------------------~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~ 140 (266)
T d1p9ag_ 85 SHNQLQSLPL------------------------LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140 (266)
T ss_dssp CSSCCSSCCC------------------------CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred cccccccccc------------------------ccccccccccccccccccceeeccccccccccccccccccccceec
Confidence 3333333222 3344444444444444444444444444444444444444444444
Q ss_pred CccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCceecccccccc
Q 047901 233 PPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLN 301 (786)
Q Consensus 233 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 301 (786)
+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+. +|..+..+++|+.|+|++|++.
T Consensus 141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~-lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccccchhcccccccccccCccccccccccceeecccCCCcc-cChhHCCCCCCCEEEecCCCCC
Confidence 4444444555555555555554444445555555555555555542 2333334555566666666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-24 Score=221.69 Aligned_cols=199 Identities=26% Similarity=0.191 Sum_probs=117.1
Q ss_pred CCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEe
Q 047901 168 RSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDL 247 (786)
Q Consensus 168 ~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 247 (786)
..+.++++++++|+.+++ .+. +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+ | .+..+++|+.|+|
T Consensus 10 ~~~~~v~C~~~~L~~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLTALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCSSCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCCeeCc-CcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccc
Confidence 344455555555554432 221 3556666666666655555566666666666666666533 1 2345566666666
Q ss_pred ecccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCC
Q 047901 248 SSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQE 327 (786)
Q Consensus 248 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 327 (786)
++|+++ ..+..+.++++|+.|++++|.+..+.+..+..+.+++.|++++|.+..+++..+..+++|+.|++++|++++.
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 666665 3344555566666666666666655555666666666666666666666666666666666666666666655
Q ss_pred cchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccccccc
Q 047901 328 IPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNIS 373 (786)
Q Consensus 328 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (786)
.+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 5556666666666666666666 45555555666666666666654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=1e-20 Score=200.71 Aligned_cols=313 Identities=24% Similarity=0.274 Sum_probs=190.5
Q ss_pred CCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccC
Q 047901 27 HLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHN 106 (786)
Q Consensus 27 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~ 106 (786)
++++|||++|.++. +|+. +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++.+.. + .+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCS
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhh-h--ccccccccccc
Confidence 46777777777754 3432 456777777777777 34543 3567777777777765432 1 13577777777
Q ss_pred CcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCc
Q 047901 107 NKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISE 186 (786)
Q Consensus 107 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 186 (786)
|++..++ .++.+++|++|++++|.++. .+.. ...+..+.+..+.... ...+..++.++.+++.+|.+..+..
T Consensus 108 n~l~~lp--~~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~~-~~~l~~l~~l~~L~l~~n~~~~~~~- 179 (353)
T d1jl5a_ 108 NQLEKLP--ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLKKLPD- 179 (353)
T ss_dssp SCCSSCC--CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSSCCC-
T ss_pred ccccccc--chhhhccceeeccccccccc-cccc---cccccchhhccccccc-cccccccccceeccccccccccccc-
Confidence 7777543 25667777777777777663 2222 2344555555544432 2345667777788888887765432
Q ss_pred ccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccccc
Q 047901 187 DFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISL 266 (786)
Q Consensus 187 ~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 266 (786)
.....+.+..+++.+..+ ..+..++.|+.+++++|.... .+. ...++..+.+.+|.+.. .+... ..+
T Consensus 180 ---~~~~~~~l~~~~~~~~~~--~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~-~~~~~---~~l 246 (353)
T d1jl5a_ 180 ---LPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPELP---QSL 246 (353)
T ss_dssp ---CCTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCCC---TTC
T ss_pred ---cccccccccccccccccc--ccccccccccccccccccccc-ccc---ccccccccccccccccc-ccccc---ccc
Confidence 223456677776666533 235667788888888887763 232 34567777888877763 22222 244
Q ss_pred ccccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCC
Q 047901 267 NKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHN 346 (786)
Q Consensus 267 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 346 (786)
...++..|.+.++. .-.......++..|.+..+. ..+++|++|+|++|+|+. +|. .+++|+.|+|++|
T Consensus 247 ~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~~----~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N 314 (353)
T d1jl5a_ 247 TFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFN 314 (353)
T ss_dssp CEEECCSSCCSEES----CCCTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred cccccccccccccc----cccchhcccccccCcccccc----ccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCC
Confidence 44555554443211 11123445666666665542 335678888888888874 443 3578888899999
Q ss_pred ccCCCCCcccccccccceeccccccccccCCcccccCCCceEEec
Q 047901 347 LFKGSIPSRICNLESLEKLNLSHNNISGQIPACFIGMSGLLSIDI 391 (786)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 391 (786)
+|+ .+|.. +.+|+.|++++|+|+. +|... .+|+.|.+
T Consensus 315 ~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~~---~~L~~L~~ 351 (353)
T d1jl5a_ 315 HLA-EVPEL---PQNLKQLHVEYNPLRE-FPDIP---ESVEDLRM 351 (353)
T ss_dssp CCS-CCCCC---CTTCCEEECCSSCCSS-CCCCC---TTCCEEEC
T ss_pred cCC-ccccc---cCCCCEEECcCCcCCC-CCccc---cccCeeEC
Confidence 888 45543 4578888999998874 45533 34555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.5e-23 Score=201.80 Aligned_cols=173 Identities=18% Similarity=0.176 Sum_probs=122.4
Q ss_pred CccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCC--------------chhhHHHHHHHHHHHhhcCCCcccceee
Q 047901 508 FDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPND--------------QMSDQKEFLNEIKALTKIRHRNIVKFYG 573 (786)
Q Consensus 508 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~~~~~e~~~l~~l~hpniv~l~~ 573 (786)
+.++++||+|+||+||+|+..+|+.||||+++...... .......+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34678999999999999998889999999876422110 0111234567888999999999998877
Q ss_pred EEecCCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCceeeCCCCcEEE
Q 047901 574 FCSHVRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDCFPPIVHRDISSNNVLLDLEYEARV 653 (786)
Q Consensus 574 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 653 (786)
+.. .++||||++++.+.+ ++...+..++.|++.++.|||++ +|+||||||+|||++++ .++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 632 379999998865432 23334567999999999999999 99999999999999854 5899
Q ss_pred eccccceecCCCCCcceeeccCccccCCCCCCCCchHHHHhhhcCcCcccchHHHHHH
Q 047901 654 SDFGTAKLLKPNSSNWTELVGTFGYVAPAHGNIGLHLAELAYTMKITEKCDVYSFGVL 711 (786)
Q Consensus 654 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~e~~~~~~~~~~sDvwslGvi 711 (786)
+|||.|+...++... .|.... -..+.+ .....|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~--------~~l~rd----~~~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR--------EILERD----VRNIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH--------HHHHHH----HHHHHH-HHHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH--------HHHHHH----HHHHHH-HHcCCCCCcccHHHHHHH
Confidence 999999876543211 111100 000112 234668889999998543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=1.6e-20 Score=199.16 Aligned_cols=298 Identities=28% Similarity=0.340 Sum_probs=138.4
Q ss_pred CCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhccc-CCcceeccc
Q 047901 51 KLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNL-MKLSYLMLD 129 (786)
Q Consensus 51 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~ 129 (786)
++++|||++|.|+. +|+ .+++|++|+|++|+|+.++.. +.+|+.|++++|+++.+. .+ ++|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~-----~lp~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALS-----DLPPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCC-----SCCTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCC---CCCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhh-----hhcccccccccc
Confidence 45566666666652 343 234556666666666544432 235556666666655332 12 235666666
Q ss_pred cccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccC
Q 047901 130 TNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEIS 209 (786)
Q Consensus 130 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~ 209 (786)
+|+++. +|. +..++.|+.|++++|.+...+... ..+..+.+..+.... ...+..++.++.|++++|.+.....
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~~ 179 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD 179 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCCC
T ss_pred cccccc-ccc-hhhhccceeecccccccccccccc---ccccchhhccccccc--cccccccccceeccccccccccccc
Confidence 666552 332 345555666666655554433322 233444444444332 2344555556666666655543221
Q ss_pred cCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCc
Q 047901 210 SNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTE 289 (786)
Q Consensus 210 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 289 (786)
.....+.+..+++.+.. . ..+..++.|+.+++++|.... .+.. ..++..+.+.+|.+... + .....
T Consensus 180 ----~~~~~~~l~~~~~~~~~-~-~~~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~-~---~~~~~ 245 (353)
T d1jl5a_ 180 ----LPLSLESIVAGNNILEE-L-PELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL-P---ELPQS 245 (353)
T ss_dssp ----CCTTCCEEECCSSCCSS-C-CCCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC-C---CCCTT
T ss_pred ----ccccccccccccccccc-c-ccccccccccccccccccccc-cccc---ccccccccccccccccc-c---ccccc
Confidence 11223444554444442 2 223455556666666655442 2222 22344455555555421 1 11233
Q ss_pred CceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecccc
Q 047901 290 LEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSH 369 (786)
Q Consensus 290 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 369 (786)
+...++..|.+..+.. ........++..|.+.+.. ..+++|++|+|++|+|+ .+|.. +++|+.|+|++
T Consensus 246 l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~~----~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~ 313 (353)
T d1jl5a_ 246 LTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASF 313 (353)
T ss_dssp CCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred cccccccccccccccc----ccchhcccccccCcccccc----ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCC
Confidence 4444444444332211 0122334445555544221 22345566666666655 33332 34555566666
Q ss_pred ccccccCCcccccCCCceEEeccCCccc
Q 047901 370 NNISGQIPACFIGMSGLLSIDISYNELR 397 (786)
Q Consensus 370 N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 397 (786)
|+|+. +|.. +.+|+.|++++|+|+
T Consensus 314 N~L~~-l~~~---~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 314 NHLAE-VPEL---PQNLKQLHVEYNPLR 337 (353)
T ss_dssp SCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred CcCCc-cccc---cCCCCEEECcCCcCC
Confidence 66553 2321 345556666666655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-20 Score=189.57 Aligned_cols=218 Identities=14% Similarity=0.061 Sum_probs=110.4
Q ss_pred ceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCcccc-ccCcCccCCCCccEEEcc-C
Q 047901 148 EILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG-EISSNWGKCHRLGTLIVS-G 225 (786)
Q Consensus 148 ~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~-~ 225 (786)
+.++++++.++.+|+.+. ++++.|++++|+|+.+.+.+|.++++|++|+|++|.+.. +.+.+|.++++++++++. .
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 344555555554444443 356666666666666666666666666666666666554 334456666666666554 3
Q ss_pred cccCCCCCccccCCccccEEEeecccccccCCC-CcccccccccccccccccCCCCccccccCC-cCceecccccccccc
Q 047901 226 NNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPM-ELGRLISLNKLILRGNQLSGHLPRALGLLT-ELEYFDLSSNRLNNS 303 (786)
Q Consensus 226 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~ 303 (786)
|++....+..|.++++|+.|++++|.+....+. .+..+..+..+...++.+..+.+..|.+++ .++.|++++|+++.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 455555555566666666666666666533222 123334444444455555544444454443 455555555555554
Q ss_pred chhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCccCCCCCcccccccccceecc
Q 047901 304 ILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNL 367 (786)
Q Consensus 304 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 367 (786)
....|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+...+..|.++++|+.|++
T Consensus 169 ~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4444433222222334444444333334444444444444444444333334444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.4e-20 Score=188.57 Aligned_cols=220 Identities=15% Similarity=0.084 Sum_probs=147.7
Q ss_pred cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCC--CCCCCCCCcEEEccC
Q 047901 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFP--PICNLSNLKYISLHN 106 (786)
Q Consensus 29 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~ 106 (786)
+.++.++++++.+++ .+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+....+ .|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~~iP~-~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVTEIPS-DLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCSSCCS-CSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCCCcCC-CCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 567777777764433 332 467888888888877666778888888888888887765432 366777777777653
Q ss_pred -CcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccC
Q 047901 107 -NKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS 185 (786)
Q Consensus 107 -N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 185 (786)
|++....+..|.++++|++|++++|+++...+.. .+..++.+..+...++++..+.+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~----------------------~~~~l~~l~~~~~~n~~l~~i~~ 145 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH----------------------KIHSLQKVLLDIQDNINIHTIER 145 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT----------------------TTCBSSCEEEEEESCTTCCEECT
T ss_pred cccccccccccccccccccccccchhhhccccccc----------------------ccccccccccccccccccccccc
Confidence 6677677777777777777777777765322111 13334555555666667777766
Q ss_pred cccCCCC-CCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCccccc
Q 047901 186 EDFGIYP-NLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLI 264 (786)
Q Consensus 186 ~~f~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 264 (786)
..|.+++ .++.|++++|+++.+.+..|.....++.+++++|+|+.+.+..|.++++|++|+|++|+|+.+.+..|.+++
T Consensus 146 ~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 225 (242)
T d1xwdc1 146 NSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK 225 (242)
T ss_dssp TSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCC
T ss_pred cccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCc
Confidence 7776654 677788888888777666665544344445677777766566677777777777777777766666677777
Q ss_pred ccccccccc
Q 047901 265 SLNKLILRG 273 (786)
Q Consensus 265 ~L~~L~L~~ 273 (786)
+|+.|++.+
T Consensus 226 ~L~~l~~~~ 234 (242)
T d1xwdc1 226 KLRARSTYN 234 (242)
T ss_dssp EEESSSEES
T ss_pred ccccCcCCC
Confidence 777766643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=3.2e-20 Score=183.80 Aligned_cols=205 Identities=18% Similarity=0.225 Sum_probs=122.0
Q ss_pred CcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCC
Q 047901 28 LAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNN 107 (786)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N 107 (786)
+..++++.+++++.. .+..+.+|++|++++|.|+.+ ..+..+++|++|+|++|++++.. ++..+++|++|++++|
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA-PLKNLTKITELELSGN 95 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG-GGTTCCSCCEEECCSC
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc-cccccccccccccccc
Confidence 344566666665543 356667777777777777754 34777777777777777776543 3667777777777777
Q ss_pred cCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcc
Q 047901 108 KLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISED 187 (786)
Q Consensus 108 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 187 (786)
.++.+ ..|.++++|+.+++++|.... ...+.....++.+.++.+.+... ..+.++++|+.|++++|.++... .
T Consensus 96 ~~~~i--~~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~L~~L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 96 PLKNV--SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI-SPLAGLTNLQYLSIGNAQVSDLT--P 168 (227)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCCCG--G
T ss_pred ccccc--ccccccccccccccccccccc--cchhccccchhhhhchhhhhchh-hhhccccccccccccccccccch--h
Confidence 77644 346677777777777776653 22344445555555555554432 12444555555666555555332 2
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEee
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLS 248 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 248 (786)
|..+++|++|+|++|+++++. .|.++++|++|+|++|+|+++. .+.++++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 555566666666666655432 2555556666666666555432 25555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=3.9e-20 Score=183.23 Aligned_cols=167 Identities=26% Similarity=0.314 Sum_probs=82.5
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLN 267 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 267 (786)
+..+++|++|++++|+|+++.+ +..+++|+.+++++|.++.+ ..+.++++|+.+++++|.+.+. ..+...+.+.
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~ 132 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ 132 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred HhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--cccccccccccccccccccccc--chhccccchh
Confidence 3444444444444444443322 44444444444444444422 2344444555555544444322 2233344455
Q ss_pred cccccccccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeeccCCc
Q 047901 268 KLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDLSHNL 347 (786)
Q Consensus 268 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 347 (786)
.+.++++.+... ..+..+++|+.|++++|.+.... .+..+++|++|+|++|++++.. .|..+++|++|+|++|+
T Consensus 133 ~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 133 VLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSC
T ss_pred hhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCc
Confidence 555555554422 22444555555555555554332 2555566666666666665432 25666666666666666
Q ss_pred cCCCCCcccccccccceeccc
Q 047901 348 FKGSIPSRICNLESLEKLNLS 368 (786)
Q Consensus 348 l~~~~~~~~~~l~~L~~L~L~ 368 (786)
+++. + .+.++++|+.|+++
T Consensus 207 lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 207 ISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCBC-G-GGTTCTTCCEEEEE
T ss_pred CCCC-c-ccccCCCCCEEEee
Confidence 6633 2 25666666666665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2.1e-22 Score=222.04 Aligned_cols=110 Identities=17% Similarity=0.037 Sum_probs=50.2
Q ss_pred CcCceeccccccccccchhhh----hcccCCcEEEecccccCCCc----chHHh-hhcCcCeeeccCCccCCC----CCc
Q 047901 288 TELEYFDLSSNRLNNSILEAL----GFMFKLFYLNFSHNQFSQEI----PEDLA-LLAHLSELDLSHNLFKGS----IPS 354 (786)
Q Consensus 288 ~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~~----~~~ 354 (786)
..|+.+++++|.+.......+ ...++|++|+|++|+++... +..+. ..+.|++|+|++|+|+.. ++.
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 345555555555544333222 22345556666665554211 11111 233455666666655421 223
Q ss_pred ccccccccceeccccccccccCCcc----cc-cCCCceEEeccCCccc
Q 047901 355 RICNLESLEKLNLSHNNISGQIPAC----FI-GMSGLLSIDISYNELR 397 (786)
Q Consensus 355 ~~~~l~~L~~L~L~~N~l~~~~p~~----~~-~l~~L~~L~l~~N~l~ 397 (786)
.+..+++|++|+|++|+|+..-... +. ....|+.|++.+|++.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 3344455666666666554321111 11 1224556666665554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.2e-22 Score=221.90 Aligned_cols=388 Identities=19% Similarity=0.133 Sum_probs=244.6
Q ss_pred CeEEEEcCCCCCcccCCcCccCCCCCCcEEECCCCCccc----cCchhccCCCCCCEEeCcCCcccccC----Ccccc-C
Q 047901 2 RVNSINLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFG----TLPPQVRNLSKLKYLDLSENELSGKI----PPEIG-L 72 (786)
Q Consensus 2 ~~~~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~ 72 (786)
+|++||++++++.+.-=..-+..+++++.|+|++|+|+. .+..++..+++|++|||++|+|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 478888888888643112245567888888888888763 23455678888888888888876321 12222 2
Q ss_pred CCCCCEEeCCCccCccc-----CCCCCCCCCCcEEEccCCcCcccCchhhc-----ccCCcceecccccccccc----CC
Q 047901 73 LTHLFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKLSGSIPEEIG-----NLMKLSYLMLDTNQFTGQ----LP 138 (786)
Q Consensus 73 l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~ 138 (786)
..+|++|+|++|+++.. ...+..+++|++|+|++|+|.......+. .......+......+... ..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 34788888888888642 23466778888888888887643222221 111222333333322211 11
Q ss_pred hhhhccCccceeecccccccCCC-----CCc-CCCCCCcEEEccCccccccc----CcccCCCCCCCEEeccCCcccc--
Q 047901 139 RNICRSGLLEILTVNDNHFLGSI-----PNL-RNCRSLVRAHLGRNNLTGNI----SEDFGIYPNLKFLDLSHNNFYG-- 206 (786)
Q Consensus 139 ~~~~~~~~L~~L~l~~N~l~~~~-----~~l-~~l~~L~~L~L~~N~l~~~~----~~~f~~l~~L~~L~L~~N~i~~-- 206 (786)
..+.....++.+.++.+.+.... ..+ ..-.....+.+..+.+.... ...+...+.++.+++++|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 12334456777777766553210 001 11234556777777665321 1234557889999999998743
Q ss_pred ---ccCcCccCCCCccEEEccCcccCCCC----CccccCCccccEEEeecccccccCCCCc-----cccccccccccccc
Q 047901 207 ---EISSNWGKCHRLGTLIVSGNNITGRI----PPEIGNSSQLHVLDLSSNHIAGEIPMEL-----GRLISLNKLILRGN 274 (786)
Q Consensus 207 ---~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~i~~~~~~~~-----~~l~~L~~L~L~~N 274 (786)
.....+.....++.|++++|.+.... ...+...+.++.+++++|.+.......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 22334556778999999999886321 2234567889999999999864322222 23357899999999
Q ss_pred ccCCCCcc----ccccCCcCceeccccccccccchhhh-----hcccCCcEEEecccccCCC----cchHHhhhcCcCee
Q 047901 275 QLSGHLPR----ALGLLTELEYFDLSSNRLNNSILEAL-----GFMFKLFYLNFSHNQFSQE----IPEDLALLAHLSEL 341 (786)
Q Consensus 275 ~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L 341 (786)
.++..... .+...++|+.|+|++|++.......+ ...+.|++|+|++|+|+.. ++..+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 98754333 33456789999999999976433333 2456799999999999743 34456777999999
Q ss_pred eccCCccCCCCCccc----c-cccccceeccccccccccCCccc----ccCCCceEE
Q 047901 342 DLSHNLFKGSIPSRI----C-NLESLEKLNLSHNNISGQIPACF----IGMSGLLSI 389 (786)
Q Consensus 342 ~L~~N~l~~~~~~~~----~-~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L 389 (786)
+|++|+|+......+ . +...|+.|++.+|.+.......+ ...++|+.|
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 999999975322222 2 33479999999999976544433 345555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=1.6e-19 Score=173.47 Aligned_cols=127 Identities=23% Similarity=0.216 Sum_probs=64.0
Q ss_pred cEEEccCcccccccCcccCCCCCCCEEeccCCcccc-ccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeec
Q 047901 171 VRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYG-EISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSS 249 (786)
Q Consensus 171 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 249 (786)
+.+++++|+++.++.+.+ +++++|+|++|+|++ +.+..|.++++|+.|+|++|++..+.+..|..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 355666666665543221 455566666666543 3344455555555555555555555555555555555555555
Q ss_pred ccccccCCCCcccccccccccccccccCCCCccccccCCcCceeccccccc
Q 047901 250 NHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRL 300 (786)
Q Consensus 250 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 300 (786)
|+|+++.+.+|.++++|++|+|++|+|+++.+++|..+++|+.|+|++|.+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 555544444444444444444444444444444444444444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=3.9e-19 Score=173.33 Aligned_cols=182 Identities=23% Similarity=0.287 Sum_probs=104.0
Q ss_pred EEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcC
Q 047901 30 YLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKL 109 (786)
Q Consensus 30 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l 109 (786)
..++..+.+++..+. ..+.+|++|++++|+|+.+. .+..+++|++|+|++|+|++++ .+..+++|++|++++|+|
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccc
Confidence 345555665544332 24556777777777776432 3666777777777777776543 355667777777777777
Q ss_pred cccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccC
Q 047901 110 SGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFG 189 (786)
Q Consensus 110 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~ 189 (786)
+++. .+.++++|+.|++++|.+.. .. .+.++++++.+++++|.++.. ..+.
T Consensus 103 ~~l~--~l~~l~~L~~L~l~~~~~~~--~~-----------------------~l~~l~~l~~l~~~~n~l~~~--~~~~ 153 (210)
T d1h6ta2 103 KDLS--SLKDLKKLKSLSLEHNGISD--IN-----------------------GLVHLPQLESLYLGNNKITDI--TVLS 153 (210)
T ss_dssp CCGG--GGTTCTTCCEEECTTSCCCC--CG-----------------------GGGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred cccc--cccccccccccccccccccc--cc-----------------------ccccccccccccccccccccc--cccc
Confidence 6442 36666666666666666542 11 233344455555555554432 2344
Q ss_pred CCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeec
Q 047901 190 IYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSS 249 (786)
Q Consensus 190 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 249 (786)
.+++|+++++++|+++++.+ +.++++|++|+|++|+|+++ + .+.++++|+.|+|++
T Consensus 154 ~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccccc--ccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence 55666666666666654432 55566666666666666543 2 456666666666653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=9.3e-20 Score=175.15 Aligned_cols=129 Identities=17% Similarity=0.192 Sum_probs=82.4
Q ss_pred CEEeccCCccccccCcCccCCCCccEEEccCcccCC-CCCccccCCccccEEEeecccccccCCCCcccccccccccccc
Q 047901 195 KFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITG-RIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRG 273 (786)
Q Consensus 195 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 273 (786)
+++++++|+++.++.+.+ +++++|+|++|+|+. +.+..|.++++|+.|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 467777777775543322 466677777777754 3345566666666666666666666666666666666666666
Q ss_pred cccCCCCccccccCCcCceeccccccccccchhhhhcccCCcEEEecccccCC
Q 047901 274 NQLSGHLPRALGLLTELEYFDLSSNRLNNSILEALGFMFKLFYLNFSHNQFSQ 326 (786)
Q Consensus 274 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 326 (786)
|+|+.+.+.+|.++++|+.|+|++|+|+.++++.|..+++|++|+|++|.+..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 66666666666666666666666666666666666666666666666666553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=4.2e-19 Score=173.04 Aligned_cols=180 Identities=20% Similarity=0.199 Sum_probs=132.3
Q ss_pred EcCCCCCcccCCcCccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccC
Q 047901 7 NLTSTGLKGTLQEFSFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQF 86 (786)
Q Consensus 7 ~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 86 (786)
+++.+.+.+.+.. ..+.+|++|++++|.++.+. .+..+++|++|+|++|+|+++. .++.+++|++|++++|+|
T Consensus 30 ~l~~~~~~~~~~~---~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECH---HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCH---HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 3455555544443 24678999999999997654 3889999999999999999654 478999999999999999
Q ss_pred cccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCC
Q 047901 87 SGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRN 166 (786)
Q Consensus 87 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~ 166 (786)
++++ .+..+++|+.|++++|.+..+ ..+.++++|+.+++++|.++. +..+..+
T Consensus 103 ~~l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l---------------------- 155 (210)
T d1h6ta2 103 KDLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRL---------------------- 155 (210)
T ss_dssp CCGG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGC----------------------
T ss_pred cccc-ccccccccccccccccccccc--ccccccccccccccccccccc--ccccccc----------------------
Confidence 8765 588899999999999999854 468999999999999999873 2233344
Q ss_pred CCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEEccC
Q 047901 167 CRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSG 225 (786)
Q Consensus 167 l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 225 (786)
++|+.+++++|+++++. .|+.+++|++|+|++|+|+.+. .|.++++|+.|+|++
T Consensus 156 -~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 156 -TKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFS 209 (210)
T ss_dssp -TTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEE
T ss_pred -ccccccccccccccccc--cccCCCCCCEEECCCCCCCCCh--hhcCCCCCCEEEccC
Confidence 44555555555555432 2566666666666666666542 366666666666653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=7.8e-19 Score=169.63 Aligned_cols=179 Identities=22% Similarity=0.269 Sum_probs=102.8
Q ss_pred cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCc
Q 047901 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNK 108 (786)
Q Consensus 29 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~ 108 (786)
..++++.+.+++..+ ...+.++++|++++|.|+.+ +.++.+++|++|+|++|++++.++ +.++++|++|++++|.
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc-ccCCcccccccccccc
Confidence 344566666654433 23556677777777777643 246667777777777777765443 6667777777777777
Q ss_pred CcccCchhhcccCCcceeccccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCccc
Q 047901 109 LSGSIPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDF 188 (786)
Q Consensus 109 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f 188 (786)
+..+. .+.++++|+.|++++|.+... ..+ .++++|+.|++++|++..+ +.+
T Consensus 96 ~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~-----------------------~~l~~L~~L~l~~n~l~~~--~~l 146 (199)
T d2omxa2 96 IADIT--PLANLTNLTGLTLFNNQITDI--DPL-----------------------KNLTNLNRLELSSNTISDI--SAL 146 (199)
T ss_dssp CCCCG--GGTTCTTCSEEECCSSCCCCC--GGG-----------------------TTCTTCSEEECCSSCCCCC--GGG
T ss_pred ccccc--ccccccccccccccccccccc--ccc-----------------------chhhhhHHhhhhhhhhccc--ccc
Confidence 66442 366677777777776665521 223 3344444555555554432 235
Q ss_pred CCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEE
Q 047901 189 GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVL 245 (786)
Q Consensus 189 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 245 (786)
..+++|++|++++|+++++. .++++++|++|++++|+|+++ +.+.++++|+.|
T Consensus 147 ~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 147 SGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp TTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccccccccccccccccCCc--cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 55556666666666555442 255566666666666666543 235555665554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.3e-18 Score=166.29 Aligned_cols=180 Identities=26% Similarity=0.307 Sum_probs=137.6
Q ss_pred CCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccc
Q 047901 52 LKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN 131 (786)
Q Consensus 52 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 131 (786)
+..+.++.+.+++..+ ...+.+|++|++++|.|+.+ +++..+++|++|+|++|+|+++.+ |.++++|++|++++|
T Consensus 20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 3345677777765433 34677888888888888754 456677888888888888876543 777888888888877
Q ss_pred cccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccCcccCCCCCCCEEeccCCccccccCcC
Q 047901 132 QFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNISEDFGIYPNLKFLDLSHNNFYGEISSN 211 (786)
Q Consensus 132 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~ 211 (786)
.+.. .+.+.+++.|+.|++++|.+..+ +.+..+++|+.|++++|++..+ ..
T Consensus 95 ~~~~-------------------------~~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~ 145 (199)
T d2omxa2 95 QIAD-------------------------ITPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SA 145 (199)
T ss_dssp CCCC-------------------------CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GG
T ss_pred cccc-------------------------ccccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--cc
Confidence 7652 12355667778888888877754 4588899999999999999864 35
Q ss_pred ccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccc
Q 047901 212 WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKL 269 (786)
Q Consensus 212 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 269 (786)
+..+++|+.|++++|+++++ ..+.++++|+.|++++|+|+++ ..++++++|++|
T Consensus 146 l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred ccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 88999999999999999965 3589999999999999999854 358888888875
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.9e-16 Score=145.24 Aligned_cols=128 Identities=21% Similarity=0.178 Sum_probs=94.2
Q ss_pred ccCCCCCCcEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCC-CCCCCCC
Q 047901 21 SFSSFPHLAYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPP-ICNLSNL 99 (786)
Q Consensus 21 ~f~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L 99 (786)
.|.+...+++|||++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|++|+|++|+|+.+++. +..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 366777888888888888655 55677788888888888888855 3478888888888888888877766 4568888
Q ss_pred cEEEccCCcCcccCc-hhhcccCCcceeccccccccccCC---hhhhccCccceee
Q 047901 100 KYISLHNNKLSGSIP-EEIGNLMKLSYLMLDTNQFTGQLP---RNICRSGLLEILT 151 (786)
Q Consensus 100 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~L~~L~ 151 (786)
++|+|++|+|+.+.. ..+..+++|++|++++|+++.... ..+..+++|+.|+
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888875533 467788888888888888763321 2455566666654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=1.2e-15 Score=133.88 Aligned_cols=102 Identities=27% Similarity=0.326 Sum_probs=75.6
Q ss_pred cEEECCCCCccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCc
Q 047901 29 AYLDLSINGFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNK 108 (786)
Q Consensus 29 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~ 108 (786)
++|||++|+|+.+. .+.++++|++|+|++|+|+. +|..|+.+++|++|++++|+|++++ ++..+++|++|++++|+
T Consensus 1 R~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSSCC--CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCCCc--ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccccC-ccccccccCeEECCCCc
Confidence 46788888886443 37777888888888888873 4566777888888888888887653 47777888888888888
Q ss_pred CcccCc-hhhcccCCcceecccccccc
Q 047901 109 LSGSIP-EEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 109 l~~~~~-~~~~~l~~L~~L~L~~N~l~ 134 (786)
|+.+.. ..+..+++|++|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 876543 56777888888888888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.3e-15 Score=140.80 Aligned_cols=110 Identities=20% Similarity=0.096 Sum_probs=53.3
Q ss_pred cCCCCCCCEEeccCCccccccCcCccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccc
Q 047901 188 FGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLN 267 (786)
Q Consensus 188 f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 267 (786)
|.+..+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|+.|++++|+|+.+.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 44555666666666666544 33445555555555555555533 2345555555555555555544333344444445
Q ss_pred cccccccccCCCCc-cccccCCcCceeccccccc
Q 047901 268 KLILRGNQLSGHLP-RALGLLTELEYFDLSSNRL 300 (786)
Q Consensus 268 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l 300 (786)
.|++++|+|+.... ..+..+++|+.|++++|++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cceeccccccccccccccccccccchhhcCCCcc
Confidence 55555544443211 2233344444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=4.4e-15 Score=130.27 Aligned_cols=102 Identities=23% Similarity=0.319 Sum_probs=76.9
Q ss_pred CEEeCcCCcccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecccccc
Q 047901 53 KYLDLSENELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTNQ 132 (786)
Q Consensus 53 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 132 (786)
|+|+|++|+|+.+ + .+..+++|++|++++|+|+++++.+..+++|++|++++|+|+++ + .|..+++|++|++++|+
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 6789999999844 3 48888999999999999988777788888999999999998865 3 48888888888888888
Q ss_pred ccccCC-hhhhccCccceeeccccccc
Q 047901 133 FTGQLP-RNICRSGLLEILTVNDNHFL 158 (786)
Q Consensus 133 l~~~~~-~~~~~~~~L~~L~l~~N~l~ 158 (786)
|+.... ..+..+++|+.|++++|.++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 874332 34555555555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.1e-15 Score=155.97 Aligned_cols=177 Identities=21% Similarity=0.207 Sum_probs=77.9
Q ss_pred CCCCEEeCCCccCccc--CCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceeccccc-ccccc-CChhhhccCccce
Q 047901 74 THLFSLDLSLNQFSGT--FPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLMLDTN-QFTGQ-LPRNICRSGLLEI 149 (786)
Q Consensus 74 ~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~~~~L~~ 149 (786)
.+|++|||+++.++.. ...+..+++|++|+|++|++++.....+..+++|++|+++++ .++.. +...+..+++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3444455544444321 111334444555555555444444444444445555555442 23211 0111122334444
Q ss_pred eecccc-cccC--CCCCc-CCCCCCcEEEccCc--ccccc-cCcccCCCCCCCEEeccCC-ccccccCcCccCCCCccEE
Q 047901 150 LTVNDN-HFLG--SIPNL-RNCRSLVRAHLGRN--NLTGN-ISEDFGIYPNLKFLDLSHN-NFYGEISSNWGKCHRLGTL 221 (786)
Q Consensus 150 L~l~~N-~l~~--~~~~l-~~l~~L~~L~L~~N--~l~~~-~~~~f~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L 221 (786)
|+++++ .++. ....+ ..+++|+.|+++++ .++.. ....+..+++|++|+|++| .+++.....+..+++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 444432 1111 00001 11245555555543 23221 1112234566666666664 3554445555566666666
Q ss_pred EccCc-ccCCCCCccccCCccccEEEeecc
Q 047901 222 IVSGN-NITGRIPPEIGNSSQLHVLDLSSN 250 (786)
Q Consensus 222 ~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N 250 (786)
+|++| .|++.....+..+++|+.|+++++
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66663 455444444555666666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=7.5e-16 Score=157.18 Aligned_cols=231 Identities=15% Similarity=0.187 Sum_probs=121.9
Q ss_pred CCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCccc-CchhhcccCCcceeccccccccccCChhhhccCccceeeccc
Q 047901 76 LFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGS-IPEEIGNLMKLSYLMLDTNQFTGQLPRNICRSGLLEILTVND 154 (786)
Q Consensus 76 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~ 154 (786)
+..+.++...+...........+|++|+|++|.++.. ....+.++++|++|+|++|.++...+..+..+++|+.|++++
T Consensus 25 ~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred ceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 4556666666554333444567999999999998743 345688999999999999998876677777777777777776
Q ss_pred c-cccCC-CCC-cCCCCCCcEEEccCc-cccccc-Cccc-CCCCCCCEEeccCCccccccCcCccCCCCccEEEccCccc
Q 047901 155 N-HFLGS-IPN-LRNCRSLVRAHLGRN-NLTGNI-SEDF-GIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLIVSGNNI 228 (786)
Q Consensus 155 N-~l~~~-~~~-l~~l~~L~~L~L~~N-~l~~~~-~~~f-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 228 (786)
+ .++.. ... ..++++|+.|+++++ +++... ...+ ...++|+.|+++++. +.+
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~----------------------~~i 162 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR----------------------KNL 162 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG----------------------GGS
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc----------------------ccc
Confidence 4 33310 011 233455555555543 232110 0111 112345555554321 112
Q ss_pred CCC-CCccccCCccccEEEeecc-cccccCCCCccccccccccccccc-ccCCCCccccccCCcCceeccccccccccch
Q 047901 229 TGR-IPPEIGNSSQLHVLDLSSN-HIAGEIPMELGRLISLNKLILRGN-QLSGHLPRALGLLTELEYFDLSSNRLNNSIL 305 (786)
Q Consensus 229 ~~~-~~~~~~~l~~L~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 305 (786)
++. +...+.++++|+.|++++| .+++.....+.++++|++|+|+++ .++......++.+++|+.|+++++ ++....
T Consensus 163 ~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l 241 (284)
T d2astb2 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTL 241 (284)
T ss_dssp CHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCH
T ss_pred ccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHH
Confidence 211 1111233455555555553 344444444555555666666553 344333344556666666666665 222111
Q ss_pred hh-hhcccCCcEEEecccccCCCcchHH
Q 047901 306 EA-LGFMFKLFYLNFSHNQFSQEIPEDL 332 (786)
Q Consensus 306 ~~-~~~l~~L~~L~L~~N~l~~~~~~~~ 332 (786)
.. ...+++| .+..+.++...++.+
T Consensus 242 ~~l~~~lp~L---~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 242 QLLKEALPHL---QINCSHFTTIARPTI 266 (284)
T ss_dssp HHHHHHSTTS---EESCCCSCCTTCSSC
T ss_pred HHHHHhCccc---cccCccCCCCCCCcc
Confidence 11 2234443 345566655444433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=3.7e-16 Score=164.62 Aligned_cols=134 Identities=20% Similarity=0.234 Sum_probs=81.7
Q ss_pred CccceeecccccccCC-----CCCcCCCCCCcEEEccCcccccc-----cCcccCCCCCCCEEeccCCccccc----cCc
Q 047901 145 GLLEILTVNDNHFLGS-----IPNLRNCRSLVRAHLGRNNLTGN-----ISEDFGIYPNLKFLDLSHNNFYGE----ISS 210 (786)
Q Consensus 145 ~~L~~L~l~~N~l~~~-----~~~l~~l~~L~~L~L~~N~l~~~-----~~~~f~~l~~L~~L~L~~N~i~~~----~~~ 210 (786)
..|+.+.+++|.+... ...+..++.|+.|+|++|+|+.. ....+...++|++|+|++|.++.. ...
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 3455555555554321 11134456677777777776532 234456677888888888877532 223
Q ss_pred CccCCCCccEEEccCcccCCCCCcc----cc--CCccccEEEeecccccccCC----CCc-ccccccccccccccccCC
Q 047901 211 NWGKCHRLGTLIVSGNNITGRIPPE----IG--NSSQLHVLDLSSNHIAGEIP----MEL-GRLISLNKLILRGNQLSG 278 (786)
Q Consensus 211 ~~~~l~~L~~L~L~~N~l~~~~~~~----~~--~l~~L~~L~Ls~N~i~~~~~----~~~-~~l~~L~~L~L~~N~l~~ 278 (786)
.+..+++|++|+|++|.|++..... +. ..+.|++|++++|+|+.... ..+ .++++|+.|+|++|++..
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 4566778888888888876432221 22 23568888888888764322 223 246678888999988864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=6.1e-16 Score=162.93 Aligned_cols=92 Identities=15% Similarity=0.137 Sum_probs=56.1
Q ss_pred chhccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCccc-----------CCCCCCCCCCcEEEccCC
Q 047901 43 PPQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSGT-----------FPPICNLSNLKYISLHNN 107 (786)
Q Consensus 43 ~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----------~~~~~~l~~L~~L~L~~N 107 (786)
...+....+|+.|+|++|.|... +...+...++|+.|+++++.+... ...+..+++|++|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 44566677888888888877532 223455677788888877654321 112345667777777777
Q ss_pred cCcccCc----hhhcccCCcceecccccccc
Q 047901 108 KLSGSIP----EEIGNLMKLSYLMLDTNQFT 134 (786)
Q Consensus 108 ~l~~~~~----~~~~~l~~L~~L~L~~N~l~ 134 (786)
.+..... ..+...++|++|++++|.++
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred ccccccccchhhhhcccccchheeccccccc
Confidence 7664322 23345566777777766654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.2e-13 Score=126.48 Aligned_cols=109 Identities=17% Similarity=0.093 Sum_probs=91.8
Q ss_pred cCccceeecccccccCCCCCcCCCCCCcEEEccCc-ccccccCcccCCCCCCCEEeccCCccccccCcCccCCCCccEEE
Q 047901 144 SGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRN-NLTGNISEDFGIYPNLKFLDLSHNNFYGEISSNWGKCHRLGTLI 222 (786)
Q Consensus 144 ~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 222 (786)
....+.++++++.+...+..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|.++++|++|+
T Consensus 7 c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred cCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34456677788887777777888899999999766 59988889999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCccccCCccccEEEeeccccc
Q 047901 223 VSGNNITGRIPPEIGNSSQLHVLDLSSNHIA 253 (786)
Q Consensus 223 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 253 (786)
|++|+|+.+.+..|..+ +|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 99999996666666544 7999999999885
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.7e-13 Score=125.45 Aligned_cols=104 Identities=18% Similarity=0.176 Sum_probs=59.5
Q ss_pred EEEcCCCCCcccCCcCccCCCCCCcEEECCCC-CccccCchhccCCCCCCEEeCcCCcccccCCccccCCCCCCEEeCCC
Q 047901 5 SINLTSTGLKGTLQEFSFSSFPHLAYLDLSIN-GFFGTLPPQVRNLSKLKYLDLSENELSGKIPPEIGLLTHLFSLDLSL 83 (786)
Q Consensus 5 ~l~l~~~~l~~~l~~~~f~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 83 (786)
.++.+.+++... +. .|.++++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 12 ~l~c~~~~~~~~-p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 12 GLRCTRDGALDS-LH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp CEECCSSCCCTT-TT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred eEEecCCCCccC-cc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 345555555532 22 2555666666666544 35555556666666666666666666666566666666666666666
Q ss_pred ccCcccCCCCCCCCCCcEEEccCCcCc
Q 047901 84 NQFSGTFPPICNLSNLKYISLHNNKLS 110 (786)
Q Consensus 84 N~l~~~~~~~~~l~~L~~L~L~~N~l~ 110 (786)
|+|+.++.......+|++|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCcccChhhhccccccccccCCCccc
Confidence 666655554333345666666666554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=2e-15 Score=144.54 Aligned_cols=131 Identities=19% Similarity=0.207 Sum_probs=73.3
Q ss_pred CCCEEeCcCC--cccccCCccccCCCCCCEEeCCCccCcccCCCCCCCCCCcEEEccCCcCcccCchhhcccCCcceecc
Q 047901 51 KLKYLDLSEN--ELSGKIPPEIGLLTHLFSLDLSLNQFSGTFPPICNLSNLKYISLHNNKLSGSIPEEIGNLMKLSYLML 128 (786)
Q Consensus 51 ~L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 128 (786)
.++.+++.++ .|+ ..+..|..+++|++|+|++|+|+.+ +.+..+++|++|+|++|+|+.+ +..+..+++|++|++
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWI 100 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEEC
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccc-ccccccccccccccc
Confidence 3455555554 233 3445666777777777777777654 3456666677777777766643 334444556666666
Q ss_pred ccccccccCChhhhccCccceeecccccccCCCCCcCCCCCCcEEEccCcccccccC-cccCCCCCCCEEeccCCccccc
Q 047901 129 DTNQFTGQLPRNICRSGLLEILTVNDNHFLGSIPNLRNCRSLVRAHLGRNNLTGNIS-EDFGIYPNLKFLDLSHNNFYGE 207 (786)
Q Consensus 129 ~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~i~~~ 207 (786)
++|+|+.. ..+.. +++|+.|++++|+|+.+.. ..|..+++|++|+|++|++...
T Consensus 101 ~~N~i~~l--~~~~~-----------------------l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 101 SYNQIASL--SGIEK-----------------------LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEECCCH--HHHHH-----------------------HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred cccccccc--ccccc-----------------------cccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 66666532 22333 3444444444444444322 3456666666666666666544
Q ss_pred cC
Q 047901 208 IS 209 (786)
Q Consensus 208 ~~ 209 (786)
.+
T Consensus 156 ~~ 157 (198)
T d1m9la_ 156 YK 157 (198)
T ss_dssp HC
T ss_pred cc
Confidence 33
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=7.4e-15 Score=140.56 Aligned_cols=108 Identities=23% Similarity=0.217 Sum_probs=43.7
Q ss_pred ccCCCCccEEEccCcccCCCCCccccCCccccEEEeecccccccCCCCcccccccccccccccccCCCCccccccCCcCc
Q 047901 212 WGKCHRLGTLIVSGNNITGRIPPEIGNSSQLHVLDLSSNHIAGEIPMELGRLISLNKLILRGNQLSGHLPRALGLLTELE 291 (786)
Q Consensus 212 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 291 (786)
+..+++|++|+|++|+|+.+ + .+.++++|+.|+|++|.|+ .++..+..+++|+.|++++|+|+.+ ..+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence 33344444444444444422 1 2444444444444444444 2222223333444444444444422 1233444444
Q ss_pred eeccccccccccch-hhhhcccCCcEEEeccccc
Q 047901 292 YFDLSSNRLNNSIL-EALGFMFKLFYLNFSHNQF 324 (786)
Q Consensus 292 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l 324 (786)
.|++++|+|+.+.. ..+..+++|++|+|++|.+
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccccccchhccccccccccCCCccceeecCCCcc
Confidence 44444444443321 3344444444444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=3e-09 Score=97.31 Aligned_cols=90 Identities=24% Similarity=0.154 Sum_probs=56.4
Q ss_pred hhhhhcccCCcEEEecccccCCCc--chHHhhhcCcCeeeccCCccCCCCCcccccccccceeccccccccccCCc----
Q 047901 305 LEALGFMFKLFYLNFSHNQFSQEI--PEDLALLAHLSELDLSHNLFKGSIPSRICNLESLEKLNLSHNNISGQIPA---- 378 (786)
Q Consensus 305 ~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~---- 378 (786)
...+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+.+..+|+.|++++|+++.....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 334455666666666666666542 34566777777777777777754333333445677888888877654432
Q ss_pred ---ccccCCCceEEeccCCcc
Q 047901 379 ---CFIGMSGLLSIDISYNEL 396 (786)
Q Consensus 379 ---~~~~l~~L~~L~l~~N~l 396 (786)
.+..+++|+.|| |+++
T Consensus 138 ~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 138 ISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHHCCCCCEEC--cCCC
Confidence 255678888775 5554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=2.2e-09 Score=98.22 Aligned_cols=100 Identities=24% Similarity=0.114 Sum_probs=55.1
Q ss_pred cccccccccccCCCCccccccCCcCceeccccccccccc--hhhhhcccCCcEEEecccccCCCcchHHhhhcCcCeeec
Q 047901 266 LNKLILRGNQLSGHLPRALGLLTELEYFDLSSNRLNNSI--LEALGFMFKLFYLNFSHNQFSQEIPEDLALLAHLSELDL 343 (786)
Q Consensus 266 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 343 (786)
+..+...+|... ..+..+..+++|+.|+|++|+|+.+. ...+..+++|+.|+|++|.|+...+-.+.....|+.|++
T Consensus 44 ~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L 122 (162)
T d1koha1 44 DVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122 (162)
T ss_dssp CCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCC
T ss_pred hhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeec
Confidence 333444444332 23334445666666666666666543 234555666666666666666544434444456677777
Q ss_pred cCCccCCCCCc-------ccccccccceec
Q 047901 344 SHNLFKGSIPS-------RICNLESLEKLN 366 (786)
Q Consensus 344 ~~N~l~~~~~~-------~~~~l~~L~~L~ 366 (786)
++|++...... .+..+++|+.||
T Consensus 123 ~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 123 DGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 77777644332 245567777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=7.4e-07 Score=88.15 Aligned_cols=150 Identities=12% Similarity=0.099 Sum_probs=102.1
Q ss_pred HHHHHHhccCccceeeccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEec
Q 047901 499 EEIIRRTKDFDAKYCIGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSH 577 (786)
Q Consensus 499 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~ 577 (786)
.++.+....|+..+..+.++.+.||+... +++.+++|+...... .....+.+|...+..+. +=-+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 45556667777666655555678999875 466788888754211 12224567888877664 3336778888888
Q ss_pred CCeeeEEEeccCCCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------
Q 047901 578 VRHSFVVYEYINRGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHDC---------------------------- 629 (786)
Q Consensus 578 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~---------------------------- 629 (786)
++..++||++++|.++.+..... .. ...++.++++.+..||+..
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred CCceEEEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 88999999999998876544211 11 2234556666666666531
Q ss_pred ----------------------------CCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 630 ----------------------------FPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 630 ----------------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01379999999999999877778999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=3.9e-06 Score=82.29 Aligned_cols=131 Identities=15% Similarity=0.105 Sum_probs=86.4
Q ss_pred eeccccC-ceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC--CCcccceeeEEecCCeeeEEEeccC
Q 047901 513 CIGKGEH-RSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR--HRNIVKFYGFCSHVRHSFVVYEYIN 589 (786)
Q Consensus 513 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~ 589 (786)
.+..|.. +.||+...+++..+++|...... ...+..|.+.++.+. .-.+.+++++..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455553 67999998888889999865421 123556777777663 2336778888888888999999998
Q ss_pred CCCHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 047901 590 RGSLATVLSNNFASEDFDWRKRMNVITGVADALSYMHHD----------------------------------------- 628 (786)
Q Consensus 590 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~----------------------------------------- 628 (786)
|.++.+. .... ...+.++++.+.-||+.
T Consensus 90 G~~~~~~--------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 90 GQDLLSS--------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp SEETTTS--------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ccccccc--------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 8655321 1111 11223333444444421
Q ss_pred --------------CCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 629 --------------CFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 629 --------------~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
..+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 012379999999999999877788999987753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.00 E-value=1.7e-06 Score=78.74 Aligned_cols=110 Identities=12% Similarity=0.021 Sum_probs=77.1
Q ss_pred CCCCCcEEECCCC-Ccccc----CchhccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCcc-----c
Q 047901 24 SFPHLAYLDLSIN-GFFGT----LPPQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSG-----T 89 (786)
Q Consensus 24 ~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~-----~ 89 (786)
+.|+|++|+|+++ .+... +-.++...++|++|+|++|.|... +...+...+.|++|+|++|.|+. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4688999999874 46432 334567788899999999998732 22345567889999999998874 2
Q ss_pred CCCCCCCCCCcEEEccCCcCcccC-------chhhcccCCcceeccccccc
Q 047901 90 FPPICNLSNLKYISLHNNKLSGSI-------PEEIGNLMKLSYLMLDTNQF 133 (786)
Q Consensus 90 ~~~~~~l~~L~~L~L~~N~l~~~~-------~~~~~~l~~L~~L~L~~N~l 133 (786)
...+...++|++|+|++|++..+. ...+..-++|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 334667788999999988776442 23344556777777776643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.69 E-value=6.2e-06 Score=74.91 Aligned_cols=15 Identities=27% Similarity=0.264 Sum_probs=7.1
Q ss_pred cCCcceecccccccc
Q 047901 120 LMKLSYLMLDTNQFT 134 (786)
Q Consensus 120 l~~L~~L~L~~N~l~ 134 (786)
.+.|++|+|++|.|+
T Consensus 71 n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 71 SPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECCSSBCC
T ss_pred cccccceeeehhhcc
Confidence 344455555554444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=0.00015 Score=75.39 Aligned_cols=80 Identities=14% Similarity=0.051 Sum_probs=48.2
Q ss_pred ceeeccccCceEEEEEcC-CCCEEEEEEcCCCC---CCCchhhHHHHHHHHHHHhhcC-C--CcccceeeEEecCCeeeE
Q 047901 511 KYCIGKGEHRSVYRAKLP-SGDKIAVKKFNSPF---PNDQMSDQKEFLNEIKALTKIR-H--RNIVKFYGFCSHVRHSFV 583 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~~e~~~l~~l~-h--pniv~l~~~~~~~~~~~l 583 (786)
.+.||.|....||+.... +++.|+||.-.... ........++...|.+.++.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 446899999999999865 46788998643211 0111112234456888777662 2 345556655 3445679
Q ss_pred EEeccCCCC
Q 047901 584 VYEYINRGS 592 (786)
Q Consensus 584 v~e~~~~g~ 592 (786)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.35 E-value=2.5e-05 Score=70.72 Aligned_cols=111 Identities=14% Similarity=0.128 Sum_probs=67.4
Q ss_pred CCCCCCcEEECCC-CCcccc----CchhccCCCCCCEEeCcCCccccc----CCccccCCCCCCEEeCCCccCcc-----
Q 047901 23 SSFPHLAYLDLSI-NGFFGT----LPPQVRNLSKLKYLDLSENELSGK----IPPEIGLLTHLFSLDLSLNQFSG----- 88 (786)
Q Consensus 23 ~~l~~L~~L~L~~-n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----- 88 (786)
.+.|.|++|+|++ +.|+.. +-.++...++|++|+|++|.|+.. +...+...++|+.|++++|.++.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4567888888886 455432 334456777888888888877632 22344566778888888877753
Q ss_pred cCCCCCCCCCCcEEEc--cCCcCcc----cCchhhcccCCcceeccccccc
Q 047901 89 TFPPICNLSNLKYISL--HNNKLSG----SIPEEIGNLMKLSYLMLDTNQF 133 (786)
Q Consensus 89 ~~~~~~~l~~L~~L~L--~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l 133 (786)
+...+...++|+.++| ++|++.. .+...+...++|+.|+++.+..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2234556677776544 3555543 1233445566677777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.24 E-value=2.2e-05 Score=71.07 Aligned_cols=95 Identities=16% Similarity=0.106 Sum_probs=60.9
Q ss_pred ccCchhccCCCCCCEEeCcC-Cccccc----CCccccCCCCCCEEeCCCccCccc-----CCCCCCCCCCcEEEccCCcC
Q 047901 40 GTLPPQVRNLSKLKYLDLSE-NELSGK----IPPEIGLLTHLFSLDLSLNQFSGT-----FPPICNLSNLKYISLHNNKL 109 (786)
Q Consensus 40 ~~~~~~~~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~L~~N~l 109 (786)
.+......+.++|++|+|++ +.|+.. .-.++...++|++|+|++|.++.. ...+...++|+.|++++|.+
T Consensus 7 ~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~ 86 (166)
T d1io0a_ 7 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 86 (166)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence 34445566778899999987 556532 233456778888888888887632 12244567888888888887
Q ss_pred cccC----chhhcccCCcceecc--cccccc
Q 047901 110 SGSI----PEEIGNLMKLSYLML--DTNQFT 134 (786)
Q Consensus 110 ~~~~----~~~~~~l~~L~~L~L--~~N~l~ 134 (786)
.... ...+...++|+.++| ++|.+.
T Consensus 87 ~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 87 SGSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred cchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 6332 234556666775444 456654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0022 Score=64.33 Aligned_cols=68 Identities=13% Similarity=0.201 Sum_probs=45.1
Q ss_pred CceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCCCc--ccceee-----EEecCCeeeEEEeccCCC
Q 047901 519 HRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRHRN--IVKFYG-----FCSHVRHSFVVYEYINRG 591 (786)
Q Consensus 519 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~~-----~~~~~~~~~lv~e~~~~g 591 (786)
--.||+++..+|+.|++|+.+.. ....+++..|.+.+..+.... ++..+. .....+..+.|+++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 35899999999999999998652 123456777888777764221 122111 234556778999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.49 E-value=0.0045 Score=63.90 Aligned_cols=73 Identities=21% Similarity=0.299 Sum_probs=47.6
Q ss_pred ceeeccccCceEEEEEcCC--------CCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcC-CCcccceeeEEecCCee
Q 047901 511 KYCIGKGEHRSVYRAKLPS--------GDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIR-HRNIVKFYGFCSHVRHS 581 (786)
Q Consensus 511 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~ 581 (786)
.+.|+.|-.-.+|++...+ .+.|++++.-.. . ..-...+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E---TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3568888889999998643 245667665321 1 1223457888888874 4444577777754
Q ss_pred eEEEeccCCCCH
Q 047901 582 FVVYEYINRGSL 593 (786)
Q Consensus 582 ~lv~e~~~~g~L 593 (786)
++||||++|..+
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.96 E-value=0.0076 Score=59.94 Aligned_cols=158 Identities=12% Similarity=0.102 Sum_probs=81.1
Q ss_pred cHHHHHHHhccCcccee-----eccccCceEEEEEcCCCCEEEEEEcCCCCCCCchhhHHHHHHHHHHHhhcCC-----C
Q 047901 497 MYEEIIRRTKDFDAKYC-----IGKGEHRSVYRAKLPSGDKIAVKKFNSPFPNDQMSDQKEFLNEIKALTKIRH-----R 566 (786)
Q Consensus 497 ~~~~~~~~~~~~~~~~~-----ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-----p 566 (786)
+.+++......|..++. |..|---+.|+.+..+| ++++|++..... .+.+..|++++..+.. |
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~------~~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE------KNDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC------HHHHHHHHHHHHhhhhcccccc
Confidence 45677777778877544 44666678999987655 589998854211 1233445666665532 2
Q ss_pred ccccee-e--EEecCCeeeEEEeccCCCCHHH--------------Hhhc---CCC-C--CCCC----------------
Q 047901 567 NIVKFY-G--FCSHVRHSFVVYEYINRGSLAT--------------VLSN---NFA-S--EDFD---------------- 607 (786)
Q Consensus 567 niv~l~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~---~~~-~--~~~~---------------- 607 (786)
..+.-. | +....+..+.++.+..+..... .++. ... . ....
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 222211 1 1223445666777766532211 0000 000 0 0000
Q ss_pred --HHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCceeeCCCCcEEEecccccee
Q 047901 608 --WRKRMNVITGVADALSYMHH-DCFPPIVHRDISSNNVLLDLEYEARVSDFGTAKL 661 (786)
Q Consensus 608 --~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 661 (786)
.......+......+.-.+. ....++||+|+.++||+++.+...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 00111112222222222221 1224799999999999999888889999998863
|